Citrus Sinensis ID: 004521
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
|
|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
| ID | Alignment graph | Length |
Definition |
RBH(Q2H) |
RBH(H2Q) |
Q cover |
H cover |
Identity |
E-value |
| Query | 747 | 2.2.26 [Sep-21-2011] | |||||||
| O81905 | 850 | Receptor-like serine/thre | yes | no | 0.982 | 0.863 | 0.491 | 0.0 | |
| O81832 | 783 | G-type lectin S-receptor- | no | no | 0.921 | 0.878 | 0.489 | 0.0 | |
| Q9S972 | 847 | Receptor-like serine/thre | no | no | 0.985 | 0.868 | 0.467 | 0.0 | |
| O81833 | 815 | G-type lectin S-receptor- | no | no | 0.958 | 0.878 | 0.492 | 0.0 | |
| Q39086 | 843 | Receptor-like serine/thre | no | no | 0.979 | 0.868 | 0.476 | 0.0 | |
| Q09092 | 857 | Putative serine/threonine | N/A | no | 0.969 | 0.844 | 0.459 | 0.0 | |
| Q9ZT07 | 833 | G-type lectin S-receptor- | no | no | 0.967 | 0.867 | 0.445 | 1e-180 | |
| Q9LPZ3 | 845 | G-type lectin S-receptor- | no | no | 0.967 | 0.855 | 0.448 | 1e-178 | |
| P0DH86 | 853 | G-type lectin S-receptor- | no | no | 0.971 | 0.851 | 0.468 | 1e-177 | |
| Q9SXB8 | 842 | G-type lectin S-receptor- | no | no | 0.963 | 0.855 | 0.418 | 1e-169 |
| >sp|O81905|SD18_ARATH Receptor-like serine/threonine-protein kinase SD1-8 OS=Arabidopsis thaliana GN=SD18 PE=1 SV=1 | Back alignment and function desciption |
|---|
Score = 722 bits (1863), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 384/782 (49%), Positives = 508/782 (64%), Gaps = 48/782 (6%)
Query: 10 KSYPPHEVVWVANRLNPINDSFGFLMINKTGNLVLTSQSNIVVWSAYLSK-EVQTPVVLQ 68
K+ VWVANR P++ S G L I+ + NLV+ QS+ VWS L+ +V++P+V +
Sbjct: 73 KAISKRTYVWVANRDTPLSSSIGTLKISDS-NLVVLDQSDTPVWSTNLTGGDVRSPLVAE 131
Query: 69 LLDSGNLVLRDEHDGDSETYFWQSFDYPSDTLLPGMKLGWDLKTGLERRVTSWKSFDDPS 128
LLD+GN VLRD + + WQSFD+P+DTLLP MKLGWD KTG R + SWKS DDPS
Sbjct: 132 LLDNGNFVLRDSKNSAPDGVLWQSFDFPTDTLLPEMKLGWDAKTGFNRFIRSWKSPDDPS 191
Query: 129 PGDFIWAIERQDNPEVVMWKGSRKFYRTGPWNGLRFSA-PSLRPNPIFSFSFVSNDVELY 187
GDF + +E + PE+ +W + YR+GPWNG+RFS P ++P F+F ++ E+
Sbjct: 192 SGDFSFKLETEGFPEIFLWNRESRMYRSGPWNGIRFSGVPEMQPFEYMVFNFTTSKEEVT 251
Query: 188 YTFNITNKAVISRIVMNQTLYVRRRFIWNKATQSWELYSDVPRDQCDTYGLCGAYGICII 247
Y+F IT V SR+ ++ + ++R F W + Q+W + P+DQCD Y CG YG C
Sbjct: 252 YSFRITKSDVYSRLSISSSGLLQR-FTWIETAQNWNQFWYAPKDQCDEYKECGVYGYCDS 310
Query: 248 GQSPVCQCLKGFKPKSG---GYVDRSQGCVRSKPLNYSRQDGFIKFTELKLPDATSSWVS 304
SPVC C+KGFKP++ G D S GCVR L+ DGF++ ++KLPD T++ V
Sbjct: 311 NTSPVCNCIKGFKPRNPQVWGLRDGSDGCVRKTLLSCGGGDGFVRLKKMKLPDTTTASVD 370
Query: 305 KSMNLKECREGCLENSSCMAYTNSDIRGGGSGCAMWFGELIDMRDFPGGGQDFYIRMSAS 364
+ + +KEC + CL + +C A+ N+DIRG GSGC W GEL D+R++ GGQD Y+R++A+
Sbjct: 371 RGIGVKECEQKCLRDCNCTAFANTDIRGSGSGCVTWTGELFDIRNYAKGGQDLYVRLAAT 430
Query: 365 EIGAKGEPTTKIVVIVISTAALLAVVLIAGYLI-RKRRRNIAEKT--------------- 408
++ K + KI+ I + LL + I +L RK++R+I +T
Sbjct: 431 DLEDKRNRSAKIIGSSIGVSVLLLLSFIIFFLWKRKQKRSILIETPIVDHQLRSRDLLMN 490
Query: 409 ----ENSRETDQENEDQNIDLELPLFELATIANATDNFSINNKLGEGGFGPVYKGTLVDG 464
+ R +EN DLELPL E +A AT+NFS NKLG+GGFG VYKG L+DG
Sbjct: 491 EVVISSRRHISRENNTD--DLELPLMEFEEVAMATNNFSNANKLGQGGFGIVYKGKLLDG 548
Query: 465 QEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMPNKSLD 524
QE+AVKRLSK S QG E KNEV L ++LQH NLV+LL CC+ EK+LIYE++ N SLD
Sbjct: 549 QEMAVKRLSKTSVQGTDEFKNEVKLIARLQHINLVRLLACCVDAGEKMLIYEYLENLSLD 608
Query: 525 SFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKIS 584
S +FD++R + L+W RF II G ARGLLYLHQDSR RIIHRDLKASN+LLD+ M PKIS
Sbjct: 609 SHLFDKSRNSKLNWQMRFDIINGIARGLLYLHQDSRFRIIHRDLKASNILLDKYMTPKIS 668
Query: 585 DFGLVRTFGGDETEGNTNRVVGTY---------DGQFSIKSDVFSFGILLLEIVSGKKNR 635
DFG+ R FG DETE NT +VVGTY DG FS+KSDVFSFG+LLLEI+S K+N+
Sbjct: 669 DFGMARIFGRDETEANTRKVVGTYGYMSPEYAMDGIFSMKSDVFSFGVLLLEIISSKRNK 728
Query: 636 GFYRSDTKVNLIGHL---WDEGIPLRLIDACIQDSCNL---ADVIRCIHIGLLCVQQHPE 689
GFY SD +NL+G + W EG L +ID I DS + +++RCI IGLLCVQ+ E
Sbjct: 729 GFYNSDRDLNLLGCVWRNWKEGKGLEIIDPIITDSSSTFRQHEILRCIQIGLLCVQERAE 788
Query: 690 DRPCMPSVILMLGSE-ILLPQPKQPGYLADRKSTEPYSSSSMP---ESSSTNTLTISELE 745
DRP M VILMLGSE +PQPK PGY +R + SSSS ES + N +T+S L+
Sbjct: 789 DRPTMSLVILMLGSESTTIPQPKAPGYCLERSLLDTDSSSSKQRDDESWTVNQITVSVLD 848
Query: 746 AR 747
AR
Sbjct: 849 AR 850
|
Involved in the regulation of cellular expansion and differentiation. Arabidopsis thaliana (taxid: 3702) EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1 |
| >sp|O81832|Y4729_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase At4g27290 OS=Arabidopsis thaliana GN=At4g27290 PE=3 SV=4 | Back alignment and function description |
|---|
Score = 695 bits (1794), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 369/754 (48%), Positives = 495/754 (65%), Gaps = 66/754 (8%)
Query: 17 VVWVANRLNPINDSFGFLMINKTGNLVLTSQSNIVVWSAYLSKEVQ-----TPVVLQLLD 71
VVWVANR +P+ D G L +++ G+L L + N ++WS+ S Q P+V Q+LD
Sbjct: 73 VVWVANRDSPLYDLSGTLKVSENGSLCLFNDRNHIIWSSSSSPSSQKASLRNPIV-QILD 131
Query: 72 SGNLVLRDEHDGDSETYFWQSFDYPSDTLLPGMKLGWDLKTGLERRVTSWKSFDDPSPGD 131
+GNLV+R+ GD + Y WQS DYP D LPGMK G + TGL R +TSW++ DDPS G+
Sbjct: 132 TGNLVVRNS--GDDQDYIWQSLDYPGDMFLPGMKYGLNFVTGLNRFLTSWRAIDDPSTGN 189
Query: 132 FIWAIERQDNPEVVMWKGSRKFYRTGPWNGLRFSA-PSLRPNPIFSFSFVSNDVELYYTF 190
+ ++ P+ + K S +RTGPWNGLRF+ P+L+PNPI+ + +V + E+YYT+
Sbjct: 190 YTNKMDPNGVPQFFLKKNSVVVFRTGPWNGLRFTGMPNLKPNPIYRYEYVFTEEEVYYTY 249
Query: 191 NITNKAVISRIVMNQTLYVRRRFIWNKATQSWELYSDVPRDQCDTYGLCGAYGICIIGQS 250
+ N +V++R+ +N ++R + W QSW Y D CD Y LCG+YG C I +S
Sbjct: 250 KLENPSVLTRMQLNPNGALQR-YTWVDNLQSWNFYLSAMMDSCDQYTLCGSYGSCNINES 308
Query: 251 PVCQCLKGF---KPKSGGYVDRSQGCVRSKPLNYSR-QDGFIKFTELKLPDATSSWVSKS 306
P C+CLKGF P++ D S+GCVR L+ + +DGF+K ++LKLPD +SW K+
Sbjct: 309 PACRCLKGFVAKTPQAWVAGDWSEGCVRRVKLDCGKGEDGFLKISKLKLPDTRTSWYDKN 368
Query: 307 MNLKECREGCLENSSCMAYTNSDIRGGGSGCAMWFGELIDMRDFPGGGQDFYIRMSASEI 366
M+L EC++ CL N +C AY+ DIR GG GC +WFG+LID+R++ GQD Y+R+++SEI
Sbjct: 369 MDLNECKKVCLRNCTCSAYSPFDIRDGGKGCILWFGDLIDIREYNENGQDLYVRLASSEI 428
Query: 367 GAKGEPTTKIVVIVISTAALLAVVLIAGYLIRKRRRNIAEKTENSRETDQENEDQNIDLE 426
++++ +SR+ ++E DLE
Sbjct: 429 ETLQRESSRV---------------------------------SSRKQEEE------DLE 449
Query: 427 LPLFELATIANATDNFSINNKLGEGGFGPVYKGTLVDGQEIAVKRLSKISEQGLKELKNE 486
LP +L T++ AT FS NKLG+GGFGPVYKGTL GQE+AVKRLS+ S QG++E KNE
Sbjct: 450 LPFLDLDTVSEATSGFSAGNKLGQGGFGPVYKGTLACGQEVAVKRLSRTSRQGVEEFKNE 509
Query: 487 VILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIIC 546
+ L +KLQHRNLVK+LG C+ EE++LIYE+ PNKSLDSFIFD+ RR LDW +R II
Sbjct: 510 IKLIAKLQHRNLVKILGYCVDEEERMLIYEYQPNKSLDSFIFDKERRRELDWPKRVEIIK 569
Query: 547 GTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNTNRVVG 606
G ARG+LYLH+DSRLRIIHRDLKASNVLLD DMN KISDFGL RT GGDETE NT RVVG
Sbjct: 570 GIARGMLYLHEDSRLRIIHRDLKASNVLLDSDMNAKISDFGLARTLGGDETEANTTRVVG 629
Query: 607 TY---------DGQFSIKSDVFSFGILLLEIVSGKKNRGFYRSDTKVNLIGHLWD---EG 654
TY DG FS+KSDVFSFG+L+LEIVSG++NRGF + K+NL+GH W E
Sbjct: 630 TYGYMSPEYQIDGYFSLKSDVFSFGVLVLEIVSGRRNRGFRNEEHKLNLLGHAWRQFLED 689
Query: 655 IPLRLIDACIQDSC-NLADVIRCIHIGLLCVQQHPEDRPCMPSVILMLGSEILLPQPKQP 713
+ID + +SC ++++V+R IHIGLLCVQQ P+DRP M V+LML SE+LL P+QP
Sbjct: 690 KAYEIIDEAVNESCTDISEVLRVIHIGLLCVQQDPKDRPNMSVVVLMLSSEMLLLDPRQP 749
Query: 714 GYLADRKSTEPYSSSSMPESSSTNTLTISELEAR 747
G+ +R + S E S N T+S ++ R
Sbjct: 750 GFFNERNLLFSDTVSINLEIPSNNFQTMSVIDPR 783
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9S972|SD16_ARATH Receptor-like serine/threonine-protein kinase SD1-6 OS=Arabidopsis thaliana GN=SD16 PE=1 SV=2 | Back alignment and function description |
|---|
Score = 675 bits (1742), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 364/779 (46%), Positives = 494/779 (63%), Gaps = 43/779 (5%)
Query: 10 KSYPPHEVVWVANRLNPINDSFGFLMINKTGNLVLTSQSNIVVWSAYLSK-EVQTPVVLQ 68
K P VWVANR NP++ S G L I+ NLV+ QS+ VWS ++ +V++PV +
Sbjct: 71 KIIPIRTYVWVANRDNPLSSSNGTLKISDN-NLVIFDQSDRPVWSTNITGGDVRSPVAAE 129
Query: 69 LLDSGNLVLRDEHDGDSETYFWQSFDYPSDTLLPGMKLGWDLKTG-LERRVTSWKSFDDP 127
LLD GN VLRD + + WQSFD+P+DTLL MK+GWD K+G R + SWK+ DDP
Sbjct: 130 LLDYGNFVLRDSKNNKPSGFLWQSFDFPTDTLLSDMKMGWDNKSGGFNRILRSWKTTDDP 189
Query: 128 SPGDFIWAIERQDNPEVVMWKGSRKFYRTGPWNGLRFSA-PSLRPNPIFSFSFVSNDVEL 186
S GDF + PE ++ YR+GPW G RFS+ P ++P SF N+ ++
Sbjct: 190 SSGDFSTKLRTSGFPEFYIYNKESITYRSGPWLGNRFSSVPGMKPVDYIDNSFTENNQQV 249
Query: 187 YYTFNITNKAVISRIVMNQTLYVRRRFIWNKATQSWELYSDVPRDQCDTYGLCGAYGICI 246
Y++ + NK I I+ + + +R W +A QSW+ P+D CD Y CG YG C
Sbjct: 250 VYSYRV-NKTNIYSILSLSSTGLLQRLTWMEAAQSWKQLWYSPKDLCDNYKECGNYGYCD 308
Query: 247 IGQSPVCQCLKGFKP--KSGGYVDRSQGCVRSKPLNYSRQDGFIKFTELKLPDATSSWVS 304
SP+C C+KGF+P + D S GCVR L+ +DGF++ +++LPD T + V
Sbjct: 309 ANTSPICNCIKGFEPMNEQAALRDDSVGCVRKTKLSCDGRDGFVRLKKMRLPDTTETSVD 368
Query: 305 KSMNLKECREGCLENSSCMAYTNSDIRGGGSGCAMWFGELIDMRDFPGGGQDFYIRMSAS 364
K + LKEC E CL+ +C A+ N+DIR GGSGC +W G L D+R++ GGQD Y+R++A
Sbjct: 369 KGIGLKECEERCLKGCNCTAFANTDIRNGGSGCVIWSGGLFDIRNYAKGGQDLYVRVAAG 428
Query: 365 EIGAKGEPTTKIVVIVISTAALLAV-VLIAGYLIRKRRRNIAEKTE-------------- 409
++ K + KI+ I + LL + +I + RK++R+I +T
Sbjct: 429 DLEDKRIKSKKIIGSSIGVSILLLLSFIIFHFWKRKQKRSITIQTPIVDLVRSQDSLMNE 488
Query: 410 --NSRETDQENEDQNIDLELPLFELATIANATDNFSINNKLGEGGFGPVYKGTLVDGQEI 467
+ + E++ LELPL E +A AT+NFS +NKLG+GGFG VYKG L+DG+EI
Sbjct: 489 LVKASRSYTSKENKTDYLELPLMEWKALAMATNNFSTDNKLGQGGFGIVYKGMLLDGKEI 548
Query: 468 AVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMPNKSLDSFI 527
AVKRLSK+S QG E NEV L +KLQH NLV+LLGCC+ EK+LIYE++ N SLDS +
Sbjct: 549 AVKRLSKMSSQGTDEFMNEVRLIAKLQHINLVRLLGCCVDKGEKMLIYEYLENLSLDSHL 608
Query: 528 FDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFG 587
FDQTR + L+W +RF II G ARGLLYLHQDSR RIIHRDLKASNVLLD++M PKISDFG
Sbjct: 609 FDQTRSSNLNWQKRFDIINGIARGLLYLHQDSRCRIIHRDLKASNVLLDKNMTPKISDFG 668
Query: 588 LVRTFGGDETEGNTNRVVGTY---------DGQFSIKSDVFSFGILLLEIVSGKKNRGFY 638
+ R FG +ETE NT RVVGTY DG FS+KSDVFSFG+LLLEI+SGK+N+GFY
Sbjct: 669 MARIFGREETEANTRRVVGTYGYMSPEYAMDGIFSMKSDVFSFGVLLLEIISGKRNKGFY 728
Query: 639 RSDTKVNLIGHL---WDEGIPLRLIDACIQDSCN----LADVIRCIHIGLLCVQQHPEDR 691
S+ +NL+G + W EG L ++D D+ + +++RCI IGLLCVQ+ EDR
Sbjct: 729 NSNRDLNLLGFVWRHWKEGKELEIVDPINIDALSSEFPTHEILRCIQIGLLCVQERAEDR 788
Query: 692 PCMPSVILMLGSEIL-LPQPKQPGYLADR--KSTEPYSSSSMPESSSTNTLTISELEAR 747
P M SV++MLGSE +PQPK+PG+ R + SS+ + + N +T+S ++AR
Sbjct: 789 PVMSSVMVMLGSETTAIPQPKRPGFCVGRSSLEVDSSSSTQRDDECTVNQVTLSVIDAR 847
|
Involved in the regulation of cellular expansion and differentiation. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|O81833|SD11_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase SD1-1 OS=Arabidopsis thaliana GN=SD11 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 674 bits (1739), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 375/762 (49%), Positives = 504/762 (66%), Gaps = 46/762 (6%)
Query: 14 PHEVVWVANRLNPINDSFGFLMINKTGNLVLTSQSNIVVWSAYLSKEVQTPV----VLQL 69
P VVWVANR NP+ + GFL ++ G+L L + +WS+ S + +L++
Sbjct: 72 PFAVVWVANRNNPLYGTSGFLNLSSLGDLQLFDGEHKALWSSSSSSTKASKTANNPLLKI 131
Query: 70 LDSGNLVLRDEHDGDSETYFWQSFDYPSDTLLPGMKLGWDLKTGLERRVTSWKSFDDPSP 129
SGNL+ DG+ E WQSFDYP +T+L GMKLG + KT +E ++SWK+ DPSP
Sbjct: 132 SCSGNLI---SSDGE-EAVLWQSFDYPMNTILAGMKLGKNFKTQMEWSLSSWKTLKDPSP 187
Query: 130 GDFIWAIERQDNPEVVMWKG--SRKFYRTGPWNGLRFS-APSL-RPNPIFSFSFVSNDVE 185
GDF +++ + P++++ K S YR G WNGL F+ AP++ R N +F + F S+ E
Sbjct: 188 GDFTLSLDTRGLPQLILRKNGDSSYSYRLGSWNGLSFTGAPAMGRENSLFDYKFTSSAQE 247
Query: 186 LYYTFNITNKAVISRIVMNQTLYVRRRFIWNKATQSWELYSDVPRDQCDTYGLCGAYGIC 245
+ Y++ ++ ++SR+V+N T + R FI +K Q W L + P D+CD Y +CGAY +C
Sbjct: 248 VNYSWTPRHR-IVSRLVLNNTGKLHR-FIQSKQNQ-WILANTAPEDECDYYSICGAYAVC 304
Query: 246 IIG--QSPVCQCLKGFKPKSGGYVDRSQG---CVRSKPLNYSRQDGFIKFTELKLPDATS 300
I +P C CL+GFKPKSG + S+G CV P N ++D F+KF LKLPD +
Sbjct: 305 GINSKNTPSCSCLQGFKPKSGRKWNISRGAYGCVHEIPTNCEKKDAFVKFPGLKLPDTSW 364
Query: 301 SW--VSKSMNLKECREGCLENSSCMAYTNSDIRGGGSGCAMWFGELIDMRDFPGGGQDFY 358
SW M L++C+ C N SC AY N+DIR GG GC +WFG+L+DMR++ GQD Y
Sbjct: 365 SWYDAKNEMTLEDCKIKCSSNCSCTAYANTDIREGGKGCLLWFGDLVDMREYSSFGQDVY 424
Query: 359 IRMSASEIGAKGEPTTKIVVIVISTAALLAVVLIAGYLIRKRRRNIAEKTENSRETDQEN 418
IRM ++I KG +VV + A++ VV+ A + + +R + EN R+ +E
Sbjct: 425 IRMGFAKIEFKGREVVGMVVGSVVAIAVVLVVVFACFRKKIMKR---YRGENFRKGIEEE 481
Query: 419 EDQNIDLELPLFELATIANATDNFSINNKLGEGGFGPVYKGTLVDGQEIAVKRLSKISEQ 478
DL+LP+F+ TI+ ATD+FS N LG GGFGPVYKG L DGQEIAVKRLS S Q
Sbjct: 482 -----DLDLPIFDRKTISIATDDFSYVNFLGRGGFGPVYKGKLEDGQEIAVKRLSANSGQ 536
Query: 479 GLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQTRRTLLDW 538
G++E KNEV L +KLQHRNLV+LLGCCIQGEE +LIYE+MPNKSLD FIFD+ R T LDW
Sbjct: 537 GVEEFKNEVKLIAKLQHRNLVRLLGCCIQGEECMLIYEYMPNKSLDFFIFDERRSTELDW 596
Query: 539 SQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETE 598
+R +II G ARG+LYLHQDSRLRIIHRDLKA NVLLD DMNPKISDFGL ++FGGD++E
Sbjct: 597 KKRMNIINGVARGILYLHQDSRLRIIHRDLKAGNVLLDNDMNPKISDFGLAKSFGGDQSE 656
Query: 599 GNTNRVVGTY---------DGQFSIKSDVFSFGILLLEIVSGKKNRGFYRSDTKVNLIGH 649
+TNRVVGTY DG FS+KSDVFSFG+L+LEI++GK NRGF +D +NL+GH
Sbjct: 657 SSTNRVVGTYGYMPPEYAIDGHFSVKSDVFSFGVLVLEIITGKTNRGFRHADHDLNLLGH 716
Query: 650 LWDEGIPLRLI----DACIQDSCNLADVIRCIHIGLLCVQQHPEDRPCMPSVILMLGSEI 705
+W + R I + ++++ + +V+RCIH+ LLCVQQ PEDRP M SV+LM GS+
Sbjct: 717 VWKMWVEDREIEVPEEEWLEETSVIPEVLRCIHVALLCVQQKPEDRPTMASVVLMFGSDS 776
Query: 706 LLPQPKQPGYLADRKSTEPYSSSSMPESSSTNTLTISELEAR 747
LP P QPG+ +R + SS S+ S N ++I+ L+ R
Sbjct: 777 SLPHPTQPGFFTNRNVPDISSSLSL---RSQNEVSITMLQGR 815
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q39086|SD17_ARATH Receptor-like serine/threonine-protein kinase SD1-7 OS=Arabidopsis thaliana GN=SD17 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 671 bits (1731), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 371/779 (47%), Positives = 500/779 (64%), Gaps = 47/779 (6%)
Query: 10 KSYPPHEVVWVANRLNPINDSFGFLMINKTGNLVLTSQSNIVVWSAYLSK-EVQTPVVLQ 68
K P VWVANR NP++ S G L I+ NLV+ QS+ VWS ++ +V++PV +
Sbjct: 71 KIIPIRTYVWVANRDNPLSSSNGTLKISGN-NLVIFDQSDRPVWSTNITGGDVRSPVAAE 129
Query: 69 LLDSGNLVLRDEHDGDSETYFWQSFDYPSDTLLPGMKLGWDLKTGLERRVTSWKSFDDPS 128
LLD+GN +LRD ++ WQSFD+P+DTLL MKLGWD KTG R + SWK+ DDPS
Sbjct: 130 LLDNGNFLLRDSNN----RLLWQSFDFPTDTLLAEMKLGWDQKTGFNRILRSWKTTDDPS 185
Query: 129 PGDFIWAIERQDNPEVVMWKGSRKFYRTGPWNGLRFSA-PSLRPNPIFSFSFVSNDVELY 187
G+F +E + PE + YR+GPWNG+RFS+ P ++F ++ E+
Sbjct: 186 SGEFSTKLETSEFPEFYICSKESILYRSGPWNGMRFSSVPGTIQVDYMVYNFTASKEEVT 245
Query: 188 YTFNITNKAVISRIVMNQTLYVRRRFIWNKATQSWELYSDVPRDQCDTYGLCGAYGICII 247
Y++ I + SR+ +N ++R W + TQSW+ P+D CD Y +CG +G C
Sbjct: 246 YSYRINKTNLYSRLYLNSAGLLQR-LTWFETTQSWKQLWYSPKDLCDNYKVCGNFGYCDS 304
Query: 248 GQSPVCQCLKGFKP---KSGGYVDRSQGCVRSKPLNYSRQDGFIKFTELKLPDATSSWVS 304
P C C+KGFKP ++ D S GC+R L+ +DGF + +KLPD T++ V
Sbjct: 305 NSLPNCYCIKGFKPVNEQAWDLRDGSAGCMRKTRLSCDGRDGFTRLKRMKLPDTTATIVD 364
Query: 305 KSMNLKECREGCLENSSCMAYTNSDIRGGGSGCAMWFGELIDMRDFPGGGQDFYIRMSAS 364
+ + LK C+E CLE+ +C A+ N+DIR GGSGC +W E++DMR++ GGQD Y+R++A+
Sbjct: 365 REIGLKVCKERCLEDCNCTAFANADIRNGGSGCVIWTREILDMRNYAKGGQDLYVRLAAA 424
Query: 365 EIGAKGEPTTKIVVIVISTAALLAV-VLIAGYLIRKRRRNIAEKTEN------------- 410
E+ K KI+ I + LL + +I + RK++R+I +T N
Sbjct: 425 ELEDKRIKNEKIIGSSIGVSILLLLSFVIFHFWKRKQKRSITIQTPNVDQVRSQDSLIND 484
Query: 411 ---SRETDQENEDQNIDLELPLFELATIANATDNFSINNKLGEGGFGPVYKGTLVDGQEI 467
SR E ++ LELPL EL +A AT+NFS +NKLG+GGFG VYKG L+DG+EI
Sbjct: 485 VVVSRRGYTSKEKKSEYLELPLLELEALATATNNFSNDNKLGQGGFGIVYKGRLLDGKEI 544
Query: 468 AVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMPNKSLDSFI 527
AVKRLSK+S QG E NEV L +KLQH NLV+LLGCC+ EK+LIYE++ N SLDS +
Sbjct: 545 AVKRLSKMSSQGTDEFMNEVRLIAKLQHINLVRLLGCCVDKGEKMLIYEYLENLSLDSHL 604
Query: 528 FDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFG 587
FDQTR + L+W +RF II G ARGLLYLHQDSR RIIHRDLKASNVLLD++M PKISDFG
Sbjct: 605 FDQTRSSNLNWQKRFDIINGIARGLLYLHQDSRCRIIHRDLKASNVLLDKNMTPKISDFG 664
Query: 588 LVRTFGGDETEGNTNRVVGTY---------DGQFSIKSDVFSFGILLLEIVSGKKNRGFY 638
+ R FG +ETE NT RVVGTY DG FS+KSDVFSFG+LLLEI+SGK+N+GFY
Sbjct: 665 MARIFGREETEANTRRVVGTYGYMSPEYAMDGIFSMKSDVFSFGVLLLEIISGKRNKGFY 724
Query: 639 RSDTKVNLIGHL---WDEGIPLRLIDACIQDSCN----LADVIRCIHIGLLCVQQHPEDR 691
S+ +NL+G + W EG L ++D DS + +++RCI IGLLCVQ+ EDR
Sbjct: 725 NSNRDLNLLGFVWRHWKEGNELEIVDPINIDSLSSKFPTHEILRCIQIGLLCVQERAEDR 784
Query: 692 PCMPSVILMLGSEIL-LPQPKQPGYLADRKSTEPYSSSSMP--ESSSTNTLTISELEAR 747
P M SV++MLGSE +PQPK+PG+ R E SSSS + + N +T+S ++AR
Sbjct: 785 PVMSSVMVMLGSETTAIPQPKRPGFCIGRSPLEADSSSSTQRDDECTVNQITLSVIDAR 843
|
Involved in the regulation of cellular expansion and differentiation. Mediates subcellular relocalization of PUB9 from nucleus to plasma membrane in a protein-phosphorylation-dependent manner. May be involved in the abscisic acid-mediated signaling pathway, at least during germination. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q09092|SRK6_BRAOE Putative serine/threonine-protein kinase receptor OS=Brassica oleracea var. acephala GN=SRK6 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 669 bits (1725), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 359/781 (45%), Positives = 500/781 (64%), Gaps = 57/781 (7%)
Query: 18 VWVANRLNPINDSFGFLMINKTGNLVLTSQSNIVVWSAYLSK-EVQTPVVLQLLDSGNLV 76
VWVANR NP++++ G L I+ NLVL SN VW L++ ++PVV +LL +GN V
Sbjct: 83 VWVANRDNPLSNAIGTLKISG-NNLVLLDHSNKPVWWTNLTRGNERSPVVAELLANGNFV 141
Query: 77 LRDEHDGDSETYFWQSFDYPSDTLLPGMKLGWDLKTGLERRVTSWKSFDDPSPGDFIWAI 136
+RD + D+ Y WQSFDYP+DTLLP MKLG++LKTGL R +TSW+S DDPS G+F + +
Sbjct: 142 MRDSSNNDASEYLWQSFDYPTDTLLPEMKLGYNLKTGLNRFLTSWRSSDDPSSGNFSYKL 201
Query: 137 ERQDNPEVVMWKGSRKFYRTGPWNGLRFSA-PSLRPNPIFSFSFVSNDVELYYTFNITNK 195
E Q PE + + + +R+GPWNG+RFS P + ++F+ N+ E+ YTF +TN
Sbjct: 202 ETQSLPEFYLSRENFPMHRSGPWNGIRFSGIPEDQKLSYMVYNFIENNEEVAYTFRMTNN 261
Query: 196 AVISRIVMNQTLYVRRRFIWNKATQSWELYSDVPRD-QCDTYGLCGAYGICIIGQSPVCQ 254
+ SR+ + Y +R W + + W + P D QCDTY +CG Y C + SPVC
Sbjct: 262 SFYSRLTLISEGYFQR-LTWYPSIRIWNRFWSSPVDPQCDTYIMCGPYAYCDVNTSPVCN 320
Query: 255 CLKGFKPKSGGYVDR---SQGCVRSKPLNYSRQDGFIKFTELKLPDATSSWVSKSMNLKE 311
C++GF P++ D+ + GC+R L+ S DGF + ++KLP+ T + V +S+ +KE
Sbjct: 321 CIQGFNPRNIQQWDQRVWAGGCIRRTQLSCS-GDGFTRMKKMKLPETTMATVDRSIGVKE 379
Query: 312 CREGCLENSSCMAYTNSDIRGGGSGCAMWFGELIDMRDFPGG---GQDFYIRMSASEIGA 368
C++ C+ + +C A+ N+DIR GGSGC +W L D+R++ GQD Y+R++A++I
Sbjct: 380 CKKRCISDCNCTAFANADIRNGGSGCVIWTERLEDIRNYATDAIDGQDLYVRLAAADIAK 439
Query: 369 KGEPTTKIVVIVISTAALLAVVLIAGYLIRKRRRNIAEKTENSRETDQENEDQNI----- 423
K + KI+ + + + LL +++ + + KR++ A+ + S Q N++ +
Sbjct: 440 KRNASGKIISLTVGVSVLLLLIM---FCLWKRKQKRAKASAISIANTQRNQNLPMNEMVL 496
Query: 424 -------------DLELPLFELATIANATDNFSINNKLGEGGFGPVYKGTLVDGQEIAVK 470
+LELPL E+ T+ AT+NFS NKLG+GGFG VYKG L+DG+EIAVK
Sbjct: 497 SSKREFSGEYKFEELELPLIEMETVVKATENFSSCNKLGQGGFGIVYKGRLLDGKEIAVK 556
Query: 471 RLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQ 530
RLSK S QG E NEV L ++LQH NLV++LGCCI+G+EK+LIYE++ N SLDS++F +
Sbjct: 557 RLSKTSVQGTDEFMNEVTLIARLQHINLVQVLGCCIEGDEKMLIYEYLENLSLDSYLFGK 616
Query: 531 TRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVR 590
TRR+ L+W++RF I G ARGLLYLHQDSR RIIHRDLK SN+LLD++M PKISDFG+ R
Sbjct: 617 TRRSKLNWNERFDITNGVARGLLYLHQDSRFRIIHRDLKVSNILLDKNMIPKISDFGMAR 676
Query: 591 TFGGDETEGNTNRVVGTYD---------GQFSIKSDVFSFGILLLEIVSGKKNRGFYRSD 641
F DETE NT +VVGTY G FS KSDVFSFG+++LEIVSGKKNRGFY D
Sbjct: 677 IFERDETEANTMKVVGTYGYMSPEYAMYGIFSEKSDVFSFGVIVLEIVSGKKNRGFYNLD 736
Query: 642 TKVNLIGHLWD---EGIPLRLIDACIQDSCNL-------ADVIRCIHIGLLCVQQHPEDR 691
+ +L+ ++W EG L ++D I DS + +V++CI IGLLCVQ+ E R
Sbjct: 737 YENDLLSYVWSRWKEGRALEIVDPVIVDSLSSQPSIFQPQEVLKCIQIGLLCVQELAEHR 796
Query: 692 PCMPSVILMLGSEIL-LPQPKQPGYLADRKSTEPYSSSSMP----ESSSTNTLTISELEA 746
P M SV+ M GSE +PQPK PGY R E SSS ES + N T S ++A
Sbjct: 797 PAMSSVVWMFGSEATEIPQPKPPGYCVRRSPYELDPSSSWQCDENESWTVNQYTCSVIDA 856
Query: 747 R 747
R
Sbjct: 857 R 857
|
Involved in sporophytic self-incompatibility system (the inability of flowering plants to achieve self-fertilization), probably acting in combination with S-locus-specific glycoproteins. Interaction with a ligand in the extracellular domain triggers the protein kinase activity of the cytoplasmic domain. Brassica oleracea var. acephala (taxid: 3713) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9ZT07|RKS1_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase RKS1 OS=Arabidopsis thaliana GN=RKS1 PE=2 SV=3 | Back alignment and function description |
|---|
Score = 631 bits (1627), Expect = e-180, Method: Compositional matrix adjust.
Identities = 345/774 (44%), Positives = 494/774 (63%), Gaps = 51/774 (6%)
Query: 17 VVWVANRLNPINDSFGFLMINKTGNLVLTSQSNI--VVWSAYLSKEVQTP-VVLQLLDSG 73
+VWVANR +PIND+ G + + GNL + + N ++WS +S + P +V L D G
Sbjct: 68 IVWVANRDHPINDTSGMVKFSNRGNLSVYASDNETELIWSTNVSDSMLEPTLVATLSDLG 127
Query: 74 NLVLRDEHDGDSETYFWQSFDYPSDTLLPGMKLGWDLKTGLERRVTSWKSFDDPSPGDFI 133
NLVL D G S FW+SFD+P+DT LP M+LG+ K GL+R +TSWKS DP GD I
Sbjct: 128 NLVLFDPVTGRS---FWESFDHPTDTFLPFMRLGFTRKDGLDRSLTSWKSHGDPGSGDLI 184
Query: 134 WAIERQDNPEVVMWKGSRKFYRTGPWNGLRFSA-PSLRPNPIFSFSFVSNDVELYYTFNI 192
+ER+ P+++++KG ++R G W G R+S P + IF+ SFV+N+ E+ +T+ +
Sbjct: 185 LRMERRGFPQLILYKGVTPWWRMGSWTGHRWSGVPEMPIGYIFNNSFVNNEDEVSFTYGV 244
Query: 193 TNKAVISRIVMNQTLYVRRRFIWNKATQSWELYSDVPRDQCDTYGLCGAYGICIIGQSPV 252
T+ +VI+R ++N+T + R F W + W + VP++QCD Y CG G C S
Sbjct: 245 TDASVITRTMVNETGTMHR-FTWIARDKRWNDFWSVPKEQCDNYAHCGPNGYCDSPSSKT 303
Query: 253 --CQCLKGFKPKSGGY---VDRSQGCVRSKPLNY-SRQDGFIKFTELKLPDATSSWVSKS 306
C CL GF+PK + D S GC + K + S +DGF+K +K+PD + + V +
Sbjct: 304 FECTCLPGFEPKFPRHWFLRDSSGGCTKKKRASICSEKDGFVKLKRMKIPDTSDASVDMN 363
Query: 307 MNLKECREGCLENSSCMAYTNS--DIRGGGSGCAMWFGELIDMRDFPGGGQDFYIRMSAS 364
+ LKEC++ CL+N SC+AY ++ + + G GC W G ++D R + GQDFYIR+
Sbjct: 364 ITLKECKQRCLKNCSCVAYASAYHESKRGAIGCLKWHGGMLDARTYLNSGQDFYIRVDKE 423
Query: 365 EI------GAKGEPTTKIVVI-VISTAALLAVVLIAGYLIRKRRRNIAEKTENSR----- 412
E+ G G+ +++I +I+ LL V+L ++R+RR++ ++ ++
Sbjct: 424 ELARWNRNGLSGKRRVLLILISLIAAVMLLTVILFC--VVRERRKSNRHRSSSANFAPVP 481
Query: 413 ----ETDQENEDQNIDLELPLFELATIANATDNFSINNKLGEGGFGPVYKGTLVDGQEIA 468
E+ + +D+ + ELPLF+L TI AT+NFS NKLG GGFGPVYKG L + EIA
Sbjct: 482 FDFDESFRFEQDKARNRELPLFDLNTIVAATNNFSSQNKLGAGGFGPVYKGVLQNRMEIA 541
Query: 469 VKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMPNKSLDSFIF 528
VKRLS+ S QG++E KNEV L SKLQHRNLV++LGCC++ EEK+L+YE++PNKSLD FIF
Sbjct: 542 VKRLSRNSGQGMEEFKNEVKLISKLQHRNLVRILGCCVELEEKMLVYEYLPNKSLDYFIF 601
Query: 529 DQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGL 588
+ +R LDW +R I+ G ARG+LYLHQDSRLRIIHRDLKASN+LLD +M PKISDFG+
Sbjct: 602 HEEQRAELDWPKRMEIVRGIARGILYLHQDSRLRIIHRDLKASNILLDSEMIPKISDFGM 661
Query: 589 VRTFGGDETEGNTNRVVGTY---------DGQFSIKSDVFSFGILLLEIVSGKKNRGFYR 639
R FGG++ EG T+RVVGT+ +GQFSIKSDV+SFG+L+LEI++GKKN F+
Sbjct: 662 ARIFGGNQMEGCTSRVVGTFGYMAPEYAMEGQFSIKSDVYSFGVLMLEIITGKKNSAFHE 721
Query: 640 SDTKVNLIGHLWD---EGIPLRLIDACI-QDSCNLADVIRCIHIGLLCVQQHPEDRPCMP 695
+ NL+GH+WD G +ID + Q++ + +V++CI IGLLCVQ++ DR M
Sbjct: 722 ESS--NLVGHIWDLWENGEATEIIDNLMDQETYDEREVMKCIQIGLLCVQENASDRVDMS 779
Query: 696 SVILMLGSEIL-LPQPKQPGYL-ADRKSTEPYSSSSMPESSSTNTLTISELEAR 747
SV++MLG LP PK P + A R+ E + S N +T S+++ R
Sbjct: 780 SVVIMLGHNATNLPNPKHPAFTSARRRGGENGACLKGQTGISVNDVTFSDIQGR 833
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9LPZ3|Y1141_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase At1g11410 OS=Arabidopsis thaliana GN=At1g11410 PE=3 SV=3 | Back alignment and function description |
|---|
Score = 627 bits (1616), Expect = e-178, Method: Compositional matrix adjust.
Identities = 351/783 (44%), Positives = 506/783 (64%), Gaps = 60/783 (7%)
Query: 17 VVWVANRLNPINDSFGFLMINKTGNLVLTSQSNIV--VWSAYLSKEVQTP-VVLQLLDSG 73
+VWVANR +PIND+ G + + GNL + + N +WS + +Q P +V +L D G
Sbjct: 71 IVWVANRDHPINDTSGLIKFSTRGNLCVYASGNGTEPIWSTDVIDMIQEPALVAKLSDLG 130
Query: 74 NLVLRDEHDGDSETYFWQSFDYPSDTLLPGMKLGWDLKTGLERRVTSWKSFDDPSPGDFI 133
NLVL D G S FW+SF++P++TLLP MK G+ ++G++R +TSW+S DP G+
Sbjct: 131 NLVLLDPVTGKS---FWESFNHPTNTLLPFMKFGFTRQSGVDRIMTSWRSPGDPGSGNIT 187
Query: 134 WAIERQDNPEVVMWKGSRKFYRTGPWNGLRFSA-PSLRPNPIFSFSFVSNDVELYYTFNI 192
+ IER+ P+++M+KG ++RTG W G R+S P + IF+ SFV+N E+ T+ +
Sbjct: 188 YRIERRGFPQMMMYKGLTLWWRTGSWTGQRWSGVPEMTNKFIFNISFVNNPDEVSITYGV 247
Query: 193 TNKAVISRIVMNQTLYVRRRFIWNKATQSWELYSDVPRDQCDTYGLCGAYGIC--IIGQS 250
+ +V +R+V+N+T ++R F WN + W + P D+CD Y CG G C +
Sbjct: 248 LDASVTTRMVLNETGTLQR-FRWNGRDKKWIGFWSAPEDKCDIYNHCGFNGYCDSTSTEK 306
Query: 251 PVCQCLKGFKPKSGG---YVDRSQGCVRSKPLNYSR-QDGFIKFTELKLPDATSSWVSKS 306
C CL G++PK+ D S GC R K + ++GF K +K+P+ ++ V +
Sbjct: 307 FECSCLPGYEPKTPRDWFLRDASDGCTRIKADSICNGKEGFAKLKRVKIPNTSAVNVDMN 366
Query: 307 MNLKECREGCLENSSCMAYTNS--DIRGGGSGCAMWFGELIDMRDFPGGGQDFYIRMSAS 364
+ LKEC + CL+N SC+AY ++ + + G GC W G ++D R + GQDFY+R+ S
Sbjct: 367 ITLKECEQRCLKNCSCVAYASAYHESQDGAKGCLTWHGNMLDTRTYLSSGQDFYLRVDKS 426
Query: 365 EI------GAKGEPTTKIVVIVISTAALLAVVLIA--GYLIRKRRRNIAEKTENSRETD- 415
E+ GA G+ ++V+I+IS A++ ++LI+ YL ++R+R + + + +
Sbjct: 427 ELARWNGNGASGKK--RLVLILISLIAVVMLLLISFHCYLRKRRQRTQSNRLRKAPSSFA 484
Query: 416 ------------QENEDQNIDLELPLFELATIANATDNFSINNKLGEGGFGPVYKGTLVD 463
+E ED++ ELPLFEL+TIA AT+NF+ NKLG GGFGPVYKG L +
Sbjct: 485 PSSFDLEDSFILEELEDKSRSRELPLFELSTIATATNNFAFQNKLGAGGFGPVYKGVLQN 544
Query: 464 GQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMPNKSL 523
G EIAVKRLSK S QG++E KNEV L SKLQHRNLV++LGCC++ EEK+L+YE++PNKSL
Sbjct: 545 GMEIAVKRLSKSSGQGMEEFKNEVKLISKLQHRNLVRILGCCVEFEEKMLVYEYLPNKSL 604
Query: 524 DSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKI 583
D FIF + +R LDW +R II G RG+LYLHQDSRLRIIHRDLKASNVLLD +M PKI
Sbjct: 605 DYFIFHEEQRAELDWPKRMGIIRGIGRGILYLHQDSRLRIIHRDLKASNVLLDNEMIPKI 664
Query: 584 SDFGLVRTFGGDETEGNTNRVVGTY---------DGQFSIKSDVFSFGILLLEIVSGKKN 634
+DFGL R FGG++ EG+TNRVVGTY DGQFSIKSDV+SFG+L+LEI++GK+N
Sbjct: 665 ADFGLARIFGGNQIEGSTNRVVGTYGYMSPEYAMDGQFSIKSDVYSFGVLILEIITGKRN 724
Query: 635 RGFYRSDTKVNLIGHLWDE---GIPLRLIDACI-QDSCNLADVIRCIHIGLLCVQQHPED 690
FY + +NL+ H+WD G + +ID + +++ + +V++C+HIGLLCVQ++ D
Sbjct: 725 SAFY--EESLNLVKHIWDRWENGEAIEIIDKLMGEETYDEGEVMKCLHIGLLCVQENSSD 782
Query: 691 RPCMPSVILMLG-SEILLPQPKQPGYLADRKSTEPYSSSS----MPESSST-NTLTISEL 744
RP M SV+ MLG + I LP PK P + A R+ SS E+SST N +T++++
Sbjct: 783 RPDMSSVVFMLGHNAIDLPSPKHPAFTAGRRRNTKTGGSSDNWPSGETSSTINDVTLTDV 842
Query: 745 EAR 747
+ R
Sbjct: 843 QGR 845
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|P0DH86|SRK_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase SRK OS=Arabidopsis thaliana GN=SRK PE=2 SV=1 | Back alignment and function description |
|---|
Score = 624 bits (1608), Expect = e-177, Method: Compositional matrix adjust.
Identities = 363/775 (46%), Positives = 483/775 (62%), Gaps = 49/775 (6%)
Query: 18 VWVANRLNPINDSFGFLMINKTGNLVLTSQSNIVVWSAYLSKEVQTPVVLQLLDSGNLVL 77
VWVANR P+++ G L I+ NLV+ S+ VWS L+ V++ VV +LLD+GN VL
Sbjct: 83 VWVANRDTPLSNPIGILKISN-ANLVILDNSDTHVWSTNLTGAVRSSVVAELLDNGNFVL 141
Query: 78 RDEHDGDSETYFWQSFDYPSDTLLPGMKLGWDLKTGLERRVTSWKSFDDPSPGDFIWAIE 137
R +S+ + WQSFD+P+DTLLP MKLG D K GL R VTSWKS DPS G F++ +E
Sbjct: 142 RGSKINESDEFLWQSFDFPTDTLLPQMKLGRDHKRGLNRFVTSWKSSFDPSSGSFMFKLE 201
Query: 138 RQDNPEVVMWKGSRKFYRTGPWNGLRFSAP-SLRPNPIFSFSFVSNDVELYYTFNITNKA 196
PE + + YR+GPW+GLRFS ++ ++F N E+ YTF +T+
Sbjct: 202 TLGLPEFFGFTSFLEVYRSGPWDGLRFSGILEMQQWDDIIYNFTENREEVAYTFRVTDHN 261
Query: 197 VISRIVMNQTLYVRRRFIWNKATQSWELYSDVPRDQCDTYGLCGAYGICIIGQSPVCQCL 256
SR+ +N T+ F+W Q W ++ +P+D CD YG+CG Y C + SP C C+
Sbjct: 262 SYSRLTIN-TVGRLEGFMWEPTQQEWNMFWFMPKDTCDLYGICGPYAYCDMSTSPTCNCI 320
Query: 257 KGFKPKSG---GYVDRSQGCVRSKPLNYSRQDGFIKFTELKLPDATSSWVSKSMNLKECR 313
KGF+P S D + C R L +D F + +K+P T++ V K + LKEC
Sbjct: 321 KGFQPLSPQDWASGDVTGRCRRKTQLTCG-EDRFFRLMNMKIPATTAAIVDKRIGLKECE 379
Query: 314 EGCLENSSCMAYTNSDIRGGGSGCAMWFGELIDMRDFPGGGQDFYIRMSASEIGAKGEPT 373
E C + +C AY NSDIR GGSGC +W GE D+R++ GQD ++R++A+E G +
Sbjct: 380 EKCKTHCNCTAYANSDIRNGGSGCIIWIGEFRDIRNYAADGQDLFVRLAAAEFGERRTIR 439
Query: 374 TKIVVIVISTAALLAVVLIAGYLIRKRRRNIAEKTE---NSRETDQE------------- 417
KI+ ++I + +L + I Y K+++ A T R+ QE
Sbjct: 440 GKIIGLIIGISLMLVLSFII-YCFWKKKQKRARATAAPIGYRDRIQELIITNGVVMSSGR 498
Query: 418 -NEDQNIDLELPLFELATIANATDNFSINNKLGEGGFGPVYKGTLVDGQEIAVKRLSKIS 476
+ DLELPL E T+ AT+NFS +N LG GGFG VYKG L+DGQEIAVKRLS++S
Sbjct: 499 RLLGEEEDLELPLTEFETVVMATENFSDSNILGRGGFGIVYKGRLLDGQEIAVKRLSEMS 558
Query: 477 EQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQTRRT-L 535
QG E KNEV L ++LQH NLV+LL CCI +EK+LIYE++ N SLDS +F+ T+ +
Sbjct: 559 SQGTNEFKNEVRLIARLQHINLVRLLSCCIYADEKILIYEYLENGSLDSHLFETTQSSNK 618
Query: 536 LDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGD 595
L+W RF II G ARGLLYLHQDSR +IIHRDLKASNVLLD++M PKISDFG+ R F D
Sbjct: 619 LNWQTRFSIINGIARGLLYLHQDSRFKIIHRDLKASNVLLDKNMTPKISDFGMARIFERD 678
Query: 596 ETEGNTNRVVGTY---------DGQFSIKSDVFSFGILLLEIVSGKKNRGFYRSDTKVNL 646
ETE NT +VVGTY +G FS+KSDVFSFG+L+LEIVSGK+NRGF+ S NL
Sbjct: 679 ETEANTRKVVGTYGYMSPEYAMEGIFSVKSDVFSFGVLVLEIVSGKRNRGFHNSGQDNNL 738
Query: 647 IGHLWD---EGIPLRLIDACIQDSCNLA------DVIRCIHIGLLCVQQHPEDRPCMPSV 697
+G+ W+ EG L ++D+ I DS + +V+RCI IGLLCVQ+ EDRP M SV
Sbjct: 739 LGYTWENWKEGKGLEIVDSIIVDSSSSMSLFQPHEVLRCIQIGLLCVQERAEDRPKMSSV 798
Query: 698 ILMLGSEI-LLPQPKQPGYLADRKSTEPYSSSSM----PESSSTNTLTISELEAR 747
+LMLGSE +PQPK+PGY R S + SSS ES + N +T+S + AR
Sbjct: 799 VLMLGSEKGEIPQPKRPGYCVGRSSLDTADSSSSTKRDSESLTVNQITVSVINAR 853
|
Female specificity determinant of self-incompatibility. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9SXB8|Y1133_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase At1g11330 OS=Arabidopsis thaliana GN=At1g11330 PE=1 SV=3 | Back alignment and function description |
|---|
Score = 594 bits (1532), Expect = e-169, Method: Compositional matrix adjust.
Identities = 326/779 (41%), Positives = 470/779 (60%), Gaps = 59/779 (7%)
Query: 13 PPHEVVWVANRLNPINDSFGFLMINKTGNLVLTSQSNIVVWSAYLSKEVQTPVV-LQLLD 71
P VVWVAN+ +PIND+ G + I + GNL +T N +VWS +S V +QL+D
Sbjct: 79 PIQTVVWVANKDSPINDTSGVISIYQDGNLAVTDGRNRLVWSTNVSVPVAPNATWVQLMD 138
Query: 72 SGNLVLRDEHDGDSETYFWQSFDYPSDTLLPGMKLGWDLKTGLERRVTSWKSFDDPSPGD 131
SGNL+L+D + W+SF +P D+ +P M LG D +TG ++TSW S DDPS G+
Sbjct: 139 SGNLMLQDNRNNGE--ILWESFKHPYDSFMPRMTLGTDGRTGGNLKLTSWTSHDDPSTGN 196
Query: 132 FIWAIERQDNPEVVMWKGSRKFYRTGPWNGLRFSAPSLRPNPIFSFSF-VSNDVELYYTF 190
+ I PE+++WK + +R+GPWNG F + +F F +++D + +
Sbjct: 197 YTAGIAPFTFPELLIWKNNVPTWRSGPWNGQVFIGLPNMDSLLFLDGFNLNSDNQGTISM 256
Query: 191 NITNKAVISRIVMNQTLYVRRRFIWNKATQSWELYSDVPRDQCDTYGLCGAYGICIIGQS 250
+ N + + ++ + ++ W+ + ++W + P CD YG CG +G C G++
Sbjct: 257 SYANDSFMYHFNLDPEGIIYQK-DWSTSMRTWRIGVKFPYTDCDAYGRCGRFGSCHAGEN 315
Query: 251 PVCQCLKGFKPKS-----GGYVDRSQGCVRSKPLNYSRQ------------DGFIKFTEL 293
P C+C+KGF PK+ GG + S GC+R PL RQ DGF+K ++
Sbjct: 316 PPCKCVKGFVPKNNTEWNGG--NWSNGCMRKAPLQCERQRNVSNGGGGGKADGFLKLQKM 373
Query: 294 KLP-DATSSWVSKSMNLKECREGCLENSSCMAYTNSDIRGGGSGCAMWFGELIDMRDFPG 352
K+P A S S+ + C + CL+N SC AY G GC +W G+L+DM+ F G
Sbjct: 374 KVPISAERSEASEQV----CPKVCLDNCSCTAYAYDR----GIGCMLWSGDLVDMQSFLG 425
Query: 353 GGQDFYIRMSASEIGAKGEPTTKIVVIVISTAALLAVVLIAGYLIRKRRRNIAEKTENSR 412
G D +IR++ SE+ I VI + AV ++ RK ++ A + S
Sbjct: 426 SGIDLFIRVAHSELKTHSNLAVMIAAPVIGVMLIAAVCVLLA--CRKYKKRPAPAKDRSA 483
Query: 413 E----------TDQENEDQNIDL-ELPLFELATIANATDNFSINNKLGEGGFGPVYKGTL 461
E +D E+ I L ELPLFE +A +TD+FS+ NKLG+GGFGPVYKG L
Sbjct: 484 ELMFKRMEALTSDNESASNQIKLKELPLFEFQVLATSTDSFSLRNKLGQGGFGPVYKGKL 543
Query: 462 VDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMPNK 521
+GQEIAVKRLS+ S QGL+EL NEV++ SKLQHRNLVKLLGCCI+GEE++L+YE+MP K
Sbjct: 544 PEGQEIAVKRLSRKSGQGLEELMNEVVVISKLQHRNLVKLLGCCIEGEERMLVYEYMPKK 603
Query: 522 SLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNP 581
SLD+++FD ++ +LDW RF+I+ G RGLLYLH+DSRL+IIHRDLKASN+LLD+++NP
Sbjct: 604 SLDAYLFDPMKQKILDWKTRFNIMEGICRGLLYLHRDSRLKIIHRDLKASNILLDENLNP 663
Query: 582 KISDFGLVRTFGGDETEGNTNRVVGTY---------DGQFSIKSDVFSFGILLLEIVSGK 632
KISDFGL R F +E E NT RVVGTY +G FS KSDVFS G++ LEI+SG+
Sbjct: 664 KISDFGLARIFRANEDEANTRRVVGTYGYMSPEYAMEGFFSEKSDVFSLGVIFLEIISGR 723
Query: 633 KNRGFYRSDTKVNLIGH---LWDEGIPLRLIDACIQDSCNLADVIRCIHIGLLCVQQHPE 689
+N ++ + +NL+ + LW++G L D + D C ++ +C+HIGLLCVQ+
Sbjct: 724 RNSSSHKEENNLNLLAYAWKLWNDGEAASLADPAVFDKCFEKEIEKCVHIGLLCVQEVAN 783
Query: 690 DRPCMPSVILMLGSEIL-LPQPKQPGYLADRKSTEPYSSSSMPESSSTNTLTISELEAR 747
DRP + +VI ML +E + L PKQP ++ R ++E SS + S N ++++ + R
Sbjct: 784 DRPNVSNVIWMLTTENMSLADPKQPAFIVRRGASEAESSDQSSQKVSINDVSLTAVTGR 842
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
Close Homologs in the Non-Redundant Database Detected by BLAST
Original result of BLAST against Nonredundant Database
| GI | Alignment Graph | Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 747 | ||||||
| 224124250 | 820 | predicted protein [Populus trichocarpa] | 0.981 | 0.893 | 0.622 | 0.0 | |
| 224113149 | 820 | predicted protein [Populus trichocarpa] | 0.943 | 0.859 | 0.631 | 0.0 | |
| 224113157 | 786 | predicted protein [Populus trichocarpa] | 0.931 | 0.885 | 0.608 | 0.0 | |
| 224113153 | 785 | predicted protein [Populus trichocarpa] | 0.930 | 0.885 | 0.607 | 0.0 | |
| 224126243 | 836 | predicted protein [Populus trichocarpa] | 0.985 | 0.880 | 0.600 | 0.0 | |
| 224115136 | 843 | predicted protein [Populus trichocarpa] | 0.982 | 0.870 | 0.579 | 0.0 | |
| 449458261 | 814 | PREDICTED: receptor-like serine/threonin | 0.975 | 0.895 | 0.584 | 0.0 | |
| 449476944 | 1267 | PREDICTED: receptor-like serine/threonin | 0.975 | 0.575 | 0.582 | 0.0 | |
| 356546914 | 788 | PREDICTED: G-type lectin S-receptor-like | 0.931 | 0.883 | 0.562 | 0.0 | |
| 356514895 | 821 | PREDICTED: G-type lectin S-receptor-like | 0.983 | 0.895 | 0.575 | 0.0 |
| >gi|224124250|ref|XP_002319283.1| predicted protein [Populus trichocarpa] gi|222857659|gb|EEE95206.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 943 bits (2437), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 471/757 (62%), Positives = 569/757 (75%), Gaps = 24/757 (3%)
Query: 10 KSYPPHEVVWVANRLNPINDSFGFLMINKTGNLVLTSQSN-IVVWSAYLSKEVQTPVVLQ 68
K+ P VVWVANR NPINDS GFLM++ TGN VL S +N VVWS+ K Q+ + +
Sbjct: 69 KNIPVRTVVWVANRNNPINDSSGFLMLDNTGNFVLVSNNNSTVVWSSNSKKAAQS-AMGE 127
Query: 69 LLDSGNLVLRDEHDGDSETYFWQSFDYPSDTLLPGMKLGWDLKTGLERRVTSWKSFDDPS 128
L DSGNLVLRDE D +S Y WQSFDYPSDTLLPGMKLGWDL+ GL+RR+++WKS DDPS
Sbjct: 128 LQDSGNLVLRDEKDDNSGIYLWQSFDYPSDTLLPGMKLGWDLRIGLDRRLSAWKSPDDPS 187
Query: 129 PGDFIWAIERQDNPEVVMWKGSRKFYRTGPWNGLRFSAP-SLRPNPIFSFSFVSNDVELY 187
GDF W + Q NPE+VMWKGS+K+YR+GPWNG+ FS +LR NP+F F FV + E+Y
Sbjct: 188 SGDFTWGTQLQSNPELVMWKGSKKYYRSGPWNGIGFSGGLALRINPVFYFDFVDDGEEVY 247
Query: 188 YTFNITNKAVISRIVMNQTLYVRRRFIWNKATQSWELYSDVPRDQCDTYGLCGAYGICII 247
YT+N+ NK++I+RIVMNQT Y R+R+ WN+ Q+W LY+ VPRD CDTY LCGAYG CI+
Sbjct: 248 YTYNLKNKSLITRIVMNQTTYFRQRYTWNEINQTWVLYATVPRDYCDTYNLCGAYGNCIM 307
Query: 248 GQSPVCQCLKGFKPKSG---GYVDRSQGCVRSKPLNYSRQDGFIKFTELKLPDATSSWVS 304
QSPVCQCL+ F P+S +D S+GCVR+KPL+ + DGF+K+ LKLPDAT+SWV+
Sbjct: 308 SQSPVCQCLEKFTPRSPESWNSMDWSKGCVRNKPLDCQKGDGFVKYVGLKLPDATNSWVN 367
Query: 305 KSMNLKECREGCLENSSCMAYTNSDIRGGGSGCAMWFGELIDMRDFPGGGQDFYIRMSAS 364
K+MNLKECR CL+N SCMAYT ++I+ SGCA+WFG+LID+R F GQ+ YIR++AS
Sbjct: 368 KTMNLKECRSKCLQNCSCMAYTATNIKER-SGCAVWFGDLIDIRQFSAAGQEIYIRLNAS 426
Query: 365 EIGAKGEPTTKIVV-IVISTAALLAVVLIAGYLIRKRRRNIAEKTENSRETDQENEDQNI 423
E AK K+ V +S ++L+A Y+ +++ ++I N E DQ +
Sbjct: 427 ESRAKAASKIKMTVGSALSIFVACGILLVAYYIFKRKAKHIGG---NREENDQIDSGPKE 483
Query: 424 DLELPLFELATIANATDNFSINNKLGEGGFGPVYKGTLVDGQEIAVKRLSKISEQGLKEL 483
DLELPLF+ TIA AT+ FS NNKLGEGGFGPVYKGTL DGQEIA K LS+ S QGL E
Sbjct: 484 DLELPLFQFTTIAKATNGFSFNNKLGEGGFGPVYKGTLEDGQEIAAKTLSRSSGQGLNEF 543
Query: 484 KNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFH 543
KNEVIL +KLQHRNLVKLLGCCIQGEEK+L+YE+MPNKSLDSFIFDQTR LLDWS+RF
Sbjct: 544 KNEVILITKLQHRNLVKLLGCCIQGEEKILVYEYMPNKSLDSFIFDQTRGKLLDWSKRFS 603
Query: 544 IICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNTNR 603
IICG ARGLLYLHQDSRLRI+HRDLKASNVLLD+DMNPKISDFGL R FGGD+TEGNT R
Sbjct: 604 IICGIARGLLYLHQDSRLRIVHRDLKASNVLLDKDMNPKISDFGLARMFGGDQTEGNTTR 663
Query: 604 VVGTY---------DGQFSIKSDVFSFGILLLEIVSGKKNRGFYRSDTKVNLIGH---LW 651
VVGTY DG FS+KSDVFSFGIL+LEI+SGKK+RGF D ++LIGH LW
Sbjct: 664 VVGTYGYMAPEYATDGLFSVKSDVFSFGILMLEIISGKKSRGFCHPDHSLSLIGHAWRLW 723
Query: 652 DEGIPLRLIDACIQDSCNLADVI-RCIHIGLLCVQQHPEDRPCMPSVILMLGSEILLPQP 710
+G PL LI+A +SCNL++VI RCI+I LLCVQQHP+DRP M +V+ MLG E LPQP
Sbjct: 724 KDGKPLGLIEAFPGESCNLSEVIMRCINISLLCVQQHPDDRPSMATVVWMLGGENTLPQP 783
Query: 711 KQPGYLADRKSTEPYSSSSMPESSSTNTLTISELEAR 747
K+PG+ P SSS E S N +T S L R
Sbjct: 784 KEPGFFKGSGPFRPSSSSKNTELFSNNEITSSLLYPR 820
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224113149|ref|XP_002332642.1| predicted protein [Populus trichocarpa] gi|222832837|gb|EEE71314.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 930 bits (2403), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 460/729 (63%), Positives = 555/729 (76%), Gaps = 24/729 (3%)
Query: 10 KSYPPHEVVWVANRLNPINDSFGFLMINKTGNLVLTSQSN-IVVWSAYLSKEVQTPVVLQ 68
K+ P VVWVANR NPINDS GFLM++ TGNLVL S +N VVWS+ K Q+ + +
Sbjct: 63 KNIPVRTVVWVANRNNPINDSSGFLMLDNTGNLVLVSNNNSTVVWSSNSKKAAQS-AMGE 121
Query: 69 LLDSGNLVLRDEHDGDSETYFWQSFDYPSDTLLPGMKLGWDLKTGLERRVTSWKSFDDPS 128
LLDSGNLVLRDE D +S Y WQSFDYPSDTLLPGMKLGWDL+ GL+RR+++WKS DDPS
Sbjct: 122 LLDSGNLVLRDEKDANSGIYLWQSFDYPSDTLLPGMKLGWDLRIGLDRRLSAWKSPDDPS 181
Query: 129 PGDFIWAIERQDNPEVVMWKGSRKFYRTGPWNGLRFSA-PSLRPNPIFSFSFVSNDVELY 187
GDF W + Q NPE+VMWKGS+++YR+GPWNG+ FS P LR NP+F F FV + E+Y
Sbjct: 182 SGDFTWGTQLQSNPELVMWKGSKEYYRSGPWNGIGFSGGPELRINPVFYFDFVDDGEEVY 241
Query: 188 YTFNITNKAVISRIVMNQTLYVRRRFIWNKATQSWELYSDVPRDQCDTYGLCGAYGICII 247
YT+N+ NK++I+RIVMNQ+ Y R+R+ WN+ Q+W LY++VPRD CDTY LCGAYG CII
Sbjct: 242 YTYNLKNKSLITRIVMNQSTYFRQRYTWNEINQTWVLYANVPRDYCDTYSLCGAYGNCII 301
Query: 248 GQSPVCQCLKGFKPKSG---GYVDRSQGCVRSKPLNYSRQDGFIKFTELKLPDATSSWVS 304
QSPVC+CL+ F PKS +D SQGCVR+KPL+ + DGF+K+ LKLPDAT+SWV+
Sbjct: 302 SQSPVCECLEKFTPKSPESWNSMDWSQGCVRNKPLDCQKGDGFVKYVGLKLPDATNSWVN 361
Query: 305 KSMNLKECREGCLENSSCMAYTNSDIRGGGSGCAMWFGELIDMRDFPGGGQDFYIRMSAS 364
K+MNLKECR CLEN SCMAYT ++I+ SGCA+WFG+LID+ P GQ+ YIRM+AS
Sbjct: 362 KTMNLKECRSICLENCSCMAYTATNIKER-SGCAIWFGDLIDITQLPAAGQEIYIRMNAS 420
Query: 365 EIGAKGEPTTKIVVIVISTAALLAVVLIAGYLIRKRRRNIAEKT----ENSRETDQENED 420
E V I +S ++L+A Y+ +++ + I + T N E DQ +
Sbjct: 421 ESSECLSLVLMAVGIALSIFVACGILLVAYYIFKRKAKLIGKVTLTAFSNREENDQIDSG 480
Query: 421 QNIDLELPLFELATIANATDNFSINNKLGEGGFGPVYKGTLVDGQEIAVKRLSKISEQGL 480
DLELPLF+ TIA AT+ FS NNKLGEGGFGPVYKGTL DGQEIA K S+ S QG+
Sbjct: 481 PKEDLELPLFQFTTIAKATNGFSFNNKLGEGGFGPVYKGTLEDGQEIAAKTHSRSSGQGI 540
Query: 481 KELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQ 540
E KNEVIL +KLQHRNLVKLLGCCIQGEEK+L+YE+MPNKSLDSFIFDQTR LLDWS+
Sbjct: 541 NEFKNEVILITKLQHRNLVKLLGCCIQGEEKILVYEYMPNKSLDSFIFDQTRGELLDWSK 600
Query: 541 RFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGN 600
RF IICG ARGLLYLHQDSRLRI+HRDLKASNVLLD+DMNPKISDFGL R FGGD+TEGN
Sbjct: 601 RFSIICGIARGLLYLHQDSRLRIVHRDLKASNVLLDKDMNPKISDFGLARMFGGDQTEGN 660
Query: 601 TNRVVGTY---------DGQFSIKSDVFSFGILLLEIVSGKKNRGFYRSDTKVNLIGH-- 649
T RVVGTY DG FS+KSDVFSFGIL+LEI+SGKK+RGFY D ++LIGH
Sbjct: 661 TTRVVGTYGYMAPEYATDGLFSVKSDVFSFGILMLEIISGKKSRGFYHPDHSLSLIGHAW 720
Query: 650 -LWDEGIPLRLIDACIQDSCNLADVI-RCIHIGLLCVQQHPEDRPCMPSVILMLGSEILL 707
LW +G PL LI+A +S NL++VI RCI+I LLCVQQHP+DRP M +V+ MLG E L
Sbjct: 721 RLWKDGKPLDLIEAFPGESRNLSEVIMRCINISLLCVQQHPDDRPSMATVVWMLGCENTL 780
Query: 708 PQPKQPGYL 716
PQP +PG+
Sbjct: 781 PQPNEPGFF 789
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224113157|ref|XP_002332644.1| predicted protein [Populus trichocarpa] gi|222832839|gb|EEE71316.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 923 bits (2385), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 459/754 (60%), Positives = 558/754 (74%), Gaps = 58/754 (7%)
Query: 10 KSYPPHEVVWVANRLNPINDSFGFLMINKTGNLVLTSQSNIVVWSAYLSKEVQTPVVLQL 69
K+ P V+WVANR NPI DS GFL I+ T NL+L S N+VVWS+ + ++P+VLQL
Sbjct: 75 KNIPVRTVLWVANRRNPIEDSSGFLTIDNTANLLLVSNRNVVVWSSNSTIVAKSPIVLQL 134
Query: 70 LDSGNLVLRDEHDGDSETYFWQSFDYPSDTLLPGMKLGWDLKTGLERRVTSWKSFDDPSP 129
LDSGNLVLRDE DS Y WQSFD+PSDTL+PGMKLGWDL+TGLERR++SW+S DDPSP
Sbjct: 135 LDSGNLVLRDEK-SDSGRYLWQSFDHPSDTLIPGMKLGWDLRTGLERRLSSWRSSDDPSP 193
Query: 130 GDFIWAIERQDNPEVVMWKGSRKFYRTGPWNGLRFS-APSLRPNPIFSFSFVSNDVELYY 188
GD W I+ Q+NPE ++W+GS++++R+GPW G+ F+ AP L NP+F +FVS++ E+Y
Sbjct: 194 GDLTWGIKLQNNPETIIWRGSQQYFRSGPWTGIAFTGAPELVQNPVFKLNFVSSEDEVYL 253
Query: 189 TFNITNKAVISRIVMNQTLYVRRRFIWNKATQSWELYSDVPRDQCDTYGLCGAYGICIIG 248
++N+ N + SRIV+NQT R + WN+ATQ+W LY+ VPRD CD Y CGA G CII
Sbjct: 254 SYNLKNISAFSRIVVNQTTNYREAYTWNEATQTWVLYASVPRDSCDNYASCGANGNCIIN 313
Query: 249 QSPVCQCLKGFKPKSG---GYVDRSQGCVRSKPLNYSRQDGFIKFTELKLPDATSSWVSK 305
P+C+CLK FKPKS +D S GCVR+KPLN + DGF+K+ LK PDAT SW++K
Sbjct: 314 DLPICRCLKKFKPKSPEKWNLMDWSDGCVRNKPLNCQKGDGFVKYLGLKWPDATHSWLNK 373
Query: 306 SMNLKECREGCLENSSCMAYTNSDIRGGGSGCAMWFGELIDMRDFPGGGQDFYIRMSASE 365
SMNL ECR CL+N SCMAY+NSD+RGGGSGC +W+G+LID+R FP GGQ+ YIRM
Sbjct: 374 SMNLNECRAKCLQNCSCMAYSNSDVRGGGSGCIIWYGDLIDIRQFPAGGQELYIRM---- 429
Query: 366 IGAKGEPTTKIVVIVISTAALLAVVLIAGYLIRKRRRNIAEKTENSRETDQENEDQNIDL 425
N +E E ++ DQ + +N DL
Sbjct: 430 -------------------------------------NPSESAEMDQQNDQITDGENEDL 452
Query: 426 ELPLFELATIANATDNFSINNKLGEGGFGPVYKGTLVDGQEIAVKRLSKISEQGLKELKN 485
ELP FE A I NAT+NFSI NKLG+GGFGPVYKGTL DGQEIAVKRLS S QG KE KN
Sbjct: 453 ELPQFEFAKIVNATNNFSIKNKLGQGGFGPVYKGTLEDGQEIAVKRLSMSSRQGSKEFKN 512
Query: 486 EVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHII 545
EVIL +KLQHRNLVKLLGC IQ EE+LL+YE+MPNKSLDSF+FDQT+ LLDWS+RF+II
Sbjct: 513 EVILINKLQHRNLVKLLGCSIQREERLLVYEYMPNKSLDSFLFDQTKSKLLDWSKRFNII 572
Query: 546 CGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNTNRVV 605
CG ARGLLYLHQDSRLRIIHRDLK+SNVLLD+DMNPKISDFGL RTFGGD+TEGNT+RVV
Sbjct: 573 CGIARGLLYLHQDSRLRIIHRDLKSSNVLLDKDMNPKISDFGLARTFGGDQTEGNTSRVV 632
Query: 606 GTY---------DGQFSIKSDVFSFGILLLEIVSGKKNRGFYRSDTKVNLIGH---LWDE 653
GTY DG FS+KSDVFSFGI+LLEIV+GKK+RGFY D ++LIG+ LW E
Sbjct: 633 GTYGYMAPEYATDGLFSVKSDVFSFGIMLLEIVTGKKSRGFYHPDNSLSLIGYAWRLWKE 692
Query: 654 GIPLRLIDACIQDSCNLADVIRCIHIGLLCVQQHPEDRPCMPSVILMLGSEILLPQPKQP 713
G PL L+D ++S NL++V++CIHI LLCVQQ+PEDRP M SV+LMLG E LP+PK+P
Sbjct: 693 GKPLELVDGLAEESWNLSEVMKCIHISLLCVQQYPEDRPSMASVVLMLGGERTLPKPKEP 752
Query: 714 GYLADRKSTEPYSSSSMPESSSTNTLTISELEAR 747
G+ DR E YSSSS ESSSTN ++ S LE R
Sbjct: 753 GFFKDRGPVEAYSSSSKVESSSTNEISTSVLEPR 786
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224113153|ref|XP_002332643.1| predicted protein [Populus trichocarpa] gi|222832838|gb|EEE71315.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 918 bits (2372), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 458/754 (60%), Positives = 557/754 (73%), Gaps = 59/754 (7%)
Query: 10 KSYPPHEVVWVANRLNPINDSFGFLMINKTGNLVLTSQSNIVVWSAYLSKEVQTPVVLQL 69
K+ P V+WVANR NPI DS G L I+ T NL+L S N+VVWS+ + ++P+VLQL
Sbjct: 75 KNIPLRTVLWVANRRNPIEDSSGLLTIDNTANLLLVSNRNVVVWSSNSTIVAKSPIVLQL 134
Query: 70 LDSGNLVLRDEHDGDSETYFWQSFDYPSDTLLPGMKLGWDLKTGLERRVTSWKSFDDPSP 129
LDSGNLVLRDE DS Y WQSFD+PSDTL+PGMKLGWDL+TGLERR++SW+S DDPSP
Sbjct: 135 LDSGNLVLRDEKS-DSGRYLWQSFDHPSDTLIPGMKLGWDLRTGLERRLSSWRSSDDPSP 193
Query: 130 GDFIWAIERQDNPEVVMWKGSRKFYRTGPWNGLRFS-APSLRPNPIFSFSFVSNDVELYY 188
GD W I+ Q+NPE ++W+GS++++R+GPW G+ F+ AP L NP+F +FVS++ E+Y
Sbjct: 194 GDLTWGIKLQNNPETIIWRGSQQYFRSGPWTGIAFTGAPELVQNPVFKLNFVSSEDEVYL 253
Query: 189 TFNITNKAVISRIVMNQTLYVRRRFIWNKATQSWELYSDVPRDQCDTYGLCGAYGICIIG 248
++N+ N + SRIV+NQT R + WN+ATQ+W LY+ VPRD CD Y CGA G CII
Sbjct: 254 SYNLKNISAFSRIVVNQTTNYREAYTWNEATQTWVLYASVPRDSCDNYASCGANGNCIIN 313
Query: 249 QSPVCQCLKGFKPKSG---GYVDRSQGCVRSKPLNYSRQDGFIKFTELKLPDATSSWVSK 305
P+C+CLK FKPKS +D S GCVR+KPLN + DGF+K+ LK PDAT SW++K
Sbjct: 314 DLPICRCLKKFKPKSPEKWNLMDWSDGCVRNKPLNCQKGDGFVKYLGLKWPDATHSWLNK 373
Query: 306 SMNLKECREGCLENSSCMAYTNSDIRGGGSGCAMWFGELIDMRDFPGGGQDFYIRMSASE 365
SMNL ECR CL+N SCMAY+NSD+RGGGSGC +W+G LID+R FP GGQ+ YIRM+ SE
Sbjct: 374 SMNLNECRAKCLQNCSCMAYSNSDVRGGGSGCIIWYGGLIDIRQFPAGGQELYIRMNPSE 433
Query: 366 IGAKGEPTTKIVVIVISTAALLAVVLIAGYLIRKRRRNIAEKTENSRETDQENEDQNIDL 425
+E ++ DQ + +N DL
Sbjct: 434 ------------------------------------------SEMDQQNDQITDGENEDL 451
Query: 426 ELPLFELATIANATDNFSINNKLGEGGFGPVYKGTLVDGQEIAVKRLSKISEQGLKELKN 485
ELP FE A I NAT+NFSI NKLG+GGFGPVYKGTL DGQEIAVKRLS S QG KE KN
Sbjct: 452 ELPQFEFAKIVNATNNFSIENKLGQGGFGPVYKGTLEDGQEIAVKRLSMSSGQGSKEFKN 511
Query: 486 EVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHII 545
EVIL +KLQHRNLVKLLGC IQ EE+LL+YE+MPNKSLDSF+FDQT+ LLDWS+RF+II
Sbjct: 512 EVILINKLQHRNLVKLLGCSIQREERLLVYEYMPNKSLDSFLFDQTKSKLLDWSKRFNII 571
Query: 546 CGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNTNRVV 605
CG ARGLLYLHQDSRLRIIHRDLK+SNVLLD+DMNPKISDFGL RTFGGD+TEGNT+RVV
Sbjct: 572 CGIARGLLYLHQDSRLRIIHRDLKSSNVLLDKDMNPKISDFGLARTFGGDQTEGNTSRVV 631
Query: 606 GTY---------DGQFSIKSDVFSFGILLLEIVSGKKNRGFYRSDTKVNLIGH---LWDE 653
GTY DG FS+KSDVFSFGI+LLEIV+GKK+RGFY D ++LIG+ LW E
Sbjct: 632 GTYGYMAPEYATDGLFSVKSDVFSFGIMLLEIVTGKKSRGFYHPDNSLSLIGYAWRLWKE 691
Query: 654 GIPLRLIDACIQDSCNLADVIRCIHIGLLCVQQHPEDRPCMPSVILMLGSEILLPQPKQP 713
G PL L+D ++S NL++V++CIHI LLCVQQ+PEDRP M SV+LMLG E LP+PK+P
Sbjct: 692 GKPLELVDGLAEESWNLSEVMKCIHISLLCVQQYPEDRPSMASVVLMLGGERTLPKPKEP 751
Query: 714 GYLADRKSTEPYSSSSMPESSSTNTLTISELEAR 747
G+ DR E YSSSS ESSSTN ++ S LE R
Sbjct: 752 GFFKDRGPVEAYSSSSKVESSSTNEISTSVLEPR 785
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224126243|ref|XP_002319790.1| predicted protein [Populus trichocarpa] gi|222858166|gb|EEE95713.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 912 bits (2356), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 466/776 (60%), Positives = 572/776 (73%), Gaps = 40/776 (5%)
Query: 10 KSYPPHEVVWVANRLNPINDSFGFLMINKTGNLVLTSQSN-IVVWSAYLSKEVQTPVVLQ 68
K+ P VVWVANR NPINDS GFLM++ TGNLVL S +N VVWS+ K Q+ + +
Sbjct: 63 KNIPVRTVVWVANRNNPINDSSGFLMLDNTGNLVLVSNNNSTVVWSSNSKKAAQS-AMGE 121
Query: 69 LLDSGNLVLRDEHDGDSETYFWQSFDYPSDTLLPGMKLGWDLKTGLERRVTSWKSFDDPS 128
LLDSGNLVLRDE D +S +Y WQSFDYPSDT+LPGMKLGWDL+ GL+RR+++WKS DDPS
Sbjct: 122 LLDSGNLVLRDEKDVNSGSYLWQSFDYPSDTMLPGMKLGWDLRIGLDRRLSAWKSPDDPS 181
Query: 129 PGDFIWAIERQDNPEVVMWKGSRKFYRTGPWNGLRFSA-PSLRPNPIFSFSFVSNDVELY 187
GDF W + Q NPE+V+WKGS K++R+GPWNG+ FS +LR NP+F F FV N E+Y
Sbjct: 182 SGDFTWGTQLQSNPELVIWKGSEKYFRSGPWNGIGFSGEAALRINPVFYFDFVDNGEEVY 241
Query: 188 YTFNITNKAVISRIVMNQTL-YVRRRFIWNKATQSWELYSDVPRDQCDTYGLCGAYGICI 246
YT+N+ NK++I+R+VMNQT ++R+R+ WN+ +Q+WELY+ VPRD CD Y LCGAYG CI
Sbjct: 242 YTYNLKNKSLITRLVMNQTTGFLRQRYTWNEISQTWELYAYVPRDYCDNYNLCGAYGNCI 301
Query: 247 IGQSPVCQCLKGFKPKSG---GYVDRSQGCVRSKPLNYSRQDGFIKFTELKLPDATSSWV 303
I QSPVC+CL+ F PKS ++ SQGCVR+KPL+ + DGF+K+ LKLPDAT+SWV
Sbjct: 302 ISQSPVCECLEKFTPKSPESWNSMNWSQGCVRNKPLDCQKGDGFVKYVGLKLPDATNSWV 361
Query: 304 SKSMNLKECREGCLENSSCMAYTNSDIRGGGSGCAMWFGELIDMRDFPGGGQDFYIRMSA 363
+K+MNLKECR CL+N SCMAYT +DI+ SGCA+WFG+LID+R FP GGQ+ YIRM+A
Sbjct: 362 NKTMNLKECRSKCLQNCSCMAYTATDIKER-SGCAIWFGDLIDIRQFPDGGQEIYIRMNA 420
Query: 364 SEIGAKGEPTTKIVVIVISTAALLAVVLIAGYLIRKRRRN------------------IA 405
SE + I +S ++L+A Y+ ++ + ++
Sbjct: 421 SESSECLSLIKMEMGIALSIFVACGMLLVAYYIFKRTEKLKAHYSFLLVYHVCDSHSLLS 480
Query: 406 EKTENSRE-TDQENEDQNIDLELPLFELATIANATDNFSINNKLGEGGFGPVYKGTLVDG 464
EKT +RE DQ + D+ELPLF+ TIA AT+ FS+NNK+GEGGFGPVYKGTL DG
Sbjct: 481 EKTGGNREENDQIDSGPMEDMELPLFQFTTIAKATNGFSLNNKIGEGGFGPVYKGTLEDG 540
Query: 465 QEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMPNKSLD 524
QEIAVK LS+ S QGL E KNEVIL +KLQHRNLVKLLGCCIQGEEK+L+YE+MPN+SLD
Sbjct: 541 QEIAVKTLSRSSGQGLNEFKNEVILITKLQHRNLVKLLGCCIQGEEKILVYEYMPNRSLD 600
Query: 525 SFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKIS 584
SFIFDQTR LLDWS+RF IICG ARGLLYLHQDSRLRI+HRDLKASNVLLD+DMNPKIS
Sbjct: 601 SFIFDQTRGKLLDWSKRFSIICGIARGLLYLHQDSRLRIVHRDLKASNVLLDKDMNPKIS 660
Query: 585 DFGLVRTFGGDETEGNTNRVVGTY---------DGQFSIKSDVFSFGILLLEIVSGKKNR 635
DFGL R GGD+TEGNT RV+GTY DG FS+KSDVFSFGIL+LEI+SGKK+R
Sbjct: 661 DFGLARMVGGDQTEGNTTRVIGTYGYMAPEYATDGLFSVKSDVFSFGILMLEIISGKKSR 720
Query: 636 GFYRSDTKVNLIGH---LWDEGIPLRLIDACIQDSCNLADVI-RCIHIGLLCVQQHPEDR 691
GFY D ++L H LW +G PL LI+A +S NL++VI RCI+I LLCVQ HP+DR
Sbjct: 721 GFYHPDRSLSLTAHAWRLWKDGKPLDLIEAFPGESRNLSEVIMRCINISLLCVQHHPDDR 780
Query: 692 PCMPSVILMLGSEILLPQPKQPGYLADRKSTEPYSSSSMPESSSTNTLTISELEAR 747
P M +V+ MLG E LPQP +PG+ P SSSS E S N T S L R
Sbjct: 781 PSMATVVWMLGGENTLPQPNEPGFFKGSGPFGPSSSSSNIELYSNNEFTASLLYPR 836
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224115136|ref|XP_002316951.1| predicted protein [Populus trichocarpa] gi|222860016|gb|EEE97563.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 882 bits (2278), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 454/783 (57%), Positives = 555/783 (70%), Gaps = 49/783 (6%)
Query: 10 KSYPPHEVVWVANRLNPINDSFGFLMINKTGNLVLTSQ-SNIVVWSAYLSKEVQTPVVLQ 68
K+ P +VWVANR NPINDS G L ++ ++VL S +N VVWS+ +K+ +P+ LQ
Sbjct: 65 KNIPVRTIVWVANRRNPINDSSGLLKVDNCSDIVLLSNNTNTVVWSSNSTKKASSPI-LQ 123
Query: 69 LLDSGNLVLRDEHDGDSETYFWQSFDYPSDTLLPGMKLGWDLKTGLERRVTSWKSFDDPS 128
LLDSGNLVLRD++DG S WQSFDYP DT+LPGMK+GWDL+ G + R++SWKS DDPS
Sbjct: 124 LLDSGNLVLRDKNDGRS-GLLWQSFDYPCDTMLPGMKIGWDLRAGFDWRLSSWKSSDDPS 182
Query: 129 PGDFIWAIERQDNPEVVMWKGSRKFYRTGPWNGLRFSAPS-LRPNPIFSFSFVSNDVELY 187
PGDF IER+ NPEVV WKGS+K YR+GPWNG+ FS + ++PNP+F F+FVSN++E+Y
Sbjct: 183 PGDFTMGIERESNPEVVAWKGSKKHYRSGPWNGVGFSGSTEVKPNPVFYFTFVSNNIEVY 242
Query: 188 YTFNITNKA-VISRIVMNQTLYVRRRFIWNKATQSWELYSDVPRDQCDTYGLCGAYGICI 246
Y FN+ +++ VI+R+V+N T R+ + WN+ TQ+W L VPRD CD YGLCGA CI
Sbjct: 243 YIFNLKSESTVITRLVLNHTTSDRQCYTWNEETQTWVLQVSVPRDHCDNYGLCGANANCI 302
Query: 247 IGQSPVCQCLKGFKPKSG---GYVDRSQGCVRSKPLNYSRQDGFIKFTELKLPDATSSWV 303
PVCQCL+ FKPKS +D SQGCVR+K L+ + DGFIKF LKLPDAT SWV
Sbjct: 303 FNAIPVCQCLEKFKPKSPEEWNKMDWSQGCVRNKELDCQKGDGFIKFDGLKLPDATHSWV 362
Query: 304 SKSMNLKECREGCLENSSCMAYTNSDIRGGGSGCAMWFGELIDMRDFPGGGQDFYIRMSA 363
+K MNLKEC+ CL N SCMAY+N DIRGGGSGCA WFG+L+D+R PGGGQ+ YIRM A
Sbjct: 363 NKDMNLKECKAKCLGNCSCMAYSNLDIRGGGSGCANWFGDLMDIRLVPGGGQELYIRMHA 422
Query: 364 SEIGAK-GEPTTKIVVIVISTAALLAVVLIAGYLIRKRRRNIAE-----KTENSRETDQE 417
SEIG + + KI I + L+ L Y + K + AE +TEN + D
Sbjct: 423 SEIGDREAKANMKIAAIATAVVGLILGTLTISYHVSKEKAKSAENTSSERTENDWKNDTN 482
Query: 418 NEDQNIDLELPLFELATIANATDNFSINNKLGEGGFGPVYKGTLVDGQEIAVKRLSKISE 477
N Q D+ELPLF + IA+AT+NFS+NNKLGEGGFGPVY+G L DG EIAVKRLS+ S
Sbjct: 483 NGGQKEDMELPLFAFSAIADATNNFSVNNKLGEGGFGPVYRGKLEDGLEIAVKRLSRCSG 542
Query: 478 QGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQTRRTLLD 537
QG E KNEVIL +KLQHRNLVKLLGCC Q EEK+LIYE+MPN+SLD FIFD+T+ LLD
Sbjct: 543 QGFSEFKNEVILINKLQHRNLVKLLGCCSQREEKMLIYEYMPNRSLDFFIFDETKGRLLD 602
Query: 538 WSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDET 597
WS+RF+II G ARGLLYLHQDSRLRIIHRDLKASNVLLD MNPKISDFGL R F D+T
Sbjct: 603 WSRRFNIISGIARGLLYLHQDSRLRIIHRDLKASNVLLDDHMNPKISDFGLARMFVADQT 662
Query: 598 EGNTNRVVG------------------------------TYDGQFSIKSDVFSFGILLLE 627
EG+T+RV DG FS+KSDVFSFG+LLLE
Sbjct: 663 EGDTSRVTSDSLASSNIPILPLCILTLNASCSGYMAPEYATDGLFSVKSDVFSFGVLLLE 722
Query: 628 IVSGKKNRGFYRSDTKVNLIGH---LWDEGIPLRLIDACIQDSCNLADVIRCIHIGLLCV 684
I+SGKK++GFY D +LIGH LW+EG LIDA +SCN ++V+RC+HI LLCV
Sbjct: 723 IISGKKSKGFYHPDH--SLIGHTWRLWNEGKASELIDALGDESCNPSEVLRCVHISLLCV 780
Query: 685 QQHPEDRPCMPSVILMLGSEILLPQPKQPGYLADRKSTEPYSSSSMPESSSTNTLTISEL 744
Q HP+DRP M SV+ MLG + LP+PK+P +L R E SSSS SSSTN +T+S
Sbjct: 781 QHHPDDRPSMASVVWMLGGDSALPKPKEPAFLNYRAPGESSSSSSKVGSSSTNEITVSVF 840
Query: 745 EAR 747
E R
Sbjct: 841 EPR 843
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|449458261|ref|XP_004146866.1| PREDICTED: receptor-like serine/threonine-protein kinase SD1-8-like [Cucumis sativus] | Back alignment and taxonomy information |
|---|
Score = 869 bits (2246), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 442/756 (58%), Positives = 549/756 (72%), Gaps = 27/756 (3%)
Query: 10 KSYPPHEVVWVANRLNPINDS--FGFLMINKTGNLVLTSQSNIVVWSAYLSKEVQTPVVL 67
K P +VWVANR NPI +S L IN T + + +++ VVW K +TP L
Sbjct: 68 KIIPVRTIVWVANRENPIRNSSAVAVLKINSTSSDLFLFENDAVVWFGKSLKPAKTPK-L 126
Query: 68 QLLDSGNLVLRDEHDGDSETYFWQSFDYPSDTLLPGMKLGWDLKTGLERRVTSWKSFDDP 127
QLLD+GNL+L+D +SE WQSFDYP+DTLLPGMKLGWD K G++RR+++WK+ DDP
Sbjct: 127 QLLDNGNLLLKD---AESEETSWQSFDYPTDTLLPGMKLGWDFKNGIQRRLSAWKTSDDP 183
Query: 128 SPGDFIWAIERQDNPEVVMWKGSRKFYRTGPWNGLRFSAPSLRPNPIFSFSFVSNDVELY 187
SPG + PE VMW GS ++ R+GPWNGL+FSA PI +S+V+N EL
Sbjct: 184 SPGSLTMEMMNTSYPEPVMWNGSSEYMRSGPWNGLQFSAKPTSALPILVYSYVNNKSELS 243
Query: 188 YTFNITNKAVISRIVMNQTLYVRRRFIWNKATQSWELYSDVPRDQCDTYGLCGAYGICII 247
Y++ + N ++I R+V+NQT+ R +W++ ++W+ Y+ +PRD CDTY +CGA+G C I
Sbjct: 244 YSYELINSSLIGRMVLNQTILRREALLWSEPEKNWKPYAAMPRDYCDTYSVCGAFGSCDI 303
Query: 248 GQSPVCQCLKGFKP---KSGGYVDRSQGCVRSKPLNYSRQDGFIKFTELKLPDATSSWVS 304
Q P CQCL GF P + +D ++GCVR+KPLN S + GF K LKLPD SWV+
Sbjct: 304 EQVPACQCLFGFHPNVQEKWNLMDYTEGCVRNKPLNCSDKTGFAKLPGLKLPDTKQSWVN 363
Query: 305 KSMNLKECREGCLENSSCMAYTNSDIRGGGSGCAMWFGELIDMRDFPGGGQDFYIRMSAS 364
+SM+L ECRE CL N SC+A+ N+DIRG GSGCA+WFGEL+D++ GGQD Y+RM AS
Sbjct: 364 ESMSLNECREKCLRNCSCVAFANTDIRGSGSGCAIWFGELVDIKVVRRGGQDLYVRMLAS 423
Query: 365 EIGAKGEPTTKIVVIVISTAALLAVVLIAG-YLIRKRRRNIAEKTENSRETDQENEDQNI 423
E+ K + + VIV + A L+ +L+ G Y+IR +RR + E T ++ E Q
Sbjct: 424 ELETKKTSSVAVGVIVGAAALLILGLLLIGFYVIRSKRRKL-EATGAGKDL----EGQED 478
Query: 424 DLELPLFELATIANATDNFSINNKLGEGGFGPVYKGTLVDGQEIAVKRLSKISEQGLKEL 483
DLELPLF LATI+NATDNFS NKLGEGGFG V++G L DG+EIAVKRLS S QG E
Sbjct: 479 DLELPLFNLATISNATDNFSNFNKLGEGGFGAVFRGRLTDGKEIAVKRLSSYSRQGTDEF 538
Query: 484 KNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFH 543
KNEVIL +KLQHRNLVKLLGCCIQGEEK+LIYE+MPNKSLDSFIFD R+ LLDWS+RF+
Sbjct: 539 KNEVILIAKLQHRNLVKLLGCCIQGEEKMLIYEYMPNKSLDSFIFDSARKKLLDWSKRFN 598
Query: 544 IICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNTNR 603
IICG ARG+LYLHQDSRLRIIHRDLKASNVLLD D+NPKISDFG+ RTFGGD+TEGNT R
Sbjct: 599 IICGVARGILYLHQDSRLRIIHRDLKASNVLLDIDLNPKISDFGMARTFGGDQTEGNTRR 658
Query: 604 VVGTY---------DGQFSIKSDVFSFGILLLEIVSGKKNRGFYRSDTKVNLIGH---LW 651
VVGTY DGQFSIKSDVFSFGIL+LEI+SG+KNRGF+R + +NLIGH LW
Sbjct: 659 VVGTYGYMAPEYAIDGQFSIKSDVFSFGILMLEIISGEKNRGFFRPNHALNLIGHAWKLW 718
Query: 652 DEGIPLRLIDACIQDSCNLADVIRCIHIGLLCVQQHPEDRPCMPSVILMLGSEILLPQPK 711
+EG PL LIDA I +S L++V+RCIH+ LLC+QQ PEDRP M +V+LML SE L QPK
Sbjct: 719 NEGKPLELIDASIGESYALSEVLRCIHVSLLCLQQLPEDRPTMSNVVLMLSSEGSLAQPK 778
Query: 712 QPGYLADRKSTEPYSSSSMPESSSTNTLTISELEAR 747
QPG+ +R S E +S S ESS TN LTI+ LEAR
Sbjct: 779 QPGFYMERDSLEVFSVSGKNESSITNELTITLLEAR 814
|
Source: Cucumis sativus Species: Cucumis sativus Genus: Cucumis Family: Cucurbitaceae Order: Cucurbitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|449476944|ref|XP_004154883.1| PREDICTED: receptor-like serine/threonine-protein kinase SD1-8-like [Cucumis sativus] | Back alignment and taxonomy information |
|---|
Score = 867 bits (2239), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 440/756 (58%), Positives = 550/756 (72%), Gaps = 27/756 (3%)
Query: 10 KSYPPHEVVWVANRLNPINDS--FGFLMINKTGNLVLTSQSNIVVWSAYLSKEVQTPVVL 67
K P +VWVANR NPI +S L IN T + + +++ VVW K +TP L
Sbjct: 68 KIIPVRTIVWVANRENPIRNSSAVAVLKINSTSSDLFLFENDAVVWFGKSLKPAKTPK-L 126
Query: 68 QLLDSGNLVLRDEHDGDSETYFWQSFDYPSDTLLPGMKLGWDLKTGLERRVTSWKSFDDP 127
QLLD+GNL+L+D +SE WQSFDYP+DTLLPGMKLGWD K G++RR+++WK+ DDP
Sbjct: 127 QLLDNGNLLLKD---AESEETSWQSFDYPTDTLLPGMKLGWDFKNGIQRRLSAWKTSDDP 183
Query: 128 SPGDFIWAIERQDNPEVVMWKGSRKFYRTGPWNGLRFSAPSLRPNPIFSFSFVSNDVELY 187
SPG + PE VMW GS ++ R+GPWNGL++SA PI +S+V+N EL
Sbjct: 184 SPGSLTMEMMNTSYPEPVMWNGSSEYMRSGPWNGLQYSAKPTSALPILVYSYVNNKSELS 243
Query: 188 YTFNITNKAVISRIVMNQTLYVRRRFIWNKATQSWELYSDVPRDQCDTYGLCGAYGICII 247
Y++ + N ++I R+V+NQT+ R +W++ ++W+ Y+ +PRD CDTY +CGA+G C I
Sbjct: 244 YSYELINSSLIGRMVLNQTILRREALLWSEPEKNWKPYAAMPRDYCDTYSVCGAFGSCDI 303
Query: 248 GQSPVCQCLKGFKP---KSGGYVDRSQGCVRSKPLNYSRQDGFIKFTELKLPDATSSWVS 304
Q P CQCL GF P + +D ++GCVR+KPLN S + GF K LKLPD SWV+
Sbjct: 304 EQVPACQCLFGFHPNVQEKWNLMDYTEGCVRNKPLNCSDKTGFAKLPGLKLPDTKQSWVN 363
Query: 305 KSMNLKECREGCLENSSCMAYTNSDIRGGGSGCAMWFGELIDMRDFPGGGQDFYIRMSAS 364
+SM+L ECRE CL N SC+A+ N+DIRG GSGCA+WFGEL+D++ GGQD Y+RM AS
Sbjct: 364 ESMSLNECREKCLRNCSCVAFANTDIRGSGSGCAIWFGELVDIKVVRRGGQDLYVRMLAS 423
Query: 365 EIGAKGEPTTKIVVIVISTAALLAVVLIAG-YLIRKRRRNIAEKTENSRETDQENEDQNI 423
E+ K + + VIV + A L+ +L+ G Y+IR +RR + E T ++ E Q
Sbjct: 424 ELETKKTSSVAVGVIVGAAALLILGLLLIGFYVIRSKRRKL-EATGAGKDL----EGQED 478
Query: 424 DLELPLFELATIANATDNFSINNKLGEGGFGPVYKGTLVDGQEIAVKRLSKISEQGLKEL 483
DLELPLF LATI+NATDNFS NKLGEGGFG V++G L DG+EIAVKRLS S QG E
Sbjct: 479 DLELPLFNLATISNATDNFSNFNKLGEGGFGAVFRGRLTDGKEIAVKRLSSYSRQGTDEF 538
Query: 484 KNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFH 543
KNEVIL +KLQHRNLVKLLGCCIQGEEK+LIYE+MPNKSLDSFIFD R+ LLDWS+RF+
Sbjct: 539 KNEVILIAKLQHRNLVKLLGCCIQGEEKMLIYEYMPNKSLDSFIFDSARKKLLDWSKRFN 598
Query: 544 IICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNTNR 603
IICG ARG+LYLHQDSRLRIIHRDLKASNVLLD D+NPKISDFG+ RTFGGD+TEGNT R
Sbjct: 599 IICGVARGILYLHQDSRLRIIHRDLKASNVLLDIDLNPKISDFGMARTFGGDQTEGNTRR 658
Query: 604 VVGTY---------DGQFSIKSDVFSFGILLLEIVSGKKNRGFYRSDTKVNLIGH---LW 651
VVGTY DGQFSIKSDVFSFGIL+LEI+SG+KNRGF+R + +NLIGH LW
Sbjct: 659 VVGTYGYMAPEYAIDGQFSIKSDVFSFGILMLEIISGEKNRGFFRPNHALNLIGHAWKLW 718
Query: 652 DEGIPLRLIDACIQDSCNLADVIRCIHIGLLCVQQHPEDRPCMPSVILMLGSEILLPQPK 711
+EG PL LIDA I +S L++V+RCIH+ LLC+QQ PEDRP M +V+LML SE L QPK
Sbjct: 719 NEGKPLELIDASIGESYALSEVLRCIHVSLLCLQQLPEDRPTMSNVVLMLSSEGSLAQPK 778
Query: 712 QPGYLADRKSTEPYSSSSMPESSSTNTLTISELEAR 747
QPG+ +R S E +S S ESS+TN LTI+ LEA+
Sbjct: 779 QPGFYMERDSLEVFSVSGKNESSTTNELTITLLEAK 814
|
Source: Cucumis sativus Species: Cucumis sativus Genus: Cucumis Family: Cucurbitaceae Order: Cucurbitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356546914|ref|XP_003541865.1| PREDICTED: G-type lectin S-receptor-like serine/threonine-protein kinase At4g27290-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 855 bits (2208), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 426/757 (56%), Positives = 542/757 (71%), Gaps = 61/757 (8%)
Query: 10 KSYPPHEVVWVANRLNPINDSFGFLMIN-KTGNLVLTSQSNIVVWSAYLSKEVQTPVVLQ 68
+ P VVWVANRLNPINDS G L +N TG LVLT + V+WS + ++PV L
Sbjct: 74 RKIPIQTVVWVANRLNPINDSSGILRMNPSTGTLVLT-HNGTVIWSTASIRRPESPVAL- 131
Query: 69 LLDSGNLVLRDEHDGDSETYFWQSFDYPSDTLLPGMKLGWDLKTGLERRVTSWKSFDDPS 128
LL+SGNLV+RDE D +SE Y W+SF+YP+DT LP MK GWDL+TGL R++ +WKS DDPS
Sbjct: 132 LLNSGNLVIRDEKDANSEDYLWESFNYPTDTFLPEMKFGWDLRTGLNRKLIAWKSPDDPS 191
Query: 129 PGDFIWAIERQDNPEVVMWKGSRKFYRTGPWNGLRFS-APSLRPNPIFSFSFVSNDVELY 187
P DF + + + PE M KG +KFYR+GPWNGL S +P ++ NPI+ F FVSN ELY
Sbjct: 192 PSDFSFGMVLNNYPEAYMMKGDQKFYRSGPWNGLHSSGSPQVKANPIYDFKFVSNKDELY 251
Query: 188 YTFNITNKAVISRIVMNQTLYVRRRFIWNKATQSWELYSDVPRDQCDTYGLCGAYGICII 247
YT+++ N ++ISR+V+N T YVR+R++W ++ Q WE+Y+ VP D CD+Y LCGA C+I
Sbjct: 252 YTYSLKNSSMISRLVLNATSYVRKRYVWIESKQRWEVYTSVPLDLCDSYSLCGANANCVI 311
Query: 248 GQSPVCQCLKGFKPK---SGGYVDRSQGCVRSKPLN--YSRQDGFIKFTELKLPDATSSW 302
SPVCQCL+GFKPK + +D S GC+R+K L+ +DGF K T LK PD T SW
Sbjct: 312 SDSPVCQCLQGFKPKLPEAWSSMDWSHGCIRNKELSCENKNKDGFNKLTLLKTPDTTHSW 371
Query: 303 VSKSMNLKECREGCLENSSCMAYTNSDIRGGGSGCAMWFGELIDMRDFPGGGQDFYIRMS 362
+ +++ L+EC+ CL+N SCMAY NSDI G GSGCAMWFG+LID+R F GGQD Y+R+
Sbjct: 372 LDQTIGLEECKAKCLDNCSCMAYANSDISGQGSGCAMWFGDLIDIRQFAAGGQDVYVRID 431
Query: 363 ASEIGAKGEPTTKIVVIVISTAALLAVVLIAGYLIRKRRRNIAEKTENSRETDQENEDQN 422
ASE+ E+++ S +++Q + Q
Sbjct: 432 ASEL---------------------------------------ERSDFSIKSNQNSGMQV 452
Query: 423 IDLELPLFELATIANATDNFSINNKLGEGGFGPVYKGTLVDGQEIAVKRLSKISEQGLKE 482
D++LP+F+L+TIA AT NF++ NK+GEGGFGPVY+G+L DGQEIAVKRLS S QGL E
Sbjct: 453 DDMDLPVFDLSTIAKATSNFTVKNKIGEGGFGPVYRGSLTDGQEIAVKRLSASSGQGLTE 512
Query: 483 LKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRF 542
KNEV L +KLQHRNLVKLLGCC++GEEK+L+YE+M N SLDSFIFD+ R LDWS+RF
Sbjct: 513 FKNEVKLIAKLQHRNLVKLLGCCLEGEEKMLVYEYMLNGSLDSFIFDEQRSGSLDWSKRF 572
Query: 543 HIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNTN 602
+IICG A+GLLYLHQDSRLRIIHRDLKASNVLLD ++NPKISDFG+ R FG D+ EGNT
Sbjct: 573 NIICGIAKGLLYLHQDSRLRIIHRDLKASNVLLDSELNPKISDFGMARIFGVDQQEGNTK 632
Query: 603 RVVGTY---------DGQFSIKSDVFSFGILLLEIVSGKKNRGFYRSDTKVNLIGH---L 650
R+VGTY DG FS+KSDVFSFG+LLLEI+SGK++RG+Y + NLIGH L
Sbjct: 633 RIVGTYGYMAPEYATDGLFSVKSDVFSFGVLLLEIISGKRSRGYYNQNHSQNLIGHAWKL 692
Query: 651 WDEGIPLRLIDACIQDSCNLADVIRCIHIGLLCVQQHPEDRPCMPSVILMLGSEILLPQP 710
W EG PL LID I+DS +L+ ++ CIH+ LLCVQQ+PEDRP M SV+LML SE+ LP+P
Sbjct: 693 WKEGRPLELIDKSIEDSSSLSQMLHCIHVSLLCVQQNPEDRPGMSSVLLMLVSELELPEP 752
Query: 711 KQPGYLADRKSTEPYSSSSMPESSSTNTLTISELEAR 747
KQPG+ + S E SS+S + SSTN +TI+ LEAR
Sbjct: 753 KQPGFFG-KYSGEADSSTSKQQLSSTNEITITLLEAR 788
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356514895|ref|XP_003526137.1| PREDICTED: G-type lectin S-receptor-like serine/threonine-protein kinase At4g27290-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 851 bits (2198), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 436/758 (57%), Positives = 534/758 (70%), Gaps = 23/758 (3%)
Query: 10 KSYPPHEVVWVANRLNPINDSFGFLMINKTGNLVLTSQSN-IVVWSAYLSKEVQTPVVLQ 68
K+ P VVWVANR NPI D+ L IN GN +L +Q+N V+WS + + VV Q
Sbjct: 67 KNIPIRTVVWVANRDNPIKDNSSKLSINTAGNFILLNQNNNTVIWSTNTTTKASL-VVAQ 125
Query: 69 LLDSGNLVLRDEHDGDSETYFWQSFDYPSDTLLPGMKLGWDLKTGLERRVTSWKSFDDPS 128
LLDSGNLVLRDE D + E Y WQSFDYPSDT LPGMK GWDLK GL R +T+WK++DDPS
Sbjct: 126 LLDSGNLVLRDEKDNNPENYSWQSFDYPSDTFLPGMKAGWDLKKGLNRVLTAWKNWDDPS 185
Query: 129 PGDFIWAIERQDNPEVVMWKGSRKFYRTGPWNGLRFS-APSLRPNPIFSFSFVSNDVELY 187
GDF R + PE VMWKG+ ++YR+GPW+G +FS +PS+ N I ++S VSN E Y
Sbjct: 186 SGDFTANSSRTNFPEEVMWKGTSEYYRSGPWDGRKFSGSPSVPTNSIVNYSVVSNKDEFY 245
Query: 188 YTFNITNKAVISRIVMNQTLYVRRRFIWNKATQSWELYSDVPRDQCDTYGLCGAYGICII 247
T+++ +K++ISR+V+NQTLYVR+R WN+ +Q+W + S++P D CD Y CGA+GIC+
Sbjct: 246 ATYSMIDKSLISRVVVNQTLYVRQRLTWNEDSQTWRVSSELPGDLCDNYSTCGAFGICVA 305
Query: 248 GQSPVCQCLKGFKPKSG---GYVDRSQGCVRSKPLN--YSRQDGFIKFTELKLPDATSSW 302
GQ+PVC CL GFKPKS ++ +QGCV ++ + +DGF KF+ LK PD SW
Sbjct: 306 GQAPVCNCLDGFKPKSTRNWTQMNWNQGCVHNQTWSCMEKNKDGFKKFSNLKAPDTERSW 365
Query: 303 VSKSMNLKECREGCLENSSCMAYTNSDIRGGGSGCAMWFGELIDMRDFPGGGQDFYIRMS 362
V+ SM L EC+ C EN SC AY N D+RG GSGCA+WFG+L+D+R P GQD YIR++
Sbjct: 366 VNASMTLDECKNKCRENCSCTAYANFDMRGEGSGCAIWFGDLLDIRLIPNAGQDLYIRLA 425
Query: 363 ASEIGAKGEPTTKIVVIVISTAALLAVVLIAGYLIRKRRRNIAEKTENSRETDQENEDQN 422
SE K + K+VVI ++++A +LI ++ +NI E + NE Q
Sbjct: 426 VSETDEKDDSKKKVVVIASIVSSVVATLLIFIFIYWSNAKNIKEIILGIEV--KNNESQQ 483
Query: 423 IDLELPLFELATIANATDNFSINNKLGEGGFGPVYKGTLVDGQEIAVKRLSKISEQGLKE 482
D ELPLF+L +IA ATD+FS +NKLGEGGFGPVYKGTL DG E+AVKRLS+ S QGLKE
Sbjct: 484 EDFELPLFDLVSIAQATDHFSDHNKLGEGGFGPVYKGTLPDGLEVAVKRLSQTSGQGLKE 543
Query: 483 LKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRF 542
KNEV+L +KLQHRNLVK+LGCCIQ EKLLIYE+M NKSLD F+FD R LLDW +RF
Sbjct: 544 FKNEVMLCAKLQHRNLVKVLGCCIQENEKLLIYEYMANKSLDVFLFDSDRSKLLDWPKRF 603
Query: 543 HIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNTN 602
+II ARGLLYLHQDSRLRIIHRDLKASNVLLD +MNPKISDFGL R GGD+ EG T
Sbjct: 604 YIINRIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGLARMCGGDQIEGKTR 663
Query: 603 RVVGTY---------DGQFSIKSDVFSFGILLLEIVSGKK-NRGFYRSDTKVNLIGH--- 649
RVVGTY DG FSIKSDVFSFG+LLLEIVSGKK NR FY +D NLIGH
Sbjct: 664 RVVGTYGYMAPEYAFDGLFSIKSDVFSFGVLLLEIVSGKKNNRLFYPNDYNNNLIGHAWS 723
Query: 650 LWDEGIPLRLIDACIQDSCNLADVIRCIHIGLLCVQQHPEDRPCMPSVILMLGSEILLPQ 709
LW+EG P+ I ++DSC L + +RCIHIGLLCVQ HP DRP M SV+++L +E LP
Sbjct: 724 LWNEGNPMEFIATSLEDSCILYEALRCIHIGLLCVQHHPNDRPNMASVVVLLSNENALPL 783
Query: 710 PKQPGYLADRKSTEPYSSSSMPESSSTNTLTISELEAR 747
PK P YL STE SSS S S N +TIS L R
Sbjct: 784 PKYPRYLITDISTERESSSEKFTSYSINDVTISMLSDR 821
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST
Original result of BLAST against Gene Ontology (AMIGO)
| ID |
Alignment graph |
Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 747 | ||||||
| TAIR|locus:2131684 | 783 | AT4G27290 [Arabidopsis thalian | 0.451 | 0.430 | 0.579 | 9e-193 | |
| TAIR|locus:2131694 | 815 | AT4G27300 [Arabidopsis thalian | 0.923 | 0.846 | 0.500 | 7.4e-185 | |
| TAIR|locus:2018506 | 847 | RK2 "receptor kinase 2" [Arabi | 0.410 | 0.362 | 0.588 | 7.4e-176 | |
| TAIR|locus:2018546 | 843 | RK1 "receptor kinase 1" [Arabi | 0.393 | 0.348 | 0.609 | 3.2e-175 | |
| TAIR|locus:2141176 | 849 | B120 [Arabidopsis thaliana (ta | 0.393 | 0.346 | 0.590 | 6.4e-153 | |
| TAIR|locus:2200151 | 830 | SD1-13 "S-domain-1 13" [Arabid | 0.969 | 0.872 | 0.424 | 1.4e-149 | |
| TAIR|locus:2200888 | 804 | AT1G61500 [Arabidopsis thalian | 0.911 | 0.847 | 0.434 | 5.5e-141 | |
| UNIPROTKB|O49974 | 848 | KIK1 "Serine/threonine-protein | 0.444 | 0.391 | 0.528 | 1.9e-140 | |
| TAIR|locus:2197729 | 805 | SD1-29 "S-domain-1 29" [Arabid | 0.911 | 0.845 | 0.420 | 5.6e-139 | |
| TAIR|locus:2197744 | 807 | AT1G61420 [Arabidopsis thalian | 0.929 | 0.859 | 0.413 | 1.2e-138 |
| TAIR|locus:2131684 AT4G27290 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1027 (366.6 bits), Expect = 9.0e-193, Sum P(2) = 9.0e-193
Identities = 204/352 (57%), Positives = 256/352 (72%)
Query: 409 ENSRETDQENEDQNIDLELPLFELATIANATDNFSINNKLGEGGFGPVYKGTLVDGQEIA 468
E+SR + ++ E++ DLELP +L T++ AT FS NKLG+GGFGPVYKGTL GQE+A
Sbjct: 434 ESSRVSSRKQEEE--DLELPFLDLDTVSEATSGFSAGNKLGQGGFGPVYKGTLACGQEVA 491
Query: 469 VKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMPNKSLDSFIF 528
VKRLS+ S QG++E KNE+ L +KLQHRNLVK+LG C+ EE++LIYE+ PNKSLDSFIF
Sbjct: 492 VKRLSRTSRQGVEEFKNEIKLIAKLQHRNLVKILGYCVDEEERMLIYEYQPNKSLDSFIF 551
Query: 529 DQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGL 588
D+ RR LDW +R II G ARG+LYLH+DSRLRIIHRDLKASNVLLD DMN KISDFGL
Sbjct: 552 DKERRRELDWPKRVEIIKGIARGMLYLHEDSRLRIIHRDLKASNVLLDSDMNAKISDFGL 611
Query: 589 VRTFGGDETEGNTNRVVGTY---------DGQFSIKSDVFSFGILLLEIVSGKKNRGFYR 639
RT GGDETE NT RVVGTY DG FS+KSDVFSFG+L+LEIVSG++NRGF
Sbjct: 612 ARTLGGDETEANTTRVVGTYGYMSPEYQIDGYFSLKSDVFSFGVLVLEIVSGRRNRGFRN 671
Query: 640 SDTKVNLIGHLWDEGIP---LRLIDACIQDSC-NLADVIRCIHIGLLCVQQHPEDRPCMP 695
+ K+NL+GH W + + +ID + +SC ++++V+R IHIGLLCVQQ P+DRP M
Sbjct: 672 EEHKLNLLGHAWRQFLEDKAYEIIDEAVNESCTDISEVLRVIHIGLLCVQQDPKDRPNMS 731
Query: 696 SVILMLGSEILLPQPKQPGYLADRKXXXXXXXXXXXXXXXXNTLTISELEAR 747
V+LML SE+LL P+QPG+ +R N T+S ++ R
Sbjct: 732 VVVLMLSSEMLLLDPRQPGFFNERNLLFSDTVSINLEIPSNNFQTMSVIDPR 783
|
|
| TAIR|locus:2131694 AT4G27300 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1793 (636.2 bits), Expect = 7.4e-185, P = 7.4e-185
Identities = 368/735 (50%), Positives = 494/735 (67%)
Query: 14 PHEVVWVANRLNPINDSFGFLMINKTGNLVLTSQSNIVVWSAY-----LSKEVQTPVVLQ 68
P VVWVANR NP+ + GFL ++ G+L L + +WS+ SK P+ L+
Sbjct: 72 PFAVVWVANRNNPLYGTSGFLNLSSLGDLQLFDGEHKALWSSSSSSTKASKTANNPL-LK 130
Query: 69 LLDSGNLVLRDEHDGDSETYFWQSFDYPSDTLLPGMKLGWDLKTGLERRVTSWKSFDDPS 128
+ SGNL+ DG+ E WQSFDYP +T+L GMKLG + KT +E ++SWK+ DPS
Sbjct: 131 ISCSGNLI---SSDGE-EAVLWQSFDYPMNTILAGMKLGKNFKTQMEWSLSSWKTLKDPS 186
Query: 129 PGDFIWAIERQDNPEVVMWK-GSRKF-YRTGPWNGLRFS-APSL-RPNPIFSFSFVSNDV 184
PGDF +++ + P++++ K G + YR G WNGL F+ AP++ R N +F + F S+
Sbjct: 187 PGDFTLSLDTRGLPQLILRKNGDSSYSYRLGSWNGLSFTGAPAMGRENSLFDYKFTSSAQ 246
Query: 185 ELYYTFNITNKAVISRIVMNQTLYVRRRFIWNKATQSWELYSDVPRDQCDTYGLCGAYGI 244
E+ Y++ ++ ++SR+V+N T + R FI +K Q W L + P D+CD Y +CGAY +
Sbjct: 247 EVNYSWTPRHR-IVSRLVLNNTGKLHR-FIQSKQNQ-WILANTAPEDECDYYSICGAYAV 303
Query: 245 CIIGQ--SPVCQCLKGFKPKSGGY--VDR-SQGCVRSKPLNYSRQDGFIKFTELKLPDAT 299
C I +P C CL+GFKPKSG + R + GCV P N ++D F+KF LKLPD +
Sbjct: 304 CGINSKNTPSCSCLQGFKPKSGRKWNISRGAYGCVHEIPTNCEKKDAFVKFPGLKLPDTS 363
Query: 300 SSW--VSKSMNLKECREGCLENSSCMAYTNSDIRGGGSGCAMWFGELIDMRDFPGGGQDF 357
SW M L++C+ C N SC AY N+DIR GG GC +WFG+L+DMR++ GQD
Sbjct: 364 WSWYDAKNEMTLEDCKIKCSSNCSCTAYANTDIREGGKGCLLWFGDLVDMREYSSFGQDV 423
Query: 358 YIRMSASEIGAKGEPTTKIVVIVISTAALLAVVLIAGYLIRKRRRNIAEKTENSRETDQE 417
YIRM ++I KG ++V +V+ + +AVVL+ + +++ + EN R+ +E
Sbjct: 424 YIRMGFAKIEFKGR---EVVGMVVGSVVAIAVVLVVVFACFRKKIMKRYRGENFRKGIEE 480
Query: 418 NEDQNIDLELPLFELATIANATDNFSINNKLGEGGFGPVYKGTLVDGQEIAVKRLSKISE 477
DL+LP+F+ TI+ ATD+FS N LG GGFGPVYKG L DGQEIAVKRLS S
Sbjct: 481 E-----DLDLPIFDRKTISIATDDFSYVNFLGRGGFGPVYKGKLEDGQEIAVKRLSANSG 535
Query: 478 QGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQTRRTLLD 537
QG++E KNEV L +KLQHRNLV+LLGCCIQGEE +LIYE+MPNKSLD FIFD+ R T LD
Sbjct: 536 QGVEEFKNEVKLIAKLQHRNLVRLLGCCIQGEECMLIYEYMPNKSLDFFIFDERRSTELD 595
Query: 538 WSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDET 597
W +R +II G ARG+LYLHQDSRLRIIHRDLKA NVLLD DMNPKISDFGL ++FGGD++
Sbjct: 596 WKKRMNIINGVARGILYLHQDSRLRIIHRDLKAGNVLLDNDMNPKISDFGLAKSFGGDQS 655
Query: 598 EGNTNRVVGTY---------DGQFSIKSDVFSFGILLLEIVSGKKNRGFYRSDTKVNLIG 648
E +TNRVVGTY DG FS+KSDVFSFG+L+LEI++GK NRGF +D +NL+G
Sbjct: 656 ESSTNRVVGTYGYMPPEYAIDGHFSVKSDVFSFGVLVLEIITGKTNRGFRHADHDLNLLG 715
Query: 649 HLWDEGIPLRLIDA----CIQDSCNLADVIRCIHIGLLCVQQHPEDRPCMPSVILMLGSE 704
H+W + R I+ ++++ + +V+RCIH+ LLCVQQ PEDRP M SV+LM GS+
Sbjct: 716 HVWKMWVEDREIEVPEEEWLEETSVIPEVLRCIHVALLCVQQKPEDRPTMASVVLMFGSD 775
Query: 705 ILLPQPKQPGYLADR 719
LP P QPG+ +R
Sbjct: 776 SSLPHPTQPGFFTNR 790
|
|
| TAIR|locus:2018506 RK2 "receptor kinase 2" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 917 (327.9 bits), Expect = 7.4e-176, Sum P(2) = 7.4e-176
Identities = 192/326 (58%), Positives = 238/326 (73%)
Query: 396 LIRKRRRNIAEKTENSRE-TDQENEDQNIDLELPLFELATIANATDNFSINNKLGEGGFG 454
L+R + + E + SR T +EN+ LELPL E +A AT+NFS +NKLG+GGFG
Sbjct: 478 LVRSQDSLMNELVKASRSYTSKENKTDY--LELPLMEWKALAMATNNFSTDNKLGQGGFG 535
Query: 455 PVYKGTLVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLI 514
VYKG L+DG+EIAVKRLSK+S QG E NEV L +KLQH NLV+LLGCC+ EK+LI
Sbjct: 536 IVYKGMLLDGKEIAVKRLSKMSSQGTDEFMNEVRLIAKLQHINLVRLLGCCVDKGEKMLI 595
Query: 515 YEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVL 574
YE++ N SLDS +FDQTR + L+W +RF II G ARGLLYLHQDSR RIIHRDLKASNVL
Sbjct: 596 YEYLENLSLDSHLFDQTRSSNLNWQKRFDIINGIARGLLYLHQDSRCRIIHRDLKASNVL 655
Query: 575 LDQDMNPKISDFGLVRTFGGDETEGNTNRVVGTY---------DGQFSIKSDVFSFGILL 625
LD++M PKISDFG+ R FG +ETE NT RVVGTY DG FS+KSDVFSFG+LL
Sbjct: 656 LDKNMTPKISDFGMARIFGREETEANTRRVVGTYGYMSPEYAMDGIFSMKSDVFSFGVLL 715
Query: 626 LEIVSGKKNRGFYRSDTKVNLIGHLW---DEGIPLRLIDACIQDSCNLA----DVIRCIH 678
LEI+SGK+N+GFY S+ +NL+G +W EG L ++D D+ + +++RCI
Sbjct: 716 LEIISGKRNKGFYNSNRDLNLLGFVWRHWKEGKELEIVDPINIDALSSEFPTHEILRCIQ 775
Query: 679 IGLLCVQQHPEDRPCMPSVILMLGSE 704
IGLLCVQ+ EDRP M SV++MLGSE
Sbjct: 776 IGLLCVQERAEDRPVMSSVMVMLGSE 801
|
|
| TAIR|locus:2018546 RK1 "receptor kinase 1" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 917 (327.9 bits), Expect = 3.2e-175, Sum P(2) = 3.2e-175
Identities = 189/310 (60%), Positives = 230/310 (74%)
Query: 411 SRETDQENEDQNIDLELPLFELATIANATDNFSINNKLGEGGFGPVYKGTLVDGQEIAVK 470
SR E ++ LELPL EL +A AT+NFS +NKLG+GGFG VYKG L+DG+EIAVK
Sbjct: 488 SRRGYTSKEKKSEYLELPLLELEALATATNNFSNDNKLGQGGFGIVYKGRLLDGKEIAVK 547
Query: 471 RLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQ 530
RLSK+S QG E NEV L +KLQH NLV+LLGCC+ EK+LIYE++ N SLDS +FDQ
Sbjct: 548 RLSKMSSQGTDEFMNEVRLIAKLQHINLVRLLGCCVDKGEKMLIYEYLENLSLDSHLFDQ 607
Query: 531 TRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVR 590
TR + L+W +RF II G ARGLLYLHQDSR RIIHRDLKASNVLLD++M PKISDFG+ R
Sbjct: 608 TRSSNLNWQKRFDIINGIARGLLYLHQDSRCRIIHRDLKASNVLLDKNMTPKISDFGMAR 667
Query: 591 TFGGDETEGNTNRVVGTY---------DGQFSIKSDVFSFGILLLEIVSGKKNRGFYRSD 641
FG +ETE NT RVVGTY DG FS+KSDVFSFG+LLLEI+SGK+N+GFY S+
Sbjct: 668 IFGREETEANTRRVVGTYGYMSPEYAMDGIFSMKSDVFSFGVLLLEIISGKRNKGFYNSN 727
Query: 642 TKVNLIGHLW---DEGIPLRLIDACIQDSCNLA----DVIRCIHIGLLCVQQHPEDRPCM 694
+NL+G +W EG L ++D DS + +++RCI IGLLCVQ+ EDRP M
Sbjct: 728 RDLNLLGFVWRHWKEGNELEIVDPINIDSLSSKFPTHEILRCIQIGLLCVQERAEDRPVM 787
Query: 695 PSVILMLGSE 704
SV++MLGSE
Sbjct: 788 SSVMVMLGSE 797
|
|
| TAIR|locus:2141176 B120 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 906 (324.0 bits), Expect = 6.4e-153, Sum P(2) = 6.4e-153
Identities = 182/308 (59%), Positives = 227/308 (73%)
Query: 426 ELPLFELATIANATDNFSINNKLGEGGFGPVYKGTLVDGQEIAVKRLSKISEQGLKELKN 485
ELP+F L IA AT++F N+LG GGFGPVYKG L DG+EIAVKRLS S QG+ E KN
Sbjct: 513 ELPVFSLNAIAIATNDFCKENELGRGGFGPVYKGVLEDGREIAVKRLSGKSGQGVDEFKN 572
Query: 486 EVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHII 545
E+IL +KLQHRNLV+LLGCC +GEEK+L+YE+MPNKSLD F+FD+T++ L+DW RF II
Sbjct: 573 EIILIAKLQHRNLVRLLGCCFEGEEKMLVYEYMPNKSLDFFLFDETKQALIDWKLRFSII 632
Query: 546 CGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNTNRVV 605
G ARGLLYLH+DSRLRIIHRDLK SNVLLD +MNPKISDFG+ R FGG++ E NT RVV
Sbjct: 633 EGIARGLLYLHRDSRLRIIHRDLKVSNVLLDAEMNPKISDFGMARIFGGNQNEANTVRVV 692
Query: 606 GTY---------DGQFSIKSDVFSFGILLLEIVSGKKNRGFYRSDTKVNLIGHLW---DE 653
GTY +G FS+KSDV+SFG+LLLEIVSGK+N RS +LIG+ W
Sbjct: 693 GTYGYMSPEYAMEGLFSVKSDVYSFGVLLLEIVSGKRNTSL-RSSEHGSLIGYAWYLYTH 751
Query: 654 GIPLRLIDACIQDSCNLADVIRCIHIGLLCVQQHPEDRPCMPSVILMLGSEIL-LPQPKQ 712
G L+D I+ +C+ + +RCIH+ +LCVQ +RP M SV+LML S+ L P+Q
Sbjct: 752 GRSEELVDPKIRVTCSKREALRCIHVAMLCVQDSAAERPNMASVLLMLESDTATLAAPRQ 811
Query: 713 PGYLADRK 720
P + + R+
Sbjct: 812 PTFTSTRR 819
|
|
| TAIR|locus:2200151 SD1-13 "S-domain-1 13" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1460 (519.0 bits), Expect = 1.4e-149, P = 1.4e-149
Identities = 329/775 (42%), Positives = 454/775 (58%)
Query: 13 PPHEVVWVANRLNPINDSFGFLMINKTGNLVLTSQSNIVVWSAYLSKEVQTPVVL-QLLD 71
P VVWVAN +PINDS G + I+K GNLV+ V WS + V +LL+
Sbjct: 67 PVQTVVWVANSNSPINDSSGMVSISKEGNLVVMDGRGQVHWSTNVLVPVAANTFYARLLN 126
Query: 72 SGNLVLRDEHDGDSETYFWQSFDYPSDTLLPGMKLGWDLKTGLERRVTSWKSFDDPSPGD 131
+GNLVL + E W+SF++P + LP M L D KTG ++ SWKS DPSPG
Sbjct: 127 TGNLVLLGTTNTGDEI-LWESFEHPQNIYLPTMSLATDTKTGRSLKLRSWKSPFDPSPGR 185
Query: 132 FIWAIERQDNPEVVMWKGSRKFYRTGPWNGLRF-SAPSL--RPNPIFSFSFVSNDVELYY 188
+ + PE+V+WK +R+GPWNG F P++ R N +F + +S+D
Sbjct: 186 YSAGLIPLPFPELVVWKDDLLMWRSGPWNGQYFIGLPNMDYRIN-LFELT-LSSDNRGSV 243
Query: 189 TFNITNKAVISRIVMNQTLYVRRRFIWNKATQSWELYSDVPRDQCDTYGLCGAYGICII- 247
+ + ++ +++ V +R WN A Q W+ + VP +CDTY CG + C
Sbjct: 244 SMSYAGNTLLYHFLLDSEGSVFQRD-WNVAIQEWKTWLKVPSTKCDTYATCGQFASCRFN 302
Query: 248 -GQSPVCQCLKGFKPKSGGYVDR---SQGCVRSKPLNY--------SRQ-DGFIKFTELK 294
G +P C C++GFKP+S + +QGCVR PL SR+ DGF++ ++K
Sbjct: 303 PGSTPPCMCIRGFKPQSYAEWNNGNWTQGCVRKAPLQCESRDNNDGSRKSDGFVRVQKMK 362
Query: 295 LPDATSSWVSKSMNLKECREGCLENSSCMAYTNSDIRGGGSGCAMWFGELIDMRDFPGGG 354
+P N ++C E CL+N SC AY+ G GC +W G L+DM++F G G
Sbjct: 363 VPHNPQR---SGANEQDCPESCLKNCSCTAYSFDR----GIGCLLWSGNLMDMQEFSGTG 415
Query: 355 QDFYIRMSASEIGAKGEPTTKIVVIVISTAALLA-VVLIAGYLIRKRR-RNIAEKTENSR 412
FYIR++ SE + + I V ++ A L A V++A + I K R +N + N R
Sbjct: 416 VVFYIRLADSEFKKRTNRSIVITVTLLVGAFLFAGTVVLALWKIAKHREKNRNTRLLNER 475
Query: 413 ETDQENEDQNIDL-------ELPLFELATIANATDNFSINNKLGEGGFGPVYKGTLVDGQ 465
+ D L ELPLFE +A AT+NFSI NKLG+GGFG VYKG L +G
Sbjct: 476 MEALSSNDVGAILVNQYKLKELPLFEFQVLAVATNNFSITNKLGQGGFGAVYKGRLQEGL 535
Query: 466 EIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMPNKSLDS 525
+IAVKRLS+ S QG++E NEV++ SKLQHRNLV+LLG CI+GEE++L+YEFMP LD+
Sbjct: 536 DIAVKRLSRTSGQGVEEFVNEVVVISKLQHRNLVRLLGFCIEGEERMLVYEFMPENCLDA 595
Query: 526 FIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISD 585
++FD ++ LLDW RF+II G RGL+YLH+DSRL+IIHRDLKASN+LLD+++NPKISD
Sbjct: 596 YLFDPVKQRLLDWKTRFNIIDGICRGLMYLHRDSRLKIIHRDLKASNILLDENLNPKISD 655
Query: 586 FGLVRTFGGDETEGNTNRVVGTYD---------GQFSIKSDVFSFGILLLEIVSGKKNRG 636
FGL R F G+E E +T RVVGTY G FS KSDVFS G++LLEIVSG++N
Sbjct: 656 FGLARIFQGNEDEVSTVRVVGTYGYMAPEYAMGGLFSEKSDVFSLGVILLEIVSGRRNSS 715
Query: 637 FYRSDTKVNLIGH---LWDEGIPLRLIDACIQDSCNLADVIRCIHIGLLCVQQHPEDRPC 693
FY NL + LW+ G + L+D I + C ++ RC+H+GLLCVQ H DRP
Sbjct: 716 FYNDGQNPNLSAYAWKLWNTGEDIALVDPVIFEECFENEIRRCVHVGLLCVQDHANDRPS 775
Query: 694 MPSVILMLGSEIL-LPQPKQPGYLADRKXXXXXXXXXXXXXXXXNTLTISELEAR 747
+ +VI ML SE LP+PKQP ++ R N ++++++ R
Sbjct: 776 VATVIWMLSSENSNLPEPKQPAFIPRRGTSEVESSGQSDPRASINNVSLTKITGR 830
|
|
| TAIR|locus:2200888 AT1G61500 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1379 (490.5 bits), Expect = 5.5e-141, P = 5.5e-141
Identities = 316/728 (43%), Positives = 439/728 (60%)
Query: 14 PHEVVWVANRLNPINDSFGFLMINKTGNLVLTSQSNIVVWSAYLSKEVQTPVVLQLLDSG 73
P VVWVANR P+ DS +L I+ +G+L+L + + VWS+ ++ + +L DSG
Sbjct: 70 PRVVVWVANREKPVTDSTAYLAISSSGSLLLLNGKHGTVWSSGVTFS-SSGCRAELSDSG 128
Query: 74 NLVLRDEHDGDSETYFWQSFDYPSDTLLPGMKLGWDLKTGLERRVTSWKSFDDPSPGDFI 133
NL + D SE WQSFD+ DTLL L ++L T +R +TSWKS+ DPSPGDF+
Sbjct: 129 NLKVIDNV---SERALWQSFDHLGDTLLHTSSLTYNLATAEKRVLTSWKSYTDPSPGDFL 185
Query: 134 WAIERQDNPEVVMWKGSRKFYRTGPWNGLRFSA-PSLRPNPIFSFSFVSNDVEL--YYTF 190
I Q + + +GS ++R+GPW RF+ P + + F+ + DV Y T+
Sbjct: 186 GQITPQVPSQGFVMRGSTPYWRSGPWAKTRFTGIPFMDESYTGPFT-LHQDVNGSGYLTY 244
Query: 191 NITNKAVISRIVMNQTLYVRRRFIWNKATQSWELYSDVPRDQCDTYGLCGAYGICIIGQS 250
+SRI + ++ ++ WELY + P+ CD YG CG +G+C++ S
Sbjct: 245 -FQRDYKLSRITLTSEGSIK---MFRDNGMGWELYYEAPKKLCDFYGACGPFGLCVMSPS 300
Query: 251 PVCQCLKGFKPKSGGYVDRSQ---GCVRSKPL----NYSRQDG--FIKFTELKLPDATSS 301
P+C+C +GF PKS R GCVR L N + +D F + +K PD
Sbjct: 301 PMCKCFRGFVPKSVEEWKRGNWTGGCVRHTELDCLGNSTGEDADDFHQIANIKPPDFYE- 359
Query: 302 WVSKSMNLKECREGCLENSSCMAYTNSDIRGGGSGCAMWFGELIDMRDFPGGGQDFYIRM 361
+ S+N +EC + C+ N SC+A+ I+G GC +W +L+D F G+ IR+
Sbjct: 360 -FASSVNAEECHQRCVHNCSCLAFAY--IKG--IGCLVWNQDLMDAVQFSATGELLSIRL 414
Query: 362 SASEI-GAKGEPTTKIVVIVISTAALLAVVLIAGYLIRKRRRNIAEKTENSRETDQENED 420
+ SE+ G K + T IV ++S + + A + R R +IA ++++ + D + +D
Sbjct: 415 ARSELDGNKRKKT--IVASIVSLTLFMILGFTAFGVWRCRVEHIAHISKDAWKNDLKPQD 472
Query: 421 QNIDLELPLFELATIANATDNFSINNKLGEGGFGPVYKGTLVDGQEIAVKRLSKISEQGL 480
L F++ TI NAT+NFS++NKLG+GGFG VYKG L DG+EIAVKRLS S QG
Sbjct: 473 VP---GLDFFDMHTIQNATNNFSLSNKLGQGGFGSVYKGKLQDGKEIAVKRLSSSSGQGK 529
Query: 481 KELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQ 540
+E NE++L SKLQHRNLV++LGCCI+ EEKLLIYEFM NKSLD+F+FD +R +DW +
Sbjct: 530 EEFMNEIVLISKLQHRNLVRVLGCCIEEEEKLLIYEFMVNKSLDTFLFDSRKRLEIDWPK 589
Query: 541 RFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGN 600
RF II G ARGLLYLH DSRLR+IHRDLK SN+LLD+ MNPKISDFGL R + G E + N
Sbjct: 590 RFDIIQGIARGLLYLHHDSRLRVIHRDLKVSNILLDEKMNPKISDFGLARMYQGTEYQDN 649
Query: 601 TNRVVGT---------YDGQFSIKSDVFSFGILLLEIVSGKK-NRGFYRSDTKVNLIGHL 650
T RVVGT + G FS KSD++SFG+L+LEI+SG+K +R Y + K LI +
Sbjct: 650 TRRVVGTLGYMSPEYAWTGMFSEKSDIYSFGVLMLEIISGEKISRFSYGVEGKT-LIAYA 708
Query: 651 WDEGIPLR---LIDACIQDSCNLADVIRCIHIGLLCVQQHPEDRPCMPSVILMLGSEILL 707
W+ R L+D + DSC+ +V RCI IGLLCVQ P DRP ++ ML + L
Sbjct: 709 WESWSEYRGIDLLDQDLADSCHPLEVGRCIQIGLLCVQHQPADRPNTLELLAMLTTTSDL 768
Query: 708 PQPKQPGY 715
P PKQP +
Sbjct: 769 PSPKQPTF 776
|
|
| UNIPROTKB|O49974 KIK1 "Serine/threonine-protein kinase" [Zea mays (taxid:4577)] | Back alignment and assigned GO terms |
|---|
Score = 922 (329.6 bits), Expect = 1.9e-140, Sum P(2) = 1.9e-140
Identities = 183/346 (52%), Positives = 241/346 (69%)
Query: 415 DQENEDQNIDLELPLFELATIANATDNFSINNKLGEGGFGPVYKGTLVDGQEIAVKRLSK 474
D + ED EL ++ L I AT NFS +NKLGEGGFGPVY GTL G+E+AVKRL +
Sbjct: 504 DDDVEDGKSH-ELKVYSLDRIRTATSNFSDSNKLGEGGFGPVYMGTLPGGEEVAVKRLCR 562
Query: 475 ISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQTRRT 534
S QGL+E KNEVIL +KLQHRNLV+LLGCCI EEK+L+YE+MPNKSLD+F+F+ ++
Sbjct: 563 NSGQGLEEFKNEVILIAKLQHRNLVRLLGCCIPREEKILVYEYMPNKSLDAFLFNPEKQR 622
Query: 535 LLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGG 594
LLDW +RF II G ARGLLYLH+DSRLR++HRDLKASN+LLD DM PKISDFG+ R FGG
Sbjct: 623 LLDWKKRFDIIEGIARGLLYLHRDSRLRVVHRDLKASNILLDADMKPKISDFGMARMFGG 682
Query: 595 DETEGNTNRVVGTY---------DGQFSIKSDVFSFGILLLEIVSGKKNRGFYRSDTKVN 645
D+ + NTNRVVGT+ +G FS+KSDV+ FG+L+LEI++GK+ F+ + +N
Sbjct: 683 DQNQFNTNRVVGTFGYMSPEYAMEGIFSVKSDVYGFGVLILEIITGKRAVSFHCHEDSLN 742
Query: 646 LIGHLW---DEGIPLRLIDACIQDSCNLADVIRCIHIGLLCVQQHPEDRPCMPSVILMLG 702
+ G+ W +E LID I+ SC++ V+RCIHI LLCVQ H ++RP +P+VILML
Sbjct: 743 IAGYAWRQWNEDNAAELIDPVIRASCSVRQVLRCIHIALLCVQDHADERPDIPTVILMLS 802
Query: 703 SEIL-LPQPKQPGYLADRKXXXXXXXXXXXXXXXXNTLTISELEAR 747
++ LP P+ P + + T+T+++L R
Sbjct: 803 NDSSSLPNPRPPTLMLRGREIESSKSSEKDRSHSIGTVTMTQLHGR 848
|
|
| TAIR|locus:2197729 SD1-29 "S-domain-1 29" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1360 (483.8 bits), Expect = 5.6e-139, P = 5.6e-139
Identities = 308/733 (42%), Positives = 421/733 (57%)
Query: 10 KSYPPHEVVWVANRLNPINDSFGFLMINKTGNLVLTSQSNIVVWS---AYLSKEVQTPVV 66
K P VVWVANR P+ S L I+ G+L+L V+WS A+ S +
Sbjct: 62 KKIVPRVVVWVANRDTPVTSSAANLTISSNGSLILLDGKQDVIWSTGKAFTSNKCHA--- 118
Query: 67 LQLLDSGNLVLRDEHDGDSETYFWQSFDYPSDTLLPGMKLGWDLKTGLERRVTSWKSFDD 126
+LLD+GN V+ D+ G+ WQSF++ +T+LP L +D G +R +T+WKS D
Sbjct: 119 -ELLDTGNFVVIDDVSGNK---LWQSFEHLGNTMLPQSSLMYDTSNGKKRVLTTWKSNSD 174
Query: 127 PSPGDFIWAIERQDNPEVVMWKGSRKFYRTGPWNGLRFSAPS-LRPNPIFSFSFVSNDVE 185
PSPG+F I Q + ++ +GS ++R GPW RFS S + + + FS V +
Sbjct: 175 PSPGEFSLEITPQIPTQGLIRRGSVPYWRCGPWAKTRFSGISGIDASYVSPFSVVQDTAA 234
Query: 186 LYYTFNITNKAVISRIVMNQTLYVRRRFIWNKATQSWELYSDVPRDQCDTYGLCGAYGIC 245
+F+ + + + T + + +W+ +W+L+ +P + CD YG CG YG+C
Sbjct: 235 GTGSFSYSTLRNYNLSYVTLTPEGKMKILWDDGN-NWKLHLSLPENPCDLYGRCGPYGLC 293
Query: 246 IIGQSPVCQCLKGFKPKSG---GYVDRSQGCVRSKPLNYSRQ----------DGFIKFTE 292
+ P C+CLKGF PKS G + + GCVR L+ + D F + T+
Sbjct: 294 VRSDPPKCECLKGFVPKSDEEWGKGNWTSGCVRRTKLSCQAKSSMKTQGKDTDIFYRMTD 353
Query: 293 LKLPDATSSWVSKSMNLKECREGCLENSSCMAYTNSDIRGGGSGCAMWFGELIDMRDFPG 352
+K PD + +N ++C +GCL N SC A+ G GC +W GEL D F
Sbjct: 354 VKTPDLHQ--FASFLNAEQCYQGCLGNCSCTAFAYIS----GIGCLVWNGELADTVQFLS 407
Query: 353 GGQDFYIRMSASEIGAKGEPTTKIVVIVISTAALLAVVLIAGYLIRKRRRNIAEKTENSR 412
G+ +IR+++SE+ G KI+V + ++ +++ A ++ + R + +N
Sbjct: 408 SGEFLFIRLASSELA--GSSRRKIIVGTTVSLSIFLILVFAAIMLWRYRAKQNDAWKNGF 465
Query: 413 ETDQENEDQNIDLELPLFELATIANATDNFSINNKLGEGGFGPVYKGTLVDGQEIAVKRL 472
E Q+ N FE+ TI AT+NFS +NKLG+GGFGPVYKG LVDG+EI VKRL
Sbjct: 466 ER-QDVSGVNF------FEMHTIRTATNNFSPSNKLGQGGFGPVYKGKLVDGKEIGVKRL 518
Query: 473 SKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQTR 532
+ S QG +E NE+ L SKLQHRNLV+LLG CI GEEKLLIYEFM NKSLD FIFD
Sbjct: 519 ASSSGQGTEEFMNEITLISKLQHRNLVRLLGYCIDGEEKLLIYEFMVNKSLDIFIFDPCL 578
Query: 533 RTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTF 592
+ LDW +RF+II G ARGLLYLH+DSRLR+IHRDLK SN+LLD MNPKISDFGL R F
Sbjct: 579 KFELDWPKRFNIIQGIARGLLYLHRDSRLRVIHRDLKVSNILLDDRMNPKISDFGLARMF 638
Query: 593 GGDETEGNTNRVVGT---------YDGQFSIKSDVFSFGILLLEIVSGKKNRGFYRSDTK 643
G + + NT RVVGT + G FS KSD++SFG+L+LEI+SGK+ F D
Sbjct: 639 QGTQYQDNTRRVVGTLGYMSPEYAWAGLFSEKSDIYSFGVLMLEIISGKRISRFIYGDES 698
Query: 644 VNLIGHLWDEGIPL---RLIDACIQDSCNLADVIRCIHIGLLCVQQHPEDRPCMPSVILM 700
L+ + WD L+D + D+C +V RC+ IGLLCVQ DRP V+ M
Sbjct: 699 KGLLAYTWDSWCETGGSNLLDRDLTDTCQAFEVARCVQIGLLCVQHEAVDRPNTLQVLSM 758
Query: 701 LGSEILLPQPKQP 713
L S LP PKQP
Sbjct: 759 LTSATDLPVPKQP 771
|
|
| TAIR|locus:2197744 AT1G61420 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1357 (482.7 bits), Expect = 1.2e-138, P = 1.2e-138
Identities = 305/737 (41%), Positives = 429/737 (58%)
Query: 10 KSYPPHEVVWVANRLNPINDSFGFLMINKTGNLVLTSQSNIVVWSAYLSKEVQTPVVLQL 69
K P VVWVANR P+ DS L I+ G+L+L + + V WS+ + V +L
Sbjct: 65 KGIIPRVVVWVANREKPVTDSTANLAISNNGSLLLFNGKHGVAWSSGEAL-VSNGSRAEL 123
Query: 70 LDSGNLVLRDEHDGDSETYFWQSFDYPSDTLLPGMKLGWDLKTGLERRVTSWKSFDDPSP 129
D+GNL++ D G + WQSFD+ DT+LP L ++L TG ++ ++SWKS+ DPS
Sbjct: 124 SDTGNLIVIDNFSGRT---LWQSFDHLGDTMLPSSTLKYNLATGEKQVLSSWKSYTDPSV 180
Query: 130 GDFIWAIERQDNPEVVMWKGSRKFYRTGPWNGLRFSAPSLRPNPIFSFSFVSNDVELYYT 189
GDF+ I Q +V++ KGS +YR+GPW RF+ L + V D +
Sbjct: 181 GDFVLQITPQVPTQVLVTKGSTPYYRSGPWAKTRFTGIPLMDDTFTGPVSVQQDTNGSGS 240
Query: 190 FNITNKAV-ISRIVMNQTLYVRRRFIWNKATQSWELYSDVPRDQCDTYGLCGAYGICIIG 248
N+ + R ++ T + W+ T W L P CD YG+CG +G+C+
Sbjct: 241 LTYLNRNDRLQRTML--TSKGTQELSWHNGTD-WVLNFVAPEHSCDYYGVCGPFGLCVKS 297
Query: 249 QSPVCQCLKGFKPKSGGYVDRSQ---GCVRSKPLNYSRQDGFIKFTE-------LKLPDA 298
P C C KGF PK R GCVR L Y + + K+ +K PD
Sbjct: 298 VPPKCTCFKGFVPKLIEEWKRGNWTGGCVRRTEL-YCQGNSTGKYANVFHPVARIKPPDF 356
Query: 299 TSSWVSKSMNLKECREGCLENSSCMAYTNSDIRGGGSGCAMWFGELIDMRDFPGGGQDFY 358
+ +N++EC++ CL N SC+A+ D G GC MW +L+D F GG+
Sbjct: 357 YE--FASFVNVEECQKSCLHNCSCLAFAYID----GIGCLMWNQDLMDAVQFSEGGELLS 410
Query: 359 IRMSASEIGAKGEPTTKIVVIVISTAALLAVVLIAGYLI-RKRRRNIAEKTENSRETDQE 417
IR++ SE+G G K + I + +L+ ++ + R R ++ A+ T ++ +
Sbjct: 411 IRLARSELG--GNKRKKAITASIVSLSLVVIIAFVAFCFWRYRVKHNADITTDASQVSWR 468
Query: 418 NEDQNIDLE-LPLFELATIANATDNFSINNKLGEGGFGPVYKGTLVDGQEIAVKRLSKIS 476
N+ + D+ L F++ TI AT+NFSI+NKLG+GGFGPVYKG L DG+EIAVKRLS S
Sbjct: 469 NDLKPQDVPGLDFFDMHTIQTATNNFSISNKLGQGGFGPVYKGKLQDGKEIAVKRLSSSS 528
Query: 477 EQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQTRRTLL 536
QG +E NE++L SKLQH+NLV++LGCCI+GEEKLLIYEFM N SLD+F+FD +R +
Sbjct: 529 GQGKEEFMNEIVLISKLQHKNLVRILGCCIEGEEKLLIYEFMLNNSLDTFLFDSRKRLEI 588
Query: 537 DWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDE 596
DW +R II G ARG+ YLH+DS L++IHRDLK SN+LLD+ MNPKISDFGL R + G E
Sbjct: 589 DWPKRLDIIQGIARGIHYLHRDSHLKVIHRDLKVSNILLDEKMNPKISDFGLARMYQGTE 648
Query: 597 TEGNTNRVVGT---------YDGQFSIKSDVFSFGILLLEIVSGKK-NRGFYRSDTKVNL 646
+ NT RVVGT + G FS KSD++SFG+L+LEI+SG+K +R Y + K L
Sbjct: 649 YQDNTRRVVGTLGYMAPEYAWTGMFSEKSDIYSFGVLMLEIISGEKISRFSYGKEEKT-L 707
Query: 647 IGHLWDEGIP---LRLIDACIQDSCNLADVIRCIHIGLLCVQQHPEDRPCMPSVILMLGS 703
I + W+ + L+D + DSC +V RC+ IGLLCVQ P DRP ++ ML +
Sbjct: 708 IAYAWESWCDTGGIDLLDKDVADSCRPLEVERCVQIGLLCVQHQPADRPNTLELLSMLTT 767
Query: 704 EILLPQPKQPGYLADRK 720
LP P+QP ++ R+
Sbjct: 768 TSDLPPPEQPTFVVHRR 784
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries
Original result of BLAST against SWISS-PROT
| ID | Name | Annotated EC number | Identity | Query coverage | Hit coverage | RBH(Q2H) | RBH(H2Q) |
| O81905 | SD18_ARATH | 2, ., 7, ., 1, 1, ., 1 | 0.4910 | 0.9825 | 0.8635 | yes | no |
EC Number Prediction by Ezypred Server
Original result from Ezypred Server
Fail to connect to Ezypred Server
EC Number Prediction by EFICAz Software
| Prediction Level | EC number | Confidence of Prediction |
| 4th Layer | 2.7.11.1 | 0.914 |
| 3rd Layer | 2.7.11 | 0.921 |
Prediction of Functionally Associated Proteins
Functionally Associated Proteins Detected by STRING
Original result from the STRING server
| Your Input: |  |
 |
 |
 |
 |
 |
 |
 |
 |
||
 | gw1.254.15.1 | annotation not avaliable (816 aa) | |||||||||
(Populus trichocarpa) | |||||||||||
Predicted Functional Partners: | |||||||||||
| Sorry, there are no predicted associations at the current settings. | |||||||||||
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST
Original result of RPS-BLAST against CDD database part I
| ID | Alignment Graph | Length |
Definition |
E-value |
| Query | 747 | |||
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 9e-52 | |
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 2e-51 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 6e-49 | |
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 3e-46 | |
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 1e-42 | |
| pfam00954 | 110 | pfam00954, S_locus_glycop, S-locus glycoprotein fa | 6e-41 | |
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 5e-40 | |
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 4e-39 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 2e-37 | |
| pfam01453 | 109 | pfam01453, B_lectin, D-mannose binding lectin | 7e-36 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 1e-33 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 1e-30 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 1e-30 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 5e-30 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 1e-29 | |
| cd05049 | 280 | cd05049, PTKc_Trk, Catalytic domain of the Protein | 3e-28 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 1e-27 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 2e-27 | |
| cd05048 | 283 | cd05048, PTKc_Ror, Catalytic Domain of the Protein | 3e-27 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 1e-26 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 2e-26 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 4e-26 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 4e-26 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 4e-26 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 9e-26 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 2e-25 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 2e-25 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 2e-25 | |
| cd05044 | 269 | cd05044, PTKc_c-ros, Catalytic domain of the Prote | 5e-25 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 6e-25 | |
| cd05033 | 266 | cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec | 8e-25 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 9e-25 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 8e-24 | |
| pfam08276 | 66 | pfam08276, PAN_2, PAN-like domain | 1e-23 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 3e-23 | |
| cd05073 | 260 | cd05073, PTKc_Hck, Catalytic domain of the Protein | 4e-23 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 5e-23 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 6e-23 | |
| cd05046 | 275 | cd05046, PTK_CCK4, Pseudokinase domain of the Prot | 7e-23 | |
| cd05050 | 288 | cd05050, PTKc_Musk, Catalytic domain of the Protei | 9e-23 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 1e-22 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 2e-22 | |
| cd05091 | 283 | cd05091, PTKc_Ror2, Catalytic domain of the Protei | 5e-22 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 6e-22 | |
| cd01098 | 84 | cd01098, PAN_AP_plant, Plant PAN/APPLE-like domain | 7e-22 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 8e-22 | |
| cd05035 | 273 | cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li | 8e-22 | |
| cd05092 | 280 | cd05092, PTKc_TrkA, Catalytic domain of the Protei | 9e-22 | |
| cd05083 | 254 | cd05083, PTKc_Chk, Catalytic domain of the Protein | 2e-21 | |
| cd05058 | 262 | cd05058, PTKc_Met_Ron, Catalytic domain of the Pro | 4e-21 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 4e-21 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 4e-21 | |
| cd05036 | 277 | cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro | 4e-21 | |
| cd05053 | 293 | cd05053, PTKc_FGFR, Catalytic domain of the Protei | 9e-21 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 1e-20 | |
| cd05093 | 288 | cd05093, PTKc_TrkB, Catalytic domain of the Protei | 1e-20 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 1e-20 | |
| cd05085 | 250 | cd05085, PTKc_Fer, Catalytic domain of the Protein | 2e-20 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 2e-20 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 2e-20 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 2e-20 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 3e-20 | |
| cd05110 | 303 | cd05110, PTKc_HER4, Catalytic domain of the Protei | 4e-20 | |
| cd05090 | 283 | cd05090, PTKc_Ror1, Catalytic domain of the Protei | 4e-20 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 5e-20 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 7e-20 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 8e-20 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 2e-19 | |
| cd05045 | 290 | cd05045, PTKc_RET, Catalytic domain of the Protein | 2e-19 | |
| cd05094 | 291 | cd05094, PTKc_TrkC, Catalytic domain of the Protei | 2e-19 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 3e-19 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 7e-19 | |
| cd07861 | 285 | cd07861, STKc_CDK1_euk, Catalytic domain of the Se | 8e-19 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 8e-19 | |
| cd05069 | 260 | cd05069, PTKc_Yes, Catalytic domain of the Protein | 9e-19 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 1e-18 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 2e-18 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 2e-18 | |
| cd00028 | 116 | cd00028, B_lectin, Bulb-type mannose-specific lect | 3e-18 | |
| cd05082 | 256 | cd05082, PTKc_Csk, Catalytic domain of the Protein | 4e-18 | |
| cd05063 | 268 | cd05063, PTKc_EphR_A2, Catalytic domain of the Pro | 5e-18 | |
| cd05065 | 269 | cd05065, PTKc_EphR_B, Catalytic domain of the Prot | 6e-18 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 7e-18 | |
| smart00108 | 114 | smart00108, B_lectin, Bulb-type mannose-specific l | 1e-17 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 1e-17 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 3e-17 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 4e-17 | |
| cd05043 | 280 | cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece | 5e-17 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 6e-17 | |
| cd05075 | 272 | cd05075, PTKc_Axl, Catalytic domain of the Protein | 6e-17 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 6e-17 | |
| cd05114 | 256 | cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro | 6e-17 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 6e-17 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 7e-17 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 7e-17 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 7e-17 | |
| cd05097 | 295 | cd05097, PTKc_DDR_like, Catalytic domain of Discoi | 8e-17 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 9e-17 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 1e-16 | |
| cd05108 | 316 | cd05108, PTKc_EGFR, Catalytic domain of the Protei | 1e-16 | |
| cd05066 | 267 | cd05066, PTKc_EphR_A, Catalytic domain of the Prot | 1e-16 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 2e-16 | |
| cd05109 | 279 | cd05109, PTKc_HER2, Catalytic domain of the Protei | 2e-16 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 3e-16 | |
| cd06637 | 272 | cd06637, STKc_TNIK, Catalytic domain of the Protei | 3e-16 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 3e-16 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 3e-16 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 4e-16 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 4e-16 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 4e-16 | |
| cd07866 | 311 | cd07866, STKc_BUR1, Catalytic domain of the Serine | 5e-16 | |
| cd05088 | 303 | cd05088, PTKc_Tie2, Catalytic domain of the Protei | 6e-16 | |
| cd06636 | 282 | cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr | 6e-16 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 9e-16 | |
| cd05051 | 296 | cd05051, PTKc_DDR, Catalytic domain of the Protein | 1e-15 | |
| cd05074 | 273 | cd05074, PTKc_Tyro3, Catalytic domain of the Prote | 1e-15 | |
| cd05099 | 314 | cd05099, PTKc_FGFR4, Catalytic domain of the Prote | 1e-15 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 1e-15 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 2e-15 | |
| cd05062 | 277 | cd05062, PTKc_IGF-1R, Catalytic domain of the Prot | 2e-15 | |
| cd05096 | 304 | cd05096, PTKc_DDR1, Catalytic domain of the Protei | 2e-15 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 2e-15 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 2e-15 | |
| cd05116 | 257 | cd05116, PTKc_Syk, Catalytic domain of the Protein | 2e-15 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 2e-15 | |
| cd05084 | 252 | cd05084, PTKc_Fes, Catalytic domain of the Protein | 4e-15 | |
| cd06639 | 291 | cd06639, STKc_myosinIIIB, Catalytic domain of the | 5e-15 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 5e-15 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 6e-15 | |
| cd06643 | 282 | cd06643, STKc_SLK, Catalytic domain of the Protein | 6e-15 | |
| cd06616 | 288 | cd06616, PKc_MKK4, Catalytic domain of the dual-sp | 7e-15 | |
| cd05061 | 288 | cd05061, PTKc_InsR, Catalytic domain of the Protei | 7e-15 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 7e-15 | |
| cd05098 | 307 | cd05098, PTKc_FGFR1, Catalytic domain of the Prote | 1e-14 | |
| cd05101 | 304 | cd05101, PTKc_FGFR2, Catalytic domain of the Prote | 1e-14 | |
| cd05115 | 257 | cd05115, PTKc_Zap-70, Catalytic domain of the Prot | 1e-14 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 2e-14 | |
| cd05089 | 297 | cd05089, PTKc_Tie1, Catalytic domain of the Protei | 2e-14 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 2e-14 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 3e-14 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 3e-14 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 4e-14 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 4e-14 | |
| cd06633 | 313 | cd06633, STKc_TAO3, Catalytic domain of the Protei | 4e-14 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 4e-14 | |
| cd06634 | 308 | cd06634, STKc_TAO2, Catalytic domain of the Protei | 5e-14 | |
| cd05095 | 296 | cd05095, PTKc_DDR2, Catalytic domain of the Protei | 5e-14 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 6e-14 | |
| PLN00009 | 294 | PLN00009, PLN00009, cyclin-dependent kinase A; Pro | 7e-14 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 8e-14 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 9e-14 | |
| cd08222 | 260 | cd08222, STKc_Nek11, Catalytic domain of the Prote | 9e-14 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 1e-13 | |
| cd05111 | 279 | cd05111, PTK_HER3, Pseudokinase domain of the Prot | 1e-13 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 1e-13 | |
| cd05047 | 270 | cd05047, PTKc_Tie, Catalytic domain of Tie Protein | 1e-13 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 2e-13 | |
| cd05064 | 266 | cd05064, PTKc_EphR_A10, Catalytic domain of the Pr | 2e-13 | |
| cd05100 | 334 | cd05100, PTKc_FGFR3, Catalytic domain of the Prote | 2e-13 | |
| cd05056 | 270 | cd05056, PTKc_FAK, Catalytic domain of the Protein | 3e-13 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 3e-13 | |
| cd05600 | 333 | cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun | 3e-13 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 5e-13 | |
| PHA03209 | 357 | PHA03209, PHA03209, serine/threonine kinase US3; P | 6e-13 | |
| cd06617 | 283 | cd06617, PKc_MKK3_6, Catalytic domain of the dual- | 9e-13 | |
| cd07839 | 284 | cd07839, STKc_CDK5, Catalytic domain of the Serine | 1e-12 | |
| cd07864 | 302 | cd07864, STKc_CDK12, Catalytic domain of the Serin | 1e-12 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 2e-12 | |
| smart00473 | 78 | smart00473, PAN_AP, divergent subfamily of APPLE d | 2e-12 | |
| cd07849 | 336 | cd07849, STKc_ERK1_2_like, Catalytic domain of Ext | 2e-12 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 3e-12 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 3e-12 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 4e-12 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 4e-12 | |
| cd05042 | 269 | cd05042, PTKc_Aatyk, Catalytic domain of the Prote | 6e-12 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 9e-12 | |
| cd07842 | 316 | cd07842, STKc_CDK8_like, Catalytic domain of Cycli | 1e-11 | |
| cd06645 | 267 | cd06645, STKc_MAP4K3, Catalytic domain of the Prot | 1e-11 | |
| cd07865 | 310 | cd07865, STKc_CDK9, Catalytic domain of the Serine | 1e-11 | |
| cd06653 | 264 | cd06653, STKc_MEKK3_like_1, Catalytic domain of MA | 1e-11 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 1e-11 | |
| PTZ00024 | 335 | PTZ00024, PTZ00024, cyclin-dependent protein kinas | 1e-11 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 2e-11 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 2e-11 | |
| cd07870 | 291 | cd07870, STKc_PFTAIRE2, Catalytic domain of the Se | 2e-11 | |
| cd07873 | 301 | cd07873, STKc_PCTAIRE1, Catalytic domain of the Se | 2e-11 | |
| cd07872 | 309 | cd07872, STKc_PCTAIRE2, Catalytic domain of the Se | 3e-11 | |
| cd05087 | 269 | cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t | 4e-11 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 8e-11 | |
| cd07844 | 291 | cd07844, STKc_PCTAIRE_like, Catalytic domain of PC | 1e-10 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 1e-10 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 1e-10 | |
| cd05589 | 324 | cd05589, STKc_PKN, Catalytic domain of the Protein | 2e-10 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 2e-10 | |
| cd06618 | 296 | cd06618, PKc_MKK7, Catalytic domain of the dual-sp | 2e-10 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 3e-10 | |
| cd06646 | 267 | cd06646, STKc_MAP4K5, Catalytic domain of the Prot | 4e-10 | |
| cd07850 | 353 | cd07850, STKc_JNK, Catalytic domain of the Serine/ | 4e-10 | |
| cd07869 | 303 | cd07869, STKc_PFTAIRE1, Catalytic domain of the Se | 5e-10 | |
| cd07862 | 290 | cd07862, STKc_CDK6, Catalytic domain of the Serine | 6e-10 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 7e-10 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 9e-10 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 1e-09 | |
| cd08216 | 314 | cd08216, PK_STRAD, Pseudokinase domain of STE20-re | 1e-09 | |
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 1e-09 | |
| cd05054 | 337 | cd05054, PTKc_VEGFR, Catalytic domain of the Prote | 1e-09 | |
| cd07851 | 343 | cd07851, STKc_p38, Catalytic domain of the Serine/ | 1e-09 | |
| cd06622 | 286 | cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of | 2e-09 | |
| cd07843 | 293 | cd07843, STKc_CDC2L1, Catalytic domain of the Seri | 2e-09 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 2e-09 | |
| cd07837 | 295 | cd07837, STKc_CdkB_plant, Catalytic domain of the | 2e-09 | |
| cd08219 | 255 | cd08219, STKc_Nek3, Catalytic domain of the Protei | 3e-09 | |
| cd07871 | 288 | cd07871, STKc_PCTAIRE3, Catalytic domain of the Se | 3e-09 | |
| cd07858 | 337 | cd07858, STKc_TEY_MAPK_plant, Catalytic domain of | 6e-09 | |
| cd07853 | 372 | cd07853, STKc_NLK, Catalytic domain of the Serine/ | 6e-09 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 7e-09 | |
| cd07879 | 342 | cd07879, STKc_p38delta_MAPK13, Catalytic domain of | 7e-09 | |
| cd06615 | 308 | cd06615, PKc_MEK, Catalytic domain of the dual-spe | 9e-09 | |
| cd07831 | 282 | cd07831, STKc_MOK, Catalytic domain of the Serine/ | 1e-08 | |
| cd05590 | 320 | cd05590, STKc_nPKC_eta, Catalytic domain of the Pr | 1e-08 | |
| cd08226 | 328 | cd08226, PK_STRAD_beta, Pseudokinase domain of STE | 2e-08 | |
| cd05603 | 321 | cd05603, STKc_SGK2, Catalytic domain of the Protei | 2e-08 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 2e-08 | |
| cd06638 | 286 | cd06638, STKc_myosinIIIA, Catalytic domain of the | 2e-08 | |
| cd07877 | 345 | cd07877, STKc_p38alpha_MAPK14, Catalytic domain of | 3e-08 | |
| cd06649 | 331 | cd06649, PKc_MEK2, Catalytic domain of the dual-sp | 3e-08 | |
| cd05078 | 258 | cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat | 3e-08 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 4e-08 | |
| cd07875 | 364 | cd07875, STKc_JNK1, Catalytic domain of the Serine | 4e-08 | |
| cd07876 | 359 | cd07876, STKc_JNK2, Catalytic domain of the Serine | 5e-08 | |
| cd07857 | 332 | cd07857, STKc_MPK1, Catalytic domain of the Serine | 5e-08 | |
| cd07863 | 288 | cd07863, STKc_CDK4, Catalytic domain of the Serine | 5e-08 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 5e-08 | |
| cd07874 | 355 | cd07874, STKc_JNK3, Catalytic domain of the Serine | 6e-08 | |
| cd05607 | 277 | cd05607, STKc_GRK7, Catalytic domain of the Protei | 6e-08 | |
| cd05587 | 324 | cd05587, STKc_cPKC, Catalytic domain of the Protei | 7e-08 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 8e-08 | |
| cd05573 | 350 | cd05573, STKc_ROCK_NDR_like, Catalytic domain of R | 8e-08 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 8e-08 | |
| cd05103 | 343 | cd05103, PTKc_VEGFR2, Catalytic domain of the Prot | 9e-08 | |
| cd05102 | 338 | cd05102, PTKc_VEGFR3, Catalytic domain of the Prot | 9e-08 | |
| cd05086 | 268 | cd05086, PTKc_Aatyk2, Catalytic domain of the Prot | 1e-07 | |
| cd05583 | 288 | cd05583, STKc_MSK_N, N-terminal catalytic domain o | 1e-07 | |
| cd07855 | 334 | cd07855, STKc_ERK5, Catalytic domain of the Serine | 1e-07 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 2e-07 | |
| cd05599 | 364 | cd05599, STKc_NDR_like, Catalytic domain of Nuclea | 2e-07 | |
| cd05613 | 290 | cd05613, STKc_MSK1_N, N-terminal catalytic domain | 2e-07 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 2e-07 | |
| cd07854 | 342 | cd07854, STKc_MAPK4_6, Catalytic domain of the Ser | 2e-07 | |
| cd05105 | 400 | cd05105, PTKc_PDGFR_alpha, Catalytic domain of the | 3e-07 | |
| cd05104 | 375 | cd05104, PTKc_Kit, Catalytic domain of the Protein | 3e-07 | |
| cd07878 | 343 | cd07878, STKc_p38beta_MAPK11, Catalytic domain of | 3e-07 | |
| pfam11883 | 48 | pfam11883, DUF3403, Domain of unknown function (DU | 6e-07 | |
| cd07880 | 343 | cd07880, STKc_p38gamma_MAPK12, Catalytic domain of | 6e-07 | |
| cd06650 | 333 | cd06650, PKc_MEK1, Catalytic domain of the dual-sp | 8e-07 | |
| cd05604 | 325 | cd05604, STKc_SGK3, Catalytic domain of the Protei | 1e-06 | |
| cd05591 | 321 | cd05591, STKc_nPKC_epsilon, Catalytic domain of th | 1e-06 | |
| cd05605 | 285 | cd05605, STKc_GRK4_like, Catalytic domain of G pro | 2e-06 | |
| cd05614 | 332 | cd05614, STKc_MSK2_N, N-terminal catalytic domain | 2e-06 | |
| PRK13184 | 932 | PRK13184, pknD, serine/threonine-protein kinase; R | 2e-06 | |
| cd05617 | 327 | cd05617, STKc_aPKC_zeta, Catalytic domain of the P | 3e-06 | |
| cd05037 | 259 | cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom | 4e-06 | |
| PHA03210 | 501 | PHA03210, PHA03210, serine/threonine kinase US3; P | 6e-06 | |
| PTZ00426 | 340 | PTZ00426, PTZ00426, cAMP-dependent protein kinase | 9e-06 | |
| PTZ00036 | 440 | PTZ00036, PTZ00036, glycogen synthase kinase; Prov | 9e-06 | |
| cd05615 | 323 | cd05615, STKc_cPKC_alpha, Catalytic domain of the | 1e-05 | |
| cd05621 | 370 | cd05621, STKc_ROCK2, Catalytic domain of the Prote | 1e-05 | |
| PHA03207 | 392 | PHA03207, PHA03207, serine/threonine kinase US3; P | 1e-05 | |
| cd05629 | 377 | cd05629, STKc_NDR_like_fungal, Catalytic domain of | 2e-05 | |
| cd07859 | 338 | cd07859, STKc_TDY_MAPK_plant, Catalytic domain of | 2e-05 | |
| cd05631 | 285 | cd05631, STKc_GRK4, Catalytic domain of the Protei | 2e-05 | |
| cd05618 | 329 | cd05618, STKc_aPKC_iota, Catalytic domain of the P | 3e-05 | |
| cd05588 | 329 | cd05588, STKc_aPKC, Catalytic domain of the Protei | 3e-05 | |
| cd05616 | 323 | cd05616, STKc_cPKC_beta, Catalytic domain of the P | 3e-05 | |
| cd05584 | 323 | cd05584, STKc_p70S6K, Catalytic domain of the Prot | 3e-05 | |
| cd05574 | 316 | cd05574, STKc_phototropin_like, Catalytic domain o | 4e-05 | |
| cd05602 | 325 | cd05602, STKc_SGK1, Catalytic domain of the Protei | 4e-05 | |
| TIGR03903 | 1266 | TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas | 5e-05 | |
| PTZ00266 | 1021 | PTZ00266, PTZ00266, NIMA-related protein kinase; P | 6e-05 | |
| cd05627 | 360 | cd05627, STKc_NDR2, Catalytic domain of the Protei | 6e-05 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 8e-05 | |
| PTZ00283 | 496 | PTZ00283, PTZ00283, serine/threonine protein kinas | 8e-05 | |
| cd05628 | 363 | cd05628, STKc_NDR1, Catalytic domain of the Protei | 1e-04 | |
| cd05606 | 278 | cd05606, STKc_beta_ARK, Catalytic domain of the Pr | 1e-04 | |
| cd05571 | 323 | cd05571, STKc_PKB, Catalytic domain of the Protein | 1e-04 | |
| cd05107 | 401 | cd05107, PTKc_PDGFR_beta, Catalytic domain of the | 1e-04 | |
| cd05586 | 330 | cd05586, STKc_Sck1_like, Catalytic domain of Suppr | 2e-04 | |
| cd07848 | 287 | cd07848, STKc_CDKL5, Catalytic domain of the Serin | 2e-04 | |
| cd05633 | 279 | cd05633, STKc_GRK3, Catalytic domain of the Protei | 2e-04 | |
| cd05076 | 274 | cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) do | 3e-04 | |
| cd05624 | 331 | cd05624, STKc_MRCK_beta, Catalytic domain of the P | 3e-04 | |
| cd07867 | 317 | cd07867, STKc_CDC2L6, Catalytic domain of Serine/T | 4e-04 | |
| cd05077 | 262 | cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) do | 5e-04 | |
| cd05626 | 381 | cd05626, STKc_LATS2, Catalytic domain of the Prote | 5e-04 | |
| cd05598 | 376 | cd05598, STKc_LATS, Catalytic domain of the Protei | 5e-04 | |
| PLN03225 | 566 | PLN03225, PLN03225, Serine/threonine-protein kinas | 8e-04 | |
| cd07868 | 317 | cd07868, STKc_CDK8, Catalytic domain of the Serine | 8e-04 | |
| cd05595 | 323 | cd05595, STKc_PKB_beta, Catalytic domain of the Pr | 0.001 | |
| cd05593 | 328 | cd05593, STKc_PKB_gamma, Catalytic domain of the P | 0.001 | |
| cd05596 | 370 | cd05596, STKc_ROCK, Catalytic domain of the Protei | 0.001 | |
| cd05120 | 155 | cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphot | 0.001 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 0.001 | |
| cd05594 | 325 | cd05594, STKc_PKB_alpha, Catalytic domain of the P | 0.001 | |
| PHA02988 | 283 | PHA02988, PHA02988, hypothetical protein; Provisio | 0.002 | |
| cd05597 | 331 | cd05597, STKc_DMPK_like, Catalytic domain of Myoto | 0.002 | |
| cd05585 | 312 | cd05585, STKc_YPK1_like, Catalytic domain of Yeast | 0.002 | |
| PHA03212 | 391 | PHA03212, PHA03212, serine/threonine kinase US3; P | 0.003 | |
| cd05601 | 330 | cd05601, STKc_CRIK, Catalytic domain of the Protei | 0.003 | |
| cd05623 | 332 | cd05623, STKc_MRCK_alpha, Catalytic domain of the | 0.004 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 180 bits (459), Expect = 9e-52
Identities = 92/278 (33%), Positives = 132/278 (47%), Gaps = 41/278 (14%)
Query: 443 SINNKLGEGGFGPVYKGTLVD-----GQEIAVKRLSKI-SEQGLKELKNEVILFSKLQHR 496
++ KLGEG FG VYKG L E+AVK L + SEQ ++E E + KL H
Sbjct: 2 TLGKKLGEGAFGEVYKGKLKGKGGKKKVEVAVKTLKEDASEQQIEEFLREARIMRKLDHP 61
Query: 497 NLVKLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLH 556
N+VKLLG C + E ++ E+M L S++ + R L S ARG+ YL
Sbjct: 62 NVVKLLGVCTEEEPLYIVMEYMEGGDLLSYL--RKNRPKLSLSDLLSFALQIARGMEYLE 119
Query: 557 QDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNTNRVVGT--------- 607
IHRDL A N L+ +++ KISDFGL R D + + R G
Sbjct: 120 ---SKNFIHRDLAARNCLVGENLVVKISDFGLSR----DLYDDDYYRKRGGKLPIRWMAP 172
Query: 608 ---YDGQFSIKSDVFSFGILLLEIVS-GKKNRGFYRSDTKVNLIGHLWDEGIPLRLIDAC 663
+G+F+ KSDV+SFG+LL EI + G++ Y + ++ +L G L C
Sbjct: 173 ESLKEGKFTSKSDVWSFGVLLWEIFTLGEQ---PYPGMSNEEVLEYL-KNGYRLPQPPNC 228
Query: 664 IQDSCNLADVIRCIHIGLLCVQQHPEDRPCMPSVILML 701
L D++ C + PEDRP ++ +L
Sbjct: 229 ---PPELYDLMLQ------CWAEDPEDRPTFSELVEIL 257
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 179 bits (456), Expect = 2e-51
Identities = 92/271 (33%), Positives = 131/271 (48%), Gaps = 40/271 (14%)
Query: 443 SINNKLGEGGFGPVYKGTLVDG-----QEIAVKRLSKI-SEQGLKELKNEVILFSKLQHR 496
++ KLGEG FG VYKGTL E+AVK L + SEQ ++E E + KL H
Sbjct: 2 TLGKKLGEGAFGEVYKGTLKGKGDGKEVEVAVKTLKEDASEQQIEEFLREARIMRKLDHP 61
Query: 497 NLVKLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLH 556
N+VKLLG C + E +++ E+MP L ++ R L S ARG+ YL
Sbjct: 62 NIVKLLGVCTEEEPLMIVMEYMPGGDLLDYLRK-NRPKELSLSDLLSFALQIARGMEYLE 120
Query: 557 QDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNTNRVVGTY-------- 608
IHRDL A N L+ +++ KISDFGL R D + + +V G
Sbjct: 121 ---SKNFIHRDLAARNCLVGENLVVKISDFGLSR----DLYDDDYYKVKGGKLPIRWMAP 173
Query: 609 ----DGQFSIKSDVFSFGILLLEIVS-GKKNRGFYRSDTKVNLIGHLWDEGIPLRLIDAC 663
+G+F+ KSDV+SFG+LL EI + G++ Y + ++ +L +G L C
Sbjct: 174 ESLKEGKFTSKSDVWSFGVLLWEIFTLGEE---PYPGMSNAEVLEYL-KKGYRLPKPPNC 229
Query: 664 IQDSCNLADVIRCIHIGLLCVQQHPEDRPCM 694
L ++ L C + PEDRP
Sbjct: 230 ---PPELYKLM------LQCWAEDPEDRPTF 251
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 172 bits (439), Expect = 6e-49
Identities = 88/283 (31%), Positives = 126/283 (44%), Gaps = 49/283 (17%)
Query: 446 NKLGEGGFGPVYKGTLVDGQ----EIAVKRLSKI-SEQGLKELKNEVILFSKLQHRNLVK 500
KLGEG FG VYKG L E+AVK L + SE+ K+ E + KL H N+V+
Sbjct: 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVR 60
Query: 501 LLGCCIQGEEKLLIYEFMPNKSLDSFI------FDQTRRTLLDWSQRFHIICGTARGLLY 554
LLG C + E L+ E+M L ++ F ++ L A+G+ Y
Sbjct: 61 LLGVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEY 120
Query: 555 LHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVR-TFGGDETEGNTNRVVGT------ 607
L + +HRDL A N L+ +D+ KISDFGL R + D T +
Sbjct: 121 LAS---KKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDDDYYRKKTGGKLPIRWMAPE 177
Query: 608 --YDGQFSIKSDVFSFGILLLEIVS-------GKKNRGFYRSDTKVNLIGHLWDEGIPLR 658
DG F+ KSDV+SFG+LL EI + G N ++ +L +G L
Sbjct: 178 SLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSNE---------EVLEYL-RKGYRLP 227
Query: 659 LIDACIQDSCNLADVIRCIHIGLLCVQQHPEDRPCMPSVILML 701
+ C + L +++ C Q PEDRP ++ L
Sbjct: 228 KPEYCPDE---LYELMLS------CWQLDPEDRPTFSELVERL 261
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 164 bits (419), Expect = 3e-46
Identities = 74/208 (35%), Positives = 102/208 (49%), Gaps = 26/208 (12%)
Query: 442 FSINNKLGEGGFGPVYKGTLVD-----GQEIAVKRLSKI-SEQGLKELKNEVILFSKLQH 495
+ KLGEG FG VYKGTL ++AVK L + SE+ +E E + KL H
Sbjct: 1 LELGKKLGEGAFGEVYKGTLKGDGEGTETKVAVKTLKEGASEEEREEFLEEASIMKKLSH 60
Query: 496 RNLVKLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYL 555
N+V+LLG C QGE ++ E+MP L F+ + L + A+G+ YL
Sbjct: 61 PNIVRLLGVCTQGEPLYIVTEYMPGGDLLDFL--RKHGEKLTLKDLLQMALQIAKGMEYL 118
Query: 556 HQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNTNRVVGTY------- 608
+HRDL A N L+ +++ KISDFGL R D+ G
Sbjct: 119 E---SKNFVHRDLAARNCLVTENLVVKISDFGLSRDIYEDDYYRKRG---GGKLPIKWMA 172
Query: 609 -----DGQFSIKSDVFSFGILLLEIVSG 631
DG+F+ KSDV+SFG+LL EI +
Sbjct: 173 PESLKDGKFTSKSDVWSFGVLLWEIFTL 200
|
Length = 258 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 153 bits (389), Expect = 1e-42
Identities = 67/194 (34%), Positives = 95/194 (48%), Gaps = 20/194 (10%)
Query: 448 LGEGGFGPVYKGT-LVDGQEIAVKRLSKISEQGLKE-LKNEVILFSKLQHRNLVKLLGCC 505
LGEGGFG VY G+++A+K + K L E L E+ + KL H N+VKL G
Sbjct: 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVF 60
Query: 506 IQGEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIH 565
L+ E+ SL + + + L + I+ GL YLH IIH
Sbjct: 61 EDENHLYLVMEYCEGGSLKDLLKENEGK--LSEDEILRILLQILEGLEYLHS---NGIIH 115
Query: 566 RDLKASNVLLDQD-MNPKISDFGLVRTFGGDETEGNTNRVVGTY----------DGQFSI 614
RDLK N+LLD D K++DFGL + D++ T +VGT G +S
Sbjct: 116 RDLKPENILLDSDNGKVKLADFGLSKLLTSDKSLLKT--IVGTPAYMAPEVLLGKGYYSE 173
Query: 615 KSDVFSFGILLLEI 628
KSD++S G++L E+
Sbjct: 174 KSDIWSLGVILYEL 187
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|201524 pfam00954, S_locus_glycop, S-locus glycoprotein family | Back alignment and domain information |
|---|
Score = 145 bits (367), Expect = 6e-41
Identities = 47/111 (42%), Positives = 71/111 (63%), Gaps = 2/111 (1%)
Query: 154 YRTGPWNGLRFS-APSLRPNPIFSFSFVSNDVELYYTFNITNKAVISRIVMNQTLYVRRR 212
+R+GPWNG+RFS P ++ + ++F N+ E+YYT+ +TN ++ SR+ ++ + R
Sbjct: 1 WRSGPWNGIRFSGIPEMQKLSYYVYNFTENNEEVYYTYRMTNNSIYSRLTLSSEGSLER- 59
Query: 213 FIWNKATQSWELYSDVPRDQCDTYGLCGAYGICIIGQSPVCQCLKGFKPKS 263
F W +Q W L+ P+DQCD YG CG YG C + SP C C+KGF PK+
Sbjct: 60 FTWIPNSQDWNLFWSAPKDQCDVYGRCGPYGYCDVNTSPKCNCIKGFVPKN 110
|
In Brassicaceae, self-incompatible plants have a self/non-self recognition system. This is sporophytically controlled by multiple alleles at a single locus (S). S-locus glycoproteins, as well as S-receptor kinases, are in linkage with the S-alleles. Length = 110 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 147 bits (374), Expect = 5e-40
Identities = 62/204 (30%), Positives = 96/204 (47%), Gaps = 21/204 (10%)
Query: 442 FSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSK--ISEQGLKELKNEVILFSKLQHRNL 498
+ + KLG G FG VYK G+ +AVK L K + + + E+ + +L H N+
Sbjct: 1 YELLRKLGSGSFGTVYKAKHKGTGKIVAVKILKKRSEKSKKDQTARREIRILRRLSHPNI 60
Query: 499 VKLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQD 558
V+L+ + L+ E+ L ++ +R L + I RGL YLH
Sbjct: 61 VRLIDAFEDKDHLYLVMEYCEGGDLFDYL---SRGGPLSEDEAKKIALQILRGLEYLH-- 115
Query: 559 SRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNTNRVVGTYD--------- 609
IIHRDLK N+LLD++ KI+DFGL + + + VGT
Sbjct: 116 -SNGIIHRDLKPENILLDENGVVKIADFGLAKKLLK--SSSSLTTFVGTPWYMAPEVLLG 172
Query: 610 -GQFSIKSDVFSFGILLLEIVSGK 632
+ K DV+S G++L E+++GK
Sbjct: 173 GNGYGPKVDVWSLGVILYELLTGK 196
|
Length = 260 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 144 bits (367), Expect = 4e-39
Identities = 72/262 (27%), Positives = 115/262 (43%), Gaps = 30/262 (11%)
Query: 442 FSINNKLGEGGFGPVYKGT-LVDGQEIAVKRLSKISEQGLKE-LKNEVILFSKLQHRNLV 499
+ I KLGEG FG VY G+ +A+K + K + +E + E+ + KL+H N+V
Sbjct: 1 YEILEKLGEGSFGKVYLARDKKTGKLVAIKVIKKKKIKKDRERILREIKILKKLKHPNIV 60
Query: 500 KLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDS 559
+L ++ L+ E+ L + + R + D ++ + L YLH
Sbjct: 61 RLYDVFEDEDKLYLVMEYCEGGDLFDLLKKRGRLSE-DEAR--FYLRQILSALEYLHS-- 115
Query: 560 RLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNTNRVVGT--Y-------DG 610
I+HRDLK N+LLD+D + K++DFGL R E VGT Y
Sbjct: 116 -KGIVHRDLKPENILLDEDGHVKLADFGLARQLDPGEK---LTTFVGTPEYMAPEVLLGK 171
Query: 611 QFSIKSDVFSFGILLLEIVSGKKNRGFYRSDTKVNLIGHLWDEGIPLRLIDACIQDSCNL 670
+ D++S G++L E+++GK F D + L + P + I S
Sbjct: 172 GYGKAVDIWSLGVILYELLTGK--PPFPGDDQLLELFKKIGKPKPPFPPPEWDI--SPEA 227
Query: 671 ADVIRCIHIGLLCVQQHPEDRP 692
D+IR + + PE R
Sbjct: 228 KDLIRK------LLVKDPEKRL 243
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 140 bits (355), Expect = 2e-37
Identities = 78/279 (27%), Positives = 124/279 (44%), Gaps = 57/279 (20%)
Query: 441 NFSINNKLGEGGFGPVYKGTLVD-GQEIAVK--RLSKISEQGLKELKNEVILFSKLQHRN 497
++ LG G FG VY D G+ +AVK LS SE+ L+ L+ E+ + S LQH N
Sbjct: 1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPN 60
Query: 498 LVKLLGCCIQGEEK-LLIY-EFMPNKSLDSFIFDQTRRTLLDWSQRF-----HIICGTAR 550
+V+ G E+ L I+ E++ SL S + ++F +I R
Sbjct: 61 IVRYYGSERDEEKNTLNIFLEYVSGGSLSSLL------------KKFGKLPEPVIRKYTR 108
Query: 551 ----GLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNTNRVVG 606
GL YLH I+HRD+K +N+L+D D K++DFG + G ET T V G
Sbjct: 109 QILEGLAYLH---SNGIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGTGSVRG 165
Query: 607 T--Y-------DGQFSIKSDVFSFGILLLEIVSGKKNRGFYRSDTKVNLIGHLW----DE 653
T + ++ +D++S G ++E+ +GK + N + L+
Sbjct: 166 TPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGK--PPWSELG---NPMAALYKIGSSG 220
Query: 654 GIPLRLIDACIQDSCNLADVIRCIHIGLLCVQQHPEDRP 692
P I + S D +R C+++ P+ RP
Sbjct: 221 EPP--EIPEHL--SEEAKDFLRK------CLRRDPKKRP 249
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|216511 pfam01453, B_lectin, D-mannose binding lectin | Back alignment and domain information |
|---|
Score = 130 bits (329), Expect = 7e-36
Identities = 57/112 (50%), Positives = 70/112 (62%), Gaps = 6/112 (5%)
Query: 17 VVWVANRLNPINDSFGFLMINKTGNLVLTSQSNIVVWSAYLSKEVQTPVVLQLLDSGNLV 76
VVWVANRLNP+ DS L++ GNLVL + VVWS+ + + V L D GNLV
Sbjct: 4 VVWVANRLNPLTDSSYTLILQSDGNLVLYDGNGRVVWSS-NTSGKGSGCVAVLQDDGNLV 62
Query: 77 LRDEHDGDSETYFWQSFDYPSDTLLPGMKLGWDLKTGLERRVTSWKSFDDPS 128
L D +S WQSFD+P+DTLLPG K G ++ G RR+TSWKS DPS
Sbjct: 63 LYD----NSGKVLWQSFDHPTDTLLPGQKDG-NVVIGGSRRLTSWKSNTDPS 109
|
These proteins include mannose-specific lectins from plants as well as bacteriocins from bacteria. Length = 109 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 129 bits (326), Expect = 1e-33
Identities = 78/262 (29%), Positives = 123/262 (46%), Gaps = 29/262 (11%)
Query: 442 FSINNKLGEGGFGPVYKGT-LVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVK 500
F I K+G+GGFG VYK G+E+A+K + S++ +++ NE+ + K +H N+VK
Sbjct: 2 FEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVK 61
Query: 501 LLGCCIQGEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSR 560
G ++ +E ++ EF SL + T +T L SQ ++ +GL YLH
Sbjct: 62 YYGSYLKKDELWIVMEFCSGGSLKD-LLKSTNQT-LTESQIAYVCKELLKGLEYLHS--- 116
Query: 561 LRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNTNRVVGT---------YDGQ 611
IIHRD+KA+N+LL D K+ DFGL N +VGT
Sbjct: 117 NGIIHRDIKAANILLTSDGEVKLIDFGLSAQL---SDTKARNTMVGTPYWMAPEVINGKP 173
Query: 612 FSIKSDVFSFGILLLEIVSGKKNRGFYRSDTKVNLIGHLWDEGIPLRLIDACIQDSCNLA 671
+ K+D++S GI +E+ GK Y + + + G P + S
Sbjct: 174 YDYKADIWSLGITAIELAEGKPP---YSELPPMKALFKIATNGPPGLRNPE--KWSDEFK 228
Query: 672 DVIRCIHIGLLCVQQHPEDRPC 693
D ++ C+Q++PE RP
Sbjct: 229 DFLK------KCLQKNPEKRPT 244
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 121 bits (307), Expect = 1e-30
Identities = 64/223 (28%), Positives = 113/223 (50%), Gaps = 28/223 (12%)
Query: 424 DLELPLFELATIANATDNFSINNKLGEGGFGPVYKGT-LVDGQEIAVKRLSKISEQGLKE 482
+L+ L ++ + + + + K+GEG G VYK T G+E+A+K++ ++ +Q +
Sbjct: 3 ELKAALKDIVSEGDPRELYKNLEKIGEGASGEVYKATDRATGKEVAIKKM-RLRKQNKEL 61
Query: 483 LKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRF 542
+ NE+++ +H N+V + G+E ++ E+M SL I Q + +
Sbjct: 62 IINEILIMKDCKHPNIVDYYDSYLVGDELWVVMEYMDGGSLTDII-TQNFVRMNE----P 116
Query: 543 HI--ICG-TARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEG 599
I +C +GL YLH +IHRD+K+ N+LL +D + K++DFG F T+
Sbjct: 117 QIAYVCREVLQGLEYLHS---QNVIHRDIKSDNILLSKDGSVKLADFG----FAAQLTKE 169
Query: 600 NTNR--VVGT-Y--------DGQFSIKSDVFSFGILLLEIVSG 631
+ R VVGT Y + K D++S GI+ +E+ G
Sbjct: 170 KSKRNSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEG 212
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 120 bits (303), Expect = 1e-30
Identities = 66/214 (30%), Positives = 105/214 (49%), Gaps = 40/214 (18%)
Query: 441 NFSINNKLGEGGFGPVYKG-TLVDGQEIAVKRLS--KISEQGLKELKNEVILFSKLQHRN 497
N+ + + +G G FG VYKG L G +A+K++S KI E+ LK + E+ L L+H N
Sbjct: 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPN 60
Query: 498 LVKLLGCCIQGEEKLLIY-EFMPNKSLDSFIFDQTRRTLLDWSQRFH------IICGTA- 549
+VK +G I+ + L I E+ N SL I ++F +
Sbjct: 61 IVKYIG-SIETSDSLYIILEYAENGSLRQII------------KKFGPFPESLVAVYVYQ 107
Query: 550 --RGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNTNRVVGT 607
+GL YLH+ +IHRD+KA+N+L +D K++DFG+ + + VVGT
Sbjct: 108 VLQGLAYLHEQG---VIHRDIKAANILTTKDGVVKLADFGVATKLNDVSKDDAS--VVGT 162
Query: 608 -Y--------DGQFSIKSDVFSFGILLLEIVSGK 632
Y S SD++S G ++E+++G
Sbjct: 163 PYWMAPEVIEMSGASTASDIWSLGCTVIELLTGN 196
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 119 bits (299), Expect = 5e-30
Identities = 79/263 (30%), Positives = 115/263 (43%), Gaps = 31/263 (11%)
Query: 442 FSINNKLGEGGFGPVYKGTLVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKL 501
F++ KLG G FG V++G + +A+K L ++ + EV +L+H++L+ L
Sbjct: 8 FTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISL 67
Query: 502 LGCCIQGEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRL 561
C GE +I E M SL +F+ + L + + C A G+ YL +
Sbjct: 68 FAVCSVGEPVYIITELMEKGSLLAFLRSPEGQV-LPVASLIDMACQVAEGMAYLEEQ--- 123
Query: 562 RIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGD-ETEGNTNRVV------GTYDGQFSI 614
IHRDL A N+L+ +D+ K++DFGL R D + G FS
Sbjct: 124 NSIHRDLAARNILVGEDLVCKVADFGLARLIKEDVYLSSDKKIPYKWTAPEAASHGTFST 183
Query: 615 KSDVFSFGILLLEIVSGKKNRGFYRSDTKVNLIGHLWDEGIPLRLIDACIQDSCNLADVI 674
KSDV+SFGILL E+ + G +V G E I A + C
Sbjct: 184 KSDVWSFGILLYEMFT----YG------QVPYPGMNNHEV--YDQITAGYRMPCPA---- 227
Query: 675 RCIH----IGLLCVQQHPEDRPC 693
+C I L C PEDRP
Sbjct: 228 KCPQEIYKIMLECWAAEPEDRPS 250
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 118 bits (297), Expect = 1e-29
Identities = 69/198 (34%), Positives = 95/198 (47%), Gaps = 15/198 (7%)
Query: 442 FSINNKLGEGGFGPVYKGTLVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKL 501
+ KLG G FG V+ GT ++AVK L K + E + KL+H LV+L
Sbjct: 8 LKLERKLGAGQFGEVWMGTWNGTTKVAVKTL-KPGTMSPEAFLQEAQIMKKLRHDKLVQL 66
Query: 502 LGCCIQGEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRL 561
C + E ++ E+M SL F+ + L Q + A G+ YL
Sbjct: 67 YAVCSEEEPIYIVTEYMSKGSLLDFLKSGEGKKLR-LPQLVDMAAQIAEGMAYLE---SR 122
Query: 562 RIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGN---------TNRVVGTYDGQF 612
IHRDL A N+L+ +++ KI+DFGL R DE T Y G+F
Sbjct: 123 NYIHRDLAARNILVGENLVCKIADFGLARLIEDDEYTAREGAKFPIKWTAPEAANY-GRF 181
Query: 613 SIKSDVFSFGILLLEIVS 630
+IKSDV+SFGILL EIV+
Sbjct: 182 TIKSDVWSFGILLTEIVT 199
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Score = 114 bits (288), Expect = 3e-28
Identities = 75/282 (26%), Positives = 122/282 (43%), Gaps = 52/282 (18%)
Query: 448 LGEGGFGPVYKGT---LVDGQE---IAVKRLSKISEQGLKE-LKNEVILFSKLQHRNLVK 500
LGEG FG V+ G L + +AVK L + + ++ + E L + QH N+VK
Sbjct: 13 LGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVK 72
Query: 501 LLGCCIQGEEKLLIYEFMPNKSLDSF---------IFDQTRRTL--LDWSQRFHIICGTA 549
G C +G+ ++++E+M + L+ F + L SQ I A
Sbjct: 73 FYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIA 132
Query: 550 RGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNTNRVVGT-- 607
G++YL + +HRDL N L+ D+ KI DFG+ R D + RV G
Sbjct: 133 SGMVYL---ASQHFVHRDLATRNCLVGYDLVVKIGDFGMSR----DVYTTDYYRVGGHTM 185
Query: 608 ------------YDGQFSIKSDVFSFGILLLEIVSGKKNRGFYRSDTKVNLIGHLWDEGI 655
Y +F+ +SDV+SFG++L EI + K + S+ +V I + +G
Sbjct: 186 LPIRWMPPESIMY-RKFTTESDVWSFGVVLWEIFTYGKQPWYGLSNEEV--IECI-TQGR 241
Query: 656 PLRLIDACIQDSCNLADVIRCIHIGLLCVQQHPEDRPCMPSV 697
L+ C + I L C ++ P+ R + +
Sbjct: 242 LLQRPRTCPSEVY---------DIMLGCWKRDPQQRINIKDI 274
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 112 bits (281), Expect = 1e-27
Identities = 67/198 (33%), Positives = 102/198 (51%), Gaps = 32/198 (16%)
Query: 448 LGEGGFGPVYKGTLVDGQEIAVKRL---SKISEQGLKELKNEVILFSKLQHRNLVKLLGC 504
+G+G FG V G GQ++AVK L S ++ L E + + L+H NLV+LLG
Sbjct: 14 IGKGEFGDVMLGDY-RGQKVAVKCLKDDSTAAQAFLAEAS----VMTTLRHPNLVQLLGV 68
Query: 505 CIQGEEKLLIYEFMPNKSLDSFIFDQTR-RTLLDWSQRFHIICGTARGLLYLHQDSRLRI 563
+QG ++ E+M SL ++ ++R R ++ +Q+ G+ YL +
Sbjct: 69 VLQGNPLYIVTEYMAKGSLVDYL--RSRGRAVITLAQQLGFALDVCEGMEYLEEK---NF 123
Query: 564 IHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNTNRVVGTY-----------DGQF 612
+HRDL A NVL+ +D+ K+SDFGL + E + + G + +F
Sbjct: 124 VHRDLAARNVLVSEDLVAKVSDFGLAK-------EASQGQDSGKLPVKWTAPEALREKKF 176
Query: 613 SIKSDVFSFGILLLEIVS 630
S KSDV+SFGILL EI S
Sbjct: 177 STKSDVWSFGILLWEIYS 194
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 112 bits (282), Expect = 2e-27
Identities = 79/274 (28%), Positives = 122/274 (44%), Gaps = 39/274 (14%)
Query: 446 NKLGEGGFGPVYKGT---LVDGQ--EIAVKRLSKIS-EQGLKELKNEVILFSKLQHRNLV 499
+LGEG FG V L D ++AVK L+ EQ + + E+ + L H N+V
Sbjct: 10 KQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIV 69
Query: 500 KLLGCC--IQGEEKLLIYEFMPNKSLDSFI----FDQTRRTLLDWSQRFHIICGTARGLL 553
K G C G LI E++P+ SL ++ + LL +S + IC +G+
Sbjct: 70 KYKGVCEKPGGRSLRLIMEYLPSGSLRDYLQRHRDQINLKRLLLFSSQ---IC---KGMD 123
Query: 554 YLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVR--TFGGDETEGNTNRVVGTY--- 608
YL R IHRDL A N+L++ + KISDFGL + D +
Sbjct: 124 YLGS---QRYIHRDLAARNILVESEDLVKISDFGLAKVLPEDKDYYYVKEPGESPIFWYA 180
Query: 609 -----DGQFSIKSDVFSFGILLLEIVS-GKKNRGFYRSDTKVNLIGHLWDEGIPLRLIDA 662
+FS SDV+SFG+ L E+ + G ++ + +IG + I RL++
Sbjct: 181 PECLRTSKFSSASDVWSFGVTLYELFTYGDPSQ--SPPAEFLRMIGIAQGQMIVTRLLEL 238
Query: 663 CIQDSCNLADVIRC----IHIGLLCVQQHPEDRP 692
+++ L C + LC + P+DRP
Sbjct: 239 -LKEGERLPRPPSCPDEVYDLMKLCWEAEPQDRP 271
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Score = 111 bits (280), Expect = 3e-27
Identities = 70/212 (33%), Positives = 106/212 (50%), Gaps = 32/212 (15%)
Query: 448 LGEGGFGPVYKGTLV------DGQEIAVKRLSKISEQGLK-ELKNEVILFSKLQHRNLVK 500
LGEG FG VYKG L +A+K L + +E ++ E + E L S LQH N+V
Sbjct: 13 LGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVC 72
Query: 501 LLGCCIQGEEKLLIYEFMPNKSLDSFIF-------------DQTRRTLLDWSQRFHIICG 547
LLG C + + +++E++ + L F+ D+T ++ LD S HI
Sbjct: 73 LLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQ 132
Query: 548 TARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVR-TFGGDETEGNTNRVV- 605
A G+ YL S +HRDL A N L+ + + KISDFGL R + D + ++
Sbjct: 133 IAAGMEYL---SSHHFVHRDLAARNCLVGEGLTVKISDFGLSRDIYSADYYRVQSKSLLP 189
Query: 606 -------GTYDGQFSIKSDVFSFGILLLEIVS 630
G+F+ +SD++SFG++L EI S
Sbjct: 190 VRWMPPEAILYGKFTTESDIWSFGVVLWEIFS 221
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 109 bits (275), Expect = 1e-26
Identities = 70/270 (25%), Positives = 111/270 (41%), Gaps = 39/270 (14%)
Query: 440 DNFSINNKLGEGGFGPVYKGTL-VDGQEIAVKRL-SKISEQGLKELKNEV-ILFSKLQHR 496
+ LG+G G VYK G+ A+K++ E+ K+L E+ L S +
Sbjct: 1 SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSC-ESP 59
Query: 497 NLVKLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTA-----RG 551
+VK G + E ++ E+M SL + + + + + +G
Sbjct: 60 YVVKCYGAFYKEGEISIVLEYMDGGSLADLL-----KKVGKIPEP---VLAYIARQILKG 111
Query: 552 LLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNTNRVVGTY--- 608
L YLH IIHRD+K SN+L++ KI+DFG+ + + T N VGT
Sbjct: 112 LDYLHTK--RHIIHRDIKPSNLLINSKGEVKIADFGISKVL--ENTLDQCNTFVGTVTYM 167
Query: 609 -----DGQ-FSIKSDVFSFGILLLEIVSGKKNRGFYRSDTKVNLIGHLWDEGIPLRLIDA 662
G+ +S +D++S G+ LLE GK + L+ + D P L
Sbjct: 168 SPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQPSFFELMQAICDGPPP-SLPAE 226
Query: 663 CIQDSCNLADVIRCIHIGLLCVQQHPEDRP 692
S D I C+Q+ P+ RP
Sbjct: 227 EF--SPEFRDFISA------CLQKDPKKRP 248
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 111 bits (278), Expect = 2e-26
Identities = 75/324 (23%), Positives = 123/324 (37%), Gaps = 36/324 (11%)
Query: 441 NFSINNKLGEGGFGPVYKGTLVDGQEIAVKRLSK---ISEQGLKELKNEVILFSKLQH-R 496
++ I KLGEG FG VY D + +A+K L+K + ++ E+ + + L H
Sbjct: 1 SYRILRKLGEGSFGEVYLA--RDRKLVALKVLAKKLESKSKEVERFLREIQILASLNHPP 58
Query: 497 NLVKLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLH 556
N+VKL L+ E++ SL+ + R+ L S+ I+ L YLH
Sbjct: 59 NIVKLYDFFQDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLH 118
Query: 557 QDSRLRIIHRDLKASNVLLDQDMN-PKISDFGLVRTFGGDETEGNT-------------- 601
IIHRD+K N+LLD+D K+ DFGL + + +
Sbjct: 119 ---SKGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYM 175
Query: 602 --NRVVGTYDGQFSIKSDVFSFGILLLEIVSGKK-NRGFYRSDTKVNLIGHLWDEGIPLR 658
++G S SD++S GI L E+++G G S + + + P
Sbjct: 176 APEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPTPSL 235
Query: 659 LIDACIQDSCNLADVIRCIHIGLLCVQQHPEDRPCMPSVI-------LMLGSEILLPQPK 711
+ S + + + P++R S + L L L K
Sbjct: 236 ASP--LSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSHDLLAHLKLKESDLSDLLK 293
Query: 712 QPGYLADRKSTEPYSSSSMPESSS 735
R S P + + +S
Sbjct: 294 PDDSAPLRLSLPPSLEALISSLNS 317
|
Length = 384 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 107 bits (270), Expect = 4e-26
Identities = 68/200 (34%), Positives = 91/200 (45%), Gaps = 29/200 (14%)
Query: 447 KLGEGGFGPVYKGTLVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCI 506
KLG G FG V++G + +AVK L K K+ E + KL+H L++L C
Sbjct: 13 KLGAGQFGEVWEGLWNNTTPVAVKTL-KPGTMDPKDFLAEAQIMKKLRHPKLIQLYAVCT 71
Query: 507 QGEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHR 566
E ++ E M SL ++ R L Q + A G+ YL + IHR
Sbjct: 72 LEEPIYIVTELMKYGSLLEYLQGGAGRAL-KLPQLIDMAAQVASGMAYLEAQN---YIHR 127
Query: 567 DLKASNVLLDQDMNPKISDFGLVRTFGGDETEG----------------NTNRVVGTYDG 610
DL A NVL+ ++ K++DFGL R D E NR
Sbjct: 128 DLAARNVLVGENNICKVADFGLARVIKEDIYEAREGAKFPIKWTAPEAALYNR------- 180
Query: 611 QFSIKSDVFSFGILLLEIVS 630
FSIKSDV+SFGILL EIV+
Sbjct: 181 -FSIKSDVWSFGILLTEIVT 199
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 107 bits (270), Expect = 4e-26
Identities = 81/273 (29%), Positives = 116/273 (42%), Gaps = 38/273 (13%)
Query: 446 NKLGEGGFGPVYKGTLV--DGQEI--AVKRLSKISEQGLK-ELKNEVILFSKLQHRNLVK 500
+LG G FG V KG + G+E+ AVK L + K E E + ++L H +V+
Sbjct: 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVR 60
Query: 501 LLGCCIQGEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSR 560
L+G C +GE +L+ E P L ++ + + D + H + A G+ YL
Sbjct: 61 LIGVC-KGEPLMLVMELAPLGPLLKYLKKRREIPVSDLKELAHQV---AMGMAYLESK-- 114
Query: 561 LRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNTNRVVG-----------TYD 609
+HRDL A NVLL KISDFG+ R G G
Sbjct: 115 -HFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDY-YRATTAGRWPLKWYAPECINY 172
Query: 610 GQFSIKSDVFSFGILLLEIVS-GKKNRGFYRSDTKVNLIGHLWDEGIPLRLIDACIQDSC 668
G+FS KSDV+S+G+ L E S G K Y +I L + G L + C Q
Sbjct: 173 GKFSSKSDVWSYGVTLWEAFSYGAKP---YGEMKGAEVIAML-ESGERLPRPEECPQ--- 225
Query: 669 NLADVIRCIHIGLLCVQQHPEDRPCMPSVILML 701
+ ++ L C + PEDRP +
Sbjct: 226 EIYSIM------LSCWKYRPEDRPTFSELESTF 252
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 107 bits (269), Expect = 4e-26
Identities = 67/201 (33%), Positives = 100/201 (49%), Gaps = 27/201 (13%)
Query: 447 KLGEGGFGPVYKGTLVDGQEIAVK--RLSKISEQGLKELKNEVILFSKLQHRNLVKLLGC 504
K+G+G FG VYKG L E+AVK R + + K L+ IL + H N+VKL+G
Sbjct: 2 KIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEIL-KQYDHPNIVKLIGV 60
Query: 505 CIQGEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRII 564
C+Q + ++ E +P SL +F+ + ++ L + + A G+ YL + I
Sbjct: 61 CVQKQPIYIVMELVPGGSLLTFL--RKKKNRLTVKKLLQMSLDAAAGMEYLESKN---CI 115
Query: 565 HRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNTNRVVGTYD--------------G 610
HRDL A N L+ ++ KISDFG+ R E EG V G
Sbjct: 116 HRDLAARNCLVGENNVLKISDFGMSR-----EEEGGIYTVSDGLKQIPIKWTAPEALNYG 170
Query: 611 QFSIKSDVFSFGILLLEIVSG 631
+++ +SDV+S+GILL E S
Sbjct: 171 RYTSESDVWSYGILLWETFSL 191
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 107 bits (269), Expect = 9e-26
Identities = 63/226 (27%), Positives = 97/226 (42%), Gaps = 40/226 (17%)
Query: 440 DNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSK---ISEQGLKELKNEVILFSKL-Q 494
D+F +GEG F V +E A+K L K I E+ +K +K E + ++L
Sbjct: 1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNG 60
Query: 495 HRNLVKLLGCCIQGEEKL-LIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLL 553
H ++KL Q EE L + E+ PN L +I + LD L
Sbjct: 61 HPGIIKLY-YTFQDEENLYFVLEYAPNGELLQYI---RKYGSLDEKCTRFYAAEILLALE 116
Query: 554 YLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNTNRV--------- 604
YLH IIHRDLK N+LLD+DM+ KI+DFG + + + +
Sbjct: 117 YLHS---KGIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNKGDATNIDSQIE 173
Query: 605 ---------VGT--Y-------DGQFSIKSDVFSFGILLLEIVSGK 632
VGT Y + SD+++ G ++ ++++GK
Sbjct: 174 KNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGK 219
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 105 bits (265), Expect = 2e-25
Identities = 63/205 (30%), Positives = 100/205 (48%), Gaps = 27/205 (13%)
Query: 442 FSINNKLGEGGFGPVYKGT-LVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVK 500
F I KLGEG +G VYK GQ +A+K + E+ L+E+ E+ + + +VK
Sbjct: 5 FDILEKLGEGSYGSVYKAIHKETGQVVAIKVVP--VEEDLQEIIKEISILKQCDSPYIVK 62
Query: 501 LLGCCIQGEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSR 560
G + + ++ E+ S+ S I T +TL + I+ T +GL YLH
Sbjct: 63 YYGSYFKNTDLWIVMEYCGAGSV-SDIMKITNKTL-TEEEIAAILYQTLKGLEYLHS--- 117
Query: 561 LRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNTNRVVGT------------- 607
+ IHRD+KA N+LL+++ K++DFG+ T N V+GT
Sbjct: 118 NKKIHRDIKAGNILLNEEGQAKLADFGVSGQLTD--TMAKRNTVIGTPFWMAPEVIQEIG 175
Query: 608 YDGQFSIKSDVFSFGILLLEIVSGK 632
Y+ K+D++S GI +E+ GK
Sbjct: 176 YNN----KADIWSLGITAIEMAEGK 196
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 106 bits (266), Expect = 2e-25
Identities = 62/212 (29%), Positives = 99/212 (46%), Gaps = 30/212 (14%)
Query: 441 NFSINNKLGEGGFGPVYKGT-LVDGQEIAVKR--LSKISEQGLKELKNEVILFSKLQHRN 497
+ I ++G+G FG VY DG+ +K LS +SE+ ++ NEV + KL H N
Sbjct: 1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPN 60
Query: 498 LVKLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQTRR-------TLLDWSQRFHIICGTAR 550
++K + + ++ E+ L I Q + +LDW F +C
Sbjct: 61 IIKYYESFEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDW---FVQLC---L 114
Query: 551 GLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNTNRVVGT--Y 608
L YLH SR +I+HRD+K N+ L + K+ DFG+ + T VVGT Y
Sbjct: 115 ALKYLH--SR-KILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTVDLAKT--VVGTPYY 169
Query: 609 -------DGQFSIKSDVFSFGILLLEIVSGKK 633
+ ++ KSD++S G +L E+ + K
Sbjct: 170 LSPELCQNKPYNYKSDIWSLGCVLYELCTLKH 201
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 105 bits (264), Expect = 2e-25
Identities = 86/266 (32%), Positives = 128/266 (48%), Gaps = 36/266 (13%)
Query: 440 DNFSINNKLGEGGFGPVYKGTLVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLV 499
+ + KLG G FG V+ G ++A+K L K + E L +LQH LV
Sbjct: 6 ETLKLVKKLGAGQFGEVWMGYYNGHTKVAIKSL-KQGSMSPEAFLAEANLMKQLQHPRLV 64
Query: 500 KLLGCCIQGEEKLLIYEFMPNKSLDSFI-----FDQTRRTLLDWSQRFHIICGTARGLLY 554
+L Q E +I E+M N SL F+ T L+D + + A G+ +
Sbjct: 65 RLYAVVTQ-EPIYIITEYMENGSLVDFLKTPEGIKLTINKLIDMAAQ------IAEGMAF 117
Query: 555 LHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDE---TEGNTNRVVGTYD-- 609
+ R IHRDL+A+N+L+ + + KI+DFGL R +E EG + T
Sbjct: 118 IE---RKNYIHRDLRAANILVSETLCCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEA 174
Query: 610 ---GQFSIKSDVFSFGILLLEIVSGKKNRGFYRSDTKVNLIGHLWDEGIPLRLIDACIQD 666
G F+IKSDV+SFGILL EIV+ R Y T +I +L + G + D C ++
Sbjct: 175 INYGTFTIKSDVWSFGILLTEIVT--YGRIPYPGMTNPEVIQNL-ERGYRMPRPDNCPEE 231
Query: 667 SCNLADVIRCIHIGLLCVQQHPEDRP 692
L +++R LC ++ PE+RP
Sbjct: 232 ---LYELMR------LCWKEKPEERP 248
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Score = 104 bits (262), Expect = 5e-25
Identities = 91/278 (32%), Positives = 123/278 (44%), Gaps = 55/278 (19%)
Query: 448 LGEGGFGPVYKGTLVD-------GQEIAVKRLSK---ISEQGLKELKNEVILFSKLQHRN 497
LG G FG VY+GT D +AVK L K E+ KE E L S H N
Sbjct: 3 LGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEK--KEFLKEAHLMSNFNHPN 60
Query: 498 LVKLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQTRRT----LLDWSQRFHIICGTARGLL 553
+VKLLG C+ E + +I E M L S++ D LL + I A+G +
Sbjct: 61 IVKLLGVCLLNEPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCV 120
Query: 554 YLHQDSRLRIIHRDLKASNVLL-----DQDMNPKISDFGLVRTFGGDETEGNTNRVVGT- 607
YL Q + IHRDL A N L+ D D KI DFGL R D + + R G
Sbjct: 121 YLEQ---MHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLAR----DIYKSDYYRKEGEG 173
Query: 608 ------------YDGQFSIKSDVFSFGILLLEIVS-GKKNRGFYRSDTKVNLIGHLWDEG 654
DG+F+ +SDV+SFG+L+ EI++ G++ Y + ++ H+ G
Sbjct: 174 LLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQP---YPALNNQEVLQHVTAGG 230
Query: 655 IPLRLIDACIQDSCNLADVIRCIHIGLLCVQQHPEDRP 692
RL Q N D I + C Q P +RP
Sbjct: 231 ---RL-----QKPENCPDKIY--QLMTNCWAQDPSERP 258
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 104 bits (262), Expect = 6e-25
Identities = 62/206 (30%), Positives = 105/206 (50%), Gaps = 30/206 (14%)
Query: 448 LGEGGFGPVYKGT-LVDGQ----EIAVKRL-SKISEQGLKELKNEVILFSKLQHRNLVKL 501
LG G FG VYKG + +G+ +A+K L + S + KE+ +E + + + H ++V+L
Sbjct: 15 LGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRL 74
Query: 502 LGCCIQGEEKLLIYEFMPNKSLDSFIFDQTRR----TLLDWSQRFHIICGTARGLLYLHQ 557
LG C+ + LI + MP L ++ + LL+W + A+G+ YL +
Sbjct: 75 LGICL-SSQVQLITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQI------AKGMSYLEE 127
Query: 558 DSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNTN---------RVVGTY 608
R++HRDL A NVL+ + KI+DFGL + DE E + +
Sbjct: 128 K---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLDVDEKEYHAEGGKVPIKWMALESIL 184
Query: 609 DGQFSIKSDVFSFGILLLEIVS-GKK 633
++ KSDV+S+G+ + E+++ G K
Sbjct: 185 HRIYTHKSDVWSYGVTVWELMTFGAK 210
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 104 bits (261), Expect = 8e-25
Identities = 62/209 (29%), Positives = 100/209 (47%), Gaps = 27/209 (12%)
Query: 440 DNFSINNKLGEGGFGPVYKGTLV--DGQEI--AVKRL-SKISEQGLKELKNEVILFSKLQ 494
+I +G G FG V +G L +EI A+K L + S++ + E + +
Sbjct: 4 SYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFD 63
Query: 495 HRNLVKLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLY 554
H N+++L G + ++I E+M N SLD F+ + Q ++ G A G+ Y
Sbjct: 64 HPNIIRLEGVVTKSRPVMIITEYMENGSLDKFL--RENDGKFTVGQLVGMLRGIASGMKY 121
Query: 555 LHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNTNRVVG-------- 606
L S + +HRDL A N+L++ ++ K+SDFGL R E T G
Sbjct: 122 L---SEMNYVHRDLAARNILVNSNLVCKVSDFGLSRRLEDSEATYTTK---GGKIPIRWT 175
Query: 607 -----TYDGQFSIKSDVFSFGILLLEIVS 630
Y +F+ SDV+SFGI++ E++S
Sbjct: 176 APEAIAY-RKFTSASDVWSFGIVMWEVMS 203
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 103 bits (260), Expect = 9e-25
Identities = 65/202 (32%), Positives = 94/202 (46%), Gaps = 29/202 (14%)
Query: 448 LGEGGFGPVYKGTLV----DGQEIAVKRLSK---ISEQGLKELKNEVILFSKLQHRNLVK 500
LG+G FG V LV G+ A+K L K I + ++ E + S++ H +VK
Sbjct: 1 LGKGSFGKVL---LVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVK 57
Query: 501 LLGCCIQGEEKL-LIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDS 559
L Q EEKL L+ E+ P L S + + RF L YLH
Sbjct: 58 LH-YAFQTEEKLYLVLEYAPGGELFSHL--SKEGRFSEERARF-YAAEIVLALEYLH--- 110
Query: 560 RLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNTNRVVGTYD---------G 610
L II+RDLK N+LLD D + K++DFGL + + + NT GT +
Sbjct: 111 SLGIIYRDLKPENILLDADGHIKLTDFGLAKELSSEGSRTNT--FCGTPEYLAPEVLLGK 168
Query: 611 QFSIKSDVFSFGILLLEIVSGK 632
+ D +S G+LL E+++GK
Sbjct: 169 GYGKAVDWWSLGVLLYEMLTGK 190
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 101 bits (255), Expect = 8e-24
Identities = 58/213 (27%), Positives = 99/213 (46%), Gaps = 36/213 (16%)
Query: 442 FSINNKLGEGGFGPVYKG-TLVDGQEIAVKRLSKISE------QGLKELKNEVILFSKLQ 494
+ ++GEG +G VYK G+ +A+K++ +E ++E+K L KL+
Sbjct: 1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIK----LLQKLR 56
Query: 495 HRNLVKLLGCCIQGEEK--LLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGL 552
H N+V+L + +++E+M + L + + SQ + GL
Sbjct: 57 HPNIVRLKEIVTSKGKGSIYMVFEYMDH-DLTGLL--DSPEVKFTESQIKCYMKQLLEGL 113
Query: 553 LYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNTNRVV------- 605
YLH + I+HRD+K SN+L++ D K++DFGL R + + TNRV+
Sbjct: 114 QYLHSN---GILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSADYTNRVITLWYRPP 170
Query: 606 ----GT--YDGQFSIKSDVFSFGILLLEIVSGK 632
G Y + D++S G +L E+ GK
Sbjct: 171 ELLLGATRYGP----EVDMWSVGCILAELFLGK 199
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|219774 pfam08276, PAN_2, PAN-like domain | Back alignment and domain information |
|---|
Score = 94.7 bits (236), Expect = 1e-23
Identities = 35/65 (53%), Positives = 46/65 (70%), Gaps = 1/65 (1%)
Query: 283 RQDGFIKFTELKLPDATSSWVSKSMNLKECREGCLENSSCMAYTNSDIRGGGSGCAMWFG 342
DGF++ +KLPD T++ V +S+ LKEC + CL N SC AY +DIR GGSGC +W G
Sbjct: 3 GGDGFLRLPNMKLPDTTAAIVDRSIGLKECEQRCLSNCSCTAYAYADIR-GGSGCLIWTG 61
Query: 343 ELIDM 347
EL+DM
Sbjct: 62 ELVDM 66
|
Length = 66 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 99.6 bits (248), Expect = 3e-23
Identities = 62/216 (28%), Positives = 107/216 (49%), Gaps = 20/216 (9%)
Query: 440 DNFSINNKLGEGGFGPVYKGTLVDGQEIAVK--RLSKISEQGLKELKNEVILFSKLQHRN 497
++ ++G G FG V+ G ++ +++A+K R +SE+ E E + KL H
Sbjct: 4 SELTLVQEIGSGQFGLVWLGYWLEKRKVAIKTIREGAMSEEDFIE---EAQVMMKLSHPK 60
Query: 498 LVKLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQ 557
LV+L G C + L++EFM + L ++ + +R + G+ YL
Sbjct: 61 LVQLYGVCTERSPICLVFEFMEHGCLSDYL--RAQRGKFSQETLLGMCLDVCEGMAYLES 118
Query: 558 DSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNTNRV---------VGTY 608
+ +IHRDL A N L+ ++ K+SDFG+ R D+ +T V ++
Sbjct: 119 SN---VIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQYTSSTGTKFPVKWSSPEVFSF 175
Query: 609 DGQFSIKSDVFSFGILLLEIVSGKKNRGFYRSDTKV 644
++S KSDV+SFG+L+ E+ S K RS+++V
Sbjct: 176 -SKYSSKSDVWSFGVLMWEVFSEGKTPYENRSNSEV 210
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
| >gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Score = 98.9 bits (246), Expect = 4e-23
Identities = 82/266 (30%), Positives = 129/266 (48%), Gaps = 36/266 (13%)
Query: 440 DNFSINNKLGEGGFGPVYKGTLVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLV 499
++ + KLG G FG V+ T ++AVK + K ++ E + LQH LV
Sbjct: 6 ESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTM-KPGSMSVEAFLAEANVMKTLQHDKLV 64
Query: 500 KLLGCCIQGEEKLLIYEFMPNKSLDSFI-FDQTRRT----LLDWSQRFHIICGTARGLLY 554
KL + E +I EFM SL F+ D+ + L+D+S + A G+ +
Sbjct: 65 KL-HAVVTKEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQI------AEGMAF 117
Query: 555 LHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDE---TEGNTNRVVGTYD-- 609
+ Q + IHRDL+A+N+L+ + KI+DFGL R +E EG + T
Sbjct: 118 IEQRN---YIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEA 174
Query: 610 ---GQFSIKSDVFSFGILLLEIVSGKKNRGFYRSDTKVNLIGHLWDEGIPLRLIDACIQD 666
G F+IKSDV+SFGILL+EIV+ R Y + +I L + G + + C ++
Sbjct: 175 INFGSFTIKSDVWSFGILLMEIVT--YGRIPYPGMSNPEVIRAL-ERGYRMPRPENCPEE 231
Query: 667 SCNLADVIRCIHIGLLCVQQHPEDRP 692
L +++ + C + PE+RP
Sbjct: 232 ---LYNIM------MRCWKNRPEERP 248
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 99.3 bits (248), Expect = 5e-23
Identities = 60/202 (29%), Positives = 100/202 (49%), Gaps = 27/202 (13%)
Query: 447 KLGEGGFGPVYKG-TLVDGQEIAVKRLSK------ISEQGLKELKNEVILFSKLQHRNLV 499
K+GEG +G VYK + G+ +A+K++ I + L+E+K L +L H N++
Sbjct: 6 KIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIK----LLKELNHPNII 61
Query: 500 KLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDS 559
KLL + L++EFM + L I + R+ L S + +GL + H
Sbjct: 62 KLLDVFRHKGDLYLVFEFM-DTDLYKLI--KDRQRGLPESLIKSYLYQLLQGLAFCHSH- 117
Query: 560 RLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNTNRVVGTY---------DG 610
I+HRDLK N+L++ + K++DFGL R+FG T+ VV + D
Sbjct: 118 --GILHRDLKPENLLINTEGVLKLADFGLARSFGSPV-RPYTHYVVTRWYRAPELLLGDK 174
Query: 611 QFSIKSDVFSFGILLLEIVSGK 632
+S D++S G + E++S +
Sbjct: 175 GYSTPVDIWSVGCIFAELLSRR 196
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 98.9 bits (246), Expect = 6e-23
Identities = 85/264 (32%), Positives = 124/264 (46%), Gaps = 31/264 (11%)
Query: 440 DNFSINNKLGEGGFGPVYKGTLVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLV 499
++ + KLG G FG V+ G + ++AVK L K ++ E L LQH LV
Sbjct: 6 ESIKLVKKLGAGQFGEVWMGYYNNSTKVAVKTL-KPGTMSVQAFLEEANLMKTLQHDKLV 64
Query: 500 KLLGCCIQGEEKLLIYEFMPNKSLDSFI-FDQTRRTLLDWSQRFHIICGTARGLLYLHQD 558
+L + E +I E+M SL F+ D+ + LL F A G+ Y+
Sbjct: 65 RLYAVVTKEEPIYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFS--AQIAEGMAYIE-- 120
Query: 559 SRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDE---TEGNTNRVVGTYD-----G 610
R IHRDL+A+NVL+ + + KI+DFGL R +E EG + T G
Sbjct: 121 -RKNYIHRDLRAANVLVSESLMCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFG 179
Query: 611 QFSIKSDVFSFGILLLEIVSGKK--NRGFYRSDTKVNLIGHLWDEGIPLRLIDACIQDSC 668
F+IKSDV+SFGILL EIV+ K G SD L G + ++ C +
Sbjct: 180 SFTIKSDVWSFGILLYEIVTYGKIPYPGMSNSDVMSAL-----QRGYRMPRMENCPDE-- 232
Query: 669 NLADVIRCIHIGLLCVQQHPEDRP 692
L D+++ C ++ E+RP
Sbjct: 233 -LYDIMK------TCWKEKAEERP 249
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Score = 98.7 bits (246), Expect = 7e-23
Identities = 61/204 (29%), Positives = 95/204 (46%), Gaps = 24/204 (11%)
Query: 448 LGEGGFGPVY----KGTLVDGQE--IAVKRLSKISEQG-LKELKNEVILFSKLQHRNLVK 500
LG G FG V+ KG +G E + VK L K ++ E + E+ +F KL H+N+V+
Sbjct: 13 LGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVR 72
Query: 501 LLGCCIQGEEKLLIYEFMPNKSLDSFI------FDQTRRTLLDWSQRFHIICGTARGLLY 554
LLG C + E +I E+ L F+ ++ + L Q+ + A G+ +
Sbjct: 73 LLGLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDH 132
Query: 555 LHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNTNRVV--------G 606
L S R +HRDL A N L+ K+S L + E N ++
Sbjct: 133 L---SNARFVHRDLAARNCLVSSQREVKVSLLSLSKDVYNSEYYKLRNALIPLRWLAPEA 189
Query: 607 TYDGQFSIKSDVFSFGILLLEIVS 630
+ FS KSDV+SFG+L+ E+ +
Sbjct: 190 VQEDDFSTKSDVWSFGVLMWEVFT 213
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275 |
| >gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Score = 98.8 bits (246), Expect = 9e-23
Identities = 75/286 (26%), Positives = 126/286 (44%), Gaps = 52/286 (18%)
Query: 448 LGEGGFGPVYKGT---LVDGQE---IAVKRLSK-ISEQGLKELKNEVILFSKLQHRNLVK 500
+G+G FG V++ L+ + +AVK L + S + + E L ++ H N+VK
Sbjct: 13 IGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVK 72
Query: 501 LLGCCIQGEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRF----------------HI 544
LLG C G+ L++E+M L+ F+ ++ R S
Sbjct: 73 LLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQ 132
Query: 545 IC---GTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRT-FGGDETEGN 600
+C A G+ YL S + +HRDL N L+ ++M KI+DFGL R + D + +
Sbjct: 133 LCIAKQVAAGMAYL---SERKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKAS 189
Query: 601 TNRVV--------GTYDGQFSIKSDVFSFGILLLEIVS-GKKNRGFYRSDTKVNLIGHLW 651
N + + +++ +SDV+++G++L EI S G + Y +I ++
Sbjct: 190 ENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQP---YYGMAHEEVIYYVR 246
Query: 652 DEGIPLRLIDACIQDSCNLADVIRCIHIGLLCVQQHPEDRPCMPSV 697
D + L D C + NL LC + P DRP S+
Sbjct: 247 DGNV-LSCPDNCPLELYNLM---------RLCWSKLPSDRPSFASI 282
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 97.6 bits (243), Expect = 1e-22
Identities = 62/208 (29%), Positives = 98/208 (47%), Gaps = 36/208 (17%)
Query: 443 SINNKLGEGGFGPVYKGTLVD-GQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKL 501
++ +KLG G +G VY+G +AVK L K ++E E + +++H NLV+L
Sbjct: 9 TMKHKLGGGQYGEVYEGVWKKYSLTVAVKTL-KEDTMEVEEFLKEAAVMKEIKHPNLVQL 67
Query: 502 LGCCIQGEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRL 561
LG C + +I EFM +L ++ + R ++ ++ + + YL + +
Sbjct: 68 LGVCTREPPFYIITEFMTYGNLLDYLRE-CNRQEVNAVVLLYMATQISSAMEYLEKKN-- 124
Query: 562 RIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNTNRVVGTYDGQ---------- 611
IHRDL A N L+ ++ K++DFGL R GD TY
Sbjct: 125 -FIHRDLAARNCLVGENHLVKVADFGLSRLMTGD-----------TYTAHAGAKFPIKWT 172
Query: 612 ---------FSIKSDVFSFGILLLEIVS 630
FSIKSDV++FG+LL EI +
Sbjct: 173 APESLAYNKFSIKSDVWAFGVLLWEIAT 200
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 97.9 bits (245), Expect = 2e-22
Identities = 71/207 (34%), Positives = 106/207 (51%), Gaps = 27/207 (13%)
Query: 442 FSINNKLGEGGFGPVYKGT-LVDGQEIAVK--RLSKISEQGLKE--LKNEVILFSKLQHR 496
+ KLGEG +G VYK G+ +A+K RL E+G+ L+ E+ L +L+H
Sbjct: 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDN-EEEGIPSTALR-EISLLKELKHP 58
Query: 497 NLVKLLGCCIQGEEKL-LIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYL 555
N+VKLL I E KL L++E+ + L ++ R L + I+ RGL Y
Sbjct: 59 NIVKLL-DVIHTERKLYLVFEYC-DMDLKKYL--DKRPGPLSPNLIKSIMYQLLRGLAYC 114
Query: 556 HQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNTNRVVGT--Y----- 608
H RI+HRDLK N+L+++D K++DFGL R FG T+ VV T Y
Sbjct: 115 HSH---RILHRDLKPQNILINRDGVLKLADFGLARAFGIPLRT-YTHEVV-TLWYRAPEI 169
Query: 609 ---DGQFSIKSDVFSFGILLLEIVSGK 632
+S D++S G + E+++GK
Sbjct: 170 LLGSKHYSTAVDIWSVGCIFAEMITGK 196
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Score = 96.6 bits (240), Expect = 5e-22
Identities = 67/213 (31%), Positives = 108/213 (50%), Gaps = 32/213 (15%)
Query: 447 KLGEGGFGPVYKGTLV------DGQEIAVKRLSKISEQGLKE-LKNEVILFSKLQHRNLV 499
+LGE FG VYKG L Q +A+K L +E L+E K+E ++ S+LQH N+V
Sbjct: 12 ELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIV 71
Query: 500 KLLGCCIQGEEKLLIYEFMPNKSLDSFIF-------------DQTRRTLLDWSQRFHIIC 546
LLG + + +I+ + + L F+ D+T ++ L+ + HI+
Sbjct: 72 CLLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVT 131
Query: 547 GTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVR-TFGGDETEGNTNRVV 605
A G+ +L S ++H+DL NVL+ +N KISD GL R + D + N ++
Sbjct: 132 QIAAGMEFL---SSHHVVHKDLATRNVLVFDKLNVKISDLGLFREVYAADYYKLMGNSLL 188
Query: 606 --------GTYDGQFSIKSDVFSFGILLLEIVS 630
G+FSI SD++S+G++L E+ S
Sbjct: 189 PIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFS 221
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 95.7 bits (238), Expect = 6e-22
Identities = 73/272 (26%), Positives = 123/272 (45%), Gaps = 47/272 (17%)
Query: 441 NFSINNKLGEGGFGPVYKGTL-VDGQEIAVKR--LSKISEQGLKELKNEVILFSKLQHRN 497
+F I NK+G+G FG V+K D + A+K+ LSK++ + +E +E + +KL
Sbjct: 1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSY 60
Query: 498 LVKLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQTRRTLLD---WSQRFHIICGTARGLLY 554
+++ + + ++ E+ N L + Q R L + W RF I GL +
Sbjct: 61 IIRYYESFLDKGKLNIVMEYAENGDLHKLLKMQRGRPLPEDQVW--RFFI--QILLGLAH 116
Query: 555 LHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNTNRVVGT------- 607
LH +I+HRD+K+ N+ LD N KI D G+ + + NT +VGT
Sbjct: 117 LHSK---KILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTNFANT--IVGTPYYLSPE 171
Query: 608 --YDGQFSIKSDVFSFGILLLEIVSGKKNRGFYRSDTKVNLIGHLWDEGIPLRLIDACIQ 665
D ++ KSDV++ G++L E +GK + ++ + LI L++I
Sbjct: 172 LCEDKPYNEKSDVWALGVVLYECCTGKHP---FDANNQGALI---------LKIIRGVFP 219
Query: 666 D-----SCNLADVIRCIHIGLLCVQQHPEDRP 692
S LA +I C+ + RP
Sbjct: 220 PVSQMYSQQLAQLID------QCLTKDYRQRP 245
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|238531 cd01098, PAN_AP_plant, Plant PAN/APPLE-like domain; present in plant S-receptor protein kinases and secreted glycoproteins | Back alignment and domain information |
|---|
Score = 89.8 bits (223), Expect = 7e-22
Identities = 34/86 (39%), Positives = 49/86 (56%), Gaps = 8/86 (9%)
Query: 278 PLNYSR---QDGFIKFTELKLPDATSSWVSKSMNLKECREGCLENSSCMAYTNSDIRGGG 334
PLN DGF+K ++KLPD ++ +++L+ECRE CL N SC AY ++ G
Sbjct: 2 PLNCGGDGSTDGFLKLPDVKLPD--NASAITAISLEECREACLSNCSCTAYAYNN---GS 56
Query: 335 SGCAMWFGELIDMRDFPGGGQDFYIR 360
GC +W G L ++R GG Y+R
Sbjct: 57 GGCLLWNGLLNNLRSLSSGGGTLYLR 82
|
PAN/APPLE domains fulfill diverse biological functions by mediating protein-protein or protein-carbohydrate interactions. S-receptor protein kinases and S-locus glycoproteins are involved in sporophytic self-incompatibility response in Brassica, one of probably many molecular mechanisms, by which hermaphrodite flowering plants avoid self-fertilization. Length = 84 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 95.2 bits (237), Expect = 8e-22
Identities = 64/197 (32%), Positives = 96/197 (48%), Gaps = 20/197 (10%)
Query: 448 LGEGGFGPVYKGTLVDGQEIAVKRLSK--ISEQGLKELKNEVILFSKLQHRNLVKLLGCC 505
LG G FG V+ G ++A+K + + +SE E E + KL H NLV+L G C
Sbjct: 12 LGSGQFGVVHLGKWRGKIDVAIKMIREGAMSEDDFIE---EAKVMMKLSHPNLVQLYGVC 68
Query: 506 IQGEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIH 565
+ ++ E+M N L +++ + R+ L + + YL + IH
Sbjct: 69 TKQRPIFIVTEYMANGCLLNYL--RERKGKLGTEWLLDMCSDVCEAMEYLESNG---FIH 123
Query: 566 RDLKASNVLLDQDMNPKISDFGLVRTFGGDE---TEGNTNRV------VGTYDGQFSIKS 616
RDL A N L+ +D K+SDFGL R D+ ++G V V Y +FS KS
Sbjct: 124 RDLAARNCLVGEDNVVKVSDFGLARYVLDDQYTSSQGTKFPVKWAPPEVFDY-SRFSSKS 182
Query: 617 DVFSFGILLLEIVSGKK 633
DV+SFG+L+ E+ S K
Sbjct: 183 DVWSFGVLMWEVFSEGK 199
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 95.7 bits (238), Expect = 8e-22
Identities = 62/215 (28%), Positives = 100/215 (46%), Gaps = 31/215 (14%)
Query: 442 FSINNKLGEGGFGPVYKGTLV--DG--QEIAVK--RLSKISEQGLKELKNEVILFSKLQH 495
+ LGEG FG V +G L DG ++AVK +L + ++E +E H
Sbjct: 1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDH 60
Query: 496 RNLVKLLGCCIQGEEK------LLIYEFMPNKSLDSFIF-----DQTRRTLLDWSQRFHI 544
N++KL+G C + ++I FM + L SF+ + L +F +
Sbjct: 61 PNVMKLIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMV 120
Query: 545 ICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRT-FGGD-ETEGNTN 602
A G+ YL S IHRDL A N +L +DM ++DFGL + + GD +G
Sbjct: 121 --DIALGMEYL---SNRNFIHRDLAARNCMLREDMTVCVADFGLSKKIYSGDYYRQGRIA 175
Query: 603 RVVGTY-------DGQFSIKSDVFSFGILLLEIVS 630
++ + D ++ KSDV++FG+ + EI +
Sbjct: 176 KMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIAT 210
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273 |
| >gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Score = 95.8 bits (238), Expect = 9e-22
Identities = 67/228 (29%), Positives = 107/228 (46%), Gaps = 38/228 (16%)
Query: 447 KLGEGGFGPVYKG---TLVDGQE---IAVKRLSKISEQGLKELKNEVILFSKLQHRNLVK 500
+LGEG FG V+ L+ Q+ +AVK L + SE ++ + E L + LQH+++V+
Sbjct: 12 ELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVR 71
Query: 501 LLGCCIQGEEKLLIYEFMPNKSLDSF---------IFDQTRRTL---LDWSQRFHIICGT 548
G C +G L+++E+M + L+ F I L Q I
Sbjct: 72 FYGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQI 131
Query: 549 ARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNTNRVVG-- 606
A G++YL + L +HRDL N L+ Q + KI DFG+ R D + RV G
Sbjct: 132 ASGMVYL---ASLHFVHRDLATRNCLVGQGLVVKIGDFGMSR----DIYSTDYYRVGGRT 184
Query: 607 -----------TYDGQFSIKSDVFSFGILLLEIVSGKKNRGFYRSDTK 643
+F+ +SD++SFG++L EI + K + S+T+
Sbjct: 185 MLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSNTE 232
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280 |
| >gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Score = 94.3 bits (234), Expect = 2e-21
Identities = 67/195 (34%), Positives = 103/195 (52%), Gaps = 16/195 (8%)
Query: 442 FSINNKLGEGGFGPVYKGTLVDGQEIAVKRLS-KISEQGLKELKNEVILFSKLQHRNLVK 500
++ +GEG FG V +G GQ++AVK + ++ Q E E + +KL H+NLV+
Sbjct: 8 LTLGEIIGEGEFGAVLQGEYT-GQKVAVKNIKCDVTAQAFLE---ETAVMTKLHHKNLVR 63
Query: 501 LLGCCIQGEEKLLIYEFMPNKSLDSFIFDQTR-RTLLDWSQRFHIICGTARGLLYLHQDS 559
LLG I ++ E M +L +F+ +TR R L+ Q A G+ YL
Sbjct: 64 LLGV-ILHNGLYIVMELMSKGNLVNFL--RTRGRALVSVIQLLQFSLDVAEGMEYLESK- 119
Query: 560 RLRIIHRDLKASNVLLDQDMNPKISDFGLVR--TFGGDETEGNTNRVV--GTYDGQFSIK 615
+++HRDL A N+L+ +D K+SDFGL R + G D ++ +FS K
Sbjct: 120 --KLVHRDLAARNILVSEDGVAKVSDFGLARVGSMGVDNSKLPVKWTAPEALKHKKFSSK 177
Query: 616 SDVFSFGILLLEIVS 630
SDV+S+G+LL E+ S
Sbjct: 178 SDVWSYGVLLWEVFS 192
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254 |
| >gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Score = 93.3 bits (232), Expect = 4e-21
Identities = 66/202 (32%), Positives = 105/202 (51%), Gaps = 26/202 (12%)
Query: 448 LGEGGFGPVYKGTLVD--GQEI--AVKRLSKISE-QGLKELKNEVILFSKLQHRNLVKLL 502
+G+G FG VY GTL+D GQ+I AVK L++I++ + +++ E I+ H N++ LL
Sbjct: 3 IGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLL 62
Query: 503 GCCIQGE-EKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRL 561
G C+ E L++ +M + L +FI +T + F + A+G+ YL
Sbjct: 63 GICLPSEGSPLVVLPYMKHGDLRNFIRSETHNPTVKDLIGFGL--QVAKGMEYLASK--- 117
Query: 562 RIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNTNRVVG-------------TY 608
+ +HRDL A N +LD+ K++DFGL R E N T
Sbjct: 118 KFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVHNHTGAKLPVKWMALESLQTQ 177
Query: 609 DGQFSIKSDVFSFGILLLEIVS 630
+F+ KSDV+SFG+LL E+++
Sbjct: 178 --KFTTKSDVWSFGVLLWELMT 197
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 93.2 bits (232), Expect = 4e-21
Identities = 77/271 (28%), Positives = 104/271 (38%), Gaps = 51/271 (18%)
Query: 447 KLGEGGFGPVYKGTLVDGQ----EIAVKRLSKISEQG-LKELKNEVILFSKLQHRNLVKL 501
KLG+G FG V +G +AVK L + + E + L H NL++L
Sbjct: 2 KLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRL 61
Query: 502 LGCCIQGEEKLLIYEFMPNKSLDSFIFDQTRR-----TLLDWSQRFHIICGTARGLLYLH 556
G + + + E P SL + TL D++ + A G+ YL
Sbjct: 62 YGVVLTHPLMM-VTELAPLGSLLDRLRKDALGHFLISTLCDYAVQI------ANGMRYLE 114
Query: 557 QDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTF--GGDETEGNTNRVV--------G 606
R IHRDL A N+LL D KI DFGL+R D + V
Sbjct: 115 SK---RFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVMEEHLKVPFAWCAPES 171
Query: 607 TYDGQFSIKSDVFSFGILLLEIVSGKKNRGFYRSDTKVNLIG----HLWD-EGIPLRLID 661
FS SDV+ FG+ L E+ + Y + L G D EG L +
Sbjct: 172 LRTRTFSHASDVWMFGVTLWEMFT-------YGEEPWAGLSGSQILKKIDKEGERLERPE 224
Query: 662 ACIQDSCNLADVIRCIHIGLLCVQQHPEDRP 692
AC QD N+ L C +P DRP
Sbjct: 225 ACPQDIYNVM---------LQCWAHNPADRP 246
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 94.5 bits (235), Expect = 4e-21
Identities = 69/208 (33%), Positives = 97/208 (46%), Gaps = 21/208 (10%)
Query: 440 DNFSINNKLGEGGFGPVYKGT---LVDGQ---EIAVKRLSKISEQGLKE-LKNEVILFSK 492
+N S LG G FG V + T L ++AVK L + +E L +E+ + S
Sbjct: 35 NNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSH 94
Query: 493 L-QHRNLVKLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARG 551
L H N+V LLG C G L+I E+ L +F+ + R + L A+G
Sbjct: 95 LGNHENIVNLLGACTIGGPILVITEYCCYGDLLNFL-RRKRESFLTLEDLLSFSYQVAKG 153
Query: 552 LLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDE---TEGNTNRVV--- 605
+ +L + IHRDL A NVLL KI DFGL R D +GN V
Sbjct: 154 MAFLASKN---CIHRDLAARNVLLTHGKIVKICDFGLARDIMNDSNYVVKGNARLPVKWM 210
Query: 606 ---GTYDGQFSIKSDVFSFGILLLEIVS 630
++ ++ +SDV+S+GILL EI S
Sbjct: 211 APESIFNCVYTFESDVWSYGILLWEIFS 238
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Score = 93.7 bits (233), Expect = 4e-21
Identities = 68/228 (29%), Positives = 101/228 (44%), Gaps = 33/228 (14%)
Query: 438 ATDNFSINNKLGEGGFGPVYKGTLV----DGQE--IAVKRLSKI-SEQGLKELKNEVILF 490
D+ ++ LG G FG VY+G D E +AVK L + SEQ + E ++
Sbjct: 4 PRDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIM 63
Query: 491 SKLQHRNLVKLLGCCIQGEEKLLIYEFMPNKSLDSFIFD----QTRRTLLDWSQRFHIIC 546
SK H+N+V+L+G + + ++ E M L SF+ + R + L
Sbjct: 64 SKFNHQNIVRLIGVSFERLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCAR 123
Query: 547 GTARGLLYLHQDSRLRIIHRDLKASNVLLDQ---DMNPKISDFGLVRTFGGDETEGNTNR 603
A+G YL ++ IHRD+ A N LL KI+DFG+ R R
Sbjct: 124 DVAKGCKYLEEN---HFIHRDIAARNCLLTCKGPGRVAKIADFGMARDIYRASYYRKGGR 180
Query: 604 VV---------GTYDGQFSIKSDVFSFGILLLEIVS-------GKKNR 635
+ DG F+ K+DV+SFG+LL EI S G+ N+
Sbjct: 181 AMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQ 228
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277 |
| >gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 92.9 bits (231), Expect = 9e-21
Identities = 66/221 (29%), Positives = 102/221 (46%), Gaps = 33/221 (14%)
Query: 440 DNFSINNKLGEGGFGPVYKGTLVD------GQEIAVKRL-SKISEQGLKELKNEVILFSK 492
D ++ LGEG FG V K V +AVK L +E+ L +L +E+ +
Sbjct: 12 DRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKM 71
Query: 493 L-QHRNLVKLLGCCIQGEEKLLIYEFMPNKSLDSFI-----------FDQTRRTLLDWSQ 540
+ +H+N++ LLG C Q ++ E+ + +L F+ D R +Q
Sbjct: 72 IGKHKNIINLLGVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQ 131
Query: 541 RFHIICG--TARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGG-DET 597
+ + ARG+ +L + IHRDL A NVL+ +D KI+DFGL R D
Sbjct: 132 KDLVSFAYQVARGMEFLASK---KCIHRDLAARNVLVTEDHVMKIADFGLARDIHHIDYY 188
Query: 598 EGNTN--------RVVGTYDGQFSIKSDVFSFGILLLEIVS 630
TN +D ++ +SDV+SFG+LL EI +
Sbjct: 189 RKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFT 229
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 92.4 bits (230), Expect = 1e-20
Identities = 76/300 (25%), Positives = 134/300 (44%), Gaps = 68/300 (22%)
Query: 440 DNFSINNKLGEGGFGPVYKG---TLVDGQ---EIAVKRLSK---ISEQGLKELKNEVILF 490
+ ++ +LG+G FG VY+G +V G+ +A+K +++ + E+ E NE +
Sbjct: 6 EKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRER--IEFLNEASVM 63
Query: 491 SKLQHRNLVKLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWS--------QRF 542
+ ++V+LLG G+ L++ E M L S++ ++RR + + Q+F
Sbjct: 64 KEFNCHHVVRLLGVVSTGQPTLVVMELMAKGDLKSYL--RSRRPEAENNPGLGPPTLQKF 121
Query: 543 HIICG-TARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNT 601
+ A G+ YL + +HRDL A N ++ +D+ KI DFG+ R D E +
Sbjct: 122 IQMAAEIADGMAYLAA---KKFVHRDLAARNCMVAEDLTVKIGDFGMTR----DIYETDY 174
Query: 602 NRVVGT-------------YDGQFSIKSDVFSFGILLLEIVS-------GKKNRGFYRSD 641
R G DG F+ KSDV+SFG++L E+ + G N +
Sbjct: 175 YRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSN------E 228
Query: 642 TKVNLIGHLWDEGIPLRLIDACIQDSCNLADVIRCIHIGLLCVQQHPEDRPCMPSVILML 701
+ + D G L L + C + + + +C Q +P+ RP ++ L
Sbjct: 229 EVLKFVI---DGGH-LDLPENCPD---------KLLELMRMCWQYNPKMRPTFLEIVSSL 275
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Score = 92.4 bits (229), Expect = 1e-20
Identities = 68/233 (29%), Positives = 110/233 (47%), Gaps = 36/233 (15%)
Query: 441 NFSINNKLGEGGFGPVYKG---TLVDGQE---IAVKRLSKISEQGLKELKNEVILFSKLQ 494
N + +LGEG FG V+ L Q+ +AVK L S+ K+ E L + LQ
Sbjct: 6 NIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQ 65
Query: 495 HRNLVKLLGCCIQGEEKLLIYEFMPNKSLDSFI----------FDQTRRTLLDWSQRFHI 544
H ++VK G C++G+ ++++E+M + L+ F+ + R L SQ HI
Sbjct: 66 HEHIVKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHI 125
Query: 545 ICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNTNRV 604
A G++YL + +HRDL N L+ +++ KI DFG+ R D + RV
Sbjct: 126 AQQIAAGMVYL---ASQHFVHRDLATRNCLVGENLLVKIGDFGMSR----DVYSTDYYRV 178
Query: 605 VG-------------TYDGQFSIKSDVFSFGILLLEIVSGKKNRGFYRSDTKV 644
G +F+ +SDV+S G++L EI + K + S+ +V
Sbjct: 179 GGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEV 231
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 92.1 bits (229), Expect = 1e-20
Identities = 80/275 (29%), Positives = 127/275 (46%), Gaps = 43/275 (15%)
Query: 448 LGEGGFGPVYK---GTLVD--GQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLL 502
LG+G FG V L D G+ +AVK+L + + L++ + E+ + LQH N+VK
Sbjct: 12 LGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYK 71
Query: 503 GCCIQ-GEEKL-LIYEFMPNKSLDSFIFDQ-----TRRTLLDWSQRFHIICGTARGLLYL 555
G C G L L+ E++P SL ++ R+ LL SQ IC +G+ YL
Sbjct: 72 GVCYSAGRRNLRLVMEYLPYGSLRDYLQKHRERLDHRKLLLYASQ----IC---KGMEYL 124
Query: 556 HQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNTNRVVGTY------- 608
R +HRDL N+L++ + KI DFGL + D+ E R G
Sbjct: 125 ---GSKRYVHRDLATRNILVESENRVKIGDFGLTKVLPQDK-EYYKVREPGESPIFWYAP 180
Query: 609 ----DGQFSIKSDVFSFGILLLEIVS-GKKNRGFYRSDTKVNLIGHLWD-EGIPLRLIDA 662
+ +FS+ SDV+SFG++L E+ + K+ + ++G+ + I LI+
Sbjct: 181 ESLTESKFSVASDVWSFGVVLYELFTYSDKSCS--PPAEFMRMMGNDKQGQMIVYHLIE- 237
Query: 663 CIQDSCNLADVIRC---IH-IGLLCVQQHPEDRPC 693
++++ L C I+ I C P RP
Sbjct: 238 LLKNNGRLPAPPGCPAEIYAIMKECWNNDPSQRPS 272
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Score = 91.2 bits (226), Expect = 2e-20
Identities = 64/192 (33%), Positives = 97/192 (50%), Gaps = 14/192 (7%)
Query: 448 LGEGGFGPVYKGTLVDGQEIAVKRLSKISEQGLK-ELKNEVILFSKLQHRNLVKLLGCCI 506
LG+G FG V+KGTL D +AVK + Q LK + +E + + H N+VKL+G C
Sbjct: 3 LGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCT 62
Query: 507 QGEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHR 566
Q + ++ E +P SF+ + ++ L Q A G+ YL + IHR
Sbjct: 63 QRQPIYIVMELVPGGDFLSFL--RKKKDELKTKQLVKFALDAAAGMAYLESKN---CIHR 117
Query: 567 DLKASNVLLDQDMNPKISDFGLVRTF-GGDETEGNTNRVVGTYD-------GQFSIKSDV 618
DL A N L+ ++ KISDFG+ R G + ++ + G++S +SDV
Sbjct: 118 DLAARNCLVGENNVLKISDFGMSRQEDDGIYSSSGLKQIPIKWTAPEALNYGRYSSESDV 177
Query: 619 FSFGILLLEIVS 630
+S+GILL E S
Sbjct: 178 WSYGILLWETFS 189
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 91.3 bits (227), Expect = 2e-20
Identities = 63/208 (30%), Positives = 100/208 (48%), Gaps = 19/208 (9%)
Query: 440 DNFSINNKLGEGGFGPVYKGTLVDGQE-IAVKR--LSKISEQGLKELKNEVILFSKLQHR 496
D++ + +G G VY + E +A+KR L K + EL+ EV S+ H
Sbjct: 1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTS-VDELRKEVQAMSQCNHP 59
Query: 497 NLVKLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLH 556
N+VK + G+E L+ ++ SL + R LD + ++ +GL YLH
Sbjct: 60 NVVKYYTSFVVGDELWLVMPYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLH 119
Query: 557 QDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTF--GGDETEGNTNRVVGT------- 607
+ + IHRD+KA N+LL +D + KI+DFG+ + GGD T VGT
Sbjct: 120 SNGQ---IHRDIKAGNILLGEDGSVKIADFGVSASLADGGDRTRKVRKTFVGTPCWMAPE 176
Query: 608 ---YDGQFSIKSDVFSFGILLLEIVSGK 632
+ K+D++SFGI +E+ +G
Sbjct: 177 VMEQVHGYDFKADIWSFGITAIELATGA 204
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 91.3 bits (227), Expect = 2e-20
Identities = 79/274 (28%), Positives = 118/274 (43%), Gaps = 63/274 (22%)
Query: 448 LGEGGFGPVYKG-TLVDGQEIAVKRLS-----KISEQGLKELKNEVILFSKLQHRNLVKL 501
LG G FG VY+G L DG AVK +S + ++ +K+L+ E+ L SKLQH N+V+
Sbjct: 8 LGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQY 67
Query: 502 LGCCIQGEEKLLIY-EFMPNKSL-----------DSFIFDQTRRTLLDWSQRFHIICGTA 549
LG + E+ L I+ E +P SL + I TR+ LL
Sbjct: 68 LG-TEREEDNLYIFLELVPGGSLAKLLKKYGSFPEPVIRLYTRQILL------------- 113
Query: 550 RGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNTNRVVGT-- 607
GL YLH +HRD+K +N+L+D + K++DFG+ + G+
Sbjct: 114 -GLEYLHDR---NTVHRDIKGANILVDTNGVVKLADFGMAKQV---VEFSFAKSFKGSPY 166
Query: 608 --------YDGQFSIKSDVFSFGILLLEIVSGKKNRGFYRSDTKVNLIGHLWD-EGIPLR 658
G + + +D++S G +LE+ +GK V IG + IP
Sbjct: 167 WMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEGVAAVFKIGRSKELPPIPDH 226
Query: 659 LIDACIQDSCNLADVIRCIHIGLLCVQQHPEDRP 692
L S D I C+Q+ P RP
Sbjct: 227 L-------SDEAKDFIL------KCLQRDPSLRP 247
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 91.2 bits (226), Expect = 2e-20
Identities = 66/202 (32%), Positives = 98/202 (48%), Gaps = 16/202 (7%)
Query: 438 ATDNFSINNKLGEGGFGPVYKGTLVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRN 497
++ + KLG G FG V+ GT ++AVK L K + E + KL+H
Sbjct: 4 PRESLQLIKKLGNGQFGEVWMGTWNGNTKVAVKTL-KPGTMSPESFLEEAQIMKKLRHDK 62
Query: 498 LVKLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQ 557
LV+L + E ++ E+M SL F+ D R L + A G+ Y+
Sbjct: 63 LVQLYAV-VSEEPIYIVTEYMSKGSLLDFLKDGEGRAL-KLPNLVDMAAQVAAGMAYIE- 119
Query: 558 DSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGN---------TNRVVGTY 608
R+ IHRDL+++N+L+ + KI+DFGL R +E T Y
Sbjct: 120 --RMNYIHRDLRSANILVGDGLVCKIADFGLARLIEDNEYTARQGAKFPIKWTAPEAALY 177
Query: 609 DGQFSIKSDVFSFGILLLEIVS 630
G+F+IKSDV+SFGILL E+V+
Sbjct: 178 -GRFTIKSDVWSFGILLTELVT 198
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 90.9 bits (225), Expect = 3e-20
Identities = 62/193 (32%), Positives = 96/193 (49%), Gaps = 16/193 (8%)
Query: 447 KLGEGGFGPVYKGTLVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCI 506
KLG+G FG V+ GT +A+K L K + E + KL+H LV+L +
Sbjct: 13 KLGQGCFGEVWMGTWNGTTRVAIKTL-KPGTMSPEAFLQEAQVMKKLRHEKLVQLYAV-V 70
Query: 507 QGEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHR 566
E ++ E+M SL F+ + L Q + A G+ Y+ R+ +HR
Sbjct: 71 SEEPIYIVTEYMSKGSLLDFLKGEMG-KYLRLPQLVDMAAQIASGMAYVE---RMNYVHR 126
Query: 567 DLKASNVLLDQDMNPKISDFGLVRTFGGDETEGN---------TNRVVGTYDGQFSIKSD 617
DL+A+N+L+ +++ K++DFGL R +E T Y G+F+IKSD
Sbjct: 127 DLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALY-GRFTIKSD 185
Query: 618 VFSFGILLLEIVS 630
V+SFGILL E+ +
Sbjct: 186 VWSFGILLTELTT 198
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Score = 91.3 bits (226), Expect = 4e-20
Identities = 62/202 (30%), Positives = 108/202 (53%), Gaps = 29/202 (14%)
Query: 448 LGEGGFGPVYKGTLVDGQE-----IAVKRLSKIS-EQGLKELKNEVILFSKLQHRNLVKL 501
LG G FG VYKG V E +A+K L++ + + E +E ++ + + H +LV+L
Sbjct: 15 LGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRL 74
Query: 502 LGCCIQGEEKLLIYEFMPNKSLDSFIFDQT----RRTLLDWSQRFHIICGTARGLLYLHQ 557
LG C+ +L + + MP+ L ++ + + LL+W + A+G++YL +
Sbjct: 75 LGVCLSPTIQL-VTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQI------AKGMMYLEE 127
Query: 558 DSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNTN---------RVVGTY 608
R++HRDL A NVL+ + KI+DFGL R GDE E N + + +
Sbjct: 128 R---RLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWMALECIH 184
Query: 609 DGQFSIKSDVFSFGILLLEIVS 630
+F+ +SDV+S+G+ + E+++
Sbjct: 185 YRKFTHQSDVWSYGVTIWELMT 206
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303 |
| >gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Score = 90.8 bits (225), Expect = 4e-20
Identities = 66/213 (30%), Positives = 100/213 (46%), Gaps = 32/213 (15%)
Query: 447 KLGEGGFGPVYKGTLV-----DGQEIAVKRLSKISE-QGLKELKNEVILFSKLQHRNLVK 500
+LGE FG +YKG L Q +A+K L I+ Q E + E L ++L H N+V
Sbjct: 12 ELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVC 71
Query: 501 LLGCCIQGEEKLLIYEFMPNKSLDSFIF--------------DQTRRTLLDWSQRFHIIC 546
LLG Q + +++E++ L F+ D T ++ LD HI
Sbjct: 72 LLGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAI 131
Query: 547 GTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVR-TFGGDETEGNTNRVV 605
A G+ YL S +H+DL A N+L+ + ++ KISD GL R + D ++
Sbjct: 132 QIAAGMEYL---SSHFFVHKDLAARNILIGEQLHVKISDLGLSREIYSADYYRVQPKSLL 188
Query: 606 --------GTYDGQFSIKSDVFSFGILLLEIVS 630
G+FS SD++SFG++L EI S
Sbjct: 189 PIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFS 221
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 90.7 bits (225), Expect = 5e-20
Identities = 73/206 (35%), Positives = 98/206 (47%), Gaps = 35/206 (16%)
Query: 448 LGEGGFG--------PVYKGTLVDGQEIAVKRLSKISEQGLKE-LKNEVILFSKLQHRNL 498
LGEG FG P GT G+ +AVK L + Q K E+ + L H N+
Sbjct: 12 LGEGHFGKVSLYCYDPANDGT---GEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENI 68
Query: 499 VKLLGCCIQGEEK--LLIYEFMPNKSLDSFI--FDQTRRTLLDWSQRFHIICGTARGLLY 554
VK GCC + K LI E++P SL ++ LL ++Q+ IC G+ Y
Sbjct: 69 VKYKGCCSEQGGKGLQLIMEYVPLGSLRDYLPKHKLNLAQLLLFAQQ---IC---EGMAY 122
Query: 555 LHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTF-GGDE---TEGNTNRVVGTY-- 608
LH IHRDL A NVLLD D KI DFGL + G E + + V Y
Sbjct: 123 LHSQ---HYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAV 179
Query: 609 ----DGQFSIKSDVFSFGILLLEIVS 630
+ +FS SDV+SFG+ L E+++
Sbjct: 180 ECLKENKFSYASDVWSFGVTLYELLT 205
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 89.9 bits (223), Expect = 7e-20
Identities = 63/209 (30%), Positives = 105/209 (50%), Gaps = 30/209 (14%)
Query: 448 LGEGGFGPVYKGTLVD-GQEIAVKRL---SKISEQG-------LKELKNEVILFSKLQHR 496
+G+G +G VY V G+ +AVK++ + I+ + +K L++E+ L H
Sbjct: 9 IGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHL 68
Query: 497 NLVKLLGCCIQGEEKLLIY-EFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYL 555
N+V+ LG EE L I+ E++P S+ S + R + GL YL
Sbjct: 69 NIVQYLGF-ETTEEYLSIFLEYVPGGSIGSCLRTYGR---FEEQLVRFFTEQVLEGLAYL 124
Query: 556 HQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVR----TFGGDET---EGN----TNRV 604
H I+HRDLKA N+L+D D KISDFG+ + + D+ +G+ V
Sbjct: 125 HSKG---ILHRDLKADNLLVDADGICKISDFGISKKSDDIYDNDQNMSMQGSVFWMAPEV 181
Query: 605 VGTYDGQFSIKSDVFSFGILLLEIVSGKK 633
+ +Y +S K D++S G ++LE+ +G++
Sbjct: 182 IHSYSQGYSAKVDIWSLGCVVLEMFAGRR 210
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 89.6 bits (223), Expect = 8e-20
Identities = 64/224 (28%), Positives = 104/224 (46%), Gaps = 39/224 (17%)
Query: 437 NATDNFSINNKLGEGGFGPVYKGTLVD-GQEIAVKRLSKISEQGLKELKNEVILFSKL-Q 494
+ T F + +GEG +G VYK GQ +A+K + I ++ +E+K E + K
Sbjct: 3 DPTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIEDE-EEEIKEEYNILRKYSN 61
Query: 495 HRNLVKLLGCCIQ-----GEEKL-LIYEFMPNKSLDSFIFDQTRRTLLDWSQRF------ 542
H N+ G I+ +++L L+ E S+ + + L +R
Sbjct: 62 HPNIATFYGAFIKKNPPGNDDQLWLVMELCGGGSVTDLV-----KGLRKKGKRLKEEWIA 116
Query: 543 HIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNTN 602
+I+ T RGL YLH++ ++IHRD+K N+LL ++ K+ DFG+ D T G N
Sbjct: 117 YILRETLRGLAYLHEN---KVIHRDIKGQNILLTKNAEVKLVDFGVSAQL--DSTLGRRN 171
Query: 603 RVVGT--------------YDGQFSIKSDVFSFGILLLEIVSGK 632
+GT D + +SDV+S GI +E+ GK
Sbjct: 172 TFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGK 215
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 88.5 bits (220), Expect = 2e-19
Identities = 60/201 (29%), Positives = 93/201 (46%), Gaps = 25/201 (12%)
Query: 446 NKLGEGGFGPVYKGTLV-DGQEIAVKRL-----SKISEQGLKELKNEVILFSKLQHRNLV 499
+LG G G V K G+ +AVK + I +Q L+EL IL K +V
Sbjct: 7 GELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELD---ILH-KCNSPYIV 62
Query: 500 KLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDS 559
G + + E+M SLD + + R + I +GL YLH
Sbjct: 63 GFYGAFYNNGDISICMEYMDGGSLDKILKEVQGRIPERILGK--IAVAVLKGLTYLH--E 118
Query: 560 RLRIIHRDLKASNVLLDQDMNPKISDFG--------LVRTFGGDETEGNTNRVVGTYDGQ 611
+ +IIHRD+K SN+L++ K+ DFG L +TF G + R+ G
Sbjct: 119 KHKIIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSLAKTFVGTSSYMAPERIQG---ND 175
Query: 612 FSIKSDVFSFGILLLEIVSGK 632
+S+KSD++S G+ L+E+ +G+
Sbjct: 176 YSVKSDIWSLGLSLIELATGR 196
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Score = 88.9 bits (220), Expect = 2e-19
Identities = 66/227 (29%), Positives = 105/227 (46%), Gaps = 40/227 (17%)
Query: 441 NFSINNKLGEGGFGPVYKGT------LVDGQEIAVKRLSKISEQG-LKELKNEVILFSKL 493
N + LGEG FG V K T +AVK L + + L++L +E L ++
Sbjct: 1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQV 60
Query: 494 QHRNLVKLLGCCIQGEEKLLIYEFMPNKSLDSFI------------FDQTRRTLLDWSQR 541
H +++KL G C Q LLI E+ SL SF+ D R + +
Sbjct: 61 NHPHVIKLYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPD 120
Query: 542 FHIIC---------GTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTF 592
+ +RG+ YL + ++++HRDL A NVL+ + KISDFGL R
Sbjct: 121 ERALTMGDLISFAWQISRGMQYL---AEMKLVHRDLAARNVLVAEGRKMKISDFGLSRDV 177
Query: 593 GGDETEGNTNR---------VVGTYDGQFSIKSDVFSFGILLLEIVS 630
+++ ++ + +D ++ +SDV+SFG+LL EIV+
Sbjct: 178 YEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVT 224
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290 |
| >gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Score = 88.9 bits (220), Expect = 2e-19
Identities = 69/233 (29%), Positives = 107/233 (45%), Gaps = 39/233 (16%)
Query: 444 INNKLGEGGFGPVYKGTLV------DGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRN 497
+ +LGEG FG V+ D +AVK L + K+ + E L + LQH +
Sbjct: 9 LKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEH 68
Query: 498 LVKLLGCCIQGEEKLLIYEFMPNKSLDSF-----------IFDQTRRT--LLDWSQRFHI 544
+VK G C G+ ++++E+M + L+ F + Q R+ L SQ HI
Sbjct: 69 IVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHI 128
Query: 545 ICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNTNRV 604
A G++YL + +HRDL N L+ ++ KI DFG+ R D + RV
Sbjct: 129 ASQIASGMVYL---ASQHFVHRDLATRNCLVGANLLVKIGDFGMSR----DVYSTDYYRV 181
Query: 605 VG-------------TYDGQFSIKSDVFSFGILLLEIVSGKKNRGFYRSDTKV 644
G +F+ +SDV+SFG++L EI + K F S+T+V
Sbjct: 182 GGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTEV 234
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 87.9 bits (218), Expect = 3e-19
Identities = 59/208 (28%), Positives = 98/208 (47%), Gaps = 27/208 (12%)
Query: 439 TDNFSINNKLGEGGFGPVYKGT-LVDGQEIAVKRL-------SKISEQGLKELKNEVILF 490
NF I K+G+G F VYK L+DG+ +A+K++ +K + LKE+ L
Sbjct: 1 LGNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEID----LL 56
Query: 491 SKLQHRNLVKLLGCCIQGEEKLLIYEFMPNKSLDSFI-FDQTRRTLLDWSQRFHIICGTA 549
+L H N++K L I+ E ++ E L I + ++ L+ +
Sbjct: 57 KQLDHPNVIKYLASFIENNELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLC 116
Query: 550 RGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNTNRVVGT-- 607
L ++H RI+HRD+K +NV + K+ D GL R F T ++ +VGT
Sbjct: 117 SALEHMHSK---RIMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHS--LVGTPY 171
Query: 608 -------YDGQFSIKSDVFSFGILLLEI 628
++ ++ KSD++S G LL E+
Sbjct: 172 YMSPERIHENGYNFKSDIWSLGCLLYEM 199
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 87.3 bits (216), Expect = 7e-19
Identities = 60/215 (27%), Positives = 113/215 (52%), Gaps = 21/215 (9%)
Query: 429 LFELATIANATDNFSINNKLGEGGFGPVYKGTLVD-GQEIAVKRLSKISEQGLKELK-NE 486
L + ++ + ++ K+G+G G VY V GQE+A+K+++ + +Q KEL NE
Sbjct: 8 LRTIVSVGDPKKKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMN-LQQQPKKELIINE 66
Query: 487 VILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIIC 546
+++ + +H N+V L + G+E ++ E++ SL D T +D Q +
Sbjct: 67 ILVMRENKHPNIVNYLDSYLVGDELWVVMEYLAGGSLT----DVVTETCMDEGQIAAVCR 122
Query: 547 GTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNTNRVVG 606
+ L +LH + ++IHRD+K+ N+LL D + K++DFG ++++ +T +VG
Sbjct: 123 ECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRST--MVG 177
Query: 607 T---------YDGQFSIKSDVFSFGILLLEIVSGK 632
T + K D++S GI+ +E+V G+
Sbjct: 178 TPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGE 212
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Score = 87.1 bits (216), Expect = 8e-19
Identities = 57/153 (37%), Positives = 82/153 (53%), Gaps = 13/153 (8%)
Query: 447 KLGEGGFGPVYKG-TLVDGQEIAVKRLSKISE-QGLKELK-NEVILFSKLQHRNLVKLLG 503
K+GEG +G VYKG GQ +A+K++ SE +G+ E+ L +LQH N+V L
Sbjct: 7 KIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQD 66
Query: 504 CCIQGEEKLLIYEFMP---NKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSR 560
+Q LI+EF+ K LDS Q L S + I+ +G+L+ H
Sbjct: 67 VLMQESRLYLIFEFLSMDLKKYLDSLPKGQYMDAELVKSYLYQIL----QGILFCH---S 119
Query: 561 LRIIHRDLKASNVLLDQDMNPKISDFGLVRTFG 593
R++HRDLK N+L+D K++DFGL R FG
Sbjct: 120 RRVLHRDLKPQNLLIDNKGVIKLADFGLARAFG 152
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 87.1 bits (216), Expect = 8e-19
Identities = 65/208 (31%), Positives = 97/208 (46%), Gaps = 24/208 (11%)
Query: 437 NATDNFSINNKLGEGGFGPVYKG-TLVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQH 495
N D + I +LG+G FG VYK G A K + SE+ L++ E+ + S+ +H
Sbjct: 2 NPNDIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKH 61
Query: 496 RNLVKLLGCCIQGEEKLLIY-EFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLY 554
N+V L E KL I EF +LDS I + R L Q ++ L +
Sbjct: 62 PNIVGLYEAYFY-ENKLWILIEFCDGGALDS-IMLELERGL-TEPQIRYVCRQMLEALNF 118
Query: 555 LHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNTNRVVGT------- 607
LH ++IHRDLKA N+LL D + K++DFG V + + +GT
Sbjct: 119 LHSH---KVIHRDLKAGNILLTLDGDVKLADFG-VSAKNKSTLQ-KRDTFIGTPYWMAPE 173
Query: 608 -------YDGQFSIKSDVFSFGILLLEI 628
D + K+D++S GI L+E+
Sbjct: 174 VVACETFKDNPYDYKADIWSLGITLIEL 201
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Score = 86.3 bits (213), Expect = 9e-19
Identities = 77/262 (29%), Positives = 127/262 (48%), Gaps = 28/262 (10%)
Query: 440 DNFSINNKLGEGGFGPVYKGTLVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLV 499
++ ++ KLG+G FG V+ GT ++A+K L K + E + KL+H LV
Sbjct: 6 ESLRLDVKLGQGCFGEVWMGTWNGTTKVAIKTL-KPGTMMPEAFLQEAQIMKKLRHDKLV 64
Query: 500 KLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDS 559
L + E ++ EFM SL F+ + + L Q + A G+ Y+
Sbjct: 65 PLYAV-VSEEPIYIVTEFMGKGSLLDFLKEGDGKYL-KLPQLVDMAAQIADGMAYIE--- 119
Query: 560 RLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGN---------TNRVVGTYDG 610
R+ IHRDL+A+N+L+ ++ KI+DFGL R +E T Y G
Sbjct: 120 RMNYIHRDLRAANILVGDNLVCKIADFGLARLIEDNEYTARQGAKFPIKWTAPEAALY-G 178
Query: 611 QFSIKSDVFSFGILLLEIVSGKKNRGFYRSDTKVNLIGHLWDEGIPLRLIDACIQDSCNL 670
+F+IKSDV+SFGILL E+V+ K R Y ++ + + G + C + +L
Sbjct: 179 RFTIKSDVWSFGILLTELVT--KGRVPYPGMVNREVLEQV-ERGYRMPCPQGCPE---SL 232
Query: 671 ADVIRCIHIGLLCVQQHPEDRP 692
++++ LC ++ P++RP
Sbjct: 233 HELMK------LCWKKDPDERP 248
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 86.2 bits (214), Expect = 1e-18
Identities = 55/209 (26%), Positives = 98/209 (46%), Gaps = 26/209 (12%)
Query: 440 DNFSINNKLGEGGFGPVYKGTLVDGQEIAVKRLSKISEQ-GLKELKNEVILFSKLQHRNL 498
+++ + ++G G +G VYK + E+ ++ K+ + ++ E+ + + +H N+
Sbjct: 3 EDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNI 62
Query: 499 VKLLGCCIQGEEKLLI-YEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQ 557
V G +KL I E+ SL I+ TR L + Q ++ T +GL YLH+
Sbjct: 63 VAYFGS-YLRRDKLWIVMEYCGGGSLQD-IYQVTRGPLSE-LQIAYVCRETLKGLAYLHE 119
Query: 558 DSRLRIIHRDLKASNVLLDQDMNPKISDFG----LVRTFGGDET----------EGNTNR 603
IHRD+K +N+LL +D + K++DFG L T ++ E
Sbjct: 120 ---TGKIHRDIKGANILLTEDGDVKLADFGVSAQLTATIAKRKSFIGTPYWMAPEVAAVE 176
Query: 604 VVGTYDGQFSIKSDVFSFGILLLEIVSGK 632
G YDG K D+++ GI +E+ +
Sbjct: 177 RKGGYDG----KCDIWALGITAIELAELQ 201
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 85.7 bits (212), Expect = 2e-18
Identities = 61/214 (28%), Positives = 98/214 (45%), Gaps = 41/214 (19%)
Query: 448 LGEGGFGPVYKG-TLVDGQEIAVKR--LSKISEQG-------LKELKNEVILFSKLQHRN 497
+G G FG VY G G+ +AVK+ L +S L L E+ L +LQH N
Sbjct: 8 IGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHEN 67
Query: 498 LVKLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRF------HIICGTARG 551
+V+ LG + + + E++P S+ LL+ F + + +G
Sbjct: 68 IVQYLGSSLDADHLNIFLEYVPGGSV---------AALLNNYGAFEETLVRNFVRQILKG 118
Query: 552 LLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNTNRVVGTYDGQ 611
L YLH IIHRD+K +N+L+D KISDFG+ + + TN + G
Sbjct: 119 LNYLHNRG---IIHRDIKGANILVDNKGGIKISDFGISKKLEANSLSTKTNGARPSLQGS 175
Query: 612 -------------FSIKSDVFSFGILLLEIVSGK 632
++ K+D++S G L++E+++GK
Sbjct: 176 VFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGK 209
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 85.6 bits (212), Expect = 2e-18
Identities = 64/206 (31%), Positives = 106/206 (51%), Gaps = 22/206 (10%)
Query: 441 NFSINNKLGEGGFGPVYKG-TLVDGQEIAVKRLSKISEQGLKELK-NEVILFSKLQHRNL 498
NF KLGEG + VYKG G+ +A+K + +E+G E+ L +L+H N+
Sbjct: 1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENI 60
Query: 499 VKLLGCCIQGEEKL-LIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQ 557
V+L I E KL L++E+M +K L ++ R LD + +G+ + H+
Sbjct: 61 VRLHDV-IHTENKLMLVFEYM-DKDLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHE 118
Query: 558 DSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNT--NRVVGTY------- 608
+ R++HRDLK N+L+++ K++DFGL R FG NT N VV +
Sbjct: 119 N---RVLHRDLKPQNLLINKRGELKLADFGLARAFG---IPVNTFSNEVVTLWYRAPDVL 172
Query: 609 --DGQFSIKSDVFSFGILLLEIVSGK 632
+S D++S G ++ E+++G+
Sbjct: 173 LGSRTYSTSIDIWSVGCIMAEMITGR 198
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|237995 cd00028, B_lectin, Bulb-type mannose-specific lectin | Back alignment and domain information |
|---|
Score = 80.4 bits (199), Expect = 3e-18
Identities = 39/80 (48%), Positives = 45/80 (56%), Gaps = 6/80 (7%)
Query: 17 VVWVANRLNPINDSFGFLMINKTGNLVLTSQSNIVVWSAYLSKEVQTPVVLQLLDSGNLV 76
VVWVANR NP + S L + GNLV+ S VVWS+ + V VL LLD GNLV
Sbjct: 43 VVWVANRDNP-SGSSCTLTLQSDGNLVIYDGSGTVVWSS-NTTRVNGNYVLVLLDDGNLV 100
Query: 77 LRDEHDGDSETYFWQSFDYP 96
L D + WQSFDYP
Sbjct: 101 LYD----SDGNFLWQSFDYP 116
|
The domain contains a three-fold internal repeat (beta-prism architecture). The consensus sequence motif QXDXNXVXY is involved in alpha-D-mannose recognition. Lectins are carbohydrate-binding proteins which specifically recognize diverse carbohydrates and mediate a wide variety of biological processes, such as cell-cell and host-pathogen interactions, serum glycoprotein turnover, and innate immune responses. Length = 116 |
| >gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Score = 84.6 bits (209), Expect = 4e-18
Identities = 61/189 (32%), Positives = 96/189 (50%), Gaps = 14/189 (7%)
Query: 448 LGEGGFGPVYKGTLVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQ 507
+G+G FG V G G ++AVK + ++ + E + ++L+H NLV+LLG ++
Sbjct: 14 IGKGEFGDVMLGDY-RGNKVAVKCIK--NDATAQAFLAEASVMTQLRHSNLVQLLGVIVE 70
Query: 508 GEEKLLIY-EFMPNKSLDSFIFDQTR-RTLLDWSQRFHIICGTARGLLYLHQDSRLRIIH 565
+ L I E+M SL ++ ++R R++L + YL ++ +H
Sbjct: 71 EKGGLYIVTEYMAKGSLVDYL--RSRGRSVLGGDCLLKFSLDVCEAMEYLEANN---FVH 125
Query: 566 RDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNT----NRVVGTYDGQFSIKSDVFSF 621
RDL A NVL+ +D K+SDFGL + + G + +FS KSDV+SF
Sbjct: 126 RDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPVKWTAPEALREKKFSTKSDVWSF 185
Query: 622 GILLLEIVS 630
GILL EI S
Sbjct: 186 GILLWEIYS 194
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256 |
| >gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Score = 84.6 bits (209), Expect = 5e-18
Identities = 61/202 (30%), Positives = 108/202 (53%), Gaps = 28/202 (13%)
Query: 448 LGEGGFGPVYKGTL-VDGQE---IAVKRLSK-ISEQGLKELKNEVILFSKLQHRNLVKLL 502
+G G FG V++G L + G++ +A+K L +E+ ++ +E + + H N+++L
Sbjct: 13 IGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLE 72
Query: 503 GCCIQGEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWS--QRFHIICGTARGLLYLHQDSR 560
G + + ++I E+M N +LD ++ D ++S Q ++ G A G+ YL S
Sbjct: 73 GVVTKFKPAMIITEYMENGALDKYLRDHDG----EFSSYQLVGMLRGIAAGMKYL---SD 125
Query: 561 LRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNTNRVVG------------TY 608
+ +HRDL A N+L++ ++ K+SDFGL R D+ EG G Y
Sbjct: 126 MNYVHRDLAARNILVNSNLECKVSDFGLSRVL-EDDPEGTYTTSGGKIPIRWTAPEAIAY 184
Query: 609 DGQFSIKSDVFSFGILLLEIVS 630
+F+ SDV+SFGI++ E++S
Sbjct: 185 R-KFTSASDVWSFGIVMWEVMS 205
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268 |
| >gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Score = 84.2 bits (208), Expect = 6e-18
Identities = 62/206 (30%), Positives = 108/206 (52%), Gaps = 26/206 (12%)
Query: 444 INNKLGEGGFGPVYKGTL-VDGQE---IAVKRL-SKISEQGLKELKNEVILFSKLQHRNL 498
I +G G FG V +G L + G+ +A+K L S +E+ ++ +E + + H N+
Sbjct: 8 IEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNI 67
Query: 499 VKLLGCCIQGEEKLLIYEFMPNKSLDSFI-FDQTRRTLLDWSQRFHIICGTARGLLYLHQ 557
+ L G + ++I EFM N +LDSF+ + + T++ Q ++ G A G+ YL
Sbjct: 68 IHLEGVVTKSRPVMIITEFMENGALDSFLRQNDGQFTVI---QLVGMLRGIAAGMKYL-- 122
Query: 558 DSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNTNRVVG----------- 606
S + +HRDL A N+L++ ++ K+SDFGL R D ++ +G
Sbjct: 123 -SEMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSSLGGKIPIRWTAPE 181
Query: 607 --TYDGQFSIKSDVFSFGILLLEIVS 630
Y +F+ SDV+S+GI++ E++S
Sbjct: 182 AIAYR-KFTSASDVWSYGIVMWEVMS 206
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 84.8 bits (209), Expect = 7e-18
Identities = 61/215 (28%), Positives = 115/215 (53%), Gaps = 21/215 (9%)
Query: 429 LFELATIANATDNFSINNKLGEGGFGPVYKGTLVD-GQEIAVKRLSKISEQGLKEL-KNE 486
L + +I + ++ K+G+G G V+ V GQE+A+K+++ + +Q KEL NE
Sbjct: 8 LRTIVSIGDPKKKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQIN-LQKQPKKELIINE 66
Query: 487 VILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIIC 546
+++ +L++ N+V L + G+E ++ E++ SL D T +D +Q +
Sbjct: 67 ILVMKELKNPNIVNFLDSFLVGDELFVVMEYLAGGSLT----DVVTETCMDEAQIAAVCR 122
Query: 547 GTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNTNRVVG 606
+ L +LH + ++IHRD+K+ NVLL D + K++DFG ++++ +T +VG
Sbjct: 123 ECLQALEFLHAN---QVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQSKRST--MVG 177
Query: 607 T---------YDGQFSIKSDVFSFGILLLEIVSGK 632
T + K D++S GI+ +E+V G+
Sbjct: 178 TPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGE 212
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|214519 smart00108, B_lectin, Bulb-type mannose-specific lectin | Back alignment and domain information |
|---|
Score = 78.9 bits (195), Expect = 1e-17
Identities = 37/79 (46%), Positives = 44/79 (55%), Gaps = 6/79 (7%)
Query: 17 VVWVANRLNPINDSFGFLMINKTGNLVLTSQSNIVVWSAYLSKEVQTPVVLQLLDSGNLV 76
VVWVANR NP++DS L + GNLVL VVWS+ + VL LLD GNLV
Sbjct: 42 VVWVANRDNPVSDS-CTLTLQSDGNLVLYDGDGRVVWSS-NTTGANGNYVLVLLDDGNLV 99
Query: 77 LRDEHDGDSETYFWQSFDY 95
+ D + WQSFDY
Sbjct: 100 IYD----SDGNFLWQSFDY 114
|
Length = 114 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 83.8 bits (208), Expect = 1e-17
Identities = 52/154 (33%), Positives = 79/154 (51%), Gaps = 12/154 (7%)
Query: 446 NKLGEGGFGPVYKGT-LVDGQEIAVKRLSKISEQGLKELKN-----EVILFSKLQHRNLV 499
KLGEG + VYK G+ +A+K++ + K+ N E+ L +L+H N++
Sbjct: 6 KKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNII 65
Query: 500 KLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDS 559
LL L++EFM L+ I D + +L + + T RGL YLH
Sbjct: 66 GLLDVFGHKSNINLVFEFMET-DLEKVIKD--KSIVLTPADIKSYMLMTLRGLEYLH--- 119
Query: 560 RLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFG 593
I+HRDLK +N+L+ D K++DFGL R+FG
Sbjct: 120 SNWILHRDLKPNNLLIASDGVLKLADFGLARSFG 153
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 81.8 bits (202), Expect = 3e-17
Identities = 64/201 (31%), Positives = 95/201 (47%), Gaps = 27/201 (13%)
Query: 447 KLGEGGFGPVYKGTLVDGQEIAVKRLSK--ISEQGLKELKNEVILFSKLQHRNLVKLLGC 504
+LG G FG V G ++A+K + + +SE E E + KL H LV+L G
Sbjct: 11 ELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSED---EFIEEAKVMMKLSHEKLVQLYGV 67
Query: 505 CIQGEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRII 564
C + ++ E+M N L +++ + +R SQ + G+ YL + I
Sbjct: 68 CTKQRPIYIVTEYMSNGCLLNYLREHGKR--FQPSQLLEMCKDVCEGMAYLESK---QFI 122
Query: 565 HRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNTNRVVGT------------YDGQF 612
HRDL A N L+D K+SDFGL R DE + VG+ +F
Sbjct: 123 HRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEYTSS----VGSKFPVRWSPPEVLLYSKF 178
Query: 613 SIKSDVFSFGILLLEIVS-GK 632
S KSDV++FG+L+ E+ S GK
Sbjct: 179 SSKSDVWAFGVLMWEVYSLGK 199
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 82.1 bits (203), Expect = 4e-17
Identities = 61/209 (29%), Positives = 102/209 (48%), Gaps = 34/209 (16%)
Query: 440 DNFSINNKLGEGGFGPVYKGTLVD-GQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNL 498
DNF K+GEG G V T G+++AVK++ +Q + L NEV++ QH N+
Sbjct: 22 DNF---VKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNI 78
Query: 499 VKLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQD 558
V++ + G+E ++ EF+ +L I TR ++ Q + + L +LH
Sbjct: 79 VEMYSSYLVGDELWVVMEFLEGGALTD-IVTHTR---MNEEQIATVCLAVLKALSFLHAQ 134
Query: 559 SRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNTNR--VVGT--------- 607
+IHRD+K+ ++LL D K+SDFG F ++ R +VGT
Sbjct: 135 ---GVIHRDIKSDSILLTSDGRVKLSDFG----FCAQVSKEVPRRKSLVGTPYWMAPEVI 187
Query: 608 ----YDGQFSIKSDVFSFGILLLEIVSGK 632
Y + D++S GI+++E+V G+
Sbjct: 188 SRLPYGTE----VDIWSLGIMVIEMVDGE 212
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Score = 81.7 bits (202), Expect = 5e-17
Identities = 66/217 (30%), Positives = 109/217 (50%), Gaps = 24/217 (11%)
Query: 435 IANATDNFSINNKLGEGGFGPVYKGTLVDG-----QEIAVKRLSK-ISEQGLKELKNEVI 488
IA + D ++++ L EG FG ++ G L+D +E+ VK + SE + L E
Sbjct: 1 IAISRDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESC 60
Query: 489 LFSKLQHRNLVKLLGCCIQGEEK-LLIYEFMPNKSLDSF-----IFDQTRRTLLDWSQRF 542
L L H+N++ +L CI+ E ++Y +M +L F + + L Q
Sbjct: 61 LLYGLSHQNILPILHVCIEDGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLV 120
Query: 543 HIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVR-TFGGD-ETEG- 599
H+ A G+ YLH + +IH+D+ A N ++D+++ KI+D L R F D G
Sbjct: 121 HMAIQIACGMSYLH---KRGVIHKDIAARNCVIDEELQVKITDNALSRDLFPMDYHCLGD 177
Query: 600 NTNRVV------GTYDGQFSIKSDVFSFGILLLEIVS 630
N NR V + ++S SDV+SFG+LL E+++
Sbjct: 178 NENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMT 214
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 81.1 bits (201), Expect = 6e-17
Identities = 57/207 (27%), Positives = 94/207 (45%), Gaps = 25/207 (12%)
Query: 446 NKLGEGGFGPVYKGTLV----DGQEIAVKRLS--KISEQGLKELKNEVILFSKLQHRNLV 499
+G+G FG V K V DG+ + K + ++E+ ++L +EV + +L+H N+V
Sbjct: 6 ETIGKGSFGTVRK---VRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIV 62
Query: 500 KLLGCCIQGEEKLL-IY-EFMPNKSLDSFIFDQTR-RTLLDWSQRFHIICGTARGLLYLH 556
+ I + L I E+ L I + R ++ + I+ L H
Sbjct: 63 RYYDRIIDRSNQTLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECH 122
Query: 557 --QDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNTNRVVGT--Y---- 608
D ++HRDLK +N+ LD + N K+ DFGL + G D + T VGT Y
Sbjct: 123 NRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKILGHDSSFAKT--YVGTPYYMSPE 180
Query: 609 ---DGQFSIKSDVFSFGILLLEIVSGK 632
+ KSD++S G L+ E+ +
Sbjct: 181 QLNHMSYDEKSDIWSLGCLIYELCALS 207
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Score = 81.2 bits (200), Expect = 6e-17
Identities = 61/213 (28%), Positives = 102/213 (47%), Gaps = 30/213 (14%)
Query: 443 SINNKLGEGGFGPVYKGTLVDGQEI---AVK--RLSKISEQGLKELKNEVILFSKLQHRN 497
++ LGEG FG V +G L I AVK +++ + +++ +E + + H N
Sbjct: 2 ALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPN 61
Query: 498 LVKLLGCCIQGEEK------LLIYEFMPNKSLDSFIF-----DQTRRTLLDWSQRFHIIC 546
+++L+G C+Q E ++I FM + L SF+ D L +
Sbjct: 62 VMRLIGVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCP--QYLPTQMLVKFMT 119
Query: 547 GTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRT-FGGD-ETEGNTNR- 603
A G+ YL S IHRDL A N +L+++MN ++DFGL + + GD +G +
Sbjct: 120 DIASGMEYL---SSKSFIHRDLAARNCMLNENMNVCVADFGLSKKIYNGDYYRQGRIAKM 176
Query: 604 ------VVGTYDGQFSIKSDVFSFGILLLEIVS 630
+ D ++ KSDV+SFG+ + EI +
Sbjct: 177 PVKWIAIESLADRVYTTKSDVWSFGVTMWEIAT 209
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 81.6 bits (202), Expect = 6e-17
Identities = 52/174 (29%), Positives = 87/174 (50%), Gaps = 21/174 (12%)
Query: 441 NFSINNKLGEGGFGPVYKGT-LVDGQEIAVKRLS------KISEQGLKELKNEVILFSKL 493
+ I ++GEG G V+K G+ +A+K+++ I Q L+E+K
Sbjct: 1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIK----ALQAC 56
Query: 494 QHRNLVKLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQR--FHIICGTARG 551
QH +VKLL G +L+ E+MP+ L + D+ R L + + ++ +G
Sbjct: 57 QHPYVVKLLDVFPHGSGFVLVMEYMPS-DLSEVLRDE-ERPLPEAQVKSYMRMLL---KG 111
Query: 552 LLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNTNRVV 605
+ Y+H I+HRDLK +N+L+ D KI+DFGL R F +E +++V
Sbjct: 112 VAYMHA---NGIMHRDLKPANLLISADGVLKIADFGLARLFSEEEPRLYSHQVA 162
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Score = 81.1 bits (200), Expect = 6e-17
Identities = 65/202 (32%), Positives = 102/202 (50%), Gaps = 28/202 (13%)
Query: 447 KLGEGGFGPVYKGTLVDGQEIAVKRLSK--ISEQGLKELKNEVILFSKLQHRNLVKLLGC 504
+LG G FG V+ G ++A+K +++ +SE+ E E + KL H LV+L G
Sbjct: 11 ELGSGQFGVVHLGKWRAQIKVAIKAINEGAMSEEDFIE---EAKVMMKLSHPKLVQLYGV 67
Query: 505 CIQGEEKLLIYEFMPNKSLDSFIFDQ----TRRTLLDWSQRFHIICGTARGLLYLHQDSR 560
C Q + ++ EFM N L +++ + ++ LL Q +C G+ YL ++S
Sbjct: 68 CTQQKPLYIVTEFMENGCLLNYLRQRQGKLSKDMLLSMCQD---VC---EGMEYLERNS- 120
Query: 561 LRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDE---TEGNTNRV------VGTYDGQ 611
IHRDL A N L+ K+SDFG+ R DE + G V V + +
Sbjct: 121 --FIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYTSSSGAKFPVKWSPPEVFNFS-K 177
Query: 612 FSIKSDVFSFGILLLEIVSGKK 633
+S KSDV+SFG+L+ E+ + K
Sbjct: 178 YSSKSDVWSFGVLMWEVFTEGK 199
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 81.1 bits (201), Expect = 6e-17
Identities = 57/208 (27%), Positives = 101/208 (48%), Gaps = 32/208 (15%)
Query: 442 FSINNKLGEGGFGPVYKGT-LVDGQEIAVKRLS-KISEQGLKELKNEVILFSKLQHRNLV 499
F++ +G+G FG VYK Q +A+K + + +E +++++ E+ S+ + +
Sbjct: 3 FTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYIT 62
Query: 500 KLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDS 559
K G ++G + +I E+ S D + LD + I+ GL YLH++
Sbjct: 63 KYYGSFLKGSKLWIIMEYCGGGS----CLDLLKPGKLDETYIAFILREVLLGLEYLHEE- 117
Query: 560 RLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNTNR--VVGT---------- 607
IHRD+KA+N+LL ++ + K++DFG+ G T + R VGT
Sbjct: 118 --GKIHRDIKAANILLSEEGDVKLADFGV----SGQLTSTMSKRNTFVGTPFWMAPEVIK 171
Query: 608 ---YDGQFSIKSDVFSFGILLLEIVSGK 632
YD K+D++S GI +E+ G+
Sbjct: 172 QSGYDE----KADIWSLGITAIELAKGE 195
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 81.0 bits (200), Expect = 7e-17
Identities = 63/205 (30%), Positives = 104/205 (50%), Gaps = 30/205 (14%)
Query: 448 LGEGGFGPVYKGTLVD-GQEIAVKR-----LSKISEQGLKELKNEVILFSKLQHRNLVKL 501
LG+G FG VY VD G+E+AVK+ S +++ + L+ E+ L LQH +V+
Sbjct: 10 LGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQY 69
Query: 502 LGCCIQGEEKLLIY-EFMPNKSLDSFIFDQTRRTLLDWSQR---FHIICGTARGLLYLHQ 557
GC ++ +E L I+ E+MP S+ + + L + R I+ G+ YLH
Sbjct: 70 YGC-LRDDETLSIFMEYMPGGSVKDQL--KAYGALTETVTRKYTRQIL----EGVEYLHS 122
Query: 558 DSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNTNR-VVGT--------Y 608
+ I+HRD+K +N+L D N K+ DFG + + G + V GT
Sbjct: 123 N---MIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSSGTGMKSVTGTPYWMSPEVI 179
Query: 609 DGQ-FSIKSDVFSFGILLLEIVSGK 632
G+ + K+DV+S G ++E+++ K
Sbjct: 180 SGEGYGRKADVWSVGCTVVEMLTEK 204
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 81.4 bits (201), Expect = 7e-17
Identities = 54/157 (34%), Positives = 84/157 (53%), Gaps = 10/157 (6%)
Query: 441 NFSINNKLGEGGFGPVYKG-TLVDGQEIAVK--RLSKISEQGLKELKNEVILFSKLQHRN 497
NF K+GEG +G VYK + G+ +A+K RL +E E+ L +L H N
Sbjct: 1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN 60
Query: 498 LVKLLGCCIQGEEKL-LIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLH 556
+VKLL I E KL L++EF+ ++ L F+ D + + + + +GL + H
Sbjct: 61 IVKLLDV-IHTENKLYLVFEFL-HQDLKKFM-DASPLSGIPLPLIKSYLFQLLQGLAFCH 117
Query: 557 QDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFG 593
R++HRDLK N+L++ + K++DFGL R FG
Sbjct: 118 SH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFG 151
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 81.0 bits (200), Expect = 7e-17
Identities = 55/208 (26%), Positives = 95/208 (45%), Gaps = 38/208 (18%)
Query: 448 LGEGGFGPVYKGTLVDGQ-EIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCI 506
LG+G +G VY + Q IA+K + + + ++ L E+ L S L+HRN+V+ LG
Sbjct: 16 LGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSDS 75
Query: 507 QGEEKLLIYEFMPNKSLDSFI------FDQTRRTLLDWSQRFHIICGTARGLLYLHQDSR 560
+ + E +P SL + + +T++ ++++ GL YLH
Sbjct: 76 ENGFFKIFMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQI------LEGLKYLHD--- 126
Query: 561 LRIIHRDLKASNVLLDQDMNP-KISDFGLVRTFGGDETEGNTNRVVGTYDGQ-------- 611
+I+HRD+K NVL++ KISDFG + G N T+ G
Sbjct: 127 NQIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAG------INPCTETFTGTLQYMAPEV 180
Query: 612 -------FSIKSDVFSFGILLLEIVSGK 632
+ +D++S G ++E+ +GK
Sbjct: 181 IDKGPRGYGAPADIWSLGCTIVEMATGK 208
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 81.6 bits (201), Expect = 8e-17
Identities = 58/218 (26%), Positives = 99/218 (45%), Gaps = 37/218 (16%)
Query: 447 KLGEGGFGPVY-------------KGTLVDGQE--IAVKRL-SKISEQGLKELKNEVILF 490
KLGEG FG V+ DGQ +AVK L + +++ + E+ +
Sbjct: 12 KLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIM 71
Query: 491 SKLQHRNLVKLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQTRRTLL---------DWSQR 541
S+L++ N+++LLG C+ + +I E+M N L+ F+ + + +
Sbjct: 72 SRLKNPNIIRLLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANL 131
Query: 542 FHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRT-FGGDETEGN 600
++ A G+ YL + L +HRDL N L+ KI+DFG+ R + GD
Sbjct: 132 LYMAVQIASGMKYL---ASLNFVHRDLATRNCLVGNHYTIKIADFGMSRNLYSGDYYRIQ 188
Query: 601 TNRVV--------GTYDGQFSIKSDVFSFGILLLEIVS 630
V+ G+F+ SDV++FG+ L E+ +
Sbjct: 189 GRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFT 226
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 80.9 bits (200), Expect = 9e-17
Identities = 58/211 (27%), Positives = 91/211 (43%), Gaps = 29/211 (13%)
Query: 440 DNFSINNKLGEGGFGPVYKGTLVDGQEIAVKRL------SKISEQGLKELKNEVILFSKL 493
+ ++LGEG G V K L + I + + +Q L+EL+ +
Sbjct: 1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELE----INKSC 56
Query: 494 QHRNLVKLLGCCIQGEEKLL--IYEFMPNKSLDSFIFDQTRRTLLDWSQRF--HIICGTA 549
+ +VK G + + E+ SLDS I+ + ++ ++ I
Sbjct: 57 KSPYIVKYYGAFLDESSSSIGIAMEYCEGGSLDS-IYKKVKKRGGRIGEKVLGKIAESVL 115
Query: 550 RGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFG--------LVRTFGGDETEGNT 601
+GL YLH +IIHRD+K SN+LL + K+ DFG L TF G
Sbjct: 116 KGLSYLHSR---KIIHRDIKPSNILLTRKGQVKLCDFGVSGELVNSLAGTFTGTSFYMAP 172
Query: 602 NRVVGTYDGQFSIKSDVFSFGILLLEIVSGK 632
R+ G +SI SDV+S G+ LLE+ +
Sbjct: 173 ERIQG---KPYSITSDVWSLGLTLLEVAQNR 200
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 80.8 bits (200), Expect = 1e-16
Identities = 49/154 (31%), Positives = 79/154 (51%), Gaps = 16/154 (10%)
Query: 447 KLGEGGFGPVYKG-TLVDGQEIAVK--RLSKISEQGLKELKNEVILFSKLQHRNLVKLLG 503
K+GEG +G VYK + G+ +A+K RL E E+ L +L H N+V+LL
Sbjct: 6 KIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLD 65
Query: 504 CCIQGEEKLLIYEFMP---NKSLDSFIFDQTRRTLLDWSQRF-HIICGTARGLLYLHQDS 559
+ L++EF+ K +DS L+ + + + + +G+ Y H
Sbjct: 66 VVHSENKLYLVFEFLDLDLKKYMDSSPLTGLDPPLI---KSYLYQLL---QGIAYCHSH- 118
Query: 560 RLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFG 593
R++HRDLK N+L+D++ K++DFGL R FG
Sbjct: 119 --RVLHRDLKPQNLLIDREGALKLADFGLARAFG 150
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Score = 81.2 bits (200), Expect = 1e-16
Identities = 61/202 (30%), Positives = 105/202 (51%), Gaps = 29/202 (14%)
Query: 448 LGEGGFGPVYKGTLV-DGQEI----AVKRLSK-ISEQGLKELKNEVILFSKLQHRNLVKL 501
LG G FG VYKG + +G+++ A+K L + S + KE+ +E + + + + ++ +L
Sbjct: 15 LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 74
Query: 502 LGCCIQGEEKLLIYEFMPNKSLDSFIFDQTRRT----LLDWSQRFHIICGTARGLLYLHQ 557
LG C+ +L I + MP L ++ + LL+W + A+G+ YL +
Sbjct: 75 LGICLTSTVQL-ITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQI------AKGMNYLEE 127
Query: 558 DSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETE--GNTNRVVGTYDGQFSI- 614
R++HRDL A NVL+ + KI+DFGL + G DE E +V + SI
Sbjct: 128 R---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGADEKEYHAEGGKVPIKWMALESIL 184
Query: 615 ------KSDVFSFGILLLEIVS 630
+SDV+S+G+ + E+++
Sbjct: 185 HRIYTHQSDVWSYGVTVWELMT 206
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316 |
| >gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Score = 80.3 bits (198), Expect = 1e-16
Identities = 60/206 (29%), Positives = 106/206 (51%), Gaps = 22/206 (10%)
Query: 441 NFSINNKLGEGGFGPVYKGTL-VDGQE---IAVKRL-SKISEQGLKELKNEVILFSKLQH 495
I +G G FG V G L + G+ +A+K L + +E+ ++ +E + + H
Sbjct: 5 CIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDH 64
Query: 496 RNLVKLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQTRR-TLLDWSQRFHIICGTARGLLY 554
N++ L G + + +++ E+M N SLD+F+ + T++ Q ++ G A G+ Y
Sbjct: 65 PNIIHLEGVVTKSKPVMIVTEYMENGSLDAFLRKHDGQFTVI---QLVGMLRGIASGMKY 121
Query: 555 LHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNTNR-----VVGTYD 609
L S + +HRDL A N+L++ ++ K+SDFGL R D T R + T
Sbjct: 122 L---SDMGYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTAP 178
Query: 610 G-----QFSIKSDVFSFGILLLEIVS 630
+F+ SDV+S+GI++ E++S
Sbjct: 179 EAIAYRKFTSASDVWSYGIVMWEVMS 204
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 79.6 bits (196), Expect = 2e-16
Identities = 59/216 (27%), Positives = 98/216 (45%), Gaps = 45/216 (20%)
Query: 446 NKLGEGGFGPVYKGTLVDGQEIAVKRLS------KISEQGLKELKNEVILFSKLQHRNLV 499
LG+G +G VY G GQ IAVK++ +E+ ++L+ EV L L+H N+V
Sbjct: 6 EVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIV 65
Query: 500 KLLGCCIQGEEKLLIYEFMPNKSLDSFI----------FDQTRRTLLDWSQRFHIICGTA 549
+ LG C+ + EF+P S+ S + F + + +LD
Sbjct: 66 QYLGTCLDDNTISIFMEFVPGGSISSILNRFGPLPEPVFCKYTKQILD------------ 113
Query: 550 RGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNTNRVVGTYD 609
G+ YLH + ++HRD+K +NV+L + K+ DFG R G + ++ +
Sbjct: 114 -GVAYLHNNC---VVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNMLKSMH 169
Query: 610 GQ-------------FSIKSDVFSFGILLLEIVSGK 632
G + KSD++S G + E+ +GK
Sbjct: 170 GTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGK 205
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Score = 79.7 bits (196), Expect = 2e-16
Identities = 61/202 (30%), Positives = 105/202 (51%), Gaps = 29/202 (14%)
Query: 448 LGEGGFGPVYKGTLV-DGQEI----AVKRLSK-ISEQGLKELKNEVILFSKLQHRNLVKL 501
LG G FG VYKG + DG+ + A+K L + S + KE+ +E + + + + +L
Sbjct: 15 LGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRL 74
Query: 502 LGCCIQGEEKLLIYEFMPNKSLDSFIFDQTRRT----LLDWSQRFHIICGTARGLLYLHQ 557
LG C+ +L + + MP L ++ + R LL+W + A+G+ YL +
Sbjct: 75 LGICLTSTVQL-VTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQI------AKGMSYLEE 127
Query: 558 DSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNTN---------RVVGTY 608
+R++HRDL A NVL+ + KI+DFGL R DETE + + +
Sbjct: 128 ---VRLVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHADGGKVPIKWMALESIL 184
Query: 609 DGQFSIKSDVFSFGILLLEIVS 630
+F+ +SDV+S+G+ + E+++
Sbjct: 185 HRRFTHQSDVWSYGVTVWELMT 206
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 80.1 bits (197), Expect = 3e-16
Identities = 65/221 (29%), Positives = 108/221 (48%), Gaps = 24/221 (10%)
Query: 447 KLGEGGFGPV-YKGTLVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCC 505
K+GEG G V G+++AVK + +Q + L NEV++ QH+N+V++
Sbjct: 28 KIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSY 87
Query: 506 IQGEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTA-RGLLYLHQDSRLRII 564
+ GEE ++ EF+ +L I QTR ++ +C + + L YLH +I
Sbjct: 88 LVGEELWVLMEFLQGGALTD-IVSQTRLN----EEQIATVCESVLQALCYLHSQG---VI 139
Query: 565 HRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNTNRVVGT---------YDGQFSIK 615
HRD+K+ ++LL D K+SDFG D + + +VGT + +
Sbjct: 140 HRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKS--LVGTPYWMAPEVISRTPYGTE 197
Query: 616 SDVFSFGILLLEIVSGKKNRGFYRSDTKVNLIGHLWDEGIP 656
D++S GI+++E+V G+ Y SD+ V + L D P
Sbjct: 198 VDIWSLGIMVIEMVDGEPP---YFSDSPVQAMKRLRDSPPP 235
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Score = 79.4 bits (195), Expect = 3e-16
Identities = 62/212 (29%), Positives = 98/212 (46%), Gaps = 29/212 (13%)
Query: 442 FSINNKLGEGGFGPVYKGTLVDGQEIAVKRLSKISEQGLKELKNEVILFSKL-QHRNLVK 500
F + +G G +G VYKG V ++A ++ ++ +E+K E+ + K HRN+
Sbjct: 8 FELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIAT 67
Query: 501 LLGCCIQ------GEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIIC-GTARGLL 553
G I+ ++ L+ EF S+ I + TL + + IC RGL
Sbjct: 68 YYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKE--EWIAYICREILRGLS 125
Query: 554 YLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNTNRVVGT------ 607
+LHQ ++IHRD+K NVLL ++ K+ DFG+ D T G N +GT
Sbjct: 126 HLHQH---KVIHRDIKGQNVLLTENAEVKLVDFGVSAQL--DRTVGRRNTFIGTPYWMAP 180
Query: 608 --------YDGQFSIKSDVFSFGILLLEIVSG 631
D + KSD++S GI +E+ G
Sbjct: 181 EVIACDENPDATYDFKSDLWSLGITAIEMAEG 212
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 79.8 bits (196), Expect = 3e-16
Identities = 58/215 (26%), Positives = 113/215 (52%), Gaps = 21/215 (9%)
Query: 429 LFELATIANATDNFSINNKLGEGGFGPVYKG-TLVDGQEIAVKRLSKISEQGLKELK-NE 486
L + ++ + ++ K+G+G G VY + GQE+A+K+++ + +Q KEL NE
Sbjct: 8 LRSIVSVGDPKKKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMN-LQQQPKKELIINE 66
Query: 487 VILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIIC 546
+++ + ++ N+V L + G+E ++ E++ SL D T +D Q +
Sbjct: 67 ILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLT----DVVTETCMDEGQIAAVCR 122
Query: 547 GTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNTNRVVG 606
+ L +LH + ++IHRD+K+ N+LL D + K++DFG ++++ +T +VG
Sbjct: 123 ECLQALDFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRST--MVG 177
Query: 607 T---------YDGQFSIKSDVFSFGILLLEIVSGK 632
T + K D++S GI+ +E+V G+
Sbjct: 178 TPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGE 212
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 78.6 bits (194), Expect = 3e-16
Identities = 58/205 (28%), Positives = 102/205 (49%), Gaps = 20/205 (9%)
Query: 441 NFSINNKLGEGGFGPVYK-GTLVDGQEIAVKR--LSKISEQGLKELKNEVILFSKLQHRN 497
+F + KLG+G +G VYK L D Q A+K L +S++ ++ NE+ + + + H N
Sbjct: 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPN 60
Query: 498 LVKLLGCCIQGEEKLLIYEFMPNKSLDSFIFD-QTRRTLLDWSQRFHIICGTARGLLYLH 556
++ + G + ++ E+ P L I + +R L+ + + I RGL LH
Sbjct: 61 IISYKEAFLDGNKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALH 120
Query: 557 QDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNTNRVVGT--------Y 608
+ +I+HRDLK++N+LL + KI D G+ + + +GT +
Sbjct: 121 E---QKILHRDLKSANILLVANDLVKIGDLGISKVL----KKNMAKTQIGTPHYMAPEVW 173
Query: 609 DGQ-FSIKSDVFSFGILLLEIVSGK 632
G+ +S KSD++S G LL E+ +
Sbjct: 174 KGRPYSYKSDIWSLGCLLYEMATFA 198
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 79.3 bits (195), Expect = 4e-16
Identities = 61/208 (29%), Positives = 101/208 (48%), Gaps = 24/208 (11%)
Query: 437 NATDNFSINNKLGEGGFGPVYKGTLVD-GQEIAVKRLSKISEQGLKELKNEVILFSKLQH 495
+ + + I +LG+G FG VYK + G A K + SE+ L++ E+ + + H
Sbjct: 9 DPNEVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNH 68
Query: 496 RNLVKLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTA-RGLLY 554
+VKLLG + ++ EF P ++D+ + + R + +IC L Y
Sbjct: 69 PYIVKLLGAFYWDGKLWIMIEFCPGGAVDAIMLELDRGLT---EPQIQVICRQMLEALQY 125
Query: 555 LHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNTNRVVGT------- 607
LH ++IIHRDLKA NVLL D + K++DFG+ + +T + +GT
Sbjct: 126 LHS---MKIIHRDLKAGNVLLTLDGDIKLADFGV--SAKNVKTLQRRDSFIGTPYWMAPE 180
Query: 608 -------YDGQFSIKSDVFSFGILLLEI 628
D + K+D++S GI L+E+
Sbjct: 181 VVMCETMKDTPYDYKADIWSLGITLIEM 208
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 78.6 bits (194), Expect = 4e-16
Identities = 66/274 (24%), Positives = 119/274 (43%), Gaps = 47/274 (17%)
Query: 448 LGEGGFGP--VYK----GTLVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKL 501
LG+G FG +Y+ +LV +E+ + RLS E+ ++ NE+++ S LQH N++
Sbjct: 8 LGKGAFGEATLYRRTEDDSLVVWKEVNLTRLS---EKERRDALNEIVILSLLQHPNIIAY 64
Query: 502 LGCCIQGEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRL 561
+ L+ E+ +L I + + L + + + Y+H+
Sbjct: 65 YNHFMDDNTLLIEMEYANGGTLYDKI-VRQKGQLFEEEMVLWYLFQIVSAVSYIHKAG-- 121
Query: 562 RIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNTNRVVGT---------YDGQF 612
I+HRD+K N+ L + K+ DFG+ + G + + T VVGT ++
Sbjct: 122 -ILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYSMAET--VVGTPYYMSPELCQGVKY 178
Query: 613 SIKSDVFSFGILLLEIVSGKKNRGFYRSDTKVNLIGHLWDEGIPLRLIDACIQDSCNLAD 672
+ KSD+++ G +L E+++ K+ +D PL L+ +Q N
Sbjct: 179 NFKSDIWALGCVLYELLTLKRT----------------FDATNPLNLVVKIVQ--GNYTP 220
Query: 673 VIRCIHIGLL-----CVQQHPEDRPCMPSVILML 701
V+ L+ +QQ PE RP V+
Sbjct: 221 VVSVYSSELISLVHSLLQQDPEKRPTADEVLDQP 254
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 78.5 bits (193), Expect = 4e-16
Identities = 59/208 (28%), Positives = 101/208 (48%), Gaps = 27/208 (12%)
Query: 441 NFSINNKLGEGGFGPVYKGT-LVDGQEIAVKRLS---KISEQGLKELKNEVILFSKLQHR 496
NF I K+G G F VY+ T L+D + +A+K++ + + ++ E+ L +L H
Sbjct: 3 NFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHP 62
Query: 497 NLVKLLGCCIQGEEKLLIYEFMPNKSLDSFI--FDQTRRTLLD---WSQRFHIICGTARG 551
N++K L I+ E ++ E L I F + +R + + W + F +C
Sbjct: 63 NVIKYLDSFIEDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVW-KYFVQLCSAVE- 120
Query: 552 LLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNTNRVVGT---- 607
H SR R++HRD+K +NV + K+ D GL R F T ++ +VGT
Sbjct: 121 ----HMHSR-RVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHS--LVGTPYYM 173
Query: 608 -----YDGQFSIKSDVFSFGILLLEIVS 630
++ ++ KSD++S G LL E+ +
Sbjct: 174 SPERIHENGYNFKSDIWSLGCLLYEMAA 201
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Score = 79.3 bits (196), Expect = 5e-16
Identities = 54/188 (28%), Positives = 87/188 (46%), Gaps = 27/188 (14%)
Query: 438 ATDNFSINNKLGEGGFGPVYKG-TLVDGQEIAVKRLSKISEQ------GLKELKNEVILF 490
++ I KLGEG FG VYK + G+ +A+K++ +E+ L+E+K +
Sbjct: 6 KLRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIK----IL 61
Query: 491 SKLQHRNLVKLLGCCI-----QGEEKLLIYEFMPNKSLD-SFIFDQTRRTLLDWSQRFHI 544
KL+H N+V L+ + ++ +Y P D S + + L I
Sbjct: 62 KKLKHPNVVPLIDMAVERPDKSKRKRGSVYMVTPYMDHDLSGLLENPSVKL----TESQI 117
Query: 545 ICGTAR---GLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNT 601
C + G+ YLH++ I+HRD+KA+N+L+D KI+DFGL R + G
Sbjct: 118 KCYMLQLLEGINYLHEN---HILHRDIKAANILIDNQGILKIADFGLARPYDGPPPNPKG 174
Query: 602 NRVVGTYD 609
GT
Sbjct: 175 GGGGGTRK 182
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311 |
| >gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Score = 78.9 bits (194), Expect = 6e-16
Identities = 70/210 (33%), Positives = 100/210 (47%), Gaps = 33/210 (15%)
Query: 448 LGEGGFGPVYKGTL-VDG--QEIAVKRLSK-ISEQGLKELKNEVILFSKL-QHRNLVKLL 502
+GEG FG V K + DG + A+KR+ + S+ ++ E+ + KL H N++ LL
Sbjct: 15 IGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLL 74
Query: 503 GCCIQGEEKLLIYEFMPNKSLDSFI-----------FDQTRRT--LLDWSQRFHIICGTA 549
G C L E+ P+ +L F+ F T L Q H A
Sbjct: 75 GACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVA 134
Query: 550 RGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDE-----TEGNTN-R 603
RG+ YL Q + IHRDL A N+L+ ++ KI+DFGL R G E T G R
Sbjct: 135 RGMDYLSQK---QFIHRDLAARNILVGENYVAKIADFGLSR---GQEVYVKKTMGRLPVR 188
Query: 604 VVGTYDGQFSI---KSDVFSFGILLLEIVS 630
+ +S+ SDV+S+G+LL EIVS
Sbjct: 189 WMAIESLNYSVYTTNSDVWSYGVLLWEIVS 218
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303 |
| >gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Score = 78.5 bits (193), Expect = 6e-16
Identities = 61/223 (27%), Positives = 101/223 (45%), Gaps = 29/223 (13%)
Query: 431 ELATIANATDNFSINNKLGEGGFGPVYKGTLVDGQEIAVKRLSKISEQGLKELKNEVILF 490
+L+ + + F + +G G +G VYKG V ++A ++ ++E +E+K E+ +
Sbjct: 7 DLSALRDPAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTEDEEEEIKLEINML 66
Query: 491 SKL-QHRNLVKLLGCCI------QGEEKLLIYEFMPNKSLDSFIFDQTRRTLL-DWSQRF 542
K HRN+ G I ++ L+ EF S+ + + L DW
Sbjct: 67 KKYSHHRNIATYYGAFIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIA-- 124
Query: 543 HIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNTN 602
+I RGL +LH ++IHRD+K NVLL ++ K+ DFG+ D T G N
Sbjct: 125 YICREILRGLAHLHAH---KVIHRDIKGQNVLLTENAEVKLVDFGVSAQL--DRTVGRRN 179
Query: 603 RVVGT--------------YDGQFSIKSDVFSFGILLLEIVSG 631
+GT D + +SD++S GI +E+ G
Sbjct: 180 TFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEG 222
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 78.0 bits (192), Expect = 9e-16
Identities = 66/203 (32%), Positives = 102/203 (50%), Gaps = 27/203 (13%)
Query: 448 LGEGGFGPVY------KGTLVDGQEIAVKRLSKIS-EQGLKELKNEVILFSKLQHRNLVK 500
LGEG FG V +G G+++AVK L S + +LK E+ + L H N+VK
Sbjct: 12 LGEGHFGKVELCRYDPEGDNT-GEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVK 70
Query: 501 LLGCCIQGEEK--LLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHI-ICGTARGLLYLHQ 557
G C + LI EF+P+ SL ++ + L ++ + IC +G+ YL
Sbjct: 71 YKGICTEDGGNGIKLIMEFLPSGSLKEYLPRNKNKINLKQQLKYAVQIC---KGMDYL-- 125
Query: 558 DSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDE----TEGNTNRVVGTY----- 608
SR + +HRDL A NVL++ + KI DFGL + D+ + + + V Y
Sbjct: 126 GSR-QYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDLDSPVFWYAPECL 184
Query: 609 -DGQFSIKSDVFSFGILLLEIVS 630
+F I SDV+SFG+ L E+++
Sbjct: 185 IQSKFYIASDVWSFGVTLYELLT 207
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Score = 78.2 bits (193), Expect = 1e-15
Identities = 79/296 (26%), Positives = 118/296 (39%), Gaps = 72/296 (24%)
Query: 447 KLGEGGFGPVYKGTLVDGQEI-----------------AVKRLSK-ISEQGLKELKNEVI 488
KLGEG FG V+ Q+ AVK L S+ ++ EV
Sbjct: 12 KLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVK 71
Query: 489 LFSKLQHRNLVKLLGCCIQGEEKLLIYEFMPNKSLDSF-----IFDQT---------RRT 534
+ S+L N+ +LLG C +I E+M N L+ F T
Sbjct: 72 ILSRLSDPNIARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFST 131
Query: 535 LLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGG 594
LL ++ A G+ YL L +HRDL N L+ ++ KI+DFG+ R
Sbjct: 132 LL------YMATQIASGMRYL---ESLNFVHRDLATRNCLVGKNYTIKIADFGMSR---- 178
Query: 595 DETEGNTNRVVG-------------TYDGQFSIKSDVFSFGILLLEIVSGKKNRGFYR-S 640
+ + RV G G+F+ KSDV++FG+ L EI++ + + + +
Sbjct: 179 NLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPYEHLT 238
Query: 641 DTKV--NLIGHLWDEG--IPLRLIDACIQDSCNLADVIRCIHIGLLCVQQHPEDRP 692
D +V N D+G I L C +D L L C ++ EDRP
Sbjct: 239 DQQVIENAGHFFRDDGRQIYLPRPPNCPKDIYELM---------LECWRRDEEDRP 285
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296 |
| >gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Score = 77.7 bits (191), Expect = 1e-15
Identities = 62/219 (28%), Positives = 105/219 (47%), Gaps = 39/219 (17%)
Query: 442 FSINNKLGEGGFGPVYKGTLV----DGQEIAVKRLSK--ISEQGLKELKNEVILFSKLQH 495
F++ LG+G FG V + L Q++AVK L S ++E E + H
Sbjct: 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDH 60
Query: 496 RNLVKLLGCCIQGEEK------LLIYEFMPNKSLDSFI---------FDQTRRTLLDWSQ 540
N++KL+G ++ K ++I FM + L +F+ F +TL+
Sbjct: 61 PNVIKLIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLV---- 116
Query: 541 RFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRT-FGGD-ETE 598
RF I A G+ YL S IHRDL A N +L+++M ++DFGL + + GD +
Sbjct: 117 RFMI--DIASGMEYL---SSKNFIHRDLAARNCMLNENMTVCVADFGLSKKIYSGDYYRQ 171
Query: 599 GNTNRVVGTY-------DGQFSIKSDVFSFGILLLEIVS 630
G +++ + D ++ SDV++FG+ + EI++
Sbjct: 172 GCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMT 210
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273 |
| >gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Score = 78.1 bits (192), Expect = 1e-15
Identities = 70/223 (31%), Positives = 106/223 (47%), Gaps = 35/223 (15%)
Query: 440 DNFSINNKLGEGGFGPVYK----GTLVDGQE----IAVKRLS-KISEQGLKELKNEVILF 490
D + LGEG FG V + G + +AVK L +++ L +L +E+ L
Sbjct: 12 DRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELM 71
Query: 491 SKL-QHRNLVKLLGCCIQGEEKLLIYEFMPNKSLDSFI-----------FDQTR--RTLL 536
+ +H+N++ LLG C Q +I E+ +L F+ FD T+ L
Sbjct: 72 KLIGKHKNIINLLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQL 131
Query: 537 DWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGG-D 595
+ ARG+ YL +SR R IHRDL A NVL+ +D KI+DFGL R D
Sbjct: 132 SFKDLVSCAYQVARGMEYL--ESR-RCIHRDLAARNVLVTEDNVMKIADFGLARGVHDID 188
Query: 596 ETEGNTNRVV--------GTYDGQFSIKSDVFSFGILLLEIVS 630
+ +N + +D ++ +SDV+SFGIL+ EI +
Sbjct: 189 YYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFT 231
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 77.0 bits (190), Expect = 1e-15
Identities = 59/232 (25%), Positives = 98/232 (42%), Gaps = 27/232 (11%)
Query: 441 NFSINNKLGEGGFGPVYKGTLVDGQEI-AVKRLSK---ISEQGLKELKNEVILFSKLQHR 496
+F + +G+G FG V D +++ A+K ++K + + ++ + NE + +L H
Sbjct: 1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHP 60
Query: 497 NLVKLLGCCIQGEEKL-LIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYL 555
LV L Q EE + L+ + + L + + + +F IC L YL
Sbjct: 61 FLVNLWYS-FQDEENMYLVVDLLLGGDLRYHL--SQKVKFSEEQVKF-WICEIVLALEYL 116
Query: 556 HQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNTNRVVGT-------- 607
H IIHRD+K N+LLD+ + I+DF + D T GT
Sbjct: 117 HSK---GIIHRDIKPDNILLDEQGHVHITDFNIATKVTPDT---LTTSTSGTPGYMAPEV 170
Query: 608 YDGQ-FSIKSDVFSFGILLLEIVSGKKNRGF-YRSDTKVNLIGHLWDEGIPL 657
Q +S+ D +S G+ E + GK R + S T + I + L
Sbjct: 171 LCRQGYSVAVDWWSLGVTAYECLRGK--RPYRGHSRTIRDQIRAKQETADVL 220
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 77.3 bits (191), Expect = 2e-15
Identities = 51/160 (31%), Positives = 89/160 (55%), Gaps = 18/160 (11%)
Query: 446 NKLGEGGFGPVYKGT-LVDGQEIAVKRLS-KISEQG--LKELKNEVILFSKLQ---HRNL 498
++GEG +G VYK L G+ +A+K++ +SE+G L L+ E+ L +L+ H N+
Sbjct: 5 AEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLR-EIALLKQLESFEHPNI 63
Query: 499 VKLLGCC--IQGEEKL---LIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLL 553
V+LL C + + +L L++E + ++ L +++ + + L ++ RG+
Sbjct: 64 VRLLDVCHGPRTDRELKLTLVFEHV-DQDLATYL-SKCPKPGLPPETIKDLMRQLLRGVD 121
Query: 554 YLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFG 593
+LH RI+HRDLK N+L+ D KI+DFGL R +
Sbjct: 122 FLHSH---RIVHRDLKPQNILVTSDGQVKIADFGLARIYS 158
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 77.0 bits (189), Expect = 2e-15
Identities = 62/220 (28%), Positives = 104/220 (47%), Gaps = 34/220 (15%)
Query: 438 ATDNFSINNKLGEGGFGPVY----KGTLVDGQE--IAVKRLSKISEQGLK-ELKNEVILF 490
A + +++ +LG+G FG VY KG + D E +A+K +++ + + E NE +
Sbjct: 4 AREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVM 63
Query: 491 SKLQHRNLVKLLGCCIQGEEKLLIYEFMPNKSLDSFIF-------DQTRRTLLDWSQRFH 543
+ ++V+LLG QG+ L+I E M L S++ + + +
Sbjct: 64 KEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQ 123
Query: 544 IICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNTNR 603
+ A G+ YL+ + + +HRDL A N ++ +D KI DFG+ R D E + R
Sbjct: 124 MAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTR----DIYETDYYR 176
Query: 604 VVGT-------------YDGQFSIKSDVFSFGILLLEIVS 630
G DG F+ SDV+SFG++L EI +
Sbjct: 177 KGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT 216
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277 |
| >gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Score = 77.7 bits (191), Expect = 2e-15
Identities = 64/234 (27%), Positives = 103/234 (44%), Gaps = 60/234 (25%)
Query: 447 KLGEGGFGPVYKGTLVDGQE-----------------IAVKRL-SKISEQGLKELKNEVI 488
KLGEG FG V+ +V+ Q+ +AVK L ++ + EV
Sbjct: 12 KLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVK 71
Query: 489 LFSKLQHRNLVKLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQTRRTLLD----------- 537
+ S+L+ N+++LLG C+ + +I E+M N L+ F+ + L D
Sbjct: 72 ILSRLKDPNIIRLLGVCVDEDPLCMITEYMENGDLNQFL---SSHHLDDKEENGNDAVPP 128
Query: 538 --------WSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLV 589
+S H+ A G+ YL S L +HRDL N L+ +++ KI+DFG+
Sbjct: 129 AHCLPAISYSSLLHVALQIASGMKYL---SSLNFVHRDLATRNCLVGENLTIKIADFGMS 185
Query: 590 RTFGGDETEGNTNRVVG-------------TYDGQFSIKSDVFSFGILLLEIVS 630
R G+ R+ G G+F+ SDV++FG+ L EI+
Sbjct: 186 RNL----YAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILM 235
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 77.5 bits (191), Expect = 2e-15
Identities = 73/259 (28%), Positives = 118/259 (45%), Gaps = 34/259 (13%)
Query: 447 KLGEGGFGPVYKGTLVDGQEI-AVKRLS---KISEQGLKELKNEVILFSKLQHRNLVKLL 502
++G G FG VY V E+ A+K++S K S + +++ EV +L+H N ++
Sbjct: 22 EIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYK 81
Query: 503 GCCIQGEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHI--IC-GTARGLLYLHQDS 559
GC ++ L+ E+ + D I + ++ L Q I IC G +GL YLH
Sbjct: 82 GCYLREHTAWLVMEYCLGSASD--ILEVHKKPL----QEVEIAAICHGALQGLAYLHSHE 135
Query: 560 RLRIIHRDLKASNVLLDQDMNPKISDFG---LV---RTFGGDETEGNTNRVVGTYDGQFS 613
R IHRD+KA N+LL + K++DFG LV +F G ++ +GQ+
Sbjct: 136 R---IHRDIKAGNILLTEPGTVKLADFGSASLVSPANSFVGTPYWMAPEVILAMDEGQYD 192
Query: 614 IKSDVFSFGILLLEIVSGKKNRGFYRSDTKVNLIGHLWDEGIPLRLIDACIQDSCNLADV 673
K DV+S GI +E+ K + ++ + H+ P + N D
Sbjct: 193 GKVDVWSLGITCIELAERKPP---LFNMNAMSALYHIAQNDSPTLSSNDWSDYFRNFVD- 248
Query: 674 IRCIHIGLLCVQQHPEDRP 692
C+Q+ P+DRP
Sbjct: 249 --------SCLQKIPQDRP 259
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 80.3 bits (198), Expect = 2e-15
Identities = 82/337 (24%), Positives = 147/337 (43%), Gaps = 28/337 (8%)
Query: 378 VIVISTAALLAVVLIAGYLIRKRRRNIAEKTENSRETDQENEDQNIDLEL---PLFELAT 434
I + A L + L+A + R RN E ENED +L+ + + T
Sbjct: 631 YITCTLGAFLVLALVAFGFVFIRGRNNLELKR------VENEDGTWELQFFDSKVSKSIT 684
Query: 435 IANATDNFSINNKLGEGGFGPVYKG-TLVDGQEIAVKRLSKISEQGLKELKNEVILFSKL 493
I + + N + G G YKG ++ +G + VK ++ ++ +E+ KL
Sbjct: 685 INDILSSLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNSIPS----SEIADMGKL 740
Query: 494 QHRNLVKLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLL 553
QH N+VKL+G C + LI+E++ K+L + + L W +R I G A+ L
Sbjct: 741 QHPNIVKLIGLCRSEKGAYLIHEYIEGKNLSEVLRN------LSWERRRKIAIGIAKALR 794
Query: 554 YLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNTNRVVG--TYDGQ 611
+LH ++ +L +++D P + L D ++ V T + +
Sbjct: 795 FLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLCTDTKCFISSAYVAPETRETK 853
Query: 612 -FSIKSDVFSFGILLLEIVSGK--KNRGFYRSDTKVNLIGHLWDEGIPLRLIDACI--QD 666
+ KSD++ FG++L+E+++GK + F + V + + + ID I
Sbjct: 854 DITEKSDIYGFGLILIELLTGKSPADAEFGVHGSIVEWARYCYSDCHLDMWIDPSIRGDV 913
Query: 667 SCNLADVIRCIHIGLLCVQQHPEDRPCMPSVILMLGS 703
S N +++ +++ L C P RPC V+ L S
Sbjct: 914 SVNQNEIVEVMNLALHCTATDPTARPCANDVLKTLES 950
|
Length = 968 |
| >gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Score = 76.5 bits (188), Expect = 2e-15
Identities = 79/271 (29%), Positives = 122/271 (45%), Gaps = 36/271 (13%)
Query: 447 KLGEGGFGPVYKG---TLVDGQEIAVKRLSKIS-EQGLK-ELKNEVILFSKLQHRNLVKL 501
+LG G FG V KG + +AVK L + + LK EL E + +L + +V++
Sbjct: 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRM 61
Query: 502 LGCCIQGEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRL 561
+G C + E +L+ E L+ F+ T + ++ H + + G+ YL + +
Sbjct: 62 IGIC-EAESWMLVMELAELGPLNKFLQKNKHVTEKNITELVHQV---SMGMKYLEETN-- 115
Query: 562 RIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDE----TEGNTNRVVGTYDGQ------ 611
+HRDL A NVLL KISDFGL + G DE + + V Y +
Sbjct: 116 -FVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAKTHGKWPVKWYAPECMNYYK 174
Query: 612 FSIKSDVFSFGILLLEIVS-GKKNRGFYRSDTKVNLIGHLWDEGIPLRLIDACIQDSCNL 670
FS KSDV+SFG+L+ E S G+K Y+ K N + + + G + C + +L
Sbjct: 175 FSSKSDVWSFGVLMWEAFSYGQKP---YKG-MKGNEVTQMIESGERMECPQRCPPEMYDL 230
Query: 671 ADVIRCIHIGLLCVQQHPEDRPCMPSVILML 701
LC ++RP V L L
Sbjct: 231 MK---------LCWTYGVDERPGFAVVELRL 252
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 77.1 bits (189), Expect = 2e-15
Identities = 55/215 (25%), Positives = 112/215 (52%), Gaps = 21/215 (9%)
Query: 429 LFELATIANATDNFSINNKLGEGGFGPVYKGT-LVDGQEIAVKRLSKISEQGLKELK-NE 486
L + ++ + ++ K+G+G G VY + GQE+A+++++ + +Q KEL NE
Sbjct: 9 LRSIVSVGDPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMN-LQQQPKKELIINE 67
Query: 487 VILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIIC 546
+++ + ++ N+V L + G+E ++ E++ SL D T +D Q +
Sbjct: 68 ILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLT----DVVTETCMDEGQIAAVCR 123
Query: 547 GTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNTNRVVG 606
+ L +LH + ++IHRD+K+ N+LL D + K++DFG ++++ + +VG
Sbjct: 124 ECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK--RSTMVG 178
Query: 607 T---------YDGQFSIKSDVFSFGILLLEIVSGK 632
T + K D++S GI+ +E++ G+
Sbjct: 179 TPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGE 213
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Score = 75.4 bits (185), Expect = 4e-15
Identities = 60/199 (30%), Positives = 91/199 (45%), Gaps = 24/199 (12%)
Query: 447 KLGEGGFGPVYKGTL-VDGQEIAVKRLSKISEQGLK-ELKNEVILFSKLQHRNLVKLLGC 504
++G G FG V+ G L D +AVK + LK + E + + H N+V+L+G
Sbjct: 2 RIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGV 61
Query: 505 CIQGEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRII 564
C Q + ++ E + +F+ +T L + ++ A G+ YL I
Sbjct: 62 CTQKQPIYIVMELVQGGDFLTFL--RTEGPRLKVKELIQMVENAAAGMEYLESKH---CI 116
Query: 565 HRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNTNRVVGTYD-------------GQ 611
HRDL A N L+ + KISDFG+ R +E +G G G+
Sbjct: 117 HRDLAARNCLVTEKNVLKISDFGMSR----EEEDGVYASTGGMKQIPVKWTAPEALNYGR 172
Query: 612 FSIKSDVFSFGILLLEIVS 630
+S +SDV+SFGILL E S
Sbjct: 173 YSSESDVWSFGILLWEAFS 191
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252 |
| >gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Score = 76.2 bits (187), Expect = 5e-15
Identities = 71/227 (31%), Positives = 105/227 (46%), Gaps = 38/227 (16%)
Query: 432 LATIANATDNFSINNKLGEGGFGPVYKGT-LVDGQEIAVKRLSKISEQGLKELKNEV-IL 489
L ++ + TD + I +G+G +G VYK T DG AVK L IS+ +E++ E IL
Sbjct: 14 LESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPISDVD-EEIEAEYNIL 72
Query: 490 FSKLQHRNLVKLLGCCIQ-----GEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRF-- 542
S H N+VK G + G + L+ E S+ + + LL QR
Sbjct: 73 QSLPNHPNVVKFYGMFYKADKLVGGQLWLVLELCNGGSVTELV-----KGLLICGQRLDE 127
Query: 543 ----HIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETE 598
+I+ G GL +LH + RIIHRD+K +N+LL + K+ DFG+
Sbjct: 128 AMISYILYGALLGLQHLHNN---RIIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLR 184
Query: 599 GNTNRVVGT--------------YDGQFSIKSDVFSFGILLLEIVSG 631
NT+ VGT YD + + DV+S GI +E+ G
Sbjct: 185 RNTS--VGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDG 229
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 75.4 bits (186), Expect = 5e-15
Identities = 62/209 (29%), Positives = 94/209 (44%), Gaps = 43/209 (20%)
Query: 451 GGFGPVY----KGTLVDGQEIAVKRLSK---ISEQGLKELKNEVILFSKLQHRNLVKLLG 503
G +G V+ K T G A+K + K I + + ++ E + S+ Q +VKL
Sbjct: 4 GAYGRVFLAKKKST---GDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLY- 59
Query: 504 CCIQGEEKL-LIYEFMPNKSLDSFI-----FDQTRRTLLDWSQRFHIICGTARGLLYLHQ 557
QG++ L L+ E++P L S + D+ D ++ I L YLH
Sbjct: 60 YSFQGKKNLYLVMEYLPGGDLASLLENVGSLDE------DVAR--IYIAEIVLALEYLHS 111
Query: 558 DSRLRIIHRDLKASNVLLDQDMNPKISDFGLV------RTFGGDETEGNTNRVVGTYD-- 609
IIHRDLK N+L+D + + K++DFGL R ++ E R+VGT D
Sbjct: 112 ---NGIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPDYI 168
Query: 610 ------GQ-FSIKSDVFSFGILLLEIVSG 631
GQ S D +S G +L E + G
Sbjct: 169 APEVILGQGHSKTVDWWSLGCILYEFLVG 197
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 75.4 bits (185), Expect = 6e-15
Identities = 59/208 (28%), Positives = 99/208 (47%), Gaps = 27/208 (12%)
Query: 441 NFSINNKLGEGGFGPVYKGT-LVDGQEIAVKRLS---KISEQGLKELKNEVILFSKLQHR 496
NF I K+G G F VY+ T L+DG +A+K++ + + + E+ L +L H
Sbjct: 3 NFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHP 62
Query: 497 NLVKLLGCCIQGEEKLLIYEFMPNKSLDSFI--FDQTRRTLLD---WSQRFHIICGTARG 551
N++K I+ E ++ E L I F + +R + + W + F +C
Sbjct: 63 NVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVW-KYFVQLCSALE- 120
Query: 552 LLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNTNRVVGT---- 607
H SR R++HRD+K +NV + K+ D GL R F T ++ +VGT
Sbjct: 121 ----HMHSR-RVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHS--LVGTPYYM 173
Query: 608 -----YDGQFSIKSDVFSFGILLLEIVS 630
++ ++ KSD++S G LL E+ +
Sbjct: 174 SPERIHENGYNFKSDIWSLGCLLYEMAA 201
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Score = 75.8 bits (186), Expect = 6e-15
Identities = 59/208 (28%), Positives = 99/208 (47%), Gaps = 24/208 (11%)
Query: 437 NATDNFSINNKLGEGGFGPVYKGTLVDGQEIAV-KRLSKISEQGLKELKNEVILFSKLQH 495
N + + I +LG+G FG VYK + +A K + SE+ L++ E+ + + H
Sbjct: 2 NPEEFWEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDH 61
Query: 496 RNLVKLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICG-TARGLLY 554
N+VKLL ++ EF ++D+ + + R + ++C T L Y
Sbjct: 62 PNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERPLT---EPQIRVVCKQTLEALNY 118
Query: 555 LHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNTNRVVGT------- 607
LH++ +IIHRDLKA N+L D + K++DFG+ + T + +GT
Sbjct: 119 LHEN---KIIHRDLKAGNILFTLDGDIKLADFGV--SAKNTRTIQRRDSFIGTPYWMAPE 173
Query: 608 -------YDGQFSIKSDVFSFGILLLEI 628
D + K+DV+S GI L+E+
Sbjct: 174 VVMCETSKDRPYDYKADVWSLGITLIEM 201
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282 |
| >gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Score = 75.5 bits (186), Expect = 7e-15
Identities = 63/210 (30%), Positives = 99/210 (47%), Gaps = 39/210 (18%)
Query: 448 LGEGGFGPVYKGTLVD-GQEIAVKRLSKISEQGLKELKN-----EVILFSKLQHRNLVKL 501
+G G FG V K G +AVKR+ ++ KE K +V++ S +VK
Sbjct: 12 IGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDE--KEQKRLLMDLDVVMRSS-DCPYIVKF 68
Query: 502 LGCCIQGEEKLLIYEFMPNKSLDSF---IFDQTRRTLLDWSQRF--HIICGTARGLLYLH 556
G + + + E M + SLD F +++ + + + I T + L YL
Sbjct: 69 YGALFREGDCWICMELM-DISLDKFYKYVYEVLKSVI---PEEILGKIAVATVKALNYLK 124
Query: 557 QDSRLRIIHRDLKASNVLLDQDMNPKISDFG----LVRTFGGDETEG----------NTN 602
++ L+IIHRD+K SN+LLD++ N K+ DFG LV + G + +
Sbjct: 125 EE--LKIIHRDVKPSNILLDRNGNIKLCDFGISGQLVDSIAKTRDAGCRPYMAPERIDPS 182
Query: 603 RVVGTYDGQFSIKSDVFSFGILLLEIVSGK 632
G YD ++SDV+S GI L E+ +GK
Sbjct: 183 ARDG-YD----VRSDVWSLGITLYEVATGK 207
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288 |
| >gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Score = 75.4 bits (185), Expect = 7e-15
Identities = 73/295 (24%), Positives = 131/295 (44%), Gaps = 46/295 (15%)
Query: 438 ATDNFSINNKLGEGGFGPVYKGT---LVDGQ---EIAVKRLSK-ISEQGLKELKNEVILF 490
+ + ++ +LG+G FG VY+G ++ G+ +AVK +++ S + E NE +
Sbjct: 4 SREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVM 63
Query: 491 SKLQHRNLVKLLGCCIQGEEKLLIYEFMPNKSLDSFIF-------DQTRRTLLDWSQRFH 543
++V+LLG +G+ L++ E M + L S++ + R +
Sbjct: 64 KGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQ 123
Query: 544 IICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNTNR 603
+ A G+ YL+ + +HRDL A N ++ D KI DFG+ R D E + R
Sbjct: 124 MAAEIADGMAYLNAK---KFVHRDLAARNCMVAHDFTVKIGDFGMTR----DIYETDYYR 176
Query: 604 VVGT-------------YDGQFSIKSDVFSFGILLLEIVSGKKNRGFYRSDTKVNLIGHL 650
G DG F+ SD++SFG++L EI S + Y+ + ++ +
Sbjct: 177 KGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQP--YQGLSNEQVLKFV 234
Query: 651 WDEGIPLRLIDACIQDSCNLADVIRCIHIGLLCVQQHPEDRPCMPSVILMLGSEI 705
D G L D C + +L +C Q +P+ RP ++ +L ++
Sbjct: 235 MDGGY-LDQPDNCPERVTDLMR---------MCWQFNPKMRPTFLEIVNLLKDDL 279
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 75.2 bits (185), Expect = 7e-15
Identities = 54/206 (26%), Positives = 102/206 (49%), Gaps = 38/206 (18%)
Query: 448 LGEGGFGPVYKGTLV-DGQEIAVKRLSKISEQG-LKELKNEVILFSKLQH---RNLVKLL 502
+G G +G VY+G V G+ +A+K ++ + + +++ EV L S+L+ N+ K
Sbjct: 9 IGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYY 68
Query: 503 GCCIQGEEKLLIYEFMPNKSLDSFIFDQTRRTLLD---WSQRFHIICGTARGLL----YL 555
G ++G +I E+ S+ RTL+ ++++ I R +L Y+
Sbjct: 69 GSYLKGPRLWIIMEYAEGGSV---------RTLMKAGPIAEKY--ISVIIREVLVALKYI 117
Query: 556 HQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNTNRVVGT-------- 607
H+ +IHRD+KA+N+L+ N K+ DFG+ ++ + VGT
Sbjct: 118 HKVG---VIHRDIKAANILVTNTGNVKLCDFGVAALL--NQNSSKRSTFVGTPYWMAPEV 172
Query: 608 -YDGQ-FSIKSDVFSFGILLLEIVSG 631
+G+ + K+D++S GI + E+ +G
Sbjct: 173 ITEGKYYDTKADIWSLGITIYEMATG 198
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Score = 75.4 bits (185), Expect = 1e-14
Identities = 67/225 (29%), Positives = 108/225 (48%), Gaps = 35/225 (15%)
Query: 438 ATDNFSINNKLGEGGFGPVYKGTLV--DGQE------IAVKRL-SKISEQGLKELKNEVI 488
D + LGEG FG V + D ++ +AVK L S +E+ L +L +E+
Sbjct: 16 PRDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEME 75
Query: 489 LFSKL-QHRNLVKLLGCCIQGEEKLLIYEFMPNKSLDSFI-----------FDQTRRTLL 536
+ + +H+N++ LLG C Q +I E+ +L ++ ++ T+
Sbjct: 76 MMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEE 135
Query: 537 DWSQRFHIICG--TARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGG 594
S + + C ARG+ YL + + IHRDL A NVL+ +D KI+DFGL R
Sbjct: 136 QLSFKDLVSCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHH 192
Query: 595 -DETEGNTNRVV--------GTYDGQFSIKSDVFSFGILLLEIVS 630
D + TN + +D ++ +SDV+SFG+LL EI +
Sbjct: 193 IDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 237
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307 |
| >gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 75.1 bits (184), Expect = 1e-14
Identities = 63/223 (28%), Positives = 105/223 (47%), Gaps = 35/223 (15%)
Query: 440 DNFSINNKLGEGGFGPVYKGTLV--------DGQEIAVKRLS-KISEQGLKELKNEVILF 490
D ++ LGEG FG V + + +AVK L +E+ L +L +E+ +
Sbjct: 15 DKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMM 74
Query: 491 SKL-QHRNLVKLLGCCIQGEEKLLIYEFMPNKSLDSFI-----------FDQTRRTLLDW 538
+ +H+N++ LLG C Q +I E+ +L ++ +D R
Sbjct: 75 KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQM 134
Query: 539 SQRFHIICG--TARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGG-D 595
+ + + C ARG+ YL + + IHRDL A NVL+ ++ KI+DFGL R D
Sbjct: 135 TFKDLVSCTYQVARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDVNNID 191
Query: 596 ETEGNTNRVV--------GTYDGQFSIKSDVFSFGILLLEIVS 630
+ TN + +D ++ +SDV+SFG+L+ EI +
Sbjct: 192 YYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 234
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304 |
| >gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Score = 74.2 bits (182), Expect = 1e-14
Identities = 60/203 (29%), Positives = 101/203 (49%), Gaps = 23/203 (11%)
Query: 447 KLGEGGFGPVYKGT--LVDGQ-EIAVKRLSKISEQGLK-ELKNEVILFSKLQHRNLVKLL 502
+LG G FG V KG + Q ++A+K L +E+ ++ E+ E + +L + +V+++
Sbjct: 2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMI 61
Query: 503 GCCIQGEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLR 562
G C + E +L+ E L+ F+ ++ + S ++ + G+ YL +
Sbjct: 62 GVC-EAEALMLVMEMASGGPLNKFL--SGKKDEITVSNVVELMHQVSMGMKYLEGKN--- 115
Query: 563 IIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNTNRVVGTYD-----------GQ 611
+HRDL A NVLL KISDFGL + G D++ R G + +
Sbjct: 116 FVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSY-YKARSAGKWPLKWYAPECINFRK 174
Query: 612 FSIKSDVFSFGILLLEIVS-GKK 633
FS +SDV+S+GI + E S G+K
Sbjct: 175 FSSRSDVWSYGITMWEAFSYGQK 197
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 73.7 bits (181), Expect = 2e-14
Identities = 55/202 (27%), Positives = 98/202 (48%), Gaps = 26/202 (12%)
Query: 448 LGEGGFGPVY------KGTLVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKL 501
+G G FG V+ LV ++I V++++K + NE + L H N+++
Sbjct: 8 VGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQ---NECQVLKLLSHPNIIEY 64
Query: 502 LGCCIQGEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRL 561
++ + +++ E+ P +L +I + +LLD H L ++H
Sbjct: 65 YENFLEDKALMIVMEYAPGGTLAEYIQKR-CNSLLDEDTILHFFVQILLALHHVHTKL-- 121
Query: 562 RIIHRDLKASNVLLDQ-DMNPKISDFGLVRTFGGDETEGNTNRVVGT--Y------DGQ- 611
I+HRDLK N+LLD+ M KI DFG+ + ++ VVGT Y +G+
Sbjct: 122 -ILHRDLKTQNILLDKHKMVVKIGDFGISKILS---SKSKAYTVVGTPCYISPELCEGKP 177
Query: 612 FSIKSDVFSFGILLLEIVSGKK 633
++ KSD+++ G +L E+ S K+
Sbjct: 178 YNQKSDIWALGCVLYELASLKR 199
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Score = 74.3 bits (182), Expect = 2e-14
Identities = 68/218 (31%), Positives = 103/218 (47%), Gaps = 33/218 (15%)
Query: 440 DNFSINNKLGEGGFGPVYKGTLV-DGQEI--AVKRLSKI-SEQGLKELKNEVILFSKL-Q 494
++ + +GEG FG V + + DG ++ A+K L + SE ++ E+ + KL
Sbjct: 2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGH 61
Query: 495 HRNLVKLLGCCIQGEEKLLIYEFMPNKSL-------------DSFIFDQTRRTLLDWSQR 541
H N++ LLG C + E+ P +L +F + + L Q
Sbjct: 62 HPNIINLLGACENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQL 121
Query: 542 FHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDE----- 596
A G+ YL S + IHRDL A NVL+ +++ KI+DFGL R G+E
Sbjct: 122 LQFASDVATGMQYL---SEKQFIHRDLAARNVLVGENLASKIADFGLSR---GEEVYVKK 175
Query: 597 TEGNTN-RVVGTYDGQFSI---KSDVFSFGILLLEIVS 630
T G R + +S+ KSDV+SFG+LL EIVS
Sbjct: 176 TMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVS 213
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 74.1 bits (183), Expect = 2e-14
Identities = 46/151 (30%), Positives = 72/151 (47%), Gaps = 16/151 (10%)
Query: 447 KLGEGGFGPVYKGTLVDGQEI-AVKR----LSKISE-QGLKELKNEVILFSKLQ-HRNLV 499
+LG+G FG VY + E+ A+K+ E L+E+K+ KL H N+V
Sbjct: 6 QLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKS----LRKLNEHPNIV 61
Query: 500 KLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDS 559
KL + +E ++E+M +L + D+ + S II +GL ++H
Sbjct: 62 KLKEVFRENDELYFVFEYM-EGNLYQLMKDRKGK-PFSESVIRSIIYQILQGLAHIH--- 116
Query: 560 RLRIIHRDLKASNVLLDQDMNPKISDFGLVR 590
+ HRDLK N+L+ KI+DFGL R
Sbjct: 117 KHGFFHRDLKPENLLVSGPEVVKIADFGLAR 147
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 73.7 bits (181), Expect = 3e-14
Identities = 62/203 (30%), Positives = 91/203 (44%), Gaps = 30/203 (14%)
Query: 448 LGEGGFGPVYKGTLVD-GQEIAVKRLSKI---SEQGLKELKNEVILFSKLQHRNLVKLLG 503
LG+GGFG V + G+ A K+L K +G + NE + K+ R +V L
Sbjct: 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSL-A 59
Query: 504 CCIQGEEKL-LIYEFMPNKSLDSFIFDQTRRTLLDWSQRFH---IICGTARGLLYLHQDS 559
+ ++ L L+ M L I++ + F+ IICG L +LHQ
Sbjct: 60 YAFETKDDLCLVMTLMNGGDLKYHIYNVGEPGFPEARAIFYAAQIICG----LEHLHQ-- 113
Query: 560 RLRIIHRDLKASNVLLDQDMNPKISDFGL-VRTFGGDETEGNTNRVVGTY---------D 609
RI++RDLK NVLLD N +ISD GL V GG + +G GT
Sbjct: 114 -RRIVYRDLKPENVLLDDHGNVRISDLGLAVELKGGKKIKGR----AGTPGYMAPEVLQG 168
Query: 610 GQFSIKSDVFSFGILLLEIVSGK 632
+ D F+ G L E+++G+
Sbjct: 169 EVYDFSVDWFALGCTLYEMIAGR 191
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 73.1 bits (180), Expect = 3e-14
Identities = 61/218 (27%), Positives = 95/218 (43%), Gaps = 49/218 (22%)
Query: 446 NKLGEGGFGPVYKG-TLVDGQEIAVK--RLSKISEQGLKELKNEVILFSKLQHRNLVKLL 502
NK+G G FG VY L G+ +AVK R+ + +KE+ +E+ + L+H NLVK
Sbjct: 6 NKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYY 65
Query: 503 GCCIQGEEKLLIYEFMPNKSLDSF-----IFDQ--TRR---TLLDWSQRFHIICGTARGL 552
G + E+ + E+ +L+ I D+ R LL GL
Sbjct: 66 GVEVHREKVYIFMEYCSGGTLEELLEHGRILDEHVIRVYTLQLL-------------EGL 112
Query: 553 LYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFG----LVRTFGGDETEGNTNRVVGT- 607
YLH I+HRD+K +N+ LD + K+ DFG L E + + GT
Sbjct: 113 AYLHSH---GIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEEVQS--LAGTP 167
Query: 608 ------------YDGQFSIKSDVFSFGILLLEIVSGKK 633
G +D++S G ++LE+ +GK+
Sbjct: 168 AYMAPEVITGGKGKGHGR-AADIWSLGCVVLEMATGKR 204
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 74.1 bits (183), Expect = 4e-14
Identities = 56/225 (24%), Positives = 96/225 (42%), Gaps = 56/225 (24%)
Query: 442 FSINNKLGEGGFGPVYKGT-LVDGQEIAVKRLSKISEQGLKELKN---EVILFSKLQHRN 497
+ + +G G +G V G+++A+K++S + L + K E+ L L+H N
Sbjct: 2 YELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNV-FDDLIDAKRILREIKLLRHLRHEN 60
Query: 498 LVKLLGCCIQGEEKLLIYEFMPNKSLDSF-----IFD----------QTRRTLLDWSQRF 542
++ LL + + S + F + + ++ + L D ++
Sbjct: 61 IIGLL-------------DILRPPSPEDFNDVYIVTELMETDLHKVIKSPQPLTDDHIQY 107
Query: 543 HIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGN-- 600
+ RGL YLH +IHRDLK SN+L++ + + KI DFGL R DE E
Sbjct: 108 -FLYQILRGLKYLH---SANVIHRDLKPSNILVNSNCDLKICDFGLARGVDPDEDEKGFL 163
Query: 601 TNRVV-------------GTYDGQFSIKSDVFSFGILLLEIVSGK 632
T VV Y +I D++S G + E+++ K
Sbjct: 164 TEYVVTRWYRAPELLLSSSRYT--KAI--DIWSVGCIFAELLTRK 204
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 73.6 bits (180), Expect = 4e-14
Identities = 56/201 (27%), Positives = 96/201 (47%), Gaps = 16/201 (7%)
Query: 442 FSINNKLGEGGFGPVYKGTLVDGQEI-AVKRLS---KISEQGLKELKNEVILFSKLQHRN 497
F+ ++G G FG VY V E+ A+K++S K S + +++ EV +++H N
Sbjct: 27 FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPN 86
Query: 498 LVKLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQ 557
++ GC ++ L+ E+ + D + + L + I G +GL YLH
Sbjct: 87 SIEYKGCYLREHTAWLVMEYCLGSASDLL---EVHKKPLQEVEIAAITHGALQGLAYLHS 143
Query: 558 DSRLRIIHRDLKASNVLLDQDMNPKISDFGL------VRTFGGDETEGNTNRVVGTYDGQ 611
+ +IHRD+KA N+LL + K++DFG +F G ++ +GQ
Sbjct: 144 HN---MIHRDIKAGNILLTEPGQVKLADFGSASIASPANSFVGTPYWMAPEVILAMDEGQ 200
Query: 612 FSIKSDVFSFGILLLEIVSGK 632
+ K DV+S GI +E+ K
Sbjct: 201 YDGKVDVWSLGITCIELAERK 221
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Score = 73.5 bits (180), Expect = 4e-14
Identities = 56/197 (28%), Positives = 95/197 (48%), Gaps = 16/197 (8%)
Query: 446 NKLGEGGFGPVYKGTLVDGQEI-AVKRLS---KISEQGLKELKNEVILFSKLQHRNLVKL 501
+++G G FG VY T E+ AVK++S K + + +++ EV +L+H N ++
Sbjct: 27 HEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEY 86
Query: 502 LGCCIQGEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRL 561
GC ++ L+ E+ + D + + L + I G +GL YLH +
Sbjct: 87 KGCYLKEHTAWLVMEYCLGSASDLL---EVHKKPLQEVEIAAITHGALQGLAYLHSHN-- 141
Query: 562 RIIHRDLKASNVLLDQDMNPKISDFGL------VRTFGGDETEGNTNRVVGTYDGQFSIK 615
+IHRD+KA N+LL + K++DFG +F G ++ +GQ+ K
Sbjct: 142 -MIHRDIKAGNILLTEPGQVKLADFGSASKSSPANSFVGTPYWMAPEVILAMDEGQYDGK 200
Query: 616 SDVFSFGILLLEIVSGK 632
DV+S GI +E+ K
Sbjct: 201 VDVWSLGITCIELAERK 217
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 73.6 bits (181), Expect = 4e-14
Identities = 59/170 (34%), Positives = 86/170 (50%), Gaps = 35/170 (20%)
Query: 441 NFSINNKLGEGGFGPVYKG-TLVDGQEIAVKRLSKISEQG---LKELKNEVILFSKLQHR 496
F N++GEG +G VY+ G+ +A+K++ +E+ + L+ E+ L L+H
Sbjct: 8 EFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLR-EITLLLNLRHP 66
Query: 497 NLVKLLGCCIQGEEKLLIYEFMPNKSLDSFIF------DQTRRTLLD-------WSQRFH 543
N+V+L E + K LDS IF +Q +LLD SQ
Sbjct: 67 NIVELK-------------EVVVGKHLDS-IFLVMEYCEQDLASLLDNMPTPFSESQVKC 112
Query: 544 IICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFG 593
++ RGL YLH++ IIHRDLK SN+LL KI+DFGL RT+G
Sbjct: 113 LMLQLLRGLQYLHENF---IIHRDLKVSNLLLTDKGCLKIADFGLARTYG 159
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Score = 73.2 bits (179), Expect = 5e-14
Identities = 67/261 (25%), Positives = 115/261 (44%), Gaps = 28/261 (10%)
Query: 442 FSINNKLGEGGFGPVYKGTLVDGQEI-AVKRLS---KISEQGLKELKNEVILFSKLQHRN 497
FS ++G G FG VY V E+ A+K++S K S + +++ EV KL+H N
Sbjct: 17 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPN 76
Query: 498 LVKLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQ 557
++ GC ++ L+ E+ + D + + L + + G +GL YLH
Sbjct: 77 TIQYRGCYLREHTAWLVMEYCLGSASDLL---EVHKKPLQEVEIAAVTHGALQGLAYLHS 133
Query: 558 DSRLRIIHRDLKASNVLLDQDMNPKISDFGL------VRTFGGDETEGNTNRVVGTYDGQ 611
+ +IHRD+KA N+LL + K+ DFG F G ++ +GQ
Sbjct: 134 HN---MIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANXFVGTPYWMAPEVILAMDEGQ 190
Query: 612 FSIKSDVFSFGILLLEIVSGKKNRGFYRSDTKVNLIGHLWDEGIPLRLIDACIQDSCNLA 671
+ K DV+S GI +E+ ++ + + ++ + H+ P + N
Sbjct: 191 YDGKVDVWSLGITCIEL--AERKPPLFNMNA-MSALYHIAQNESPALQSGHWSEYFRNFV 247
Query: 672 DVIRCIHIGLLCVQQHPEDRP 692
D C+Q+ P+DRP
Sbjct: 248 DS---------CLQKIPQDRP 259
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308 |
| >gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Score = 73.0 bits (179), Expect = 5e-14
Identities = 60/230 (26%), Positives = 103/230 (44%), Gaps = 46/230 (20%)
Query: 440 DNFSINNKLGEGGFGPVY------------KGTLVDGQE-----IAVKRL-SKISEQGLK 481
+ KLGEG FG V+ K +D +AVK L ++
Sbjct: 5 KRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARN 64
Query: 482 ELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMPNKSLDSFI--------FDQTRR 533
+ E+ + S+L+ N+++LL CI + +I E+M N L+ F+ ++
Sbjct: 65 DFLKEIKIMSRLKDPNIIRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADV 124
Query: 534 TLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFG 593
+ +S + A G+ YL S L +HRDL N L+ ++ KI+DFG+ R
Sbjct: 125 VTISYSTLIFMATQIASGMKYL---SSLNFVHRDLATRNCLVGKNYTIKIADFGMSRNL- 180
Query: 594 GDETEGNTNRVVG---------TYD----GQFSIKSDVFSFGILLLEIVS 630
G+ R+ G +++ G+F+ SDV++FG+ L EI++
Sbjct: 181 ---YSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILT 227
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 72.4 bits (177), Expect = 6e-14
Identities = 53/202 (26%), Positives = 101/202 (50%), Gaps = 20/202 (9%)
Query: 442 FSINNKLGEGGFGPVYKGTLVDGQEIAVKRLSKI--SEQGLKELKNEVILFSKLQHRNLV 499
F+ ++G+G FG VYKG +E+ ++ + +E +++++ E+ + S+ +
Sbjct: 6 FTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYIT 65
Query: 500 KLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDS 559
+ G ++G + +I E++ S D + L+ + I+ +GL YLH +
Sbjct: 66 RYYGSYLKGTKLWIIMEYLGGGS----ALDLLKPGPLEETYIATILREILKGLDYLHSE- 120
Query: 560 RLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNTNRVVGT---------YDG 610
R IHRD+KA+NVLL + + K++DFG+ +T+ N VGT
Sbjct: 121 --RKIHRDIKAANVLLSEQGDVKLADFGVAGQL--TDTQIKRNTFVGTPFWMAPEVIKQS 176
Query: 611 QFSIKSDVFSFGILLLEIVSGK 632
+ K+D++S GI +E+ G+
Sbjct: 177 AYDFKADIWSLGITAIELAKGE 198
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Score = 72.5 bits (178), Expect = 7e-14
Identities = 65/210 (30%), Positives = 104/210 (49%), Gaps = 27/210 (12%)
Query: 440 DNFSINNKLGEGGFGPVYKGT-LVDGQEIAVK--RLSKISEQGLKELKNEVILFSKLQHR 496
D + K+GEG +G VYK V + IA+K RL + E E+ L ++QH
Sbjct: 2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHG 61
Query: 497 NLVKLLGCCIQGEEKL-LIYEFMP---NKSLDSFIFDQTRRTLLDWSQRFHIICGTARGL 552
N+V+L + E++L L++E++ K +DS D + L + + I+ RG+
Sbjct: 62 NIVRLQDV-VHSEKRLYLVFEYLDLDLKKHMDSSP-DFAKNPRLIKTYLYQIL----RGI 115
Query: 553 LYLHQDSRLRIIHRDLKASNVLLDQDMNP-KISDFGLVRTFGGDETEGNTNRVVGTY--- 608
Y H R++HRDLK N+L+D+ N K++DFGL R F G T+ VV +
Sbjct: 116 AYCHSH---RVLHRDLKPQNLLIDRRTNALKLADFGLARAF-GIPVRTFTHEVVTLWYRA 171
Query: 609 ------DGQFSIKSDVFSFGILLLEIVSGK 632
+S D++S G + E+V+ K
Sbjct: 172 PEILLGSRHYSTPVDIWSVGCIFAEMVNQK 201
|
Length = 294 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 72.4 bits (177), Expect = 8e-14
Identities = 57/203 (28%), Positives = 98/203 (48%), Gaps = 22/203 (10%)
Query: 440 DNFSINNKLGEGGFGPVYKGTL-VDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNL 498
DNF K+GEG G V T+ G+ +AVK++ +Q + L NEV++ QH N+
Sbjct: 23 DNFI---KIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENV 79
Query: 499 VKLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQD 558
V++ + G+E ++ EF+ +L D T ++ Q + + L LH
Sbjct: 80 VEMYNSYLVGDELWVVMEFLEGGALT----DIVTHTRMNEEQIAAVCLAVLKALSVLHAQ 135
Query: 559 SRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNTNRVVGT---------YD 609
+IHRD+K+ ++LL D K+SDFG + + +VGT
Sbjct: 136 G---VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKS--LVGTPYWMAPELISR 190
Query: 610 GQFSIKSDVFSFGILLLEIVSGK 632
+ + D++S GI+++E+V G+
Sbjct: 191 LPYGPEVDIWSLGIMVIEMVDGE 213
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 72.1 bits (177), Expect = 9e-14
Identities = 57/201 (28%), Positives = 92/201 (45%), Gaps = 30/201 (14%)
Query: 448 LGEGGFGPVYK------GTLVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKL 501
LG G G V K GT++ + + + S + +Q L+EL+ + + + +V
Sbjct: 13 LGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQ----IMHECRSPYIVSF 68
Query: 502 LGCCIQGEEKLLIYEFMPNKSLDSFI--FDQTRRTLLDWSQRFHIICGTARGLLYLHQDS 559
G + + EFM SLD +L I GL YL+ +
Sbjct: 69 YGAFLNENNICMCMEFMDCGSLDRIYKKGGPIPVEILG-----KIAVAVVEGLTYLY--N 121
Query: 560 RLRIIHRDLKASNVLLDQDMNPKISDFG--------LVRTFGGDETEGNTNRVVGTYDGQ 611
RI+HRD+K SN+L++ K+ DFG + TF G T + R+ G G+
Sbjct: 122 VHRIMHRDIKPSNILVNSRGQIKLCDFGVSGELINSIADTFVGTSTYMSPERIQG---GK 178
Query: 612 FSIKSDVFSFGILLLEIVSGK 632
+++KSDV+S GI ++E+ GK
Sbjct: 179 YTVKSDVWSLGISIIELALGK 199
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Score = 71.5 bits (175), Expect = 9e-14
Identities = 64/210 (30%), Positives = 97/210 (46%), Gaps = 36/210 (17%)
Query: 442 FSINNKLGEGGFGPVYKGTLVDGQEIAVKRLSKISEQGLKELK-NEVI-------LFSKL 493
+ + +LG+G FG VY + D + +A +RL + E + EL NE + L SKL
Sbjct: 2 YILQQRLGKGSFGTVY--LVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKL 59
Query: 494 QHRNLVKLLGCCIQGEEKLLIYEFMPNKSLDSFI--FDQTRRTLLDWSQRFHIICGTARG 551
H +VK ++ + +I E+ + LD + T +TL + +Q G
Sbjct: 60 DHPAIVKFHASFLERDAFCIITEYCEGRDLDCKLEELKHTGKTLSE-NQVCEWFIQLLLG 118
Query: 552 LLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNTNRVVGT---- 607
+ Y+HQ RI+HRDLKA N+ L ++ KI DFG+ R G T GT
Sbjct: 119 VHYMHQR---RILHRDLKAKNIFLKNNL-LKIGDFGVSRLLMGSCDLATT--FTGTPYYM 172
Query: 608 ---------YDGQFSIKSDVFSFGILLLEI 628
YD KSD++S G +L E+
Sbjct: 173 SPEALKHQGYDS----KSDIWSLGCILYEM 198
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 72.4 bits (177), Expect = 1e-13
Identities = 54/196 (27%), Positives = 95/196 (48%), Gaps = 19/196 (9%)
Query: 447 KLGEGGFGPVYKGTLV-DGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCC 505
K+GEG G V T G+++AVK++ +Q + L NEV++ H N+V +
Sbjct: 29 KIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSY 88
Query: 506 IQGEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIH 565
+ G+E ++ EF+ +L D T ++ Q + R L YLH +IH
Sbjct: 89 LVGDELWVVMEFLEGGALT----DIVTHTRMNEEQIATVCLSVLRALSYLHNQG---VIH 141
Query: 566 RDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNTNRVVGT---------YDGQFSIKS 616
RD+K+ ++LL D K+SDFG + + + +VGT + +
Sbjct: 142 RDIKSDSILLTSDGRIKLSDFGFCAQVSKEVPKRKS--LVGTPYWMAPEVISRLPYGTEV 199
Query: 617 DVFSFGILLLEIVSGK 632
D++S GI+++E++ G+
Sbjct: 200 DIWSLGIMVIEMIDGE 215
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Score = 71.9 bits (176), Expect = 1e-13
Identities = 55/198 (27%), Positives = 97/198 (48%), Gaps = 21/198 (10%)
Query: 448 LGEGGFGPVYKGTLV-DGQEI----AVKRL-SKISEQGLKELKNEVILFSKLQHRNLVKL 501
LG G FG V+KG + +G I A+K + + Q +E+ + ++ L H +V+L
Sbjct: 15 LGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRL 74
Query: 502 LGCCIQGEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRL 561
LG C G L+ + P SL + + R LD + + A+G+ YL +
Sbjct: 75 LGIC-PGASLQLVTQLSPLGSLLDHV--RQHRDSLDPQRLLNWCVQIAKGMYYLEEH--- 128
Query: 562 RIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNTNRVVGTYD---------GQF 612
R++HR+L A N+LL D +I+DFG+ D+ + + G++
Sbjct: 129 RMVHRNLAARNILLKSDSIVQIADFGVADLLYPDDKKYFYSEHKTPIKWMALESILFGRY 188
Query: 613 SIKSDVFSFGILLLEIVS 630
+ +SDV+S+G+ + E++S
Sbjct: 189 THQSDVWSYGVTVWEMMS 206
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 71.6 bits (175), Expect = 1e-13
Identities = 55/202 (27%), Positives = 102/202 (50%), Gaps = 20/202 (9%)
Query: 442 FSINNKLGEGGFGPVYKGTLVDGQEI-AVKRLS-KISEQGLKELKNEVILFSKLQHRNLV 499
F+ ++G+G FG V+KG Q++ A+K + + +E +++++ E+ + S+ +
Sbjct: 6 FTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVT 65
Query: 500 KLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDS 559
K G ++G + +I E++ S D R D Q ++ +GL YLH +
Sbjct: 66 KYYGSYLKGTKLWIIMEYLGGGS----ALDLLRAGPFDEFQIATMLKEILKGLDYLHSEK 121
Query: 560 RLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNTNRVVGT---------YDG 610
+ IHRD+KA+NVLL + + K++DFG+ +T+ N VGT
Sbjct: 122 K---IHRDIKAANVLLSEQGDVKLADFGVAGQL--TDTQIKRNTFVGTPFWMAPEVIQQS 176
Query: 611 QFSIKSDVFSFGILLLEIVSGK 632
+ K+D++S GI +E+ G+
Sbjct: 177 AYDSKADIWSLGITAIELAKGE 198
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 71.6 bits (175), Expect = 1e-13
Identities = 68/210 (32%), Positives = 101/210 (48%), Gaps = 33/210 (15%)
Query: 448 LGEGGFGPVYKGTLV-DGQEI--AVKRLSK-ISEQGLKELKNEVILFSKL-QHRNLVKLL 502
+GEG FG V K + DG + A+KR+ + S+ ++ E+ + KL H N++ LL
Sbjct: 3 IGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLL 62
Query: 503 GCCIQGEEKLLIYEFMPNKSL-------------DSFIFDQTRRTLLDWSQRFHIICGTA 549
G C L E+ P+ +L +F + + L Q H A
Sbjct: 63 GACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVA 122
Query: 550 RGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDE-----TEGNTN-R 603
RG+ YL S+ + IHRDL A N+L+ ++ KI+DFGL R G E T G R
Sbjct: 123 RGMDYL---SQKQFIHRDLAARNILVGENYVAKIADFGLSR---GQEVYVKKTMGRLPVR 176
Query: 604 VVGTYDGQFSI---KSDVFSFGILLLEIVS 630
+ +S+ SDV+S+G+LL EIVS
Sbjct: 177 WMAIESLNYSVYTTNSDVWSYGVLLWEIVS 206
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 71.3 bits (174), Expect = 2e-13
Identities = 54/202 (26%), Positives = 99/202 (49%), Gaps = 20/202 (9%)
Query: 442 FSINNKLGEGGFGPVYKGTLVDGQEIAVKRLSKI--SEQGLKELKNEVILFSKLQHRNLV 499
F+ K+G+G FG V+KG Q++ ++ + +E +++++ E+ + S+ +
Sbjct: 6 FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVT 65
Query: 500 KLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDS 559
K G ++ + +I E++ S D LD +Q I+ +GL YLH +
Sbjct: 66 KYYGSYLKDTKLWIIMEYLGGGS----ALDLLEPGPLDETQIATILREILKGLDYLHSEK 121
Query: 560 RLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNTNRVVGT---------YDG 610
+ IHRD+KA+NVLL + K++DFG+ +T+ N VGT
Sbjct: 122 K---IHRDIKAANVLLSEHGEVKLADFGVAGQL--TDTQIKRNTFVGTPFWMAPEVIKQS 176
Query: 611 QFSIKSDVFSFGILLLEIVSGK 632
+ K+D++S GI +E+ G+
Sbjct: 177 AYDSKADIWSLGITAIELAKGE 198
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Score = 70.7 bits (173), Expect = 2e-13
Identities = 61/207 (29%), Positives = 97/207 (46%), Gaps = 22/207 (10%)
Query: 440 DNFSIN--NKLGEGGFGPVYKG--TLVDGQE--IAVKRL-SKISEQGLKELKNEVILFSK 492
DN SI LG G FG + +G L +E +A+ L + S++ + E + +
Sbjct: 3 DNKSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQ 62
Query: 493 LQHRNLVKLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGL 552
H N+V+L G +G +++ E+M N +LDSF+ + L Q ++ G A G+
Sbjct: 63 FDHSNIVRLEGVITRGNTMMIVTEYMSNGALDSFL--RKHEGQLVAGQLMGMLPGLASGM 120
Query: 553 LYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFG---------LVRTFGGDETEGNTNR 603
YL S + +H+ L A VL++ D+ KIS F + T G
Sbjct: 121 KYL---SEMGYVHKGLAAHKVLVNSDLVCKISGFRRLQEDKSEAIYTTMSGKSPVLWAAP 177
Query: 604 VVGTYDGQFSIKSDVFSFGILLLEIVS 630
Y FS SDV+SFGI++ E++S
Sbjct: 178 EAIQY-HHFSSASDVWSFGIVMWEVMS 203
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 71.6 bits (175), Expect = 2e-13
Identities = 62/221 (28%), Positives = 104/221 (47%), Gaps = 35/221 (15%)
Query: 442 FSINNKLGEGGFGPVYKGTLVDGQE--------IAVKRLSK-ISEQGLKELKNEVILFSK 492
++ LGEG FG V + + +AVK L +++ L +L +E+ +
Sbjct: 14 LTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKM 73
Query: 493 L-QHRNLVKLLGCCIQGEEKLLIYEFMPNKSLDSFI-----------FDQTRRTLLDWSQ 540
+ +H+N++ LLG C Q ++ E+ +L ++ FD + +
Sbjct: 74 IGKHKNIINLLGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTF 133
Query: 541 RFHIICG--TARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGG-DET 597
+ + C ARG+ YL + + IHRDL A NVL+ +D KI+DFGL R D
Sbjct: 134 KDLVSCAYQVARGMEYL---ASQKCIHRDLAARNVLVTEDNVMKIADFGLARDVHNIDYY 190
Query: 598 EGNTNRVV--------GTYDGQFSIKSDVFSFGILLLEIVS 630
+ TN + +D ++ +SDV+SFG+LL EI +
Sbjct: 191 KKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFT 231
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334 |
| >gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Score = 70.5 bits (173), Expect = 3e-13
Identities = 54/215 (25%), Positives = 90/215 (41%), Gaps = 34/215 (15%)
Query: 440 DNFSINNKLGEGGFGPVYKGTLVDGQ----EIAVKRLSKISEQGLKEL-KNEVILFSKLQ 494
++ ++ +GEG FG VY+G + + +AVK + ++E E + +
Sbjct: 6 EDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFD 65
Query: 495 HRNLVKLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLY 554
H ++VKL+G + ++ E P L S++ Q + LD + + L Y
Sbjct: 66 HPHIVKLIGVITE-NPVWIVMELAPLGELRSYL--QVNKYSLDLASLILYSYQLSTALAY 122
Query: 555 LHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDE---------------TEG 599
L R +HRD+ A NVL+ K+ DFGL R + E
Sbjct: 123 LES---KRFVHRDIAARNVLVSSPDCVKLGDFGLSRYLEDESYYKASKGKLPIKWMAPES 179
Query: 600 NTNRVVGTYDGQFSIKSDVFSFGILLLEIVS-GKK 633
R +F+ SDV+ FG+ + EI+ G K
Sbjct: 180 INFR-------RFTSASDVWMFGVCMWEILMLGVK 207
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 70.3 bits (172), Expect = 3e-13
Identities = 71/274 (25%), Positives = 119/274 (43%), Gaps = 54/274 (19%)
Query: 448 LGEGGFGPVYK------GTLVDGQEIAVKRLSKISEQG--LKELKNEVILFSKLQHRNLV 499
LG G F Y+ GTL+ +++ R + SEQ ++ L+ E+ L ++L H +++
Sbjct: 8 LGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTS-SEQEEVVEALRKEIRLMARLNHPHII 66
Query: 500 KLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDS 559
++LG + L E+M S+ + + RGL YLH++
Sbjct: 67 RMLGATCEDSHFNLFVEWMAGGSVSHLLSKYGAFKEAVIINYTEQLL---RGLSYLHEN- 122
Query: 560 RLRIIHRDLKASNVLLD---QDMNPKISDFGLVRTF-----GGDETEGNTNRVVGTYD-- 609
+IIHRD+K +N+L+D Q + +I+DFG G E +G +++GT
Sbjct: 123 --QIIHRDVKGANLLIDSTGQRL--RIADFGAAARLAAKGTGAGEFQG---QLLGTIAFM 175
Query: 610 -------GQFSIKSDVFSFGILLLEIVSGKKNRGFYRSDTKVNLIGHLWDE----GIPLR 658
Q+ DV+S G +++E+ + K + + LI + IP
Sbjct: 176 APEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLALIFKIASATTAPSIPEH 235
Query: 659 LIDACIQDSCNLADVIRCIHIGLLCVQQHPEDRP 692
L S L DV L C++ PEDRP
Sbjct: 236 L-------SPGLRDVT------LRCLELQPEDRP 256
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 70.9 bits (174), Expect = 3e-13
Identities = 58/207 (28%), Positives = 87/207 (42%), Gaps = 32/207 (15%)
Query: 442 FSINNKLGEGGFGPVYKGTLVDGQEI-AVKRLSKISEQGLKE---LKNEVILFSKLQHRN 497
F I ++G+GG+G V+ D EI A+KR+ K L E + E + + +
Sbjct: 3 FQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEW 62
Query: 498 LVKLLGCCIQGEEKL-LIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHI---ICGTARGLL 553
LVKLL Q +E L L E++P + + L + RF++
Sbjct: 63 LVKLL-YAFQDDEYLYLAMEYVPGGDFRTLL--NNLGVLSEDHARFYMAEMFEAVDA--- 116
Query: 554 YLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNTNRVVGT------ 607
LH L IHRDLK N L+D + K++DFGL + N VVG+
Sbjct: 117 -LH---ELGYIHRDLKPENFLIDASGHIKLTDFGLSK-----GIVTYANSVVGSPDYMAP 167
Query: 608 ---YDGQFSIKSDVFSFGILLLEIVSG 631
+ D +S G +L E + G
Sbjct: 168 EVLRGKGYDFTVDYWSLGCMLYEFLCG 194
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 69.7 bits (171), Expect = 5e-13
Identities = 57/207 (27%), Positives = 98/207 (47%), Gaps = 39/207 (18%)
Query: 447 KLGEGGFGPVYKGTLVD-GQEIAVKRLSKISEQGLKELKN----EVILFSKLQHRNLVKL 501
+GEG +G V K + GQ +A+K+ + + K +K E+ + +L+H NLV L
Sbjct: 8 LVGEGSYGMVMKCKHKETGQIVAIKKFLESEDD--KMVKKIAMREIRMLKQLRHENLVNL 65
Query: 502 LGCCIQGEEKLLIYEFMPNKSLDSFI-------FDQTRRTLLDWSQRFHIICGTARGLLY 554
+ + + L++EF+ + LD + R+ L F I+ RG+ +
Sbjct: 66 IEVFRRKKRLYLVFEFVDHTVLDDLEKYPNGLDESRVRKYL------FQIL----RGIEF 115
Query: 555 LHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTF---GGDETEGNTNR-------V 604
H + IIHRD+K N+L+ Q K+ DFG RT G T+ R +
Sbjct: 116 CHSHN---IIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYTDYVATRWYRAPELL 172
Query: 605 VGTYDGQFSIKSDVFSFGILLLEIVSG 631
VG D ++ D+++ G L+ E+++G
Sbjct: 173 VG--DTKYGRAVDIWAVGCLVTEMLTG 197
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 70.7 bits (173), Expect = 6e-13
Identities = 56/226 (24%), Positives = 102/226 (45%), Gaps = 21/226 (9%)
Query: 413 ETDQENEDQNIDLELPLFELATIANATDNFSINNKLGEGGFGPVYKGTLVDGQEIAVKRL 472
++ E++D + D +P + A A+ +++ L G G V+ T GQ V +
Sbjct: 39 DSASESDDDDDDGLIPTKQKAREVVASLGYTVIKTLTPGSEGRVFVAT-KPGQPDPV--V 95
Query: 473 SKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQTR 532
KI ++G + E +L + H +++++ + G ++ +P+ S D + + R
Sbjct: 96 LKIGQKGTTLI--EAMLLQNVNHPSVIRMKDTLVSGAITCMV---LPHYSSDLYTYLTKR 150
Query: 533 RTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVR-- 590
L Q I GL YLH RIIHRD+K N+ ++ I D G +
Sbjct: 151 SRPLPIDQALIIEKQILEGLRYLHA---QRIIHRDVKTENIFINDVDQVCIGDLGAAQFP 207
Query: 591 ----TFGG--DETEGNTNRVVGTYDGQFSIKSDVFSFGILLLEIVS 630
F G E N V+ +++ K+D++S GI+L E+++
Sbjct: 208 VVAPAFLGLAGTVETNAPEVLAR--DKYNSKADIWSAGIVLFEMLA 251
|
Length = 357 |
| >gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Score = 69.0 bits (169), Expect = 9e-13
Identities = 60/218 (27%), Positives = 99/218 (45%), Gaps = 39/218 (17%)
Query: 440 DNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRL-SKISEQGLKELKNEV-ILFSKLQHR 496
D+ + +LG G +G V K V G +AVKR+ + ++ Q K L ++ I +
Sbjct: 1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCP 60
Query: 497 NLVKLLGCCIQGEEKLLIYEFMPNKSLDSF---IFDQTRRTLLDWSQRFHIICGTARGLL 553
V G + + + E M + SLD F ++D+ D + I + L
Sbjct: 61 YTVTFYGALFREGDVWICMEVM-DTSLDKFYKKVYDKGLTIPEDILGK--IAVSIVKALE 117
Query: 554 YLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGN-TNRVVGTYDG-- 610
YLH S+L +IHRD+K SNVL++++ K+ DFG+ G + V T D
Sbjct: 118 YLH--SKLSVIHRDVKPSNVLINRNGQVKLCDFGI---------SGYLVDSVAKTIDAGC 166
Query: 611 ----------------QFSIKSDVFSFGILLLEIVSGK 632
+ +KSDV+S GI ++E+ +G+
Sbjct: 167 KPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGR 204
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283 |
| >gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Score = 69.0 bits (169), Expect = 1e-12
Identities = 46/151 (30%), Positives = 83/151 (54%), Gaps = 11/151 (7%)
Query: 447 KLGEGGFGPVYKGTLVDGQEI-AVKRLSKISE-QGLKELK-NEVILFSKLQHRNLVKLLG 503
K+GEG +G V+K + EI A+KR+ + +G+ E+ L +L+H+N+V+L
Sbjct: 7 KIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYD 66
Query: 504 CCIQGEEKL-LIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLR 562
+ ++KL L++E+ ++ L + FD + D + +GL + H
Sbjct: 67 V-LHSDKKLTLVFEYC-DQDLKKY-FDSCNGDI-DPEIVKSFMFQLLKGLAFCHSH---N 119
Query: 563 IIHRDLKASNVLLDQDMNPKISDFGLVRTFG 593
++HRDLK N+L++++ K++DFGL R FG
Sbjct: 120 VLHRDLKPQNLLINKNGELKLADFGLARAFG 150
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284 |
| >gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Score = 69.0 bits (169), Expect = 1e-12
Identities = 62/229 (27%), Positives = 107/229 (46%), Gaps = 56/229 (24%)
Query: 440 DNFSINNKLGEGGFGPVYKGTLVD-GQEIAVKRLSKISEQ------GLKELKNEVILFSK 492
D F I ++GEG +G VYK D G+ +A+K++ +E+ ++E+K + +
Sbjct: 7 DKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIK----ILRQ 62
Query: 493 LQHRNLVKLLGCCIQGEEKL----------LIYEFMPN-------KSLDSFIFDQTR--- 532
L HRN+V L ++ L L++E+M + L F D +
Sbjct: 63 LNHRNIVNLKEIVTDKQDALDFKKDKGAFYLVFEYMDHDLMGLLESGLVHFSEDHIKSFM 122
Query: 533 RTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTF 592
+ LL+ GL Y H+ + L HRD+K SN+LL+ K++DFGL R +
Sbjct: 123 KQLLE-------------GLNYCHKKNFL---HRDIKCSNILLNNKGQIKLADFGLARLY 166
Query: 593 GGDETEGNTNRVVGTY---------DGQFSIKSDVFSFGILLLEIVSGK 632
+E+ TN+V+ + + ++ DV+S G +L E+ + K
Sbjct: 167 NSEESRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKK 215
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 69.1 bits (170), Expect = 2e-12
Identities = 55/172 (31%), Positives = 86/172 (50%), Gaps = 27/172 (15%)
Query: 442 FSINNKLGEGGFGPVYKGTLVD---GQEIAVKRLSKI-----SEQGLKELKNEVILFSKL 493
+ I KLG+G +G V+K +D + +A+K KI + + E++ +L
Sbjct: 9 YEILQKLGKGAYGIVWKA--IDRRTKEVVALK---KIFDAFRNATDAQRTFREIMFLQEL 63
Query: 494 -QHRNLVKLLGCCIQGEEKLLIY---EFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTA 549
H N+VKLL I+ E IY E+M L + I R +L+ + +I+
Sbjct: 64 GDHPNIVKLLNV-IKAENDKDIYLVFEYM-ETDLHAVI----RANILEDVHKRYIMYQLL 117
Query: 550 RGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFG-GDETEGN 600
+ L Y+H S +IHRDLK SN+LL+ D K++DFGL R+ +E N
Sbjct: 118 KALKYIH--SG-NVIHRDLKPSNILLNSDCRVKLADFGLARSLSELEENPEN 166
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|214680 smart00473, PAN_AP, divergent subfamily of APPLE domains | Back alignment and domain information |
|---|
Score = 62.6 bits (152), Expect = 2e-12
Identities = 29/81 (35%), Positives = 39/81 (48%), Gaps = 6/81 (7%)
Query: 282 SRQDGFIKFTELKLPDATSSWVSKSMNLKECREGCLE-NSSCMAYTNSDIRGGGSGCAMW 340
D F++ KLP S V +L+EC CL N SC ++T ++ G GC +W
Sbjct: 1 KSDDCFVRLPNTKLPG-FSRIVISVASLEECASKCLNSNCSCRSFTYNN---GTKGCLLW 56
Query: 341 -FGELIDMRDFPGGGQDFYIR 360
L D R FP GG D Y +
Sbjct: 57 SESSLGDARLFPSGGVDLYEK 77
|
Apple-like domains present in Plasminogen, C. elegans hypothetical ORFs and the extracellular portion of plant receptor-like protein kinases. Predicted to possess protein- and/or carbohydrate-binding functions. Length = 78 |
| >gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 68.5 bits (168), Expect = 2e-12
Identities = 56/220 (25%), Positives = 99/220 (45%), Gaps = 38/220 (17%)
Query: 437 NATDNFSINNKLGEGGFGPVYKGT-LVDGQEIAVKRLSKISEQ-----GLKELKNEVILF 490
+ + + +GEG +G V T G ++A+K++S Q L+E+K +
Sbjct: 2 DVGPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIK----IL 57
Query: 491 SKLQHRNLVKLLGCCIQG-----EEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHII 545
+ +H N++ +L + ++ E M D + +T+ D Q F +
Sbjct: 58 RRFKHENIIGILDIIRPPSFESFNDVYIVQELMET---DLYKLIKTQHLSNDHIQYF--L 112
Query: 546 CGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNTNRV- 604
RGL Y+H + ++HRDLK SN+LL+ + + KI DFGL R D +T +
Sbjct: 113 YQILRGLKYIHSAN---VLHRDLKPSNLLLNTNCDLKICDFGLARI--ADPEHDHTGFLT 167
Query: 605 --VGT--YDG--------QFSIKSDVFSFGILLLEIVSGK 632
V T Y ++ D++S G +L E++S +
Sbjct: 168 EYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNR 207
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 68.3 bits (167), Expect = 3e-12
Identities = 57/217 (26%), Positives = 102/217 (47%), Gaps = 31/217 (14%)
Query: 432 LATIANATDNFSINNKLGEGGFGPVYKGT-LVDGQEIAVKRLSK------ISEQGLKELK 484
T+ T+ + +G G FG V + GQ +A+K++ K ++++ +ELK
Sbjct: 2 FGTVFEITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELK 61
Query: 485 NEVILFSKLQHRNLVKLLGCCIQGEEKL-LIYEFMPNKSLDSFIFDQTRRTLLDWSQRF- 542
L L+H N++ L I E + + E + D +R + Q F
Sbjct: 62 ----LLKHLRHENIISLSDIFISPLEDIYFVTELL---GTDLHRLLTSRPLEKQFIQYFL 114
Query: 543 -HIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNT 601
I+ RGL Y+H ++HRDLK SN+L++++ + KI DFGL R T +
Sbjct: 115 YQIL----RGLKYVHSAG---VVHRDLKPSNILINENCDLKICDFGLARIQDPQMTGYVS 167
Query: 602 NR------VVGTYDGQFSIKSDVFSFGILLLEIVSGK 632
R ++ T+ ++ ++ D++S G + E++ GK
Sbjct: 168 TRYYRAPEIMLTWQ-KYDVEVDIWSAGCIFAEMLEGK 203
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 67.0 bits (163), Expect = 3e-12
Identities = 64/214 (29%), Positives = 100/214 (46%), Gaps = 46/214 (21%)
Query: 448 LGEGGFGPVYKGTLVD-GQEIAVKRL-----SKISEQGLKELKNEVILFSKLQHRNLVKL 501
LG+G FG VY VD G+E+A K++ S + + + L+ E+ L LQH +V+
Sbjct: 10 LGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQY 69
Query: 502 LGCCI-QGEEKLLIY-EFMPNKSL-----------DSFIFDQTRRTLLDWSQRFHIICGT 548
GC + E+ L I+ E+MP S+ +S TR+ L
Sbjct: 70 YGCLRDRAEKTLTIFMEYMPGGSVKDQLKAYGALTESVTRKYTRQIL------------- 116
Query: 549 ARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNTNR-VVGT 607
G+ YLH + I+HRD+K +N+L D N K+ DFG + G R V GT
Sbjct: 117 -EGMSYLHSN---MIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICMSGTGIRSVTGT 172
Query: 608 --------YDGQ-FSIKSDVFSFGILLLEIVSGK 632
G+ + K+DV+S G ++E+++ K
Sbjct: 173 PYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEK 206
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 67.9 bits (166), Expect = 4e-12
Identities = 61/216 (28%), Positives = 93/216 (43%), Gaps = 54/216 (25%)
Query: 446 NKLGEGGFGPVYK----GTLVDGQEIAVKRLSKISEQGLK-ELKNEVILFSKLQHRNLVK 500
N++G G G VYK T G+ A+K + E ++ ++ E+ + + H N+VK
Sbjct: 80 NRIGSGAGGTVYKVIHRPT---GRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVK 136
Query: 501 LLGCCIQGEEKLLIYEFMPNKSLDS-------FIFDQTRRTLLDWSQRFHIICGTARGLL 553
E ++ EFM SL+ F+ D R+ L G+
Sbjct: 137 CHDMFDHNGEIQVLLEFMDGGSLEGTHIADEQFLADVARQIL--------------SGIA 182
Query: 554 YLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNTNRVVGT------ 607
YLH R I+HRD+K SN+L++ N KI+DFG+ R +T N VGT
Sbjct: 183 YLH---RRHIVHRDIKPSNLLINSAKNVKIADFGVSRILA--QTMDPCNSSVGTIAYMSP 237
Query: 608 -----------YDGQFSIKSDVFSFGILLLEIVSGK 632
YDG D++S G+ +LE G+
Sbjct: 238 ERINTDLNHGAYDG---YAGDIWSLGVSILEFYLGR 270
|
Length = 353 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 66.9 bits (163), Expect = 4e-12
Identities = 59/206 (28%), Positives = 95/206 (46%), Gaps = 21/206 (10%)
Query: 441 NFSINNKLGEGGFGPVY--KGTLVDGQEIAVKR--LSKISEQGLKELKNEVILFSKLQHR 496
+ I K+GEG FG +Y K D + +K L+K+ + + K EVIL +K++H
Sbjct: 1 RYEIIKKIGEGSFGKIYLAKAK-SDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHP 59
Query: 497 NLVKLLGCCIQGEEKLLI-YEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYL 555
N+V Q +L I E+ L I Q R L Q + GL ++
Sbjct: 60 NIVTFFA-SFQENGRLFIVMEYCDGGDLMKRINRQ-RGVLFSEDQILSWFVQISLGLKHI 117
Query: 556 HQDSRLRIIHRDLKASNVLLDQD-MNPKISDFGLVRTFGGDETEGNTNRVVGTY------ 608
H +I+HRD+K+ N+ L ++ M K+ DFG+ R D E V Y
Sbjct: 118 HDR---KILHRDIKSQNIFLSKNGMVAKLGDFGIARQL-NDSMELAYTCVGTPYYLSPEI 173
Query: 609 --DGQFSIKSDVFSFGILLLEIVSGK 632
+ ++ K+D++S G +L E+ + K
Sbjct: 174 CQNRPYNNKTDIWSLGCVLYELCTLK 199
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Score = 66.4 bits (162), Expect = 6e-12
Identities = 48/157 (30%), Positives = 70/157 (44%), Gaps = 25/157 (15%)
Query: 446 NKLGEGGFGPVYKG---TLVDGQEIAVKRL---SKISEQGLKELKNEVILFSKLQHRNLV 499
+++G G FG V G + + VK L + EQ L EV + +L H N++
Sbjct: 1 DEIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLL--FLQEVQPYRELNHPNVL 58
Query: 500 KLLGCCIQGEEKLLIYEFMPNKSLDSFI--------FDQTRRTLLDWSQRFHIICGTARG 551
+ LG CI+ LL+ EF P L +++ + L + C A G
Sbjct: 59 QCLGQCIESIPYLLVLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQ------RMACEVASG 112
Query: 552 LLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGL 588
LL+LHQ IH DL N L D++ KI D+GL
Sbjct: 113 LLWLHQ---ADFIHSDLALRNCQLTADLSVKIGDYGL 146
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 66.0 bits (162), Expect = 9e-12
Identities = 70/222 (31%), Positives = 99/222 (44%), Gaps = 58/222 (26%)
Query: 440 DNFSINNKLGEGGFGPV----YKGTLVDGQEIAVKRLSK--ISEQGLKE-LKNEVILFSK 492
D+F LG G FG V +KG+ G+ A+K LSK I + E + NE +
Sbjct: 1 DDFEFIKTLGTGSFGRVMLVRHKGS---GKYYALKILSKAKIVKLKQVEHVLNEKRILQS 57
Query: 493 LQHRNLVKLLGCCIQGEEKL-LIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTAR- 550
++H LV L G Q + L L+ E++P L F R+ S RF AR
Sbjct: 58 IRHPFLVNLYGS-FQDDSNLYLVMEYVPGGEL----FSHLRK-----SGRFPE--PVARF 105
Query: 551 -------GLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNTNR 603
L YLH L I++RDLK N+LLD D KI+DFG + +G T
Sbjct: 106 YAAQVVLALEYLHS---LDIVYRDLKPENLLLDSDGYIKITDFGFAK-----RVKGRTYT 157
Query: 604 VVGT-------------YDGQFSIKS-DVFSFGILLLEIVSG 631
+ GT Y K+ D ++ GIL+ E+++G
Sbjct: 158 LCGTPEYLAPEIILSKGYG-----KAVDWWALGILIYEMLAG 194
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 66.2 bits (162), Expect = 1e-11
Identities = 46/179 (25%), Positives = 76/179 (42%), Gaps = 46/179 (25%)
Query: 442 FSINNKLGEGGFGPVYKG---TLVDGQEIAVKRL--SKISEQGLKELK-NEVILFSKLQH 495
+ I +G G +G VYK DG+E A+K+ K G+ + E+ L +L+H
Sbjct: 2 YEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKH 61
Query: 496 RNLVKLLGCCIQGEEKLLIYEFMPNKSLDSFIFD--------------QTRRTLLD---- 537
N+V L+ ++ +K + +FD Q +R +
Sbjct: 62 ENVVSLVEVFLEHADKSV-----------YLLFDYAEHDLWQIIKFHRQAKRVSIPPSMV 110
Query: 538 WSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNP----KISDFGLVRTF 592
S + I+ G+ YLH + ++HRDLK +N+L+ + KI D GL R F
Sbjct: 111 KSLLWQILN----GVHYLHSN---WVLHRDLKPANILVMGEGPERGVVKIGDLGLARLF 162
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316 |
| >gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Score = 65.5 bits (159), Expect = 1e-11
Identities = 44/153 (28%), Positives = 81/153 (52%), Gaps = 7/153 (4%)
Query: 437 NATDNFSINNKLGEGGFGPVYKGTLVDGQEIAVKRLSKISE-QGLKELKNEVILFSKLQH 495
N ++F + ++G G +G VYK V+ E+A ++ K+ + ++ E+I+ +H
Sbjct: 6 NPQEDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKH 65
Query: 496 RNLVKLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYL 555
N+V G ++ ++ + EF SL I+ T L SQ ++ T +GL YL
Sbjct: 66 SNIVAYFGSYLRRDKLWICMEFCGGGSLQD-IYHVTGP--LSESQIAYVSRETLQGLYYL 122
Query: 556 HQDSRLRIIHRDLKASNVLLDQDMNPKISDFGL 588
H + +HRD+K +N+LL + + K++DFG+
Sbjct: 123 HSKGK---MHRDIKGANILLTDNGHVKLADFGV 152
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267 |
| >gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Score = 66.2 bits (162), Expect = 1e-11
Identities = 54/186 (29%), Positives = 91/186 (48%), Gaps = 44/186 (23%)
Query: 446 NKLGEGGFGPVYKG-TLVDGQEIAVKRLSKISEQ------GLKELKNEVILFSKLQHRNL 498
K+G+G FG V+K Q +A+K++ +E+ L+E+K IL L+H N+
Sbjct: 18 AKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIK---IL-QLLKHENV 73
Query: 499 VKLLGCC---IQGEEK-----LLIYEF--------MPNKSLDSFIFDQTRRTLLDWSQRF 542
V L+ C + L++EF + NK++ F + ++ +
Sbjct: 74 VNLIEICRTKATPYNRYKGSFYLVFEFCEHDLAGLLSNKNVK-FTLSEIKKVMK------ 126
Query: 543 HIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGN-- 600
++ GL Y+H R +I+HRD+KA+N+L+ +D K++DFGL R F +
Sbjct: 127 MLL----NGLYYIH---RNKILHRDMKAANILITKDGILKLADFGLARAFSLSKNSKPNR 179
Query: 601 -TNRVV 605
TNRVV
Sbjct: 180 YTNRVV 185
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310 |
| >gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 65.4 bits (159), Expect = 1e-11
Identities = 52/162 (32%), Positives = 78/162 (48%), Gaps = 28/162 (17%)
Query: 441 NFSINNKLGEGGFGPVYKGTLVD-GQEIAVKRL-----SKISEQGLKELKNEVILFSKLQ 494
N+ + LG G FG VY D G+E+AVK++ S+ + + + L+ E+ L L+
Sbjct: 3 NWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLR 62
Query: 495 HRNLVKLLGCCIQGEEKLL--IYEFMPN-------KSLDSFIFDQTRRTLLDWSQRFHII 545
H +V+ GC EEK L E+MP K+ + + TRR Q
Sbjct: 63 HDRIVQYYGCLRDPEEKKLSIFVEYMPGGSIKDQLKAYGALTENVTRRYTRQILQ----- 117
Query: 546 CGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFG 587
G+ YLH + I+HRD+K +N+L D N K+ DFG
Sbjct: 118 -----GVSYLHSN---MIVHRDIKGANILRDSAGNVKLGDFG 151
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 65.7 bits (160), Expect = 1e-11
Identities = 67/266 (25%), Positives = 115/266 (43%), Gaps = 50/266 (18%)
Query: 448 LGEGGFGPVYKGTLVDGQEI-AVKRLS-KISEQGLKELKNEVILFSKLQHRNLVKLLGCC 505
LG G G VYK + + I AVK + I+ + K++ +E+ + K ++ G
Sbjct: 9 LGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAF 68
Query: 506 IQGEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIH 565
+ EFM SLD ++ + +L I +GL YL L+I+H
Sbjct: 69 FVENRISICTEFMDGGSLD--VYRKIPEHVLG-----RIAVAVVKGLTYLWS---LKILH 118
Query: 566 RDLKASNVLLDQDMNPKISDFG--------LVRTFGGDETEGNTNRVVGTYDGQFSIKSD 617
RD+K SN+L++ K+ DFG + +T+ G R+ G Q+ I SD
Sbjct: 119 RDVKPSNMLVNTRGQVKLCDFGVSTQLVNSIAKTYVGTNAYMAPERISGE---QYGIHSD 175
Query: 618 VFSFGILLLEIVSGK-------KNRGFYRSDTKVNLIGHLWDEGIPLRLIDACIQDSCNL 670
V+S GI +E+ G+ KN+G +PL+L+ + + +
Sbjct: 176 VWSLGISFMELALGRFPYPQIQKNQGSL----------------MPLQLLQCIVDEDPPV 219
Query: 671 ADV----IRCIHIGLLCVQQHPEDRP 692
V + +H C+++ P++RP
Sbjct: 220 LPVGQFSEKFVHFITQCMRKQPKERP 245
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 65.9 bits (161), Expect = 1e-11
Identities = 57/232 (24%), Positives = 100/232 (43%), Gaps = 56/232 (24%)
Query: 444 INNKLGEGGFGPVYKG-TLVDGQEIAVKRL-------------SKISEQG-----LKELK 484
LGEG +G V K + G+ +A+K++ + G L+ELK
Sbjct: 13 KGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELK 72
Query: 485 NEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHI 544
+ ++++H N++ L+ ++G+ L+ + M S + D R+ L SQ I
Sbjct: 73 ----IMNEIKHENIMGLVDVYVEGDFINLVMDIM--ASDLKKVVD--RKIRLTESQVKCI 124
Query: 545 ICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGD--------- 595
+ GL LH+ +HRDL +N+ ++ KI+DFGL R +G
Sbjct: 125 LLQILNGLNVLHKWY---FMHRDLSPANIFINSKGICKIADFGLARRYGYPPYSDTLSKD 181
Query: 596 ----ETEGNTNRVV-----------GTYDGQFSIKSDVFSFGILLLEIVSGK 632
E T++VV G F++ D++S G + E+++GK
Sbjct: 182 ETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAV--DMWSVGCIFAELLTGK 231
|
Length = 335 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 64.9 bits (159), Expect = 2e-11
Identities = 59/204 (28%), Positives = 92/204 (45%), Gaps = 34/204 (16%)
Query: 448 LGEGGFGPVYKGTLV-DGQEIAVKRLSK--ISEQGLKE-LKNEVILFSKLQHRNLVKLLG 503
LG GGFG V + + A+K + K I E G +E + +E + + H +VKL
Sbjct: 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLY- 59
Query: 504 CCIQGEEKL-LIYEFMPNKSLDSFIFDQTRRTLLD-WSQRFHIICGTARGLLYLHQDSRL 561
+ ++ + ++ E+ L + + D R L D ++ RF+I C YLH
Sbjct: 60 RTFKDKKYIYMLMEYCLGGELWTILRD---RGLFDEYTARFYIACVV-LAFEYLH---NR 112
Query: 562 RIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNTNRVVGT-------------Y 608
II+RDLK N+LLD + K+ DFG + + T GT Y
Sbjct: 113 GIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQ---KTWTFCGTPEYVAPEIILNKGY 169
Query: 609 DGQFSIKSDVFSFGILLLEIVSGK 632
D D +S GILL E+++G+
Sbjct: 170 D----FSVDYWSLGILLYELLTGR 189
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 64.7 bits (157), Expect = 2e-11
Identities = 61/217 (28%), Positives = 98/217 (45%), Gaps = 38/217 (17%)
Query: 441 NFSINNKLGEGGFGPVYKGTLVD-GQEIAVKRL-----SKISEQGLKELKNEVILFSKLQ 494
N+ + LG+G FG VY D G+E+AVK++ S + + + L+ E+ L L
Sbjct: 3 NWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLL 62
Query: 495 HRNLVKLLGCCIQGEEKLL--IYEFMPNKSLDSFIFDQ-------TRRTLLDWSQRFHII 545
H +V+ GC E+ L E MP S I DQ T ++++
Sbjct: 63 HERIVQYYGCLRDPMERTLSIFMEHMPGGS----IKDQLKSYGALTENVTRKYTRQI--- 115
Query: 546 CGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGN-TNRV 604
G+ YLH + I+HRD+K +N+L D N K+ DFG + G V
Sbjct: 116 ---LEGVSYLHSN---MIVHRDIKGANILRDSVGNVKLGDFGASKRLQTICLSGTGMKSV 169
Query: 605 VGT--------YDGQ-FSIKSDVFSFGILLLEIVSGK 632
GT G+ + K+D++S G ++E+++ K
Sbjct: 170 TGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEK 206
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
| >gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 65.0 bits (158), Expect = 2e-11
Identities = 52/148 (35%), Positives = 80/148 (54%), Gaps = 10/148 (6%)
Query: 447 KLGEGGFGPVYKG-TLVDGQEIAVKRLSKISEQGLK-ELKNEVILFSKLQHRNLVKLLGC 504
KLGEG + VYKG + ++GQ +A+K +S +E+G+ E L L+H N+V LL
Sbjct: 12 KLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIV-LLHD 70
Query: 505 CIQGEEKL-LIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRI 563
I +E L ++E+M + L ++ Q L ++ R + RGL Y+H I
Sbjct: 71 IIHTKETLTFVFEYM-HTDLAQYMI-QHPGGLHPYNVRLFMF-QLLRGLAYIH---GQHI 124
Query: 564 IHRDLKASNVLLDQDMNPKISDFGLVRT 591
+HRDLK N+L+ K++DFGL R
Sbjct: 125 LHRDLKPQNLLISYLGELKLADFGLARA 152
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291 |
| >gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 65.0 bits (158), Expect = 2e-11
Identities = 58/199 (29%), Positives = 99/199 (49%), Gaps = 20/199 (10%)
Query: 446 NKLGEGGFGPVYKG-TLVDGQEIAVKRLSKISEQGLK-ELKNEVILFSKLQHRNLVKLLG 503
+KLGEG + VYKG + + +A+K + E+G EV L L+H N+V L
Sbjct: 12 DKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHD 71
Query: 504 CCIQGEEKL-LIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLR 562
I E+ L L++E++ +K L ++ D + + F + RGL Y H R +
Sbjct: 72 I-IHTEKSLTLVFEYL-DKDLKQYLDDCGNSINMHNVKLF--LFQLLRGLNYCH---RRK 124
Query: 563 IIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNTNRVVGTY---------DGQFS 613
++HRDLK N+L+++ K++DFGL R T+ +N VV + +S
Sbjct: 125 VLHRDLKPQNLLINERGELKLADFGLARA-KSIPTKTYSNEVVTLWYRPPDILLGSTDYS 183
Query: 614 IKSDVFSFGILLLEIVSGK 632
+ D++ G + E+ +G+
Sbjct: 184 TQIDMWGVGCIFYEMSTGR 202
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301 |
| >gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 65.0 bits (158), Expect = 3e-11
Identities = 55/198 (27%), Positives = 96/198 (48%), Gaps = 18/198 (9%)
Query: 446 NKLGEGGFGPVYKG-TLVDGQEIAVKRLSKISEQGLK-ELKNEVILFSKLQHRNLVKLLG 503
KLGEG + V+KG + + +A+K + E+G EV L L+H N+V L
Sbjct: 12 EKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHD 71
Query: 504 CCIQGEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRI 563
+ L++E++ +K L ++ D + + F + RGL Y H R ++
Sbjct: 72 IVHTDKSLTLVFEYL-DKDLKQYMDDCGNIMSMHNVKIF--LYQILRGLAYCH---RRKV 125
Query: 564 IHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNTNRVVGTY---------DGQFSI 614
+HRDLK N+L+++ K++DFGL R T+ +N VV + ++S
Sbjct: 126 LHRDLKPQNLLINERGELKLADFGLARA-KSVPTKTYSNEVVTLWYRPPDVLLGSSEYST 184
Query: 615 KSDVFSFGILLLEIVSGK 632
+ D++ G + E+ SG+
Sbjct: 185 QIDMWGVGCIFFEMASGR 202
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309 |
| >gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Score = 63.8 bits (155), Expect = 4e-11
Identities = 49/148 (33%), Positives = 72/148 (48%), Gaps = 9/148 (6%)
Query: 447 KLGEGGFGPVYKGTLVDG---QEIAVKRL-SKISEQGLKELKNEVILFSKLQHRNLVKLL 502
++G G FG V G + G ++ VK L S Q + E + LQH NL++ L
Sbjct: 2 EIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCL 61
Query: 503 GCCIQGEEKLLIYEFMPNKSLDSFIFDQTRRTLL--DWSQRFHIICGTARGLLYLHQDSR 560
G C + LL+ EF P L ++ + L+ D + + C A GLL+LH+++
Sbjct: 62 GQCTEVTPYLLVMEFCPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNN- 120
Query: 561 LRIIHRDLKASNVLLDQDMNPKISDFGL 588
IH DL N LL D+ KI D+GL
Sbjct: 121 --FIHSDLALRNCLLTADLTVKIGDYGL 146
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 63.6 bits (155), Expect = 8e-11
Identities = 60/204 (29%), Positives = 95/204 (46%), Gaps = 32/204 (15%)
Query: 448 LGEGGFGPV----YKGTLVDGQEIAVKRLSK---ISEQGLKELKNEVILFSKL-QHRNLV 499
LG+G FG V KGT + AVK L K + + ++ E + + +H L
Sbjct: 3 LGKGSFGKVLLAELKGT---DELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLT 59
Query: 500 KLLGCCIQGEEKL-LIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQD 558
+L C Q +++L + E++ L I Q + RF+ GL +LH+
Sbjct: 60 QLH-SCFQTKDRLFFVMEYVNGGDLMFHI--QRSGRFDEPRARFYAAE-IVLGLQFLHER 115
Query: 559 SRLRIIHRDLKASNVLLDQDMNPKISDFGLVRT-FGGDETEGNTNRVVGTYD-------- 609
II+RDLK NVLLD + + KI+DFG+ + G T T+ GT D
Sbjct: 116 G---IIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGVT---TSTFCGTPDYIAPEILS 169
Query: 610 GQ-FSIKSDVFSFGILLLEIVSGK 632
Q + D ++ G+LL E+++G+
Sbjct: 170 YQPYGPAVDWWALGVLLYEMLAGQ 193
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 63.2 bits (154), Expect = 1e-10
Identities = 51/154 (33%), Positives = 78/154 (50%), Gaps = 24/154 (15%)
Query: 447 KLGEGGFGPVYKG-TLVDGQEIAVKRLSKISEQGLK-ELKNEVILFSKLQHRNLVKLLGC 504
KLGEG + VYKG + + GQ +A+K + E+G E L L+H N+V L
Sbjct: 12 KLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIV-TLHD 70
Query: 505 CIQGEEKL-LIYEFMPNKSLDSFIFDQTR-------RTLLDWSQRFHIICGTARGLLYLH 556
I ++ L L++E++ + L ++ D R L F ++ RGL Y H
Sbjct: 71 IIHTKKTLTLVFEYL-DTDLKQYMDDCGGGLSMHNVRLFL-----FQLL----RGLAYCH 120
Query: 557 QDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVR 590
Q R++HRDLK N+L+ + K++DFGL R
Sbjct: 121 QR---RVLHRDLKPQNLLISERGELKLADFGLAR 151
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 62.5 bits (152), Expect = 1e-10
Identities = 55/219 (25%), Positives = 102/219 (46%), Gaps = 40/219 (18%)
Query: 441 NFSINNKLGEGGFGPVYK-------GTLVDGQEIAVKRLS-----KISEQGLKELKNEV- 487
+++ LG G FG VYK L+ +EI V + + ++ + ++ +EV
Sbjct: 1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVT 60
Query: 488 ILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMPNKSL-DSFIFDQTRRTLLDWSQRF---- 542
I+ +L+H N+V+ ++ + ++ + + L + F +L + QRF
Sbjct: 61 IIKEQLRHPNIVRYYKTFLENDRLYIVMDLIEGAPLGEHFN------SLKEKKQRFTEER 114
Query: 543 --HIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGN 600
+I L YLH++ R I+HRDL +N++L +D I+DFGL + E
Sbjct: 115 IWNIFVQMVLALRYLHKEKR--IVHRDLTPNNIMLGEDDKVTITDFGLAKQKQ---PESK 169
Query: 601 TNRVVGTY---------DGQFSIKSDVFSFGILLLEIVS 630
VVGT + + K+DV++FG +L ++ +
Sbjct: 170 LTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCT 208
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 62.7 bits (153), Expect = 1e-10
Identities = 48/206 (23%), Positives = 87/206 (42%), Gaps = 22/206 (10%)
Query: 440 DNFSINNKLGEGGFGPVYKG-TLVDGQEIAVKRLSKISEQGLKELKN----EVILFSKLQ 494
+ + + +GEG +G V K G+ +A+K+ K SE +++K EV + +L+
Sbjct: 1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKF-KESEDD-EDVKKTALREVKVLRQLR 58
Query: 495 HRNLVKLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLY 554
H N+V L + L++E++ L+ + L I + + Y
Sbjct: 59 HENIVNLKEAFRRKGRLYLVFEYVERTLLELL---EASPGGLPPDAVRSYIWQLLQAIAY 115
Query: 555 LHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNTNRVVGTY------ 608
H IIHRD+K N+L+ + K+ DFG R T+ V +
Sbjct: 116 CH---SHNIIHRDIKPENILVSESGVLKLCDFGFARALRARPASPLTDYVATRWYRAPEL 172
Query: 609 ---DGQFSIKSDVFSFGILLLEIVSG 631
D + DV++ G ++ E++ G
Sbjct: 173 LVGDTNYGKPVDVWAIGCIMAELLDG 198
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Score = 62.4 bits (152), Expect = 2e-10
Identities = 52/156 (33%), Positives = 74/156 (47%), Gaps = 30/156 (19%)
Query: 448 LGEGGFGPV----YKGTLVDGQEIAVKRLSK---ISEQGLKELKNEVILF---SKLQHRN 497
LG G FG V YK T G+ A+K L K I+ ++ L E +F + +H
Sbjct: 7 LGRGHFGKVLLAEYKKT---GELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPF 63
Query: 498 LVKLLGCCIQGEEKL-LIYEFMPNKSLDSFI----FDQTRRTLLDWSQRFHIICGTARGL 552
LV L C Q E+ + + E+ L I F + R F+ C GL
Sbjct: 64 LVNLF-ACFQTEDHVCFVMEYAAGGDLMMHIHTDVFSEPR-------AVFYAAC-VVLGL 114
Query: 553 LYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGL 588
YLH++ +I++RDLK N+LLD + KI+DFGL
Sbjct: 115 QYLHEN---KIVYRDLKLDNLLLDTEGFVKIADFGL 147
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 61.8 bits (150), Expect = 2e-10
Identities = 63/211 (29%), Positives = 91/211 (43%), Gaps = 43/211 (20%)
Query: 448 LGEGGFGPVY------KGTLVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKL 501
LG+GGFG V G L +++ KRL K +G + E + +K+ R +V L
Sbjct: 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKK--RKGYEGAMVEKRILAKVHSRFIVSL 58
Query: 502 LGCCIQGEEKL-LIYEFMPNKSLDSFIFD--------QTRRTLLDWSQRFHIICGTARGL 552
Q + L L+ M L I++ R +Q II G L
Sbjct: 59 -AYAFQTKTDLCLVMTIMNGGDLRYHIYNVDEENPGFPEPRACFYTAQ---IISG----L 110
Query: 553 LYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTF--GGDETEGNTNRVVGT--- 607
+LHQ RII+RDLK NVLLD D N +ISD GL G +T+G GT
Sbjct: 111 EHLHQR---RIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQSKTKG----YAGTPGF 163
Query: 608 ------YDGQFSIKSDVFSFGILLLEIVSGK 632
++ D F+ G+ L E+++ +
Sbjct: 164 MAPELLQGEEYDFSVDYFALGVTLYEMIAAR 194
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Score = 62.0 bits (151), Expect = 2e-10
Identities = 59/214 (27%), Positives = 89/214 (41%), Gaps = 50/214 (23%)
Query: 448 LGEGGFGPVYKGT-LVDGQEIAVKRLSKISEQGLKELKN-----EVILFSKLQHR--NLV 499
+G G G VYK G +AVK++ + + +E K +V+L S H +V
Sbjct: 23 IGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNK--EENKRILMDLDVVLKS---HDCPYIV 77
Query: 500 KLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRF-------HIICGTARGL 552
K G I + + E M S D+ LL Q + + L
Sbjct: 78 KCYGYFITDSDVFICMELM------STCLDK----LLKRIQGPIPEDILGKMTVAIVKAL 127
Query: 553 LYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFG----LVRTFGGDETEG--------- 599
YL + +IHRD+K SN+LLD N K+ DFG LV + + G
Sbjct: 128 HYLKEKHG--VIHRDVKPSNILLDASGNVKLCDFGISGRLVDSKAKTRSAGCAAYMAPER 185
Query: 600 -NTNRVVGTYDGQFSIKSDVFSFGILLLEIVSGK 632
+ YD I++DV+S GI L+E+ +G+
Sbjct: 186 IDPPDPNPKYD----IRADVWSLGISLVELATGQ 215
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 61.7 bits (150), Expect = 3e-10
Identities = 50/211 (23%), Positives = 97/211 (45%), Gaps = 34/211 (16%)
Query: 440 DNFSINNKLGEGGFGPVYKGT-LVDGQEIAVKRLS---KISEQGLKELKNEVILFSKLQH 495
D+ +G G FG V+ + A+K ++ I + + + NE + ++ H
Sbjct: 1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSH 60
Query: 496 RNLVKLLGCCIQGEEKLL--IYEFMPNKSLDSFIFDQTRRTLLDWSQRFH---IICGTAR 550
+++L + +++ L + E++P L S++ + + + F+ I+C
Sbjct: 61 PFIIRLF--WTEHDQRFLYMLMEYVPGGELFSYL--RNSGRFSNSTGLFYASEIVCA--- 113
Query: 551 GLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNTNRVVGT--Y 608
L YLH I++RDLK N+LLD++ + K++DFG + + T + GT Y
Sbjct: 114 -LEYLHS---KEIVYRDLKPENILLDKEGHIKLTDFGFAK-----KLRDRTWTLCGTPEY 164
Query: 609 DGQFSIKS-------DVFSFGILLLEIVSGK 632
I+S D ++ GIL+ E++ G
Sbjct: 165 LAPEVIQSKGHNKAVDWWALGILIYEMLVGY 195
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Score = 60.8 bits (147), Expect = 4e-10
Identities = 42/154 (27%), Positives = 78/154 (50%), Gaps = 9/154 (5%)
Query: 437 NATDNFSINNKLGEGGFGPVYKGTLVDGQEIAVKRLSKISEQG--LKELKNEVILFSKLQ 494
N ++ + ++G G +G VYK + E+A ++ K+ E G ++ E+ + + +
Sbjct: 6 NPQHDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKL-EPGDDFSLIQQEIFMVKECK 64
Query: 495 HRNLVKLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLY 554
H N+V G + E+ + E+ SL I+ T L Q ++ T +GL Y
Sbjct: 65 HCNIVAYFGSYLSREKLWICMEYCGGGSLQD-IYHVTGP--LSELQIAYVCRETLQGLAY 121
Query: 555 LHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGL 588
LH ++ HRD+K +N+LL + + K++DFG+
Sbjct: 122 LHSKGKM---HRDIKGANILLTDNGDVKLADFGV 152
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267 |
| >gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Score = 61.7 bits (150), Expect = 4e-10
Identities = 55/194 (28%), Positives = 85/194 (43%), Gaps = 39/194 (20%)
Query: 461 LVDGQEIAVKRLSK--ISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFM 518
V GQ +A+K+LS+ + K E++L + H+N++ LL F
Sbjct: 38 TVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNV------------FT 85
Query: 519 PNKSLDSF--------IFD----QTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHR 566
P KSL+ F + D Q + LD + +++ G+ +LH IIHR
Sbjct: 86 PQKSLEEFQDVYLVMELMDANLCQVIQMDLDHERMSYLLYQMLCGIKHLHSAG---IIHR 142
Query: 567 DLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNTNRVVGTY--------DGQFSIKSDV 618
DLK SN+++ D KI DFGL RT G T VV Y + D+
Sbjct: 143 DLKPSNIVVKSDCTLKILDFGLARTAGTSFMM--TPYVVTRYYRAPEVILGMGYKENVDI 200
Query: 619 FSFGILLLEIVSGK 632
+S G ++ E++ G
Sbjct: 201 WSVGCIMGEMIRGT 214
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353 |
| >gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 61.2 bits (148), Expect = 5e-10
Identities = 59/204 (28%), Positives = 99/204 (48%), Gaps = 20/204 (9%)
Query: 440 DNFSINNKLGEGGFGPVYKG-TLVDGQEIAVKRLSKISEQGLK-ELKNEVILFSKLQHRN 497
D++ KLGEG + VYKG + V+G+ +A+K + E+G E L L+H N
Sbjct: 5 DSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHAN 64
Query: 498 LVKLLGCCIQGEEKL-LIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLH 556
+V LL I +E L L++E++ + L ++ + + F + RGL Y+H
Sbjct: 65 IV-LLHDIIHTKETLTLVFEYV-HTDLCQYMDKHPGGLHPENVKLF--LFQLLRGLSYIH 120
Query: 557 QDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNTNRVVGTY-------- 608
Q I+HRDLK N+L+ K++DFGL R + +N VV +
Sbjct: 121 QRY---ILHRDLKPQNLLISDTGELKLADFGLARA-KSVPSHTYSNEVVTLWYRPPDVLL 176
Query: 609 -DGQFSIKSDVFSFGILLLEIVSG 631
++S D++ G + +E++ G
Sbjct: 177 GSTEYSTCLDMWGVGCIFVEMIQG 200
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303 |
| >gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Score = 60.8 bits (147), Expect = 6e-10
Identities = 62/240 (25%), Positives = 106/240 (44%), Gaps = 49/240 (20%)
Query: 447 KLGEGGFGPVYKGTLVD--GQEIAVKRLS-KISEQG--LKELKNEVIL--FSKLQHRNLV 499
++GEG +G V+K + G+ +A+KR+ + E+G L ++ +L +H N+V
Sbjct: 8 EIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVV 67
Query: 500 KLLGCCIQG----EEKL-LIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTA----- 549
+L C E KL L++E + DQ T LD + T
Sbjct: 68 RLFDVCTVSRTDRETKLTLVFEHV----------DQDLTTYLDKVPEPGVPTETIKDMMF 117
Query: 550 ---RGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNTNRVVG 606
RGL +LH R++HRDLK N+L+ K++DFGL R + + VV
Sbjct: 118 QLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIY---SFQMALTSVVV 171
Query: 607 T---------YDGQFSIKSDVFSFGILLLEIVSGKKNRGFYRSDTKVNLIGHLWDE-GIP 656
T ++ D++S G + E+ + + +R + V+ +G + D G+P
Sbjct: 172 TLWYRAPEVLLQSSYATPVDLWSVGCIFAEMF---RRKPLFRGSSDVDQLGKILDVIGLP 228
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 60.6 bits (147), Expect = 7e-10
Identities = 67/217 (30%), Positives = 97/217 (44%), Gaps = 58/217 (26%)
Query: 448 LGEGGFGPVYKGTLVDGQEIAVKRLSKISEQGLKELKNEVILF-----SKLQHRNLVKL- 501
LG+G FG V L E +K LK +V+L + R ++ L
Sbjct: 3 LGKGSFGKVMLAELKGTNEFF----------AIKALKKDVVLEDDDVECTMVERRVLALA 52
Query: 502 --------LGCCIQGEEKLL-IYEFMPNKSL-----DSFIFDQTRRTLLDWSQRFH---I 544
L C Q +E L + E++ L S FD+ R RF+ I
Sbjct: 53 WEHPFLTHLFCTFQTKEHLFFVMEYLNGGDLMFHIQSSGRFDEAR-------ARFYAAEI 105
Query: 545 ICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNTNRV 604
ICG L +LH+ II+RDLK NVLLD+D + KI+DFG+ + E + +T
Sbjct: 106 ICG----LQFLHKKG---IIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGEGKAST--F 156
Query: 605 VGTYD--------GQ-FSIKSDVFSFGILLLEIVSGK 632
GT D GQ ++ D +SFG+LL E++ G+
Sbjct: 157 CGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQ 193
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 59.8 bits (145), Expect = 9e-10
Identities = 57/196 (29%), Positives = 86/196 (43%), Gaps = 28/196 (14%)
Query: 451 GGFGPVYKG-TLVDGQEIAVKRLSKISEQGLKELKN----EVILFSKLQHRNLVKLLGCC 505
G FG VY G A+K L K ++ N I+ + + + KL
Sbjct: 7 GAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSF 66
Query: 506 IQGEEKLLIYEFMPNKSLDSFIFDQTRRTL-LDWSQRFHIICGTARGLLYLHQDSRLRII 564
+ L+ E++ S I +T L DW++++ I G+ LHQ II
Sbjct: 67 QSKDYLYLVMEYLNGGDCASLI--KTLGGLPEDWAKQY--IAEVVLGVEDLHQRG---II 119
Query: 565 HRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNTNRVVGTYD--------GQFSIK- 615
HRD+K N+L+DQ + K++DFGL R G E + + VGT D G K
Sbjct: 120 HRDIKPENLLIDQTGHLKLTDFGLSRN--GLENK----KFVGTPDYLAPETILGVGDDKM 173
Query: 616 SDVFSFGILLLEIVSG 631
SD +S G ++ E + G
Sbjct: 174 SDWWSLGCVIFEFLFG 189
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 59.5 bits (144), Expect = 1e-09
Identities = 56/206 (27%), Positives = 96/206 (46%), Gaps = 34/206 (16%)
Query: 447 KLGEGGFGPVYKGTLV----DGQEIAVKRL--SKISEQGLKELKNEVILFSKLQHRNLVK 500
K+GEG FG K LV DG++ +K + SK+S + +E + EV + S ++H N+V+
Sbjct: 7 KIGEGSFG---KAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQ 63
Query: 501 LLGCCIQGEEKLLIYEFMPNKSLDSFIFDQ-----TRRTLLDWSQRFHIICGTARGLLYL 555
+ ++ ++ L I Q +LDW F IC L ++
Sbjct: 64 YQESFEENGNLYIVMDYCEGGDLYKKINAQRGVLFPEDQILDW---FVQIC---LALKHV 117
Query: 556 HQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNTNRVVGT-------- 607
H +I+HRD+K+ N+ L +D K+ DFG+ R T +GT
Sbjct: 118 HDR---KILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVELART--CIGTPYYLSPEI 172
Query: 608 -YDGQFSIKSDVFSFGILLLEIVSGK 632
+ ++ KSD+++ G +L E+ + K
Sbjct: 173 CENRPYNNKSDIWALGCVLYEMCTLK 198
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Score = 60.1 bits (146), Expect = 1e-09
Identities = 51/214 (23%), Positives = 81/214 (37%), Gaps = 47/214 (21%)
Query: 448 LGEGGFGPVYK----GTLVDGQEIAVKR--LSKISEQGLKELKNEVILFSKLQHRNLVKL 501
+ + K TLV AVK+ L S++ LK L+ E+I +LQH N++
Sbjct: 10 FEDLMIVHLAKHKPTNTLV-----AVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPY 64
Query: 502 LGCCIQGEEKLLIYEFMPNKS----LDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQ 557
+ I E ++ M S L + + + F I+ L Y+H
Sbjct: 65 VTSFIVDSELYVVSPLMAYGSCEDLLKTHFPEGLPELAI----AF-ILKDVLNALDYIHS 119
Query: 558 DSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNTNRVVGTYDGQFSI--- 614
IHR +KAS++LL D +S + G RVV + + S+
Sbjct: 120 ---KGFIHRSVKASHILLSGDGKVVLSGLRYSVSM---IKHGKRQRVVHDF-PKSSVKNL 172
Query: 615 -----------------KSDVFSFGILLLEIVSG 631
KSD++S GI E+ +G
Sbjct: 173 PWLSPEVLQQNLQGYNEKSDIYSVGITACELANG 206
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 59.7 bits (145), Expect = 1e-09
Identities = 52/198 (26%), Positives = 97/198 (48%), Gaps = 21/198 (10%)
Query: 447 KLGEGGFGPVYKGTLVD-GQEIAVKRLSKISEQGL--KELKNEVILFSKLQHRNLVKLLG 503
K+GEG +G V+K + GQ +A+K+ + + + K E+ + +L+H NLV L+
Sbjct: 8 KIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIE 67
Query: 504 CCIQGEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRI 563
+ + L++E+ + L+ ++ R + + + II T + + + H+
Sbjct: 68 VFRRKRKLHLVFEYCDHTVLNEL--EKNPRGVPEHLIK-KIIWQTLQAVNFCHK---HNC 121
Query: 564 IHRDLKASNVLLDQDMNPKISDFGLVRTF---GGDETEGNTNR-------VVGTYDGQFS 613
IHRD+K N+L+ + K+ DFG R G D T+ R +VG D Q+
Sbjct: 122 IHRDVKPENILITKQGQIKLCDFGFARILTGPGDDYTDYVATRWYRAPELLVG--DTQYG 179
Query: 614 IKSDVFSFGILLLEIVSG 631
DV++ G + E+++G
Sbjct: 180 PPVDVWAIGCVFAELLTG 197
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
| >gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 60.2 bits (146), Expect = 1e-09
Identities = 71/270 (26%), Positives = 107/270 (39%), Gaps = 85/270 (31%)
Query: 440 DNFSINNKLGEGGFGPVYKGTLVDGQE------IAVKRL---SKISEQG--LKELKNEVI 488
D + LG G FG V + + ++ +AVK L + SE + ELK I
Sbjct: 7 DRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELK---I 63
Query: 489 LFSKLQHRNLVKLLGCCIQGEEKLLI------------------YEFMPNKS-------- 522
L H N+V LLG C + L++ F P ++
Sbjct: 64 LIHIGHHLNVVNLLGACTKPGGPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREM 123
Query: 523 ---------LDS-----------FIFDQTRRTLL------DWSQRF----HIICGT---A 549
LDS FI D++ + + + +I + A
Sbjct: 124 KQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGDELYKEPLTLEDLISYSFQVA 183
Query: 550 RGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDET---EGNTNRVV- 605
RG+ +L SR + IHRDL A N+LL ++ KI DFGL R D +G+ +
Sbjct: 184 RGMEFL--ASR-KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLK 240
Query: 606 -----GTYDGQFSIKSDVFSFGILLLEIVS 630
+D ++ +SDV+SFG+LL EI S
Sbjct: 241 WMAPESIFDKVYTTQSDVWSFGVLLWEIFS 270
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337 |
| >gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 60.4 bits (147), Expect = 1e-09
Identities = 48/162 (29%), Positives = 70/162 (43%), Gaps = 37/162 (22%)
Query: 448 LGEGGFGPVYKGTLVD-GQEIAVKRLSK--ISEQGLKELKNEVILFSKLQHRNLVKLLGC 504
+G G +G V G+++A+K+LS+ S K E+ L + H N++ LL
Sbjct: 23 VGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDV 82
Query: 505 CIQGEEKLLIYEFMPNKSLDSF----------------IFDQTRRTLLDWSQRFHIICGT 548
F P SL+ F I + L D +F ++
Sbjct: 83 ------------FTPASSLEDFQDVYLVTHLMGADLNNIVKCQK--LSDDHIQF-LVYQI 127
Query: 549 ARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVR 590
RGL Y+H IIHRDLK SN+ +++D KI DFGL R
Sbjct: 128 LRGLKYIHS---AGIIHRDLKPSNIAVNEDCELKILDFGLAR 166
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343 |
| >gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 59.1 bits (143), Expect = 2e-09
Identities = 65/275 (23%), Positives = 111/275 (40%), Gaps = 37/275 (13%)
Query: 440 DNFSINNKLGEGGFGPVYK------GTLVDGQEIAVKRLSKISEQGLKELKNEVILFSKL 493
D + ++LG+G +G VYK G + +EI RL + E ++ E+ + K
Sbjct: 1 DEIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEI---RLE-LDESKFNQIIMELDILHKA 56
Query: 494 QHRNLVKLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLL 553
+V G + E+M SLD + I +GL
Sbjct: 57 VSPYIVDFYGAFFIEGAVYMCMEYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLK 116
Query: 554 YLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFG--------LVRTFGGDETEGNTNRVV 605
+L ++ IIHRD+K +NVL++ + K+ DFG L +T G ++ R+
Sbjct: 117 FLKEE--HNIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVASLAKTNIGCQSYMAPERIK 174
Query: 606 G---TYDGQFSIKSDVFSFGILLLEIVSGKKNRGFYRSDTKVNLIGHLWD--EGIPLRLI 660
+ ++++SDV+S G+ +LE+ G R Y +T N+ L +G P L
Sbjct: 175 SGGPNQNPTYTVQSDVWSLGLSILEMALG---RYPYPPETYANIFAQLSAIVDGDPPTLP 231
Query: 661 DACIQDSCNLADVIRCIHIGLLCVQQHPEDRPCMP 695
D+ + C+ + P RP
Sbjct: 232 SGYSDDAQDFVA---------KCLNKIPNRRPTYA 257
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286 |
| >gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Score = 59.2 bits (144), Expect = 2e-09
Identities = 48/172 (27%), Positives = 81/172 (47%), Gaps = 35/172 (20%)
Query: 440 DNFSINNKLGEGGFGPVYKGTLVDGQEI-AVKRLSKISEQG----LKELKNEVILFSKLQ 494
D + N++ EG +G VY+ EI A+K+L K+ ++ + L+ E+ + KLQ
Sbjct: 5 DEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKL-KMEKEKEGFPITSLR-EINILLKLQ 62
Query: 495 HRNLVKLLGCCIQGEEKLLIYEFMPNKSLDS-FI----FDQTRRTLLD-WSQRFHI---- 544
H N+V + E + +LD ++ + ++L++ Q F
Sbjct: 63 HPNIVT-------------VKEVVVGSNLDKIYMVMEYVEHDLKSLMETMKQPFLQSEVK 109
Query: 545 --ICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGG 594
+ G+ +LH + I+HRDLK SN+LL+ KI DFGL R +G
Sbjct: 110 CLMLQLLSGVAHLHDNW---ILHRDLKTSNLLLNNRGILKICDFGLAREYGS 158
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 59.6 bits (144), Expect = 2e-09
Identities = 67/209 (32%), Positives = 95/209 (45%), Gaps = 42/209 (20%)
Query: 448 LGEGGFGPVY----KGTLVDGQEIAVKRLSK----ISEQGLKELKNEVILFSKLQHRNLV 499
LG+G FG V+ KGT Q A+K L K + + + + +L +H L
Sbjct: 3 LGKGSFGKVFLAELKGT---NQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLT 59
Query: 500 KLLGCCIQGEEKLL-IYEFMPNKSLDSFI-----FDQTRRTLLDWSQRFHIICGTARGLL 553
L C Q +E L + E++ L I FD R T IICG L
Sbjct: 60 HLY-CTFQTKENLFFVMEYLNGGDLMFHIQSCHKFDLPRATFY----AAEIICG----LQ 110
Query: 554 YLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVR-TFGGDETEGNTNRVVGTYD--- 609
+LH I++RDLK N+LLD D + KI+DFG+ + GD T GT D
Sbjct: 111 FLHSKG---IVYRDLKLDNILLDTDGHIKIADFGMCKENMLGD---AKTCTFCGTPDYIA 164
Query: 610 -----GQ-FSIKSDVFSFGILLLEIVSGK 632
GQ ++ D +SFG+LL E++ G+
Sbjct: 165 PEILLGQKYNTSVDWWSFGVLLYEMLIGQ 193
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Score = 59.1 bits (143), Expect = 2e-09
Identities = 47/167 (28%), Positives = 78/167 (46%), Gaps = 20/167 (11%)
Query: 440 DNFSINNKLGEGGFGPVYKG-TLVDGQEIAVKR-LSKISEQGLKELK-NEVILFSKLQHR 496
D + K+GEG +G VYK G+ +A+K+ ++ E+G+ E+ L L
Sbjct: 1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSES 60
Query: 497 N-LVKLLGCCIQGEEKL------LIYEFMPNKSLDSFIFDQTRR---TLLDWSQRFHIIC 546
+V+LL EEK L++E++ + L F+ D R L +
Sbjct: 61 IYIVRLL-DVEHVEEKNGKPSLYLVFEYL-DSDLKKFM-DSNGRGPGRPLPAKTIKSFMY 117
Query: 547 GTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNP-KISDFGLVRTF 592
+G+ + H + ++HRDLK N+L+D+ KI+D GL R F
Sbjct: 118 QLLKGVAHCH---KHGVMHRDLKPQNLLVDKQKGLLKIADLGLGRAF 161
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295 |
| >gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Score = 58.4 bits (141), Expect = 3e-09
Identities = 57/206 (27%), Positives = 96/206 (46%), Gaps = 37/206 (17%)
Query: 448 LGEGGFGPVYKGTLV----DGQEIAVK--RLSKISEQGLKELKNEVILFSKLQHRNLVKL 501
+GEG FG + LV Q+ A+K RL K S +++ + E +L +K++H N+V
Sbjct: 8 VGEGSFG---RALLVQHVNSDQKYAMKEIRLPK-SSSAVEDSRKEAVLLAKMKHPNIVAF 63
Query: 502 LGCCIQGEEKL-LIYEFMPNKSLDSFIFDQ-----TRRTLLDWSQRFHIICGTARGLLYL 555
+ + L ++ E+ L I Q T+L W F +C G+ ++
Sbjct: 64 KES-FEADGHLYIVMEYCDGGDLMQKIKLQRGKLFPEDTILQW---FVQMC---LGVQHI 116
Query: 556 HQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNTNRVVGT-------- 607
H+ R++HRD+K+ N+ L Q+ K+ DFG R T VGT
Sbjct: 117 HEK---RVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGAYACT--YVGTPYYVPPEI 171
Query: 608 -YDGQFSIKSDVFSFGILLLEIVSGK 632
+ ++ KSD++S G +L E+ + K
Sbjct: 172 WENMPYNNKSDIWSLGCILYELCTLK 197
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255 |
| >gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Score = 58.5 bits (141), Expect = 3e-09
Identities = 56/199 (28%), Positives = 96/199 (48%), Gaps = 20/199 (10%)
Query: 446 NKLGEGGFGPVYKG-TLVDGQEIAVKRLSKISEQGLK-ELKNEVILFSKLQHRNLVKLLG 503
+KLGEG + V+KG + + +A+K + E+G EV L L+H N+V L
Sbjct: 11 DKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHD 70
Query: 504 CCIQGEEKL-LIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLR 562
I E L L++E++ + L ++ L+ + RGL Y H + +
Sbjct: 71 I-IHTERCLTLVFEYLDS-DLKQYL--DNCGNLMSMHNVKIFMFQLLRGLSYCH---KRK 123
Query: 563 IIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNTNRVVGTY---------DGQFS 613
I+HRDLK N+L+++ K++DFGL R T+ +N VV + ++S
Sbjct: 124 ILHRDLKPQNLLINEKGELKLADFGLARA-KSVPTKTYSNEVVTLWYRPPDVLLGSTEYS 182
Query: 614 IKSDVFSFGILLLEIVSGK 632
D++ G +L E+ +G+
Sbjct: 183 TPIDMWGVGCILYEMATGR 201
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288 |
| >gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 58.2 bits (141), Expect = 6e-09
Identities = 55/208 (26%), Positives = 96/208 (46%), Gaps = 37/208 (17%)
Query: 448 LGEGGFGPVYKGTLVD-GQEIAVKRLSKISE------QGLKELKNEVILFSKLQHRNLVK 500
+G G +G V + +++A+K+++ + + L+E+K L L H N++
Sbjct: 13 IGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIK----LLRHLDHENVIA 68
Query: 501 LLGCCI-----QGEEKLLIYEFMPNKSLDSFIFDQTRRTLL-DWSQRFHIICGTARGLLY 554
+ + ++YE M + L I ++ +TL D Q F + RGL Y
Sbjct: 69 IKDIMPPPHREAFNDVYIVYELM-DTDLHQII--RSSQTLSDDHCQYF--LYQLLRGLKY 123
Query: 555 LHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEG-NTNRVVGTY----- 608
+H + ++HRDLK SN+LL+ + + KI DFGL RT E T VV +
Sbjct: 124 IHSAN---VLHRDLKPSNLLLNANCDLKICDFGLART--TSEKGDFMTEYVVTRWYRAPE 178
Query: 609 ----DGQFSIKSDVFSFGILLLEIVSGK 632
+++ DV+S G + E++ K
Sbjct: 179 LLLNCSEYTTAIDVWSVGCIFAELLGRK 206
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337 |
| >gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Score = 58.2 bits (141), Expect = 6e-09
Identities = 55/208 (26%), Positives = 91/208 (43%), Gaps = 36/208 (17%)
Query: 448 LGEGGFGPVYKGT-LVDGQEIAVKRLSKI------SEQGLKELKNEVILFSKLQHRNLVK 500
+G G FG V+ T DG+ +A+K++ + ++ +ELK + +H N++
Sbjct: 8 IGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELK----MLCFFKHDNVLS 63
Query: 501 LLGCCIQG-----EEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRF--HIICGTARGLL 553
L EE ++ E M L I + D + F I+ RGL
Sbjct: 64 ALDILQPPHIDPFEEIYVVTELM-QSDLHKIIVSPQPLSS-DHVKVFLYQIL----RGLK 117
Query: 554 YLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNTNRVVGTY----- 608
YLH I+HRD+K N+L++ + KI DFGL R DE++ T VV Y
Sbjct: 118 YLHS---AGILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDESKHMTQEVVTQYYRAPE 174
Query: 609 ----DGQFSIKSDVFSFGILLLEIVSGK 632
++ D++S G + E++ +
Sbjct: 175 ILMGSRHYTSAVDIWSVGCIFAELLGRR 202
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 57.6 bits (139), Expect = 7e-09
Identities = 64/205 (31%), Positives = 97/205 (47%), Gaps = 34/205 (16%)
Query: 448 LGEGGFGPVYKGTLV-DGQEIAVKRLSK----ISEQGLKELKNEVILFSKLQHRNLVKLL 502
LG+G FG V L G+ AVK L K I + + + +L ++ L L
Sbjct: 3 LGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLY 62
Query: 503 GCCIQGEEKLL-IYEFMPNKSLDSFIFDQTRRTLLDWSQRFH---IICGTARGLLYLHQD 558
C Q +E L + EF+ L I D+ R L + F+ I+CG L +LH
Sbjct: 63 -CTFQTKEHLFFVMEFLNGGDLMFHIQDKGRFDL--YRATFYAAEIVCG----LQFLHSK 115
Query: 559 SRLRIIHRDLKASNVLLDQDMNPKISDFGLVR--TFGGDETEGNTNRVVGTYD------- 609
II+RDLK NV+LD+D + KI+DFG+ + FG + + GT D
Sbjct: 116 G---IIYRDLKLDNVMLDRDGHIKIADFGMCKENVFG----DNRASTFCGTPDYIAPEIL 168
Query: 610 --GQFSIKSDVFSFGILLLEIVSGK 632
+++ D +SFG+LL E++ G+
Sbjct: 169 QGLKYTFSVDWWSFGVLLYEMLIGQ 193
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 58.0 bits (140), Expect = 7e-09
Identities = 55/197 (27%), Positives = 91/197 (46%), Gaps = 19/197 (9%)
Query: 448 LGEGGFGPVYKGT-LVDGQEIAVKRLSKI--SEQGLKELKNEVILFSKLQHRNLVKLLG- 503
+G G +G V G+++A+K+LS+ SE K E+ L +QH N++ LL
Sbjct: 23 VGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDV 82
Query: 504 --CCIQGEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRL 561
+ G+E Y MP D + L + +++ GL Y+H
Sbjct: 83 FTSAVSGDEFQDFYLVMPYMQTD---LQKIMGHPLSEDKVQYLVYQMLCGLKYIHSAG-- 137
Query: 562 RIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNTNR------VVGTYDGQFSIK 615
IIHRDLK N+ +++D KI DFGL R + T R V+ + ++
Sbjct: 138 -IIHRDLKPGNLAVNEDCELKILDFGLARHADAEMTGYVVTRWYRAPEVILNW-MHYNQT 195
Query: 616 SDVFSFGILLLEIVSGK 632
D++S G ++ E+++GK
Sbjct: 196 VDIWSVGCIMAEMLTGK 212
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342 |
| >gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Score = 57.1 bits (138), Expect = 9e-09
Identities = 29/91 (31%), Positives = 53/91 (58%), Gaps = 13/91 (14%)
Query: 550 RGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFG--------LVRTFGGDETEGNT 601
RGL YL + + +I+HRD+K SN+L++ K+ DFG + +F G + +
Sbjct: 110 RGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFVGTRSYMSP 167
Query: 602 NRVVGTYDGQFSIKSDVFSFGILLLEIVSGK 632
R+ GT ++++SD++S G+ L+E+ G+
Sbjct: 168 ERLQGT---HYTVQSDIWSLGLSLVEMAIGR 195
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308 |
| >gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Score = 56.9 bits (138), Expect = 1e-08
Identities = 51/203 (25%), Positives = 93/203 (45%), Gaps = 31/203 (15%)
Query: 446 NKLGEGGFGPVYKG-TLVDGQEIAVKRLSKISEQGLKELKN--EVILFSKLQ-HRNLVKL 501
K+GEG F V K + G+ A+K + K + L+++ N E+ +L H N+++L
Sbjct: 5 GKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHF-KSLEQVNNLREIQALRRLSPHPNILRL 63
Query: 502 LGCCIQGEEK--LLIYEFMPNKSLDSFIFD--QTRRTLLDWSQRFHIICGTARGLLYLHQ 557
+ + L++E M D +++ + R+ L + + + L ++H+
Sbjct: 64 IEVLFDRKTGRLALVFELM-----DMNLYELIKGRKRPLPEKRVKSYMYQLLKSLDHMHR 118
Query: 558 DSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDE--TEGNTNRVVGTY------- 608
+ I HRD+K N+L+ D K++DFG R TE + R Y
Sbjct: 119 NG---IFHRDIKPENILIKDD-ILKLADFGSCRGIYSKPPYTEYISTR---WYRAPECLL 171
Query: 609 -DGQFSIKSDVFSFGILLLEIVS 630
DG + K D+++ G + EI+S
Sbjct: 172 TDGYYGPKMDIWAVGCVFFEILS 194
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282 |
| >gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Score = 56.8 bits (137), Expect = 1e-08
Identities = 60/199 (30%), Positives = 92/199 (46%), Gaps = 24/199 (12%)
Query: 448 LGEGGFGPVYKGTL-VDGQEIAVKRLSK---ISEQGLK-ELKNEVILFSKLQHRNLVKLL 502
LG+G FG V L G+ AVK L K + + ++ + + IL H L +L
Sbjct: 3 LGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLY 62
Query: 503 GCCIQGEEKLL-IYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRL 561
CC Q ++L + EF+ L I Q R + RF+ T+ L++LH
Sbjct: 63 -CCFQTPDRLFFVMEFVNGGDLMFHI--QKSRRFDEARARFYAAEITS-ALMFLHDKG-- 116
Query: 562 RIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNTNRVVGTYD---------GQF 612
II+RDLK NVLLD + + K++DFG+ + G T+ GT D +
Sbjct: 117 -IIYRDLKLDNVLLDHEGHCKLADFGMCKE--GIFNGKTTSTFCGTPDYIAPEILQEMLY 173
Query: 613 SIKSDVFSFGILLLEIVSG 631
D ++ G+LL E++ G
Sbjct: 174 GPSVDWWAMGVLLYEMLCG 192
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320 |
| >gnl|CDD|173766 cd08226, PK_STRAD_beta, Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Score = 56.5 bits (136), Expect = 2e-08
Identities = 59/204 (28%), Positives = 88/204 (43%), Gaps = 51/204 (25%)
Query: 459 GTLVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFM 518
GTLV + + L +E+ LK L+NEV+L +H N++ G +I FM
Sbjct: 25 GTLV---TVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFM 81
Query: 519 ----PNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVL 574
N L ++ + L+ +I+ G RGL YLHQ+ IHR++KAS++L
Sbjct: 82 AYGSANSLLKTYFPEGMSEALIG-----NILFGALRGLNYLHQNG---YIHRNIKASHIL 133
Query: 575 LDQDMNPKISDFGLVRTFGGDE-----TEGNTNRVVGTYD-GQFS--------------- 613
+ D GLV G G +VV YD QFS
Sbjct: 134 ISGD--------GLVSLSGLSHLYSLVRNGQKAKVV--YDFPQFSTSVLPWLSPELLRQD 183
Query: 614 -----IKSDVFSFGILLLEIVSGK 632
+KSD++S GI E+ +G+
Sbjct: 184 LYGYNVKSDIYSVGITACELATGR 207
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. STRAD-beta is also referred to as ALS2CR2 (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 2 protein), since the human gene encoding it is located within the juvenile ALS2 critical region on chromosome 2q33-q34. It is not linked to the development of ALS2. Length = 328 |
| >gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Score = 56.5 bits (136), Expect = 2e-08
Identities = 56/166 (33%), Positives = 77/166 (46%), Gaps = 15/166 (9%)
Query: 448 LGEGGFGPVYKGTL-VDGQEIAVKRLSKISEQGLKELKNEV----ILFSKLQHRNLVKLL 502
+G+G FG V DG AVK L K + KE + + +L L+H LV L
Sbjct: 3 IGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGL- 61
Query: 503 GCCIQGEEKL-LIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRL 561
Q EKL + +++ L F Q R L+ RF+ A + YLH L
Sbjct: 62 HYSFQTAEKLYFVLDYVNGGEL--FFHLQRERCFLEPRARFYA-AEVASAIGYLHS---L 115
Query: 562 RIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNTNRVVGT 607
II+RDLK N+LLD + ++DFGL + G E E T+ GT
Sbjct: 116 NIIYRDLKPENILLDSQGHVVLTDFGLCKE--GVEPEETTSTFCGT 159
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 56.8 bits (137), Expect = 2e-08
Identities = 46/139 (33%), Positives = 64/139 (46%), Gaps = 21/139 (15%)
Query: 519 PNKSLDSFIFDQTRRTL-LDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQ 577
++S DS + T + LD A+G+ +L + IHRD+ A NVLL
Sbjct: 191 SSQSSDSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFL---ASKNCIHRDVAARNVLLTD 247
Query: 578 DMNPKISDFGLVRTFGGDET---EGNTNRVV------GTYDGQFSIKSDVFSFGILLLEI 628
KI DFGL R D +GN V +D ++++SDV+S+GILL EI
Sbjct: 248 GRVAKICDFGLARDIMNDSNYVVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEI 307
Query: 629 VS-GKK-------NRGFYR 639
S GK N FY+
Sbjct: 308 FSLGKSPYPGILVNSKFYK 326
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Score = 55.8 bits (134), Expect = 2e-08
Identities = 57/222 (25%), Positives = 96/222 (43%), Gaps = 38/222 (17%)
Query: 437 NATDNFSINNKLGEGGFGPVYK-GTLVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQ- 494
+ +D + I +G+G +G V+K +G + AVK L I + +E++ E + L
Sbjct: 15 DPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIHDID-EEIEAEYNILKALSD 73
Query: 495 HRNLVKLLGC-----CIQGEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRF------H 543
H N+VK G G++ L+ E S+ + + L +R +
Sbjct: 74 HPNVVKFYGMYYKKDVKNGDQLWLVLELCNGGSVTDLV-----KGFLKRGERMEEPIIAY 128
Query: 544 IICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNTNR 603
I+ GL +LH + + IHRD+K +N+LL + K+ DFG+ NT+
Sbjct: 129 ILHEALMGLQHLHVN---KTIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNTS- 184
Query: 604 VVGT--------------YDGQFSIKSDVFSFGILLLEIVSG 631
VGT D + + DV+S GI +E+ G
Sbjct: 185 -VGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDG 225
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286 |
| >gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 55.8 bits (134), Expect = 3e-08
Identities = 62/226 (27%), Positives = 99/226 (43%), Gaps = 48/226 (21%)
Query: 434 TIANATDNFSINNKLGEGGFGPVYKG-TLVDGQEIAVKRLSKISEQGL--KELKNEVILF 490
TI + + + +G G +G V G +AVK+LS+ + + K E+ L
Sbjct: 11 TIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLL 70
Query: 491 SKLQHRNLVKLLGCCIQGEEKLLIYEFMPNKSLDSF--IFDQTR------------RTLL 536
++H N++ LL F P +SL+ F ++ T + L
Sbjct: 71 KHMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLT 118
Query: 537 DWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDE 596
D +F +I RGL Y+H IIHRDLK SN+ +++D KI DFGL R DE
Sbjct: 119 DDHVQF-LIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR-HTDDE 173
Query: 597 TEGNTNRVVGT--YDG--------QFSIKSDVFSFGILLLEIVSGK 632
G V T Y ++ D++S G ++ E+++G+
Sbjct: 174 MTG----YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 215
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345 |
| >gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Score = 55.8 bits (134), Expect = 3e-08
Identities = 53/205 (25%), Positives = 97/205 (47%), Gaps = 22/205 (10%)
Query: 440 DNFSINNKLGEGGFGPVYKGTLVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHR--- 496
D+F ++LG G G V K I ++L + + ++N++I ++ H
Sbjct: 5 DDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIK--PAIRNQIIRELQVLHECNS 62
Query: 497 -NLVKLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYL 555
+V G E + E M SLD + + +R + + I RGL YL
Sbjct: 63 PYIVGFYGAFYSDGEISICMEHMDGGSLDQ-VLKEAKRIPEEILGKVSI--AVLRGLAYL 119
Query: 556 HQDSRLRIIHRDLKASNVLLDQDMNPKISDFG--------LVRTFGGDETEGNTNRVVGT 607
+ + +I+HRD+K SN+L++ K+ DFG + +F G + + R+ GT
Sbjct: 120 RE--KHQIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFVGTRSYMSPERLQGT 177
Query: 608 YDGQFSIKSDVFSFGILLLEIVSGK 632
+ +S++SD++S G+ L+E+ G+
Sbjct: 178 H---YSVQSDIWSMGLSLVELAIGR 199
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331 |
| >gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 54.9 bits (132), Expect = 3e-08
Identities = 68/283 (24%), Positives = 115/283 (40%), Gaps = 63/283 (22%)
Query: 448 LGEGGFGPVYKGT---LVDGQ-----EIAVKRLSKISEQGLKELKNEVILFSKLQHRNLV 499
LG+G F ++KG + D E+ +K L K + + S+L H++LV
Sbjct: 3 LGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLV 62
Query: 500 KLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDS 559
G C+ G+E +++ E++ SLD+++ + + L++ S + + A L +L
Sbjct: 63 LNYGVCVCGDESIMVQEYVKFGSLDTYL--KKNKNLINISWKLEVAKQLAWALHFLEDKG 120
Query: 560 RLRIIHRDLKASNVLL-----DQDMNP---KISDFGLVRTFGGDETEGNTNRV------V 605
+ H ++ A NVLL + NP K+SD G+ T E R+
Sbjct: 121 ---LTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISITVLPKEIL--LERIPWVPPEC 175
Query: 606 GTYDGQFSIKSDVFSFGILLLEIVSG----------KKNRGFYRSDTKVNLIGHLWDEGI 655
S+ +D +SFG L EI SG +K FY + + L W E
Sbjct: 176 IENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQKKLQFY--EDRHQLPAPKWTE-- 231
Query: 656 PLRLIDACIQDSCNLADVIRCIHIGLLCVQQHPEDRPCMPSVI 698
LA++I C+ P+ RP ++I
Sbjct: 232 --------------LANLINQ------CMDYEPDFRPSFRAII 254
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 55.0 bits (132), Expect = 4e-08
Identities = 69/268 (25%), Positives = 120/268 (44%), Gaps = 40/268 (14%)
Query: 448 LGEGGFGPVYKGTLV----DGQEIAVKRLS--KISEQGLKELKNEVILFSKLQHRNLVKL 501
+G+G +G V +LV DG++ +K+L+ S + K + E L S+L+H N+V
Sbjct: 8 VGKGSYGEV---SLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAY 64
Query: 502 LGCCIQGEEKLL--IYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDS 559
+GE+ LL + F L + +Q + L + +Q A L YLH+
Sbjct: 65 RESW-EGEDGLLYIVMGFCEGGDLYHKLKEQKGKLLPE-NQVVEWFVQIAMALQYLHEK- 121
Query: 560 RLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNTNRVVGT---------YDG 610
I+HRDLK NV L + K+ D G+ R +T ++GT +
Sbjct: 122 --HILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQCDMAST--LIGTPYYMSPELFSNK 177
Query: 611 QFSIKSDVFSFGILLLEIVSGKKNRGFYRSDTKVNLIGHLWDEGIPLRLIDACIQDSCNL 670
++ KSDV++ G + E+ + K F D +L+ + + +P D + L
Sbjct: 178 PYNYKSDVWALGCCVYEMATLK--HAFNAKDMN-SLVYRIIEGKLPPMPKDYSPE----L 230
Query: 671 ADVIRCIHIGLLCVQQHPEDRPCMPSVI 698
++I +L + PE RP + S++
Sbjct: 231 GELIA----TMLS--KRPEKRPSVKSIL 252
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Score = 55.8 bits (134), Expect = 4e-08
Identities = 43/143 (30%), Positives = 68/143 (47%), Gaps = 29/143 (20%)
Query: 465 QEIAVKRLSKI--SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMPNKS 522
+ +A+K+LS+ ++ K E++L + H+N++ LL F P KS
Sbjct: 50 RNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNV------------FTPQKS 97
Query: 523 LDSF--------IFD----QTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKA 570
L+ F + D Q + LD + +++ G+ +LH IIHRDLK
Sbjct: 98 LEEFQDVYIVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKP 154
Query: 571 SNVLLDQDMNPKISDFGLVRTFG 593
SN+++ D KI DFGL RT G
Sbjct: 155 SNIVVKSDCTLKILDFGLARTAG 177
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364 |
| >gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Score = 55.4 bits (133), Expect = 5e-08
Identities = 45/144 (31%), Positives = 67/144 (46%), Gaps = 29/144 (20%)
Query: 462 VDGQEIAVKRLSKI--SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMP 519
V G +AVK+LS+ ++ K E++L + H+N++ LL F P
Sbjct: 44 VLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNV------------FTP 91
Query: 520 NKSLDSF--------IFD----QTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRD 567
KSL+ F + D Q LD + +++ G+ +LH IIHRD
Sbjct: 92 QKSLEEFQDVYLVMELMDANLCQVIHMELDHERMSYLLYQMLCGIKHLHSAG---IIHRD 148
Query: 568 LKASNVLLDQDMNPKISDFGLVRT 591
LK SN+++ D KI DFGL RT
Sbjct: 149 LKPSNIVVKSDCTLKILDFGLART 172
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359 |
| >gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Score = 55.1 bits (133), Expect = 5e-08
Identities = 58/220 (26%), Positives = 97/220 (44%), Gaps = 41/220 (18%)
Query: 441 NFSINNKLGEGGFGPV----YKGTLVDGQEIAVKRLSKI------SEQGLKELKNEVILF 490
+ + +LG+G +G V T + + +A+K+++ + +++ L+ELK +L
Sbjct: 1 RYELIKELGQGAYGIVCSARNAET-SEEETVAIKKITNVFSKKILAKRALRELK---LLR 56
Query: 491 SKLQHRNLVKLLGCCI---QGEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHI--- 544
H+N+ L I +L +YE + L I ++ + L D H
Sbjct: 57 HFRGHKNITCLYDMDIVFPGNFNELYLYEELMEADLHQII--RSGQPLTD----AHFQSF 110
Query: 545 ICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTF--GGDETEGNTN 602
I GL Y+H + ++HRDLK N+L++ D KI DFGL R F E G
Sbjct: 111 IYQILCGLKYIHSAN---VLHRDLKPGNLLVNADCELKICDFGLARGFSENPGENAGFMT 167
Query: 603 RVVGT--YDG--------QFSIKSDVFSFGILLLEIVSGK 632
V T Y ++ DV+S G +L E++ K
Sbjct: 168 EYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRK 207
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332 |
| >gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Score = 55.0 bits (132), Expect = 5e-08
Identities = 51/171 (29%), Positives = 78/171 (45%), Gaps = 44/171 (25%)
Query: 447 KLGEGGFGPVYKGTLVD-GQEIAVKRLS-KISEQGLK-ELKNEVILFSKLQ---HRNLVK 500
++G G +G VYK G +A+K + + +E GL EV L +L+ H N+V+
Sbjct: 7 EIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVR 66
Query: 501 LLGCCIQG----EEKL-LIYEFMPNKSLDSFIFDQTRRTLL--------------DWSQR 541
L+ C E K+ L++E + DQ RT L D ++
Sbjct: 67 LMDVCATSRTDRETKVTLVFEHV----------DQDLRTYLDKVPPPGLPAETIKDLMRQ 116
Query: 542 FHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTF 592
F RGL +LH + I+HRDLK N+L+ K++DFGL R +
Sbjct: 117 F------LRGLDFLHAN---CIVHRDLKPENILVTSGGQVKLADFGLARIY 158
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 55.2 bits (133), Expect = 5e-08
Identities = 64/203 (31%), Positives = 100/203 (49%), Gaps = 31/203 (15%)
Query: 448 LGEGGFGPVY---KGTLVD-GQEIAVKRLSKISEQGLK-----ELKNEVILFSKLQHRNL 498
LG+G FG V+ K T D GQ A+K L K + LK K E + +++ H +
Sbjct: 4 LGQGSFGKVFLVRKITGPDAGQLYAMKVLKKAT---LKVRDRVRTKMERDILAEVNHPFI 60
Query: 499 VKLLGCCIQGEEKL-LIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQ 557
VKL Q E KL LI +F+ L + + + T D +F++ A L +LH
Sbjct: 61 VKL-HYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEED--VKFYL-AELALALDHLH- 115
Query: 558 DSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNTNRVVGTYDGQ------ 611
L II+RDLK N+LLD++ + K++DFGL + + E GT +
Sbjct: 116 --SLGIIYRDLKPENILLDEEGHIKLTDFGLSKE--SIDHEKKAYSFCGTVEYMAPEVVN 171
Query: 612 ---FSIKSDVFSFGILLLEIVSG 631
+ +D +SFG+L+ E+++G
Sbjct: 172 RRGHTQSADWWSFGVLMFEMLTG 194
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Score = 55.1 bits (132), Expect = 6e-08
Identities = 43/143 (30%), Positives = 68/143 (47%), Gaps = 29/143 (20%)
Query: 465 QEIAVKRLSKI--SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMPNKS 522
+ +A+K+LS+ ++ K E++L + H+N++ LL F P KS
Sbjct: 43 RNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNV------------FTPQKS 90
Query: 523 LDSF--------IFD----QTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKA 570
L+ F + D Q + LD + +++ G+ +LH IIHRDLK
Sbjct: 91 LEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKP 147
Query: 571 SNVLLDQDMNPKISDFGLVRTFG 593
SN+++ D KI DFGL RT G
Sbjct: 148 SNIVVKSDCTLKILDFGLARTAG 170
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355 |
| >gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Score = 54.2 bits (130), Expect = 6e-08
Identities = 54/197 (27%), Positives = 87/197 (44%), Gaps = 18/197 (9%)
Query: 448 LGEGGFGPV------YKGTLVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKL 501
LG+GGFG V G + +++ KRL K S + + L+ E++ K+ +V L
Sbjct: 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEIL--EKVNSPFIVNL 58
Query: 502 LGCCIQGEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRL 561
L+ M L I++ R L + + H G+L+LH +
Sbjct: 59 AYAFESKTHLCLVMSLMNGGDLKYHIYNVGERGL-EMERVIHYSAQITCGILHLHS---M 114
Query: 562 RIIHRDLKASNVLLDQDMNPKISDFGL-VRTFGGDET--EGNTNRVVGT---YDGQFSIK 615
I++RD+K NVLLD N ++SD GL V G TN + + +S
Sbjct: 115 DIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGKTITQRAGTNGYMAPEILKEEPYSYP 174
Query: 616 SDVFSFGILLLEIVSGK 632
D F+ G + E+V+G+
Sbjct: 175 VDWFAMGCSIYEMVAGR 191
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277 |
| >gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Score = 54.8 bits (132), Expect = 7e-08
Identities = 37/95 (38%), Positives = 52/95 (54%), Gaps = 18/95 (18%)
Query: 549 ARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVR--TFGGDETEGNTNRVVG 606
A GL +LH II+RDLK NV+LD + + KI+DFG+ + FGG T G
Sbjct: 111 AIGLFFLHSKG---IIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGGK----TTRTFCG 163
Query: 607 TYD--------GQFSIKS-DVFSFGILLLEIVSGK 632
T D Q KS D ++FG+LL E+++G+
Sbjct: 164 TPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQ 198
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 54.4 bits (131), Expect = 8e-08
Identities = 54/166 (32%), Positives = 78/166 (46%), Gaps = 15/166 (9%)
Query: 448 LGEGGFGPVYKGT-LVDGQEIAVKRLSKISEQGLKELKNEV----ILFSKLQHRNLVKLL 502
+G+G FG V DG+ AVK L K + KE K+ + +L ++H LV L
Sbjct: 3 IGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGL- 61
Query: 503 GCCIQGEEKL-LIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRL 561
Q +KL + +++ L F Q R+ + RF+ A L YLH L
Sbjct: 62 HYSFQTADKLYFVLDYVNGGEL--FFHLQRERSFPEPRARFYA-AEIASALGYLHS---L 115
Query: 562 RIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNTNRVVGT 607
II+RDLK N+LLD + ++DFGL + G E T+ GT
Sbjct: 116 NIIYRDLKPENILLDSQGHVVLTDFGLCKE--GIEHSKTTSTFCGT 159
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 54.6 bits (132), Expect = 8e-08
Identities = 51/163 (31%), Positives = 78/163 (47%), Gaps = 30/163 (18%)
Query: 440 DNFSINNKLGEGGFGPVYKGTLV----DGQEIAVKRLSKISEQGLKELKNEVILFSKLQH 495
D+F + +G G FG V+ LV GQ A+K L K +K +N++
Sbjct: 1 DDFEVIKVIGRGAFGEVW---LVRDKDTGQVYAMKVLRK--SDMIK--RNQIAHV--RAE 51
Query: 496 RN---------LVKLLGCCIQGEEKL-LIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHII 545
R+ +VKL Q EE L L+ E+MP L + + + + + RF+I
Sbjct: 52 RDILADADSPWIVKLY-YSFQDEEHLYLVMEYMPGGDLMNLLIRK--DVFPEETARFYI- 107
Query: 546 CGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGL 588
A +L L +L IHRD+K N+L+D D + K++DFGL
Sbjct: 108 ---AELVLALDSVHKLGFIHRDIKPDNILIDADGHIKLADFGL 147
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 54.3 bits (130), Expect = 8e-08
Identities = 55/198 (27%), Positives = 85/198 (42%), Gaps = 20/198 (10%)
Query: 448 LGEGGFGPVYKGTL-VDGQEIAVKRLSKI---SEQGLKELKNEVILFSKLQHRNLVKLLG 503
LG+GGFG V + G+ A K+L K +G NE + K+ R +V L
Sbjct: 8 LGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAY 67
Query: 504 CCIQGEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFH---IICGTARGLLYLHQDSR 560
+ L+ M L I+ + F+ I CG L LHQ+
Sbjct: 68 AYETKDALCLVLTLMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCG----LEDLHQE-- 121
Query: 561 LRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNTNRVVG------TYDGQFSI 614
RI++RDLK N+LLD + +ISD GL +T VG + +++
Sbjct: 122 -RIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQTIKGRVGTVGYMAPEVVKNERYTF 180
Query: 615 KSDVFSFGILLLEIVSGK 632
D ++ G LL E+++G+
Sbjct: 181 SPDWWALGCLLYEMIAGQ 198
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 54.3 bits (130), Expect = 9e-08
Identities = 38/100 (38%), Positives = 56/100 (56%), Gaps = 15/100 (15%)
Query: 543 HIICGT---ARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDET-- 597
+IC + A+G+ +L SR + IHRDL A N+LL ++ KI DFGL R D
Sbjct: 180 DLICYSFQVAKGMEFLA--SR-KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYV 236
Query: 598 -EGNTNRVV------GTYDGQFSIKSDVFSFGILLLEIVS 630
+G+ + +D ++I+SDV+SFG+LL EI S
Sbjct: 237 RKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 276
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343 |
| >gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 54.2 bits (130), Expect = 9e-08
Identities = 51/163 (31%), Positives = 75/163 (46%), Gaps = 23/163 (14%)
Query: 549 ARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDET---EGNTNRVV 605
ARG+ +L SR + IHRDL A N+LL ++ KI DFGL R D +G+ +
Sbjct: 184 ARGMEFLA--SR-KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPL 240
Query: 606 ------GTYDGQFSIKSDVFSFGILLLEIVSGKKNRGFYRSDTKVNLIGHLWDEGIPLRL 659
+D ++ +SDV+SFG+LL EI S + G +E RL
Sbjct: 241 KWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGAS----------PYPGVQINEEFCQRL 290
Query: 660 IDACIQDSCNLADVIRCIHIGLLCVQQHPEDRPCMPSVILMLG 702
D + A I L C Q P++RP +++ +LG
Sbjct: 291 KDGTRMRAPENATP-EIYRIMLACWQGDPKERPTFSALVEILG 332
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338 |
| >gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 53.3 bits (128), Expect = 1e-07
Identities = 40/150 (26%), Positives = 69/150 (46%), Gaps = 14/150 (9%)
Query: 447 KLGEGGFGPVYKGTLVDGQEIA---VKRLSKISEQGLKELKNEVIL----FSKLQHRNLV 499
++G G FG V + +A VK L + KE +NE + + LQH N++
Sbjct: 2 EIGNGWFGKVLLSEIYTDTGVARVVVKELK--ANASSKE-QNEFLQQGDPYRILQHPNIL 58
Query: 500 KLLGCCIQGEEKLLIYEFMPNKSLDSFIF-DQTRRTLLDWSQRFHIICGTARGLLYLHQD 558
+ LG C++ LL++E+ L S++ +Q R + C A G+ ++H
Sbjct: 59 QCLGQCVEAIPYLLVFEYCELGDLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMH-- 116
Query: 559 SRLRIIHRDLKASNVLLDQDMNPKISDFGL 588
+ +H DL N L D+ K+ D+G+
Sbjct: 117 -KHNFLHSDLALRNCFLTSDLTVKVGDYGI 145
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268 |
| >gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Score = 53.6 bits (129), Expect = 1e-07
Identities = 53/211 (25%), Positives = 92/211 (43%), Gaps = 27/211 (12%)
Query: 441 NFSINNKLGEGGFGPVY----KGTLVDGQEIAVKRLSKIS----EQGLKELKNEVILFSK 492
NF + LG G +G V+ G G+ A+K L K + + + + E +
Sbjct: 1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEA 60
Query: 493 LQHRNLVKLLGCCIQGEEKL-LIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARG 551
++ + L Q + KL LI +++ L + ++ + T + R +I A
Sbjct: 61 VRRCPFLVTLHYAFQTDTKLHLILDYVNGGELFTHLYQREHFTESE--VRVYI----AEI 114
Query: 552 LLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNTNRVVGTY--- 608
+L L +L II+RD+K N+LLD + + ++DFGL + F +E E GT
Sbjct: 115 VLALDHLHQLGIIYRDIKLENILLDSEGHVVLTDFGLSKEFLAEEEE-RAYSFCGTIEYM 173
Query: 609 --------DGQFSIKSDVFSFGILLLEIVSG 631
G D +S G+L E+++G
Sbjct: 174 APEVIRGGSGGHDKAVDWWSLGVLTFELLTG 204
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288 |
| >gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Score = 53.9 bits (130), Expect = 1e-07
Identities = 42/178 (23%), Positives = 72/178 (40%), Gaps = 54/178 (30%)
Query: 440 DNFSINNKLGEGGFGPVYKGTLVD---GQEIAVKRLSKISE------QGLKELKNEVILF 490
+ +G G +G V +D G+++A+K++ + + L+ELK +
Sbjct: 5 SRYKPIENIGSGAYGVVCSA--IDTRSGKKVAIKKIPHAFDVPTLAKRTLRELK----IL 58
Query: 491 SKLQHRNLVKLLGCCIQGEEKLLIYEFMPNKSL--DSF-IFDQTRRTLLDWSQRFHIICG 547
+H N++ + P + D + + D L S HII
Sbjct: 59 RHFKHDNIIAIRDI------------LRPPGADFKDVYVVMD------LMESDLHHIIHS 100
Query: 548 TA---------------RGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVR 590
RGL Y+H + +IHRDLK SN+L+++D +I DFG+ R
Sbjct: 101 DQPLTEEHIRYFLYQLLRGLKYIHSAN---VIHRDLKPSNLLVNEDCELRIGDFGMAR 155
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 53.4 bits (128), Expect = 2e-07
Identities = 54/202 (26%), Positives = 89/202 (44%), Gaps = 28/202 (13%)
Query: 448 LGEGGFGPVYKGTL-VDGQEIAVKRLSKI---SEQGLKELKNEVILFSKLQHRNLVKLLG 503
LG+GGFG V + G+ A KRL K +G NE + K+ + +V L
Sbjct: 8 LGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAY 67
Query: 504 CCIQGEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFH---IICGTARGLLYLHQDSR 560
+ L+ M L I++ + F+ I+CG L LH+++
Sbjct: 68 AYETKDALCLVLTIMNGGDLKFHIYNMGNPGFEEERALFYAAEILCG----LEDLHREN- 122
Query: 561 LRIIHRDLKASNVLLDQDMNPKISDFGL-VRTFGGDETEGNTNRVVGTY---------DG 610
++RDLK N+LLD + +ISD GL V+ G+ G VGT +
Sbjct: 123 --TVYRDLKPENILLDDYGHIRISDLGLAVKIPEGESIRGR----VGTVGYMAPEVLNNQ 176
Query: 611 QFSIKSDVFSFGILLLEIVSGK 632
++++ D + G L+ E++ G+
Sbjct: 177 RYTLSPDYWGLGCLIYEMIEGQ 198
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 53.5 bits (129), Expect = 2e-07
Identities = 51/157 (32%), Positives = 75/157 (47%), Gaps = 34/157 (21%)
Query: 448 LGEGGFGPVYKGTLV----DGQEIAVKRLSKISEQGLKE----LKNEVILFSKLQHRNLV 499
+G G FG V LV G A+K+L K SE KE ++ E + ++ + +V
Sbjct: 9 IGRGAFGEV---RLVQKKDTGHIYAMKKLRK-SEMLEKEQVAHVRAERDILAEADNPWVV 64
Query: 500 KLLGCCIQGEEKL-LIYEFMPNKSL-------DSFIFDQTRRTLLDWSQRFHIICGTARG 551
KL Q E L LI E++P + D+F ++TR F+I A
Sbjct: 65 KLY-YSFQDENYLYLIMEYLPGGDMMTLLMKKDTFTEEETR---------FYI----AET 110
Query: 552 LLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGL 588
+L + +L IHRD+K N+LLD + K+SDFGL
Sbjct: 111 ILAIDSIHKLGYIHRDIKPDNLLLDAKGHIKLSDFGL 147
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364 |
| >gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Score = 53.1 bits (127), Expect = 2e-07
Identities = 54/210 (25%), Positives = 92/210 (43%), Gaps = 25/210 (11%)
Query: 441 NFSINNKLGEGGFGPVYKGTLVDGQE----IAVKRLSKIS----EQGLKELKNEVILFSK 492
NF + LG G +G V+ V G + A+K L K + + + + E +
Sbjct: 1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEH 60
Query: 493 LQHRNLVKLLGCCIQGEEKL-LIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARG 551
++ + L Q + KL LI +++ L + + + R Q I G
Sbjct: 61 IRQSPFLVTLHYAFQTDTKLHLILDYINGGELFTHLSQRERFK----EQEVQIYSGEI-- 114
Query: 552 LLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNTN--------- 602
+L L +L II+RD+K N+LLD + + ++DFGL + F DE E +
Sbjct: 115 VLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFHEDEVERAYSFCGTIEYMA 174
Query: 603 -RVVGTYDGQFSIKSDVFSFGILLLEIVSG 631
+V DG D +S G+L+ E+++G
Sbjct: 175 PDIVRGGDGGHDKAVDWWSMGVLMYELLTG 204
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 53.3 bits (128), Expect = 2e-07
Identities = 62/214 (28%), Positives = 98/214 (45%), Gaps = 44/214 (20%)
Query: 441 NFSINNKLGEGGFGPV----YKGTLVDGQEIAVKRLSK---ISEQGLKELKNEVILFSKL 493
+F + LG G FG V +KGT G+ A+K L K + + ++ + E + +L
Sbjct: 19 DFEMGETLGTGSFGRVRIAKHKGT---GEYYAIKCLKKREILKMKQVQHVAQEKSILMEL 75
Query: 494 QHRNLVKLLGCCIQGEEKL-LIYEFMPNKSLDSFIFDQTR---RTLLDWSQRFHIICGTA 549
H +V ++ C Q E ++ + EF+ L F R R D ++ +H A
Sbjct: 76 SHPFIVNMM-CSFQDENRVYFLLEFVVGGEL----FTHLRKAGRFPNDVAKFYH-----A 125
Query: 550 RGLL---YLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNTNRVVG 606
+L YLH II+RDLK N+LLD + K++DFG F + T + G
Sbjct: 126 ELVLAFEYLHS---KDIIYRDLKPENLLLDNKGHVKVTDFG----FAKKVPD-RTFTLCG 177
Query: 607 T--YDGQFSIKS-------DVFSFGILLLEIVSG 631
T Y I+S D ++ G+LL E ++G
Sbjct: 178 TPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAG 211
|
Length = 329 |
| >gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Score = 53.2 bits (128), Expect = 2e-07
Identities = 43/169 (25%), Positives = 67/169 (39%), Gaps = 44/169 (26%)
Query: 448 LGEGGFGPVYKGTLVD---GQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGC 504
LG G G V+ VD + +AVK++ Q +K E+ + +L H N+VK
Sbjct: 13 LGCGSNGLVFSA--VDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVK---- 66
Query: 505 CIQGEEKLLIYE--FMPNKSLDSFIFDQTR-------RTLLDWSQRFHIICGTA------ 549
+YE L + T + ++ + G
Sbjct: 67 ---------VYEVLGPSGSDLTEDVGSLTELNSVYIVQEYMETDLANVLEQGPLSEEHAR 117
Query: 550 -------RGLLYLHQDSRLRIIHRDLKASNVLLDQ-DMNPKISDFGLVR 590
RGL Y+H + ++HRDLK +NV ++ D+ KI DFGL R
Sbjct: 118 LFMYQLLRGLKYIHSAN---VLHRDLKPANVFINTEDLVLKIGDFGLAR 163
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342 |
| >gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Score = 53.1 bits (127), Expect = 3e-07
Identities = 37/91 (40%), Positives = 49/91 (53%), Gaps = 12/91 (13%)
Query: 549 ARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDE---TEGNTNRVV 605
ARG+ +L + +HRDL A NVLL Q KI DFGL R D ++G+T V
Sbjct: 247 ARGMEFLASKN---CVHRDLAARNVLLAQGKIVKICDFGLARDIMHDSNYVSKGSTFLPV 303
Query: 606 ------GTYDGQFSIKSDVFSFGILLLEIVS 630
+D ++ SDV+S+GILL EI S
Sbjct: 304 KWMAPESIFDNLYTTLSDVWSYGILLWEIFS 334
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400 |
| >gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Score = 53.0 bits (127), Expect = 3e-07
Identities = 31/76 (40%), Positives = 40/76 (52%), Gaps = 9/76 (11%)
Query: 564 IHRDLKASNVLLDQDMNPKISDFGLVRTFGGDET---EGNTNRVV------GTYDGQFSI 614
IHRDL A N+LL KI DFGL R D +GN V ++ ++
Sbjct: 236 IHRDLAARNILLTHGRITKICDFGLARDIRNDSNYVVKGNARLPVKWMAPESIFNCVYTF 295
Query: 615 KSDVFSFGILLLEIVS 630
+SDV+S+GILL EI S
Sbjct: 296 ESDVWSYGILLWEIFS 311
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375 |
| >gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 52.7 bits (126), Expect = 3e-07
Identities = 59/212 (27%), Positives = 94/212 (44%), Gaps = 48/212 (22%)
Query: 448 LGEGGFGPVYKGTLVD-GQEIAVKRLSKISEQGL--KELKNEVILFSKLQHRNLVKLLGC 504
+G G +G V Q++AVK+LS+ + + + E+ L ++H N++ LL
Sbjct: 23 VGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDV 82
Query: 505 CIQGEEKLLIYEFMPNKSLDSF--IFDQTR------------RTLLDWSQRFHIICGTAR 550
F P S+++F ++ T + L D +F +I R
Sbjct: 83 ------------FTPATSIENFNEVYLVTNLMGADLNNIVKCQKLSDEHVQF-LIYQLLR 129
Query: 551 GLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNTNRVVGT--Y 608
GL Y+H IIHRDLK SNV +++D +I DFGL R DE G V T Y
Sbjct: 130 GLKYIHSAG---IIHRDLKPSNVAVNEDCELRILDFGLARQ-ADDEMTG----YVATRWY 181
Query: 609 DG--------QFSIKSDVFSFGILLLEIVSGK 632
++ D++S G ++ E++ GK
Sbjct: 182 RAPEIMLNWMHYNQTVDIWSVGCIMAELLKGK 213
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343 |
| >gnl|CDD|221289 pfam11883, DUF3403, Domain of unknown function (DUF3403) | Back alignment and domain information |
|---|
Score = 46.2 bits (110), Expect = 6e-07
Identities = 20/43 (46%), Positives = 27/43 (62%), Gaps = 2/43 (4%)
Query: 707 LPQPKQPGYLADRKSTEPYSSSSMP--ESSSTNTLTISELEAR 747
+PQPKQPG+ R E SSSS ES + N +T+S ++AR
Sbjct: 6 IPQPKQPGFCVGRSPYETDSSSSTQRDESWTVNQVTVSVIDAR 48
|
This domain is functionally uncharacterized. This domain is found in eukaryotes. This presumed domain is about 50 amino acids in length. This domain is found associated with pfam00069, pfam08276, pfam00954, pfam01453. Length = 48 |
| >gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 51.9 bits (124), Expect = 6e-07
Identities = 55/207 (26%), Positives = 90/207 (43%), Gaps = 38/207 (18%)
Query: 448 LGEGGFGPV-YKGTLVDGQEIAVKRLSKI--SEQGLKELKNEVILFSKLQHRNLVKLLGC 504
+G G +G V G ++A+K+L + SE K E+ L ++H N++ LL
Sbjct: 23 VGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDV 82
Query: 505 CIQGEEKLLIYEFMPNKSLDSFI-------FDQTRRTLLDWSQRF------HIICGTARG 551
F P+ SLD F F T L ++ ++ +G
Sbjct: 83 ------------FTPDLSLDRFHDFYLVMPFMGTDLGKLMKHEKLSEDRIQFLVYQMLKG 130
Query: 552 LLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNTNR------VV 605
L Y+H IIHRDLK N+ +++D KI DFGL R + T R V+
Sbjct: 131 LKYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGLARQTDSEMTGYVVTRWYRAPEVI 187
Query: 606 GTYDGQFSIKSDVFSFGILLLEIVSGK 632
+ ++ D++S G ++ E+++GK
Sbjct: 188 LNW-MHYTQTVDIWSVGCIMAEMLTGK 213
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343 |
| >gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Score = 51.6 bits (123), Expect = 8e-07
Identities = 52/207 (25%), Positives = 97/207 (46%), Gaps = 26/207 (12%)
Query: 440 DNFSINNKLGEGGFGPVYKGTLVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHR--- 496
D+F ++LG G G V+K + I ++L + + ++N++I ++ H
Sbjct: 5 DDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIK--PAIRNQIIRELQVLHECNS 62
Query: 497 -NLVKLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQTR--RTLLDWSQRFHIICGTARGLL 553
+V G E + E M SLD + R +L + +GL
Sbjct: 63 PYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILG-----KVSIAVIKGLT 117
Query: 554 YLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFG--------LVRTFGGDETEGNTNRVV 605
YL + + +I+HRD+K SN+L++ K+ DFG + +F G + + R+
Sbjct: 118 YLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFVGTRSYMSPERLQ 175
Query: 606 GTYDGQFSIKSDVFSFGILLLEIVSGK 632
GT+ +S++SD++S G+ L+E+ G+
Sbjct: 176 GTH---YSVQSDIWSMGLSLVEMAIGR 199
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333 |
| >gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Score = 50.8 bits (121), Expect = 1e-06
Identities = 49/149 (32%), Positives = 72/149 (48%), Gaps = 13/149 (8%)
Query: 448 LGEGGFGPVYKGTL-VDGQEIAVKRLSKISEQGLKELKNEV----ILFSKLQHRNLVKLL 502
+G+G FG V +DG+ AVK L K KE K+ + +L ++H LV L
Sbjct: 3 IGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGL- 61
Query: 503 GCCIQGEEKL-LIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRL 561
Q EKL + +F+ L F Q R+ + RF+ A L YLH +
Sbjct: 62 HYSFQTTEKLYFVLDFVNGGEL--FFHLQRERSFPEPRARFYA-AEIASALGYLHS---I 115
Query: 562 RIIHRDLKASNVLLDQDMNPKISDFGLVR 590
I++RDLK N+LLD + ++DFGL +
Sbjct: 116 NIVYRDLKPENILLDSQGHVVLTDFGLCK 144
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325 |
| >gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Score = 50.6 bits (121), Expect = 1e-06
Identities = 55/201 (27%), Positives = 95/201 (47%), Gaps = 26/201 (12%)
Query: 448 LGEGGFGPVYKGTLVDGQEI-AVKRLSK---ISEQGLK-ELKNEVILFSKLQHRNLVKLL 502
LG+G FG V L E+ A+K L K + + + + + IL +H L L
Sbjct: 3 LGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALH 62
Query: 503 GCCIQGEEKLL-IYEFMPNKSLDSFIFDQTRRTLLDWSQ-RFHIICGTARGLLYLHQDSR 560
CC Q +++L + E++ L +F R D + RF+ T L++LH+
Sbjct: 63 -CCFQTKDRLFFVMEYVNGGDL---MFQIQRSRKFDEPRSRFYAAEVTL-ALMFLHRHG- 116
Query: 561 LRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNTNRVVGTYD---------GQ 611
+I+RDLK N+LLD + + K++DFG+ + G T GT D +
Sbjct: 117 --VIYRDLKLDNILLDAEGHCKLADFGMCKE--GILNGVTTTTFCGTPDYIAPEILQELE 172
Query: 612 FSIKSDVFSFGILLLEIVSGK 632
+ D ++ G+L+ E+++G+
Sbjct: 173 YGPSVDWWALGVLMYEMMAGQ 193
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321 |
| >gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 50.2 bits (120), Expect = 2e-06
Identities = 62/215 (28%), Positives = 89/215 (41%), Gaps = 54/215 (25%)
Query: 448 LGEGGFGPVYKGTL-VDGQEIAVKRLSKISEQGLKELK------NEVILFSKLQHRNLVK 500
LG+GGFG V + G+ A K+L K + +K+ K NE + K+ R +V
Sbjct: 8 LGKGGFGEVCACQVRATGKMYACKKLEK---KRIKKRKGEAMALNEKQILEKVNSRFVVS 64
Query: 501 LL-------GCCI------QGEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICG 547
L C+ G+ K IY FD+ R I CG
Sbjct: 65 LAYAYETKDALCLVLTLMNGGDLKFHIYNMGNPG------FDEERAVFY----AAEITCG 114
Query: 548 TARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGL-VRTFGGDETEGNTNRVVG 606
L LH R RI++RDLK N+LLD + +ISD GL V G+ G VG
Sbjct: 115 ----LEDLH---RERIVYRDLKPENILLDDYGHIRISDLGLAVEIPEGETIRGR----VG 163
Query: 607 TY---------DGQFSIKSDVFSFGILLLEIVSGK 632
T + +++ D + G L+ E++ GK
Sbjct: 164 TVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGK 198
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285 |
| >gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Score = 50.0 bits (119), Expect = 2e-06
Identities = 54/210 (25%), Positives = 96/210 (45%), Gaps = 26/210 (12%)
Query: 441 NFSINNKLGEGGFGPVYKGTLVDGQE----IAVKRLSKIS----EQGLKELKNEVILFSK 492
NF + LG G +G V+ V G + A+K L K + + ++ + E +
Sbjct: 1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEH 60
Query: 493 LQHRNLVKLLGCCIQGEEKL-LIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARG 551
++ + L Q E KL LI +++ + + ++ R + RF+ +
Sbjct: 61 VRQSPFLVTLHYAFQTEAKLHLILDYVSGGEMFTHLYQ--RDNFSEDEVRFY----SGEI 114
Query: 552 LLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNTNRVVGT--YD 609
+L L +L I++RD+K N+LLD + + ++DFGL + F +E E T GT Y
Sbjct: 115 ILALEHLHKLGIVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEEKE-RTYSFCGTIEYM 173
Query: 610 GQFSIKS--------DVFSFGILLLEIVSG 631
I+ D +S GIL+ E+++G
Sbjct: 174 APEIIRGKGGHGKAVDWWSLGILIFELLTG 203
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332 |
| >gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Score = 50.9 bits (122), Expect = 2e-06
Identities = 57/238 (23%), Positives = 97/238 (40%), Gaps = 64/238 (26%)
Query: 442 FSINNKLGEGGFGPVYKG-TLVDGQEIAVKRLSK-ISEQGL--KELKNEVILFSKLQHRN 497
+ I +G+GG G VY V + +A+K++ + +SE L K E + + L H
Sbjct: 4 YDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPG 63
Query: 498 LVKLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQTRRTLLD--WSQR-------------- 541
+V + C G+ +Y MP +I T ++LL W +
Sbjct: 64 IVPVYSICSDGD---PVYYTMP------YIEGYTLKSLLKSVWQKESLSKELAEKTSVGA 114
Query: 542 ----FHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDET 597
FH IC T Y+H S+ ++HRDLK N+LL I D+G +E
Sbjct: 115 FLSIFHKICATIE---YVH--SK-GVLHRDLKPDNILLGLFGEVVILDWGAAIFKKLEEE 168
Query: 598 E------GNTN----------RVVGTYD---------GQFSIKSDVFSFGILLLEIVS 630
+ N ++VGT D S +D+++ G++L ++++
Sbjct: 169 DLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLT 226
|
Length = 932 |
| >gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Score = 49.6 bits (118), Expect = 3e-06
Identities = 52/201 (25%), Positives = 93/201 (46%), Gaps = 26/201 (12%)
Query: 448 LGEGGFGPVYKGTLVDGQEIAVKRLSKIS----EQGLKELKNEVILFSKLQHRNLVKLLG 503
+G G + V L +I ++ K ++ + ++ E +F + + L
Sbjct: 3 IGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLH 62
Query: 504 CCIQGEEKL-LIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHI--ICGTARGLLYLHQDSR 560
C Q +L L+ E++ L Q +R L + RF+ IC L +LH+
Sbjct: 63 SCFQTTSRLFLVIEYVNGGDL--MFHMQRQRKLPEEHARFYAAEIC---IALNFLHERG- 116
Query: 561 LRIIHRDLKASNVLLDQDMNPKISDFGLVRT--FGGDETE---GNTN----RVVGTYDGQ 611
II+RDLK NVLLD D + K++D+G+ + GD T G N ++ +
Sbjct: 117 --IIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPGDTTSTFCGTPNYIAPEILRGEEYG 174
Query: 612 FSIKSDVFSFGILLLEIVSGK 632
FS+ D ++ G+L+ E+++G+
Sbjct: 175 FSV--DWWALGVLMFEMMAGR 193
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327 |
| >gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 48.6 bits (116), Expect = 4e-06
Identities = 56/209 (26%), Positives = 93/209 (44%), Gaps = 30/209 (14%)
Query: 448 LGEGGFGPVYKGTL-VDGQEIAVKRLSKISEQGLKELKNE----------VILFSKLQHR 496
LG+G F +YKG L V V ++S LK L ++ L S+L H+
Sbjct: 3 LGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVV-LKVLGSDHRDSLAFFETASLMSQLSHK 61
Query: 497 NLVKLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLH 556
+LVKL G C++ +E +++ E++ LD F+ + L W + + A L YL
Sbjct: 62 HLVKLYGVCVR-DENIMVEEYVKFGPLDVFLHREKNNVSLHW--KLDVAKQLASALHYLE 118
Query: 557 QDSRLRIIHRDLKASNVLLDQDMNP-------KISDFGLVRTFGG-DETEGNTNRVVGTY 608
+++H ++ N+L+ + K+SD G+ T +E +
Sbjct: 119 DK---KLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIPITVLSREERVERIPWIAPEC 175
Query: 609 --DGQFSIKS--DVFSFGILLLEIVSGKK 633
+GQ S+ D +SFG LLEI S +
Sbjct: 176 IRNGQASLTIAADKWSFGTTLLEICSNGE 204
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259 |
| >gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 49.3 bits (117), Expect = 6e-06
Identities = 47/172 (27%), Positives = 79/172 (45%), Gaps = 40/172 (23%)
Query: 482 ELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYE---FMPNKSLD----SFIFDQTRRT 534
+L+NE++ +L H N++K+ E++L E +M + D SF++D+
Sbjct: 209 QLENEILALGRLNHENILKI--------EEILRSEANTYMITQKYDFDLYSFMYDEA--- 257
Query: 535 LLDWS------QRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGL 588
DW Q I+ + Y+H ++IHRD+K N+ L+ D + DFG
Sbjct: 258 -FDWKDRPLLKQTRAIMKQLLCAVEYIHDK---KLIHRDIKLENIFLNCDGKIVLGDFGT 313
Query: 589 VRTFGGDETEGNTNRVVGTY----------DGQFSIKSDVFSFGILLLEIVS 630
F E E VGT DG I +D++S G++LL+++S
Sbjct: 314 AMPF-EKEREAFDYGWVGTVATNSPEILAGDGYCEI-TDIWSCGLILLDMLS 363
|
Length = 501 |
| >gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 48.1 bits (114), Expect = 9e-06
Identities = 44/159 (27%), Positives = 73/159 (45%), Gaps = 17/159 (10%)
Query: 440 DNFSINNKLGEGGFGPVYKGTLVDGQ--EIAVKRLSK---ISEQGLKELKNEVILFSKLQ 494
++F+ LG G FG V T + +A+KR K I ++ + + +E + + +
Sbjct: 30 EDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYIN 89
Query: 495 HRNLVKLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICG---TARG 551
H V L G L+ EF+ +F+ RR ++RF G A+
Sbjct: 90 HPFCVNLYGSFKDESYLYLVLEFVIGGEFFTFL----RR-----NKRFPNDVGCFYAAQI 140
Query: 552 LLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVR 590
+L L I++RDLK N+LLD+D K++DFG +
Sbjct: 141 VLIFEYLQSLNIVYRDLKPENLLLDKDGFIKMTDFGFAK 179
|
Length = 340 |
| >gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Score = 48.5 bits (115), Expect = 9e-06
Identities = 49/195 (25%), Positives = 92/195 (47%), Gaps = 30/195 (15%)
Query: 406 EKTENSRETDQENEDQNIDLELPLFELATIANATDNFSINNKLGEGGFGPVYKGTLVDGQ 465
E++ N+ + E+E++ ID ++ + ++ + N +G G FG VY+ +D
Sbjct: 39 ERSHNNNAGEDEDEEKMIDNDIN-------RSPNKSYKLGNIIGNGSFGVVYEAICIDTS 91
Query: 466 E-IAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGC----CIQGEEKLL----IYE 516
E +A+K++ + + +EL ++ L H N++ L C + EK + + E
Sbjct: 92 EKVAIKKVLQDPQYKNREL----LIMKNLNHINIIFLKDYYYTECFKKNEKNIFLNVVME 147
Query: 517 FMP---NKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNV 573
F+P +K + + + L + +C R L Y+H I HRDLK N+
Sbjct: 148 FIPQTVHKYMKHYARNNHALPLFLVKLYSYQLC---RALAYIHSKF---ICHRDLKPQNL 201
Query: 574 LLDQDMNP-KISDFG 587
L+D + + K+ DFG
Sbjct: 202 LIDPNTHTLKLCDFG 216
|
Length = 440 |
| >gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Score = 47.7 bits (113), Expect = 1e-05
Identities = 31/94 (32%), Positives = 51/94 (54%), Gaps = 16/94 (17%)
Query: 549 ARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNTNRV-VGT 607
+ GL +LH+ II+RDLK NV+LD + + KI+DFG+ + +G T R GT
Sbjct: 111 SVGLFFLHRRG---IIYRDLKLDNVMLDSEGHIKIADFGMCKE---HMVDGVTTRTFCGT 164
Query: 608 YD---------GQFSIKSDVFSFGILLLEIVSGK 632
D + D +++G+LL E+++G+
Sbjct: 165 PDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQ 198
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323 |
| >gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Score = 47.7 bits (113), Expect = 1e-05
Identities = 60/241 (24%), Positives = 109/241 (45%), Gaps = 42/241 (17%)
Query: 419 EDQNIDLELPLFE-----LATIANATDNFSINNKLGEGGFGPVYKGTLVDGQEI-AVKRL 472
+++NID L +E + + +++ + +G G FG V Q++ A+K L
Sbjct: 17 KNKNIDNFLNRYEKIVRKIRKLQMKAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLL 76
Query: 473 SKI-----SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKL-LIYEFMPNKSLDSF 526
SK S+ + +++ F+ + V L C Q ++ L ++ E+MP L +
Sbjct: 77 SKFEMIKRSDSAFFWEERDIMAFA---NSPWVVQLFCAFQDDKYLYMVMEYMPGGDLVNL 133
Query: 527 I--FDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKIS 584
+ +D + W++ + TA +L L + +IHRD+K N+LLD+ + K++
Sbjct: 134 MSNYDVPEK----WAKFY-----TAEVVLALDAIHSMGLIHRDVKPDNMLLDKHGHLKLA 184
Query: 585 DFGLVRTFGGDETEG-NTNRVVGTY-------------DGQFSIKSDVFSFGILLLEIVS 630
DFG DET + VGT DG + + D +S G+ L E++
Sbjct: 185 DFGTCMKM--DETGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLV 242
Query: 631 G 631
G
Sbjct: 243 G 243
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370 |
| >gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 47.9 bits (114), Expect = 1e-05
Identities = 66/307 (21%), Positives = 106/307 (34%), Gaps = 52/307 (16%)
Query: 407 KTENSRETDQENEDQNIDLELPLFELATIANATD----NFSINNKLGEGGFGPVYKGTL- 461
+ D+E+ D+ E + ++ ++I + L G G V+ T
Sbjct: 55 THATDYDADEESLSPQTDVCQEPCETTSSSDPASVVRMQYNILSSLTPGSEGEVFVCTKH 114
Query: 462 --VDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMP 519
+++ VK ++ G K E+ + + HR ++ L+ K + MP
Sbjct: 115 GDEQRKKVIVKAVT-----GGKTPGREIDILKTISHRAIINLIHAY---RWKSTVCMVMP 166
Query: 520 NKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDM 579
D F + R L Q I L YLH IIHRD+K N+ LD+
Sbjct: 167 KYKCDLFTYVD-RSGPLPLEQAITIQRRLLEALAYLHGRG---IIHRDVKTENIFLDEPE 222
Query: 580 NPKISDFGLVRTFGGDETEGNTNRVVGTYDGQ---------FSIKSDVFSFGILLLEIVS 630
N + DFG GT + + K+D++S G++L E+
Sbjct: 223 NAVLGDFGAACKLDAHPDTPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSV 282
Query: 631 GKKNRGFYRSDTKVNLIGHLWDEGIPLRLIDACIQ---------DSCNLADVIRCIHIGL 681
KN + +V LR I C+Q S NL C H
Sbjct: 283 --KNVTLF--GKQVKSSSS------QLRSIIRCMQVHPLEFPQNGSTNL-----CKHFKQ 327
Query: 682 LCVQQHP 688
+ P
Sbjct: 328 YAIVLRP 334
|
Length = 392 |
| >gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 47.5 bits (113), Expect = 2e-05
Identities = 48/167 (28%), Positives = 74/167 (44%), Gaps = 30/167 (17%)
Query: 440 DNFSINNKLGEGGFGPVYKGTLV----DGQEIAVKRLSK---ISEQGLKELKNEVILFSK 492
++F +G+G FG V LV G+ A+K L K + L +K E + ++
Sbjct: 1 EDFHTVKVIGKGAFGEV---RLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAE 57
Query: 493 LQHRNLVKLLGCCIQGEEKLLIYEFMPNKSL-------DSFIFDQTRRTLLDWSQRFHII 545
+V L + LI EF+P L D+F D TR F++
Sbjct: 58 SDSPWVVSLYYSFQDAQYLYLIMEFLPGGDLMTMLIKYDTFSEDVTR---------FYM- 107
Query: 546 CGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTF 592
A +L + +L IHRD+K N+L+D+ + K+SDFGL F
Sbjct: 108 ---AECVLAIEAVHKLGFIHRDIKPDNILIDRGGHIKLSDFGLSTGF 151
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377 |
| >gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 47.1 bits (112), Expect = 2e-05
Identities = 29/95 (30%), Positives = 47/95 (49%), Gaps = 15/95 (15%)
Query: 550 RGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDE------TEGNTNR 603
R L Y+H + + HRDLK N+L + D KI DFGL R D T+ R
Sbjct: 114 RALKYIHTAN---VFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATR 170
Query: 604 ------VVGTYDGQFSIKSDVFSFGILLLEIVSGK 632
+ G++ +++ D++S G + E+++GK
Sbjct: 171 WYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGK 205
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338 |
| >gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Score = 46.9 bits (111), Expect = 2e-05
Identities = 55/202 (27%), Positives = 84/202 (41%), Gaps = 28/202 (13%)
Query: 448 LGEGGFGPVYKGTL-VDGQEIAVKRLSKI---SEQGLKELKNEVILFSKLQHRNLVKLLG 503
LG+GGFG V + G+ A K+L K +G NE + K+ R +V L
Sbjct: 8 LGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAY 67
Query: 504 CCIQGEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFH---IICGTARGLLYLHQDSR 560
+ L+ M L I++ + F+ + CG L R
Sbjct: 68 AYETKDALCLVLTIMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCG-------LEDLQR 120
Query: 561 LRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNTNR-VVGTY---------DG 610
RI++RDLK N+LLD + +ISD GL EG T R VGT +
Sbjct: 121 ERIVYRDLKPENILLDDRGHIRISDLGLAVQI----PEGETVRGRVGTVGYMAPEVINNE 176
Query: 611 QFSIKSDVFSFGILLLEIVSGK 632
+++ D + G L+ E++ G+
Sbjct: 177 KYTFSPDWWGLGCLIYEMIQGQ 198
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285 |
| >gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Score = 46.6 bits (110), Expect = 3e-05
Identities = 45/166 (27%), Positives = 82/166 (49%), Gaps = 18/166 (10%)
Query: 477 EQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLL-IYEFMPNKSLDSFIFDQTRRTL 535
++ + ++ E +F + + + L C Q E +L + E++ L Q +R L
Sbjct: 36 DEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNGGDL--MFHMQRQRKL 93
Query: 536 LDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRT--FG 593
+ RF+ + L YLH+ II+RDLK NVLLD + + K++D+G+ +
Sbjct: 94 PEEHARFYS-AEISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRP 149
Query: 594 GDETE---GNTN----RVVGTYDGQFSIKSDVFSFGILLLEIVSGK 632
GD T G N ++ D FS+ D ++ G+L+ E+++G+
Sbjct: 150 GDTTSTFCGTPNYIAPEILRGEDYGFSV--DWWALGVLMFEMMAGR 193
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329 |
| >gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Score = 46.7 bits (111), Expect = 3e-05
Identities = 44/143 (30%), Positives = 71/143 (49%), Gaps = 22/143 (15%)
Query: 502 LGCCIQGEEKL-LIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHI--ICGTARGLLYLHQD 558
L C Q E +L + EF+ L Q +R L + RF+ I L +LH+
Sbjct: 61 LHSCFQTESRLFFVIEFVSGGDL--MFHMQRQRKLPEEHARFYSAEIS---LALNFLHER 115
Query: 559 SRLRIIHRDLKASNVLLDQDMNPKISDFGLVRT--FGGDETE---GNTN----RVVGTYD 609
II+RDLK NVLLD + + K++D+G+ + GD T G N ++ D
Sbjct: 116 G---IIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPGDTTSTFCGTPNYIAPEILRGED 172
Query: 610 GQFSIKSDVFSFGILLLEIVSGK 632
FS+ D ++ G+L+ E+++G+
Sbjct: 173 YGFSV--DWWALGVLMFEMMAGR 193
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329 |
| >gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Score = 46.5 bits (110), Expect = 3e-05
Identities = 32/93 (34%), Positives = 48/93 (51%), Gaps = 14/93 (15%)
Query: 549 ARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNTNRVVGTY 608
A GL +LH II+RDLK NV+LD + + KI+DFG+ + D T GT
Sbjct: 111 AIGLFFLHSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKENMWDGV--TTKTFCGTP 165
Query: 609 D---------GQFSIKSDVFSFGILLLEIVSGK 632
D + D ++FG+LL E+++G+
Sbjct: 166 DYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQ 198
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323 |
| >gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 46.3 bits (110), Expect = 3e-05
Identities = 44/153 (28%), Positives = 74/153 (48%), Gaps = 18/153 (11%)
Query: 448 LGEGGFGPVYKGTLVDGQE----IAVKRLSKI----SEQGLKELKNEVILFSKLQHRNLV 499
LG+GG+G V++ V G + A+K L K +++ K E + ++H +V
Sbjct: 4 LGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIV 63
Query: 500 KLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQTRR--TLLDWSQRFHIICGTARGLLYLHQ 557
L+ G + LI E++ L F R ++ + F++ + L +LHQ
Sbjct: 64 DLIYAFQTGGKLYLILEYLSGGEL----FMHLEREGIFMEDTACFYL-SEISLALEHLHQ 118
Query: 558 DSRLRIIHRDLKASNVLLDQDMNPKISDFGLVR 590
II+RDLK N+LLD + K++DFGL +
Sbjct: 119 ---QGIIYRDLKPENILLDAQGHVKLTDFGLCK 148
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323 |
| >gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 46.1 bits (110), Expect = 4e-05
Identities = 63/235 (26%), Positives = 94/235 (40%), Gaps = 64/235 (27%)
Query: 447 KLGEGGFGPVY----KGTLVDGQEIAVKRLSKISEQGLKELKN---EVILFSKLQHRNLV 499
LG+G G V+ KGT G+ A+K L K ++K E + + L H L
Sbjct: 8 LLGKGDVGRVFLVRLKGT---GKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLP 64
Query: 500 KLLGCCIQGEEKL-LIYEFMPNKSLDSFIFDQTRRTLLDWSQRFH---IICGTARGLLYL 555
L Q E L L+ ++ P L + Q + L + RF+ ++ L YL
Sbjct: 65 TLY-ASFQTETYLCLVMDYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLA----LEYL 119
Query: 556 HQDSRLRIIHRDLKASNVLLDQDMNPKISDFGL--------------------------- 588
H L I++RDLK N+LL + + +SDF L
Sbjct: 120 HL---LGIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPVSKALRKGSRRSSVNSI 176
Query: 589 -VRTFGGDETEGNTNRVVGT--Y--------DGQ-FSIKSDVFSFGILLLEIVSG 631
TF +E +N VGT Y DG ++ D ++ GILL E++ G
Sbjct: 177 PSETF-SEEPSFRSNSFVGTEEYIAPEVISGDGHGSAV--DWWTLGILLYEMLYG 228
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316 |
| >gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Score = 46.2 bits (109), Expect = 4e-05
Identities = 52/166 (31%), Positives = 77/166 (46%), Gaps = 15/166 (9%)
Query: 448 LGEGGFGPVYKGT-LVDGQEIAVKRLSKISEQGLKELKNEV----ILFSKLQHRNLVKLL 502
+G+G FG V + + AVK L K + KE K+ + +L ++H LV L
Sbjct: 3 IGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGL- 61
Query: 503 GCCIQGEEKL-LIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRL 561
Q +KL + +++ L F Q R L+ RF+ A L YLH L
Sbjct: 62 HFSFQTADKLYFVLDYINGGEL--FYHLQRERCFLEPRARFYA-AEIASALGYLHS---L 115
Query: 562 RIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNTNRVVGT 607
I++RDLK N+LLD + ++DFGL + E G T+ GT
Sbjct: 116 NIVYRDLKPENILLDSQGHIVLTDFGLCKE--NIEHNGTTSTFCGT 159
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325 |
| >gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein | Back alignment and domain information |
|---|
Score = 46.4 bits (110), Expect = 5e-05
Identities = 45/190 (23%), Positives = 82/190 (43%), Gaps = 27/190 (14%)
Query: 464 GQEIAVKRLSKISEQGLKE---LKNEVILFSKLQHRNLVKLLGCCIQGEEKLL-IYEFMP 519
G E+A+K L + + + + E L ++L H N+V LL L ++E++P
Sbjct: 3 GHEVAIKLLRTDAPEEEHQRARFRRETALCARLYHPNIVALLDSGEAPPGLLFAVFEYVP 62
Query: 520 NKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLL---D 576
++L + L + ++ L H I+HRDLK N+++
Sbjct: 63 GRTLREVLAADG---ALPAGETGRLMLQVLDALACAHNQG---IVHRDLKPQNIMVSQTG 116
Query: 577 QDMNPKISDFGLVRTFGGDE-----TEGNTNRVVGT--YDG--QF-----SIKSDVFSFG 622
+ K+ DFG+ G T T V+GT Y Q + SD++++G
Sbjct: 117 VRPHAKVLDFGIGTLLPGVRDADVATLTRTTEVLGTPTYCAPEQLRGEPVTPNSDLYAWG 176
Query: 623 ILLLEIVSGK 632
++ LE ++G+
Sbjct: 177 LIFLECLTGQ 186
|
This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266 |
| >gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 46.3 bits (109), Expect = 6e-05
Identities = 68/259 (26%), Positives = 106/259 (40%), Gaps = 63/259 (24%)
Query: 440 DNFSINNKLGEGGFGPVYKGTLVDGQEIAVKRLSKISEQGLKE-----LKNEVILFSKLQ 494
+ + + K+G G FG V+ QE + IS +GLKE L EV + +L+
Sbjct: 13 NEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWK--AISYRGLKEREKSQLVIEVNVMRELK 70
Query: 495 HRNLVKLLGCCI-QGEEKLLI-YEFMPNKSLDSFIFDQTRRTLLDWSQRF-----HIICG 547
H+N+V+ + + + +KL I EF L R + + F H I
Sbjct: 71 HKNIVRYIDRFLNKANQKLYILMEFCDAGDLS--------RNIQKCYKMFGKIEEHAIVD 122
Query: 548 TARGLL----YLHQ----DSRLRIIHRDLKASNVLLD-------------QDMN----PK 582
R LL Y H + R++HRDLK N+ L ++N K
Sbjct: 123 ITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNLNGRPIAK 182
Query: 583 ISDFGLVRTFGGDETEGNTNRVVGT-----------YDGQFSIKSDVFSFGILLLEIVSG 631
I DFGL + G E + VGT + KSD+++ G ++ E+ SG
Sbjct: 183 IGDFGLSKNIG---IESMAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSG 239
Query: 632 KKNRGFYRSDTKVNLIGHL 650
K F++++ LI L
Sbjct: 240 KTP--FHKANNFSQLISEL 256
|
Length = 1021 |
| >gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Score = 45.4 bits (107), Expect = 6e-05
Identities = 43/153 (28%), Positives = 72/153 (47%), Gaps = 10/153 (6%)
Query: 440 DNFSINNKLGEGGFGPVYKGTLVD-GQEIAVKRLSK---ISEQGLKELKNEVILFSKLQH 495
D+F +G G FG V D G A+K L K + ++ + ++ E + +
Sbjct: 1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADG 60
Query: 496 RNLVKLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYL 555
+VK+ LI EF+P + + + + TL + + +F+I A +L +
Sbjct: 61 AWVVKMFYSFQDKRNLYLIMEFLPGGDMMTLLM--KKDTLSEEATQFYI----AETVLAI 114
Query: 556 HQDSRLRIIHRDLKASNVLLDQDMNPKISDFGL 588
+L IHRD+K N+LLD + K+SDFGL
Sbjct: 115 DAIHQLGFIHRDIKPDNLLLDAKGHVKLSDFGL 147
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 45.2 bits (107), Expect = 8e-05
Identities = 32/86 (37%), Positives = 44/86 (51%), Gaps = 8/86 (9%)
Query: 440 DNFSINNKLGEGGFGPVYKGTLVD-GQE-----IAVKRLSKISEQGLKE-LKNEVILFSK 492
DN LG G FG V + T G+E +AVK L + +E L +E+ + S
Sbjct: 38 DNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSH 97
Query: 493 L-QHRNLVKLLGCCIQGEEKLLIYEF 517
L QH+N+V LLG C G L+I E+
Sbjct: 98 LGQHKNIVNLLGACTHGGPVLVITEY 123
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 45.6 bits (108), Expect = 8e-05
Identities = 28/91 (30%), Positives = 48/91 (52%), Gaps = 9/91 (9%)
Query: 552 LLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNTNRVVGT--YD 609
LL +H +IHRD+K++N+LL + K+ DFG + + ++ GT Y
Sbjct: 153 LLAVHHVHSKHMIHRDIKSANILLCSNGLVKLGDFGFSKMYAATVSDDVGRTFCGTPYYV 212
Query: 610 G-------QFSIKSDVFSFGILLLEIVSGKK 633
+S K+D+FS G+LL E+++ K+
Sbjct: 213 APEIWRRKPYSKKADMFSLGVLLYELLTLKR 243
|
Length = 496 |
| >gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Score = 45.0 bits (106), Expect = 1e-04
Identities = 42/153 (27%), Positives = 71/153 (46%), Gaps = 10/153 (6%)
Query: 440 DNFSINNKLGEGGFGPVYKGTLVD-GQEIAVKRLSK---ISEQGLKELKNEVILFSKLQH 495
++F +G G FG V D G A+K L K + ++ + ++ E + +
Sbjct: 1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADS 60
Query: 496 RNLVKLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYL 555
+VK+ LI EF+P + + + + TL + +F+I A +L +
Sbjct: 61 LWVVKMFYSFQDKLNLYLIMEFLPGGDMMTLLM--KKDTLTEEETQFYI----AETVLAI 114
Query: 556 HQDSRLRIIHRDLKASNVLLDQDMNPKISDFGL 588
+L IHRD+K N+LLD + K+SDFGL
Sbjct: 115 DSIHQLGFIHRDIKPDNLLLDSKGHVKLSDFGL 147
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363 |
| >gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Score = 44.5 bits (105), Expect = 1e-04
Identities = 59/206 (28%), Positives = 83/206 (40%), Gaps = 37/206 (17%)
Query: 448 LGEGGFGPVYKGTLVD-GQEIAVKRLSKIS---EQGLKELKNEVILFSKLQHRNLVKLLG 503
+G GGFG VY D G+ A+K L K +QG NE I+ S LV
Sbjct: 2 IGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLS------LVSTGD 55
Query: 504 C----CIQGEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYL---- 555
C C+ Y F L SFI D L + H + A Y
Sbjct: 56 CPFIVCMS-------YAFHTPDKL-SFILDLMNGGDLHYHLSQHGVFSEAEMRFYAAEII 107
Query: 556 ----HQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDE------TEGNTNRVV 605
H +R +++RDLK +N+LLD+ + +ISD GL F + T G V
Sbjct: 108 LGLEHMHNRF-VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASVGTHGYMAPEV 166
Query: 606 GTYDGQFSIKSDVFSFGILLLEIVSG 631
+ +D FS G +L +++ G
Sbjct: 167 LQKGVAYDSSADWFSLGCMLFKLLRG 192
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278 |
| >gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Score = 44.4 bits (105), Expect = 1e-04
Identities = 31/100 (31%), Positives = 51/100 (51%), Gaps = 18/100 (18%)
Query: 552 LLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNTNRV-VGT--Y 608
L YLH +++RDLK N++LD+D + KI+DFGL + ++G T + GT Y
Sbjct: 108 LGYLH---SCDVVYRDLKLENLMLDKDGHIKITDFGLCKE---GISDGATMKTFCGTPEY 161
Query: 609 -------DGQFSIKSDVFSFGILLLEIVSGKKNRGFYRSD 641
D + D + G+++ E++ G+ FY D
Sbjct: 162 LAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR--LPFYNQD 199
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323 |
| >gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Score = 44.6 bits (105), Expect = 1e-04
Identities = 29/76 (38%), Positives = 42/76 (55%), Gaps = 9/76 (11%)
Query: 564 IHRDLKASNVLLDQDMNPKISDFGLVRTFGGDE---TEGNTNRVV------GTYDGQFSI 614
+HRDL A NVL+ + KI DFGL R D ++G+T + ++ ++
Sbjct: 261 VHRDLAARNVLICEGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLYTT 320
Query: 615 KSDVFSFGILLLEIVS 630
SDV+SFGILL EI +
Sbjct: 321 LSDVWSFGILLWEIFT 336
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401 |
| >gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 44.2 bits (104), Expect = 2e-04
Identities = 57/214 (26%), Positives = 94/214 (43%), Gaps = 29/214 (13%)
Query: 448 LGEGGFGPVYKGTLVDGQEI-AVKRLSKISEQGLKEL-----KNEVILFSKLQHRNLVKL 501
+G+G FG VY+ D + I A+K LSK KE+ + +++ + L +
Sbjct: 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVG 60
Query: 502 LGCCIQGEEKL-LIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSR 560
L Q + L L+ ++M L F Q + +F+I A +L L +
Sbjct: 61 LKFSFQTDSDLYLVTDYMSGGEL--FWHLQKEGRFSEDRAKFYI----AELVLALEHLHK 114
Query: 561 LRIIHRDLKASNVLLDQDMNPKISDFGLVR-TFGGDETEGNTNRVVGTY----------D 609
I++RDLK N+LLD + + DFGL + ++T TN GT +
Sbjct: 115 YDIVYRDLKPENILLDATGHIALCDFGLSKANLTDNKT---TNTFCGTTEYLAPEVLLDE 171
Query: 610 GQFSIKSDVFSFGILLLEIVSGKKNRGFYRSDTK 643
++ D +S G+L+ E+ G FY DT+
Sbjct: 172 KGYTKHVDFWSLGVLVFEMCCGWSP--FYAEDTQ 203
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330 |
| >gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Score = 43.8 bits (103), Expect = 2e-04
Identities = 47/209 (22%), Positives = 93/209 (44%), Gaps = 27/209 (12%)
Query: 440 DNFSINNKLGEGGFGPVYKGTLVDGQEI-AVKRL------SKISEQGLKELKNEVILFSK 492
+ F + +GEG +G V K + +EI A+K+ ++ E L+ELK +
Sbjct: 1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELK----MLRT 56
Query: 493 LQHRNLVKLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGL 552
L+ N+V+L + + L++E++ L+ + ++ + R +I + +
Sbjct: 57 LKQENIVELKEAFRRRGKLYLVFEYVEKNMLE--LLEEMPNGVPPEKVRSYIY-QLIKAI 113
Query: 553 LYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNTNRVVGT----- 607
+ H++ I+HRD+K N+L+ + K+ DFG R + + N V T
Sbjct: 114 HWCHKND---IVHRDIKPENLLISHNDVLKLCDFGFARNL-SEGSNANYTEYVATRWYRS 169
Query: 608 ----YDGQFSIKSDVFSFGILLLEIVSGK 632
+ D++S G +L E+ G+
Sbjct: 170 PELLLGAPYGKAVDMWSVGCILGELSDGQ 198
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287 |
| >gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Score = 43.5 bits (102), Expect = 2e-04
Identities = 58/207 (28%), Positives = 83/207 (40%), Gaps = 39/207 (18%)
Query: 448 LGEGGFGPVYKGTLVD-GQEIAVKRLSKIS---EQGLKELKNEVILFSKLQHRNLVKLLG 503
+G GGFG VY D G+ A+K L K +QG NE I+ S LV
Sbjct: 2 IGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLS------LVSTGD 55
Query: 504 C----CIQGEEKLLIYEF-MPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYL--- 555
C C + Y F P+K FI D L + H + Y
Sbjct: 56 CPFIVC-------MTYAFHTPDKL--CFILDLMNGGDLHYHLSQHGVFSEKEMRFYATEI 106
Query: 556 -----HQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDE------TEGNTNRV 604
H +R +++RDLK +N+LLD+ + +ISD GL F + T G
Sbjct: 107 ILGLEHMHNRF-VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASVGTHGYMAPE 165
Query: 605 VGTYDGQFSIKSDVFSFGILLLEIVSG 631
V + +D FS G +L +++ G
Sbjct: 166 VLQKGTAYDSSADWFSLGCMLFKLLRG 192
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279 |
| >gnl|CDD|133207 cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 43.4 bits (102), Expect = 3e-04
Identities = 40/153 (26%), Positives = 70/153 (45%), Gaps = 20/153 (13%)
Query: 489 LFSKLQHRNLVKLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGT 548
L S++ H +L + G C++G E +++ EF+ + LD + + R + W + +
Sbjct: 69 LMSQVSHIHLAFVHGVCVRGSENIMVEEFVEHGPLDVCLRKEKGRVPVAW--KITVAQQL 126
Query: 549 ARGLLYLHQDSRLRIIHRDLKASNVL-----LDQDMNP--KISDFGLVRTFGGDETEGNT 601
A L YL + ++H ++ A N+L L + +P K+SD G+ +F E
Sbjct: 127 ASALSYLEDKN---LVHGNVCAKNILLARLGLAEGTSPFIKLSDPGV--SFTALSREERV 181
Query: 602 NRVVGTYD------GQFSIKSDVFSFGILLLEI 628
R+ S +D +SFG LLEI
Sbjct: 182 ERIPWIAPECVPGGNSLSTAADKWSFGTTLLEI 214
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 274 |
| >gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Score = 43.1 bits (101), Expect = 3e-04
Identities = 31/106 (29%), Positives = 53/106 (50%), Gaps = 19/106 (17%)
Query: 541 RFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGN 600
RF+I A +L +H +L +HRD+K NVLLD + + +++DFG D T
Sbjct: 105 RFYI----AEMVLAIHSIHQLHYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGTV-Q 159
Query: 601 TNRVVGTYD--------------GQFSIKSDVFSFGILLLEIVSGK 632
++ VGT D G++ + D +S G+ + E++ G+
Sbjct: 160 SSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGE 205
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331 |
| >gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Score = 42.7 bits (100), Expect = 4e-04
Identities = 39/158 (24%), Positives = 71/158 (44%), Gaps = 15/158 (9%)
Query: 447 KLGEGGFGPVYKGTLVDGQEIAVKRLSKISEQGLK-ELKNEVILFSKLQHRNLVKLLGCC 505
K+G G +G VYK DG++ L +I G+ E+ L +L+H N++ L
Sbjct: 8 KVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGISMSACREIALLRELKHPNVIALQKVF 67
Query: 506 IQGEEK--LLIYEFMPNKSLDSFIFDQTRRT-----LLDWSQRFHIICGTARGLLYLHQD 558
+ ++ L++++ + F + + L S ++ G+ YLH +
Sbjct: 68 LSHSDRKVWLLFDYAEHDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHAN 127
Query: 559 SRLRIIHRDLKASNVLL----DQDMNPKISDFGLVRTF 592
++HRDLK +N+L+ + KI+D G R F
Sbjct: 128 ---WVLHRDLKPANILVMGEGPERGRVKIADMGFARLF 162
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317 |
| >gnl|CDD|173643 cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 42.2 bits (99), Expect = 5e-04
Identities = 50/214 (23%), Positives = 88/214 (41%), Gaps = 47/214 (21%)
Query: 448 LGEGGFGPVYKGTLVD---------GQEIAVKRLSKISEQGLKELK----NEVILFSKLQ 494
LG G +Y G L E +K + K+ + +++ + ++
Sbjct: 3 LGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVS 62
Query: 495 HRNLVKLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLY 554
H+++V L G C++ E +++ EF+ LD F+ ++ +L +F + A L Y
Sbjct: 63 HKHIVLLYGVCVRDVENIMVEEFVEFGPLDLFMHRKS--DVLTTPWKFKVAKQLASALSY 120
Query: 555 LHQDSRLRIIHRDLKASNVLL-----DQDMNP--KISDFGLVRTFGGDE----------- 596
L +D L +H ++ N+LL D + P K+SD G+ T +
Sbjct: 121 L-EDKDL--VHGNVCTKNILLAREGIDGECGPFIKLSDPGIPITVLSRQECVERIPWIAP 177
Query: 597 --TEGNTNRVVGTYDGQFSIKSDVFSFGILLLEI 628
E + N SI +D +SFG L EI
Sbjct: 178 ECVEDSKN---------LSIAADKWSFGTTLWEI 202
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 262 |
| >gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Score = 42.7 bits (100), Expect = 5e-04
Identities = 39/149 (26%), Positives = 68/149 (45%), Gaps = 10/149 (6%)
Query: 448 LGEGGFGPVYKGTLVDGQEI-AVKRLSK---ISEQGLKELKNEVILFSKLQHRNLVKLLG 503
LG G FG V VD + A+K L K ++ + +K E + ++ + +VKL
Sbjct: 9 LGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYY 68
Query: 504 CCIQGEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRI 563
+ + +++P + S + + RF+I A L + ++
Sbjct: 69 SFQDKDNLYFVMDYIPGGDMMSLLIRM--EVFPEVLARFYI----AELTLAIESVHKMGF 122
Query: 564 IHRDLKASNVLLDQDMNPKISDFGLVRTF 592
IHRD+K N+L+D D + K++DFGL F
Sbjct: 123 IHRDIKPDNILIDLDGHIKLTDFGLCTGF 151
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381 |
| >gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Score = 42.5 bits (100), Expect = 5e-04
Identities = 41/155 (26%), Positives = 71/155 (45%), Gaps = 22/155 (14%)
Query: 448 LGEGGFGPVYKGTLVDGQEI-AVKRLSK---ISEQGLKELKNEVILFSKLQHRNLVKLLG 503
+G G FG V VD + A+K L K + +K E + ++ + +VKL
Sbjct: 9 IGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLY- 67
Query: 504 CCIQGEEKL-LIYEFMPNKSLDSF-----IFDQTRRTLLDWSQRFHIICGTARGLLYLHQ 557
Q ++ L + +++P + S IF++ RF+I A +
Sbjct: 68 YSFQDKDNLYFVMDYIPGGDMMSLLIRLGIFEEDL-------ARFYI----AELTCAIES 116
Query: 558 DSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTF 592
++ IHRD+K N+L+D+D + K++DFGL F
Sbjct: 117 VHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGF 151
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376 |
| >gnl|CDD|215638 PLN03225, PLN03225, Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Score = 42.5 bits (100), Expect = 8e-04
Identities = 15/26 (57%), Positives = 19/26 (73%)
Query: 440 DNFSINNKLGEGGFGPVYKGTLVDGQ 465
D+F + KLGEG FG VYK +LV+ Q
Sbjct: 132 DDFVLGKKLGEGAFGVVYKASLVNKQ 157
|
Length = 566 |
| >gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Score = 42.0 bits (98), Expect = 8e-04
Identities = 38/158 (24%), Positives = 70/158 (44%), Gaps = 15/158 (9%)
Query: 447 KLGEGGFGPVYKGTLVDGQEIAVKRLSKISEQGLK-ELKNEVILFSKLQHRNLVKLLGCC 505
K+G G +G VYK DG++ L +I G+ E+ L +L+H N++ L
Sbjct: 8 KVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGISMSACREIALLRELKHPNVISLQKVF 67
Query: 506 IQGEEK--LLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLY-----LHQD 558
+ ++ L++++ + F + + + + G + LLY +H
Sbjct: 68 LSHADRKVWLLFDYAEHDLWHIIKFHRASKAN---KKPVQLPRGMVKSLLYQILDGIHYL 124
Query: 559 SRLRIIHRDLKASNVLL----DQDMNPKISDFGLVRTF 592
++HRDLK +N+L+ + KI+D G R F
Sbjct: 125 HANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLF 162
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317 |
| >gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Score = 41.5 bits (97), Expect = 0.001
Identities = 28/99 (28%), Positives = 46/99 (46%), Gaps = 16/99 (16%)
Query: 552 LLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNTNRVVGT---- 607
L YLH +++RD+K N++LD+D + KI+DFGL + G GT
Sbjct: 108 LEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCKE--GISDGATMKTFCGTPEYL 162
Query: 608 -----YDGQFSIKSDVFSFGILLLEIVSGKKNRGFYRSD 641
D + D + G+++ E++ G+ FY D
Sbjct: 163 APEVLEDNDYGRAVDWWGLGVVMYEMMCGR--LPFYNQD 199
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323 |
| >gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Score = 41.6 bits (97), Expect = 0.001
Identities = 30/98 (30%), Positives = 47/98 (47%), Gaps = 12/98 (12%)
Query: 551 GLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNTNRVVGTY-- 608
L YLH +I++RDLK N++LD+D + KI+DFGL + D T Y
Sbjct: 107 ALDYLHSG---KIVYRDLKLENLMLDKDGHIKITDFGLCKEGITDAATMKTFCGTPEYLA 163
Query: 609 -----DGQFSIKSDVFSFGILLLEIVSGKKNRGFYRSD 641
D + D + G+++ E++ G+ FY D
Sbjct: 164 PEVLEDNDYGRAVDWWGLGVVMYEMMCGR--LPFYNQD 199
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328 |
| >gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Score = 41.7 bits (98), Expect = 0.001
Identities = 54/224 (24%), Positives = 99/224 (44%), Gaps = 37/224 (16%)
Query: 431 ELATIANATDNFSINNKLGEGGFGPVYKGTLVDGQEI-AVKRLSKISEQGLKELKNEVIL 489
++ + ++F + +G G FG V +++ A+K LSK + +K +++
Sbjct: 34 KITKLRMKAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKF--EMIK--RSDSAF 89
Query: 490 FSK----LQHRN--LVKLLGCCIQGEEKL-LIYEFMPNKSLDSFI--FDQTRRTLLDWSQ 540
F + + H N + L Q ++ L ++ E+MP L + + +D W+
Sbjct: 90 FWEERDIMAHANSEWIVQLHYAFQDDKYLYMVMEYMPGGDLVNLMSNYDIPE----KWA- 144
Query: 541 RFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGN 600
RF+ TA +L L + IHRD+K N+LLD+ + K++DFG +
Sbjct: 145 RFY----TAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMDANGMV-R 199
Query: 601 TNRVVGT-------------YDGQFSIKSDVFSFGILLLEIVSG 631
+ VGT DG + + D +S G+ L E++ G
Sbjct: 200 CDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVG 243
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370 |
| >gnl|CDD|240159 cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Score = 40.1 bits (94), Expect = 0.001
Identities = 31/143 (21%), Positives = 52/143 (36%), Gaps = 15/143 (10%)
Query: 447 KLGEGGFGPVYKGTLVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLV--KLLGC 504
L G VY ++ +K S + + + EV + L + L K+L
Sbjct: 5 LLKGGLTNRVYLLGT-KDEDYVLKINP--SREKGADREREVAILQLLARKGLPVPKVLAS 61
Query: 505 CIQGEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRII 564
L+ E++ ++LD + ++ I A L LHQ L +
Sbjct: 62 GESDGWSYLLMEWIEGETLDE----------VSEEEKEDIAEQLAELLAKLHQLPLLVLC 111
Query: 565 HRDLKASNVLLDQDMNPKISDFG 587
H DL N+L+D I D+
Sbjct: 112 HGDLHPGNILVDDGKILGIIDWE 134
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves as precursors to the synthesis of important biological compounds, such as the major phospholipids, phosphatidylcholine and phosphatidylethanolamine and the amino acids, threonine, methionine, and isoleucine. Length = 155 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 42.2 bits (99), Expect = 0.001
Identities = 45/172 (26%), Positives = 75/172 (43%), Gaps = 44/172 (25%)
Query: 440 DNFSINNKLGEGGFGPVYKG-TLVDGQEIAVKRLSK---ISEQGLKELKNE--------- 486
+ F I + G FG VY G + + AVK + K I++ + +++ E
Sbjct: 4 EEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKS 63
Query: 487 ---VILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMPNKSLDSFI-----FDQTRRTLLDW 538
V L+ LQ N V L+ E++ + S + FD+ +
Sbjct: 64 PFIVHLYYSLQSANNV------------YLVMEYLIGGDVKSLLHIYGYFDE------EM 105
Query: 539 SQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVR 590
+ ++ I A L YLH+ IIHRDLK N+L+ + + K++DFGL +
Sbjct: 106 AVKY--ISEVALALDYLHRHG---IIHRDLKPDNMLISNEGHIKLTDFGLSK 152
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Score = 41.2 bits (96), Expect = 0.001
Identities = 29/100 (29%), Positives = 48/100 (48%), Gaps = 15/100 (15%)
Query: 551 GLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNTNRVVGT--- 607
L YLH + +++RDLK N++LD+D + KI+DFGL + G + GT
Sbjct: 107 ALDYLHSEKN--VVYRDLKLENLMLDKDGHIKITDFGLCKE--GIKDGATMKTFCGTPEY 162
Query: 608 ------YDGQFSIKSDVFSFGILLLEIVSGKKNRGFYRSD 641
D + D + G+++ E++ G+ FY D
Sbjct: 163 LAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR--LPFYNQD 200
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325 |
| >gnl|CDD|165291 PHA02988, PHA02988, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 40.9 bits (96), Expect = 0.002
Identities = 41/196 (20%), Positives = 87/196 (44%), Gaps = 31/196 (15%)
Query: 456 VYKGTLVDGQEIAVKRLSK-------ISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQG 508
+YKG + +E+ ++ K + + E+KN ++ N++K+ G I
Sbjct: 36 IYKGIF-NNKEVIIRTFKKFHKGHKVLIDITENEIKN----LRRIDSNNILKIYGFIIDI 90
Query: 509 EEKL----LIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQ-DSRLRI 563
+ L LI E+ L + + L + + + +GL L++ ++
Sbjct: 91 VDDLPRLSLILEYCTRGYLREVLDKEKD---LSFKTKLDMAIDCCKGLYNLYKYTNK--- 144
Query: 564 IHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNTNRVV-GTYD------GQFSIKS 616
+++L + + L+ ++ KI GL + + N N +V +Y +++IK
Sbjct: 145 PYKNLTSVSFLVTENYKLKIICHGLEKILSSPPFK-NVNFMVYFSYKMLNDIFSEYTIKD 203
Query: 617 DVFSFGILLLEIVSGK 632
D++S G++L EI +GK
Sbjct: 204 DIYSLGVVLWEIFTGK 219
|
Length = 283 |
| >gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 40.9 bits (96), Expect = 0.002
Identities = 40/161 (24%), Positives = 72/161 (44%), Gaps = 26/161 (16%)
Query: 541 RFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGN 600
RF++ A +L + +L +HRD+K NVLLD++ + +++DFG D T
Sbjct: 105 RFYL----AEMVLAIDSVHQLGYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLADGTV-Q 159
Query: 601 TNRVVGTYD--------------GQFSIKSDVFSFGILLLEIVSGKKNRGFYRSDTKVNL 646
+N VGT D G++ + D +S G+ + E++ G+ FY +++ V
Sbjct: 160 SNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETP--FY-AESLVET 216
Query: 647 IGHLWDEGIPLRLIDACIQDSCNLADVIRCIHIGLLCVQQH 687
G + + + S D+IR L+C +
Sbjct: 217 YGKIMNHKEHFQFPPDVTDVSEEAKDLIR----RLICSPET 253
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331 |
| >gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 40.7 bits (95), Expect = 0.002
Identities = 57/203 (28%), Positives = 91/203 (44%), Gaps = 33/203 (16%)
Query: 448 LGEGGFGPVYKGTLVDGQEI-AVKRLSK---ISEQGLKELKNEVILFSKLQHRNLVKLLG 503
+G+G FG V + D Q I A+K + K +S + E + +++ +V L
Sbjct: 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPL-K 59
Query: 504 CCIQGEEKL-LIYEFMPNKSLDSFI-----FDQTRRTLLDWSQRFHIICGTARGLLYLHQ 557
Q EKL L+ F+ L + FD +R RF+ TA L L
Sbjct: 60 FSFQSPEKLYLVLAFINGGELFHHLQREGRFDLSR-------ARFY----TAELLCALEN 108
Query: 558 DSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNTNRVVGTYD-------- 609
+ +I+RDLK N+LLD + + DFGL + D+ + TN GT +
Sbjct: 109 LHKFNVIYRDLKPENILLDYQGHIALCDFGLCKLNMKDDDK--TNTFCGTPEYLAPELLL 166
Query: 610 GQFSIKS-DVFSFGILLLEIVSG 631
G K+ D ++ G+LL E+++G
Sbjct: 167 GHGYTKAVDWWTLGVLLYEMLTG 189
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312 |
| >gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 40.4 bits (94), Expect = 0.003
Identities = 38/167 (22%), Positives = 68/167 (40%), Gaps = 39/167 (23%)
Query: 486 EVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHII 545
E + + H ++++L G + LI +P D + + +R + I
Sbjct: 133 EAHILRAINHPSIIQLKGTFTYNKFTCLI---LPRYKTDLYCYLAAKRNI--------AI 181
Query: 546 C-------GTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETE 598
C R + YLH++ RIIHRD+KA N+ ++ + + DFG F D
Sbjct: 182 CDILAIERSVLRAIQYLHEN---RIIHRDIKAENIFINHPGDVCLGDFG-AACFPVDINA 237
Query: 599 GNTNRVVGTYDGQFSIKS-------------DVFSFGILLLEIVSGK 632
N+ G + G + + D++S GI+L E+ +
Sbjct: 238 ---NKYYG-WAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCH 280
|
Length = 391 |
| >gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Score = 39.8 bits (93), Expect = 0.003
Identities = 49/218 (22%), Positives = 95/218 (43%), Gaps = 37/218 (16%)
Query: 440 DNFSINNKLGEGGFGPVY----KGTLVDGQEIAVKRLSK---ISEQGLKELKNEVILFSK 492
+F + + +G G FG V K T G A+K + K ++++ + + E + S
Sbjct: 1 KDFDVKSLVGRGHFGEVQVVREKAT---GDIYAMKVMKKSVLLAQETVSFFEEERDILSI 57
Query: 493 LQHRNLVKLLGCCIQGEEKLLIYEFMPNKSLDSFI---FDQTRRTLLDWSQRFHIICGTA 549
+ +L + L+ E+ P L S + DQ + +F++ A
Sbjct: 58 SNSPWIPQLQYAFQDKDNLYLVMEYQPGGDLLSLLNRYEDQFDEDMA----QFYL----A 109
Query: 550 RGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNTNRVVGTYD 609
+L +H ++ +HRD+K NVL+D+ + K++DFG ++ N+ VGT D
Sbjct: 110 ELVLAIHSVHQMGYVHRDIKPENVLIDRTGHIKLADFGSAARLTANKMV-NSKLPVGTPD 168
Query: 610 ---------------GQFSIKSDVFSFGILLLEIVSGK 632
G + ++ D +S G++ E++ G+
Sbjct: 169 YIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGR 206
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330 |
| >gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Score = 39.7 bits (92), Expect = 0.004
Identities = 36/145 (24%), Positives = 67/145 (46%), Gaps = 28/145 (19%)
Query: 560 RLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNTNRVVGTYD---------- 609
+L +HRD+K N+L+D + + +++DFG D T ++ VGT D
Sbjct: 120 QLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTV-QSSVAVGTPDYISPEILQAM 178
Query: 610 ----GQFSIKSDVFSFGILLLEIVSGKKNRGFYRS---DTKVNLIGHLWDEGIPLRLIDA 662
G++ + D +S G+ + E++ G+ FY +T ++ H P ++ D
Sbjct: 179 EDGKGKYGPECDWWSLGVCMYEMLYGETP--FYAESLVETYGKIMNHKERFQFPAQVTDV 236
Query: 663 CIQDSCNLADVIRCIHIGLLCVQQH 687
S + D+IR L+C ++H
Sbjct: 237 ----SEDAKDLIR----RLICSREH 253
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332 |
Conserved Domains Detected by HHsearch
Original result of HHsearch against CDD database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 747 | |||
| KOG1187 | 361 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0197 | 468 | consensus Tyrosine kinases [Signal transduction me | 100.0 | |
| KOG0192 | 362 | consensus Tyrosine kinase specific for activated ( | 100.0 | |
| KOG1026 | 774 | consensus Nerve growth factor receptor TRKA and re | 100.0 | |
| KOG0196 | 996 | consensus Tyrosine kinase, EPH (ephrin) receptor f | 100.0 | |
| KOG0581 | 364 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG0595 | 429 | consensus Serine/threonine-protein kinase involved | 100.0 | |
| KOG0615 | 475 | consensus Serine/threonine protein kinase Chk2 and | 100.0 | |
| KOG1095 | 1025 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| KOG0575 | 592 | consensus Polo-like serine/threonine protein kinas | 100.0 | |
| KOG1094 | 807 | consensus Discoidin domain receptor DDR1 [Signal t | 100.0 | |
| KOG0194 | 474 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| KOG0193 | 678 | consensus Serine/threonine protein kinase RAF [Sig | 100.0 | |
| KOG0593 | 396 | consensus Predicted protein kinase KKIAMRE [Genera | 100.0 | |
| KOG0591 | 375 | consensus NIMA (never in mitosis)-related G2-speci | 100.0 | |
| KOG0600 | 560 | consensus Cdc2-related protein kinase [Cell cycle | 100.0 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0592 | 604 | consensus 3-phosphoinositide-dependent protein kin | 100.0 | |
| KOG0198 | 313 | consensus MEKK and related serine/threonine protei | 100.0 | |
| KOG0598 | 357 | consensus Ribosomal protein S6 kinase and related | 100.0 | |
| KOG4278 | 1157 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| KOG0659 | 318 | consensus Cdk activating kinase (CAK)/RNA polymera | 100.0 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 100.0 | |
| KOG0661 | 538 | consensus MAPK related serine/threonine protein ki | 100.0 | |
| KOG0582 | 516 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG4721 | 904 | consensus Serine/threonine protein kinase, contain | 100.0 | |
| KOG0578 | 550 | consensus p21-activated serine/threonine protein k | 100.0 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 100.0 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 100.0 | |
| KOG1025 | 1177 | consensus Epidermal growth factor receptor EGFR an | 100.0 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 100.0 | |
| KOG1989 | 738 | consensus ARK protein kinase family [Signal transd | 100.0 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 100.0 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 100.0 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 100.0 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 100.0 | |
| KOG2345 | 302 | consensus Serine/threonine protein kinase/TGF-beta | 100.0 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 100.0 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 100.0 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 100.0 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0663 | 419 | consensus Protein kinase PITSLRE and related kinas | 100.0 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 100.0 | |
| KOG0583 | 370 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 100.0 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 100.0 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 100.0 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 100.0 | |
| KOG3653 | 534 | consensus Transforming growth factor beta/activin | 100.0 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 100.0 | |
| KOG0199 | 1039 | consensus ACK and related non-receptor tyrosine ki | 100.0 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 100.0 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 100.0 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0611 | 668 | consensus Predicted serine/threonine protein kinas | 100.0 | |
| KOG0580 | 281 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 100.0 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 100.0 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 100.0 | |
| KOG4257 | 974 | consensus Focal adhesion tyrosine kinase FAK, cont | 100.0 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 100.0 | |
| KOG0585 | 576 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| KOG0597 | 808 | consensus Serine-threonine protein kinase FUSED [G | 100.0 | |
| KOG0616 | 355 | consensus cAMP-dependent protein kinase catalytic | 100.0 | |
| KOG0605 | 550 | consensus NDR and related serine/threonine kinases | 100.0 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 100.0 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 100.0 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 100.0 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 100.0 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 100.0 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 100.0 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 100.0 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 100.0 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 100.0 | |
| KOG0594 | 323 | consensus Protein kinase PCTAIRE and related kinas | 100.0 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 100.0 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 100.0 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| KOG0658 | 364 | consensus Glycogen synthase kinase-3 [Carbohydrate | 100.0 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 100.0 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 100.0 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 100.0 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 100.0 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 100.0 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 100.0 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 100.0 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 100.0 | |
| KOG0201 | 467 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| KOG0588 | 786 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 100.0 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 100.0 | |
| KOG0694 | 694 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 100.0 | |
| KOG0660 | 359 | consensus Mitogen-activated protein kinase [Signal | 100.0 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 100.0 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 100.0 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 100.0 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 100.0 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 100.0 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0589 | 426 | consensus Serine/threonine protein kinase [General | 100.0 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 100.0 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 100.0 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 100.0 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 100.0 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 100.0 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 100.0 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 100.0 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 100.0 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 100.0 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 100.0 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 100.0 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 100.0 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 100.0 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 100.0 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 100.0 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 100.0 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 100.0 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 100.0 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 100.0 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 100.0 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 100.0 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 100.0 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 100.0 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 100.0 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 100.0 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 100.0 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 100.0 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 100.0 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 100.0 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 100.0 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 100.0 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 100.0 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 100.0 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 100.0 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 100.0 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 100.0 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 100.0 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 100.0 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 100.0 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 100.0 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 100.0 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 100.0 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 100.0 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 100.0 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 100.0 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 100.0 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 100.0 | |
| KOG0200 | 609 | consensus Fibroblast/platelet-derived growth facto | 100.0 | |
| KOG0667 | 586 | consensus Dual-specificity tyrosine-phosphorylatio | 100.0 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 100.0 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 99.98 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 99.98 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 99.98 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 99.98 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 99.98 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 99.98 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 99.98 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 99.98 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 99.98 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 99.98 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 99.98 | |
| KOG4279 | 1226 | consensus Serine/threonine protein kinase [Signal | 99.98 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 99.98 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 99.98 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 99.98 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 99.98 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 99.98 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 99.98 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 99.98 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 99.98 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 99.98 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 99.98 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 99.98 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 99.98 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 99.98 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 99.98 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 99.98 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 99.98 | |
| PTZ00284 | 467 | protein kinase; Provisional | 99.98 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 99.98 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 99.98 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 99.98 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 99.98 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 99.98 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 99.98 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 99.97 | |
| KOG0599 | 411 | consensus Phosphorylase kinase gamma subunit [Carb | 99.97 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 99.97 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 99.97 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 99.97 | |
| KOG0032 | 382 | consensus Ca2+/calmodulin-dependent protein kinase | 99.97 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 99.97 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 99.97 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 99.97 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 99.97 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 99.97 | |
| KOG2052 | 513 | consensus Activin A type IB receptor, serine/threo | 99.97 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 99.97 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 99.97 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 99.97 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 99.97 | |
| KOG1024 | 563 | consensus Receptor-like protein tyrosine kinase RY | 99.97 | |
| KOG0577 | 948 | consensus Serine/threonine protein kinase [Signal | 99.97 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 99.97 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 99.97 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 99.97 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 99.97 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 99.97 | |
| KOG0584 | 632 | consensus Serine/threonine protein kinase [General | 99.97 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 99.97 | |
| KOG0610 | 459 | consensus Putative serine/threonine protein kinase | 99.97 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 99.97 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 99.97 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 99.97 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 99.97 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 99.97 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 99.97 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 99.97 | |
| KOG4717 | 864 | consensus Serine/threonine protein kinase [Signal | 99.97 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 99.97 | |
| KOG0596 | 677 | consensus Dual specificity; serine/threonine and t | 99.97 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 99.97 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 99.97 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 99.97 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 99.97 | |
| KOG4250 | 732 | consensus TANK binding protein kinase TBK1 [Signal | 99.97 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 99.97 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 99.97 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 99.97 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 99.97 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 99.97 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 99.97 | |
| KOG0033 | 355 | consensus Ca2+/calmodulin-dependent protein kinase | 99.97 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 99.97 | |
| KOG0574 | 502 | consensus STE20-like serine/threonine kinase MST [ | 99.97 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 99.97 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 99.97 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 99.97 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 99.97 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 99.97 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 99.97 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 99.97 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 99.97 | |
| KOG0983 | 391 | consensus Mitogen-activated protein kinase (MAPK) | 99.97 | |
| KOG0586 | 596 | consensus Serine/threonine protein kinase [General | 99.97 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 99.97 | |
| KOG0579 | 1187 | consensus Ste20-like serine/threonine protein kina | 99.97 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 99.97 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 99.97 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 99.97 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 99.97 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 99.97 | |
| KOG4645 | 1509 | consensus MAPKKK (MAP kinase kinase kinase) SSK2 a | 99.96 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 99.96 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 99.96 | |
| KOG1006 | 361 | consensus Mitogen-activated protein kinase (MAPK) | 99.96 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 99.96 | |
| PF01453 | 114 | B_lectin: D-mannose binding lectin; InterPro: IPR0 | 99.96 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 99.96 | |
| KOG0607 | 463 | consensus MAP kinase-interacting kinase and relate | 99.96 | |
| KOG1151 | 775 | consensus Tousled-like protein kinase [Signal tran | 99.96 | |
| KOG0666 | 438 | consensus Cyclin C-dependent kinase CDK8 [Transcri | 99.96 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 99.96 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 99.96 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.96 | |
| KOG0986 | 591 | consensus G protein-coupled receptor kinase [Signa | 99.96 | |
| KOG0612 | 1317 | consensus Rho-associated, coiled-coil containing p | 99.95 | |
| KOG0662 | 292 | consensus Cyclin-dependent kinase CDK5 [Intracellu | 99.95 | |
| KOG0984 | 282 | consensus Mitogen-activated protein kinase (MAPK) | 99.95 | |
| KOG0690 | 516 | consensus Serine/threonine protein kinase [Signal | 99.95 | |
| KOG0604 | 400 | consensus MAP kinase-activated protein kinase 2 [S | 99.95 | |
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 99.95 | |
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 99.95 | |
| KOG0669 | 376 | consensus Cyclin T-dependent kinase CDK9 [Cell cyc | 99.95 | |
| KOG4236 | 888 | consensus Serine/threonine protein kinase PKC mu/P | 99.95 | |
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 99.95 | |
| KOG0671 | 415 | consensus LAMMER dual specificity kinases [Signal | 99.95 | |
| KOG0587 | 953 | consensus Traf2- and Nck-interacting kinase and re | 99.95 | |
| PF00954 | 110 | S_locus_glycop: S-locus glycoprotein family; Inter | 99.94 | |
| KOG0696 | 683 | consensus Serine/threonine protein kinase [Signal | 99.94 | |
| KOG0664 | 449 | consensus Nemo-like MAPK-related serine/threonine | 99.94 | |
| KOG0608 | 1034 | consensus Warts/lats-like serine threonine kinases | 99.94 | |
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 99.93 | |
| KOG0614 | 732 | consensus cGMP-dependent protein kinase [Signal tr | 99.93 | |
| KOG1027 | 903 | consensus Serine/threonine protein kinase and endo | 99.93 | |
| KOG0668 | 338 | consensus Casein kinase II, alpha subunit [Signal | 99.93 | |
| KOG1345 | 378 | consensus Serine/threonine kinase [Signal transduc | 99.92 | |
| KOG0695 | 593 | consensus Serine/threonine protein kinase [Signal | 99.92 | |
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 99.91 | |
| KOG1290 | 590 | consensus Serine/threonine protein kinase [Signal | 99.9 | |
| KOG1152 | 772 | consensus Signal transduction serine/threonine kin | 99.9 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 99.9 | |
| KOG0670 | 752 | consensus U4/U6-associated splicing factor PRP4 [R | 99.9 | |
| KOG0665 | 369 | consensus Jun-N-terminal kinase (JNK) [Signal tran | 99.89 | |
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.87 | |
| KOG1167 | 418 | consensus Serine/threonine protein kinase of the C | 99.85 | |
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.85 | |
| KOG1164 | 322 | consensus Casein kinase (serine/threonine/tyrosine | 99.84 | |
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.83 | |
| KOG0195 | 448 | consensus Integrin-linked kinase [Signal transduct | 99.83 | |
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.83 | |
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 99.83 | |
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.82 | |
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.79 | |
| KOG1163 | 341 | consensus Casein kinase (serine/threonine/tyrosine | 99.79 | |
| KOG1023 | 484 | consensus Natriuretic peptide receptor, guanylate | 99.78 | |
| PRK10345 | 210 | hypothetical protein; Provisional | 99.77 | |
| KOG1165 | 449 | consensus Casein kinase (serine/threonine/tyrosine | 99.77 | |
| cd00028 | 116 | B_lectin Bulb-type mannose-specific lectin. The do | 99.76 | |
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.75 | |
| KOG1240 | 1431 | consensus Protein kinase containing WD40 repeats [ | 99.73 | |
| smart00090 | 237 | RIO RIO-like kinase. | 99.71 | |
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 99.71 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.71 | |
| smart00108 | 114 | B_lectin Bulb-type mannose-specific lectin. | 99.71 | |
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 99.7 | |
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.7 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 99.69 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 99.69 | |
| KOG1166 | 974 | consensus Mitotic checkpoint serine/threonine prot | 99.67 | |
| KOG4158 | 598 | consensus BRPK/PTEN-induced protein kinase [Signal | 99.66 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 99.61 | |
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 99.6 | |
| PF08276 | 66 | PAN_2: PAN-like domain; InterPro: IPR013227 PAN do | 99.59 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.56 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 99.56 | |
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 99.46 | |
| KOG1033 | 516 | consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati | 99.45 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.35 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.33 | |
| cd00129 | 80 | PAN_APPLE PAN/APPLE-like domain; present in N-term | 99.33 | |
| cd01098 | 84 | PAN_AP_plant Plant PAN/APPLE-like domain; present | 99.28 | |
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 99.27 | |
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 99.27 | |
| KOG1266 | 458 | consensus Protein kinase [Signal transduction mech | 99.17 | |
| KOG1243 | 690 | consensus Protein kinase [General function predict | 99.15 | |
| cd05146 | 197 | RIO3_euk RIO kinase family; eukaryotic RIO3, catal | 99.14 | |
| cd05154 | 223 | ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an | 99.08 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 98.99 | |
| COG3642 | 204 | Mn2+-dependent serine/threonine protein kinase [Si | 98.99 | |
| KOG3087 | 229 | consensus Serine/threonine protein kinase [General | 98.91 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 98.89 | |
| PF01163 | 188 | RIO1: RIO1 family; InterPro: IPR018934 Protein pho | 98.79 | |
| PRK15123 | 268 | lipopolysaccharide core heptose(I) kinase RfaP; Pr | 98.78 | |
| KOG3741 | 655 | consensus Poly(A) ribonuclease subunit [RNA proces | 98.76 | |
| COG0478 | 304 | RIO-like serine/threonine protein kinase fused to | 98.55 | |
| smart00108 | 114 | B_lectin Bulb-type mannose-specific lectin. | 98.5 | |
| COG0661 | 517 | AarF Predicted unusual protein kinase [General fun | 98.48 | |
| PF06293 | 206 | Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; | 98.45 | |
| PRK09902 | 216 | hypothetical protein; Provisional | 98.44 | |
| cd00028 | 116 | B_lectin Bulb-type mannose-specific lectin. The do | 98.44 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 98.39 | |
| TIGR02172 | 226 | Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou | 98.25 | |
| smart00473 | 78 | PAN_AP divergent subfamily of APPLE domains. Apple | 98.22 | |
| PF06176 | 229 | WaaY: Lipopolysaccharide core biosynthesis protein | 98.14 | |
| KOG1235 | 538 | consensus Predicted unusual protein kinase [Genera | 98.07 | |
| PF01636 | 239 | APH: Phosphotransferase enzyme family This family | 98.07 | |
| cd05150 | 244 | APH Aminoglycoside 3'-phosphotransferase (APH). Th | 98.06 | |
| PF12260 | 188 | PIP49_C: Protein-kinase domain of FAM69; InterPro: | 98.03 | |
| COG1718 | 268 | RIO1 Serine/threonine protein kinase involved in c | 98.0 | |
| COG4248 | 637 | Uncharacterized protein with protein kinase and he | 97.88 | |
| PF10707 | 199 | YrbL-PhoP_reg: PhoP regulatory network protein Yrb | 97.87 | |
| PLN02876 | 822 | acyl-CoA dehydrogenase | 97.8 | |
| cd05155 | 235 | APH_ChoK_like_1 Uncharacterized bacterial proteins | 97.7 | |
| PRK10593 | 297 | hypothetical protein; Provisional | 97.69 | |
| KOG2137 | 700 | consensus Protein kinase [Signal transduction mech | 97.64 | |
| PF11883 | 48 | DUF3403: Domain of unknown function (DUF3403); Int | 97.59 | |
| PF13095 | 207 | FTA2: Kinetochore Sim4 complex subunit FTA2 | 97.54 | |
| TIGR02721 | 256 | ycfN_thiK thiamine kinase. Members of this family | 97.49 | |
| cd05157 | 235 | ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes. | 97.44 | |
| PRK09550 | 401 | mtnK methylthioribose kinase; Reviewed | 97.4 | |
| PF01453 | 114 | B_lectin: D-mannose binding lectin; InterPro: IPR0 | 97.4 | |
| COG2112 | 201 | Predicted Ser/Thr protein kinase [Signal transduct | 97.31 | |
| cd05153 | 296 | HomoserineK_II Homoserine Kinase, type II. Homoser | 97.21 | |
| cd05156 | 302 | ChoK_euk Choline Kinase (ChoK) in eukaryotes. The | 96.97 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 96.93 | |
| PRK05231 | 319 | homoserine kinase; Provisional | 96.84 | |
| TIGR00938 | 307 | thrB_alt homoserine kinase, Neisseria type. Homose | 96.83 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 96.82 | |
| COG3173 | 321 | Predicted aminoglycoside phosphotransferase [Gener | 96.51 | |
| cd05152 | 276 | MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH | 96.51 | |
| cd01100 | 73 | APPLE_Factor_XI_like Subfamily of PAN/APPLE-like d | 96.5 | |
| PF03881 | 288 | Fructosamin_kin: Fructosamine kinase; InterPro: IP | 96.37 | |
| PLN02236 | 344 | choline kinase | 96.27 | |
| KOG2268 | 465 | consensus Serine/threonine protein kinase [Signal | 96.24 | |
| PLN02756 | 418 | S-methyl-5-thioribose kinase | 95.89 | |
| KOG1093 | 725 | consensus Predicted protein kinase (contains TBC a | 95.77 | |
| TIGR01767 | 370 | MTRK 5-methylthioribose kinase. This enzyme is inv | 95.69 | |
| TIGR02906 | 313 | spore_CotS spore coat protein, CotS family. Member | 95.13 | |
| PF01633 | 211 | Choline_kinase: Choline/ethanolamine kinase; Inter | 95.06 |
| >KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-51 Score=436.38 Aligned_cols=278 Identities=42% Similarity=0.722 Sum_probs=234.3
Q ss_pred CCCcccHHHHHHHhcCCCccceecccCCeeEEEEEecCCcEEEEEEecccccccHHHHHHHHHHHhccCCCceeeEEeEE
Q 004521 426 ELPLFELATIANATDNFSINNKLGEGGFGPVYKGTLVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCC 505 (747)
Q Consensus 426 ~~~~~~~~~~~~~~~~~~~~~~lg~G~fg~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~ 505 (747)
....|++.++..+|++|...+.||+|+||.||+|.+.+|+.||||++.....+..++|.+|+.++.+++|||||+|+|||
T Consensus 61 ~~~~fs~~el~~AT~~Fs~~~~ig~Ggfg~VYkG~l~~~~~vAVK~~~~~~~~~~~eF~~Ei~~ls~l~H~Nlv~LlGyC 140 (361)
T KOG1187|consen 61 PLRSFSYDELRKATNNFSESNLIGEGGFGTVYKGVLSDGTVVAVKRLSSNSGQGEREFLNEVEILSRLRHPNLVKLLGYC 140 (361)
T ss_pred CcceeeHHHHHHHHhCCchhcceecCCCeEEEEEEECCCCEEEEEEecCCCCcchhHHHHHHHHHhcCCCcCcccEEEEE
Confidence 56689999999999999999999999999999999999999999998764332156799999999999999999999999
Q ss_pred EeCC-eeEEEEecCCCCChhhHhhhcCCCCcCChhHHHHHHHHHHHHHHHhhhcCCCceEecccCcCcEEEcCCCCceEe
Q 004521 506 IQGE-EKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKIS 584 (747)
Q Consensus 506 ~~~~-~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NIll~~~~~~kl~ 584 (747)
.+.+ +.+||||||++|+|.++|+..... .++|..|++||.++|+||+|||+...++||||||||+|||||+++++||+
T Consensus 141 ~e~~~~~~LVYEym~nGsL~d~L~~~~~~-~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~aKls 219 (361)
T KOG1187|consen 141 LEGGEHRLLVYEYMPNGSLEDHLHGKKGE-PLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFNAKLS 219 (361)
T ss_pred ecCCceEEEEEEccCCCCHHHHhCCCCCC-CCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCCEEcc
Confidence 9999 599999999999999999875544 79999999999999999999999988899999999999999999999999
Q ss_pred cccCccccCC-CCCcc-----ccceeeecc--CCCCCccccchhHHHHHHHHHhCCCCCCCCCCcchhhhhH---hHHhc
Q 004521 585 DFGLVRTFGG-DETEG-----NTNRVVGTY--DGQFSIKSDVFSFGILLLEIVSGKKNRGFYRSDTKVNLIG---HLWDE 653 (747)
Q Consensus 585 DFGla~~~~~-~~~~~-----~~~~~~~~~--~~~~s~ksDVwS~Gvvl~elltg~~p~~~~~~~~~~~~~~---~~~~~ 653 (747)
|||+|+.... ..... ...+....+ .+..+.|+|||||||+|+||+||+++.+.........+.. ..+.+
T Consensus 220 DFGLa~~~~~~~~~~~~~~~gt~gY~~PEy~~~g~lt~KsDVySFGVvllElitgr~~~d~~~~~~~~~l~~w~~~~~~~ 299 (361)
T KOG1187|consen 220 DFGLAKLGPEGDTSVSTTVMGTFGYLAPEYASTGKLTEKSDVYSFGVVLLELITGRKAVDQSRPRGELSLVEWAKPLLEE 299 (361)
T ss_pred CccCcccCCccccceeeecCCCCccCChhhhccCCcCcccccccchHHHHHHHhCCcccCCCCCcccccHHHHHHHHHHC
Confidence 9999976654 22211 111111222 3678999999999999999999998876443222222333 34677
Q ss_pred CCcccccchhhh-ccCCH-HHHHHHHHHHHhccCCCCCCCCCHHHHHHHhcCC
Q 004521 654 GIPLRLIDACIQ-DSCNL-ADVIRCIHIGLLCVQQHPEDRPCMPSVILMLGSE 704 (747)
Q Consensus 654 ~~~~~~~d~~l~-~~~~~-~~~~~~~~l~~~Cl~~dP~~RPt~~~v~~~L~~~ 704 (747)
+...+++|+.+. ..... +++.++.++|++|++.+|.+||+|.+|+++|+..
T Consensus 300 ~~~~eiiD~~l~~~~~~~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~~L~~~ 352 (361)
T KOG1187|consen 300 GKLREIVDPRLKEGEYPDEKEVKKLAELALRCLRPDPKERPTMSQVVKELEGI 352 (361)
T ss_pred cchhheeCCCccCCCCChHHHHHHHHHHHHHHcCcCCCcCcCHHHHHHHHHhh
Confidence 788999999987 55554 7899999999999999999999999999999654
|
|
| >KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-44 Score=379.87 Aligned_cols=246 Identities=32% Similarity=0.527 Sum_probs=200.6
Q ss_pred CCccceecccCCeeEEEEEecCCcEEEEEEecccccccHHHHHHHHHHHhccCCCceeeEEeEEEeCCeeEEEEecCCCC
Q 004521 442 FSINNKLGEGGFGPVYKGTLVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMPNK 521 (747)
Q Consensus 442 ~~~~~~lg~G~fg~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~g 521 (747)
+.+.+.||+|.||.|+.|.++....||+|.++.. ....+.|.+|+++|++|+|+|||+++|+|..+++++||||||++|
T Consensus 208 l~l~~~LG~G~FG~V~~g~~~~~~~vavk~ik~~-~m~~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~piyIVtE~m~~G 286 (468)
T KOG0197|consen 208 LKLIRELGSGQFGEVWLGKWNGSTKVAVKTIKEG-SMSPEAFLREAQIMKKLRHEKLVKLYGVCTKQEPIYIVTEYMPKG 286 (468)
T ss_pred HHHHHHhcCCccceEEEEEEcCCCcccceEEecc-ccChhHHHHHHHHHHhCcccCeEEEEEEEecCCceEEEEEecccC
Confidence 4456899999999999999988889999999863 455678999999999999999999999999999999999999999
Q ss_pred ChhhHhhhcCCCCcCChhHHHHHHHHHHHHHHHhhhcCCCceEecccCcCcEEEcCCCCceEecccCccccCCCCCcccc
Q 004521 522 SLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNT 601 (747)
Q Consensus 522 sL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~ 601 (747)
+|.+||.. ..+..+...+.+.++.|||+||+||++++ +|||||+++||||+++..+||+||||||....+.+....
T Consensus 287 sLl~yLr~-~~~~~l~~~~Ll~~a~qIaeGM~YLes~~---~IHRDLAARNiLV~~~~~vKIsDFGLAr~~~d~~Y~~~~ 362 (468)
T KOG0197|consen 287 SLLDYLRT-REGGLLNLPQLLDFAAQIAEGMAYLESKN---YIHRDLAARNILVDEDLVVKISDFGLARLIGDDEYTASE 362 (468)
T ss_pred cHHHHhhh-cCCCccchHHHHHHHHHHHHHHHHHHhCC---ccchhhhhhheeeccCceEEEcccccccccCCCceeecC
Confidence 99999976 33456889999999999999999999988 999999999999999999999999999965544443221
Q ss_pred ceee--------eccCCCCCccccchhHHHHHHHHHh-CCCCCCCCCCcchhhhhHhHHhcCCcccccchhhhccCCHHH
Q 004521 602 NRVV--------GTYDGQFSIKSDVFSFGILLLEIVS-GKKNRGFYRSDTKVNLIGHLWDEGIPLRLIDACIQDSCNLAD 672 (747)
Q Consensus 602 ~~~~--------~~~~~~~s~ksDVwS~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~ 672 (747)
..-. .-..+.|+.|||||||||+||||+| |+.|++..... +.+.. ...|.+..-++.+.
T Consensus 363 ~~kfPIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT~G~~py~~msn~---ev~~~-le~GyRlp~P~~CP-------- 430 (468)
T KOG0197|consen 363 GGKFPIKWTAPEALNYGKFSSKSDVWSFGVLLWELFTYGRVPYPGMSNE---EVLEL-LERGYRLPRPEGCP-------- 430 (468)
T ss_pred CCCCCceecCHHHHhhCCcccccceeehhhhHHHHhccCCCCCCCCCHH---HHHHH-HhccCcCCCCCCCC--------
Confidence 1110 1125789999999999999999999 77775544322 23322 34555544433332
Q ss_pred HHHHHHHHHhccCCCCCCCCCHHHHHHHhcCCC
Q 004521 673 VIRCIHIGLLCVQQHPEDRPCMPSVILMLGSEI 705 (747)
Q Consensus 673 ~~~~~~l~~~Cl~~dP~~RPt~~~v~~~L~~~~ 705 (747)
..+.+||..||+.+|++|||+..+...|+...
T Consensus 431 -~~vY~lM~~CW~~~P~~RPtF~~L~~~l~~~~ 462 (468)
T KOG0197|consen 431 -DEVYELMKSCWHEDPEDRPTFETLREVLEDFF 462 (468)
T ss_pred -HHHHHHHHHHhhCCcccCCCHHHHHHHHHHhh
Confidence 23778999999999999999999999988653
|
|
| >KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-42 Score=369.43 Aligned_cols=246 Identities=32% Similarity=0.503 Sum_probs=195.9
Q ss_pred CCccceecccCCeeEEEEEecCCcEEEEEEecccc--cccHHHHHHHHHHHhccCCCceeeEEeEEEeCC-eeEEEEecC
Q 004521 442 FSINNKLGEGGFGPVYKGTLVDGQEIAVKRLSKIS--EQGLKELKNEVILFSKLQHRNLVKLLGCCIQGE-EKLLIYEFM 518 (747)
Q Consensus 442 ~~~~~~lg~G~fg~Vy~~~~~~g~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~-~~~lV~E~~ 518 (747)
+.+.+.||+|+||+||+|.+.....||||++.... ....++|.+|+.+|.+++|||||+|+|+|.+.. ...+|||||
T Consensus 43 l~~~~~iG~G~~g~V~~~~~~g~~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~~~~iVtEy~ 122 (362)
T KOG0192|consen 43 LPIEEVLGSGSFGTVYKGKWRGTDVVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTSPPGSLCIVTEYM 122 (362)
T ss_pred hhhhhhcccCCceeEEEEEeCCceeEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCceEEEEEeC
Confidence 34456799999999999999655559999997532 222679999999999999999999999999988 789999999
Q ss_pred CCCChhhHhhhcCCCCcCChhHHHHHHHHHHHHHHHhhhcCCCceEecccCcCcEEEcCCC-CceEecccCccccCCCCC
Q 004521 519 PNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDM-NPKISDFGLVRTFGGDET 597 (747)
Q Consensus 519 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NIll~~~~-~~kl~DFGla~~~~~~~~ 597 (747)
++|+|.++|+.. .+..+++..+++++.|||+||.|||+++. ||||||||+||||+.++ ++||+|||+++.......
T Consensus 123 ~~GsL~~~l~~~-~~~~l~~~~~l~~aldiArGm~YLH~~~~--iIHrDLK~~NiLv~~~~~~~KI~DFGlsr~~~~~~~ 199 (362)
T KOG0192|consen 123 PGGSLSVLLHKK-RKRKLPLKVRLRIALDIARGMEYLHSEGP--IIHRDLKSDNILVDLKGKTLKIADFGLSREKVISKT 199 (362)
T ss_pred CCCcHHHHHhhc-ccCCCCHHHHHHHHHHHHHHHHHHhcCCC--eeecccChhhEEEcCCCCEEEECCCccceeeccccc
Confidence 999999999775 45679999999999999999999999874 99999999999999998 999999999987654210
Q ss_pred ccccceeeec--------c---CCCCCccccchhHHHHHHHHHhCCCCCCCCCCcchhhhhHhHHhcCCcccccchhhhc
Q 004521 598 EGNTNRVVGT--------Y---DGQFSIKSDVFSFGILLLEIVSGKKNRGFYRSDTKVNLIGHLWDEGIPLRLIDACIQD 666 (747)
Q Consensus 598 ~~~~~~~~~~--------~---~~~~s~ksDVwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 666 (747)
. .....|| + ...|+.|+|||||||+||||+||+.||..... ......+...+.+..+...
T Consensus 200 ~--~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~---~~~~~~v~~~~~Rp~~p~~---- 270 (362)
T KOG0192|consen 200 S--MTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAP---VQVASAVVVGGLRPPIPKE---- 270 (362)
T ss_pred c--ccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCH---HHHHHHHHhcCCCCCCCcc----
Confidence 0 0001121 1 34699999999999999999999999764332 3333333444444444333
Q ss_pred cCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhcCC
Q 004521 667 SCNLADVIRCIHIGLLCVQQHPEDRPCMPSVILMLGSE 704 (747)
Q Consensus 667 ~~~~~~~~~~~~l~~~Cl~~dP~~RPt~~~v~~~L~~~ 704 (747)
....+..++.+||+.||.+||++.+|+.+|+..
T Consensus 271 -----~~~~l~~l~~~CW~~dp~~RP~f~ei~~~l~~~ 303 (362)
T KOG0192|consen 271 -----CPPHLSSLMERCWLVDPSRRPSFLEIVSRLESI 303 (362)
T ss_pred -----CCHHHHHHHHHhCCCCCCcCCCHHHHHHHHHHH
Confidence 223366777789999999999999999999864
|
|
| >KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-42 Score=384.22 Aligned_cols=252 Identities=30% Similarity=0.497 Sum_probs=204.9
Q ss_pred hcCCCccceecccCCeeEEEEEecC------CcEEEEEEecccccc-cHHHHHHHHHHHhccCCCceeeEEeEEEeCCee
Q 004521 439 TDNFSINNKLGEGGFGPVYKGTLVD------GQEIAVKRLSKISEQ-GLKELKNEVILFSKLQHRNLVKLLGCCIQGEEK 511 (747)
Q Consensus 439 ~~~~~~~~~lg~G~fg~Vy~~~~~~------g~~vavK~l~~~~~~-~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~ 511 (747)
..+....+.||+|+||.||+|+... ...||||.|+..... ..++|++|+++++.++|||||+|+|+|.++++.
T Consensus 485 r~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a~~~~~~dF~REaeLla~l~H~nIVrLlGVC~~~~P~ 564 (774)
T KOG1026|consen 485 RSDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKAENQARQDFRREAELLAELQHPNIVRLLGVCREGDPL 564 (774)
T ss_pred hhheeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEccCCee
Confidence 3456667899999999999998543 457999999975544 788999999999999999999999999999999
Q ss_pred EEEEecCCCCChhhHhhhcCC-----------CCcCChhHHHHHHHHHHHHHHHhhhcCCCceEecccCcCcEEEcCCCC
Q 004521 512 LLIYEFMPNKSLDSFIFDQTR-----------RTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMN 580 (747)
Q Consensus 512 ~lV~E~~~~gsL~~~l~~~~~-----------~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NIll~~~~~ 580 (747)
++|+|||..|+|.+||..... ..+|+..+.+.||.|||.||+||-++. +|||||+.+|+||.++..
T Consensus 565 ~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~~---FVHRDLATRNCLVge~l~ 641 (774)
T KOG1026|consen 565 CMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSHH---FVHRDLATRNCLVGENLV 641 (774)
T ss_pred EEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCc---ccccchhhhhceeccceE
Confidence 999999999999999975322 234888999999999999999999887 999999999999999999
Q ss_pred ceEecccCccccCCCCCcccc-ceeeec--------cCCCCCccccchhHHHHHHHHHh-CCCCCCCCCCcchhhhhHhH
Q 004521 581 PKISDFGLVRTFGGDETEGNT-NRVVGT--------YDGQFSIKSDVFSFGILLLEIVS-GKKNRGFYRSDTKVNLIGHL 650 (747)
Q Consensus 581 ~kl~DFGla~~~~~~~~~~~~-~~~~~~--------~~~~~s~ksDVwS~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~ 650 (747)
|||+||||+|..-..++.... .....- ..+.||.+||||||||+||||++ |+.|+.....++..+.
T Consensus 642 VKIsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~kFTteSDVWs~GVvLWEIFsyG~QPy~glSn~EVIe~---- 717 (774)
T KOG1026|consen 642 VKISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYGKFTTESDVWSFGVVLWEIFSYGKQPYYGLSNQEVIEC---- 717 (774)
T ss_pred EEecccccchhhhhhhhhcccCCceeeeecCCHHHhhcCcccchhhhhhhhhhhhhhhccccCcccccchHHHHHH----
Confidence 999999999976554443222 111111 26899999999999999999999 8899765554433322
Q ss_pred HhcCCcccccchhhhccCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhcCCCC
Q 004521 651 WDEGIPLRLIDACIQDSCNLADVIRCIHIGLLCVQQHPEDRPCMPSVILMLGSEIL 706 (747)
Q Consensus 651 ~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dP~~RPt~~~v~~~L~~~~~ 706 (747)
...+......+.+ ..+++.||+.||+.+|++||+++||-..|+....
T Consensus 718 i~~g~lL~~Pe~C---------P~~vY~LM~~CW~~~P~~RPsF~eI~~~L~~~~~ 764 (774)
T KOG1026|consen 718 IRAGQLLSCPENC---------PTEVYSLMLECWNENPKRRPSFKEIHSRLQAWAQ 764 (774)
T ss_pred HHcCCcccCCCCC---------CHHHHHHHHHHhhcCcccCCCHHHHHHHHHHHHh
Confidence 2444444443333 3348899999999999999999999999987543
|
|
| >KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-42 Score=371.43 Aligned_cols=248 Identities=28% Similarity=0.440 Sum_probs=202.1
Q ss_pred cCCCccceecccCCeeEEEEEecC----CcEEEEEEeccc-ccccHHHHHHHHHHHhccCCCceeeEEeEEEeCCeeEEE
Q 004521 440 DNFSINNKLGEGGFGPVYKGTLVD----GQEIAVKRLSKI-SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLI 514 (747)
Q Consensus 440 ~~~~~~~~lg~G~fg~Vy~~~~~~----g~~vavK~l~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV 514 (747)
....+.+.||.|.||.|++|+++- ...||||.|+.. .+....+|+.|+.||.++.||||++|.|+....++.++|
T Consensus 629 s~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~GytekqrrdFL~EAsIMGQFdHPNIIrLEGVVTks~PvMIi 708 (996)
T KOG0196|consen 629 SCVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIRLEGVVTKSKPVMII 708 (996)
T ss_pred hheEEEEEEecccccceecccccCCCCcceeEEEeeeccCccHHHHhhhhhhhhhcccCCCCcEEEEEEEEecCceeEEE
Confidence 356778999999999999999854 347999999863 456678999999999999999999999999999999999
Q ss_pred EecCCCCChhhHhhhcCCCCcCChhHHHHHHHHHHHHHHHhhhcCCCceEecccCcCcEEEcCCCCceEecccCccccCC
Q 004521 515 YEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGG 594 (747)
Q Consensus 515 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NIll~~~~~~kl~DFGla~~~~~ 594 (747)
.|||+||+|+.||+.+. +.+.+.+...++++||.||.||-+.+ +|||||.++|||++.+..+|++||||+|.+..
T Consensus 709 TEyMENGsLDsFLR~~D--GqftviQLVgMLrGIAsGMkYLsdm~---YVHRDLAARNILVNsnLvCKVsDFGLSRvled 783 (996)
T KOG0196|consen 709 TEYMENGSLDSFLRQND--GQFTVIQLVGMLRGIASGMKYLSDMN---YVHRDLAARNILVNSNLVCKVSDFGLSRVLED 783 (996)
T ss_pred hhhhhCCcHHHHHhhcC--CceEeehHHHHHHHHHHHhHHHhhcC---chhhhhhhhheeeccceEEEeccccceeeccc
Confidence 99999999999997643 55999999999999999999999988 99999999999999999999999999998765
Q ss_pred CCCccccceeee------c-----cCCCCCccccchhHHHHHHHHHh-CCCCCCCCCCcchhhhhHhHHhcCCcccccch
Q 004521 595 DETEGNTNRVVG------T-----YDGQFSIKSDVFSFGILLLEIVS-GKKNRGFYRSDTKVNLIGHLWDEGIPLRLIDA 662 (747)
Q Consensus 595 ~~~~~~~~~~~~------~-----~~~~~s~ksDVwS~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 662 (747)
+.. ..+...-| + ....++.++|||||||++||.++ |++|+-..+..+. +. ..+++....
T Consensus 784 d~~-~~ytt~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVmSyGERPYWdmSNQdV---Ik-aIe~gyRLP---- 854 (996)
T KOG0196|consen 784 DPE-AAYTTLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDV---IK-AIEQGYRLP---- 854 (996)
T ss_pred CCC-ccccccCCccceeecChhHhhhcccCchhhccccceEEEEecccCCCcccccchHHH---HH-HHHhccCCC----
Confidence 542 22221111 1 14679999999999999999998 8999754443322 22 223443322
Q ss_pred hhhccCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhcCCCC
Q 004521 663 CIQDSCNLADVIRCIHIGLLCVQQHPEDRPCMPSVILMLGSEIL 706 (747)
Q Consensus 663 ~l~~~~~~~~~~~~~~l~~~Cl~~dP~~RPt~~~v~~~L~~~~~ 706 (747)
.++.....+.+||+.|||+|-.+||.+.+|+.+|++++-
T Consensus 855 -----pPmDCP~aL~qLMldCWqkdR~~RP~F~qiV~~lDklIr 893 (996)
T KOG0196|consen 855 -----PPMDCPAALYQLMLDCWQKDRNRRPKFAQIVSTLDKLIR 893 (996)
T ss_pred -----CCCCCcHHHHHHHHHHHHHHhhcCCCHHHHHHHHHHHhc
Confidence 222233457889999999999999999999999988653
|
|
| >KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-40 Score=337.98 Aligned_cols=240 Identities=27% Similarity=0.366 Sum_probs=192.3
Q ss_pred CCCccceecccCCeeEEEEEecC-CcEEEEEEecc-cccccHHHHHHHHHHHhccCCCceeeEEeEEEeCC-eeEEEEec
Q 004521 441 NFSINNKLGEGGFGPVYKGTLVD-GQEIAVKRLSK-ISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGE-EKLLIYEF 517 (747)
Q Consensus 441 ~~~~~~~lg~G~fg~Vy~~~~~~-g~~vavK~l~~-~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~-~~~lV~E~ 517 (747)
+++..+.||+|..|+||+++++. ++.+|+|.+.. ......+++.+|++++++.+||+||+++|.|.... ...++|||
T Consensus 80 dle~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~~isI~mEY 159 (364)
T KOG0581|consen 80 DLERLGVLGSGNGGTVYKVRHKPTGKIYALKVILLNIDPALQKQILRELEILRSCQSPYIVGFYGAFYSNGEEISICMEY 159 (364)
T ss_pred HhhhhhhcccCCCcEEEEEEEcCCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCceEEeehhh
Confidence 44457899999999999999865 78999999954 34556789999999999999999999999999999 59999999
Q ss_pred CCCCChhhHhhhcCCCCcCChhHHHHHHHHHHHHHHHhhh-cCCCceEecccCcCcEEEcCCCCceEecccCccccCCCC
Q 004521 518 MPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQ-DSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDE 596 (747)
Q Consensus 518 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~-~~~~~iiHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~ 596 (747)
|.+|||++++... +.+++...-+|+.+|++||.|||+ .+ ||||||||+||||+..|++||+|||.++.+....
T Consensus 160 MDgGSLd~~~k~~---g~i~E~~L~~ia~~VL~GL~YLh~~~~---IIHRDIKPsNlLvNskGeVKicDFGVS~~lvnS~ 233 (364)
T KOG0581|consen 160 MDGGSLDDILKRV---GRIPEPVLGKIARAVLRGLSYLHEERK---IIHRDIKPSNLLVNSKGEVKICDFGVSGILVNSI 233 (364)
T ss_pred cCCCCHHHHHhhc---CCCCHHHHHHHHHHHHHHHHHHhhccC---eeeccCCHHHeeeccCCCEEeccccccHHhhhhh
Confidence 9999999999653 458999999999999999999996 54 9999999999999999999999999998875441
Q ss_pred Cccccceeeecc---------CCCCCccccchhHHHHHHHHHhCCCCCCCCC--CcchhhhhHhHHhcCCcccccchhhh
Q 004521 597 TEGNTNRVVGTY---------DGQFSIKSDVFSFGILLLEIVSGKKNRGFYR--SDTKVNLIGHLWDEGIPLRLIDACIQ 665 (747)
Q Consensus 597 ~~~~~~~~~~~~---------~~~~s~ksDVwS~Gvvl~elltg~~p~~~~~--~~~~~~~~~~~~~~~~~~~~~d~~l~ 665 (747)
.....||. +..|+.++||||||++|+|+.+|+.|+.... ......++..+. .+.++.+.+.
T Consensus 234 ----a~tfvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~~~~~~~~~~Ll~~Iv-~~ppP~lP~~--- 305 (364)
T KOG0581|consen 234 ----ANTFVGTSAYMSPERISGESYSVKSDIWSLGLSLLELAIGRFPYPPPNPPYLDIFELLCAIV-DEPPPRLPEG--- 305 (364)
T ss_pred ----cccccccccccChhhhcCCcCCcccceecccHHHHHHhhCCCCCCCcCCCCCCHHHHHHHHh-cCCCCCCCcc---
Confidence 22233332 5689999999999999999999999976541 122233333333 3333333332
Q ss_pred ccCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 004521 666 DSCNLADVIRCIHIGLLCVQQHPEDRPCMPSVIL 699 (747)
Q Consensus 666 ~~~~~~~~~~~~~l~~~Cl~~dP~~RPt~~~v~~ 699 (747)
.+. .++..++-.||+.||.+||++.|+++
T Consensus 306 -~fS----~ef~~FV~~CL~Kdp~~R~s~~qLl~ 334 (364)
T KOG0581|consen 306 -EFS----PEFRSFVSCCLRKDPSERPSAKQLLQ 334 (364)
T ss_pred -cCC----HHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 122 23556777999999999999999876
|
|
| >KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-40 Score=336.13 Aligned_cols=190 Identities=29% Similarity=0.524 Sum_probs=166.0
Q ss_pred hcCCCccceecccCCeeEEEEEecC-CcEEEEEEeccc--ccccHHHHHHHHHHHhccCCCceeeEEeEEEeCCeeEEEE
Q 004521 439 TDNFSINNKLGEGGFGPVYKGTLVD-GQEIAVKRLSKI--SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIY 515 (747)
Q Consensus 439 ~~~~~~~~~lg~G~fg~Vy~~~~~~-g~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 515 (747)
..+|.+.++||+|+||+||+|++.. +.+||||.+.+. .....+.+..|+.+|+.++|||||++++++..++..+|||
T Consensus 9 ~~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~i~lVM 88 (429)
T KOG0595|consen 9 VGDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCIEDDDFIYLVM 88 (429)
T ss_pred cccceehhhccCcceEEEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEEecCCeEEEEE
Confidence 4578889999999999999999865 899999999764 5556677899999999999999999999999999999999
Q ss_pred ecCCCCChhhHhhhcCCCCcCChhHHHHHHHHHHHHHHHhhhcCCCceEecccCcCcEEEcCC------CCceEecccCc
Q 004521 516 EFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQD------MNPKISDFGLV 589 (747)
Q Consensus 516 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NIll~~~------~~~kl~DFGla 589 (747)
|||.+|+|.+||+.. +.+++.....++.|||.||++||+++ ||||||||+||||+.. -.+||+|||+|
T Consensus 89 EyC~gGDLs~yi~~~---~~l~e~t~r~Fm~QLA~alq~L~~~~---IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGfA 162 (429)
T KOG0595|consen 89 EYCNGGDLSDYIRRR---GRLPEATARHFMQQLASALQFLHENN---IIHRDLKPQNILLSTTARNDTSPVLKIADFGFA 162 (429)
T ss_pred EeCCCCCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCCcceEEeccCCCCCCCceEEecccchh
Confidence 999999999999654 35899999999999999999999998 9999999999999865 45799999999
Q ss_pred cccCCCCCccccceeeecc---------CCCCCccccchhHHHHHHHHHhCCCCCCC
Q 004521 590 RTFGGDETEGNTNRVVGTY---------DGQFSIKSDVFSFGILLLEIVSGKKNRGF 637 (747)
Q Consensus 590 ~~~~~~~~~~~~~~~~~~~---------~~~~s~ksDVwS~Gvvl~elltg~~p~~~ 637 (747)
|.+..... ....+|+. ...|+.|+|+||+|+|||++++|+.||..
T Consensus 163 R~L~~~~~---a~tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~a 216 (429)
T KOG0595|consen 163 RFLQPGSM---AETLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCLTGKPPFDA 216 (429)
T ss_pred hhCCchhH---HHHhhCCccccCHHHHHhccccchhhHHHHHHHHHHHHhCCCCccc
Confidence 98864332 22233331 57899999999999999999999999753
|
|
| >KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-40 Score=337.54 Aligned_cols=244 Identities=24% Similarity=0.323 Sum_probs=186.9
Q ss_pred HhcCCCccceecccCCeeEEEEEec-CCcEEEEEEecccc-------cccHHHHHHHHHHHhccCCCceeeEEeEEEeCC
Q 004521 438 ATDNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKIS-------EQGLKELKNEVILFSKLQHRNLVKLLGCCIQGE 509 (747)
Q Consensus 438 ~~~~~~~~~~lg~G~fg~Vy~~~~~-~g~~vavK~l~~~~-------~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~ 509 (747)
..+.|.+.+.||+|+||.|-+|..+ +|+.||||++.+.. ........+|+++|++|+|||||++++++...+
T Consensus 170 ~~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~~d 249 (475)
T KOG0615|consen 170 FNDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEVPD 249 (475)
T ss_pred hcceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeecCC
Confidence 3457888899999999999999864 59999999997521 112234579999999999999999999999999
Q ss_pred eeEEEEecCCCCChhhHhhhcCCCCcCChhHHHHHHHHHHHHHHHhhhcCCCceEecccCcCcEEEcCC---CCceEecc
Q 004521 510 EKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQD---MNPKISDF 586 (747)
Q Consensus 510 ~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NIll~~~---~~~kl~DF 586 (747)
..|+||||+++|.|.+++..+ +.+.+..-..+++|++.|+.|||++| |+||||||+|||+..+ ..+||+||
T Consensus 250 s~YmVlE~v~GGeLfd~vv~n---k~l~ed~~K~~f~Qll~avkYLH~~G---I~HRDiKPeNILl~~~~e~~llKItDF 323 (475)
T KOG0615|consen 250 SSYMVLEYVEGGELFDKVVAN---KYLREDLGKLLFKQLLTAVKYLHSQG---IIHRDIKPENILLSNDAEDCLLKITDF 323 (475)
T ss_pred ceEEEEEEecCccHHHHHHhc---cccccchhHHHHHHHHHHHHHHHHcC---cccccCCcceEEeccCCcceEEEeccc
Confidence 999999999999999998653 44777788889999999999999999 9999999999999766 78999999
Q ss_pred cCccccCCCCCccccceeeecc-----------CCC-CCccccchhHHHHHHHHHhCCCCCCCCCCcchhhhhHhHHhcC
Q 004521 587 GLVRTFGGDETEGNTNRVVGTY-----------DGQ-FSIKSDVFSFGILLLEIVSGKKNRGFYRSDTKVNLIGHLWDEG 654 (747)
Q Consensus 587 Gla~~~~~~~~~~~~~~~~~~~-----------~~~-~s~ksDVwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~ 654 (747)
|+|+..+.... ....+||. +.. +..|+|+||+|||||-+++|..||.....+. .+..++.+ |
T Consensus 324 GlAK~~g~~sf---m~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~--sl~eQI~~-G 397 (475)
T KOG0615|consen 324 GLAKVSGEGSF---MKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDP--SLKEQILK-G 397 (475)
T ss_pred chhhcccccee---hhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCCc--cHHHHHhc-C
Confidence 99998763221 12233332 222 3459999999999999999999976443322 12223222 2
Q ss_pred CcccccchhhhccCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 004521 655 IPLRLIDACIQDSCNLADVIRCIHIGLLCVQQHPEDRPCMPSVIL 699 (747)
Q Consensus 655 ~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dP~~RPt~~~v~~ 699 (747)
...... ....+--++..+++-++|..||++|||+.|+++
T Consensus 398 ~y~f~p------~~w~~Iseea~dlI~~mL~VdP~~R~s~~eaL~ 436 (475)
T KOG0615|consen 398 RYAFGP------LQWDRISEEALDLINWMLVVDPENRPSADEALN 436 (475)
T ss_pred cccccC------hhhhhhhHHHHHHHHHhhEeCcccCcCHHHHhc
Confidence 211110 111122345677888999999999999999875
|
|
| >KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-39 Score=374.03 Aligned_cols=251 Identities=33% Similarity=0.539 Sum_probs=201.3
Q ss_pred hcCCCccceecccCCeeEEEEEecC--Cc----EEEEEEeccc-ccccHHHHHHHHHHHhccCCCceeeEEeEEEeCCee
Q 004521 439 TDNFSINNKLGEGGFGPVYKGTLVD--GQ----EIAVKRLSKI-SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEK 511 (747)
Q Consensus 439 ~~~~~~~~~lg~G~fg~Vy~~~~~~--g~----~vavK~l~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~ 511 (747)
.++.+..+.||+|+||.||+|...+ |. .||||.+++. +.+...+|.+|..+|++++|||||+++|+|.+....
T Consensus 691 ~~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~~~~ 770 (1025)
T KOG1095|consen 691 RKNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLSSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLDSGPP 770 (1025)
T ss_pred hhheEeeeeeccccccceEEEEEecCCCCccceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCcceeeEEEeecCCCCc
Confidence 3456667899999999999999754 43 4999999874 556678999999999999999999999999999999
Q ss_pred EEEEecCCCCChhhHhhhcCC----CCcCChhHHHHHHHHHHHHHHHhhhcCCCceEecccCcCcEEEcCCCCceEeccc
Q 004521 512 LLIYEFMPNKSLDSFIFDQTR----RTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFG 587 (747)
Q Consensus 512 ~lV~E~~~~gsL~~~l~~~~~----~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NIll~~~~~~kl~DFG 587 (747)
++++|||++|+|..||++... ...+...+.+.|+.|||+|+.||+++. +|||||+++|+||++...+||+|||
T Consensus 771 ~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~~---fvHRDLAaRNCLL~~~r~VKIaDFG 847 (1025)
T KOG1095|consen 771 LILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESKH---FVHRDLAARNCLLDERRVVKIADFG 847 (1025)
T ss_pred EEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhCC---CcCcchhhhheeecccCcEEEcccc
Confidence 999999999999999987521 346889999999999999999999988 9999999999999999999999999
Q ss_pred CccccCCCCCccccce--e-e-----ec-cCCCCCccccchhHHHHHHHHHh-CCCCCCCCCCcchhhhhHhHHhcCCcc
Q 004521 588 LVRTFGGDETEGNTNR--V-V-----GT-YDGQFSIKSDVFSFGILLLEIVS-GKKNRGFYRSDTKVNLIGHLWDEGIPL 657 (747)
Q Consensus 588 la~~~~~~~~~~~~~~--~-~-----~~-~~~~~s~ksDVwS~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~ 657 (747)
|||.+...++...... . . .. .++.|+.|+|||||||+||||+| |..||.. ....+.+......+ +.
T Consensus 848 lArDiy~~~yyr~~~~a~lPvkWm~PEsl~d~iFtskSDvWsFGVllWEifslG~~PY~~---~~n~~v~~~~~~gg-RL 923 (1025)
T KOG1095|consen 848 LARDIYDKDYYRKHGEAMLPVKWMPPESLKDGIFTSKSDVWSFGVLLWEIFSLGATPYPS---RSNFEVLLDVLEGG-RL 923 (1025)
T ss_pred hhHhhhhchheeccCccccceecCCHHHHhhcccccccchhhhHHHHHHHHhCCCCCCCC---cchHHHHHHHHhCC-cc
Confidence 9996544443322221 1 0 00 26899999999999999999999 7778543 33334444344444 22
Q ss_pred cccchhhhccCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhcCCC
Q 004521 658 RLIDACIQDSCNLADVIRCIHIGLLCVQQHPEDRPCMPSVILMLGSEI 705 (747)
Q Consensus 658 ~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dP~~RPt~~~v~~~L~~~~ 705 (747)
..+. .....+++||.+||+.+|++||++..|++.+....
T Consensus 924 ~~P~---------~CP~~ly~lM~~CW~~~pe~RP~F~~i~~q~~~i~ 962 (1025)
T KOG1095|consen 924 DPPS---------YCPEKLYQLMLQCWKHDPEDRPSFRTIVEQDPAIS 962 (1025)
T ss_pred CCCC---------CCChHHHHHHHHHccCChhhCccHHHHHhhhhhhh
Confidence 2211 22345779999999999999999999999887754
|
|
| >KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-39 Score=343.60 Aligned_cols=238 Identities=24% Similarity=0.375 Sum_probs=194.5
Q ss_pred cCCCccceecccCCeeEEEEEe-cCCcEEEEEEecc---cccccHHHHHHHHHHHhccCCCceeeEEeEEEeCCeeEEEE
Q 004521 440 DNFSINNKLGEGGFGPVYKGTL-VDGQEIAVKRLSK---ISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIY 515 (747)
Q Consensus 440 ~~~~~~~~lg~G~fg~Vy~~~~-~~g~~vavK~l~~---~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 515 (747)
..|...+.||+|||+.||+++. ..|+.||+|++.+ ......+.+.+|++|.++|+|||||+++++|++.++.|||+
T Consensus 18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~nVYivL 97 (592)
T KOG0575|consen 18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSNNVYIVL 97 (592)
T ss_pred ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCCceEEEE
Confidence 4688899999999999999998 6799999999976 24455678899999999999999999999999999999999
Q ss_pred ecCCCCChhhHhhhcCCCCcCChhHHHHHHHHHHHHHHHhhhcCCCceEecccCcCcEEEcCCCCceEecccCccccCCC
Q 004521 516 EFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGD 595 (747)
Q Consensus 516 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NIll~~~~~~kl~DFGla~~~~~~ 595 (747)
|+|++++|.+++. +++.+++.+++.+++||+.||.|||+++ |||||||..|+||+++.++||+|||||..+..+
T Consensus 98 ELC~~~sL~el~K---rrk~ltEpEary~l~QIv~GlkYLH~~~---IiHRDLKLGNlfL~~~~~VKIgDFGLAt~le~~ 171 (592)
T KOG0575|consen 98 ELCHRGSLMELLK---RRKPLTEPEARYFLRQIVEGLKYLHSLG---IIHRDLKLGNLFLNENMNVKIGDFGLATQLEYD 171 (592)
T ss_pred EecCCccHHHHHH---hcCCCCcHHHHHHHHHHHHHHHHHHhcC---ceecccchhheeecCcCcEEecccceeeeecCc
Confidence 9999999999984 5667999999999999999999999998 999999999999999999999999999988755
Q ss_pred CCccccceeeecc---------CCCCCccccchhHHHHHHHHHhCCCCCCCCCCcchhhhhHhHHhcCCcccccchhhhc
Q 004521 596 ETEGNTNRVVGTY---------DGQFSIKSDVFSFGILLLEIVSGKKNRGFYRSDTKVNLIGHLWDEGIPLRLIDACIQD 666 (747)
Q Consensus 596 ~~~~~~~~~~~~~---------~~~~s~ksDVwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 666 (747)
+.. ....+||+ ...++..+||||+|||||-||.|++||+... ..+.+..+....... +.
T Consensus 172 ~Er--k~TlCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~PPFetk~---vkety~~Ik~~~Y~~-------P~ 239 (592)
T KOG0575|consen 172 GER--KKTLCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRPPFETKT---VKETYNKIKLNEYSM-------PS 239 (592)
T ss_pred ccc--cceecCCCcccChhHhccCCCCCchhhhhhhhHHHhhhhCCCCcccch---HHHHHHHHHhcCccc-------cc
Confidence 322 22344553 4568899999999999999999999975322 222333332222111 00
Q ss_pred cCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 004521 667 SCNLADVIRCIHIGLLCVQQHPEDRPCMPSVIL 699 (747)
Q Consensus 667 ~~~~~~~~~~~~l~~~Cl~~dP~~RPt~~~v~~ 699 (747)
... ..+.+|+.++|+.||.+|||+++|+.
T Consensus 240 ~ls----~~A~dLI~~lL~~~P~~Rpsl~~vL~ 268 (592)
T KOG0575|consen 240 HLS----AEAKDLIRKLLRPNPSERPSLDEVLD 268 (592)
T ss_pred ccC----HHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 011 12345666899999999999999985
|
|
| >KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-39 Score=340.29 Aligned_cols=257 Identities=26% Similarity=0.429 Sum_probs=201.4
Q ss_pred HhcCCCccceecccCCeeEEEEEecCCcEEEEEEecccc-cccHHHHHHHHHHHhccCCCceeeEEeEEEeCCeeEEEEe
Q 004521 438 ATDNFSINNKLGEGGFGPVYKGTLVDGQEIAVKRLSKIS-EQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYE 516 (747)
Q Consensus 438 ~~~~~~~~~~lg~G~fg~Vy~~~~~~g~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E 516 (747)
..+...+.++||+|.||.|.++....+..||||+++... ....++|.+|+++|.+++|||||+++|+|..++++++|+|
T Consensus 536 PRs~L~~~ekiGeGqFGEVhLCeveg~lkVAVK~Lr~~a~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~DePicmI~E 615 (807)
T KOG1094|consen 536 PRSRLRFKEKIGEGQFGEVHLCEVEGPLKVAVKILRPDATKNARNDFLKEIKILSRLKHPNIVELLGVCVQDDPLCMITE 615 (807)
T ss_pred chhheehhhhhcCcccceeEEEEecCceEEEEeecCcccchhHHHHHHHHHHHHhccCCCCeeEEEeeeecCCchHHHHH
Confidence 345667789999999999999999888999999999744 3445899999999999999999999999999999999999
Q ss_pred cCCCCChhhHhhhcCCCCcCChhHHHHHHHHHHHHHHHhhhcCCCceEecccCcCcEEEcCCCCceEecccCccccCCCC
Q 004521 517 FMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDE 596 (747)
Q Consensus 517 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~ 596 (747)
||++|+|..||..+.... +.-....+|+.|||.||+||.+.+ ++||||.++|||+|.++++||+|||++|.+-..+
T Consensus 616 YmEnGDLnqFl~aheapt-~~t~~~vsi~tqiasgmaYLes~n---fVHrd~a~rNcLv~~e~~iKiadfgmsR~lysg~ 691 (807)
T KOG1094|consen 616 YMENGDLNQFLSAHELPT-AETAPGVSICTQIASGMAYLESLN---FVHRDLATRNCLVDGEFTIKIADFGMSRNLYSGD 691 (807)
T ss_pred HHhcCcHHHHHHhccCcc-cccchhHHHHHHHHHHHHHHHhhc---hhhccccccceeecCcccEEecCcccccccccCC
Confidence 999999999997764433 455677789999999999999877 9999999999999999999999999999765554
Q ss_pred Cccccceeeec---------cCCCCCccccchhHHHHHHHHHh--CCCCCCCCCCcchhhhhHhHHhcCCcccccchhhh
Q 004521 597 TEGNTNRVVGT---------YDGQFSIKSDVFSFGILLLEIVS--GKKNRGFYRSDTKVNLIGHLWDEGIPLRLIDACIQ 665 (747)
Q Consensus 597 ~~~~~~~~~~~---------~~~~~s~ksDVwS~Gvvl~ellt--g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 665 (747)
+.....+.+-+ ..+.++.++|||+|||+|||+++ ..+|+.....+...+-.......+-....+ .
T Consensus 692 yy~vqgr~vlpiRwmawEsillgkFttaSDvWafgvTlwE~~~~C~e~Py~~lt~e~vven~~~~~~~~~~~~~l-~--- 767 (807)
T KOG1094|consen 692 YYRVQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEVFMLCREQPYSQLTDEQVVENAGEFFRDQGRQVVL-S--- 767 (807)
T ss_pred ceeeecceeeeeeehhHHHHHhccccchhhhhhhHHHHHHHHHHHhhCchhhhhHHHHHHhhhhhcCCCCcceec-c---
Confidence 43332222211 26899999999999999999876 667865443332222222222222111111 1
Q ss_pred ccCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhcCC
Q 004521 666 DSCNLADVIRCIHIGLLCVQQHPEDRPCMPSVILMLGSE 704 (747)
Q Consensus 666 ~~~~~~~~~~~~~l~~~Cl~~dP~~RPt~~~v~~~L~~~ 704 (747)
.+......++++++.||..|-++||++++|...|+..
T Consensus 768 --~P~~cp~~lyelml~Cw~~es~~RPsFe~lh~~lq~~ 804 (807)
T KOG1094|consen 768 --RPPACPQGLYELMLRCWRRESEQRPSFEQLHLFLQED 804 (807)
T ss_pred --CCCcCcHHHHHHHHHHhchhhhcCCCHHHHHHHHHHh
Confidence 1112234577899999999999999999999999764
|
|
| >KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-39 Score=345.82 Aligned_cols=252 Identities=30% Similarity=0.462 Sum_probs=198.6
Q ss_pred hcCCCccceecccCCeeEEEEEecC--C--cE-EEEEEecc---cccccHHHHHHHHHHHhccCCCceeeEEeEEEeCCe
Q 004521 439 TDNFSINNKLGEGGFGPVYKGTLVD--G--QE-IAVKRLSK---ISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEE 510 (747)
Q Consensus 439 ~~~~~~~~~lg~G~fg~Vy~~~~~~--g--~~-vavK~l~~---~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~ 510 (747)
.++..+.++||+|+||.||+|++.. + .. ||||..+. ......++|++|+++|++++|||||+++|++....+
T Consensus 156 H~~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yGVa~~~~P 235 (474)
T KOG0194|consen 156 HSDIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYGVAVLEEP 235 (474)
T ss_pred ccCccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCc
Confidence 3455666999999999999999754 2 23 89999874 446778899999999999999999999999999999
Q ss_pred eEEEEecCCCCChhhHhhhcCCCCcCChhHHHHHHHHHHHHHHHhhhcCCCceEecccCcCcEEEcCCCCceEecccCcc
Q 004521 511 KLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVR 590 (747)
Q Consensus 511 ~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NIll~~~~~~kl~DFGla~ 590 (747)
.++|||+|.||+|.++|..... .++..+++.++.+.|.||+|||+++ +|||||.++|+|++.++.+||+||||++
T Consensus 236 l~ivmEl~~gGsL~~~L~k~~~--~v~~~ek~~~~~~AA~Gl~YLh~k~---~IHRDIAARNcL~~~~~~vKISDFGLs~ 310 (474)
T KOG0194|consen 236 LMLVMELCNGGSLDDYLKKNKK--SLPTLEKLRFCYDAARGLEYLHSKN---CIHRDIAARNCLYSKKGVVKISDFGLSR 310 (474)
T ss_pred cEEEEEecCCCcHHHHHHhCCC--CCCHHHHHHHHHHHHhHHHHHHHCC---CcchhHhHHHheecCCCeEEeCcccccc
Confidence 9999999999999999966433 5899999999999999999999998 9999999999999999999999999987
Q ss_pred ccCCCCCcc------ccceeeecc-CCCCCccccchhHHHHHHHHHh-CCCCCCCCCCcchhhhhHhHHhcCCcccccch
Q 004521 591 TFGGDETEG------NTNRVVGTY-DGQFSIKSDVFSFGILLLEIVS-GKKNRGFYRSDTKVNLIGHLWDEGIPLRLIDA 662 (747)
Q Consensus 591 ~~~~~~~~~------~~~~~~~~~-~~~~s~ksDVwS~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 662 (747)
.-....... .....+.+. .+.|+.++|||||||++||+++ |..|+.... ......++...+.+.....
T Consensus 311 ~~~~~~~~~~~~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~---~~~v~~kI~~~~~r~~~~~- 386 (474)
T KOG0194|consen 311 AGSQYVMKKFLKKLPIRWLAPETLNTGIFSFKTDVWSFGVLLWEIFENGAEPYPGMK---NYEVKAKIVKNGYRMPIPS- 386 (474)
T ss_pred CCcceeeccccccCcceecChhhhccCccccccchhheeeeEEeeeccCCCCCCCCC---HHHHHHHHHhcCccCCCCC-
Confidence 643111111 000111111 4689999999999999999999 788854332 3333444445555544433
Q ss_pred hhhccCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhcCCCCC
Q 004521 663 CIQDSCNLADVIRCIHIGLLCVQQHPEDRPCMPSVILMLGSEILL 707 (747)
Q Consensus 663 ~l~~~~~~~~~~~~~~l~~~Cl~~dP~~RPt~~~v~~~L~~~~~~ 707 (747)
..+.+ +..++.+||+.+|++||+|.++.+.|+.+...
T Consensus 387 -----~~p~~---~~~~~~~c~~~~p~~R~tm~~i~~~l~~~~~~ 423 (474)
T KOG0194|consen 387 -----KTPKE---LAKVMKQCWKKDPEDRPTMSTIKKKLEALEKK 423 (474)
T ss_pred -----CCHHH---HHHHHHHhccCChhhccCHHHHHHHHHHHHhc
Confidence 22333 44566699999999999999999999876543
|
|
| >KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-38 Score=338.22 Aligned_cols=256 Identities=28% Similarity=0.460 Sum_probs=195.2
Q ss_pred HHHHHHhcCCCccceecccCCeeEEEEEecCCcEEEEEEecc--cccccHHHHHHHHHHHhccCCCceeeEEeEEEeCCe
Q 004521 433 ATIANATDNFSINNKLGEGGFGPVYKGTLVDGQEIAVKRLSK--ISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEE 510 (747)
Q Consensus 433 ~~~~~~~~~~~~~~~lg~G~fg~Vy~~~~~~g~~vavK~l~~--~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~ 510 (747)
.+.....+.+.+...||+|.||+||+|++.+ .||||.+.. ...+..+.|++|+..+++-+|.||+-|+|+|.....
T Consensus 385 ~~WeIp~~ev~l~~rIGsGsFGtV~Rg~whG--dVAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~p~~ 462 (678)
T KOG0193|consen 385 EEWEIPPEEVLLGERIGSGSFGTVYRGRWHG--DVAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILLFMGACMNPPL 462 (678)
T ss_pred cccccCHHHhhccceeccccccceeeccccc--ceEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhheeeehhhcCCce
Confidence 3344445566778999999999999999853 699999975 345578899999999999999999999999998887
Q ss_pred eEEEEecCCCCChhhHhhhcCCCCcCChhHHHHHHHHHHHHHHHhhhcCCCceEecccCcCcEEEcCCCCceEecccCcc
Q 004521 511 KLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVR 590 (747)
Q Consensus 511 ~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NIll~~~~~~kl~DFGla~ 590 (747)
.+|..+|++.+|+.+|+... ..++..+.+.|++|||+||.|||.++ |||||||..||+|.+++.|||+||||+.
T Consensus 463 -AIiTqwCeGsSLY~hlHv~e--tkfdm~~~idIAqQiaqGM~YLHAK~---IIHrDLKSnNIFl~~~~kVkIgDFGLat 536 (678)
T KOG0193|consen 463 -AIITQWCEGSSLYTHLHVQE--TKFDMNTTIDIAQQIAQGMDYLHAKN---IIHRDLKSNNIFLHEDLKVKIGDFGLAT 536 (678)
T ss_pred -eeeehhccCchhhhhccchh--hhhhHHHHHHHHHHHHHhhhhhhhhh---hhhhhccccceEEccCCcEEEeccccee
Confidence 99999999999999997643 55889999999999999999999998 9999999999999999999999999985
Q ss_pred ccC---C-CCCcccc--------ceeeeccCCCCCccccchhHHHHHHHHHhCCCCCCCCCCcchhhhhHhHHhcCCccc
Q 004521 591 TFG---G-DETEGNT--------NRVVGTYDGQFSIKSDVFSFGILLLEIVSGKKNRGFYRSDTKVNLIGHLWDEGIPLR 658 (747)
Q Consensus 591 ~~~---~-~~~~~~~--------~~~~~~~~~~~s~ksDVwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 658 (747)
.-. + .+..... +.+.-.-..+|++.+||||||+|+|||++|..|+.... .+.+.++...|...
T Consensus 537 vk~~w~g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi~~----~dqIifmVGrG~l~- 611 (678)
T KOG0193|consen 537 VKTRWSGEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSIQN----RDQIIFMVGRGYLM- 611 (678)
T ss_pred eeeeeccccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCCCC----hhheEEEecccccC-
Confidence 321 1 1111000 00111115789999999999999999999999975221 12222222333221
Q ss_pred ccchhhhccCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhcCCC
Q 004521 659 LIDACIQDSCNLADVIRCIHIGLLCVQQHPEDRPCMPSVILMLGSEI 705 (747)
Q Consensus 659 ~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dP~~RPt~~~v~~~L~~~~ 705 (747)
.|.......... .+.+|+..||..++++||.+.+|+.+|+.+.
T Consensus 612 -pd~s~~~s~~pk---~mk~Ll~~C~~~~~~eRP~F~~il~~l~~l~ 654 (678)
T KOG0193|consen 612 -PDLSKIRSNCPK---AMKRLLSDCWKFDREERPLFPQLLSKLEELL 654 (678)
T ss_pred -ccchhhhccCHH---HHHHHHHHHHhcCcccCccHHHHHHHHHHhh
Confidence 121111122222 3556677999999999999999999888764
|
|
| >KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-38 Score=311.27 Aligned_cols=254 Identities=20% Similarity=0.302 Sum_probs=189.2
Q ss_pred cCCCccceecccCCeeEEEEEecC-CcEEEEEEecccc--cccHHHHHHHHHHHhccCCCceeeEEeEEEeCCeeEEEEe
Q 004521 440 DNFSINNKLGEGGFGPVYKGTLVD-GQEIAVKRLSKIS--EQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYE 516 (747)
Q Consensus 440 ~~~~~~~~lg~G~fg~Vy~~~~~~-g~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E 516 (747)
+.|+...++|+|+||.||+++.++ |+.||||++.... ....+-.++|+++|++++|+|||.++.+|......+||+|
T Consensus 2 ekYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrklhLVFE 81 (396)
T KOG0593|consen 2 EKYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVFRRKRKLHLVFE 81 (396)
T ss_pred cHHhhhhccccCcceEEEEeccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcceeEEEee
Confidence 467778899999999999999876 9999999997532 2334556899999999999999999999999999999999
Q ss_pred cCCCCChhhHhhhcCCCCcCChhHHHHHHHHHHHHHHHhhhcCCCceEecccCcCcEEEcCCCCceEecccCccccCCC-
Q 004521 517 FMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGD- 595 (747)
Q Consensus 517 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NIll~~~~~~kl~DFGla~~~~~~- 595 (747)
|++..-|+++= ... .-++...+.+++.|+++|+.|+|+++ +|||||||+||||+.++.+||+|||+||.+...
T Consensus 82 ~~dhTvL~eLe-~~p--~G~~~~~vk~~l~Q~l~ai~~cHk~n---~IHRDIKPENILit~~gvvKLCDFGFAR~L~~pg 155 (396)
T KOG0593|consen 82 YCDHTVLHELE-RYP--NGVPSELVKKYLYQLLKAIHFCHKNN---CIHRDIKPENILITQNGVVKLCDFGFARTLSAPG 155 (396)
T ss_pred ecchHHHHHHH-hcc--CCCCHHHHHHHHHHHHHHhhhhhhcC---eecccCChhheEEecCCcEEeccchhhHhhcCCc
Confidence 99876665543 222 23788999999999999999999998 999999999999999999999999999998742
Q ss_pred CCccc--cceeeecc-----CCCCCccccchhHHHHHHHHHhCCCCCCCCCCcchhhhhHhHH------------hcCCc
Q 004521 596 ETEGN--TNRVVGTY-----DGQFSIKSDVFSFGILLLEIVSGKKNRGFYRSDTKVNLIGHLW------------DEGIP 656 (747)
Q Consensus 596 ~~~~~--~~~~~~~~-----~~~~s~ksDVwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~------------~~~~~ 656 (747)
+.... .++....+ +.+|...+||||+||++.||++|...|+..++-+....+.... ..+..
T Consensus 156 d~YTDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQLy~I~ktLG~L~prhq~iF~~N~~F 235 (396)
T KOG0593|consen 156 DNYTDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQLYLIRKTLGNLIPRHQSIFSSNPFF 235 (396)
T ss_pred chhhhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcchHHHHHHHHHHHcccCHHHHHHhccCCce
Confidence 21110 11111111 4789999999999999999999999876544333333332221 11121
Q ss_pred ccccchhhhccCCHH-----HHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 004521 657 LRLIDACIQDSCNLA-----DVIRCIHIGLLCVQQHPEDRPCMPSVIL 699 (747)
Q Consensus 657 ~~~~d~~l~~~~~~~-----~~~~~~~l~~~Cl~~dP~~RPt~~~v~~ 699 (747)
..+.-+......+++ -..-+++++..|++.||.+|++-++++.
T Consensus 236 ~Gv~lP~~~~~epLe~k~p~~s~~~ld~~k~cL~~dP~~R~sc~qll~ 283 (396)
T KOG0593|consen 236 HGVRLPEPEHPEPLERKYPKISNVLLDLLKKCLKMDPDDRLSCEQLLH 283 (396)
T ss_pred eeeecCCCCCccchhhhcccchHHHHHHHHHHhcCCccccccHHHHhc
Confidence 112111111111111 1224578899999999999999999873
|
|
| >KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-39 Score=312.89 Aligned_cols=250 Identities=25% Similarity=0.384 Sum_probs=195.9
Q ss_pred cCCCccceecccCCeeEEEEEe-cCCcEEEEEEecc--cccccHHHHHHHHHHHhccCCCceeeEEe-EEEeCCe-eEEE
Q 004521 440 DNFSINNKLGEGGFGPVYKGTL-VDGQEIAVKRLSK--ISEQGLKELKNEVILFSKLQHRNLVKLLG-CCIQGEE-KLLI 514 (747)
Q Consensus 440 ~~~~~~~~lg~G~fg~Vy~~~~-~~g~~vavK~l~~--~~~~~~~~~~~E~~~l~~l~H~niv~l~g-~~~~~~~-~~lV 514 (747)
.+|.+.++||+|.||+||++.. .+|..||.|.+.- .+....+....|+.+|++|+|||||++++ -+.++.+ .+||
T Consensus 19 ~~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~evlniv 98 (375)
T KOG0591|consen 19 ADYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNEVLNIV 98 (375)
T ss_pred HHHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccchhhHHH
Confidence 3678889999999999999984 6799999999874 34556678999999999999999999999 4455555 7899
Q ss_pred EecCCCCChhhHhhhcC-CCCcCChhHHHHHHHHHHHHHHHhhhcC-CCceEecccCcCcEEEcCCCCceEecccCcccc
Q 004521 515 YEFMPNKSLDSFIFDQT-RRTLLDWSQRFHIICGTARGLLYLHQDS-RLRIIHRDLKASNVLLDQDMNPKISDFGLVRTF 592 (747)
Q Consensus 515 ~E~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~gl~yLH~~~-~~~iiHrDlkp~NIll~~~~~~kl~DFGla~~~ 592 (747)
|||+..|+|...+..-+ .+..+++..+++++.|++.||..+|..- +..|+||||||.||+|+.+|.+||+||||+|.+
T Consensus 99 mE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~gvvKLGDfGL~r~l 178 (375)
T KOG0591|consen 99 MELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANGVVKLGDFGLGRFL 178 (375)
T ss_pred HHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCCceeeccchhHhHh
Confidence 99999999999986533 4567999999999999999999999832 123999999999999999999999999999998
Q ss_pred CCCCCccccceeeecc---------CCCCCccccchhHHHHHHHHHhCCCCCCCCCCcchhhhhHhHHhcCCcccccchh
Q 004521 593 GGDETEGNTNRVVGTY---------DGQFSIKSDVFSFGILLLEIVSGKKNRGFYRSDTKVNLIGHLWDEGIPLRLIDAC 663 (747)
Q Consensus 593 ~~~~~~~~~~~~~~~~---------~~~~s~ksDVwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 663 (747)
....... ...+||+ +..|+.|+||||+||++|||..-..||... ....+......+....+.+..
T Consensus 179 ~s~~tfA--~S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEMcaL~~PF~g~----n~~~L~~KI~qgd~~~~p~~~ 252 (375)
T KOG0591|consen 179 SSKTTFA--HSLVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEMCALQSPFYGD----NLLSLCKKIEQGDYPPLPDEH 252 (375)
T ss_pred cchhHHH--HhhcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHHHhcCCCcccc----cHHHHHHHHHcCCCCCCcHHH
Confidence 7654422 2234442 678999999999999999999999997532 222333344555555444332
Q ss_pred hhccCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhcC
Q 004521 664 IQDSCNLADVIRCIHIGLLCVQQHPEDRPCMPSVILMLGS 703 (747)
Q Consensus 664 l~~~~~~~~~~~~~~l~~~Cl~~dP~~RPt~~~v~~~L~~ 703 (747)
. -..+..|+-.|+..||+.||+...+++-++.
T Consensus 253 Y--------S~~l~~li~~ci~vd~~~RP~t~~~v~di~~ 284 (375)
T KOG0591|consen 253 Y--------STDLRELINMCIAVDPEQRPDTVPYVQDIQS 284 (375)
T ss_pred h--------hhHHHHHHHHHccCCcccCCCcchHHHHHHH
Confidence 2 1234456668999999999996566555544
|
|
| >KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-37 Score=323.02 Aligned_cols=255 Identities=24% Similarity=0.353 Sum_probs=193.9
Q ss_pred hcCCCccceecccCCeeEEEEEec-CCcEEEEEEecccc--cccHHHHHHHHHHHhccCCCceeeEEeEEEeC--CeeEE
Q 004521 439 TDNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKIS--EQGLKELKNEVILFSKLQHRNLVKLLGCCIQG--EEKLL 513 (747)
Q Consensus 439 ~~~~~~~~~lg~G~fg~Vy~~~~~-~g~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~--~~~~l 513 (747)
.+.|+.+++||+|.||.||+|+.. +|+.||+|+++... +....-..+|+.||++|+||||++|.+...+. ..+||
T Consensus 116 ~~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~siYl 195 (560)
T KOG0600|consen 116 ADSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIVTSKLSGSIYL 195 (560)
T ss_pred hHHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEEEecCCceEEE
Confidence 346777899999999999999964 59999999998643 45566778999999999999999999999887 68999
Q ss_pred EEecCCCCChhhHhhhcCCCCcCChhHHHHHHHHHHHHHHHhhhcCCCceEecccCcCcEEEcCCCCceEecccCccccC
Q 004521 514 IYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFG 593 (747)
Q Consensus 514 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NIll~~~~~~kl~DFGla~~~~ 593 (747)
|+|||+ -+|..++... .-.++..++..++.|++.||+|+|..+ |+|||||.+|||||.+|.+||+|||||+.+.
T Consensus 196 VFeYMd-hDL~GLl~~p--~vkft~~qIKc~mkQLl~Gl~~cH~~g---vlHRDIK~SNiLidn~G~LKiaDFGLAr~y~ 269 (560)
T KOG0600|consen 196 VFEYMD-HDLSGLLSSP--GVKFTEPQIKCYMKQLLEGLEYCHSRG---VLHRDIKGSNILIDNNGVLKIADFGLARFYT 269 (560)
T ss_pred EEeccc-chhhhhhcCC--CcccChHHHHHHHHHHHHHHHHHhhcC---eeeccccccceEEcCCCCEEeccccceeecc
Confidence 999997 5677777442 335899999999999999999999998 9999999999999999999999999999887
Q ss_pred CCCCccccceeeecc---------CCCCCccccchhHHHHHHHHHhCCCCCCCCCCcchhhhhHhH--------HhcCCc
Q 004521 594 GDETEGNTNRVVGTY---------DGQFSIKSDVFSFGILLLEIVSGKKNRGFYRSDTKVNLIGHL--------WDEGIP 656 (747)
Q Consensus 594 ~~~~~~~~~~~~~~~---------~~~~s~ksDVwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~--------~~~~~~ 656 (747)
.......+..++..+ ...|+.++|+||.||||.||+.|+..+......+....+..+ |....+
T Consensus 270 ~~~~~~~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEveQl~kIfklcGSP~e~~W~~~kL 349 (560)
T KOG0600|consen 270 PSGSAPYTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTEVEQLHKIFKLCGSPTEDYWPVSKL 349 (560)
T ss_pred CCCCcccccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccHHHHHHHHHHHhCCCChhccccccC
Confidence 777665555554332 467999999999999999999999986544333333333332 221111
Q ss_pred cc--ccchhhhccCCHHH-----HHHHHHHHHhccCCCCCCCCCHHHHHH
Q 004521 657 LR--LIDACIQDSCNLAD-----VIRCIHIGLLCVQQHPEDRPCMPSVIL 699 (747)
Q Consensus 657 ~~--~~d~~l~~~~~~~~-----~~~~~~l~~~Cl~~dP~~RPt~~~v~~ 699 (747)
+. .+.+.-.....+.+ ....++|+-.+|..||.+|.|+.++++
T Consensus 350 P~~~~~kp~~~y~r~l~E~~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~ 399 (560)
T KOG0600|consen 350 PHATIFKPQQPYKRRLRETFKDFPASALDLLEKLLSLDPDKRGTASSALQ 399 (560)
T ss_pred CcccccCCCCcccchHHHHhccCCHHHHHHHHHHhccCccccccHHHHhc
Confidence 10 00000000011111 123456777899999999999998864
|
|
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-37 Score=333.20 Aligned_cols=251 Identities=29% Similarity=0.460 Sum_probs=189.2
Q ss_pred hcCCCccceecccCCeeEEEEEec------CCcEEEEEEecccc-cccHHHHHHHHHHHhcc-CCCceeeEEeEEEeCC-
Q 004521 439 TDNFSINNKLGEGGFGPVYKGTLV------DGQEIAVKRLSKIS-EQGLKELKNEVILFSKL-QHRNLVKLLGCCIQGE- 509 (747)
Q Consensus 439 ~~~~~~~~~lg~G~fg~Vy~~~~~------~g~~vavK~l~~~~-~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~- 509 (747)
.++|++.++||+|+||.||+|... .++.||||+++... ....+.+.+|+.++.++ +||||+++++++...+
T Consensus 6 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~ 85 (338)
T cd05102 6 RDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASEHKALMSELKILIHIGNHLNVVNLLGACTKPNG 85 (338)
T ss_pred hhHceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccccchHHHHHHHHHHHHHHHhccCcceeeEEeEecCCCC
Confidence 467899999999999999999742 25689999997532 23456789999999999 8999999999987654
Q ss_pred eeEEEEecCCCCChhhHhhhcCC---------------------------------------------------------
Q 004521 510 EKLLIYEFMPNKSLDSFIFDQTR--------------------------------------------------------- 532 (747)
Q Consensus 510 ~~~lV~E~~~~gsL~~~l~~~~~--------------------------------------------------------- 532 (747)
..++||||+++|+|.+++.....
T Consensus 86 ~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 165 (338)
T cd05102 86 PLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQETDD 165 (338)
T ss_pred ceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccchhccc
Confidence 57899999999999999864321
Q ss_pred --CCcCChhHHHHHHHHHHHHHHHhhhcCCCceEecccCcCcEEEcCCCCceEecccCccccCCCCCccccc-------e
Q 004521 533 --RTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNTN-------R 603 (747)
Q Consensus 533 --~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~-------~ 603 (747)
...+++..+..++.||++||+|||+.+ |+||||||+|||++.++.+||+|||+++.+.......... .
T Consensus 166 ~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~y 242 (338)
T cd05102 166 LWKSPLTMEDLICYSFQVARGMEFLASRK---CIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPLKW 242 (338)
T ss_pred cccCCCCHHHHHHHHHHHHHHHHHHHHCC---EECCCCccceEEEcCCCcEEEeecccccccccCcchhcccCCCCCccc
Confidence 124778888999999999999999988 9999999999999999999999999998653322111100 0
Q ss_pred eeec--cCCCCCccccchhHHHHHHHHHh-CCCCCCCCCCcchhhhhHhHHhcCCcccccchhhhccCCHHHHHHHHHHH
Q 004521 604 VVGT--YDGQFSIKSDVFSFGILLLEIVS-GKKNRGFYRSDTKVNLIGHLWDEGIPLRLIDACIQDSCNLADVIRCIHIG 680 (747)
Q Consensus 604 ~~~~--~~~~~s~ksDVwS~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~ 680 (747)
..+. ....++.++|||||||+||||++ |..||....... .+......+......+ .. ...+.+++
T Consensus 243 ~aPE~~~~~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~~---~~~~~~~~~~~~~~~~-----~~----~~~l~~li 310 (338)
T cd05102 243 MAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINE---EFCQRLKDGTRMRAPE-----NA----TPEIYRIM 310 (338)
T ss_pred cCcHHhhcCCCCcccCHHHHHHHHHHHHhCCCCCCCCCCccH---HHHHHHhcCCCCCCCC-----CC----CHHHHHHH
Confidence 1111 24668999999999999999997 999975432211 1112222222211111 11 12366788
Q ss_pred HhccCCCCCCCCCHHHHHHHhcCC
Q 004521 681 LLCVQQHPEDRPCMPSVILMLGSE 704 (747)
Q Consensus 681 ~~Cl~~dP~~RPt~~~v~~~L~~~ 704 (747)
.+||+.||.+||++.+|+++|+..
T Consensus 311 ~~cl~~dp~~RPs~~el~~~l~~~ 334 (338)
T cd05102 311 LACWQGDPKERPTFSALVEILGDL 334 (338)
T ss_pred HHHccCChhhCcCHHHHHHHHHHH
Confidence 899999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-37 Score=323.44 Aligned_cols=244 Identities=27% Similarity=0.359 Sum_probs=194.1
Q ss_pred HhcCCCccceecccCCeeEEEEEecC-CcEEEEEEecc---cccccHHHHHHHHHHHhcc-CCCceeeEEeEEEeCCeeE
Q 004521 438 ATDNFSINNKLGEGGFGPVYKGTLVD-GQEIAVKRLSK---ISEQGLKELKNEVILFSKL-QHRNLVKLLGCCIQGEEKL 512 (747)
Q Consensus 438 ~~~~~~~~~~lg~G~fg~Vy~~~~~~-g~~vavK~l~~---~~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~ 512 (747)
...+|.+.+.||+|+|++|++|+..+ ++++|||++.+ ..+...+.+..|-.+|.+| .||.|++|+-.|.+...+|
T Consensus 71 ~~~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~sLY 150 (604)
T KOG0592|consen 71 TPNDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEESLY 150 (604)
T ss_pred ChhhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecccceE
Confidence 44689999999999999999999755 89999999976 2344456678899999999 8999999999999999999
Q ss_pred EEEecCCCCChhhHhhhcCCCCcCChhHHHHHHHHHHHHHHHhhhcCCCceEecccCcCcEEEcCCCCceEecccCcccc
Q 004521 513 LIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTF 592 (747)
Q Consensus 513 lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NIll~~~~~~kl~DFGla~~~ 592 (747)
+|+||+++|+|.++|.+. +.+++.....++.+|+.||+|||+.| ||||||||+|||||+++++||+|||.|+.+
T Consensus 151 FvLe~A~nGdll~~i~K~---Gsfde~caR~YAAeIldAleylH~~G---IIHRDlKPENILLd~dmhikITDFGsAK~l 224 (604)
T KOG0592|consen 151 FVLEYAPNGDLLDLIKKY---GSFDETCARFYAAEILDALEYLHSNG---IIHRDLKPENILLDKDGHIKITDFGSAKIL 224 (604)
T ss_pred EEEEecCCCcHHHHHHHh---CcchHHHHHHHHHHHHHHHHHHHhcC---ceeccCChhheeEcCCCcEEEeeccccccC
Confidence 999999999999999653 56899999999999999999999999 999999999999999999999999999988
Q ss_pred CCCCCc---------cc--cceeeecc---------CCCCCccccchhHHHHHHHHHhCCCCCCCCCCcchhhhhHhHHh
Q 004521 593 GGDETE---------GN--TNRVVGTY---------DGQFSIKSDVFSFGILLLEIVSGKKNRGFYRSDTKVNLIGHLWD 652 (747)
Q Consensus 593 ~~~~~~---------~~--~~~~~~~~---------~~~~s~ksDVwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~ 652 (747)
.+.... .. ...++||. +...+..+|+|+||||||.|+.|.+||...........+..+ .
T Consensus 225 ~~~~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCilyQmlaG~PPFra~NeyliFqkI~~l-~ 303 (604)
T KOG0592|consen 225 SPSQKSQENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCILYQMLAGQPPFRAANEYLIFQKIQAL-D 303 (604)
T ss_pred ChhhccccCccCcccccCcccceeeeecccCHHHhcCCCCCcccchHHHHHHHHHHhcCCCCCccccHHHHHHHHHHh-c
Confidence 643322 11 13356663 577889999999999999999999997543322111111111 1
Q ss_pred cCCcccccchhhhccCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHh
Q 004521 653 EGIPLRLIDACIQDSCNLADVIRCIHIGLLCVQQHPEDRPCMPSVILML 701 (747)
Q Consensus 653 ~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dP~~RPt~~~v~~~L 701 (747)
-..++.+. +.+.+|+.+.|..||.+|+|..+|-+..
T Consensus 304 y~fp~~fp-------------~~a~dLv~KLLv~dp~~Rlt~~qIk~Hp 339 (604)
T KOG0592|consen 304 YEFPEGFP-------------EDARDLIKKLLVRDPSDRLTSQQIKAHP 339 (604)
T ss_pred ccCCCCCC-------------HHHHHHHHHHHccCccccccHHHHhhCc
Confidence 11111111 2244566688999999999999998753
|
|
| >KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-37 Score=320.12 Aligned_cols=247 Identities=27% Similarity=0.385 Sum_probs=188.3
Q ss_pred cCCCccceecccCCeeEEEEEecC-CcEEEEEEecccccccHHHHHHHHHHHhccCCCceeeEEeEEEeCC--eeEEEEe
Q 004521 440 DNFSINNKLGEGGFGPVYKGTLVD-GQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGE--EKLLIYE 516 (747)
Q Consensus 440 ~~~~~~~~lg~G~fg~Vy~~~~~~-g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~--~~~lV~E 516 (747)
.++...+.||+|+||+||++...+ |...|||.+...+....+.+.+|+.+|.+++|||||+++|.....+ ..+++||
T Consensus 17 ~~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~~~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~i~mE 96 (313)
T KOG0198|consen 17 SNWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDSPTSESLEREIRILSRLNHPNIVQYYGSSSSRENDEYNIFME 96 (313)
T ss_pred chhhhhccccCccceEEEEEEecCCCcceeeeeeecccchhHHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeEeeee
Confidence 456678999999999999999865 8999999987643333678999999999999999999999865555 5889999
Q ss_pred cCCCCChhhHhhhcCCCCcCChhHHHHHHHHHHHHHHHhhhcCCCceEecccCcCcEEEcC-CCCceEecccCccccCCC
Q 004521 517 FMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQ-DMNPKISDFGLVRTFGGD 595 (747)
Q Consensus 517 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NIll~~-~~~~kl~DFGla~~~~~~ 595 (747)
|+++|+|.+++..... .+++..+..++.||++||+|||+++ ||||||||+||||+. ++.+||+|||+++.....
T Consensus 97 y~~~GsL~~~~~~~g~--~l~E~~v~~ytr~iL~GL~ylHs~g---~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~~~ 171 (313)
T KOG0198|consen 97 YAPGGSLSDLIKRYGG--KLPEPLVRRYTRQILEGLAYLHSKG---IVHCDIKPANILLDPSNGDVKLADFGLAKKLESK 171 (313)
T ss_pred ccCCCcHHHHHHHcCC--CCCHHHHHHHHHHHHHHHHHHHhCC---EeccCcccceEEEeCCCCeEEeccCccccccccc
Confidence 9999999999976443 5999999999999999999999998 999999999999999 799999999999877641
Q ss_pred CCc-cccceeeecc--------C-C-CCCccccchhHHHHHHHHHhCCCCCCCCCCcchhhhhHhHHhcCCcccccchhh
Q 004521 596 ETE-GNTNRVVGTY--------D-G-QFSIKSDVFSFGILLLEIVSGKKNRGFYRSDTKVNLIGHLWDEGIPLRLIDACI 664 (747)
Q Consensus 596 ~~~-~~~~~~~~~~--------~-~-~~s~ksDVwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 664 (747)
... .......|+. . + ....++|||||||++.||+||+.||... ......+..+......+.+.+.
T Consensus 172 ~~~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~--~~~~~~~~~ig~~~~~P~ip~~-- 247 (313)
T KOG0198|consen 172 GTKSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEF--FEEAEALLLIGREDSLPEIPDS-- 247 (313)
T ss_pred cccccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhh--cchHHHHHHHhccCCCCCCCcc--
Confidence 111 1111122221 2 2 2234999999999999999999997643 1122222222222222222222
Q ss_pred hccCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhc
Q 004521 665 QDSCNLADVIRCIHIGLLCVQQHPEDRPCMPSVILMLG 702 (747)
Q Consensus 665 ~~~~~~~~~~~~~~l~~~Cl~~dP~~RPt~~~v~~~L~ 702 (747)
. .....+++.+|++.||++|||+.++++.--
T Consensus 248 ---l----s~~a~~Fl~~C~~~~p~~Rpta~eLL~hpf 278 (313)
T KOG0198|consen 248 ---L----SDEAKDFLRKCFKRDPEKRPTAEELLEHPF 278 (313)
T ss_pred ---c----CHHHHHHHHHHhhcCcccCcCHHHHhhChh
Confidence 1 112456777999999999999999998653
|
|
| >KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-37 Score=312.32 Aligned_cols=233 Identities=26% Similarity=0.346 Sum_probs=184.9
Q ss_pred hcCCCccceecccCCeeEEEEEecC-CcEEEEEEeccc---ccccHHHHHHHHHHHhccCCCceeeEEeEEEeCCeeEEE
Q 004521 439 TDNFSINNKLGEGGFGPVYKGTLVD-GQEIAVKRLSKI---SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLI 514 (747)
Q Consensus 439 ~~~~~~~~~lg~G~fg~Vy~~~~~~-g~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV 514 (747)
.++|++.+.||+|+||+||.++..+ ++.+|+|.+++. .....+..++|..+|.+++||+||+++..+.+.+..|||
T Consensus 24 ~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~kLylV 103 (357)
T KOG0598|consen 24 PDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQTEEKLYLV 103 (357)
T ss_pred hhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecccCCeEEEE
Confidence 4689999999999999999999766 889999999862 334577899999999999999999999999999999999
Q ss_pred EecCCCCChhhHhhhcCCCCcCChhHHHHHHHHHHHHHHHhhhcCCCceEecccCcCcEEEcCCCCceEecccCccccCC
Q 004521 515 YEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGG 594 (747)
Q Consensus 515 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NIll~~~~~~kl~DFGla~~~~~ 594 (747)
+||+.||.|..+|.. ...+++..+.-++.+|+.||.|||+.+ ||||||||+|||||++|+++|+||||++....
T Consensus 104 ld~~~GGeLf~hL~~---eg~F~E~~arfYlaEi~lAL~~LH~~g---IiyRDlKPENILLd~~GHi~LtDFgL~k~~~~ 177 (357)
T KOG0598|consen 104 LDYLNGGELFYHLQR---EGRFSEDRARFYLAEIVLALGYLHSKG---IIYRDLKPENILLDEQGHIKLTDFGLCKEDLK 177 (357)
T ss_pred EeccCCccHHHHHHh---cCCcchhHHHHHHHHHHHHHHHHHhCC---eeeccCCHHHeeecCCCcEEEeccccchhccc
Confidence 999999999999954 345888888888999999999999998 99999999999999999999999999996543
Q ss_pred CCCccccceeeecc---------CCCCCccccchhHHHHHHHHHhCCCCCCCCCCcchhhhhHhHHhcCCcccccchhhh
Q 004521 595 DETEGNTNRVVGTY---------DGQFSIKSDVFSFGILLLEIVSGKKNRGFYRSDTKVNLIGHLWDEGIPLRLIDACIQ 665 (747)
Q Consensus 595 ~~~~~~~~~~~~~~---------~~~~s~ksDVwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 665 (747)
.... +...+||. +..|+..+|+||+||++|||++|..||..... ...+..+.... .. ..+..+
T Consensus 178 ~~~~--t~tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~G~pPF~~~~~---~~~~~~I~~~k-~~-~~p~~l- 249 (357)
T KOG0598|consen 178 DGDA--TRTFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTGKPPFYAEDV---KKMYDKILKGK-LP-LPPGYL- 249 (357)
T ss_pred CCCc--cccccCCccccChHHHhcCCCCcccchHhHHHHHHHHhhCCCCCcCccH---HHHHHHHhcCc-CC-CCCccC-
Confidence 3322 22245553 67899999999999999999999999753322 22222222221 00 001001
Q ss_pred ccCCHHHHHHHHHHHHhccCCCCCCCC
Q 004521 666 DSCNLADVIRCIHIGLLCVQQHPEDRP 692 (747)
Q Consensus 666 ~~~~~~~~~~~~~l~~~Cl~~dP~~RP 692 (747)
. ....+++...++.||++|-
T Consensus 250 ----s---~~ardll~~LL~rdp~~RL 269 (357)
T KOG0598|consen 250 ----S---EEARDLLKKLLKRDPRQRL 269 (357)
T ss_pred ----C---HHHHHHHHHHhccCHHHhc
Confidence 1 1234556688999999996
|
|
| >KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=328.82 Aligned_cols=245 Identities=28% Similarity=0.461 Sum_probs=200.8
Q ss_pred cCCCccceecccCCeeEEEEEecC-CcEEEEEEecccccccHHHHHHHHHHHhccCCCceeeEEeEEEeCCeeEEEEecC
Q 004521 440 DNFSINNKLGEGGFGPVYKGTLVD-GQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFM 518 (747)
Q Consensus 440 ~~~~~~~~lg~G~fg~Vy~~~~~~-g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~ 518 (747)
.+.....+||-|.||.||.|.++. .-.||||.|+. +....++|..|..+|+.|+|||+|+|+|+|..+..+|||.|||
T Consensus 267 tdItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKE-DtMeveEFLkEAAvMKeikHpNLVqLLGVCT~EpPFYIiTEfM 345 (1157)
T KOG4278|consen 267 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKE-DTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTHEPPFYIITEFM 345 (1157)
T ss_pred hheeeeeccCCCcccceeeeeeeccceeeehhhhhh-cchhHHHHHHHHHHHHhhcCccHHHHhhhhccCCCeEEEEecc
Confidence 355667899999999999999876 67899999976 5667899999999999999999999999999999999999999
Q ss_pred CCCChhhHhhhcCCCCcCChhHHHHHHHHHHHHHHHhhhcCCCceEecccCcCcEEEcCCCCceEecccCccccCCCCCc
Q 004521 519 PNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETE 598 (747)
Q Consensus 519 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~ 598 (747)
.+|+|.+||++.. +..++.-..+.++.||+.||+||...+ +|||||.++|+|+.++..+||+||||+|.+.++.+.
T Consensus 346 ~yGNLLdYLRecn-r~ev~avvLlyMAtQIsSaMeYLEkkn---FIHRDLAARNCLVgEnhiVKvADFGLsRlMtgDTYT 421 (1157)
T KOG4278|consen 346 CYGNLLDYLRECN-RSEVPAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHIVKVADFGLSRLMTGDTYT 421 (1157)
T ss_pred cCccHHHHHHHhc-hhhcchhHHHHHHHHHHHHHHHHHHhh---hhhhhhhhhhccccccceEEeeccchhhhhcCCcee
Confidence 9999999998754 345777888999999999999999888 999999999999999999999999999999877654
Q ss_pred cccce--------eeeccCCCCCccccchhHHHHHHHHHh-CCCCCCCCCCcchhhhhHhHHhcCCcccccchhhhccCC
Q 004521 599 GNTNR--------VVGTYDGQFSIKSDVFSFGILLLEIVS-GKKNRGFYRSDTKVNLIGHLWDEGIPLRLIDACIQDSCN 669 (747)
Q Consensus 599 ~~~~~--------~~~~~~~~~s~ksDVwS~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~ 669 (747)
..... ..+..-..|+.|+|||+|||+||||.| |..|+... +..+.+ .+.+.+..++-.+.+
T Consensus 422 AHAGAKFPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIATYGMsPYPGi---dlSqVY-~LLEkgyRM~~PeGC------ 491 (1157)
T KOG4278|consen 422 AHAGAKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPYPGI---DLSQVY-GLLEKGYRMDGPEGC------ 491 (1157)
T ss_pred cccCccCcccccCcccccccccccchhhHHHHHHHHHHHhcCCCCCCCc---cHHHHH-HHHhccccccCCCCC------
Confidence 32211 111124678999999999999999999 66675422 222222 234455555444333
Q ss_pred HHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhc
Q 004521 670 LADVIRCIHIGLLCVQQHPEDRPCMPSVILMLG 702 (747)
Q Consensus 670 ~~~~~~~~~l~~~Cl~~dP~~RPt~~~v~~~L~ 702 (747)
..++++||++||+.+|.+||++.|+-+.|+
T Consensus 492 ---PpkVYeLMraCW~WsPsDRPsFaeiHqafE 521 (1157)
T KOG4278|consen 492 ---PPKVYELMRACWNWSPSDRPSFAEIHQAFE 521 (1157)
T ss_pred ---CHHHHHHHHHHhcCCcccCccHHHHHHHHH
Confidence 234788999999999999999999998886
|
|
| >KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-37 Score=294.24 Aligned_cols=255 Identities=25% Similarity=0.356 Sum_probs=191.9
Q ss_pred cCCCccceecccCCeeEEEEEec-CCcEEEEEEecccc--cccHHHHHHHHHHHhccCCCceeeEEeEEEeCCeeEEEEe
Q 004521 440 DNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKIS--EQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYE 516 (747)
Q Consensus 440 ~~~~~~~~lg~G~fg~Vy~~~~~-~g~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E 516 (747)
++|...++||+|.||.||+|+.. .|+.||||+++... +.......+|++.|+.++|+||+.+++++.+.+...||+|
T Consensus 2 ~rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F~~~~~l~lVfE 81 (318)
T KOG0659|consen 2 DRYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDVFPHKSNLSLVFE 81 (318)
T ss_pred chhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhhccCCCceEEEEE
Confidence 46777899999999999999975 49999999997532 2234567899999999999999999999999999999999
Q ss_pred cCCCCChhhHhhhcCCCCcCChhHHHHHHHHHHHHHHHhhhcCCCceEecccCcCcEEEcCCCCceEecccCccccCCCC
Q 004521 517 FMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDE 596 (747)
Q Consensus 517 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~ 596 (747)
||+ .+|+..+.+. ...+...++..++.++++|++|||++. |+||||||.|+|++++|.+||+|||+|+.++...
T Consensus 82 fm~-tdLe~vIkd~--~i~l~pa~iK~y~~m~LkGl~y~H~~~---IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~p~ 155 (318)
T KOG0659|consen 82 FMP-TDLEVVIKDK--NIILSPADIKSYMLMTLKGLAYCHSKW---ILHRDLKPNNLLISSDGQLKIADFGLARFFGSPN 155 (318)
T ss_pred ecc-ccHHHHhccc--ccccCHHHHHHHHHHHHHHHHHHHhhh---hhcccCCccceEEcCCCcEEeecccchhccCCCC
Confidence 996 8999999663 446888999999999999999999998 9999999999999999999999999999987665
Q ss_pred Cccccceeeecc--------CCCCCccccchhHHHHHHHHHhCCCCCCCCCCcchhhhhHhHHhcCCc------ccccch
Q 004521 597 TEGNTNRVVGTY--------DGQFSIKSDVFSFGILLLEIVSGKKNRGFYRSDTKVNLIGHLWDEGIP------LRLIDA 662 (747)
Q Consensus 597 ~~~~~~~~~~~~--------~~~~s~ksDVwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~------~~~~d~ 662 (747)
.......+...| ...|+..+||||.|||+.||+-|.+-+...++-+....+-.+...... ..+.|-
T Consensus 156 ~~~~~~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~sDidQL~~If~~LGTP~~~~WP~~~~lpdY 235 (318)
T KOG0659|consen 156 RIQTHQVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDSDIDQLSKIFRALGTPTPDQWPEMTSLPDY 235 (318)
T ss_pred cccccceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCchHHHHHHHHHHcCCCCcccCccccccccH
Confidence 443322221111 467999999999999999999998765433322222222222111111 111111
Q ss_pred h--------hhccCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 004521 663 C--------IQDSCNLADVIRCIHIGLLCVQQHPEDRPCMPSVILM 700 (747)
Q Consensus 663 ~--------l~~~~~~~~~~~~~~l~~~Cl~~dP~~RPt~~~v~~~ 700 (747)
. .....-......+++++..++..||.+|+++.|++++
T Consensus 236 ~~~~~~P~~~~~~lf~aas~d~ldLl~~m~~ynP~~Rita~qaL~~ 281 (318)
T KOG0659|consen 236 VKIQQFPKPPLNNLFPAASSDALDLLSKMLTYNPKKRITASQALKH 281 (318)
T ss_pred HHHhcCCCCccccccccccHHHHHHHHhhhccCchhcccHHHHhcc
Confidence 0 0000011122345788889999999999999998765
|
|
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-36 Score=321.22 Aligned_cols=255 Identities=25% Similarity=0.410 Sum_probs=186.8
Q ss_pred cCCCccceecccCCeeEEEEEecC-----------------CcEEEEEEeccc-ccccHHHHHHHHHHHhccCCCceeeE
Q 004521 440 DNFSINNKLGEGGFGPVYKGTLVD-----------------GQEIAVKRLSKI-SEQGLKELKNEVILFSKLQHRNLVKL 501 (747)
Q Consensus 440 ~~~~~~~~lg~G~fg~Vy~~~~~~-----------------g~~vavK~l~~~-~~~~~~~~~~E~~~l~~l~H~niv~l 501 (747)
++|.+.++||+|+||.||++.+.+ +..||+|.+... ......+|.+|+.++.+++||||+++
T Consensus 5 ~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~ 84 (304)
T cd05096 5 GHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKILSRLKDPNIIRL 84 (304)
T ss_pred hhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCCHHHHHHHHHHHHHHhhcCCCCeeEE
Confidence 578889999999999999997532 336999998753 23345679999999999999999999
Q ss_pred EeEEEeCCeeEEEEecCCCCChhhHhhhcC----------------CCCcCChhHHHHHHHHHHHHHHHhhhcCCCceEe
Q 004521 502 LGCCIQGEEKLLIYEFMPNKSLDSFIFDQT----------------RRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIH 565 (747)
Q Consensus 502 ~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~----------------~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiH 565 (747)
++++.+.+..++||||+++|+|.+++.... ....+++..+++++.||+.||.|||+.+ |+|
T Consensus 85 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---ivH 161 (304)
T cd05096 85 LGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLN---FVH 161 (304)
T ss_pred EEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHCC---ccc
Confidence 999999999999999999999999985422 1134678889999999999999999988 999
Q ss_pred cccCcCcEEEcCCCCceEecccCccccCCCCCccccc-------eeeec--cCCCCCccccchhHHHHHHHHHhC--CCC
Q 004521 566 RDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNTN-------RVVGT--YDGQFSIKSDVFSFGILLLEIVSG--KKN 634 (747)
Q Consensus 566 rDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~-------~~~~~--~~~~~s~ksDVwS~Gvvl~elltg--~~p 634 (747)
|||||+|||++.++.+||+|||+++.+.......... ..... ..+.++.++||||||+++|||+++ ..|
T Consensus 162 ~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p 241 (304)
T cd05096 162 RDLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILMLCKEQP 241 (304)
T ss_pred cCcchhheEEcCCccEEECCCccceecccCceeEecCcCCCCccccCHHHHhcCCCCchhhhHHHHHHHHHHHHccCCCC
Confidence 9999999999999999999999998654322111100 00000 145789999999999999999975 445
Q ss_pred CCCCCCcchhhhhHhHHhcCCcccccchhhhccCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhcC
Q 004521 635 RGFYRSDTKVNLIGHLWDEGIPLRLIDACIQDSCNLADVIRCIHIGLLCVQQHPEDRPCMPSVILMLGS 703 (747)
Q Consensus 635 ~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dP~~RPt~~~v~~~L~~ 703 (747)
+.......................... .... ....+.+++.+||+.+|++||||.+|.++|++
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~----~~~~~~~li~~cl~~~p~~RPs~~~i~~~l~~ 304 (304)
T cd05096 242 YGELTDEQVIENAGEFFRDQGRQVYLF--RPPP----CPQGLYELMLQCWSRDCRERPSFSDIHAFLTE 304 (304)
T ss_pred CCcCCHHHHHHHHHHHhhhcccccccc--CCCC----CCHHHHHHHHHHccCCchhCcCHHHHHHHHhC
Confidence 433222111111111111111000000 0001 12346778889999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-36 Score=313.63 Aligned_cols=240 Identities=18% Similarity=0.303 Sum_probs=184.7
Q ss_pred ceecccCCeeEEEEEecCCcEEEEEEeccccccc---HHHHHHHHHHHhccCCCceeeEEeEEEe----CCeeEEEEecC
Q 004521 446 NKLGEGGFGPVYKGTLVDGQEIAVKRLSKISEQG---LKELKNEVILFSKLQHRNLVKLLGCCIQ----GEEKLLIYEFM 518 (747)
Q Consensus 446 ~~lg~G~fg~Vy~~~~~~g~~vavK~l~~~~~~~---~~~~~~E~~~l~~l~H~niv~l~g~~~~----~~~~~lV~E~~ 518 (747)
..||+|++|.||+|+. +|+.||||+++...... .+.|.+|+.++.+++||||++++|++.+ ....++||||+
T Consensus 26 ~~i~~g~~~~v~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~~~~~~~lv~Ey~ 104 (283)
T PHA02988 26 VLIKENDQNSIYKGIF-NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILEYC 104 (283)
T ss_pred eEEeeCCceEEEEEEE-CCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecccCCCceEEEEEeC
Confidence 6899999999999998 68999999997643322 5678899999999999999999999977 34678999999
Q ss_pred CCCChhhHhhhcCCCCcCChhHHHHHHHHHHHHHHHhhhc-CCCceEecccCcCcEEEcCCCCceEecccCccccCCCCC
Q 004521 519 PNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQD-SRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDET 597 (747)
Q Consensus 519 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~-~~~~iiHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~ 597 (747)
++|+|.+++... ..+++.....++.+++.||.|||+. + ++||||||+|||+++++.+||+|||+++.+.....
T Consensus 105 ~~g~L~~~l~~~---~~~~~~~~~~i~~~i~~~l~~lH~~~~---~~Hrdlkp~nill~~~~~~kl~dfg~~~~~~~~~~ 178 (283)
T PHA02988 105 TRGYLREVLDKE---KDLSFKTKLDMAIDCCKGLYNLYKYTN---KPYKNLTSVSFLVTENYKLKIICHGLEKILSSPPF 178 (283)
T ss_pred CCCcHHHHHhhC---CCCChhHHHHHHHHHHHHHHHHHhcCC---CCCCcCChhhEEECCCCcEEEcccchHhhhccccc
Confidence 999999999643 3588999999999999999999984 5 78999999999999999999999999986543221
Q ss_pred ccc--cceeeec----cCCCCCccccchhHHHHHHHHHhCCCCCCCCCCcchhhhhHhHHhcCCcccccchhhhccCCHH
Q 004521 598 EGN--TNRVVGT----YDGQFSIKSDVFSFGILLLEIVSGKKNRGFYRSDTKVNLIGHLWDEGIPLRLIDACIQDSCNLA 671 (747)
Q Consensus 598 ~~~--~~~~~~~----~~~~~s~ksDVwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~ 671 (747)
... .....+. ....++.++|||||||++|||++|+.||.... ...........+....+. ...
T Consensus 179 ~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~---~~~~~~~i~~~~~~~~~~-----~~~--- 247 (283)
T PHA02988 179 KNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLT---TKEIYDLIINKNNSLKLP-----LDC--- 247 (283)
T ss_pred cccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCC---HHHHHHHHHhcCCCCCCC-----CcC---
Confidence 110 0000111 12578999999999999999999999975332 222222222222211111 111
Q ss_pred HHHHHHHHHHhccCCCCCCCCCHHHHHHHhcCC
Q 004521 672 DVIRCIHIGLLCVQQHPEDRPCMPSVILMLGSE 704 (747)
Q Consensus 672 ~~~~~~~l~~~Cl~~dP~~RPt~~~v~~~L~~~ 704 (747)
...+.+++.+||+.||++|||+.+|++.|+..
T Consensus 248 -~~~l~~li~~cl~~dp~~Rps~~ell~~l~~~ 279 (283)
T PHA02988 248 -PLEIKCIVEACTSHDSIKRPNIKEILYNLSLY 279 (283)
T ss_pred -cHHHHHHHHHHhcCCcccCcCHHHHHHHHHHH
Confidence 22366788899999999999999999999764
|
|
| >KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-37 Score=320.24 Aligned_cols=257 Identities=23% Similarity=0.294 Sum_probs=192.9
Q ss_pred HhcCCCccceecccCCeeEEEEEec-CCcEEEEEEecccccc-cHHHHHHHHHHHhccC-CCceeeEEeEEEeCC-eeEE
Q 004521 438 ATDNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKISEQ-GLKELKNEVILFSKLQ-HRNLVKLLGCCIQGE-EKLL 513 (747)
Q Consensus 438 ~~~~~~~~~~lg~G~fg~Vy~~~~~-~g~~vavK~l~~~~~~-~~~~~~~E~~~l~~l~-H~niv~l~g~~~~~~-~~~l 513 (747)
..++|.+.++||.|.||.||+|+-. .|..||||++++.-.. ..-.=.+|+..|++|. |||||++..++.+.+ .+++
T Consensus 8 ~m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s~ee~~nLREvksL~kln~hpniikL~Evi~d~~~~L~f 87 (538)
T KOG0661|consen 8 FMDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNPHPNIIKLKEVIRDNDRILYF 87 (538)
T ss_pred HHHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhccHHHHHHHHHHHHHHhcCCCCcchhhHHHhhccCceEee
Confidence 4568999999999999999999864 4899999999863222 1222368999999998 999999999999888 8999
Q ss_pred EEecCCCCChhhHhhhcCCCCcCChhHHHHHHHHHHHHHHHhhhcCCCceEecccCcCcEEEcCCCCceEecccCccccC
Q 004521 514 IYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFG 593 (747)
Q Consensus 514 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NIll~~~~~~kl~DFGla~~~~ 593 (747)
|||||+ .+|++++.++ +..+++..+..|+.||++||+|+|.+| +.||||||+|||+.....+||+|||+||...
T Consensus 88 VfE~Md-~NLYqLmK~R--~r~fse~~irnim~QilqGL~hiHk~G---fFHRDlKPENiLi~~~~~iKiaDFGLARev~ 161 (538)
T KOG0661|consen 88 VFEFMD-CNLYQLMKDR--NRLFSESDIRNIMYQILQGLAHIHKHG---FFHRDLKPENILISGNDVIKIADFGLAREVR 161 (538)
T ss_pred eHHhhh-hhHHHHHhhc--CCcCCHHHHHHHHHHHHHHHHHHHhcC---cccccCChhheEecccceeEecccccccccc
Confidence 999996 7999999764 667999999999999999999999999 9999999999999999999999999999876
Q ss_pred CCCCccc--cceeeec-----cCCCCCccccchhHHHHHHHHHhCCCCCCCCCCcchhhhhHhHHhcCC-----------
Q 004521 594 GDETEGN--TNRVVGT-----YDGQFSIKSDVFSFGILLLEIVSGKKNRGFYRSDTKVNLIGHLWDEGI----------- 655 (747)
Q Consensus 594 ~~~~~~~--~~~~~~~-----~~~~~s~ksDVwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~----------- 655 (747)
....... .++.... ..+.|+.+.|+|++|||++||.+-+..|...+..+....+..+.....
T Consensus 162 SkpPYTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dqi~KIc~VLGtP~~~~~~eg~~La 241 (538)
T KOG0661|consen 162 SKPPYTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASEIDQIYKICEVLGTPDKDSWPEGYNLA 241 (538)
T ss_pred cCCCcchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcHHHHHHHHHHHhCCCccccchhHHHHH
Confidence 5433211 1111111 267899999999999999999999988764433222222222211100
Q ss_pred ------cccccchhhhccCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHh
Q 004521 656 ------PLRLIDACIQDSCNLADVIRCIHIGLLCVQQHPEDRPCMPSVILML 701 (747)
Q Consensus 656 ------~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dP~~RPt~~~v~~~L 701 (747)
.+......+..-.. ....++++++.+|+..||.+|||+.+.+++-
T Consensus 242 ~~mnf~~P~~~~~~l~~L~p-~~s~~~~~li~~ll~WDP~kRpTA~~al~~p 292 (538)
T KOG0661|consen 242 SAMNFRFPQVKPSPLKDLLP-NASSEAASLIERLLAWDPDKRPTASQALQHP 292 (538)
T ss_pred HHhccCCCcCCCCChHHhCc-ccCHHHHHHHHHHhcCCCccCccHHHHhcCc
Confidence 00011001110000 1234567788899999999999999998753
|
|
| >KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-36 Score=306.74 Aligned_cols=253 Identities=24% Similarity=0.353 Sum_probs=195.0
Q ss_pred hcCCCccceecccCCeeEEEEEe-cCCcEEEEEEeccc-ccccHHHHHHHHHHHhccCCCceeeEEeEEEeCCeeEEEEe
Q 004521 439 TDNFSINNKLGEGGFGPVYKGTL-VDGQEIAVKRLSKI-SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYE 516 (747)
Q Consensus 439 ~~~~~~~~~lg~G~fg~Vy~~~~-~~g~~vavK~l~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E 516 (747)
.+.|++...||.|..++||+|+. +.+..||||++.-. .....+.+++|+..|..++||||++++..|..+..+++||.
T Consensus 25 ~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~ld~l~kE~~~msl~~HPNIv~~~~sFvv~~~LWvVmp 104 (516)
T KOG0582|consen 25 AKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNNDLDALRKEVQTMSLIDHPNIVTYHCSFVVDSELWVVMP 104 (516)
T ss_pred ccceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhhHHHHHHHHHHhhhcCCCCcceEEEEEEecceeEEeeh
Confidence 35799999999999999999985 45899999998642 22337899999999999999999999999999999999999
Q ss_pred cCCCCChhhHhhhcCCCCcCChhHHHHHHHHHHHHHHHhhhcCCCceEecccCcCcEEEcCCCCceEecccCccccCCCC
Q 004521 517 FMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDE 596 (747)
Q Consensus 517 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~ 596 (747)
||.+||+.+++...-..+ +++..+..|.+++++||.|||.+| .||||||+.||||+++|.+||+|||.+-.+....
T Consensus 105 fMa~GS~ldIik~~~~~G-l~E~~Ia~iLre~LkaL~YLH~~G---~IHRdvKAgnILi~~dG~VkLadFgvsa~l~~~G 180 (516)
T KOG0582|consen 105 FMAGGSLLDIIKTYYPDG-LEEASIATILREVLKALDYLHQNG---HIHRDVKAGNILIDSDGTVKLADFGVSASLFDSG 180 (516)
T ss_pred hhcCCcHHHHHHHHcccc-ccHHHHHHHHHHHHHHHHHHHhcC---ceecccccccEEEcCCCcEEEcCceeeeeecccC
Confidence 999999999997755443 899999999999999999999999 9999999999999999999999999876554332
Q ss_pred Cccc-c-ceeeecc-----------CCCCCccccchhHHHHHHHHHhCCCCCCCCCCcchhhhhHhHHhcCCcccccchh
Q 004521 597 TEGN-T-NRVVGTY-----------DGQFSIKSDVFSFGILLLEIVSGKKNRGFYRSDTKVNLIGHLWDEGIPLRLIDAC 663 (747)
Q Consensus 597 ~~~~-~-~~~~~~~-----------~~~~s~ksDVwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 663 (747)
.... . ....++. ...|+.|+|||||||+..||.+|..||..+.+. ..+....+. .++.+.-..
T Consensus 181 ~R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pPm---kvLl~tLqn-~pp~~~t~~ 256 (516)
T KOG0582|consen 181 DRQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPPM---KVLLLTLQN-DPPTLLTSG 256 (516)
T ss_pred ceeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCChH---HHHHHHhcC-CCCCccccc
Confidence 1111 1 2223332 356899999999999999999999998765543 222222222 222111111
Q ss_pred hhccCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 004521 664 IQDSCNLADVIRCIHIGLLCVQQHPEDRPCMPSVIL 699 (747)
Q Consensus 664 l~~~~~~~~~~~~~~l~~~Cl~~dP~~RPt~~~v~~ 699 (747)
+..+.....-....+++-.||+.||.+|||++++++
T Consensus 257 ~~~d~~k~~~ksf~e~i~~CL~kDP~kRptAskLlk 292 (516)
T KOG0582|consen 257 LDKDEDKKFSKSFREMIALCLVKDPSKRPTASKLLK 292 (516)
T ss_pred CChHHhhhhcHHHHHHHHHHhhcCcccCCCHHHHhc
Confidence 122212222224456677899999999999999985
|
|
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-36 Score=326.70 Aligned_cols=250 Identities=29% Similarity=0.436 Sum_probs=189.7
Q ss_pred hcCCCccceecccCCeeEEEEEe------cCCcEEEEEEeccc-ccccHHHHHHHHHHHhcc-CCCceeeEEeEEEeCCe
Q 004521 439 TDNFSINNKLGEGGFGPVYKGTL------VDGQEIAVKRLSKI-SEQGLKELKNEVILFSKL-QHRNLVKLLGCCIQGEE 510 (747)
Q Consensus 439 ~~~~~~~~~lg~G~fg~Vy~~~~------~~g~~vavK~l~~~-~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~ 510 (747)
.++|++.+.||+|+||.||+|+. ..+..||||+++.. .....+.+.+|+.++..+ +||||+++++++...+.
T Consensus 34 ~~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~~~~ 113 (375)
T cd05104 34 RNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHINIVNLLGACTVGGP 113 (375)
T ss_pred hHHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcCcHHHHHHHHHHHHHHHhcCCcceeeeeeeeccCCc
Confidence 45788899999999999999974 23568999999753 233456788999999999 89999999999999999
Q ss_pred eEEEEecCCCCChhhHhhhcCC----------------------------------------------------------
Q 004521 511 KLLIYEFMPNKSLDSFIFDQTR---------------------------------------------------------- 532 (747)
Q Consensus 511 ~~lV~E~~~~gsL~~~l~~~~~---------------------------------------------------------- 532 (747)
.++||||+++|+|.+++.....
T Consensus 114 ~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 193 (375)
T cd05104 114 TLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSVRSGS 193 (375)
T ss_pred ceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCcccccccccccccccccce
Confidence 9999999999999999864221
Q ss_pred --------------CCcCChhHHHHHHHHHHHHHHHhhhcCCCceEecccCcCcEEEcCCCCceEecccCccccCCCCCc
Q 004521 533 --------------RTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETE 598 (747)
Q Consensus 533 --------------~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~ 598 (747)
...+++..+.+++.||++||+|||+.+ |+||||||+|||++.++.+||+|||+++........
T Consensus 194 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~ 270 (375)
T cd05104 194 YIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASKN---CIHRDLAARNILLTHGRITKICDFGLARDIRNDSNY 270 (375)
T ss_pred ecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCchhhEEEECCCcEEEecCccceeccCcccc
Confidence 124788899999999999999999988 999999999999999999999999999866433211
Q ss_pred cccc-------eeeec--cCCCCCccccchhHHHHHHHHHh-CCCCCCCCCCcchhhhhHhHHhcCCcccccchhhhccC
Q 004521 599 GNTN-------RVVGT--YDGQFSIKSDVFSFGILLLEIVS-GKKNRGFYRSDTKVNLIGHLWDEGIPLRLIDACIQDSC 668 (747)
Q Consensus 599 ~~~~-------~~~~~--~~~~~s~ksDVwS~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~ 668 (747)
.... ..... ....++.++|||||||++|||++ |..|+....... . .......+...... ..
T Consensus 271 ~~~~~~~~~~~y~aPE~~~~~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~~~--~-~~~~~~~~~~~~~~------~~ 341 (375)
T cd05104 271 VVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVDS--K-FYKMIKEGYRMLSP------EC 341 (375)
T ss_pred cccCCCCCCcceeChhHhcCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCchH--H-HHHHHHhCccCCCC------CC
Confidence 1000 11111 24678899999999999999998 777864332211 1 11122222211110 01
Q ss_pred CHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhcC
Q 004521 669 NLADVIRCIHIGLLCVQQHPEDRPCMPSVILMLGS 703 (747)
Q Consensus 669 ~~~~~~~~~~l~~~Cl~~dP~~RPt~~~v~~~L~~ 703 (747)
. ...+.+|+.+||+.||++||+|.+|+++|+.
T Consensus 342 ~---~~~l~~li~~cl~~dP~~RPs~~eil~~l~~ 373 (375)
T cd05104 342 A---PSEMYDIMKSCWDADPLKRPTFKQIVQLIEQ 373 (375)
T ss_pred C---CHHHHHHHHHHccCChhHCcCHHHHHHHHHh
Confidence 1 1246678889999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-37 Score=320.92 Aligned_cols=230 Identities=29% Similarity=0.468 Sum_probs=179.7
Q ss_pred cceecccCCeeEEEEEecCCcEEEEEEecccccccHHHHHHHHHHHhccCCCceeeEEeEEEeCCeeEEEEecCCCCChh
Q 004521 445 NNKLGEGGFGPVYKGTLVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMPNKSLD 524 (747)
Q Consensus 445 ~~~lg~G~fg~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gsL~ 524 (747)
++-||+|+-|.||+|++ .++.||||+++... ..+++-|++|+|+||+.|.|+|....-++||||||+.|.|.
T Consensus 129 LeWlGSGaQGAVF~Grl-~netVAVKKV~elk-------ETdIKHLRkLkH~NII~FkGVCtqsPcyCIiMEfCa~GqL~ 200 (904)
T KOG4721|consen 129 LEWLGSGAQGAVFLGRL-HNETVAVKKVRELK-------ETDIKHLRKLKHPNIITFKGVCTQSPCYCIIMEFCAQGQLY 200 (904)
T ss_pred hhhhccCcccceeeeec-cCceehhHHHhhhh-------hhhHHHHHhccCcceeeEeeeecCCceeEEeeeccccccHH
Confidence 47899999999999999 57899999986432 24678899999999999999999999999999999999999
Q ss_pred hHhhhcCCCCcCChhHHHHHHHHHHHHHHHhhhcCCCceEecccCcCcEEEcCCCCceEecccCccccCCCCCcccccee
Q 004521 525 SFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNTNRV 604 (747)
Q Consensus 525 ~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~ 604 (747)
..|.. +..+.......+..+||.||.|||.+. |||||||.-||||..+..+||+|||-++.+....+.. .+
T Consensus 201 ~VLka---~~~itp~llv~Wsk~IA~GM~YLH~hK---IIHRDLKSPNiLIs~~d~VKIsDFGTS~e~~~~STkM---SF 271 (904)
T KOG4721|consen 201 EVLKA---GRPITPSLLVDWSKGIAGGMNYLHLHK---IIHRDLKSPNILISYDDVVKISDFGTSKELSDKSTKM---SF 271 (904)
T ss_pred HHHhc---cCccCHHHHHHHHHHhhhhhHHHHHhh---HhhhccCCCceEeeccceEEeccccchHhhhhhhhhh---hh
Confidence 99954 345777888899999999999999987 9999999999999999999999999998775443221 23
Q ss_pred eec---------cCCCCCccccchhHHHHHHHHHhCCCCCCCCCCcchhhhhHhHHhcCCcccccchhhhccCCHHHHHH
Q 004521 605 VGT---------YDGQFSIKSDVFSFGILLLEIVSGKKNRGFYRSDTKVNLIGHLWDEGIPLRLIDACIQDSCNLADVIR 675 (747)
Q Consensus 605 ~~~---------~~~~~s~ksDVwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~ 675 (747)
.|+ .+.+.++|+|||||||||||||||+.|+...... ..+|.-|.. .+.-.+...+ ++-
T Consensus 272 aGTVaWMAPEvIrnePcsEKVDIwSfGVVLWEmLT~EiPYkdVdss------AIIwGVGsN--sL~LpvPstc-P~G--- 339 (904)
T KOG4721|consen 272 AGTVAWMAPEVIRNEPCSEKVDIWSFGVVLWEMLTGEIPYKDVDSS------AIIWGVGSN--SLHLPVPSTC-PDG--- 339 (904)
T ss_pred hhhHhhhCHHHhhcCCcccccceehhHHHHHHHHhcCCCccccchh------eeEEeccCC--cccccCcccC-chH---
Confidence 333 2678899999999999999999999996422211 112222211 1111111111 122
Q ss_pred HHHHHHhccCCCCCCCCCHHHHHHHhcC
Q 004521 676 CIHIGLLCVQQHPEDRPCMPSVILMLGS 703 (747)
Q Consensus 676 ~~~l~~~Cl~~dP~~RPt~~~v~~~L~~ 703 (747)
+.-|+.+||+..|..||+|++|+..|+=
T Consensus 340 fklL~Kqcw~sKpRNRPSFrqil~HldI 367 (904)
T KOG4721|consen 340 FKLLLKQCWNSKPRNRPSFRQILLHLDI 367 (904)
T ss_pred HHHHHHHHHhcCCCCCccHHHHHHHHhh
Confidence 3335568999999999999999999964
|
|
| >KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-36 Score=318.83 Aligned_cols=240 Identities=27% Similarity=0.419 Sum_probs=193.7
Q ss_pred cCCCccceecccCCeeEEEEEec-CCcEEEEEEecccccccHHHHHHHHHHHhccCCCceeeEEeEEEeCCeeEEEEecC
Q 004521 440 DNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFM 518 (747)
Q Consensus 440 ~~~~~~~~lg~G~fg~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~ 518 (747)
..|....+||+|+.|.||.|+.. .++.||||++........+-+.+|+.+|+..+|+|||+++..+..++++++|||||
T Consensus 273 ~~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~~keLilnEi~Vm~~~~H~NiVnfl~Sylv~deLWVVMEym 352 (550)
T KOG0578|consen 273 SKYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQPKKELLLNEILVMRDLHHPNIVNFLDSYLVGDELWVVMEYM 352 (550)
T ss_pred hhhcchhhhccccccceeeeeeccCCceEEEEEEEeccCCchhhhHHHHHHHHhccchHHHHHHHHhcccceeEEEEeec
Confidence 45777789999999999999864 58899999998755555667889999999999999999999999999999999999
Q ss_pred CCCChhhHhhhcCCCCcCChhHHHHHHHHHHHHHHHhhhcCCCceEecccCcCcEEEcCCCCceEecccCccccCCCCCc
Q 004521 519 PNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETE 598 (747)
Q Consensus 519 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~ 598 (747)
++|+|.+.+. ...+++.++..|++++++||+|||.++ |||||||.+|||++.++.+||+|||++..+.....
T Consensus 353 ~ggsLTDvVt----~~~~~E~qIA~Icre~l~aL~fLH~~g---IiHrDIKSDnILL~~~g~vKltDFGFcaqi~~~~~- 424 (550)
T KOG0578|consen 353 EGGSLTDVVT----KTRMTEGQIAAICREILQGLKFLHARG---IIHRDIKSDNILLTMDGSVKLTDFGFCAQISEEQS- 424 (550)
T ss_pred CCCchhhhhh----cccccHHHHHHHHHHHHHHHHHHHhcc---eeeeccccceeEeccCCcEEEeeeeeeeccccccC-
Confidence 9999999983 345899999999999999999999999 99999999999999999999999999988765554
Q ss_pred cccceeeecc---------CCCCCccccchhHHHHHHHHHhCCCCCCCCCCcchhhhhHhHHhcCCcccccchhhhccCC
Q 004521 599 GNTNRVVGTY---------DGQFSIKSDVFSFGILLLEIVSGKKNRGFYRSDTKVNLIGHLWDEGIPLRLIDACIQDSCN 669 (747)
Q Consensus 599 ~~~~~~~~~~---------~~~~s~ksDVwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~ 669 (747)
.+...+|++ ...|++|+||||||++++||+-|+.||-...+-...+++ ...+.+. +-.+...
T Consensus 425 -KR~TmVGTPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMveGEPPYlnE~PlrAlyLI---a~ng~P~-lk~~~kl---- 495 (550)
T KOG0578|consen 425 -KRSTMVGTPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLI---ATNGTPK-LKNPEKL---- 495 (550)
T ss_pred -ccccccCCCCccchhhhhhcccCccccchhhhhHHHHHhcCCCCccCCChHHHHHHH---hhcCCCC-cCCcccc----
Confidence 344455653 578999999999999999999999997543322222222 2333222 1111110
Q ss_pred HHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 004521 670 LADVIRCIHIGLLCVQQHPEDRPCMPSVIL 699 (747)
Q Consensus 670 ~~~~~~~~~l~~~Cl~~dP~~RPt~~~v~~ 699 (747)
-..+.++..+||+.|+++||++.|+++
T Consensus 496 ---S~~~kdFL~~cL~~dv~~RasA~eLL~ 522 (550)
T KOG0578|consen 496 ---SPELKDFLDRCLVVDVEQRASAKELLE 522 (550)
T ss_pred ---CHHHHHHHHHHhhcchhcCCCHHHHhc
Confidence 112345667999999999999999986
|
|
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-36 Score=309.49 Aligned_cols=241 Identities=37% Similarity=0.614 Sum_probs=180.4
Q ss_pred ccceecccCCeeEEEEEec-----CCcEEEEEEeccc-ccccHHHHHHHHHHHhccCCCceeeEEeEEEeCCeeEEEEec
Q 004521 444 INNKLGEGGFGPVYKGTLV-----DGQEIAVKRLSKI-SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEF 517 (747)
Q Consensus 444 ~~~~lg~G~fg~Vy~~~~~-----~g~~vavK~l~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~ 517 (747)
+.+.||+|.||.||+|.+. .+..|+||.++.. ..+..+.|.+|++.+++++||||++++|++...+..++|+||
T Consensus 3 ~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~lv~e~ 82 (259)
T PF07714_consen 3 LIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPSSSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLFLVMEY 82 (259)
T ss_dssp EEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTTSSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEEEEEE-
T ss_pred EeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccccccccceeeeecccccccccccccccccccccccccccccccc
Confidence 4578999999999999987 2568999999653 334478999999999999999999999999988889999999
Q ss_pred CCCCChhhHhhhcCCCCcCChhHHHHHHHHHHHHHHHhhhcCCCceEecccCcCcEEEcCCCCceEecccCccccCCCCC
Q 004521 518 MPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDET 597 (747)
Q Consensus 518 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~ 597 (747)
+++|+|.++|... ....+++..++.|+.||++||.|||+.+ ++|+||+++||++++++.+||+|||+++.......
T Consensus 83 ~~~g~L~~~L~~~-~~~~~~~~~~~~i~~~i~~~l~~Lh~~~---iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~~~~~ 158 (259)
T PF07714_consen 83 CPGGSLDDYLKSK-NKEPLSEQQRLSIAIQIAEALSYLHSNN---IIHGNLSPSNILLDSNGQVKLSDFGLSRPISEKSK 158 (259)
T ss_dssp -TTEBHHHHHHHT-CTTTSBHHHHHHHHHHHHHHHHHHHHTT---EEEST-SGGGEEEETTTEEEEESTTTGEETTTSSS
T ss_pred ccccccccccccc-cccccccccccccccccccccccccccc---ccccccccccccccccccccccccccccccccccc
Confidence 9999999999775 2345899999999999999999999988 99999999999999999999999999987632211
Q ss_pred ccccc------eeeec---cCCCCCccccchhHHHHHHHHHh-CCCCCCCCCCcchhhhhHhHHhcCCcccccchhhhcc
Q 004521 598 EGNTN------RVVGT---YDGQFSIKSDVFSFGILLLEIVS-GKKNRGFYRSDTKVNLIGHLWDEGIPLRLIDACIQDS 667 (747)
Q Consensus 598 ~~~~~------~~~~~---~~~~~s~ksDVwS~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~ 667 (747)
..... ....+ ....++.++||||||+++|||++ |+.|+... ........+ .++......+..
T Consensus 159 ~~~~~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~~~~~p~~~~---~~~~~~~~~-~~~~~~~~~~~~---- 230 (259)
T PF07714_consen 159 YKNDSSQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILTLGKFPFSDY---DNEEIIEKL-KQGQRLPIPDNC---- 230 (259)
T ss_dssp EEESTTSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHTTSSGTTTTS---CHHHHHHHH-HTTEETTSBTTS----
T ss_pred ccccccccccccccccccccccccccccccccccccccccccccccccccc---ccccccccc-cccccceeccch----
Confidence 10000 00010 14558999999999999999999 67775433 222233333 333222211111
Q ss_pred CCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHh
Q 004521 668 CNLADVIRCIHIGLLCVQQHPEDRPCMPSVILML 701 (747)
Q Consensus 668 ~~~~~~~~~~~l~~~Cl~~dP~~RPt~~~v~~~L 701 (747)
...+.+++.+||+.+|++||+|.+|++.|
T Consensus 231 -----~~~~~~li~~C~~~~p~~RPs~~~i~~~L 259 (259)
T PF07714_consen 231 -----PKDIYSLIQQCWSHDPEKRPSFQEILQEL 259 (259)
T ss_dssp -----BHHHHHHHHHHT-SSGGGS--HHHHHHHH
T ss_pred -----hHHHHHHHHHHcCCChhhCcCHHHHHhcC
Confidence 12356788899999999999999999876
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=324.61 Aligned_cols=251 Identities=29% Similarity=0.449 Sum_probs=190.0
Q ss_pred hcCCCccceecccCCeeEEEEEec------CCcEEEEEEeccc-ccccHHHHHHHHHHHhcc-CCCceeeEEeEEEeCCe
Q 004521 439 TDNFSINNKLGEGGFGPVYKGTLV------DGQEIAVKRLSKI-SEQGLKELKNEVILFSKL-QHRNLVKLLGCCIQGEE 510 (747)
Q Consensus 439 ~~~~~~~~~lg~G~fg~Vy~~~~~------~g~~vavK~l~~~-~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~ 510 (747)
.++|++.+.||+|+||.||+|+.. ++..||||+++.. .......+.+|+.+++.+ +|+||+++++++.....
T Consensus 37 ~~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~~~~~ 116 (374)
T cd05106 37 RDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQHKNIVNLLGACTHGGP 116 (374)
T ss_pred HHHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCCHHHHHHHHHHHHHHHhhccCCceeeEeeEecCCCC
Confidence 457888999999999999998742 2457999999753 233356788999999999 89999999999999999
Q ss_pred eEEEEecCCCCChhhHhhhcCC----------------------------------------------------------
Q 004521 511 KLLIYEFMPNKSLDSFIFDQTR---------------------------------------------------------- 532 (747)
Q Consensus 511 ~~lV~E~~~~gsL~~~l~~~~~---------------------------------------------------------- 532 (747)
.++||||+++|+|.+++.....
T Consensus 117 ~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 196 (374)
T cd05106 117 VLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSSQSSD 196 (374)
T ss_pred eEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCcccccccccc
Confidence 9999999999999999864211
Q ss_pred ---------CCcCChhHHHHHHHHHHHHHHHhhhcCCCceEecccCcCcEEEcCCCCceEecccCccccCCCCCccccc-
Q 004521 533 ---------RTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNTN- 602 (747)
Q Consensus 533 ---------~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~- 602 (747)
...+++.++++++.||++||.|||+.+ |+||||||+|||+++++.+||+|||+++.+..........
T Consensus 197 ~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~g---iiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~~~~~~~ 273 (374)
T cd05106 197 SKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASKN---CIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVVKGN 273 (374)
T ss_pred ccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHCC---EEeccCchheEEEeCCCeEEEeeceeeeeccCCcceeeccC
Confidence 124778889999999999999999988 9999999999999999999999999998654322111000
Q ss_pred ------eeeec--cCCCCCccccchhHHHHHHHHHh-CCCCCCCCCCcchhhhhHhHHhcCCcccccchhhhccCCHHHH
Q 004521 603 ------RVVGT--YDGQFSIKSDVFSFGILLLEIVS-GKKNRGFYRSDTKVNLIGHLWDEGIPLRLIDACIQDSCNLADV 673 (747)
Q Consensus 603 ------~~~~~--~~~~~s~ksDVwS~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~ 673 (747)
..... ....++.++|||||||++|||++ |+.||....... .+......+......+ .. .
T Consensus 274 ~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~---~~~~~~~~~~~~~~~~-----~~----~ 341 (374)
T cd05106 274 ARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNS---KFYKMVKRGYQMSRPD-----FA----P 341 (374)
T ss_pred CCCccceeCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCccccccH---HHHHHHHcccCccCCC-----CC----C
Confidence 00000 14678999999999999999997 999975432211 1111122221111111 01 1
Q ss_pred HHHHHHHHhccCCCCCCCCCHHHHHHHhcCC
Q 004521 674 IRCIHIGLLCVQQHPEDRPCMPSVILMLGSE 704 (747)
Q Consensus 674 ~~~~~l~~~Cl~~dP~~RPt~~~v~~~L~~~ 704 (747)
..+.+++.+||+.||++||++.+|+++|+..
T Consensus 342 ~~l~~li~~cl~~dp~~RPs~~~l~~~l~~~ 372 (374)
T cd05106 342 PEIYSIMKMCWNLEPTERPTFSQISQLIQRQ 372 (374)
T ss_pred HHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 2356778899999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-35 Score=356.51 Aligned_cols=256 Identities=25% Similarity=0.433 Sum_probs=191.9
Q ss_pred hcCCCccceecccCCeeEEEEEe-cCCcEEEEEEecccccccHHHHHHHHHHHhccCCCceeeEEeEEEeCCeeEEEEec
Q 004521 439 TDNFSINNKLGEGGFGPVYKGTL-VDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEF 517 (747)
Q Consensus 439 ~~~~~~~~~lg~G~fg~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~ 517 (747)
...|...+.||+|+||.||+|+. .++..||||++...... ...|++++++++|||||+++|+|.+.+..++||||
T Consensus 689 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~----~~~~~~~l~~l~HpnIv~~~~~~~~~~~~~lv~Ey 764 (968)
T PLN00113 689 LSSLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNSI----PSSEIADMGKLQHPNIVKLIGLCRSEKGAYLIHEY 764 (968)
T ss_pred HhhCCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCccc----cHHHHHHHhhCCCCCcceEEEEEEcCCCCEEEEeC
Confidence 45677788999999999999997 46899999998753322 23468899999999999999999999999999999
Q ss_pred CCCCChhhHhhhcCCCCcCChhHHHHHHHHHHHHHHHhhhcCCCceEecccCcCcEEEcCCCCceEecccCccccCCCCC
Q 004521 518 MPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDET 597 (747)
Q Consensus 518 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~ 597 (747)
+++|+|.+++.. ++|.++.+|+.|||+||+|||..+..+|+||||||+||+++.++.+++. ||..........
T Consensus 765 ~~~g~L~~~l~~------l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~~~~~~~~~~~ 837 (968)
T PLN00113 765 IEGKNLSEVLRN------LSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLCTDTK 837 (968)
T ss_pred CCCCcHHHHHhc------CCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE-eccccccccCCC
Confidence 999999999942 7899999999999999999997655669999999999999999988876 666544322211
Q ss_pred ccc-cceeee--ccCCCCCccccchhHHHHHHHHHhCCCCCCCCCCcc--hhhhhHhHHhcCCcccccchhhhc--cCCH
Q 004521 598 EGN-TNRVVG--TYDGQFSIKSDVFSFGILLLEIVSGKKNRGFYRSDT--KVNLIGHLWDEGIPLRLIDACIQD--SCNL 670 (747)
Q Consensus 598 ~~~-~~~~~~--~~~~~~s~ksDVwS~Gvvl~elltg~~p~~~~~~~~--~~~~~~~~~~~~~~~~~~d~~l~~--~~~~ 670 (747)
... ..+..+ .....++.|+|||||||++|||+||+.|+....... ...+.............+|+.+.. ....
T Consensus 838 ~~~t~~y~aPE~~~~~~~~~~sDv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 917 (968)
T PLN00113 838 CFISSAYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADAEFGVHGSIVEWARYCYSDCHLDMWIDPSIRGDVSVNQ 917 (968)
T ss_pred ccccccccCcccccCCCCCcccchhhHHHHHHHHHhCCCCCCcccCCCCcHHHHHHHhcCccchhheeCccccCCCCccH
Confidence 110 111111 124578999999999999999999999974322111 111111111122223334444322 2345
Q ss_pred HHHHHHHHHHHhccCCCCCCCCCHHHHHHHhcCCC
Q 004521 671 ADVIRCIHIGLLCVQQHPEDRPCMPSVILMLGSEI 705 (747)
Q Consensus 671 ~~~~~~~~l~~~Cl~~dP~~RPt~~~v~~~L~~~~ 705 (747)
++..++.+++.+||+.||++||+|.||+++|+...
T Consensus 918 ~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~~~ 952 (968)
T PLN00113 918 NEIVEVMNLALHCTATDPTARPCANDVLKTLESAS 952 (968)
T ss_pred HHHHHHHHHHHhhCcCCchhCcCHHHHHHHHHHhh
Confidence 66778899999999999999999999999998753
|
|
| >KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-36 Score=328.09 Aligned_cols=241 Identities=28% Similarity=0.450 Sum_probs=193.4
Q ss_pred ccceecccCCeeEEEEEe-cCC----cEEEEEEecc-cccccHHHHHHHHHHHhccCCCceeeEEeEEEeCCeeEEEEec
Q 004521 444 INNKLGEGGFGPVYKGTL-VDG----QEIAVKRLSK-ISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEF 517 (747)
Q Consensus 444 ~~~~lg~G~fg~Vy~~~~-~~g----~~vavK~l~~-~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~ 517 (747)
..++||+|+||+||+|.+ .+| -+||||++.. ...+...+|.+|+-+|.+++||||++|+|+|.... ..||++|
T Consensus 700 k~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~-~qlvtq~ 778 (1177)
T KOG1025|consen 700 KDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTSPKASIELLDEALRMASLDHPNLLRLLGVCMLST-LQLVTQL 778 (1177)
T ss_pred hhceeccccceeEEeeeEecCCceecceeEEEEeeccCCchhhHHHHHHHHHHhcCCCchHHHHhhhcccch-HHHHHHh
Confidence 357999999999999986 334 3799999875 34556789999999999999999999999998776 7899999
Q ss_pred CCCCChhhHhhhcCCCCcCChhHHHHHHHHHHHHHHHhhhcCCCceEecccCcCcEEEcCCCCceEecccCccccCCCCC
Q 004521 518 MPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDET 597 (747)
Q Consensus 518 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~ 597 (747)
|+.|+|.+|++.+ +..+.....+.+..|||+||.|||++. ++||||.++|||+.+-..+||.|||+++.+..++.
T Consensus 779 mP~G~LlDyvr~h--r~~igsq~lLnw~~QIAkgM~YLe~qr---lVHrdLaaRNVLVksP~hvkitdfgla~ll~~d~~ 853 (1177)
T KOG1025|consen 779 MPLGCLLDYVREH--RDNIGSQDLLNWCYQIAKGMKYLEEQR---LVHRDLAARNVLVKSPNHVKITDFGLAKLLAPDEK 853 (1177)
T ss_pred cccchHHHHHHHh--hccccHHHHHHHHHHHHHHHHHHHhcc---hhhhhhhhhheeecCCCeEEEEecchhhccCcccc
Confidence 9999999999764 445888999999999999999999887 99999999999999999999999999999987766
Q ss_pred ccccceeeec---------cCCCCCccccchhHHHHHHHHHh-CCCCCCCCCCcchhhhhHhHHhcCCcccccchhhhcc
Q 004521 598 EGNTNRVVGT---------YDGQFSIKSDVFSFGILLLEIVS-GKKNRGFYRSDTKVNLIGHLWDEGIPLRLIDACIQDS 667 (747)
Q Consensus 598 ~~~~~~~~~~---------~~~~~s~ksDVwS~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~ 667 (747)
........-. ....|+.++|||||||++||++| |.+|+.....+ .+...++.+....
T Consensus 854 ey~~~~gK~pikwmale~i~~~~~thqSDVWsfGVtiWElmTFGa~Py~gi~~~----eI~dlle~geRLs--------- 920 (1177)
T KOG1025|consen 854 EYSAPGGKVPIKWMALESIRIRKYTHQSDVWSFGVTIWELMTFGAKPYDGIPAE----EIPDLLEKGERLS--------- 920 (1177)
T ss_pred cccccccccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHHhcCCCccCCCCHH----HhhHHHhccccCC---------
Confidence 5433221111 25789999999999999999999 88886533322 2222233333221
Q ss_pred CCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhcC
Q 004521 668 CNLADVIRCIHIGLLCVQQHPEDRPCMPSVILMLGS 703 (747)
Q Consensus 668 ~~~~~~~~~~~l~~~Cl~~dP~~RPt~~~v~~~L~~ 703 (747)
+++-..+.+..++.+||..|+..||+++++...+..
T Consensus 921 qPpiCtiDVy~~mvkCwmid~~~rp~fkel~~~fs~ 956 (1177)
T KOG1025|consen 921 QPPICTIDVYMVMVKCWMIDADSRPTFKELAEEFSR 956 (1177)
T ss_pred CCCCccHHHHHHHHHHhccCcccCccHHHHHHHHHH
Confidence 222234457889999999999999999999876643
|
|
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-35 Score=303.56 Aligned_cols=247 Identities=29% Similarity=0.450 Sum_probs=192.5
Q ss_pred hcCCCccceecccCCeeEEEEEecCCcEEEEEEecccccccHHHHHHHHHHHhccCCCceeeEEeEEEeCCeeEEEEecC
Q 004521 439 TDNFSINNKLGEGGFGPVYKGTLVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFM 518 (747)
Q Consensus 439 ~~~~~~~~~lg~G~fg~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~ 518 (747)
.++|++.++||+|+||.||+|...++..||+|.+... ....+.+.+|+.++++++|+||+++++++...+..++||||+
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~v~iK~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 83 (261)
T cd05072 5 RESIKLVKKLGAGQFGEVWMGYYNNSTKVAVKTLKPG-TMSVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIYIITEYM 83 (261)
T ss_pred hHHeEEeeecCCcCCceEEEEEecCCceEEEEEccCC-chhHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcEEEEecC
Confidence 3578889999999999999999888889999998652 334678999999999999999999999999999999999999
Q ss_pred CCCChhhHhhhcCCCCcCChhHHHHHHHHHHHHHHHhhhcCCCceEecccCcCcEEEcCCCCceEecccCccccCCCCCc
Q 004521 519 PNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETE 598 (747)
Q Consensus 519 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~ 598 (747)
++++|.+++.... ...+++..++.++.|+++||+|||+.+ ++||||||+||+++.++.+||+|||+++........
T Consensus 84 ~~~~L~~~l~~~~-~~~~~~~~~~~~~~~l~~~l~~LH~~~---i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~~ 159 (261)
T cd05072 84 AKGSLLDFLKSDE-GGKVLLPKLIDFSAQIAEGMAYIERKN---YIHRDLRAANVLVSESLMCKIADFGLARVIEDNEYT 159 (261)
T ss_pred CCCcHHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccchhhEEecCCCcEEECCCccceecCCCcee
Confidence 9999999986532 345788999999999999999999987 999999999999999999999999999876432211
Q ss_pred cccc------eeeec--cCCCCCccccchhHHHHHHHHHh-CCCCCCCCCCcchhhhhHhHHhcCCcccccchhhhccCC
Q 004521 599 GNTN------RVVGT--YDGQFSIKSDVFSFGILLLEIVS-GKKNRGFYRSDTKVNLIGHLWDEGIPLRLIDACIQDSCN 669 (747)
Q Consensus 599 ~~~~------~~~~~--~~~~~s~ksDVwS~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~ 669 (747)
.... ..... ..+.++.++|||||||++|||++ |+.|+.... ....... ...+...... ..
T Consensus 160 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~---~~~~~~~-~~~~~~~~~~-----~~-- 228 (261)
T cd05072 160 AREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMS---NSDVMSA-LQRGYRMPRM-----EN-- 228 (261)
T ss_pred ccCCCccceecCCHHHhccCCCChhhhhhhhHHHHHHHHccCCCCCCCCC---HHHHHHH-HHcCCCCCCC-----CC--
Confidence 1000 00000 14567889999999999999998 888865322 1112221 1222111111 11
Q ss_pred HHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhcC
Q 004521 670 LADVIRCIHIGLLCVQQHPEDRPCMPSVILMLGS 703 (747)
Q Consensus 670 ~~~~~~~~~l~~~Cl~~dP~~RPt~~~v~~~L~~ 703 (747)
....+.+++.+||+.+|++||++.+++++|+.
T Consensus 229 --~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 260 (261)
T cd05072 229 --CPDELYDIMKTCWKEKAEERPTFDYLQSVLDD 260 (261)
T ss_pred --CCHHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence 11236678889999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-35 Score=305.51 Aligned_cols=247 Identities=25% Similarity=0.378 Sum_probs=189.0
Q ss_pred cCCCccceecccCCeeEEEEEec----CCcEEEEEEecccc-cccHHHHHHHHHHHhccCCCceeeEEeEEEeCCeeEEE
Q 004521 440 DNFSINNKLGEGGFGPVYKGTLV----DGQEIAVKRLSKIS-EQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLI 514 (747)
Q Consensus 440 ~~~~~~~~lg~G~fg~Vy~~~~~----~g~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV 514 (747)
++|++.+.||+|+||.||+|.+. .+..||+|.++... ......|.+|+.++++++||||++++|++..++..++|
T Consensus 5 ~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 84 (266)
T cd05064 5 KSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLEGVITRGNTMMIV 84 (266)
T ss_pred HHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEecCCCcEEE
Confidence 56888999999999999999863 25689999987632 23346789999999999999999999999999999999
Q ss_pred EecCCCCChhhHhhhcCCCCcCChhHHHHHHHHHHHHHHHhhhcCCCceEecccCcCcEEEcCCCCceEecccCccccCC
Q 004521 515 YEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGG 594 (747)
Q Consensus 515 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NIll~~~~~~kl~DFGla~~~~~ 594 (747)
|||+++|+|.+++... ...+++..++.++.||+.||+|||+.+ ++||||||+|||++.++.+||+|||.+.....
T Consensus 85 ~e~~~~~~L~~~l~~~--~~~l~~~~~~~~~~~i~~al~~lH~~~---iiH~dikp~nili~~~~~~~l~dfg~~~~~~~ 159 (266)
T cd05064 85 TEYMSNGALDSFLRKH--EGQLVAGQLMGMLPGLASGMKYLSEMG---YVHKGLAAHKVLVNSDLVCKISGFRRLQEDKS 159 (266)
T ss_pred EEeCCCCcHHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHHHCC---EeeccccHhhEEEcCCCcEEECCCcccccccc
Confidence 9999999999998653 235889999999999999999999988 99999999999999999999999998765422
Q ss_pred CCCcccc-----ceee-ec--cCCCCCccccchhHHHHHHHHHh-CCCCCCCCCCcchhhhhHhHHhcCCcccccchhhh
Q 004521 595 DETEGNT-----NRVV-GT--YDGQFSIKSDVFSFGILLLEIVS-GKKNRGFYRSDTKVNLIGHLWDEGIPLRLIDACIQ 665 (747)
Q Consensus 595 ~~~~~~~-----~~~~-~~--~~~~~s~ksDVwS~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 665 (747)
....... .... .. ....++.++|||||||++||+++ |+.|+..... ...+.. ..++......
T Consensus 160 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~p~~~~~~---~~~~~~-~~~~~~~~~~----- 230 (266)
T cd05064 160 EAIYTTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMSG---QDVIKA-VEDGFRLPAP----- 230 (266)
T ss_pred cchhcccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHhcCCCCCcCcCCH---HHHHHH-HHCCCCCCCC-----
Confidence 2111000 0000 00 14678899999999999999875 9999643221 112221 1222211111
Q ss_pred ccCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhcCC
Q 004521 666 DSCNLADVIRCIHIGLLCVQQHPEDRPCMPSVILMLGSE 704 (747)
Q Consensus 666 ~~~~~~~~~~~~~l~~~Cl~~dP~~RPt~~~v~~~L~~~ 704 (747)
.. ....+.+++.+||+.+|.+||++.+|.+.|+..
T Consensus 231 ~~----~~~~~~~li~~c~~~~p~~RP~~~~i~~~l~~~ 265 (266)
T cd05064 231 RN----CPNLLHQLMLDCWQKERGERPRFSQIHSILSKM 265 (266)
T ss_pred CC----CCHHHHHHHHHHcCCCchhCCCHHHHHHHHHhh
Confidence 11 122466788899999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-35 Score=330.04 Aligned_cols=249 Identities=26% Similarity=0.308 Sum_probs=196.9
Q ss_pred hcCCCccceecccCCeeEEEEEecCC-cEEEEEEecccccccHHHHHHHHHHHhccC-CCceeeEEeEE-Ee------CC
Q 004521 439 TDNFSINNKLGEGGFGPVYKGTLVDG-QEIAVKRLSKISEQGLKELKNEVILFSKLQ-HRNLVKLLGCC-IQ------GE 509 (747)
Q Consensus 439 ~~~~~~~~~lg~G~fg~Vy~~~~~~g-~~vavK~l~~~~~~~~~~~~~E~~~l~~l~-H~niv~l~g~~-~~------~~ 509 (747)
..++++.+.|.+|||+.||.|....+ ..+|+|++-..++...+.+++|+++|++|+ |+|||.+++.+ .. .-
T Consensus 36 ~~~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~~~~~ 115 (738)
T KOG1989|consen 36 SHRVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVNDEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSNNGVW 115 (738)
T ss_pred CEEEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecCCHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCCCcee
Confidence 34677889999999999999998775 999999998778888999999999999997 99999999943 22 13
Q ss_pred eeEEEEecCCCCChhhHhhhcCCCCcCChhHHHHHHHHHHHHHHHhhhcCCCceEecccCcCcEEEcCCCCceEecccCc
Q 004521 510 EKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLV 589 (747)
Q Consensus 510 ~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NIll~~~~~~kl~DFGla 589 (747)
+.+|+||||++|+|-+++....... |++.++++|+.++++|+.+||... ++|||||||-+||||+.+++.||||||.|
T Consensus 116 EvllLmEyC~gg~Lvd~mn~Rlq~~-lte~eVLkIf~dv~~AVa~mH~~~-pPiIHRDLKiENvLls~~g~~KLCDFGSa 193 (738)
T KOG1989|consen 116 EVLLLMEYCKGGSLVDFMNTRLQTR-LTEDEVLKIFYDVCEAVAAMHYLK-PPIIHRDLKIENVLLSADGNYKLCDFGSA 193 (738)
T ss_pred EEEeehhhccCCcHHHHHHHHHhcc-CChHHHHHHHHHHHHHHHHHhcCC-CccchhhhhhhheEEcCCCCEEeCccccc
Confidence 5689999999999999997655544 999999999999999999999874 78999999999999999999999999988
Q ss_pred cccCCCC-Cc-----------cccceeee------cc-CCCCCccccchhHHHHHHHHHhCCCCCCCCCCcchhhhhHhH
Q 004521 590 RTFGGDE-TE-----------GNTNRVVG------TY-DGQFSIKSDVFSFGILLLEIVSGKKNRGFYRSDTKVNLIGHL 650 (747)
Q Consensus 590 ~~~~~~~-~~-----------~~~~~~~~------~~-~~~~s~ksDVwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~ 650 (747)
....... .. ..++.... .| +..+++|+|||+|||+||-|+....||+...
T Consensus 194 tt~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~sg----------- 262 (738)
T KOG1989|consen 194 TTKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEESG----------- 262 (738)
T ss_pred ccccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcCc-----------
Confidence 6432221 10 00111111 11 5679999999999999999999999976321
Q ss_pred HhcCCcccccchhhhccCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhcCCC
Q 004521 651 WDEGIPLRLIDACIQDSCNLADVIRCIHIGLLCVQQHPEDRPCMPSVILMLGSEI 705 (747)
Q Consensus 651 ~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dP~~RPt~~~v~~~L~~~~ 705 (747)
...++......+.......++..|+..||+.||.+||++-+|+..+..+.
T Consensus 263 -----~laIlng~Y~~P~~p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~~~~l~ 312 (738)
T KOG1989|consen 263 -----KLAILNGNYSFPPFPNYSDRLKDLIRTMLQPNPDERPNIYQVLEEIFELA 312 (738)
T ss_pred -----ceeEEeccccCCCCccHHHHHHHHHHHHhccCcccCCCHHHHHHHHHHHh
Confidence 12223333322233344556777888999999999999999998887654
|
|
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-35 Score=301.99 Aligned_cols=244 Identities=26% Similarity=0.423 Sum_probs=189.4
Q ss_pred cCCCccceecccCCeeEEEEEecCCcEEEEEEecccccccHHHHHHHHHHHhccCCCceeeEEeEEEeCCeeEEEEecCC
Q 004521 440 DNFSINNKLGEGGFGPVYKGTLVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMP 519 (747)
Q Consensus 440 ~~~~~~~~lg~G~fg~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~ 519 (747)
++|++.+.||+|+||.||++...++..+|+|.+.. .....+.+.+|+.++++++||||+++++++...+..++||||++
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~a~K~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~~~ 82 (256)
T cd05114 4 SELTFMKELGSGQFGVVHLGKWRAQIKVAIKAINE-GAMSEEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIVTEFME 82 (256)
T ss_pred HHcEEeeEecCCcCceEEEEEeccCceEEEEeccc-CCccHHHHHHHHHHHHHCCCCCceeEEEEEccCCCEEEEEEcCC
Confidence 45788899999999999999998888999999864 23345688999999999999999999999999999999999999
Q ss_pred CCChhhHhhhcCCCCcCChhHHHHHHHHHHHHHHHhhhcCCCceEecccCcCcEEEcCCCCceEecccCccccCCCCCcc
Q 004521 520 NKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEG 599 (747)
Q Consensus 520 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~ 599 (747)
+|+|.+++.... ..+++..+..++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||+++.........
T Consensus 83 ~~~L~~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~~~~~~ 157 (256)
T cd05114 83 NGCLLNYLRQRQ--GKLSKDMLLSMCQDVCEGMEYLERNS---FIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYTS 157 (256)
T ss_pred CCcHHHHHHhCc--cCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccCcceEEEcCCCeEEECCCCCccccCCCceec
Confidence 999999986432 35889999999999999999999988 9999999999999999999999999988653322111
Q ss_pred ccc------eeeec--cCCCCCccccchhHHHHHHHHHh-CCCCCCCCCCcchhhhhHhHHhcCCcccccchhhhccCCH
Q 004521 600 NTN------RVVGT--YDGQFSIKSDVFSFGILLLEIVS-GKKNRGFYRSDTKVNLIGHLWDEGIPLRLIDACIQDSCNL 670 (747)
Q Consensus 600 ~~~------~~~~~--~~~~~s~ksDVwS~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~ 670 (747)
... ...+. ....++.++||||||+++|||++ |+.|+.... ......... .+.... .+. .
T Consensus 158 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~---~~~~~~~i~-~~~~~~--~~~----~-- 225 (256)
T cd05114 158 SSGAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKS---NYEVVEMIS-RGFRLY--RPK----L-- 225 (256)
T ss_pred cCCCCCchhhCChhhcccCccchhhhhHHHHHHHHHHHcCCCCCCCCCC---HHHHHHHHH-CCCCCC--CCC----C--
Confidence 000 00010 13467889999999999999999 888864322 122222221 111111 111 0
Q ss_pred HHHHHHHHHHHhccCCCCCCCCCHHHHHHHhc
Q 004521 671 ADVIRCIHIGLLCVQQHPEDRPCMPSVILMLG 702 (747)
Q Consensus 671 ~~~~~~~~l~~~Cl~~dP~~RPt~~~v~~~L~ 702 (747)
....+.+++.+||+.+|.+||+|.++++.|.
T Consensus 226 -~~~~~~~li~~c~~~~p~~Rps~~~l~~~l~ 256 (256)
T cd05114 226 -ASMTVYEVMYSCWHEKPEGRPTFAELLRAIT 256 (256)
T ss_pred -CCHHHHHHHHHHccCCcccCcCHHHHHHhhC
Confidence 1234678889999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-35 Score=312.65 Aligned_cols=241 Identities=20% Similarity=0.234 Sum_probs=185.0
Q ss_pred cCCCccceecccCCeeEEEEEecC-CcEEEEEEeccc---ccccHHHHHHHHHHHhccCCCceeeEEeEEEeCCeeEEEE
Q 004521 440 DNFSINNKLGEGGFGPVYKGTLVD-GQEIAVKRLSKI---SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIY 515 (747)
Q Consensus 440 ~~~~~~~~lg~G~fg~Vy~~~~~~-g~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 515 (747)
++|++.+.||+|+||.||+|+... ++.||||.+.+. .....+.+.+|+.++++++||||+++++++.+++..++||
T Consensus 18 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 97 (329)
T PTZ00263 18 SDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENRVYFLL 97 (329)
T ss_pred hheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcCCEEEEEE
Confidence 578889999999999999999864 889999998752 2234567899999999999999999999999999999999
Q ss_pred ecCCCCChhhHhhhcCCCCcCChhHHHHHHHHHHHHHHHhhhcCCCceEecccCcCcEEEcCCCCceEecccCccccCCC
Q 004521 516 EFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGD 595 (747)
Q Consensus 516 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NIll~~~~~~kl~DFGla~~~~~~ 595 (747)
||+++|+|.+++... ..+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++.....
T Consensus 98 e~~~~~~L~~~l~~~---~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~ 171 (329)
T PTZ00263 98 EFVVGGELFTHLRKA---GRFPNDVAKFYHAELVLAFEYLHSKD---IIYRDLKPENLLLDNKGHVKVTDFGFAKKVPDR 171 (329)
T ss_pred cCCCCChHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHEEECCCCCEEEeeccCceEcCCC
Confidence 999999999998653 34788889999999999999999988 999999999999999999999999999876433
Q ss_pred CCccc--cceeeec--cCCCCCccccchhHHHHHHHHHhCCCCCCCCCCcchhhhhHhHHhcCCcccccchhhhccCCHH
Q 004521 596 ETEGN--TNRVVGT--YDGQFSIKSDVFSFGILLLEIVSGKKNRGFYRSDTKVNLIGHLWDEGIPLRLIDACIQDSCNLA 671 (747)
Q Consensus 596 ~~~~~--~~~~~~~--~~~~~s~ksDVwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~ 671 (747)
..... ....... ....++.++|||||||++|||++|+.||.... ........ ..+... + ....+
T Consensus 172 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~---~~~~~~~i-~~~~~~-~-----p~~~~-- 239 (329)
T PTZ00263 172 TFTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDT---PFRIYEKI-LAGRLK-F-----PNWFD-- 239 (329)
T ss_pred cceecCChhhcCHHHHcCCCCCCcceeechHHHHHHHHcCCCCCCCCC---HHHHHHHH-hcCCcC-C-----CCCCC--
Confidence 22110 0000000 14567899999999999999999999974321 11122221 122111 1 01111
Q ss_pred HHHHHHHHHHhccCCCCCCCCC-----HHHHHHH
Q 004521 672 DVIRCIHIGLLCVQQHPEDRPC-----MPSVILM 700 (747)
Q Consensus 672 ~~~~~~~l~~~Cl~~dP~~RPt-----~~~v~~~ 700 (747)
.++.+++.+||+.||.+||+ +.+++..
T Consensus 240 --~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~h 271 (329)
T PTZ00263 240 --GRARDLVKGLLQTDHTKRLGTLKGGVADVKNH 271 (329)
T ss_pred --HHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcC
Confidence 23557778999999999997 6777643
|
|
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-35 Score=320.31 Aligned_cols=252 Identities=29% Similarity=0.415 Sum_probs=190.3
Q ss_pred hcCCCccceecccCCeeEEEEEecC------CcEEEEEEecccc-cccHHHHHHHHHHHhccC-CCceeeEEeEEEeCCe
Q 004521 439 TDNFSINNKLGEGGFGPVYKGTLVD------GQEIAVKRLSKIS-EQGLKELKNEVILFSKLQ-HRNLVKLLGCCIQGEE 510 (747)
Q Consensus 439 ~~~~~~~~~lg~G~fg~Vy~~~~~~------g~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~-H~niv~l~g~~~~~~~ 510 (747)
.++|.+.++||+|+||.||+|+... +..||||+++... ....+.|.+|+.+++++. ||||+++++++.+...
T Consensus 36 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~~~~~ 115 (400)
T cd05105 36 RDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARSSEKQALMSELKIMTHLGPHLNIVNLLGACTKSGP 115 (400)
T ss_pred ccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCCeeeEEEEEccCCc
Confidence 4688889999999999999998532 3479999997532 333567999999999996 9999999999999999
Q ss_pred eEEEEecCCCCChhhHhhhcCC----------------------------------------------------------
Q 004521 511 KLLIYEFMPNKSLDSFIFDQTR---------------------------------------------------------- 532 (747)
Q Consensus 511 ~~lV~E~~~~gsL~~~l~~~~~---------------------------------------------------------- 532 (747)
.+|||||+++|+|.++|.....
T Consensus 116 ~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 195 (400)
T cd05105 116 IYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVPMLEIK 195 (400)
T ss_pred eEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccchhhhhh
Confidence 9999999999999999864210
Q ss_pred -----------------------------------CCcCChhHHHHHHHHHHHHHHHhhhcCCCceEecccCcCcEEEcC
Q 004521 533 -----------------------------------RTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQ 577 (747)
Q Consensus 533 -----------------------------------~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NIll~~ 577 (747)
...+++.++..++.||++||.|||+.+ |+||||||+|||++.
T Consensus 196 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivH~dikp~Nill~~ 272 (400)
T cd05105 196 EASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASKN---CVHRDLAARNVLLAQ 272 (400)
T ss_pred hhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChHhEEEeC
Confidence 123678888999999999999999988 999999999999999
Q ss_pred CCCceEecccCccccCCCCCccccc-------eeeec--cCCCCCccccchhHHHHHHHHHh-CCCCCCCCCCcchhhhh
Q 004521 578 DMNPKISDFGLVRTFGGDETEGNTN-------RVVGT--YDGQFSIKSDVFSFGILLLEIVS-GKKNRGFYRSDTKVNLI 647 (747)
Q Consensus 578 ~~~~kl~DFGla~~~~~~~~~~~~~-------~~~~~--~~~~~s~ksDVwS~Gvvl~ellt-g~~p~~~~~~~~~~~~~ 647 (747)
++.+||+|||+++.+.......... ..... ....++.++|||||||++|||++ |..|+.....+. ...
T Consensus 273 ~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt~g~~P~~~~~~~~--~~~ 350 (400)
T cd05105 273 GKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGMIVDS--TFY 350 (400)
T ss_pred CCEEEEEeCCcceeccccccccccCCcCCCcceEChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCcccchhH--HHH
Confidence 9999999999998654322111100 11111 14568899999999999999997 888865332211 111
Q ss_pred HhHHhcCCcccccchhhhccCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhcCCC
Q 004521 648 GHLWDEGIPLRLIDACIQDSCNLADVIRCIHIGLLCVQQHPEDRPCMPSVILMLGSEI 705 (747)
Q Consensus 648 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dP~~RPt~~~v~~~L~~~~ 705 (747)
.....+...... . .....+.+++.+||+.||++||++.+|+++|+.+.
T Consensus 351 -~~~~~~~~~~~~-----~----~~~~~l~~li~~cl~~dP~~RPt~~~l~~~l~~l~ 398 (400)
T cd05105 351 -NKIKSGYRMAKP-----D----HATQEVYDIMVKCWNSEPEKRPSFLHLSDIVESLL 398 (400)
T ss_pred -HHHhcCCCCCCC-----c----cCCHHHHHHHHHHCccCHhHCcCHHHHHHHHHHHc
Confidence 111222111111 1 11234667888999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-34 Score=301.71 Aligned_cols=247 Identities=30% Similarity=0.455 Sum_probs=193.3
Q ss_pred hcCCCccceecccCCeeEEEEEecCCcEEEEEEecccccccHHHHHHHHHHHhccCCCceeeEEeEEEeCCeeEEEEecC
Q 004521 439 TDNFSINNKLGEGGFGPVYKGTLVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFM 518 (747)
Q Consensus 439 ~~~~~~~~~lg~G~fg~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~ 518 (747)
.++|++.+.||+|+||.||+|...+++.||+|.++.. ....+++.+|+.++++++|+||+++++++...+..++||||+
T Consensus 5 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~v~iK~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 83 (261)
T cd05068 5 RTSIQLLRKLGAGQFGEVWEGLWNNTTPVAVKTLKPG-TMDPKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIYIVTELM 83 (261)
T ss_pred hhheeeEEEecccCCccEEEEEecCCeEEEEEeeCCC-cccHHHHHHHHHHHHHCCCCCccceeEEEecCCCeeeeeecc
Confidence 3568889999999999999999877889999998753 334678999999999999999999999999999999999999
Q ss_pred CCCChhhHhhhcCCCCcCChhHHHHHHHHHHHHHHHhhhcCCCceEecccCcCcEEEcCCCCceEecccCccccCCCCCc
Q 004521 519 PNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETE 598 (747)
Q Consensus 519 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~ 598 (747)
++++|.+++.... ...+++..+..++.|++.||.|||+.+ |+||||||+||++++++.+||+|||+++.+......
T Consensus 84 ~~~~L~~~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~~ 159 (261)
T cd05068 84 KYGSLLEYLQGGA-GRALKLPQLIDMAAQVASGMAYLEAQN---YIHRDLAARNVLVGENNICKVADFGLARVIKEDIYE 159 (261)
T ss_pred cCCcHHHHHhccC-CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCCcceEEEcCCCCEEECCcceEEEccCCccc
Confidence 9999999986533 345899999999999999999999988 999999999999999999999999999876532211
Q ss_pred cccc------eeeec--cCCCCCccccchhHHHHHHHHHh-CCCCCCCCCCcchhhhhHhHHhcCCcccccchhhhccCC
Q 004521 599 GNTN------RVVGT--YDGQFSIKSDVFSFGILLLEIVS-GKKNRGFYRSDTKVNLIGHLWDEGIPLRLIDACIQDSCN 669 (747)
Q Consensus 599 ~~~~------~~~~~--~~~~~s~ksDVwS~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~ 669 (747)
.... ...+. ....++.++||||||+++|||++ |+.|+.... ........ .........
T Consensus 160 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~---~~~~~~~~-~~~~~~~~~--------- 226 (261)
T cd05068 160 AREGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMT---NAEVLQQV-DQGYRMPCP--------- 226 (261)
T ss_pred ccCCCcCceeccCccccccCCCCchhhHHHHHHHHHHHHhcCCCCCCCCC---HHHHHHHH-HcCCCCCCC---------
Confidence 1100 00011 13567889999999999999999 888864322 22222222 111111110
Q ss_pred HHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhcC
Q 004521 670 LADVIRCIHIGLLCVQQHPEDRPCMPSVILMLGS 703 (747)
Q Consensus 670 ~~~~~~~~~l~~~Cl~~dP~~RPt~~~v~~~L~~ 703 (747)
......+.+++.+|++.+|++||++.+|++.|+.
T Consensus 227 ~~~~~~~~~li~~~l~~~P~~Rp~~~~l~~~l~~ 260 (261)
T cd05068 227 PGCPKELYDIMLDCWKEDPDDRPTFETLQWKLED 260 (261)
T ss_pred CcCCHHHHHHHHHHhhcCcccCCCHHHHHHHHhc
Confidence 0112346778889999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-36 Score=284.59 Aligned_cols=256 Identities=21% Similarity=0.244 Sum_probs=196.1
Q ss_pred hcCCCccceecccCCeeEEEEE-ecCCcEEEEEEecccccccHHHHHHHHHHHhccCCCceeeEEeEEEeCC-----eeE
Q 004521 439 TDNFSINNKLGEGGFGPVYKGT-LVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGE-----EKL 512 (747)
Q Consensus 439 ~~~~~~~~~lg~G~fg~Vy~~~-~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~-----~~~ 512 (747)
.++|.+.++||+|||+-||.++ +.+++.+|+|++.-...++.+..++|++..++++|||+++++++...+. ..|
T Consensus 20 ~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~~~~~y 99 (302)
T KOG2345|consen 20 NKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHSQEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKDGKHEAY 99 (302)
T ss_pred CceEEEeeeecCCCceeeeeecccCcccchhhheeeccchHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhccCceeEE
Confidence 4689999999999999999998 4568899999998767778889999999999999999999999876544 489
Q ss_pred EEEecCCCCChhhHhhhcCCC-CcCChhHHHHHHHHHHHHHHHhhhcCCCceEecccCcCcEEEcCCCCceEecccCccc
Q 004521 513 LIYEFMPNKSLDSFIFDQTRR-TLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRT 591 (747)
Q Consensus 513 lV~E~~~~gsL~~~l~~~~~~-~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NIll~~~~~~kl~DFGla~~ 591 (747)
|+++|...|+|.+.+.....+ ..+++.++++|+.+|++||++||+.. ++++||||||.|||+.+.+.++|.|||.+..
T Consensus 100 ll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~~-~~yAH~DiKP~NILls~~~~~vl~D~GS~~~ 178 (302)
T KOG2345|consen 100 LLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEKE-PPYAHRDIKPANILLSDSGLPVLMDLGSATQ 178 (302)
T ss_pred EEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhccC-CcccccCCCcceeEecCCCceEEEeccCccc
Confidence 999999999999999765543 47999999999999999999999986 5799999999999999999999999998864
Q ss_pred cCCCC---C------------cc----ccceeeeccCCCCCccccchhHHHHHHHHHhCCCCCCCCCCcchhhhhHhHHh
Q 004521 592 FGGDE---T------------EG----NTNRVVGTYDGQFSIKSDVFSFGILLLEIVSGKKNRGFYRSDTKVNLIGHLWD 652 (747)
Q Consensus 592 ~~~~~---~------------~~----~~~~~~~~~~~~~s~ksDVwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~ 652 (747)
..-.. . .. .++..--..+...++++|||||||+||+|+.|..||+....... .+..+..
T Consensus 179 a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~~~Gg--SlaLAv~ 256 (302)
T KOG2345|consen 179 APIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERIYQQGG--SLALAVQ 256 (302)
T ss_pred cceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHHhhcCC--eEEEeee
Confidence 32100 0 00 00000011146789999999999999999999999863221110 0111111
Q ss_pred cCCcccccchhhhccCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhcCCC
Q 004521 653 EGIPLRLIDACIQDSCNLADVIRCIHIGLLCVQQHPEDRPCMPSVILMLGSEI 705 (747)
Q Consensus 653 ~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dP~~RPt~~~v~~~L~~~~ 705 (747)
.+... .+......+.+.+++.+|++.||.+||+..+++..++.+.
T Consensus 257 n~q~s--------~P~~~~yse~l~~lik~mlqvdP~qRP~i~~ll~~~d~Li 301 (302)
T KOG2345|consen 257 NAQIS--------IPNSSRYSEALHQLIKSMLQVDPNQRPTIPELLSKLDDLI 301 (302)
T ss_pred ccccc--------cCCCCCccHHHHHHHHHHhcCCcccCCCHHHHHHHHHhhc
Confidence 11111 1111112344667888999999999999999999988753
|
|
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-35 Score=302.77 Aligned_cols=248 Identities=30% Similarity=0.486 Sum_probs=195.6
Q ss_pred hcCCCccceecccCCeeEEEEEecCCcEEEEEEecccccccHHHHHHHHHHHhccCCCceeeEEeEEEeCCeeEEEEecC
Q 004521 439 TDNFSINNKLGEGGFGPVYKGTLVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFM 518 (747)
Q Consensus 439 ~~~~~~~~~lg~G~fg~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~ 518 (747)
..+|++.++||+|+||.||+|...+++.+|+|.+.........++.+|+.+++.++|+||+++++++...+..++||||+
T Consensus 5 ~~~y~~~~~ig~g~~~~vy~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~ 84 (261)
T cd05148 5 REEFTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVYIITELM 84 (261)
T ss_pred HHHHHHhhhhccCCCccEEEeEecCCCcEEEEeccccchhhHHHHHHHHHHHhcCCCcchhheeeeEecCCCeEEEEeec
Confidence 45688899999999999999999889999999998755556678999999999999999999999999999999999999
Q ss_pred CCCChhhHhhhcCCCCcCChhHHHHHHHHHHHHHHHhhhcCCCceEecccCcCcEEEcCCCCceEecccCccccCCCCCc
Q 004521 519 PNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETE 598 (747)
Q Consensus 519 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~ 598 (747)
++++|.+++.... ...+++..+..++.||+.||.|||+.+ ++|+||||+||++++++.+||+|||++..+......
T Consensus 85 ~~~~L~~~~~~~~-~~~~~~~~~~~~~~~i~~al~~lH~~~---i~h~dl~~~nilv~~~~~~kl~d~g~~~~~~~~~~~ 160 (261)
T cd05148 85 EKGSLLAFLRSPE-GQVLPVASLIDMACQVAEGMAYLEEQN---SIHRDLAARNILVGEDLVCKVADFGLARLIKEDVYL 160 (261)
T ss_pred ccCCHHHHHhcCC-CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccCcceEEEcCCceEEEccccchhhcCCcccc
Confidence 9999999996543 345899999999999999999999988 999999999999999999999999999876432211
Q ss_pred cccce----eeec---cCCCCCccccchhHHHHHHHHHh-CCCCCCCCCCcchhhhhHhHHhcCCcccccchhhhccCCH
Q 004521 599 GNTNR----VVGT---YDGQFSIKSDVFSFGILLLEIVS-GKKNRGFYRSDTKVNLIGHLWDEGIPLRLIDACIQDSCNL 670 (747)
Q Consensus 599 ~~~~~----~~~~---~~~~~s~ksDVwS~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~ 670 (747)
..... ...+ ....++.++||||||+++|||++ |+.|+.... ......... .+...... .
T Consensus 161 ~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~---~~~~~~~~~-~~~~~~~~-----~---- 227 (261)
T cd05148 161 SSDKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMN---NHEVYDQIT-AGYRMPCP-----A---- 227 (261)
T ss_pred ccCCCCceEecCHHHHccCCCCchhhHHHHHHHHHHHHcCCCCCCCcCC---HHHHHHHHH-hCCcCCCC-----C----
Confidence 11000 0001 14568889999999999999999 788864332 112222221 21111110 1
Q ss_pred HHHHHHHHHHHhccCCCCCCCCCHHHHHHHhcC
Q 004521 671 ADVIRCIHIGLLCVQQHPEDRPCMPSVILMLGS 703 (747)
Q Consensus 671 ~~~~~~~~l~~~Cl~~dP~~RPt~~~v~~~L~~ 703 (747)
.....+.+++.+||+.+|.+|||+.++++.|++
T Consensus 228 ~~~~~~~~~i~~~l~~~p~~Rpt~~~l~~~L~~ 260 (261)
T cd05148 228 KCPQEIYKIMLECWAAEPEDRPSFKALREELDN 260 (261)
T ss_pred CCCHHHHHHHHHHcCCCchhCcCHHHHHHHHhc
Confidence 112346688889999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-34 Score=301.22 Aligned_cols=247 Identities=27% Similarity=0.441 Sum_probs=191.0
Q ss_pred cCCCccceecccCCeeEEEEEecC----CcEEEEEEeccc-ccccHHHHHHHHHHHhccCCCceeeEEeEEEeCCeeEEE
Q 004521 440 DNFSINNKLGEGGFGPVYKGTLVD----GQEIAVKRLSKI-SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLI 514 (747)
Q Consensus 440 ~~~~~~~~lg~G~fg~Vy~~~~~~----g~~vavK~l~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV 514 (747)
++|++.+.||+|+||.||+|++.. ...||||.++.. ......+|.+|+.++++++||||+++++++...+..++|
T Consensus 4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv 83 (266)
T cd05033 4 SYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRPVMII 83 (266)
T ss_pred HHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCcceEeEEEecCCceEEE
Confidence 578889999999999999998743 357999998753 233456789999999999999999999999999999999
Q ss_pred EecCCCCChhhHhhhcCCCCcCChhHHHHHHHHHHHHHHHhhhcCCCceEecccCcCcEEEcCCCCceEecccCccccCC
Q 004521 515 YEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGG 594 (747)
Q Consensus 515 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NIll~~~~~~kl~DFGla~~~~~ 594 (747)
|||+++++|.+++.... ..+++..+..++.|++.||+|||+.+ |+||||||+||++++++.+||+|||+++.+..
T Consensus 84 ~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~~l~~~l~~Lh~~~---i~H~di~p~nili~~~~~~~l~dfg~~~~~~~ 158 (266)
T cd05033 84 TEYMENGSLDKFLREND--GKFTVGQLVGMLRGIASGMKYLSEMN---YVHRDLAARNILVNSNLVCKVSDFGLSRRLED 158 (266)
T ss_pred EEcCCCCCHHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCcceEEEcCCCCEEECccchhhcccc
Confidence 99999999999986533 35899999999999999999999988 99999999999999999999999999987752
Q ss_pred CCCccccc-------eeeec--cCCCCCccccchhHHHHHHHHHh-CCCCCCCCCCcchhhhhHhHHhcCCcccccchhh
Q 004521 595 DETEGNTN-------RVVGT--YDGQFSIKSDVFSFGILLLEIVS-GKKNRGFYRSDTKVNLIGHLWDEGIPLRLIDACI 664 (747)
Q Consensus 595 ~~~~~~~~-------~~~~~--~~~~~s~ksDVwS~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 664 (747)
........ ..... ....++.++||||||+++|||++ |..|+.... ........ ..+......
T Consensus 159 ~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~---~~~~~~~~-~~~~~~~~~---- 230 (266)
T cd05033 159 SEATYTTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMS---NQDVIKAV-EDGYRLPPP---- 230 (266)
T ss_pred cccceeccCCCCCccccChhhhccCCCccccchHHHHHHHHHHHccCCCCCCCCC---HHHHHHHH-HcCCCCCCC----
Confidence 22111100 00001 13567889999999999999998 988864322 11222221 111111110
Q ss_pred hccCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhcCC
Q 004521 665 QDSCNLADVIRCIHIGLLCVQQHPEDRPCMPSVILMLGSE 704 (747)
Q Consensus 665 ~~~~~~~~~~~~~~l~~~Cl~~dP~~RPt~~~v~~~L~~~ 704 (747)
. .....+.+++.+||+.+|++||++.+|+++|+..
T Consensus 231 -~----~~~~~l~~li~~cl~~~p~~Rp~~~ei~~~l~~~ 265 (266)
T cd05033 231 -M----DCPSALYQLMLDCWQKDRNERPTFSQIVSTLDKM 265 (266)
T ss_pred -C----CCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 0 1123466888899999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=310.03 Aligned_cols=247 Identities=27% Similarity=0.482 Sum_probs=188.0
Q ss_pred cCCCccceecccCCeeEEEEEecC-Cc----EEEEEEeccc-ccccHHHHHHHHHHHhccCCCceeeEEeEEEeCCeeEE
Q 004521 440 DNFSINNKLGEGGFGPVYKGTLVD-GQ----EIAVKRLSKI-SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLL 513 (747)
Q Consensus 440 ~~~~~~~~lg~G~fg~Vy~~~~~~-g~----~vavK~l~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~l 513 (747)
.+|++.+.||+|+||.||+|++.. +. .||||.++.. .....+++.+|+.+++.++||||++++|++... ..++
T Consensus 7 ~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~-~~~~ 85 (316)
T cd05108 7 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQL 85 (316)
T ss_pred hhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC-Ccee
Confidence 468889999999999999998643 33 4899998753 234467899999999999999999999999865 5679
Q ss_pred EEecCCCCChhhHhhhcCCCCcCChhHHHHHHHHHHHHHHHhhhcCCCceEecccCcCcEEEcCCCCceEecccCccccC
Q 004521 514 IYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFG 593 (747)
Q Consensus 514 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NIll~~~~~~kl~DFGla~~~~ 593 (747)
|+||+++|+|.+++.... ..+++..++.++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++.+.
T Consensus 86 v~e~~~~g~l~~~l~~~~--~~~~~~~~~~~~~qi~~~L~~LH~~~---iiH~dlkp~Nill~~~~~~kl~DfG~a~~~~ 160 (316)
T cd05108 86 ITQLMPFGCLLDYVREHK--DNIGSQYLLNWCVQIAKGMNYLEERR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLG 160 (316)
T ss_pred eeecCCCCCHHHHHHhcc--ccCCHHHHHHHHHHHHHHHHHHHhcC---eeccccchhheEecCCCcEEEcccccccccc
Confidence 999999999999996533 34788999999999999999999988 9999999999999999999999999998765
Q ss_pred CCCCccccc-------eeee--ccCCCCCccccchhHHHHHHHHHh-CCCCCCCCCCcchhhhhHhHHhcCCcccccchh
Q 004521 594 GDETEGNTN-------RVVG--TYDGQFSIKSDVFSFGILLLEIVS-GKKNRGFYRSDTKVNLIGHLWDEGIPLRLIDAC 663 (747)
Q Consensus 594 ~~~~~~~~~-------~~~~--~~~~~~s~ksDVwS~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 663 (747)
......... .... .....++.++|||||||++|||++ |+.|+...... . +......+......
T Consensus 161 ~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t~g~~p~~~~~~~---~-~~~~~~~~~~~~~~--- 233 (316)
T cd05108 161 ADEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPAS---E-ISSILEKGERLPQP--- 233 (316)
T ss_pred CCCcceeccCCccceeecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHH---H-HHHHHhCCCCCCCC---
Confidence 332211100 0000 124678899999999999999998 89986532211 1 11222222111110
Q ss_pred hhccCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhcCCC
Q 004521 664 IQDSCNLADVIRCIHIGLLCVQQHPEDRPCMPSVILMLGSEI 705 (747)
Q Consensus 664 l~~~~~~~~~~~~~~l~~~Cl~~dP~~RPt~~~v~~~L~~~~ 705 (747)
... ...+.+++.+||+.+|.+||++.+|+..|....
T Consensus 234 --~~~----~~~~~~li~~cl~~~p~~Rps~~~l~~~l~~~~ 269 (316)
T cd05108 234 --PIC----TIDVYMIMVKCWMIDADSRPKFRELIIEFSKMA 269 (316)
T ss_pred --CCC----CHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence 111 123567888999999999999999999987653
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-34 Score=303.35 Aligned_cols=248 Identities=30% Similarity=0.499 Sum_probs=190.6
Q ss_pred cCCCccceecccCCeeEEEEEecC-C-----cEEEEEEeccc-ccccHHHHHHHHHHHhccCCCceeeEEeEEEeCCeeE
Q 004521 440 DNFSINNKLGEGGFGPVYKGTLVD-G-----QEIAVKRLSKI-SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKL 512 (747)
Q Consensus 440 ~~~~~~~~lg~G~fg~Vy~~~~~~-g-----~~vavK~l~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~ 512 (747)
++|++.+.||+|+||.||+|.... + ..||+|.+... .......|.+|+.++.+++||||+++++++...+..+
T Consensus 5 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~ 84 (283)
T cd05048 5 SAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKEQPTC 84 (283)
T ss_pred HHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCCCHHHHHHHHHHHHHHHhcCCcccceEEEEEcCCCceE
Confidence 468888999999999999998643 2 57999998753 2334567899999999999999999999999999999
Q ss_pred EEEecCCCCChhhHhhhcCC-------------CCcCChhHHHHHHHHHHHHHHHhhhcCCCceEecccCcCcEEEcCCC
Q 004521 513 LIYEFMPNKSLDSFIFDQTR-------------RTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDM 579 (747)
Q Consensus 513 lV~E~~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NIll~~~~ 579 (747)
++|||+++++|.+++..... ...+++..++.++.|+++||.|||+.+ ++||||||+||++++++
T Consensus 85 ~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~~---i~H~dlkp~Nil~~~~~ 161 (283)
T cd05048 85 MLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSHH---FVHRDLAARNCLVGEGL 161 (283)
T ss_pred EEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccccceEEEcCCC
Confidence 99999999999999965322 145788899999999999999999988 99999999999999999
Q ss_pred CceEecccCccccCCCCCccccc-------eeeec--cCCCCCccccchhHHHHHHHHHh-CCCCCCCCCCcchhhhhHh
Q 004521 580 NPKISDFGLVRTFGGDETEGNTN-------RVVGT--YDGQFSIKSDVFSFGILLLEIVS-GKKNRGFYRSDTKVNLIGH 649 (747)
Q Consensus 580 ~~kl~DFGla~~~~~~~~~~~~~-------~~~~~--~~~~~s~ksDVwS~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~ 649 (747)
.+||+|||+++............ ...+. ....++.++|||||||++|||++ |..|+...... ... .
T Consensus 162 ~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~el~~~g~~p~~~~~~~---~~~-~ 237 (283)
T cd05048 162 TVKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFSNQ---EVI-E 237 (283)
T ss_pred cEEECCCcceeeccccccccccCCCcccccccCHHHhccCcCchhhhHHHHHHHHHHHHcCCCCCCCCCCHH---HHH-H
Confidence 99999999998653322111000 00111 24678899999999999999998 99886533221 111 1
Q ss_pred HHhcCCcccccchhhhccCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhcC
Q 004521 650 LWDEGIPLRLIDACIQDSCNLADVIRCIHIGLLCVQQHPEDRPCMPSVILMLGS 703 (747)
Q Consensus 650 ~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dP~~RPt~~~v~~~L~~ 703 (747)
....+...... . .....+.+|+.+||+.||.+||++.+|++.|++
T Consensus 238 ~i~~~~~~~~~-----~----~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~l~~ 282 (283)
T cd05048 238 MIRSRQLLPCP-----E----DCPARVYALMIECWNEIPARRPRFKDIHTRLRS 282 (283)
T ss_pred HHHcCCcCCCc-----c----cCCHHHHHHHHHHccCChhhCcCHHHHHHHHhc
Confidence 22222222111 1 112346678889999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-34 Score=299.26 Aligned_cols=244 Identities=27% Similarity=0.434 Sum_probs=189.4
Q ss_pred cCCCccceecccCCeeEEEEEecCCcEEEEEEecccccccHHHHHHHHHHHhccCCCceeeEEeEEEeCCeeEEEEecCC
Q 004521 440 DNFSINNKLGEGGFGPVYKGTLVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMP 519 (747)
Q Consensus 440 ~~~~~~~~lg~G~fg~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~ 519 (747)
++|++.+.||+|+||.||+|...++..+|||.++.. .....+|.+|+.++.+++||||+++++++......++||||++
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~aik~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 82 (256)
T cd05113 4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEG-SMSEDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIVTEYMS 82 (256)
T ss_pred HHeEEeeEecCcccceEEEEEecCCCcEEEEEcCCC-cccHHHHHHHHHHHhcCCCCCeeeEEEEEccCCCcEEEEEcCC
Confidence 467888999999999999999877778999998752 3345679999999999999999999999999999999999999
Q ss_pred CCChhhHhhhcCCCCcCChhHHHHHHHHHHHHHHHhhhcCCCceEecccCcCcEEEcCCCCceEecccCccccCCCCCcc
Q 004521 520 NKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEG 599 (747)
Q Consensus 520 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~ 599 (747)
+|+|.+++.... ..+++..++.++.||+.||+|||+.+ ++|+||||+||+++.++.+||+|||+++.........
T Consensus 83 ~~~l~~~i~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~~~~~~ 157 (256)
T cd05113 83 NGCLLNYLREHG--KRFQPSQLLEMCKDVCEGMAYLESKQ---FIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEYTS 157 (256)
T ss_pred CCcHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccCcceEEEcCCCCEEECCCccceecCCCceee
Confidence 999999986532 25899999999999999999999988 9999999999999999999999999988654322111
Q ss_pred ccc------eeeec--cCCCCCccccchhHHHHHHHHHh-CCCCCCCCCCcchhhhhHhHHhcCCcccccchhhhccCCH
Q 004521 600 NTN------RVVGT--YDGQFSIKSDVFSFGILLLEIVS-GKKNRGFYRSDTKVNLIGHLWDEGIPLRLIDACIQDSCNL 670 (747)
Q Consensus 600 ~~~------~~~~~--~~~~~s~ksDVwS~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~ 670 (747)
... ..... ....++.++|||||||++|||++ |+.|+...... ...... ..+....... .
T Consensus 158 ~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~---~~~~~~-~~~~~~~~~~-----~--- 225 (256)
T cd05113 158 SVGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNNS---ETVEKV-SQGLRLYRPH-----L--- 225 (256)
T ss_pred cCCCccChhhCCHHHHhcCcccchhHHHHHHHHHHHHhcCCCCCcCcCCHH---HHHHHH-hcCCCCCCCC-----C---
Confidence 000 00000 13567889999999999999999 88887533321 122222 1111111100 0
Q ss_pred HHHHHHHHHHHhccCCCCCCCCCHHHHHHHhc
Q 004521 671 ADVIRCIHIGLLCVQQHPEDRPCMPSVILMLG 702 (747)
Q Consensus 671 ~~~~~~~~l~~~Cl~~dP~~RPt~~~v~~~L~ 702 (747)
....+.+++.+||+.+|.+||++.+|++.|+
T Consensus 226 -~~~~~~~li~~cl~~~p~~Rp~~~~ll~~~~ 256 (256)
T cd05113 226 -ASEKVYAIMYSCWHEKAEERPTFQQLLSSIE 256 (256)
T ss_pred -CCHHHHHHHHHHcCCCcccCCCHHHHHHhhC
Confidence 1234677888999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-34 Score=302.94 Aligned_cols=244 Identities=23% Similarity=0.301 Sum_probs=183.8
Q ss_pred CCccceecccCCeeEEEEEec-CCcEEEEEEecccc---cccHHHHHHHHHHHhccCCCceeeEEeEEEeCCeeEEEEec
Q 004521 442 FSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKIS---EQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEF 517 (747)
Q Consensus 442 ~~~~~~lg~G~fg~Vy~~~~~-~g~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~ 517 (747)
|+..+.||+|+||.||++... +++.||||.+.+.. ......+.+|+.++.+++|+||+++++++.+.+..++||||
T Consensus 2 f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~~lv~e~ 81 (285)
T cd05631 2 FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDALCLVLTI 81 (285)
T ss_pred ceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCeEEEEEEe
Confidence 677899999999999999874 58999999986422 23345678999999999999999999999999999999999
Q ss_pred CCCCChhhHhhhcCCCCcCChhHHHHHHHHHHHHHHHhhhcCCCceEecccCcCcEEEcCCCCceEecccCccccCCCCC
Q 004521 518 MPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDET 597 (747)
Q Consensus 518 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~ 597 (747)
+++|+|..++.... ...+++..+..++.|++.||+|||+.+ |+||||||+|||+++++.+||+|||+++.......
T Consensus 82 ~~~g~L~~~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~---iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~~ 157 (285)
T cd05631 82 MNGGDLKFHIYNMG-NPGFDEQRAIFYAAELCCGLEDLQRER---IVYRDLKPENILLDDRGHIRISDLGLAVQIPEGET 157 (285)
T ss_pred cCCCcHHHHHHhhC-CCCCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCCCHHHEEECCCCCEEEeeCCCcEEcCCCCe
Confidence 99999998886432 235889999999999999999999988 99999999999999999999999999987543221
Q ss_pred cc----ccceeeec--cCCCCCccccchhHHHHHHHHHhCCCCCCCCCCcchhhhhHhHHhcCCcccccchhhhccCCHH
Q 004521 598 EG----NTNRVVGT--YDGQFSIKSDVFSFGILLLEIVSGKKNRGFYRSDTKVNLIGHLWDEGIPLRLIDACIQDSCNLA 671 (747)
Q Consensus 598 ~~----~~~~~~~~--~~~~~s~ksDVwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~ 671 (747)
.. ........ .+..++.++|||||||+||||++|+.||...........+........ .. .....
T Consensus 158 ~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~-~~-----~~~~~--- 228 (285)
T cd05631 158 VRGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVKREEVDRRVKEDQ-EE-----YSEKF--- 228 (285)
T ss_pred ecCCCCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHhCCCCCCCCCcchhHHHHHHHhhccc-cc-----CCccC---
Confidence 10 00110111 146789999999999999999999999764332211111111111110 00 01111
Q ss_pred HHHHHHHHHHhccCCCCCCCCC-----HHHHHH
Q 004521 672 DVIRCIHIGLLCVQQHPEDRPC-----MPSVIL 699 (747)
Q Consensus 672 ~~~~~~~l~~~Cl~~dP~~RPt-----~~~v~~ 699 (747)
...+.+|+.+||+.||.+||+ +.++++
T Consensus 229 -s~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~ 260 (285)
T cd05631 229 -SEDAKSICRMLLTKNPKERLGCRGNGAAGVKQ 260 (285)
T ss_pred -CHHHHHHHHHHhhcCHHHhcCCCCCCHHHHhc
Confidence 123556778999999999997 777775
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-34 Score=303.36 Aligned_cols=248 Identities=28% Similarity=0.469 Sum_probs=191.5
Q ss_pred cCCCccceecccCCeeEEEEEecC------CcEEEEEEecccccc-cHHHHHHHHHHHhccCCCceeeEEeEEEeCCeeE
Q 004521 440 DNFSINNKLGEGGFGPVYKGTLVD------GQEIAVKRLSKISEQ-GLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKL 512 (747)
Q Consensus 440 ~~~~~~~~lg~G~fg~Vy~~~~~~------g~~vavK~l~~~~~~-~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~ 512 (747)
++|.+.+.||+|+||.||+|+..+ ++.||||.++..... ..+.+.+|++++++++|+||+++++++......+
T Consensus 5 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~ 84 (280)
T cd05049 5 DTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVKFYGVCTEGDPPI 84 (280)
T ss_pred HHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCCHHHHHHHHHHHHHHHhcCCCCchheeeEEecCCCeE
Confidence 468888999999999999998643 478999999764333 4678999999999999999999999999999999
Q ss_pred EEEecCCCCChhhHhhhcC-----------CCCcCChhHHHHHHHHHHHHHHHhhhcCCCceEecccCcCcEEEcCCCCc
Q 004521 513 LIYEFMPNKSLDSFIFDQT-----------RRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNP 581 (747)
Q Consensus 513 lV~E~~~~gsL~~~l~~~~-----------~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NIll~~~~~~ 581 (747)
+||||+++++|.+++.... ....+++..+..++.|++.||.|||+.+ ++||||||+||+++.++.+
T Consensus 85 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~---i~h~dlkp~nili~~~~~~ 161 (280)
T cd05049 85 MVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQH---FVHRDLATRNCLVGYDLVV 161 (280)
T ss_pred EEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhCC---eeccccccceEEEcCCCeE
Confidence 9999999999999996532 1345788999999999999999999988 9999999999999999999
Q ss_pred eEecccCccccCCCCCccccc-------eeeec--cCCCCCccccchhHHHHHHHHHh-CCCCCCCCCCcchhhhhHhHH
Q 004521 582 KISDFGLVRTFGGDETEGNTN-------RVVGT--YDGQFSIKSDVFSFGILLLEIVS-GKKNRGFYRSDTKVNLIGHLW 651 (747)
Q Consensus 582 kl~DFGla~~~~~~~~~~~~~-------~~~~~--~~~~~s~ksDVwS~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~ 651 (747)
||+|||+++............ ..... ....++.++|||||||++|||++ |+.|+...... ..... .
T Consensus 162 kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e~~~~g~~p~~~~~~~---~~~~~-~ 237 (280)
T cd05049 162 KIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSNE---EVIEC-I 237 (280)
T ss_pred EECCcccceecccCcceecCCCCcccceecChhhhccCCcchhhhHHHHHHHHHHHHhcCCCCCCCCCHH---HHHHH-H
Confidence 999999998653322111000 00011 14678899999999999999999 99986433221 11111 1
Q ss_pred hcCCcccccchhhhccCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhcC
Q 004521 652 DEGIPLRLIDACIQDSCNLADVIRCIHIGLLCVQQHPEDRPCMPSVILMLGS 703 (747)
Q Consensus 652 ~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dP~~RPt~~~v~~~L~~ 703 (747)
..+....... . ....+.+++.+||+.||++||++.||++.|+.
T Consensus 238 ~~~~~~~~~~-----~----~~~~~~~li~~~l~~~p~~Rp~~~eil~~l~~ 280 (280)
T cd05049 238 TQGRLLQRPR-----T----CPSEVYDIMLGCWKRDPQQRINIKDIHERLQK 280 (280)
T ss_pred HcCCcCCCCC-----C----CCHHHHHHHHHHcCCCcccCCCHHHHHHHhhC
Confidence 2222211111 1 11336678889999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-34 Score=286.36 Aligned_cols=255 Identities=22% Similarity=0.250 Sum_probs=185.1
Q ss_pred hcCCCccceecccCCeeEEEEEecC-CcEEEEEEeccccc--ccHHHHHHHHHHHhccCCCceeeEEeEEEeC--CeeEE
Q 004521 439 TDNFSINNKLGEGGFGPVYKGTLVD-GQEIAVKRLSKISE--QGLKELKNEVILFSKLQHRNLVKLLGCCIQG--EEKLL 513 (747)
Q Consensus 439 ~~~~~~~~~lg~G~fg~Vy~~~~~~-g~~vavK~l~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~--~~~~l 513 (747)
.+.|+..+.|++|.||.||+|+.+. ++.||+|+++-..+ ..--.-.+|+.+|.+++|||||.+-.+.+.. +..|+
T Consensus 75 v~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~d~iy~ 154 (419)
T KOG0663|consen 75 VEEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVVGSNMDKIYI 154 (419)
T ss_pred HHHHHHHhhcccCcceeEEEeccCCcceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEeccccceeee
Confidence 4568888999999999999999865 88999999975221 1223457899999999999999998887654 56899
Q ss_pred EEecCCCCChhhHhhhcCCCCcCChhHHHHHHHHHHHHHHHhhhcCCCceEecccCcCcEEEcCCCCceEecccCccccC
Q 004521 514 IYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFG 593 (747)
Q Consensus 514 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NIll~~~~~~kl~DFGla~~~~ 593 (747)
|||||+ -+|..++.... ..+...++.-++.|+++|++|||.+. |+||||||+|+|++..|.+||+|||+||.++
T Consensus 155 VMe~~E-hDLksl~d~m~--q~F~~~evK~L~~QlL~glk~lH~~w---ilHRDLK~SNLLm~~~G~lKiaDFGLAR~yg 228 (419)
T KOG0663|consen 155 VMEYVE-HDLKSLMETMK--QPFLPGEVKTLMLQLLRGLKHLHDNW---ILHRDLKTSNLLLSHKGILKIADFGLAREYG 228 (419)
T ss_pred eHHHHH-hhHHHHHHhcc--CCCchHHHHHHHHHHHHHHHHHhhce---eEecccchhheeeccCCcEEecccchhhhhc
Confidence 999997 68888886543 45888899999999999999999998 9999999999999999999999999999987
Q ss_pred CCCCccccceeeecc--------CCCCCccccchhHHHHHHHHHhCCCCCCCCCCcchhhhhHhHHhc---CCcccc---
Q 004521 594 GDETEGNTNRVVGTY--------DGQFSIKSDVFSFGILLLEIVSGKKNRGFYRSDTKVNLIGHLWDE---GIPLRL--- 659 (747)
Q Consensus 594 ~~~~~~~~~~~~~~~--------~~~~s~ksDVwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~---~~~~~~--- 659 (747)
........-.+.-.| ...|+...|+||+|||+.||+++++.|.....-+..+.+...... ..-+.+
T Consensus 229 sp~k~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~dQl~~If~llGtPte~iwpg~~~l 308 (419)
T KOG0663|consen 229 SPLKPYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSEIDQLDKIFKLLGTPSEAIWPGYSEL 308 (419)
T ss_pred CCcccCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCchHHHHHHHHHHhCCCccccCCCcccc
Confidence 664332222111111 467999999999999999999999987544333222222222110 000000
Q ss_pred -----------cchhhhccCCHH-HHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 004521 660 -----------IDACIQDSCNLA-DVIRCIHIGLLCVQQHPEDRPCMPSVIL 699 (747)
Q Consensus 660 -----------~d~~l~~~~~~~-~~~~~~~l~~~Cl~~dP~~RPt~~~v~~ 699 (747)
.-..+....... --+.-+++.-..+..||.+|.|+.+.++
T Consensus 309 p~~k~~~f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA~~~L~ 360 (419)
T KOG0663|consen 309 PAVKKMTFSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRITAEDGLK 360 (419)
T ss_pred chhhccccCCCCchhhhhhccccccchhHHHHHHHHhccCccccccHHHhhc
Confidence 000011000000 0123456667889999999999998764
|
|
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-35 Score=313.56 Aligned_cols=249 Identities=20% Similarity=0.257 Sum_probs=187.6
Q ss_pred cCCCccceecccCCeeEEEEEecC-CcEEEEEEecccc---cccHHHHHHHHHHHhccCCCceeeEEeEEEeCCeeEEEE
Q 004521 440 DNFSINNKLGEGGFGPVYKGTLVD-GQEIAVKRLSKIS---EQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIY 515 (747)
Q Consensus 440 ~~~~~~~~lg~G~fg~Vy~~~~~~-g~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 515 (747)
++|++.+.||+|+||.||+|+..+ ++.||||++++.. ....+.+.+|+.++..++||||+++++++...+..++||
T Consensus 1 ~~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~ 80 (333)
T cd05600 1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYLAM 80 (333)
T ss_pred CCcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCCEEEEEE
Confidence 368899999999999999999865 8899999997532 234567889999999999999999999999999999999
Q ss_pred ecCCCCChhhHhhhcCCCCcCChhHHHHHHHHHHHHHHHhhhcCCCceEecccCcCcEEEcCCCCceEecccCccccCCC
Q 004521 516 EFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGD 595 (747)
Q Consensus 516 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NIll~~~~~~kl~DFGla~~~~~~ 595 (747)
||+++|+|.+++.. ...+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++.....
T Consensus 81 e~~~g~~L~~~l~~---~~~l~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~~~ 154 (333)
T cd05600 81 EYVPGGDFRTLLNN---LGVLSEDHARFYMAEMFEAVDALHELG---YIHRDLKPENFLIDASGHIKLTDFGLSKGIVTY 154 (333)
T ss_pred eCCCCCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEECCCCCEEEEeCcCCcccccc
Confidence 99999999999954 235888999999999999999999988 999999999999999999999999999865431
Q ss_pred CCc--cccceeeec--cCCCCCccccchhHHHHHHHHHhCCCCCCCCCCcchhhhhHhHHhcCCcccccchhhhccCCHH
Q 004521 596 ETE--GNTNRVVGT--YDGQFSIKSDVFSFGILLLEIVSGKKNRGFYRSDTKVNLIGHLWDEGIPLRLIDACIQDSCNLA 671 (747)
Q Consensus 596 ~~~--~~~~~~~~~--~~~~~s~ksDVwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~ 671 (747)
... .......+. ....++.++|||||||++|||++|+.||....... .............. +... .....
T Consensus 155 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~---~~~~i~~~~~~~~~--~~~~-~~~~~ 228 (333)
T cd05600 155 ANSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNE---TWENLKYWKETLQR--PVYD-DPRFN 228 (333)
T ss_pred cCCcccCccccChhHhcCCCCCCccceecchHHHhhhhhCCCCCCCCCHHH---HHHHHHhccccccC--CCCC-ccccc
Confidence 111 011111111 14578899999999999999999999975332221 11111111000000 0000 00001
Q ss_pred HHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 004521 672 DVIRCIHIGLLCVQQHPEDRPCMPSVILM 700 (747)
Q Consensus 672 ~~~~~~~l~~~Cl~~dP~~RPt~~~v~~~ 700 (747)
....+.+++.+||+.+|.+||++.++++.
T Consensus 229 ~s~~~~~li~~~l~~~~~rr~s~~~ll~h 257 (333)
T cd05600 229 LSDEAWDLITKLINDPSRRFGSLEDIKNH 257 (333)
T ss_pred cCHHHHHHHHHHhhChhhhcCCHHHHHhC
Confidence 12235677789999999999999999875
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-34 Score=309.23 Aligned_cols=239 Identities=21% Similarity=0.340 Sum_probs=186.4
Q ss_pred HHhcCCCccceecccCCeeEEEEEec-CCcEEEEEEeccc----cc-ccHHHHHHHHHHHhccC-CCceeeEEeEEEeCC
Q 004521 437 NATDNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKI----SE-QGLKELKNEVILFSKLQ-HRNLVKLLGCCIQGE 509 (747)
Q Consensus 437 ~~~~~~~~~~~lg~G~fg~Vy~~~~~-~g~~vavK~l~~~----~~-~~~~~~~~E~~~l~~l~-H~niv~l~g~~~~~~ 509 (747)
...++|.+.+.||+|+||+|+.|... .++.||||.+.+. .. ...+.+.+|+.++++++ ||||++++.++....
T Consensus 14 ~~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~ 93 (370)
T KOG0583|consen 14 LSIGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATPT 93 (370)
T ss_pred cccCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecCC
Confidence 34568999999999999999999865 4899999977652 11 34556778999999998 999999999999999
Q ss_pred eeEEEEecCCCCChhhHhhhcCCCCcCChhHHHHHHHHHHHHHHHhhhcCCCceEecccCcCcEEEcCC-CCceEecccC
Q 004521 510 EKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQD-MNPKISDFGL 588 (747)
Q Consensus 510 ~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NIll~~~-~~~kl~DFGl 588 (747)
..++||||+.+|+|.+++.. .+.+.+.++..+++|++.|++|+|+.+ |+||||||+|||++.+ +++||+|||+
T Consensus 94 ~~~ivmEy~~gGdL~~~i~~---~g~l~E~~ar~~F~Qlisav~y~H~~g---i~HRDLK~ENilld~~~~~~Kl~DFG~ 167 (370)
T KOG0583|consen 94 KIYIVMEYCSGGDLFDYIVN---KGRLKEDEARKYFRQLISAVAYCHSRG---IVHRDLKPENILLDGNEGNLKLSDFGL 167 (370)
T ss_pred eEEEEEEecCCccHHHHHHH---cCCCChHHHHHHHHHHHHHHHHHHhCC---EeeCCCCHHHEEecCCCCCEEEecccc
Confidence 99999999999999999966 345788999999999999999999998 9999999999999999 9999999999
Q ss_pred ccccC-CCCCccccceeeecc---------CCC-C-CccccchhHHHHHHHHHhCCCCCCCCCCcchhhhhHhHHhcCC-
Q 004521 589 VRTFG-GDETEGNTNRVVGTY---------DGQ-F-SIKSDVFSFGILLLEIVSGKKNRGFYRSDTKVNLIGHLWDEGI- 655 (747)
Q Consensus 589 a~~~~-~~~~~~~~~~~~~~~---------~~~-~-s~ksDVwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~- 655 (747)
+.... .+.. .....|+. +.. | ..++||||+||+||.|++|+.||.. .....+...+.....
T Consensus 168 s~~~~~~~~~---l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d---~~~~~l~~ki~~~~~~ 241 (370)
T KOG0583|consen 168 SAISPGEDGL---LKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDD---SNVPNLYRKIRKGEFK 241 (370)
T ss_pred ccccCCCCCc---ccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCC---ccHHHHHHHHhcCCcc
Confidence 99873 2211 11122221 222 5 4799999999999999999999764 222222222211111
Q ss_pred cccccchhhhccCCHHHHHHHHHHHHhccCCCCCCCCCHHHHH
Q 004521 656 PLRLIDACIQDSCNLADVIRCIHIGLLCVQQHPEDRPCMPSVI 698 (747)
Q Consensus 656 ~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dP~~RPt~~~v~ 698 (747)
.+..++ -..+..++.+|++.||.+|+++.+|+
T Consensus 242 ~p~~~~-----------S~~~~~Li~~mL~~~P~~R~t~~~i~ 273 (370)
T KOG0583|consen 242 IPSYLL-----------SPEARSLIEKMLVPDPSTRITLLEIL 273 (370)
T ss_pred CCCCcC-----------CHHHHHHHHHHcCCCcccCCCHHHHh
Confidence 111110 12355677799999999999999998
|
|
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-34 Score=299.94 Aligned_cols=247 Identities=28% Similarity=0.468 Sum_probs=191.4
Q ss_pred cCCCccceecccCCeeEEEEEecC-CcEEEEEEecccccccHHHHHHHHHHHhccCCCceeeEEeEEEeCCeeEEEEecC
Q 004521 440 DNFSINNKLGEGGFGPVYKGTLVD-GQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFM 518 (747)
Q Consensus 440 ~~~~~~~~lg~G~fg~Vy~~~~~~-g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~ 518 (747)
.+|.+.+.||+|+||.||+|...+ ++.||+|.+.. ......++.+|++++++++|+||+++++++......++||||+
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 84 (263)
T cd05052 6 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKE-DTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFM 84 (263)
T ss_pred HHeEEeeecCCcccceEEEEEEecCCceEEEEEecC-CchHHHHHHHHHHHHHhCCCCChhheEEEEcCCCCcEEEEEeC
Confidence 357778999999999999999754 88999999875 3344678999999999999999999999999999999999999
Q ss_pred CCCChhhHhhhcCCCCcCChhHHHHHHHHHHHHHHHhhhcCCCceEecccCcCcEEEcCCCCceEecccCccccCCCCCc
Q 004521 519 PNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETE 598 (747)
Q Consensus 519 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~ 598 (747)
++++|.+++.... ...+++..++.++.|+++||+|||+.+ ++||||||+||++++++.+||+|||+++........
T Consensus 85 ~~~~L~~~~~~~~-~~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~dlkp~nil~~~~~~~kl~df~~~~~~~~~~~~ 160 (263)
T cd05052 85 TYGNLLDYLRECN-RQEVNAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYT 160 (263)
T ss_pred CCCcHHHHHHhCC-CCCCCHHHHHHHHHHHHHHHHHHHhCC---EeecccCcceEEEcCCCcEEeCCCccccccccceee
Confidence 9999999986532 345889999999999999999999988 999999999999999999999999999876543221
Q ss_pred cccc------eeeec--cCCCCCccccchhHHHHHHHHHh-CCCCCCCCCCcchhhhhHhHHhcCCcccccchhhhccCC
Q 004521 599 GNTN------RVVGT--YDGQFSIKSDVFSFGILLLEIVS-GKKNRGFYRSDTKVNLIGHLWDEGIPLRLIDACIQDSCN 669 (747)
Q Consensus 599 ~~~~------~~~~~--~~~~~s~ksDVwS~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~ 669 (747)
.... ..... ....++.++|||||||++|||++ |..|+..... ...... ...+...... ...
T Consensus 161 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~---~~~~~~-~~~~~~~~~~-----~~~- 230 (263)
T cd05052 161 AHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDL---SQVYEL-LEKGYRMERP-----EGC- 230 (263)
T ss_pred ccCCCCCccccCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCH---HHHHHH-HHCCCCCCCC-----CCC-
Confidence 1100 00011 24567889999999999999998 8888653221 111111 1221111111 111
Q ss_pred HHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhcCC
Q 004521 670 LADVIRCIHIGLLCVQQHPEDRPCMPSVILMLGSE 704 (747)
Q Consensus 670 ~~~~~~~~~l~~~Cl~~dP~~RPt~~~v~~~L~~~ 704 (747)
...+.+++.+||+.+|++||++.+++++|+..
T Consensus 231 ---~~~~~~li~~cl~~~p~~Rp~~~~l~~~l~~~ 262 (263)
T cd05052 231 ---PPKVYELMRACWQWNPSDRPSFAEIHQAFETM 262 (263)
T ss_pred ---CHHHHHHHHHHccCCcccCCCHHHHHHHHHhh
Confidence 13466788899999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-34 Score=310.54 Aligned_cols=194 Identities=24% Similarity=0.313 Sum_probs=160.6
Q ss_pred hcCCCccceecccCCeeEEEEEecC-CcEEEEEEeccc-ccccHHHHHHHHHHHhccCCCceeeEEeEEEeCCeeEEEEe
Q 004521 439 TDNFSINNKLGEGGFGPVYKGTLVD-GQEIAVKRLSKI-SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYE 516 (747)
Q Consensus 439 ~~~~~~~~~lg~G~fg~Vy~~~~~~-g~~vavK~l~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E 516 (747)
.++|++.+.||+|+||.||+++... +..+|+|.+... .....+.+.+|++++++++||||+++++++..++..++|||
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 83 (331)
T cd06649 4 DDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME 83 (331)
T ss_pred cccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEee
Confidence 3689999999999999999999764 788999998753 23345679999999999999999999999999999999999
Q ss_pred cCCCCChhhHhhhcCCCCcCChhHHHHHHHHHHHHHHHhhhcCCCceEecccCcCcEEEcCCCCceEecccCccccCCCC
Q 004521 517 FMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDE 596 (747)
Q Consensus 517 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~ 596 (747)
|+++++|.+++... ..+++..+..++.|++.||.|||+.+ +|+||||||+|||++.++.+||+|||+++.+....
T Consensus 84 ~~~~~~L~~~l~~~---~~~~~~~~~~~~~~i~~~l~~lH~~~--~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 158 (331)
T cd06649 84 HMDGGSLDQVLKEA---KRIPEEILGKVSIAVLRGLAYLREKH--QIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM 158 (331)
T ss_pred cCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHhhcC--CEEcCCCChhhEEEcCCCcEEEccCcccccccccc
Confidence 99999999998543 34788999999999999999999853 39999999999999999999999999987653322
Q ss_pred Cccc--c-ceeee--ccCCCCCccccchhHHHHHHHHHhCCCCCCC
Q 004521 597 TEGN--T-NRVVG--TYDGQFSIKSDVFSFGILLLEIVSGKKNRGF 637 (747)
Q Consensus 597 ~~~~--~-~~~~~--~~~~~~s~ksDVwS~Gvvl~elltg~~p~~~ 637 (747)
.... . ..... ..+..++.++|||||||++|||++|+.|+..
T Consensus 159 ~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~ 204 (331)
T cd06649 159 ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPP 204 (331)
T ss_pred cccCCCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCC
Confidence 1110 0 00000 1145688999999999999999999999753
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-34 Score=302.20 Aligned_cols=250 Identities=26% Similarity=0.431 Sum_probs=188.6
Q ss_pred HhcCCCccceecccCCeeEEEEEec------CCcEEEEEEecccc-cccHHHHHHHHHHHhccCCCceeeEEeEEEeCCe
Q 004521 438 ATDNFSINNKLGEGGFGPVYKGTLV------DGQEIAVKRLSKIS-EQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEE 510 (747)
Q Consensus 438 ~~~~~~~~~~lg~G~fg~Vy~~~~~------~g~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~ 510 (747)
..++|++.+.||+|+||.||+|... .+..||||.+.... .....+|.+|+.+++.++||||+++++++.....
T Consensus 4 ~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~ 83 (277)
T cd05062 4 AREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQP 83 (277)
T ss_pred cHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCC
Confidence 3567999999999999999999753 24679999986422 2345578999999999999999999999999999
Q ss_pred eEEEEecCCCCChhhHhhhcCC-------CCcCChhHHHHHHHHHHHHHHHhhhcCCCceEecccCcCcEEEcCCCCceE
Q 004521 511 KLLIYEFMPNKSLDSFIFDQTR-------RTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKI 583 (747)
Q Consensus 511 ~~lV~E~~~~gsL~~~l~~~~~-------~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NIll~~~~~~kl 583 (747)
.++||||+++++|.+++..... ...+++..+..++.|+++||.|||+.+ ++||||||+||++++++.+||
T Consensus 84 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---~vH~dlkp~Nil~~~~~~~~l 160 (277)
T cd05062 84 TLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNANK---FVHRDLAARNCMVAEDFTVKI 160 (277)
T ss_pred eEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCcchheEEEcCCCCEEE
Confidence 9999999999999999865321 224677889999999999999999987 999999999999999999999
Q ss_pred ecccCccccCCCCCccccc-------eeeec--cCCCCCccccchhHHHHHHHHHh-CCCCCCCCCCcchhhhhHhHHhc
Q 004521 584 SDFGLVRTFGGDETEGNTN-------RVVGT--YDGQFSIKSDVFSFGILLLEIVS-GKKNRGFYRSDTKVNLIGHLWDE 653 (747)
Q Consensus 584 ~DFGla~~~~~~~~~~~~~-------~~~~~--~~~~~s~ksDVwS~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~ 653 (747)
+|||+++.+.......... ..... ....++.++|||||||++|||++ |..|+..... ........ .
T Consensus 161 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~p~~~~~~---~~~~~~~~-~ 236 (277)
T cd05062 161 GDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSN---EQVLRFVM-E 236 (277)
T ss_pred CCCCCccccCCcceeecCCCCccCHhhcChhHhhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCH---HHHHHHHH-c
Confidence 9999987653322211100 00011 14568899999999999999999 6777643221 12222211 1
Q ss_pred CCcccccchhhhccCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhcC
Q 004521 654 GIPLRLIDACIQDSCNLADVIRCIHIGLLCVQQHPEDRPCMPSVILMLGS 703 (747)
Q Consensus 654 ~~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dP~~RPt~~~v~~~L~~ 703 (747)
.......+ . ....+.+++.+||+.+|++||++.+++++|++
T Consensus 237 ~~~~~~~~-----~----~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~ 277 (277)
T cd05062 237 GGLLDKPD-----N----CPDMLFELMRMCWQYNPKMRPSFLEIISSIKE 277 (277)
T ss_pred CCcCCCCC-----C----CCHHHHHHHHHHcCCChhhCcCHHHHHHHhhC
Confidence 11111111 1 11246678889999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-34 Score=303.93 Aligned_cols=254 Identities=21% Similarity=0.264 Sum_probs=183.4
Q ss_pred cCCCccceecccCCeeEEEEEec-CCcEEEEEEecccc-cccHHHHHHHHHHHhccCCCceeeEEeEEEeCCeeEEEEec
Q 004521 440 DNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKIS-EQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEF 517 (747)
Q Consensus 440 ~~~~~~~~lg~G~fg~Vy~~~~~-~g~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~ 517 (747)
++|.+.++||+|+||.||+|+.. +++.||+|.++... ......+.+|+.++++++||||+++++++...+..++||||
T Consensus 5 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 84 (288)
T cd07871 5 ETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDIIHTERCLTLVFEY 84 (288)
T ss_pred ccceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccccCCcchhHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEEeC
Confidence 46888999999999999999875 48899999987532 23345778999999999999999999999999999999999
Q ss_pred CCCCChhhHhhhcCCCCcCChhHHHHHHHHHHHHHHHhhhcCCCceEecccCcCcEEEcCCCCceEecccCccccCCCCC
Q 004521 518 MPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDET 597 (747)
Q Consensus 518 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~ 597 (747)
++ ++|.+++... ...+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++.......
T Consensus 85 ~~-~~l~~~l~~~--~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~~~~~ 158 (288)
T cd07871 85 LD-SDLKQYLDNC--GNLMSMHNVKIFMFQLLRGLSYCHKRK---ILHRDLKPQNLLINEKGELKLADFGLARAKSVPTK 158 (288)
T ss_pred CC-cCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEECcCcceeeccCCCc
Confidence 97 5898888543 234788999999999999999999988 99999999999999999999999999976532221
Q ss_pred cccc-----ceeeec-c--CCCCCccccchhHHHHHHHHHhCCCCCCCCCCcchhhhhHhHHhcCC------------cc
Q 004521 598 EGNT-----NRVVGT-Y--DGQFSIKSDVFSFGILLLEIVSGKKNRGFYRSDTKVNLIGHLWDEGI------------PL 657 (747)
Q Consensus 598 ~~~~-----~~~~~~-~--~~~~s~ksDVwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~------------~~ 657 (747)
.... ....+. . ...++.++||||+||++|||++|+.||...........+........ ..
T Consensus 159 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (288)
T cd07871 159 TYSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIFRLLGTPTEETWPGITSNEEFR 238 (288)
T ss_pred cccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhccccchhhh
Confidence 1100 000011 1 24578899999999999999999999754322221111111100000 00
Q ss_pred cccchhhhccCCH----HHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 004521 658 RLIDACIQDSCNL----ADVIRCIHIGLLCVQQHPEDRPCMPSVIL 699 (747)
Q Consensus 658 ~~~d~~l~~~~~~----~~~~~~~~l~~~Cl~~dP~~RPt~~~v~~ 699 (747)
....+........ ..-..+.+++.+||+.||.+|||+.|+++
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~ 284 (288)
T cd07871 239 SYLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALR 284 (288)
T ss_pred ccccCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhc
Confidence 0000000000000 00123567888999999999999999975
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-34 Score=302.20 Aligned_cols=248 Identities=30% Similarity=0.478 Sum_probs=188.2
Q ss_pred cCCCccceecccCCeeEEEEEe-----cCCcEEEEEEeccc-ccccHHHHHHHHHHHhccCCCceeeEEeEEEeCCeeEE
Q 004521 440 DNFSINNKLGEGGFGPVYKGTL-----VDGQEIAVKRLSKI-SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLL 513 (747)
Q Consensus 440 ~~~~~~~~lg~G~fg~Vy~~~~-----~~g~~vavK~l~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~l 513 (747)
++|++.+.||+|+||.||+|+. ..+..||+|.+... ..+....|.+|+.++++++||||+++++++..+...++
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 84 (283)
T cd05090 5 SAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQPVCM 84 (283)
T ss_pred hhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCceEE
Confidence 4677889999999999999985 23578999999753 33445678999999999999999999999999999999
Q ss_pred EEecCCCCChhhHhhhcCC--------------CCcCChhHHHHHHHHHHHHHHHhhhcCCCceEecccCcCcEEEcCCC
Q 004521 514 IYEFMPNKSLDSFIFDQTR--------------RTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDM 579 (747)
Q Consensus 514 V~E~~~~gsL~~~l~~~~~--------------~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NIll~~~~ 579 (747)
||||+++++|.+++..... ...+++.+.+.++.|++.||.|||+.+ ++||||||+|||+++++
T Consensus 85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---i~H~dlkp~nili~~~~ 161 (283)
T cd05090 85 LFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSHF---FVHKDLAARNILIGEQL 161 (283)
T ss_pred EEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhcC---eehhccccceEEEcCCC
Confidence 9999999999999854321 234788899999999999999999988 99999999999999999
Q ss_pred CceEecccCccccCCCCCccccc-------eeeec--cCCCCCccccchhHHHHHHHHHh-CCCCCCCCCCcchhhhhHh
Q 004521 580 NPKISDFGLVRTFGGDETEGNTN-------RVVGT--YDGQFSIKSDVFSFGILLLEIVS-GKKNRGFYRSDTKVNLIGH 649 (747)
Q Consensus 580 ~~kl~DFGla~~~~~~~~~~~~~-------~~~~~--~~~~~s~ksDVwS~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~ 649 (747)
.+||+|||+++............ ..... ....++.++|||||||+||||++ |..|+..... ......
T Consensus 162 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~g~~p~~~~~~---~~~~~~ 238 (283)
T cd05090 162 HVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSN---QEVIEM 238 (283)
T ss_pred cEEeccccccccccCCcceecccCCCccceecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCH---HHHHHH
Confidence 99999999998654322111000 00011 13568899999999999999999 8888643221 111111
Q ss_pred HHhcCCcccccchhhhccCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhcC
Q 004521 650 LWDEGIPLRLIDACIQDSCNLADVIRCIHIGLLCVQQHPEDRPCMPSVILMLGS 703 (747)
Q Consensus 650 ~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dP~~RPt~~~v~~~L~~ 703 (747)
. ........ ....+ .++.+++.+||+.+|++||++.+|.++|..
T Consensus 239 ~-~~~~~~~~-----~~~~~----~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~ 282 (283)
T cd05090 239 V-RKRQLLPC-----SEDCP----PRMYSLMTECWQEGPSRRPRFKDIHTRLRS 282 (283)
T ss_pred H-HcCCcCCC-----CCCCC----HHHHHHHHHHcccCcccCcCHHHHHHHhhc
Confidence 1 11111111 11111 245678889999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-34 Score=311.50 Aligned_cols=251 Identities=29% Similarity=0.460 Sum_probs=188.5
Q ss_pred cCCCccceecccCCeeEEEEEecC------CcEEEEEEecccc-cccHHHHHHHHHHHhcc-CCCceeeEEeEEEeC-Ce
Q 004521 440 DNFSINNKLGEGGFGPVYKGTLVD------GQEIAVKRLSKIS-EQGLKELKNEVILFSKL-QHRNLVKLLGCCIQG-EE 510 (747)
Q Consensus 440 ~~~~~~~~lg~G~fg~Vy~~~~~~------g~~vavK~l~~~~-~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~-~~ 510 (747)
++|++.+.||+|+||.||+|...+ ++.||+|+++... ....+.+..|+.++.++ +|+||++++++|... ..
T Consensus 7 ~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~~~~~ 86 (337)
T cd05054 7 DRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELKILIHIGHHLNVVNLLGACTKPGGP 86 (337)
T ss_pred HHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCCCHHHHHHHHHHHHHHHhhccCcchhheeeeEecCCCC
Confidence 578899999999999999997432 4789999987532 23345688899999999 899999999988754 56
Q ss_pred eEEEEecCCCCChhhHhhhcCC----------------------------------------------------------
Q 004521 511 KLLIYEFMPNKSLDSFIFDQTR---------------------------------------------------------- 532 (747)
Q Consensus 511 ~~lV~E~~~~gsL~~~l~~~~~---------------------------------------------------------- 532 (747)
.++||||+++++|.+++.....
T Consensus 87 ~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 166 (337)
T cd05054 87 LMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGDELY 166 (337)
T ss_pred EEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchhhhHHh
Confidence 7899999999999999854321
Q ss_pred CCcCChhHHHHHHHHHHHHHHHhhhcCCCceEecccCcCcEEEcCCCCceEecccCccccCCCCCccccc-------eee
Q 004521 533 RTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNTN-------RVV 605 (747)
Q Consensus 533 ~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~-------~~~ 605 (747)
...+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++.+.......... ...
T Consensus 167 ~~~l~~~~~~~~~~qi~~aL~~lH~~~---ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~~~~~y~a 243 (337)
T cd05054 167 KEPLTLEDLISYSFQVARGMEFLASRK---CIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMA 243 (337)
T ss_pred hcCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCcceEEEeCCCcEEEeccccchhcccCcchhhccCCCCCccccC
Confidence 125789999999999999999999988 9999999999999999999999999998764322111110 001
Q ss_pred e--ccCCCCCccccchhHHHHHHHHHh-CCCCCCCCCCcchhhhhHhHHhcCCcccccchhhhccCCHHHHHHHHHHHHh
Q 004521 606 G--TYDGQFSIKSDVFSFGILLLEIVS-GKKNRGFYRSDTKVNLIGHLWDEGIPLRLIDACIQDSCNLADVIRCIHIGLL 682 (747)
Q Consensus 606 ~--~~~~~~s~ksDVwS~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~ 682 (747)
. .....++.++|||||||+||||++ |..|+....... ........+......+ .....+.+++.+
T Consensus 244 PE~~~~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~~---~~~~~~~~~~~~~~~~---------~~~~~~~~l~~~ 311 (337)
T cd05054 244 PESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDE---EFCRRLKEGTRMRAPE---------YATPEIYSIMLD 311 (337)
T ss_pred cHHhcCCCCCccccHHHHHHHHHHHHHcCCCCCCCCCccH---HHHHHHhccCCCCCCc---------cCCHHHHHHHHH
Confidence 1 125678999999999999999998 988865322111 1111222222211111 112346788899
Q ss_pred ccCCCCCCCCCHHHHHHHhcCCC
Q 004521 683 CVQQHPEDRPCMPSVILMLGSEI 705 (747)
Q Consensus 683 Cl~~dP~~RPt~~~v~~~L~~~~ 705 (747)
||+.+|++||++.+|+++|+...
T Consensus 312 cl~~~p~~RPs~~ell~~l~~~~ 334 (337)
T cd05054 312 CWHNNPEDRPTFSELVEILGDLL 334 (337)
T ss_pred HccCChhhCcCHHHHHHHHHHHH
Confidence 99999999999999999998643
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-34 Score=298.46 Aligned_cols=247 Identities=26% Similarity=0.437 Sum_probs=187.4
Q ss_pred CCccceecccCCeeEEEEEecC----CcEEEEEEeccc--ccccHHHHHHHHHHHhccCCCceeeEEeEEEeCCe-----
Q 004521 442 FSINNKLGEGGFGPVYKGTLVD----GQEIAVKRLSKI--SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEE----- 510 (747)
Q Consensus 442 ~~~~~~lg~G~fg~Vy~~~~~~----g~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~----- 510 (747)
|.+.+.||+|+||.||+|++.. +..||||+++.. .......+.+|+.+++.++||||+++++++...+.
T Consensus 1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 80 (273)
T cd05035 1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIP 80 (273)
T ss_pred CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccCc
Confidence 5677899999999999998743 367999998742 23345679999999999999999999999876554
Q ss_pred -eEEEEecCCCCChhhHhhhcC---CCCcCChhHHHHHHHHHHHHHHHhhhcCCCceEecccCcCcEEEcCCCCceEecc
Q 004521 511 -KLLIYEFMPNKSLDSFIFDQT---RRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDF 586 (747)
Q Consensus 511 -~~lV~E~~~~gsL~~~l~~~~---~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NIll~~~~~~kl~DF 586 (747)
.++|+||+++++|..++.... ....+++..+..++.|++.||.|||+.+ ++||||||+||++++++.+||+||
T Consensus 81 ~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~df 157 (273)
T cd05035 81 KPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNRN---FIHRDLAARNCMLREDMTVCVADF 157 (273)
T ss_pred ccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCC---eeccccchheEEECCCCeEEECCc
Confidence 689999999999999985532 2235889999999999999999999988 999999999999999999999999
Q ss_pred cCccccCCCCCccccc-------ee--eeccCCCCCccccchhHHHHHHHHHh-CCCCCCCCCCcchhhhhHhHHhcCCc
Q 004521 587 GLVRTFGGDETEGNTN-------RV--VGTYDGQFSIKSDVFSFGILLLEIVS-GKKNRGFYRSDTKVNLIGHLWDEGIP 656 (747)
Q Consensus 587 Gla~~~~~~~~~~~~~-------~~--~~~~~~~~s~ksDVwS~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~ 656 (747)
|+++............ .. .......++.++||||||+++|||++ |..|+.... ......... .+..
T Consensus 158 g~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~il~el~~~g~~p~~~~~---~~~~~~~~~-~~~~ 233 (273)
T cd05035 158 GLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVE---NHEIYDYLR-HGNR 233 (273)
T ss_pred cceeeccccccccccccccCCccccCHhhcccCCCCcccchHHHHHHHHHHHhCCCCCCCCCC---HHHHHHHHH-cCCC
Confidence 9998764332211000 00 00124568899999999999999999 778864322 222222222 2211
Q ss_pred ccccchhhhccCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhcCC
Q 004521 657 LRLIDACIQDSCNLADVIRCIHIGLLCVQQHPEDRPCMPSVILMLGSE 704 (747)
Q Consensus 657 ~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dP~~RPt~~~v~~~L~~~ 704 (747)
..... .....+.+++.+||+.||++||++.+|++.|+.+
T Consensus 234 ~~~~~---------~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~l~~~ 272 (273)
T cd05035 234 LKQPE---------DCLDELYDLMYSCWRADPKDRPTFTKLREVLENI 272 (273)
T ss_pred CCCCc---------CCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 11111 1123467788899999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-34 Score=303.81 Aligned_cols=250 Identities=28% Similarity=0.446 Sum_probs=193.0
Q ss_pred cCCCccceecccCCeeEEEEEec------CCcEEEEEEecccccccHHHHHHHHHHHhccCCCceeeEEeEEEeCCeeEE
Q 004521 440 DNFSINNKLGEGGFGPVYKGTLV------DGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLL 513 (747)
Q Consensus 440 ~~~~~~~~lg~G~fg~Vy~~~~~------~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~l 513 (747)
.+|.+.+.||+|+||.||+|+.. ++..+++|.+........+.+.+|+.++++++|+||+++++++......++
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 84 (291)
T cd05094 5 RDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKFYGVCGDGDPLIM 84 (291)
T ss_pred HHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCccHHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCceEE
Confidence 35778899999999999999753 245799999876555556789999999999999999999999999999999
Q ss_pred EEecCCCCChhhHhhhcC-------------CCCcCChhHHHHHHHHHHHHHHHhhhcCCCceEecccCcCcEEEcCCCC
Q 004521 514 IYEFMPNKSLDSFIFDQT-------------RRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMN 580 (747)
Q Consensus 514 V~E~~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NIll~~~~~ 580 (747)
||||+++++|.+++.... ....+++..++.++.||+.||+|||+.+ |+||||||+||+++.++.
T Consensus 85 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---i~H~dlkp~Nil~~~~~~ 161 (291)
T cd05094 85 VFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQH---FVHRDLATRNCLVGANLL 161 (291)
T ss_pred EEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccCcceEEEccCCc
Confidence 999999999999996532 1234889999999999999999999988 999999999999999999
Q ss_pred ceEecccCccccCCCCCccccc-------eeeec--cCCCCCccccchhHHHHHHHHHh-CCCCCCCCCCcchhhhhHhH
Q 004521 581 PKISDFGLVRTFGGDETEGNTN-------RVVGT--YDGQFSIKSDVFSFGILLLEIVS-GKKNRGFYRSDTKVNLIGHL 650 (747)
Q Consensus 581 ~kl~DFGla~~~~~~~~~~~~~-------~~~~~--~~~~~s~ksDVwS~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~ 650 (747)
+||+|||+++............ ...+. ....++.++|||||||++|||++ |+.|+...... ..+..
T Consensus 162 ~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~---~~~~~- 237 (291)
T cd05094 162 VKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNT---EVIEC- 237 (291)
T ss_pred EEECCCCcccccCCCceeecCCCCCcceeecChHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHH---HHHHH-
Confidence 9999999997654322111000 00011 14567889999999999999999 89886433221 12211
Q ss_pred HhcCCcccccchhhhccCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhcCCC
Q 004521 651 WDEGIPLRLIDACIQDSCNLADVIRCIHIGLLCVQQHPEDRPCMPSVILMLGSEI 705 (747)
Q Consensus 651 ~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dP~~RPt~~~v~~~L~~~~ 705 (747)
...+....... . ....+.+++.+||+.+|++||++.+|+++|+.+.
T Consensus 238 ~~~~~~~~~~~-----~----~~~~~~~li~~~l~~~P~~Rpt~~~v~~~l~~~~ 283 (291)
T cd05094 238 ITQGRVLERPR-----V----CPKEVYDIMLGCWQREPQQRLNIKEIYKILHALG 283 (291)
T ss_pred HhCCCCCCCCc-----c----CCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHH
Confidence 22222221111 1 1234667888999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-34 Score=301.87 Aligned_cols=255 Identities=23% Similarity=0.384 Sum_probs=187.3
Q ss_pred cCCCccceecccCCeeEEEEEec-----------------CCcEEEEEEeccc-ccccHHHHHHHHHHHhccCCCceeeE
Q 004521 440 DNFSINNKLGEGGFGPVYKGTLV-----------------DGQEIAVKRLSKI-SEQGLKELKNEVILFSKLQHRNLVKL 501 (747)
Q Consensus 440 ~~~~~~~~lg~G~fg~Vy~~~~~-----------------~g~~vavK~l~~~-~~~~~~~~~~E~~~l~~l~H~niv~l 501 (747)
++|++.++||+|+||.||++... +...+|+|.++.. .......|.+|+.++++++|+||+++
T Consensus 5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~ 84 (296)
T cd05095 5 KRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKIMSRLKDPNIIRL 84 (296)
T ss_pred hhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceE
Confidence 56899999999999999998532 2346899998753 33345689999999999999999999
Q ss_pred EeEEEeCCeeEEEEecCCCCChhhHhhhcCC--------CCcCChhHHHHHHHHHHHHHHHhhhcCCCceEecccCcCcE
Q 004521 502 LGCCIQGEEKLLIYEFMPNKSLDSFIFDQTR--------RTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNV 573 (747)
Q Consensus 502 ~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~--------~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NI 573 (747)
++++...+..++||||+++++|.+++..... ...+++..+..++.|++.||+|||+.+ ++||||||+||
T Consensus 85 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~---i~H~dlkp~Ni 161 (296)
T cd05095 85 LAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSLN---FVHRDLATRNC 161 (296)
T ss_pred EEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHCC---eecccCChheE
Confidence 9999999999999999999999999865321 124778889999999999999999988 99999999999
Q ss_pred EEcCCCCceEecccCccccCCCCCccccc-------eeee--ccCCCCCccccchhHHHHHHHHHh--CCCCCCCCCCcc
Q 004521 574 LLDQDMNPKISDFGLVRTFGGDETEGNTN-------RVVG--TYDGQFSIKSDVFSFGILLLEIVS--GKKNRGFYRSDT 642 (747)
Q Consensus 574 ll~~~~~~kl~DFGla~~~~~~~~~~~~~-------~~~~--~~~~~~s~ksDVwS~Gvvl~ellt--g~~p~~~~~~~~ 642 (747)
|++.++.+||+|||+++.+.......... .... ...+.++.++|||||||++|||++ |..|+.......
T Consensus 162 li~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~DiwSlG~~l~el~~~~~~~p~~~~~~~~ 241 (296)
T cd05095 162 LVGKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQLSDEQ 241 (296)
T ss_pred EEcCCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcCCccchhhhhHHHHHHHHHHHhCCCCCccccChHH
Confidence 99999999999999998653322111000 0000 124678899999999999999998 566654322211
Q ss_pred hhhhhHhHHhcCCcccccchhhhccCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhcC
Q 004521 643 KVNLIGHLWDEGIPLRLIDACIQDSCNLADVIRCIHIGLLCVQQHPEDRPCMPSVILMLGS 703 (747)
Q Consensus 643 ~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dP~~RPt~~~v~~~L~~ 703 (747)
................... . ... ....+.+++.+||+.||++||+|.+|++.|+.
T Consensus 242 ~~~~~~~~~~~~~~~~~~~-~-~~~----~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~ 296 (296)
T cd05095 242 VIENTGEFFRDQGRQVYLP-K-PAL----CPDSLYKLMLSCWRRNAKERPSFQEIHATLLE 296 (296)
T ss_pred HHHHHHHHHhhccccccCC-C-CCC----CCHHHHHHHHHHcCCCcccCCCHHHHHHHHhC
Confidence 1111111111110000000 0 011 11346678889999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-34 Score=300.18 Aligned_cols=247 Identities=26% Similarity=0.423 Sum_probs=185.5
Q ss_pred cCCCccceecccCCeeEEEEEecC-Cc----EEEEEEecccc-cccHHHHHHHHHHHhccCCCceeeEEeEEEeCCeeEE
Q 004521 440 DNFSINNKLGEGGFGPVYKGTLVD-GQ----EIAVKRLSKIS-EQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLL 513 (747)
Q Consensus 440 ~~~~~~~~lg~G~fg~Vy~~~~~~-g~----~vavK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~l 513 (747)
++|++.+.||+|+||.||+|+... ++ .+++|.+.... .....++..|+.+++++.||||+++++++. ....++
T Consensus 7 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~-~~~~~~ 85 (279)
T cd05111 7 TELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRLLGICP-GASLQL 85 (279)
T ss_pred hhceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccccchHHHHHHHHHHHHHhcCCCCCcceEEEEEC-CCccEE
Confidence 467788999999999999998743 44 47778775422 234567888899999999999999999875 455789
Q ss_pred EEecCCCCChhhHhhhcCCCCcCChhHHHHHHHHHHHHHHHhhhcCCCceEecccCcCcEEEcCCCCceEecccCccccC
Q 004521 514 IYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFG 593 (747)
Q Consensus 514 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NIll~~~~~~kl~DFGla~~~~ 593 (747)
|+||+++|+|.+++... ...+++..+..++.||+.||.|||+.+ ++||||||+|||+++++.+||+|||+++...
T Consensus 86 i~e~~~~gsL~~~l~~~--~~~~~~~~~~~i~~qi~~~l~~lH~~~---iiH~dlkp~nili~~~~~~kl~Dfg~~~~~~ 160 (279)
T cd05111 86 VTQLSPLGSLLDHVRQH--RDSLDPQRLLNWCVQIAKGMYYLEEHR---MVHRNLAARNILLKSDSIVQIADFGVADLLY 160 (279)
T ss_pred EEEeCCCCcHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHHHCC---EeccccCcceEEEcCCCcEEEcCCccceecc
Confidence 99999999999999653 345899999999999999999999988 9999999999999999999999999998764
Q ss_pred CCCCccccceeeec---------cCCCCCccccchhHHHHHHHHHh-CCCCCCCCCCcchhhhhHhHHhcCCcccccchh
Q 004521 594 GDETEGNTNRVVGT---------YDGQFSIKSDVFSFGILLLEIVS-GKKNRGFYRSDTKVNLIGHLWDEGIPLRLIDAC 663 (747)
Q Consensus 594 ~~~~~~~~~~~~~~---------~~~~~s~ksDVwS~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 663 (747)
............++ ..+.++.++|||||||++|||++ |+.|+...... .+......+.......
T Consensus 161 ~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~----~~~~~~~~~~~~~~~~-- 234 (279)
T cd05111 161 PDDKKYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPH----EVPDLLEKGERLAQPQ-- 234 (279)
T ss_pred CCCcccccCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCCCCCHH----HHHHHHHCCCcCCCCC--
Confidence 33221111111111 14678899999999999999998 88886432211 1122222222211111
Q ss_pred hhccCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhcCCC
Q 004521 664 IQDSCNLADVIRCIHIGLLCVQQHPEDRPCMPSVILMLGSEI 705 (747)
Q Consensus 664 l~~~~~~~~~~~~~~l~~~Cl~~dP~~RPt~~~v~~~L~~~~ 705 (747)
.+ ...+.+++.+||..+|++||++.++++.|....
T Consensus 235 ---~~----~~~~~~li~~c~~~~p~~Rps~~el~~~l~~~~ 269 (279)
T cd05111 235 ---IC----TIDVYMVMVKCWMIDENVRPTFKELANEFTRMA 269 (279)
T ss_pred ---CC----CHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHH
Confidence 11 123566788999999999999999999997744
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-34 Score=301.68 Aligned_cols=250 Identities=29% Similarity=0.488 Sum_probs=193.0
Q ss_pred cCCCccceecccCCeeEEEEEec------CCcEEEEEEecccccccHHHHHHHHHHHhccCCCceeeEEeEEEeCCeeEE
Q 004521 440 DNFSINNKLGEGGFGPVYKGTLV------DGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLL 513 (747)
Q Consensus 440 ~~~~~~~~lg~G~fg~Vy~~~~~------~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~l 513 (747)
++|.+.+.||+|+||.||++... ++..+|+|.+........+.+.+|+.++++++||||+++++++...+..++
T Consensus 5 ~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 84 (288)
T cd05093 5 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIM 84 (288)
T ss_pred HHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEE
Confidence 47888999999999999999852 245699999977555667789999999999999999999999999999999
Q ss_pred EEecCCCCChhhHhhhcC----------CCCcCChhHHHHHHHHHHHHHHHhhhcCCCceEecccCcCcEEEcCCCCceE
Q 004521 514 IYEFMPNKSLDSFIFDQT----------RRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKI 583 (747)
Q Consensus 514 V~E~~~~gsL~~~l~~~~----------~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NIll~~~~~~kl 583 (747)
||||+++++|.+++.... ....+++..++.++.|++.||+|||+.+ ++||||||+||++++++.+||
T Consensus 85 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~~---i~H~dlkp~Nili~~~~~~kl 161 (288)
T cd05093 85 VFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQH---FVHRDLATRNCLVGENLLVKI 161 (288)
T ss_pred EEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccCcceEEEccCCcEEe
Confidence 999999999999986532 1234899999999999999999999988 999999999999999999999
Q ss_pred ecccCccccCCCCCccccc-------eeeec--cCCCCCccccchhHHHHHHHHHh-CCCCCCCCCCcchhhhhHhHHhc
Q 004521 584 SDFGLVRTFGGDETEGNTN-------RVVGT--YDGQFSIKSDVFSFGILLLEIVS-GKKNRGFYRSDTKVNLIGHLWDE 653 (747)
Q Consensus 584 ~DFGla~~~~~~~~~~~~~-------~~~~~--~~~~~s~ksDVwS~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~ 653 (747)
+|||+++............ ...+. ....++.++|||||||++|||++ |..|+..... ...+... ..
T Consensus 162 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t~g~~p~~~~~~---~~~~~~i-~~ 237 (288)
T cd05093 162 GDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSN---NEVIECI-TQ 237 (288)
T ss_pred ccCCccccccCCceeecCCCCCccccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCH---HHHHHHH-Hc
Confidence 9999998654332211110 00000 13567889999999999999999 8888643221 1122221 22
Q ss_pred CCcccccchhhhccCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhcCCC
Q 004521 654 GIPLRLIDACIQDSCNLADVIRCIHIGLLCVQQHPEDRPCMPSVILMLGSEI 705 (747)
Q Consensus 654 ~~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dP~~RPt~~~v~~~L~~~~ 705 (747)
+...... ...+ ..+.+++.+||+.+|.+||++.+|++.|+...
T Consensus 238 ~~~~~~~-----~~~~----~~l~~li~~~l~~~p~~Rpt~~~v~~~l~~~~ 280 (288)
T cd05093 238 GRVLQRP-----RTCP----KEVYDLMLGCWQREPHMRLNIKEIHSLLQNLA 280 (288)
T ss_pred CCcCCCC-----CCCC----HHHHHHHHHHccCChhhCCCHHHHHHHHHHHH
Confidence 2211111 1111 23677888999999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-34 Score=312.60 Aligned_cols=241 Identities=24% Similarity=0.329 Sum_probs=178.9
Q ss_pred cCCCccceecccCCeeEEEEEec-CCcEEEEEEeccc-ccccHHHHHHHHHHHhccCCCceeeEEeEEEeCCeeEEEEec
Q 004521 440 DNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKI-SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEF 517 (747)
Q Consensus 440 ~~~~~~~~lg~G~fg~Vy~~~~~-~g~~vavK~l~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~ 517 (747)
++|+..++||+|+||.||+|+.. +++.||||++... .....+.+.+|+++++.++|+||+++++++...+..++||||
T Consensus 74 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 153 (353)
T PLN00034 74 SELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQVLLEF 153 (353)
T ss_pred HHHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCCcHHHHHHHHHHHHHHHhCCCCCcceeeeEeccCCeEEEEEec
Confidence 35666789999999999999975 4899999998653 233456789999999999999999999999999999999999
Q ss_pred CCCCChhhHhhhcCCCCcCChhHHHHHHHHHHHHHHHhhhcCCCceEecccCcCcEEEcCCCCceEecccCccccCCCCC
Q 004521 518 MPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDET 597 (747)
Q Consensus 518 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~ 597 (747)
+++++|.... ...+..+..++.||+.||+|||+.+ |+||||||+|||+++++.+||+|||+++.+.....
T Consensus 154 ~~~~~L~~~~-------~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~~~~~ 223 (353)
T PLN00034 154 MDGGSLEGTH-------IADEQFLADVARQILSGIAYLHRRH---IVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMD 223 (353)
T ss_pred CCCCcccccc-------cCCHHHHHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEcCCCCEEEcccccceecccccc
Confidence 9999986432 2456778899999999999999988 99999999999999999999999999986543211
Q ss_pred c-----cccceeeec-------cCCCCCccccchhHHHHHHHHHhCCCCCCCCCCcchhhhhHhHHhcCCcccccchhhh
Q 004521 598 E-----GNTNRVVGT-------YDGQFSIKSDVFSFGILLLEIVSGKKNRGFYRSDTKVNLIGHLWDEGIPLRLIDACIQ 665 (747)
Q Consensus 598 ~-----~~~~~~~~~-------~~~~~s~ksDVwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 665 (747)
. ......... .....+.++|||||||+||||++|+.||................ ....... .
T Consensus 224 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~-~~~~~~~-----~ 297 (353)
T PLN00034 224 PCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGDWASLMCAIC-MSQPPEA-----P 297 (353)
T ss_pred cccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHHh-ccCCCCC-----C
Confidence 1 000000000 01233568999999999999999999986322221111111111 1111110 0
Q ss_pred ccCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 004521 666 DSCNLADVIRCIHIGLLCVQQHPEDRPCMPSVILM 700 (747)
Q Consensus 666 ~~~~~~~~~~~~~l~~~Cl~~dP~~RPt~~~v~~~ 700 (747)
. .....+.+++.+||+.||++||++.||++.
T Consensus 298 ~----~~~~~l~~li~~~l~~~P~~Rpt~~ell~h 328 (353)
T PLN00034 298 A----TASREFRHFISCCLQREPAKRWSAMQLLQH 328 (353)
T ss_pred C----ccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 1 112236677889999999999999999874
|
|
| >KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-34 Score=298.82 Aligned_cols=255 Identities=28% Similarity=0.417 Sum_probs=196.5
Q ss_pred cCCCccceecccCCeeEEEEEecCCcEEEEEEecccccccHHHHHHHHHHHhc--cCCCceeeEEeEEEeCC----eeEE
Q 004521 440 DNFSINNKLGEGGFGPVYKGTLVDGQEIAVKRLSKISEQGLKELKNEVILFSK--LQHRNLVKLLGCCIQGE----EKLL 513 (747)
Q Consensus 440 ~~~~~~~~lg~G~fg~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~--l~H~niv~l~g~~~~~~----~~~l 513 (747)
+...+.++||+|+||.||||.+. ++.||||++. .+..+.|++|-+|... ++|+||++|+++-.... +.+|
T Consensus 210 ~pl~l~eli~~Grfg~V~KaqL~-~~~VAVKifp---~~~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~eywL 285 (534)
T KOG3653|consen 210 DPLQLLELIGRGRFGCVWKAQLD-NRLVAVKIFP---EQEKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRMEYWL 285 (534)
T ss_pred CchhhHHHhhcCccceeehhhcc-CceeEEEecC---HHHHHHHHhHHHHHhccCccchhHHHhhchhccCCccccceeE
Confidence 34555789999999999999995 5999999995 4566789999998875 58999999999987665 7899
Q ss_pred EEecCCCCChhhHhhhcCCCCcCChhHHHHHHHHHHHHHHHhhhc------CCCceEecccCcCcEEEcCCCCceEeccc
Q 004521 514 IYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQD------SRLRIIHRDLKASNVLLDQDMNPKISDFG 587 (747)
Q Consensus 514 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~------~~~~iiHrDlkp~NIll~~~~~~kl~DFG 587 (747)
|+||.++|+|.+||.. ..++|....+|+..+++||+|||+. .+++|+|||||++||||.+++++.|+|||
T Consensus 286 Vt~fh~kGsL~dyL~~----ntisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccIaDFG 361 (534)
T KOG3653|consen 286 VTEFHPKGSLCDYLKA----NTISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCIADFG 361 (534)
T ss_pred EeeeccCCcHHHHHHh----ccccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEeeccc
Confidence 9999999999999954 4589999999999999999999975 35789999999999999999999999999
Q ss_pred CccccCCCCCccccceeeecc--------CCCCC-------ccccchhHHHHHHHHHhCCCCCCCCC-------------
Q 004521 588 LVRTFGGDETEGNTNRVVGTY--------DGQFS-------IKSDVFSFGILLLEIVSGKKNRGFYR------------- 639 (747)
Q Consensus 588 la~~~~~~~~~~~~~~~~~~~--------~~~~s-------~ksDVwS~Gvvl~elltg~~p~~~~~------------- 639 (747)
||..+............+||. ++..+ .+.||||+|.|||||++...-.....
T Consensus 362 LAl~~~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp~Yqlpfe~evG 441 (534)
T KOG3653|consen 362 LALRLEPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPVPEYQLPFEAEVG 441 (534)
T ss_pred eeEEecCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCCCcccCchhHHhc
Confidence 999887665555444455552 22222 36899999999999999765431100
Q ss_pred -CcchhhhhHhHHhcCCcccccchhhhccCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhcCCCC
Q 004521 640 -SDTKVNLIGHLWDEGIPLRLIDACIQDSCNLADVIRCIHIGLLCVQQHPEDRPCMPSVILMLGSEIL 706 (747)
Q Consensus 640 -~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dP~~RPt~~~v~~~L~~~~~ 706 (747)
.....++...+..+..++.+.+..... ..+.-+.+.+..||..||+.|.|+.=|.+.+..+..
T Consensus 442 ~hPt~e~mq~~VV~kK~RP~~p~~W~~h----~~~~~l~et~EeCWDhDaeARLTA~Cv~eR~~~l~~ 505 (534)
T KOG3653|consen 442 NHPTLEEMQELVVRKKQRPKIPDAWRKH----AGMAVLCETIEECWDHDAEARLTAGCVEERMAELMM 505 (534)
T ss_pred CCCCHHHHHHHHHhhccCCCChhhhhcC----ccHHHHHHHHHHHcCCchhhhhhhHHHHHHHHHHhc
Confidence 001112222334455556666655543 223445667779999999999999999888877643
|
|
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-34 Score=301.49 Aligned_cols=253 Identities=26% Similarity=0.396 Sum_probs=189.5
Q ss_pred hcCCCccceecccCCeeEEEEEecC-----------------CcEEEEEEeccc-ccccHHHHHHHHHHHhccCCCceee
Q 004521 439 TDNFSINNKLGEGGFGPVYKGTLVD-----------------GQEIAVKRLSKI-SEQGLKELKNEVILFSKLQHRNLVK 500 (747)
Q Consensus 439 ~~~~~~~~~lg~G~fg~Vy~~~~~~-----------------g~~vavK~l~~~-~~~~~~~~~~E~~~l~~l~H~niv~ 500 (747)
.++|++.++||+|+||.||+|+..+ +..||+|.+... .....+++.+|++++++++||||++
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~ 83 (296)
T cd05051 4 RQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKILSRLSDPNIAR 83 (296)
T ss_pred hhhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCHHHHHHHHHHHHHHHhcCCCCEeE
Confidence 3578899999999999999998643 246899998753 2345678999999999999999999
Q ss_pred EEeEEEeCCeeEEEEecCCCCChhhHhhhcCC--------CCcCChhHHHHHHHHHHHHHHHhhhcCCCceEecccCcCc
Q 004521 501 LLGCCIQGEEKLLIYEFMPNKSLDSFIFDQTR--------RTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASN 572 (747)
Q Consensus 501 l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~--------~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~N 572 (747)
+++++..++..++||||+++++|.+++..... ...+++..++.++.|++.||+|||+.+ |+||||||+|
T Consensus 84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~---i~H~dlkp~N 160 (296)
T cd05051 84 LLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLN---FVHRDLATRN 160 (296)
T ss_pred EEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHcC---ccccccchhc
Confidence 99999999999999999999999999965431 225889999999999999999999988 9999999999
Q ss_pred EEEcCCCCceEecccCccccCCCCCccccce-------eeec--cCCCCCccccchhHHHHHHHHHh--CCCCCCCCCCc
Q 004521 573 VLLDQDMNPKISDFGLVRTFGGDETEGNTNR-------VVGT--YDGQFSIKSDVFSFGILLLEIVS--GKKNRGFYRSD 641 (747)
Q Consensus 573 Ill~~~~~~kl~DFGla~~~~~~~~~~~~~~-------~~~~--~~~~~s~ksDVwS~Gvvl~ellt--g~~p~~~~~~~ 641 (747)
|+++.++.+||+|||+++.+........... .... ....++.++|||||||++|||++ +..|+....
T Consensus 161 ili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~~~~-- 238 (296)
T cd05051 161 CLVGKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPYEHLT-- 238 (296)
T ss_pred eeecCCCceEEccccceeecccCcceeecCcCCCCceecCHHHhhcCCCCccchhhhhHHHHHHHHhcCCCCCCCCcC--
Confidence 9999999999999999986543321111110 1111 13578899999999999999998 556653222
Q ss_pred chhhhhHhHH---hcCCcccccchhhhccCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhcC
Q 004521 642 TKVNLIGHLW---DEGIPLRLIDACIQDSCNLADVIRCIHIGLLCVQQHPEDRPCMPSVILMLGS 703 (747)
Q Consensus 642 ~~~~~~~~~~---~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dP~~RPt~~~v~~~L~~ 703 (747)
....+.... ........... .......+.+++.+||+.||.+||++.+|++.|+.
T Consensus 239 -~~~~~~~~~~~~~~~~~~~~~~~------~~~~~~~l~~li~~cl~~~p~~Rpt~~el~~~L~~ 296 (296)
T cd05051 239 -DQQVIENAGHFFRDDGRQIYLPR------PPNCPKDIYELMLECWRRDEEDRPTFREIHLFLQR 296 (296)
T ss_pred -hHHHHHHHHhccccccccccCCC------ccCCCHHHHHHHHHHhccChhcCCCHHHHHHHhcC
Confidence 111222111 11111111100 00111357788999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-34 Score=296.20 Aligned_cols=243 Identities=28% Similarity=0.438 Sum_probs=188.3
Q ss_pred CCCccceecccCCeeEEEEEecCCcEEEEEEecccccccHHHHHHHHHHHhccCCCceeeEEeEEEeCCeeEEEEecCCC
Q 004521 441 NFSINNKLGEGGFGPVYKGTLVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMPN 520 (747)
Q Consensus 441 ~~~~~~~lg~G~fg~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~ 520 (747)
+|++.+.||+|+||.||+|...++..+|+|.+.+. ......|.+|+.++++++|+||+++++++...+..++||||+++
T Consensus 5 ~~~~~~~lg~G~~~~v~~~~~~~~~~~~iK~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~ 83 (256)
T cd05059 5 ELTFLKELGSGQFGVVHLGKWRGKIDVAIKMIREG-AMSEDDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIVTEYMAN 83 (256)
T ss_pred HcchhhhhccCCCceEEEeEecCCccEEEEEeccC-CCCHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCceEEEEecCCC
Confidence 57788999999999999999877778999998642 23446788999999999999999999999999999999999999
Q ss_pred CChhhHhhhcCCCCcCChhHHHHHHHHHHHHHHHhhhcCCCceEecccCcCcEEEcCCCCceEecccCccccCCCCCccc
Q 004521 521 KSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGN 600 (747)
Q Consensus 521 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~ 600 (747)
++|.+++.... ..+++..++.++.|++.||+|||+.+ ++||||||+||++++++.+||+|||+++..........
T Consensus 84 ~~L~~~l~~~~--~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~~~~~~~ 158 (256)
T cd05059 84 GCLLNYLRERK--GKLGTEWLLDMCSDVCEAMEYLESNG---FIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQYTSS 158 (256)
T ss_pred CCHHHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHHHCC---cccccccHhhEEECCCCcEEECCcccceeccccccccc
Confidence 99999986533 35889999999999999999999988 99999999999999999999999999986543221111
Q ss_pred cc------eeeec--cCCCCCccccchhHHHHHHHHHh-CCCCCCCCCCcchhhhhHhHHhcCCcccccchhhhccCCHH
Q 004521 601 TN------RVVGT--YDGQFSIKSDVFSFGILLLEIVS-GKKNRGFYRSDTKVNLIGHLWDEGIPLRLIDACIQDSCNLA 671 (747)
Q Consensus 601 ~~------~~~~~--~~~~~s~ksDVwS~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~ 671 (747)
.. ..... ....++.++||||||+++|||++ |+.|+...... ...... ..+...... ..
T Consensus 159 ~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~---~~~~~~-~~~~~~~~~-----~~---- 225 (256)
T cd05059 159 QGTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNS---EVVESV-SAGYRLYRP-----KL---- 225 (256)
T ss_pred CCCCCCccccCHHHhccCCCCchhhHHHHHHHHHHHhccCCCCCCCCCHH---HHHHHH-HcCCcCCCC-----CC----
Confidence 00 01111 14568889999999999999999 78886533221 112111 122111110 11
Q ss_pred HHHHHHHHHHhccCCCCCCCCCHHHHHHHhc
Q 004521 672 DVIRCIHIGLLCVQQHPEDRPCMPSVILMLG 702 (747)
Q Consensus 672 ~~~~~~~l~~~Cl~~dP~~RPt~~~v~~~L~ 702 (747)
....+.+++.+||+.+|++||+|.+|+++|.
T Consensus 226 ~~~~~~~li~~cl~~~p~~Rpt~~~~l~~l~ 256 (256)
T cd05059 226 APTEVYTIMYSCWHEKPEDRPAFKKLLSQLT 256 (256)
T ss_pred CCHHHHHHHHHHhcCChhhCcCHHHHHHHhC
Confidence 1224667888999999999999999999873
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-35 Score=313.78 Aligned_cols=240 Identities=28% Similarity=0.433 Sum_probs=190.6
Q ss_pred CCccceecccCCeeEEEEEecC--Cc--EEEEEEeccccc-ccHHHHHHHHHHHhccCCCceeeEEeEEEeCCeeEEEEe
Q 004521 442 FSINNKLGEGGFGPVYKGTLVD--GQ--EIAVKRLSKISE-QGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYE 516 (747)
Q Consensus 442 ~~~~~~lg~G~fg~Vy~~~~~~--g~--~vavK~l~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E 516 (747)
....++||+|.||.|++|.+.. |+ .||||.++.... .....|++|+.+|.+|+|+|+++|+|+..+ ....+|+|
T Consensus 112 i~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~~mddflrEas~M~~L~H~hliRLyGvVl~-qp~mMV~E 190 (1039)
T KOG0199|consen 112 IKLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNAIMDDFLREASHMLKLQHPHLIRLYGVVLD-QPAMMVFE 190 (1039)
T ss_pred HHHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccchhHHHHHHHHHHHHhccCcceeEEeeeecc-chhhHHhh
Confidence 3446899999999999999854 44 689999986433 367899999999999999999999999987 78899999
Q ss_pred cCCCCChhhHhhhcCCCCcCChhHHHHHHHHHHHHHHHhhhcCCCceEecccCcCcEEEcCCCCceEecccCccccCCCC
Q 004521 517 FMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDE 596 (747)
Q Consensus 517 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~ 596 (747)
+++.|+|.+.|++ ..+..|.......++.|||.||.||.++. +|||||.++|+||-..-.+||+||||.|.++..+
T Consensus 191 LaplGSLldrLrk-a~~~~llv~~Lcdya~QiA~aM~YLeskr---lvHRDLAARNlllasprtVKI~DFGLmRaLg~ne 266 (1039)
T KOG0199|consen 191 LAPLGSLLDRLRK-AKKAILLVSRLCDYAMQIAKAMQYLESKR---LVHRDLAARNLLLASPRTVKICDFGLMRALGENE 266 (1039)
T ss_pred hcccchHHHHHhh-ccccceeHHHHHHHHHHHHHHHHHHhhhh---hhhhhhhhhhheecccceeeeecccceeccCCCC
Confidence 9999999999987 45567888899999999999999999988 9999999999999999999999999999987665
Q ss_pred Cccccce---eeec-------cCCCCCccccchhHHHHHHHHHh-CCCCCCCCCCcchhhhhHhHHhcCCcccccchhhh
Q 004521 597 TEGNTNR---VVGT-------YDGQFSIKSDVFSFGILLLEIVS-GKKNRGFYRSDTKVNLIGHLWDEGIPLRLIDACIQ 665 (747)
Q Consensus 597 ~~~~~~~---~~~~-------~~~~~s~ksDVwS~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 665 (747)
....... +.-+ ....|+.++|||+|||+||||+| |+.||.... ...++..+ +++...
T Consensus 267 d~Yvm~p~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMFtyGEePW~G~~---g~qIL~~i-D~~erL-------- 334 (1039)
T KOG0199|consen 267 DMYVMAPQRKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMFTYGEEPWVGCR---GIQILKNI-DAGERL-------- 334 (1039)
T ss_pred cceEecCCCcCcccccCHhHhccccccccchhhhhhhhHHhhhccCCCCCCCCC---HHHHHHhc-cccccC--------
Confidence 4432111 1111 15789999999999999999999 667754322 22222222 222211
Q ss_pred ccCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 004521 666 DSCNLADVIRCIHIGLLCVQQHPEDRPCMPSVIL 699 (747)
Q Consensus 666 ~~~~~~~~~~~~~l~~~Cl~~dP~~RPt~~~v~~ 699 (747)
.......+++++++..||..+|.+||||..|++
T Consensus 335 -pRPk~csedIY~imk~cWah~paDRptFsair~ 367 (1039)
T KOG0199|consen 335 -PRPKYCSEDIYQIMKNCWAHNPADRPTFSAIRE 367 (1039)
T ss_pred -CCCCCChHHHHHHHHHhccCCccccccHHHHHH
Confidence 112233456888999999999999999999973
|
|
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-34 Score=301.90 Aligned_cols=253 Identities=19% Similarity=0.256 Sum_probs=184.6
Q ss_pred cCCCccceecccCCeeEEEEEecC-CcEEEEEEeccc--ccccHHHHHHHHHHHhccCCCceeeEEeEEEeCCeeEEEEe
Q 004521 440 DNFSINNKLGEGGFGPVYKGTLVD-GQEIAVKRLSKI--SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYE 516 (747)
Q Consensus 440 ~~~~~~~~lg~G~fg~Vy~~~~~~-g~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E 516 (747)
++|++.+.||+|+||.||+++... ++.+|||+++.. .....+.+.+|+.++++++||||+++++++...+..++|||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (287)
T cd07848 1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVFE 80 (287)
T ss_pred CCceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhEecCCEEEEEEe
Confidence 468899999999999999999864 789999998753 23345678899999999999999999999999999999999
Q ss_pred cCCCCChhhHhhhcCCCCcCChhHHHHHHHHHHHHHHHhhhcCCCceEecccCcCcEEEcCCCCceEecccCccccCCCC
Q 004521 517 FMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDE 596 (747)
Q Consensus 517 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~ 596 (747)
|++++.|..+.. ....+++..+..++.||+.||.|||+.+ |+||||||+||+++.++.+||+|||+++.+....
T Consensus 81 ~~~~~~l~~~~~---~~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~ 154 (287)
T cd07848 81 YVEKNMLELLEE---MPNGVPPEKVRSYIYQLIKAIHWCHKND---IVHRDIKPENLLISHNDVLKLCDFGFARNLSEGS 154 (287)
T ss_pred cCCCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCcEEEeeccCcccccccc
Confidence 999887765542 2345888999999999999999999988 9999999999999999999999999998764322
Q ss_pred Cccccceeeec---------cCCCCCccccchhHHHHHHHHHhCCCCCCCCCCcchhhhhHhHH------------hcCC
Q 004521 597 TEGNTNRVVGT---------YDGQFSIKSDVFSFGILLLEIVSGKKNRGFYRSDTKVNLIGHLW------------DEGI 655 (747)
Q Consensus 597 ~~~~~~~~~~~---------~~~~~s~ksDVwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~------------~~~~ 655 (747)
..... ...++ .+..++.++|||||||++|||++|+.||...........+.... ....
T Consensus 155 ~~~~~-~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (287)
T cd07848 155 NANYT-EYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQMKLFYSNPR 233 (287)
T ss_pred ccccc-ccccccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCHHHHHhhhccch
Confidence 11100 01111 14568899999999999999999999976432211111111100 0000
Q ss_pred cccccchhhhccCCH------HHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 004521 656 PLRLIDACIQDSCNL------ADVIRCIHIGLLCVQQHPEDRPCMPSVIL 699 (747)
Q Consensus 656 ~~~~~d~~l~~~~~~------~~~~~~~~l~~~Cl~~dP~~RPt~~~v~~ 699 (747)
......+........ ..-..+.+++.+||+.||++|||+.++++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~ 283 (287)
T cd07848 234 FHGLRFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLN 283 (287)
T ss_pred hcccccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 000000000000000 01123678888999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-34 Score=303.12 Aligned_cols=254 Identities=23% Similarity=0.386 Sum_probs=185.8
Q ss_pred cCCCccceecccCCeeEEEEEecC---------------CcEEEEEEeccc-ccccHHHHHHHHHHHhccCCCceeeEEe
Q 004521 440 DNFSINNKLGEGGFGPVYKGTLVD---------------GQEIAVKRLSKI-SEQGLKELKNEVILFSKLQHRNLVKLLG 503 (747)
Q Consensus 440 ~~~~~~~~lg~G~fg~Vy~~~~~~---------------g~~vavK~l~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g 503 (747)
++|++.+.||+|+||.||+++..+ ...||+|.++.. .......|.+|++++++++|+||+++++
T Consensus 5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~ 84 (295)
T cd05097 5 QQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRLLG 84 (295)
T ss_pred HhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCcCeEEE
Confidence 578899999999999999987642 235899998753 3334567999999999999999999999
Q ss_pred EEEeCCeeEEEEecCCCCChhhHhhhcCC---------CCcCChhHHHHHHHHHHHHHHHhhhcCCCceEecccCcCcEE
Q 004521 504 CCIQGEEKLLIYEFMPNKSLDSFIFDQTR---------RTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVL 574 (747)
Q Consensus 504 ~~~~~~~~~lV~E~~~~gsL~~~l~~~~~---------~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NIl 574 (747)
++...+..++||||+++++|.+++..... ...+++..++.++.|++.||+|||+.+ ++||||||+||+
T Consensus 85 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---i~H~dlkp~Nil 161 (295)
T cd05097 85 VCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASLN---FVHRDLATRNCL 161 (295)
T ss_pred EEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhcC---eeccccChhhEE
Confidence 99999999999999999999999854321 123688899999999999999999988 999999999999
Q ss_pred EcCCCCceEecccCccccCCCCCcccccee-------ee--ccCCCCCccccchhHHHHHHHHHhC--CCCCCCCCCcch
Q 004521 575 LDQDMNPKISDFGLVRTFGGDETEGNTNRV-------VG--TYDGQFSIKSDVFSFGILLLEIVSG--KKNRGFYRSDTK 643 (747)
Q Consensus 575 l~~~~~~kl~DFGla~~~~~~~~~~~~~~~-------~~--~~~~~~s~ksDVwS~Gvvl~elltg--~~p~~~~~~~~~ 643 (747)
+++++.+||+|||+++.+............ .. ...+.++.++|||||||++|||+++ ..|+........
T Consensus 162 l~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~~l~el~~~~~~~p~~~~~~~~~ 241 (295)
T cd05097 162 VGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSLLSDEQV 241 (295)
T ss_pred EcCCCcEEecccccccccccCcceeccCcCcCceeecChhhhccCCcCchhhHHHHHHHHHHHHHcCCCCCCcccChHHH
Confidence 999999999999999765332211100000 00 0145688999999999999999984 455432222111
Q ss_pred hhhhHhHHhcCCcccccchhhhccCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhc
Q 004521 644 VNLIGHLWDEGIPLRLIDACIQDSCNLADVIRCIHIGLLCVQQHPEDRPCMPSVILMLG 702 (747)
Q Consensus 644 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dP~~RPt~~~v~~~L~ 702 (747)
.......+.......... ... .....+.+++.+||+.+|++||+|.+|+++|+
T Consensus 242 ~~~~~~~~~~~~~~~~~~--~~~----~~~~~l~~li~~~l~~~p~~RPs~~~i~~~l~ 294 (295)
T cd05097 242 IENTGEFFRNQGRQIYLS--QTP----LCPSPVFKLMMRCWSRDIKDRPTFNKIHHFLR 294 (295)
T ss_pred HHHHHHhhhhccccccCC--CCC----CCCHHHHHHHHHHcCCCchhCcCHHHHHHHHh
Confidence 111111111110000000 000 01235778889999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-34 Score=303.86 Aligned_cols=241 Identities=18% Similarity=0.207 Sum_probs=184.6
Q ss_pred cCCCccceecccCCeeEEEEEec-CCcEEEEEEeccc---ccccHHHHHHHHHHHhccCCCceeeEEeEEEeCCeeEEEE
Q 004521 440 DNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKI---SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIY 515 (747)
Q Consensus 440 ~~~~~~~~lg~G~fg~Vy~~~~~-~g~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 515 (747)
++|++.+.||+|+||.||+|... +++.||+|++... .....+.+.+|+.++++++||||+++++++.+....++||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 80 (291)
T cd05612 1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYMLM 80 (291)
T ss_pred CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCCeEEEEE
Confidence 46888999999999999999976 4889999998642 1234567889999999999999999999999999999999
Q ss_pred ecCCCCChhhHhhhcCCCCcCChhHHHHHHHHHHHHHHHhhhcCCCceEecccCcCcEEEcCCCCceEecccCccccCCC
Q 004521 516 EFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGD 595 (747)
Q Consensus 516 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NIll~~~~~~kl~DFGla~~~~~~ 595 (747)
||+++|+|.+++... ..+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++.+...
T Consensus 81 e~~~~~~L~~~~~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~ 154 (291)
T cd05612 81 EYVPGGELFSYLRNS---GRFSNSTGLFYASEIVCALEYLHSKE---IVYRDLKPENILLDKEGHIKLTDFGFAKKLRDR 154 (291)
T ss_pred eCCCCCCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHeEECCCCCEEEEecCcchhccCC
Confidence 999999999998643 35888999999999999999999988 999999999999999999999999999876432
Q ss_pred CCcc--ccceeeec--cCCCCCccccchhHHHHHHHHHhCCCCCCCCCCcchhhhhHhHHhcCCcccccchhhhccCCHH
Q 004521 596 ETEG--NTNRVVGT--YDGQFSIKSDVFSFGILLLEIVSGKKNRGFYRSDTKVNLIGHLWDEGIPLRLIDACIQDSCNLA 671 (747)
Q Consensus 596 ~~~~--~~~~~~~~--~~~~~s~ksDVwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~ 671 (747)
.... ........ ....++.++|||||||++|||++|+.|+.... ......... .+.. .+ ....
T Consensus 155 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~---~~~~~~~i~-~~~~-~~-----~~~~--- 221 (291)
T cd05612 155 TWTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDN---PFGIYEKIL-AGKL-EF-----PRHL--- 221 (291)
T ss_pred cccccCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC---HHHHHHHHH-hCCc-CC-----CccC---
Confidence 2110 00000000 14567899999999999999999999975322 112222211 1111 00 1111
Q ss_pred HHHHHHHHHHhccCCCCCCCCC-----HHHHHHH
Q 004521 672 DVIRCIHIGLLCVQQHPEDRPC-----MPSVILM 700 (747)
Q Consensus 672 ~~~~~~~l~~~Cl~~dP~~RPt-----~~~v~~~ 700 (747)
-..+.+++.+||+.||.+||+ +.++++.
T Consensus 222 -~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h 254 (291)
T cd05612 222 -DLYAKDLIKKLLVVDRTRRLGNMKNGADDVKNH 254 (291)
T ss_pred -CHHHHHHHHHHcCCCHHHccCCccCCHHHHhcC
Confidence 123556778999999999995 7777654
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-34 Score=296.51 Aligned_cols=247 Identities=26% Similarity=0.452 Sum_probs=183.5
Q ss_pred CCccceecccCCeeEEEEEecC-Cc--EEEEEEeccc--ccccHHHHHHHHHHHhccCCCceeeEEeEEEeC------Ce
Q 004521 442 FSINNKLGEGGFGPVYKGTLVD-GQ--EIAVKRLSKI--SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQG------EE 510 (747)
Q Consensus 442 ~~~~~~lg~G~fg~Vy~~~~~~-g~--~vavK~l~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~------~~ 510 (747)
|.+.+.||+|+||.||+|+..+ +. .+|+|.++.. .....+.+.+|+.+++.++|+||+++++++... ..
T Consensus 1 ~~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 80 (272)
T cd05075 1 LALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPS 80 (272)
T ss_pred CccccccCcccCceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCC
Confidence 3467899999999999999765 33 6899988652 334467889999999999999999999988543 24
Q ss_pred eEEEEecCCCCChhhHhhhcC---CCCcCChhHHHHHHHHHHHHHHHhhhcCCCceEecccCcCcEEEcCCCCceEeccc
Q 004521 511 KLLIYEFMPNKSLDSFIFDQT---RRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFG 587 (747)
Q Consensus 511 ~~lV~E~~~~gsL~~~l~~~~---~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NIll~~~~~~kl~DFG 587 (747)
.++||||+++|+|.+++.... ....+++..+..++.|++.||+|||+.+ |+||||||+|||+++++.+||+|||
T Consensus 81 ~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg 157 (272)
T cd05075 81 PVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSKS---FIHRDLAARNCMLNENMNVCVADFG 157 (272)
T ss_pred cEEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHCC---eeccccchhheEEcCCCCEEECCCC
Confidence 689999999999999874322 2345889999999999999999999988 9999999999999999999999999
Q ss_pred CccccCCCCCccc------c-ceeee--ccCCCCCccccchhHHHHHHHHHh-CCCCCCCCCCcchhhhhHhHHhcCCcc
Q 004521 588 LVRTFGGDETEGN------T-NRVVG--TYDGQFSIKSDVFSFGILLLEIVS-GKKNRGFYRSDTKVNLIGHLWDEGIPL 657 (747)
Q Consensus 588 la~~~~~~~~~~~------~-~~~~~--~~~~~~s~ksDVwS~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~ 657 (747)
+++.+........ . ..... .....++.++||||||+++|||++ |+.|+... ......... ..+...
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~---~~~~~~~~~-~~~~~~ 233 (272)
T cd05075 158 LSKKIYNGDYYRQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGV---ENSEIYDYL-RQGNRL 233 (272)
T ss_pred cccccCcccceecCCcccCCcccCCHHHccCCCcChHHHHHHHHHHHHHHHcCCCCCCCCC---CHHHHHHHH-HcCCCC
Confidence 9987643221100 0 00000 014567889999999999999999 77786432 122222222 222211
Q ss_pred cccchhhhccCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhcCC
Q 004521 658 RLIDACIQDSCNLADVIRCIHIGLLCVQQHPEDRPCMPSVILMLGSE 704 (747)
Q Consensus 658 ~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dP~~RPt~~~v~~~L~~~ 704 (747)
.... . ....+.+++.+||+.+|++|||+.+|++.|+..
T Consensus 234 ~~~~-----~----~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~~~ 271 (272)
T cd05075 234 KQPP-----D----CLDGLYSLMSSCWLLNPKDRPSFETLRCELEKA 271 (272)
T ss_pred CCCC-----C----CCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 1111 1 112356788899999999999999999999763
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-34 Score=294.61 Aligned_cols=239 Identities=26% Similarity=0.410 Sum_probs=183.2
Q ss_pred ceecccCCeeEEEEEec-CCcEEEEEEeccc-ccccHHHHHHHHHHHhccCCCceeeEEeEEEeCCeeEEEEecCCCCCh
Q 004521 446 NKLGEGGFGPVYKGTLV-DGQEIAVKRLSKI-SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMPNKSL 523 (747)
Q Consensus 446 ~~lg~G~fg~Vy~~~~~-~g~~vavK~l~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gsL 523 (747)
+.||+|+||.||+|+.. +++.+|+|.+... ..+....+.+|++++++++||||+++++++......++||||+++++|
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (252)
T cd05084 1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDF 80 (252)
T ss_pred CccCcccCccEEEEEEecCCceEEEEecCccCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEeeccCCcH
Confidence 46999999999999975 5889999987643 334456799999999999999999999999999999999999999999
Q ss_pred hhHhhhcCCCCcCChhHHHHHHHHHHHHHHHhhhcCCCceEecccCcCcEEEcCCCCceEecccCccccCCCCCcccc--
Q 004521 524 DSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNT-- 601 (747)
Q Consensus 524 ~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~-- 601 (747)
.+++... ...+++..++.++.|+++||.|||+.+ ++||||||+||+++.++.+||+|||+++...........
T Consensus 81 ~~~~~~~--~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~ 155 (252)
T cd05084 81 LTFLRTE--GPRLKVKELIQMVENAAAGMEYLESKH---CIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGGM 155 (252)
T ss_pred HHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccchheEEEcCCCcEEECccccCcccccccccccCCC
Confidence 9998542 335889999999999999999999988 999999999999999999999999998764322111000
Q ss_pred -----ceeeec--cCCCCCccccchhHHHHHHHHHh-CCCCCCCCCCcchhhhhHhHHhcCCcccccchhhhccCCHHHH
Q 004521 602 -----NRVVGT--YDGQFSIKSDVFSFGILLLEIVS-GKKNRGFYRSDTKVNLIGHLWDEGIPLRLIDACIQDSCNLADV 673 (747)
Q Consensus 602 -----~~~~~~--~~~~~s~ksDVwS~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~ 673 (747)
...... ..+.++.++||||||+++|||++ |..|+...... .... ........... . ...
T Consensus 156 ~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~~---~~~~-~~~~~~~~~~~-----~----~~~ 222 (252)
T cd05084 156 KQIPVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLSNQ---QTRE-AIEQGVRLPCP-----E----LCP 222 (252)
T ss_pred CCCceeecCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccCHH---HHHH-HHHcCCCCCCc-----c----cCC
Confidence 001111 14567889999999999999998 77776432211 1111 11111111111 1 112
Q ss_pred HHHHHHHHhccCCCCCCCCCHHHHHHHhc
Q 004521 674 IRCIHIGLLCVQQHPEDRPCMPSVILMLG 702 (747)
Q Consensus 674 ~~~~~l~~~Cl~~dP~~RPt~~~v~~~L~ 702 (747)
..+.+++.+||+.+|++||++.+|+++|+
T Consensus 223 ~~~~~li~~~l~~~p~~Rps~~~~~~~l~ 251 (252)
T cd05084 223 DAVYRLMERCWEYDPGQRPSFSTVHQELQ 251 (252)
T ss_pred HHHHHHHHHHcCCChhhCcCHHHHHHHHh
Confidence 34667888999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-34 Score=295.22 Aligned_cols=252 Identities=22% Similarity=0.337 Sum_probs=191.4
Q ss_pred cCCCccceecccCCeeEEEEEec-CCcEEEEEEeccc---ccccHHHHHHHHHHHhccCCCceeeEEeEEEeCCeeEEEE
Q 004521 440 DNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKI---SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIY 515 (747)
Q Consensus 440 ~~~~~~~~lg~G~fg~Vy~~~~~-~g~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 515 (747)
++|++.+.||+|+||.||+|+.. +++.||||.+... .......+.+|+.+++.++||||+++++++...+..++|+
T Consensus 2 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 81 (267)
T cd08228 2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNIVL 81 (267)
T ss_pred cceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECCeEEEEE
Confidence 47889999999999999999975 5899999987642 2333457889999999999999999999999999999999
Q ss_pred ecCCCCChhhHhhhcC-CCCcCChhHHHHHHHHHHHHHHHhhhcCCCceEecccCcCcEEEcCCCCceEecccCccccCC
Q 004521 516 EFMPNKSLDSFIFDQT-RRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGG 594 (747)
Q Consensus 516 E~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NIll~~~~~~kl~DFGla~~~~~ 594 (747)
||+++++|.+++.... ....++...+..++.|+++||.|||+.+ ++|+||||+||+++.++.++|+|||++..+..
T Consensus 82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~~~nil~~~~~~~~l~d~g~~~~~~~ 158 (267)
T cd08228 82 ELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSRR---VMHRDIKPANVFITATGVVKLGDLGLGRFFSS 158 (267)
T ss_pred EecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhCC---eeCCCCCHHHEEEcCCCCEEECccccceeccc
Confidence 9999999999886432 2345788999999999999999999988 99999999999999999999999999886543
Q ss_pred CCCcc-----ccceeeec--cCCCCCccccchhHHHHHHHHHhCCCCCCCCCCcchhhhhHhHHhcCCcccccchhhhcc
Q 004521 595 DETEG-----NTNRVVGT--YDGQFSIKSDVFSFGILLLEIVSGKKNRGFYRSDTKVNLIGHLWDEGIPLRLIDACIQDS 667 (747)
Q Consensus 595 ~~~~~-----~~~~~~~~--~~~~~s~ksDVwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~ 667 (747)
..... ........ ....++.++||||||+++|||++|+.|+...... ....... ..........
T Consensus 159 ~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~-~~~~~~~-~~~~~~~~~~------- 229 (267)
T cd08228 159 KTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMN-LFSLCQK-IEQCDYPPLP------- 229 (267)
T ss_pred hhHHHhcCCCCccccChhhhccCCCCchhhHHHHHHHHHHHhcCCCCCcccccc-HHHHHHH-HhcCCCCCCC-------
Confidence 22110 00000010 1356788999999999999999999996422111 1112211 1111111111
Q ss_pred CCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhcCC
Q 004521 668 CNLADVIRCIHIGLLCVQQHPEDRPCMPSVILMLGSE 704 (747)
Q Consensus 668 ~~~~~~~~~~~l~~~Cl~~dP~~RPt~~~v~~~L~~~ 704 (747)
.......+.+++.+||+.+|++||++.+|++.|++.
T Consensus 230 -~~~~~~~~~~li~~cl~~~p~~Rp~~~~vl~~~~~~ 265 (267)
T cd08228 230 -TEHYSEKLRELVSMCIYPDPDQRPDIGYVHQIAKQM 265 (267)
T ss_pred -hhhcCHHHHHHHHHHCCCCcccCcCHHHHHHHHHHh
Confidence 011123466788899999999999999999999764
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-35 Score=294.37 Aligned_cols=238 Identities=24% Similarity=0.390 Sum_probs=190.5
Q ss_pred cCCCccceecccCCeeEEEEEe-cCCcEEEEEEeccc---ccccHHHHHHHHHHHhccCCCceeeEEeEEEeCCeeEEEE
Q 004521 440 DNFSINNKLGEGGFGPVYKGTL-VDGQEIAVKRLSKI---SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIY 515 (747)
Q Consensus 440 ~~~~~~~~lg~G~fg~Vy~~~~-~~g~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 515 (747)
.+|++.+.||+|.||.|-+|.. ..|+.||||.+++. +++..-.+++|++||..|+||||++++.+|+..+.+.|||
T Consensus 53 HRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENkdKIvivM 132 (668)
T KOG0611|consen 53 HRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENKDKIVIVM 132 (668)
T ss_pred hHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCCceEEEEE
Confidence 4788889999999999999986 56999999999873 4556677899999999999999999999999999999999
Q ss_pred ecCCCCChhhHhhhcCCCCcCChhHHHHHHHHHHHHHHHhhhcCCCceEecccCcCcEEEcCCCCceEecccCccccCCC
Q 004521 516 EFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGD 595 (747)
Q Consensus 516 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NIll~~~~~~kl~DFGla~~~~~~ 595 (747)
||..+|.|++|+.. +..|++.+..++++||..|+.|.|.+. ++|||||.+|||||.++++||+||||+..+...
T Consensus 133 EYaS~GeLYDYiSe---r~~LsErEaRhfFRQIvSAVhYCHknr---VvHRDLKLENILLD~N~NiKIADFGLSNly~~~ 206 (668)
T KOG0611|consen 133 EYASGGELYDYISE---RGSLSEREARHFFRQIVSAVHYCHKNR---VVHRDLKLENILLDQNNNIKIADFGLSNLYADK 206 (668)
T ss_pred EecCCccHHHHHHH---hccccHHHHHHHHHHHHHHHHHHhhcc---ceecccchhheeecCCCCeeeeccchhhhhccc
Confidence 99999999999954 455999999999999999999999988 999999999999999999999999999877544
Q ss_pred CCccccceeeecc---------CCCC-CccccchhHHHHHHHHHhCCCCCCCCCCcchhhhhHhHHhcCCcccccchhhh
Q 004521 596 ETEGNTNRVVGTY---------DGQF-SIKSDVFSFGILLLEIVSGKKNRGFYRSDTKVNLIGHLWDEGIPLRLIDACIQ 665 (747)
Q Consensus 596 ~~~~~~~~~~~~~---------~~~~-s~ksDVwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 665 (747)
.... .++|.. +.+| .+.+|-||+||+||-|+.|..||+.... ..++.++ ..|...+..
T Consensus 207 kfLq---TFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~Dh---k~lvrQI-s~GaYrEP~----- 274 (668)
T KOG0611|consen 207 KFLQ---TFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRDH---KRLVRQI-SRGAYREPE----- 274 (668)
T ss_pred cHHH---HhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCchH---HHHHHHh-hcccccCCC-----
Confidence 3321 111110 2223 5689999999999999999999764322 2233332 233222111
Q ss_pred ccCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHh
Q 004521 666 DSCNLADVIRCIHIGLLCVQQHPEDRPCMPSVILML 701 (747)
Q Consensus 666 ~~~~~~~~~~~~~l~~~Cl~~dP~~RPt~~~v~~~L 701 (747)
.+. ...-|+.|+|..||++|-|+.+|....
T Consensus 275 ---~PS---dA~gLIRwmLmVNP~RRATieDiAsHW 304 (668)
T KOG0611|consen 275 ---TPS---DASGLIRWMLMVNPERRATIEDIASHW 304 (668)
T ss_pred ---CCc---hHHHHHHHHHhcCcccchhHHHHhhhh
Confidence 111 133566699999999999999998765
|
|
| >KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-35 Score=276.67 Aligned_cols=241 Identities=25% Similarity=0.310 Sum_probs=192.4
Q ss_pred HhcCCCccceecccCCeeEEEEEecC-CcEEEEEEeccc---ccccHHHHHHHHHHHhccCCCceeeEEeEEEeCCeeEE
Q 004521 438 ATDNFSINNKLGEGGFGPVYKGTLVD-GQEIAVKRLSKI---SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLL 513 (747)
Q Consensus 438 ~~~~~~~~~~lg~G~fg~Vy~~~~~~-g~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~l 513 (747)
+.++|++.+.||+|.||.||.|+.+. +-.||+|++.+. ..+...++.+|++|-..|+||||+++++++.+....||
T Consensus 20 ~l~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~~riyL 99 (281)
T KOG0580|consen 20 TLDDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDSKRIYL 99 (281)
T ss_pred chhhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheeccceeEE
Confidence 34689999999999999999999754 779999999762 33456789999999999999999999999999999999
Q ss_pred EEecCCCCChhhHhhhcCCCCcCChhHHHHHHHHHHHHHHHhhhcCCCceEecccCcCcEEEcCCCCceEecccCccccC
Q 004521 514 IYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFG 593 (747)
Q Consensus 514 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NIll~~~~~~kl~DFGla~~~~ 593 (747)
++||.++|.|...|.+.. ...+++.....++.|+|.||.|+|..+ +|||||||+|+|++..+..||+|||-+..-.
T Consensus 100 ilEya~~gel~k~L~~~~-~~~f~e~~~a~Yi~q~A~Al~y~h~k~---VIhRdiKpenlLlg~~~~lkiAdfGwsV~~p 175 (281)
T KOG0580|consen 100 ILEYAPRGELYKDLQEGR-MKRFDEQRAATYIKQLANALLYCHLKR---VIHRDIKPENLLLGSAGELKIADFGWSVHAP 175 (281)
T ss_pred EEEecCCchHHHHHHhcc-cccccccchhHHHHHHHHHHHHhccCC---cccCCCCHHHhccCCCCCeeccCCCceeecC
Confidence 999999999999997533 345888899999999999999999887 9999999999999999999999999876543
Q ss_pred CCCCccccceeeecc---------CCCCCccccchhHHHHHHHHHhCCCCCCCCCCcchhhhhHhHHhcCCcccccchhh
Q 004521 594 GDETEGNTNRVVGTY---------DGQFSIKSDVFSFGILLLEIVSGKKNRGFYRSDTKVNLIGHLWDEGIPLRLIDACI 664 (747)
Q Consensus 594 ~~~~~~~~~~~~~~~---------~~~~s~ksDVwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 664 (747)
.......+|+. +..++.++|+|++||+.||++.|.+||+... ..+.+..+.+-. +.++
T Consensus 176 ----~~kR~tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg~ppFes~~---~~etYkrI~k~~----~~~p-- 242 (281)
T KOG0580|consen 176 ----SNKRKTLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVGLPPFESQS---HSETYKRIRKVD----LKFP-- 242 (281)
T ss_pred ----CCCceeeecccccCCHhhcCCCCccchhhHHHHHHHHHHHHhcCCchhhhh---hHHHHHHHHHcc----ccCC--
Confidence 12233344543 5678999999999999999999999976443 222233222111 1111
Q ss_pred hccCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 004521 665 QDSCNLADVIRCIHIGLLCVQQHPEDRPCMPSVILM 700 (747)
Q Consensus 665 ~~~~~~~~~~~~~~l~~~Cl~~dP~~RPt~~~v~~~ 700 (747)
... ...+.+++.+|+..+|.+|.+..|++..
T Consensus 243 -~~i----s~~a~dlI~~ll~~~p~~r~~l~~v~~h 273 (281)
T KOG0580|consen 243 -STI----SGGAADLISRLLVKNPIERLALTEVMDH 273 (281)
T ss_pred -ccc----ChhHHHHHHHHhccCccccccHHHHhhh
Confidence 111 1125567789999999999999998763
|
|
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-34 Score=305.85 Aligned_cols=194 Identities=23% Similarity=0.325 Sum_probs=159.8
Q ss_pred hcCCCccceecccCCeeEEEEEec-CCcEEEEEEeccc-ccccHHHHHHHHHHHhccCCCceeeEEeEEEeCCeeEEEEe
Q 004521 439 TDNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKI-SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYE 516 (747)
Q Consensus 439 ~~~~~~~~~lg~G~fg~Vy~~~~~-~g~~vavK~l~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E 516 (747)
.++|++.++||+|+||.||++... ++..+|+|.+... .......+.+|++++++++|+||+++++++...+..++|||
T Consensus 4 ~~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 83 (333)
T cd06650 4 DDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME 83 (333)
T ss_pred hhhhheeccccCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCcccceeEEEEECCEEEEEEe
Confidence 368999999999999999999986 4788999988653 23345678999999999999999999999999999999999
Q ss_pred cCCCCChhhHhhhcCCCCcCChhHHHHHHHHHHHHHHHhhhcCCCceEecccCcCcEEEcCCCCceEecccCccccCCCC
Q 004521 517 FMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDE 596 (747)
Q Consensus 517 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~ 596 (747)
|+++++|.+++... ..+++..+..++.+++.||.|||+.+ +|+||||||+|||++.++.+||+|||+++.+....
T Consensus 84 ~~~~~~L~~~l~~~---~~~~~~~~~~~~~~l~~~l~~lH~~~--~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~~ 158 (333)
T cd06650 84 HMDGGSLDQVLKKA---GRIPEQILGKVSIAVIKGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM 158 (333)
T ss_pred cCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHhcC--CEEecCCChhhEEEcCCCCEEEeeCCcchhhhhhc
Confidence 99999999998542 34788999999999999999999742 39999999999999999999999999987653221
Q ss_pred Ccc---ccceeee--ccCCCCCccccchhHHHHHHHHHhCCCCCCC
Q 004521 597 TEG---NTNRVVG--TYDGQFSIKSDVFSFGILLLEIVSGKKNRGF 637 (747)
Q Consensus 597 ~~~---~~~~~~~--~~~~~~s~ksDVwS~Gvvl~elltg~~p~~~ 637 (747)
... ....... ..+..++.++|||||||++|||++|+.|+..
T Consensus 159 ~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~ 204 (333)
T cd06650 159 ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPP 204 (333)
T ss_pred cccCCCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCC
Confidence 110 0000000 0145688899999999999999999999753
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-34 Score=301.25 Aligned_cols=254 Identities=29% Similarity=0.397 Sum_probs=184.9
Q ss_pred CccceecccCCeeEEEEEe-----cCCcEEEEEEecccc-cccHHHHHHHHHHHhccCCCceeeEEeEEEeC--CeeEEE
Q 004521 443 SINNKLGEGGFGPVYKGTL-----VDGQEIAVKRLSKIS-EQGLKELKNEVILFSKLQHRNLVKLLGCCIQG--EEKLLI 514 (747)
Q Consensus 443 ~~~~~lg~G~fg~Vy~~~~-----~~g~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~--~~~~lV 514 (747)
.+.+.||+|+||+||++.. .+++.||+|.++... ......|.+|++++++++||||+++++++... ...++|
T Consensus 7 ~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv 86 (283)
T cd05080 7 KKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKGLQLI 86 (283)
T ss_pred eeceecccCCCcEEEEeeEccccCCCCceEEEEEeccccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCceEEEE
Confidence 7789999999999988653 347789999987532 23456789999999999999999999998764 357899
Q ss_pred EecCCCCChhhHhhhcCCCCcCChhHHHHHHHHHHHHHHHhhhcCCCceEecccCcCcEEEcCCCCceEecccCccccCC
Q 004521 515 YEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGG 594 (747)
Q Consensus 515 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NIll~~~~~~kl~DFGla~~~~~ 594 (747)
|||+++++|.+++.. ..+++.+++.++.|++.||.|||+.+ |+||||||+|||+++++.+||+|||+++.+..
T Consensus 87 ~e~~~~~~l~~~~~~----~~l~~~~~~~i~~~l~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~ 159 (283)
T cd05080 87 MEYVPLGSLRDYLPK----HKLNLAQLLLFAQQICEGMAYLHSQH---YIHRDLAARNVLLDNDRLVKIGDFGLAKAVPE 159 (283)
T ss_pred ecCCCCCCHHHHHHH----cCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccChheEEEcCCCcEEEeecccccccCC
Confidence 999999999999854 24899999999999999999999988 99999999999999999999999999986643
Q ss_pred CCCcc-------ccceeeec---cCCCCCccccchhHHHHHHHHHhCCCCCCCCCCcchhhhhHhHH---hcCCcccccc
Q 004521 595 DETEG-------NTNRVVGT---YDGQFSIKSDVFSFGILLLEIVSGKKNRGFYRSDTKVNLIGHLW---DEGIPLRLID 661 (747)
Q Consensus 595 ~~~~~-------~~~~~~~~---~~~~~s~ksDVwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~---~~~~~~~~~d 661 (747)
..... .......+ ....++.++||||||+++|||++|+.|+........ ....... .......+.+
T Consensus 160 ~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~ 238 (283)
T cd05080 160 GHEYYRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKKFE-EMIGPKQGQMTVVRLIELLE 238 (283)
T ss_pred cchhhccCCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHHHHhCCCCCCCCcchhh-hhhcccccccchhhhhhhhh
Confidence 22110 00000111 145688999999999999999999999653221110 0010000 0000000111
Q ss_pred hhhhccCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhcCC
Q 004521 662 ACIQDSCNLADVIRCIHIGLLCVQQHPEDRPCMPSVILMLGSE 704 (747)
Q Consensus 662 ~~l~~~~~~~~~~~~~~l~~~Cl~~dP~~RPt~~~v~~~L~~~ 704 (747)
..............+.+++.+||+.+|++||++.+|+++|+..
T Consensus 239 ~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~~l~~~ 281 (283)
T cd05080 239 RGMRLPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIPILKEM 281 (283)
T ss_pred cCCCCCCCCCCCHHHHHHHHHHhccChhhCCCHHHHHHHHHHh
Confidence 1110001111123466788899999999999999999999754
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-34 Score=312.90 Aligned_cols=252 Identities=27% Similarity=0.399 Sum_probs=189.0
Q ss_pred HhcCCCccceecccCCeeEEEEEecC------CcEEEEEEecccc-cccHHHHHHHHHHHhccC-CCceeeEEeEEEeCC
Q 004521 438 ATDNFSINNKLGEGGFGPVYKGTLVD------GQEIAVKRLSKIS-EQGLKELKNEVILFSKLQ-HRNLVKLLGCCIQGE 509 (747)
Q Consensus 438 ~~~~~~~~~~lg~G~fg~Vy~~~~~~------g~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~-H~niv~l~g~~~~~~ 509 (747)
..++|.+.++||+|+||.||+|++.+ ++.||||+++... ....+.+.+|+.++.++. ||||+++++++...+
T Consensus 35 ~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~~H~niv~~~~~~~~~~ 114 (401)
T cd05107 35 PRDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSSEKQALMSELKIMSHLGPHLNIVNLLGACTKGG 114 (401)
T ss_pred cHHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCChhHHHHHHHHHHHHHhcCCCCCeEEEEEEEccCC
Confidence 34567788999999999999998632 4689999997532 233457899999999997 999999999999999
Q ss_pred eeEEEEecCCCCChhhHhhhcCC---------------------------------------------------------
Q 004521 510 EKLLIYEFMPNKSLDSFIFDQTR--------------------------------------------------------- 532 (747)
Q Consensus 510 ~~~lV~E~~~~gsL~~~l~~~~~--------------------------------------------------------- 532 (747)
..++||||+++|+|.++++....
T Consensus 115 ~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 194 (401)
T cd05107 115 PIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYVPMQD 194 (401)
T ss_pred CcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCccchhc
Confidence 99999999999999999964321
Q ss_pred --------------------------------------CCcCChhHHHHHHHHHHHHHHHhhhcCCCceEecccCcCcEE
Q 004521 533 --------------------------------------RTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVL 574 (747)
Q Consensus 533 --------------------------------------~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NIl 574 (747)
...+++..++.++.||+.||+|||+.+ ++||||||+|||
T Consensus 195 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrdlkp~NiL 271 (401)
T cd05107 195 MKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASKN---CVHRDLAARNVL 271 (401)
T ss_pred chhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCC---cCcccCCcceEE
Confidence 123677788999999999999999887 999999999999
Q ss_pred EcCCCCceEecccCccccCCCCCcccc-------ceeeec--cCCCCCccccchhHHHHHHHHHh-CCCCCCCCCCcchh
Q 004521 575 LDQDMNPKISDFGLVRTFGGDETEGNT-------NRVVGT--YDGQFSIKSDVFSFGILLLEIVS-GKKNRGFYRSDTKV 644 (747)
Q Consensus 575 l~~~~~~kl~DFGla~~~~~~~~~~~~-------~~~~~~--~~~~~s~ksDVwS~Gvvl~ellt-g~~p~~~~~~~~~~ 644 (747)
+++++.+||+|||+++.+......... ...... ....++.++|||||||++|||++ |+.|+......
T Consensus 272 l~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~e~l~~g~~P~~~~~~~--- 348 (401)
T cd05107 272 ICEGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPELPMN--- 348 (401)
T ss_pred EeCCCEEEEEecCcceecccccccccCCCcCCCCceeChHHhcCCCCCcHhHHHHHHHHHHHHHHcCCCCCCCCCch---
Confidence 999999999999999865332211100 011011 14567889999999999999998 88886533211
Q ss_pred hhhHhHHhcCCcccccchhhhccCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhcCC
Q 004521 645 NLIGHLWDEGIPLRLIDACIQDSCNLADVIRCIHIGLLCVQQHPEDRPCMPSVILMLGSE 704 (747)
Q Consensus 645 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dP~~RPt~~~v~~~L~~~ 704 (747)
.........+...... ... ...+.+++.+||+.+|.+||++.+|++.|+..
T Consensus 349 ~~~~~~~~~~~~~~~p-----~~~----~~~l~~li~~cl~~~P~~RPs~~ell~~L~~~ 399 (401)
T cd05107 349 EQFYNAIKRGYRMAKP-----AHA----SDEIYEIMQKCWEEKFEIRPDFSQLVHLVGDL 399 (401)
T ss_pred HHHHHHHHcCCCCCCC-----CCC----CHHHHHHHHHHcCCChhHCcCHHHHHHHHHHH
Confidence 1111222222211111 111 13466778899999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-34 Score=300.78 Aligned_cols=249 Identities=31% Similarity=0.488 Sum_probs=188.3
Q ss_pred CCCccceecccCCeeEEEEEecC------CcEEEEEEecccc-cccHHHHHHHHHHHhccCCCceeeEEeEEEeCCeeEE
Q 004521 441 NFSINNKLGEGGFGPVYKGTLVD------GQEIAVKRLSKIS-EQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLL 513 (747)
Q Consensus 441 ~~~~~~~lg~G~fg~Vy~~~~~~------g~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~l 513 (747)
+|.+.+.||+|+||.||+|+... ...+|+|.+.... ....+.+.+|+.+++.++||||+++++.+...+..++
T Consensus 1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 80 (290)
T cd05045 1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPLLL 80 (290)
T ss_pred CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCCcEE
Confidence 47788999999999999998632 3578999887532 2345678999999999999999999999999999999
Q ss_pred EEecCCCCChhhHhhhcC---------------------CCCcCChhHHHHHHHHHHHHHHHhhhcCCCceEecccCcCc
Q 004521 514 IYEFMPNKSLDSFIFDQT---------------------RRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASN 572 (747)
Q Consensus 514 V~E~~~~gsL~~~l~~~~---------------------~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~N 572 (747)
|+||+.+++|.+++.... ....+++..++.++.|++.||+|||+.+ |+||||||+|
T Consensus 81 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~---ivH~dikp~n 157 (290)
T cd05045 81 IVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEMK---LVHRDLAARN 157 (290)
T ss_pred EEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHCC---eehhhhhhhe
Confidence 999999999999985421 1234788999999999999999999988 9999999999
Q ss_pred EEEcCCCCceEecccCccccCCCCCccccc-------eeee--ccCCCCCccccchhHHHHHHHHHh-CCCCCCCCCCcc
Q 004521 573 VLLDQDMNPKISDFGLVRTFGGDETEGNTN-------RVVG--TYDGQFSIKSDVFSFGILLLEIVS-GKKNRGFYRSDT 642 (747)
Q Consensus 573 Ill~~~~~~kl~DFGla~~~~~~~~~~~~~-------~~~~--~~~~~~s~ksDVwS~Gvvl~ellt-g~~p~~~~~~~~ 642 (747)
||+++++.+||+|||+++............ .... .....++.++||||||+++|||++ |+.|+....
T Consensus 158 ill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~--- 234 (290)
T cd05045 158 VLVAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIA--- 234 (290)
T ss_pred EEEcCCCcEEeccccccccccCccchhcccCCCCCccccCHHHHccCCcchHhHHHHHHHHHHHHHhcCCCCCCCCC---
Confidence 999999999999999998653322111000 0000 014567889999999999999999 888864322
Q ss_pred hhhhhHhHHhcCCcccccchhhhccCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhcCCC
Q 004521 643 KVNLIGHLWDEGIPLRLIDACIQDSCNLADVIRCIHIGLLCVQQHPEDRPCMPSVILMLGSEI 705 (747)
Q Consensus 643 ~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dP~~RPt~~~v~~~L~~~~ 705 (747)
..... ............ ... ...+.+++.+||+.+|++||++.++++.|++..
T Consensus 235 ~~~~~-~~~~~~~~~~~~-----~~~----~~~~~~~i~~cl~~~P~~Rp~~~~i~~~l~~~~ 287 (290)
T cd05045 235 PERLF-NLLKTGYRMERP-----ENC----SEEMYNLMLTCWKQEPDKRPTFADISKELEKMM 287 (290)
T ss_pred HHHHH-HHHhCCCCCCCC-----CCC----CHHHHHHHHHHccCCcccCCCHHHHHHHHHHHH
Confidence 11111 112222111111 111 134667888999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-34 Score=301.45 Aligned_cols=253 Identities=23% Similarity=0.291 Sum_probs=182.5
Q ss_pred hcCCCccceecccCCeeEEEEEec-CCcEEEEEEecccc-cccHHHHHHHHHHHhccCCCceeeEEeEEEeCCeeEEEEe
Q 004521 439 TDNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKIS-EQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYE 516 (747)
Q Consensus 439 ~~~~~~~~~lg~G~fg~Vy~~~~~-~g~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E 516 (747)
.++|++.+.||+|+||.||+|+.. +++.||||+++... ......+.+|+.+++.++||||+++++++.+....++|||
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 83 (303)
T cd07869 4 ADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDIIHTKETLTLVFE 83 (303)
T ss_pred cccceEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccccccchhHHHHHHHHhhCCCCCcCeEEEEEecCCeEEEEEE
Confidence 367999999999999999999986 58899999987532 2334567889999999999999999999999999999999
Q ss_pred cCCCCChhhHhhhcCCCCcCChhHHHHHHHHHHHHHHHhhhcCCCceEecccCcCcEEEcCCCCceEecccCccccCCCC
Q 004521 517 FMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDE 596 (747)
Q Consensus 517 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~ 596 (747)
|++ ++|.+++... ...++...+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++......
T Consensus 84 ~~~-~~l~~~~~~~--~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~ 157 (303)
T cd07869 84 YVH-TDLCQYMDKH--PGGLHPENVKLFLFQLLRGLSYIHQRY---ILHRDLKPQNLLISDTGELKLADFGLARAKSVPS 157 (303)
T ss_pred CCC-cCHHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEECCCCcceeccCCC
Confidence 996 6787777543 345788999999999999999999988 9999999999999999999999999987543221
Q ss_pred Cccc-----cceeeec-c--CCCCCccccchhHHHHHHHHHhCCCCCCCCCCcchhhhhHhH---HhcCCc---------
Q 004521 597 TEGN-----TNRVVGT-Y--DGQFSIKSDVFSFGILLLEIVSGKKNRGFYRSDTKVNLIGHL---WDEGIP--------- 656 (747)
Q Consensus 597 ~~~~-----~~~~~~~-~--~~~~s~ksDVwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~---~~~~~~--------- 656 (747)
.... .....+. . ...++.++|||||||++|||++|+.||...... ...+... ......
T Consensus 158 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (303)
T cd07869 158 HTYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDI--QDQLERIFLVLGTPNEDTWPGVHSL 235 (303)
T ss_pred ccCCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCccH--HHHHHHHHHHhCCCChhhccchhhc
Confidence 1100 0000111 1 245788999999999999999999998643221 1111111 000000
Q ss_pred ccccchhhh--ccCCHH-------HHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 004521 657 LRLIDACIQ--DSCNLA-------DVIRCIHIGLLCVQQHPEDRPCMPSVIL 699 (747)
Q Consensus 657 ~~~~d~~l~--~~~~~~-------~~~~~~~l~~~Cl~~dP~~RPt~~~v~~ 699 (747)
......... ...... ....+.+++.+||+.||++|||+.++++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l~ 287 (303)
T cd07869 236 PHFKPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALS 287 (303)
T ss_pred cccccccccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHhc
Confidence 000000000 000000 0123556788999999999999998875
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-34 Score=297.58 Aligned_cols=249 Identities=25% Similarity=0.457 Sum_probs=191.2
Q ss_pred hcCCCccceecccCCeeEEEEEecC------CcEEEEEEecccc-cccHHHHHHHHHHHhccCCCceeeEEeEEEeCCee
Q 004521 439 TDNFSINNKLGEGGFGPVYKGTLVD------GQEIAVKRLSKIS-EQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEK 511 (747)
Q Consensus 439 ~~~~~~~~~lg~G~fg~Vy~~~~~~------g~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~ 511 (747)
.++|.+.+.||+|+||.||+|...+ +..||+|.+.... .....++.+|+.+++.++|+||+++++++......
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~ 84 (277)
T cd05032 5 REKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVRLLGVVSTGQPT 84 (277)
T ss_pred hHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCccCHHHHHHHHHHHHHHHhCCCCceeEEEEEEcCCCCc
Confidence 3578889999999999999998753 3689999986532 23456789999999999999999999999999999
Q ss_pred EEEEecCCCCChhhHhhhcCC-------CCcCChhHHHHHHHHHHHHHHHhhhcCCCceEecccCcCcEEEcCCCCceEe
Q 004521 512 LLIYEFMPNKSLDSFIFDQTR-------RTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKIS 584 (747)
Q Consensus 512 ~lV~E~~~~gsL~~~l~~~~~-------~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NIll~~~~~~kl~ 584 (747)
++||||+++++|.+++..... ...+++..++.++.|++.||.|||+.+ |+||||||+||+++.++.+||+
T Consensus 85 ~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~di~p~nill~~~~~~kl~ 161 (277)
T cd05032 85 LVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAKK---FVHRDLAARNCMVAEDLTVKIG 161 (277)
T ss_pred EEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccChheEEEcCCCCEEEC
Confidence 999999999999999965322 234788899999999999999999988 9999999999999999999999
Q ss_pred cccCccccCCCCCccccce-------eeec--cCCCCCccccchhHHHHHHHHHh-CCCCCCCCCCcchhhhhHhHHhcC
Q 004521 585 DFGLVRTFGGDETEGNTNR-------VVGT--YDGQFSIKSDVFSFGILLLEIVS-GKKNRGFYRSDTKVNLIGHLWDEG 654 (747)
Q Consensus 585 DFGla~~~~~~~~~~~~~~-------~~~~--~~~~~s~ksDVwS~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~ 654 (747)
|||+++.+........... ..+. ..+.++.++|||||||++|||++ |+.|+..... ........ .+
T Consensus 162 dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~---~~~~~~~~-~~ 237 (277)
T cd05032 162 DFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSN---EEVLKFVI-DG 237 (277)
T ss_pred CcccchhhccCcccccCCCCCccccccCHHHHhcCCCCcccchHHHHHHHHHhhccCCCCCccCCH---HHHHHHHh-cC
Confidence 9999986543322111000 0011 14668899999999999999998 8888653222 12222222 22
Q ss_pred CcccccchhhhccCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhcC
Q 004521 655 IPLRLIDACIQDSCNLADVIRCIHIGLLCVQQHPEDRPCMPSVILMLGS 703 (747)
Q Consensus 655 ~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dP~~RPt~~~v~~~L~~ 703 (747)
......+. . ...+.+++.+||+.+|++|||+.+|++.|+.
T Consensus 238 ~~~~~~~~-----~----~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~ 277 (277)
T cd05032 238 GHLDLPEN-----C----PDKLLELMRMCWQYNPKMRPTFLEIVSSLKD 277 (277)
T ss_pred CCCCCCCC-----C----CHHHHHHHHHHcCCChhhCCCHHHHHHHhcC
Confidence 22221111 1 2346678889999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=306.42 Aligned_cols=245 Identities=25% Similarity=0.461 Sum_probs=194.8
Q ss_pred hcCCCccceecccCCeeEEEEEecC---Cc--EEEEEEecc-cccccHHHHHHHHHHHhccCCCceeeEEeEEEeCCeeE
Q 004521 439 TDNFSINNKLGEGGFGPVYKGTLVD---GQ--EIAVKRLSK-ISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKL 512 (747)
Q Consensus 439 ~~~~~~~~~lg~G~fg~Vy~~~~~~---g~--~vavK~l~~-~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~ 512 (747)
.+.....++||+|-||.||+|+..+ |. .||||..+. ...+..+.|+.|..+|+.++|||||+++|+|.+ .+.+
T Consensus 388 Re~Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~d~tekflqEa~iMrnfdHphIikLIGv~~e-~P~W 466 (974)
T KOG4257|consen 388 RELITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTPDDTEKFLQEASIMRNFDHPHIIKLIGVCVE-QPMW 466 (974)
T ss_pred hhhccHHHhhcCCcccceeeeEecccccCcceeeeeehhccCCChhhHHHHHHHHHHHHhCCCcchhheeeeeec-ccee
Confidence 3445566899999999999998643 32 699999987 445567889999999999999999999999976 5789
Q ss_pred EEEecCCCCChhhHhhhcCCCCcCChhHHHHHHHHHHHHHHHhhhcCCCceEecccCcCcEEEcCCCCceEecccCcccc
Q 004521 513 LIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTF 592 (747)
Q Consensus 513 lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NIll~~~~~~kl~DFGla~~~ 592 (747)
+|||.++.|.|.+||... +..|+......++.||+.||+|||+.. +|||||.++|||+.+...+||+|||++|.+
T Consensus 467 ivmEL~~~GELr~yLq~n--k~sL~l~tL~ly~~Qi~talaYLeSkr---fVHRDIAaRNiLVsSp~CVKLaDFGLSR~~ 541 (974)
T KOG4257|consen 467 IVMELAPLGELREYLQQN--KDSLPLRTLTLYCYQICTALAYLESKR---FVHRDIAARNILVSSPQCVKLADFGLSRYL 541 (974)
T ss_pred EEEecccchhHHHHHHhc--cccchHHHHHHHHHHHHHHHHHHHhhc---hhhhhhhhhheeecCcceeeecccchhhhc
Confidence 999999999999999654 345888999999999999999999987 999999999999999999999999999998
Q ss_pred CCCCCccccceeee-------c-cCCCCCccccchhHHHHHHHHHh-CCCCCCCCCCcchhhhhHhHHhcCCcccccchh
Q 004521 593 GGDETEGNTNRVVG-------T-YDGQFSIKSDVFSFGILLLEIVS-GKKNRGFYRSDTKVNLIGHLWDEGIPLRLIDAC 663 (747)
Q Consensus 593 ~~~~~~~~~~~~~~-------~-~~~~~s~ksDVwS~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 663 (747)
..+..........+ . --.+|+.++|||-|||.+|||++ |.+||......+ .+.++ +.|.+....+.+
T Consensus 542 ed~~yYkaS~~kLPIKWmaPESINfRrFTtASDVWMFgVCmWEIl~lGvkPfqgvkNsD---VI~~i-EnGeRlP~P~nC 617 (974)
T KOG4257|consen 542 EDDAYYKASRGKLPIKWMAPESINFRRFTTASDVWMFGVCMWEILSLGVKPFQGVKNSD---VIGHI-ENGERLPCPPNC 617 (974)
T ss_pred cccchhhccccccceeecCccccchhcccchhhHHHHHHHHHHHHHhcCCccccccccc---eEEEe-cCCCCCCCCCCC
Confidence 76655433211110 0 13678999999999999999998 899976443222 22222 344444443333
Q ss_pred hhccCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhc
Q 004521 664 IQDSCNLADVIRCIHIGLLCVQQHPEDRPCMPSVILMLG 702 (747)
Q Consensus 664 l~~~~~~~~~~~~~~l~~~Cl~~dP~~RPt~~~v~~~L~ 702 (747)
. ..++.++-+||..||.+||++.+|...|+
T Consensus 618 P---------p~LYslmskcWayeP~kRPrftei~~~ls 647 (974)
T KOG4257|consen 618 P---------PALYSLMSKCWAYEPSKRPRFTEIKAILS 647 (974)
T ss_pred C---------hHHHHHHHHHhccCcccCCcHHHHHHHHH
Confidence 2 34778899999999999999999988774
|
|
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-34 Score=320.66 Aligned_cols=243 Identities=16% Similarity=0.203 Sum_probs=186.7
Q ss_pred CCCccceecccCCeeEEEEEecC--CcEEEEEEecccccccHHHHHHHHHHHhccCCCceeeEEeEEEeCCeeEEEEecC
Q 004521 441 NFSINNKLGEGGFGPVYKGTLVD--GQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFM 518 (747)
Q Consensus 441 ~~~~~~~lg~G~fg~Vy~~~~~~--g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~ 518 (747)
.|.+.+.||+|+||.||+|.... ++.||+|.+..........+++|+.+++.++|||||++++++...+..+|||||+
T Consensus 68 ~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~E~~ 147 (478)
T PTZ00267 68 MYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLNDERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYG 147 (478)
T ss_pred eEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCEEEEEEECC
Confidence 48889999999999999998643 5778888875544445567889999999999999999999999999999999999
Q ss_pred CCCChhhHhhhc-CCCCcCChhHHHHHHHHHHHHHHHhhhcCCCceEecccCcCcEEEcCCCCceEecccCccccCCCCC
Q 004521 519 PNKSLDSFIFDQ-TRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDET 597 (747)
Q Consensus 519 ~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~ 597 (747)
++|+|.++|... .....+++..+..++.||+.||+|||+.+ |+||||||+||||+.++.+||+|||+++.+.....
T Consensus 148 ~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~---ivHrDlkp~NIll~~~~~~kL~DFgla~~~~~~~~ 224 (478)
T PTZ00267 148 SGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSRK---MMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVS 224 (478)
T ss_pred CCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCC---EEECCcCHHhEEECCCCcEEEEeCcCceecCCccc
Confidence 999999988643 23446888999999999999999999988 99999999999999999999999999987644322
Q ss_pred ccccceeeec---------cCCCCCccccchhHHHHHHHHHhCCCCCCCCCCcchhhhhHhHHhcCCcccccchhhhccC
Q 004521 598 EGNTNRVVGT---------YDGQFSIKSDVFSFGILLLEIVSGKKNRGFYRSDTKVNLIGHLWDEGIPLRLIDACIQDSC 668 (747)
Q Consensus 598 ~~~~~~~~~~---------~~~~~s~ksDVwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~ 668 (747)
........|+ ....++.++|||||||++|||++|+.|+.... ....+..... +....+. ...
T Consensus 225 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~Pf~~~~---~~~~~~~~~~-~~~~~~~-----~~~ 295 (478)
T PTZ00267 225 LDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGPS---QREIMQQVLY-GKYDPFP-----CPV 295 (478)
T ss_pred cccccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCC---HHHHHHHHHh-CCCCCCC-----ccC
Confidence 1111111122 14568999999999999999999999974321 1122222211 1111110 011
Q ss_pred CHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 004521 669 NLADVIRCIHIGLLCVQQHPEDRPCMPSVIL 699 (747)
Q Consensus 669 ~~~~~~~~~~l~~~Cl~~dP~~RPt~~~v~~ 699 (747)
...+.+++.+||+.+|++||++.+++.
T Consensus 296 ----s~~~~~li~~~L~~dP~~Rps~~~~l~ 322 (478)
T PTZ00267 296 ----SSGMKALLDPLLSKNPALRPTTQQLLH 322 (478)
T ss_pred ----CHHHHHHHHHHhccChhhCcCHHHHHh
Confidence 123567788999999999999999864
|
|
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-34 Score=305.48 Aligned_cols=232 Identities=21% Similarity=0.243 Sum_probs=178.8
Q ss_pred ceecccCCeeEEEEEec-CCcEEEEEEeccc---ccccHHHHHHHHHHHhccCCCceeeEEeEEEeCCeeEEEEecCCCC
Q 004521 446 NKLGEGGFGPVYKGTLV-DGQEIAVKRLSKI---SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMPNK 521 (747)
Q Consensus 446 ~~lg~G~fg~Vy~~~~~-~g~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~g 521 (747)
+.||+|+||.||+++.. +|+.||||++++. .......+.+|+.++++++||||+++++++...+..++||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~ 80 (323)
T cd05571 1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeCCCCC
Confidence 46999999999999875 4889999999753 2334567889999999999999999999999999999999999999
Q ss_pred ChhhHhhhcCCCCcCChhHHHHHHHHHHHHHHHhhhcCCCceEecccCcCcEEEcCCCCceEecccCccccCCCCCcccc
Q 004521 522 SLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNT 601 (747)
Q Consensus 522 sL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~ 601 (747)
+|.+++.. ...+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++.........
T Consensus 81 ~L~~~l~~---~~~~~~~~~~~~~~qi~~~L~~lH~~~---ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~~-- 152 (323)
T cd05571 81 ELFFHLSR---ERVFSEDRARFYGAEIVSALGYLHSCD---VVYRDLKLENLMLDKDGHIKITDFGLCKEGISDGATM-- 152 (323)
T ss_pred cHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEeCCCCHHHEEECCCCCEEEeeCCCCcccccCCCcc--
Confidence 99998854 335889999999999999999999988 9999999999999999999999999987542221110
Q ss_pred ceeeec---------cCCCCCccccchhHHHHHHHHHhCCCCCCCCCCcchhhhhHhHHhcCCcccccchhhhccCCHHH
Q 004521 602 NRVVGT---------YDGQFSIKSDVFSFGILLLEIVSGKKNRGFYRSDTKVNLIGHLWDEGIPLRLIDACIQDSCNLAD 672 (747)
Q Consensus 602 ~~~~~~---------~~~~~s~ksDVwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~ 672 (747)
....|+ ....++.++|||||||++|||++|+.||.... ............ . .+ ....
T Consensus 153 ~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~---~~~~~~~~~~~~-~-~~-----p~~~---- 218 (323)
T cd05571 153 KTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQD---HEKLFELILMEE-I-RF-----PRTL---- 218 (323)
T ss_pred cceecCccccChhhhcCCCCCccccCcccchhhhhhhcCCCCCCCCC---HHHHHHHHHcCC-C-CC-----CCCC----
Confidence 111111 14568899999999999999999999974321 111222111111 0 11 1111
Q ss_pred HHHHHHHHHhccCCCCCCCC-----CHHHHHH
Q 004521 673 VIRCIHIGLLCVQQHPEDRP-----CMPSVIL 699 (747)
Q Consensus 673 ~~~~~~l~~~Cl~~dP~~RP-----t~~~v~~ 699 (747)
...+.+++.+||+.||++|| ++.++++
T Consensus 219 ~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~ 250 (323)
T cd05571 219 SPEAKSLLAGLLKKDPKQRLGGGPEDAKEIME 250 (323)
T ss_pred CHHHHHHHHHHccCCHHHcCCCCCCCHHHHHc
Confidence 12355677899999999999 7888875
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=295.25 Aligned_cols=247 Identities=27% Similarity=0.451 Sum_probs=190.3
Q ss_pred cCCCccceecccCCeeEEEEEecC-C---cEEEEEEeccc-ccccHHHHHHHHHHHhccCCCceeeEEeEEEeCCeeEEE
Q 004521 440 DNFSINNKLGEGGFGPVYKGTLVD-G---QEIAVKRLSKI-SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLI 514 (747)
Q Consensus 440 ~~~~~~~~lg~G~fg~Vy~~~~~~-g---~~vavK~l~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV 514 (747)
++|+..+.||+|+||.||+|+... + ..+|+|.++.. .....+.+..|++++++++|+||+++.+++...+..++|
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 84 (268)
T cd05063 5 SHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFKPAMII 84 (268)
T ss_pred HHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCCCeeEEEEEEccCCCcEEE
Confidence 467888999999999999999753 3 37999998753 233456789999999999999999999999999999999
Q ss_pred EecCCCCChhhHhhhcCCCCcCChhHHHHHHHHHHHHHHHhhhcCCCceEecccCcCcEEEcCCCCceEecccCccccCC
Q 004521 515 YEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGG 594 (747)
Q Consensus 515 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NIll~~~~~~kl~DFGla~~~~~ 594 (747)
|||+++++|.+++... ...+++.++..++.|++.||+|||+.+ ++||||||+||+++.++.+||+|||+++....
T Consensus 85 ~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~ 159 (268)
T cd05063 85 TEYMENGALDKYLRDH--DGEFSSYQLVGMLRGIAAGMKYLSDMN---YVHRDLAARNILVNSNLECKVSDFGLSRVLED 159 (268)
T ss_pred EEcCCCCCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccchhhEEEcCCCcEEECCCccceeccc
Confidence 9999999999998653 245899999999999999999999988 99999999999999999999999999886643
Q ss_pred CCCccccc--------eeeec--cCCCCCccccchhHHHHHHHHHh-CCCCCCCCCCcchhhhhHhHHhcCCcccccchh
Q 004521 595 DETEGNTN--------RVVGT--YDGQFSIKSDVFSFGILLLEIVS-GKKNRGFYRSDTKVNLIGHLWDEGIPLRLIDAC 663 (747)
Q Consensus 595 ~~~~~~~~--------~~~~~--~~~~~s~ksDVwS~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 663 (747)
........ ..... ....++.++|||||||++|||++ |+.|+..... ....... ..+......
T Consensus 160 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell~~g~~p~~~~~~---~~~~~~i-~~~~~~~~~--- 232 (268)
T cd05063 160 DPEGTYTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSN---HEVMKAI-NDGFRLPAP--- 232 (268)
T ss_pred ccccceeccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHHHhCCCCCCCcCCH---HHHHHHH-hcCCCCCCC---
Confidence 22111000 00011 13567889999999999999998 9999743322 1122221 111111100
Q ss_pred hhccCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhcCC
Q 004521 664 IQDSCNLADVIRCIHIGLLCVQQHPEDRPCMPSVILMLGSE 704 (747)
Q Consensus 664 l~~~~~~~~~~~~~~l~~~Cl~~dP~~RPt~~~v~~~L~~~ 704 (747)
. .....+.+++.+||+.+|++||+|.+|++.|+..
T Consensus 233 --~----~~~~~~~~li~~c~~~~p~~Rp~~~~i~~~l~~~ 267 (268)
T cd05063 233 --M----DCPSAVYQLMLQCWQQDRARRPRFVDIVNLLDKL 267 (268)
T ss_pred --C----CCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 0 1123467889999999999999999999999764
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-34 Score=295.18 Aligned_cols=247 Identities=26% Similarity=0.357 Sum_probs=185.1
Q ss_pred HHhcCCCccceecccCCeeEEEEEec-CCcEEEEEEecccc--------------cccHHHHHHHHHHHhccCCCceeeE
Q 004521 437 NATDNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKIS--------------EQGLKELKNEVILFSKLQHRNLVKL 501 (747)
Q Consensus 437 ~~~~~~~~~~~lg~G~fg~Vy~~~~~-~g~~vavK~l~~~~--------------~~~~~~~~~E~~~l~~l~H~niv~l 501 (747)
...+.|++.+.||+|.||.|-+|+.. +++.||||++.+.. ....+..++|+.+|++++|||||+|
T Consensus 94 k~lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV~L 173 (576)
T KOG0585|consen 94 KQLNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVVKL 173 (576)
T ss_pred eehhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCeeEE
Confidence 34578999999999999999999964 58999999996521 1123578999999999999999999
Q ss_pred EeEEEeC--CeeEEEEecCCCCChhhHhhhcCCCCc-CChhHHHHHHHHHHHHHHHhhhcCCCceEecccCcCcEEEcCC
Q 004521 502 LGCCIQG--EEKLLIYEFMPNKSLDSFIFDQTRRTL-LDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQD 578 (747)
Q Consensus 502 ~g~~~~~--~~~~lV~E~~~~gsL~~~l~~~~~~~~-l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NIll~~~ 578 (747)
+.+..+. +..|||+|||..|.+...- .... +...+++++++++..||+|||.++ ||||||||+|+||+++
T Consensus 174 iEvLDDP~s~~~YlVley~s~G~v~w~p----~d~~els~~~Ar~ylrDvv~GLEYLH~Qg---iiHRDIKPsNLLl~~~ 246 (576)
T KOG0585|consen 174 IEVLDDPESDKLYLVLEYCSKGEVKWCP----PDKPELSEQQARKYLRDVVLGLEYLHYQG---IIHRDIKPSNLLLSSD 246 (576)
T ss_pred EEeecCcccCceEEEEEeccCCccccCC----CCcccccHHHHHHHHHHHHHHHHHHHhcC---eeccccchhheEEcCC
Confidence 9998764 5789999999998875432 2333 899999999999999999999999 9999999999999999
Q ss_pred CCceEecccCccccCCCCCcc---ccceeeecc-------------CCCCCccccchhHHHHHHHHHhCCCCCCCCCCcc
Q 004521 579 MNPKISDFGLVRTFGGDETEG---NTNRVVGTY-------------DGQFSIKSDVFSFGILLLEIVSGKKNRGFYRSDT 642 (747)
Q Consensus 579 ~~~kl~DFGla~~~~~~~~~~---~~~~~~~~~-------------~~~~s~ksDVwS~Gvvl~elltg~~p~~~~~~~~ 642 (747)
|++||+|||.+.......... ......||. ....+.+.||||+||+||.|+.|+.||- .+.
T Consensus 247 g~VKIsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~---~~~ 323 (576)
T KOG0585|consen 247 GTVKISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFF---DDF 323 (576)
T ss_pred CcEEeeccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCcc---cch
Confidence 999999999987652211110 011122321 1234568999999999999999999963 222
Q ss_pred hhhhhHhHHhcCCcccccchhhhccCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhc
Q 004521 643 KVNLIGHLWDEGIPLRLIDACIQDSCNLADVIRCIHIGLLCVQQHPEDRPCMPSVILMLG 702 (747)
Q Consensus 643 ~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dP~~RPt~~~v~~~L~ 702 (747)
...+...+..+. +......+.-+.+..|++++|++||++|.+..+|....=
T Consensus 324 ~~~l~~KIvn~p---------L~fP~~pe~~e~~kDli~~lL~KdP~~Ri~l~~ik~Hpw 374 (576)
T KOG0585|consen 324 ELELFDKIVNDP---------LEFPENPEINEDLKDLIKRLLEKDPEQRITLPDIKLHPW 374 (576)
T ss_pred HHHHHHHHhcCc---------ccCCCcccccHHHHHHHHHHhhcChhheeehhhheecce
Confidence 223333332221 111122233445567888999999999999999987653
|
|
| >KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-35 Score=305.53 Aligned_cols=237 Identities=25% Similarity=0.392 Sum_probs=188.6
Q ss_pred cCCCccceecccCCeeEEEEEecC-CcEEEEEEeccc--ccccHHHHHHHHHHHhccCCCceeeEEeEEEeCCeeEEEEe
Q 004521 440 DNFSINNKLGEGGFGPVYKGTLVD-GQEIAVKRLSKI--SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYE 516 (747)
Q Consensus 440 ~~~~~~~~lg~G~fg~Vy~~~~~~-g~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E 516 (747)
++|.+.+.||+|+||.||||+.+. .+.||+|.+.+. .+...+.+++|++|+++++|||||.++++|+...+.++|.|
T Consensus 2 e~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~~~vVte 81 (808)
T KOG0597|consen 2 EQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLESFETSAHLWVVTE 81 (808)
T ss_pred cchhHHHHhcCCccceeeecccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHhhcccceEEEEeh
Confidence 478888999999999999998765 789999999763 34556789999999999999999999999999999999999
Q ss_pred cCCCCChhhHhhhcCCCCcCChhHHHHHHHHHHHHHHHhhhcCCCceEecccCcCcEEEcCCCCceEecccCccccCCCC
Q 004521 517 FMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDE 596 (747)
Q Consensus 517 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~ 596 (747)
|+.+ +|..+|.. ...++++.+..|+.++..||.|||+.. |+|||+||+||||+..+++|++|||+||.+....
T Consensus 82 ~a~g-~L~~il~~---d~~lpEe~v~~~a~~LVsaL~yLhs~r---ilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~~~t 154 (808)
T KOG0597|consen 82 YAVG-DLFTILEQ---DGKLPEEQVRAIAYDLVSALYYLHSNR---ILHRDMKPQNILLEKGGTLKLCDFGLARAMSTNT 154 (808)
T ss_pred hhhh-hHHHHHHh---ccCCCHHHHHHHHHHHHHHHHHHHhcC---cccccCCcceeeecCCCceeechhhhhhhcccCc
Confidence 9986 99999954 445999999999999999999999988 9999999999999999999999999999876533
Q ss_pred Cccccceeeec---------cCCCCCccccchhHHHHHHHHHhCCCCCCCCCCcchhhhhHhHHhcCCcccccchhhhcc
Q 004521 597 TEGNTNRVVGT---------YDGQFSIKSDVFSFGILLLEIVSGKKNRGFYRSDTKVNLIGHLWDEGIPLRLIDACIQDS 667 (747)
Q Consensus 597 ~~~~~~~~~~~---------~~~~~s~ksDVwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~ 667 (747)
.- ...+.|+ .+.+|+..+|.||+||||||+.+|++||.. .....+...+..+......
T Consensus 155 ~v--ltsikGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~G~PPF~a---~si~~Lv~~I~~d~v~~p~-------- 221 (808)
T KOG0597|consen 155 SV--LTSIKGTPLYMAPELVEEQPYDHTSDLWSLGCILYELYVGQPPFYA---RSITQLVKSILKDPVKPPS-------- 221 (808)
T ss_pred ee--eeeccCcccccCHHHHcCCCccchhhHHHHHHHHHHHhcCCCCchH---HHHHHHHHHHhcCCCCCcc--------
Confidence 21 1122222 167899999999999999999999999631 1122233333333221110
Q ss_pred CCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 004521 668 CNLADVIRCIHIGLLCVQQHPEDRPCMPSVIL 699 (747)
Q Consensus 668 ~~~~~~~~~~~l~~~Cl~~dP~~RPt~~~v~~ 699 (747)
..-..+..+....|+.||.+|.+-.+++.
T Consensus 222 ---~~S~~f~nfl~gLL~kdP~~RltW~~Ll~ 250 (808)
T KOG0597|consen 222 ---TASSSFVNFLQGLLIKDPAQRLTWTDLLG 250 (808)
T ss_pred ---cccHHHHHHHHHHhhcChhhcccHHHHhc
Confidence 11112344555789999999999999875
|
|
| >KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-34 Score=279.23 Aligned_cols=188 Identities=28% Similarity=0.384 Sum_probs=165.7
Q ss_pred cCCCccceecccCCeeEEEEEecC-CcEEEEEEeccc---ccccHHHHHHHHHHHhccCCCceeeEEeEEEeCCeeEEEE
Q 004521 440 DNFSINNKLGEGGFGPVYKGTLVD-GQEIAVKRLSKI---SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIY 515 (747)
Q Consensus 440 ~~~~~~~~lg~G~fg~Vy~~~~~~-g~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 515 (747)
++|++.+.||.|+||.|.+++.+. |..+|+|++.+. .-...+...+|..+|+.+.||+++++++.+.+....+|||
T Consensus 44 ~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~~lymvm 123 (355)
T KOG0616|consen 44 QDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNSNLYMVM 123 (355)
T ss_pred hhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeeccCCeEEEEE
Confidence 578889999999999999999865 889999999863 2344567889999999999999999999999999999999
Q ss_pred ecCCCCChhhHhhhcCCCCcCChhHHHHHHHHHHHHHHHhhhcCCCceEecccCcCcEEEcCCCCceEecccCccccCCC
Q 004521 516 EFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGD 595 (747)
Q Consensus 516 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NIll~~~~~~kl~DFGla~~~~~~ 595 (747)
||+++|.|..+|+.. ..+++..+.-++.||+.||+|||+.+ |++|||||+|||||.+|.+||+|||+|+...+.
T Consensus 124 eyv~GGElFS~Lrk~---~rF~e~~arFYAAeivlAleylH~~~---iiYRDLKPENiLlD~~G~iKitDFGFAK~v~~r 197 (355)
T KOG0616|consen 124 EYVPGGELFSYLRKS---GRFSEPHARFYAAEIVLALEYLHSLD---IIYRDLKPENLLLDQNGHIKITDFGFAKRVSGR 197 (355)
T ss_pred eccCCccHHHHHHhc---CCCCchhHHHHHHHHHHHHHHHHhcC---eeeccCChHHeeeccCCcEEEEeccceEEecCc
Confidence 999999999999653 34888999999999999999999988 999999999999999999999999999987554
Q ss_pred CCccccceeeecc---------CCCCCccccchhHHHHHHHHHhCCCCCCCC
Q 004521 596 ETEGNTNRVVGTY---------DGQFSIKSDVFSFGILLLEIVSGKKNRGFY 638 (747)
Q Consensus 596 ~~~~~~~~~~~~~---------~~~~s~ksDVwS~Gvvl~elltg~~p~~~~ 638 (747)
+...+|+. ...|+.++|.|||||++|||+.|..||...
T Consensus 198 -----T~TlCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG~pPF~~~ 244 (355)
T KOG0616|consen 198 -----TWTLCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGYPPFYDD 244 (355)
T ss_pred -----EEEecCCccccChHHhhcCCCCcchhHHHHHHHHHHHHcCCCCCcCC
Confidence 23344443 578999999999999999999999997543
|
|
| >KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-34 Score=300.28 Aligned_cols=245 Identities=22% Similarity=0.328 Sum_probs=187.1
Q ss_pred HHHhcCCCccceecccCCeeEEEEEecC-CcEEEEEEeccc---ccccHHHHHHHHHHHhccCCCceeeEEeEEEeCCee
Q 004521 436 ANATDNFSINNKLGEGGFGPVYKGTLVD-GQEIAVKRLSKI---SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEK 511 (747)
Q Consensus 436 ~~~~~~~~~~~~lg~G~fg~Vy~~~~~~-g~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~ 511 (747)
....++|+++++||+|+||.||+++-++ |..+|+|+|++. .....+.++.|..+|....+|+||+|+..|.+.+.+
T Consensus 137 r~~~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~~~L 216 (550)
T KOG0605|consen 137 RLSLDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQDKEYL 216 (550)
T ss_pred cCCcccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecCCCee
Confidence 3356799999999999999999999766 999999999873 345677899999999999999999999999999999
Q ss_pred EEEEecCCCCChhhHhhhcCCCCcCChhHHHHHHHHHHHHHHHhhhcCCCceEecccCcCcEEEcCCCCceEecccCccc
Q 004521 512 LLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRT 591 (747)
Q Consensus 512 ~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NIll~~~~~~kl~DFGla~~ 591 (747)
||||||++||++..+|.. ...|++..+...+.+++-|++-||+.| +|||||||+|+|||..|++||+||||+.-
T Consensus 217 YLiMEylPGGD~mTLL~~---~~~L~e~~arfYiaE~vlAI~~iH~~g---yIHRDIKPdNlLiD~~GHiKLSDFGLs~g 290 (550)
T KOG0605|consen 217 YLIMEYLPGGDMMTLLMR---KDTLTEDWARFYIAETVLAIESIHQLG---YIHRDIKPDNLLIDAKGHIKLSDFGLSTG 290 (550)
T ss_pred EEEEEecCCccHHHHHHh---cCcCchHHHHHHHHHHHHHHHHHHHcC---cccccCChhheeecCCCCEeeccccccch
Confidence 999999999999999954 456888888889999999999999998 99999999999999999999999999853
Q ss_pred cCCCCC---------------ccccce------------------------------eeecc---------CCCCCcccc
Q 004521 592 FGGDET---------------EGNTNR------------------------------VVGTY---------DGQFSIKSD 617 (747)
Q Consensus 592 ~~~~~~---------------~~~~~~------------------------------~~~~~---------~~~~s~ksD 617 (747)
+..... ...... .+|++ +..|+..+|
T Consensus 291 l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kgY~~~cD 370 (550)
T KOG0605|consen 291 LDKKHRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKGYGKECD 370 (550)
T ss_pred hhhhhhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCCCCcccc
Confidence 321000 000000 11221 456899999
Q ss_pred chhHHHHHHHHHhCCCCCCCCCCcchhhhhHhH--HhcCCcccccchhhhccCCHHHHHHHHHHHHhccCCCCCCCCC--
Q 004521 618 VFSFGILLLEIVSGKKNRGFYRSDTKVNLIGHL--WDEGIPLRLIDACIQDSCNLADVIRCIHIGLLCVQQHPEDRPC-- 693 (747)
Q Consensus 618 VwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~--~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dP~~RPt-- 693 (747)
+||+|||+||||.|-+||....+. .....+ |+.... ..+.. ... .++.+++.+|+. ||++|--
T Consensus 371 wWSLG~ImyEmLvGyPPF~s~tp~---~T~rkI~nwr~~l~--fP~~~---~~s----~eA~DLI~rll~-d~~~RLG~~ 437 (550)
T KOG0605|consen 371 WWSLGCIMYEMLVGYPPFCSETPQ---ETYRKIVNWRETLK--FPEEV---DLS----DEAKDLITRLLC-DPENRLGSK 437 (550)
T ss_pred HHHHHHHHHHHHhCCCCCCCCCHH---HHHHHHHHHhhhcc--CCCcC---ccc----HHHHHHHHHHhc-CHHHhcCcc
Confidence 999999999999999997543332 222222 222211 11100 011 345567778888 9999975
Q ss_pred -HHHHHH
Q 004521 694 -MPSVIL 699 (747)
Q Consensus 694 -~~~v~~ 699 (747)
+.||-+
T Consensus 438 G~~EIK~ 444 (550)
T KOG0605|consen 438 GAEEIKK 444 (550)
T ss_pred cHHHHhc
Confidence 555544
|
|
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-33 Score=292.50 Aligned_cols=245 Identities=29% Similarity=0.485 Sum_probs=191.8
Q ss_pred cCCCccceecccCCeeEEEEEecCCcEEEEEEecccccccHHHHHHHHHHHhccCCCceeeEEeEEEeCCeeEEEEecCC
Q 004521 440 DNFSINNKLGEGGFGPVYKGTLVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMP 519 (747)
Q Consensus 440 ~~~~~~~~lg~G~fg~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~ 519 (747)
++|++.+.||+|+||.||+|... |+.||||.+..... ..+++.+|+.++++++|+||+++++++......++||||++
T Consensus 6 ~~~~~~~~ig~g~~g~v~~~~~~-~~~v~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~ 83 (256)
T cd05039 6 KELKLGATIGKGEFGDVMLGDYR-GQKVAVKCLKDDST-AAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLYIVTEYMA 83 (256)
T ss_pred hhccceeeeecCCCceEEEEEec-CcEEEEEEeccchh-HHHHHHHHHHHHHhcCCcceeeeEEEEcCCCCeEEEEEecC
Confidence 57888999999999999999874 78999999976433 56789999999999999999999999999999999999999
Q ss_pred CCChhhHhhhcCCCCcCChhHHHHHHHHHHHHHHHhhhcCCCceEecccCcCcEEEcCCCCceEecccCccccCCCCCcc
Q 004521 520 NKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEG 599 (747)
Q Consensus 520 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~ 599 (747)
+++|.+++..... ..+++..+..++.|++.||.|||+.+ ++||||||+||+++.++.+||+|||+++.........
T Consensus 84 ~~~L~~~~~~~~~-~~~~~~~~~~~~~qi~~~l~~lh~~~---i~H~di~p~Nili~~~~~~~l~d~g~~~~~~~~~~~~ 159 (256)
T cd05039 84 KGSLVDYLRSRGR-AVITLAQQLGFALDVCEGMEYLEEKN---FVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQDSG 159 (256)
T ss_pred CCcHHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHhCC---ccchhcccceEEEeCCCCEEEcccccccccccccccC
Confidence 9999999865332 35899999999999999999999988 9999999999999999999999999998764322211
Q ss_pred ccc--eeee--ccCCCCCccccchhHHHHHHHHHh-CCCCCCCCCCcchhhhhHhHHhcCCcccccchhhhccCCHHHHH
Q 004521 600 NTN--RVVG--TYDGQFSIKSDVFSFGILLLEIVS-GKKNRGFYRSDTKVNLIGHLWDEGIPLRLIDACIQDSCNLADVI 674 (747)
Q Consensus 600 ~~~--~~~~--~~~~~~s~ksDVwS~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~ 674 (747)
... .... ...+.++.++||||||+++|||++ |..|+..... ...... ...+......+ . ...
T Consensus 160 ~~~~~~~ape~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~---~~~~~~-~~~~~~~~~~~-----~----~~~ 226 (256)
T cd05039 160 KLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPL---KDVVPH-VEKGYRMEAPE-----G----CPP 226 (256)
T ss_pred CCcccccCchhhcCCcCCcHHHHHHHHHHHHHHHhcCCCCCCCCCH---HHHHHH-HhcCCCCCCcc-----C----CCH
Confidence 111 0001 124567889999999999999998 8888653321 111111 12221111111 1 123
Q ss_pred HHHHHHHhccCCCCCCCCCHHHHHHHhcC
Q 004521 675 RCIHIGLLCVQQHPEDRPCMPSVILMLGS 703 (747)
Q Consensus 675 ~~~~l~~~Cl~~dP~~RPt~~~v~~~L~~ 703 (747)
.+.+++.+||+.+|++||++.+|+++|++
T Consensus 227 ~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 255 (256)
T cd05039 227 EVYKVMKDCWELDPAKRPTFKQLREQLAL 255 (256)
T ss_pred HHHHHHHHHhccChhhCcCHHHHHHHHhc
Confidence 46678889999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-34 Score=297.87 Aligned_cols=247 Identities=28% Similarity=0.461 Sum_probs=189.2
Q ss_pred cCCCccceecccCCeeEEEEEec------CCcEEEEEEecccccccHHHHHHHHHHHhccCCCceeeEEeEEEeCCeeEE
Q 004521 440 DNFSINNKLGEGGFGPVYKGTLV------DGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLL 513 (747)
Q Consensus 440 ~~~~~~~~lg~G~fg~Vy~~~~~------~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~l 513 (747)
.+|...++||+|+||.||++... ++..+|+|.+..........+.+|++++++++|+||+++++++......++
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 84 (280)
T cd05092 5 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRFYGVCTEGRPLLM 84 (280)
T ss_pred HhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcCCHHHHHHHHHHHHHHhcCCCCCCceEEEEEecCCceEE
Confidence 46777899999999999999742 256899999887666667789999999999999999999999999999999
Q ss_pred EEecCCCCChhhHhhhcCC------------CCcCChhHHHHHHHHHHHHHHHhhhcCCCceEecccCcCcEEEcCCCCc
Q 004521 514 IYEFMPNKSLDSFIFDQTR------------RTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNP 581 (747)
Q Consensus 514 V~E~~~~gsL~~~l~~~~~------------~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NIll~~~~~~ 581 (747)
||||+++++|.+++..... ...+++..++.++.|++.||+|||+.+ ++||||||+|||+++++.+
T Consensus 85 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~---i~H~dlkp~nil~~~~~~~ 161 (280)
T cd05092 85 VFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASLH---FVHRDLATRNCLVGQGLVV 161 (280)
T ss_pred EEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHCC---eecccccHhhEEEcCCCCE
Confidence 9999999999999865421 134788999999999999999999988 9999999999999999999
Q ss_pred eEecccCccccCCCCCccccc-------eeee--ccCCCCCccccchhHHHHHHHHHh-CCCCCCCCCCcchhhhhHhHH
Q 004521 582 KISDFGLVRTFGGDETEGNTN-------RVVG--TYDGQFSIKSDVFSFGILLLEIVS-GKKNRGFYRSDTKVNLIGHLW 651 (747)
Q Consensus 582 kl~DFGla~~~~~~~~~~~~~-------~~~~--~~~~~~s~ksDVwS~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~ 651 (747)
||+|||+++............ .... .....++.++|||||||++|||++ |+.|+..... .......
T Consensus 162 kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~---~~~~~~~- 237 (280)
T cd05092 162 KIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSN---TEAIECI- 237 (280)
T ss_pred EECCCCceeEcCCCceeecCCCccccccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCccCCH---HHHHHHH-
Confidence 999999997654322111000 0001 114568899999999999999998 8888642221 1111111
Q ss_pred hcCCcccccchhhhccCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhc
Q 004521 652 DEGIPLRLIDACIQDSCNLADVIRCIHIGLLCVQQHPEDRPCMPSVILMLG 702 (747)
Q Consensus 652 ~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dP~~RPt~~~v~~~L~ 702 (747)
..+....... .. ...+.+++.+||+.||++||++.+|++.|+
T Consensus 238 ~~~~~~~~~~-----~~----~~~~~~li~~cl~~~P~~Rp~~~~l~~~l~ 279 (280)
T cd05092 238 TQGRELERPR-----TC----PPEVYAIMQGCWQREPQQRMVIKDIHSRLQ 279 (280)
T ss_pred HcCccCCCCC-----CC----CHHHHHHHHHHccCChhhCCCHHHHHHHHh
Confidence 1111111111 11 123567888999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-34 Score=301.23 Aligned_cols=252 Identities=29% Similarity=0.461 Sum_probs=191.8
Q ss_pred HhcCCCccceecccCCeeEEEEEecC------CcEEEEEEeccc-ccccHHHHHHHHHHHhcc-CCCceeeEEeEEEeCC
Q 004521 438 ATDNFSINNKLGEGGFGPVYKGTLVD------GQEIAVKRLSKI-SEQGLKELKNEVILFSKL-QHRNLVKLLGCCIQGE 509 (747)
Q Consensus 438 ~~~~~~~~~~lg~G~fg~Vy~~~~~~------g~~vavK~l~~~-~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~ 509 (747)
..++|++.+.||+|+||.||++...+ ...+|+|.+... ......++.+|+.++.++ +|+||+++++++..++
T Consensus 10 ~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~ 89 (293)
T cd05053 10 PRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGVCTQEG 89 (293)
T ss_pred CHhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEcCCC
Confidence 34578888999999999999998643 368999998753 233456788999999999 8999999999999999
Q ss_pred eeEEEEecCCCCChhhHhhhc-------------CCCCcCChhHHHHHHHHHHHHHHHhhhcCCCceEecccCcCcEEEc
Q 004521 510 EKLLIYEFMPNKSLDSFIFDQ-------------TRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLD 576 (747)
Q Consensus 510 ~~~lV~E~~~~gsL~~~l~~~-------------~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NIll~ 576 (747)
..++||||+++|+|.+++... .....+++..++.++.|++.||.|||+.+ |+||||||+||+++
T Consensus 90 ~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~---ivH~dlkp~Nil~~ 166 (293)
T cd05053 90 PLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASKK---CIHRDLAARNVLVT 166 (293)
T ss_pred CeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHCC---ccccccceeeEEEc
Confidence 999999999999999998642 12345889999999999999999999988 99999999999999
Q ss_pred CCCCceEecccCccccCCCCCccccc-------eeeec--cCCCCCccccchhHHHHHHHHHh-CCCCCCCCCCcchhhh
Q 004521 577 QDMNPKISDFGLVRTFGGDETEGNTN-------RVVGT--YDGQFSIKSDVFSFGILLLEIVS-GKKNRGFYRSDTKVNL 646 (747)
Q Consensus 577 ~~~~~kl~DFGla~~~~~~~~~~~~~-------~~~~~--~~~~~s~ksDVwS~Gvvl~ellt-g~~p~~~~~~~~~~~~ 646 (747)
.++.+||+|||+++.+.......... ..... ....++.++|||||||++|||++ |..|+...... ..
T Consensus 167 ~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~---~~ 243 (293)
T cd05053 167 EDHVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVE---EL 243 (293)
T ss_pred CCCeEEeCccccccccccccceeccCCCCCCccccCHHHhccCCcCcccceeehhhHHHHHhcCCCCCCCCCCHH---HH
Confidence 99999999999998664322111000 00011 24568899999999999999998 88886432211 11
Q ss_pred hHhHHhcCCcccccchhhhccCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhcCCC
Q 004521 647 IGHLWDEGIPLRLIDACIQDSCNLADVIRCIHIGLLCVQQHPEDRPCMPSVILMLGSEI 705 (747)
Q Consensus 647 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dP~~RPt~~~v~~~L~~~~ 705 (747)
.. ....+..... .......+.+++.+||+.+|++|||+.+|++.|+..+
T Consensus 244 ~~-~~~~~~~~~~---------~~~~~~~~~~li~~~l~~~p~~Rps~~eil~~l~~~~ 292 (293)
T cd05053 244 FK-LLKEGYRMEK---------PQNCTQELYHLMRDCWHEVPSQRPTFKQLVEDLDRML 292 (293)
T ss_pred HH-HHHcCCcCCC---------CCCCCHHHHHHHHHHcccCcccCcCHHHHHHHHHHhh
Confidence 11 1112211111 0111234677889999999999999999999998653
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-34 Score=298.57 Aligned_cols=250 Identities=27% Similarity=0.425 Sum_probs=192.1
Q ss_pred hcCCCccceecccCCeeEEEEEecC-----CcEEEEEEeccc-ccccHHHHHHHHHHHhccCCCceeeEEeEEEe-CCee
Q 004521 439 TDNFSINNKLGEGGFGPVYKGTLVD-----GQEIAVKRLSKI-SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQ-GEEK 511 (747)
Q Consensus 439 ~~~~~~~~~lg~G~fg~Vy~~~~~~-----g~~vavK~l~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~-~~~~ 511 (747)
.++|.+.+.||+|+||.||+|...+ +..|++|++... .....+.+.+|+.++++++|+||+++++++.. ....
T Consensus 5 ~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~ 84 (280)
T cd05043 5 RDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILHVCIEDGEPP 84 (280)
T ss_pred hhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCCC
Confidence 4678889999999999999999765 688999998753 33446678999999999999999999999876 4678
Q ss_pred EEEEecCCCCChhhHhhhcCCC-----CcCChhHHHHHHHHHHHHHHHhhhcCCCceEecccCcCcEEEcCCCCceEecc
Q 004521 512 LLIYEFMPNKSLDSFIFDQTRR-----TLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDF 586 (747)
Q Consensus 512 ~lV~E~~~~gsL~~~l~~~~~~-----~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NIll~~~~~~kl~DF 586 (747)
++++||+++++|.+++...... ..+++..+..++.|++.||+|||+.+ ++||||||+||++++++.+||+||
T Consensus 85 ~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~---i~H~di~p~nil~~~~~~~kl~d~ 161 (280)
T cd05043 85 FVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKRG---VIHKDIAARNCVIDEELQVKITDN 161 (280)
T ss_pred EEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccCHhhEEEcCCCcEEECCC
Confidence 9999999999999998654322 46899999999999999999999988 999999999999999999999999
Q ss_pred cCccccCCCCCccccc-------eeeec--cCCCCCccccchhHHHHHHHHHh-CCCCCCCCCCcchhhhhHhHHhcCCc
Q 004521 587 GLVRTFGGDETEGNTN-------RVVGT--YDGQFSIKSDVFSFGILLLEIVS-GKKNRGFYRSDTKVNLIGHLWDEGIP 656 (747)
Q Consensus 587 Gla~~~~~~~~~~~~~-------~~~~~--~~~~~s~ksDVwS~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~ 656 (747)
|+++.+.......... ..... ....++.++||||||+++||+++ |+.|+.... ....... ...+..
T Consensus 162 g~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~---~~~~~~~-~~~~~~ 237 (280)
T cd05043 162 ALSRDLFPMDYHCLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEID---PFEMAAY-LKDGYR 237 (280)
T ss_pred CCcccccCCceEEeCCCCCcchhccCHHHHhcCCCCchhhHHHhHHHHHHHhcCCCCCcCcCC---HHHHHHH-HHcCCC
Confidence 9998764332211000 00000 14567899999999999999999 999864322 1222222 222211
Q ss_pred ccccchhhhccCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhcCC
Q 004521 657 LRLIDACIQDSCNLADVIRCIHIGLLCVQQHPEDRPCMPSVILMLGSE 704 (747)
Q Consensus 657 ~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dP~~RPt~~~v~~~L~~~ 704 (747)
.... .. ....+.+++.+||+.+|++||++.+|+++|+..
T Consensus 238 ~~~~-----~~----~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~~~ 276 (280)
T cd05043 238 LAQP-----IN----CPDELFAVMACCWALDPEERPSFSQLVQCLTDF 276 (280)
T ss_pred CCCC-----Cc----CCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHH
Confidence 1110 00 112466788899999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-33 Score=296.46 Aligned_cols=248 Identities=29% Similarity=0.472 Sum_probs=188.3
Q ss_pred hcCCCccceecccCCeeEEEEEecC------CcEEEEEEecccc-cccHHHHHHHHHHHhccCCCceeeEEeEEEeCCee
Q 004521 439 TDNFSINNKLGEGGFGPVYKGTLVD------GQEIAVKRLSKIS-EQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEK 511 (747)
Q Consensus 439 ~~~~~~~~~lg~G~fg~Vy~~~~~~------g~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~ 511 (747)
.++|.+.+.||+|+||.||+|.+.+ +..||+|.+.... ......|.+|+.++++++|+||+++++++.+....
T Consensus 5 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~ 84 (277)
T cd05036 5 RDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVRLIGVSFERLPR 84 (277)
T ss_pred HHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCc
Confidence 4578889999999999999998754 4678999886432 33446799999999999999999999999999999
Q ss_pred EEEEecCCCCChhhHhhhcCC----CCcCChhHHHHHHHHHHHHHHHhhhcCCCceEecccCcCcEEEcCCC---CceEe
Q 004521 512 LLIYEFMPNKSLDSFIFDQTR----RTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDM---NPKIS 584 (747)
Q Consensus 512 ~lV~E~~~~gsL~~~l~~~~~----~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NIll~~~~---~~kl~ 584 (747)
++||||+++++|.+++..... ...+++..++.++.||+.||+|||+.+ ++||||||+||+++.++ .+||+
T Consensus 85 ~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~nil~~~~~~~~~~kl~ 161 (277)
T cd05036 85 FILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEENH---FIHRDIAARNCLLTCKGPGRVAKIA 161 (277)
T ss_pred EEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccchheEEEeccCCCcceEec
Confidence 999999999999999865432 235889999999999999999999988 99999999999998764 58999
Q ss_pred cccCccccCCCCCccccc-------eeeec--cCCCCCccccchhHHHHHHHHHh-CCCCCCCCCCcchhhhhHhHHhcC
Q 004521 585 DFGLVRTFGGDETEGNTN-------RVVGT--YDGQFSIKSDVFSFGILLLEIVS-GKKNRGFYRSDTKVNLIGHLWDEG 654 (747)
Q Consensus 585 DFGla~~~~~~~~~~~~~-------~~~~~--~~~~~s~ksDVwS~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~ 654 (747)
|||+++.+.......... ...+. ....++.++|||||||++|||++ |..||...... ..........
T Consensus 162 dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~~g~~pf~~~~~~---~~~~~~~~~~ 238 (277)
T cd05036 162 DFGMARDIYRASYYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQ---EVMEFVTGGG 238 (277)
T ss_pred cCccccccCCccceecCCCCCccHhhCCHHHHhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHH---HHHHHHHcCC
Confidence 999998763322111000 00011 14668999999999999999997 88886532221 1221111111
Q ss_pred CcccccchhhhccCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhc
Q 004521 655 IPLRLIDACIQDSCNLADVIRCIHIGLLCVQQHPEDRPCMPSVILMLG 702 (747)
Q Consensus 655 ~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dP~~RPt~~~v~~~L~ 702 (747)
.... .... ...+.+++.+||+.+|++||++.+|++.|+
T Consensus 239 -~~~~-----~~~~----~~~~~~~i~~cl~~~p~~Rps~~~vl~~l~ 276 (277)
T cd05036 239 -RLDP-----PKGC----PGPVYRIMTDCWQHTPEDRPNFATILERIQ 276 (277)
T ss_pred -cCCC-----CCCC----CHHHHHHHHHHcCCCcccCcCHHHHHHHhh
Confidence 1111 0111 234667888999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-34 Score=299.35 Aligned_cols=247 Identities=30% Similarity=0.477 Sum_probs=186.8
Q ss_pred CCCccceecccCCeeEEEEEecC------CcEEEEEEeccccc-ccHHHHHHHHHHHhccCCCceeeEEeEEEeCCeeEE
Q 004521 441 NFSINNKLGEGGFGPVYKGTLVD------GQEIAVKRLSKISE-QGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLL 513 (747)
Q Consensus 441 ~~~~~~~lg~G~fg~Vy~~~~~~------g~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~l 513 (747)
+|.+.++||+|+||.||+|+..+ ++.||||+++.... ...+.+.+|+.++..++||||+++++++......++
T Consensus 6 ~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~~ 85 (283)
T cd05091 6 TVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQPLSM 85 (283)
T ss_pred HHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCCceEE
Confidence 46678899999999999998643 47899999975332 234678899999999999999999999999999999
Q ss_pred EEecCCCCChhhHhhhcC-------------CCCcCChhHHHHHHHHHHHHHHHhhhcCCCceEecccCcCcEEEcCCCC
Q 004521 514 IYEFMPNKSLDSFIFDQT-------------RRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMN 580 (747)
Q Consensus 514 V~E~~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NIll~~~~~ 580 (747)
++||+++++|.+++.... ....+++..+..++.|++.||.|||+.+ |+||||||+||++++++.
T Consensus 86 ~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~g---i~H~dlkp~Nil~~~~~~ 162 (283)
T cd05091 86 IFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSHH---VVHKDLATRNVLVFDKLN 162 (283)
T ss_pred EEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHcC---ccccccchhheEecCCCc
Confidence 999999999999985321 1234788889999999999999999988 999999999999999999
Q ss_pred ceEecccCccccCCCCCccccc-------eeee--ccCCCCCccccchhHHHHHHHHHh-CCCCCCCCCCcchhhhhHhH
Q 004521 581 PKISDFGLVRTFGGDETEGNTN-------RVVG--TYDGQFSIKSDVFSFGILLLEIVS-GKKNRGFYRSDTKVNLIGHL 650 (747)
Q Consensus 581 ~kl~DFGla~~~~~~~~~~~~~-------~~~~--~~~~~~s~ksDVwS~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~ 650 (747)
+||+|||+++............ .... ...+.++.++||||||+++|||++ |..|+..... .......
T Consensus 163 ~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~---~~~~~~i 239 (283)
T cd05091 163 VKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSN---QDVIEMI 239 (283)
T ss_pred eEecccccccccccchheeeccCccCCccccCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCH---HHHHHHH
Confidence 9999999988654322111000 0000 014668899999999999999998 7777543221 1222221
Q ss_pred HhcCCcccccchhhhccCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhcC
Q 004521 651 WDEGIPLRLIDACIQDSCNLADVIRCIHIGLLCVQQHPEDRPCMPSVILMLGS 703 (747)
Q Consensus 651 ~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dP~~RPt~~~v~~~L~~ 703 (747)
..+...... ... ...+.+++.+||+.+|.+||++.+|++.|+.
T Consensus 240 -~~~~~~~~~-----~~~----~~~~~~li~~cl~~~p~~RP~~~~i~~~l~~ 282 (283)
T cd05091 240 -RNRQVLPCP-----DDC----PAWVYTLMLECWNEFPSRRPRFKDIHSRLRT 282 (283)
T ss_pred -HcCCcCCCC-----CCC----CHHHHHHHHHHhCCCcccCCCHHHHHHHhhC
Confidence 222211111 111 2236678889999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-33 Score=296.15 Aligned_cols=255 Identities=24% Similarity=0.415 Sum_probs=187.5
Q ss_pred cCCCccceecccCCeeEEEEEec-----CCcEEEEEEecccccccHHHHHHHHHHHhccCCCceeeEEeEEEeC--CeeE
Q 004521 440 DNFSINNKLGEGGFGPVYKGTLV-----DGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQG--EEKL 512 (747)
Q Consensus 440 ~~~~~~~~lg~G~fg~Vy~~~~~-----~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~--~~~~ 512 (747)
++|++.+.||+|+||.||++... +++.||+|++........+.|.+|++++++++||||+++++++... ...+
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 83 (284)
T cd05081 4 RHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLR 83 (284)
T ss_pred ccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCCCceE
Confidence 46888899999999999999753 4789999999876566677899999999999999999999987543 4578
Q ss_pred EEEecCCCCChhhHhhhcCCCCcCChhHHHHHHHHHHHHHHHhhhcCCCceEecccCcCcEEEcCCCCceEecccCcccc
Q 004521 513 LIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTF 592 (747)
Q Consensus 513 lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NIll~~~~~~kl~DFGla~~~ 592 (747)
+||||+++++|.+++... ...+++..+..++.|++.||+|||+.+ |+||||||+||++++++.+||+|||+++.+
T Consensus 84 lv~e~~~~~~L~~~l~~~--~~~l~~~~~~~~~~~l~~aL~~LH~~~---i~H~dlkp~nili~~~~~~~l~dfg~~~~~ 158 (284)
T cd05081 84 LVMEYLPYGSLRDYLQKH--RERLDHRKLLLYASQICKGMEYLGSKR---YVHRDLATRNILVESENRVKIGDFGLTKVL 158 (284)
T ss_pred EEEEecCCCCHHHHHHhc--CcCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCCHhhEEECCCCeEEECCCcccccc
Confidence 999999999999998543 235899999999999999999999988 999999999999999999999999999876
Q ss_pred CCCCCcccc------c-eeeec---cCCCCCccccchhHHHHHHHHHhCCCCCCCCCCcchhhhhHhHHhcCCc-cc---
Q 004521 593 GGDETEGNT------N-RVVGT---YDGQFSIKSDVFSFGILLLEIVSGKKNRGFYRSDTKVNLIGHLWDEGIP-LR--- 658 (747)
Q Consensus 593 ~~~~~~~~~------~-~~~~~---~~~~~s~ksDVwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~-~~--- 658 (747)
......... . ....+ .+..++.++|||||||++|||++|..++...... ..... ..... ..
T Consensus 159 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~----~~~~~-~~~~~~~~~~~ 233 (284)
T cd05081 159 PQDKEYYKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSCSPPAE----FMRMM-GNDKQGQMIVY 233 (284)
T ss_pred cCCCcceeecCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHHHHhhcCCcCCCcchh----hhhhc-ccccccccchH
Confidence 433211000 0 00010 1456888999999999999999987764321110 00000 00000 00
Q ss_pred ----ccchhhhccCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhcCC
Q 004521 659 ----LIDACIQDSCNLADVIRCIHIGLLCVQQHPEDRPCMPSVILMLGSE 704 (747)
Q Consensus 659 ----~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dP~~RPt~~~v~~~L~~~ 704 (747)
.+...............+.+++.+||+.+|++||||.+|++.|+..
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~~ 283 (284)
T cd05081 234 HLIELLKNNGRLPAPPGCPAEIYAIMKECWNNDPSQRPSFSELALQVEAI 283 (284)
T ss_pred HHHHHHhcCCcCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHhc
Confidence 0000000000001123466788899999999999999999999753
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-33 Score=291.67 Aligned_cols=252 Identities=24% Similarity=0.351 Sum_probs=193.1
Q ss_pred cCCCccceecccCCeeEEEEEec-CCcEEEEEEeccc---ccccHHHHHHHHHHHhccCCCceeeEEeEEEeCCeeEEEE
Q 004521 440 DNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKI---SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIY 515 (747)
Q Consensus 440 ~~~~~~~~lg~G~fg~Vy~~~~~-~g~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 515 (747)
++|++.+.||+|+||.||+|... +++.||+|.++.. .....+.+.+|++++++++|+||+++++++...+..++||
T Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 81 (267)
T cd08224 2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENNELNIVL 81 (267)
T ss_pred CceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEE
Confidence 57899999999999999999986 6899999988642 2334568999999999999999999999999999999999
Q ss_pred ecCCCCChhhHhhhcC-CCCcCChhHHHHHHHHHHHHHHHhhhcCCCceEecccCcCcEEEcCCCCceEecccCccccCC
Q 004521 516 EFMPNKSLDSFIFDQT-RRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGG 594 (747)
Q Consensus 516 E~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NIll~~~~~~kl~DFGla~~~~~ 594 (747)
||+++++|.+++.... ....+++.++..++.++++||.|||+.+ |+||||+|+||+++.++.++|+|||+++.+..
T Consensus 82 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~dl~p~nil~~~~~~~~l~d~~~~~~~~~ 158 (267)
T cd08224 82 ELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSKR---IMHRDIKPANVFITATGVVKLGDLGLGRFFSS 158 (267)
T ss_pred ecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhCC---EecCCcChhhEEECCCCcEEEeccceeeeccC
Confidence 9999999999986532 2445889999999999999999999988 99999999999999999999999999876543
Q ss_pred CCCccc----c-ceeee--ccCCCCCccccchhHHHHHHHHHhCCCCCCCCCCcchhhhhHhHHhcCCcccccchhhhcc
Q 004521 595 DETEGN----T-NRVVG--TYDGQFSIKSDVFSFGILLLEIVSGKKNRGFYRSDTKVNLIGHLWDEGIPLRLIDACIQDS 667 (747)
Q Consensus 595 ~~~~~~----~-~~~~~--~~~~~~s~ksDVwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~ 667 (747)
...... . ..... ..+..++.++|||||||++|||++|+.|+...... ....... ...+....+..
T Consensus 159 ~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~-~~~~~~~-~~~~~~~~~~~------ 230 (267)
T cd08224 159 KTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMN-LYSLCKK-IEKCDYPPLPA------ 230 (267)
T ss_pred CCcccceecCCccccCHHHhccCCCCchhcHHHHHHHHHHHHHCCCCcccCCcc-HHHHHhh-hhcCCCCCCCh------
Confidence 221110 0 00001 11456788999999999999999999996432211 1111111 11111111111
Q ss_pred CCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhcCC
Q 004521 668 CNLADVIRCIHIGLLCVQQHPEDRPCMPSVILMLGSE 704 (747)
Q Consensus 668 ~~~~~~~~~~~l~~~Cl~~dP~~RPt~~~v~~~L~~~ 704 (747)
......+.+++.+||+.+|++||++.+|+++|+..
T Consensus 231 --~~~~~~~~~~i~~cl~~~p~~Rp~~~~il~~~~~~ 265 (267)
T cd08224 231 --DHYSEELRDLVSRCINPDPEKRPDISYVLQVAKEM 265 (267)
T ss_pred --hhcCHHHHHHHHHHcCCCcccCCCHHHHHHHHHHh
Confidence 01123456788899999999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-33 Score=292.17 Aligned_cols=246 Identities=30% Similarity=0.462 Sum_probs=190.0
Q ss_pred hcCCCccceecccCCeeEEEEEecCCcEEEEEEecccccccHHHHHHHHHHHhccCCCceeeEEeEEEeCCeeEEEEecC
Q 004521 439 TDNFSINNKLGEGGFGPVYKGTLVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFM 518 (747)
Q Consensus 439 ~~~~~~~~~lg~G~fg~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~ 518 (747)
.++|++.++||+|+||.||+|...+++.||+|.+... ......+.+|+.++++++|+||+++++++. .+..++||||+
T Consensus 5 ~~~~~~~~~ig~G~~g~v~~~~~~~~~~~a~K~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~~ 82 (260)
T cd05067 5 RETLKLVKKLGAGQFGEVWMGYYNGHTKVAIKSLKQG-SMSPEAFLAEANLMKQLQHPRLVRLYAVVT-QEPIYIITEYM 82 (260)
T ss_pred hHHceeeeeeccCccceEEeeecCCCceEEEEEecCC-CCcHHHHHHHHHHHHhcCCcCeeeEEEEEc-cCCcEEEEEcC
Confidence 3578889999999999999999888999999998753 334568999999999999999999999864 56789999999
Q ss_pred CCCChhhHhhhcCCCCcCChhHHHHHHHHHHHHHHHhhhcCCCceEecccCcCcEEEcCCCCceEecccCccccCCCCCc
Q 004521 519 PNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETE 598 (747)
Q Consensus 519 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~ 598 (747)
++++|.+++.... ...+++.++..++.|++.||+|||+.+ ++||||||+||+++.++.++|+|||+++........
T Consensus 83 ~~~~L~~~~~~~~-~~~~~~~~~~~i~~~i~~al~~LH~~~---i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~~ 158 (260)
T cd05067 83 ENGSLVDFLKTPE-GIKLTINKLIDMAAQIAEGMAFIERKN---YIHRDLRAANILVSETLCCKIADFGLARLIEDNEYT 158 (260)
T ss_pred CCCCHHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHhcCC---eecccccHHhEEEcCCCCEEEccCcceeecCCCCcc
Confidence 9999999986533 345889999999999999999999988 999999999999999999999999999776522211
Q ss_pred ccc------ceeeec--cCCCCCccccchhHHHHHHHHHh-CCCCCCCCCCcchhhhhHhHHhcCCcccccchhhhccCC
Q 004521 599 GNT------NRVVGT--YDGQFSIKSDVFSFGILLLEIVS-GKKNRGFYRSDTKVNLIGHLWDEGIPLRLIDACIQDSCN 669 (747)
Q Consensus 599 ~~~------~~~~~~--~~~~~s~ksDVwS~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~ 669 (747)
... ...... ....++.++||||||+++|||++ |+.|+.... ....... ...+...... ..
T Consensus 159 ~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~---~~~~~~~-~~~~~~~~~~-----~~-- 227 (260)
T cd05067 159 AREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMT---NPEVIQN-LERGYRMPRP-----DN-- 227 (260)
T ss_pred cccCCcccccccCHHHhccCCcCcccchHHHHHHHHHHHhCCCCCCCCCC---hHHHHHH-HHcCCCCCCC-----CC--
Confidence 100 000000 13567889999999999999999 999875322 1111111 1222111111 11
Q ss_pred HHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhcC
Q 004521 670 LADVIRCIHIGLLCVQQHPEDRPCMPSVILMLGS 703 (747)
Q Consensus 670 ~~~~~~~~~l~~~Cl~~dP~~RPt~~~v~~~L~~ 703 (747)
....+.+++.+||+.+|++||++++++.+|+.
T Consensus 228 --~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 259 (260)
T cd05067 228 --CPEELYELMRLCWKEKPEERPTFEYLRSVLED 259 (260)
T ss_pred --CCHHHHHHHHHHccCChhhCCCHHHHHHHhhc
Confidence 11246778889999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-34 Score=295.76 Aligned_cols=247 Identities=19% Similarity=0.312 Sum_probs=186.9
Q ss_pred cCCCccceecccCCeeEEEEEec-CCcEEEEEEecccccccHHHHHHHHHHHhccCCCceeeEEeEEEeCCeeEEEEecC
Q 004521 440 DNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFM 518 (747)
Q Consensus 440 ~~~~~~~~lg~G~fg~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~ 518 (747)
++|++.+.||+|+||.||+|+.. +++.||+|++..........+.+|+.++++++||||+++++++...+..++||||+
T Consensus 9 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~~~iv~e~~ 88 (267)
T cd06646 9 HDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGSYLSREKLWICMEYC 88 (267)
T ss_pred hhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCccchHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEEEEEeCC
Confidence 57899999999999999999974 58899999987544455667889999999999999999999999999999999999
Q ss_pred CCCChhhHhhhcCCCCcCChhHHHHHHHHHHHHHHHhhhcCCCceEecccCcCcEEEcCCCCceEecccCccccCCCCCc
Q 004521 519 PNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETE 598 (747)
Q Consensus 519 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~ 598 (747)
++++|.+++.. ...+++..+..++.|++.||.|||+.+ |+||||||+||+++.++.+||+|||+++.+......
T Consensus 89 ~~~~L~~~~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~~~ 162 (267)
T cd06646 89 GGGSLQDIYHV---TGPLSELQIAYVCRETLQGLAYLHSKG---KMHRDIKGANILLTDNGDVKLADFGVAAKITATIAK 162 (267)
T ss_pred CCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEECCCCCEEECcCccceeecccccc
Confidence 99999998854 235789999999999999999999988 999999999999999999999999999865322111
Q ss_pred cc-----cce-----eeeccCCCCCccccchhHHHHHHHHHhCCCCCCCCCCcchhhhhHhHHhcCCcccccchhhhccC
Q 004521 599 GN-----TNR-----VVGTYDGQFSIKSDVFSFGILLLEIVSGKKNRGFYRSDTKVNLIGHLWDEGIPLRLIDACIQDSC 668 (747)
Q Consensus 599 ~~-----~~~-----~~~~~~~~~s~ksDVwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~ 668 (747)
.. ... ..+.....++.++|||||||++|||++|+.|+......... .......... +......
T Consensus 163 ~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~~---~~~~~~~~~~----~~~~~~~ 235 (267)
T cd06646 163 RKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRAL---FLMSKSNFQP----PKLKDKT 235 (267)
T ss_pred cCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhhh---eeeecCCCCC----CCCcccc
Confidence 00 000 00111345778999999999999999999996422211110 0000111000 0111000
Q ss_pred CHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHh
Q 004521 669 NLADVIRCIHIGLLCVQQHPEDRPCMPSVILML 701 (747)
Q Consensus 669 ~~~~~~~~~~l~~~Cl~~dP~~RPt~~~v~~~L 701 (747)
.....+.+++.+||+.+|++||++.+|++.|
T Consensus 236 --~~~~~~~~li~~~l~~~P~~Rp~~~~il~~l 266 (267)
T cd06646 236 --KWSSTFHNFVKISLTKNPKKRPTAERLLTHL 266 (267)
T ss_pred --ccCHHHHHHHHHHhhCChhhCcCHHHHhcCC
Confidence 0113456788899999999999999998754
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=302.10 Aligned_cols=233 Identities=22% Similarity=0.267 Sum_probs=178.1
Q ss_pred ecccCCeeEEEEEecC-CcEEEEEEeccc---ccccHHHHHHHHHHHhccCCCceeeEEeEEEeCCeeEEEEecCCCCCh
Q 004521 448 LGEGGFGPVYKGTLVD-GQEIAVKRLSKI---SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMPNKSL 523 (747)
Q Consensus 448 lg~G~fg~Vy~~~~~~-g~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gsL 523 (747)
||+|+||.||+|+..+ ++.||+|.+++. .......+.+|+.++++++||||+++++++...+..++||||+++|+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L 80 (312)
T cd05585 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGEL 80 (312)
T ss_pred CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCCCCCcH
Confidence 7999999999999764 789999998752 234456788999999999999999999999999999999999999999
Q ss_pred hhHhhhcCCCCcCChhHHHHHHHHHHHHHHHhhhcCCCceEecccCcCcEEEcCCCCceEecccCccccCCCCCccccce
Q 004521 524 DSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNTNR 603 (747)
Q Consensus 524 ~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~ 603 (747)
.+++... ..+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++......... ..
T Consensus 81 ~~~l~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~---i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~--~~ 152 (312)
T cd05585 81 FHHLQRE---GRFDLSRARFYTAELLCALENLHKFN---VIYRDLKPENILLDYQGHIALCDFGLCKLNMKDDDKT--NT 152 (312)
T ss_pred HHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCC---eEeCCCCHHHeEECCCCcEEEEECcccccCccCCCcc--cc
Confidence 9998642 34889999999999999999999988 9999999999999999999999999998643221111 11
Q ss_pred eeec---------cCCCCCccccchhHHHHHHHHHhCCCCCCCCCCcchhhhhHhHHhcCCcccccchhhhccCCHHHHH
Q 004521 604 VVGT---------YDGQFSIKSDVFSFGILLLEIVSGKKNRGFYRSDTKVNLIGHLWDEGIPLRLIDACIQDSCNLADVI 674 (747)
Q Consensus 604 ~~~~---------~~~~~s~ksDVwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~ 674 (747)
..|+ .+..++.++|||||||++|||++|+.||.... ............ ..+. ...+ .
T Consensus 153 ~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~---~~~~~~~~~~~~--~~~~-----~~~~----~ 218 (312)
T cd05585 153 FCGTPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDEN---VNEMYRKILQEP--LRFP-----DGFD----R 218 (312)
T ss_pred ccCCcccCCHHHHcCCCCCCccceechhHHHHHHHhCCCCcCCCC---HHHHHHHHHcCC--CCCC-----CcCC----H
Confidence 1111 14568899999999999999999999975322 112222221111 1111 1111 2
Q ss_pred HHHHHHHhccCCCCCCCCCHHHHHHHhc
Q 004521 675 RCIHIGLLCVQQHPEDRPCMPSVILMLG 702 (747)
Q Consensus 675 ~~~~l~~~Cl~~dP~~RPt~~~v~~~L~ 702 (747)
.+.+++.+||+.||.+||++.++.+.|.
T Consensus 219 ~~~~li~~~L~~dp~~R~~~~~~~e~l~ 246 (312)
T cd05585 219 DAKDLLIGLLSRDPTRRLGYNGAQEIKN 246 (312)
T ss_pred HHHHHHHHHcCCCHHHcCCCCCHHHHHc
Confidence 3556778999999999987655555554
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-33 Score=303.62 Aligned_cols=244 Identities=17% Similarity=0.235 Sum_probs=185.1
Q ss_pred cCCCccceecccCCeeEEEEEec-CCcEEEEEEeccc---ccccHHHHHHHHHHHhccCCCceeeEEeEEEeCCeeEEEE
Q 004521 440 DNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKI---SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIY 515 (747)
Q Consensus 440 ~~~~~~~~lg~G~fg~Vy~~~~~-~g~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 515 (747)
++|.+.+.||+|+||.||+++.. +++.||+|++++. ..+..+.+.+|+.+++.++|+||+++++++.+.+..++||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (330)
T cd05601 1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYLVM 80 (330)
T ss_pred CCceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCCeEEEEE
Confidence 46888999999999999999975 4889999999753 2334567889999999999999999999999999999999
Q ss_pred ecCCCCChhhHhhhcCCCCcCChhHHHHHHHHHHHHHHHhhhcCCCceEecccCcCcEEEcCCCCceEecccCccccCCC
Q 004521 516 EFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGD 595 (747)
Q Consensus 516 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NIll~~~~~~kl~DFGla~~~~~~ 595 (747)
||+++|+|.+++... ...+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++.+...
T Consensus 81 e~~~~~~L~~~l~~~--~~~l~~~~~~~~~~qi~~aL~~lH~~~---i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~ 155 (330)
T cd05601 81 EYQPGGDLLSLLNRY--EDQFDEDMAQFYLAELVLAIHSVHQMG---YVHRDIKPENVLIDRTGHIKLADFGSAARLTAN 155 (330)
T ss_pred CCCCCCCHHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEcccCchHheEECCCCCEEeccCCCCeECCCC
Confidence 999999999999653 235889999999999999999999988 999999999999999999999999999876433
Q ss_pred CCccc------cceeeec--------cCCCCCccccchhHHHHHHHHHhCCCCCCCCCCcchhhhhHhHHhcCCcccccc
Q 004521 596 ETEGN------TNRVVGT--------YDGQFSIKSDVFSFGILLLEIVSGKKNRGFYRSDTKVNLIGHLWDEGIPLRLID 661 (747)
Q Consensus 596 ~~~~~------~~~~~~~--------~~~~~s~ksDVwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~d 661 (747)
..... .....+. ....++.++|||||||++|||++|+.||..... ...+...........+.+
T Consensus 156 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~---~~~~~~i~~~~~~~~~~~ 232 (330)
T cd05601 156 KMVNSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTS---AKTYNNIMNFQRFLKFPE 232 (330)
T ss_pred CceeeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCH---HHHHHHHHcCCCccCCCC
Confidence 22110 0000000 034578899999999999999999999753222 112222211111111111
Q ss_pred hhhhccCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 004521 662 ACIQDSCNLADVIRCIHIGLLCVQQHPEDRPCMPSVIL 699 (747)
Q Consensus 662 ~~l~~~~~~~~~~~~~~l~~~Cl~~dP~~RPt~~~v~~ 699 (747)
. . .....+..++..|++ +|.+||++.++++
T Consensus 233 ~-----~--~~~~~~~~li~~ll~-~p~~R~t~~~l~~ 262 (330)
T cd05601 233 D-----P--KVSSDFLDLIQSLLC-GQKERLGYEGLCC 262 (330)
T ss_pred C-----C--CCCHHHHHHHHHHcc-ChhhCCCHHHHhC
Confidence 0 0 011224456668887 9999999999985
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-34 Score=301.51 Aligned_cols=251 Identities=28% Similarity=0.451 Sum_probs=188.4
Q ss_pred cCCCccceecccCCeeEEEEEecC-Cc--EEEEEEeccc-ccccHHHHHHHHHHHhcc-CCCceeeEEeEEEeCCeeEEE
Q 004521 440 DNFSINNKLGEGGFGPVYKGTLVD-GQ--EIAVKRLSKI-SEQGLKELKNEVILFSKL-QHRNLVKLLGCCIQGEEKLLI 514 (747)
Q Consensus 440 ~~~~~~~~lg~G~fg~Vy~~~~~~-g~--~vavK~l~~~-~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lV 514 (747)
++|++.+.||+|+||.||+|...+ +. .+++|.++.. .....+.|.+|+.+++++ +||||+++++++......++|
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv 81 (297)
T cd05089 2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYLYIA 81 (297)
T ss_pred ccceeeeeecCCCcceEEEEEecCCCCcceeEEEEccccCCHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCcceEE
Confidence 578889999999999999998754 33 5788888742 334456789999999999 799999999999999999999
Q ss_pred EecCCCCChhhHhhhcC-------------CCCcCChhHHHHHHHHHHHHHHHhhhcCCCceEecccCcCcEEEcCCCCc
Q 004521 515 YEFMPNKSLDSFIFDQT-------------RRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNP 581 (747)
Q Consensus 515 ~E~~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NIll~~~~~~ 581 (747)
|||+++++|.+++.... ....+++..++.++.|++.||+|||+.+ |+||||||+|||+++++.+
T Consensus 82 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~---ivH~dlkp~Nill~~~~~~ 158 (297)
T cd05089 82 IEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEKQ---FIHRDLAARNVLVGENLAS 158 (297)
T ss_pred EEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCcCCcceEEECCCCeE
Confidence 99999999999996532 1134888999999999999999999988 9999999999999999999
Q ss_pred eEecccCccccCCCCCcccc--c--eeeec--cCCCCCccccchhHHHHHHHHHh-CCCCCCCCCCcchhhhhHhHHhcC
Q 004521 582 KISDFGLVRTFGGDETEGNT--N--RVVGT--YDGQFSIKSDVFSFGILLLEIVS-GKKNRGFYRSDTKVNLIGHLWDEG 654 (747)
Q Consensus 582 kl~DFGla~~~~~~~~~~~~--~--~~~~~--~~~~~s~ksDVwS~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~ 654 (747)
||+|||++............ . ..... ....++.++|||||||++|||++ |..||..... ....... ..+
T Consensus 159 kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t~g~~pf~~~~~---~~~~~~~-~~~ 234 (297)
T cd05089 159 KIADFGLSRGEEVYVKKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTC---AELYEKL-PQG 234 (297)
T ss_pred EECCcCCCccccceeccCCCCcCccccCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCH---HHHHHHH-hcC
Confidence 99999998643211110000 0 00011 14567899999999999999998 9898643221 1122111 111
Q ss_pred CcccccchhhhccCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhcCCCC
Q 004521 655 IPLRLIDACIQDSCNLADVIRCIHIGLLCVQQHPEDRPCMPSVILMLGSEIL 706 (747)
Q Consensus 655 ~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dP~~RPt~~~v~~~L~~~~~ 706 (747)
...... ... ...+.+++.+||+.+|.+||++.+|++.|+....
T Consensus 235 ~~~~~~-----~~~----~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~~~ 277 (297)
T cd05089 235 YRMEKP-----RNC----DDEVYELMRQCWRDRPYERPPFAQISVQLSRMLE 277 (297)
T ss_pred CCCCCC-----CCC----CHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHH
Confidence 111111 111 1235678889999999999999999999987543
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-33 Score=292.61 Aligned_cols=238 Identities=29% Similarity=0.435 Sum_probs=181.8
Q ss_pred eecccCCeeEEEEEec---CCcEEEEEEecccc--cccHHHHHHHHHHHhccCCCceeeEEeEEEeCCeeEEEEecCCCC
Q 004521 447 KLGEGGFGPVYKGTLV---DGQEIAVKRLSKIS--EQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMPNK 521 (747)
Q Consensus 447 ~lg~G~fg~Vy~~~~~---~g~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~g 521 (747)
+||+|+||.||+|.+. ++..+|+|+++... ....+++.+|+.++++++||||+++++++. .+..++||||++++
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~~~~~lv~e~~~~~ 80 (257)
T cd05116 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICE-AESWMLVMELAELG 80 (257)
T ss_pred cCCCcCCcceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEc-CCCcEEEEecCCCC
Confidence 6899999999999753 47889999986432 234568999999999999999999999985 45678999999999
Q ss_pred ChhhHhhhcCCCCcCChhHHHHHHHHHHHHHHHhhhcCCCceEecccCcCcEEEcCCCCceEecccCccccCCCCCcccc
Q 004521 522 SLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNT 601 (747)
Q Consensus 522 sL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~ 601 (747)
+|.+++... ..+++..+..++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||+++.+.........
T Consensus 81 ~L~~~l~~~---~~~~~~~~~~i~~qi~~al~~lH~~~---i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~~~~~ 154 (257)
T cd05116 81 PLNKFLQKN---KHVTEKNITELVHQVSMGMKYLEETN---FVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKA 154 (257)
T ss_pred cHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccchhhEEEcCCCeEEECCCccccccCCCCCeeee
Confidence 999998542 35889999999999999999999988 999999999999999999999999999876543321100
Q ss_pred c--------eeeec--cCCCCCccccchhHHHHHHHHHh-CCCCCCCCCCcchhhhhHhHHhcCCcccccchhhhccCCH
Q 004521 602 N--------RVVGT--YDGQFSIKSDVFSFGILLLEIVS-GKKNRGFYRSDTKVNLIGHLWDEGIPLRLIDACIQDSCNL 670 (747)
Q Consensus 602 ~--------~~~~~--~~~~~s~ksDVwS~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~ 670 (747)
. ..... ....++.++|||||||++|||++ |..|+...... .... ....+....... ..
T Consensus 155 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~---~~~~-~i~~~~~~~~~~-----~~-- 223 (257)
T cd05116 155 KTHGKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKGN---EVTQ-MIESGERMECPQ-----RC-- 223 (257)
T ss_pred cCCCCCCccccCHhHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHH---HHHH-HHHCCCCCCCCC-----CC--
Confidence 0 00000 13567789999999999999998 89897533221 2222 222222221111 11
Q ss_pred HHHHHHHHHHHhccCCCCCCCCCHHHHHHHhcCC
Q 004521 671 ADVIRCIHIGLLCVQQHPEDRPCMPSVILMLGSE 704 (747)
Q Consensus 671 ~~~~~~~~l~~~Cl~~dP~~RPt~~~v~~~L~~~ 704 (747)
...+.+++.+||+.||++||+|.+|++.|++-
T Consensus 224 --~~~l~~li~~~~~~~p~~Rp~~~~i~~~l~~~ 255 (257)
T cd05116 224 --PPEMYDLMKLCWTYGVDERPGFAVVELRLRNY 255 (257)
T ss_pred --CHHHHHHHHHHhccCchhCcCHHHHHHHHhcc
Confidence 12356788899999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-33 Score=295.61 Aligned_cols=236 Identities=22% Similarity=0.329 Sum_probs=175.9
Q ss_pred eecccCCeeEEEEEecC-------------------------CcEEEEEEecccccccHHHHHHHHHHHhccCCCceeeE
Q 004521 447 KLGEGGFGPVYKGTLVD-------------------------GQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKL 501 (747)
Q Consensus 447 ~lg~G~fg~Vy~~~~~~-------------------------g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l 501 (747)
.||+|+||.||+|++.. ...||+|.+.........+|.+|+.+++.++||||+++
T Consensus 2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~~~~l~h~niv~~ 81 (274)
T cd05076 2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSHRDIALAFFETASLMSQVSHIHLAFV 81 (274)
T ss_pred CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHHHHHHHHHHHHHHHHhcCCCCCeeeE
Confidence 69999999999997521 13589999876444555678999999999999999999
Q ss_pred EeEEEeCCeeEEEEecCCCCChhhHhhhcCCCCcCChhHHHHHHHHHHHHHHHhhhcCCCceEecccCcCcEEEcCCC--
Q 004521 502 LGCCIQGEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDM-- 579 (747)
Q Consensus 502 ~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NIll~~~~-- 579 (747)
++++......++||||+++|+|..++... ...+++..+..++.||++||+|||+.+ |+||||||+|||++..+
T Consensus 82 ~~~~~~~~~~~lv~ey~~~g~L~~~l~~~--~~~~~~~~~~~i~~qi~~~l~~lH~~~---iiH~dlkp~Nill~~~~~~ 156 (274)
T cd05076 82 HGVCVRGSENIMVEEFVEHGPLDVCLRKE--KGRVPVAWKITVAQQLASALSYLEDKN---LVHGNVCAKNILLARLGLA 156 (274)
T ss_pred EEEEEeCCceEEEEecCCCCcHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHcCC---ccCCCCCcccEEEeccCcc
Confidence 99999999999999999999999998543 345889999999999999999999987 99999999999997654
Q ss_pred -----CceEecccCccccCCCCCccc-cceeeec-c--CCCCCccccchhHHHHHHHHH-hCCCCCCCCCCcchhhhhHh
Q 004521 580 -----NPKISDFGLVRTFGGDETEGN-TNRVVGT-Y--DGQFSIKSDVFSFGILLLEIV-SGKKNRGFYRSDTKVNLIGH 649 (747)
Q Consensus 580 -----~~kl~DFGla~~~~~~~~~~~-~~~~~~~-~--~~~~s~ksDVwS~Gvvl~ell-tg~~p~~~~~~~~~~~~~~~ 649 (747)
.+||+|||++........... ....... . ...++.++|||||||++|||+ +|+.|+..........
T Consensus 157 ~~~~~~~kl~d~g~~~~~~~~~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~---- 232 (274)
T cd05076 157 EGTSPFIKLSDPGVSFTALSREERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTPSEKER---- 232 (274)
T ss_pred cCccceeeecCCccccccccccccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCccccChHHHHH----
Confidence 379999998865432221111 1111111 1 245789999999999999995 6888865332221111
Q ss_pred HHhcCCcccccchhhhccCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhc
Q 004521 650 LWDEGIPLRLIDACIQDSCNLADVIRCIHIGLLCVQQHPEDRPCMPSVILMLG 702 (747)
Q Consensus 650 ~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dP~~RPt~~~v~~~L~ 702 (747)
...... .+. ... ...+.+++.+||+.+|++||+|.+|++.|.
T Consensus 233 ~~~~~~--~~~-----~~~----~~~~~~li~~cl~~~p~~Rps~~~il~~L~ 274 (274)
T cd05076 233 FYEKKH--RLP-----EPS----CKELATLISQCLTYEPTQRPSFRTILRDLT 274 (274)
T ss_pred HHHhcc--CCC-----CCC----ChHHHHHHHHHcccChhhCcCHHHHHHhhC
Confidence 111110 000 111 124667888999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-33 Score=293.02 Aligned_cols=246 Identities=27% Similarity=0.441 Sum_probs=188.4
Q ss_pred cCCCccceecccCCeeEEEEEecCCcEEEEEEecccccccHHHHHHHHHHHhccCCCceeeEEeEEEeCCeeEEEEecCC
Q 004521 440 DNFSINNKLGEGGFGPVYKGTLVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMP 519 (747)
Q Consensus 440 ~~~~~~~~lg~G~fg~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~ 519 (747)
++|++.++||+|+||.||+|+..+...||+|+++.. ....+.|.+|++++++++|+||+++++++. ....++||||++
T Consensus 6 ~~~~~~~~lg~g~~~~v~~~~~~~~~~valK~~~~~-~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv~e~~~ 83 (262)
T cd05071 6 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPG-TMSPEAFLQEAQVMKKLRHEKLVQLYAVVS-EEPIYIVTEYMS 83 (262)
T ss_pred HHeeEeeecCCCCCCcEEEEEecCCceEEEEecccC-ccCHHHHHHHHHHHHhCCCCCcceEEEEEC-CCCcEEEEEcCC
Confidence 468899999999999999999877778999999752 234567999999999999999999999874 456799999999
Q ss_pred CCChhhHhhhcCCCCcCChhHHHHHHHHHHHHHHHhhhcCCCceEecccCcCcEEEcCCCCceEecccCccccCCCCCcc
Q 004521 520 NKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEG 599 (747)
Q Consensus 520 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~ 599 (747)
+|+|.+++.... ...+++..+..++.|+++||+|||+.+ ++||||||+||++++++.+||+|||+++.+.......
T Consensus 84 ~~~L~~~~~~~~-~~~~~~~~~~~~~~~l~~aL~~lH~~~---i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~~~~~~~ 159 (262)
T cd05071 84 KGSLLDFLKGEM-GKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTA 159 (262)
T ss_pred CCcHHHHHhhcc-ccCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccCcccEEEcCCCcEEeccCCceeecccccccc
Confidence 999999996532 335789999999999999999999988 9999999999999999999999999998664332211
Q ss_pred cc------ceeeec--cCCCCCccccchhHHHHHHHHHh-CCCCCCCCCCcchhhhhHhHHhcCCcccccchhhhccCCH
Q 004521 600 NT------NRVVGT--YDGQFSIKSDVFSFGILLLEIVS-GKKNRGFYRSDTKVNLIGHLWDEGIPLRLIDACIQDSCNL 670 (747)
Q Consensus 600 ~~------~~~~~~--~~~~~s~ksDVwS~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~ 670 (747)
.. ...... ....++.++||||||+++|||++ |..|+.... ........ ..+..... ..
T Consensus 160 ~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~g~~p~~~~~---~~~~~~~~-~~~~~~~~---------~~ 226 (262)
T cd05071 160 RQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMV---NREVLDQV-ERGYRMPC---------PP 226 (262)
T ss_pred ccCCcccceecCHhHhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCC---hHHHHHHH-hcCCCCCC---------cc
Confidence 00 001111 14568899999999999999999 777764322 11222211 11111110 11
Q ss_pred HHHHHHHHHHHhccCCCCCCCCCHHHHHHHhcCC
Q 004521 671 ADVIRCIHIGLLCVQQHPEDRPCMPSVILMLGSE 704 (747)
Q Consensus 671 ~~~~~~~~l~~~Cl~~dP~~RPt~~~v~~~L~~~ 704 (747)
.....+.+++.+|++.+|++||++.+++++|+..
T Consensus 227 ~~~~~l~~li~~~l~~~p~~Rp~~~~~~~~l~~~ 260 (262)
T cd05071 227 ECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDY 260 (262)
T ss_pred ccCHHHHHHHHHHccCCcccCCCHHHHHHHHHHh
Confidence 1223467888999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-33 Score=291.60 Aligned_cols=245 Identities=29% Similarity=0.472 Sum_probs=188.8
Q ss_pred cCCCccceecccCCeeEEEEEecCCcEEEEEEecccccccHHHHHHHHHHHhccCCCceeeEEeEEEeCCeeEEEEecCC
Q 004521 440 DNFSINNKLGEGGFGPVYKGTLVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMP 519 (747)
Q Consensus 440 ~~~~~~~~lg~G~fg~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~ 519 (747)
++|++.++||+|+||.||+|...++..+|+|.++.. ....+.+.+|+.++++++|+||+++++++. ....++||||++
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~k~~~~~-~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv~e~~~ 83 (260)
T cd05070 6 ESLQLIKKLGNGQFGEVWMGTWNGNTKVAVKTLKPG-TMSPESFLEEAQIMKKLRHDKLVQLYAVVS-EEPIYIVTEYMS 83 (260)
T ss_pred HHhhhhheeccccCceEEEEEecCCceeEEEEecCC-CCCHHHHHHHHHHHHhcCCCceEEEEeEEC-CCCcEEEEEecC
Confidence 468889999999999999999888889999998753 234567999999999999999999999875 456899999999
Q ss_pred CCChhhHhhhcCCCCcCChhHHHHHHHHHHHHHHHhhhcCCCceEecccCcCcEEEcCCCCceEecccCccccCCCCCcc
Q 004521 520 NKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEG 599 (747)
Q Consensus 520 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~ 599 (747)
+++|.+++.... ...+++..+..++.|++.||.|||+.+ ++||||||+||++++++.+||+|||+++.+.......
T Consensus 84 ~~~L~~~~~~~~-~~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~di~p~Nili~~~~~~~l~dfg~~~~~~~~~~~~ 159 (260)
T cd05070 84 KGSLLDFLKDGE-GRALKLPNLVDMAAQVAAGMAYIERMN---YIHRDLRSANILVGDGLVCKIADFGLARLIEDNEYTA 159 (260)
T ss_pred CCcHHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCccceEEEeCCceEEeCCceeeeeccCccccc
Confidence 999999986532 234789999999999999999999988 9999999999999999999999999998764332111
Q ss_pred cc------ceeeec--cCCCCCccccchhHHHHHHHHHh-CCCCCCCCCCcchhhhhHhHHhcCCcccccchhhhccCCH
Q 004521 600 NT------NRVVGT--YDGQFSIKSDVFSFGILLLEIVS-GKKNRGFYRSDTKVNLIGHLWDEGIPLRLIDACIQDSCNL 670 (747)
Q Consensus 600 ~~------~~~~~~--~~~~~s~ksDVwS~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~ 670 (747)
.. ...... ....++.++||||||+++|||++ |..|+.... ........ ..+...... .
T Consensus 160 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~---~~~~~~~~-~~~~~~~~~-----~---- 226 (260)
T cd05070 160 RQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMN---NREVLEQV-ERGYRMPCP-----Q---- 226 (260)
T ss_pred ccCCCCCccccChHHHhcCCCcchhhhHHHHHHHHHHHhcCCCCCCCCC---HHHHHHHH-HcCCCCCCC-----C----
Confidence 10 000011 14567889999999999999999 888864322 11222222 111111111 1
Q ss_pred HHHHHHHHHHHhccCCCCCCCCCHHHHHHHhcC
Q 004521 671 ADVIRCIHIGLLCVQQHPEDRPCMPSVILMLGS 703 (747)
Q Consensus 671 ~~~~~~~~l~~~Cl~~dP~~RPt~~~v~~~L~~ 703 (747)
.....+.+++.+|++.+|++|||+.+++++|+.
T Consensus 227 ~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~ 259 (260)
T cd05070 227 DCPISLHELMLQCWKKDPEERPTFEYLQSFLED 259 (260)
T ss_pred cCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence 112346678889999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-33 Score=285.97 Aligned_cols=257 Identities=24% Similarity=0.314 Sum_probs=187.0
Q ss_pred cCCCccceecccCCeeEEEEEec-CCcEEEEEEeccccc--ccHHHHHHHHHHHhccCCCc-eeeEEeEEEeCC------
Q 004521 440 DNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKISE--QGLKELKNEVILFSKLQHRN-LVKLLGCCIQGE------ 509 (747)
Q Consensus 440 ~~~~~~~~lg~G~fg~Vy~~~~~-~g~~vavK~l~~~~~--~~~~~~~~E~~~l~~l~H~n-iv~l~g~~~~~~------ 509 (747)
..|...++||+|.||+||+|+.. +|+.||+|+++-..+ ..-....+|+.++++++|+| ||++++++...+
T Consensus 11 ~~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~~ 90 (323)
T KOG0594|consen 11 FDYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGIG 90 (323)
T ss_pred HHHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeecccccccc
Confidence 35666788999999999999965 489999999975333 23345689999999999999 999999999887
Q ss_pred eeEEEEecCCCCChhhHhhhcCCC-CcCChhHHHHHHHHHHHHHHHhhhcCCCceEecccCcCcEEEcCCCCceEecccC
Q 004521 510 EKLLIYEFMPNKSLDSFIFDQTRR-TLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGL 588 (747)
Q Consensus 510 ~~~lV~E~~~~gsL~~~l~~~~~~-~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NIll~~~~~~kl~DFGl 588 (747)
..++|+||+. .+|..++...... ..++...+..++.||++||+|||+++ |+||||||+||||++.|.+||+|||+
T Consensus 91 ~l~lvfe~~d-~DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~~---IlHRDLKPQNlLi~~~G~lKlaDFGl 166 (323)
T KOG0594|consen 91 KLYLVFEFLD-RDLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSHG---ILHRDLKPQNLLISSSGVLKLADFGL 166 (323)
T ss_pred eEEEEEEeec-ccHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhCC---eecccCCcceEEECCCCcEeeeccch
Confidence 7889999995 7899998664432 34677889999999999999999998 99999999999999999999999999
Q ss_pred ccccCCCCCccccceeeecc--------CCCCCccccchhHHHHHHHHHhCCCCCCCCCCcchhhhhHhHHh----cCCc
Q 004521 589 VRTFGGDETEGNTNRVVGTY--------DGQFSIKSDVFSFGILLLEIVSGKKNRGFYRSDTKVNLIGHLWD----EGIP 656 (747)
Q Consensus 589 a~~~~~~~~~~~~~~~~~~~--------~~~~s~ksDVwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~----~~~~ 656 (747)
|+.+.-.........+...| ...|+...||||+|||+.||++++..|...........+..... +.++
T Consensus 167 Ara~~ip~~~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se~~ql~~If~~lGtP~e~~Wp 246 (323)
T KOG0594|consen 167 ARAFSIPMRTYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSEIDQLFRIFRLLGTPNEKDWP 246 (323)
T ss_pred HHHhcCCcccccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcHHHHHHHHHHHcCCCCccCCC
Confidence 99776333322222222222 34699999999999999999998887654433111111111110 0010
Q ss_pred c--cccchh--hhc---cCCHHH-----HHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 004521 657 L--RLIDAC--IQD---SCNLAD-----VIRCIHIGLLCVQQHPEDRPCMPSVILM 700 (747)
Q Consensus 657 ~--~~~d~~--l~~---~~~~~~-----~~~~~~l~~~Cl~~dP~~RPt~~~v~~~ 700 (747)
. .+.+-. ... ..+... .....+++.+||+.+|.+|.|+...+.+
T Consensus 247 ~v~~~~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~h 302 (323)
T KOG0594|consen 247 GVSSLPDYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKGALTH 302 (323)
T ss_pred CccccccccccCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcCHHHHhcC
Confidence 0 000100 000 000100 1245678889999999999999999876
|
|
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-33 Score=305.60 Aligned_cols=250 Identities=28% Similarity=0.450 Sum_probs=186.7
Q ss_pred cCCCccceecccCCeeEEEEEe------cCCcEEEEEEecccc-cccHHHHHHHHHHHhcc-CCCceeeEEeEEEeC-Ce
Q 004521 440 DNFSINNKLGEGGFGPVYKGTL------VDGQEIAVKRLSKIS-EQGLKELKNEVILFSKL-QHRNLVKLLGCCIQG-EE 510 (747)
Q Consensus 440 ~~~~~~~~lg~G~fg~Vy~~~~------~~g~~vavK~l~~~~-~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~-~~ 510 (747)
++|++.+.||+|+||.||+|.. ..++.||||+++... ......+.+|+.++.++ +|+||+++++++... ..
T Consensus 7 ~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~ 86 (343)
T cd05103 7 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGP 86 (343)
T ss_pred hHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCChHHHHHHHHHHHHHHhccCCccHhhhcceeecCCCc
Confidence 5789999999999999999974 246789999997532 33456788999999999 789999999988654 45
Q ss_pred eEEEEecCCCCChhhHhhhcCC----------------------------------------------------------
Q 004521 511 KLLIYEFMPNKSLDSFIFDQTR---------------------------------------------------------- 532 (747)
Q Consensus 511 ~~lV~E~~~~gsL~~~l~~~~~---------------------------------------------------------- 532 (747)
.++||||+++|+|.+++.....
T Consensus 87 ~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 166 (343)
T cd05103 87 LMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEA 166 (343)
T ss_pred eEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccchhhhh
Confidence 7899999999999999864211
Q ss_pred ------CCcCChhHHHHHHHHHHHHHHHhhhcCCCceEecccCcCcEEEcCCCCceEecccCccccCCCCCcccc-----
Q 004521 533 ------RTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNT----- 601 (747)
Q Consensus 533 ------~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~----- 601 (747)
...+++..+..++.||++||+|||+.+ |+||||||+|||++.++.+||+|||+++...........
T Consensus 167 ~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~ 243 (343)
T cd05103 167 EQEDLYKKVLTLEDLICYSFQVAKGMEFLASRK---CIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARL 243 (343)
T ss_pred hhhhhhhccCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCccCeEEEcCCCcEEEEecccccccccCcchhhcCCCCC
Confidence 123678888999999999999999988 999999999999999999999999999865322111100
Q ss_pred --ceeeec--cCCCCCccccchhHHHHHHHHHh-CCCCCCCCCCcchhhhhHhHHhcCCcccccchhhhccCCHHHHHHH
Q 004521 602 --NRVVGT--YDGQFSIKSDVFSFGILLLEIVS-GKKNRGFYRSDTKVNLIGHLWDEGIPLRLIDACIQDSCNLADVIRC 676 (747)
Q Consensus 602 --~~~~~~--~~~~~s~ksDVwS~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~ 676 (747)
...... ....++.++||||||+++|||++ |..|+...... .. .......+....... .. ...+
T Consensus 244 ~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~--~~-~~~~~~~~~~~~~~~-----~~----~~~~ 311 (343)
T cd05103 244 PLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKID--EE-FCRRLKEGTRMRAPD-----YT----TPEM 311 (343)
T ss_pred CcceECcHHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCcccc--HH-HHHHHhccCCCCCCC-----CC----CHHH
Confidence 011111 24568899999999999999997 88886532211 11 111122222211111 11 1246
Q ss_pred HHHHHhccCCCCCCCCCHHHHHHHhcCC
Q 004521 677 IHIGLLCVQQHPEDRPCMPSVILMLGSE 704 (747)
Q Consensus 677 ~~l~~~Cl~~dP~~RPt~~~v~~~L~~~ 704 (747)
.+++.+||+.+|++||++.+|++.|+..
T Consensus 312 ~~~~~~cl~~~p~~Rps~~eil~~l~~~ 339 (343)
T cd05103 312 YQTMLDCWHGEPSQRPTFSELVEHLGNL 339 (343)
T ss_pred HHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence 7888899999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-33 Score=319.23 Aligned_cols=249 Identities=22% Similarity=0.272 Sum_probs=188.3
Q ss_pred HHHhcCCCccceecccCCeeEEEEEec-CCcEEEEEEeccc--ccccHHHHHHHHHHHhccCCCceeeEEeEEEeCC---
Q 004521 436 ANATDNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKI--SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGE--- 509 (747)
Q Consensus 436 ~~~~~~~~~~~~lg~G~fg~Vy~~~~~-~g~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~--- 509 (747)
....++|.+.+.||+|+||+||+|+.. +++.||||++... .......+.+|+.++..++|+||++++..+....
T Consensus 28 ~~~~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~~~ 107 (496)
T PTZ00283 28 KEQAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDPRN 107 (496)
T ss_pred cccCCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecceecccccC
Confidence 334568999999999999999999864 5899999998642 3445567889999999999999999988775433
Q ss_pred -----eeEEEEecCCCCChhhHhhhcC-CCCcCChhHHHHHHHHHHHHHHHhhhcCCCceEecccCcCcEEEcCCCCceE
Q 004521 510 -----EKLLIYEFMPNKSLDSFIFDQT-RRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKI 583 (747)
Q Consensus 510 -----~~~lV~E~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NIll~~~~~~kl 583 (747)
..++||||+++|+|.+++.... ....+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||
T Consensus 108 ~~~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~~---IiHrDLKP~NILl~~~~~vkL 184 (496)
T PTZ00283 108 PENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSKH---MIHRDIKSANILLCSNGLVKL 184 (496)
T ss_pred cccceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEeCCCCEEE
Confidence 3579999999999999986533 2346889999999999999999999988 999999999999999999999
Q ss_pred ecccCccccCCCCCccccceeeec---------cCCCCCccccchhHHHHHHHHHhCCCCCCCCCCcchhhhhHhHHhcC
Q 004521 584 SDFGLVRTFGGDETEGNTNRVVGT---------YDGQFSIKSDVFSFGILLLEIVSGKKNRGFYRSDTKVNLIGHLWDEG 654 (747)
Q Consensus 584 ~DFGla~~~~~~~~~~~~~~~~~~---------~~~~~s~ksDVwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~ 654 (747)
+|||+++.+.............|+ ....++.++|||||||+||||++|+.||.... ....+.... .+
T Consensus 185 ~DFGls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvilyeLltG~~Pf~~~~---~~~~~~~~~-~~ 260 (496)
T PTZ00283 185 GDFGFSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGEN---MEEVMHKTL-AG 260 (496)
T ss_pred EecccCeeccccccccccccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCC---HHHHHHHHh-cC
Confidence 999999876433221111111121 14568999999999999999999999975322 112222211 11
Q ss_pred CcccccchhhhccCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 004521 655 IPLRLIDACIQDSCNLADVIRCIHIGLLCVQQHPEDRPCMPSVILM 700 (747)
Q Consensus 655 ~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dP~~RPt~~~v~~~ 700 (747)
....+. ... ...+.+++.+||+.||.+||++.+++++
T Consensus 261 ~~~~~~-----~~~----~~~l~~li~~~L~~dP~~RPs~~ell~~ 297 (496)
T PTZ00283 261 RYDPLP-----PSI----SPEMQEIVTALLSSDPKRRPSSSKLLNM 297 (496)
T ss_pred CCCCCC-----CCC----CHHHHHHHHHHcccChhhCcCHHHHHhC
Confidence 111111 111 1235677889999999999999999864
|
|
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-33 Score=288.79 Aligned_cols=243 Identities=24% Similarity=0.342 Sum_probs=188.7
Q ss_pred CCCccceecccCCeeEEEEEec-CCcEEEEEEecc--cccccHHHHHHHHHHHhccCCCceeeEEeEEEeCCeeEEEEec
Q 004521 441 NFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSK--ISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEF 517 (747)
Q Consensus 441 ~~~~~~~lg~G~fg~Vy~~~~~-~g~~vavK~l~~--~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~ 517 (747)
+|++.+.||+|+||.||+|+.. +++.|++|.+.. ......+.+.+|++++++++||||+++++++.+.+..++||||
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08529 1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIVMEY 80 (256)
T ss_pred CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeeeccCCEEEEEEEe
Confidence 4777899999999999999975 488999999864 2344567889999999999999999999999999999999999
Q ss_pred CCCCChhhHhhhcCCCCcCChhHHHHHHHHHHHHHHHhhhcCCCceEecccCcCcEEEcCCCCceEecccCccccCCCCC
Q 004521 518 MPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDET 597 (747)
Q Consensus 518 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~ 597 (747)
+++++|.+++.... ...+++..+..++.|++.||.|||+.+ ++|+||||+||++++++.+||+|||+++.+.....
T Consensus 81 ~~~~~L~~~l~~~~-~~~~~~~~~~~i~~~l~~al~~lH~~~---i~h~dl~~~nili~~~~~~~l~df~~~~~~~~~~~ 156 (256)
T cd08529 81 AENGDLHKLLKMQR-GRPLPEDQVWRFFIQILLGLAHLHSKK---ILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTN 156 (256)
T ss_pred CCCCcHHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcceEEEeCCCCEEEcccccceeccCccc
Confidence 99999999997642 346889999999999999999999987 99999999999999999999999999887644322
Q ss_pred cccc-----ceeeec--cCCCCCccccchhHHHHHHHHHhCCCCCCCCCCcchhhhhHhHHhcCCcccccchhhhccCCH
Q 004521 598 EGNT-----NRVVGT--YDGQFSIKSDVFSFGILLLEIVSGKKNRGFYRSDTKVNLIGHLWDEGIPLRLIDACIQDSCNL 670 (747)
Q Consensus 598 ~~~~-----~~~~~~--~~~~~s~ksDVwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~ 670 (747)
.... ...... ....++.++|||||||++|||++|+.|+.... ........ ..+....+..
T Consensus 157 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~---~~~~~~~~-~~~~~~~~~~--------- 223 (256)
T cd08529 157 FANTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANN---QGALILKI-IRGVFPPVSQ--------- 223 (256)
T ss_pred hhhccccCccccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCC---HHHHHHHH-HcCCCCCCcc---------
Confidence 1110 000000 14567889999999999999999999975332 11222211 1122111111
Q ss_pred HHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 004521 671 ADVIRCIHIGLLCVQQHPEDRPCMPSVILM 700 (747)
Q Consensus 671 ~~~~~~~~l~~~Cl~~dP~~RPt~~~v~~~ 700 (747)
.....+.+++.+||+.+|++||++.++++.
T Consensus 224 ~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~ 253 (256)
T cd08529 224 MYSQQLAQLIDQCLTKDYRQRPDTFQLLRN 253 (256)
T ss_pred ccCHHHHHHHHHHccCCcccCcCHHHHhhC
Confidence 112346678889999999999999999864
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-33 Score=294.46 Aligned_cols=247 Identities=27% Similarity=0.449 Sum_probs=188.9
Q ss_pred cCCCccceecccCCeeEEEEEecC-C---cEEEEEEeccc-ccccHHHHHHHHHHHhccCCCceeeEEeEEEeCCeeEEE
Q 004521 440 DNFSINNKLGEGGFGPVYKGTLVD-G---QEIAVKRLSKI-SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLI 514 (747)
Q Consensus 440 ~~~~~~~~lg~G~fg~Vy~~~~~~-g---~~vavK~l~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV 514 (747)
.+|++.+.||+|+||.||+|.... + ..||||.+... .....++|..|+.++++++||||+++++++.++...++|
T Consensus 4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv 83 (269)
T cd05065 4 SCVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRPVMII 83 (269)
T ss_pred HHeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCcCcceEEEEECCCCceEEE
Confidence 357788999999999999999754 3 36999998753 344567899999999999999999999999999999999
Q ss_pred EecCCCCChhhHhhhcCCCCcCChhHHHHHHHHHHHHHHHhhhcCCCceEecccCcCcEEEcCCCCceEecccCccccCC
Q 004521 515 YEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGG 594 (747)
Q Consensus 515 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NIll~~~~~~kl~DFGla~~~~~ 594 (747)
|||+++++|.+++... ...+++.+++.++.|++.||.|||+.+ ++|+||||+||+++.++.+||+|||+++.+..
T Consensus 84 ~e~~~~~~L~~~l~~~--~~~~~~~~~~~i~~~l~~al~~lH~~g---~~H~dl~p~nili~~~~~~kl~dfg~~~~~~~ 158 (269)
T cd05065 84 TEFMENGALDSFLRQN--DGQFTVIQLVGMLRGIAAGMKYLSEMN---YVHRDLAARNILVNSNLVCKVSDFGLSRFLED 158 (269)
T ss_pred EecCCCCcHHHHHhhC--CCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccChheEEEcCCCcEEECCCcccccccc
Confidence 9999999999998653 345889999999999999999999988 99999999999999999999999999876543
Q ss_pred CCCccccc----------eeeec--cCCCCCccccchhHHHHHHHHHh-CCCCCCCCCCcchhhhhHhHHhcCCcccccc
Q 004521 595 DETEGNTN----------RVVGT--YDGQFSIKSDVFSFGILLLEIVS-GKKNRGFYRSDTKVNLIGHLWDEGIPLRLID 661 (747)
Q Consensus 595 ~~~~~~~~----------~~~~~--~~~~~s~ksDVwS~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~d 661 (747)
........ ..... ....++.++|||||||++|||++ |..|+...... ...... .........
T Consensus 159 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~~~---~~~~~i-~~~~~~~~~- 233 (269)
T cd05065 159 DTSDPTYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQ---DVINAI-EQDYRLPPP- 233 (269)
T ss_pred CccccccccccCCCcceeecCHhHhccCcccchhhhhhhHHHHHHHhcCCCCCCCCCCHH---HHHHHH-HcCCcCCCc-
Confidence 22111000 00000 14567889999999999999987 99886432211 111111 111111100
Q ss_pred hhhhccCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhcCC
Q 004521 662 ACIQDSCNLADVIRCIHIGLLCVQQHPEDRPCMPSVILMLGSE 704 (747)
Q Consensus 662 ~~l~~~~~~~~~~~~~~l~~~Cl~~dP~~RPt~~~v~~~L~~~ 704 (747)
... ...+.+++.+||+.+|.+||+|.+|+++|+..
T Consensus 234 ----~~~----~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 268 (269)
T cd05065 234 ----MDC----PTALHQLMLDCWQKDRNARPKFGQIVSTLDKM 268 (269)
T ss_pred ----ccC----CHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 111 12356788899999999999999999999764
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-34 Score=306.35 Aligned_cols=253 Identities=21% Similarity=0.359 Sum_probs=179.4
Q ss_pred CCCccceecccCCeeEEEEEec-CCcEEEEEEeccc--ccccHHHHHHHHHHHhccCCCceeeEEeEEEeCC-----eeE
Q 004521 441 NFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKI--SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGE-----EKL 512 (747)
Q Consensus 441 ~~~~~~~lg~G~fg~Vy~~~~~-~g~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~-----~~~ 512 (747)
+|++.+.||+|+||.||+|+.. +++.||||++... .......+.+|+.++++++||||+++++++.... ..+
T Consensus 1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~ 80 (338)
T cd07859 1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIY 80 (338)
T ss_pred CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceEE
Confidence 4788899999999999999975 4899999998742 2233457889999999999999999999986543 479
Q ss_pred EEEecCCCCChhhHhhhcCCCCcCChhHHHHHHHHHHHHHHHhhhcCCCceEecccCcCcEEEcCCCCceEecccCcccc
Q 004521 513 LIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTF 592 (747)
Q Consensus 513 lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NIll~~~~~~kl~DFGla~~~ 592 (747)
+||||+. ++|.+++.. ...+++..+..++.||++||.|||+.+ |+||||||+|||++.++.+||+|||+++..
T Consensus 81 lv~e~~~-~~L~~~l~~---~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIll~~~~~~kL~Dfg~~~~~ 153 (338)
T cd07859 81 VVFELME-SDLHQVIKA---NDDLTPEHHQFFLYQLLRALKYIHTAN---VFHRDLKPKNILANADCKLKICDFGLARVA 153 (338)
T ss_pred EEEecCC-CCHHHHHHh---cccCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCcEEEccCcccccc
Confidence 9999995 689888854 234889999999999999999999998 999999999999999999999999999865
Q ss_pred CCCCCcc--------ccceee----eccCCCCCccccchhHHHHHHHHHhCCCCCCCCCCcchhhhhHhHHh--------
Q 004521 593 GGDETEG--------NTNRVV----GTYDGQFSIKSDVFSFGILLLEIVSGKKNRGFYRSDTKVNLIGHLWD-------- 652 (747)
Q Consensus 593 ~~~~~~~--------~~~~~~----~~~~~~~s~ksDVwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~-------- 652 (747)
....... ...... ......++.++|||||||++|||++|+.||...........+.....
T Consensus 154 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (338)
T cd07859 154 FNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGTPSPETIS 233 (338)
T ss_pred ccccCccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHHH
Confidence 3221110 000001 11125688999999999999999999999754322111111100000
Q ss_pred ---cCCcccccchhhh-ccCCH-----HHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 004521 653 ---EGIPLRLIDACIQ-DSCNL-----ADVIRCIHIGLLCVQQHPEDRPCMPSVILM 700 (747)
Q Consensus 653 ---~~~~~~~~d~~l~-~~~~~-----~~~~~~~~l~~~Cl~~dP~~RPt~~~v~~~ 700 (747)
............. ..... .....+.+++.+||+.||++||++.++++.
T Consensus 234 ~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~h 290 (338)
T cd07859 234 RVRNEKARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALAD 290 (338)
T ss_pred HhhhhhHHHHHHhhcccCCCchHHhcCCCChHHHHHHHHHcCcCcccCCCHHHHhcC
Confidence 0000000000000 00000 001235678889999999999999999864
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-34 Score=290.89 Aligned_cols=249 Identities=24% Similarity=0.307 Sum_probs=182.4
Q ss_pred CCCccceecccCCeeEEEEEecC-CcEEEEEEecccccccHHHHHHHHHHHhccCCCceeeEEeEEEeCCe-----eEEE
Q 004521 441 NFSINNKLGEGGFGPVYKGTLVD-GQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEE-----KLLI 514 (747)
Q Consensus 441 ~~~~~~~lg~G~fg~Vy~~~~~~-g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~-----~~lV 514 (747)
.|...+++|.|+||.||+|++.. ++.||||+.-...+ .--+|+.+|++++|||||+|+-++....+ ..||
T Consensus 25 ~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r----~knrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~lnlV 100 (364)
T KOG0658|consen 25 SYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKR----YKNRELQIMRKLDHPNIVRLLYFFSSSTESDEVYLNLV 100 (364)
T ss_pred EEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCCC----cCcHHHHHHHhcCCcCeeeEEEEEEecCCCchhHHHHH
Confidence 45667899999999999999865 78999999864222 22368999999999999999998876433 2489
Q ss_pred EecCCCCChhhHhhhcC-CCCcCChhHHHHHHHHHHHHHHHhhhcCCCceEecccCcCcEEEcCC-CCceEecccCcccc
Q 004521 515 YEFMPNKSLDSFIFDQT-RRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQD-MNPKISDFGLVRTF 592 (747)
Q Consensus 515 ~E~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NIll~~~-~~~kl~DFGla~~~ 592 (747)
||||+ .+|..+++... .+..++...+.-+..||.+||.|||+.+ |+||||||+|+|+|.+ |.+||+|||.|+.+
T Consensus 101 leymP-~tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~~---IcHRDIKPqNlLvD~~tg~LKicDFGSAK~L 176 (364)
T KOG0658|consen 101 LEYMP-ETLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSHG---ICHRDIKPQNLLVDPDTGVLKICDFGSAKVL 176 (364)
T ss_pred HHhch-HHHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhcC---cccCCCChheEEEcCCCCeEEeccCCcceee
Confidence 99998 68888886421 2345777888889999999999999988 9999999999999977 89999999999998
Q ss_pred CCCCCccccceeeecc---------CCCCCccccchhHHHHHHHHHhCCCCCCCCCCcchhhhhHhHHhcCCc-------
Q 004521 593 GGDETEGNTNRVVGTY---------DGQFSIKSDVFSFGILLLEIVSGKKNRGFYRSDTKVNLIGHLWDEGIP------- 656 (747)
Q Consensus 593 ~~~~~~~~~~~~~~~~---------~~~~s~ksDVwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~------- 656 (747)
...+.... +.+..+ ...|+.+.||||.|||+.||+-|+..|...+......++..+......
T Consensus 177 ~~~epniS--YicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~~dQL~eIik~lG~Pt~e~I~~mn 254 (364)
T KOG0658|consen 177 VKGEPNIS--YICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDSSVDQLVEIIKVLGTPTREDIKSMN 254 (364)
T ss_pred ccCCCcee--EEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCCHHHHHHHHHHHhCCCCHHHHhhcC
Confidence 66554321 122111 467999999999999999999999987765444333333333211110
Q ss_pred ---ccccchhhhcc-----CCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 004521 657 ---LRLIDACIQDS-----CNLADVIRCIHIGLLCVQQHPEDRPCMPSVIL 699 (747)
Q Consensus 657 ---~~~~d~~l~~~-----~~~~~~~~~~~l~~~Cl~~dP~~RPt~~~v~~ 699 (747)
.+...+.+... .......+.++++.++++.+|.+|.++.|+++
T Consensus 255 ~~y~~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~ 305 (364)
T KOG0658|consen 255 PNYTEFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALA 305 (364)
T ss_pred cccccccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHhc
Confidence 01111111110 11122334677888999999999999999875
|
|
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-33 Score=299.72 Aligned_cols=253 Identities=27% Similarity=0.424 Sum_probs=191.4
Q ss_pred hcCCCccceecccCCeeEEEEEec--------CCcEEEEEEeccc-ccccHHHHHHHHHHHhcc-CCCceeeEEeEEEeC
Q 004521 439 TDNFSINNKLGEGGFGPVYKGTLV--------DGQEIAVKRLSKI-SEQGLKELKNEVILFSKL-QHRNLVKLLGCCIQG 508 (747)
Q Consensus 439 ~~~~~~~~~lg~G~fg~Vy~~~~~--------~g~~vavK~l~~~-~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~ 508 (747)
.++|.+.+.||+|+||.||+|+.. ++..||+|.+... .....+.+.+|+.+++.+ +||||+++++++...
T Consensus 14 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~ 93 (304)
T cd05101 14 RDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD 93 (304)
T ss_pred HHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccccchHHHHHHHHHHHHHHhhccCCCchheeEEEecC
Confidence 457888999999999999999742 2457999998753 234457899999999999 899999999999999
Q ss_pred CeeEEEEecCCCCChhhHhhhcCC-------------CCcCChhHHHHHHHHHHHHHHHhhhcCCCceEecccCcCcEEE
Q 004521 509 EEKLLIYEFMPNKSLDSFIFDQTR-------------RTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLL 575 (747)
Q Consensus 509 ~~~~lV~E~~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NIll 575 (747)
...++||||+++|+|.+++..... ...+++.+++.++.||++||.|||+.+ |+||||||+||++
T Consensus 94 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~g---ivH~dlkp~Nili 170 (304)
T cd05101 94 GPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQK---CIHRDLAARNVLV 170 (304)
T ss_pred CceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHCC---eeecccccceEEE
Confidence 999999999999999999975321 235788899999999999999999988 9999999999999
Q ss_pred cCCCCceEecccCccccCCCCCccccc-------eeee--ccCCCCCccccchhHHHHHHHHHh-CCCCCCCCCCcchhh
Q 004521 576 DQDMNPKISDFGLVRTFGGDETEGNTN-------RVVG--TYDGQFSIKSDVFSFGILLLEIVS-GKKNRGFYRSDTKVN 645 (747)
Q Consensus 576 ~~~~~~kl~DFGla~~~~~~~~~~~~~-------~~~~--~~~~~~s~ksDVwS~Gvvl~ellt-g~~p~~~~~~~~~~~ 645 (747)
+.++.+||+|||+++.+.......... .... .....++.++||||||+++|||++ |..|+.... ...
T Consensus 171 ~~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~---~~~ 247 (304)
T cd05101 171 TENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIP---VEE 247 (304)
T ss_pred cCCCcEEECCCccceecccccccccccCCCCCceeeCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCC---HHH
Confidence 999999999999998764322111110 0111 124568899999999999999998 677754222 112
Q ss_pred hhHhHHhcCCcccccchhhhccCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhcCCCCC
Q 004521 646 LIGHLWDEGIPLRLIDACIQDSCNLADVIRCIHIGLLCVQQHPEDRPCMPSVILMLGSEILL 707 (747)
Q Consensus 646 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dP~~RPt~~~v~~~L~~~~~~ 707 (747)
.... ...+...... . .....+.+++.+||+.+|.+||+|.+|++.|+.+..+
T Consensus 248 ~~~~-~~~~~~~~~~-----~----~~~~~~~~li~~cl~~~p~~Rps~~e~l~~l~~~~~~ 299 (304)
T cd05101 248 LFKL-LKEGHRMDKP-----A----NCTNELYMMMRDCWHAIPSHRPTFKQLVEDLDRILTL 299 (304)
T ss_pred HHHH-HHcCCcCCCC-----C----CCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHHHHh
Confidence 2221 1222211111 1 1123466788899999999999999999999876443
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-33 Score=292.14 Aligned_cols=245 Identities=26% Similarity=0.394 Sum_probs=178.6
Q ss_pred ceecccCCeeEEEEEecC---CcEEEEEEecccc-cccHHHHHHHHHHHhccCCCceeeEEeEEEeCCeeEEEEecCCCC
Q 004521 446 NKLGEGGFGPVYKGTLVD---GQEIAVKRLSKIS-EQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMPNK 521 (747)
Q Consensus 446 ~~lg~G~fg~Vy~~~~~~---g~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~g 521 (747)
+.||+|+||.||+|+..+ +..+|+|.++... ......+.+|+.++++++||||+++++++.+....++||||+++|
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g 80 (269)
T cd05087 1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCPLG 80 (269)
T ss_pred CcccccCCceEEEEEEcCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEECCCCC
Confidence 368999999999998654 4579999987532 233457889999999999999999999999999999999999999
Q ss_pred ChhhHhhhcCC--CCcCChhHHHHHHHHHHHHHHHhhhcCCCceEecccCcCcEEEcCCCCceEecccCccccCCCCCcc
Q 004521 522 SLDSFIFDQTR--RTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEG 599 (747)
Q Consensus 522 sL~~~l~~~~~--~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~ 599 (747)
+|.+++..... ....++..+..++.|++.||+|||+.+ ++||||||+||+++.++.+||+|||+++.........
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~~~ 157 (269)
T cd05087 81 DLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNN---FIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYV 157 (269)
T ss_pred cHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCC---EeccccCcceEEEcCCCcEEECCccccccccCcceee
Confidence 99999965332 234567788899999999999999988 9999999999999999999999999987543322111
Q ss_pred cccee-------eec-c--------CCCCCccccchhHHHHHHHHHh-CCCCCCCCCCcchhhhhHhHHhcCCcccccch
Q 004521 600 NTNRV-------VGT-Y--------DGQFSIKSDVFSFGILLLEIVS-GKKNRGFYRSDTKVNLIGHLWDEGIPLRLIDA 662 (747)
Q Consensus 600 ~~~~~-------~~~-~--------~~~~s~ksDVwS~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 662 (747)
..... ... . ...++.++||||||+++|||++ |+.|+...... ......... ....+.++
T Consensus 158 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~---~~~~~~~~~-~~~~~~~~ 233 (269)
T cd05087 158 TPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDE---QVLTYTVRE-QQLKLPKP 233 (269)
T ss_pred cCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChH---HHHHHHhhc-ccCCCCCC
Confidence 10000 000 0 1235789999999999999996 99997543222 111111111 11222222
Q ss_pred hhhccCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhc
Q 004521 663 CIQDSCNLADVIRCIHIGLLCVQQHPEDRPCMPSVILMLG 702 (747)
Q Consensus 663 ~l~~~~~~~~~~~~~~l~~~Cl~~dP~~RPt~~~v~~~L~ 702 (747)
.+.... ...+.+++..|+ .+|++|||+.+|++.|+
T Consensus 234 ~~~~~~----~~~~~~l~~~c~-~~P~~Rpt~~~l~~~l~ 268 (269)
T cd05087 234 RLKLPL----SDRWYEVMQFCW-LQPEQRPSAEEVHLLLS 268 (269)
T ss_pred ccCCCC----ChHHHHHHHHHh-cCcccCCCHHHHHHHhc
Confidence 222111 112445667898 58999999999999885
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-33 Score=295.93 Aligned_cols=249 Identities=27% Similarity=0.458 Sum_probs=189.9
Q ss_pred hcCCCccceecccCCeeEEEEEec------CCcEEEEEEeccc-ccccHHHHHHHHHHHhccCCCceeeEEeEEEeCCee
Q 004521 439 TDNFSINNKLGEGGFGPVYKGTLV------DGQEIAVKRLSKI-SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEK 511 (747)
Q Consensus 439 ~~~~~~~~~lg~G~fg~Vy~~~~~------~g~~vavK~l~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~ 511 (747)
.++|++.+.||+|+||.||+|... ++..||+|.+... .....+++.+|+.++++++||||+++++++..+...
T Consensus 4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~~~~ 83 (288)
T cd05050 4 RNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVKLLGVCAVGKPM 83 (288)
T ss_pred hHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCcCHHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCcc
Confidence 357888999999999999999863 3678999998753 234456799999999999999999999999999999
Q ss_pred EEEEecCCCCChhhHhhhcCC-------------------CCcCChhHHHHHHHHHHHHHHHhhhcCCCceEecccCcCc
Q 004521 512 LLIYEFMPNKSLDSFIFDQTR-------------------RTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASN 572 (747)
Q Consensus 512 ~lV~E~~~~gsL~~~l~~~~~-------------------~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~N 572 (747)
++||||+++++|.+++..... ...+++..++.++.|++.||+|||+.+ ++||||||+|
T Consensus 84 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~~---i~H~dl~p~n 160 (288)
T cd05050 84 CLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSERK---FVHRDLATRN 160 (288)
T ss_pred EEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCC---eecccccHhh
Confidence 999999999999999964321 124778889999999999999999988 9999999999
Q ss_pred EEEcCCCCceEecccCccccCCCCCcccc-------ceeeec--cCCCCCccccchhHHHHHHHHHh-CCCCCCCCCCcc
Q 004521 573 VLLDQDMNPKISDFGLVRTFGGDETEGNT-------NRVVGT--YDGQFSIKSDVFSFGILLLEIVS-GKKNRGFYRSDT 642 (747)
Q Consensus 573 Ill~~~~~~kl~DFGla~~~~~~~~~~~~-------~~~~~~--~~~~~s~ksDVwS~Gvvl~ellt-g~~p~~~~~~~~ 642 (747)
|++++++.+||+|||+++.+......... ...... ....++.++|||||||++|||++ |..|+....
T Consensus 161 il~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~~~~p~~~~~--- 237 (288)
T cd05050 161 CLVGENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYGMA--- 237 (288)
T ss_pred eEecCCCceEECccccceecccCccccccCCCccChhhcCHHHHhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCC---
Confidence 99999999999999998765332211000 000000 14678899999999999999998 777753221
Q ss_pred hhhhhHhHHhcCCcccccchhhhccCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhcC
Q 004521 643 KVNLIGHLWDEGIPLRLIDACIQDSCNLADVIRCIHIGLLCVQQHPEDRPCMPSVILMLGS 703 (747)
Q Consensus 643 ~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dP~~RPt~~~v~~~L~~ 703 (747)
........ ..+......+ .....+.+++.+||+.+|.+||++.||++.|+.
T Consensus 238 ~~~~~~~~-~~~~~~~~~~---------~~~~~l~~li~~~l~~~p~~Rpt~~el~~~l~~ 288 (288)
T cd05050 238 HEEVIYYV-RDGNVLSCPD---------NCPLELYNLMRLCWSKLPSDRPSFASINRILQR 288 (288)
T ss_pred HHHHHHHH-hcCCCCCCCC---------CCCHHHHHHHHHHcccCcccCCCHHHHHHHhhC
Confidence 11222221 2222111111 112346778899999999999999999999873
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-33 Score=295.87 Aligned_cols=252 Identities=26% Similarity=0.456 Sum_probs=189.2
Q ss_pred HhcCCCccceecccCCeeEEEEEecC------CcEEEEEEecccc-cccHHHHHHHHHHHhccCCCceeeEEeEEEeCCe
Q 004521 438 ATDNFSINNKLGEGGFGPVYKGTLVD------GQEIAVKRLSKIS-EQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEE 510 (747)
Q Consensus 438 ~~~~~~~~~~lg~G~fg~Vy~~~~~~------g~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~ 510 (747)
..++|++.+.||+|+||.||+|...+ +..||+|.+.... ......+.+|+.++++++||||+++++++.....
T Consensus 4 ~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~ 83 (288)
T cd05061 4 SREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVSKGQP 83 (288)
T ss_pred cHHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCC
Confidence 35689999999999999999997542 4589999886432 2234568899999999999999999999999999
Q ss_pred eEEEEecCCCCChhhHhhhcCC-------CCcCChhHHHHHHHHHHHHHHHhhhcCCCceEecccCcCcEEEcCCCCceE
Q 004521 511 KLLIYEFMPNKSLDSFIFDQTR-------RTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKI 583 (747)
Q Consensus 511 ~~lV~E~~~~gsL~~~l~~~~~-------~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NIll~~~~~~kl 583 (747)
.++||||+++|+|.+++..... ...+.+..+..++.|++.||.|||+.+ |+||||||+||++++++.+||
T Consensus 84 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dikp~nili~~~~~~~L 160 (288)
T cd05061 84 TLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKK---FVHRDLAARNCMVAHDFTVKI 160 (288)
T ss_pred cEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---CcCCCCChheEEEcCCCcEEE
Confidence 9999999999999999965321 234567788999999999999999988 999999999999999999999
Q ss_pred ecccCccccCCCCCccccc-------eeee--ccCCCCCccccchhHHHHHHHHHh-CCCCCCCCCCcchhhhhHhHHhc
Q 004521 584 SDFGLVRTFGGDETEGNTN-------RVVG--TYDGQFSIKSDVFSFGILLLEIVS-GKKNRGFYRSDTKVNLIGHLWDE 653 (747)
Q Consensus 584 ~DFGla~~~~~~~~~~~~~-------~~~~--~~~~~~s~ksDVwS~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~ 653 (747)
+|||+++............ .... ...+.++.++|||||||++|||++ |..|+.... ...........
T Consensus 161 ~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l~el~~~~~~p~~~~~---~~~~~~~~~~~ 237 (288)
T cd05061 161 GDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLS---NEQVLKFVMDG 237 (288)
T ss_pred CcCCccccccccccccccCCCcccccccCHHHhccCCCChHhHHHHHHHHHHHHHhCCCCCCCCCC---HHHHHHHHHcC
Confidence 9999998653322111000 0000 114568899999999999999999 677754221 11222222111
Q ss_pred CCcccccchhhhccCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhcCCC
Q 004521 654 GIPLRLIDACIQDSCNLADVIRCIHIGLLCVQQHPEDRPCMPSVILMLGSEI 705 (747)
Q Consensus 654 ~~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dP~~RPt~~~v~~~L~~~~ 705 (747)
+. .... .. ....+.+++.+||+.+|++||++.++++.|++..
T Consensus 238 ~~-~~~~-----~~----~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~~ 279 (288)
T cd05061 238 GY-LDQP-----DN----CPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDDL 279 (288)
T ss_pred CC-CCCC-----CC----CCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhhc
Confidence 11 1110 11 1234677888999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-33 Score=304.39 Aligned_cols=242 Identities=21% Similarity=0.266 Sum_probs=184.9
Q ss_pred hcCCCccceecccCCeeEEEEEecC--CcEEEEEEeccc---ccccHHHHHHHHHHHhccCCCceeeEEeEEEeCCeeEE
Q 004521 439 TDNFSINNKLGEGGFGPVYKGTLVD--GQEIAVKRLSKI---SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLL 513 (747)
Q Consensus 439 ~~~~~~~~~lg~G~fg~Vy~~~~~~--g~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~l 513 (747)
.++|++.+.||+|+||.||+|+... +..||+|++.+. .....+.+.+|+.+++.++||||+++++++.+.+..++
T Consensus 29 ~~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~l 108 (340)
T PTZ00426 29 YEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDESYLYL 108 (340)
T ss_pred hhhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeCCEEEE
Confidence 3578889999999999999998644 368999998652 23345678899999999999999999999999999999
Q ss_pred EEecCCCCChhhHhhhcCCCCcCChhHHHHHHHHHHHHHHHhhhcCCCceEecccCcCcEEEcCCCCceEecccCccccC
Q 004521 514 IYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFG 593 (747)
Q Consensus 514 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NIll~~~~~~kl~DFGla~~~~ 593 (747)
||||+++|+|.+++... ..+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+++.+.
T Consensus 109 v~Ey~~~g~L~~~i~~~---~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDLkp~NILl~~~~~ikL~DFG~a~~~~ 182 (340)
T PTZ00426 109 VLEFVIGGEFFTFLRRN---KRFPNDVGCFYAAQIVLIFEYLQSLN---IVYRDLKPENLLLDKDGFIKMTDFGFAKVVD 182 (340)
T ss_pred EEeCCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eEccCCCHHHEEECCCCCEEEecCCCCeecC
Confidence 99999999999998643 34889999999999999999999988 9999999999999999999999999998764
Q ss_pred CCCCccc-c-ceeeec--cCCCCCccccchhHHHHHHHHHhCCCCCCCCCCcchhhhhHhHHhcCCcccccchhhhccCC
Q 004521 594 GDETEGN-T-NRVVGT--YDGQFSIKSDVFSFGILLLEIVSGKKNRGFYRSDTKVNLIGHLWDEGIPLRLIDACIQDSCN 669 (747)
Q Consensus 594 ~~~~~~~-~-~~~~~~--~~~~~s~ksDVwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~ 669 (747)
....... + ....+. .+..++.++|||||||++|||++|+.||.... ......... .+.. .+ ....+
T Consensus 183 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~---~~~~~~~i~-~~~~-~~-----p~~~~ 252 (340)
T PTZ00426 183 TRTYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYANE---PLLIYQKIL-EGII-YF-----PKFLD 252 (340)
T ss_pred CCcceecCChhhcCHHHHhCCCCCccccccchhhHHHHHhcCCCCCCCCC---HHHHHHHHh-cCCC-CC-----CCCCC
Confidence 3221110 0 000000 14567889999999999999999999975322 111222221 1111 00 01111
Q ss_pred HHHHHHHHHHHHhccCCCCCCCC-----CHHHHHHH
Q 004521 670 LADVIRCIHIGLLCVQQHPEDRP-----CMPSVILM 700 (747)
Q Consensus 670 ~~~~~~~~~l~~~Cl~~dP~~RP-----t~~~v~~~ 700 (747)
..+.+++.+|++.||++|+ ++.++++.
T Consensus 253 ----~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~h 284 (340)
T PTZ00426 253 ----NNCKHLMKKLLSHDLTKRYGNLKKGAQNVKEH 284 (340)
T ss_pred ----HHHHHHHHHHcccCHHHcCCCCCCCHHHHHcC
Confidence 1245677799999999995 88888765
|
|
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-33 Score=298.07 Aligned_cols=250 Identities=30% Similarity=0.454 Sum_probs=190.3
Q ss_pred hcCCCccceecccCCeeEEEEEec------CCcEEEEEEecccc-cccHHHHHHHHHHHhcc-CCCceeeEEeEEEeCCe
Q 004521 439 TDNFSINNKLGEGGFGPVYKGTLV------DGQEIAVKRLSKIS-EQGLKELKNEVILFSKL-QHRNLVKLLGCCIQGEE 510 (747)
Q Consensus 439 ~~~~~~~~~lg~G~fg~Vy~~~~~------~g~~vavK~l~~~~-~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~ 510 (747)
.++|.+.+.||+|+||.||+++.. .+..||||.++... ....+.+.+|+.+++++ +|+||+++++++...+.
T Consensus 34 ~~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~ 113 (302)
T cd05055 34 RNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLLGACTIGGP 113 (302)
T ss_pred HHHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCChHHHHHHHHHHHHHHhccCCCCcceEEEEEecCCc
Confidence 357888999999999999999752 24579999987532 33356789999999999 79999999999999999
Q ss_pred eEEEEecCCCCChhhHhhhcCCCCcCChhHHHHHHHHHHHHHHHhhhcCCCceEecccCcCcEEEcCCCCceEecccCcc
Q 004521 511 KLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVR 590 (747)
Q Consensus 511 ~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NIll~~~~~~kl~DFGla~ 590 (747)
.++||||+++|+|.+++.... ...+++.++..++.|++.||+|||+.+ |+|+||||+|||++.++.+||+|||+++
T Consensus 114 ~~lv~e~~~~~~L~~~i~~~~-~~~l~~~~~~~i~~~i~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~~l~dfg~~~ 189 (302)
T cd05055 114 ILVITEYCCYGDLLNFLRRKR-ESFLTLEDLLSFSYQVAKGMAFLASKN---CIHRDLAARNVLLTHGKIVKICDFGLAR 189 (302)
T ss_pred eEEEEEcCCCCcHHHHHHhCC-CCCCCHHHHHHHHHHHHHHHHHHHHCC---eehhhhccceEEEcCCCeEEECCCcccc
Confidence 999999999999999986432 234899999999999999999999988 9999999999999999999999999998
Q ss_pred ccCCCCCccccceee-------ec--cCCCCCccccchhHHHHHHHHHh-CCCCCCCCCCcchhhhhHhHHhcCCccccc
Q 004521 591 TFGGDETEGNTNRVV-------GT--YDGQFSIKSDVFSFGILLLEIVS-GKKNRGFYRSDTKVNLIGHLWDEGIPLRLI 660 (747)
Q Consensus 591 ~~~~~~~~~~~~~~~-------~~--~~~~~s~ksDVwS~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 660 (747)
.+............. .. ....++.++|||||||++|||++ |..|+...... .........+......
T Consensus 190 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~t~g~~p~~~~~~~---~~~~~~~~~~~~~~~~ 266 (302)
T cd05055 190 DIMNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPVD---SKFYKLIKEGYRMAQP 266 (302)
T ss_pred cccCCCceeecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHHhCCCCCcCCCCch---HHHHHHHHcCCcCCCC
Confidence 664332211100000 00 14567889999999999999998 88886432221 1111112222111110
Q ss_pred chhhhccCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhcCC
Q 004521 661 DACIQDSCNLADVIRCIHIGLLCVQQHPEDRPCMPSVILMLGSE 704 (747)
Q Consensus 661 d~~l~~~~~~~~~~~~~~l~~~Cl~~dP~~RPt~~~v~~~L~~~ 704 (747)
.. ....+.+++.+||+.+|++||++.+|++.|+..
T Consensus 267 -----~~----~~~~~~~li~~cl~~~p~~Rpt~~ell~~l~~~ 301 (302)
T cd05055 267 -----EH----APAEIYDIMKTCWDADPLKRPTFKQIVQLIGKQ 301 (302)
T ss_pred -----CC----CCHHHHHHHHHHcCCCchhCcCHHHHHHHHHhh
Confidence 00 123466788899999999999999999999763
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-33 Score=293.91 Aligned_cols=249 Identities=27% Similarity=0.420 Sum_probs=187.9
Q ss_pred cCCCccceecccCCeeEEEEEec-CCc----EEEEEEeccc-ccccHHHHHHHHHHHhccCCCceeeEEeEEEeCCeeEE
Q 004521 440 DNFSINNKLGEGGFGPVYKGTLV-DGQ----EIAVKRLSKI-SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLL 513 (747)
Q Consensus 440 ~~~~~~~~lg~G~fg~Vy~~~~~-~g~----~vavK~l~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~l 513 (747)
++|++.++||+|+||+||+|+.. +++ .||+|.++.. .....+++.+|+.+++.++|+||+++++++.. ...++
T Consensus 7 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~-~~~~l 85 (279)
T cd05109 7 TELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRLLGICLT-STVQL 85 (279)
T ss_pred hheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCCCHHHHHHHHHHHHHHHhcCCCCCceEEEEEcC-CCcEE
Confidence 56888899999999999999853 344 4899998752 33446688999999999999999999999975 45789
Q ss_pred EEecCCCCChhhHhhhcCCCCcCChhHHHHHHHHHHHHHHHhhhcCCCceEecccCcCcEEEcCCCCceEecccCccccC
Q 004521 514 IYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFG 593 (747)
Q Consensus 514 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NIll~~~~~~kl~DFGla~~~~ 593 (747)
++||+++|+|.+++... ...+++..++.++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++.+.
T Consensus 86 ~~~~~~~g~l~~~l~~~--~~~~~~~~~~~~~~qi~~~L~~lH~~~---iiH~dlkp~Nil~~~~~~~kL~dfG~~~~~~ 160 (279)
T cd05109 86 VTQLMPYGCLLDYVREN--KDRIGSQDLLNWCVQIAKGMSYLEEVR---LVHRDLAARNVLVKSPNHVKITDFGLARLLD 160 (279)
T ss_pred EEEcCCCCCHHHHHhhc--cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccccceEEEcCCCcEEECCCCceeecc
Confidence 99999999999998653 235889999999999999999999988 9999999999999999999999999998764
Q ss_pred CCCCcccc-------ceeee--ccCCCCCccccchhHHHHHHHHHh-CCCCCCCCCCcchhhhhHhHHhcCCcccccchh
Q 004521 594 GDETEGNT-------NRVVG--TYDGQFSIKSDVFSFGILLLEIVS-GKKNRGFYRSDTKVNLIGHLWDEGIPLRLIDAC 663 (747)
Q Consensus 594 ~~~~~~~~-------~~~~~--~~~~~~s~ksDVwS~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 663 (747)
........ ..... .....++.++|||||||++|||++ |..|+..... ... ......+.......
T Consensus 161 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~---~~~-~~~~~~~~~~~~~~-- 234 (279)
T cd05109 161 IDETEYHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPA---REI-PDLLEKGERLPQPP-- 234 (279)
T ss_pred cccceeecCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCH---HHH-HHHHHCCCcCCCCc--
Confidence 32221100 00000 124568899999999999999998 8888643221 111 11222222111110
Q ss_pred hhccCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhcCCCCC
Q 004521 664 IQDSCNLADVIRCIHIGLLCVQQHPEDRPCMPSVILMLGSEILL 707 (747)
Q Consensus 664 l~~~~~~~~~~~~~~l~~~Cl~~dP~~RPt~~~v~~~L~~~~~~ 707 (747)
. ....+.+++.+||+.||++||++.+++..|+.....
T Consensus 235 ---~----~~~~~~~li~~~l~~dp~~Rp~~~~l~~~l~~~~~~ 271 (279)
T cd05109 235 ---I----CTIDVYMIMVKCWMIDSECRPRFRELVDEFSRMARD 271 (279)
T ss_pred ---c----CCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhcC
Confidence 1 112456788899999999999999999998766443
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-33 Score=293.31 Aligned_cols=245 Identities=24% Similarity=0.375 Sum_probs=177.5
Q ss_pred ceecccCCeeEEEEEecC---CcEEEEEEeccc-ccccHHHHHHHHHHHhccCCCceeeEEeEEEeCCeeEEEEecCCCC
Q 004521 446 NKLGEGGFGPVYKGTLVD---GQEIAVKRLSKI-SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMPNK 521 (747)
Q Consensus 446 ~~lg~G~fg~Vy~~~~~~---g~~vavK~l~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~g 521 (747)
++||+|+||.||+|+..+ ...+|+|.+... .......|.+|+.+++.++|+||+++++.+.+....++||||+++|
T Consensus 1 ~~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~~~~g 80 (269)
T cd05042 1 DEIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCPLG 80 (269)
T ss_pred CcCCccCCceEEEEEEecCCCCeEEEEeecCccCChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEEeCCCC
Confidence 369999999999997644 347888887643 2334567889999999999999999999999999999999999999
Q ss_pred ChhhHhhhcCC--CCcCChhHHHHHHHHHHHHHHHhhhcCCCceEecccCcCcEEEcCCCCceEecccCccccCCCCCcc
Q 004521 522 SLDSFIFDQTR--RTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEG 599 (747)
Q Consensus 522 sL~~~l~~~~~--~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~ 599 (747)
+|.+++..... ....++.....++.||+.||+|||+.+ |+||||||+|||+++++.+||+|||+++.........
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~ 157 (269)
T cd05042 81 DLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQAD---FIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYI 157 (269)
T ss_pred cHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhcC---EecccccHhheEecCCCcEEEeccccccccccchhee
Confidence 99999966432 223567788899999999999999988 9999999999999999999999999987543221110
Q ss_pred c------c-ceeeec---------cCCCCCccccchhHHHHHHHHHh-CCCCCCCCCCcchhhhhHhHHhcCCcccccch
Q 004521 600 N------T-NRVVGT---------YDGQFSIKSDVFSFGILLLEIVS-GKKNRGFYRSDTKVNLIGHLWDEGIPLRLIDA 662 (747)
Q Consensus 600 ~------~-~~~~~~---------~~~~~s~ksDVwS~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 662 (747)
. + ...... ....++.++|||||||++|||++ |..|+.... ....+....... ...+..+
T Consensus 158 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~---~~~~~~~~~~~~-~~~~~~~ 233 (269)
T cd05042 158 TKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLS---DEQVLKQVVREQ-DIKLPKP 233 (269)
T ss_pred ccCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCC---HHHHHHHHhhcc-CccCCCC
Confidence 0 0 000000 12456889999999999999999 677754322 122222222222 1222222
Q ss_pred hhhccCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhc
Q 004521 663 CIQDSCNLADVIRCIHIGLLCVQQHPEDRPCMPSVILMLG 702 (747)
Q Consensus 663 ~l~~~~~~~~~~~~~~l~~~Cl~~dP~~RPt~~~v~~~L~ 702 (747)
.+....+ ..+.+++..|| .||++||++.+|+++|.
T Consensus 234 ~~~~~~~----~~~~~~~~~~~-~dp~~Rpt~~~v~~~l~ 268 (269)
T cd05042 234 QLDLKYS----DRWYEVMQFCW-LDPETRPTAEEVHELLT 268 (269)
T ss_pred cccccCC----HHHHHHHHHHh-cCcccccCHHHHHHHhc
Confidence 2222111 22345666788 59999999999999884
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-33 Score=290.12 Aligned_cols=245 Identities=29% Similarity=0.454 Sum_probs=187.2
Q ss_pred cCCCccceecccCCeeEEEEEecCCcEEEEEEecccccccHHHHHHHHHHHhccCCCceeeEEeEEEeCCeeEEEEecCC
Q 004521 440 DNFSINNKLGEGGFGPVYKGTLVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMP 519 (747)
Q Consensus 440 ~~~~~~~~lg~G~fg~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~ 519 (747)
++|.+.++||+|+||.||+|...++..+|+|.+... ....+.+.+|+.++++++|+||+++++++. ....++||||++
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~lK~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~~~ 83 (260)
T cd05069 6 ESLRLDVKLGQGCFGEVWMGTWNGTTKVAIKTLKPG-TMMPEAFLQEAQIMKKLRHDKLVPLYAVVS-EEPIYIVTEFMG 83 (260)
T ss_pred HHeeeeeeecCcCCCeEEEEEEcCCceEEEEEcccC-CccHHHHHHHHHHHHhCCCCCeeeEEEEEc-CCCcEEEEEcCC
Confidence 468888999999999999999877778999988652 334567899999999999999999999875 456899999999
Q ss_pred CCChhhHhhhcCCCCcCChhHHHHHHHHHHHHHHHhhhcCCCceEecccCcCcEEEcCCCCceEecccCccccCCCCCcc
Q 004521 520 NKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEG 599 (747)
Q Consensus 520 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~ 599 (747)
+++|.+++.... ...+++..+..++.|++.||.|||+.+ ++|+||||+||++++++.+||+|||+++.........
T Consensus 84 ~~~L~~~~~~~~-~~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~~~~~~ 159 (260)
T cd05069 84 KGSLLDFLKEGD-GKYLKLPQLVDMAAQIADGMAYIERMN---YIHRDLRAANILVGDNLVCKIADFGLARLIEDNEYTA 159 (260)
T ss_pred CCCHHHHHhhCC-CCCCCHHHHHHHHHHHHHHHHHHHhCC---EeecccCcceEEEcCCCeEEECCCccceEccCCcccc
Confidence 999999996532 335789999999999999999999988 9999999999999999999999999998654322111
Q ss_pred ccc------eeeec--cCCCCCccccchhHHHHHHHHHh-CCCCCCCCCCcchhhhhHhHHhcCCcccccchhhhccCCH
Q 004521 600 NTN------RVVGT--YDGQFSIKSDVFSFGILLLEIVS-GKKNRGFYRSDTKVNLIGHLWDEGIPLRLIDACIQDSCNL 670 (747)
Q Consensus 600 ~~~------~~~~~--~~~~~s~ksDVwS~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~ 670 (747)
... ..... ....++.++|||||||++|||++ |+.|+.... ........ ..+...... .
T Consensus 160 ~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~---~~~~~~~~-~~~~~~~~~---------~ 226 (260)
T cd05069 160 RQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMV---NREVLEQV-ERGYRMPCP---------Q 226 (260)
T ss_pred cCCCccchhhCCHHHhccCCcChHHHHHHHHHHHHHHHhCCCCCCCCCC---HHHHHHHH-HcCCCCCCC---------c
Confidence 000 00000 13567889999999999999999 888864322 22222222 111111110 0
Q ss_pred HHHHHHHHHHHhccCCCCCCCCCHHHHHHHhcC
Q 004521 671 ADVIRCIHIGLLCVQQHPEDRPCMPSVILMLGS 703 (747)
Q Consensus 671 ~~~~~~~~l~~~Cl~~dP~~RPt~~~v~~~L~~ 703 (747)
.....+.+++.+||+.+|++||++.+|+++|+.
T Consensus 227 ~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 259 (260)
T cd05069 227 GCPESLHELMKLCWKKDPDERPTFEYIQSFLED 259 (260)
T ss_pred ccCHHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence 112345677889999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-33 Score=295.82 Aligned_cols=252 Identities=22% Similarity=0.336 Sum_probs=177.9
Q ss_pred cCCCccceecccCCeeEEEEEec--CCcEEEEEEecccc--cccHHHHHHHHHHHhcc---CCCceeeEEeEEEe-----
Q 004521 440 DNFSINNKLGEGGFGPVYKGTLV--DGQEIAVKRLSKIS--EQGLKELKNEVILFSKL---QHRNLVKLLGCCIQ----- 507 (747)
Q Consensus 440 ~~~~~~~~lg~G~fg~Vy~~~~~--~g~~vavK~l~~~~--~~~~~~~~~E~~~l~~l---~H~niv~l~g~~~~----- 507 (747)
++|++.+.||+|+||.||+|+.. +++.||||+++... ......+.+|+.+++.+ +||||+++++++..
T Consensus 1 ~~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~ 80 (290)
T cd07862 1 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDR 80 (290)
T ss_pred CCcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCC
Confidence 36888999999999999999863 36889999986422 22334566777777665 69999999999863
Q ss_pred CCeeEEEEecCCCCChhhHhhhcCCCCcCChhHHHHHHHHHHHHHHHhhhcCCCceEecccCcCcEEEcCCCCceEeccc
Q 004521 508 GEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFG 587 (747)
Q Consensus 508 ~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NIll~~~~~~kl~DFG 587 (747)
....++||||+. ++|.+++.... ...+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||
T Consensus 81 ~~~~~lv~e~~~-~~l~~~~~~~~-~~~~~~~~~~~i~~qi~~aL~~lH~~~---iiH~dlkp~Nil~~~~~~~kl~Dfg 155 (290)
T cd07862 81 ETKLTLVFEHVD-QDLTTYLDKVP-EPGVPTETIKDMMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLADFG 155 (290)
T ss_pred CCcEEEEEccCC-CCHHHHHHhCC-CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEEcCCCCEEEcccc
Confidence 345789999996 68998886533 234889999999999999999999988 9999999999999999999999999
Q ss_pred CccccCCCCCcc----ccceeeec--cCCCCCccccchhHHHHHHHHHhCCCCCCCCCCcchhhhhHhHHhc-C------
Q 004521 588 LVRTFGGDETEG----NTNRVVGT--YDGQFSIKSDVFSFGILLLEIVSGKKNRGFYRSDTKVNLIGHLWDE-G------ 654 (747)
Q Consensus 588 la~~~~~~~~~~----~~~~~~~~--~~~~~s~ksDVwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~-~------ 654 (747)
+++......... ........ ....++.++|||||||++|||++|+.||....... .+...... +
T Consensus 156 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~---~~~~i~~~~~~~~~~~ 232 (290)
T cd07862 156 LARIYSFQMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVD---QLGKILDVIGLPGEED 232 (290)
T ss_pred ceEeccCCcccccccccccccChHHHhCCCCCCccchHHHHHHHHHHHcCCCCcCCCCHHH---HHHHHHHHhCCCChhh
Confidence 998654332110 00000000 14568899999999999999999999975432211 11111100 0
Q ss_pred Cccc--ccchhhh--ccCCHH-----HHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 004521 655 IPLR--LIDACIQ--DSCNLA-----DVIRCIHIGLLCVQQHPEDRPCMPSVIL 699 (747)
Q Consensus 655 ~~~~--~~d~~l~--~~~~~~-----~~~~~~~l~~~Cl~~dP~~RPt~~~v~~ 699 (747)
.... +....+. .....+ ....+.+++.+||+.||++|||+.++++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~ 286 (290)
T cd07862 233 WPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS 286 (290)
T ss_pred chhhhcccchhccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHhc
Confidence 0000 0000000 000011 1123457888999999999999999985
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-33 Score=290.96 Aligned_cols=237 Identities=21% Similarity=0.323 Sum_probs=177.0
Q ss_pred ceecccCCeeEEEEEecC-------------CcEEEEEEecccccccHHHHHHHHHHHhccCCCceeeEEeEEEeCCeeE
Q 004521 446 NKLGEGGFGPVYKGTLVD-------------GQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKL 512 (747)
Q Consensus 446 ~~lg~G~fg~Vy~~~~~~-------------g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~ 512 (747)
+.||+|+||.||+|+... ...|++|.+..........|.+|+.+++.++||||+++++++......+
T Consensus 1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~~~~ 80 (262)
T cd05077 1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVSHKHIVLLYGVCVRDVENI 80 (262)
T ss_pred CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhhhhHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCE
Confidence 468999999999998532 2258999887655555668899999999999999999999999999999
Q ss_pred EEEecCCCCChhhHhhhcCCCCcCChhHHHHHHHHHHHHHHHhhhcCCCceEecccCcCcEEEcCCCC-------ceEec
Q 004521 513 LIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMN-------PKISD 585 (747)
Q Consensus 513 lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NIll~~~~~-------~kl~D 585 (747)
+||||+++++|..++... ...+++..+++++.||++||+|||+.+ |+||||||+|||++.++. +|++|
T Consensus 81 lv~e~~~~~~l~~~~~~~--~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~Nill~~~~~~~~~~~~~~l~d 155 (262)
T cd05077 81 MVEEFVEFGPLDLFMHRK--SDVLTTPWKFKVAKQLASALSYLEDKD---LVHGNVCTKNILLAREGIDGECGPFIKLSD 155 (262)
T ss_pred EEEecccCCCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHhhhCC---eECCCCCcccEEEecCCccCCCCceeEeCC
Confidence 999999999999888542 345899999999999999999999988 999999999999987664 89999
Q ss_pred ccCccccCCCCCccccc-eeeec---cCCCCCccccchhHHHHHHHHH-hCCCCCCCCCCcchhhhhHhHHhcCCccccc
Q 004521 586 FGLVRTFGGDETEGNTN-RVVGT---YDGQFSIKSDVFSFGILLLEIV-SGKKNRGFYRSDTKVNLIGHLWDEGIPLRLI 660 (747)
Q Consensus 586 FGla~~~~~~~~~~~~~-~~~~~---~~~~~s~ksDVwS~Gvvl~ell-tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 660 (747)
||++............. ...+. ....++.++|||||||++|||+ +|..|+....... ........ . ...
T Consensus 156 ~g~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~----~~~~~~~~-~-~~~ 229 (262)
T cd05077 156 PGIPITVLSRQECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLAE----KERFYEGQ-C-MLV 229 (262)
T ss_pred CCCCccccCcccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcchhH----HHHHHhcC-c-cCC
Confidence 99987654322211111 11111 1356788999999999999998 4777754221111 11111111 1 010
Q ss_pred chhhhccCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhc
Q 004521 661 DACIQDSCNLADVIRCIHIGLLCVQQHPEDRPCMPSVILMLG 702 (747)
Q Consensus 661 d~~l~~~~~~~~~~~~~~l~~~Cl~~dP~~RPt~~~v~~~L~ 702 (747)
. .. ...+.+|+.+||+.||.+||++.+|++.|+
T Consensus 230 ~------~~---~~~~~~li~~cl~~dp~~Rp~~~~il~~~~ 262 (262)
T cd05077 230 T------PS---CKELADLMTHCMNYDPNQRPFFRAIMRDIN 262 (262)
T ss_pred C------CC---hHHHHHHHHHHcCCChhhCcCHHHHHHhcC
Confidence 0 01 234567888999999999999999998774
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-34 Score=309.44 Aligned_cols=244 Identities=23% Similarity=0.321 Sum_probs=186.9
Q ss_pred cCCCccceecccCCeeEEEEEec-CCcEEEEEEeccc---ccccHHHHHHHHHHHhccCCCceeeEEeEEEeCCeeEEEE
Q 004521 440 DNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKI---SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIY 515 (747)
Q Consensus 440 ~~~~~~~~lg~G~fg~Vy~~~~~-~g~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 515 (747)
++|.+.+.||+|+||.||+|+.. +++.||||++++. .......+.+|+.++..++|+||+++++++.+++..++||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (350)
T cd05573 1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYLVM 80 (350)
T ss_pred CCceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheecCCeEEEEE
Confidence 46889999999999999999976 4899999999752 2245567899999999999999999999999999999999
Q ss_pred ecCCCCChhhHhhhcCCCCcCChhHHHHHHHHHHHHHHHhhhcCCCceEecccCcCcEEEcCCCCceEecccCccccCCC
Q 004521 516 EFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGD 595 (747)
Q Consensus 516 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NIll~~~~~~kl~DFGla~~~~~~ 595 (747)
||+++++|.+++... ..+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++.+...
T Consensus 81 e~~~~~~L~~~l~~~---~~l~~~~~~~i~~qi~~aL~~LH~~g---iiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~ 154 (350)
T cd05573 81 EYMPGGDLMNLLIRK---DVFPEETARFYIAELVLALDSVHKLG---FIHRDIKPDNILIDADGHIKLADFGLCKKMNKA 154 (350)
T ss_pred cCCCCCCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEeecCCCCccCccc
Confidence 999999999999653 45889999999999999999999988 999999999999999999999999999876443
Q ss_pred CC---------------------------ccccceeeec---------cCCCCCccccchhHHHHHHHHHhCCCCCCCCC
Q 004521 596 ET---------------------------EGNTNRVVGT---------YDGQFSIKSDVFSFGILLLEIVSGKKNRGFYR 639 (747)
Q Consensus 596 ~~---------------------------~~~~~~~~~~---------~~~~~s~ksDVwS~Gvvl~elltg~~p~~~~~ 639 (747)
.. ........++ ....++.++|||||||+||||++|+.||....
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~ 234 (350)
T cd05573 155 KDREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPFYSDT 234 (350)
T ss_pred CcccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCceeeEecchhhhhhccCCCCCCCCC
Confidence 30 0000011111 14578899999999999999999999975433
Q ss_pred CcchhhhhHhHHhcCCcccccchhhhccCCHHHHHHHHHHHHhccCCCCCCCCC-HHHHHHH
Q 004521 640 SDTKVNLIGHLWDEGIPLRLIDACIQDSCNLADVIRCIHIGLLCVQQHPEDRPC-MPSVILM 700 (747)
Q Consensus 640 ~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dP~~RPt-~~~v~~~ 700 (747)
. ......+........+... .. ....+.+++.+|++ +|.+||+ +.++++.
T Consensus 235 ~---~~~~~~i~~~~~~~~~p~~---~~----~~~~~~~li~~ll~-dp~~R~~s~~~ll~h 285 (350)
T cd05573 235 L---QETYNKIINWKESLRFPPD---PP----VSPEAIDLICRLLC-DPEDRLGSFEEIKSH 285 (350)
T ss_pred H---HHHHHHHhccCCcccCCCC---CC----CCHHHHHHHHHHcc-ChhhcCCCHHHHhcC
Confidence 1 1112111110000001000 00 11235566778997 9999999 9999875
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-33 Score=301.88 Aligned_cols=233 Identities=21% Similarity=0.253 Sum_probs=179.2
Q ss_pred ceecccCCeeEEEEEec-CCcEEEEEEeccc---ccccHHHHHHHHHHHhccCCCceeeEEeEEEeCCeeEEEEecCCCC
Q 004521 446 NKLGEGGFGPVYKGTLV-DGQEIAVKRLSKI---SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMPNK 521 (747)
Q Consensus 446 ~~lg~G~fg~Vy~~~~~-~g~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~g 521 (747)
+.||+|+||.||++... +++.||||++.+. .......+.+|+.+++.++||||+++++++...+..++||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~~g 80 (328)
T cd05593 1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGG 80 (328)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEeCCCCC
Confidence 46999999999999975 4899999999752 2344567889999999999999999999999999999999999999
Q ss_pred ChhhHhhhcCCCCcCChhHHHHHHHHHHHHHHHhhhcCCCceEecccCcCcEEEcCCCCceEecccCccccCCCCCcccc
Q 004521 522 SLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNT 601 (747)
Q Consensus 522 sL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~ 601 (747)
+|..++... ..+++.++..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++.........
T Consensus 81 ~L~~~l~~~---~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~~~~~~-- 152 (328)
T cd05593 81 ELFFHLSRE---RVFSEDRTRFYGAEIVSALDYLHSGK---IVYRDLKLENLMLDKDGHIKITDFGLCKEGITDAATM-- 152 (328)
T ss_pred CHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCC---eEecccCHHHeEECCCCcEEEecCcCCccCCCccccc--
Confidence 999888542 35889999999999999999999988 9999999999999999999999999987543221110
Q ss_pred ceeeec---------cCCCCCccccchhHHHHHHHHHhCCCCCCCCCCcchhhhhHhHHhcCCcccccchhhhccCCHHH
Q 004521 602 NRVVGT---------YDGQFSIKSDVFSFGILLLEIVSGKKNRGFYRSDTKVNLIGHLWDEGIPLRLIDACIQDSCNLAD 672 (747)
Q Consensus 602 ~~~~~~---------~~~~~s~ksDVwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~ 672 (747)
....++ ....++.++|||||||+||||++|+.||..... ............ . +....
T Consensus 153 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~---~~~~~~~~~~~~--~-----~p~~~---- 218 (328)
T cd05593 153 KTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH---EKLFELILMEDI--K-----FPRTL---- 218 (328)
T ss_pred ccccCCcCccChhhhcCCCCCccCCccccchHHHHHhhCCCCCCCCCH---HHHHHHhccCCc--c-----CCCCC----
Confidence 001111 145688999999999999999999999753221 111111111110 0 11111
Q ss_pred HHHHHHHHHhccCCCCCCCC-----CHHHHHHH
Q 004521 673 VIRCIHIGLLCVQQHPEDRP-----CMPSVILM 700 (747)
Q Consensus 673 ~~~~~~l~~~Cl~~dP~~RP-----t~~~v~~~ 700 (747)
...+.+++.+||+.||.+|| ++.++++.
T Consensus 219 ~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h 251 (328)
T cd05593 219 SADAKSLLSGLLIKDPNKRLGGGPDDAKEIMRH 251 (328)
T ss_pred CHHHHHHHHHHcCCCHHHcCCCCCCCHHHHhcC
Confidence 12355677799999999997 88888764
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-33 Score=290.42 Aligned_cols=247 Identities=31% Similarity=0.507 Sum_probs=192.7
Q ss_pred hcCCCccceecccCCeeEEEEEecCCcEEEEEEecccccccHHHHHHHHHHHhccCCCceeeEEeEEEeCCeeEEEEecC
Q 004521 439 TDNFSINNKLGEGGFGPVYKGTLVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFM 518 (747)
Q Consensus 439 ~~~~~~~~~lg~G~fg~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~ 518 (747)
.++|.+.++||+|+||.||+|...+++.+|||.+.. .....+++.+|+.++++++|+||+++++++......++||||+
T Consensus 5 ~~~~~i~~~ig~g~~~~v~~~~~~~~~~~~vK~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~ 83 (261)
T cd05034 5 RESLKLERKLGAGQFGEVWMGTWNGTTKVAVKTLKP-GTMSPEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPIYIVTEYM 83 (261)
T ss_pred hhheeeeeeeccCcceEEEEEEEcCCceEEEEEecC-CccCHHHHHHHHHHHhhCCCCCEeeeeeeeecCCceEEEEecc
Confidence 467899999999999999999988888999999875 3344678999999999999999999999999989999999999
Q ss_pred CCCChhhHhhhcCCCCcCChhHHHHHHHHHHHHHHHhhhcCCCceEecccCcCcEEEcCCCCceEecccCccccCCCCCc
Q 004521 519 PNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETE 598 (747)
Q Consensus 519 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~ 598 (747)
++++|.+++.... ...+++..+..++.+++.||.|||+.+ ++|+||||+||++++++.+||+|||+++.+......
T Consensus 84 ~~~~L~~~i~~~~-~~~~~~~~~~~~~~~i~~al~~lh~~~---i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~ 159 (261)
T cd05034 84 SKGSLLDFLKSGE-GKKLRLPQLVDMAAQIAEGMAYLESRN---YIHRDLAARNILVGENLVCKIADFGLARLIEDDEYT 159 (261)
T ss_pred CCCCHHHHHhccc-cCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCcchheEEEcCCCCEEECccccceeccchhhh
Confidence 9999999996532 235899999999999999999999988 999999999999999999999999998876432111
Q ss_pred ccc------ceeee--ccCCCCCccccchhHHHHHHHHHh-CCCCCCCCCCcchhhhhHhHHhcCCcccccchhhhccCC
Q 004521 599 GNT------NRVVG--TYDGQFSIKSDVFSFGILLLEIVS-GKKNRGFYRSDTKVNLIGHLWDEGIPLRLIDACIQDSCN 669 (747)
Q Consensus 599 ~~~------~~~~~--~~~~~~s~ksDVwS~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~ 669 (747)
... ..... ..+..++.++||||||+++|||++ |+.|+.... ....+... ..+...... ...
T Consensus 160 ~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~---~~~~~~~~-~~~~~~~~~-----~~~- 229 (261)
T cd05034 160 AREGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMT---NREVLEQV-ERGYRMPRP-----PNC- 229 (261)
T ss_pred hhhccCCCccccCHHHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCC---HHHHHHHH-HcCCCCCCC-----CCC-
Confidence 100 00000 014567889999999999999999 888864221 11222221 111111110 011
Q ss_pred HHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhcC
Q 004521 670 LADVIRCIHIGLLCVQQHPEDRPCMPSVILMLGS 703 (747)
Q Consensus 670 ~~~~~~~~~l~~~Cl~~dP~~RPt~~~v~~~L~~ 703 (747)
...+.+++.+|++.+|++||++.++++.|+.
T Consensus 230 ---~~~~~~~i~~~l~~~p~~Rp~~~~l~~~l~~ 260 (261)
T cd05034 230 ---PEELYDLMLQCWDKDPEERPTFEYLQSFLED 260 (261)
T ss_pred ---CHHHHHHHHHHcccCcccCCCHHHHHHHHhc
Confidence 2346678889999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-33 Score=292.45 Aligned_cols=247 Identities=27% Similarity=0.450 Sum_probs=189.1
Q ss_pred cCCCccceecccCCeeEEEEEecC----CcEEEEEEeccc-ccccHHHHHHHHHHHhccCCCceeeEEeEEEeCCeeEEE
Q 004521 440 DNFSINNKLGEGGFGPVYKGTLVD----GQEIAVKRLSKI-SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLI 514 (747)
Q Consensus 440 ~~~~~~~~lg~G~fg~Vy~~~~~~----g~~vavK~l~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV 514 (747)
.+|++.+.||+|+||.||+|+... +..+|+|.++.. .....+.+.+|+.++++++||||+++++++..++..++|
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 83 (267)
T cd05066 4 SCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKPVMIV 83 (267)
T ss_pred HHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEEE
Confidence 468888999999999999998642 347999998753 233456889999999999999999999999999999999
Q ss_pred EecCCCCChhhHhhhcCCCCcCChhHHHHHHHHHHHHHHHhhhcCCCceEecccCcCcEEEcCCCCceEecccCccccCC
Q 004521 515 YEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGG 594 (747)
Q Consensus 515 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NIll~~~~~~kl~DFGla~~~~~ 594 (747)
|||+++++|.+++.... ..+++.+++.++.|++.||.|||+.+ ++||||||+|||++.++.+||+|||+++.+..
T Consensus 84 ~e~~~~~~L~~~~~~~~--~~~~~~~~~~i~~~i~~~l~~lH~~~---i~h~dlkp~nili~~~~~~~l~dfg~~~~~~~ 158 (267)
T cd05066 84 TEYMENGSLDAFLRKHD--GQFTVIQLVGMLRGIASGMKYLSDMG---YVHRDLAARNILVNSNLVCKVSDFGLSRVLED 158 (267)
T ss_pred EEcCCCCCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHCC---EeehhhchhcEEECCCCeEEeCCCCccccccc
Confidence 99999999999996532 35789999999999999999999988 99999999999999999999999999987643
Q ss_pred CCCccccc-------eeeec---cCCCCCccccchhHHHHHHHHHh-CCCCCCCCCCcchhhhhHhHHhcCCcccccchh
Q 004521 595 DETEGNTN-------RVVGT---YDGQFSIKSDVFSFGILLLEIVS-GKKNRGFYRSDTKVNLIGHLWDEGIPLRLIDAC 663 (747)
Q Consensus 595 ~~~~~~~~-------~~~~~---~~~~~s~ksDVwS~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 663 (747)
........ ..... ....++.++||||||+++||+++ |..|+...... ...... .++.....
T Consensus 159 ~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~~---~~~~~~-~~~~~~~~---- 230 (267)
T cd05066 159 DPEAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQ---DVIKAI-EEGYRLPA---- 230 (267)
T ss_pred ccceeeecCCCccceeecCHhHhccCccCchhhhHHHHHHHHHHhcCCCCCcccCCHH---HHHHHH-hCCCcCCC----
Confidence 32211100 00011 13568899999999999999887 99996533221 111111 12111110
Q ss_pred hhccCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhcCC
Q 004521 664 IQDSCNLADVIRCIHIGLLCVQQHPEDRPCMPSVILMLGSE 704 (747)
Q Consensus 664 l~~~~~~~~~~~~~~l~~~Cl~~dP~~RPt~~~v~~~L~~~ 704 (747)
.. .....+.+++.+|++.+|.+||+|.++++.|+..
T Consensus 231 -~~----~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 266 (267)
T cd05066 231 -PM----DCPAALHQLMLDCWQKDRNERPKFEQIVSILDKL 266 (267)
T ss_pred -CC----CCCHHHHHHHHHHcccCchhCCCHHHHHHHHHhh
Confidence 00 0122356788899999999999999999999763
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-33 Score=301.76 Aligned_cols=234 Identities=20% Similarity=0.242 Sum_probs=178.1
Q ss_pred ceecccCCeeEEEEEec-CCcEEEEEEeccc---ccccHHHHHHHHHHHhccCCCceeeEEeEEEeCCeeEEEEecCCCC
Q 004521 446 NKLGEGGFGPVYKGTLV-DGQEIAVKRLSKI---SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMPNK 521 (747)
Q Consensus 446 ~~lg~G~fg~Vy~~~~~-~g~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~g 521 (747)
+.||+|+||.||+++.. +|+.||+|.++.. .......+.+|+.++++++||||+++++++...+..++||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (323)
T cd05595 1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEeCCCCC
Confidence 46999999999999975 4899999999752 2334567788999999999999999999999999999999999999
Q ss_pred ChhhHhhhcCCCCcCChhHHHHHHHHHHHHHHHhhhcCCCceEecccCcCcEEEcCCCCceEecccCccccCCCCCcc--
Q 004521 522 SLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEG-- 599 (747)
Q Consensus 522 sL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~-- 599 (747)
+|..++... ..+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++.........
T Consensus 81 ~L~~~l~~~---~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~ 154 (323)
T cd05595 81 ELFFHLSRE---RVFTEERARFYGAEIVSALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKT 154 (323)
T ss_pred cHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHEEEcCCCCEEecccHHhccccCCCCcccc
Confidence 999888542 35889999999999999999999988 9999999999999999999999999987542221110
Q ss_pred ---ccceeeec--cCCCCCccccchhHHHHHHHHHhCCCCCCCCCCcchhhhhHhHHhcCCcccccchhhhccCCHHHHH
Q 004521 600 ---NTNRVVGT--YDGQFSIKSDVFSFGILLLEIVSGKKNRGFYRSDTKVNLIGHLWDEGIPLRLIDACIQDSCNLADVI 674 (747)
Q Consensus 600 ---~~~~~~~~--~~~~~s~ksDVwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~ 674 (747)
........ ....++.++|||||||++|||++|+.|+..... ............ . +....+ .
T Consensus 155 ~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~---~~~~~~~~~~~~--~-----~p~~~~----~ 220 (323)
T cd05595 155 FCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH---ERLFELILMEEI--R-----FPRTLS----P 220 (323)
T ss_pred ccCCcCcCCcccccCCCCCchhchhhhHHHHHHHHhCCCCCCCCCH---HHHHHHHhcCCC--C-----CCCCCC----H
Confidence 00001111 145688999999999999999999999753221 111222111111 0 111111 2
Q ss_pred HHHHHHHhccCCCCCCCC-----CHHHHHH
Q 004521 675 RCIHIGLLCVQQHPEDRP-----CMPSVIL 699 (747)
Q Consensus 675 ~~~~l~~~Cl~~dP~~RP-----t~~~v~~ 699 (747)
.+.+++.+||+.||.+|| ++.++++
T Consensus 221 ~~~~li~~~L~~dP~~R~~~~~~~~~~~l~ 250 (323)
T cd05595 221 EAKSLLAGLLKKDPKQRLGGGPSDAKEVME 250 (323)
T ss_pred HHHHHHHHHccCCHHHhCCCCCCCHHHHHc
Confidence 345677799999999998 7888765
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-33 Score=297.28 Aligned_cols=235 Identities=24% Similarity=0.333 Sum_probs=176.5
Q ss_pred CCccceecccCCeeEEEEEec-CCcEEEEEEeccc---ccccHHHHHHHHHHH---hccCCCceeeEEeEEEeCCeeEEE
Q 004521 442 FSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKI---SEQGLKELKNEVILF---SKLQHRNLVKLLGCCIQGEEKLLI 514 (747)
Q Consensus 442 ~~~~~~lg~G~fg~Vy~~~~~-~g~~vavK~l~~~---~~~~~~~~~~E~~~l---~~l~H~niv~l~g~~~~~~~~~lV 514 (747)
|++.+.||+|+||.||+|... +++.||||.+++. .....+.+.+|++++ +.++||||+++++++...+..++|
T Consensus 1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv 80 (324)
T cd05589 1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCFV 80 (324)
T ss_pred CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEEEE
Confidence 567899999999999999875 4889999999753 223345667776655 567899999999999999999999
Q ss_pred EecCCCCChhhHhhhcCCCCcCChhHHHHHHHHHHHHHHHhhhcCCCceEecccCcCcEEEcCCCCceEecccCccccCC
Q 004521 515 YEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGG 594 (747)
Q Consensus 515 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NIll~~~~~~kl~DFGla~~~~~ 594 (747)
|||+++++|..++.. ..+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++....
T Consensus 81 ~E~~~~~~L~~~~~~----~~l~~~~~~~~~~qi~~al~~lH~~~---ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~~~ 153 (324)
T cd05589 81 MEYAAGGDLMMHIHT----DVFSEPRAVFYAACVVLGLQYLHENK---IVYRDLKLDNLLLDTEGFVKIADFGLCKEGMG 153 (324)
T ss_pred EcCCCCCcHHHHhhc----CCCCHHHHHHHHHHHHHHHHHHHhCC---eEecCCCHHHeEECCCCcEEeCcccCCccCCC
Confidence 999999999988743 35899999999999999999999988 99999999999999999999999999875422
Q ss_pred CCCccccceeeec---------cCCCCCccccchhHHHHHHHHHhCCCCCCCCCCcchhhhhHhHHhcCCcccccchhhh
Q 004521 595 DETEGNTNRVVGT---------YDGQFSIKSDVFSFGILLLEIVSGKKNRGFYRSDTKVNLIGHLWDEGIPLRLIDACIQ 665 (747)
Q Consensus 595 ~~~~~~~~~~~~~---------~~~~~s~ksDVwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 665 (747)
..... ....++ .+..++.++|||||||++|||++|+.||.... ............ .. . .
T Consensus 154 ~~~~~--~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~G~~pf~~~~---~~~~~~~i~~~~-~~-~-----p 221 (324)
T cd05589 154 FGDRT--STFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDD---EEEVFDSIVNDE-VR-Y-----P 221 (324)
T ss_pred CCCcc--cccccCccccCHhHhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCC---HHHHHHHHHhCC-CC-C-----C
Confidence 21111 001111 14568899999999999999999999975322 112222221111 10 0 0
Q ss_pred ccCCHHHHHHHHHHHHhccCCCCCCCC-----CHHHHHH
Q 004521 666 DSCNLADVIRCIHIGLLCVQQHPEDRP-----CMPSVIL 699 (747)
Q Consensus 666 ~~~~~~~~~~~~~l~~~Cl~~dP~~RP-----t~~~v~~ 699 (747)
... ...+.+++.+||+.||.+|| ++.++++
T Consensus 222 ~~~----~~~~~~li~~~L~~dP~~R~~~~~~~~~~l~~ 256 (324)
T cd05589 222 RFL----SREAISIMRRLLRRNPERRLGSGEKDAEDVKK 256 (324)
T ss_pred CCC----CHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhh
Confidence 111 12355678899999999999 4666655
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-33 Score=287.12 Aligned_cols=239 Identities=28% Similarity=0.407 Sum_probs=184.1
Q ss_pred ceecccCCeeEEEEEecCCcEEEEEEecccc-cccHHHHHHHHHHHhccCCCceeeEEeEEEeCCeeEEEEecCCCCChh
Q 004521 446 NKLGEGGFGPVYKGTLVDGQEIAVKRLSKIS-EQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMPNKSLD 524 (747)
Q Consensus 446 ~~lg~G~fg~Vy~~~~~~g~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gsL~ 524 (747)
+.||+|+||.||+|...+++.+|+|.+.... ......+.+|+.++++++||||+++++++......++||||+++++|.
T Consensus 1 ~~ig~g~~g~vy~~~~~~~~~~a~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~ 80 (250)
T cd05085 1 ELLGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGGDFL 80 (250)
T ss_pred CccCCCCCceEEEEEecCCcEEEEEecCCcCCHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECCCCCcHH
Confidence 4699999999999998888999999987533 233457889999999999999999999999999999999999999999
Q ss_pred hHhhhcCCCCcCChhHHHHHHHHHHHHHHHhhhcCCCceEecccCcCcEEEcCCCCceEecccCccccCCCCCcccc---
Q 004521 525 SFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNT--- 601 (747)
Q Consensus 525 ~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~--- 601 (747)
+++... ...+++..+..++.|++.||.|||+.+ ++||||||+||+++.++.+||+|||+++...........
T Consensus 81 ~~~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~---~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~ 155 (250)
T cd05085 81 SFLRKK--KDELKTKQLVKFALDAAAGMAYLESKN---CIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYSSSGLKQ 155 (250)
T ss_pred HHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccChheEEEcCCCeEEECCCccceeccccccccCCCCC
Confidence 998543 235789999999999999999999988 999999999999999999999999998754322111000
Q ss_pred ---ceeeec--cCCCCCccccchhHHHHHHHHHh-CCCCCCCCCCcchhhhhHhHHhcCCcccccchhhhccCCHHHHHH
Q 004521 602 ---NRVVGT--YDGQFSIKSDVFSFGILLLEIVS-GKKNRGFYRSDTKVNLIGHLWDEGIPLRLIDACIQDSCNLADVIR 675 (747)
Q Consensus 602 ---~~~~~~--~~~~~s~ksDVwS~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~ 675 (747)
...... ..+.++.++||||||+++|||++ |..|+.... ....... ...+....... .....
T Consensus 156 ~~~~y~aPE~~~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~---~~~~~~~-~~~~~~~~~~~---------~~~~~ 222 (250)
T cd05085 156 IPIKWTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGMT---NQQAREQ-VEKGYRMSCPQ---------KCPDD 222 (250)
T ss_pred CcccccCHHHhccCCCCchhHHHHHHHHHHHHhcCCCCCCCCCC---HHHHHHH-HHcCCCCCCCC---------CCCHH
Confidence 000010 13567889999999999999999 888864322 1111111 11221111111 11234
Q ss_pred HHHHHHhccCCCCCCCCCHHHHHHHhc
Q 004521 676 CIHIGLLCVQQHPEDRPCMPSVILMLG 702 (747)
Q Consensus 676 ~~~l~~~Cl~~dP~~RPt~~~v~~~L~ 702 (747)
+.+++.+|++.+|++||++.++++.|.
T Consensus 223 ~~~li~~~l~~~p~~Rp~~~~l~~~l~ 249 (250)
T cd05085 223 VYKVMQRCWDYKPENRPKFSELQKELA 249 (250)
T ss_pred HHHHHHHHcccCcccCCCHHHHHHHhc
Confidence 677888999999999999999999885
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-33 Score=294.67 Aligned_cols=246 Identities=23% Similarity=0.271 Sum_probs=184.6
Q ss_pred CCCccceecccCCeeEEEEEec-CCcEEEEEEecccc---cccHHHHHHHHHHHhccCCCceeeEEeEEEeCCeeEEEEe
Q 004521 441 NFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKIS---EQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYE 516 (747)
Q Consensus 441 ~~~~~~~lg~G~fg~Vy~~~~~-~g~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E 516 (747)
+|++.+.||+|+||.||++... +++.||||.+.... ......+.+|+.++++++||||+++++++..++..++|||
T Consensus 1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (285)
T cd05605 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCeEEEEEe
Confidence 4778899999999999999975 48899999986521 2234567889999999999999999999999999999999
Q ss_pred cCCCCChhhHhhhcCCCCcCChhHHHHHHHHHHHHHHHhhhcCCCceEecccCcCcEEEcCCCCceEecccCccccCCCC
Q 004521 517 FMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDE 596 (747)
Q Consensus 517 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~ 596 (747)
|+++|+|.+++.... ...+++..+..++.|++.||.|||+.+ |+||||||+||++++++.++|+|||+++......
T Consensus 81 ~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~ 156 (285)
T cd05605 81 LMNGGDLKFHIYNMG-NPGFDEERAVFYAAEITCGLEDLHRER---IVYRDLKPENILLDDYGHIRISDLGLAVEIPEGE 156 (285)
T ss_pred ccCCCcHHHHHHhcC-cCCCCHHHHHHHHHHHHHHHHHHHHCC---cEecCCCHHHEEECCCCCEEEeeCCCceecCCCC
Confidence 999999998886532 345899999999999999999999988 9999999999999999999999999998754322
Q ss_pred Ccc----ccceeeec--cCCCCCccccchhHHHHHHHHHhCCCCCCCCCCcchhhhhHhHHhcCCcccccchhhhccCCH
Q 004521 597 TEG----NTNRVVGT--YDGQFSIKSDVFSFGILLLEIVSGKKNRGFYRSDTKVNLIGHLWDEGIPLRLIDACIQDSCNL 670 (747)
Q Consensus 597 ~~~----~~~~~~~~--~~~~~s~ksDVwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~ 670 (747)
... ........ ....++.++|||||||++|||++|+.||...........+........ .. ...
T Consensus 157 ~~~~~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~~~-~~---------~~~ 226 (285)
T cd05605 157 TIRGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKVKREEVERRVKEDQ-EE---------YSE 226 (285)
T ss_pred ccccccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHHCCCCCCCCchhhHHHHHHHHhhhcc-cc---------cCc
Confidence 110 00000011 145688899999999999999999999764322211111111111110 00 011
Q ss_pred HHHHHHHHHHHhccCCCCCCCC-----CHHHHHHH
Q 004521 671 ADVIRCIHIGLLCVQQHPEDRP-----CMPSVILM 700 (747)
Q Consensus 671 ~~~~~~~~l~~~Cl~~dP~~RP-----t~~~v~~~ 700 (747)
.....+.+++.+||+.||.+|| ++.++++.
T Consensus 227 ~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~ 261 (285)
T cd05605 227 KFSEAARSICRQLLTKDPGFRLGCRGEGAEEVKAH 261 (285)
T ss_pred ccCHHHHHHHHHHccCCHHHhcCCCCCCHHHHhcC
Confidence 1122356788899999999999 77787653
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=297.79 Aligned_cols=238 Identities=24% Similarity=0.427 Sum_probs=190.5
Q ss_pred CCCccceecccCCeeEEEEEecC-CcEEEEEEecc-cccccHHHHHHHHHHHhccCCCceeeEEeEEEeCCeeEEEEecC
Q 004521 441 NFSINNKLGEGGFGPVYKGTLVD-GQEIAVKRLSK-ISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFM 518 (747)
Q Consensus 441 ~~~~~~~lg~G~fg~Vy~~~~~~-g~~vavK~l~~-~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~ 518 (747)
.|+..+.||+|+||.||+|.... ++.||+|++.- ......++++.|+.++..++|+||.+++|.+..+...+++||||
T Consensus 14 ~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~~deIediqqei~~Ls~~~~~~it~yygsyl~g~~LwiiMey~ 93 (467)
T KOG0201|consen 14 LYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEAEDEIEDIQQEISVLSQCDSPNITEYYGSYLKGTKLWIIMEYC 93 (467)
T ss_pred ccccchhccccccceeeeeeeccccceEEEEEechhhcchhhHHHHHHHHHHHhcCcchHHhhhhheeecccHHHHHHHh
Confidence 46667899999999999999755 88999999975 34556788999999999999999999999999999999999999
Q ss_pred CCCChhhHhhhcCCCCcCChhHHHHHHHHHHHHHHHhhhcCCCceEecccCcCcEEEcCCCCceEecccCccccCCCCCc
Q 004521 519 PNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETE 598 (747)
Q Consensus 519 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~ 598 (747)
.+|++.+.|. ....+.+..+.-|+++++.||.|||.++ .+|||||+.|||+.++|.+||+|||.+-.+......
T Consensus 94 ~gGsv~~lL~---~~~~~~E~~i~~ilre~l~~l~ylH~~~---kiHrDIKaanil~s~~g~vkl~DfgVa~ql~~~~~r 167 (467)
T KOG0201|consen 94 GGGSVLDLLK---SGNILDEFEIAVILREVLKGLDYLHSEK---KIHRDIKAANILLSESGDVKLADFGVAGQLTNTVKR 167 (467)
T ss_pred cCcchhhhhc---cCCCCccceeeeehHHHHHHhhhhhhcc---eecccccccceeEeccCcEEEEecceeeeeechhhc
Confidence 9999999984 3344578888889999999999999998 999999999999999999999999999776544332
Q ss_pred cccceeeecc---------CCCCCccccchhHHHHHHHHHhCCCCCCCCCCcchhhhhHhHHhcCCcccccchhhhccCC
Q 004521 599 GNTNRVVGTY---------DGQFSIKSDVFSFGILLLEIVSGKKNRGFYRSDTKVNLIGHLWDEGIPLRLIDACIQDSCN 669 (747)
Q Consensus 599 ~~~~~~~~~~---------~~~~s~ksDVwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~ 669 (747)
. ..++|++ ...|+.|+||||||++.+||.+|.+|+....+.....++ ....++. +.+.+.
T Consensus 168 r--~tfvGTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~GePP~s~~hPmrvlflI----pk~~PP~-----L~~~~S 236 (467)
T KOG0201|consen 168 R--KTFVGTPFWMAPEVIKQSGYDTKADIWSLGITAIELAKGEPPHSKLHPMRVLFLI----PKSAPPR-----LDGDFS 236 (467)
T ss_pred c--ccccccccccchhhhccccccchhhhhhhhHHHHHHhcCCCCCcccCcceEEEec----cCCCCCc-----cccccC
Confidence 2 3345553 457999999999999999999999997655543322222 1122222 222111
Q ss_pred HHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 004521 670 LADVIRCIHIGLLCVQQHPEDRPCMPSVIL 699 (747)
Q Consensus 670 ~~~~~~~~~l~~~Cl~~dP~~RPt~~~v~~ 699 (747)
. -+.+++-.||+.||+.||++.++++
T Consensus 237 ~----~~kEFV~~CL~k~P~~RpsA~~LLK 262 (467)
T KOG0201|consen 237 P----PFKEFVEACLDKNPEFRPSAKELLK 262 (467)
T ss_pred H----HHHHHHHHHhhcCcccCcCHHHHhh
Confidence 1 1345666899999999999999985
|
|
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-33 Score=291.06 Aligned_cols=252 Identities=23% Similarity=0.341 Sum_probs=190.6
Q ss_pred cCCCccceecccCCeeEEEEEe-cCCcEEEEEEeccc---ccccHHHHHHHHHHHhccCCCceeeEEeEEEeCCeeEEEE
Q 004521 440 DNFSINNKLGEGGFGPVYKGTL-VDGQEIAVKRLSKI---SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIY 515 (747)
Q Consensus 440 ~~~~~~~~lg~G~fg~Vy~~~~-~~g~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 515 (747)
++|++.+.||+|+||.||+|.. .+++.+|||.+... ......++.+|+.+++.++|+||+++++++..++..++||
T Consensus 2 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~ 81 (267)
T cd08229 2 ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVL 81 (267)
T ss_pred chhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCCeEEEEE
Confidence 4688889999999999999996 46899999988642 2234467889999999999999999999999999999999
Q ss_pred ecCCCCChhhHhhhcC-CCCcCChhHHHHHHHHHHHHHHHhhhcCCCceEecccCcCcEEEcCCCCceEecccCccccCC
Q 004521 516 EFMPNKSLDSFIFDQT-RRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGG 594 (747)
Q Consensus 516 E~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NIll~~~~~~kl~DFGla~~~~~ 594 (747)
||+++++|.+++.... ....+++..++.++.||++||.|||+.+ ++|+||||+||+++.++.++|+|||++..+..
T Consensus 82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~ 158 (267)
T cd08229 82 ELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSRR---VMHRDIKPANVFITATGVVKLGDLGLGRFFSS 158 (267)
T ss_pred EecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCCEEECcchhhhcccc
Confidence 9999999999986422 2456899999999999999999999988 99999999999999999999999999876543
Q ss_pred CCCcc----cccee-eec--cCCCCCccccchhHHHHHHHHHhCCCCCCCCCCcchhhhhHhHHhcCCcccccchhhhcc
Q 004521 595 DETEG----NTNRV-VGT--YDGQFSIKSDVFSFGILLLEIVSGKKNRGFYRSDTKVNLIGHLWDEGIPLRLIDACIQDS 667 (747)
Q Consensus 595 ~~~~~----~~~~~-~~~--~~~~~s~ksDVwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~ 667 (747)
..... ..... ... ....++.++||||||+++|||++|..|+...... ....... ......... ..
T Consensus 159 ~~~~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~-~~~~~~~-~~~~~~~~~-----~~- 230 (267)
T cd08229 159 KTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMN-LYSLCKK-IEQCDYPPL-----PS- 230 (267)
T ss_pred CCcccccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHHHhCCCCcccccch-HHHHhhh-hhcCCCCCC-----Cc-
Confidence 22110 00000 000 1356788999999999999999999996422111 1111111 111111111 00
Q ss_pred CCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhcCC
Q 004521 668 CNLADVIRCIHIGLLCVQQHPEDRPCMPSVILMLGSE 704 (747)
Q Consensus 668 ~~~~~~~~~~~l~~~Cl~~dP~~RPt~~~v~~~L~~~ 704 (747)
......+.+++.+||+.+|++||||.+|+++++..
T Consensus 231 --~~~~~~~~~li~~~l~~~p~~Rpt~~~i~~~~~~~ 265 (267)
T cd08229 231 --DHYSEELRQLVNMCINPDPEKRPDITYVYDVAKRM 265 (267)
T ss_pred --ccccHHHHHHHHHhcCCCcccCCCHHHHHHHHhhh
Confidence 11123466788899999999999999999998754
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-33 Score=298.56 Aligned_cols=249 Identities=29% Similarity=0.455 Sum_probs=186.3
Q ss_pred cCCCccceecccCCeeEEEEEecC-Cc--EEEEEEeccc-ccccHHHHHHHHHHHhcc-CCCceeeEEeEEEeCCeeEEE
Q 004521 440 DNFSINNKLGEGGFGPVYKGTLVD-GQ--EIAVKRLSKI-SEQGLKELKNEVILFSKL-QHRNLVKLLGCCIQGEEKLLI 514 (747)
Q Consensus 440 ~~~~~~~~lg~G~fg~Vy~~~~~~-g~--~vavK~l~~~-~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lV 514 (747)
++|++.+.||+|+||.||+|.... +. .+|+|.++.. .....+.+.+|+.++.++ +|+||+++++++..++..++|
T Consensus 7 ~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~~~~lv 86 (303)
T cd05088 7 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA 86 (303)
T ss_pred hhceeeeeecCCCCceEEEEEEccCCceeeEEEEEecccCCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCCCceEE
Confidence 578888999999999999999754 44 4688877642 334456789999999999 899999999999999999999
Q ss_pred EecCCCCChhhHhhhcCC-------------CCcCChhHHHHHHHHHHHHHHHhhhcCCCceEecccCcCcEEEcCCCCc
Q 004521 515 YEFMPNKSLDSFIFDQTR-------------RTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNP 581 (747)
Q Consensus 515 ~E~~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NIll~~~~~~ 581 (747)
|||+++++|.+++..... ...+++.+++.++.||++||+|||+.+ ++||||||+|||+++++.+
T Consensus 87 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~g---i~H~dlkp~Nili~~~~~~ 163 (303)
T cd05088 87 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYVA 163 (303)
T ss_pred EEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhCC---ccccccchheEEecCCCcE
Confidence 999999999999965321 235789999999999999999999988 9999999999999999999
Q ss_pred eEecccCccccCCCCCccc---c-ceeeec--cCCCCCccccchhHHHHHHHHHh-CCCCCCCCCCcchhhhhHhHHhcC
Q 004521 582 KISDFGLVRTFGGDETEGN---T-NRVVGT--YDGQFSIKSDVFSFGILLLEIVS-GKKNRGFYRSDTKVNLIGHLWDEG 654 (747)
Q Consensus 582 kl~DFGla~~~~~~~~~~~---~-~~~~~~--~~~~~s~ksDVwS~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~ 654 (747)
||+|||+++.......... . ...... ....++.++|||||||++|||+| |..|+...... ...... ..+
T Consensus 164 kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~---~~~~~~-~~~ 239 (303)
T cd05088 164 KIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCA---ELYEKL-PQG 239 (303)
T ss_pred EeCccccCcccchhhhcccCCCcccccCHHHHhccCCcccccchhhhhHHHHHHhcCCCCcccCChH---HHHHHH-hcC
Confidence 9999999864321110000 0 000000 13457889999999999999998 89886422211 111111 111
Q ss_pred CcccccchhhhccCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhcCC
Q 004521 655 IPLRLIDACIQDSCNLADVIRCIHIGLLCVQQHPEDRPCMPSVILMLGSE 704 (747)
Q Consensus 655 ~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dP~~RPt~~~v~~~L~~~ 704 (747)
...... .. ....+.+++.+||+.+|++||++.+++++|+..
T Consensus 240 ~~~~~~-----~~----~~~~~~~li~~~l~~~p~~Rp~~~~il~~l~~~ 280 (303)
T cd05088 240 YRLEKP-----LN----CDDEVYDLMRQCWREKPYERPSFAQILVSLNRM 280 (303)
T ss_pred CcCCCC-----CC----CCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 111110 00 112356788899999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-33 Score=286.57 Aligned_cols=244 Identities=27% Similarity=0.438 Sum_probs=186.1
Q ss_pred cCCCccceecccCCeeEEEEEecCCcEEEEEEecccccccHHHHHHHHHHHhccCCCceeeEEeEEEe-CCeeEEEEecC
Q 004521 440 DNFSINNKLGEGGFGPVYKGTLVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQ-GEEKLLIYEFM 518 (747)
Q Consensus 440 ~~~~~~~~lg~G~fg~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~-~~~~~lV~E~~ 518 (747)
++|.+.+.||+|+||.||++... +..+|+|.++.. ...+.|.+|+.++++++|+|++++++++.. ++..++||||+
T Consensus 6 ~~~~~~~~lg~g~~~~v~~~~~~-~~~~~~k~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e~~ 82 (256)
T cd05082 6 KELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKND--ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYM 82 (256)
T ss_pred HhCeeeeeecccCCCeEEEEEEc-CCcEEEEEeCCC--chHHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCceEEEEECC
Confidence 47888899999999999999864 788999998642 335679999999999999999999998654 45689999999
Q ss_pred CCCChhhHhhhcCCCCcCChhHHHHHHHHHHHHHHHhhhcCCCceEecccCcCcEEEcCCCCceEecccCccccCCCCCc
Q 004521 519 PNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETE 598 (747)
Q Consensus 519 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~ 598 (747)
++++|.+++.... ...+++..++.++.|++.||+|||+.+ ++||||||+||+++.++.+||+|||+++........
T Consensus 83 ~~~~L~~~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~ 158 (256)
T cd05082 83 AKGSLVDYLRSRG-RSVLGGDCLLKFSLDVCEAMEYLEANN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDT 158 (256)
T ss_pred CCCcHHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHhCC---EeccccchheEEEcCCCcEEecCCccceeccccCCC
Confidence 9999999986533 335889999999999999999999988 999999999999999999999999998865432221
Q ss_pred cccc--eeeec--cCCCCCccccchhHHHHHHHHHh-CCCCCCCCCCcchhhhhHhHHhcCCcccccchhhhccCCHHHH
Q 004521 599 GNTN--RVVGT--YDGQFSIKSDVFSFGILLLEIVS-GKKNRGFYRSDTKVNLIGHLWDEGIPLRLIDACIQDSCNLADV 673 (747)
Q Consensus 599 ~~~~--~~~~~--~~~~~s~ksDVwS~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~ 673 (747)
.... ..... ....++.++||||||+++|||++ |+.|+..... ...... ...+......+ .. .
T Consensus 159 ~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~~---~~~~~~-~~~~~~~~~~~-----~~----~ 225 (256)
T cd05082 159 GKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPL---KDVVPR-VEKGYKMDAPD-----GC----P 225 (256)
T ss_pred CccceeecCHHHHccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCCH---HHHHHH-HhcCCCCCCCC-----CC----C
Confidence 1111 00011 14568889999999999999998 8888643211 111111 11221111111 11 2
Q ss_pred HHHHHHHHhccCCCCCCCCCHHHHHHHhcC
Q 004521 674 IRCIHIGLLCVQQHPEDRPCMPSVILMLGS 703 (747)
Q Consensus 674 ~~~~~l~~~Cl~~dP~~RPt~~~v~~~L~~ 703 (747)
..+.+++.+||+.+|++|||+.++++.|+.
T Consensus 226 ~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~ 255 (256)
T cd05082 226 PVVYDVMKQCWHLDAATRPSFLQLREQLEH 255 (256)
T ss_pred HHHHHHHHHHhcCChhhCcCHHHHHHHHhc
Confidence 235678889999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-33 Score=298.38 Aligned_cols=254 Identities=21% Similarity=0.287 Sum_probs=183.2
Q ss_pred cCCCccceecccCCeeEEEEEec-CCcEEEEEEecccc-cccHHHHHHHHHHHhccCCCceeeEEeEEEeCCeeEEEEec
Q 004521 440 DNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKIS-EQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEF 517 (747)
Q Consensus 440 ~~~~~~~~lg~G~fg~Vy~~~~~-~g~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~ 517 (747)
++|.+.++||+|+||.||+|+.. +++.||+|.++... ......+.+|+.++++++||||+++++++..++..++||||
T Consensus 6 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 85 (309)
T cd07872 6 ETYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIVHTDKSLTLVFEY 85 (309)
T ss_pred CceEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccCCcchhHHHHHHHHHhCCCCCcceEEEEEeeCCeEEEEEeC
Confidence 56888999999999999999875 47889999987532 23345678899999999999999999999999999999999
Q ss_pred CCCCChhhHhhhcCCCCcCChhHHHHHHHHHHHHHHHhhhcCCCceEecccCcCcEEEcCCCCceEecccCccccCCCCC
Q 004521 518 MPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDET 597 (747)
Q Consensus 518 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~ 597 (747)
+++ +|.+++... ...+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++.......
T Consensus 86 ~~~-~l~~~~~~~--~~~~~~~~~~~~~~qi~~aL~~lH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~ 159 (309)
T cd07872 86 LDK-DLKQYMDDC--GNIMSMHNVKIFLYQILRGLAYCHRRK---VLHRDLKPQNLLINERGELKLADFGLARAKSVPTK 159 (309)
T ss_pred CCC-CHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEECccccceecCCCcc
Confidence 974 888887543 335788999999999999999999988 99999999999999999999999999976533221
Q ss_pred cccc-----ceeeec---cCCCCCccccchhHHHHHHHHHhCCCCCCCCCCcchhhhhHhHHhcCCc---ccc------c
Q 004521 598 EGNT-----NRVVGT---YDGQFSIKSDVFSFGILLLEIVSGKKNRGFYRSDTKVNLIGHLWDEGIP---LRL------I 660 (747)
Q Consensus 598 ~~~~-----~~~~~~---~~~~~s~ksDVwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~---~~~------~ 660 (747)
.... ...... ....++.++|||||||++|||++|+.||...........+......... ..+ .
T Consensus 160 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (309)
T cd07872 160 TYSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTEETWPGISSNDEFK 239 (309)
T ss_pred ccccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhhcchhhhh
Confidence 1100 000011 1245788999999999999999999997543322221111111100000 000 0
Q ss_pred chhhhc--cCC-----HHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 004521 661 DACIQD--SCN-----LADVIRCIHIGLLCVQQHPEDRPCMPSVIL 699 (747)
Q Consensus 661 d~~l~~--~~~-----~~~~~~~~~l~~~Cl~~dP~~RPt~~~v~~ 699 (747)
+..... ... ..--..+.+++.+||+.||.+|||+.|+++
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~ 285 (309)
T cd07872 240 NYNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMK 285 (309)
T ss_pred hhhcCccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHHhc
Confidence 000000 000 000123567888999999999999999976
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-33 Score=297.54 Aligned_cols=249 Identities=29% Similarity=0.423 Sum_probs=189.1
Q ss_pred cCCCccceecccCCeeEEEEEecC--------CcEEEEEEeccc-ccccHHHHHHHHHHHhcc-CCCceeeEEeEEEeCC
Q 004521 440 DNFSINNKLGEGGFGPVYKGTLVD--------GQEIAVKRLSKI-SEQGLKELKNEVILFSKL-QHRNLVKLLGCCIQGE 509 (747)
Q Consensus 440 ~~~~~~~~lg~G~fg~Vy~~~~~~--------g~~vavK~l~~~-~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~ 509 (747)
++|.+.+.||+|+||.||+++... ...+|+|.+... ......++.+|+.+++++ +|+||+++++++....
T Consensus 18 ~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~ 97 (307)
T cd05098 18 DRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDG 97 (307)
T ss_pred HHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCCChHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCC
Confidence 578999999999999999997532 347999998753 234456788999999999 7999999999999999
Q ss_pred eeEEEEecCCCCChhhHhhhcCC-------------CCcCChhHHHHHHHHHHHHHHHhhhcCCCceEecccCcCcEEEc
Q 004521 510 EKLLIYEFMPNKSLDSFIFDQTR-------------RTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLD 576 (747)
Q Consensus 510 ~~~lV~E~~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NIll~ 576 (747)
..++||||+++|+|.+++..... ...+++.++++++.|++.||+|||+.+ ++||||||+||+++
T Consensus 98 ~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~g---i~H~dlkp~Nill~ 174 (307)
T cd05098 98 PLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASKK---CIHRDLAARNVLVT 174 (307)
T ss_pred ceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCC---cccccccHHheEEc
Confidence 99999999999999999975422 234888999999999999999999988 99999999999999
Q ss_pred CCCCceEecccCccccCCCCCcccc-------ceeee--ccCCCCCccccchhHHHHHHHHHh-CCCCCCCCCCcchhhh
Q 004521 577 QDMNPKISDFGLVRTFGGDETEGNT-------NRVVG--TYDGQFSIKSDVFSFGILLLEIVS-GKKNRGFYRSDTKVNL 646 (747)
Q Consensus 577 ~~~~~kl~DFGla~~~~~~~~~~~~-------~~~~~--~~~~~~s~ksDVwS~Gvvl~ellt-g~~p~~~~~~~~~~~~ 646 (747)
.++.+||+|||+++........... ....+ ..+..++.++|||||||++|||++ |..|+..... ...
T Consensus 175 ~~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~~g~~p~~~~~~---~~~ 251 (307)
T cd05098 175 EDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPV---EEL 251 (307)
T ss_pred CCCcEEECCCcccccccccchhhccccCCCccceeChHHhccCCCCcHHHHHHHHHHHHHHHcCCCCCCCcCCH---HHH
Confidence 9999999999998765432111000 01111 124568899999999999999998 7788643221 111
Q ss_pred hHhHHhcCCcccccchhhhccCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhcCC
Q 004521 647 IGHLWDEGIPLRLIDACIQDSCNLADVIRCIHIGLLCVQQHPEDRPCMPSVILMLGSE 704 (747)
Q Consensus 647 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dP~~RPt~~~v~~~L~~~ 704 (747)
......+....... .....+.+++.+||+.+|++||+|.+|++.|+.+
T Consensus 252 -~~~~~~~~~~~~~~---------~~~~~~~~li~~~l~~~p~~Rps~~evl~~l~~~ 299 (307)
T cd05098 252 -FKLLKEGHRMDKPS---------NCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRI 299 (307)
T ss_pred -HHHHHcCCCCCCCC---------cCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHH
Confidence 11112222111111 1123456788899999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-33 Score=299.24 Aligned_cols=251 Identities=27% Similarity=0.421 Sum_probs=189.9
Q ss_pred cCCCccceecccCCeeEEEEEecC--------CcEEEEEEeccc-ccccHHHHHHHHHHHhcc-CCCceeeEEeEEEeCC
Q 004521 440 DNFSINNKLGEGGFGPVYKGTLVD--------GQEIAVKRLSKI-SEQGLKELKNEVILFSKL-QHRNLVKLLGCCIQGE 509 (747)
Q Consensus 440 ~~~~~~~~lg~G~fg~Vy~~~~~~--------g~~vavK~l~~~-~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~ 509 (747)
.+|++.+.||+|+||.||++.... ...||+|.++.. .....+++.+|+.+++++ +||||+++++++...+
T Consensus 12 ~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~ 91 (334)
T cd05100 12 TRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDG 91 (334)
T ss_pred hHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccccCHHHHHHHHHHHHHHHhhcCCCCeeeeeEEEccCC
Confidence 468889999999999999997421 236899988752 233467899999999999 7999999999999999
Q ss_pred eeEEEEecCCCCChhhHhhhcC-------------CCCcCChhHHHHHHHHHHHHHHHhhhcCCCceEecccCcCcEEEc
Q 004521 510 EKLLIYEFMPNKSLDSFIFDQT-------------RRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLD 576 (747)
Q Consensus 510 ~~~lV~E~~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NIll~ 576 (747)
..++||||+++|+|.+++.... ....+++.++..++.|+++||.|||+.+ |+||||||+|||++
T Consensus 92 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~g---ivH~dlkp~Nill~ 168 (334)
T cd05100 92 PLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQK---CIHRDLAARNVLVT 168 (334)
T ss_pred ceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCC---eeccccccceEEEc
Confidence 9999999999999999986532 1234788999999999999999999988 99999999999999
Q ss_pred CCCCceEecccCccccCCCCCccccc-------eeee--ccCCCCCccccchhHHHHHHHHHh-CCCCCCCCCCcchhhh
Q 004521 577 QDMNPKISDFGLVRTFGGDETEGNTN-------RVVG--TYDGQFSIKSDVFSFGILLLEIVS-GKKNRGFYRSDTKVNL 646 (747)
Q Consensus 577 ~~~~~kl~DFGla~~~~~~~~~~~~~-------~~~~--~~~~~~s~ksDVwS~Gvvl~ellt-g~~p~~~~~~~~~~~~ 646 (747)
.++.+||+|||+++.+.......... .... .....++.++||||||+++|||++ |..|+.... ....
T Consensus 169 ~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~---~~~~ 245 (334)
T cd05100 169 EDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIP---VEEL 245 (334)
T ss_pred CCCcEEECCcccceecccccccccccCCCcCceEcCHHHhccCCcCchhhhHHHHHHHHHHHhcCCCCCCCCC---HHHH
Confidence 99999999999998654322111000 0001 114568889999999999999999 778764322 1112
Q ss_pred hHhHHhcCCcccccchhhhccCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhcCCCC
Q 004521 647 IGHLWDEGIPLRLIDACIQDSCNLADVIRCIHIGLLCVQQHPEDRPCMPSVILMLGSEIL 706 (747)
Q Consensus 647 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dP~~RPt~~~v~~~L~~~~~ 706 (747)
... ...+....... . ....+.+++.+||+.+|++||+|.+|++.|+....
T Consensus 246 ~~~-~~~~~~~~~~~-----~----~~~~l~~li~~cl~~~p~~Rps~~ell~~l~~~~~ 295 (334)
T cd05100 246 FKL-LKEGHRMDKPA-----N----CTHELYMIMRECWHAVPSQRPTFKQLVEDLDRVLT 295 (334)
T ss_pred HHH-HHcCCCCCCCC-----C----CCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHhh
Confidence 111 12222111111 1 12246678889999999999999999999987653
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=303.06 Aligned_cols=248 Identities=23% Similarity=0.336 Sum_probs=190.4
Q ss_pred cCCCccceecccCCeeEEEEEec-CCcEEEEEEeccc---ccccHHHHHHHHHHHhccCCCceeeEEeEEEeCCeeEEEE
Q 004521 440 DNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKI---SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIY 515 (747)
Q Consensus 440 ~~~~~~~~lg~G~fg~Vy~~~~~-~g~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 515 (747)
+-|++.+.||.|+-|.|..|++. .|+.+|||++.+. .......+.+|+.||+.|.|||+++++++.++..+.|||+
T Consensus 12 GpwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~~lylvl 91 (786)
T KOG0588|consen 12 GPWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQHLYLVL 91 (786)
T ss_pred cceeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeeccCceEEEEE
Confidence 45778899999999999999975 4999999999763 2334556889999999999999999999999999999999
Q ss_pred ecCCCCChhhHhhhcCCCCcCChhHHHHHHHHHHHHHHHhhhcCCCceEecccCcCcEEEcCCCCceEecccCccccCCC
Q 004521 516 EFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGD 595 (747)
Q Consensus 516 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NIll~~~~~~kl~DFGla~~~~~~ 595 (747)
||+++|-|.++|.. ++.+++.++.+++.||+.|+.|+|..+ |+||||||+|+|||.++++||+|||+|....++
T Consensus 92 Eyv~gGELFdylv~---kG~l~e~eaa~ff~QIi~gv~yCH~~~---icHRDLKpENlLLd~~~nIKIADFGMAsLe~~g 165 (786)
T KOG0588|consen 92 EYVPGGELFDYLVR---KGPLPEREAAHFFRQILDGVSYCHAFN---ICHRDLKPENLLLDVKNNIKIADFGMASLEVPG 165 (786)
T ss_pred EecCCchhHHHHHh---hCCCCCHHHHHHHHHHHHHHHHHhhhc---ceeccCCchhhhhhcccCEeeeccceeecccCC
Confidence 99999999999954 456899999999999999999999988 999999999999999999999999999764333
Q ss_pred CCc----cccceeeecc--CCCC-CccccchhHHHHHHHHHhCCCCCCCCCCcchhhhhHhHHhcCCcccccchhhhccC
Q 004521 596 ETE----GNTNRVVGTY--DGQF-SIKSDVFSFGILLLEIVSGKKNRGFYRSDTKVNLIGHLWDEGIPLRLIDACIQDSC 668 (747)
Q Consensus 596 ~~~----~~~~~~~~~~--~~~~-s~ksDVwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~ 668 (747)
... +.+.+..... +..| +.++||||.|||||.||||+.||+ ++.-..++.++ +.|... +.+..
T Consensus 166 klLeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFd---DdNir~LLlKV-~~G~f~-MPs~I----- 235 (786)
T KOG0588|consen 166 KLLETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFD---DDNIRVLLLKV-QRGVFE-MPSNI----- 235 (786)
T ss_pred ccccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCC---CccHHHHHHHH-HcCccc-CCCcC-----
Confidence 211 1111111111 2223 469999999999999999999975 22223333332 333322 11111
Q ss_pred CHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH--hcCCCCC
Q 004521 669 NLADVIRCIHIGLLCVQQHPEDRPCMPSVILM--LGSEILL 707 (747)
Q Consensus 669 ~~~~~~~~~~l~~~Cl~~dP~~RPt~~~v~~~--L~~~~~~ 707 (747)
. . ++.+|+.+|+..||..|.|+.||++. |.+....
T Consensus 236 s-~---eaQdLLr~ml~VDp~~RiT~~eI~kHP~l~g~~~~ 272 (786)
T KOG0588|consen 236 S-S---EAQDLLRRMLDVDPSTRITTEEILKHPFLSGYTSL 272 (786)
T ss_pred C-H---HHHHHHHHHhccCccccccHHHHhhCchhhcCCCC
Confidence 1 1 13455668999999999999999984 4444433
|
|
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-33 Score=291.51 Aligned_cols=242 Identities=24% Similarity=0.270 Sum_probs=178.4
Q ss_pred ecccCCeeEEEEEecC-CcEEEEEEecccc---cccHHHHHHHHHHHhccCCCceeeEEeEEEeCCeeEEEEecCCCCCh
Q 004521 448 LGEGGFGPVYKGTLVD-GQEIAVKRLSKIS---EQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMPNKSL 523 (747)
Q Consensus 448 lg~G~fg~Vy~~~~~~-g~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gsL 523 (747)
||+|+||.||+++... |+.+|+|.+.... ....+.+..|++++++++||||+++++++..+...++||||+++++|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g~~L 80 (277)
T cd05607 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDL 80 (277)
T ss_pred CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecCCCCCH
Confidence 7999999999998754 8999999986421 12234566799999999999999999999999999999999999999
Q ss_pred hhHhhhcCCCCcCChhHHHHHHHHHHHHHHHhhhcCCCceEecccCcCcEEEcCCCCceEecccCccccCCCCCcc----
Q 004521 524 DSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEG---- 599 (747)
Q Consensus 524 ~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~---- 599 (747)
..++.... ...+++..+..++.||+.||+|||+.+ |+||||||+||+++.++.+||+|||++..........
T Consensus 81 ~~~~~~~~-~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~~~~~~~~ 156 (277)
T cd05607 81 KYHIYNVG-ERGLEMERVIHYSAQITCGILHLHSMD---IVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGKTITQRAG 156 (277)
T ss_pred HHHHHhcc-ccCCCHHHHHHHHHHHHHHHHHHHHCC---EEEccCChHhEEEcCCCCEEEeeceeeeecCCCceeeccCC
Confidence 98886533 234888999999999999999999988 9999999999999999999999999987654322110
Q ss_pred ccceeeec--cCCCCCccccchhHHHHHHHHHhCCCCCCCCCCcchhhhhHhHHhcCCcccccchhhhccCCHHHHHHHH
Q 004521 600 NTNRVVGT--YDGQFSIKSDVFSFGILLLEIVSGKKNRGFYRSDTKVNLIGHLWDEGIPLRLIDACIQDSCNLADVIRCI 677 (747)
Q Consensus 600 ~~~~~~~~--~~~~~s~ksDVwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~ 677 (747)
........ ....++.++|||||||++|||++|+.|+...........+.......... ... ... ...+.
T Consensus 157 ~~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~-~~~----~~~----~~~~~ 227 (277)
T cd05607 157 TNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKVAKEELKRRTLEDEVK-FEH----QNF----TEESK 227 (277)
T ss_pred CCCccCHHHHccCCCCCchhHHHHHHHHHHHHhCCCCCCCCcchhhHHHHHHHhhccccc-ccc----ccC----CHHHH
Confidence 00000000 14568899999999999999999999976433221111111111111100 000 001 12356
Q ss_pred HHHHhccCCCCCCCCCHHHHHHHhc
Q 004521 678 HIGLLCVQQHPEDRPCMPSVILMLG 702 (747)
Q Consensus 678 ~l~~~Cl~~dP~~RPt~~~v~~~L~ 702 (747)
+++.+||+.||++||++.|+++.+.
T Consensus 228 ~li~~~L~~~P~~R~~~~~~~~~~~ 252 (277)
T cd05607 228 DICRLFLAKKPEDRLGSREKNDDPR 252 (277)
T ss_pred HHHHHHhccCHhhCCCCccchhhhh
Confidence 7788999999999999987764443
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-33 Score=304.57 Aligned_cols=243 Identities=21% Similarity=0.283 Sum_probs=182.1
Q ss_pred cCCCccceecccCCeeEEEEEecC-CcEEEEEEeccc---ccccHHHHHHHHHHHhccCCCceeeEEeEEEeCCeeEEEE
Q 004521 440 DNFSINNKLGEGGFGPVYKGTLVD-GQEIAVKRLSKI---SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIY 515 (747)
Q Consensus 440 ~~~~~~~~lg~G~fg~Vy~~~~~~-g~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 515 (747)
++|++.+.||+|+||.||+|+... ++.||||++... .......+.+|+.++..++||||+++++++.++...++||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~ 80 (364)
T cd05599 1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDENYLYLIM 80 (364)
T ss_pred CCceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCeEEEEE
Confidence 478899999999999999999754 889999999752 2334567889999999999999999999999999999999
Q ss_pred ecCCCCChhhHhhhcCCCCcCChhHHHHHHHHHHHHHHHhhhcCCCceEecccCcCcEEEcCCCCceEecccCccccCCC
Q 004521 516 EFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGD 595 (747)
Q Consensus 516 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NIll~~~~~~kl~DFGla~~~~~~ 595 (747)
||+++|+|.+++... ..+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++.+...
T Consensus 81 E~~~~g~L~~~l~~~---~~l~~~~~~~~~~qi~~aL~~lH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~ 154 (364)
T cd05599 81 EYLPGGDMMTLLMKK---DTFTEEETRFYIAETILAIDSIHKLG---YIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKS 154 (364)
T ss_pred CCCCCcHHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeEECCCCCEEEeecccceecccc
Confidence 999999999998643 35899999999999999999999988 999999999999999999999999998765321
Q ss_pred CCcc------------------------------------ccceeeec---------cCCCCCccccchhHHHHHHHHHh
Q 004521 596 ETEG------------------------------------NTNRVVGT---------YDGQFSIKSDVFSFGILLLEIVS 630 (747)
Q Consensus 596 ~~~~------------------------------------~~~~~~~~---------~~~~~s~ksDVwS~Gvvl~ellt 630 (747)
.... ......|+ ....++.++|||||||++|||++
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~ 234 (364)
T cd05599 155 HRTEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEMLV 234 (364)
T ss_pred ccccccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCCCeeeeecchhHHHHhhc
Confidence 1100 00001122 14568899999999999999999
Q ss_pred CCCCCCCCCCcchhhhhHhHHhcCCcccccchhhhccCCHHHHHHHHHHHHhccCCCCCCCCC---HHHHHH
Q 004521 631 GKKNRGFYRSDTKVNLIGHLWDEGIPLRLIDACIQDSCNLADVIRCIHIGLLCVQQHPEDRPC---MPSVIL 699 (747)
Q Consensus 631 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dP~~RPt---~~~v~~ 699 (747)
|..||..... ...............+.... ..+ . .+.+++.+|+. +|.+|++ +.++++
T Consensus 235 G~~Pf~~~~~---~~~~~~i~~~~~~~~~~~~~---~~s-~---~~~~li~~ll~-~p~~R~~~~~~~~ll~ 295 (364)
T cd05599 235 GYPPFCSDNP---QETYRKIINWKETLQFPDEV---PLS-P---EAKDLIKRLCC-EAERRLGNNGVNEIKS 295 (364)
T ss_pred CCCCCCCCCH---HHHHHHHHcCCCccCCCCCC---CCC-H---HHHHHHHHHcc-CHhhcCCCCCHHHHhc
Confidence 9999753321 11222221111111111100 011 1 23455567886 9999998 777766
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-33 Score=286.46 Aligned_cols=239 Identities=27% Similarity=0.408 Sum_probs=180.5
Q ss_pred eecccCCeeEEEEEec---CCcEEEEEEecccc-cccHHHHHHHHHHHhccCCCceeeEEeEEEeCCeeEEEEecCCCCC
Q 004521 447 KLGEGGFGPVYKGTLV---DGQEIAVKRLSKIS-EQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMPNKS 522 (747)
Q Consensus 447 ~lg~G~fg~Vy~~~~~---~g~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gs 522 (747)
.||+|+||.||+|++. .+..||+|.+.... ....+.|.+|+.++++++|+||+++++++. ....++||||+++++
T Consensus 2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~-~~~~~lv~e~~~~~~ 80 (257)
T cd05115 2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIGVCE-AEALMLVMEMASGGP 80 (257)
T ss_pred ccCCCCcccEEEEEEecCCCceeEEEEEcccccChHHHHHHHHHHHHHHhcCCCCeEEEEEEEc-CCCeEEEEEeCCCCC
Confidence 4899999999999864 35579999987543 334567999999999999999999999885 457899999999999
Q ss_pred hhhHhhhcCCCCcCChhHHHHHHHHHHHHHHHhhhcCCCceEecccCcCcEEEcCCCCceEecccCccccCCCCCccccc
Q 004521 523 LDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNTN 602 (747)
Q Consensus 523 L~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~ 602 (747)
|.+++... ...+++..+++++.|++.||.|||+.+ ++||||||+|||++.++.+||+|||+++.+..........
T Consensus 81 L~~~l~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~ 155 (257)
T cd05115 81 LNKFLSGK--KDEITVSNVVELMHQVSMGMKYLEGKN---FVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKAR 155 (257)
T ss_pred HHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHHhcC---eeecccchheEEEcCCCcEEeccCCccccccCCccceecc
Confidence 99998642 345899999999999999999999988 9999999999999999999999999998654332211000
Q ss_pred --------eeeec--cCCCCCccccchhHHHHHHHHHh-CCCCCCCCCCcchhhhhHhHHhcCCcccccchhhhccCCHH
Q 004521 603 --------RVVGT--YDGQFSIKSDVFSFGILLLEIVS-GKKNRGFYRSDTKVNLIGHLWDEGIPLRLIDACIQDSCNLA 671 (747)
Q Consensus 603 --------~~~~~--~~~~~s~ksDVwS~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~ 671 (747)
..... ....++.++|||||||++|||++ |..|+..... ..... ....+...... ..
T Consensus 156 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~---~~~~~-~~~~~~~~~~~-----~~---- 222 (257)
T cd05115 156 SAGKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKMKG---PEVMS-FIEQGKRLDCP-----AE---- 222 (257)
T ss_pred CCCCCCcccCCHHHHccCCCCchhhHHHHHHHHHHHhcCCCCCcCcCCH---HHHHH-HHHCCCCCCCC-----CC----
Confidence 00000 13567889999999999999996 9998653321 11111 11222211111 11
Q ss_pred HHHHHHHHHHhccCCCCCCCCCHHHHHHHhcCC
Q 004521 672 DVIRCIHIGLLCVQQHPEDRPCMPSVILMLGSE 704 (747)
Q Consensus 672 ~~~~~~~l~~~Cl~~dP~~RPt~~~v~~~L~~~ 704 (747)
....+.+++.+||+.+|++||++.+|.+.|+..
T Consensus 223 ~~~~l~~li~~c~~~~~~~Rp~~~~i~~~l~~~ 255 (257)
T cd05115 223 CPPEMYALMKDCWIYKWEDRPNFAKVEERMRTY 255 (257)
T ss_pred CCHHHHHHHHHHcCCChhhCcCHHHHHHHHhhh
Confidence 123455678899999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-33 Score=291.96 Aligned_cols=238 Identities=23% Similarity=0.303 Sum_probs=178.1
Q ss_pred ecccCCeeEEEEEec-CCcEEEEEEeccc---ccccHHHHHHHHHHHhccCCCceeeEEeEEEeCCeeEEEEecCCCCCh
Q 004521 448 LGEGGFGPVYKGTLV-DGQEIAVKRLSKI---SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMPNKSL 523 (747)
Q Consensus 448 lg~G~fg~Vy~~~~~-~g~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gsL 523 (747)
||+|+||+||++... +++.+|+|.+.+. .....+.+..|+.++++++|+||+++.+++......++||||+++|+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L 80 (280)
T cd05608 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGDL 80 (280)
T ss_pred CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCCCCH
Confidence 799999999999875 4889999998652 223346778899999999999999999999999999999999999999
Q ss_pred hhHhhhcC-CCCcCChhHHHHHHHHHHHHHHHhhhcCCCceEecccCcCcEEEcCCCCceEecccCccccCCCCCccc--
Q 004521 524 DSFIFDQT-RRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGN-- 600 (747)
Q Consensus 524 ~~~l~~~~-~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~-- 600 (747)
..++.... ....+++..+..++.||+.||.|||+.+ |+||||||+||+++.++.+||+|||+++.+........
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~ 157 (280)
T cd05608 81 RYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRR---IIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQSKTKGY 157 (280)
T ss_pred HHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEeeCccceecCCCCcccccc
Confidence 98875432 2346899999999999999999999988 99999999999999999999999999976543322110
Q ss_pred ---cceeeec--cCCCCCccccchhHHHHHHHHHhCCCCCCCCCCcchhhh-hHhHHhcCCcccccchhhhccCCHHHHH
Q 004521 601 ---TNRVVGT--YDGQFSIKSDVFSFGILLLEIVSGKKNRGFYRSDTKVNL-IGHLWDEGIPLRLIDACIQDSCNLADVI 674 (747)
Q Consensus 601 ---~~~~~~~--~~~~~s~ksDVwS~Gvvl~elltg~~p~~~~~~~~~~~~-~~~~~~~~~~~~~~d~~l~~~~~~~~~~ 674 (747)
....... ....++.++|||||||++|||++|+.||........... ........ .. ... ....
T Consensus 158 ~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~--~~-----~~~----~~~~ 226 (280)
T cd05608 158 AGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRILNDS--VT-----YPD----KFSP 226 (280)
T ss_pred CCCcCccCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCcchhHHHHHHhhcccC--CC-----Ccc----cCCH
Confidence 0000011 146788999999999999999999999754322211111 11111000 00 001 1122
Q ss_pred HHHHHHHhccCCCCCCCC-----CHHHHHH
Q 004521 675 RCIHIGLLCVQQHPEDRP-----CMPSVIL 699 (747)
Q Consensus 675 ~~~~l~~~Cl~~dP~~RP-----t~~~v~~ 699 (747)
.+.+++.+||+.||++|| ++.++++
T Consensus 227 ~~~~li~~~l~~~P~~R~~~~~~~~~~~l~ 256 (280)
T cd05608 227 ASKSFCEALLAKDPEKRLGFRDGNCDGLRT 256 (280)
T ss_pred HHHHHHHHHhcCCHHHhcCCCCCCHHHHhc
Confidence 356777899999999999 6677765
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-33 Score=306.16 Aligned_cols=244 Identities=20% Similarity=0.265 Sum_probs=180.0
Q ss_pred CCCccceecccCCeeEEEEEecC-CcEEEEEEeccc---ccccHHHHHHHHHHHhccCCCceeeEEeEEEeCCeeEEEEe
Q 004521 441 NFSINNKLGEGGFGPVYKGTLVD-GQEIAVKRLSKI---SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYE 516 (747)
Q Consensus 441 ~~~~~~~lg~G~fg~Vy~~~~~~-g~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E 516 (747)
.|++.+.||+|+||+||+|+... ++.||||++.+. .....+.+.+|+.++++++|+||+++++++.+.+..++|||
T Consensus 2 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv~E 81 (381)
T cd05626 2 MFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMD 81 (381)
T ss_pred CceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEEEEEEe
Confidence 57888999999999999998754 789999999752 23345678999999999999999999999999999999999
Q ss_pred cCCCCChhhHhhhcCCCCcCChhHHHHHHHHHHHHHHHhhhcCCCceEecccCcCcEEEcCCCCceEecccCccccCCCC
Q 004521 517 FMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDE 596 (747)
Q Consensus 517 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~ 596 (747)
|+++|+|.+++... ..+++..+..++.||+.||+|||+.+ |+||||||+||||+.++.+||+|||+++.+....
T Consensus 82 ~~~gg~L~~~l~~~---~~~~e~~~~~~~~qi~~aL~~LH~~g---ivHrDlKp~Nili~~~~~~kL~DFGl~~~~~~~~ 155 (381)
T cd05626 82 YIPGGDMMSLLIRM---EVFPEVLARFYIAELTLAIESVHKMG---FIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTH 155 (381)
T ss_pred cCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCcHHHEEECCCCCEEEeeCcCCccccccc
Confidence 99999999998643 34788888999999999999999988 9999999999999999999999999986432110
Q ss_pred Ccc---------------------------------------------ccceeeecc---------CCCCCccccchhHH
Q 004521 597 TEG---------------------------------------------NTNRVVGTY---------DGQFSIKSDVFSFG 622 (747)
Q Consensus 597 ~~~---------------------------------------------~~~~~~~~~---------~~~~s~ksDVwS~G 622 (747)
... ......|+. ...++.++||||||
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlG 235 (381)
T cd05626 156 NSKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVG 235 (381)
T ss_pred ccccccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCCCCccceeehh
Confidence 000 000112221 45688999999999
Q ss_pred HHHHHHHhCCCCCCCCCCcchhhhhHhHHhcCCcccccchhhhccCCHHHHHHHHHHHHh--ccCCCCCCCCCHHHHHHH
Q 004521 623 ILLLEIVSGKKNRGFYRSDTKVNLIGHLWDEGIPLRLIDACIQDSCNLADVIRCIHIGLL--CVQQHPEDRPCMPSVILM 700 (747)
Q Consensus 623 vvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~--Cl~~dP~~RPt~~~v~~~ 700 (747)
|++|||++|+.||....... .............+.. . ...+ .+ +.+++.+ |+..+|..||++.+|++.
T Consensus 236 ~il~elltG~~Pf~~~~~~~---~~~~i~~~~~~~~~~~-~--~~~s-~~---~~dli~~ll~~~~~~~~R~~~~~~l~h 305 (381)
T cd05626 236 VILFEMLVGQPPFLAPTPTE---TQLKVINWENTLHIPP-Q--VKLS-PE---AVDLITKLCCSAEERLGRNGADDIKAH 305 (381)
T ss_pred hHHHHHHhCCCCCcCCCHHH---HHHHHHccccccCCCC-C--CCCC-HH---HHHHHHHHccCcccccCCCCHHHHhcC
Confidence 99999999999975432211 1111111111111110 0 0111 12 2333433 677788889999999874
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-33 Score=299.85 Aligned_cols=243 Identities=21% Similarity=0.270 Sum_probs=181.5
Q ss_pred CCCccceecccCCeeEEEEEec----CCcEEEEEEeccc----ccccHHHHHHHHHHHhcc-CCCceeeEEeEEEeCCee
Q 004521 441 NFSINNKLGEGGFGPVYKGTLV----DGQEIAVKRLSKI----SEQGLKELKNEVILFSKL-QHRNLVKLLGCCIQGEEK 511 (747)
Q Consensus 441 ~~~~~~~lg~G~fg~Vy~~~~~----~g~~vavK~l~~~----~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~ 511 (747)
+|++.+.||+|+||.||+++.. .++.||+|++.+. .....+.+..|+.++.++ +|+||+++++++...+..
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (332)
T cd05614 1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKL 80 (332)
T ss_pred CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCEE
Confidence 4788899999999999998753 4789999998752 223345688999999999 599999999999999999
Q ss_pred EEEEecCCCCChhhHhhhcCCCCcCChhHHHHHHHHHHHHHHHhhhcCCCceEecccCcCcEEEcCCCCceEecccCccc
Q 004521 512 LLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRT 591 (747)
Q Consensus 512 ~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NIll~~~~~~kl~DFGla~~ 591 (747)
++||||+++|+|.+++... ..+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++.
T Consensus 81 ~lv~e~~~~g~L~~~l~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~---ivHrDlkp~Nili~~~~~~kl~DfG~~~~ 154 (332)
T cd05614 81 HLILDYVSGGEMFTHLYQR---DNFSEDEVRFYSGEIILALEHLHKLG---IVYRDIKLENILLDSEGHVVLTDFGLSKE 154 (332)
T ss_pred EEEEeCCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---cEecCCCHHHeEECCCCCEEEeeCcCCcc
Confidence 9999999999999998642 34889999999999999999999988 99999999999999999999999999986
Q ss_pred cCCCCCccccceeeec--------c--CCCCCccccchhHHHHHHHHHhCCCCCCCCCCcchhhhhHhHHhcCCcccccc
Q 004521 592 FGGDETEGNTNRVVGT--------Y--DGQFSIKSDVFSFGILLLEIVSGKKNRGFYRSDTKVNLIGHLWDEGIPLRLID 661 (747)
Q Consensus 592 ~~~~~~~~~~~~~~~~--------~--~~~~s~ksDVwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~d 661 (747)
+......... ...|+ . ...++.++|||||||+||||++|+.||...........+........
T Consensus 155 ~~~~~~~~~~-~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~------ 227 (332)
T cd05614 155 FLSEEKERTY-SFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQSEVSRRILKCD------ 227 (332)
T ss_pred ccccCCCccc-cccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCCCHHHHHHHHhcCC------
Confidence 5332211110 11111 1 23478899999999999999999999754332222111111111110
Q ss_pred hhhhccCCHHHHHHHHHHHHhccCCCCCCCC-----CHHHHHHH
Q 004521 662 ACIQDSCNLADVIRCIHIGLLCVQQHPEDRP-----CMPSVILM 700 (747)
Q Consensus 662 ~~l~~~~~~~~~~~~~~l~~~Cl~~dP~~RP-----t~~~v~~~ 700 (747)
+.+....+ ..+.+++.+||+.||++|| ++.++++.
T Consensus 228 ~~~~~~~~----~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h 267 (332)
T cd05614 228 PPFPSFIG----PEAQDLLHKLLRKDPKKRLGAGPQGASEIKEH 267 (332)
T ss_pred CCCCCCCC----HHHHHHHHHHcCCCHHHcCCCCCCCHHHHHcC
Confidence 01111111 2245677799999999999 66677653
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-33 Score=303.52 Aligned_cols=234 Identities=26% Similarity=0.370 Sum_probs=189.1
Q ss_pred HHhcCCCccceecccCCeeEEEEEecC-CcEEEEEEecc---cccccHHHHHHHHHHHhcc-CCCceeeEEeEEEeCCee
Q 004521 437 NATDNFSINNKLGEGGFGPVYKGTLVD-GQEIAVKRLSK---ISEQGLKELKNEVILFSKL-QHRNLVKLLGCCIQGEEK 511 (747)
Q Consensus 437 ~~~~~~~~~~~lg~G~fg~Vy~~~~~~-g~~vavK~l~~---~~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~ 511 (747)
...++|.+.++||+|+||+|+++.++. ++.+|||.+++ ...+..+..+.|.+|+... +||.|++++.++...++.
T Consensus 365 ~~l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~~l 444 (694)
T KOG0694|consen 365 LTLDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKEHL 444 (694)
T ss_pred ccccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccCCeE
Confidence 345789999999999999999999865 78999999997 3566788899999998877 599999999999999999
Q ss_pred EEEEecCCCCChhhHhhhcCCCCcCChhHHHHHHHHHHHHHHHhhhcCCCceEecccCcCcEEEcCCCCceEecccCccc
Q 004521 512 LLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRT 591 (747)
Q Consensus 512 ~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NIll~~~~~~kl~DFGla~~ 591 (747)
++||||+.+|++..+. ....+++..+.-++..|+.||.|||+++ ||+||||.+|||||.+|++||+||||++.
T Consensus 445 ~fvmey~~Ggdm~~~~----~~~~F~e~rarfyaAev~l~L~fLH~~~---IIYRDlKLdNiLLD~eGh~kiADFGlcKe 517 (694)
T KOG0694|consen 445 FFVMEYVAGGDLMHHI----HTDVFSEPRARFYAAEVVLGLQFLHENG---IIYRDLKLDNLLLDTEGHVKIADFGLCKE 517 (694)
T ss_pred EEEEEecCCCcEEEEE----ecccccHHHHHHHHHHHHHHHHHHHhcC---ceeeecchhheEEcccCcEEecccccccc
Confidence 9999999999955444 3356899999999999999999999999 99999999999999999999999999997
Q ss_pred cCCCCCccccceeeecc---------CCCCCccccchhHHHHHHHHHhCCCCCCCCCCcchhhhhHhHHhc-CCcccccc
Q 004521 592 FGGDETEGNTNRVVGTY---------DGQFSIKSDVFSFGILLLEIVSGKKNRGFYRSDTKVNLIGHLWDE-GIPLRLID 661 (747)
Q Consensus 592 ~~~~~~~~~~~~~~~~~---------~~~~s~ksDVwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~-~~~~~~~d 661 (747)
-..... .+.+++||. +..|+.++|.|||||+|||||.|..||...+. .++...+..+ ...+.
T Consensus 518 ~m~~g~--~TsTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~gddE---ee~FdsI~~d~~~yP~--- 589 (694)
T KOG0694|consen 518 GMGQGD--RTSTFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLVGESPFPGDDE---EEVFDSIVNDEVRYPR--- 589 (694)
T ss_pred cCCCCC--ccccccCChhhcChhhhccCcccchhhHHHHHHHHHHHHcCCCCCCCCCH---HHHHHHHhcCCCCCCC---
Confidence 653333 344566664 67899999999999999999999999753332 2222222211 11111
Q ss_pred hhhhccCCHHHHHHHHHHHHhccCCCCCCCCCH
Q 004521 662 ACIQDSCNLADVIRCIHIGLLCVQQHPEDRPCM 694 (747)
Q Consensus 662 ~~l~~~~~~~~~~~~~~l~~~Cl~~dP~~RPt~ 694 (747)
--..+.+.|+.+.+..+|++|-.+
T Consensus 590 ---------~ls~ea~~il~~ll~k~p~kRLG~ 613 (694)
T KOG0694|consen 590 ---------FLSKEAIAIMRRLLRKNPEKRLGS 613 (694)
T ss_pred ---------cccHHHHHHHHHHhccCcccccCC
Confidence 112235667778999999999877
|
|
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-33 Score=287.98 Aligned_cols=246 Identities=29% Similarity=0.455 Sum_probs=189.7
Q ss_pred hcCCCccceecccCCeeEEEEEecCCcEEEEEEecccccccHHHHHHHHHHHhccCCCceeeEEeEEEeCCeeEEEEecC
Q 004521 439 TDNFSINNKLGEGGFGPVYKGTLVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFM 518 (747)
Q Consensus 439 ~~~~~~~~~lg~G~fg~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~ 518 (747)
.++|.+.++||+|+||.||++...++..+|+|.++.. ....+.+.+|+.++++++|+||+++.+++.. ...++||||+
T Consensus 5 ~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~iK~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~v~e~~ 82 (260)
T cd05073 5 RESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPG-SMSVEAFLAEANVMKTLQHDKLVKLHAVVTK-EPIYIITEFM 82 (260)
T ss_pred ccceeEEeEecCccceEEEEEEecCCccEEEEecCCC-hhHHHHHHHHHHHHHhcCCCCcceEEEEEcC-CCeEEEEEeC
Confidence 3578889999999999999999877888999988752 3345678999999999999999999999887 7789999999
Q ss_pred CCCChhhHhhhcCCCCcCChhHHHHHHHHHHHHHHHhhhcCCCceEecccCcCcEEEcCCCCceEecccCccccCCCCCc
Q 004521 519 PNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETE 598 (747)
Q Consensus 519 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~ 598 (747)
++++|.+++.... ...+++..+..++.|++.||.|||+.+ ++|+||||+||+++.++.+||+|||++..+......
T Consensus 83 ~~~~L~~~~~~~~-~~~~~~~~~~~~~~~l~~aL~~lH~~~---i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~ 158 (260)
T cd05073 83 AKGSLLDFLKSDE-GSKQPLPKLIDFSAQIAEGMAFIEQRN---YIHRDLRAANILVSASLVCKIADFGLARVIEDNEYT 158 (260)
T ss_pred CCCcHHHHHHhCC-ccccCHHHHHHHHHHHHHHHHHHHhCC---ccccccCcceEEEcCCCcEEECCCcceeeccCCCcc
Confidence 9999999996532 345788999999999999999999987 999999999999999999999999998766432211
Q ss_pred cccc------eeeec--cCCCCCccccchhHHHHHHHHHh-CCCCCCCCCCcchhhhhHhHHhcCCcccccchhhhccCC
Q 004521 599 GNTN------RVVGT--YDGQFSIKSDVFSFGILLLEIVS-GKKNRGFYRSDTKVNLIGHLWDEGIPLRLIDACIQDSCN 669 (747)
Q Consensus 599 ~~~~------~~~~~--~~~~~s~ksDVwS~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~ 669 (747)
.... ...+. ....++.++|||||||++|||++ |+.|+.... ...... ....+...... .
T Consensus 159 ~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~---~~~~~~-~~~~~~~~~~~-----~--- 226 (260)
T cd05073 159 AREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMS---NPEVIR-ALERGYRMPRP-----E--- 226 (260)
T ss_pred cccCCcccccccCHhHhccCCcCccccchHHHHHHHHHHhcCCCCCCCCC---HHHHHH-HHhCCCCCCCc-----c---
Confidence 1100 00000 13567889999999999999999 888864322 111111 11222211111 1
Q ss_pred HHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhcC
Q 004521 670 LADVIRCIHIGLLCVQQHPEDRPCMPSVILMLGS 703 (747)
Q Consensus 670 ~~~~~~~~~l~~~Cl~~dP~~RPt~~~v~~~L~~ 703 (747)
.....+.+++.+|++.+|++||++.++.++|+.
T Consensus 227 -~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~L~~ 259 (260)
T cd05073 227 -NCPEELYNIMMRCWKNRPEERPTFEYIQSVLDD 259 (260)
T ss_pred -cCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence 112346678889999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-33 Score=308.59 Aligned_cols=251 Identities=22% Similarity=0.317 Sum_probs=182.4
Q ss_pred CCCccceecccCCeeEEEEEec-CCcEEEEEEeccc--ccccHHHHHHHHHHHhccCCCceeeEEeEEEeCC-----eeE
Q 004521 441 NFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKI--SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGE-----EKL 512 (747)
Q Consensus 441 ~~~~~~~lg~G~fg~Vy~~~~~-~g~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~-----~~~ 512 (747)
+|++.++||+|+||.||++... +++.||||++... .....+.+.+|+.+++.++|+||+++++++.... ..+
T Consensus 1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 80 (372)
T cd07853 1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIY 80 (372)
T ss_pred CCcccceeeeCCCEEEEEEEECCCCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceEE
Confidence 4778899999999999999974 5899999998652 2234567889999999999999999999998776 789
Q ss_pred EEEecCCCCChhhHhhhcCCCCcCChhHHHHHHHHHHHHHHHhhhcCCCceEecccCcCcEEEcCCCCceEecccCcccc
Q 004521 513 LIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTF 592 (747)
Q Consensus 513 lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NIll~~~~~~kl~DFGla~~~ 592 (747)
+||||+. ++|.+++.. ...+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++..
T Consensus 81 lv~e~~~-~~l~~~~~~---~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivH~dlkp~Nili~~~~~~kL~Dfg~a~~~ 153 (372)
T cd07853 81 VVTELMQ-SDLHKIIVS---PQPLSSDHVKVFLYQILRGLKYLHSAG---ILHRDIKPGNLLVNSNCVLKICDFGLARVE 153 (372)
T ss_pred EEeeccc-cCHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChHHEEECCCCCEEeccccceeec
Confidence 9999997 678777743 345889999999999999999999988 999999999999999999999999999865
Q ss_pred CCCCCccccc------eeeec-c--CCCCCccccchhHHHHHHHHHhCCCCCCCCCCcchhhhhHhHHh-----------
Q 004521 593 GGDETEGNTN------RVVGT-Y--DGQFSIKSDVFSFGILLLEIVSGKKNRGFYRSDTKVNLIGHLWD----------- 652 (747)
Q Consensus 593 ~~~~~~~~~~------~~~~~-~--~~~~s~ksDVwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~----------- 652 (747)
.......... ..... . ...++.++|||||||++|||++|+.||...........+.....
T Consensus 154 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~ 233 (372)
T cd07853 154 EPDESKHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLITDLLGTPSLEAMRSAC 233 (372)
T ss_pred ccCccccCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHHhh
Confidence 4322211110 00000 0 23478899999999999999999999754332211111111000
Q ss_pred ---------cCCcccccchhhhccCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 004521 653 ---------EGIPLRLIDACIQDSCNLADVIRCIHIGLLCVQQHPEDRPCMPSVILM 700 (747)
Q Consensus 653 ---------~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dP~~RPt~~~v~~~ 700 (747)
............ .........+.+++.+||+.||.+|||+.++++.
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~h 288 (372)
T cd07853 234 EGARAHILRGPHKPPSLPVLY--TLSSQATHEAVHLLCRMLVFDPDKRISAADALAH 288 (372)
T ss_pred HHHHHHHHhCCCCCCchHHhc--ccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhcC
Confidence 000000000000 0000112346678889999999999999999864
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-33 Score=288.17 Aligned_cols=235 Identities=24% Similarity=0.392 Sum_probs=177.0
Q ss_pred ceecccCCeeEEEEEecCCc-----------EEEEEEecccccccHHHHHHHHHHHhccCCCceeeEEeEEEeCCeeEEE
Q 004521 446 NKLGEGGFGPVYKGTLVDGQ-----------EIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLI 514 (747)
Q Consensus 446 ~~lg~G~fg~Vy~~~~~~g~-----------~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV 514 (747)
+.||+|+||.||+|.+.+.. .+++|.+...... ...|.+|+.++++++||||+++++++.. ...++|
T Consensus 1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~-~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~lv 78 (259)
T cd05037 1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRD-SLAFFETASLMSQLSHKHLVKLYGVCVR-DENIMV 78 (259)
T ss_pred CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchhh-HHHHHHHHHHHHcCCCcchhheeeEEec-CCcEEE
Confidence 46999999999999986532 5788887653332 6789999999999999999999999988 778999
Q ss_pred EecCCCCChhhHhhhcCCCCcCChhHHHHHHHHHHHHHHHhhhcCCCceEecccCcCcEEEcCCC-------CceEeccc
Q 004521 515 YEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDM-------NPKISDFG 587 (747)
Q Consensus 515 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NIll~~~~-------~~kl~DFG 587 (747)
|||+++|+|.+++..... .+++..++.++.||+.||+|||+.+ |+||||||+|||++.++ .+||+|||
T Consensus 79 ~e~~~~~~L~~~l~~~~~--~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dlkp~Nill~~~~~~~~~~~~~kl~Dfg 153 (259)
T cd05037 79 EEYVKFGPLDVFLHREKN--NVSLHWKLDVAKQLASALHYLEDKK---LVHGNVCGKNILVARYGLNEGYVPFIKLSDPG 153 (259)
T ss_pred EEcCCCCcHHHHHHhhcc--CCCHHHHHHHHHHHHHHHHHHhhCC---eecccCccceEEEecCccccCCceeEEeCCCC
Confidence 999999999999965332 5889999999999999999999988 99999999999999888 79999999
Q ss_pred CccccCCCCCccccc-eeeec-c-C--CCCCccccchhHHHHHHHHHhC-CCCCCCCCCcchhhhhHhHHhcCCcccccc
Q 004521 588 LVRTFGGDETEGNTN-RVVGT-Y-D--GQFSIKSDVFSFGILLLEIVSG-KKNRGFYRSDTKVNLIGHLWDEGIPLRLID 661 (747)
Q Consensus 588 la~~~~~~~~~~~~~-~~~~~-~-~--~~~s~ksDVwS~Gvvl~elltg-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~d 661 (747)
+++............ ..... . . ..++.++|||||||++|||++| ..|+......... ..+.........
T Consensus 154 ~a~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~~~~~----~~~~~~~~~~~~- 228 (259)
T cd05037 154 IPITVLSREERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSEKE----RFYQDQHRLPMP- 228 (259)
T ss_pred cccccccccccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCchhHH----HHHhcCCCCCCC-
Confidence 998754322111111 11111 1 1 3688899999999999999995 6665433211111 111111100000
Q ss_pred hhhhccCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhc
Q 004521 662 ACIQDSCNLADVIRCIHIGLLCVQQHPEDRPCMPSVILMLG 702 (747)
Q Consensus 662 ~~l~~~~~~~~~~~~~~l~~~Cl~~dP~~RPt~~~v~~~L~ 702 (747)
. ...+.+++.+||+.+|.+||++.+|++.|+
T Consensus 229 -------~---~~~~~~li~~~l~~~p~~Rpt~~~il~~l~ 259 (259)
T cd05037 229 -------D---CAELANLINQCWTYDPTKRPSFRAILRDLN 259 (259)
T ss_pred -------C---chHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence 0 145667888999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-33 Score=285.01 Aligned_cols=249 Identities=25% Similarity=0.341 Sum_probs=185.8
Q ss_pred cCCCccceecccCCeeEEEEEecC-CcEEEEEEecc--cccccHHHHHHHHHHHhccCCCceeeEEeEEEe-----CCee
Q 004521 440 DNFSINNKLGEGGFGPVYKGTLVD-GQEIAVKRLSK--ISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQ-----GEEK 511 (747)
Q Consensus 440 ~~~~~~~~lg~G~fg~Vy~~~~~~-g~~vavK~l~~--~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~-----~~~~ 511 (747)
..|...+.||+|+||.|..|.... |+.||||++.. .+....+...+|+++|+.++|+||+.+.+.+.. -+..
T Consensus 22 ~~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~f~Dv 101 (359)
T KOG0660|consen 22 RYYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDKFNDV 101 (359)
T ss_pred ceecccccccCcceeeEEEEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeeccccccccccee
Confidence 455557899999999999999754 89999999974 344556788899999999999999999999866 3467
Q ss_pred EEEEecCCCCChhhHhhhcCCCCcCChhHHHHHHHHHHHHHHHhhhcCCCceEecccCcCcEEEcCCCCceEecccCccc
Q 004521 512 LLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRT 591 (747)
Q Consensus 512 ~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NIll~~~~~~kl~DFGla~~ 591 (747)
|+|+|+| ..+|...+.. ...|+......+++||++||.|+|+.+ |+||||||+|+|++.+...||+|||+||.
T Consensus 102 YiV~elM-etDL~~iik~---~~~L~d~H~q~f~YQiLrgLKyiHSAn---ViHRDLKPsNll~n~~c~lKI~DFGLAR~ 174 (359)
T KOG0660|consen 102 YLVFELM-ETDLHQIIKS---QQDLTDDHAQYFLYQILRGLKYIHSAN---VIHRDLKPSNLLLNADCDLKICDFGLARY 174 (359)
T ss_pred EEehhHH-hhHHHHHHHc---CccccHHHHHHHHHHHHHhcchhhccc---ccccccchhheeeccCCCEEeccccceee
Confidence 9999999 5889888854 334888999999999999999999998 99999999999999999999999999998
Q ss_pred cCCCCCccc-cceeeec---------cCCCCCccccchhHHHHHHHHHhCCCCCCCCCCcchhhhhHhHHhcC-------
Q 004521 592 FGGDETEGN-TNRVVGT---------YDGQFSIKSDVFSFGILLLEIVSGKKNRGFYRSDTKVNLIGHLWDEG------- 654 (747)
Q Consensus 592 ~~~~~~~~~-~~~~~~~---------~~~~~s~ksDVwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~------- 654 (747)
......... +.++... ....|+.+.||||.|||+.||++|+..|.....-+...++.......
T Consensus 175 ~~~~~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql~lI~~~lGtP~~e~l~~ 254 (359)
T KOG0660|consen 175 LDKFFEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQLQLILELLGTPSEEDLQK 254 (359)
T ss_pred ccccCcccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCchHHHHHHHHHhcCCCCHHHHHH
Confidence 854311111 1111111 15689999999999999999999999876544333322222221110
Q ss_pred --------------CcccccchhhhccCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 004521 655 --------------IPLRLIDACIQDSCNLADVIRCIHIGLLCVQQHPEDRPCMPSVIL 699 (747)
Q Consensus 655 --------------~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dP~~RPt~~~v~~ 699 (747)
......-..+-...+ ...+++..++|..||.+|+|++|.++
T Consensus 255 i~s~~ar~yi~slp~~p~~~f~~~fp~a~----p~AidLlekmL~fdP~kRita~eAL~ 309 (359)
T KOG0660|consen 255 IRSEKARPYIKSLPQIPKQPFSSIFPNAN----PLAIDLLEKMLVFDPKKRITAEEALA 309 (359)
T ss_pred hccHHHHHHHHhCCCCCCCCHHHHcCCCC----HHHHHHHHHHhccCccccCCHHHHhc
Confidence 000000000001111 23456777899999999999999876
|
|
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-33 Score=303.65 Aligned_cols=191 Identities=25% Similarity=0.359 Sum_probs=160.1
Q ss_pred cCCCccceecccCCeeEEEEEecC-CcEEEEEEeccc---ccccHHHHHHHHHHHhccCCCceeeEEeEEEeCCeeEEEE
Q 004521 440 DNFSINNKLGEGGFGPVYKGTLVD-GQEIAVKRLSKI---SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIY 515 (747)
Q Consensus 440 ~~~~~~~~lg~G~fg~Vy~~~~~~-g~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 515 (747)
++|++.+.||+|+||+||+++... ++.||||++++. .......+.+|+.++.+++|+||+++++.+.+....++||
T Consensus 1 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~~lv~ 80 (363)
T cd05628 1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLIM 80 (363)
T ss_pred CCceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCCeEEEEE
Confidence 478889999999999999998754 889999999753 2234467889999999999999999999999999999999
Q ss_pred ecCCCCChhhHhhhcCCCCcCChhHHHHHHHHHHHHHHHhhhcCCCceEecccCcCcEEEcCCCCceEecccCccccCCC
Q 004521 516 EFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGD 595 (747)
Q Consensus 516 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NIll~~~~~~kl~DFGla~~~~~~ 595 (747)
||+++|+|.+++... ..+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++.+...
T Consensus 81 E~~~gg~L~~~l~~~---~~l~~~~~~~~~~qi~~aL~~lH~~g---ivHrDlKp~NILi~~~~~vkL~DFGla~~~~~~ 154 (363)
T cd05628 81 EFLPGGDMMTLLMKK---DTLTEEETQFYIAETVLAIDSIHQLG---FIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKA 154 (363)
T ss_pred cCCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCC---eEecCCCHHHeEECCCCCEEEeeccCccccccc
Confidence 999999999998642 45889999999999999999999988 999999999999999999999999998765321
Q ss_pred CCcc---------------------------------ccceeeecc---------CCCCCccccchhHHHHHHHHHhCCC
Q 004521 596 ETEG---------------------------------NTNRVVGTY---------DGQFSIKSDVFSFGILLLEIVSGKK 633 (747)
Q Consensus 596 ~~~~---------------------------------~~~~~~~~~---------~~~~s~ksDVwS~Gvvl~elltg~~ 633 (747)
.... ......|+. +..++.++|||||||+||||++|+.
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~ 234 (363)
T cd05628 155 HRTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYP 234 (363)
T ss_pred ccccccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCCCchhhhhhHHHHHHHHhCCC
Confidence 1000 000112221 4568899999999999999999999
Q ss_pred CCC
Q 004521 634 NRG 636 (747)
Q Consensus 634 p~~ 636 (747)
||.
T Consensus 235 Pf~ 237 (363)
T cd05628 235 PFC 237 (363)
T ss_pred CCC
Confidence 975
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-32 Score=290.51 Aligned_cols=254 Identities=22% Similarity=0.294 Sum_probs=183.2
Q ss_pred CCCccceecccCCeeEEEEEec-CCcEEEEEEeccc--ccccHHHHHHHHHHHhccCCCceeeEEeEEEeCCeeEEEEec
Q 004521 441 NFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKI--SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEF 517 (747)
Q Consensus 441 ~~~~~~~lg~G~fg~Vy~~~~~-~g~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~ 517 (747)
+|++.+.||+|++|.||+|+.. +++.||||+++.. .....+.+.+|+.++++++||||+++++++.++...++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (285)
T cd07861 1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLMQESRLYLIFEF 80 (285)
T ss_pred CceEeeEecccCceEEEEEEECCCCcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeEEEEEec
Confidence 4778899999999999999975 4889999998642 223456788999999999999999999999999999999999
Q ss_pred CCCCChhhHhhhcCCCCcCChhHHHHHHHHHHHHHHHhhhcCCCceEecccCcCcEEEcCCCCceEecccCccccCCCCC
Q 004521 518 MPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDET 597 (747)
Q Consensus 518 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~ 597 (747)
++ ++|.+++........+++..+..++.||++||.|||+.+ ++||||||+||+++.++.+||+|||+++.......
T Consensus 81 ~~-~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~ 156 (285)
T cd07861 81 LS-MDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSRR---VLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPVR 156 (285)
T ss_pred CC-CCHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCCHHHEEEcCCCcEEECcccceeecCCCcc
Confidence 97 689888865444456899999999999999999999988 99999999999999999999999999876543221
Q ss_pred cccc-----ceeeec-c--CCCCCccccchhHHHHHHHHHhCCCCCCCCCCcchhhhhHhHHhcC------Ccc------
Q 004521 598 EGNT-----NRVVGT-Y--DGQFSIKSDVFSFGILLLEIVSGKKNRGFYRSDTKVNLIGHLWDEG------IPL------ 657 (747)
Q Consensus 598 ~~~~-----~~~~~~-~--~~~~s~ksDVwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~------~~~------ 657 (747)
.... ...... . ...++.++|||||||++|||++|+.|+...............+... ...
T Consensus 157 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (285)
T cd07861 157 VYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFRIFRILGTPTEDVWPGVTSLPDYK 236 (285)
T ss_pred cccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhcchhhHHHH
Confidence 1100 000011 1 2346889999999999999999999875322111100000000000 000
Q ss_pred ----cccchhhhccCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 004521 658 ----RLIDACIQDSCNLADVIRCIHIGLLCVQQHPEDRPCMPSVIL 699 (747)
Q Consensus 658 ----~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dP~~RPt~~~v~~ 699 (747)
.......... ...-..++.+++.+||+.||.+|||+.+|+.
T Consensus 237 ~~~~~~~~~~~~~~-~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~ 281 (285)
T cd07861 237 NTFPKWKKGSLRSA-VKNLDEDGLDLLEKMLIYDPAKRISAKKALN 281 (285)
T ss_pred hhccccCcchhHHh-cCCCCHHHHHHHHHHhcCChhhCCCHHHHhc
Confidence 0000000000 0001123457888999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-33 Score=291.09 Aligned_cols=251 Identities=27% Similarity=0.407 Sum_probs=186.3
Q ss_pred cCCCccceecccCCeeEEEEEec-----CCcEEEEEEecccc-cccHHHHHHHHHHHhccCCCceeeEEeEEEeC--Cee
Q 004521 440 DNFSINNKLGEGGFGPVYKGTLV-----DGQEIAVKRLSKIS-EQGLKELKNEVILFSKLQHRNLVKLLGCCIQG--EEK 511 (747)
Q Consensus 440 ~~~~~~~~lg~G~fg~Vy~~~~~-----~g~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~--~~~ 511 (747)
..|++.+.||+|+||.||+++.. .+..||+|.++... ....+.+.+|+.++++++||||+++++++... ...
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 83 (284)
T cd05079 4 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGI 83 (284)
T ss_pred hhhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccccHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCCce
Confidence 35678899999999999999742 47789999987532 34456799999999999999999999999875 567
Q ss_pred EEEEecCCCCChhhHhhhcCCCCcCChhHHHHHHHHHHHHHHHhhhcCCCceEecccCcCcEEEcCCCCceEecccCccc
Q 004521 512 LLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRT 591 (747)
Q Consensus 512 ~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NIll~~~~~~kl~DFGla~~ 591 (747)
++||||+++++|.+++... ...+++..+..++.|++.||+|||+.+ ++||||||+||+++.++.+||+|||+++.
T Consensus 84 ~lv~e~~~g~~L~~~l~~~--~~~~~~~~~~~i~~~i~~aL~~lH~~g---i~H~dlkp~Nil~~~~~~~~l~dfg~~~~ 158 (284)
T cd05079 84 KLIMEFLPSGSLKEYLPRN--KNKINLKQQLKYAVQICKGMDYLGSRQ---YVHRDLAARNVLVESEHQVKIGDFGLTKA 158 (284)
T ss_pred EEEEEccCCCCHHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecccchheEEEcCCCCEEECCCccccc
Confidence 8999999999999998543 235899999999999999999999988 99999999999999999999999999987
Q ss_pred cCCCCCccc-ccee------e---eccCCCCCccccchhHHHHHHHHHhCCCCCCCCCCc-----------chhhhhHhH
Q 004521 592 FGGDETEGN-TNRV------V---GTYDGQFSIKSDVFSFGILLLEIVSGKKNRGFYRSD-----------TKVNLIGHL 650 (747)
Q Consensus 592 ~~~~~~~~~-~~~~------~---~~~~~~~s~ksDVwS~Gvvl~elltg~~p~~~~~~~-----------~~~~~~~~~ 650 (747)
+........ .... . ...+..++.++|||||||++|||++++.|....... .........
T Consensus 159 ~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ellt~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (284)
T cd05079 159 IETDKEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSESSPMTLFLKMIGPTHGQMTVTRLVRV 238 (284)
T ss_pred cccCccceeecCCCCCCccccCHHHhccCCCCccccchhhhhhhhhhhcCCCCCccccchhhhhcccccccccHHHHHHH
Confidence 643321100 0000 0 012456888999999999999999987763211000 000000000
Q ss_pred HhcCCcccccchhhhccCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhcCC
Q 004521 651 WDEGIPLRLIDACIQDSCNLADVIRCIHIGLLCVQQHPEDRPCMPSVILMLGSE 704 (747)
Q Consensus 651 ~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dP~~RPt~~~v~~~L~~~ 704 (747)
...+..... ... ....+.+++.+||+.+|++||++.+|++.|+..
T Consensus 239 ~~~~~~~~~-----~~~----~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~~~ 283 (284)
T cd05079 239 LEEGKRLPR-----PPN----CPEEVYQLMRKCWEFQPSKRTTFQNLIEGFEAI 283 (284)
T ss_pred HHcCccCCC-----CCC----CCHHHHHHHHHHccCCcccCcCHHHHHHHHHhh
Confidence 111111110 011 123577888999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-32 Score=292.23 Aligned_cols=243 Identities=22% Similarity=0.371 Sum_probs=186.9
Q ss_pred hcCCCccceecccCCeeEEEEEec-CCcEEEEEEecccccccHHHHHHHHHHHhccCCCceeeEEeEEEeCCeeEEEEec
Q 004521 439 TDNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEF 517 (747)
Q Consensus 439 ~~~~~~~~~lg~G~fg~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~ 517 (747)
..+|++.+.||+|+||.||+|... +++.||+|.+........+.+.+|+.+++.++|+||+++++.+..+...++||||
T Consensus 19 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~~~~lv~e~ 98 (296)
T cd06654 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEY 98 (296)
T ss_pred ccceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCcchHHHHHHHHHHHHhCCCCCEeeEEEEEEeCCEEEEeecc
Confidence 357888999999999999999864 5889999998765555567889999999999999999999999999999999999
Q ss_pred CCCCChhhHhhhcCCCCcCChhHHHHHHHHHHHHHHHhhhcCCCceEecccCcCcEEEcCCCCceEecccCccccCCCCC
Q 004521 518 MPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDET 597 (747)
Q Consensus 518 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~ 597 (747)
+++++|.+++.. ..+++.++..++.|++.||.|||+.+ |+||||||+||+++.++.+||+|||+++.......
T Consensus 99 ~~~~~L~~~~~~----~~~~~~~~~~i~~ql~~aL~~LH~~g---i~H~dLkp~Nill~~~~~~kl~dfg~~~~~~~~~~ 171 (296)
T cd06654 99 LAGGSLTDVVTE----TCMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS 171 (296)
T ss_pred cCCCCHHHHHHh----cCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEcCCCCEEECccccchhcccccc
Confidence 999999999843 24788999999999999999999988 99999999999999999999999999876543221
Q ss_pred ccc-----cceeeec--cCCCCCccccchhHHHHHHHHHhCCCCCCCCCCcchhhhhHhHHhcCCcccccchhhhccCCH
Q 004521 598 EGN-----TNRVVGT--YDGQFSIKSDVFSFGILLLEIVSGKKNRGFYRSDTKVNLIGHLWDEGIPLRLIDACIQDSCNL 670 (747)
Q Consensus 598 ~~~-----~~~~~~~--~~~~~s~ksDVwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~ 670 (747)
... ....... ....++.++|||||||++|||++|+.||...... .........+.. .+.. ..
T Consensus 172 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~---~~~~~~~~~~~~-~~~~-------~~ 240 (296)
T cd06654 172 KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPL---RALYLIATNGTP-ELQN-------PE 240 (296)
T ss_pred ccCcccCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHH---HhHHHHhcCCCC-CCCC-------cc
Confidence 110 0000001 1455788999999999999999999997532211 111111111111 0000 01
Q ss_pred HHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 004521 671 ADVIRCIHIGLLCVQQHPEDRPCMPSVIL 699 (747)
Q Consensus 671 ~~~~~~~~l~~~Cl~~dP~~RPt~~~v~~ 699 (747)
.....+.+++.+||+.+|++||++.+|++
T Consensus 241 ~~~~~l~~li~~~l~~~p~~Rpt~~eil~ 269 (296)
T cd06654 241 KLSAIFRDFLNRCLDMDVEKRGSAKELLQ 269 (296)
T ss_pred ccCHHHHHHHHHHCcCCcccCcCHHHHhh
Confidence 11133567888999999999999999987
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-33 Score=294.82 Aligned_cols=255 Identities=21% Similarity=0.259 Sum_probs=184.6
Q ss_pred cCCCccceecccCCeeEEEEEecC-CcEEEEEEeccc-ccccHHHHHHHHHHHhccCCCceeeEEeEEEeCCeeEEEEec
Q 004521 440 DNFSINNKLGEGGFGPVYKGTLVD-GQEIAVKRLSKI-SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEF 517 (747)
Q Consensus 440 ~~~~~~~~lg~G~fg~Vy~~~~~~-g~~vavK~l~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~ 517 (747)
++|++.+.||+|+||.||++.... +..+|+|.+... ......++.+|++++.+++||||+++++++..++..++||||
T Consensus 1 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ey 80 (308)
T cd06615 1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISICMEH 80 (308)
T ss_pred CCceEEeeccCCCCeEEEEEEEcCCCeEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCEEEEEeec
Confidence 468889999999999999998754 788999988643 233456788999999999999999999999999999999999
Q ss_pred CCCCChhhHhhhcCCCCcCChhHHHHHHHHHHHHHHHhhh-cCCCceEecccCcCcEEEcCCCCceEecccCccccCCCC
Q 004521 518 MPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQ-DSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDE 596 (747)
Q Consensus 518 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~-~~~~~iiHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~ 596 (747)
+++++|.+++... ..+++..+..++.|+++||.|||+ .+ ++||||||+|||++.++.+||+|||+++.+....
T Consensus 81 ~~~~~L~~~l~~~---~~~~~~~~~~~~~~i~~~l~~lH~~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~ 154 (308)
T cd06615 81 MDGGSLDQVLKKA---GRIPENILGKISIAVLRGLTYLREKHK---IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM 154 (308)
T ss_pred cCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhhCC---EEECCCChHHEEEecCCcEEEccCCCcccccccc
Confidence 9999999999643 457889999999999999999997 35 9999999999999999999999999987653221
Q ss_pred Cccc---cceeee--ccCCCCCccccchhHHHHHHHHHhCCCCCCCCCCcchhhhhHhHHhcCCcc--------------
Q 004521 597 TEGN---TNRVVG--TYDGQFSIKSDVFSFGILLLEIVSGKKNRGFYRSDTKVNLIGHLWDEGIPL-------------- 657 (747)
Q Consensus 597 ~~~~---~~~~~~--~~~~~~s~ksDVwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~-------------- 657 (747)
.... ...... ..+..++.++|||||||++|||++|+.|+...........+..........
T Consensus 155 ~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (308)
T cd06615 155 ANSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPDAKELEAMFGRPVSEGEAKESHRPVSGHPPDSP 234 (308)
T ss_pred cccCCCCcCccChhHhcCCCCCccchHHHHHHHHHHHHhCCCCCCCcchhhHHHhhcCccccccccCCcccccCCCCCcc
Confidence 1100 000000 114567889999999999999999999975322111111110000000000
Q ss_pred ------cccchhhh----ccCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 004521 658 ------RLIDACIQ----DSCNLADVIRCIHIGLLCVQQHPEDRPCMPSVILM 700 (747)
Q Consensus 658 ------~~~d~~l~----~~~~~~~~~~~~~l~~~Cl~~dP~~RPt~~~v~~~ 700 (747)
.+.+.... ..........+.+++.+||+.+|++||++.+|++.
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~ 287 (308)
T cd06615 235 RPMAIFELLDYIVNEPPPKLPSGAFSDEFQDFVDKCLKKNPKERADLKELTKH 287 (308)
T ss_pred chhhHHHHHHHHhcCCCccCcCcccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 00000000 00000011236688899999999999999999875
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-33 Score=304.56 Aligned_cols=246 Identities=20% Similarity=0.243 Sum_probs=185.5
Q ss_pred HhcCCCccceecccCCeeEEEEEecC-CcEEEEEEeccc---ccccHHHHHHHHHHHhccCCCceeeEEeEEEeCCeeEE
Q 004521 438 ATDNFSINNKLGEGGFGPVYKGTLVD-GQEIAVKRLSKI---SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLL 513 (747)
Q Consensus 438 ~~~~~~~~~~lg~G~fg~Vy~~~~~~-g~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~l 513 (747)
..++|++.+.||+|+||.||+++... ++.||+|.+.+. .....+.+.+|+.+++.++||||+++++++.+....++
T Consensus 41 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~~~~~l 120 (370)
T cd05596 41 KAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDKYLYM 120 (370)
T ss_pred CHHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEEE
Confidence 34679999999999999999999764 889999999652 22344567899999999999999999999999999999
Q ss_pred EEecCCCCChhhHhhhcCCCCcCChhHHHHHHHHHHHHHHHhhhcCCCceEecccCcCcEEEcCCCCceEecccCccccC
Q 004521 514 IYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFG 593 (747)
Q Consensus 514 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NIll~~~~~~kl~DFGla~~~~ 593 (747)
||||+++|+|.+++.. ..++...+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++.+.
T Consensus 121 v~Ey~~gg~L~~~l~~----~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDLkp~NILl~~~~~~kL~DfG~~~~~~ 193 (370)
T cd05596 121 VMEYMPGGDLVNLMSN----YDIPEKWARFYTAEVVLALDAIHSMG---FIHRDVKPDNMLLDKSGHLKLADFGTCMKMD 193 (370)
T ss_pred EEcCCCCCcHHHHHHh----cCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEEcCCCCEEEEeccceeecc
Confidence 9999999999999854 23778888899999999999999988 9999999999999999999999999998764
Q ss_pred CCCCc------cccceeeec------cCCCCCccccchhHHHHHHHHHhCCCCCCCCCCcchhhhhHhHHhcCCcccccc
Q 004521 594 GDETE------GNTNRVVGT------YDGQFSIKSDVFSFGILLLEIVSGKKNRGFYRSDTKVNLIGHLWDEGIPLRLID 661 (747)
Q Consensus 594 ~~~~~------~~~~~~~~~------~~~~~s~ksDVwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~d 661 (747)
..... .......+. ....++.++|||||||+||||++|+.||..... ...............+.+
T Consensus 194 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~---~~~~~~i~~~~~~~~~~~ 270 (370)
T cd05596 194 ANGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSL---VGTYSKIMDHKNSLTFPD 270 (370)
T ss_pred CCCcccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCH---HHHHHHHHcCCCcCCCCC
Confidence 32211 011111111 123478999999999999999999999753321 112222221111111111
Q ss_pred hhhhccCCHHHHHHHHHHHHhccCCCCCC--CCCHHHHHHH
Q 004521 662 ACIQDSCNLADVIRCIHIGLLCVQQHPED--RPCMPSVILM 700 (747)
Q Consensus 662 ~~l~~~~~~~~~~~~~~l~~~Cl~~dP~~--RPt~~~v~~~ 700 (747)
. . .. -..+.+++.+||+.+|.+ ||++.++++.
T Consensus 271 ~-~--~~----s~~~~~li~~~L~~~p~r~~R~s~~ell~h 304 (370)
T cd05596 271 D-I--EI----SKQAKDLICAFLTDREVRLGRNGVDEIKSH 304 (370)
T ss_pred c-C--CC----CHHHHHHHHHHccChhhccCCCCHHHHhcC
Confidence 0 0 01 123556777999999987 9999999764
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-33 Score=286.98 Aligned_cols=243 Identities=24% Similarity=0.350 Sum_probs=184.5
Q ss_pred cCCCccceecccCCeeEEEEEec-CCcEEEEEEecccc-----cccHHHHHHHHHHHhccCCCceeeEEeEEEeCCeeEE
Q 004521 440 DNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKIS-----EQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLL 513 (747)
Q Consensus 440 ~~~~~~~~lg~G~fg~Vy~~~~~-~g~~vavK~l~~~~-----~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~l 513 (747)
++|.+.+.||+|++|.||++... +++.+|+|.+.... ....+.+.+|+.++++++||||+++++++...+..++
T Consensus 2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~ 81 (263)
T cd06625 2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDETLSI 81 (263)
T ss_pred CcccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCCeEEE
Confidence 57888999999999999999875 48999999986421 1234578899999999999999999999999999999
Q ss_pred EEecCCCCChhhHhhhcCCCCcCChhHHHHHHHHHHHHHHHhhhcCCCceEecccCcCcEEEcCCCCceEecccCccccC
Q 004521 514 IYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFG 593 (747)
Q Consensus 514 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NIll~~~~~~kl~DFGla~~~~ 593 (747)
|+||+++++|.+++... ..+++..+..++.|++.||.|||+.+ |+||||+|+||++++++.+||+|||+++.+.
T Consensus 82 v~e~~~~~~l~~~~~~~---~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dl~p~nilv~~~~~~~l~dfg~~~~~~ 155 (263)
T cd06625 82 FMEYMPGGSVKDQLKAY---GALTETVTRKYTRQILEGVEYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKRLQ 155 (263)
T ss_pred EEEECCCCcHHHHHHHh---CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeecccceecc
Confidence 99999999999998543 34788999999999999999999988 9999999999999999999999999987653
Q ss_pred CCCCccc--------cceeee--ccCCCCCccccchhHHHHHHHHHhCCCCCCCCCCcchhhhhHhHHhcCCcccccchh
Q 004521 594 GDETEGN--------TNRVVG--TYDGQFSIKSDVFSFGILLLEIVSGKKNRGFYRSDTKVNLIGHLWDEGIPLRLIDAC 663 (747)
Q Consensus 594 ~~~~~~~--------~~~~~~--~~~~~~s~ksDVwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 663 (747)
....... ...... ..+..++.++||||||+++|||++|+.|+.... ................+
T Consensus 156 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~---~~~~~~~~~~~~~~~~~---- 228 (263)
T cd06625 156 TICSSGTGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFE---AMAAIFKIATQPTNPQL---- 228 (263)
T ss_pred ccccccccccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHHhCCCCccccc---hHHHHHHHhccCCCCCC----
Confidence 3211100 000000 113457899999999999999999999964221 11111111111111111
Q ss_pred hhccCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 004521 664 IQDSCNLADVIRCIHIGLLCVQQHPEDRPCMPSVILM 700 (747)
Q Consensus 664 l~~~~~~~~~~~~~~l~~~Cl~~dP~~RPt~~~v~~~ 700 (747)
... ....+.+++.+||+.+|.+||++.+++++
T Consensus 229 -~~~----~~~~~~~li~~~l~~~p~~Rpt~~~ll~~ 260 (263)
T cd06625 229 -PSH----VSPDARNFLRRTFVENAKKRPSAEELLRH 260 (263)
T ss_pred -Ccc----CCHHHHHHHHHHhhcCcccCCCHHHHhhC
Confidence 111 11235567789999999999999999875
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-32 Score=294.83 Aligned_cols=249 Identities=29% Similarity=0.458 Sum_probs=189.0
Q ss_pred cCCCccceecccCCeeEEEEEec--------CCcEEEEEEeccc-ccccHHHHHHHHHHHhcc-CCCceeeEEeEEEeCC
Q 004521 440 DNFSINNKLGEGGFGPVYKGTLV--------DGQEIAVKRLSKI-SEQGLKELKNEVILFSKL-QHRNLVKLLGCCIQGE 509 (747)
Q Consensus 440 ~~~~~~~~lg~G~fg~Vy~~~~~--------~g~~vavK~l~~~-~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~ 509 (747)
++|.+.+.||+|+||.||+++.. ....+|+|.++.. ......++..|+.+++++ +||||+++++++....
T Consensus 12 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~ 91 (314)
T cd05099 12 DRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKNIINLLGVCTQEG 91 (314)
T ss_pred HHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCChHHHHHHHHHHHHHHhccCCCCeeeEEEEEccCC
Confidence 57888999999999999999752 2457999998753 234456788999999999 6999999999999999
Q ss_pred eeEEEEecCCCCChhhHhhhcCC-------------CCcCChhHHHHHHHHHHHHHHHhhhcCCCceEecccCcCcEEEc
Q 004521 510 EKLLIYEFMPNKSLDSFIFDQTR-------------RTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLD 576 (747)
Q Consensus 510 ~~~lV~E~~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NIll~ 576 (747)
..++||||+++|+|.+++..... ...+++.++..++.||+.||.|||+.+ ++||||||+|||++
T Consensus 92 ~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~g---i~H~dlkp~Nill~ 168 (314)
T cd05099 92 PLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESRR---CIHRDLAARNVLVT 168 (314)
T ss_pred ceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHCC---eeeccccceeEEEc
Confidence 99999999999999999965321 235888999999999999999999988 99999999999999
Q ss_pred CCCCceEecccCccccCCCCCcccc-------ceeeec--cCCCCCccccchhHHHHHHHHHh-CCCCCCCCCCcchhhh
Q 004521 577 QDMNPKISDFGLVRTFGGDETEGNT-------NRVVGT--YDGQFSIKSDVFSFGILLLEIVS-GKKNRGFYRSDTKVNL 646 (747)
Q Consensus 577 ~~~~~kl~DFGla~~~~~~~~~~~~-------~~~~~~--~~~~~s~ksDVwS~Gvvl~ellt-g~~p~~~~~~~~~~~~ 646 (747)
.++.+||+|||+++........... ...... ....++.++|||||||++|||++ |..|+..... ...
T Consensus 169 ~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~---~~~ 245 (314)
T cd05099 169 EDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGIPV---EEL 245 (314)
T ss_pred CCCcEEEccccccccccccccccccccCCCCccccCHHHHccCCcCccchhhHHHHHHHHHHhCCCCCCCCCCH---HHH
Confidence 9999999999999866432111100 000011 24568899999999999999999 7888643221 112
Q ss_pred hHhHHhcCCcccccchhhhccCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhcCC
Q 004521 647 IGHLWDEGIPLRLIDACIQDSCNLADVIRCIHIGLLCVQQHPEDRPCMPSVILMLGSE 704 (747)
Q Consensus 647 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dP~~RPt~~~v~~~L~~~ 704 (747)
.... ..+...... ... ...+.+++.+||+.+|++||++.++++.|+..
T Consensus 246 ~~~~-~~~~~~~~~-----~~~----~~~l~~li~~cl~~~p~~Rps~~~ll~~l~~~ 293 (314)
T cd05099 246 FKLL-REGHRMDKP-----SNC----THELYMLMRECWHAVPTQRPTFKQLVEALDKV 293 (314)
T ss_pred HHHH-HcCCCCCCC-----CCC----CHHHHHHHHHHcCCCcccCcCHHHHHHHHHHH
Confidence 2211 222111111 111 12355788899999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-32 Score=285.83 Aligned_cols=240 Identities=28% Similarity=0.414 Sum_probs=184.3
Q ss_pred ceecccCCeeEEEEEecC--C--cEEEEEEeccccc-ccHHHHHHHHHHHhccCCCceeeEEeEEEeCCeeEEEEecCCC
Q 004521 446 NKLGEGGFGPVYKGTLVD--G--QEIAVKRLSKISE-QGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMPN 520 (747)
Q Consensus 446 ~~lg~G~fg~Vy~~~~~~--g--~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~ 520 (747)
+.||+|++|.||+|.+.. + ..||||.++.... ...+.+.+|+.++++++||||+++++++.. ...++||||+++
T Consensus 1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~~~ 79 (257)
T cd05040 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLYGVVLT-HPLMMVTELAPL 79 (257)
T ss_pred CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccHHHHHHHHHHHHHHhhcCCCCccceeEEEcC-CeEEEEEEecCC
Confidence 468999999999998743 3 3699999987544 567789999999999999999999999988 889999999999
Q ss_pred CChhhHhhhcCCCCcCChhHHHHHHHHHHHHHHHhhhcCCCceEecccCcCcEEEcCCCCceEecccCccccCCCCCccc
Q 004521 521 KSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGN 600 (747)
Q Consensus 521 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~ 600 (747)
++|.+++..... ..+++..++.++.|+++||+|||+.+ ++|+||||+||+++.++.+||+|||+++.+........
T Consensus 80 ~~L~~~l~~~~~-~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~ 155 (257)
T cd05040 80 GSLLDRLRKDAL-GHFLISTLCDYAVQIANGMRYLESKR---FIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYV 155 (257)
T ss_pred CcHHHHHHhccc-ccCcHHHHHHHHHHHHHHHHHHHhCC---ccccccCcccEEEecCCEEEecccccccccccccccee
Confidence 999999976432 46899999999999999999999988 99999999999999999999999999987654221110
Q ss_pred cc-eeee------c---cCCCCCccccchhHHHHHHHHHh-CCCCCCCCCCcchhhhhHhHHhcCCcccccchhhhccCC
Q 004521 601 TN-RVVG------T---YDGQFSIKSDVFSFGILLLEIVS-GKKNRGFYRSDTKVNLIGHLWDEGIPLRLIDACIQDSCN 669 (747)
Q Consensus 601 ~~-~~~~------~---~~~~~s~ksDVwS~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~ 669 (747)
.. ...+ + ....++.++|||||||++|||++ |+.|+..... ................. .
T Consensus 156 ~~~~~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~---~~~~~~~~~~~~~~~~~-----~--- 224 (257)
T cd05040 156 MEEHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSG---SQILKKIDKEGERLERP-----E--- 224 (257)
T ss_pred cccCCCCCceecCHHHhcccCcCchhhhHHHHHHHHHHHhCCCCCCCCCCH---HHHHHHHHhcCCcCCCC-----c---
Confidence 00 0001 0 13567889999999999999999 9999643221 11222111111111100 0
Q ss_pred HHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhc
Q 004521 670 LADVIRCIHIGLLCVQQHPEDRPCMPSVILMLG 702 (747)
Q Consensus 670 ~~~~~~~~~l~~~Cl~~dP~~RPt~~~v~~~L~ 702 (747)
.....+.+++.+||+.+|++||++.+|++.|.
T Consensus 225 -~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~ 256 (257)
T cd05040 225 -ACPQDIYNVMLQCWAHNPADRPTFAALREFLP 256 (257)
T ss_pred -cCCHHHHHHHHHHCCCCcccCCCHHHHHHHhc
Confidence 11234667888999999999999999999885
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-33 Score=303.12 Aligned_cols=244 Identities=21% Similarity=0.258 Sum_probs=180.3
Q ss_pred cCCCccceecccCCeeEEEEEec-CCcEEEEEEeccc---ccccHHHHHHHHHHHhccCCCceeeEEeEEEeCCeeEEEE
Q 004521 440 DNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKI---SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIY 515 (747)
Q Consensus 440 ~~~~~~~~lg~G~fg~Vy~~~~~-~g~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 515 (747)
++|.+.+.||+|+||.||+++.. +++.||||++.+. .....+.+.+|++++++++||||+++++++.+....++||
T Consensus 1 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~ 80 (377)
T cd05629 1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQYLYLIM 80 (377)
T ss_pred CCceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCeeEEEE
Confidence 46888999999999999999875 4889999998652 2334567889999999999999999999999999999999
Q ss_pred ecCCCCChhhHhhhcCCCCcCChhHHHHHHHHHHHHHHHhhhcCCCceEecccCcCcEEEcCCCCceEecccCccccCCC
Q 004521 516 EFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGD 595 (747)
Q Consensus 516 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NIll~~~~~~kl~DFGla~~~~~~ 595 (747)
||+++|+|.+++... ..+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++.+...
T Consensus 81 E~~~gg~L~~~l~~~---~~~~~~~~~~~~~ql~~aL~~LH~~g---ivHrDlkp~NIll~~~~~~kl~DfGla~~~~~~ 154 (377)
T cd05629 81 EFLPGGDLMTMLIKY---DTFSEDVTRFYMAECVLAIEAVHKLG---FIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQ 154 (377)
T ss_pred eCCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEECCCCCEEEeecccccccccc
Confidence 999999999998542 35788889999999999999999988 999999999999999999999999999643211
Q ss_pred CCc------------c---------------------------------ccceeeecc---------CCCCCccccchhH
Q 004521 596 ETE------------G---------------------------------NTNRVVGTY---------DGQFSIKSDVFSF 621 (747)
Q Consensus 596 ~~~------------~---------------------------------~~~~~~~~~---------~~~~s~ksDVwS~ 621 (747)
... . ......|+. ...++.++|||||
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSl 234 (377)
T cd05629 155 HDSAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWSL 234 (377)
T ss_pred cccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCCCCceeeEec
Confidence 000 0 000011221 4568899999999
Q ss_pred HHHHHHHHhCCCCCCCCCCcchhhhhHhHHhcCCcccccchhhhccCCHHHHHHHHHHHHhccCCCCCCC---CCHHHHH
Q 004521 622 GILLLEIVSGKKNRGFYRSDTKVNLIGHLWDEGIPLRLIDACIQDSCNLADVIRCIHIGLLCVQQHPEDR---PCMPSVI 698 (747)
Q Consensus 622 Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dP~~R---Pt~~~v~ 698 (747)
||+||||++|+.||..... ...............+.+.. ..+ ..+.+++.+|++ +|.+| |++.+++
T Consensus 235 Gvil~elltG~~Pf~~~~~---~~~~~~i~~~~~~~~~p~~~---~~s----~~~~dli~~lL~-~~~~r~~r~~~~~~l 303 (377)
T cd05629 235 GAIMFECLIGWPPFCSENS---HETYRKIINWRETLYFPDDI---HLS----VEAEDLIRRLIT-NAENRLGRGGAHEIK 303 (377)
T ss_pred chhhhhhhcCCCCCCCCCH---HHHHHHHHccCCccCCCCCC---CCC----HHHHHHHHHHhc-CHhhcCCCCCHHHHh
Confidence 9999999999999753322 11111111111111111100 011 224456667887 66665 5888887
Q ss_pred HH
Q 004521 699 LM 700 (747)
Q Consensus 699 ~~ 700 (747)
+.
T Consensus 304 ~h 305 (377)
T cd05629 304 SH 305 (377)
T ss_pred cC
Confidence 75
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-33 Score=296.95 Aligned_cols=232 Identities=23% Similarity=0.290 Sum_probs=177.3
Q ss_pred CCCccceecccCCeeEEEEEecC-CcEEEEEEeccc---ccccHHHHHHHHHHHhcc-CCCceeeEEeEEEeCCeeEEEE
Q 004521 441 NFSINNKLGEGGFGPVYKGTLVD-GQEIAVKRLSKI---SEQGLKELKNEVILFSKL-QHRNLVKLLGCCIQGEEKLLIY 515 (747)
Q Consensus 441 ~~~~~~~lg~G~fg~Vy~~~~~~-g~~vavK~l~~~---~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lV~ 515 (747)
+|.+.+.||+|+||.||+|+... ++.||||.+++. .....+.+..|..++..+ +|++|+++++++...+..++||
T Consensus 1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05616 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFVM 80 (323)
T ss_pred CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEEE
Confidence 47888999999999999999765 789999998753 223345677788888877 6899999999999999999999
Q ss_pred ecCCCCChhhHhhhcCCCCcCChhHHHHHHHHHHHHHHHhhhcCCCceEecccCcCcEEEcCCCCceEecccCccccCCC
Q 004521 516 EFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGD 595 (747)
Q Consensus 516 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NIll~~~~~~kl~DFGla~~~~~~ 595 (747)
||+++|+|..++... ..+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++.....
T Consensus 81 E~~~~g~L~~~~~~~---~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~kL~DfG~~~~~~~~ 154 (323)
T cd05616 81 EYVNGGDLMYQIQQV---GRFKEPHAVFYAAEIAIGLFFLHSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKENMWD 154 (323)
T ss_pred cCCCCCCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---EEecCCCHHHeEECCCCcEEEccCCCceecCCC
Confidence 999999999888543 34888999999999999999999988 999999999999999999999999999754322
Q ss_pred CCccccceeeec---------cCCCCCccccchhHHHHHHHHHhCCCCCCCCCCcchhhhhHhHHhcCCcccccchhhhc
Q 004521 596 ETEGNTNRVVGT---------YDGQFSIKSDVFSFGILLLEIVSGKKNRGFYRSDTKVNLIGHLWDEGIPLRLIDACIQD 666 (747)
Q Consensus 596 ~~~~~~~~~~~~---------~~~~~s~ksDVwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 666 (747)
.... ....|+ ....++.++|||||||++|||++|+.||..... ......... ... .+ ..
T Consensus 155 ~~~~--~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~---~~~~~~i~~-~~~-~~-----p~ 222 (323)
T cd05616 155 GVTT--KTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDE---DELFQSIME-HNV-AY-----PK 222 (323)
T ss_pred CCcc--ccCCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHhCCCCCCCCCH---HHHHHHHHh-CCC-CC-----CC
Confidence 1111 001111 146789999999999999999999999753322 222222211 111 01 01
Q ss_pred cCCHHHHHHHHHHHHhccCCCCCCCCCH
Q 004521 667 SCNLADVIRCIHIGLLCVQQHPEDRPCM 694 (747)
Q Consensus 667 ~~~~~~~~~~~~l~~~Cl~~dP~~RPt~ 694 (747)
.. ...+.+++.+|++.+|.+|++.
T Consensus 223 ~~----s~~~~~li~~~l~~~p~~R~~~ 246 (323)
T cd05616 223 SM----SKEAVAICKGLMTKHPGKRLGC 246 (323)
T ss_pred cC----CHHHHHHHHHHcccCHHhcCCC
Confidence 11 1235677889999999999985
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-32 Score=287.44 Aligned_cols=251 Identities=23% Similarity=0.302 Sum_probs=185.6
Q ss_pred HHHhcCCCccceecccCCeeEEEEEecC-CcEEEEEEecccccccHHHHHHHHHHHhccCCCceeeEEeEEEeCCeeEEE
Q 004521 436 ANATDNFSINNKLGEGGFGPVYKGTLVD-GQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLI 514 (747)
Q Consensus 436 ~~~~~~~~~~~~lg~G~fg~Vy~~~~~~-g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV 514 (747)
+.+++++.....||+|+||.||+|+..+ +..||+|.+........+.+.+|+.++++++|+||+++++++..++..++|
T Consensus 4 ~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 83 (268)
T cd06624 4 EYEYDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSDSENGFFKIF 83 (268)
T ss_pred ccccccCCceEEEecCCceEEEEeEecCCCcEEEEEEecCCCHHHHHHHHHHHHHHHhcCCCCeeeeeeeeccCCEEEEE
Confidence 3455666667899999999999999654 778999998765555677899999999999999999999999999999999
Q ss_pred EecCCCCChhhHhhhcCCCCcCChhHHHHHHHHHHHHHHHhhhcCCCceEecccCcCcEEEcC-CCCceEecccCccccC
Q 004521 515 YEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQ-DMNPKISDFGLVRTFG 593 (747)
Q Consensus 515 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NIll~~-~~~~kl~DFGla~~~~ 593 (747)
+||+++++|.+++.........++..+..++.||+.||.|||+.+ |+||||||+||+++. ++.+||+|||++..+.
T Consensus 84 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~h~dl~p~nil~~~~~~~~~l~dfg~~~~~~ 160 (268)
T cd06624 84 MEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDNQ---IVHRDIKGDNVLVNTYSGVVKISDFGTSKRLA 160 (268)
T ss_pred EecCCCCCHHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEcCCCCeEEEecchhheecc
Confidence 999999999999965322212277888899999999999999988 999999999999986 6799999999987653
Q ss_pred CCCCccc-----cceeeec----cCCCCCccccchhHHHHHHHHHhCCCCCCCCCCcchhhhhHhHHhcCCcccccchhh
Q 004521 594 GDETEGN-----TNRVVGT----YDGQFSIKSDVFSFGILLLEIVSGKKNRGFYRSDTKVNLIGHLWDEGIPLRLIDACI 664 (747)
Q Consensus 594 ~~~~~~~-----~~~~~~~----~~~~~s~ksDVwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 664 (747)
....... ....... ....++.++|||||||++|||++|+.|+......... ....... ..... +
T Consensus 161 ~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~~~-~~~~~~~-~~~~~-----~ 233 (268)
T cd06624 161 GINPCTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQAA-MFKVGMF-KIHPE-----I 233 (268)
T ss_pred cCCCccccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccChhhh-Hhhhhhh-ccCCC-----C
Confidence 3211100 0000011 0134788999999999999999999997532211111 0000000 00011 1
Q ss_pred hccCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 004521 665 QDSCNLADVIRCIHIGLLCVQQHPEDRPCMPSVILM 700 (747)
Q Consensus 665 ~~~~~~~~~~~~~~l~~~Cl~~dP~~RPt~~~v~~~ 700 (747)
.. .....+..++.+||+.+|.+||++.+|++.
T Consensus 234 ~~----~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~ 265 (268)
T cd06624 234 PE----SLSAEAKNFILRCFEPDPDKRASAHDLLQD 265 (268)
T ss_pred Cc----ccCHHHHHHHHHHcCCCchhCCCHHHHHhC
Confidence 11 112335677889999999999999999763
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-33 Score=286.29 Aligned_cols=244 Identities=27% Similarity=0.475 Sum_probs=188.7
Q ss_pred cCCCccceecccCCeeEEEEEecCCcEEEEEEecccccccHHHHHHHHHHHhccCCCceeeEEeEEEeCCeeEEEEecCC
Q 004521 440 DNFSINNKLGEGGFGPVYKGTLVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMP 519 (747)
Q Consensus 440 ~~~~~~~~lg~G~fg~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~ 519 (747)
.+|++.+.||+|+||.||+|...+++.+|+|.+... ......|.+|++++++++||||+++++++......++||||++
T Consensus 4 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~k~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~ 82 (256)
T cd05112 4 SELTLVQEIGSGQFGLVWLGYWLEKRKVAIKTIREG-AMSEEDFIEEAQVMMKLSHPKLVQLYGVCTERSPICLVFEFME 82 (256)
T ss_pred hHeEEEeeecCcccceEEEEEEeCCCeEEEEECCCC-CCCHHHHHHHHHHHHhCCCCCeeeEEEEEccCCceEEEEEcCC
Confidence 467788999999999999999877889999998752 3345679999999999999999999999999999999999999
Q ss_pred CCChhhHhhhcCCCCcCChhHHHHHHHHHHHHHHHhhhcCCCceEecccCcCcEEEcCCCCceEecccCccccCCCCCcc
Q 004521 520 NKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEG 599 (747)
Q Consensus 520 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~ 599 (747)
+++|.+++... ...+++..+..++.+++.||+|||+.+ ++|+||||+||+++.++.+||+|||+++.........
T Consensus 83 ~~~L~~~~~~~--~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~~ 157 (256)
T cd05112 83 HGCLSDYLRAQ--RGKFSQETLLGMCLDVCEGMAYLESSN---VIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQYTS 157 (256)
T ss_pred CCcHHHHHHhC--ccCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccccceEEEcCCCeEEECCCcceeecccCcccc
Confidence 99999998643 235789999999999999999999988 9999999999999999999999999987654322111
Q ss_pred ccc------eeee--ccCCCCCccccchhHHHHHHHHHh-CCCCCCCCCCcchhhhhHhHHhcCCcccccchhhhccCCH
Q 004521 600 NTN------RVVG--TYDGQFSIKSDVFSFGILLLEIVS-GKKNRGFYRSDTKVNLIGHLWDEGIPLRLIDACIQDSCNL 670 (747)
Q Consensus 600 ~~~------~~~~--~~~~~~s~ksDVwS~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~ 670 (747)
... .... ...+.++.++||||||+++|||++ |+.|+.... ........ ..+... ..+..
T Consensus 158 ~~~~~~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~---~~~~~~~~-~~~~~~--~~~~~------ 225 (256)
T cd05112 158 STGTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRS---NSEVVETI-NAGFRL--YKPRL------ 225 (256)
T ss_pred cCCCccchhhcCHhHhccCCcChHHHHHHHHHHHHHHHcCCCCCCCcCC---HHHHHHHH-hCCCCC--CCCCC------
Confidence 000 0000 013567889999999999999998 888864322 11122211 111111 11111
Q ss_pred HHHHHHHHHHHhccCCCCCCCCCHHHHHHHhc
Q 004521 671 ADVIRCIHIGLLCVQQHPEDRPCMPSVILMLG 702 (747)
Q Consensus 671 ~~~~~~~~l~~~Cl~~dP~~RPt~~~v~~~L~ 702 (747)
....+.+|+.+||+.+|++||++.+++++|+
T Consensus 226 -~~~~~~~l~~~~l~~~p~~Rp~~~~~l~~l~ 256 (256)
T cd05112 226 -ASQSVYELMQHCWKERPEDRPSFSLLLHQLA 256 (256)
T ss_pred -CCHHHHHHHHHHcccChhhCCCHHHHHHhhC
Confidence 1234778899999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >KOG0589 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-33 Score=298.81 Aligned_cols=242 Identities=24% Similarity=0.359 Sum_probs=194.3
Q ss_pred cCCCccceecccCCeeEEEEEecC-CcEEEEEEecc--cccccHHHHHHHHHHHhccCCCceeeEEeEEEeCCe-eEEEE
Q 004521 440 DNFSINNKLGEGGFGPVYKGTLVD-GQEIAVKRLSK--ISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEE-KLLIY 515 (747)
Q Consensus 440 ~~~~~~~~lg~G~fg~Vy~~~~~~-g~~vavK~l~~--~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~-~~lV~ 515 (747)
++|...+++|+|+||.++..+++. ++.+++|.+.- ......+....|+.++++++|||||.+.+.++.++. .+|||
T Consensus 4 ~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~Ivm 83 (426)
T KOG0589|consen 4 DNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLCIVM 83 (426)
T ss_pred chhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchhcCCceEEEEE
Confidence 578889999999999999988754 77899999864 344455578899999999999999999999999988 89999
Q ss_pred ecCCCCChhhHhhhcCCCCcCChhHHHHHHHHHHHHHHHhhhcCCCceEecccCcCcEEEcCCCCceEecccCccccCCC
Q 004521 516 EFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGD 595 (747)
Q Consensus 516 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NIll~~~~~~kl~DFGla~~~~~~ 595 (747)
+|++||+|.+.|...+ ...++++.+..++.|++.|+.|||++. |+|||||+.||++..+..|||+|||+|+.+..+
T Consensus 84 ~Y~eGg~l~~~i~~~k-~~~f~E~~i~~~~~Q~~~av~ylH~~~---iLHRDlK~~Nifltk~~~VkLgDfGlaK~l~~~ 159 (426)
T KOG0589|consen 84 EYCEGGDLAQLIKEQK-GVLFPEERILKWFVQILLAVNYLHENR---VLHRDLKCANIFLTKDKKVKLGDFGLAKILNPE 159 (426)
T ss_pred eecCCCCHHHHHHHHh-hccccHHHHHHHHHHHHHHHHHHHhhh---hhcccchhhhhhccccCceeecchhhhhhcCCc
Confidence 9999999999997654 567899999999999999999999877 999999999999999999999999999998776
Q ss_pred CCccccceeeecc---------CCCCCccccchhHHHHHHHHHhCCCCCCCCCCcchhhhhHhHHhcCCcccccchhhhc
Q 004521 596 ETEGNTNRVVGTY---------DGQFSIKSDVFSFGILLLEIVSGKKNRGFYRSDTKVNLIGHLWDEGIPLRLIDACIQD 666 (747)
Q Consensus 596 ~~~~~~~~~~~~~---------~~~~s~ksDVwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 666 (747)
... ...+.|+. +.+|+.|+|||||||++|||++-+++|...+. ..++..+... ....+..
T Consensus 160 ~~~--a~tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~lk~aF~a~~m---~~Li~ki~~~-~~~Plp~----- 228 (426)
T KOG0589|consen 160 DSL--ASTVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMCTLKPAFKASNM---SELILKINRG-LYSPLPS----- 228 (426)
T ss_pred hhh--hheecCCCcccCHHHhCCCCCCccCcchhhcchHHHHHhcccccCccch---HHHHHHHhhc-cCCCCCc-----
Confidence 521 22244442 67899999999999999999999999753332 2333333222 1111111
Q ss_pred cCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 004521 667 SCNLADVIRCIHIGLLCVQQHPEDRPCMPSVILM 700 (747)
Q Consensus 667 ~~~~~~~~~~~~l~~~Cl~~dP~~RPt~~~v~~~ 700 (747)
....+ +..++..|++.+|..||++.+++.+
T Consensus 229 -~ys~e---l~~lv~~~l~~~P~~RPsa~~LL~~ 258 (426)
T KOG0589|consen 229 -MYSSE---LRSLVKSMLRKNPEHRPSALELLRR 258 (426)
T ss_pred -cccHH---HHHHHHHHhhcCCccCCCHHHHhhC
Confidence 11122 4445668999999999999999875
|
|
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-33 Score=304.66 Aligned_cols=184 Identities=20% Similarity=0.285 Sum_probs=152.6
Q ss_pred hcCCCccceecccCCeeEEEEEecC-CcEEEEEEecccccccHHHHHHHHHHHhccCCCceeeEEeEEEeCCeeEEEEec
Q 004521 439 TDNFSINNKLGEGGFGPVYKGTLVD-GQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEF 517 (747)
Q Consensus 439 ~~~~~~~~~lg~G~fg~Vy~~~~~~-g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~ 517 (747)
..+|++.+.||+|+||.||++.... ++.||+|.... ..+.+|++++++++||||+++++++......++|+|+
T Consensus 91 ~~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~~------~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~ 164 (391)
T PHA03212 91 KAGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQR------GGTATEAHILRAINHPSIIQLKGTFTYNKFTCLILPR 164 (391)
T ss_pred cCCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechhh------hhhHHHHHHHHhCCCCCCCCEeEEEEECCeeEEEEec
Confidence 3579999999999999999999754 88999997542 3567899999999999999999999999999999999
Q ss_pred CCCCChhhHhhhcCCCCcCChhHHHHHHHHHHHHHHHhhhcCCCceEecccCcCcEEEcCCCCceEecccCccccCCCCC
Q 004521 518 MPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDET 597 (747)
Q Consensus 518 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~ 597 (747)
+. ++|..++... ..+++.+++.++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++.......
T Consensus 165 ~~-~~L~~~l~~~---~~l~~~~~~~i~~qi~~aL~ylH~~~---IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~~~~~ 237 (391)
T PHA03212 165 YK-TDLYCYLAAK---RNIAICDILAIERSVLRAIQYLHENR---IIHRDIKAENIFINHPGDVCLGDFGAACFPVDINA 237 (391)
T ss_pred CC-CCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChHhEEEcCCCCEEEEeCCcccccccccc
Confidence 95 7888887542 34789999999999999999999988 99999999999999999999999999975322111
Q ss_pred ccccceeeec---------cCCCCCccccchhHHHHHHHHHhCCCCCC
Q 004521 598 EGNTNRVVGT---------YDGQFSIKSDVFSFGILLLEIVSGKKNRG 636 (747)
Q Consensus 598 ~~~~~~~~~~---------~~~~~s~ksDVwS~Gvvl~elltg~~p~~ 636 (747)
.. .....|+ ....++.++|||||||+||||++|+.|+.
T Consensus 238 ~~-~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~ 284 (391)
T PHA03212 238 NK-YYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLF 284 (391)
T ss_pred cc-cccccCccCCCChhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCcC
Confidence 00 0001111 14568999999999999999999998753
|
|
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-32 Score=285.63 Aligned_cols=239 Identities=33% Similarity=0.514 Sum_probs=182.7
Q ss_pred ceecccCCeeEEEEEecC----CcEEEEEEeccccc-ccHHHHHHHHHHHhccCCCceeeEEeEEEeCCeeEEEEecCCC
Q 004521 446 NKLGEGGFGPVYKGTLVD----GQEIAVKRLSKISE-QGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMPN 520 (747)
Q Consensus 446 ~~lg~G~fg~Vy~~~~~~----g~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~ 520 (747)
++||+|+||.||+|+... +..+|+|.+..... ...+++.+|+.+++++.|+||+++++++. .+..++||||+++
T Consensus 1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~v~e~~~~ 79 (257)
T cd05060 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLIGVCK-GEPLMLVMELAPL 79 (257)
T ss_pred CccCccCceeEEEeEeeccCCCcceEEEEecccccchHHHHHHHHHHHHHHhcCCCCeeeEEEEEc-CCceEEEEEeCCC
Confidence 479999999999997533 26899999875332 34568999999999999999999999876 4568999999999
Q ss_pred CChhhHhhhcCCCCcCChhHHHHHHHHHHHHHHHhhhcCCCceEecccCcCcEEEcCCCCceEecccCccccCCCCCccc
Q 004521 521 KSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGN 600 (747)
Q Consensus 521 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~ 600 (747)
++|.+++.... .+++..+..++.|++.||+|||..+ ++|+||||+|||++.++.+||+|||+++.+........
T Consensus 80 ~~L~~~l~~~~---~~~~~~~~~~~~qi~~~l~~lh~~~---i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~~~~~ 153 (257)
T cd05060 80 GPLLKYLKKRR---EIPVSDLKELAHQVAMGMAYLESKH---FVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYR 153 (257)
T ss_pred CcHHHHHHhCC---CCCHHHHHHHHHHHHHHHHHHhhcC---eeccCcccceEEEcCCCcEEeccccccceeecCCcccc
Confidence 99999996533 5889999999999999999999988 99999999999999999999999999987643332111
Q ss_pred cc--------eeeec--cCCCCCccccchhHHHHHHHHHh-CCCCCCCCCCcchhhhhHhHHhcCCcccccchhhhccCC
Q 004521 601 TN--------RVVGT--YDGQFSIKSDVFSFGILLLEIVS-GKKNRGFYRSDTKVNLIGHLWDEGIPLRLIDACIQDSCN 669 (747)
Q Consensus 601 ~~--------~~~~~--~~~~~s~ksDVwS~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~ 669 (747)
.. ...+. ....++.++|||||||++|||++ |..|+..... ....... ......... ...
T Consensus 154 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~~---~~~~~~~-~~~~~~~~~-----~~~- 223 (257)
T cd05060 154 ATTAGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKG---AEVIAML-ESGERLPRP-----EEC- 223 (257)
T ss_pred cccCccccccccCHHHhcCCCCCccchHHHHHHHHHHHHcCCCCCcccCCH---HHHHHHH-HcCCcCCCC-----CCC-
Confidence 00 00000 14568889999999999999998 8998753322 1222222 122111111 111
Q ss_pred HHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhcCC
Q 004521 670 LADVIRCIHIGLLCVQQHPEDRPCMPSVILMLGSE 704 (747)
Q Consensus 670 ~~~~~~~~~l~~~Cl~~dP~~RPt~~~v~~~L~~~ 704 (747)
...+.+++.+||+.+|++||++.+|+++|++.
T Consensus 224 ---~~~l~~li~~cl~~~p~~Rp~~~~l~~~l~~~ 255 (257)
T cd05060 224 ---PQEIYSIMLSCWKYRPEDRPTFSELESTFRRD 255 (257)
T ss_pred ---CHHHHHHHHHHhcCChhhCcCHHHHHHHHHhc
Confidence 13466788899999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-33 Score=296.85 Aligned_cols=234 Identities=23% Similarity=0.300 Sum_probs=176.9
Q ss_pred ceecccCCeeEEEEEec----CCcEEEEEEeccc----ccccHHHHHHHHHHHhccCCCceeeEEeEEEeCCeeEEEEec
Q 004521 446 NKLGEGGFGPVYKGTLV----DGQEIAVKRLSKI----SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEF 517 (747)
Q Consensus 446 ~~lg~G~fg~Vy~~~~~----~g~~vavK~l~~~----~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~ 517 (747)
+.||+|+||.||+++.. .++.||||.+++. .......+.+|+.+++.++||||+++++++..++..++||||
T Consensus 2 ~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~e~ 81 (323)
T cd05584 2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLILEY 81 (323)
T ss_pred ceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEEEeC
Confidence 68999999999999853 4789999998752 223345678999999999999999999999999999999999
Q ss_pred CCCCChhhHhhhcCCCCcCChhHHHHHHHHHHHHHHHhhhcCCCceEecccCcCcEEEcCCCCceEecccCccccCCCCC
Q 004521 518 MPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDET 597 (747)
Q Consensus 518 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~ 597 (747)
+++++|.+++.. ...+.+..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++.......
T Consensus 82 ~~~~~L~~~~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 155 (323)
T cd05584 82 LSGGELFMHLER---EGIFMEDTACFYLSEISLALEHLHQQG---IIYRDLKPENILLDAQGHVKLTDFGLCKESIHEGT 155 (323)
T ss_pred CCCchHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCCEEEeeCcCCeecccCCC
Confidence 999999999854 334778888899999999999999988 99999999999999999999999999875432221
Q ss_pred ccc-----cceeeec--cCCCCCccccchhHHHHHHHHHhCCCCCCCCCCcchhhhhHhHHhcCCcccccchhhhccCCH
Q 004521 598 EGN-----TNRVVGT--YDGQFSIKSDVFSFGILLLEIVSGKKNRGFYRSDTKVNLIGHLWDEGIPLRLIDACIQDSCNL 670 (747)
Q Consensus 598 ~~~-----~~~~~~~--~~~~~s~ksDVwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~ 670 (747)
... ....... ....++.++|||||||++|||++|+.||.... ....+..... +.. .+ ....
T Consensus 156 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~pf~~~~---~~~~~~~~~~-~~~-~~-----~~~~-- 223 (323)
T cd05584 156 VTHTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAEN---RKKTIDKILK-GKL-NL-----PPYL-- 223 (323)
T ss_pred cccccCCCccccChhhccCCCCCCcceecccHHHHHHHhcCCCCCCCCC---HHHHHHHHHc-CCC-CC-----CCCC--
Confidence 110 0000011 13457889999999999999999999975322 1122222211 111 11 1111
Q ss_pred HHHHHHHHHHHhccCCCCCCCC-----CHHHHHH
Q 004521 671 ADVIRCIHIGLLCVQQHPEDRP-----CMPSVIL 699 (747)
Q Consensus 671 ~~~~~~~~l~~~Cl~~dP~~RP-----t~~~v~~ 699 (747)
...+.+++.+||+.+|++|| ++.++++
T Consensus 224 --~~~~~~li~~~l~~~p~~R~~~~~~~~~~l~~ 255 (323)
T cd05584 224 --TPEARDLLKKLLKRNPSSRLGAGPGDAAEVQS 255 (323)
T ss_pred --CHHHHHHHHHHcccCHhHcCCCCCCCHHHHhc
Confidence 12355777899999999999 7888766
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-33 Score=290.80 Aligned_cols=251 Identities=28% Similarity=0.434 Sum_probs=189.5
Q ss_pred cCCCccceecccCCeeEEEEEec-----CCcEEEEEEecccccc-cHHHHHHHHHHHhccCCCceeeEEeEEEe--CCee
Q 004521 440 DNFSINNKLGEGGFGPVYKGTLV-----DGQEIAVKRLSKISEQ-GLKELKNEVILFSKLQHRNLVKLLGCCIQ--GEEK 511 (747)
Q Consensus 440 ~~~~~~~~lg~G~fg~Vy~~~~~-----~g~~vavK~l~~~~~~-~~~~~~~E~~~l~~l~H~niv~l~g~~~~--~~~~ 511 (747)
+.|++.+.||+|+||.||+|+.. .+..+|||.++..... ..+.|.+|+++++.++|+||+++++++.. ....
T Consensus 4 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~~~~ 83 (284)
T cd05038 4 RHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKYKGVCEKPGGRSL 83 (284)
T ss_pred hhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccchHHHHHHHHHHHHHHhCCCCChheEEeeeecCCCCce
Confidence 35777899999999999999864 2678999999764332 46789999999999999999999999987 5578
Q ss_pred EEEEecCCCCChhhHhhhcCCCCcCChhHHHHHHHHHHHHHHHhhhcCCCceEecccCcCcEEEcCCCCceEecccCccc
Q 004521 512 LLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRT 591 (747)
Q Consensus 512 ~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NIll~~~~~~kl~DFGla~~ 591 (747)
++||||+++++|.+++.... ..+++..+..++.|++.||+|||+.+ ++|+||||+||+++.++.+||+|||++..
T Consensus 84 ~lv~e~~~~~~l~~~l~~~~--~~~~~~~~~~~~~~l~~aL~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~ 158 (284)
T cd05038 84 RLIMEYLPSGSLRDYLQRHR--DQINLKRLLLFSSQICKGMDYLGSQR---YIHRDLAARNILVESEDLVKISDFGLAKV 158 (284)
T ss_pred EEEEecCCCCCHHHHHHhCc--cccCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHhEEEcCCCCEEEcccccccc
Confidence 99999999999999996533 24899999999999999999999988 99999999999999999999999999987
Q ss_pred cCCCCCccccc--------eeee--ccCCCCCccccchhHHHHHHHHHhCCCCCCCCCCcch-----------hhhhHhH
Q 004521 592 FGGDETEGNTN--------RVVG--TYDGQFSIKSDVFSFGILLLEIVSGKKNRGFYRSDTK-----------VNLIGHL 650 (747)
Q Consensus 592 ~~~~~~~~~~~--------~~~~--~~~~~~s~ksDVwS~Gvvl~elltg~~p~~~~~~~~~-----------~~~~~~~ 650 (747)
........... .... .....++.++||||||+++|||++|+.|+........ ...+...
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (284)
T cd05038 159 LPEDKDYYYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQMIVTRLLEL 238 (284)
T ss_pred cccCCcceeccCCCCCcccccCcHHHccCCCCcccchHHHhhhhheeeccCCCcccccchhccccccccccccHHHHHHH
Confidence 65322110000 0000 1145678899999999999999999988643211110 0000001
Q ss_pred HhcCCcccccchhhhccCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhcCC
Q 004521 651 WDEGIPLRLIDACIQDSCNLADVIRCIHIGLLCVQQHPEDRPCMPSVILMLGSE 704 (747)
Q Consensus 651 ~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dP~~RPt~~~v~~~L~~~ 704 (747)
....... .........+.+++.+||+.+|++||+|.+|+++|+..
T Consensus 239 ~~~~~~~---------~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~i 283 (284)
T cd05038 239 LKEGERL---------PRPPSCPDEVYDLMKLCWEAEPQDRPSFADLILIVDRL 283 (284)
T ss_pred HHcCCcC---------CCCccCCHHHHHHHHHHhccChhhCCCHHHHHHHHhhc
Confidence 1111100 00111124577889999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-33 Score=289.22 Aligned_cols=237 Identities=25% Similarity=0.377 Sum_probs=177.2
Q ss_pred ceecccCCeeEEEEEecC--------CcEEEEEEecccccccHHHHHHHHHHHhccCCCceeeEEeEEEeCCeeEEEEec
Q 004521 446 NKLGEGGFGPVYKGTLVD--------GQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEF 517 (747)
Q Consensus 446 ~~lg~G~fg~Vy~~~~~~--------g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~ 517 (747)
+.||+|+||.||+|.... ...+|+|.+........+++.+|+.+++.++||||+++++++..+...++||||
T Consensus 1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~ 80 (258)
T cd05078 1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMVQEY 80 (258)
T ss_pred CCCCcccchhheeeeecccccccccccchhhHHhhcchhHHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcEEEEec
Confidence 469999999999998643 234888888665455567889999999999999999999999999999999999
Q ss_pred CCCCChhhHhhhcCCCCcCChhHHHHHHHHHHHHHHHhhhcCCCceEecccCcCcEEEcCCCC--------ceEecccCc
Q 004521 518 MPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMN--------PKISDFGLV 589 (747)
Q Consensus 518 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NIll~~~~~--------~kl~DFGla 589 (747)
+++|+|..++.... ..+++..++.++.||+.||+|||+.+ |+||||||+||+++.++. +|++|||++
T Consensus 81 ~~~g~L~~~l~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~---iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g~~ 155 (258)
T cd05078 81 VKFGSLDTYLKKNK--NLINISWKLEVAKQLAWALHFLEDKG---LTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGIS 155 (258)
T ss_pred CCCCcHHHHHhcCC--CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCccceEEEecccccccCCCceEEecccccc
Confidence 99999999996533 35889999999999999999999988 999999999999987765 599999998
Q ss_pred cccCCCCCccccceeeec--c--CCCCCccccchhHHHHHHHHHhCC-CCCCCCCCcchhhhhHhHHhcCCcccccchhh
Q 004521 590 RTFGGDETEGNTNRVVGT--Y--DGQFSIKSDVFSFGILLLEIVSGK-KNRGFYRSDTKVNLIGHLWDEGIPLRLIDACI 664 (747)
Q Consensus 590 ~~~~~~~~~~~~~~~~~~--~--~~~~s~ksDVwS~Gvvl~elltg~-~p~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 664 (747)
.................+ . ...++.++|||||||++|||++|. .|+.... ...... .... ...+.
T Consensus 156 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~---~~~~~~-~~~~--~~~~~---- 225 (258)
T cd05078 156 ITVLPKEILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALD---SQKKLQ-FYED--RHQLP---- 225 (258)
T ss_pred cccCCchhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhcc---HHHHHH-HHHc--cccCC----
Confidence 765433221111111111 1 235788999999999999999995 4432211 111111 1111 01111
Q ss_pred hccCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhc
Q 004521 665 QDSCNLADVIRCIHIGLLCVQQHPEDRPCMPSVILMLG 702 (747)
Q Consensus 665 ~~~~~~~~~~~~~~l~~~Cl~~dP~~RPt~~~v~~~L~ 702 (747)
... ...+.+++.+||+.+|++|||+.+|++.|+
T Consensus 226 -~~~----~~~~~~li~~~l~~~p~~Rps~~~il~~l~ 258 (258)
T cd05078 226 -APK----WTELANLINQCMDYEPDFRPSFRAIIRDLN 258 (258)
T ss_pred -CCC----cHHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence 111 134667888999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-32 Score=288.49 Aligned_cols=245 Identities=26% Similarity=0.380 Sum_probs=184.1
Q ss_pred HhcCCCccceecccCCeeEEEEEecC-CcEEEEEEecccccccHHHHHHHHHHHhcc-CCCceeeEEeEEEeC------C
Q 004521 438 ATDNFSINNKLGEGGFGPVYKGTLVD-GQEIAVKRLSKISEQGLKELKNEVILFSKL-QHRNLVKLLGCCIQG------E 509 (747)
Q Consensus 438 ~~~~~~~~~~lg~G~fg~Vy~~~~~~-g~~vavK~l~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~------~ 509 (747)
+.+.|++.+.||+|+||.||+|...+ ++.||+|.+... ......+..|+.++.++ +|+||+++++++... .
T Consensus 4 ~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~-~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~ 82 (272)
T cd06637 4 PAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVT-GDEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDD 82 (272)
T ss_pred hhhhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcC-CccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCCCc
Confidence 45678889999999999999998754 789999998653 34456788999999998 799999999998763 4
Q ss_pred eeEEEEecCCCCChhhHhhhcCCCCcCChhHHHHHHHHHHHHHHHhhhcCCCceEecccCcCcEEEcCCCCceEecccCc
Q 004521 510 EKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLV 589 (747)
Q Consensus 510 ~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NIll~~~~~~kl~DFGla 589 (747)
..++||||+++++|.+++... ....+++..+..++.|++.||+|||+.+ |+|+||||+||++++++.+||+|||++
T Consensus 83 ~~~iv~e~~~~~~L~~~l~~~-~~~~l~~~~~~~~~~qi~~~l~~LH~~~---ivh~dl~~~nili~~~~~~~l~Dfg~~ 158 (272)
T cd06637 83 QLWLVMEFCGAGSVTDLIKNT-KGNTLKEEWIAYICREILRGLSHLHQHK---VIHRDIKGQNVLLTENAEVKLVDFGVS 158 (272)
T ss_pred EEEEEEEcCCCCcHHHHHHhc-cCCCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCCHHHEEECCCCCEEEccCCCc
Confidence 578999999999999998653 2345889999999999999999999988 999999999999999999999999999
Q ss_pred cccCCCCCccc----------cceeeec--cCCCCCccccchhHHHHHHHHHhCCCCCCCCCCcchhhhhHhHHhcCCcc
Q 004521 590 RTFGGDETEGN----------TNRVVGT--YDGQFSIKSDVFSFGILLLEIVSGKKNRGFYRSDTKVNLIGHLWDEGIPL 657 (747)
Q Consensus 590 ~~~~~~~~~~~----------~~~~~~~--~~~~~s~ksDVwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~ 657 (747)
+.......... ++...+. ....++.++|||||||++|||++|+.|+........ ........ ..
T Consensus 159 ~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~~~~---~~~~~~~~-~~ 234 (272)
T cd06637 159 AQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRA---LFLIPRNP-AP 234 (272)
T ss_pred eecccccccCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCHHHH---HHHHhcCC-CC
Confidence 76532211100 0000000 134678899999999999999999999753221111 11111111 11
Q ss_pred cccchhhhccCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 004521 658 RLIDACIQDSCNLADVIRCIHIGLLCVQQHPEDRPCMPSVIL 699 (747)
Q Consensus 658 ~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dP~~RPt~~~v~~ 699 (747)
...+. .. ...+.+++.+||+.+|.+||++.+|++
T Consensus 235 ~~~~~----~~----~~~~~~li~~~l~~~p~~Rpt~~~il~ 268 (272)
T cd06637 235 RLKSK----KW----SKKFQSFIESCLVKNHSQRPTTEQLMK 268 (272)
T ss_pred CCCCC----Cc----CHHHHHHHHHHcCCChhhCCCHHHHhh
Confidence 11111 11 123567888999999999999999875
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-32 Score=283.83 Aligned_cols=241 Identities=34% Similarity=0.538 Sum_probs=186.9
Q ss_pred ceecccCCeeEEEEEecC----CcEEEEEEecccccc-cHHHHHHHHHHHhccCCCceeeEEeEEEeCCeeEEEEecCCC
Q 004521 446 NKLGEGGFGPVYKGTLVD----GQEIAVKRLSKISEQ-GLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMPN 520 (747)
Q Consensus 446 ~~lg~G~fg~Vy~~~~~~----g~~vavK~l~~~~~~-~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~ 520 (747)
+.||+|+||.||+|.... +..+|+|.+...... ..+.+.+|++++..++|+||+++++++......++||||+++
T Consensus 1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (262)
T cd00192 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYMEG 80 (262)
T ss_pred CccccCCceEEEEEEEecCCCCCceEEeEeeccccchhHHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEEeccC
Confidence 479999999999999754 789999999764333 367899999999999999999999999999999999999999
Q ss_pred CChhhHhhhcCC------CCcCChhHHHHHHHHHHHHHHHhhhcCCCceEecccCcCcEEEcCCCCceEecccCccccCC
Q 004521 521 KSLDSFIFDQTR------RTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGG 594 (747)
Q Consensus 521 gsL~~~l~~~~~------~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NIll~~~~~~kl~DFGla~~~~~ 594 (747)
++|.+++..... ...+++..+..++.|++.||+|||+.+ ++||||||+||++++++.+||+|||.++....
T Consensus 81 ~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~di~p~nili~~~~~~~l~dfg~~~~~~~ 157 (262)
T cd00192 81 GDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASKK---FVHRDLAARNCLVGEDLVVKISDFGLSRDVYD 157 (262)
T ss_pred CcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcCC---cccCccCcceEEECCCCcEEEccccccccccc
Confidence 999999976421 356899999999999999999999988 99999999999999999999999999987754
Q ss_pred CCCcccccee------eec---cCCCCCccccchhHHHHHHHHHh-CCCCCCCCCCcchhhhhHhHHhcCCcccccchhh
Q 004521 595 DETEGNTNRV------VGT---YDGQFSIKSDVFSFGILLLEIVS-GKKNRGFYRSDTKVNLIGHLWDEGIPLRLIDACI 664 (747)
Q Consensus 595 ~~~~~~~~~~------~~~---~~~~~s~ksDVwS~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 664 (747)
.......... ..+ ....++.++||||||+++|||++ |..|+.... ........ ..+.......
T Consensus 158 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~---~~~~~~~~-~~~~~~~~~~--- 230 (262)
T cd00192 158 DDYYRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLS---NEEVLEYL-RKGYRLPKPE--- 230 (262)
T ss_pred ccccccccCCCcCccccCHHHhccCCcchhhccHHHHHHHHHHHhcCCCCCCCCC---HHHHHHHH-HcCCCCCCCc---
Confidence 3210000000 000 13468899999999999999999 588865432 11222222 1121111111
Q ss_pred hccCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhc
Q 004521 665 QDSCNLADVIRCIHIGLLCVQQHPEDRPCMPSVILMLG 702 (747)
Q Consensus 665 ~~~~~~~~~~~~~~l~~~Cl~~dP~~RPt~~~v~~~L~ 702 (747)
.. ...+.+++.+||+.+|.+||++.++++.|+
T Consensus 231 --~~----~~~~~~li~~~l~~~p~~Rps~~~l~~~l~ 262 (262)
T cd00192 231 --YC----PDELYELMLSCWQLDPEDRPTFSELVERLE 262 (262)
T ss_pred --cC----ChHHHHHHHHHccCCcccCcCHHHHHHhhC
Confidence 11 234667888999999999999999999874
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-33 Score=288.62 Aligned_cols=243 Identities=29% Similarity=0.453 Sum_probs=181.6
Q ss_pred ceecccCCeeEEEEEecC-Cc--EEEEEEeccc-ccccHHHHHHHHHHHhcc-CCCceeeEEeEEEeCCeeEEEEecCCC
Q 004521 446 NKLGEGGFGPVYKGTLVD-GQ--EIAVKRLSKI-SEQGLKELKNEVILFSKL-QHRNLVKLLGCCIQGEEKLLIYEFMPN 520 (747)
Q Consensus 446 ~~lg~G~fg~Vy~~~~~~-g~--~vavK~l~~~-~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lV~E~~~~ 520 (747)
+.||+|+||.||+|++.+ +. .+|+|.++.. .....+.+.+|+.++.++ +||||+++++++...+..++||||+++
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 80 (270)
T cd05047 1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPH 80 (270)
T ss_pred CcCCCCCCceEEEEEEcCCCCeeEEEEEEccccCCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEeCCC
Confidence 368999999999999855 43 5788888753 334556889999999999 899999999999999999999999999
Q ss_pred CChhhHhhhcC-------------CCCcCChhHHHHHHHHHHHHHHHhhhcCCCceEecccCcCcEEEcCCCCceEeccc
Q 004521 521 KSLDSFIFDQT-------------RRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFG 587 (747)
Q Consensus 521 gsL~~~l~~~~-------------~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NIll~~~~~~kl~DFG 587 (747)
|+|.+++.... ....+++.++..++.|++.||+|||+.+ ++||||||+||++++++.+||+|||
T Consensus 81 ~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~~---i~H~dikp~nili~~~~~~kl~dfg 157 (270)
T cd05047 81 GNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYVAKIADFG 157 (270)
T ss_pred CcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccccceEEEcCCCeEEECCCC
Confidence 99999986532 1234788999999999999999999987 9999999999999999999999999
Q ss_pred CccccCCCCCcccc----ceeeec--cCCCCCccccchhHHHHHHHHHh-CCCCCCCCCCcchhhhhHhHHhcCCccccc
Q 004521 588 LVRTFGGDETEGNT----NRVVGT--YDGQFSIKSDVFSFGILLLEIVS-GKKNRGFYRSDTKVNLIGHLWDEGIPLRLI 660 (747)
Q Consensus 588 la~~~~~~~~~~~~----~~~~~~--~~~~~s~ksDVwS~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 660 (747)
+++........... ...... ....++.++|||||||++|||++ |..||.... ........ ..+......
T Consensus 158 l~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~---~~~~~~~~-~~~~~~~~~ 233 (270)
T cd05047 158 LSRGQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMT---CAELYEKL-PQGYRLEKP 233 (270)
T ss_pred CccccchhhhccCCCCccccCChHHHccCCCCchhhHHHHHHHHHHHHcCCCCCccccC---HHHHHHHH-hCCCCCCCC
Confidence 98632211100000 000011 14567889999999999999997 888864221 11111111 111111111
Q ss_pred chhhhccCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhcCC
Q 004521 661 DACIQDSCNLADVIRCIHIGLLCVQQHPEDRPCMPSVILMLGSE 704 (747)
Q Consensus 661 d~~l~~~~~~~~~~~~~~l~~~Cl~~dP~~RPt~~~v~~~L~~~ 704 (747)
.. ....+.+++.+||+.+|.+||++.++++.|+..
T Consensus 234 -----~~----~~~~~~~li~~~l~~~p~~Rps~~~il~~l~~~ 268 (270)
T cd05047 234 -----LN----CDDEVYDLMRQCWREKPYERPSFAQILVSLNRM 268 (270)
T ss_pred -----Cc----CCHHHHHHHHHHcccChhhCCCHHHHHHHHHHh
Confidence 11 112366888899999999999999999999764
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-32 Score=296.71 Aligned_cols=231 Identities=21% Similarity=0.320 Sum_probs=173.4
Q ss_pred ceecccCCeeEEEEEecC-CcEEEEEEeccc---ccccHHHHHHHHHHHhcc-CCCceeeEEeEEEeCCeeEEEEecCCC
Q 004521 446 NKLGEGGFGPVYKGTLVD-GQEIAVKRLSKI---SEQGLKELKNEVILFSKL-QHRNLVKLLGCCIQGEEKLLIYEFMPN 520 (747)
Q Consensus 446 ~~lg~G~fg~Vy~~~~~~-g~~vavK~l~~~---~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lV~E~~~~ 520 (747)
+.||+|+||.||+|+... ++.+|+|.+++. .....+.+.+|+.++.++ +||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~~ 80 (329)
T cd05618 1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNG 80 (329)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCCCC
Confidence 479999999999999754 789999999753 233455678899988876 899999999999999999999999999
Q ss_pred CChhhHhhhcCCCCcCChhHHHHHHHHHHHHHHHhhhcCCCceEecccCcCcEEEcCCCCceEecccCccccCCCCCccc
Q 004521 521 KSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGN 600 (747)
Q Consensus 521 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~ 600 (747)
|+|..++... ..+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++.........
T Consensus 81 ~~L~~~~~~~---~~l~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~~~~~~- 153 (329)
T cd05618 81 GDLMFHMQRQ---RKLPEEHARFYSAEISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTT- 153 (329)
T ss_pred CCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEECCCCCEEEeeCCccccccCCCCcc-
Confidence 9999888542 35889999999999999999999988 9999999999999999999999999987542211110
Q ss_pred cceeeec---------cCCCCCccccchhHHHHHHHHHhCCCCCCCCCCcch-----hhhhHhHHhcCCcccccchhhhc
Q 004521 601 TNRVVGT---------YDGQFSIKSDVFSFGILLLEIVSGKKNRGFYRSDTK-----VNLIGHLWDEGIPLRLIDACIQD 666 (747)
Q Consensus 601 ~~~~~~~---------~~~~~s~ksDVwS~Gvvl~elltg~~p~~~~~~~~~-----~~~~~~~~~~~~~~~~~d~~l~~ 666 (747)
....|+ .+..++.++|||||||++|||++|+.||........ ...+........ ..+ ..
T Consensus 154 -~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~-~~~-----p~ 226 (329)
T cd05618 154 -STFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQ-IRI-----PR 226 (329)
T ss_pred -ccccCCccccCHHHHcCCCCCCccceecccHHHHHHhhCCCCCccCCCcCCcccccHHHHHHHHhcCC-CCC-----CC
Confidence 001111 145678899999999999999999999853221111 111111111111 111 11
Q ss_pred cCCHHHHHHHHHHHHhccCCCCCCCCCH
Q 004521 667 SCNLADVIRCIHIGLLCVQQHPEDRPCM 694 (747)
Q Consensus 667 ~~~~~~~~~~~~l~~~Cl~~dP~~RPt~ 694 (747)
.. ...+.+++.+||+.||.+||+.
T Consensus 227 ~~----~~~~~~ll~~~L~~dP~~R~~~ 250 (329)
T cd05618 227 SL----SVKAASVLKSFLNKDPKERLGC 250 (329)
T ss_pred CC----CHHHHHHHHHHhcCCHHHcCCC
Confidence 11 1235577789999999999983
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-32 Score=294.98 Aligned_cols=233 Identities=20% Similarity=0.291 Sum_probs=177.7
Q ss_pred ceecccCCeeEEEEEecC-CcEEEEEEeccc---ccccHHHHHHHHHHHhcc-CCCceeeEEeEEEeCCeeEEEEecCCC
Q 004521 446 NKLGEGGFGPVYKGTLVD-GQEIAVKRLSKI---SEQGLKELKNEVILFSKL-QHRNLVKLLGCCIQGEEKLLIYEFMPN 520 (747)
Q Consensus 446 ~~lg~G~fg~Vy~~~~~~-g~~vavK~l~~~---~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lV~E~~~~ 520 (747)
+.||+|+||.||+|+... ++.||||++++. .....+.+..|.+++..+ +||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~ 80 (321)
T cd05591 1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVNG 80 (321)
T ss_pred CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCCCC
Confidence 469999999999999765 789999998753 234456678899998866 799999999999999999999999999
Q ss_pred CChhhHhhhcCCCCcCChhHHHHHHHHHHHHHHHhhhcCCCceEecccCcCcEEEcCCCCceEecccCccccCCCCCccc
Q 004521 521 KSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGN 600 (747)
Q Consensus 521 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~ 600 (747)
|+|..++... ..+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++.........
T Consensus 81 ~~L~~~l~~~---~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~~~~~~- 153 (321)
T cd05591 81 GDLMFQIQRS---RKFDEPRSRFYAAEVTLALMFLHRHG---VIYRDLKLDNILLDAEGHCKLADFGMCKEGILNGVTT- 153 (321)
T ss_pred CcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEEeecccceecccCCccc-
Confidence 9999888543 34888999999999999999999988 9999999999999999999999999987542221111
Q ss_pred cceeeec---------cCCCCCccccchhHHHHHHHHHhCCCCCCCCCCcchhhhhHhHHhcCCcccccchhhhccCCHH
Q 004521 601 TNRVVGT---------YDGQFSIKSDVFSFGILLLEIVSGKKNRGFYRSDTKVNLIGHLWDEGIPLRLIDACIQDSCNLA 671 (747)
Q Consensus 601 ~~~~~~~---------~~~~~s~ksDVwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~ 671 (747)
....++ ....++.++|||||||++|||++|+.||.... .............. .....+
T Consensus 154 -~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~---~~~~~~~i~~~~~~-------~p~~~~-- 220 (321)
T cd05591 154 -TTFCGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADN---EDDLFESILHDDVL-------YPVWLS-- 220 (321)
T ss_pred -cccccCccccCHHHHcCCCCCCccceechhHHHHHHhcCCCCCCCCC---HHHHHHHHHcCCCC-------CCCCCC--
Confidence 011111 14568899999999999999999999975332 22222222221110 000011
Q ss_pred HHHHHHHHHHhccCCCCCCCC-------CHHHHHHH
Q 004521 672 DVIRCIHIGLLCVQQHPEDRP-------CMPSVILM 700 (747)
Q Consensus 672 ~~~~~~~l~~~Cl~~dP~~RP-------t~~~v~~~ 700 (747)
..+.+++.+||+.||++|| ++.++++.
T Consensus 221 --~~~~~ll~~~L~~dp~~R~~~~~~~~~~~~~~~h 254 (321)
T cd05591 221 --KEAVSILKAFMTKNPNKRLGCVASQGGEDAIKQH 254 (321)
T ss_pred --HHHHHHHHHHhccCHHHcCCCCCCCCCHHHHhcC
Confidence 2355677799999999999 77777654
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-32 Score=287.95 Aligned_cols=243 Identities=23% Similarity=0.314 Sum_probs=182.4
Q ss_pred cCCCccceecccCCeeEEEEEec-CCcEEEEEEeccc-ccccHHHHHHHHHHHhccCCCceeeEEeEEEeCCeeEEEEec
Q 004521 440 DNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKI-SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEF 517 (747)
Q Consensus 440 ~~~~~~~~lg~G~fg~Vy~~~~~-~g~~vavK~l~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~ 517 (747)
++|++.+.||+|+||.||+|+.. +++.||+|.+... .....+++.+|++++++++||||+++++++...+..++||||
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 80 (279)
T cd06619 1 QDIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAFFVENRISICTEF 80 (279)
T ss_pred CcchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCCChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCEEEEEEec
Confidence 35778899999999999999864 5889999998653 334456799999999999999999999999999999999999
Q ss_pred CCCCChhhHhhhcCCCCcCChhHHHHHHHHHHHHHHHhhhcCCCceEecccCcCcEEEcCCCCceEecccCccccCCCCC
Q 004521 518 MPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDET 597 (747)
Q Consensus 518 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~ 597 (747)
+++++|..+. .+++..+..++.|++.||.|||+.+ |+|+||||+|||++.++.+||+|||++..+.....
T Consensus 81 ~~~~~l~~~~-------~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~~~~ 150 (279)
T cd06619 81 MDGGSLDVYR-------KIPEHVLGRIAVAVVKGLTYLWSLK---ILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNSIA 150 (279)
T ss_pred CCCCChHHhh-------cCCHHHHHHHHHHHHHHHHHHHHCC---EeeCCCCHHHEEECCCCCEEEeeCCcceecccccc
Confidence 9999997553 3678888999999999999999988 99999999999999999999999999976543221
Q ss_pred ccc--c-ceeee--ccCCCCCccccchhHHHHHHHHHhCCCCCCCCCCcchhhh---hHhHHhcCCcccccchhhhccCC
Q 004521 598 EGN--T-NRVVG--TYDGQFSIKSDVFSFGILLLEIVSGKKNRGFYRSDTKVNL---IGHLWDEGIPLRLIDACIQDSCN 669 (747)
Q Consensus 598 ~~~--~-~~~~~--~~~~~~s~ksDVwS~Gvvl~elltg~~p~~~~~~~~~~~~---~~~~~~~~~~~~~~d~~l~~~~~ 669 (747)
... + ..... .....++.++||||||+++|||++|+.|+........... ............+.. ..
T Consensus 151 ~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~-- 224 (279)
T cd06619 151 KTYVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCIVDEDPPVLPV----GQ-- 224 (279)
T ss_pred cCCCCChhhcCceeecCCCCCCcchHHHHHHHHHHHHhCCCCchhhcccccccchHHHHHHHhccCCCCCCC----Cc--
Confidence 110 0 00001 1145688999999999999999999999754322111100 001111111111100 01
Q ss_pred HHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 004521 670 LADVIRCIHIGLLCVQQHPEDRPCMPSVILM 700 (747)
Q Consensus 670 ~~~~~~~~~l~~~Cl~~dP~~RPt~~~v~~~ 700 (747)
....+.+++.+|++.+|.+||++.++++.
T Consensus 225 --~~~~~~~li~~~l~~~P~~Rp~~~eil~~ 253 (279)
T cd06619 225 --FSEKFVHFITQCMRKQPKERPAPENLMDH 253 (279)
T ss_pred --CCHHHHHHHHHHhhCChhhCCCHHHHhcC
Confidence 11235678889999999999999998864
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-32 Score=283.38 Aligned_cols=239 Identities=29% Similarity=0.450 Sum_probs=184.3
Q ss_pred ceecccCCeeEEEEEecCCcEEEEEEeccccc-ccHHHHHHHHHHHhccCCCceeeEEeEEEeCCeeEEEEecCCCCChh
Q 004521 446 NKLGEGGFGPVYKGTLVDGQEIAVKRLSKISE-QGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMPNKSLD 524 (747)
Q Consensus 446 ~~lg~G~fg~Vy~~~~~~g~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gsL~ 524 (747)
++||+|+||.||++...+++.||+|.++.... ...+.+.+|++++++++|+||+++++++......++||||+++++|.
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~l~ 80 (251)
T cd05041 1 EKIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGGSLL 80 (251)
T ss_pred CccccCCCceEEEEEEeCCCcEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEcCCCCcHH
Confidence 47999999999999987799999999875333 35568999999999999999999999999999999999999999999
Q ss_pred hHhhhcCCCCcCChhHHHHHHHHHHHHHHHhhhcCCCceEecccCcCcEEEcCCCCceEecccCccccCCCCCccccc--
Q 004521 525 SFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNTN-- 602 (747)
Q Consensus 525 ~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~-- 602 (747)
+++... ...+++..+..++.+++.||.|||+++ ++||||||+||+++.++.+||+|||+++............
T Consensus 81 ~~l~~~--~~~~~~~~~~~~~~~~~~~l~~lH~~~---i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~ 155 (251)
T cd05041 81 TFLRKK--KNRLTVKKLLQMSLDAAAGMEYLESKN---CIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLK 155 (251)
T ss_pred HHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHhCC---EehhhcCcceEEEcCCCcEEEeeccccccccCCcceeccccC
Confidence 998653 235788999999999999999999988 9999999999999999999999999998654211111100
Q ss_pred -----eeeec--cCCCCCccccchhHHHHHHHHHh-CCCCCCCCCCcchhhhhHhHHhcCCcccccchhhhccCCHHHHH
Q 004521 603 -----RVVGT--YDGQFSIKSDVFSFGILLLEIVS-GKKNRGFYRSDTKVNLIGHLWDEGIPLRLIDACIQDSCNLADVI 674 (747)
Q Consensus 603 -----~~~~~--~~~~~s~ksDVwS~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~ 674 (747)
..... ..+.++.++|||||||++|||++ |..|+....... .... .......... . ....
T Consensus 156 ~~~~~y~~PE~~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~~~---~~~~-~~~~~~~~~~-----~----~~~~ 222 (251)
T cd05041 156 QIPIKWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGMSNQQ---TRER-IESGYRMPAP-----Q----LCPE 222 (251)
T ss_pred cceeccCChHhhccCCCCcchhHHHHHHHHHHHHhccCCCCccCCHHH---HHHH-HhcCCCCCCC-----c----cCCH
Confidence 00000 14568899999999999999999 777764332211 1111 1111111110 0 1123
Q ss_pred HHHHHHHhccCCCCCCCCCHHHHHHHhc
Q 004521 675 RCIHIGLLCVQQHPEDRPCMPSVILMLG 702 (747)
Q Consensus 675 ~~~~l~~~Cl~~dP~~RPt~~~v~~~L~ 702 (747)
.+.+++.+||+.+|.+||++.+|++.|+
T Consensus 223 ~~~~li~~~l~~~p~~Rp~~~ell~~l~ 250 (251)
T cd05041 223 EIYRLMLQCWAYDPENRPSFSEIYNELQ 250 (251)
T ss_pred HHHHHHHHHhccChhhCcCHHHHHHHhh
Confidence 4677888999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-33 Score=298.29 Aligned_cols=233 Identities=21% Similarity=0.254 Sum_probs=178.0
Q ss_pred ceecccCCeeEEEEEec-CCcEEEEEEeccc---ccccHHHHHHHHHHHhccCCCceeeEEeEEEeCCeeEEEEecCCCC
Q 004521 446 NKLGEGGFGPVYKGTLV-DGQEIAVKRLSKI---SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMPNK 521 (747)
Q Consensus 446 ~~lg~G~fg~Vy~~~~~-~g~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~g 521 (747)
+.||+|+||.||+++.. +++.||+|.+++. .......+.+|+++++.++||||+++++++...+..++||||+++|
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (325)
T cd05594 1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (325)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeCCCCC
Confidence 46999999999999875 4889999999752 2334567788999999999999999999999999999999999999
Q ss_pred ChhhHhhhcCCCCcCChhHHHHHHHHHHHHHHHhhh-cCCCceEecccCcCcEEEcCCCCceEecccCccccCCCCCccc
Q 004521 522 SLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQ-DSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGN 600 (747)
Q Consensus 522 sL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~-~~~~~iiHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~ 600 (747)
+|..++.. ...+++..+..++.||+.||+|||+ .+ |+||||||+|||++.++.+||+|||+++..........
T Consensus 81 ~L~~~l~~---~~~l~~~~~~~~~~qi~~aL~~lH~~~~---ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~ 154 (325)
T cd05594 81 ELFFHLSR---ERVFSEDRARFYGAEIVSALDYLHSEKN---VVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMK 154 (325)
T ss_pred cHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhcCC---EEecCCCCCeEEECCCCCEEEecCCCCeecCCCCcccc
Confidence 99988854 2358899999999999999999997 56 99999999999999999999999999875432211110
Q ss_pred cceeeec---------cCCCCCccccchhHHHHHHHHHhCCCCCCCCCCcchhhhhHhHHhcCCcccccchhhhccCCHH
Q 004521 601 TNRVVGT---------YDGQFSIKSDVFSFGILLLEIVSGKKNRGFYRSDTKVNLIGHLWDEGIPLRLIDACIQDSCNLA 671 (747)
Q Consensus 601 ~~~~~~~---------~~~~~s~ksDVwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~ 671 (747)
...++ .+..++.++|||||||+||||++|+.||..... ............ .+ ....+
T Consensus 155 --~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tG~~Pf~~~~~---~~~~~~i~~~~~--~~-----p~~~~-- 220 (325)
T cd05594 155 --TFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH---EKLFELILMEEI--RF-----PRTLS-- 220 (325)
T ss_pred --cccCCcccCCHHHHccCCCCCccccccccceeeeeccCCCCCCCCCH---HHHHHHHhcCCC--CC-----CCCCC--
Confidence 01111 145788999999999999999999999753221 111111111110 01 11111
Q ss_pred HHHHHHHHHHhccCCCCCCCC-----CHHHHHHH
Q 004521 672 DVIRCIHIGLLCVQQHPEDRP-----CMPSVILM 700 (747)
Q Consensus 672 ~~~~~~~l~~~Cl~~dP~~RP-----t~~~v~~~ 700 (747)
..+.+++.+||+.||++|| ++.++++.
T Consensus 221 --~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h 252 (325)
T cd05594 221 --PEAKSLLSGLLKKDPKQRLGGGPDDAKEIMQH 252 (325)
T ss_pred --HHHHHHHHHHhhcCHHHhCCCCCCCHHHHhcC
Confidence 2345677799999999996 89998754
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-32 Score=296.33 Aligned_cols=236 Identities=20% Similarity=0.306 Sum_probs=177.5
Q ss_pred ceecccCCeeEEEEEecC-CcEEEEEEeccc---ccccHHHHHHHHHHHhcc-CCCceeeEEeEEEeCCeeEEEEecCCC
Q 004521 446 NKLGEGGFGPVYKGTLVD-GQEIAVKRLSKI---SEQGLKELKNEVILFSKL-QHRNLVKLLGCCIQGEEKLLIYEFMPN 520 (747)
Q Consensus 446 ~~lg~G~fg~Vy~~~~~~-g~~vavK~l~~~---~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lV~E~~~~ 520 (747)
+.||+|+||.||+++... ++.||||++++. .....+.+..|..++.++ +||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (329)
T cd05588 1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVSG 80 (329)
T ss_pred CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCCCC
Confidence 479999999999999754 889999999752 233456688999999998 799999999999999999999999999
Q ss_pred CChhhHhhhcCCCCcCChhHHHHHHHHHHHHHHHhhhcCCCceEecccCcCcEEEcCCCCceEecccCccccCCCCCccc
Q 004521 521 KSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGN 600 (747)
Q Consensus 521 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~ 600 (747)
|+|..++... ..+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++.........
T Consensus 81 g~L~~~~~~~---~~l~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~~~~~- 153 (329)
T cd05588 81 GDLMFHMQRQ---RKLPEEHARFYSAEISLALNFLHERG---IIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPGDTT- 153 (329)
T ss_pred CCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEECCCCCEEECcCccccccccCCCcc-
Confidence 9999888542 35899999999999999999999988 9999999999999999999999999987532111110
Q ss_pred cceeeec---------cCCCCCccccchhHHHHHHHHHhCCCCCCCCCCcc-----hhhhhHhHHhcCCcccccchhhhc
Q 004521 601 TNRVVGT---------YDGQFSIKSDVFSFGILLLEIVSGKKNRGFYRSDT-----KVNLIGHLWDEGIPLRLIDACIQD 666 (747)
Q Consensus 601 ~~~~~~~---------~~~~~s~ksDVwS~Gvvl~elltg~~p~~~~~~~~-----~~~~~~~~~~~~~~~~~~d~~l~~ 666 (747)
....|+ .+..++.++|||||||++|||++|+.||....... ....+........ ..+ ..
T Consensus 154 -~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~-~~~-----p~ 226 (329)
T cd05588 154 -STFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVILEKQ-IRI-----PR 226 (329)
T ss_pred -ccccCCccccCHHHHcCCCCCCccceechHHHHHHHHHCCCCcccccccccccccchHHHHHHHHcCC-CCC-----CC
Confidence 011111 14568899999999999999999999986432111 1111111111111 111 11
Q ss_pred cCCHHHHHHHHHHHHhccCCCCCCCCC------HHHHHH
Q 004521 667 SCNLADVIRCIHIGLLCVQQHPEDRPC------MPSVIL 699 (747)
Q Consensus 667 ~~~~~~~~~~~~l~~~Cl~~dP~~RPt------~~~v~~ 699 (747)
..+ ..+.+++.+||+.||.+||+ +.++++
T Consensus 227 ~~~----~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~ 261 (329)
T cd05588 227 SLS----VKASSVLKGFLNKDPKERLGCHPQTGFRDIKS 261 (329)
T ss_pred CCC----HHHHHHHHHHhccCHHHcCCCCCCCCHHHHhc
Confidence 111 23566778999999999997 566664
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-33 Score=310.25 Aligned_cols=253 Identities=18% Similarity=0.262 Sum_probs=176.7
Q ss_pred hcCCCccceecccCCeeEEEEEecC-CcEEEEEEecccccccHHHHHHHHHHHhccCCCceeeEEeEEEeC--------C
Q 004521 439 TDNFSINNKLGEGGFGPVYKGTLVD-GQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQG--------E 509 (747)
Q Consensus 439 ~~~~~~~~~lg~G~fg~Vy~~~~~~-g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~--------~ 509 (747)
.++|.+.+.||+|+||.||+|...+ ++.||||++.... ....+|+.+++.++||||+++++++... .
T Consensus 65 ~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~----~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~~~~ 140 (440)
T PTZ00036 65 NKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP----QYKNRELLIMKNLNHINIIFLKDYYYTECFKKNEKNI 140 (440)
T ss_pred CCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCc----chHHHHHHHHHhcCCCCCcceeeeEeecccccCCCce
Confidence 4679999999999999999999754 8899999885421 2345799999999999999999887432 1
Q ss_pred eeEEEEecCCCCChhhHhhhc-CCCCcCChhHHHHHHHHHHHHHHHhhhcCCCceEecccCcCcEEEcCCC-CceEeccc
Q 004521 510 EKLLIYEFMPNKSLDSFIFDQ-TRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDM-NPKISDFG 587 (747)
Q Consensus 510 ~~~lV~E~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NIll~~~~-~~kl~DFG 587 (747)
..++||||++ ++|.+++... .....+++..+..++.||+.||+|||+.+ |+||||||+||||+.++ .+||+|||
T Consensus 141 ~l~lvmE~~~-~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~~---IiHrDLKp~NILl~~~~~~vkL~DFG 216 (440)
T PTZ00036 141 FLNVVMEFIP-QTVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSKF---ICHRDLKPQNLLIDPNTHTLKLCDFG 216 (440)
T ss_pred EEEEEEecCC-ccHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCcCHHHEEEcCCCCceeeeccc
Confidence 3568999998 4677766432 23456889999999999999999999988 99999999999999665 79999999
Q ss_pred CccccCCCCCccc----cceeeec-c--CCCCCccccchhHHHHHHHHHhCCCCCCCCCCcchhhhhHhHHhcCC-----
Q 004521 588 LVRTFGGDETEGN----TNRVVGT-Y--DGQFSIKSDVFSFGILLLEIVSGKKNRGFYRSDTKVNLIGHLWDEGI----- 655 (747)
Q Consensus 588 la~~~~~~~~~~~----~~~~~~~-~--~~~~s~ksDVwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~----- 655 (747)
+|+.+........ .....+. . ...++.++|||||||+||||++|..||...........+........
T Consensus 217 la~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~p~~~~~~ 296 (440)
T PTZ00036 217 SAKNLLAGQRSVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQLVRIIQVLGTPTEDQLK 296 (440)
T ss_pred cchhccCCCCcccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHH
Confidence 9987643221110 0001111 1 23688999999999999999999999754322111111111110000
Q ss_pred ----------cccccchhhhccCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 004521 656 ----------PLRLIDACIQDSCNLADVIRCIHIGLLCVQQHPEDRPCMPSVIL 699 (747)
Q Consensus 656 ----------~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dP~~RPt~~~v~~ 699 (747)
...+....+...........+.+++.+||+.||.+|||+.|+++
T Consensus 297 ~~~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~ 350 (440)
T PTZ00036 297 EMNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALA 350 (440)
T ss_pred HhchhhhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHhC
Confidence 00000000000000011234677888999999999999999975
|
|
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-32 Score=285.12 Aligned_cols=245 Identities=21% Similarity=0.368 Sum_probs=175.9
Q ss_pred ceecccCCeeEEEEEecCC---cEEEEEEecccc-cccHHHHHHHHHHHhccCCCceeeEEeEEEeCCeeEEEEecCCCC
Q 004521 446 NKLGEGGFGPVYKGTLVDG---QEIAVKRLSKIS-EQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMPNK 521 (747)
Q Consensus 446 ~~lg~G~fg~Vy~~~~~~g---~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~g 521 (747)
++||+|+||.||+|...++ ..+++|.+.... ....+.|.+|+.+++.++||||+++++.+......++||||+++|
T Consensus 1 ~~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~ 80 (268)
T cd05086 1 QEIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYCELG 80 (268)
T ss_pred CcCCCCcCceEEEEEEEcCCCcceEEEEEecCCCChHHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEecCCCC
Confidence 3699999999999986443 356677766432 344678999999999999999999999999999999999999999
Q ss_pred ChhhHhhhcCC-CCcCChhHHHHHHHHHHHHHHHhhhcCCCceEecccCcCcEEEcCCCCceEecccCccccCCCCCc--
Q 004521 522 SLDSFIFDQTR-RTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETE-- 598 (747)
Q Consensus 522 sL~~~l~~~~~-~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~-- 598 (747)
+|.+++..... ...+++..+..++.||++||+|||+.+ ++||||||+|||++.++.+||+|||++.........
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~---i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~ 157 (268)
T cd05086 81 DLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKHN---FLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIET 157 (268)
T ss_pred cHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCC---eeccCCccceEEEcCCccEEecccccccccCcchhhhc
Confidence 99999965422 234667778899999999999999988 999999999999999999999999998643211100
Q ss_pred -----ccc----ceeee-----ccCCCCCccccchhHHHHHHHHHhC-CCCCCCCCCcchhhhhHhHHhcCCcccccchh
Q 004521 599 -----GNT----NRVVG-----TYDGQFSIKSDVFSFGILLLEIVSG-KKNRGFYRSDTKVNLIGHLWDEGIPLRLIDAC 663 (747)
Q Consensus 599 -----~~~----~~~~~-----~~~~~~s~ksDVwS~Gvvl~elltg-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 663 (747)
... ..... .....++.++|||||||++|||+++ ..|+... .....+.....+. ...+.++.
T Consensus 158 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~---~~~~~~~~~~~~~-~~~~~~~~ 233 (268)
T cd05086 158 EDDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHL---SDREVLNHVIKDQ-QVKLFKPQ 233 (268)
T ss_pred ccCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCC---CHHHHHHHHHhhc-ccccCCCc
Confidence 000 00000 0123457899999999999999985 5564322 2222233322222 22233333
Q ss_pred hhccCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhc
Q 004521 664 IQDSCNLADVIRCIHIGLLCVQQHPEDRPCMPSVILMLG 702 (747)
Q Consensus 664 l~~~~~~~~~~~~~~l~~~Cl~~dP~~RPt~~~v~~~L~ 702 (747)
+..... .++.+++..|| .+|.+||++.+|++.|.
T Consensus 234 ~~~~~~----~~~~~l~~~c~-~~P~~Rp~~~~i~~~l~ 267 (268)
T cd05086 234 LELPYS----ERWYEVLQFCW-LSPEKRATAEEVHRLLT 267 (268)
T ss_pred cCCCCc----HHHHHHHHHHh-hCcccCCCHHHHHHHhc
Confidence 322222 23445666899 57999999999999885
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-32 Score=286.09 Aligned_cols=249 Identities=27% Similarity=0.417 Sum_probs=188.2
Q ss_pred cCCCccceecccCCeeEEEEEecC------CcEEEEEEecccccc-cHHHHHHHHHHHhccCCCceeeEEeEEEeCCeeE
Q 004521 440 DNFSINNKLGEGGFGPVYKGTLVD------GQEIAVKRLSKISEQ-GLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKL 512 (747)
Q Consensus 440 ~~~~~~~~lg~G~fg~Vy~~~~~~------g~~vavK~l~~~~~~-~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~ 512 (747)
++|++.+.||+|+||.||+|+... .+.|++|.+...... ..+++.+|++++++++|+||+++++++.+....+
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 84 (275)
T cd05046 5 SNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVRLLGLCREAEPHY 84 (275)
T ss_pred HhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCccchHHHHHHHHHHHHHHhcCCcceeeeEEEECCCCcce
Confidence 578889999999999999998642 467999988653333 4578999999999999999999999999999999
Q ss_pred EEEecCCCCChhhHhhhcCCC------CcCChhHHHHHHHHHHHHHHHhhhcCCCceEecccCcCcEEEcCCCCceEecc
Q 004521 513 LIYEFMPNKSLDSFIFDQTRR------TLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDF 586 (747)
Q Consensus 513 lV~E~~~~gsL~~~l~~~~~~------~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NIll~~~~~~kl~DF 586 (747)
+||||+++++|.+++...... ..+++..+..++.|++.||+|||+.+ |+||||||+||+++.++.+||+||
T Consensus 85 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~---i~H~dlkp~Nili~~~~~~~l~~~ 161 (275)
T cd05046 85 MILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNAR---FVHRDLAARNCLVSSQREVKVSLL 161 (275)
T ss_pred EEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhcC---cccCcCccceEEEeCCCcEEEccc
Confidence 999999999999999654422 25899999999999999999999988 999999999999999999999999
Q ss_pred cCccccCCCCCccccce-----ee-ec--cCCCCCccccchhHHHHHHHHHh-CCCCCCCCCCcchhhhhHhHHhcCCcc
Q 004521 587 GLVRTFGGDETEGNTNR-----VV-GT--YDGQFSIKSDVFSFGILLLEIVS-GKKNRGFYRSDTKVNLIGHLWDEGIPL 657 (747)
Q Consensus 587 Gla~~~~~~~~~~~~~~-----~~-~~--~~~~~s~ksDVwS~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~ 657 (747)
|+++............. .. .. ....++.++||||||+++|||++ |..|+..... ...... ...+...
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~~~~~p~~~~~~---~~~~~~-~~~~~~~ 237 (275)
T cd05046 162 SLSKDVYNSEYYKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSD---EEVLNR-LQAGKLE 237 (275)
T ss_pred ccccccCcccccccCCceeEEeecChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCccccch---HHHHHH-HHcCCcC
Confidence 99875432221110000 00 00 13557889999999999999999 6777642211 111111 1111111
Q ss_pred cccchhhhccCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhcC
Q 004521 658 RLIDACIQDSCNLADVIRCIHIGLLCVQQHPEDRPCMPSVILMLGS 703 (747)
Q Consensus 658 ~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dP~~RPt~~~v~~~L~~ 703 (747)
... .... ...+.+++.+||+.+|.+||++.+++++|..
T Consensus 238 ~~~----~~~~----~~~l~~~i~~~l~~~p~~Rp~~~~~l~~l~~ 275 (275)
T cd05046 238 LPV----PEGC----PSRLYKLMTRCWAVNPKDRPSFSELVSALGE 275 (275)
T ss_pred CCC----CCCC----CHHHHHHHHHHcCCCcccCCCHHHHHHHhcC
Confidence 110 1111 1246678889999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-32 Score=283.08 Aligned_cols=243 Identities=28% Similarity=0.466 Sum_probs=185.5
Q ss_pred cCCCccceecccCCeeEEEEEecCCcEEEEEEecccccccHHHHHHHHHHHhccCCCceeeEEeEEEeCCeeEEEEecCC
Q 004521 440 DNFSINNKLGEGGFGPVYKGTLVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMP 519 (747)
Q Consensus 440 ~~~~~~~~lg~G~fg~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~ 519 (747)
++|++.+.||+|+||.||++.. .++.+|+|.++.. ...+.+.+|+.++++++||||+++++++... ..++||||++
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~-~~~~~~iK~~~~~--~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~~v~e~~~ 81 (254)
T cd05083 6 QKLTLGEIIGEGEFGAVLQGEY-TGQKVAVKNIKCD--VTAQAFLEETAVMTKLHHKNLVRLLGVILHN-GLYIVMELMS 81 (254)
T ss_pred HHceeeeeeccCCCCceEeccc-CCCceEEEeecCc--chHHHHHHHHHHHHhCCCCCcCeEEEEEcCC-CcEEEEECCC
Confidence 4688899999999999999975 6788999998642 2346789999999999999999999998754 4799999999
Q ss_pred CCChhhHhhhcCCCCcCChhHHHHHHHHHHHHHHHhhhcCCCceEecccCcCcEEEcCCCCceEecccCccccCCCCCcc
Q 004521 520 NKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEG 599 (747)
Q Consensus 520 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~ 599 (747)
+++|.+++.... ...+++..++.++.|++.||.|||+.+ ++||||||+||+++.++.+||+|||+++.........
T Consensus 82 ~~~L~~~l~~~~-~~~~~~~~~~~~~~qi~~al~~lH~~~---~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~~~~~~~ 157 (254)
T cd05083 82 KGNLVNFLRTRG-RALVSVIQLLQFSLDVAEGMEYLESKK---LVHRDLAARNILVSEDGVAKVSDFGLARVGSMGVDNS 157 (254)
T ss_pred CCCHHHHHHhcC-cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccCcceEEEcCCCcEEECCCccceeccccCCCC
Confidence 999999996543 335789999999999999999999988 9999999999999999999999999987643221111
Q ss_pred cc--ceeeec--cCCCCCccccchhHHHHHHHHHh-CCCCCCCCCCcchhhhhHhHHhcCCcccccchhhhccCCHHHHH
Q 004521 600 NT--NRVVGT--YDGQFSIKSDVFSFGILLLEIVS-GKKNRGFYRSDTKVNLIGHLWDEGIPLRLIDACIQDSCNLADVI 674 (747)
Q Consensus 600 ~~--~~~~~~--~~~~~s~ksDVwS~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~ 674 (747)
.. ...... ..+.++.++|||||||++|||++ |+.|+..... .... .....+......+ .. ..
T Consensus 158 ~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~---~~~~-~~~~~~~~~~~~~-----~~----~~ 224 (254)
T cd05083 158 KLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSL---KEVK-ECVEKGYRMEPPE-----GC----PA 224 (254)
T ss_pred CCCceecCHHHhccCCcCchhhHHHHHHHHHHHHhCCCCCCccCCH---HHHH-HHHhCCCCCCCCC-----cC----CH
Confidence 00 000111 14678889999999999999998 8888643221 1111 1122222111111 11 23
Q ss_pred HHHHHHHhccCCCCCCCCCHHHHHHHhcC
Q 004521 675 RCIHIGLLCVQQHPEDRPCMPSVILMLGS 703 (747)
Q Consensus 675 ~~~~l~~~Cl~~dP~~RPt~~~v~~~L~~ 703 (747)
.+.+++.+||+.+|++||++.+|++.|+.
T Consensus 225 ~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 253 (254)
T cd05083 225 DVYVLMTSCWETEPKKRPSFHKLREKLEK 253 (254)
T ss_pred HHHHHHHHHcCCChhhCcCHHHHHHHHcc
Confidence 45678889999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-32 Score=287.79 Aligned_cols=243 Identities=25% Similarity=0.360 Sum_probs=184.7
Q ss_pred CCccceecccCCeeEEEEEecC-CcEEEEEEecccccccHHHHHHHHHHHhccCCCceeeEEeEEEeCCeeEEEEecCCC
Q 004521 442 FSINNKLGEGGFGPVYKGTLVD-GQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMPN 520 (747)
Q Consensus 442 ~~~~~~lg~G~fg~Vy~~~~~~-g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~ 520 (747)
|++.+.||+|+||.||+|.... +..+++|.+........+.+.+|+++++.++||||+++++++..++..++||||+++
T Consensus 7 ~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~v~e~~~~ 86 (282)
T cd06643 7 WEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAG 86 (282)
T ss_pred HHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCCCHHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEEEEEEecCC
Confidence 5677899999999999999865 778899998765555667899999999999999999999999999999999999999
Q ss_pred CChhhHhhhcCCCCcCChhHHHHHHHHHHHHHHHhhhcCCCceEecccCcCcEEEcCCCCceEecccCccccCCCCCcc-
Q 004521 521 KSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEG- 599 (747)
Q Consensus 521 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~- 599 (747)
++|..++... ...+++..+..++.|+++||.|||+.+ ++||||||+||+++.++.+||+|||+++.........
T Consensus 87 ~~l~~~~~~~--~~~l~~~~~~~~~~qi~~~L~~LH~~~---i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~~~~~ 161 (282)
T cd06643 87 GAVDAVMLEL--ERPLTEPQIRVVCKQTLEALNYLHENK---IIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRD 161 (282)
T ss_pred CcHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCcccEEEccCCCEEEccccccccccccccccc
Confidence 9999887542 345899999999999999999999988 9999999999999999999999999987653221110
Q ss_pred ----ccceeeec-------cCCCCCccccchhHHHHHHHHHhCCCCCCCCCCcchhhhhHhHHhcCCcccccchhhhccC
Q 004521 600 ----NTNRVVGT-------YDGQFSIKSDVFSFGILLLEIVSGKKNRGFYRSDTKVNLIGHLWDEGIPLRLIDACIQDSC 668 (747)
Q Consensus 600 ----~~~~~~~~-------~~~~~s~ksDVwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~ 668 (747)
......+. ....++.++|||||||++|||++|+.|+..... ......... .....+..+ ...
T Consensus 162 ~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~---~~~~~~~~~-~~~~~~~~~---~~~ 234 (282)
T cd06643 162 SFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNP---MRVLLKIAK-SEPPTLAQP---SRW 234 (282)
T ss_pred cccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCH---HHHHHHHhh-cCCCCCCCc---ccc
Confidence 00000000 134577899999999999999999999653321 111111111 111111111 011
Q ss_pred CHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 004521 669 NLADVIRCIHIGLLCVQQHPEDRPCMPSVILM 700 (747)
Q Consensus 669 ~~~~~~~~~~l~~~Cl~~dP~~RPt~~~v~~~ 700 (747)
...+.+++.+||+.+|.+||++.++++.
T Consensus 235 ----~~~~~~li~~~l~~~p~~Rp~~~~il~~ 262 (282)
T cd06643 235 ----SSEFKDFLKKCLEKNVDARWTTTQLLQH 262 (282)
T ss_pred ----CHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 1235678889999999999999988654
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-32 Score=285.43 Aligned_cols=246 Identities=20% Similarity=0.346 Sum_probs=188.8
Q ss_pred cCCCccceecccCCeeEEEEEecC-CcEEEEEEecccccccHHHHHHHHHHHhccCCCceeeEEeEEEeCCeeEEEEecC
Q 004521 440 DNFSINNKLGEGGFGPVYKGTLVD-GQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFM 518 (747)
Q Consensus 440 ~~~~~~~~lg~G~fg~Vy~~~~~~-g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~ 518 (747)
++|++.+.||+|+||.||+|.... ++.+++|.+........+.+.+|+.++++++||||+++++++......+++|||+
T Consensus 3 ~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l~~e~~ 82 (262)
T cd06613 3 EDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWIVMEYC 82 (262)
T ss_pred cceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCchhhHHHHHHHHHHHHhCCCCChhceEEEEEeCCEEEEEEeCC
Confidence 578889999999999999999754 7889999997655556788999999999999999999999999999999999999
Q ss_pred CCCChhhHhhhcCCCCcCChhHHHHHHHHHHHHHHHhhhcCCCceEecccCcCcEEEcCCCCceEecccCccccCCCCCc
Q 004521 519 PNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETE 598 (747)
Q Consensus 519 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~ 598 (747)
++++|.+++... ...+++.++..++.|++.||.|||+.+ |+|+||||+||++++++.+||+|||++.........
T Consensus 83 ~~~~l~~~~~~~--~~~l~~~~~~~~~~ql~~~l~~lh~~~---i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~ 157 (262)
T cd06613 83 GGGSLQDIYQVT--RGPLSELQIAYVCRETLKGLAYLHETG---KIHRDIKGANILLTEDGDVKLADFGVSAQLTATIAK 157 (262)
T ss_pred CCCcHHHHHHhh--ccCCCHHHHHHHHHHHHHHHHHHHhCC---ceecCCChhhEEECCCCCEEECccccchhhhhhhhc
Confidence 999999988653 245889999999999999999999988 999999999999999999999999998765432111
Q ss_pred c----------ccceeeeccCCCCCccccchhHHHHHHHHHhCCCCCCCCCCcchhhhhHhHHhcCCcccccchhhhccC
Q 004521 599 G----------NTNRVVGTYDGQFSIKSDVFSFGILLLEIVSGKKNRGFYRSDTKVNLIGHLWDEGIPLRLIDACIQDSC 668 (747)
Q Consensus 599 ~----------~~~~~~~~~~~~~s~ksDVwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~ 668 (747)
. .++...+.....++.++||||||+++|||++|+.|+........ ............. +. .
T Consensus 158 ~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~~~---~~~~~~~~~~~~~----~~--~ 228 (262)
T cd06613 158 RKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMRA---LFLISKSNFPPPK----LK--D 228 (262)
T ss_pred cccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHHHH---HHHHHhccCCCcc----cc--c
Confidence 0 00000011123678899999999999999999999753321111 1111111111100 00 0
Q ss_pred CHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 004521 669 NLADVIRCIHIGLLCVQQHPEDRPCMPSVIL 699 (747)
Q Consensus 669 ~~~~~~~~~~l~~~Cl~~dP~~RPt~~~v~~ 699 (747)
.......+.+++.+||+.+|.+||++.+|+.
T Consensus 229 ~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~ 259 (262)
T cd06613 229 KEKWSPVFHDFIKKCLTKDPKKRPTATKLLQ 259 (262)
T ss_pred hhhhhHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 1112234677888999999999999999975
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-32 Score=289.97 Aligned_cols=232 Identities=24% Similarity=0.302 Sum_probs=173.6
Q ss_pred ceecccCCeeEEEEEecC-CcEEEEEEeccc---ccccHHHHHHHHHHHhc-cCCCceeeEEeEEEeCCeeEEEEecCCC
Q 004521 446 NKLGEGGFGPVYKGTLVD-GQEIAVKRLSKI---SEQGLKELKNEVILFSK-LQHRNLVKLLGCCIQGEEKLLIYEFMPN 520 (747)
Q Consensus 446 ~~lg~G~fg~Vy~~~~~~-g~~vavK~l~~~---~~~~~~~~~~E~~~l~~-l~H~niv~l~g~~~~~~~~~lV~E~~~~ 520 (747)
+.||+|+||.||+|+..+ ++.||||.++.. .....+.+..|..++.. .+||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~g 80 (316)
T cd05592 1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 469999999999999765 789999999752 22344556667777765 4899999999999999999999999999
Q ss_pred CChhhHhhhcCCCCcCChhHHHHHHHHHHHHHHHhhhcCCCceEecccCcCcEEEcCCCCceEecccCccccCCCCCccc
Q 004521 521 KSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGN 600 (747)
Q Consensus 521 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~ 600 (747)
|+|..++... ..+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++.........
T Consensus 81 g~L~~~~~~~---~~~~~~~~~~~~~qi~~al~~LH~~~---ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~~~- 153 (316)
T cd05592 81 GDLMFHIQSS---GRFDEARARFYAAEIICGLQFLHKKG---IIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGEGKA- 153 (316)
T ss_pred CcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---EEeCCCCHHHeEECCCCCEEEccCcCCeECCCCCCcc-
Confidence 9999988543 34888999999999999999999988 9999999999999999999999999998643222111
Q ss_pred cceeeec---------cCCCCCccccchhHHHHHHHHHhCCCCCCCCCCcchhhhhHhHHhcCCcccccchhhhccCCHH
Q 004521 601 TNRVVGT---------YDGQFSIKSDVFSFGILLLEIVSGKKNRGFYRSDTKVNLIGHLWDEGIPLRLIDACIQDSCNLA 671 (747)
Q Consensus 601 ~~~~~~~---------~~~~~s~ksDVwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~ 671 (747)
....|+ .+..++.++|||||||++|||++|+.||.... .......... .. .. +....+
T Consensus 154 -~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~Pf~~~~---~~~~~~~i~~-~~-~~-----~~~~~~-- 220 (316)
T cd05592 154 -STFCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGED---EDELFDSILN-DR-PH-----FPRWIS-- 220 (316)
T ss_pred -ccccCCccccCHHHHcCCCCCCcccchhHHHHHHHHHhCCCCCCCCC---HHHHHHHHHc-CC-CC-----CCCCCC--
Confidence 111111 14568899999999999999999999975332 1222222111 11 00 011111
Q ss_pred HHHHHHHHHHhccCCCCCCCCCHH-HHHH
Q 004521 672 DVIRCIHIGLLCVQQHPEDRPCMP-SVIL 699 (747)
Q Consensus 672 ~~~~~~~l~~~Cl~~dP~~RPt~~-~v~~ 699 (747)
..+.+++.+||+.+|.+||++. ++++
T Consensus 221 --~~~~~ll~~~l~~~P~~R~~~~~~l~~ 247 (316)
T cd05592 221 --KEAKDCLSKLFERDPTKRLGVDGDIRQ 247 (316)
T ss_pred --HHHHHHHHHHccCCHHHcCCChHHHHc
Confidence 2245677799999999999976 4543
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-32 Score=288.10 Aligned_cols=244 Identities=27% Similarity=0.382 Sum_probs=186.7
Q ss_pred cCCCccceecccCCeeEEEEEecC-CcEEEEEEecccccccHHHHHHHHHHHhccCCCceeeEEeEEEeCCeeEEEEecC
Q 004521 440 DNFSINNKLGEGGFGPVYKGTLVD-GQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFM 518 (747)
Q Consensus 440 ~~~~~~~~lg~G~fg~Vy~~~~~~-g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~ 518 (747)
+.|++.++||+|+||.||+|+... ++.+++|.+........+.+.+|+.+++.++|+||+++++++..+...++||||+
T Consensus 12 ~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 91 (292)
T cd06644 12 EVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFYWDGKLWIMIEFC 91 (292)
T ss_pred hhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccCCHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCCeEEEEEecC
Confidence 568889999999999999999865 8899999998766666778999999999999999999999999999999999999
Q ss_pred CCCChhhHhhhcCCCCcCChhHHHHHHHHHHHHHHHhhhcCCCceEecccCcCcEEEcCCCCceEecccCccccCCCCCc
Q 004521 519 PNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETE 598 (747)
Q Consensus 519 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~ 598 (747)
++++|..++.... ..+++..+..++.|++.||.|||+.+ ++||||||+||+++.++.+||+|||++.........
T Consensus 92 ~~~~l~~~~~~~~--~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~~~ 166 (292)
T cd06644 92 PGGAVDAIMLELD--RGLTEPQIQVICRQMLEALQYLHSMK---IIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKTLQR 166 (292)
T ss_pred CCCcHHHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHhcCC---eeecCCCcceEEEcCCCCEEEccCccceeccccccc
Confidence 9999988875432 35889999999999999999999987 999999999999999999999999998754322111
Q ss_pred ----------cccceeeec--cCCCCCccccchhHHHHHHHHHhCCCCCCCCCCcchhhhhHhHHhcCCcccccchhhhc
Q 004521 599 ----------GNTNRVVGT--YDGQFSIKSDVFSFGILLLEIVSGKKNRGFYRSDTKVNLIGHLWDEGIPLRLIDACIQD 666 (747)
Q Consensus 599 ----------~~~~~~~~~--~~~~~s~ksDVwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 666 (747)
..++...+. ....++.++|||||||++|||++|+.|+...... ...... .......... ..
T Consensus 167 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~---~~~~~~-~~~~~~~~~~---~~ 239 (292)
T cd06644 167 RDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPM---RVLLKI-AKSEPPTLSQ---PS 239 (292)
T ss_pred cceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccHH---HHHHHH-hcCCCccCCC---Cc
Confidence 001111000 1345688999999999999999999997533211 111111 1111111110 00
Q ss_pred cCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 004521 667 SCNLADVIRCIHIGLLCVQQHPEDRPCMPSVIL 699 (747)
Q Consensus 667 ~~~~~~~~~~~~l~~~Cl~~dP~~RPt~~~v~~ 699 (747)
.....+.+++.+||+.+|++||++.+|++
T Consensus 240 ----~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 268 (292)
T cd06644 240 ----KWSMEFRDFLKTALDKHPETRPSAAQLLE 268 (292)
T ss_pred ----ccCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence 11123567788999999999999999875
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-32 Score=286.75 Aligned_cols=255 Identities=22% Similarity=0.300 Sum_probs=185.9
Q ss_pred cCCCccceecccCCeeEEEEEecC-CcEEEEEEecccc--cccHHHHHHHHHHHhccCCCceeeEEeEEEeCCeeEEEEe
Q 004521 440 DNFSINNKLGEGGFGPVYKGTLVD-GQEIAVKRLSKIS--EQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYE 516 (747)
Q Consensus 440 ~~~~~~~~lg~G~fg~Vy~~~~~~-g~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E 516 (747)
++|++.+.||+|+||.||+|+... ++.||+|++.... ....+.+.+|+.++++++|+||+++++++......++|||
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e 80 (286)
T cd07847 1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFRRKRKLHLVFE 80 (286)
T ss_pred CceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCEEEEEEe
Confidence 468888999999999999999864 8999999986432 2344678899999999999999999999999999999999
Q ss_pred cCCCCChhhHhhhcCCCCcCChhHHHHHHHHHHHHHHHhhhcCCCceEecccCcCcEEEcCCCCceEecccCccccCCCC
Q 004521 517 FMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDE 596 (747)
Q Consensus 517 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~ 596 (747)
|++++.|..++.. ...+++..+..++.|++.||+|||+.+ ++||||||+||+++.++.+||+|||++..+....
T Consensus 81 ~~~~~~l~~~~~~---~~~~~~~~~~~~~~ql~~~l~~LH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~ 154 (286)
T cd07847 81 YCDHTVLNELEKN---PRGVPEHLIKKIIWQTLQAVNFCHKHN---CIHRDVKPENILITKQGQIKLCDFGFARILTGPG 154 (286)
T ss_pred ccCccHHHHHHhC---CCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCChhhEEEcCCCcEEECccccceecCCCc
Confidence 9999988877643 234899999999999999999999988 9999999999999999999999999998764432
Q ss_pred Ccc----ccceeeec--c--CCCCCccccchhHHHHHHHHHhCCCCCCCCCCcchhhhhHhHHhc------------CCc
Q 004521 597 TEG----NTNRVVGT--Y--DGQFSIKSDVFSFGILLLEIVSGKKNRGFYRSDTKVNLIGHLWDE------------GIP 656 (747)
Q Consensus 597 ~~~----~~~~~~~~--~--~~~~s~ksDVwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~------------~~~ 656 (747)
... .......+ . ...++.++|||||||++|||++|+.||...........+...... ...
T Consensus 155 ~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (286)
T cd07847 155 DDYTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDLIPRHQQIFSTNQFF 234 (286)
T ss_pred ccccCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChHHhhhccccccc
Confidence 110 00000000 1 245788999999999999999999997533322111111110000 000
Q ss_pred ccccchhhhccCCHH-----HHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 004521 657 LRLIDACIQDSCNLA-----DVIRCIHIGLLCVQQHPEDRPCMPSVILM 700 (747)
Q Consensus 657 ~~~~d~~l~~~~~~~-----~~~~~~~l~~~Cl~~dP~~RPt~~~v~~~ 700 (747)
.....+........+ ....+.+++.+||+.+|++||++.+++.+
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~ 283 (286)
T cd07847 235 KGLSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLEH 283 (286)
T ss_pred ccccCCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhcC
Confidence 000000000000111 12346678889999999999999998753
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-32 Score=284.55 Aligned_cols=241 Identities=29% Similarity=0.455 Sum_probs=177.6
Q ss_pred ceecccCCeeEEEEEecC----CcEEEEEEeccc-ccccHHHHHHHHHHHhccCCCceeeEEeEEEe-CCeeEEEEecCC
Q 004521 446 NKLGEGGFGPVYKGTLVD----GQEIAVKRLSKI-SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQ-GEEKLLIYEFMP 519 (747)
Q Consensus 446 ~~lg~G~fg~Vy~~~~~~----g~~vavK~l~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~-~~~~~lV~E~~~ 519 (747)
+.||+|+||.||+|...+ ...+|+|++... .....+.+.+|+.+++.++||||+++++++.. +...++||||++
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~~ 80 (262)
T cd05058 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPYMK 80 (262)
T ss_pred CcccccCCceEEEEEEecCCCceEEEEEEecCccCCHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEecCC
Confidence 468999999999998642 357999998642 23446788899999999999999999998764 456789999999
Q ss_pred CCChhhHhhhcCCCCcCChhHHHHHHHHHHHHHHHhhhcCCCceEecccCcCcEEEcCCCCceEecccCccccCCCCCcc
Q 004521 520 NKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEG 599 (747)
Q Consensus 520 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~ 599 (747)
+++|.+++.... ..+.+..+..++.|+++||.|||+.+ ++||||||+|||++.++.+||+|||+++.+.......
T Consensus 81 ~~~L~~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~~~~ 155 (262)
T cd05058 81 HGDLRNFIRSET--HNPTVKDLIGFGLQVAKGMEYLASKK---FVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYS 155 (262)
T ss_pred CCCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccCcceEEEcCCCcEEECCccccccccCCccee
Confidence 999999996532 33677888999999999999999987 9999999999999999999999999997653321100
Q ss_pred c--------c-ceeeec--cCCCCCccccchhHHHHHHHHHhCCC-CCCCCCCcchhhhhHhHHhcCCcccccchhhhcc
Q 004521 600 N--------T-NRVVGT--YDGQFSIKSDVFSFGILLLEIVSGKK-NRGFYRSDTKVNLIGHLWDEGIPLRLIDACIQDS 667 (747)
Q Consensus 600 ~--------~-~~~~~~--~~~~~s~ksDVwS~Gvvl~elltg~~-p~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~ 667 (747)
. + ...... ....++.++|||||||++|||++|.. |+.. ........... .+...... ..
T Consensus 156 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~---~~~~~~~~~~~-~~~~~~~~-----~~ 226 (262)
T cd05058 156 VHNHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPD---VDSFDITVYLL-QGRRLLQP-----EY 226 (262)
T ss_pred ecccccCcCCccccChhHhccCccchHHHHHHHHHHHHHHHcCCCCCCCC---CCHHHHHHHHh-cCCCCCCC-----Cc
Confidence 0 0 000011 14567889999999999999999654 4322 11112222221 11111110 00
Q ss_pred CCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhcCC
Q 004521 668 CNLADVIRCIHIGLLCVQQHPEDRPCMPSVILMLGSE 704 (747)
Q Consensus 668 ~~~~~~~~~~~l~~~Cl~~dP~~RPt~~~v~~~L~~~ 704 (747)
. ...+.+++.+||+.+|++||++.+|++.|+..
T Consensus 227 ~----~~~~~~li~~cl~~~p~~Rp~~~~il~~l~~~ 259 (262)
T cd05058 227 C----PDPLYEVMLSCWHPKPEMRPTFSELVSRIEQI 259 (262)
T ss_pred C----CHHHHHHHHHHcCCChhhCCCHHHHHHHHHHH
Confidence 1 12466788899999999999999999999764
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-32 Score=291.21 Aligned_cols=243 Identities=22% Similarity=0.372 Sum_probs=186.7
Q ss_pred hcCCCccceecccCCeeEEEEEec-CCcEEEEEEecccccccHHHHHHHHHHHhccCCCceeeEEeEEEeCCeeEEEEec
Q 004521 439 TDNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEF 517 (747)
Q Consensus 439 ~~~~~~~~~lg~G~fg~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~ 517 (747)
..+|++.+.||+|+||.||+|... +++.||+|.+........+.+.+|+.+++.++|+||+++++++..++..++||||
T Consensus 18 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~ 97 (297)
T cd06656 18 KKKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEY 97 (297)
T ss_pred hhhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCEEEEeecc
Confidence 368999999999999999999964 5899999999764445567788999999999999999999999999999999999
Q ss_pred CCCCChhhHhhhcCCCCcCChhHHHHHHHHHHHHHHHhhhcCCCceEecccCcCcEEEcCCCCceEecccCccccCCCCC
Q 004521 518 MPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDET 597 (747)
Q Consensus 518 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~ 597 (747)
+++++|.+++.. ..+++.++..++.|++.||.|||+.+ ++||||||+|||++.++.+||+|||++........
T Consensus 98 ~~~~~L~~~~~~----~~~~~~~~~~~~~~l~~~L~~LH~~~---i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~~~~~ 170 (297)
T cd06656 98 LAGGSLTDVVTE----TCMDEGQIAAVCRECLQALDFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS 170 (297)
T ss_pred cCCCCHHHHHHh----CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEECcCccceEccCCcc
Confidence 999999999843 34788999999999999999999988 99999999999999999999999999876543322
Q ss_pred cccc----ceeee---ccCCCCCccccchhHHHHHHHHHhCCCCCCCCCCcchhhhhHhHHhcCCcccccchhhhccCCH
Q 004521 598 EGNT----NRVVG---TYDGQFSIKSDVFSFGILLLEIVSGKKNRGFYRSDTKVNLIGHLWDEGIPLRLIDACIQDSCNL 670 (747)
Q Consensus 598 ~~~~----~~~~~---~~~~~~s~ksDVwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~ 670 (747)
.... ..... ..+..++.++|||||||++|||++|+.||........ +......+.. .... ..
T Consensus 171 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~~---~~~~~~~~~~-~~~~-------~~ 239 (297)
T cd06656 171 KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRA---LYLIATNGTP-ELQN-------PE 239 (297)
T ss_pred CcCcccCCccccCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcchh---eeeeccCCCC-CCCC-------cc
Confidence 1100 00000 1145678899999999999999999999743221111 0001111110 0000 00
Q ss_pred HHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 004521 671 ADVIRCIHIGLLCVQQHPEDRPCMPSVIL 699 (747)
Q Consensus 671 ~~~~~~~~l~~~Cl~~dP~~RPt~~~v~~ 699 (747)
.....+.+++.+||+.+|++||++.+|++
T Consensus 240 ~~~~~~~~li~~~l~~~p~~Rps~~~il~ 268 (297)
T cd06656 240 RLSAVFRDFLNRCLEMDVDRRGSAKELLQ 268 (297)
T ss_pred ccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 11123456788999999999999999987
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-32 Score=294.03 Aligned_cols=229 Identities=23% Similarity=0.276 Sum_probs=175.4
Q ss_pred ceecccCCeeEEEEEe----cCCcEEEEEEecccc--cccHHHHHHHHHHHhccCCCceeeEEeEEEeCCeeEEEEecCC
Q 004521 446 NKLGEGGFGPVYKGTL----VDGQEIAVKRLSKIS--EQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMP 519 (747)
Q Consensus 446 ~~lg~G~fg~Vy~~~~----~~g~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~ 519 (747)
+.||+|+||.||+++. ..|+.+|+|++.+.. ......+..|++++++++||||+++++++...+..++||||++
T Consensus 2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 81 (318)
T cd05582 2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILDFLR 81 (318)
T ss_pred ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEEcCCC
Confidence 6799999999999875 247899999997532 2234567889999999999999999999999999999999999
Q ss_pred CCChhhHhhhcCCCCcCChhHHHHHHHHHHHHHHHhhhcCCCceEecccCcCcEEEcCCCCceEecccCccccCCCCCcc
Q 004521 520 NKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEG 599 (747)
Q Consensus 520 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~ 599 (747)
+|+|.+++.. ...+++..+..++.||++||.|||+.+ |+||||||+|||++.++.+||+|||+++.........
T Consensus 82 ~~~L~~~l~~---~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~~~ 155 (318)
T cd05582 82 GGDLFTRLSK---EVMFTEEDVKFYLAELALALDHLHSLG---IIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKA 155 (318)
T ss_pred CCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHeEECCCCcEEEeeccCCcccCCCCCce
Confidence 9999999854 235899999999999999999999988 9999999999999999999999999988654331111
Q ss_pred ccceeeec---------cCCCCCccccchhHHHHHHHHHhCCCCCCCCCCcchhhhhHhHHhcCCcccccchhhhccCCH
Q 004521 600 NTNRVVGT---------YDGQFSIKSDVFSFGILLLEIVSGKKNRGFYRSDTKVNLIGHLWDEGIPLRLIDACIQDSCNL 670 (747)
Q Consensus 600 ~~~~~~~~---------~~~~~s~ksDVwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~ 670 (747)
. ...++ ....++.++|||||||++|||++|+.|+.... ............ . .+ ....+
T Consensus 156 ~--~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~---~~~~~~~i~~~~-~-~~-----p~~~~- 222 (318)
T cd05582 156 Y--SFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKD---RKETMTMILKAK-L-GM-----PQFLS- 222 (318)
T ss_pred e--cccCChhhcCHHHHcCCCCCCccceeccceEeeeeccCCCCCCCCC---HHHHHHHHHcCC-C-CC-----CCCCC-
Confidence 0 01111 13567889999999999999999999975322 222222221111 1 01 01111
Q ss_pred HHHHHHHHHHHhccCCCCCCCCCHHH
Q 004521 671 ADVIRCIHIGLLCVQQHPEDRPCMPS 696 (747)
Q Consensus 671 ~~~~~~~~l~~~Cl~~dP~~RPt~~~ 696 (747)
..+.+++.+||+.||++||++.+
T Consensus 223 ---~~~~~li~~~l~~~P~~R~~a~~ 245 (318)
T cd05582 223 ---PEAQSLLRALFKRNPANRLGAGP 245 (318)
T ss_pred ---HHHHHHHHHHhhcCHhHcCCCCC
Confidence 23456777999999999999665
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-32 Score=291.50 Aligned_cols=253 Identities=21% Similarity=0.285 Sum_probs=182.9
Q ss_pred cCCCccceecccCCeeEEEEEec-CCcEEEEEEecccc-cccHHHHHHHHHHHhccCCCceeeEEeEEEeCCeeEEEEec
Q 004521 440 DNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKIS-EQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEF 517 (747)
Q Consensus 440 ~~~~~~~~lg~G~fg~Vy~~~~~-~g~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~ 517 (747)
++|.+.+.||+|+||.||+|+.. +++.||+|.++... ......+.+|+.++++++||||+++++++...+..++||||
T Consensus 6 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~e~ 85 (301)
T cd07873 6 ETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEY 85 (301)
T ss_pred cceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccccCchhHHHHHHHHHHhcCCCCcceEEEEEecCCeEEEEEec
Confidence 57888999999999999999875 47899999987432 33345678899999999999999999999999999999999
Q ss_pred CCCCChhhHhhhcCCCCcCChhHHHHHHHHHHHHHHHhhhcCCCceEecccCcCcEEEcCCCCceEecccCccccCCCCC
Q 004521 518 MPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDET 597 (747)
Q Consensus 518 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~ 597 (747)
++ ++|.+++... ...+++..+..++.||++||+|||+.+ |+|+||||+||++++++.+||+|||+++.......
T Consensus 86 ~~-~~l~~~l~~~--~~~~~~~~~~~~~~qi~~aL~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~ 159 (301)
T cd07873 86 LD-KDLKQYLDDC--GNSINMHNVKLFLFQLLRGLNYCHRRK---VLHRDLKPQNLLINERGELKLADFGLARAKSIPTK 159 (301)
T ss_pred cc-cCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCHHHEEECCCCcEEECcCcchhccCCCCC
Confidence 97 6898888553 335788999999999999999999988 99999999999999999999999999876432221
Q ss_pred cccc-----ceeeec-c--CCCCCccccchhHHHHHHHHHhCCCCCCCCCCcchhhhhHhHHhcC---Cc----------
Q 004521 598 EGNT-----NRVVGT-Y--DGQFSIKSDVFSFGILLLEIVSGKKNRGFYRSDTKVNLIGHLWDEG---IP---------- 656 (747)
Q Consensus 598 ~~~~-----~~~~~~-~--~~~~s~ksDVwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~---~~---------- 656 (747)
.... ...... . ...++.++|||||||++|||++|+.||...........+....... ..
T Consensus 160 ~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (301)
T cd07873 160 TYSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEEFK 239 (301)
T ss_pred cccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhchhhhcccccc
Confidence 1100 000000 0 2357889999999999999999999975432211111111110000 00
Q ss_pred ----ccccchhhhccCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 004521 657 ----LRLIDACIQDSCNLADVIRCIHIGLLCVQQHPEDRPCMPSVIL 699 (747)
Q Consensus 657 ----~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dP~~RPt~~~v~~ 699 (747)
.......+... ...-...+.+++.+||+.||.+|||+.++++
T Consensus 240 ~~~~~~~~~~~~~~~-~~~~~~~~~~li~~ml~~dp~~R~t~~eil~ 285 (301)
T cd07873 240 SYNYPKYRADCLHNH-APRLDSDGAELLSKLLQFEGRKRISAEEAMK 285 (301)
T ss_pred ccccCccccccHHhh-cCCCCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence 00000000000 0000123457888999999999999999986
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-32 Score=302.66 Aligned_cols=192 Identities=23% Similarity=0.337 Sum_probs=158.5
Q ss_pred CCCccceecccCCeeEEEEEecC-CcEEEEEEeccc---ccccHHHHHHHHHHHhccCCCceeeEEeEEEeCCeeEEEEe
Q 004521 441 NFSINNKLGEGGFGPVYKGTLVD-GQEIAVKRLSKI---SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYE 516 (747)
Q Consensus 441 ~~~~~~~lg~G~fg~Vy~~~~~~-g~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E 516 (747)
+|++.+.||+|+||.||+++... ++.||||.+.+. .....+.+.+|+.++++++|+||+++++.+.+++..++|||
T Consensus 2 ~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~E 81 (376)
T cd05598 2 MFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMD 81 (376)
T ss_pred CceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCCEEEEEEe
Confidence 68899999999999999999754 889999998652 22345678899999999999999999999999999999999
Q ss_pred cCCCCChhhHhhhcCCCCcCChhHHHHHHHHHHHHHHHhhhcCCCceEecccCcCcEEEcCCCCceEecccCccccCCCC
Q 004521 517 FMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDE 596 (747)
Q Consensus 517 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~ 596 (747)
|+++|+|.+++.. ...+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+|..+....
T Consensus 82 ~~~~g~L~~~i~~---~~~~~~~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~Nill~~~~~ikL~DFG~a~~~~~~~ 155 (376)
T cd05598 82 YIPGGDMMSLLIR---LGIFEEDLARFYIAELTCAIESVHKMG---FIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTH 155 (376)
T ss_pred CCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCCHHHEEECCCCCEEEEeCCCCccccccc
Confidence 9999999999854 235788888999999999999999988 9999999999999999999999999985331100
Q ss_pred Cc-----------------------------------------cccceeeecc---------CCCCCccccchhHHHHHH
Q 004521 597 TE-----------------------------------------GNTNRVVGTY---------DGQFSIKSDVFSFGILLL 626 (747)
Q Consensus 597 ~~-----------------------------------------~~~~~~~~~~---------~~~~s~ksDVwS~Gvvl~ 626 (747)
.. .......|+. ...++.++|||||||+||
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvily 235 (376)
T cd05598 156 DSKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILY 235 (376)
T ss_pred cccccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCCcceeeeeccceee
Confidence 00 0000011221 456788999999999999
Q ss_pred HHHhCCCCCCCC
Q 004521 627 EIVSGKKNRGFY 638 (747)
Q Consensus 627 elltg~~p~~~~ 638 (747)
||++|+.||...
T Consensus 236 ell~G~~Pf~~~ 247 (376)
T cd05598 236 EMLVGQPPFLAD 247 (376)
T ss_pred ehhhCCCCCCCC
Confidence 999999997543
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-32 Score=299.91 Aligned_cols=246 Identities=19% Similarity=0.236 Sum_probs=182.4
Q ss_pred HHhcCCCccceecccCCeeEEEEEecC-CcEEEEEEeccc---ccccHHHHHHHHHHHhccCCCceeeEEeEEEeCCeeE
Q 004521 437 NATDNFSINNKLGEGGFGPVYKGTLVD-GQEIAVKRLSKI---SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKL 512 (747)
Q Consensus 437 ~~~~~~~~~~~lg~G~fg~Vy~~~~~~-g~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~ 512 (747)
...++|++.+.||+|+||.||+++... ++.+|+|.+.+. .....+.+.+|+.+++.++||||+++++++.++...+
T Consensus 40 ~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~~ 119 (370)
T cd05621 40 MKAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDKYLY 119 (370)
T ss_pred CCHHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEE
Confidence 345689999999999999999999865 789999998642 2234456889999999999999999999999999999
Q ss_pred EEEecCCCCChhhHhhhcCCCCcCChhHHHHHHHHHHHHHHHhhhcCCCceEecccCcCcEEEcCCCCceEecccCcccc
Q 004521 513 LIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTF 592 (747)
Q Consensus 513 lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NIll~~~~~~kl~DFGla~~~ 592 (747)
+||||+++|+|.+++... .+++..+..++.||+.||+|||+.+ |+||||||+|||+++++.+||+|||+++.+
T Consensus 120 lv~Ey~~gg~L~~~l~~~----~~~~~~~~~~~~qil~aL~~LH~~~---IvHrDLKp~NILl~~~~~~kL~DFG~a~~~ 192 (370)
T cd05621 120 MVMEYMPGGDLVNLMSNY----DVPEKWAKFYTAEVVLALDAIHSMG---LIHRDVKPDNMLLDKHGHLKLADFGTCMKM 192 (370)
T ss_pred EEEcCCCCCcHHHHHHhc----CCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHEEECCCCCEEEEecccceec
Confidence 999999999999998532 3788899999999999999999988 999999999999999999999999999876
Q ss_pred CCCCCccccceeeecc-------------CCCCCccccchhHHHHHHHHHhCCCCCCCCCCcchhhhhHhHHhcCCcccc
Q 004521 593 GGDETEGNTNRVVGTY-------------DGQFSIKSDVFSFGILLLEIVSGKKNRGFYRSDTKVNLIGHLWDEGIPLRL 659 (747)
Q Consensus 593 ~~~~~~~~~~~~~~~~-------------~~~~s~ksDVwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 659 (747)
....... .....|+. .+.++.++|||||||+||||++|+.||..... ...............+
T Consensus 193 ~~~~~~~-~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~---~~~~~~i~~~~~~~~~ 268 (370)
T cd05621 193 DETGMVR-CDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSL---VGTYSKIMDHKNSLNF 268 (370)
T ss_pred ccCCcee-cccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCH---HHHHHHHHhCCcccCC
Confidence 4322110 00111110 13478899999999999999999999753221 1122222211111111
Q ss_pred cchhhhccCCHHHHHHHHHHHHhccCCCCCC--CCCHHHHHHH
Q 004521 660 IDACIQDSCNLADVIRCIHIGLLCVQQHPED--RPCMPSVILM 700 (747)
Q Consensus 660 ~d~~l~~~~~~~~~~~~~~l~~~Cl~~dP~~--RPt~~~v~~~ 700 (747)
.+. ..-...+.+++..|++.++.+ ||++.++++.
T Consensus 269 p~~-------~~~s~~~~~li~~~L~~~~~r~~R~~~~e~l~h 304 (370)
T cd05621 269 PED-------VEISKHAKNLICAFLTDREVRLGRNGVEEIKQH 304 (370)
T ss_pred CCc-------ccCCHHHHHHHHHHccCchhccCCCCHHHHhcC
Confidence 110 000112345566788755543 8899998875
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-32 Score=284.64 Aligned_cols=247 Identities=24% Similarity=0.393 Sum_probs=183.9
Q ss_pred CCccceecccCCeeEEEEEec----CCcEEEEEEeccc--ccccHHHHHHHHHHHhccCCCceeeEEeEEEeCC------
Q 004521 442 FSINNKLGEGGFGPVYKGTLV----DGQEIAVKRLSKI--SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGE------ 509 (747)
Q Consensus 442 ~~~~~~lg~G~fg~Vy~~~~~----~g~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~------ 509 (747)
|.+.+.||+|+||.||+|.+. .++.||||.+... .....+++.+|+.++++++||||+++++++...+
T Consensus 1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 80 (273)
T cd05074 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLP 80 (273)
T ss_pred CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCccc
Confidence 566789999999999999863 2678999998652 2344667899999999999999999999987643
Q ss_pred eeEEEEecCCCCChhhHhhhcC---CCCcCChhHHHHHHHHHHHHHHHhhhcCCCceEecccCcCcEEEcCCCCceEecc
Q 004521 510 EKLLIYEFMPNKSLDSFIFDQT---RRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDF 586 (747)
Q Consensus 510 ~~~lV~E~~~~gsL~~~l~~~~---~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NIll~~~~~~kl~DF 586 (747)
..++++||+++|+|..++.... ....+++.....++.||+.||+|||+.+ |+||||||+||+++.++.+||+||
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~nili~~~~~~kl~df 157 (273)
T cd05074 81 IPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSKN---FIHRDLAARNCMLNENMTVCVADF 157 (273)
T ss_pred ceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---EeecccchhhEEEcCCCCEEECcc
Confidence 2378899999999998875322 1234788899999999999999999988 999999999999999999999999
Q ss_pred cCccccCCCCCcccccee------e---eccCCCCCccccchhHHHHHHHHHh-CCCCCCCCCCcchhhhhHhHHhcCCc
Q 004521 587 GLVRTFGGDETEGNTNRV------V---GTYDGQFSIKSDVFSFGILLLEIVS-GKKNRGFYRSDTKVNLIGHLWDEGIP 656 (747)
Q Consensus 587 Gla~~~~~~~~~~~~~~~------~---~~~~~~~s~ksDVwS~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~ 656 (747)
|+++.+............ . ......++.++||||||+++|||++ |+.|+.... .............
T Consensus 158 g~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~il~el~~~g~~p~~~~~---~~~~~~~~~~~~~- 233 (273)
T cd05074 158 GLSKKIYSGDYYRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVE---NSEIYNYLIKGNR- 233 (273)
T ss_pred cccccccCCcceecCCCccCchhhcCHhHHhcCccchhhhhHHHHHHHHHHhhCCCCCCCCCC---HHHHHHHHHcCCc-
Confidence 999876432211110000 0 0114557889999999999999999 777754221 1222222221111
Q ss_pred ccccchhhhccCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhcCC
Q 004521 657 LRLIDACIQDSCNLADVIRCIHIGLLCVQQHPEDRPCMPSVILMLGSE 704 (747)
Q Consensus 657 ~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dP~~RPt~~~v~~~L~~~ 704 (747)
.... ......+.+++.+||+.+|++||++.+|++.|+++
T Consensus 234 ~~~~---------~~~~~~~~~l~~~~l~~~p~~Rps~~~~~~~l~~~ 272 (273)
T cd05074 234 LKQP---------PDCLEDVYELMCQCWSPEPKCRPSFQHLRDQLELI 272 (273)
T ss_pred CCCC---------CCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 1110 01123577888999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-32 Score=294.97 Aligned_cols=231 Identities=22% Similarity=0.348 Sum_probs=174.4
Q ss_pred ceecccCCeeEEEEEecC-CcEEEEEEeccc---ccccHHHHHHHHHHHhcc-CCCceeeEEeEEEeCCeeEEEEecCCC
Q 004521 446 NKLGEGGFGPVYKGTLVD-GQEIAVKRLSKI---SEQGLKELKNEVILFSKL-QHRNLVKLLGCCIQGEEKLLIYEFMPN 520 (747)
Q Consensus 446 ~~lg~G~fg~Vy~~~~~~-g~~vavK~l~~~---~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lV~E~~~~ 520 (747)
+.||+|+||.||+++... ++.+|+|++++. .....+.+.+|+.++.++ +||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (327)
T cd05617 1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNG 80 (327)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCCC
Confidence 479999999999999754 789999999753 233456688999999888 699999999999999999999999999
Q ss_pred CChhhHhhhcCCCCcCChhHHHHHHHHHHHHHHHhhhcCCCceEecccCcCcEEEcCCCCceEecccCccccCCCCCccc
Q 004521 521 KSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGN 600 (747)
Q Consensus 521 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~ 600 (747)
|+|..++... ..+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++.........
T Consensus 81 ~~L~~~~~~~---~~l~~~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~- 153 (327)
T cd05617 81 GDLMFHMQRQ---RKLPEEHARFYAAEICIALNFLHERG---IIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPGDTT- 153 (327)
T ss_pred CcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEEeCCCCEEEeccccceeccCCCCce-
Confidence 9999888542 35899999999999999999999988 9999999999999999999999999987532211110
Q ss_pred cceeeec---------cCCCCCccccchhHHHHHHHHHhCCCCCCCCCCcchh---hhhHhHHhcCCcccccchhhhccC
Q 004521 601 TNRVVGT---------YDGQFSIKSDVFSFGILLLEIVSGKKNRGFYRSDTKV---NLIGHLWDEGIPLRLIDACIQDSC 668 (747)
Q Consensus 601 ~~~~~~~---------~~~~~s~ksDVwS~Gvvl~elltg~~p~~~~~~~~~~---~~~~~~~~~~~~~~~~d~~l~~~~ 668 (747)
....++ .+..++.++|||||||+||||++|+.||......... ..+....... ...+ ....
T Consensus 154 -~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~-~~~~-----p~~~ 226 (327)
T cd05617 154 -STFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVILEK-PIRI-----PRFL 226 (327)
T ss_pred -ecccCCcccCCHHHHCCCCCCchheeehhHHHHHHHHhCCCCCCccCCCcccccHHHHHHHHHhC-CCCC-----CCCC
Confidence 001111 1467889999999999999999999998543222111 1111111111 1111 1111
Q ss_pred CHHHHHHHHHHHHhccCCCCCCCCCH
Q 004521 669 NLADVIRCIHIGLLCVQQHPEDRPCM 694 (747)
Q Consensus 669 ~~~~~~~~~~l~~~Cl~~dP~~RPt~ 694 (747)
+ ..+.+++.+||+.||.+||++
T Consensus 227 ~----~~~~~li~~~L~~dP~~R~~~ 248 (327)
T cd05617 227 S----VKASHVLKGFLNKDPKERLGC 248 (327)
T ss_pred C----HHHHHHHHHHhccCHHHcCCC
Confidence 1 234567779999999999984
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-32 Score=294.28 Aligned_cols=232 Identities=23% Similarity=0.288 Sum_probs=176.7
Q ss_pred CCCccceecccCCeeEEEEEecC-CcEEEEEEeccc---ccccHHHHHHHHHHHhccCC-CceeeEEeEEEeCCeeEEEE
Q 004521 441 NFSINNKLGEGGFGPVYKGTLVD-GQEIAVKRLSKI---SEQGLKELKNEVILFSKLQH-RNLVKLLGCCIQGEEKLLIY 515 (747)
Q Consensus 441 ~~~~~~~lg~G~fg~Vy~~~~~~-g~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~H-~niv~l~g~~~~~~~~~lV~ 515 (747)
+|++.+.||+|+||.||+|+..+ ++.||||++++. .....+.+..|..++..++| ++|+++++++...+..++||
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (324)
T cd05587 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVM 80 (324)
T ss_pred CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEEEE
Confidence 47888999999999999999765 789999999752 23445678889999999976 56889999999999999999
Q ss_pred ecCCCCChhhHhhhcCCCCcCChhHHHHHHHHHHHHHHHhhhcCCCceEecccCcCcEEEcCCCCceEecccCccccCCC
Q 004521 516 EFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGD 595 (747)
Q Consensus 516 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NIll~~~~~~kl~DFGla~~~~~~ 595 (747)
||+++|+|.+++... ..+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++.....
T Consensus 81 E~~~~g~L~~~~~~~---~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~ 154 (324)
T cd05587 81 EYVNGGDLMYHIQQV---GKFKEPHAVFYAAEIAIGLFFLHSKG---IIYRDLKLDNVMLDAEGHIKIADFGMCKENIFG 154 (324)
T ss_pred cCCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEEcCCCCEEEeecCcceecCCC
Confidence 999999999988543 34788999999999999999999988 999999999999999999999999998753211
Q ss_pred CCccccceeeec---------cCCCCCccccchhHHHHHHHHHhCCCCCCCCCCcchhhhhHhHHhcCCcccccchhhhc
Q 004521 596 ETEGNTNRVVGT---------YDGQFSIKSDVFSFGILLLEIVSGKKNRGFYRSDTKVNLIGHLWDEGIPLRLIDACIQD 666 (747)
Q Consensus 596 ~~~~~~~~~~~~---------~~~~~s~ksDVwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 666 (747)
.... ....|+ ....++.++|||||||++|||++|+.||.... .......... ... .+ ..
T Consensus 155 ~~~~--~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~---~~~~~~~i~~-~~~-~~-----~~ 222 (324)
T cd05587 155 GKTT--RTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGED---EDELFQSIME-HNV-SY-----PK 222 (324)
T ss_pred CCce--eeecCCccccChhhhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCC---HHHHHHHHHc-CCC-CC-----CC
Confidence 1110 011111 14567899999999999999999999975322 1122222211 110 01 11
Q ss_pred cCCHHHHHHHHHHHHhccCCCCCCCCCH
Q 004521 667 SCNLADVIRCIHIGLLCVQQHPEDRPCM 694 (747)
Q Consensus 667 ~~~~~~~~~~~~l~~~Cl~~dP~~RPt~ 694 (747)
..+ ..+.+++.+||+.||.+||+.
T Consensus 223 ~~~----~~~~~li~~~l~~~P~~R~~~ 246 (324)
T cd05587 223 SLS----KEAVSICKGLLTKHPAKRLGC 246 (324)
T ss_pred CCC----HHHHHHHHHHhhcCHHHcCCC
Confidence 111 235567789999999999986
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-33 Score=288.18 Aligned_cols=245 Identities=27% Similarity=0.459 Sum_probs=182.9
Q ss_pred CCccceecccCCeeEEEEEecC-CcEEEEEEeccccccc--HHHHHHHHHHHhccCCCceeeEEeEEEeCCeeEEEEecC
Q 004521 442 FSINNKLGEGGFGPVYKGTLVD-GQEIAVKRLSKISEQG--LKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFM 518 (747)
Q Consensus 442 ~~~~~~lg~G~fg~Vy~~~~~~-g~~vavK~l~~~~~~~--~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~ 518 (747)
|++.+.||+|+||+||+++... ++.+|+|.+....... .....+|+.++++++||||+++++++.+....++||||+
T Consensus 1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~v~~~~ 80 (260)
T PF00069_consen 1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQDDNYLYIVMEYC 80 (260)
T ss_dssp EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEESSEEEEEEEEE
T ss_pred CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccccchhhhhhhcccccccccccccccccccccccccccccc
Confidence 5678999999999999999866 6789999997643222 223456999999999999999999999999999999999
Q ss_pred CCCChhhHhhhcCCCCcCChhHHHHHHHHHHHHHHHhhhcCCCceEecccCcCcEEEcCCCCceEecccCccccCCCCCc
Q 004521 519 PNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETE 598 (747)
Q Consensus 519 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~ 598 (747)
++++|.+++. ....+++..+..++.||++||+|||+.+ |+|+||||+||++++++.++|+|||.+.........
T Consensus 81 ~~~~L~~~l~---~~~~~~~~~~~~~~~qi~~~L~~Lh~~~---i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~~~~~~~ 154 (260)
T PF00069_consen 81 PGGSLQDYLQ---KNKPLSEEEILKIAYQILEALAYLHSKG---IVHRDIKPENILLDENGEVKLIDFGSSVKLSENNEN 154 (260)
T ss_dssp TTEBHHHHHH---HHSSBBHHHHHHHHHHHHHHHHHHHHTT---EEESSBSGGGEEESTTSEEEESSGTTTEESTSTTSE
T ss_pred cccccccccc---cccccccccccccccccccccccccccc---cccccccccccccccccccccccccccccccccccc
Confidence 9999999996 2345899999999999999999999998 999999999999999999999999998753111110
Q ss_pred -----cccceeeec--c-CCCCCccccchhHHHHHHHHHhCCCCCCCCCCcchhhhhHhHHhcCCcccccchhhhccCCH
Q 004521 599 -----GNTNRVVGT--Y-DGQFSIKSDVFSFGILLLEIVSGKKNRGFYRSDTKVNLIGHLWDEGIPLRLIDACIQDSCNL 670 (747)
Q Consensus 599 -----~~~~~~~~~--~-~~~~s~ksDVwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~ 670 (747)
.......+. . ...++.++||||+|+++|||++|+.|+...........+....... ...........
T Consensus 155 ~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~- 229 (260)
T PF00069_consen 155 FNPFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESNSDDQLEIIEKILKRP----LPSSSQQSREK- 229 (260)
T ss_dssp BSSSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSHHHHHHHHHHHHHTH----HHHHTTSHTTS-
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccccchhhhhhhhhccccc----ccccccccchh-
Confidence 000000011 1 4678999999999999999999999976431111211211111100 00000000000
Q ss_pred HHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 004521 671 ADVIRCIHIGLLCVQQHPEDRPCMPSVIL 699 (747)
Q Consensus 671 ~~~~~~~~l~~~Cl~~dP~~RPt~~~v~~ 699 (747)
...+.+++.+||+.||++||++.++++
T Consensus 230 --~~~l~~li~~~l~~~p~~R~~~~~l~~ 256 (260)
T PF00069_consen 230 --SEELRDLIKKMLSKDPEQRPSAEELLK 256 (260)
T ss_dssp --HHHHHHHHHHHSSSSGGGSTTHHHHHT
T ss_pred --HHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 145677888999999999999999975
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-32 Score=287.89 Aligned_cols=251 Identities=24% Similarity=0.336 Sum_probs=184.5
Q ss_pred CCCccceecccCCeeEEEEEec-CCcEEEEEEeccccc-----ccHHHHHHHHHHHhccCCCceeeEEeEEEeCCeeEEE
Q 004521 441 NFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKISE-----QGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLI 514 (747)
Q Consensus 441 ~~~~~~~lg~G~fg~Vy~~~~~-~g~~vavK~l~~~~~-----~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV 514 (747)
+|++.+.||+|+||.||+|... +++.||||.++.... .....+..|++++++++|+||+++++++.+.+..++|
T Consensus 1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 80 (298)
T cd07841 1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKSNINLV 80 (298)
T ss_pred CceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecCCEEEEE
Confidence 4777899999999999999975 589999999975322 2345677899999999999999999999999999999
Q ss_pred EecCCCCChhhHhhhcCCCCcCChhHHHHHHHHHHHHHHHhhhcCCCceEecccCcCcEEEcCCCCceEecccCccccCC
Q 004521 515 YEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGG 594 (747)
Q Consensus 515 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NIll~~~~~~kl~DFGla~~~~~ 594 (747)
|||+ +++|.+++.... ..+++..+..++.||++||.|||+.+ |+|+||||+||+++.++.+||+|||+++....
T Consensus 81 ~e~~-~~~L~~~i~~~~--~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~ 154 (298)
T cd07841 81 FEFM-ETDLEKVIKDKS--IVLTPADIKSYMLMTLRGLEYLHSNW---ILHRDLKPNNLLIASDGVLKLADFGLARSFGS 154 (298)
T ss_pred Eccc-CCCHHHHHhccC--CCCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCChhhEEEcCCCCEEEccceeeeeccC
Confidence 9999 899999985432 35899999999999999999999988 99999999999999999999999999987654
Q ss_pred CCCccccc-----eeeec---cCCCCCccccchhHHHHHHHHHhCCCCCCCCCCcchhhhhHhHHhc-C-----------
Q 004521 595 DETEGNTN-----RVVGT---YDGQFSIKSDVFSFGILLLEIVSGKKNRGFYRSDTKVNLIGHLWDE-G----------- 654 (747)
Q Consensus 595 ~~~~~~~~-----~~~~~---~~~~~s~ksDVwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~-~----------- 654 (747)
........ ..... ....++.++|||||||++|||++|..++..... ...+...... +
T Consensus 155 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~ 231 (298)
T cd07841 155 PNRKMTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSD---IDQLGKIFEALGTPTEENWPGVT 231 (298)
T ss_pred CCccccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCcc---HHHHHHHHHHcCCCchhhhhhcc
Confidence 32111110 00011 124578899999999999999999766543221 1111111100 0
Q ss_pred CcccccchhhhccCC-----HHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 004521 655 IPLRLIDACIQDSCN-----LADVIRCIHIGLLCVQQHPEDRPCMPSVILM 700 (747)
Q Consensus 655 ~~~~~~d~~l~~~~~-----~~~~~~~~~l~~~Cl~~dP~~RPt~~~v~~~ 700 (747)
............... ......+.+++.+||+.+|++||++.+|+++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~~ 282 (298)
T cd07841 232 SLPDYVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALEH 282 (298)
T ss_pred cccccccccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhhC
Confidence 000000000000001 1112456788899999999999999999984
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-32 Score=293.45 Aligned_cols=227 Identities=24% Similarity=0.320 Sum_probs=173.9
Q ss_pred ceecccCCeeEEEEEecC-CcEEEEEEeccc---ccccHHHHHHHHHHHhcc-CCCceeeEEeEEEeCCeeEEEEecCCC
Q 004521 446 NKLGEGGFGPVYKGTLVD-GQEIAVKRLSKI---SEQGLKELKNEVILFSKL-QHRNLVKLLGCCIQGEEKLLIYEFMPN 520 (747)
Q Consensus 446 ~~lg~G~fg~Vy~~~~~~-g~~vavK~l~~~---~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lV~E~~~~ 520 (747)
+.||+|+||.||+|+... ++.||||++++. .....+.+..|..++..+ +||||+++++++...+..++||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~~ 80 (320)
T cd05590 1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVNG 80 (320)
T ss_pred CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCCCC
Confidence 479999999999999764 889999998752 234456778888888876 699999999999999999999999999
Q ss_pred CChhhHhhhcCCCCcCChhHHHHHHHHHHHHHHHhhhcCCCceEecccCcCcEEEcCCCCceEecccCccccCCCCCccc
Q 004521 521 KSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGN 600 (747)
Q Consensus 521 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~ 600 (747)
|+|..++... ..+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++.........
T Consensus 81 g~L~~~i~~~---~~l~~~~~~~~~~ql~~~L~~lH~~~---ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~~~~~~- 153 (320)
T cd05590 81 GDLMFHIQKS---RRFDEARARFYAAEITSALMFLHDKG---IIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNGKTT- 153 (320)
T ss_pred chHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCCHHHeEECCCCcEEEeeCCCCeecCcCCCcc-
Confidence 9999988543 34889999999999999999999988 9999999999999999999999999987542221110
Q ss_pred cceeeec---------cCCCCCccccchhHHHHHHHHHhCCCCCCCCCCcchhhhhHhHHhcCCcccccchhhhccCCHH
Q 004521 601 TNRVVGT---------YDGQFSIKSDVFSFGILLLEIVSGKKNRGFYRSDTKVNLIGHLWDEGIPLRLIDACIQDSCNLA 671 (747)
Q Consensus 601 ~~~~~~~---------~~~~~s~ksDVwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~ 671 (747)
....|+ ....++.++|||||||++|||++|+.||.... ........... ... . ....
T Consensus 154 -~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~---~~~~~~~i~~~-~~~-~-----~~~~--- 219 (320)
T cd05590 154 -STFCGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAEN---EDDLFEAILND-EVV-Y-----PTWL--- 219 (320)
T ss_pred -cccccCccccCHHHHcCCCCCCccchhhhHHHHHHHhhCCCCCCCCC---HHHHHHHHhcC-CCC-C-----CCCC---
Confidence 011111 14567889999999999999999999975332 12222222111 110 0 0001
Q ss_pred HHHHHHHHHHhccCCCCCCCCCH
Q 004521 672 DVIRCIHIGLLCVQQHPEDRPCM 694 (747)
Q Consensus 672 ~~~~~~~l~~~Cl~~dP~~RPt~ 694 (747)
...+.+++.+||+.||.+||++
T Consensus 220 -~~~~~~li~~~L~~dP~~R~~~ 241 (320)
T cd05590 220 -SQDAVDILKAFMTKNPTMRLGS 241 (320)
T ss_pred -CHHHHHHHHHHcccCHHHCCCC
Confidence 1235567789999999999998
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-32 Score=288.85 Aligned_cols=247 Identities=22% Similarity=0.355 Sum_probs=186.3
Q ss_pred cCCCccceecccCCeeEEEEEec-CCcEEEEEEeccc-ccccHHHHHHHHHHHhccCCCceeeEEeEEEeCCeeEEEEec
Q 004521 440 DNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKI-SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEF 517 (747)
Q Consensus 440 ~~~~~~~~lg~G~fg~Vy~~~~~-~g~~vavK~l~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~ 517 (747)
++|++.+.||+|+||.||++... .++.+|+|.++.. .......+.+|+.++++++|+||+++++++...+..++||||
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 80 (286)
T cd06622 1 DEIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYMCMEY 80 (286)
T ss_pred ChhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeecccCHHHHHHHHHHHHHHHhcCCCcHHhhhhheecCCeEEEEEee
Confidence 36788899999999999999986 5899999988652 333456889999999999999999999999999999999999
Q ss_pred CCCCChhhHhhhcCCCCcCChhHHHHHHHHHHHHHHHhhhc-CCCceEecccCcCcEEEcCCCCceEecccCccccCCCC
Q 004521 518 MPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQD-SRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDE 596 (747)
Q Consensus 518 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~-~~~~iiHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~ 596 (747)
+++++|..++........+++..+..++.|++.||.|||+. + |+||||||+||+++.++.+||+|||++..+....
T Consensus 81 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~ 157 (286)
T cd06622 81 MDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEHN---IIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVASL 157 (286)
T ss_pred cCCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhcCC---EeeCCCCHHHEEECCCCCEEEeecCCcccccCCc
Confidence 99999999986543344689999999999999999999974 5 9999999999999999999999999987653222
Q ss_pred Cccc--------cceeeec---cCCCCCccccchhHHHHHHHHHhCCCCCCCCCCcchhhhhHhHHhcCCcccccchhhh
Q 004521 597 TEGN--------TNRVVGT---YDGQFSIKSDVFSFGILLLEIVSGKKNRGFYRSDTKVNLIGHLWDEGIPLRLIDACIQ 665 (747)
Q Consensus 597 ~~~~--------~~~~~~~---~~~~~s~ksDVwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 665 (747)
.... ++...+. ....++.++|||||||++|||++|+.||...........+.. ...+....+..
T Consensus 158 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~-~~~~~~~~~~~---- 232 (286)
T cd06622 158 AKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYANIFAQLSA-IVDGDPPTLPS---- 232 (286)
T ss_pred cccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcchhhHHHHHHH-HhhcCCCCCCc----
Confidence 1111 0000000 123468899999999999999999999753322111111111 11111111111
Q ss_pred ccCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 004521 666 DSCNLADVIRCIHIGLLCVQQHPEDRPCMPSVIL 699 (747)
Q Consensus 666 ~~~~~~~~~~~~~l~~~Cl~~dP~~RPt~~~v~~ 699 (747)
.....+..++.+||+.+|++||++.+++.
T Consensus 233 -----~~~~~~~~li~~~l~~~p~~Rp~~~~l~~ 261 (286)
T cd06622 233 -----GYSDDAQDFVAKCLNKIPNRRPTYAQLLE 261 (286)
T ss_pred -----ccCHHHHHHHHHHcccCcccCCCHHHHhc
Confidence 11233567888999999999999999886
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-32 Score=286.42 Aligned_cols=246 Identities=20% Similarity=0.335 Sum_probs=185.5
Q ss_pred cCCCccceecccCCeeEEEEEec-CCcEEEEEEecccccccHHHHHHHHHHHhccCCCceeeEEeEEEeCCeeEEEEecC
Q 004521 440 DNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFM 518 (747)
Q Consensus 440 ~~~~~~~~lg~G~fg~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~ 518 (747)
++|.+.+.||+|+||.||+|+.. +++.||+|.++.........+.+|+.+++.++||||+++++.+...+..++||||+
T Consensus 9 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~~~lv~e~~ 88 (267)
T cd06645 9 EDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLWICMEFC 88 (267)
T ss_pred HHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEEecc
Confidence 47888899999999999999875 48899999987654455567889999999999999999999999999999999999
Q ss_pred CCCChhhHhhhcCCCCcCChhHHHHHHHHHHHHHHHhhhcCCCceEecccCcCcEEEcCCCCceEecccCccccCCCCCc
Q 004521 519 PNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETE 598 (747)
Q Consensus 519 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~ 598 (747)
++++|.+++... ..+++.++..++.|++.||.|||+.+ ++|+||||+||+++.++.+||+|||++..+......
T Consensus 89 ~~~~L~~~~~~~---~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~~~~ 162 (267)
T cd06645 89 GGGSLQDIYHVT---GPLSESQIAYVSRETLQGLYYLHSKG---KMHRDIKGANILLTDNGHVKLADFGVSAQITATIAK 162 (267)
T ss_pred CCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEECcceeeeEccCcccc
Confidence 999999998542 35889999999999999999999988 999999999999999999999999998765322110
Q ss_pred c-----ccceee-----eccCCCCCccccchhHHHHHHHHHhCCCCCCCCCCcchhhhhHhHHhcCCcccccchhhhccC
Q 004521 599 G-----NTNRVV-----GTYDGQFSIKSDVFSFGILLLEIVSGKKNRGFYRSDTKVNLIGHLWDEGIPLRLIDACIQDSC 668 (747)
Q Consensus 599 ~-----~~~~~~-----~~~~~~~s~ksDVwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~ 668 (747)
. ...... ......++.++|||||||++|||++|+.|+....... ................... ..
T Consensus 163 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~---~~~~~~~~~~~~~~~~~~~--~~ 237 (267)
T cd06645 163 RKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMR---ALFLMTKSNFQPPKLKDKM--KW 237 (267)
T ss_pred cccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccchh---hHHhhhccCCCCCcccccC--CC
Confidence 0 000000 0113457889999999999999999999964322111 1111111111111110000 01
Q ss_pred CHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 004521 669 NLADVIRCIHIGLLCVQQHPEDRPCMPSVILM 700 (747)
Q Consensus 669 ~~~~~~~~~~l~~~Cl~~dP~~RPt~~~v~~~ 700 (747)
...+.+++.+||+.+|++||++.+|+++
T Consensus 238 ----~~~~~~li~~~l~~~P~~R~~~~~ll~~ 265 (267)
T cd06645 238 ----SNSFHHFVKMALTKNPKKRPTAEKLLQH 265 (267)
T ss_pred ----CHHHHHHHHHHccCCchhCcCHHHHhcC
Confidence 1235678889999999999999998763
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-32 Score=290.89 Aligned_cols=228 Identities=22% Similarity=0.272 Sum_probs=171.0
Q ss_pred ceecccCCeeEEEEEec-CCcEEEEEEecccc---cccHHHHHHHHH-HHhccCCCceeeEEeEEEeCCeeEEEEecCCC
Q 004521 446 NKLGEGGFGPVYKGTLV-DGQEIAVKRLSKIS---EQGLKELKNEVI-LFSKLQHRNLVKLLGCCIQGEEKLLIYEFMPN 520 (747)
Q Consensus 446 ~~lg~G~fg~Vy~~~~~-~g~~vavK~l~~~~---~~~~~~~~~E~~-~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~ 520 (747)
+.||+|+||+||+|+.. +|+.||||++.+.. ....+++..|.. +++.++||||+++++++...+..++||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (323)
T cd05575 1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYVNG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcCCCC
Confidence 47999999999999985 48999999987521 223345555555 56789999999999999999999999999999
Q ss_pred CChhhHhhhcCCCCcCChhHHHHHHHHHHHHHHHhhhcCCCceEecccCcCcEEEcCCCCceEecccCccccCCCCCccc
Q 004521 521 KSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGN 600 (747)
Q Consensus 521 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~ 600 (747)
|+|..++.. ...+++..+..++.||++||.|||+.+ |+||||||+|||++.++.+||+|||+++.........
T Consensus 81 g~L~~~l~~---~~~~~~~~~~~~~~qi~~~l~~lH~~g---ivH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~- 153 (323)
T cd05575 81 GELFFHLQR---ERSFPEPRARFYAAEIASALGYLHSLN---IIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHSKTT- 153 (323)
T ss_pred CCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCCHHHeEECCCCcEEEeccCCCcccccCCCcc-
Confidence 999998854 335888999999999999999999988 9999999999999999999999999987532211110
Q ss_pred cceeeec---------cCCCCCccccchhHHHHHHHHHhCCCCCCCCCCcchhhhhHhHHhcCCcccccchhhhccCCHH
Q 004521 601 TNRVVGT---------YDGQFSIKSDVFSFGILLLEIVSGKKNRGFYRSDTKVNLIGHLWDEGIPLRLIDACIQDSCNLA 671 (747)
Q Consensus 601 ~~~~~~~---------~~~~~s~ksDVwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~ 671 (747)
....++ ....++.++|||||||++|||++|+.||.... ............ . .+ ....
T Consensus 154 -~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~---~~~~~~~i~~~~-~-~~-----~~~~--- 219 (323)
T cd05575 154 -STFCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRD---TAEMYDNILNKP-L-RL-----KPNI--- 219 (323)
T ss_pred -ccccCChhhcChhhhcCCCCCccccccccchhhhhhhcCCCCCCCCC---HHHHHHHHHcCC-C-CC-----CCCC---
Confidence 011111 14568899999999999999999999975322 112222211111 0 11 1111
Q ss_pred HHHHHHHHHHhccCCCCCCCCCHH
Q 004521 672 DVIRCIHIGLLCVQQHPEDRPCMP 695 (747)
Q Consensus 672 ~~~~~~~l~~~Cl~~dP~~RPt~~ 695 (747)
...+.+++.+||+.||.+||++.
T Consensus 220 -~~~~~~li~~~l~~~p~~R~~~~ 242 (323)
T cd05575 220 -SVSARHLLEGLLQKDRTKRLGAK 242 (323)
T ss_pred -CHHHHHHHHHHhhcCHHhCCCCC
Confidence 12355677799999999999985
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-32 Score=282.90 Aligned_cols=242 Identities=25% Similarity=0.406 Sum_probs=187.1
Q ss_pred cCCCccceecccCCeeEEEEEecC-CcEEEEEEecccccccHHHHHHHHHHHhccCCCceeeEEeEEEeCCeeEEEEecC
Q 004521 440 DNFSINNKLGEGGFGPVYKGTLVD-GQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFM 518 (747)
Q Consensus 440 ~~~~~~~~lg~G~fg~Vy~~~~~~-g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~ 518 (747)
++|++.+.||+|+||.||+|+..+ ++.+++|.+..... .+++.+|++++++++|+||+++++++......++++||+
T Consensus 3 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~--~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~ 80 (256)
T cd06612 3 EVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEED--LQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWIVMEYC 80 (256)
T ss_pred ccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHHH--HHHHHHHHHHHHhCCCCcEeeeeeeeecCCcEEEEEecC
Confidence 578899999999999999999865 78999999875322 678999999999999999999999999999999999999
Q ss_pred CCCChhhHhhhcCCCCcCChhHHHHHHHHHHHHHHHhhhcCCCceEecccCcCcEEEcCCCCceEecccCccccCCCCCc
Q 004521 519 PNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETE 598 (747)
Q Consensus 519 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~ 598 (747)
++++|.+++... ...+++..+..++.|+++||.|||+.+ ++|+||+|+||++++++.+||+|||++.........
T Consensus 81 ~~~~L~~~l~~~--~~~l~~~~~~~~~~~l~~~l~~lh~~~---i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~~~~~ 155 (256)
T cd06612 81 GAGSVSDIMKIT--NKTLTEEEIAAILYQTLKGLEYLHSNK---KIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMAK 155 (256)
T ss_pred CCCcHHHHHHhC--ccCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcceEEECCCCcEEEcccccchhcccCccc
Confidence 999999998543 345899999999999999999999988 999999999999999999999999998876433211
Q ss_pred ccc-----ceeeec--cCCCCCccccchhHHHHHHHHHhCCCCCCCCCCcchhhhhHhHHhcCCcccccchhhhccCCHH
Q 004521 599 GNT-----NRVVGT--YDGQFSIKSDVFSFGILLLEIVSGKKNRGFYRSDTKVNLIGHLWDEGIPLRLIDACIQDSCNLA 671 (747)
Q Consensus 599 ~~~-----~~~~~~--~~~~~s~ksDVwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~ 671 (747)
... ...... .+..++.++|||||||++|||++|+.|+.......... ......... +.. ...
T Consensus 156 ~~~~~~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~~~~----~~~~~~~~~-----~~~--~~~ 224 (256)
T cd06612 156 RNTVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHPMRAIF----MIPNKPPPT-----LSD--PEK 224 (256)
T ss_pred cccccCCccccCHHHHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCcchhhhhh----hhccCCCCC-----CCc--hhh
Confidence 100 000000 14567889999999999999999999975332211110 000000000 000 011
Q ss_pred HHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 004521 672 DVIRCIHIGLLCVQQHPEDRPCMPSVIL 699 (747)
Q Consensus 672 ~~~~~~~l~~~Cl~~dP~~RPt~~~v~~ 699 (747)
....+.+++.+||+.+|++||++.+|++
T Consensus 225 ~~~~~~~~i~~~l~~~P~~Rps~~~il~ 252 (256)
T cd06612 225 WSPEFNDFVKKCLVKDPEERPSAIQLLQ 252 (256)
T ss_pred cCHHHHHHHHHHHhcChhhCcCHHHHhc
Confidence 1124567888999999999999999986
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-32 Score=292.60 Aligned_cols=234 Identities=22% Similarity=0.299 Sum_probs=176.7
Q ss_pred CCCccceecccCCeeEEEEEec-CCcEEEEEEeccc---ccccHHHHHHHHHHHhccC-CCceeeEEeEEEeCCeeEEEE
Q 004521 441 NFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKI---SEQGLKELKNEVILFSKLQ-HRNLVKLLGCCIQGEEKLLIY 515 (747)
Q Consensus 441 ~~~~~~~lg~G~fg~Vy~~~~~-~g~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~-H~niv~l~g~~~~~~~~~lV~ 515 (747)
+|+..+.||+|+||.||+|+.. +++.||+|++.+. .....+.+..|..+++.+. |++|+++++++...+..++||
T Consensus 1 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05615 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFVM 80 (323)
T ss_pred CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEEEE
Confidence 3677899999999999999875 4889999998752 2334566888999998885 577889999999999999999
Q ss_pred ecCCCCChhhHhhhcCCCCcCChhHHHHHHHHHHHHHHHhhhcCCCceEecccCcCcEEEcCCCCceEecccCccccCCC
Q 004521 516 EFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGD 595 (747)
Q Consensus 516 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NIll~~~~~~kl~DFGla~~~~~~ 595 (747)
||+++|+|.+++... ..+++.++..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++.....
T Consensus 81 Ey~~~g~L~~~i~~~---~~l~~~~~~~i~~qi~~al~~lH~~~---ivHrDikp~Nill~~~~~ikL~Dfg~~~~~~~~ 154 (323)
T cd05615 81 EYVNGGDLMYHIQQV---GKFKEPQAVFYAAEISVGLFFLHRRG---IIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVD 154 (323)
T ss_pred cCCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEEeccccccccCCC
Confidence 999999999988543 34889999999999999999999988 999999999999999999999999998764322
Q ss_pred CCcc-----ccceeeec--cCCCCCccccchhHHHHHHHHHhCCCCCCCCCCcchhhhhHhHHhcCCcccccchhhhccC
Q 004521 596 ETEG-----NTNRVVGT--YDGQFSIKSDVFSFGILLLEIVSGKKNRGFYRSDTKVNLIGHLWDEGIPLRLIDACIQDSC 668 (747)
Q Consensus 596 ~~~~-----~~~~~~~~--~~~~~s~ksDVwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~ 668 (747)
.... ........ ....++.++|||||||++|||++|+.|+.... ............ . .. ....
T Consensus 155 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~---~~~~~~~i~~~~-~-~~-----p~~~ 224 (323)
T cd05615 155 GVTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGED---EDELFQSIMEHN-V-SY-----PKSL 224 (323)
T ss_pred CccccCccCCccccCHHHHcCCCCCCccchhhhHHHHHHHHhCCCCCCCCC---HHHHHHHHHhCC-C-CC-----CccC
Confidence 1110 00000000 14568899999999999999999999975332 122222221111 0 01 0111
Q ss_pred CHHHHHHHHHHHHhccCCCCCCCCCH
Q 004521 669 NLADVIRCIHIGLLCVQQHPEDRPCM 694 (747)
Q Consensus 669 ~~~~~~~~~~l~~~Cl~~dP~~RPt~ 694 (747)
+ ..+.+++.+||+.+|.+|++.
T Consensus 225 ~----~~~~~li~~~l~~~p~~R~~~ 246 (323)
T cd05615 225 S----KEAVSICKGLMTKHPSKRLGC 246 (323)
T ss_pred C----HHHHHHHHHHcccCHhhCCCC
Confidence 1 235667789999999999985
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-32 Score=303.48 Aligned_cols=185 Identities=23% Similarity=0.308 Sum_probs=154.0
Q ss_pred hcCCCccceecccCCeeEEEEEecC-CcEEEEEEecccccccHHHHHHHHHHHhccCCCceeeEEeEEEeCCeeEEEEec
Q 004521 439 TDNFSINNKLGEGGFGPVYKGTLVD-GQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEF 517 (747)
Q Consensus 439 ~~~~~~~~~lg~G~fg~Vy~~~~~~-g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~ 517 (747)
..+|.+.+.||+|+||.||+|+... ++.||||... ...+.+|++++++++|+|||++++++..++..++|||+
T Consensus 168 ~~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~------~~~~~~E~~iL~~L~HpnIv~l~~~~~~~~~~~lv~e~ 241 (461)
T PHA03211 168 GLGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGW------YASSVHEARLLRRLSHPAVLALLDVRVVGGLTCLVLPK 241 (461)
T ss_pred cCCeEEEEEEccCCCeEEEEEEECCCCCEEEEeccc------ccCHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEEc
Confidence 4579999999999999999999865 7899999643 23467899999999999999999999999999999999
Q ss_pred CCCCChhhHhhhcCCCCcCChhHHHHHHHHHHHHHHHhhhcCCCceEecccCcCcEEEcCCCCceEecccCccccCCCCC
Q 004521 518 MPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDET 597 (747)
Q Consensus 518 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~ 597 (747)
+. ++|..++... ...+++.+++.|+.||++||.|||+.+ |+||||||+||||+.++.+||+|||+++.+.....
T Consensus 242 ~~-~~L~~~l~~~--~~~l~~~~~~~i~~qi~~aL~yLH~~g---IvHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~~ 315 (461)
T PHA03211 242 YR-SDLYTYLGAR--LRPLGLAQVTAVARQLLSAIDYIHGEG---IIHRDIKTENVLVNGPEDICLGDFGAACFARGSWS 315 (461)
T ss_pred cC-CCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---EEECcCCHHHEEECCCCCEEEcccCCceecccccc
Confidence 95 7888888543 235899999999999999999999988 99999999999999999999999999987643322
Q ss_pred ccccceeeec---------cCCCCCccccchhHHHHHHHHHhCCCCC
Q 004521 598 EGNTNRVVGT---------YDGQFSIKSDVFSFGILLLEIVSGKKNR 635 (747)
Q Consensus 598 ~~~~~~~~~~---------~~~~~s~ksDVwS~Gvvl~elltg~~p~ 635 (747)
........|+ .+..++.++|||||||+||||++|..++
T Consensus 316 ~~~~~~~~GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g~~~l 362 (461)
T PHA03211 316 TPFHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASL 362 (461)
T ss_pred cccccccCCCcCCcCHHHHcCCCCCchHHHHHHHHHHHHHHHcCCCc
Confidence 1111111222 1456899999999999999999988764
|
|
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-32 Score=286.93 Aligned_cols=246 Identities=26% Similarity=0.376 Sum_probs=187.7
Q ss_pred hcCCCccceecccCCeeEEEEEec-CCcEEEEEEecccccccHHHHHHHHHHHhccCCCceeeEEeEEEeCCeeEEEEec
Q 004521 439 TDNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEF 517 (747)
Q Consensus 439 ~~~~~~~~~lg~G~fg~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~ 517 (747)
.++|++.+.||+|+||.||+++.. ++..+|+|.+........+.|.+|+.++++++|+||+++++.+..+...++||||
T Consensus 4 ~~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 83 (280)
T cd06611 4 NDIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYFYENKLWILIEF 83 (280)
T ss_pred hhHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeCCHHHHHHHHHHHHHHHhCCCCceeEEEEEEecCCeEEEEeec
Confidence 357888999999999999999975 4889999998765555667899999999999999999999999999999999999
Q ss_pred CCCCChhhHhhhcCCCCcCChhHHHHHHHHHHHHHHHhhhcCCCceEecccCcCcEEEcCCCCceEecccCccccCCCCC
Q 004521 518 MPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDET 597 (747)
Q Consensus 518 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~ 597 (747)
+++++|.+++.... ..+++..+..++.|++.||.|||+.+ |+|+||||+||+++.++.+||+|||++........
T Consensus 84 ~~~~~L~~~~~~~~--~~l~~~~~~~~~~ql~~~l~~lh~~~---i~h~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~ 158 (280)
T cd06611 84 CDGGALDSIMLELE--RGLTEPQIRYVCRQMLEALNFLHSHK---VIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQ 158 (280)
T ss_pred cCCCcHHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChhhEEECCCCCEEEccCccchhhccccc
Confidence 99999999986532 35899999999999999999999988 99999999999999999999999998865432211
Q ss_pred ccc----cceeeec--------cCCCCCccccchhHHHHHHHHHhCCCCCCCCCCcchhhhhHhHHhcCCcccccchhhh
Q 004521 598 EGN----TNRVVGT--------YDGQFSIKSDVFSFGILLLEIVSGKKNRGFYRSDTKVNLIGHLWDEGIPLRLIDACIQ 665 (747)
Q Consensus 598 ~~~----~~~~~~~--------~~~~~s~ksDVwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 665 (747)
... ......+ ....++.++||||||+++|||++|+.|+..... ...+... ..+....+..+
T Consensus 159 ~~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~---~~~~~~~-~~~~~~~~~~~--- 231 (280)
T cd06611 159 KRDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNP---MRVLLKI-LKSEPPTLDQP--- 231 (280)
T ss_pred ccceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCH---HHHHHHH-hcCCCCCcCCc---
Confidence 100 0000000 124577899999999999999999999753321 1111111 11111111100
Q ss_pred ccCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 004521 666 DSCNLADVIRCIHIGLLCVQQHPEDRPCMPSVILM 700 (747)
Q Consensus 666 ~~~~~~~~~~~~~l~~~Cl~~dP~~RPt~~~v~~~ 700 (747)
... ...+.+++.+||+.+|.+||++.+|++.
T Consensus 232 ~~~----~~~~~~li~~~l~~~p~~Rps~~~il~~ 262 (280)
T cd06611 232 SKW----SSSFNDFLKSCLVKDPDDRPTAAELLKH 262 (280)
T ss_pred ccC----CHHHHHHHHHHhccChhhCcCHHHHhcC
Confidence 001 1235567789999999999999999763
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-32 Score=289.86 Aligned_cols=247 Identities=24% Similarity=0.340 Sum_probs=186.7
Q ss_pred cCCCccceecccCCeeEEEEEec-CCcEEEEEEeccc-ccccHHHHHHHHHHHhccCCCceeeEEeEEEeCCeeEEEEec
Q 004521 440 DNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKI-SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEF 517 (747)
Q Consensus 440 ~~~~~~~~lg~G~fg~Vy~~~~~-~g~~vavK~l~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~ 517 (747)
++|++.+.||+|+||+||++... +++.+|+|++... .....+.+.+|+++++.++||||+++++++......++||||
T Consensus 5 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 84 (284)
T cd06620 5 EDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAFLNENNICMCMEF 84 (284)
T ss_pred HHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecCcchHHHHHHHHHHHHHHcCCCCcceEeeeEecCCEEEEEEec
Confidence 46888899999999999999875 4889999987653 234467899999999999999999999999999999999999
Q ss_pred CCCCChhhHhhhcCCCCcCChhHHHHHHHHHHHHHHHhhh-cCCCceEecccCcCcEEEcCCCCceEecccCccccCCCC
Q 004521 518 MPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQ-DSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDE 596 (747)
Q Consensus 518 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~-~~~~~iiHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~ 596 (747)
+++++|.+++.. ...+++..+..++.+++.||.|||+ .+ ++||||||+||++++++.++|+|||++.......
T Consensus 85 ~~~~~L~~~~~~---~~~~~~~~~~~~~~~i~~~l~~LH~~~~---i~H~dl~p~nil~~~~~~~~l~d~gl~~~~~~~~ 158 (284)
T cd06620 85 MDCGSLDRIYKK---GGPIPVEILGKIAVAVVEGLTYLYNVHR---IMHRDIKPSNILVNSRGQIKLCDFGVSGELINSI 158 (284)
T ss_pred CCCCCHHHHHHh---ccCCCHHHHHHHHHHHHHHHHHHHHhcC---eeccCCCHHHEEECCCCcEEEccCCcccchhhhc
Confidence 999999998854 2358899999999999999999997 45 9999999999999999999999999987543221
Q ss_pred Cccc--c-ceeee--ccCCCCCccccchhHHHHHHHHHhCCCCCCCCCCcch-----h---hhhHhHHhcCCcccccchh
Q 004521 597 TEGN--T-NRVVG--TYDGQFSIKSDVFSFGILLLEIVSGKKNRGFYRSDTK-----V---NLIGHLWDEGIPLRLIDAC 663 (747)
Q Consensus 597 ~~~~--~-~~~~~--~~~~~~s~ksDVwS~Gvvl~elltg~~p~~~~~~~~~-----~---~~~~~~~~~~~~~~~~d~~ 663 (747)
.... . ..... .....++.++|||||||++|||++|+.|+........ . ........+ ....+
T Consensus 159 ~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~---- 233 (284)
T cd06620 159 ADTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQIVQE-PPPRL---- 233 (284)
T ss_pred cCccccCcccCCHHHHccCCCCccchHHHHHHHHHHHHhCCCCCcccchhhhhhhhhhHHHHHHHHHhhc-cCCCC----
Confidence 1100 0 00000 0145778899999999999999999999764332110 0 111111111 11111
Q ss_pred hhccCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHh
Q 004521 664 IQDSCNLADVIRCIHIGLLCVQQHPEDRPCMPSVILML 701 (747)
Q Consensus 664 l~~~~~~~~~~~~~~l~~~Cl~~dP~~RPt~~~v~~~L 701 (747)
.. ......+.+++.+||+.||.+||++.||+++.
T Consensus 234 -~~---~~~~~~~~~li~~~l~~dp~~Rpt~~e~~~~~ 267 (284)
T cd06620 234 -PS---SDFPEDLRDFVDACLLKDPTERPTPQQLCAMP 267 (284)
T ss_pred -Cc---hhcCHHHHHHHHHHhcCCcccCcCHHHHhcCc
Confidence 00 01123466788899999999999999999874
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-32 Score=289.27 Aligned_cols=231 Identities=25% Similarity=0.305 Sum_probs=174.1
Q ss_pred ceecccCCeeEEEEEecC-CcEEEEEEecccc---cccHHHHHHHHHHHhcc-CCCceeeEEeEEEeCCeeEEEEecCCC
Q 004521 446 NKLGEGGFGPVYKGTLVD-GQEIAVKRLSKIS---EQGLKELKNEVILFSKL-QHRNLVKLLGCCIQGEEKLLIYEFMPN 520 (747)
Q Consensus 446 ~~lg~G~fg~Vy~~~~~~-g~~vavK~l~~~~---~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lV~E~~~~ 520 (747)
+.||+|+||.||+|+... |+.||+|.+++.. ....+.+..|..++..+ +||||+++++++.+.+..++||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~ 80 (316)
T cd05620 1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCCCC
Confidence 479999999999999864 8899999997531 23455677788888754 899999999999999999999999999
Q ss_pred CChhhHhhhcCCCCcCChhHHHHHHHHHHHHHHHhhhcCCCceEecccCcCcEEEcCCCCceEecccCccccCCCCCccc
Q 004521 521 KSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGN 600 (747)
Q Consensus 521 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~ 600 (747)
|+|..++... ..+++..+..++.||++||+|||+.+ |+||||||+|||++.++.+||+|||+++.........
T Consensus 81 g~L~~~i~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~---ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~- 153 (316)
T cd05620 81 GDLMFHIQDK---GRFDLYRATFYAAEIVCGLQFLHSKG---IIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGDNRA- 153 (316)
T ss_pred CcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEECCCCCEEeCccCCCeecccCCCce-
Confidence 9999988542 34788999999999999999999988 9999999999999999999999999987532111100
Q ss_pred cceeeec---------cCCCCCccccchhHHHHHHHHHhCCCCCCCCCCcchhhhhHhHHhcCCcccccchhhhccCCHH
Q 004521 601 TNRVVGT---------YDGQFSIKSDVFSFGILLLEIVSGKKNRGFYRSDTKVNLIGHLWDEGIPLRLIDACIQDSCNLA 671 (747)
Q Consensus 601 ~~~~~~~---------~~~~~s~ksDVwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~ 671 (747)
....++ ....++.++|||||||++|||++|+.||.... ......... ... ..+ .....
T Consensus 154 -~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~Pf~~~~---~~~~~~~~~-~~~-~~~-----~~~~~-- 220 (316)
T cd05620 154 -STFCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDD---EDELFESIR-VDT-PHY-----PRWIT-- 220 (316)
T ss_pred -eccCCCcCccCHHHHcCCCCCcccchhhhHHHHHHHHhCCCCCCCCC---HHHHHHHHH-hCC-CCC-----CCCCC--
Confidence 011111 14578899999999999999999999975322 122222211 111 111 11111
Q ss_pred HHHHHHHHHHhccCCCCCCCCCHH-HHH
Q 004521 672 DVIRCIHIGLLCVQQHPEDRPCMP-SVI 698 (747)
Q Consensus 672 ~~~~~~~l~~~Cl~~dP~~RPt~~-~v~ 698 (747)
..+.+++.+||+.||++||++. ++.
T Consensus 221 --~~~~~li~~~l~~dP~~R~~~~~~~~ 246 (316)
T cd05620 221 --KESKDILEKLFERDPTRRLGVVGNIR 246 (316)
T ss_pred --HHHHHHHHHHccCCHHHcCCChHHHH
Confidence 2345677799999999999985 554
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-32 Score=288.63 Aligned_cols=242 Identities=23% Similarity=0.386 Sum_probs=186.4
Q ss_pred cCCCccceecccCCeeEEEEEe-cCCcEEEEEEecccccccHHHHHHHHHHHhccCCCceeeEEeEEEeCCeeEEEEecC
Q 004521 440 DNFSINNKLGEGGFGPVYKGTL-VDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFM 518 (747)
Q Consensus 440 ~~~~~~~~lg~G~fg~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~ 518 (747)
.+|++.+.||.|+||.||+|.. .+++.||+|.+........+.+.+|+.+++.++||||+++++++...+..++|+||+
T Consensus 19 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 98 (296)
T cd06655 19 KKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDSFLVGDELFVVMEYL 98 (296)
T ss_pred ceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecccCchHHHHHHHHHHHHhcCCCceeeeeeeEecCceEEEEEEec
Confidence 4688899999999999999986 458999999987644555678899999999999999999999999999999999999
Q ss_pred CCCChhhHhhhcCCCCcCChhHHHHHHHHHHHHHHHhhhcCCCceEecccCcCcEEEcCCCCceEecccCccccCCCCCc
Q 004521 519 PNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETE 598 (747)
Q Consensus 519 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~ 598 (747)
++++|..++.. ..+++.++..++.|++.||+|||+.+ ++||||||+||+++.++.+||+|||++..+......
T Consensus 99 ~~~~L~~~~~~----~~l~~~~~~~i~~~l~~al~~LH~~~---i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~~~~~~ 171 (296)
T cd06655 99 AGGSLTDVVTE----TCMDEAQIAAVCRECLQALEFLHANQ---VIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQSK 171 (296)
T ss_pred CCCcHHHHHHh----cCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEccCccchhccccccc
Confidence 99999998843 34889999999999999999999988 999999999999999999999999998865433221
Q ss_pred ccc-----ceeee--ccCCCCCccccchhHHHHHHHHHhCCCCCCCCCCcchhhhhHhHHhcCCcccccchhhhccCCHH
Q 004521 599 GNT-----NRVVG--TYDGQFSIKSDVFSFGILLLEIVSGKKNRGFYRSDTKVNLIGHLWDEGIPLRLIDACIQDSCNLA 671 (747)
Q Consensus 599 ~~~-----~~~~~--~~~~~~s~ksDVwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~ 671 (747)
... ..... .....++.++|||||||++|||++|+.|+........ ........ ...+.. ....
T Consensus 172 ~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg~~pf~~~~~~~~---~~~~~~~~-~~~~~~---~~~~--- 241 (296)
T cd06655 172 RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRA---LYLIATNG-TPELQN---PEKL--- 241 (296)
T ss_pred CCCcCCCccccCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH---HHHHHhcC-CcccCC---cccC---
Confidence 110 00001 1145578899999999999999999999753322111 11111111 111100 0111
Q ss_pred HHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 004521 672 DVIRCIHIGLLCVQQHPEDRPCMPSVIL 699 (747)
Q Consensus 672 ~~~~~~~l~~~Cl~~dP~~RPt~~~v~~ 699 (747)
...+.+++.+||+.+|.+||++.+|++
T Consensus 242 -~~~~~~li~~~l~~dp~~Rpt~~~il~ 268 (296)
T cd06655 242 -SPIFRDFLNRCLEMDVEKRGSAKELLQ 268 (296)
T ss_pred -CHHHHHHHHHHhhcChhhCCCHHHHhh
Confidence 123556778999999999999999985
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-32 Score=283.35 Aligned_cols=242 Identities=28% Similarity=0.427 Sum_probs=183.0
Q ss_pred CCCccceecccCCeeEEEEEecCCcEEEEEEecccc------cccHHHHHHHHHHHhccCCCceeeEEeEEEeCCeeEEE
Q 004521 441 NFSINNKLGEGGFGPVYKGTLVDGQEIAVKRLSKIS------EQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLI 514 (747)
Q Consensus 441 ~~~~~~~lg~G~fg~Vy~~~~~~g~~vavK~l~~~~------~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV 514 (747)
+|.+.+.||+|+||.||+|...+++.+|||.+.... ....+.+.+|++++++++|+||+++++++.+....++|
T Consensus 1 ~~~~~~~ig~g~~~~v~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 80 (265)
T cd06631 1 EWTKGEVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISIF 80 (265)
T ss_pred CccccceEeccCCeEEEEEEEcCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCCeEEEE
Confidence 477789999999999999998789999999986421 22345688999999999999999999999999999999
Q ss_pred EecCCCCChhhHhhhcCCCCcCChhHHHHHHHHHHHHHHHhhhcCCCceEecccCcCcEEEcCCCCceEecccCccccCC
Q 004521 515 YEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGG 594 (747)
Q Consensus 515 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NIll~~~~~~kl~DFGla~~~~~ 594 (747)
|||+++++|.+++... ..+++..+..++.|++.||+|||+.+ |+|+||+|+||++++++.+||+|||+++....
T Consensus 81 ~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~ 154 (265)
T cd06631 81 MEFVPGGSISSILNRF---GPLPEPVFCKYTKQILDGVAYLHNNC---VVHRDIKGNNVMLMPNGIIKLIDFGCARRLAW 154 (265)
T ss_pred EecCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCcCHHhEEECCCCeEEeccchhhHhhhh
Confidence 9999999999999543 34788999999999999999999988 99999999999999999999999999876532
Q ss_pred CCCcc----ccceeeec---------cCCCCCccccchhHHHHHHHHHhCCCCCCCCCCcchhhhhHhHHhcCCcccccc
Q 004521 595 DETEG----NTNRVVGT---------YDGQFSIKSDVFSFGILLLEIVSGKKNRGFYRSDTKVNLIGHLWDEGIPLRLID 661 (747)
Q Consensus 595 ~~~~~----~~~~~~~~---------~~~~~s~ksDVwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~d 661 (747)
..... ......++ ....++.++|||||||++|||++|+.|+...... ...............+
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~--~~~~~~~~~~~~~~~~-- 230 (265)
T cd06631 155 VGLHGTHSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDRL--AAMFYIGAHRGLMPRL-- 230 (265)
T ss_pred ccccccccccccccCCCccccChhhhcCCCCcchhhHHHHHHHHHHHHhCCCccccCChH--HHHHHhhhccCCCCCC--
Confidence 11100 00000011 1345788999999999999999999997532211 1111111111111111
Q ss_pred hhhhccCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 004521 662 ACIQDSCNLADVIRCIHIGLLCVQQHPEDRPCMPSVIL 699 (747)
Q Consensus 662 ~~l~~~~~~~~~~~~~~l~~~Cl~~dP~~RPt~~~v~~ 699 (747)
.... ...+..++.+||+.+|.+||++.++++
T Consensus 231 ---~~~~----~~~~~~~i~~~l~~~p~~Rp~~~~~l~ 261 (265)
T cd06631 231 ---PDSF----SAAAIDFVTSCLTRDQHERPSALQLLR 261 (265)
T ss_pred ---CCCC----CHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 1111 123567788999999999999999875
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-32 Score=302.33 Aligned_cols=191 Identities=24% Similarity=0.350 Sum_probs=157.9
Q ss_pred CCCccceecccCCeeEEEEEecC-CcEEEEEEecccc---cccHHHHHHHHHHHhccCCCceeeEEeEEEeCCeeEEEEe
Q 004521 441 NFSINNKLGEGGFGPVYKGTLVD-GQEIAVKRLSKIS---EQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYE 516 (747)
Q Consensus 441 ~~~~~~~lg~G~fg~Vy~~~~~~-g~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E 516 (747)
.|++.++||+|+||.||+|+... ++.+|+|++.+.. ....+.+.+|+.++++++|+||+++++.+.+.+..++|||
T Consensus 2 ~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~~lv~E 81 (382)
T cd05625 2 MFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMD 81 (382)
T ss_pred CcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEEEEEEe
Confidence 57888999999999999999754 7899999987522 2345678899999999999999999999999999999999
Q ss_pred cCCCCChhhHhhhcCCCCcCChhHHHHHHHHHHHHHHHhhhcCCCceEecccCcCcEEEcCCCCceEecccCccccCCCC
Q 004521 517 FMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDE 596 (747)
Q Consensus 517 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~ 596 (747)
|+++|+|.+++... ..+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++.+....
T Consensus 82 ~~~gg~L~~~l~~~---~~~~e~~~~~~~~qi~~al~~lH~~~---ivHrDlKp~NILl~~~g~~kL~DFGla~~~~~~~ 155 (382)
T cd05625 82 YIPGGDMMSLLIRM---GIFPEDLARFYIAELTCAVESVHKMG---FIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTH 155 (382)
T ss_pred CCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEEeECCCCccccccc
Confidence 99999999998543 35788888999999999999999988 9999999999999999999999999976432100
Q ss_pred C---------------------------------------------ccccceeeecc---------CCCCCccccchhHH
Q 004521 597 T---------------------------------------------EGNTNRVVGTY---------DGQFSIKSDVFSFG 622 (747)
Q Consensus 597 ~---------------------------------------------~~~~~~~~~~~---------~~~~s~ksDVwS~G 622 (747)
. ........|+. ...++.++||||||
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlG 235 (382)
T cd05625 156 DSKYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVG 235 (382)
T ss_pred cccccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCCCCeeeEEech
Confidence 0 00000111221 45688999999999
Q ss_pred HHHHHHHhCCCCCCC
Q 004521 623 ILLLEIVSGKKNRGF 637 (747)
Q Consensus 623 vvl~elltg~~p~~~ 637 (747)
|+||||++|+.||..
T Consensus 236 vil~elltG~~Pf~~ 250 (382)
T cd05625 236 VILYEMLVGQPPFLA 250 (382)
T ss_pred HHHHHHHhCCCCCCC
Confidence 999999999999753
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-32 Score=292.11 Aligned_cols=233 Identities=24% Similarity=0.287 Sum_probs=178.4
Q ss_pred ceecccCCeeEEEEEecC-CcEEEEEEeccc---ccccHHHHHHHHHHHhcc-CCCceeeEEeEEEeCCeeEEEEecCCC
Q 004521 446 NKLGEGGFGPVYKGTLVD-GQEIAVKRLSKI---SEQGLKELKNEVILFSKL-QHRNLVKLLGCCIQGEEKLLIYEFMPN 520 (747)
Q Consensus 446 ~~lg~G~fg~Vy~~~~~~-g~~vavK~l~~~---~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lV~E~~~~ 520 (747)
+.||+|+||.||+|+... ++.||||.+++. .......+..|..++..+ +||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (318)
T cd05570 1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNG 80 (318)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 479999999999999865 789999999753 234456678899999888 799999999999999999999999999
Q ss_pred CChhhHhhhcCCCCcCChhHHHHHHHHHHHHHHHhhhcCCCceEecccCcCcEEEcCCCCceEecccCccccCCCCCccc
Q 004521 521 KSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGN 600 (747)
Q Consensus 521 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~ 600 (747)
|+|..++... ..+++..+..++.||+.||.|||+.+ |+||||||+|||+++++.+||+|||+++.........
T Consensus 81 ~~L~~~~~~~---~~l~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~- 153 (318)
T cd05570 81 GDLMFHIQRS---GRFDEPRARFYAAEIVLGLQFLHERG---IIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGVTT- 153 (318)
T ss_pred CCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHhCC---eEccCCCHHHeEECCCCcEEecccCCCeecCcCCCcc-
Confidence 9999888543 35899999999999999999999988 9999999999999999999999999987532211111
Q ss_pred cceeeec---------cCCCCCccccchhHHHHHHHHHhCCCCCCCCCCcchhhhhHhHHhcCCcccccchhhhccCCHH
Q 004521 601 TNRVVGT---------YDGQFSIKSDVFSFGILLLEIVSGKKNRGFYRSDTKVNLIGHLWDEGIPLRLIDACIQDSCNLA 671 (747)
Q Consensus 601 ~~~~~~~---------~~~~~s~ksDVwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~ 671 (747)
....++ .+..++.++|||||||++|||++|+.||.... ........... .. .+ ....
T Consensus 154 -~~~~g~~~y~aPE~~~~~~~~~~~DiwslGvil~~l~~G~~pf~~~~---~~~~~~~i~~~-~~-~~-----~~~~--- 219 (318)
T cd05570 154 -STFCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDD---EDELFQSILED-EV-RY-----PRWL--- 219 (318)
T ss_pred -cceecCccccCHHHhcCCCCCcchhhhhHHHHHHHHhhCCCCCCCCC---HHHHHHHHHcC-CC-CC-----CCcC---
Confidence 111111 14678899999999999999999999975322 12222221111 11 00 0111
Q ss_pred HHHHHHHHHHhccCCCCCCCCCH-----HHHHHH
Q 004521 672 DVIRCIHIGLLCVQQHPEDRPCM-----PSVILM 700 (747)
Q Consensus 672 ~~~~~~~l~~~Cl~~dP~~RPt~-----~~v~~~ 700 (747)
...+.+++.+||+.||.+||++ .++++.
T Consensus 220 -~~~~~~li~~~l~~dP~~R~s~~~~~~~~ll~~ 252 (318)
T cd05570 220 -SKEAKSILKSFLTKNPEKRLGCLPTGEQDIKGH 252 (318)
T ss_pred -CHHHHHHHHHHccCCHHHcCCCCCCCHHHHhcC
Confidence 1235677889999999999999 777653
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-32 Score=291.39 Aligned_cols=232 Identities=25% Similarity=0.313 Sum_probs=175.2
Q ss_pred ceecccCCeeEEEEEecC-CcEEEEEEeccc---ccccHHHHHHHHHHHhc-cCCCceeeEEeEEEeCCeeEEEEecCCC
Q 004521 446 NKLGEGGFGPVYKGTLVD-GQEIAVKRLSKI---SEQGLKELKNEVILFSK-LQHRNLVKLLGCCIQGEEKLLIYEFMPN 520 (747)
Q Consensus 446 ~~lg~G~fg~Vy~~~~~~-g~~vavK~l~~~---~~~~~~~~~~E~~~l~~-l~H~niv~l~g~~~~~~~~~lV~E~~~~ 520 (747)
+.||+|+||.||+|+..+ ++.||||.++.. .....+.+..|..++.. ++||||+++++++.+.+..++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~~ 80 (316)
T cd05619 1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCCCC
Confidence 479999999999999865 789999999753 23344567778888876 4899999999999999999999999999
Q ss_pred CChhhHhhhcCCCCcCChhHHHHHHHHHHHHHHHhhhcCCCceEecccCcCcEEEcCCCCceEecccCccccCCCCCccc
Q 004521 521 KSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGN 600 (747)
Q Consensus 521 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~ 600 (747)
|+|..++... ..+++.++..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++.........
T Consensus 81 g~L~~~l~~~---~~~~~~~~~~~~~qi~~al~~LH~~~---ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~- 153 (316)
T cd05619 81 GDLMFHIQSC---HKFDLPRATFYAAEIICGLQFLHSKG---IVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDAKT- 153 (316)
T ss_pred CcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHhCC---eEeCCCCHHHEEECCCCCEEEccCCcceECCCCCCce-
Confidence 9999998542 34788999999999999999999988 9999999999999999999999999987532211110
Q ss_pred cceeeec---------cCCCCCccccchhHHHHHHHHHhCCCCCCCCCCcchhhhhHhHHhcCCcccccchhhhccCCHH
Q 004521 601 TNRVVGT---------YDGQFSIKSDVFSFGILLLEIVSGKKNRGFYRSDTKVNLIGHLWDEGIPLRLIDACIQDSCNLA 671 (747)
Q Consensus 601 ~~~~~~~---------~~~~~s~ksDVwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~ 671 (747)
....++ .+..++.++|||||||++|||++|+.||.... ........ ..... . .....
T Consensus 154 -~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~---~~~~~~~i-~~~~~-~-----~~~~~--- 219 (316)
T cd05619 154 -CTFCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHD---EEELFQSI-RMDNP-C-----YPRWL--- 219 (316)
T ss_pred -eeecCCccccCHHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCCC---HHHHHHHH-HhCCC-C-----CCccC---
Confidence 001111 14568899999999999999999999975322 11222221 11110 0 00111
Q ss_pred HHHHHHHHHHhccCCCCCCCCCHH-HHHH
Q 004521 672 DVIRCIHIGLLCVQQHPEDRPCMP-SVIL 699 (747)
Q Consensus 672 ~~~~~~~l~~~Cl~~dP~~RPt~~-~v~~ 699 (747)
...+.+++.+||+.||++||++. ++.+
T Consensus 220 -~~~~~~li~~~l~~~P~~R~~~~~~l~~ 247 (316)
T cd05619 220 -TREAKDILVKLFVREPERRLGVKGDIRQ 247 (316)
T ss_pred -CHHHHHHHHHHhccCHhhcCCChHHHHc
Confidence 12355677899999999999997 5543
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-32 Score=286.30 Aligned_cols=246 Identities=27% Similarity=0.473 Sum_probs=188.2
Q ss_pred cCCCccceecccCCeeEEEEEecC-Cc----EEEEEEecccc-cccHHHHHHHHHHHhccCCCceeeEEeEEEeCCeeEE
Q 004521 440 DNFSINNKLGEGGFGPVYKGTLVD-GQ----EIAVKRLSKIS-EQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLL 513 (747)
Q Consensus 440 ~~~~~~~~lg~G~fg~Vy~~~~~~-g~----~vavK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~l 513 (747)
.+|++.+.||+|+||.||+|...+ |+ .+|+|.+.... .....++.+|+.++++++||||+++++++.. ...++
T Consensus 7 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~ 85 (279)
T cd05057 7 TELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRLLGICLS-SQVQL 85 (279)
T ss_pred HHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEec-CceEE
Confidence 467888999999999999998643 33 68999887543 3345688999999999999999999999987 78899
Q ss_pred EEecCCCCChhhHhhhcCCCCcCChhHHHHHHHHHHHHHHHhhhcCCCceEecccCcCcEEEcCCCCceEecccCccccC
Q 004521 514 IYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFG 593 (747)
Q Consensus 514 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NIll~~~~~~kl~DFGla~~~~ 593 (747)
||||+++|+|.+++... ...+++..+..++.||+.||+|||+.+ ++||||||+||+++.++.+||+|||+++.+.
T Consensus 86 v~e~~~~g~L~~~l~~~--~~~~~~~~~~~~~~qi~~~l~~LH~~~---i~H~di~p~nil~~~~~~~kL~dfg~~~~~~ 160 (279)
T cd05057 86 ITQLMPLGCLLDYVRNH--KDNIGSQYLLNWCVQIAKGMSYLEEKR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLD 160 (279)
T ss_pred EEecCCCCcHHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHhCC---EEecccCcceEEEcCCCeEEECCCccccccc
Confidence 99999999999998653 234899999999999999999999987 9999999999999999999999999998764
Q ss_pred CCCCccccc-------ee--eeccCCCCCccccchhHHHHHHHHHh-CCCCCCCCCCcchhhhhHhHHhcCCcccccchh
Q 004521 594 GDETEGNTN-------RV--VGTYDGQFSIKSDVFSFGILLLEIVS-GKKNRGFYRSDTKVNLIGHLWDEGIPLRLIDAC 663 (747)
Q Consensus 594 ~~~~~~~~~-------~~--~~~~~~~~s~ksDVwS~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 663 (747)
......... .. .......++.++||||||+++||+++ |+.|+...... ... .....+..... +
T Consensus 161 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~---~~~-~~~~~~~~~~~--~- 233 (279)
T cd05057 161 VDEKEYHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAV---EIP-DLLEKGERLPQ--P- 233 (279)
T ss_pred CcccceecCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHHhcCCCCCCCCCCHH---HHH-HHHhCCCCCCC--C-
Confidence 332211100 00 00114567889999999999999999 99997543221 111 11122111110 0
Q ss_pred hhccCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhcCC
Q 004521 664 IQDSCNLADVIRCIHIGLLCVQQHPEDRPCMPSVILMLGSE 704 (747)
Q Consensus 664 l~~~~~~~~~~~~~~l~~~Cl~~dP~~RPt~~~v~~~L~~~ 704 (747)
... ...+.+++.+||..+|.+||++.++++.|...
T Consensus 234 --~~~----~~~~~~~~~~~l~~~p~~Rp~~~~l~~~l~~~ 268 (279)
T cd05057 234 --PIC----TIDVYMVLVKCWMIDAESRPTFKELINEFSKM 268 (279)
T ss_pred --CCC----CHHHHHHHHHHcCCChhhCCCHHHHHHHHHHH
Confidence 111 12356778899999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-32 Score=287.58 Aligned_cols=254 Identities=23% Similarity=0.342 Sum_probs=187.7
Q ss_pred HHHHHHhcCCCccceecccCCeeEEEEEecC-CcEEEEEEecccccccHHHHHHHHHHHhcc-CCCceeeEEeEEE----
Q 004521 433 ATIANATDNFSINNKLGEGGFGPVYKGTLVD-GQEIAVKRLSKISEQGLKELKNEVILFSKL-QHRNLVKLLGCCI---- 506 (747)
Q Consensus 433 ~~~~~~~~~~~~~~~lg~G~fg~Vy~~~~~~-g~~vavK~l~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~---- 506 (747)
..+..+.++|++.+.||+|+||.||+++... ++.+|+|.+... .....++.+|+.+++++ +||||+++++++.
T Consensus 11 ~~~~~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~-~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~ 89 (286)
T cd06638 11 DSFPDPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPI-HDIDEEIEAEYNILKALSDHPNVVKFYGMYYKKDV 89 (286)
T ss_pred ecCCCcccceeeeeeeccCCCcEEEEEEECCCCceeEEEeeccc-cchHHHHHHHHHHHHHHhcCCCeeeeeeeeeeccc
Confidence 4445567899999999999999999998754 789999988652 23346788999999999 6999999999985
Q ss_pred -eCCeeEEEEecCCCCChhhHhhhcC-CCCcCChhHHHHHHHHHHHHHHHhhhcCCCceEecccCcCcEEEcCCCCceEe
Q 004521 507 -QGEEKLLIYEFMPNKSLDSFIFDQT-RRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKIS 584 (747)
Q Consensus 507 -~~~~~~lV~E~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NIll~~~~~~kl~ 584 (747)
.++..++||||+++++|.+++.... ....+++..+..++.|+++||.|||+.+ |+||||||+||+++.++.+||+
T Consensus 90 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nili~~~~~~kl~ 166 (286)
T cd06638 90 KNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVNK---TIHRDVKGNNILLTTEGGVKLV 166 (286)
T ss_pred CCCCeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhCC---ccccCCCHHhEEECCCCCEEEc
Confidence 3456899999999999999886432 3345888999999999999999999988 9999999999999999999999
Q ss_pred cccCccccCCCCCccc-----cceeeec-------cCCCCCccccchhHHHHHHHHHhCCCCCCCCCCcchhhhhHhHHh
Q 004521 585 DFGLVRTFGGDETEGN-----TNRVVGT-------YDGQFSIKSDVFSFGILLLEIVSGKKNRGFYRSDTKVNLIGHLWD 652 (747)
Q Consensus 585 DFGla~~~~~~~~~~~-----~~~~~~~-------~~~~~s~ksDVwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~ 652 (747)
|||+++.+........ .....+. ....++.++|||||||++|||++|+.|+...... ..+... .
T Consensus 167 dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~~---~~~~~~-~ 242 (286)
T cd06638 167 DFGVSAQLTSTRLRRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPM---RALFKI-P 242 (286)
T ss_pred cCCceeecccCCCccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCchh---HHHhhc-c
Confidence 9999876543221110 0000000 1245788999999999999999999997533211 111111 1
Q ss_pred cCCcccccchhhhccCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHh
Q 004521 653 EGIPLRLIDACIQDSCNLADVIRCIHIGLLCVQQHPEDRPCMPSVILML 701 (747)
Q Consensus 653 ~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dP~~RPt~~~v~~~L 701 (747)
......+.++. .. ...+..++.+||+.+|++||++.+|++.+
T Consensus 243 ~~~~~~~~~~~---~~----~~~~~~li~~~l~~~p~~Rps~~ell~~~ 284 (286)
T cd06638 243 RNPPPTLHQPE---LW----SNEFNDFIRKCLTKDYEKRPTVSDLLQHV 284 (286)
T ss_pred ccCCCcccCCC---Cc----CHHHHHHHHHHccCCcccCCCHHHHhhcc
Confidence 11111111110 01 12366788899999999999999998753
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-32 Score=284.43 Aligned_cols=241 Identities=24% Similarity=0.383 Sum_probs=186.7
Q ss_pred cCCCccceecccCCeeEEEEEec-CCcEEEEEEecccc-cccHHHHHHHHHHHhccCCCceeeEEeEEEeCCeeEEEEec
Q 004521 440 DNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKIS-EQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEF 517 (747)
Q Consensus 440 ~~~~~~~~lg~G~fg~Vy~~~~~-~g~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~ 517 (747)
++|++.+.||.|+||.||+|+.. +++.+|+|.+.... ......+.+|+.+++.++|+||+++++++.++...++|+||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (274)
T cd06609 1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWIIMEY 80 (274)
T ss_pred ChhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccccchHHHHHHHHHHHHHHcCCCCeeeeeEEEEECCeEEEEEEe
Confidence 36788899999999999999976 48899999987532 34456789999999999999999999999999999999999
Q ss_pred CCCCChhhHhhhcCCCCcCChhHHHHHHHHHHHHHHHhhhcCCCceEecccCcCcEEEcCCCCceEecccCccccCCCCC
Q 004521 518 MPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDET 597 (747)
Q Consensus 518 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~ 597 (747)
+++++|.+++... .+++..+..++.|++.||.|||+.+ ++||||+|+||++++++.++|+|||+++.+.....
T Consensus 81 ~~~~~L~~~~~~~----~~~~~~~~~~~~ql~~~l~~lh~~~---i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~ 153 (274)
T cd06609 81 CGGGSCLDLLKPG----KLDETYIAFILREVLLGLEYLHEEG---KIHRDIKAANILLSEEGDVKLADFGVSGQLTSTMS 153 (274)
T ss_pred eCCCcHHHHHhhc----CCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEEcccccceeeccccc
Confidence 9999999998542 6899999999999999999999988 99999999999999999999999999987654321
Q ss_pred ccccc----eeee---ccCCCCCccccchhHHHHHHHHHhCCCCCCCCCCcchhhhhHhHHhcCCcccccchhhhccCCH
Q 004521 598 EGNTN----RVVG---TYDGQFSIKSDVFSFGILLLEIVSGKKNRGFYRSDTKVNLIGHLWDEGIPLRLIDACIQDSCNL 670 (747)
Q Consensus 598 ~~~~~----~~~~---~~~~~~s~ksDVwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~ 670 (747)
..... .... ..+..++.++|||||||++|||++|+.|+..... ...... ........+....
T Consensus 154 ~~~~~~~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~tg~~p~~~~~~---~~~~~~-~~~~~~~~~~~~~------- 222 (274)
T cd06609 154 KRNTFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLHP---MRVLFL-IPKNNPPSLEGNK------- 222 (274)
T ss_pred ccccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccCch---HHHHHH-hhhcCCCCCcccc-------
Confidence 10000 0001 1134588999999999999999999999753321 111111 1112122111110
Q ss_pred HHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 004521 671 ADVIRCIHIGLLCVQQHPEDRPCMPSVIL 699 (747)
Q Consensus 671 ~~~~~~~~l~~~Cl~~dP~~RPt~~~v~~ 699 (747)
....+.+++.+||+.+|++||++.++++
T Consensus 223 -~~~~~~~~l~~~l~~~p~~Rpt~~~il~ 250 (274)
T cd06609 223 -FSKPFKDFVSLCLNKDPKERPSAKELLK 250 (274)
T ss_pred -cCHHHHHHHHHHhhCChhhCcCHHHHhh
Confidence 1123556778999999999999999976
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-32 Score=282.98 Aligned_cols=240 Identities=26% Similarity=0.439 Sum_probs=182.9
Q ss_pred CCCccceecccCCeeEEEEEec-CCcEEEEEEeccccc---------ccHHHHHHHHHHHhccCCCceeeEEeEEEeCCe
Q 004521 441 NFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKISE---------QGLKELKNEVILFSKLQHRNLVKLLGCCIQGEE 510 (747)
Q Consensus 441 ~~~~~~~lg~G~fg~Vy~~~~~-~g~~vavK~l~~~~~---------~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~ 510 (747)
+|.+...||+|+||.||+|... +++.+|+|.+..... ...+.+.+|+.++++++||||+++++++.+.+.
T Consensus 1 ~~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 80 (267)
T cd06628 1 KWIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADH 80 (267)
T ss_pred CccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCc
Confidence 3677889999999999999875 478999998864221 123568899999999999999999999999999
Q ss_pred eEEEEecCCCCChhhHhhhcCCCCcCChhHHHHHHHHHHHHHHHhhhcCCCceEecccCcCcEEEcCCCCceEecccCcc
Q 004521 511 KLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVR 590 (747)
Q Consensus 511 ~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NIll~~~~~~kl~DFGla~ 590 (747)
.++||||+++++|.+++... ..+++..+..++.|++.||+|||+.+ ++||||+|+||+++.++.+||+|||+++
T Consensus 81 ~~lv~e~~~~~~L~~~l~~~---~~l~~~~~~~~~~~l~~~l~~lH~~~---ivH~di~p~nil~~~~~~~~l~dfg~~~ 154 (267)
T cd06628 81 LNIFLEYVPGGSVAALLNNY---GAFEETLVRNFVRQILKGLNYLHNRG---IIHRDIKGANILVDNKGGIKISDFGISK 154 (267)
T ss_pred cEEEEEecCCCCHHHHHHhc---cCccHHHHHHHHHHHHHHHHHHHhcC---cccccCCHHHEEEcCCCCEEecccCCCc
Confidence 99999999999999999543 35788999999999999999999988 9999999999999999999999999998
Q ss_pred ccCCCCCccccc----eeeec---------cCCCCCccccchhHHHHHHHHHhCCCCCCCCCCcchhhhhHhHHhcCCcc
Q 004521 591 TFGGDETEGNTN----RVVGT---------YDGQFSIKSDVFSFGILLLEIVSGKKNRGFYRSDTKVNLIGHLWDEGIPL 657 (747)
Q Consensus 591 ~~~~~~~~~~~~----~~~~~---------~~~~~s~ksDVwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~ 657 (747)
.+.......... ...++ ....++.++|||||||++|||++|+.|+..... ...+... ......
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~---~~~~~~~-~~~~~~ 230 (267)
T cd06628 155 KLEANSLSTKTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQ---LQAIFKI-GENASP 230 (267)
T ss_pred ccccccccCCccccccccCCCcCccChhHhccCCCCchhhhHHHHHHHHHHhhCCCCCCCccH---HHHHHHH-hccCCC
Confidence 765321111000 00011 135678899999999999999999999753221 1111111 111111
Q ss_pred cccchhhhccCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 004521 658 RLIDACIQDSCNLADVIRCIHIGLLCVQQHPEDRPCMPSVIL 699 (747)
Q Consensus 658 ~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dP~~RPt~~~v~~ 699 (747)
.+ ... ....+.+++.+||+.+|.+||++.+|++
T Consensus 231 ~~-----~~~----~~~~~~~li~~~l~~~p~~Rp~~~~il~ 263 (267)
T cd06628 231 EI-----PSN----ISSEAIDFLEKTFEIDHNKRPTAAELLK 263 (267)
T ss_pred cC-----Ccc----cCHHHHHHHHHHccCCchhCcCHHHHhh
Confidence 11 111 1234566778999999999999999876
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-32 Score=284.71 Aligned_cols=242 Identities=34% Similarity=0.524 Sum_probs=183.0
Q ss_pred ceecccCCeeEEEEEecC-------CcEEEEEEecccc-cccHHHHHHHHHHHhccCCCceeeEEeEEEeCCeeEEEEec
Q 004521 446 NKLGEGGFGPVYKGTLVD-------GQEIAVKRLSKIS-EQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEF 517 (747)
Q Consensus 446 ~~lg~G~fg~Vy~~~~~~-------g~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~ 517 (747)
+.||+|+||.||+|+..+ ++.+|||.+.... .....++.+|+.+++.++||||+++++++...+..++||||
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (269)
T cd05044 1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIMEL 80 (269)
T ss_pred CccccccceeEEeeeecccccCcccceeehhhhhhcccchhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEEEec
Confidence 369999999999998643 2579999886532 34567899999999999999999999999999999999999
Q ss_pred CCCCChhhHhhhcC----CCCcCChhHHHHHHHHHHHHHHHhhhcCCCceEecccCcCcEEEcCCC-----CceEecccC
Q 004521 518 MPNKSLDSFIFDQT----RRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDM-----NPKISDFGL 588 (747)
Q Consensus 518 ~~~gsL~~~l~~~~----~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NIll~~~~-----~~kl~DFGl 588 (747)
+++++|.+++.... ....+++.+++.++.|++.||.|||+.+ ++|+||||+||+++.+. .+||+|||+
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~~~~~~l~dfg~ 157 (269)
T cd05044 81 MEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQMH---FIHRDLAARNCLVSEKGYDADRVVKIGDFGL 157 (269)
T ss_pred cCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhCC---cccCCCChheEEEecCCCCCCcceEECCccc
Confidence 99999999996532 2234788999999999999999999887 99999999999999887 899999999
Q ss_pred ccccCCCCCcccc-------ceeeec--cCCCCCccccchhHHHHHHHHHh-CCCCCCCCCCcchhhhhHhHHhcCCccc
Q 004521 589 VRTFGGDETEGNT-------NRVVGT--YDGQFSIKSDVFSFGILLLEIVS-GKKNRGFYRSDTKVNLIGHLWDEGIPLR 658 (747)
Q Consensus 589 a~~~~~~~~~~~~-------~~~~~~--~~~~~s~ksDVwS~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 658 (747)
++........... ...... ..+.++.++|||||||++|||++ |+.|+.... ........ ..+....
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt~g~~p~~~~~---~~~~~~~~-~~~~~~~ 233 (269)
T cd05044 158 ARDIYKSDYYRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALN---NQEVLQHV-TAGGRLQ 233 (269)
T ss_pred ccccccccccccCcccCCCccccCHHHHccCCcccchhHHHHHHHHHHHHHcCCCCCcccC---HHHHHHHH-hcCCccC
Confidence 9765432211100 000011 24678899999999999999998 898865322 11222211 1111111
Q ss_pred ccchhhhccCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhcC
Q 004521 659 LIDACIQDSCNLADVIRCIHIGLLCVQQHPEDRPCMPSVILMLGS 703 (747)
Q Consensus 659 ~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dP~~RPt~~~v~~~L~~ 703 (747)
.. . .....+.+++.+||+.+|.+||++.+|+++|+.
T Consensus 234 ~~-----~----~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 269 (269)
T cd05044 234 KP-----E----NCPDKIYQLMTNCWAQDPSERPTFDRIQEILQN 269 (269)
T ss_pred Cc-----c----cchHHHHHHHHHHcCCCcccCCCHHHHHHHHhC
Confidence 10 0 112345678889999999999999999999863
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-32 Score=280.83 Aligned_cols=243 Identities=22% Similarity=0.309 Sum_probs=185.9
Q ss_pred CCCccceecccCCeeEEEEEec-CCcEEEEEEeccc-ccccHHHHHHHHHHHhccCCCceeeEEeEEEeCCeeEEEEecC
Q 004521 441 NFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKI-SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFM 518 (747)
Q Consensus 441 ~~~~~~~lg~G~fg~Vy~~~~~-~g~~vavK~l~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~ 518 (747)
+|++.+.||+|+||.||+++.. +++.+|+|.++.. .....+.+.+|+.+++.++|+||+++++.+..+...++||||+
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (255)
T cd08219 1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVMEYC 80 (255)
T ss_pred CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcchHHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEeeC
Confidence 4778899999999999999875 4889999998642 2344567889999999999999999999999999999999999
Q ss_pred CCCChhhHhhhcCCCCcCChhHHHHHHHHHHHHHHHhhhcCCCceEecccCcCcEEEcCCCCceEecccCccccCCCCCc
Q 004521 519 PNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETE 598 (747)
Q Consensus 519 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~ 598 (747)
++++|.+++... ....++...+..++.|++.||.|||+.+ |+|+||||+||++++++.++|+|||+++.+......
T Consensus 81 ~~~~l~~~~~~~-~~~~~~~~~~~~~~~~i~~al~~lH~~~---i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~~ 156 (255)
T cd08219 81 DGGDLMQKIKLQ-RGKLFPEDTILQWFVQMCLGVQHIHEKR---VLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGAY 156 (255)
T ss_pred CCCcHHHHHHhc-cCCCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCcceEEECCCCcEEEcccCcceeecccccc
Confidence 999999988543 2345788999999999999999999988 999999999999999999999999999766432211
Q ss_pred ccc----ceeeec---cCCCCCccccchhHHHHHHHHHhCCCCCCCCCCcchhhhhHhHHhcCCcccccchhhhccCCHH
Q 004521 599 GNT----NRVVGT---YDGQFSIKSDVFSFGILLLEIVSGKKNRGFYRSDTKVNLIGHLWDEGIPLRLIDACIQDSCNLA 671 (747)
Q Consensus 599 ~~~----~~~~~~---~~~~~s~ksDVwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~ 671 (747)
... .....+ ....++.++||||||+++|||++|+.|+.... ........ ..+....+.. ..
T Consensus 157 ~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~---~~~~~~~~-~~~~~~~~~~-----~~--- 224 (255)
T cd08219 157 ACTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQANS---WKNLILKV-CQGSYKPLPS-----HY--- 224 (255)
T ss_pred cccccCCccccCHHHHccCCcCchhhhhhhchhheehhhccCCCCCCC---HHHHHHHH-hcCCCCCCCc-----cc---
Confidence 100 000000 13567889999999999999999999975321 11122111 1222211111 11
Q ss_pred HHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 004521 672 DVIRCIHIGLLCVQQHPEDRPCMPSVILM 700 (747)
Q Consensus 672 ~~~~~~~l~~~Cl~~dP~~RPt~~~v~~~ 700 (747)
...+.+++.+||+.||++||++.+|+..
T Consensus 225 -~~~~~~li~~~l~~~P~~Rp~~~~il~~ 252 (255)
T cd08219 225 -SYELRSLIKQMFKRNPRSRPSATTILSR 252 (255)
T ss_pred -CHHHHHHHHHHHhCCcccCCCHHHHhhc
Confidence 1235577789999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-32 Score=289.27 Aligned_cols=228 Identities=21% Similarity=0.260 Sum_probs=170.5
Q ss_pred ceecccCCeeEEEEEecC-CcEEEEEEecccc---cccHHHHHHHHH-HHhccCCCceeeEEeEEEeCCeeEEEEecCCC
Q 004521 446 NKLGEGGFGPVYKGTLVD-GQEIAVKRLSKIS---EQGLKELKNEVI-LFSKLQHRNLVKLLGCCIQGEEKLLIYEFMPN 520 (747)
Q Consensus 446 ~~lg~G~fg~Vy~~~~~~-g~~vavK~l~~~~---~~~~~~~~~E~~-~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~ 520 (747)
+.||+|+||.||+|+..+ ++.||+|++.+.. ......+.+|.. +++.++||||+++++++.+.+..++||||+++
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 80 (321)
T cd05603 1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYVNG 80 (321)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 479999999999999854 8899999987521 223345555554 67889999999999999999999999999999
Q ss_pred CChhhHhhhcCCCCcCChhHHHHHHHHHHHHHHHhhhcCCCceEecccCcCcEEEcCCCCceEecccCccccCCCCCccc
Q 004521 521 KSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGN 600 (747)
Q Consensus 521 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~ 600 (747)
++|..++.. ...+++..+..++.||++||.|||+.+ |+||||||+||||+.++.+||+|||+++.........
T Consensus 81 ~~L~~~l~~---~~~~~~~~~~~~~~qi~~~L~~lH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~- 153 (321)
T cd05603 81 GELFFHLQR---ERCFLEPRARFYAAEVASAIGYLHSLN---IIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPEETT- 153 (321)
T ss_pred CCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeEECCCCCEEEccCCCCccCCCCCCcc-
Confidence 999888854 234788888999999999999999988 9999999999999999999999999987532211110
Q ss_pred cceeeec---------cCCCCCccccchhHHHHHHHHHhCCCCCCCCCCcchhhhhHhHHhcCCcccccchhhhccCCHH
Q 004521 601 TNRVVGT---------YDGQFSIKSDVFSFGILLLEIVSGKKNRGFYRSDTKVNLIGHLWDEGIPLRLIDACIQDSCNLA 671 (747)
Q Consensus 601 ~~~~~~~---------~~~~~s~ksDVwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~ 671 (747)
....++ ....++.++|||||||++|||++|+.||.... ............ ..+. ..
T Consensus 154 -~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~---~~~~~~~i~~~~--~~~~-----~~---- 218 (321)
T cd05603 154 -STFCGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSRD---VSQMYDNILHKP--LQLP-----GG---- 218 (321)
T ss_pred -ccccCCcccCCHHHhcCCCCCCcCcccccchhhhhhhcCCCCCCCCC---HHHHHHHHhcCC--CCCC-----CC----
Confidence 111111 14568899999999999999999999974321 112222221111 1111 11
Q ss_pred HHHHHHHHHHhccCCCCCCCCCHH
Q 004521 672 DVIRCIHIGLLCVQQHPEDRPCMP 695 (747)
Q Consensus 672 ~~~~~~~l~~~Cl~~dP~~RPt~~ 695 (747)
....+.+++.+||+.+|.+||+..
T Consensus 219 ~~~~~~~li~~~l~~~p~~R~~~~ 242 (321)
T cd05603 219 KTVAACDLLVGLLHKDQRRRLGAK 242 (321)
T ss_pred CCHHHHHHHHHHccCCHhhcCCCC
Confidence 122356778899999999999764
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-32 Score=285.21 Aligned_cols=246 Identities=24% Similarity=0.401 Sum_probs=187.2
Q ss_pred cCCCccceecccCCeeEEEEEecC----CcEEEEEEecccc-cccHHHHHHHHHHHhccCCCceeeEEeEEEeCCeeEEE
Q 004521 440 DNFSINNKLGEGGFGPVYKGTLVD----GQEIAVKRLSKIS-EQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLI 514 (747)
Q Consensus 440 ~~~~~~~~lg~G~fg~Vy~~~~~~----g~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV 514 (747)
++|.+.+.||+|+||.||+|...+ ...||||...... ....+.+.+|+.++++++||||+++++++.+ +..++|
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-~~~~lv 84 (270)
T cd05056 6 EDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKLIGVITE-NPVWIV 84 (270)
T ss_pred hhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcCCHHHHHHHHHHHHHHHhCCCCchhceeEEEcC-CCcEEE
Confidence 467888999999999999998644 2468999887543 4456689999999999999999999999875 557899
Q ss_pred EecCCCCChhhHhhhcCCCCcCChhHHHHHHHHHHHHHHHhhhcCCCceEecccCcCcEEEcCCCCceEecccCccccCC
Q 004521 515 YEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGG 594 (747)
Q Consensus 515 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NIll~~~~~~kl~DFGla~~~~~ 594 (747)
|||+++++|.+++.... ..+++..++.++.+++.||+|||+.+ ++||||||+||+++.++.+||+|||+++....
T Consensus 85 ~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~~l~~~l~~lH~~~---~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~ 159 (270)
T cd05056 85 MELAPLGELRSYLQVNK--YSLDLASLILYSYQLSTALAYLESKR---FVHRDIAARNVLVSSPDCVKLGDFGLSRYLED 159 (270)
T ss_pred EEcCCCCcHHHHHHhCC--CCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccChheEEEecCCCeEEccCceeeeccc
Confidence 99999999999996532 34899999999999999999999988 99999999999999999999999999986644
Q ss_pred CCCcccc------ceeeec--cCCCCCccccchhHHHHHHHHHh-CCCCCCCCCCcchhhhhHhHHhcCCcccccchhhh
Q 004521 595 DETEGNT------NRVVGT--YDGQFSIKSDVFSFGILLLEIVS-GKKNRGFYRSDTKVNLIGHLWDEGIPLRLIDACIQ 665 (747)
Q Consensus 595 ~~~~~~~------~~~~~~--~~~~~s~ksDVwS~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 665 (747)
....... ....+. ....++.++||||||+++|||++ |..||..... ....... ..+......
T Consensus 160 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~---~~~~~~~-~~~~~~~~~----- 230 (270)
T cd05056 160 ESYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKN---NDVIGRI-ENGERLPMP----- 230 (270)
T ss_pred ccceecCCCCccccccChhhhccCCCCchhhhHHHHHHHHHHHHcCCCCCCCCCH---HHHHHHH-HcCCcCCCC-----
Confidence 3211110 000011 13567889999999999999996 9999753322 1222222 122111111
Q ss_pred ccCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhcCC
Q 004521 666 DSCNLADVIRCIHIGLLCVQQHPEDRPCMPSVILMLGSE 704 (747)
Q Consensus 666 ~~~~~~~~~~~~~l~~~Cl~~dP~~RPt~~~v~~~L~~~ 704 (747)
... ...+.+++.+|+..+|.+||++.+++..|++.
T Consensus 231 ~~~----~~~~~~li~~~l~~~P~~Rpt~~~~~~~l~~~ 265 (270)
T cd05056 231 PNC----PPTLYSLMTKCWAYDPSKRPRFTELKAQLSDI 265 (270)
T ss_pred CCC----CHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 111 12466788899999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-32 Score=279.13 Aligned_cols=244 Identities=22% Similarity=0.342 Sum_probs=187.5
Q ss_pred CCCccceecccCCeeEEEEEecC-CcEEEEEEeccc--ccccHHHHHHHHHHHhccCCCceeeEEeEEEeCCeeEEEEec
Q 004521 441 NFSINNKLGEGGFGPVYKGTLVD-GQEIAVKRLSKI--SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEF 517 (747)
Q Consensus 441 ~~~~~~~lg~G~fg~Vy~~~~~~-g~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~ 517 (747)
+|+..+.||+|+||.||.++... ++.+++|.+... .....+.+.+|+.++++++|+||+++++++.+.+..++||||
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~~~e~ 80 (256)
T cd08221 1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEMEY 80 (256)
T ss_pred CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEEecCCeEEEEEEe
Confidence 47888999999999999998644 889999997642 345567789999999999999999999999999999999999
Q ss_pred CCCCChhhHhhhcCCCCcCChhHHHHHHHHHHHHHHHhhhcCCCceEecccCcCcEEEcCCCCceEecccCccccCCCCC
Q 004521 518 MPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDET 597 (747)
Q Consensus 518 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~ 597 (747)
+++++|.+++.... ...+++..+..++.|+++||.|||+.+ ++|+||+|+||++++++.+||+|||+++.......
T Consensus 81 ~~~~~L~~~~~~~~-~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~~~~ 156 (256)
T cd08221 81 ANGGTLYDKIVRQK-GQLFEEEMVLWYLFQIVSAVSYIHKAG---ILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYS 156 (256)
T ss_pred cCCCcHHHHHHhcc-ccCCCHHHHHHHHHHHHHHHHHHHhCC---ccccCCChHhEEEeCCCCEEECcCcceEEcccccc
Confidence 99999999986542 345889999999999999999999988 99999999999999999999999999987644331
Q ss_pred cccc-----ceeeec--cCCCCCccccchhHHHHHHHHHhCCCCCCCCCCcchhhhhHhHHhcCCcccccchhhhccCCH
Q 004521 598 EGNT-----NRVVGT--YDGQFSIKSDVFSFGILLLEIVSGKKNRGFYRSDTKVNLIGHLWDEGIPLRLIDACIQDSCNL 670 (747)
Q Consensus 598 ~~~~-----~~~~~~--~~~~~s~ksDVwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~ 670 (747)
.... ...... .+..++.++||||||+++|||++|+.|+..... ....... ..+...... ..
T Consensus 157 ~~~~~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~---~~~~~~~-~~~~~~~~~-----~~--- 224 (256)
T cd08221 157 MAETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATNP---LNLVVKI-VQGNYTPVV-----SV--- 224 (256)
T ss_pred cccccCCCccccCHhhcCCCCCCCcchhHHHHHHHHHHHHCCCCCCCCCH---HHHHHHH-HcCCCCCCc-----cc---
Confidence 1000 000000 134578899999999999999999999653221 1112111 112111111 11
Q ss_pred HHHHHHHHHHHhccCCCCCCCCCHHHHHHHh
Q 004521 671 ADVIRCIHIGLLCVQQHPEDRPCMPSVILML 701 (747)
Q Consensus 671 ~~~~~~~~l~~~Cl~~dP~~RPt~~~v~~~L 701 (747)
....+.+++.+||+.+|.+||++.++++.+
T Consensus 225 -~~~~~~~~i~~~l~~~p~~R~s~~~ll~~~ 254 (256)
T cd08221 225 -YSSELISLVHSLLQQDPEKRPTADEVLDQP 254 (256)
T ss_pred -cCHHHHHHHHHHcccCcccCCCHHHHhhCc
Confidence 112356778899999999999999998764
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-32 Score=300.97 Aligned_cols=250 Identities=19% Similarity=0.253 Sum_probs=181.3
Q ss_pred hcCCCccceecccCCeeEEEEEecC---CcEEEEEEecccccccHHHHHHHHHHHhccCCCceeeEEeEEEeCCeeEEEE
Q 004521 439 TDNFSINNKLGEGGFGPVYKGTLVD---GQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIY 515 (747)
Q Consensus 439 ~~~~~~~~~lg~G~fg~Vy~~~~~~---g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 515 (747)
..+|.+.+.||+|+||.||++...+ ++.||||.+... +.+.+|++++++++||||+++++++......++||
T Consensus 91 ~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~-----~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~ 165 (392)
T PHA03207 91 RMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG-----KTPGREIDILKTISHRAIINLIHAYRWKSTVCMVM 165 (392)
T ss_pred cCceEEEEeecCCCCeEEEEEEEcCCccceeEEEEecccc-----ccHHHHHHHHHhcCCCCccceeeeEeeCCEEEEEe
Confidence 3579999999999999999997543 578999988642 24568999999999999999999999999999999
Q ss_pred ecCCCCChhhHhhhcCCCCcCChhHHHHHHHHHHHHHHHhhhcCCCceEecccCcCcEEEcCCCCceEecccCccccCCC
Q 004521 516 EFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGD 595 (747)
Q Consensus 516 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NIll~~~~~~kl~DFGla~~~~~~ 595 (747)
|++. ++|.+++. ....+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++.+...
T Consensus 166 e~~~-~~l~~~l~---~~~~l~~~~~~~i~~ql~~aL~~LH~~g---ivHrDlkp~Nill~~~~~~~l~DfG~a~~~~~~ 238 (392)
T PHA03207 166 PKYK-CDLFTYVD---RSGPLPLEQAITIQRRLLEALAYLHGRG---IIHRDVKTENIFLDEPENAVLGDFGAACKLDAH 238 (392)
T ss_pred hhcC-CCHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEcCCCCEEEccCccccccCcc
Confidence 9996 68888883 2345899999999999999999999988 999999999999999999999999999766443
Q ss_pred CCccccceeeec---------cCCCCCccccchhHHHHHHHHHhCCCCCCCCCCcchhhhhHhHHhc-C-Ccccccc---
Q 004521 596 ETEGNTNRVVGT---------YDGQFSIKSDVFSFGILLLEIVSGKKNRGFYRSDTKVNLIGHLWDE-G-IPLRLID--- 661 (747)
Q Consensus 596 ~~~~~~~~~~~~---------~~~~~s~ksDVwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~-~-~~~~~~d--- 661 (747)
..........++ ....++.++|||||||+||||++|+.|+...........+..+... + ....+..
T Consensus 239 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~l~~i~~~~~~~~~~~~~~~~ 318 (392)
T PHA03207 239 PDTPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIRCMQVHPLEFPQNGS 318 (392)
T ss_pred cccccccccccccCccCHhHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHHHHHHHHhccCccccCCccc
Confidence 221111111122 1356889999999999999999999997543322111111111000 0 0000000
Q ss_pred -----------hhhhccCCH-------HHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 004521 662 -----------ACIQDSCNL-------ADVIRCIHIGLLCVQQHPEDRPCMPSVILM 700 (747)
Q Consensus 662 -----------~~l~~~~~~-------~~~~~~~~l~~~Cl~~dP~~RPt~~~v~~~ 700 (747)
......... .....+..++.+||+.||++||++.+++.+
T Consensus 319 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~~ 375 (392)
T PHA03207 319 TNLCKHFKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDILSL 375 (392)
T ss_pred hhHHHHHHhhcccccCCccccchhhccCcchhHHHHHHHHhccChhhCCCHHHHhhC
Confidence 000000000 001234567789999999999999999875
|
|
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-32 Score=297.71 Aligned_cols=250 Identities=19% Similarity=0.235 Sum_probs=184.6
Q ss_pred HHHHHhcCCCccceecccCCeeEEEEEecC-CcEEEEEEeccc---ccccHHHHHHHHHHHhccCCCceeeEEeEEEeCC
Q 004521 434 TIANATDNFSINNKLGEGGFGPVYKGTLVD-GQEIAVKRLSKI---SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGE 509 (747)
Q Consensus 434 ~~~~~~~~~~~~~~lg~G~fg~Vy~~~~~~-g~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~ 509 (747)
++....++|++.+.||+|+||.||+++... ++.+|+|.+.+. .....+.+.+|+.+++.++||||+++++++.++.
T Consensus 37 ~~~~~~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~ 116 (371)
T cd05622 37 DLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDR 116 (371)
T ss_pred hcCcchhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCC
Confidence 344456799999999999999999999865 789999998642 2233456889999999999999999999999999
Q ss_pred eeEEEEecCCCCChhhHhhhcCCCCcCChhHHHHHHHHHHHHHHHhhhcCCCceEecccCcCcEEEcCCCCceEecccCc
Q 004521 510 EKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLV 589 (747)
Q Consensus 510 ~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NIll~~~~~~kl~DFGla 589 (747)
..++||||+++|+|.+++.. ..++...+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||++
T Consensus 117 ~~~lv~Ey~~gg~L~~~~~~----~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDLkp~NIll~~~~~ikL~DfG~a 189 (371)
T cd05622 117 YLYMVMEYMPGGDLVNLMSN----YDVPEKWARFYTAEVVLALDAIHSMG---FIHRDVKPDNMLLDKSGHLKLADFGTC 189 (371)
T ss_pred EEEEEEcCCCCCcHHHHHHh----cCCCHHHHHHHHHHHHHHHHHHHHCC---EEeCCCCHHHEEECCCCCEEEEeCCce
Confidence 99999999999999999854 23788888999999999999999988 999999999999999999999999999
Q ss_pred cccCCCCCccccceeeecc-------------CCCCCccccchhHHHHHHHHHhCCCCCCCCCCcchhhhhHhHHhcCCc
Q 004521 590 RTFGGDETEGNTNRVVGTY-------------DGQFSIKSDVFSFGILLLEIVSGKKNRGFYRSDTKVNLIGHLWDEGIP 656 (747)
Q Consensus 590 ~~~~~~~~~~~~~~~~~~~-------------~~~~s~ksDVwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~ 656 (747)
+.+........ ....|+. ...++.++|||||||+||||++|+.||.... .......+......
T Consensus 190 ~~~~~~~~~~~-~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~---~~~~~~~i~~~~~~ 265 (371)
T cd05622 190 MKMNKEGMVRC-DTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADS---LVGTYSKIMNHKNS 265 (371)
T ss_pred eEcCcCCcccc-cCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCC---HHHHHHHHHcCCCc
Confidence 87643221110 0111110 1347899999999999999999999975322 11222222221111
Q ss_pred ccccchhhhccCCHHHHHHHHHHHHhccCCCCCC--CCCHHHHHHHh
Q 004521 657 LRLIDACIQDSCNLADVIRCIHIGLLCVQQHPED--RPCMPSVILML 701 (747)
Q Consensus 657 ~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dP~~--RPt~~~v~~~L 701 (747)
..+.+. ... ...+.+++.+|++.++.+ ||++.+|++..
T Consensus 266 ~~~~~~---~~~----s~~~~~li~~~L~~~~~r~~r~~~~ei~~h~ 305 (371)
T cd05622 266 LTFPDD---NDI----SKEAKNLICAFLTDREVRLGRNGVEEIKRHL 305 (371)
T ss_pred ccCCCc---CCC----CHHHHHHHHHHcCChhhhcCCCCHHHHhcCc
Confidence 111111 011 122445667888744433 78888888753
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-32 Score=285.15 Aligned_cols=244 Identities=22% Similarity=0.279 Sum_probs=181.5
Q ss_pred CCccceecccCCeeEEEEEec-CCcEEEEEEecccc---cccHHHHHHHHHHHhccCCCceeeEEeEEEeCCeeEEEEec
Q 004521 442 FSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKIS---EQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEF 517 (747)
Q Consensus 442 ~~~~~~lg~G~fg~Vy~~~~~-~g~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~ 517 (747)
|+..+.||+|+||+||+|... +++.+|+|.+.... ......+.+|++++++++|+||+++.+++..++..++||||
T Consensus 2 ~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~ 81 (285)
T cd05632 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVLTI 81 (285)
T ss_pred ceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCCEEEEEEEe
Confidence 566789999999999999875 48899999986522 22345678899999999999999999999999999999999
Q ss_pred CCCCChhhHhhhcCCCCcCChhHHHHHHHHHHHHHHHhhhcCCCceEecccCcCcEEEcCCCCceEecccCccccCCCCC
Q 004521 518 MPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDET 597 (747)
Q Consensus 518 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~ 597 (747)
+++++|.+++.... ...+++..+..++.|++.||.|||+.+ |+||||||+||++++++.+||+|||+++.......
T Consensus 82 ~~~~~L~~~~~~~~-~~~~~~~~~~~~~~ql~~~l~~lH~~~---iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~ 157 (285)
T cd05632 82 MNGGDLKFHIYNMG-NPGFEEERALFYAAEILCGLEDLHREN---TVYRDLKPENILLDDYGHIRISDLGLAVKIPEGES 157 (285)
T ss_pred ccCccHHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCCHHHEEECCCCCEEEecCCcceecCCCCc
Confidence 99999998886533 235899999999999999999999988 99999999999999999999999999876532211
Q ss_pred cc----ccceeeec--cCCCCCccccchhHHHHHHHHHhCCCCCCCCCCcchhhhhHhHHhcCCcccccchhhhccCCHH
Q 004521 598 EG----NTNRVVGT--YDGQFSIKSDVFSFGILLLEIVSGKKNRGFYRSDTKVNLIGHLWDEGIPLRLIDACIQDSCNLA 671 (747)
Q Consensus 598 ~~----~~~~~~~~--~~~~~s~ksDVwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~ 671 (747)
.. ........ ....++.++|||||||++|||++|+.||...........+......... . .....
T Consensus 158 ~~~~~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~~~~~~~~~~~~~~~-~-----~~~~~--- 228 (285)
T cd05632 158 IRGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVKREEVDRRVLETEE-V-----YSAKF--- 228 (285)
T ss_pred ccCCCCCcCccChHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhhcccc-c-----cCccC---
Confidence 10 00000000 1456889999999999999999999997543222111111111111110 0 01111
Q ss_pred HHHHHHHHHHhccCCCCCCCCC-----HHHHHH
Q 004521 672 DVIRCIHIGLLCVQQHPEDRPC-----MPSVIL 699 (747)
Q Consensus 672 ~~~~~~~l~~~Cl~~dP~~RPt-----~~~v~~ 699 (747)
...+.+|+..||+.||++||+ +.+++.
T Consensus 229 -~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~ 260 (285)
T cd05632 229 -SEEAKSICKMLLTKDPKQRLGCQEEGAGEVKR 260 (285)
T ss_pred -CHHHHHHHHHHccCCHhHcCCCcccChHHHHc
Confidence 123456778999999999999 556554
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-32 Score=288.22 Aligned_cols=240 Identities=23% Similarity=0.396 Sum_probs=183.9
Q ss_pred CCCccceecccCCeeEEEEEecC-CcEEEEEEeccc-ccccHHHHHHHHHHHhccCCCceeeEEeEEEeCCeeEEEEecC
Q 004521 441 NFSINNKLGEGGFGPVYKGTLVD-GQEIAVKRLSKI-SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFM 518 (747)
Q Consensus 441 ~~~~~~~lg~G~fg~Vy~~~~~~-g~~vavK~l~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~ 518 (747)
.|+..+.||+|+||.||+|.... ++.||+|.+... .....+.+.+|+.++++++||||+++++++......++||||+
T Consensus 5 ~y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 84 (277)
T cd06642 5 LFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWIIMEYL 84 (277)
T ss_pred HHHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccchHHHHHHHHHHHHHHcCCCCccHhhhcccccCCceEEEEEcc
Confidence 45667889999999999998754 789999998743 2344567899999999999999999999999999999999999
Q ss_pred CCCChhhHhhhcCCCCcCChhHHHHHHHHHHHHHHHhhhcCCCceEecccCcCcEEEcCCCCceEecccCccccCCCCCc
Q 004521 519 PNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETE 598 (747)
Q Consensus 519 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~ 598 (747)
++++|.+++.. ..+++..+..++.|+++||.|||+.+ ++|+||+|+||++++++.+||+|||+++.+......
T Consensus 85 ~~~~L~~~~~~----~~~~~~~~~~~~~~i~~~l~~lH~~~---ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~~ 157 (277)
T cd06642 85 GGGSALDLLKP----GPLEETYIATILREILKGLDYLHSER---KIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIK 157 (277)
T ss_pred CCCcHHHHhhc----CCCCHHHHHHHHHHHHHHHHHHhcCC---eeccCCChheEEEeCCCCEEEccccccccccCcchh
Confidence 99999998843 35789999999999999999999988 999999999999999999999999999766433211
Q ss_pred ccc-----ceeeec--cCCCCCccccchhHHHHHHHHHhCCCCCCCCCCcchhhhhHhHHhcCCcccccchhhhccCCHH
Q 004521 599 GNT-----NRVVGT--YDGQFSIKSDVFSFGILLLEIVSGKKNRGFYRSDTKVNLIGHLWDEGIPLRLIDACIQDSCNLA 671 (747)
Q Consensus 599 ~~~-----~~~~~~--~~~~~s~ksDVwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~ 671 (747)
... ...... ....++.++|||||||++|||++|+.|+....... ... ......... +.. .
T Consensus 158 ~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~---~~~-~~~~~~~~~-----~~~----~ 224 (277)
T cd06642 158 RNTFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLHPMR---VLF-LIPKNSPPT-----LEG----Q 224 (277)
T ss_pred hhcccCcccccCHHHhCcCCCchhhhHHHHHHHHHHHHhCCCCCcccchhh---HHh-hhhcCCCCC-----CCc----c
Confidence 100 000000 13567889999999999999999999964322111 111 111111111 111 1
Q ss_pred HHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 004521 672 DVIRCIHIGLLCVQQHPEDRPCMPSVILM 700 (747)
Q Consensus 672 ~~~~~~~l~~~Cl~~dP~~RPt~~~v~~~ 700 (747)
....+.+++.+||+.+|.+||+|.+|+++
T Consensus 225 ~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 253 (277)
T cd06642 225 YSKPFKEFVEACLNKDPRFRPTAKELLKH 253 (277)
T ss_pred cCHHHHHHHHHHccCCcccCcCHHHHHHh
Confidence 12345678889999999999999999984
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-32 Score=281.94 Aligned_cols=247 Identities=20% Similarity=0.357 Sum_probs=184.7
Q ss_pred CCCccceecccCCeeEEEEEecC--CcEEEEEEeccc----------ccccHHHHHHHHHHHhc-cCCCceeeEEeEEEe
Q 004521 441 NFSINNKLGEGGFGPVYKGTLVD--GQEIAVKRLSKI----------SEQGLKELKNEVILFSK-LQHRNLVKLLGCCIQ 507 (747)
Q Consensus 441 ~~~~~~~lg~G~fg~Vy~~~~~~--g~~vavK~l~~~----------~~~~~~~~~~E~~~l~~-l~H~niv~l~g~~~~ 507 (747)
+|++.+.||+|+||.||+|.... ++.+|+|.+... ......++..|+.++.+ ++||||+++++++..
T Consensus 1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~ 80 (269)
T cd08528 1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLE 80 (269)
T ss_pred CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEcc
Confidence 47788999999999999999865 678999987531 12234567788888875 799999999999999
Q ss_pred CCeeEEEEecCCCCChhhHhhhc-CCCCcCChhHHHHHHHHHHHHHHHhhh-cCCCceEecccCcCcEEEcCCCCceEec
Q 004521 508 GEEKLLIYEFMPNKSLDSFIFDQ-TRRTLLDWSQRFHIICGTARGLLYLHQ-DSRLRIIHRDLKASNVLLDQDMNPKISD 585 (747)
Q Consensus 508 ~~~~~lV~E~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~ia~gl~yLH~-~~~~~iiHrDlkp~NIll~~~~~~kl~D 585 (747)
.+..++||||+++++|.+++... .....+++..++.++.|++.||.|||+ .+ ++|+||+|+||+++.++.+||+|
T Consensus 81 ~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~---i~H~dl~~~nil~~~~~~~~l~d 157 (269)
T cd08528 81 NDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEKR---IVHRDLTPNNIMLGEDDKVTITD 157 (269)
T ss_pred CCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccCCc---eeecCCCHHHEEECCCCcEEEec
Confidence 99999999999999999988542 234458899999999999999999996 45 99999999999999999999999
Q ss_pred ccCccccCCCCCcccc----ceeee--ccCCCCCccccchhHHHHHHHHHhCCCCCCCCCCcchhhhhHhHHhcCCcccc
Q 004521 586 FGLVRTFGGDETEGNT----NRVVG--TYDGQFSIKSDVFSFGILLLEIVSGKKNRGFYRSDTKVNLIGHLWDEGIPLRL 659 (747)
Q Consensus 586 FGla~~~~~~~~~~~~----~~~~~--~~~~~~s~ksDVwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 659 (747)
||++............ ..... .....++.++||||||+++|||++|+.|+.... ........ .++.....
T Consensus 158 fg~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~~g~~p~~~~~---~~~~~~~~-~~~~~~~~ 233 (269)
T cd08528 158 FGLAKQKQPESKLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTN---MLSLATKI-VEAVYEPL 233 (269)
T ss_pred ccceeecccccccccccCcccCcChhhhcCCCCchHHHHHHHHHHHHHHHhCCCcccccC---HHHHHHHH-hhccCCcC
Confidence 9999865443210000 00000 014567899999999999999999999964221 11111111 11111111
Q ss_pred cchhhhccCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhc
Q 004521 660 IDACIQDSCNLADVIRCIHIGLLCVQQHPEDRPCMPSVILMLG 702 (747)
Q Consensus 660 ~d~~l~~~~~~~~~~~~~~l~~~Cl~~dP~~RPt~~~v~~~L~ 702 (747)
.. .. ....+.+++.+||+.||++||++.||..+|+
T Consensus 234 ~~----~~----~~~~l~~li~~cl~~~p~~Rp~~~e~~~~~~ 268 (269)
T cd08528 234 PE----GM----YSEDVTDVITSCLTPDAEARPDIIQVSAMIS 268 (269)
T ss_pred Cc----cc----CCHHHHHHHHHHCCCCCccCCCHHHHHHHhc
Confidence 11 01 1134667888999999999999999999986
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-32 Score=295.07 Aligned_cols=187 Identities=20% Similarity=0.282 Sum_probs=151.7
Q ss_pred HHhcCCCccceecccCCeeEEEEEecC-CcEEEEEEecccccccHHHHHHHHHHHhccCCCceeeEEeEEEeCCeeEEEE
Q 004521 437 NATDNFSINNKLGEGGFGPVYKGTLVD-GQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIY 515 (747)
Q Consensus 437 ~~~~~~~~~~~lg~G~fg~Vy~~~~~~-g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 515 (747)
....+|++.+.||+|+||.||+|+... ++.||+|..... ....|+.++++++|+||+++++++......++||
T Consensus 63 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~------~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 136 (357)
T PHA03209 63 VASLGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKG------TTLIEAMLLQNVNHPSVIRMKDTLVSGAITCMVL 136 (357)
T ss_pred hhhcCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCcc------ccHHHHHHHHhCCCCCCcChhheEEeCCeeEEEE
Confidence 344679999999999999999999865 678999975432 2356899999999999999999999999999999
Q ss_pred ecCCCCChhhHhhhcCCCCcCChhHHHHHHHHHHHHHHHhhhcCCCceEecccCcCcEEEcCCCCceEecccCccccCCC
Q 004521 516 EFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGD 595 (747)
Q Consensus 516 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NIll~~~~~~kl~DFGla~~~~~~ 595 (747)
||+. ++|.+++... ...+++..+..|+.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++.....
T Consensus 137 e~~~-~~l~~~l~~~--~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~ 210 (357)
T PHA03209 137 PHYS-SDLYTYLTKR--SRPLPIDQALIIEKQILEGLRYLHAQR---IIHRDVKTENIFINDVDQVCIGDLGAAQFPVVA 210 (357)
T ss_pred EccC-CcHHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEEecCccccccccC
Confidence 9995 6888888543 345899999999999999999999988 999999999999999999999999999753322
Q ss_pred CCcc----ccceeee--ccCCCCCccccchhHHHHHHHHHhCCCCC
Q 004521 596 ETEG----NTNRVVG--TYDGQFSIKSDVFSFGILLLEIVSGKKNR 635 (747)
Q Consensus 596 ~~~~----~~~~~~~--~~~~~~s~ksDVwS~Gvvl~elltg~~p~ 635 (747)
.... ....... .....++.++|||||||++|||+++..++
T Consensus 211 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~~~~ 256 (357)
T PHA03209 211 PAFLGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTI 256 (357)
T ss_pred cccccccccccccCCeecCCCCCCchhhHHHHHHHHHHHHHcCCcc
Confidence 1110 0000000 11456889999999999999999976654
|
|
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-32 Score=291.93 Aligned_cols=231 Identities=21% Similarity=0.250 Sum_probs=172.5
Q ss_pred ceecccCCeeEEEEEec-CCcEEEEEEeccc---ccccHHHHHHHHH-HHhccCCCceeeEEeEEEeCCeeEEEEecCCC
Q 004521 446 NKLGEGGFGPVYKGTLV-DGQEIAVKRLSKI---SEQGLKELKNEVI-LFSKLQHRNLVKLLGCCIQGEEKLLIYEFMPN 520 (747)
Q Consensus 446 ~~lg~G~fg~Vy~~~~~-~g~~vavK~l~~~---~~~~~~~~~~E~~-~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~ 520 (747)
+.||+|+||.||+|+.. +|+.+|||++.+. ......++..|.. +++.++||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05604 1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNG 80 (325)
T ss_pred CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcCCCC
Confidence 46999999999999875 4899999998752 2233445566655 46779999999999999999999999999999
Q ss_pred CChhhHhhhcCCCCcCChhHHHHHHHHHHHHHHHhhhcCCCceEecccCcCcEEEcCCCCceEecccCccccCCCCCccc
Q 004521 521 KSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGN 600 (747)
Q Consensus 521 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~ 600 (747)
|+|..++.. ...+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++.........
T Consensus 81 ~~L~~~l~~---~~~~~~~~~~~~~~qi~~al~~lH~~g---ivH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~~~~~~- 153 (325)
T cd05604 81 GELFFHLQR---ERSFPEPRARFYAAEIASALGYLHSIN---IVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQSDTT- 153 (325)
T ss_pred CCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHeEECCCCCEEEeecCCcccCCCCCCCc-
Confidence 999988854 335889999999999999999999988 9999999999999999999999999987532211110
Q ss_pred cceeeec---------cCCCCCccccchhHHHHHHHHHhCCCCCCCCCCcchhhhhHhHHhcCCcccccchhhhccCCHH
Q 004521 601 TNRVVGT---------YDGQFSIKSDVFSFGILLLEIVSGKKNRGFYRSDTKVNLIGHLWDEGIPLRLIDACIQDSCNLA 671 (747)
Q Consensus 601 ~~~~~~~---------~~~~~s~ksDVwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~ 671 (747)
....++ .+..++.++|||||||++|||++|+.||.... ........... .. . . ....
T Consensus 154 -~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~---~~~~~~~~~~~-~~-~-~----~~~~--- 219 (325)
T cd05604 154 -TTFCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRD---VAEMYDNILHK-PL-V-L----RPGA--- 219 (325)
T ss_pred -ccccCChhhCCHHHHcCCCCCCcCccccccceehhhhcCCCCCCCCC---HHHHHHHHHcC-Cc-c-C----CCCC---
Confidence 111111 14568899999999999999999999975322 11222222111 10 0 0 0111
Q ss_pred HHHHHHHHHHhccCCCCCCCCCHHHHH
Q 004521 672 DVIRCIHIGLLCVQQHPEDRPCMPSVI 698 (747)
Q Consensus 672 ~~~~~~~l~~~Cl~~dP~~RPt~~~v~ 698 (747)
...+.+++.+|++.+|.+||++.+.+
T Consensus 220 -~~~~~~ll~~ll~~~p~~R~~~~~~~ 245 (325)
T cd05604 220 -SLTAWSILEELLEKDRQRRLGAKEDF 245 (325)
T ss_pred -CHHHHHHHHHHhccCHHhcCCCCCCH
Confidence 12345677799999999999986433
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-32 Score=292.65 Aligned_cols=246 Identities=19% Similarity=0.225 Sum_probs=180.8
Q ss_pred cCCCccceecccCCeeEEEEEecC-CcEEEEEEeccc---ccccHHHHHHHHHHHhccCCCceeeEEeEEEeCCeeEEEE
Q 004521 440 DNFSINNKLGEGGFGPVYKGTLVD-GQEIAVKRLSKI---SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIY 515 (747)
Q Consensus 440 ~~~~~~~~lg~G~fg~Vy~~~~~~-g~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 515 (747)
++|.+.+.||+|+||.||+++... ++.||+|.+.+. .......+.+|..++..++|+||+++++++.+.+..++||
T Consensus 1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~~lv~ 80 (331)
T cd05624 1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDENYLYLVM 80 (331)
T ss_pred CCceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence 478899999999999999999764 789999998652 2233456888999999999999999999999999999999
Q ss_pred ecCCCCChhhHhhhcCCCCcCChhHHHHHHHHHHHHHHHhhhcCCCceEecccCcCcEEEcCCCCceEecccCccccCCC
Q 004521 516 EFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGD 595 (747)
Q Consensus 516 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NIll~~~~~~kl~DFGla~~~~~~ 595 (747)
||+++|+|.+++... ...+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++.+...
T Consensus 81 Ey~~gg~L~~~l~~~--~~~l~~~~~~~~~~qi~~~L~~lH~~~---iiHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~ 155 (331)
T cd05624 81 DYYVGGDLLTLLSKF--EDRLPEDMARFYIAEMVLAIHSIHQLH---YVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQD 155 (331)
T ss_pred eCCCCCcHHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCchHHEEEcCCCCEEEEeccceeeccCC
Confidence 999999999999653 235788999999999999999999988 999999999999999999999999999876443
Q ss_pred CCccccceeeecc--------C------CCCCccccchhHHHHHHHHHhCCCCCCCCCCcchhhhhHhHHhcCCcccccc
Q 004521 596 ETEGNTNRVVGTY--------D------GQFSIKSDVFSFGILLLEIVSGKKNRGFYRSDTKVNLIGHLWDEGIPLRLID 661 (747)
Q Consensus 596 ~~~~~~~~~~~~~--------~------~~~s~ksDVwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~d 661 (747)
..... ....|+. . +.++.++|||||||+||||++|+.||.... ................+..
T Consensus 156 ~~~~~-~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~---~~~~~~~i~~~~~~~~~p~ 231 (331)
T cd05624 156 GTVQS-SVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAES---LVETYGKIMNHEERFQFPS 231 (331)
T ss_pred Cceee-ccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCC---HHHHHHHHHcCCCcccCCC
Confidence 22110 0011110 1 457889999999999999999999975322 1122222222111111111
Q ss_pred hhhhccCCHHHHHHHHHHHHhccCCCCCC--CCCHHHHHHH
Q 004521 662 ACIQDSCNLADVIRCIHIGLLCVQQHPED--RPCMPSVILM 700 (747)
Q Consensus 662 ~~l~~~~~~~~~~~~~~l~~~Cl~~dP~~--RPt~~~v~~~ 700 (747)
... .. ...+.+++.+|+..++.+ |+++.++++.
T Consensus 232 -~~~-~~----~~~~~~li~~ll~~~~~~~~~~~~~~~~~h 266 (331)
T cd05624 232 -HIT-DV----SEEAKDLIQRLICSRERRLGQNGIEDFKKH 266 (331)
T ss_pred -ccc-cC----CHHHHHHHHHHccCchhhcCCCCHHHHhcC
Confidence 010 01 123445666777755443 5678888754
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-32 Score=316.95 Aligned_cols=251 Identities=18% Similarity=0.233 Sum_probs=185.3
Q ss_pred cCCCccceecccCCeeEEEEEecC-CcEEEEEEecccc---cccHHHHHHHHHHHhccCCCceeeEEeEEEeCCeeEEEE
Q 004521 440 DNFSINNKLGEGGFGPVYKGTLVD-GQEIAVKRLSKIS---EQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIY 515 (747)
Q Consensus 440 ~~~~~~~~lg~G~fg~Vy~~~~~~-g~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 515 (747)
++|++.++||+|+||.||+|+... ++.||||+++... ....+.|.+|++++++++||||+++++++.+.+..++||
T Consensus 2 grYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~lyLVM 81 (932)
T PRK13184 2 QRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGDPVYYTM 81 (932)
T ss_pred CCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCEEEEEE
Confidence 578999999999999999999764 8899999997522 223567999999999999999999999999999999999
Q ss_pred ecCCCCChhhHhhhcCC--------CCcCChhHHHHHHHHHHHHHHHhhhcCCCceEecccCcCcEEEcCCCCceEeccc
Q 004521 516 EFMPNKSLDSFIFDQTR--------RTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFG 587 (747)
Q Consensus 516 E~~~~gsL~~~l~~~~~--------~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NIll~~~~~~kl~DFG 587 (747)
||+++++|.+++..... ...+++..+++++.||++||+|||+.+ |+||||||+|||++.++.+||+|||
T Consensus 82 EY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~G---IIHRDLKPeNILLd~dg~vKLiDFG 158 (932)
T PRK13184 82 PYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSKG---VLHRDLKPDNILLGLFGEVVILDWG 158 (932)
T ss_pred EcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHCC---ccccCCchheEEEcCCCCEEEEecC
Confidence 99999999999864211 123566788899999999999999988 9999999999999999999999999
Q ss_pred CccccCCCCCc----------------cccceeeecc---------CCCCCccccchhHHHHHHHHHhCCCCCCCCCCcc
Q 004521 588 LVRTFGGDETE----------------GNTNRVVGTY---------DGQFSIKSDVFSFGILLLEIVSGKKNRGFYRSDT 642 (747)
Q Consensus 588 la~~~~~~~~~----------------~~~~~~~~~~---------~~~~s~ksDVwS~Gvvl~elltg~~p~~~~~~~~ 642 (747)
+++........ .......|+. +..++.++|||||||++|||++|+.|+.......
T Consensus 159 LAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDIWSLGVILyELLTG~~PF~~~~~~k 238 (932)
T PRK13184 159 AAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRRKKGRK 238 (932)
T ss_pred cceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCcHhHHHHHHHHHHHHHHCCCCCCCcchhh
Confidence 99876211100 0000112221 4568899999999999999999999975321110
Q ss_pred hhhhhHhHHhcCCcccccchhhhccCCHHHHHHHHHHHHhccCCCCCCCC-CHHHHHHHhcCC
Q 004521 643 KVNLIGHLWDEGIPLRLIDACIQDSCNLADVIRCIHIGLLCVQQHPEDRP-CMPSVILMLGSE 704 (747)
Q Consensus 643 ~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dP~~RP-t~~~v~~~L~~~ 704 (747)
..... ....+.... + ...-...+.+++.+|++.||++|| ++.++++.|+..
T Consensus 239 ---i~~~~-~i~~P~~~~-p------~~~iP~~L~~LI~rcL~~DP~kR~ss~eeLl~~Le~~ 290 (932)
T PRK13184 239 ---ISYRD-VILSPIEVA-P------YREIPPFLSQIAMKALAVDPAERYSSVQELKQDLEPH 290 (932)
T ss_pred ---hhhhh-hccChhhcc-c------cccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence 00000 000000000 0 001112356788899999999995 567777766543
|
|
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-32 Score=288.83 Aligned_cols=246 Identities=28% Similarity=0.501 Sum_probs=184.4
Q ss_pred cCCCccceecccCCeeEEEEEecC-Cc----EEEEEEecccc-cccHHHHHHHHHHHhccCCCceeeEEeEEEeCCeeEE
Q 004521 440 DNFSINNKLGEGGFGPVYKGTLVD-GQ----EIAVKRLSKIS-EQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLL 513 (747)
Q Consensus 440 ~~~~~~~~lg~G~fg~Vy~~~~~~-g~----~vavK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~l 513 (747)
++|+..+.||+|+||.||+|+... +. .||+|.+.... .....++.+|+.++++++||||++++|++... ..++
T Consensus 7 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~-~~~~ 85 (303)
T cd05110 7 TELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRLLGVCLSP-TIQL 85 (303)
T ss_pred hhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEcCC-Ccee
Confidence 467778999999999999998643 43 57888886532 23345788999999999999999999998754 4679
Q ss_pred EEecCCCCChhhHhhhcCCCCcCChhHHHHHHHHHHHHHHHhhhcCCCceEecccCcCcEEEcCCCCceEecccCccccC
Q 004521 514 IYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFG 593 (747)
Q Consensus 514 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NIll~~~~~~kl~DFGla~~~~ 593 (747)
|+||+++|+|.+++... ...+++..+..++.|++.||.|||+.+ |+||||||+||+++.++.+||+|||+++.+.
T Consensus 86 v~e~~~~g~l~~~~~~~--~~~~~~~~~~~~~~qi~~~L~~LH~~~---ivH~dikp~Nill~~~~~~kL~Dfg~~~~~~ 160 (303)
T cd05110 86 VTQLMPHGCLLDYVHEH--KDNIGSQLLLNWCVQIAKGMMYLEERR---LVHRDLAARNVLVKSPNHVKITDFGLARLLE 160 (303)
T ss_pred eehhcCCCCHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHhhcC---eeccccccceeeecCCCceEEcccccccccc
Confidence 99999999999998653 234788999999999999999999988 9999999999999999999999999998764
Q ss_pred CCCCccccc-------eee--eccCCCCCccccchhHHHHHHHHHh-CCCCCCCCCCcchhhhhHhHHhcCCcccccchh
Q 004521 594 GDETEGNTN-------RVV--GTYDGQFSIKSDVFSFGILLLEIVS-GKKNRGFYRSDTKVNLIGHLWDEGIPLRLIDAC 663 (747)
Q Consensus 594 ~~~~~~~~~-------~~~--~~~~~~~s~ksDVwS~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 663 (747)
......... ... ......++.++|||||||++|||++ |+.|+...... ... .....+......
T Consensus 161 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t~g~~p~~~~~~~---~~~-~~~~~~~~~~~~--- 233 (303)
T cd05110 161 GDEKEYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTR---EIP-DLLEKGERLPQP--- 233 (303)
T ss_pred CcccccccCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHHHhCCCCCCCCCCHH---HHH-HHHHCCCCCCCC---
Confidence 332211110 000 0114567889999999999999998 88886432211 111 111221111110
Q ss_pred hhccCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhcCC
Q 004521 664 IQDSCNLADVIRCIHIGLLCVQQHPEDRPCMPSVILMLGSE 704 (747)
Q Consensus 664 l~~~~~~~~~~~~~~l~~~Cl~~dP~~RPt~~~v~~~L~~~ 704 (747)
... ...+..++..||..+|++||+|.+|+++|+..
T Consensus 234 --~~~----~~~~~~li~~c~~~~p~~Rp~~~~l~~~l~~~ 268 (303)
T cd05110 234 --PIC----TIDVYMVMVKCWMIDADSRPKFKELAAEFSRM 268 (303)
T ss_pred --CCC----CHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 111 13466788899999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-32 Score=284.89 Aligned_cols=244 Identities=23% Similarity=0.314 Sum_probs=182.1
Q ss_pred CCccceecccCCeeEEEEEecC-CcEEEEEEecccc---cccHHHHHHHHHHHhccCCCceeeEEeEEEeCCeeEEEEec
Q 004521 442 FSINNKLGEGGFGPVYKGTLVD-GQEIAVKRLSKIS---EQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEF 517 (747)
Q Consensus 442 ~~~~~~lg~G~fg~Vy~~~~~~-g~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~ 517 (747)
|+..+.||+|+||.||++.... ++.+|||.+.... ....+.+.+|+.++++++|+||+++++.+.+.+..++||||
T Consensus 2 f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~ 81 (285)
T cd05630 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTL 81 (285)
T ss_pred ceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCEEEEEEEe
Confidence 6677899999999999998754 8899999986522 22335678899999999999999999999999999999999
Q ss_pred CCCCChhhHhhhcCCCCcCChhHHHHHHHHHHHHHHHhhhcCCCceEecccCcCcEEEcCCCCceEecccCccccCCCCC
Q 004521 518 MPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDET 597 (747)
Q Consensus 518 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~ 597 (747)
+++++|.+++.... ...+++..+..++.|++.||.|||+.+ |+||||||+||+++.++.++|+|||++........
T Consensus 82 ~~g~~L~~~l~~~~-~~~l~~~~~~~~~~qi~~~l~~lH~~~---iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~ 157 (285)
T cd05630 82 MNGGDLKFHIYHMG-EAGFEEGRAVFYAAEICCGLEDLHQER---IVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQT 157 (285)
T ss_pred cCCCcHHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCCCHHHEEECCCCCEEEeeccceeecCCCcc
Confidence 99999999886533 234889999999999999999999988 99999999999999999999999999876543221
Q ss_pred cc----ccceeeec--cCCCCCccccchhHHHHHHHHHhCCCCCCCCCCcchhhhhHhHHhcCCcccccchhhhccCCHH
Q 004521 598 EG----NTNRVVGT--YDGQFSIKSDVFSFGILLLEIVSGKKNRGFYRSDTKVNLIGHLWDEGIPLRLIDACIQDSCNLA 671 (747)
Q Consensus 598 ~~----~~~~~~~~--~~~~~s~ksDVwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~ 671 (747)
.. ........ ....++.++|||||||++|||++|+.||.................. .... ......
T Consensus 158 ~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~~~~~~~~-~~~~-----~~~~~~-- 229 (285)
T cd05630 158 IKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKE-VQEE-----YSEKFS-- 229 (285)
T ss_pred ccCCCCCccccChHHHcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCccchHHHHHhhhhh-hhhh-----cCccCC--
Confidence 10 00000000 1456889999999999999999999997643222111111111110 0000 011111
Q ss_pred HHHHHHHHHHhccCCCCCCCCC-----HHHHHH
Q 004521 672 DVIRCIHIGLLCVQQHPEDRPC-----MPSVIL 699 (747)
Q Consensus 672 ~~~~~~~l~~~Cl~~dP~~RPt-----~~~v~~ 699 (747)
..+.+++.+||+.||++||+ +.++++
T Consensus 230 --~~~~~li~~~l~~~p~~R~s~~~~~~~~~~~ 260 (285)
T cd05630 230 --PDARSLCKMLLCKDPKERLGCQGGGAREVKE 260 (285)
T ss_pred --HHHHHHHHHHhhcCHHHccCCCCCchHHHHc
Confidence 22456777999999999999 777775
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-32 Score=292.55 Aligned_cols=190 Identities=20% Similarity=0.242 Sum_probs=152.9
Q ss_pred ccceeccc--CCeeEEEEEec-CCcEEEEEEeccc--ccccHHHHHHHHHHHhccCCCceeeEEeEEEeCCeeEEEEecC
Q 004521 444 INNKLGEG--GFGPVYKGTLV-DGQEIAVKRLSKI--SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFM 518 (747)
Q Consensus 444 ~~~~lg~G--~fg~Vy~~~~~-~g~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~ 518 (747)
+.++||+| +|++||+++.. +|+.||||++... .....+.+.+|+.+++.++||||+++++++..++..++||||+
T Consensus 2 ~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~ 81 (327)
T cd08227 2 LLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFM 81 (327)
T ss_pred hhhhccccccceEEEEEEeecccCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEEEEEecc
Confidence 46789999 78899999875 4899999998753 2334567888999999999999999999999999999999999
Q ss_pred CCCChhhHhhhcCCCCcCChhHHHHHHHHHHHHHHHhhhcCCCceEecccCcCcEEEcCCCCceEecccCccccCCCCCc
Q 004521 519 PNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETE 598 (747)
Q Consensus 519 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~ 598 (747)
++|+|.+++..... ..+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.++++||+.+.........
T Consensus 82 ~~~~l~~~~~~~~~-~~l~~~~~~~i~~qi~~~L~~LH~~~---iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~~~~~ 157 (327)
T cd08227 82 AYGSAKDLICTHFM-DGMSELAIAYILQGVLKALDYIHHMG---YVHRSVKASHILISVDGKVYLSGLRSNLSMINHGQR 157 (327)
T ss_pred CCCcHHHHHHhhcc-CCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCChhhEEEecCCcEEEcccchhhcccccccc
Confidence 99999999865332 34889999999999999999999988 999999999999999999999999865433211100
Q ss_pred c-------c-----cceeeec-c---CCCCCccccchhHHHHHHHHHhCCCCCCC
Q 004521 599 G-------N-----TNRVVGT-Y---DGQFSIKSDVFSFGILLLEIVSGKKNRGF 637 (747)
Q Consensus 599 ~-------~-----~~~~~~~-~---~~~~s~ksDVwS~Gvvl~elltg~~p~~~ 637 (747)
. . ....... . ...++.++|||||||++|||++|+.||..
T Consensus 158 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~ 212 (327)
T cd08227 158 LRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKD 212 (327)
T ss_pred ccccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCC
Confidence 0 0 0000000 1 13578999999999999999999999753
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-32 Score=290.05 Aligned_cols=192 Identities=19% Similarity=0.276 Sum_probs=158.7
Q ss_pred cCCCccceecccCCeeEEEEEecC-CcEEEEEEeccc---ccccHHHHHHHHHHHhccCCCceeeEEeEEEeCCeeEEEE
Q 004521 440 DNFSINNKLGEGGFGPVYKGTLVD-GQEIAVKRLSKI---SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIY 515 (747)
Q Consensus 440 ~~~~~~~~lg~G~fg~Vy~~~~~~-g~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 515 (747)
++|++.++||+|+||.||+++... ++.+|+|.+.+. .......+.+|+.++..++|+||+++++++.+.+..++||
T Consensus 1 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (332)
T cd05623 1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDENNLYLVM 80 (332)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCEEEEEE
Confidence 468889999999999999999865 788999998642 2233456889999999999999999999999999999999
Q ss_pred ecCCCCChhhHhhhcCCCCcCChhHHHHHHHHHHHHHHHhhhcCCCceEecccCcCcEEEcCCCCceEecccCccccCCC
Q 004521 516 EFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGD 595 (747)
Q Consensus 516 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NIll~~~~~~kl~DFGla~~~~~~ 595 (747)
||+++|+|.+++... ...+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++.+...
T Consensus 81 ey~~~g~L~~~l~~~--~~~l~~~~~~~~~~qi~~al~~lH~~~---iiHrDlkp~Nili~~~~~~kL~DfG~a~~~~~~ 155 (332)
T cd05623 81 DYYVGGDLLTLLSKF--EDRLPEDMARFYLAEMVIAIDSVHQLH---YVHRDIKPDNILMDMNGHIRLADFGSCLKLMED 155 (332)
T ss_pred eccCCCcHHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHEEECCCCCEEEeecchheecccC
Confidence 999999999999653 234888899999999999999999988 999999999999999999999999998765332
Q ss_pred CCcc------ccceeeec-------cCCCCCccccchhHHHHHHHHHhCCCCCC
Q 004521 596 ETEG------NTNRVVGT-------YDGQFSIKSDVFSFGILLLEIVSGKKNRG 636 (747)
Q Consensus 596 ~~~~------~~~~~~~~-------~~~~~s~ksDVwS~Gvvl~elltg~~p~~ 636 (747)
.... ........ ....++.++|||||||+||||++|+.||.
T Consensus 156 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~ 209 (332)
T cd05623 156 GTVQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFY 209 (332)
T ss_pred CcceecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCC
Confidence 2111 00111111 02457889999999999999999999975
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-32 Score=286.04 Aligned_cols=256 Identities=27% Similarity=0.379 Sum_probs=189.5
Q ss_pred ccHHHHHHHhcCCCccceecccCCeeEEEEEec-CCcEEEEEEecccccccHHHHHHHHHHHhcc-CCCceeeEEeEEEe
Q 004521 430 FELATIANATDNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKISEQGLKELKNEVILFSKL-QHRNLVKLLGCCIQ 507 (747)
Q Consensus 430 ~~~~~~~~~~~~~~~~~~lg~G~fg~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~ 507 (747)
+...++..+.++|++.+.||+|+||.||++... +++.+|+|.+... ......+.+|+.+++++ +||||+++++++..
T Consensus 12 ~~~~~~~~~~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~-~~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~ 90 (291)
T cd06639 12 LGLESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPI-SDVDEEIEAEYNILQSLPNHPNVVKFYGMFYK 90 (291)
T ss_pred hhcccCCCCCCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEeccc-ccHHHHHHHHHHHHHHhcCCCCeEEEEEEEEe
Confidence 334455566789999999999999999999975 4889999998653 23346778899999999 89999999999876
Q ss_pred CC-----eeEEEEecCCCCChhhHhhhcC-CCCcCChhHHHHHHHHHHHHHHHhhhcCCCceEecccCcCcEEEcCCCCc
Q 004521 508 GE-----EKLLIYEFMPNKSLDSFIFDQT-RRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNP 581 (747)
Q Consensus 508 ~~-----~~~lV~E~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NIll~~~~~~ 581 (747)
.+ ..++||||+++++|.+++.... ....+++..++.++.|++.||+|||+.+ ++||||||+||+++.++.+
T Consensus 91 ~~~~~~~~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dlkp~nili~~~~~~ 167 (291)
T cd06639 91 ADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNNR---IIHRDVKGNNILLTTEGGV 167 (291)
T ss_pred ccccCCCeeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEEcCCCCE
Confidence 43 5799999999999999886422 2345889999999999999999999988 9999999999999999999
Q ss_pred eEecccCccccCCCCCccc-----cceeeec-------cCCCCCccccchhHHHHHHHHHhCCCCCCCCCCcchhhhhHh
Q 004521 582 KISDFGLVRTFGGDETEGN-----TNRVVGT-------YDGQFSIKSDVFSFGILLLEIVSGKKNRGFYRSDTKVNLIGH 649 (747)
Q Consensus 582 kl~DFGla~~~~~~~~~~~-----~~~~~~~-------~~~~~s~ksDVwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~ 649 (747)
||+|||+++.+........ ....... ....++.++|||||||++|||++|+.|+..... ...+..
T Consensus 168 kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~---~~~~~~ 244 (291)
T cd06639 168 KLVDFGVSAQLTSTRLRRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHP---VKTLFK 244 (291)
T ss_pred EEeecccchhcccccccccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcH---HHHHHH
Confidence 9999999886543221100 0000000 112368899999999999999999999643221 111111
Q ss_pred HHhcCCcccccchhhhccCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 004521 650 LWDEGIPLRLIDACIQDSCNLADVIRCIHIGLLCVQQHPEDRPCMPSVILM 700 (747)
Q Consensus 650 ~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dP~~RPt~~~v~~~ 700 (747)
. .......+.++ ......+.+++.+||+.+|++||++.++++.
T Consensus 245 ~-~~~~~~~~~~~-------~~~~~~l~~li~~~l~~~p~~Rps~~~il~~ 287 (291)
T cd06639 245 I-PRNPPPTLLHP-------EKWCRSFNHFISQCLIKDFEARPSVTHLLEH 287 (291)
T ss_pred H-hcCCCCCCCcc-------cccCHHHHHHHHHHhhcChhhCcCHHHHhcC
Confidence 1 11111111111 0112246778889999999999999999864
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-31 Score=279.49 Aligned_cols=248 Identities=26% Similarity=0.433 Sum_probs=189.1
Q ss_pred cCCCccceecccCCeeEEEEEec-CCcEEEEEEeccc-ccccHHHHHHHHHHHhccCCCceeeEEeEEEeCCeeEEEEec
Q 004521 440 DNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKI-SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEF 517 (747)
Q Consensus 440 ~~~~~~~~lg~G~fg~Vy~~~~~-~g~~vavK~l~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~ 517 (747)
++|++.+.||.|+||+||+|... ++..+|+|++... .....+.+.+|+.+++.++|+||+++++.+..++..++||||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~ 80 (267)
T cd06610 1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVMPY 80 (267)
T ss_pred CcceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcchHHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCEEEEEEec
Confidence 47889999999999999999965 4789999998642 233567899999999999999999999999999999999999
Q ss_pred CCCCChhhHhhhcCCCCcCChhHHHHHHHHHHHHHHHhhhcCCCceEecccCcCcEEEcCCCCceEecccCccccCCCCC
Q 004521 518 MPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDET 597 (747)
Q Consensus 518 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~ 597 (747)
+++++|.+++........+++..+..++.|++.||+|||+.+ ++||||+|+||++++++.+||+|||++..+.....
T Consensus 81 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh~~~---i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~~~~~ 157 (267)
T cd06610 81 LSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSNG---QIHRDIKAGNILLGEDGSVKIADFGVSASLADGGD 157 (267)
T ss_pred cCCCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHhEEEcCCCCEEEcccchHHHhccCcc
Confidence 999999999976444456899999999999999999999988 99999999999999999999999999876654322
Q ss_pred cc--ccceeeec---------cC-CCCCccccchhHHHHHHHHHhCCCCCCCCCCcchhhhhHhHHhcCCcccccchhhh
Q 004521 598 EG--NTNRVVGT---------YD-GQFSIKSDVFSFGILLLEIVSGKKNRGFYRSDTKVNLIGHLWDEGIPLRLIDACIQ 665 (747)
Q Consensus 598 ~~--~~~~~~~~---------~~-~~~s~ksDVwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 665 (747)
.. ......++ .. ..++.++|||||||++|||++|+.|+...... ......... .... +.
T Consensus 158 ~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~---~~~~~~~~~-~~~~-----~~ 228 (267)
T cd06610 158 RTRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPM---KVLMLTLQN-DPPS-----LE 228 (267)
T ss_pred ccccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChh---hhHHHHhcC-CCCC-----cC
Confidence 21 01111111 02 26788999999999999999999997533221 111111111 1111 11
Q ss_pred ccCC-HHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 004521 666 DSCN-LADVIRCIHIGLLCVQQHPEDRPCMPSVIL 699 (747)
Q Consensus 666 ~~~~-~~~~~~~~~l~~~Cl~~dP~~RPt~~~v~~ 699 (747)
.... ..-...+.+++.+||+.||++||++.+|++
T Consensus 229 ~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~ll~ 263 (267)
T cd06610 229 TGADYKKYSKSFRKMISLCLQKDPSKRPTAEELLK 263 (267)
T ss_pred CccccccccHHHHHHHHHHcCCChhhCcCHHHHhh
Confidence 1000 011234567888999999999999999986
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-32 Score=285.88 Aligned_cols=252 Identities=22% Similarity=0.311 Sum_probs=182.4
Q ss_pred cCCCccceecccCCeeEEEEEec-CCcEEEEEEecccc-cccHHHHHHHHHHHhccCCCceeeEEeEEEeCCeeEEEEec
Q 004521 440 DNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKIS-EQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEF 517 (747)
Q Consensus 440 ~~~~~~~~lg~G~fg~Vy~~~~~-~g~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~ 517 (747)
++|++.+.||+|++|.||+|+.. +++.||||.+.... ......+.+|++++++++|+||+++++++.+.+..++||||
T Consensus 5 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 84 (291)
T cd07844 5 ETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTLHDIIHTKKTLTLVFEY 84 (291)
T ss_pred cceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccccCCchhHHHHHHHHhhCCCcceeeEEEEEecCCeEEEEEec
Confidence 57888999999999999999976 58899999986532 22334677899999999999999999999999999999999
Q ss_pred CCCCChhhHhhhcCCCCcCChhHHHHHHHHHHHHHHHhhhcCCCceEecccCcCcEEEcCCCCceEecccCccccCCCCC
Q 004521 518 MPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDET 597 (747)
Q Consensus 518 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~ 597 (747)
++ ++|.+++.... ..+++..+..++.|+++||.|||+.+ |+||||||+||+++.++.+||+|||+++.......
T Consensus 85 ~~-~~L~~~~~~~~--~~~~~~~~~~~~~ql~~al~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~ 158 (291)
T cd07844 85 LD-TDLKQYMDDCG--GGLSMHNVRLFLFQLLRGLAYCHQRR---VLHRDLKPQNLLISERGELKLADFGLARAKSVPSK 158 (291)
T ss_pred CC-CCHHHHHHhCC--CCCCHHHHHHHHHHHHHHHHHHHhCC---eecccCCHHHEEEcCCCCEEECccccccccCCCCc
Confidence 98 58998886533 35789999999999999999999988 99999999999999999999999999875432111
Q ss_pred ccc-----cceeeec-c--CCCCCccccchhHHHHHHHHHhCCCCCCCCCCcchhhhhHhHHh---cCCcc---------
Q 004521 598 EGN-----TNRVVGT-Y--DGQFSIKSDVFSFGILLLEIVSGKKNRGFYRSDTKVNLIGHLWD---EGIPL--------- 657 (747)
Q Consensus 598 ~~~-----~~~~~~~-~--~~~~s~ksDVwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~---~~~~~--------- 657 (747)
... ....... . ...++.++||||||+++|||++|+.|+..... ........+. .....
T Consensus 159 ~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (291)
T cd07844 159 TYSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTD--VEDQLHKIFRVLGTPTEETWPGVSSNP 236 (291)
T ss_pred cccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCcc--HHHHHHHHHHhcCCCChhhhhhhhhcc
Confidence 100 0000011 1 23478899999999999999999999753321 1111111100 00000
Q ss_pred -------ccc-chhhhc-cCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 004521 658 -------RLI-DACIQD-SCNLADVIRCIHIGLLCVQQHPEDRPCMPSVIL 699 (747)
Q Consensus 658 -------~~~-d~~l~~-~~~~~~~~~~~~l~~~Cl~~dP~~RPt~~~v~~ 699 (747)
... ...+.. .........+.+++.+||+.+|++||++.++++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rps~~e~l~ 287 (291)
T cd07844 237 EFKPYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMK 287 (291)
T ss_pred ccccccccccCChhHHHhCcCCCCchhHHHHHHHHhccCcccccCHHHHhc
Confidence 000 000000 001111245567888999999999999999875
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-32 Score=290.37 Aligned_cols=191 Identities=24% Similarity=0.330 Sum_probs=159.4
Q ss_pred cCCCccceecccCCeeEEEEEecC-CcEEEEEEeccc---ccccHHHHHHHHHHHhccCCCceeeEEeEEEeCCeeEEEE
Q 004521 440 DNFSINNKLGEGGFGPVYKGTLVD-GQEIAVKRLSKI---SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIY 515 (747)
Q Consensus 440 ~~~~~~~~lg~G~fg~Vy~~~~~~-g~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 515 (747)
++|++.+.||+|+||.||+++... ++.||+|.+.+. .....+.+.+|+.++..++|+||+++++++.+.+..++||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (331)
T cd05597 1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDENNLYLVM 80 (331)
T ss_pred CCceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCCeEEEEE
Confidence 478899999999999999999754 889999998752 2234566889999999999999999999999999999999
Q ss_pred ecCCCCChhhHhhhcCCCCcCChhHHHHHHHHHHHHHHHhhhcCCCceEecccCcCcEEEcCCCCceEecccCccccCCC
Q 004521 516 EFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGD 595 (747)
Q Consensus 516 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NIll~~~~~~kl~DFGla~~~~~~ 595 (747)
||+++|+|.+++... ...+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++.+...
T Consensus 81 e~~~g~~L~~~l~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~ 155 (331)
T cd05597 81 DYYVGGDLLTLLSKF--EDRLPEDMARFYLAEMVLAIDSVHQLG---YVHRDIKPDNVLLDKNGHIRLADFGSCLRLLAD 155 (331)
T ss_pred ecCCCCcHHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEECCCCHHHEEECCCCCEEEEECCceeecCCC
Confidence 999999999998542 234888999999999999999999988 999999999999999999999999998765432
Q ss_pred CCccccceeeecc--------------CCCCCccccchhHHHHHHHHHhCCCCCC
Q 004521 596 ETEGNTNRVVGTY--------------DGQFSIKSDVFSFGILLLEIVSGKKNRG 636 (747)
Q Consensus 596 ~~~~~~~~~~~~~--------------~~~~s~ksDVwS~Gvvl~elltg~~p~~ 636 (747)
..... ....++. ...++.++|||||||++|||++|+.||.
T Consensus 156 ~~~~~-~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~ 209 (331)
T cd05597 156 GTVQS-NVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFY 209 (331)
T ss_pred CCccc-cceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCC
Confidence 22110 0011110 2457889999999999999999999975
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-32 Score=288.41 Aligned_cols=254 Identities=22% Similarity=0.312 Sum_probs=183.6
Q ss_pred cCCCccceecccCCeeEEEEEecC-CcEEEEEEecccc--cccHHHHHHHHHHHhccCCCceeeEEeEEEeCCeeEEEEe
Q 004521 440 DNFSINNKLGEGGFGPVYKGTLVD-GQEIAVKRLSKIS--EQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYE 516 (747)
Q Consensus 440 ~~~~~~~~lg~G~fg~Vy~~~~~~-g~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E 516 (747)
++|++.++||+|+||.||+|...+ ++.+|+|++.... ....+.+.+|+++++.++||||+++++++..++..++|||
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 80 (286)
T cd07846 1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLVFE 80 (286)
T ss_pred CceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhcccCCeEEEEEe
Confidence 468888999999999999999864 8899999986522 2235678899999999999999999999999999999999
Q ss_pred cCCCCChhhHhhhcCCCCcCChhHHHHHHHHHHHHHHHhhhcCCCceEecccCcCcEEEcCCCCceEecccCccccCCCC
Q 004521 517 FMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDE 596 (747)
Q Consensus 517 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~ 596 (747)
|+++++|..+... ...+++.++..++.||++||.|||+.+ ++|+||+|+||++++++.+||+|||+++.+....
T Consensus 81 ~~~~~~l~~~~~~---~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~~~ 154 (286)
T cd07846 81 FVDHTVLDDLEKY---PNGLDESRVRKYLFQILRGIEFCHSHN---IIHRDIKPENILVSQSGVVKLCDFGFARTLAAPG 154 (286)
T ss_pred cCCccHHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEECCCCcEEEEeeeeeeeccCCc
Confidence 9999999887643 234899999999999999999999988 9999999999999999999999999988654322
Q ss_pred Ccccc---c--eeeec---cCCCCCccccchhHHHHHHHHHhCCCCCCCCCCcchhhhhHhHHhc------------CCc
Q 004521 597 TEGNT---N--RVVGT---YDGQFSIKSDVFSFGILLLEIVSGKKNRGFYRSDTKVNLIGHLWDE------------GIP 656 (747)
Q Consensus 597 ~~~~~---~--~~~~~---~~~~~s~ksDVwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~------------~~~ 656 (747)
..... . ..... ....++.++||||||+++|||++|+.|+...........+...... ...
T Consensus 155 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (286)
T cd07846 155 EVYTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRHQEIFQKNPLF 234 (286)
T ss_pred cccCcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHhCCCchhhHHHhccchHh
Confidence 11100 0 00000 0234678999999999999999999886532211100000000000 000
Q ss_pred ccccchhhhccCC-----HHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 004521 657 LRLIDACIQDSCN-----LADVIRCIHIGLLCVQQHPEDRPCMPSVIL 699 (747)
Q Consensus 657 ~~~~d~~l~~~~~-----~~~~~~~~~l~~~Cl~~dP~~RPt~~~v~~ 699 (747)
.....+....... ......+.+++.+||+.+|++||++.+|++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~ 282 (286)
T cd07846 235 AGMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLH 282 (286)
T ss_pred hccccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhc
Confidence 0000000000000 011234677889999999999999999876
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-32 Score=282.65 Aligned_cols=240 Identities=23% Similarity=0.367 Sum_probs=185.8
Q ss_pred CCCccceecccCCeeEEEEEecC-CcEEEEEEeccc-ccccHHHHHHHHHHHhccCCCceeeEEeEEEeCCeeEEEEecC
Q 004521 441 NFSINNKLGEGGFGPVYKGTLVD-GQEIAVKRLSKI-SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFM 518 (747)
Q Consensus 441 ~~~~~~~lg~G~fg~Vy~~~~~~-g~~vavK~l~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~ 518 (747)
.|+..+.||+|+||.||+|+... ++.||+|.+... .......+.+|+.+++++.|+||+++++++.+....++||||+
T Consensus 5 ~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 84 (277)
T cd06640 5 LFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWIIMEYL 84 (277)
T ss_pred hhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEecC
Confidence 56777899999999999999754 889999998743 2344678899999999999999999999999999999999999
Q ss_pred CCCChhhHhhhcCCCCcCChhHHHHHHHHHHHHHHHhhhcCCCceEecccCcCcEEEcCCCCceEecccCccccCCCCCc
Q 004521 519 PNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETE 598 (747)
Q Consensus 519 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~ 598 (747)
++++|.+++.. ..+++.++..++.|++.||+|||+.+ ++|+||+|+||+++.++.++|+|||++..+......
T Consensus 85 ~~~~L~~~i~~----~~l~~~~~~~~~~~l~~~l~~lh~~~---ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~~ 157 (277)
T cd06640 85 GGGSALDLLRA----GPFDEFQIATMLKEILKGLDYLHSEK---KIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIK 157 (277)
T ss_pred CCCcHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhCC---ccCcCCChhhEEEcCCCCEEEcccccceeccCCccc
Confidence 99999998843 34788899999999999999999987 999999999999999999999999999776443211
Q ss_pred ccc----ceeeec---cCCCCCccccchhHHHHHHHHHhCCCCCCCCCCcchhhhhHhHHhcCCcccccchhhhccCCHH
Q 004521 599 GNT----NRVVGT---YDGQFSIKSDVFSFGILLLEIVSGKKNRGFYRSDTKVNLIGHLWDEGIPLRLIDACIQDSCNLA 671 (747)
Q Consensus 599 ~~~----~~~~~~---~~~~~s~ksDVwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~ 671 (747)
... .....+ ....++.++|||||||++|||++|..|+....... ... ......... ....
T Consensus 158 ~~~~~~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~---~~~-~~~~~~~~~---------~~~~ 224 (277)
T cd06640 158 RNTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHPMR---VLF-LIPKNNPPT---------LTGE 224 (277)
T ss_pred cccccCcccccCHhHhccCCCccHHHHHHHHHHHHHHHHCCCCCCCcChHh---Hhh-hhhcCCCCC---------Cchh
Confidence 100 000011 14567889999999999999999999965332111 111 111111111 1112
Q ss_pred HHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 004521 672 DVIRCIHIGLLCVQQHPEDRPCMPSVILM 700 (747)
Q Consensus 672 ~~~~~~~l~~~Cl~~dP~~RPt~~~v~~~ 700 (747)
....+.+++.+||+.+|++||++.++++.
T Consensus 225 ~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 253 (277)
T cd06640 225 FSKPFKEFIDACLNKDPSFRPTAKELLKH 253 (277)
T ss_pred hhHHHHHHHHHHcccCcccCcCHHHHHhC
Confidence 23446678889999999999999999765
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-32 Score=284.96 Aligned_cols=254 Identities=21% Similarity=0.286 Sum_probs=177.2
Q ss_pred CCCccceecccCCeeEEEEEecC-CcEEEEEEecccc--cccHHHHHHHHHHHhcc---CCCceeeEEeEEEeC-----C
Q 004521 441 NFSINNKLGEGGFGPVYKGTLVD-GQEIAVKRLSKIS--EQGLKELKNEVILFSKL---QHRNLVKLLGCCIQG-----E 509 (747)
Q Consensus 441 ~~~~~~~lg~G~fg~Vy~~~~~~-g~~vavK~l~~~~--~~~~~~~~~E~~~l~~l---~H~niv~l~g~~~~~-----~ 509 (747)
+|++.+.||+|+||.||+|+..+ ++.||+|.++... ......+.+|+.+++++ +||||+++++++... .
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~ 80 (288)
T cd07863 1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRET 80 (288)
T ss_pred CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCc
Confidence 47888999999999999999764 8899999987522 22234566777777665 699999999998653 4
Q ss_pred eeEEEEecCCCCChhhHhhhcCCCCcCChhHHHHHHHHHHHHHHHhhhcCCCceEecccCcCcEEEcCCCCceEecccCc
Q 004521 510 EKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLV 589 (747)
Q Consensus 510 ~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NIll~~~~~~kl~DFGla 589 (747)
..++||||++ ++|.+++.... ...+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++
T Consensus 81 ~~~lv~e~~~-~~l~~~~~~~~-~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dikp~Nili~~~~~~kl~dfg~~ 155 (288)
T cd07863 81 KVTLVFEHVD-QDLRTYLDKVP-PPGLPAETIKDLMRQFLRGLDFLHANC---IVHRDLKPENILVTSGGQVKLADFGLA 155 (288)
T ss_pred eEEEEEcccc-cCHHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEECccCcc
Confidence 5789999998 58888885432 234899999999999999999999988 999999999999999999999999999
Q ss_pred cccCCCCCccc----cceeee--ccCCCCCccccchhHHHHHHHHHhCCCCCCCCCCcchhhhhHhHHhc----CCcc--
Q 004521 590 RTFGGDETEGN----TNRVVG--TYDGQFSIKSDVFSFGILLLEIVSGKKNRGFYRSDTKVNLIGHLWDE----GIPL-- 657 (747)
Q Consensus 590 ~~~~~~~~~~~----~~~~~~--~~~~~~s~ksDVwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~----~~~~-- 657 (747)
+.+........ .....+ .....++.++|||||||++|||++|+.||...........+...... ....
T Consensus 156 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (288)
T cd07863 156 RIYSCQMALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWPRDV 235 (288)
T ss_pred ccccCcccCCCccccccccCchHhhCCCCCCcchhhhHHHHHHHHHhCCcCcCCCCHHHHHHHHHHHhCCCChhhCcccc
Confidence 87643221110 000001 01456889999999999999999999987533221111111110000 0000
Q ss_pred cccchhhhc-------cCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 004521 658 RLIDACIQD-------SCNLADVIRCIHIGLLCVQQHPEDRPCMPSVIL 699 (747)
Q Consensus 658 ~~~d~~l~~-------~~~~~~~~~~~~l~~~Cl~~dP~~RPt~~~v~~ 699 (747)
......... .........+.+++.+||+.||++|||+.+++.
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~ 284 (288)
T cd07863 236 TLPRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQ 284 (288)
T ss_pred cccccccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhc
Confidence 000000000 000011234567888999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-32 Score=294.61 Aligned_cols=191 Identities=27% Similarity=0.346 Sum_probs=153.5
Q ss_pred HhcCCCccceecccCCeeEEEEEecC-CcEEEEEEeccc--ccccHHHHHHHHHHHhccCCCceeeEEeEEEeCC-----
Q 004521 438 ATDNFSINNKLGEGGFGPVYKGTLVD-GQEIAVKRLSKI--SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGE----- 509 (747)
Q Consensus 438 ~~~~~~~~~~lg~G~fg~Vy~~~~~~-g~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~----- 509 (747)
..++|++.+.||+|+||.||++.... |+.||||++... .......+.+|+.+++.++||||+++++++....
T Consensus 19 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 98 (359)
T cd07876 19 VLKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEF 98 (359)
T ss_pred hhhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCcccc
Confidence 45789999999999999999998754 889999998652 2334567889999999999999999999986543
Q ss_pred -eeEEEEecCCCCChhhHhhhcCCCCcCChhHHHHHHHHHHHHHHHhhhcCCCceEecccCcCcEEEcCCCCceEecccC
Q 004521 510 -EKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGL 588 (747)
Q Consensus 510 -~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NIll~~~~~~kl~DFGl 588 (747)
..++||||+++ +|...+.. .+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+
T Consensus 99 ~~~~lv~e~~~~-~l~~~~~~-----~~~~~~~~~~~~qi~~~L~~LH~~~---ivHrDlkp~NIl~~~~~~~kl~Dfg~ 169 (359)
T cd07876 99 QDVYLVMELMDA-NLCQVIHM-----ELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGL 169 (359)
T ss_pred ceeEEEEeCCCc-CHHHHHhc-----cCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEEecCCC
Confidence 46899999975 56555522 3778889999999999999999998 99999999999999999999999999
Q ss_pred ccccCCCCCccc----cceeee--ccCCCCCccccchhHHHHHHHHHhCCCCCCC
Q 004521 589 VRTFGGDETEGN----TNRVVG--TYDGQFSIKSDVFSFGILLLEIVSGKKNRGF 637 (747)
Q Consensus 589 a~~~~~~~~~~~----~~~~~~--~~~~~~s~ksDVwS~Gvvl~elltg~~p~~~ 637 (747)
++.......... .....+ ..+..++.++|||||||++|||++|+.||..
T Consensus 170 a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~ 224 (359)
T cd07876 170 ARTACTNFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQG 224 (359)
T ss_pred ccccccCccCCCCcccCCCCCchhccCCCCCcchhhHHHHHHHHHHHhCCCCCCC
Confidence 976533221100 000000 1245688999999999999999999999753
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-31 Score=278.21 Aligned_cols=246 Identities=25% Similarity=0.306 Sum_probs=191.1
Q ss_pred cCCCccceecccCCeeEEEEEecC-CcEEEEEEeccccc-ccHHHHHHHHHHHhccCCCceeeEEeEEEeCCeeEEEEec
Q 004521 440 DNFSINNKLGEGGFGPVYKGTLVD-GQEIAVKRLSKISE-QGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEF 517 (747)
Q Consensus 440 ~~~~~~~~lg~G~fg~Vy~~~~~~-g~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~ 517 (747)
++|++.+.||+|++|.||+|+... ++.|+||++..... ...+.+.+|+..+.+++|+||+++++++...+..++||||
T Consensus 1 ~~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (264)
T cd06623 1 SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIVLEY 80 (264)
T ss_pred CcceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeEEEEEEe
Confidence 368888999999999999999875 89999999876433 4567899999999999999999999999999999999999
Q ss_pred CCCCChhhHhhhcCCCCcCChhHHHHHHHHHHHHHHHhhh-cCCCceEecccCcCcEEEcCCCCceEecccCccccCCCC
Q 004521 518 MPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQ-DSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDE 596 (747)
Q Consensus 518 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~-~~~~~iiHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~ 596 (747)
+++++|.+++... ..+++..+..++.|+++||.|||+ .+ ++||||+|+||+++.++.++|+|||++.......
T Consensus 81 ~~~~~L~~~l~~~---~~l~~~~~~~~~~~l~~~l~~lh~~~~---~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~~~~ 154 (264)
T cd06623 81 MDGGSLADLLKKV---GKIPEPVLAYIARQILKGLDYLHTKRH---IIHRDIKPSNLLINSKGEVKIADFGISKVLENTL 154 (264)
T ss_pred cCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHhccCC---CccCCCCHHHEEECCCCCEEEccCccceecccCC
Confidence 9999999999653 458999999999999999999999 87 9999999999999999999999999988764433
Q ss_pred Cccccce----e-e--eccCCCCCccccchhHHHHHHHHHhCCCCCCCCCCcchhhhhHhHHhcCCcccccchhhhccCC
Q 004521 597 TEGNTNR----V-V--GTYDGQFSIKSDVFSFGILLLEIVSGKKNRGFYRSDTKVNLIGHLWDEGIPLRLIDACIQDSCN 669 (747)
Q Consensus 597 ~~~~~~~----~-~--~~~~~~~s~ksDVwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~ 669 (747)
....... . . ......++.++||||||+++|||++|+.|+................... ...+. ...
T Consensus 155 ~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~-~~~~~-----~~~- 227 (264)
T cd06623 155 DQCNTFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQPSFFELMQAICDGP-PPSLP-----AEE- 227 (264)
T ss_pred CcccceeecccccCHhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCccccccCHHHHHHHHhcCC-CCCCC-----ccc-
Confidence 2210000 0 0 0113567889999999999999999999975443212222222222111 11110 100
Q ss_pred HHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 004521 670 LADVIRCIHIGLLCVQQHPEDRPCMPSVILM 700 (747)
Q Consensus 670 ~~~~~~~~~l~~~Cl~~dP~~RPt~~~v~~~ 700 (747)
....+.+++.+||+.+|++||++.++++.
T Consensus 228 --~~~~l~~li~~~l~~~p~~R~~~~~ll~~ 256 (264)
T cd06623 228 --FSPEFRDFISACLQKDPKKRPSAAELLQH 256 (264)
T ss_pred --CCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence 12346677789999999999999999874
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-32 Score=293.95 Aligned_cols=254 Identities=22% Similarity=0.277 Sum_probs=180.2
Q ss_pred HhcCCCccceecccCCeeEEEEEec-CCcEEEEEEecccc--cccHHHHHHHHHHHhccCCCceeeEEeEEEeC------
Q 004521 438 ATDNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKIS--EQGLKELKNEVILFSKLQHRNLVKLLGCCIQG------ 508 (747)
Q Consensus 438 ~~~~~~~~~~lg~G~fg~Vy~~~~~-~g~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~------ 508 (747)
..++|.+.+.||+|+||.||+|... +++.||||++.... ....+.+.+|+.++++++||||+++++++...
T Consensus 13 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 92 (343)
T cd07878 13 VPERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIENF 92 (343)
T ss_pred hhhhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhccccccccc
Confidence 4578999999999999999999875 47899999987522 23345678999999999999999999987643
Q ss_pred CeeEEEEecCCCCChhhHhhhcCCCCcCChhHHHHHHHHHHHHHHHhhhcCCCceEecccCcCcEEEcCCCCceEecccC
Q 004521 509 EEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGL 588 (747)
Q Consensus 509 ~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NIll~~~~~~kl~DFGl 588 (747)
...++++|++ +++|..++.. ..+++..+..++.||++||.|||+.+ |+||||||+|||+++++.+||+|||+
T Consensus 93 ~~~~~~~~~~-~~~l~~~~~~----~~l~~~~~~~i~~qi~~aL~~LH~~~---ivHrdikp~Nil~~~~~~~kl~Dfg~ 164 (343)
T cd07878 93 NEVYLVTNLM-GADLNNIVKC----QKLSDEHVQFLIYQLLRGLKYIHSAG---IIHRDLKPSNVAVNEDCELRILDFGL 164 (343)
T ss_pred CcEEEEeecC-CCCHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCC---eecccCChhhEEECCCCCEEEcCCcc
Confidence 3468999988 7889887732 34889999999999999999999988 99999999999999999999999999
Q ss_pred ccccCCCCCccccc--eeeec-c--CCCCCccccchhHHHHHHHHHhCCCCCCCCCCcchhhhhHhHHhcCCcccccc--
Q 004521 589 VRTFGGDETEGNTN--RVVGT-Y--DGQFSIKSDVFSFGILLLEIVSGKKNRGFYRSDTKVNLIGHLWDEGIPLRLID-- 661 (747)
Q Consensus 589 a~~~~~~~~~~~~~--~~~~~-~--~~~~s~ksDVwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~d-- 661 (747)
++............ ..... . ...++.++|||||||++|||++|+.||...........+...... .......
T Consensus 165 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~-~~~~~~~~~ 243 (343)
T cd07878 165 ARQADDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQLKRIMEVVGT-PSPEVLKKI 243 (343)
T ss_pred ceecCCCcCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCC-CCHHHHHhc
Confidence 98764332211100 00011 0 245788999999999999999999997532211111000000000 0000000
Q ss_pred ------h---hhhc--cCCHH-----HHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 004521 662 ------A---CIQD--SCNLA-----DVIRCIHIGLLCVQQHPEDRPCMPSVILM 700 (747)
Q Consensus 662 ------~---~l~~--~~~~~-----~~~~~~~l~~~Cl~~dP~~RPt~~~v~~~ 700 (747)
. .+.. ..... ....+.+++.+|++.||.+|||+.++++.
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dp~~R~s~~ell~h 298 (343)
T cd07878 244 SSEHARKYIQSLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALAH 298 (343)
T ss_pred chhhHHHHhhccccccchhHHHhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 0 0000 00000 01135678889999999999999999853
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-31 Score=277.46 Aligned_cols=243 Identities=23% Similarity=0.284 Sum_probs=184.2
Q ss_pred CCCccceecccCCeeEEEEEecC-CcEEEEEEeccc--ccccHHHHHHHHHHHhccCCCceeeEEeEEEeC-CeeEEEEe
Q 004521 441 NFSINNKLGEGGFGPVYKGTLVD-GQEIAVKRLSKI--SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQG-EEKLLIYE 516 (747)
Q Consensus 441 ~~~~~~~lg~G~fg~Vy~~~~~~-g~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~-~~~~lV~E 516 (747)
+|++.+.||+|++|.||+++... ++.+|+|++... .....+.+.+|++++++++|+|++++++.+... ...++|||
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e 80 (257)
T cd08223 1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVMG 80 (257)
T ss_pred CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEEEec
Confidence 47889999999999999999754 789999998642 234456789999999999999999999987644 45789999
Q ss_pred cCCCCChhhHhhhcCCCCcCChhHHHHHHHHHHHHHHHhhhcCCCceEecccCcCcEEEcCCCCceEecccCccccCCCC
Q 004521 517 FMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDE 596 (747)
Q Consensus 517 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~ 596 (747)
|+++++|.+++.... ...+++.++..++.+++.|++|||+.+ ++||||||+||+++.++.+||+|||+++.+....
T Consensus 81 ~~~~~~l~~~l~~~~-~~~l~~~~~~~~~~~l~~~l~~lH~~~---i~H~di~p~nil~~~~~~~~l~df~~~~~~~~~~ 156 (257)
T cd08223 81 FCEGGDLYHKLKEQK-GKLLPENQVVEWFVQIAMALQYLHEKH---ILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQC 156 (257)
T ss_pred ccCCCcHHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCchhEEEecCCcEEEecccceEEecccC
Confidence 999999999986532 345899999999999999999999988 9999999999999999999999999998664322
Q ss_pred Ccccc-----ceeeec--cCCCCCccccchhHHHHHHHHHhCCCCCCCCCCcchhhhhHhHHhcCCcccccchhhhccCC
Q 004521 597 TEGNT-----NRVVGT--YDGQFSIKSDVFSFGILLLEIVSGKKNRGFYRSDTKVNLIGHLWDEGIPLRLIDACIQDSCN 669 (747)
Q Consensus 597 ~~~~~-----~~~~~~--~~~~~s~ksDVwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~ 669 (747)
..... ...... ....++.++||||||++++||++|+.|+.... ...... ....+....+. .
T Consensus 157 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~---~~~~~~-~~~~~~~~~~~-----~--- 224 (257)
T cd08223 157 DMASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKD---MNSLVY-RIIEGKLPPMP-----K--- 224 (257)
T ss_pred CccccccCCcCccChhHhcCCCCCchhhhHHHHHHHHHHHcCCCCCCCCC---HHHHHH-HHHhcCCCCCc-----c---
Confidence 11100 000000 14567889999999999999999999965322 111111 11222221111 1
Q ss_pred HHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 004521 670 LADVIRCIHIGLLCVQQHPEDRPCMPSVILM 700 (747)
Q Consensus 670 ~~~~~~~~~l~~~Cl~~dP~~RPt~~~v~~~ 700 (747)
.....+.+++.+|++.+|++||++.++++.
T Consensus 225 -~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~ 254 (257)
T cd08223 225 -DYSPELGELIATMLSKRPEKRPSVKSILRQ 254 (257)
T ss_pred -ccCHHHHHHHHHHhccCcccCCCHHHHhcC
Confidence 112346678889999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-32 Score=278.95 Aligned_cols=241 Identities=26% Similarity=0.392 Sum_probs=184.1
Q ss_pred CCCccceecccCCeeEEEEEec-CCcEEEEEEecccc-----cccHHHHHHHHHHHhccCCCceeeEEeEEEeCCeeEEE
Q 004521 441 NFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKIS-----EQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLI 514 (747)
Q Consensus 441 ~~~~~~~lg~G~fg~Vy~~~~~-~g~~vavK~l~~~~-----~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV 514 (747)
+|+..+.||+|+||.||+|... +++.|++|.+.... .+..+.+.+|+.++++++|+||+++++++......++|
T Consensus 1 ~~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 80 (258)
T cd06632 1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLYIF 80 (258)
T ss_pred CccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecCCeEEEE
Confidence 4667789999999999999986 68999999986532 23457899999999999999999999999999999999
Q ss_pred EecCCCCChhhHhhhcCCCCcCChhHHHHHHHHHHHHHHHhhhcCCCceEecccCcCcEEEcCCCCceEecccCccccCC
Q 004521 515 YEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGG 594 (747)
Q Consensus 515 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NIll~~~~~~kl~DFGla~~~~~ 594 (747)
+||+++++|.+++... ..+++..+..++.|+++||.|||+.+ ++|+||+|+||+++.++.+||+|||++.....
T Consensus 81 ~e~~~~~~L~~~~~~~---~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~~~ 154 (258)
T cd06632 81 LELVPGGSLAKLLKKY---GSFPEPVIRLYTRQILLGLEYLHDRN---TVHRDIKGANILVDTNGVVKLADFGMAKQVVE 154 (258)
T ss_pred EEecCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEccCccceeccc
Confidence 9999999999998543 34789999999999999999999988 99999999999999999999999999876543
Q ss_pred CCCc-c--ccceeeec---cCC-CCCccccchhHHHHHHHHHhCCCCCCCCCCcchhhhhHhHHhcCCcccccchhhhcc
Q 004521 595 DETE-G--NTNRVVGT---YDG-QFSIKSDVFSFGILLLEIVSGKKNRGFYRSDTKVNLIGHLWDEGIPLRLIDACIQDS 667 (747)
Q Consensus 595 ~~~~-~--~~~~~~~~---~~~-~~s~ksDVwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~ 667 (747)
.... . .......+ ... .++.++|+||||+++|||++|+.|+.... ................+. ..
T Consensus 155 ~~~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~---~~~~~~~~~~~~~~~~~~-----~~ 226 (258)
T cd06632 155 FSFAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLE---GVAAVFKIGRSKELPPIP-----DH 226 (258)
T ss_pred cccccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCc---HHHHHHHHHhcccCCCcC-----CC
Confidence 3210 0 00000011 122 37889999999999999999999975432 111111111111111111 11
Q ss_pred CCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 004521 668 CNLADVIRCIHIGLLCVQQHPEDRPCMPSVIL 699 (747)
Q Consensus 668 ~~~~~~~~~~~l~~~Cl~~dP~~RPt~~~v~~ 699 (747)
. ...+.+++.+||+.+|.+||++.++++
T Consensus 227 ~----~~~~~~li~~~l~~~p~~Rp~~~~~l~ 254 (258)
T cd06632 227 L----SDEAKDFILKCLQRDPSLRPTAAELLE 254 (258)
T ss_pred c----CHHHHHHHHHHhhcCcccCcCHHHHhc
Confidence 1 133556788999999999999999975
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-32 Score=287.51 Aligned_cols=239 Identities=25% Similarity=0.398 Sum_probs=182.2
Q ss_pred CCccceecccCCeeEEEEEec-CCcEEEEEEecccccccHHHHHHHHHHHhccCCCceeeEEeEEEeCCeeEEEEecCCC
Q 004521 442 FSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMPN 520 (747)
Q Consensus 442 ~~~~~~lg~G~fg~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~ 520 (747)
|.....||+|+||.||++... ++..||||.+........+.+.+|+.+++.++|+||+++++.+...+..++||||+++
T Consensus 24 ~~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~lv~e~~~~ 103 (292)
T cd06658 24 LDSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVMEFLEG 103 (292)
T ss_pred HhhhhcccCCCCeEEEEEEECCCCCEEEEEEEecchHHHHHHHHHHHHHHHhCCCCcHHHHHHheecCCeEEEEEeCCCC
Confidence 333467999999999999875 4889999998764555567789999999999999999999999999999999999999
Q ss_pred CChhhHhhhcCCCCcCChhHHHHHHHHHHHHHHHhhhcCCCceEecccCcCcEEEcCCCCceEecccCccccCCCCCccc
Q 004521 521 KSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGN 600 (747)
Q Consensus 521 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~ 600 (747)
++|.+++.. ..+++..+..++.||+.||.|||+.+ |+||||||+||++++++.+||+|||++...........
T Consensus 104 ~~L~~~~~~----~~l~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~~~~~~~ 176 (292)
T cd06658 104 GALTDIVTH----TRMNEEQIATVCLSVLRALSYLHNQG---VIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVPKRK 176 (292)
T ss_pred CcHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEcCCCCEEEccCcchhhcccccccCc
Confidence 999998843 34788999999999999999999988 99999999999999999999999999876533221110
Q ss_pred cceeeec---------cCCCCCccccchhHHHHHHHHHhCCCCCCCCCCcchhhhhHhHHhcCCcccccchhhhccCCHH
Q 004521 601 TNRVVGT---------YDGQFSIKSDVFSFGILLLEIVSGKKNRGFYRSDTKVNLIGHLWDEGIPLRLIDACIQDSCNLA 671 (747)
Q Consensus 601 ~~~~~~~---------~~~~~s~ksDVwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~ 671 (747)
...++ ....++.++|||||||++|||++|+.|+..... ...... ........+.+ ...
T Consensus 177 --~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~---~~~~~~-~~~~~~~~~~~-----~~~-- 243 (292)
T cd06658 177 --SLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPP---LQAMRR-IRDNLPPRVKD-----SHK-- 243 (292)
T ss_pred --eeecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH---HHHHHH-HHhcCCCcccc-----ccc--
Confidence 01111 135678899999999999999999999643221 111111 11111111111 000
Q ss_pred HHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 004521 672 DVIRCIHIGLLCVQQHPEDRPCMPSVILM 700 (747)
Q Consensus 672 ~~~~~~~l~~~Cl~~dP~~RPt~~~v~~~ 700 (747)
....+..++.+||+.||.+|||+.++++.
T Consensus 244 ~~~~~~~li~~~l~~~P~~Rpt~~~il~~ 272 (292)
T cd06658 244 VSSVLRGFLDLMLVREPSQRATAQELLQH 272 (292)
T ss_pred cCHHHHHHHHHHccCChhHCcCHHHHhhC
Confidence 11234567778999999999999999874
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-31 Score=311.20 Aligned_cols=249 Identities=22% Similarity=0.276 Sum_probs=183.5
Q ss_pred HhcCCCccceecccCCeeEEEEEecC-CcEEEEEEeccc--ccccHHHHHHHHHHHhccCCCceeeEEeEEEeC--CeeE
Q 004521 438 ATDNFSINNKLGEGGFGPVYKGTLVD-GQEIAVKRLSKI--SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQG--EEKL 512 (747)
Q Consensus 438 ~~~~~~~~~~lg~G~fg~Vy~~~~~~-g~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~--~~~~ 512 (747)
..++|.+.++||+|+||+||+++... +..+|+|.+... .......|..|+.++++|+|||||++++++... ...+
T Consensus 11 ~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~~~~ly 90 (1021)
T PTZ00266 11 RLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKANQKLY 90 (1021)
T ss_pred ccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEecCCCEEE
Confidence 44689999999999999999999765 778999988642 334456789999999999999999999988654 5689
Q ss_pred EEEecCCCCChhhHhhhcC-CCCcCChhHHHHHHHHHHHHHHHhhhcCC----CceEecccCcCcEEEcC----------
Q 004521 513 LIYEFMPNKSLDSFIFDQT-RRTLLDWSQRFHIICGTARGLLYLHQDSR----LRIIHRDLKASNVLLDQ---------- 577 (747)
Q Consensus 513 lV~E~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~gl~yLH~~~~----~~iiHrDlkp~NIll~~---------- 577 (747)
|||||+++|+|.++|.... ....+++..++.|+.||+.||.|||+.+. .+||||||||+||||+.
T Consensus 91 IVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~lg~i~~ 170 (1021)
T PTZ00266 91 ILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITA 170 (1021)
T ss_pred EEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCccccccccc
Confidence 9999999999999986532 23468999999999999999999998531 34999999999999964
Q ss_pred -------CCCceEecccCccccCCCCCcc----ccceeeec----cCCCCCccccchhHHHHHHHHHhCCCCCCCCCCcc
Q 004521 578 -------DMNPKISDFGLVRTFGGDETEG----NTNRVVGT----YDGQFSIKSDVFSFGILLLEIVSGKKNRGFYRSDT 642 (747)
Q Consensus 578 -------~~~~kl~DFGla~~~~~~~~~~----~~~~~~~~----~~~~~s~ksDVwS~Gvvl~elltg~~p~~~~~~~~ 642 (747)
...+||+|||+++.+....... ......+. ....++.++||||||||||||++|+.||.... .
T Consensus 171 ~~~n~ng~~iVKLsDFGlAr~l~~~s~~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk~PF~~~~--~ 248 (1021)
T PTZ00266 171 QANNLNGRPIAKIGDFGLSKNIGIESMAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFHKAN--N 248 (1021)
T ss_pred cccccCCCCceEEccCCccccccccccccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCCCCCCcCC--c
Confidence 2348999999998764322110 00111111 12457899999999999999999999975322 1
Q ss_pred hhhhhHhHHhcCCcccccchhhhccCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 004521 643 KVNLIGHLWDEGIPLRLIDACIQDSCNLADVIRCIHIGLLCVQQHPEDRPCMPSVIL 699 (747)
Q Consensus 643 ~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dP~~RPt~~~v~~ 699 (747)
...++.. ..... .+. + ... ...+.+|+..||+.+|.+||++.++++
T Consensus 249 ~~qli~~-lk~~p--~lp---i-~~~----S~eL~dLI~~~L~~dPeeRPSa~QlL~ 294 (1021)
T PTZ00266 249 FSQLISE-LKRGP--DLP---I-KGK----SKELNILIKNLLNLSAKERPSALQCLG 294 (1021)
T ss_pred HHHHHHH-HhcCC--CCC---c-CCC----CHHHHHHHHHHhcCChhHCcCHHHHhc
Confidence 1112211 11111 110 0 001 123567888999999999999999984
|
|
| >KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-32 Score=312.65 Aligned_cols=254 Identities=30% Similarity=0.450 Sum_probs=200.1
Q ss_pred HHHhcCCCccceecccCCeeEEEEEecC--------CcEEEEEEeccc-ccccHHHHHHHHHHHhcc-CCCceeeEEeEE
Q 004521 436 ANATDNFSINNKLGEGGFGPVYKGTLVD--------GQEIAVKRLSKI-SEQGLKELKNEVILFSKL-QHRNLVKLLGCC 505 (747)
Q Consensus 436 ~~~~~~~~~~~~lg~G~fg~Vy~~~~~~--------g~~vavK~l~~~-~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~ 505 (747)
+...++..+.+.||+|.||.|++|.... ...||||.++.. .....+.+..|+++|+.+ +|+||+.++|+|
T Consensus 292 e~~~~~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~~~~~~~~~El~~m~~~g~H~niv~llG~~ 371 (609)
T KOG0200|consen 292 EIPRENLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASSSEKKDLMSELNVLKELGKHPNIVNLLGAC 371 (609)
T ss_pred eechhhccccceeecccccceEeEEEeecccccccceEEEEEEecccccCcHHHHHHHHHHHHHHHhcCCcchhhheeee
Confidence 3344555667799999999999998531 347999999863 345677899999999998 699999999999
Q ss_pred EeCCeeEEEEecCCCCChhhHhhhcC-----CC--------CcCChhHHHHHHHHHHHHHHHhhhcCCCceEecccCcCc
Q 004521 506 IQGEEKLLIYEFMPNKSLDSFIFDQT-----RR--------TLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASN 572 (747)
Q Consensus 506 ~~~~~~~lV~E~~~~gsL~~~l~~~~-----~~--------~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~N 572 (747)
.+++..++|+||++.|+|.++|+... .. ..+...+.+.++.|||.||+||++.. +|||||+++|
T Consensus 372 t~~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~~---~vHRDLAaRN 448 (609)
T KOG0200|consen 372 TQDGPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASVP---CVHRDLAARN 448 (609)
T ss_pred ccCCceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhCC---ccchhhhhhh
Confidence 99999999999999999999997755 00 23888999999999999999999887 9999999999
Q ss_pred EEEcCCCCceEecccCccccCCCCCccccc---eee------e-ccCCCCCccccchhHHHHHHHHHh-CCCCCCCCCCc
Q 004521 573 VLLDQDMNPKISDFGLVRTFGGDETEGNTN---RVV------G-TYDGQFSIKSDVFSFGILLLEIVS-GKKNRGFYRSD 641 (747)
Q Consensus 573 Ill~~~~~~kl~DFGla~~~~~~~~~~~~~---~~~------~-~~~~~~s~ksDVwS~Gvvl~ellt-g~~p~~~~~~~ 641 (747)
||+.++..+||+|||+||............ ..+ . -....|+.|+|||||||+||||+| |..|+.....
T Consensus 449 VLi~~~~~~kIaDFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl~~~~ft~kSDVWSfGI~L~EifsLG~~PYp~~~~- 527 (609)
T KOG0200|consen 449 VLITKNKVIKIADFGLARDHYNKDYYRTKSSAGTLPVKWMAPESLFDRVFTSKSDVWSFGILLWEIFTLGGTPYPGIPP- 527 (609)
T ss_pred EEecCCCEEEEccccceeccCCCCceEecCCCCccceeecCHHHhccCcccccchhhHHHHHHHHHhhCCCCCCCCCCc-
Confidence 999999999999999999655444332111 011 1 125689999999999999999999 6777643211
Q ss_pred chhhhhHhHHhcCCcccccchhhhccCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhcCC
Q 004521 642 TKVNLIGHLWDEGIPLRLIDACIQDSCNLADVIRCIHIGLLCVQQHPEDRPCMPSVILMLGSE 704 (747)
Q Consensus 642 ~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dP~~RPt~~~v~~~L~~~ 704 (747)
...+.. ..++|...+..+.+ ..++..+|..||+.+|++||++.++++.|+..
T Consensus 528 -~~~l~~-~l~~G~r~~~P~~c---------~~eiY~iM~~CW~~~p~~RP~F~~~~~~~~~~ 579 (609)
T KOG0200|consen 528 -TEELLE-FLKEGNRMEQPEHC---------SDEIYDLMKSCWNADPEDRPTFSECVEFFEKH 579 (609)
T ss_pred -HHHHHH-HHhcCCCCCCCCCC---------CHHHHHHHHHHhCCCcccCCCHHHHHHHHHHH
Confidence 222222 45666665544433 23477899999999999999999999999884
|
|
| >KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-32 Score=295.44 Aligned_cols=191 Identities=23% Similarity=0.324 Sum_probs=160.1
Q ss_pred CCCccceecccCCeeEEEEEecC-CcEEEEEEecccccccHHHHHHHHHHHhccC-C-----CceeeEEeEEEeCCeeEE
Q 004521 441 NFSINNKLGEGGFGPVYKGTLVD-GQEIAVKRLSKISEQGLKELKNEVILFSKLQ-H-----RNLVKLLGCCIQGEEKLL 513 (747)
Q Consensus 441 ~~~~~~~lg~G~fg~Vy~~~~~~-g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~-H-----~niv~l~g~~~~~~~~~l 513 (747)
+|++.+.||+|.||.|.+|.... ++.||||+++. ......+-..|+.+|..|+ | -|+|++++++...++.+|
T Consensus 187 rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN-~k~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr~Hlci 265 (586)
T KOG0667|consen 187 RYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKN-KKRFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYFRNHLCI 265 (586)
T ss_pred EEEEEEEecccccceeEEEEecCCCcEEEEEeecc-ChHHHHHHHHHHHHHHHHhccCCCCCeeEEEeeeccccccceee
Confidence 78999999999999999999755 89999999986 4455667788999999996 4 489999999999999999
Q ss_pred EEecCCCCChhhHhhhcCCCCcCChhHHHHHHHHHHHHHHHhhhcCCCceEecccCcCcEEEcCC--CCceEecccCccc
Q 004521 514 IYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQD--MNPKISDFGLVRT 591 (747)
Q Consensus 514 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NIll~~~--~~~kl~DFGla~~ 591 (747)
|+|.+. -+|+++|....- ..++...+..|+.||+.||.+||+.+ |||+||||+||||..- ..+||+|||.|..
T Consensus 266 VfELL~-~NLYellK~n~f-~Glsl~~ir~~~~Qil~~L~~L~~l~---IIHcDLKPENILL~~~~r~~vKVIDFGSSc~ 340 (586)
T KOG0667|consen 266 VFELLS-TNLYELLKNNKF-RGLSLPLVRKFAQQILTALLFLHELG---IIHCDLKPENILLKDPKRSRIKVIDFGSSCF 340 (586)
T ss_pred eehhhh-hhHHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCChhheeeccCCcCceeEEecccccc
Confidence 999994 899999976543 34899999999999999999999988 9999999999999643 4799999999987
Q ss_pred cCCCCCccccceeeec----cCCCCCccccchhHHHHHHHHHhCCCCCCC
Q 004521 592 FGGDETEGNTNRVVGT----YDGQFSIKSDVFSFGILLLEIVSGKKNRGF 637 (747)
Q Consensus 592 ~~~~~~~~~~~~~~~~----~~~~~s~ksDVwS~Gvvl~elltg~~p~~~ 637 (747)
...........+.... .+.+|+.+.||||||||+.||++|.+.|..
T Consensus 341 ~~q~vytYiQSRfYRAPEVILGlpY~~~IDmWSLGCIlAEL~tG~PLfpG 390 (586)
T KOG0667|consen 341 ESQRVYTYIQSRFYRAPEVILGLPYDTAIDMWSLGCILAELFTGEPLFPG 390 (586)
T ss_pred cCCcceeeeeccccccchhhccCCCCCccceeehhhhHHhHhcCccccCC
Confidence 6544432222222222 267899999999999999999999776543
|
|
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-32 Score=281.68 Aligned_cols=246 Identities=24% Similarity=0.368 Sum_probs=182.1
Q ss_pred CCCccceecccCCeeEEEEEec-CCcEEEEEEeccccc----------ccHHHHHHHHHHHhccCCCceeeEEeEEEeCC
Q 004521 441 NFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKISE----------QGLKELKNEVILFSKLQHRNLVKLLGCCIQGE 509 (747)
Q Consensus 441 ~~~~~~~lg~G~fg~Vy~~~~~-~g~~vavK~l~~~~~----------~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~ 509 (747)
+|.+.+.||+|+||.||+|... +++.+|+|.++.... ...+.+.+|+.++++++|+||+++++++...+
T Consensus 2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 81 (272)
T cd06629 2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEE 81 (272)
T ss_pred ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccCC
Confidence 4667889999999999999865 588999998753111 12346888999999999999999999999999
Q ss_pred eeEEEEecCCCCChhhHhhhcCCCCcCChhHHHHHHHHHHHHHHHhhhcCCCceEecccCcCcEEEcCCCCceEecccCc
Q 004521 510 EKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLV 589 (747)
Q Consensus 510 ~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NIll~~~~~~kl~DFGla 589 (747)
..++||||+++++|.+++... ..+++..+..++.||+.||.|||+.+ ++||||+|+||+++.++.+||+|||++
T Consensus 82 ~~~lv~e~~~~~~L~~~l~~~---~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~~~nil~~~~~~~~l~d~~~~ 155 (272)
T cd06629 82 YLSIFLEYVPGGSIGSCLRTY---GRFEEQLVRFFTEQVLEGLAYLHSKG---ILHRDLKADNLLVDADGICKISDFGIS 155 (272)
T ss_pred ceEEEEecCCCCcHHHHHhhc---cCCCHHHHHHHHHHHHHHHHHHhhCC---eeecCCChhhEEEcCCCeEEEeecccc
Confidence 999999999999999998653 45888999999999999999999987 999999999999999999999999999
Q ss_pred cccCCCCCccccceeeec---------cC--CCCCccccchhHHHHHHHHHhCCCCCCCCCCcchhhhhHhHHhcCCccc
Q 004521 590 RTFGGDETEGNTNRVVGT---------YD--GQFSIKSDVFSFGILLLEIVSGKKNRGFYRSDTKVNLIGHLWDEGIPLR 658 (747)
Q Consensus 590 ~~~~~~~~~~~~~~~~~~---------~~--~~~s~ksDVwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 658 (747)
+...............++ .. ..++.++||||||+++||+++|..|+.... ....+...........
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~---~~~~~~~~~~~~~~~~ 232 (272)
T cd06629 156 KKSDDIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEE---AIAAMFKLGNKRSAPP 232 (272)
T ss_pred ccccccccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcc---hHHHHHHhhccccCCc
Confidence 765322111100000010 01 247889999999999999999999964221 1111111111111111
Q ss_pred ccchhhhccCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 004521 659 LIDACIQDSCNLADVIRCIHIGLLCVQQHPEDRPCMPSVILM 700 (747)
Q Consensus 659 ~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dP~~RPt~~~v~~~ 700 (747)
+.+ ... ......+.+++.+||+.+|.+||++.+|++.
T Consensus 233 ~~~-~~~----~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 269 (272)
T cd06629 233 IPP-DVS----MNLSPVALDFLNACFTINPDNRPTARELLQH 269 (272)
T ss_pred CCc-ccc----ccCCHHHHHHHHHHhcCChhhCCCHHHHhhC
Confidence 111 110 1112345667889999999999999999864
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.2e-31 Score=282.02 Aligned_cols=245 Identities=24% Similarity=0.377 Sum_probs=180.5
Q ss_pred cCCCccceecccCCeeEEEEEec-CCcEEEEEEecccc-cccHHHHHHHHHH-HhccCCCceeeEEeEEEeCCeeEEEEe
Q 004521 440 DNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKIS-EQGLKELKNEVIL-FSKLQHRNLVKLLGCCIQGEEKLLIYE 516 (747)
Q Consensus 440 ~~~~~~~~lg~G~fg~Vy~~~~~-~g~~vavK~l~~~~-~~~~~~~~~E~~~-l~~l~H~niv~l~g~~~~~~~~~lV~E 516 (747)
++|++.+.||+|+||.||+++.. +|+.||+|+++... .....++..|+.+ ++.++||||+++++++..+...++|||
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~lv~e 80 (283)
T cd06617 1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGALFREGDVWICME 80 (283)
T ss_pred CCceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcHHHHHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEEEEhh
Confidence 46888999999999999999976 48999999987532 2334456666665 566789999999999999999999999
Q ss_pred cCCCCChhhHhhhc-CCCCcCChhHHHHHHHHHHHHHHHhhhc-CCCceEecccCcCcEEEcCCCCceEecccCccccCC
Q 004521 517 FMPNKSLDSFIFDQ-TRRTLLDWSQRFHIICGTARGLLYLHQD-SRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGG 594 (747)
Q Consensus 517 ~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~ia~gl~yLH~~-~~~~iiHrDlkp~NIll~~~~~~kl~DFGla~~~~~ 594 (747)
|++ |+|.+++... .....+++..+..++.||+.||+|||++ + ++||||||+||+++.++.+||+|||+++.+..
T Consensus 81 ~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~---i~h~dlkp~nil~~~~~~~kl~dfg~~~~~~~ 156 (283)
T cd06617 81 VMD-TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKLS---VIHRDVKPSNVLINRNGQVKLCDFGISGYLVD 156 (283)
T ss_pred hhc-ccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhcCC---eecCCCCHHHEEECCCCCEEEeeccccccccc
Confidence 997 7888887553 2335689999999999999999999986 6 99999999999999999999999999886533
Q ss_pred CCCcc---------ccceeeecc-CCCCCccccchhHHHHHHHHHhCCCCCCCCCCcchhhhhHhHHhcCCcccccchhh
Q 004521 595 DETEG---------NTNRVVGTY-DGQFSIKSDVFSFGILLLEIVSGKKNRGFYRSDTKVNLIGHLWDEGIPLRLIDACI 664 (747)
Q Consensus 595 ~~~~~---------~~~~~~~~~-~~~~s~ksDVwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 664 (747)
..... .++...+.. ...++.++||||||+++|||++|+.|+..... ....+.... .+....+....
T Consensus 157 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~--~~~~~~~~~-~~~~~~~~~~~- 232 (283)
T cd06617 157 SVAKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKT--PFQQLKQVV-EEPSPQLPAEK- 232 (283)
T ss_pred ccccccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCcccc--CHHHHHHHH-hcCCCCCCccc-
Confidence 21110 000011111 14568899999999999999999999743221 111111111 11111111111
Q ss_pred hccCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 004521 665 QDSCNLADVIRCIHIGLLCVQQHPEDRPCMPSVIL 699 (747)
Q Consensus 665 ~~~~~~~~~~~~~~l~~~Cl~~dP~~RPt~~~v~~ 699 (747)
. ...+.+++.+||+.+|.+||++.+|++
T Consensus 233 ---~----~~~l~~li~~~l~~~p~~Rp~~~~il~ 260 (283)
T cd06617 233 ---F----SPEFQDFVNKCLKKNYKERPNYPELLQ 260 (283)
T ss_pred ---c----CHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 1 123567888999999999999999976
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.5e-31 Score=285.01 Aligned_cols=243 Identities=25% Similarity=0.367 Sum_probs=183.6
Q ss_pred cCCCccceecccCCeeEEEEEec-CCcEEEEEEecccc---cccHHHHHHHHHHHhccCCCceeeEEeEEEeCCeeEEEE
Q 004521 440 DNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKIS---EQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIY 515 (747)
Q Consensus 440 ~~~~~~~~lg~G~fg~Vy~~~~~-~g~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 515 (747)
+.|.+.+.||+|+||.||+|+.. +++.||+|.+.... .+..+++.+|+.+++.++||||+++++++...+..++||
T Consensus 15 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~lv~ 94 (307)
T cd06607 15 KLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTAWLVM 94 (307)
T ss_pred hhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCCeEEEEH
Confidence 46888899999999999999975 48899999986432 233457889999999999999999999999999999999
Q ss_pred ecCCCCChhhHhhhcCCCCcCChhHHHHHHHHHHHHHHHhhhcCCCceEecccCcCcEEEcCCCCceEecccCccccCCC
Q 004521 516 EFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGD 595 (747)
Q Consensus 516 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NIll~~~~~~kl~DFGla~~~~~~ 595 (747)
||++ |+|.+++... ...+++..+..++.|++.||.|||+.+ |+||||+|+||+++.++.+||+|||+++.....
T Consensus 95 e~~~-g~l~~~~~~~--~~~l~~~~~~~~~~ql~~~L~~LH~~~---i~H~dl~p~nIl~~~~~~~kL~dfg~~~~~~~~ 168 (307)
T cd06607 95 EYCL-GSASDILEVH--KKPLQEVEIAAICHGALQGLAYLHSHE---RIHRDIKAGNILLTEPGTVKLADFGSASLVSPA 168 (307)
T ss_pred HhhC-CCHHHHHHHc--ccCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCcccEEECCCCCEEEeecCcceecCCC
Confidence 9997 6777776432 235899999999999999999999988 999999999999999999999999998765433
Q ss_pred CCcccc------ceeeeccCCCCCccccchhHHHHHHHHHhCCCCCCCCCCcchhhhhHhHHhcCCcccccchhhhccCC
Q 004521 596 ETEGNT------NRVVGTYDGQFSIKSDVFSFGILLLEIVSGKKNRGFYRSDTKVNLIGHLWDEGIPLRLIDACIQDSCN 669 (747)
Q Consensus 596 ~~~~~~------~~~~~~~~~~~s~ksDVwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~ 669 (747)
...... +...+.....++.++||||||+++|||++|+.|+.... .......... .....+. .
T Consensus 169 ~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~---~~~~~~~~~~-~~~~~~~--------~ 236 (307)
T cd06607 169 NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMN---AMSALYHIAQ-NDSPTLS--------S 236 (307)
T ss_pred CCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCcc---HHHHHHHHhc-CCCCCCC--------c
Confidence 221111 11111123568889999999999999999999964221 1111111111 1111110 0
Q ss_pred HHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 004521 670 LADVIRCIHIGLLCVQQHPEDRPCMPSVILM 700 (747)
Q Consensus 670 ~~~~~~~~~l~~~Cl~~dP~~RPt~~~v~~~ 700 (747)
......+.+++.+||+.+|++||+|.+|+.+
T Consensus 237 ~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 267 (307)
T cd06607 237 NDWSDYFRNFVDSCLQKIPQDRPSSEELLKH 267 (307)
T ss_pred hhhCHHHHHHHHHHhcCChhhCcCHHHHhcC
Confidence 1112346778889999999999999999874
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=99.98 E-value=8.6e-32 Score=289.29 Aligned_cols=234 Identities=21% Similarity=0.249 Sum_probs=172.2
Q ss_pred ceecccCCeeEEEEEecC-CcEEEEEEecccc---cccHHHHHHHHH-HHhccCCCceeeEEeEEEeCCeeEEEEecCCC
Q 004521 446 NKLGEGGFGPVYKGTLVD-GQEIAVKRLSKIS---EQGLKELKNEVI-LFSKLQHRNLVKLLGCCIQGEEKLLIYEFMPN 520 (747)
Q Consensus 446 ~~lg~G~fg~Vy~~~~~~-g~~vavK~l~~~~---~~~~~~~~~E~~-~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~ 520 (747)
+.||+|+||.||+|+... ++.+|+|++.+.. ......+..|.. +++.++||||+++++++...+..++||||+++
T Consensus 1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05602 1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYING 80 (325)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEeCCCC
Confidence 479999999999999764 7889999987521 223334444544 56788999999999999999999999999999
Q ss_pred CChhhHhhhcCCCCcCChhHHHHHHHHHHHHHHHhhhcCCCceEecccCcCcEEEcCCCCceEecccCccccCCCCCccc
Q 004521 521 KSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGN 600 (747)
Q Consensus 521 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~ 600 (747)
++|.+++... ..+.+..+..++.||++||+|||+.+ |+||||||+|||++.++.+||+|||+++........
T Consensus 81 ~~L~~~~~~~---~~~~~~~~~~~~~qi~~~L~~lH~~g---iiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~~~~~-- 152 (325)
T cd05602 81 GELFYHLQRE---RCFLEPRARFYAAEIASALGYLHSLN---IVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNGT-- 152 (325)
T ss_pred CcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEECCCCCEEEccCCCCcccccCCCC--
Confidence 9999998542 34778888889999999999999988 999999999999999999999999999754322111
Q ss_pred cceeeec---------cCCCCCccccchhHHHHHHHHHhCCCCCCCCCCcchhhhhHhHHhcCCcccccchhhhccCCHH
Q 004521 601 TNRVVGT---------YDGQFSIKSDVFSFGILLLEIVSGKKNRGFYRSDTKVNLIGHLWDEGIPLRLIDACIQDSCNLA 671 (747)
Q Consensus 601 ~~~~~~~---------~~~~~s~ksDVwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~ 671 (747)
.....++ ....++.++|||||||++|||++|+.||.... ............. .+ . ...
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~---~~~~~~~i~~~~~--~~-~----~~~--- 219 (325)
T cd05602 153 TSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRN---TAEMYDNILNKPL--QL-K----PNI--- 219 (325)
T ss_pred cccccCCccccCHHHHcCCCCCCccccccccHHHHHHhcCCCCCCCCC---HHHHHHHHHhCCc--CC-C----CCC---
Confidence 1111111 14568899999999999999999999975322 1122222211110 00 0 111
Q ss_pred HHHHHHHHHHhccCCCCCCCCCHHHHHHHh
Q 004521 672 DVIRCIHIGLLCVQQHPEDRPCMPSVILML 701 (747)
Q Consensus 672 ~~~~~~~l~~~Cl~~dP~~RPt~~~v~~~L 701 (747)
...+.+++.+|++.+|.+||++.+.+..+
T Consensus 220 -~~~~~~li~~~l~~~p~~R~~~~~~~~~i 248 (325)
T cd05602 220 -TNSARHLLEGLLQKDRTKRLGAKDDFMEI 248 (325)
T ss_pred -CHHHHHHHHHHcccCHHHCCCCCCCHHHH
Confidence 11245667799999999999987544433
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.8e-31 Score=276.38 Aligned_cols=243 Identities=21% Similarity=0.313 Sum_probs=186.2
Q ss_pred CCCccceecccCCeeEEEEEec-CCcEEEEEEeccc--ccccHHHHHHHHHHHhccCCCceeeEEeEEEeCCeeEEEEec
Q 004521 441 NFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKI--SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEF 517 (747)
Q Consensus 441 ~~~~~~~lg~G~fg~Vy~~~~~-~g~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~ 517 (747)
+|++.+.||+|+||.||+++.. +++.+|+|.+... .....+++.+|+.++++++||||+++++++...+..++|+||
T Consensus 1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08218 1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVMDY 80 (256)
T ss_pred CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeeecCCCeEEEEEec
Confidence 4788899999999999999875 4889999998642 234456889999999999999999999999999999999999
Q ss_pred CCCCChhhHhhhcCCCCcCChhHHHHHHHHHHHHHHHhhhcCCCceEecccCcCcEEEcCCCCceEecccCccccCCCCC
Q 004521 518 MPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDET 597 (747)
Q Consensus 518 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~ 597 (747)
+++++|.+++.... ...+++.+++.++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++..+.....
T Consensus 81 ~~~~~l~~~~~~~~-~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~~~~ 156 (256)
T cd08218 81 CEGGDLYKKINAQR-GVLFPEDQILDWFVQICLALKHVHDRK---ILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVE 156 (256)
T ss_pred CCCCcHHHHHHhcc-CCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCEEEeeccceeecCcchh
Confidence 99999999886432 234788999999999999999999988 99999999999999999999999999976543221
Q ss_pred ccc-----cceeee--ccCCCCCccccchhHHHHHHHHHhCCCCCCCCCCcchhhhhHhHHhcCCcccccchhhhccCCH
Q 004521 598 EGN-----TNRVVG--TYDGQFSIKSDVFSFGILLLEIVSGKKNRGFYRSDTKVNLIGHLWDEGIPLRLIDACIQDSCNL 670 (747)
Q Consensus 598 ~~~-----~~~~~~--~~~~~~s~ksDVwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~ 670 (747)
... ...... .....++.++|||||||+++||++|+.|+... .......... .+...... .
T Consensus 157 ~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~---~~~~~~~~~~-~~~~~~~~-----~---- 223 (256)
T cd08218 157 LARTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAG---NMKNLVLKII-RGSYPPVS-----S---- 223 (256)
T ss_pred hhhhccCCccccCHHHhCCCCCCCccchhHHHHHHHHHHcCCCCccCC---CHHHHHHHHh-cCCCCCCc-----c----
Confidence 110 000000 11456788999999999999999999996432 1112221111 11111111 1
Q ss_pred HHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 004521 671 ADVIRCIHIGLLCVQQHPEDRPCMPSVILM 700 (747)
Q Consensus 671 ~~~~~~~~l~~~Cl~~dP~~RPt~~~v~~~ 700 (747)
.....+.+++.+||+.+|.+||+|.+|++.
T Consensus 224 ~~~~~~~~li~~~l~~~p~~Rp~~~~vl~~ 253 (256)
T cd08218 224 HYSYDLRNLVSQLFKRNPRDRPSVNSILEK 253 (256)
T ss_pred cCCHHHHHHHHHHhhCChhhCcCHHHHhhC
Confidence 112236678889999999999999999873
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.5e-31 Score=280.53 Aligned_cols=253 Identities=24% Similarity=0.275 Sum_probs=186.7
Q ss_pred cCCCccceecccCCeeEEEEEecC-CcEEEEEEecccc-cccHHHHHHHHHHHhccCCCceeeEEeEEEeC--CeeEEEE
Q 004521 440 DNFSINNKLGEGGFGPVYKGTLVD-GQEIAVKRLSKIS-EQGLKELKNEVILFSKLQHRNLVKLLGCCIQG--EEKLLIY 515 (747)
Q Consensus 440 ~~~~~~~~lg~G~fg~Vy~~~~~~-g~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~--~~~~lV~ 515 (747)
++|+..+.||.|++|.||++.... ++.+|+|.+.... ......+.+|++++++++||||+++++++... ...++||
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~ 80 (287)
T cd06621 1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGIAM 80 (287)
T ss_pred CceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCchHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEEEE
Confidence 367888999999999999999854 7899999987532 24456799999999999999999999998654 3679999
Q ss_pred ecCCCCChhhHhhhcC-CCCcCChhHHHHHHHHHHHHHHHhhhcCCCceEecccCcCcEEEcCCCCceEecccCccccCC
Q 004521 516 EFMPNKSLDSFIFDQT-RRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGG 594 (747)
Q Consensus 516 E~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NIll~~~~~~kl~DFGla~~~~~ 594 (747)
||+++++|.+++.... ....++...+..++.||+.||.|||+.+ ++|+||+|+||++++++.+||+|||++.....
T Consensus 81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~---i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~ 157 (287)
T cd06621 81 EYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSRK---IIHRDIKPSNILLTRKGQVKLCDFGVSGELVN 157 (287)
T ss_pred EecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEecCCeEEEeeccccccccc
Confidence 9999999999875422 2345788999999999999999999988 99999999999999999999999999875432
Q ss_pred CCCccc--cc-eeee--ccCCCCCccccchhHHHHHHHHHhCCCCCCCCCC--cchhhhhHhHHhcCCcccccchhhhcc
Q 004521 595 DETEGN--TN-RVVG--TYDGQFSIKSDVFSFGILLLEIVSGKKNRGFYRS--DTKVNLIGHLWDEGIPLRLIDACIQDS 667 (747)
Q Consensus 595 ~~~~~~--~~-~~~~--~~~~~~s~ksDVwS~Gvvl~elltg~~p~~~~~~--~~~~~~~~~~~~~~~~~~~~d~~l~~~ 667 (747)
...... .. .... .....++.++||||||+++|||++|+.|+..... ........+.. ......+.+. ...
T Consensus 158 ~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~-~~~- 234 (287)
T cd06621 158 SLAGTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIV-NMPNPELKDE-PGN- 234 (287)
T ss_pred cccccccCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccCCCCChHHHHHHHh-cCCchhhccC-CCC-
Confidence 211100 00 0000 1145678899999999999999999999764422 11122222211 1111111111 100
Q ss_pred CCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 004521 668 CNLADVIRCIHIGLLCVQQHPEDRPCMPSVIL 699 (747)
Q Consensus 668 ~~~~~~~~~~~l~~~Cl~~dP~~RPt~~~v~~ 699 (747)
.......+.+++.+||+.+|.+|||+.||++
T Consensus 235 -~~~~~~~~~~li~~~l~~~p~~Rpt~~eil~ 265 (287)
T cd06621 235 -GIKWSEEFKDFIKQCLEKDPTRRPTPWDMLE 265 (287)
T ss_pred -CCchHHHHHHHHHHHcCCCcccCCCHHHHHh
Confidence 0111234678889999999999999999987
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.7e-31 Score=278.35 Aligned_cols=241 Identities=26% Similarity=0.394 Sum_probs=177.7
Q ss_pred cCCCccceecccCCeeEEEEEecC-CcEEEEEEecccc-----cccHHHHHHHHHHHhccCCCceeeEEeEEEeC--Cee
Q 004521 440 DNFSINNKLGEGGFGPVYKGTLVD-GQEIAVKRLSKIS-----EQGLKELKNEVILFSKLQHRNLVKLLGCCIQG--EEK 511 (747)
Q Consensus 440 ~~~~~~~~lg~G~fg~Vy~~~~~~-g~~vavK~l~~~~-----~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~--~~~ 511 (747)
.+|+..+.||+|+||.||+|...+ ++.||+|++.... .+..+.+.+|+.++++++||||+++++++.+. ...
T Consensus 2 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (266)
T cd06651 2 INWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTL 81 (266)
T ss_pred CCccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEE
Confidence 478889999999999999998754 8899999986421 22345688999999999999999999998763 567
Q ss_pred EEEEecCCCCChhhHhhhcCCCCcCChhHHHHHHHHHHHHHHHhhhcCCCceEecccCcCcEEEcCCCCceEecccCccc
Q 004521 512 LLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRT 591 (747)
Q Consensus 512 ~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NIll~~~~~~kl~DFGla~~ 591 (747)
++++||+++++|.+++... ..+++.....++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||+++.
T Consensus 82 ~l~~e~~~~~~L~~~l~~~---~~l~~~~~~~~~~qi~~~l~~LH~~~---i~H~~l~p~nil~~~~~~~~l~dfg~~~~ 155 (266)
T cd06651 82 TIFMEYMPGGSVKDQLKAY---GALTESVTRKYTRQILEGMSYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKR 155 (266)
T ss_pred EEEEeCCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEECCCCCEEEccCCCccc
Confidence 8999999999999998543 34788999999999999999999887 99999999999999999999999999876
Q ss_pred cCCCCCccc-cceeeec---------cCCCCCccccchhHHHHHHHHHhCCCCCCCCCCcchhhhhHhHHhcCCcccccc
Q 004521 592 FGGDETEGN-TNRVVGT---------YDGQFSIKSDVFSFGILLLEIVSGKKNRGFYRSDTKVNLIGHLWDEGIPLRLID 661 (747)
Q Consensus 592 ~~~~~~~~~-~~~~~~~---------~~~~~s~ksDVwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~d 661 (747)
+........ .....++ .+..++.++|||||||++|||++|+.|+.... ....+...........
T Consensus 156 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~~g~~pf~~~~---~~~~~~~~~~~~~~~~--- 229 (266)
T cd06651 156 LQTICMSGTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYE---AMAAIFKIATQPTNPQ--- 229 (266)
T ss_pred cccccccCCccccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHHHHCCCCccccc---hHHHHHHHhcCCCCCC---
Confidence 532111000 0000011 14567889999999999999999999975321 1111111111111111
Q ss_pred hhhhccCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 004521 662 ACIQDSCNLADVIRCIHIGLLCVQQHPEDRPCMPSVIL 699 (747)
Q Consensus 662 ~~l~~~~~~~~~~~~~~l~~~Cl~~dP~~RPt~~~v~~ 699 (747)
+.. .....++.+++||..+|++||+|.+|++
T Consensus 230 --~~~-----~~~~~~~~li~~~~~~p~~Rp~~~eil~ 260 (266)
T cd06651 230 --LPS-----HISEHARDFLGCIFVEARHRPSAEELLR 260 (266)
T ss_pred --Cch-----hcCHHHHHHHHHhcCChhhCcCHHHHhc
Confidence 111 1111222234789999999999999975
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=99.98 E-value=6.5e-32 Score=294.98 Aligned_cols=191 Identities=26% Similarity=0.340 Sum_probs=153.8
Q ss_pred HhcCCCccceecccCCeeEEEEEecC-CcEEEEEEeccc--ccccHHHHHHHHHHHhccCCCceeeEEeEEEeC------
Q 004521 438 ATDNFSINNKLGEGGFGPVYKGTLVD-GQEIAVKRLSKI--SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQG------ 508 (747)
Q Consensus 438 ~~~~~~~~~~lg~G~fg~Vy~~~~~~-g~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~------ 508 (747)
..++|.+.+.||+|+||.||++.... ++.||||++... .....+.+.+|+.+++.++||||+++++++...
T Consensus 22 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~~ 101 (364)
T cd07875 22 VLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEF 101 (364)
T ss_pred hhcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeeccccccccc
Confidence 35689999999999999999998754 889999998752 233456788999999999999999999987643
Q ss_pred CeeEEEEecCCCCChhhHhhhcCCCCcCChhHHHHHHHHHHHHHHHhhhcCCCceEecccCcCcEEEcCCCCceEecccC
Q 004521 509 EEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGL 588 (747)
Q Consensus 509 ~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NIll~~~~~~kl~DFGl 588 (747)
...++||||+++ +|..++.. .+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+
T Consensus 102 ~~~~lv~e~~~~-~l~~~~~~-----~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~DfG~ 172 (364)
T cd07875 102 QDVYIVMELMDA-NLCQVIQM-----ELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGL 172 (364)
T ss_pred CeEEEEEeCCCC-CHHHHHHh-----cCCHHHHHHHHHHHHHHHHHHhhCC---eecCCCCHHHEEECCCCcEEEEeCCC
Confidence 356999999974 67766632 3778889999999999999999988 99999999999999999999999999
Q ss_pred ccccCCCCCccc---c-ceeee--ccCCCCCccccchhHHHHHHHHHhCCCCCCC
Q 004521 589 VRTFGGDETEGN---T-NRVVG--TYDGQFSIKSDVFSFGILLLEIVSGKKNRGF 637 (747)
Q Consensus 589 a~~~~~~~~~~~---~-~~~~~--~~~~~~s~ksDVwS~Gvvl~elltg~~p~~~ 637 (747)
++.......... + ..... ..+..++.++|||||||+||||++|+.||..
T Consensus 173 a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~ 227 (364)
T cd07875 173 ARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPG 227 (364)
T ss_pred ccccCCCCcccCCcccCCcCCHHHHhCCCCCchhhHHhHHHHHHHHHhCCCCCCC
Confidence 986543221110 0 00000 0145688999999999999999999999753
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=99.98 E-value=4.5e-32 Score=295.25 Aligned_cols=255 Identities=23% Similarity=0.261 Sum_probs=180.9
Q ss_pred HHhcCCCccceecccCCeeEEEEEec-CCcEEEEEEeccc--ccccHHHHHHHHHHHhccCCCceeeEEeEEEeCC----
Q 004521 437 NATDNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKI--SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGE---- 509 (747)
Q Consensus 437 ~~~~~~~~~~~lg~G~fg~Vy~~~~~-~g~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~---- 509 (747)
...++|.+.+.||+|+||.||++... .++.||||++... .....+.+.+|+.+++.++||||+++++++....
T Consensus 14 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 93 (355)
T cd07874 14 TVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEE 93 (355)
T ss_pred hhhhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeeeeccccccc
Confidence 34578999999999999999999875 4889999998753 2334567888999999999999999999986543
Q ss_pred --eeEEEEecCCCCChhhHhhhcCCCCcCChhHHHHHHHHHHHHHHHhhhcCCCceEecccCcCcEEEcCCCCceEeccc
Q 004521 510 --EKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFG 587 (747)
Q Consensus 510 --~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NIll~~~~~~kl~DFG 587 (747)
..++||||+++ +|...+.. .+++..+..++.|+++||.|||+.+ |+||||||+|||++.++.+||+|||
T Consensus 94 ~~~~~lv~e~~~~-~l~~~~~~-----~l~~~~~~~~~~qi~~aL~~LH~~g---ivHrDikp~Nill~~~~~~kl~Dfg 164 (355)
T cd07874 94 FQDVYLVMELMDA-NLCQVIQM-----ELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFG 164 (355)
T ss_pred cceeEEEhhhhcc-cHHHHHhh-----cCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChHHEEECCCCCEEEeeCc
Confidence 46899999974 66666532 3788889999999999999999988 9999999999999999999999999
Q ss_pred CccccCCCCCccc---c-ceeee--ccCCCCCccccchhHHHHHHHHHhCCCCCCCCCCcchhh-hhHhH----------
Q 004521 588 LVRTFGGDETEGN---T-NRVVG--TYDGQFSIKSDVFSFGILLLEIVSGKKNRGFYRSDTKVN-LIGHL---------- 650 (747)
Q Consensus 588 la~~~~~~~~~~~---~-~~~~~--~~~~~~s~ksDVwS~Gvvl~elltg~~p~~~~~~~~~~~-~~~~~---------- 650 (747)
+++.......... + ..... ..+..++.++|||||||++|||++|+.||.......... .+...
T Consensus 165 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (355)
T cd07874 165 LARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKK 244 (355)
T ss_pred ccccCCCccccCCccccCCccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHh
Confidence 9986543221100 0 00000 014568899999999999999999999975332111100 00000
Q ss_pred --------Hh-cCCcccc------cchhhh--ccCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 004521 651 --------WD-EGIPLRL------IDACIQ--DSCNLADVIRCIHIGLLCVQQHPEDRPCMPSVILM 700 (747)
Q Consensus 651 --------~~-~~~~~~~------~d~~l~--~~~~~~~~~~~~~l~~~Cl~~dP~~RPt~~~v~~~ 700 (747)
.. ......+ .+.... ..........+.+++.+||+.||++|||+.|+++.
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~~ell~h 311 (355)
T cd07874 245 LQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQH 311 (355)
T ss_pred hcHHHHHHHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCchhcCCHHHHhcC
Confidence 00 0000000 000000 00011112346688889999999999999999975
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.5e-31 Score=284.69 Aligned_cols=249 Identities=18% Similarity=0.221 Sum_probs=187.5
Q ss_pred cCCCccceecccCCeeEEEEEecC-CcEEEEEEecccc---cccHHHHHHHHHHHhccCCCceeeEEeEEEeCCeeEEEE
Q 004521 440 DNFSINNKLGEGGFGPVYKGTLVD-GQEIAVKRLSKIS---EQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIY 515 (747)
Q Consensus 440 ~~~~~~~~lg~G~fg~Vy~~~~~~-g~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 515 (747)
++|++.+.||+|+||.||++.... ++.||+|.+.... ....+.+.+|+.+++.++||||+++++.+..++..++||
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (305)
T cd05609 1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETKRHLCMVM 80 (305)
T ss_pred CCceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCCEEEEEE
Confidence 368889999999999999999765 7899999987532 234567889999999999999999999999999999999
Q ss_pred ecCCCCChhhHhhhcCCCCcCChhHHHHHHHHHHHHHHHhhhcCCCceEecccCcCcEEEcCCCCceEecccCccccCCC
Q 004521 516 EFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGD 595 (747)
Q Consensus 516 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NIll~~~~~~kl~DFGla~~~~~~ 595 (747)
||+++++|.+++... ..+++..+..++.|++.||.|||+.+ ++||||||+||+++.++.+||+|||+++.....
T Consensus 81 e~~~g~~L~~~l~~~---~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~NIll~~~~~~~l~dfg~~~~~~~~ 154 (305)
T cd05609 81 EYVEGGDCATLLKNI---GALPVDMARMYFAETVLALEYLHNYG---IVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMS 154 (305)
T ss_pred ecCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCchHHEEECCCCCEEEeeCCCccccCcC
Confidence 999999999999543 35889999999999999999999988 999999999999999999999999998742110
Q ss_pred CCc--------------------cccceeeec--cCCCCCccccchhHHHHHHHHHhCCCCCCCCCCcchhhhhHhHHhc
Q 004521 596 ETE--------------------GNTNRVVGT--YDGQFSIKSDVFSFGILLLEIVSGKKNRGFYRSDTKVNLIGHLWDE 653 (747)
Q Consensus 596 ~~~--------------------~~~~~~~~~--~~~~~s~ksDVwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~ 653 (747)
... ......... ....++.++||||||+++|||++|+.|+... ............
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~vl~el~~g~~pf~~~---~~~~~~~~~~~~ 231 (305)
T cd05609 155 LTTNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGD---TPEELFGQVISD 231 (305)
T ss_pred ccccccccccccchhhccccCCccCccccCchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCC---CHHHHHHHHHhc
Confidence 000 000000000 1456789999999999999999999996422 122222222111
Q ss_pred CCcccccchhhhccCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhcCCC
Q 004521 654 GIPLRLIDACIQDSCNLADVIRCIHIGLLCVQQHPEDRPCMPSVILMLGSEI 705 (747)
Q Consensus 654 ~~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dP~~RPt~~~v~~~L~~~~ 705 (747)
. ... +..... ....+..++.+||+.+|++||++.++.++|+...
T Consensus 232 ~-~~~---~~~~~~----~~~~~~~li~~~l~~~P~~R~~~~~~~~ll~~~~ 275 (305)
T cd05609 232 D-IEW---PEGDEA----LPADAQDLISRLLRQNPLERLGTGGAFEVKQHRF 275 (305)
T ss_pred c-cCC---CCcccc----CCHHHHHHHHHHhccChhhccCccCHHHHHhCcc
Confidence 1 110 000000 1123567888999999999999888888887743
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=99.98 E-value=1e-31 Score=282.84 Aligned_cols=251 Identities=22% Similarity=0.306 Sum_probs=182.1
Q ss_pred CCCccceecccCCeeEEEEEec-CCcEEEEEEeccc--ccccHHHHHHHHHHHhccCCCceeeEEeEEEeCCeeEEEEec
Q 004521 441 NFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKI--SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEF 517 (747)
Q Consensus 441 ~~~~~~~lg~G~fg~Vy~~~~~-~g~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~ 517 (747)
+|++.+.||+|+||.||+|+.. +++.||||++... .....+.+.+|++++++++||||+++++++.+.+..++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (284)
T cd07860 1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEF 80 (284)
T ss_pred CceeeeeecCCCceEEEEEEECCCCCEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhcccCCcEEEEeec
Confidence 4788899999999999999875 4889999998642 223346788999999999999999999999999999999999
Q ss_pred CCCCChhhHhhhcCCCCcCChhHHHHHHHHHHHHHHHhhhcCCCceEecccCcCcEEEcCCCCceEecccCccccCCCCC
Q 004521 518 MPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDET 597 (747)
Q Consensus 518 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~ 597 (747)
+. ++|.+++.... ...+++..+..++.|+++||+|||+.+ ++|+||+|+||+++.++.+||+|||+++.+.....
T Consensus 81 ~~-~~l~~~~~~~~-~~~l~~~~~~~~~~~i~~~l~~lh~~~---i~H~~l~p~nill~~~~~~~l~dfg~~~~~~~~~~ 155 (284)
T cd07860 81 LH-QDLKKFMDASP-LSGIPLPLIKSYLFQLLQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR 155 (284)
T ss_pred cc-cCHHHHHHhCC-CCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEEeeccchhhcccCcc
Confidence 96 68988885532 345899999999999999999999988 99999999999999999999999999876543221
Q ss_pred cccc-----ceeeec--c-CCCCCccccchhHHHHHHHHHhCCCCCCCCCCcchhhhhHhHHh-cCCcccc---------
Q 004521 598 EGNT-----NRVVGT--Y-DGQFSIKSDVFSFGILLLEIVSGKKNRGFYRSDTKVNLIGHLWD-EGIPLRL--------- 659 (747)
Q Consensus 598 ~~~~-----~~~~~~--~-~~~~s~ksDVwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~-~~~~~~~--------- 659 (747)
.... ...... . ...++.++|||||||++|||+||+.|+...... ........ .+.....
T Consensus 156 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (284)
T cd07860 156 TYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEI---DQLFRIFRTLGTPDEVVWPGVTSLP 232 (284)
T ss_pred ccccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHH---HHHHHHHHHhCCCChhhhhhhhHHH
Confidence 1100 000000 1 234678999999999999999999997532211 11111100 0000000
Q ss_pred ---------cchhhhccCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 004521 660 ---------IDACIQDSCNLADVIRCIHIGLLCVQQHPEDRPCMPSVILM 700 (747)
Q Consensus 660 ---------~d~~l~~~~~~~~~~~~~~l~~~Cl~~dP~~RPt~~~v~~~ 700 (747)
....+... ...-...+.+++.+||+.||.+||++.++++.
T Consensus 233 ~~~~~~~~~~~~~~~~~-~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~ 281 (284)
T cd07860 233 DYKPSFPKWARQDFSKV-VPPLDEDGRDLLSQMLHYDPNKRISAKAALAH 281 (284)
T ss_pred HHHhhcccccccCHHHH-cccCCHHHHHHHHHhcCCCcccCCCHHHHhcC
Confidence 00000000 00001234578889999999999999999753
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=99.98 E-value=5.7e-32 Score=294.92 Aligned_cols=192 Identities=26% Similarity=0.368 Sum_probs=160.1
Q ss_pred cCCCccceecccCCeeEEEEEecC-CcEEEEEEeccc---ccccHHHHHHHHHHHhccCCCceeeEEeEEEeCCeeEEEE
Q 004521 440 DNFSINNKLGEGGFGPVYKGTLVD-GQEIAVKRLSKI---SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIY 515 (747)
Q Consensus 440 ~~~~~~~~lg~G~fg~Vy~~~~~~-g~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 515 (747)
++|++.+.||+|+||.||+++... ++.||||+++.. .......+.+|+.++..++|+||+++++.+.+.+..++||
T Consensus 1 ~~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~ 80 (360)
T cd05627 1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLIM 80 (360)
T ss_pred CCceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence 468889999999999999999764 889999999752 2334567889999999999999999999999999999999
Q ss_pred ecCCCCChhhHhhhcCCCCcCChhHHHHHHHHHHHHHHHhhhcCCCceEecccCcCcEEEcCCCCceEecccCccccCCC
Q 004521 516 EFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGD 595 (747)
Q Consensus 516 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NIll~~~~~~kl~DFGla~~~~~~ 595 (747)
||+++|+|.+++.. ...+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++.+...
T Consensus 81 E~~~gg~L~~~l~~---~~~l~~~~~~~~~~qi~~~L~~lH~~g---ivHrDLkp~NIli~~~~~vkL~DfG~~~~~~~~ 154 (360)
T cd05627 81 EFLPGGDMMTLLMK---KDTLSEEATQFYIAETVLAIDAIHQLG---FIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKA 154 (360)
T ss_pred eCCCCccHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEccCCCHHHEEECCCCCEEEeeccCCcccccc
Confidence 99999999999854 235889999999999999999999988 999999999999999999999999998754321
Q ss_pred CCcc---------------------------------ccceeeec---------cCCCCCccccchhHHHHHHHHHhCCC
Q 004521 596 ETEG---------------------------------NTNRVVGT---------YDGQFSIKSDVFSFGILLLEIVSGKK 633 (747)
Q Consensus 596 ~~~~---------------------------------~~~~~~~~---------~~~~~s~ksDVwS~Gvvl~elltg~~ 633 (747)
.... ......|+ .+..++.++|||||||+||||++|+.
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvilyel~tG~~ 234 (360)
T cd05627 155 HRTEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYP 234 (360)
T ss_pred cccccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCCCcceeccccceeeecccCCC
Confidence 1000 00011122 14568899999999999999999999
Q ss_pred CCCC
Q 004521 634 NRGF 637 (747)
Q Consensus 634 p~~~ 637 (747)
||..
T Consensus 235 Pf~~ 238 (360)
T cd05627 235 PFCS 238 (360)
T ss_pred CCCC
Confidence 9753
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.3e-32 Score=292.16 Aligned_cols=247 Identities=28% Similarity=0.430 Sum_probs=192.3
Q ss_pred eecccCCeeEEEEEecC-CcEEEEEEecccccccHHHHHHHHHHHhccCCCceeeEEeEEEeCCeeEEEEecCCCCChhh
Q 004521 447 KLGEGGFGPVYKGTLVD-GQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMPNKSLDS 525 (747)
Q Consensus 447 ~lg~G~fg~Vy~~~~~~-g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gsL~~ 525 (747)
.||+|.||+||.|++.+ ...+|||.+.....+..+-+..|+.+-++|+|.|||+++|.+.+++..-+.||-++||+|.+
T Consensus 582 VLGKGTYG~VYA~RD~~tqvrIaIKEIpekdsr~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEqVPGGSLSs 661 (1226)
T KOG4279|consen 582 VLGKGTYGTVYAARDMDTQVRIAIKEIPEKDSREVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQVPGGSLSS 661 (1226)
T ss_pred EeecCceeEEEeeccccceeEEEeeecccccchhhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeecCCCCcHHH
Confidence 79999999999999876 45799999987777778889999999999999999999999999999999999999999999
Q ss_pred HhhhcCCCCcC--ChhHHHHHHHHHHHHHHHhhhcCCCceEecccCcCcEEEcC-CCCceEecccCccccCCCCCccccc
Q 004521 526 FIFDQTRRTLL--DWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQ-DMNPKISDFGLVRTFGGDETEGNTN 602 (747)
Q Consensus 526 ~l~~~~~~~~l--~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NIll~~-~~~~kl~DFGla~~~~~~~~~~~~~ 602 (747)
+|.. +-+++ ++...-.+.+||++||.|||++. |||||||-+||||+. .|.+||+|||-++.+.+-.. -++
T Consensus 662 LLrs--kWGPlKDNEstm~fYtkQILeGLkYLHen~---IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAginP--~TE 734 (1226)
T KOG4279|consen 662 LLRS--KWGPLKDNESTMNFYTKQILEGLKYLHENK---IVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAGINP--CTE 734 (1226)
T ss_pred HHHh--ccCCCccchhHHHHHHHHHHHHhhhhhhcc---eeeccccCCcEEEeeccceEEecccccchhhccCCc--ccc
Confidence 9965 34455 67777788999999999999988 999999999999975 68899999999988754332 122
Q ss_pred eeeecc-----------CCCCCccccchhHHHHHHHHHhCCCCCCCCCCcchhhhhHhHHhcCCcccccchhhhccCCHH
Q 004521 603 RVVGTY-----------DGQFSIKSDVFSFGILLLEIVSGKKNRGFYRSDTKVNLIGHLWDEGIPLRLIDACIQDSCNLA 671 (747)
Q Consensus 603 ~~~~~~-----------~~~~s~ksDVwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~ 671 (747)
.+.|+. ...|..++|||||||++.||.||++||....+..... ++-|... ..+ +.+.+
T Consensus 735 TFTGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~ElgspqAAM-----FkVGmyK--vHP----~iPee 803 (1226)
T KOG4279|consen 735 TFTGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQAAM-----FKVGMYK--VHP----PIPEE 803 (1226)
T ss_pred ccccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCChhHhh-----hhhccee--cCC----CCcHH
Confidence 233332 3568999999999999999999999976443322211 2222221 111 12223
Q ss_pred HHHHHHHHHHhccCCCCCCCCCHHHHHH--HhcCCCCCCCCC
Q 004521 672 DVIRCIHIGLLCVQQHPEDRPCMPSVIL--MLGSEILLPQPK 711 (747)
Q Consensus 672 ~~~~~~~l~~~Cl~~dP~~RPt~~~v~~--~L~~~~~~~~p~ 711 (747)
--.++..++++|+.+||.+||++.++++ +|+-....+.|+
T Consensus 804 lsaeak~FilrcFepd~~~R~sA~~LL~DpFlq~~~kk~r~~ 845 (1226)
T KOG4279|consen 804 LSAEAKNFILRCFEPDPCDRPSAKDLLQDPFLQHNNKKPRPK 845 (1226)
T ss_pred HHHHHHHHHHHHcCCCcccCccHHHhccCcccccCCCCCCCC
Confidence 3445678999999999999999999985 444333334444
|
|
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.1e-31 Score=275.70 Aligned_cols=243 Identities=35% Similarity=0.565 Sum_probs=186.2
Q ss_pred CCccceecccCCeeEEEEEecC-----CcEEEEEEecccccc-cHHHHHHHHHHHhccCCCceeeEEeEEEeCCeeEEEE
Q 004521 442 FSINNKLGEGGFGPVYKGTLVD-----GQEIAVKRLSKISEQ-GLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIY 515 (747)
Q Consensus 442 ~~~~~~lg~G~fg~Vy~~~~~~-----g~~vavK~l~~~~~~-~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 515 (747)
|++.+.||+|+||.||+++..+ +..||+|.+...... ..+.+..|+.++..++|+||+++++++.+.+..++||
T Consensus 1 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~i~ 80 (258)
T smart00219 1 LTLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDADEQQIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLMIVM 80 (258)
T ss_pred CcccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCChHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCeeEEEE
Confidence 3567899999999999999764 378999999764333 5678999999999999999999999999999999999
Q ss_pred ecCCCCChhhHhhhcCCCCcCChhHHHHHHHHHHHHHHHhhhcCCCceEecccCcCcEEEcCCCCceEecccCccccCCC
Q 004521 516 EFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGD 595 (747)
Q Consensus 516 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NIll~~~~~~kl~DFGla~~~~~~ 595 (747)
||+++++|.+++..... ..+++..+..++.|++.||+|||+.+ ++|+||||+||++++++.+||+|||+++.....
T Consensus 81 e~~~~~~l~~~~~~~~~-~~~~~~~~~~~~~ql~~~l~~lh~~~---~~h~dl~~~nil~~~~~~~~l~dfg~~~~~~~~ 156 (258)
T smart00219 81 EYMEGGDLLDYLRKNRP-KELSLSDLLSFALQIARGMEYLESKN---FIHRDLAARNCLVGENLVVKISDFGLSRDLYDD 156 (258)
T ss_pred eccCCCCHHHHHHhhhh-ccCCHHHHHHHHHHHHHHHHHHhcCC---eeecccccceEEEccCCeEEEcccCCceecccc
Confidence 99999999999865332 12899999999999999999999988 999999999999999999999999999866543
Q ss_pred CCcccc------ceeeec--cCCCCCccccchhHHHHHHHHHh-CCCCCCCCCCcchhhhhHhHHhcCCcccccchhhhc
Q 004521 596 ETEGNT------NRVVGT--YDGQFSIKSDVFSFGILLLEIVS-GKKNRGFYRSDTKVNLIGHLWDEGIPLRLIDACIQD 666 (747)
Q Consensus 596 ~~~~~~------~~~~~~--~~~~~s~ksDVwS~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 666 (747)
...... ....+. ....++.++||||+|++++||++ |..|+... ......... ..+.......
T Consensus 157 ~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~g~~p~~~~---~~~~~~~~~-~~~~~~~~~~----- 227 (258)
T smart00219 157 DYYKKKGGKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGESPYPGM---SNEEVLEYL-KKGYRLPKPE----- 227 (258)
T ss_pred cccccccCCCcccccChHHhccCCCCcchhHHHHHHHHHHHHhCCCCCCCCC---CHHHHHHHH-hcCCCCCCCC-----
Confidence 221110 000000 14568899999999999999999 67775432 111222221 1111111111
Q ss_pred cCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHh
Q 004521 667 SCNLADVIRCIHIGLLCVQQHPEDRPCMPSVILML 701 (747)
Q Consensus 667 ~~~~~~~~~~~~l~~~Cl~~dP~~RPt~~~v~~~L 701 (747)
. ....+.+++.+|++.+|++|||+.+++++|
T Consensus 228 ~----~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~l 258 (258)
T smart00219 228 N----CPPEIYKLMLQCWAEDPEDRPTFSELVEIL 258 (258)
T ss_pred c----CCHHHHHHHHHHCcCChhhCcCHHHHHhhC
Confidence 1 123466788899999999999999999875
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.1e-31 Score=280.54 Aligned_cols=247 Identities=26% Similarity=0.390 Sum_probs=186.4
Q ss_pred HhcCCCccceecccCCeeEEEEEec-CCcEEEEEEecccccccHHHHHHHHHHHhcc-CCCceeeEEeEEEeCC------
Q 004521 438 ATDNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKISEQGLKELKNEVILFSKL-QHRNLVKLLGCCIQGE------ 509 (747)
Q Consensus 438 ~~~~~~~~~~lg~G~fg~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~------ 509 (747)
.+++|++.+.||+|+||.||+|... +++.+++|.+.... ...+.+.+|+.+++++ +|+||+++++++....
T Consensus 4 ~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~ 82 (275)
T cd06608 4 PTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIE-DEEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGNDD 82 (275)
T ss_pred chhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCc-hhHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCcce
Confidence 4678999999999999999999985 47899999987533 3456799999999999 7999999999997655
Q ss_pred eeEEEEecCCCCChhhHhhhcC-CCCcCChhHHHHHHHHHHHHHHHhhhcCCCceEecccCcCcEEEcCCCCceEecccC
Q 004521 510 EKLLIYEFMPNKSLDSFIFDQT-RRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGL 588 (747)
Q Consensus 510 ~~~lV~E~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NIll~~~~~~kl~DFGl 588 (747)
..++||||+++++|.+++.... ....+++..+..++.|+++||.|||+.+ ++|+||+|+||++++++.+||+|||+
T Consensus 83 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~---i~H~~l~p~ni~~~~~~~~~l~d~~~ 159 (275)
T cd06608 83 QLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHENK---VIHRDIKGQNILLTKNAEVKLVDFGV 159 (275)
T ss_pred EEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCC---cccCCCCHHHEEEccCCeEEECCCcc
Confidence 4799999999999999986532 2456899999999999999999999988 99999999999999999999999999
Q ss_pred ccccCCCCCccc----------cceeee--ccCCCCCccccchhHHHHHHHHHhCCCCCCCCCCcchhhhhHhHHhcCCc
Q 004521 589 VRTFGGDETEGN----------TNRVVG--TYDGQFSIKSDVFSFGILLLEIVSGKKNRGFYRSDTKVNLIGHLWDEGIP 656 (747)
Q Consensus 589 a~~~~~~~~~~~----------~~~~~~--~~~~~~s~ksDVwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~ 656 (747)
+........... ++...+ .....++.++|||||||++|||++|+.|+..... ...+.... ....
T Consensus 160 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~---~~~~~~~~-~~~~ 235 (275)
T cd06608 160 SAQLDSTLGRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHP---MRALFKIP-RNPP 235 (275)
T ss_pred ceecccchhhhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccch---HHHHHHhh-ccCC
Confidence 876532211110 000000 0134578899999999999999999999753221 11111111 1111
Q ss_pred ccccchhhhccCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 004521 657 LRLIDACIQDSCNLADVIRCIHIGLLCVQQHPEDRPCMPSVIL 699 (747)
Q Consensus 657 ~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dP~~RPt~~~v~~ 699 (747)
..+.. .......+.+++.+||..||++|||+.+|++
T Consensus 236 ~~~~~-------~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~ 271 (275)
T cd06608 236 PTLKS-------PENWSKKFNDFISECLIKNYEQRPFMEELLE 271 (275)
T ss_pred CCCCc-------hhhcCHHHHHHHHHHhhcChhhCcCHHHHhc
Confidence 11111 1111234667888999999999999999986
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.2e-31 Score=282.13 Aligned_cols=251 Identities=25% Similarity=0.387 Sum_probs=185.4
Q ss_pred HHHHHHHhcCCCccceecccCCeeEEEEEecC-CcEEEEEEecccccccHHHHHHHHHHHhcc-CCCceeeEEeEEEe--
Q 004521 432 LATIANATDNFSINNKLGEGGFGPVYKGTLVD-GQEIAVKRLSKISEQGLKELKNEVILFSKL-QHRNLVKLLGCCIQ-- 507 (747)
Q Consensus 432 ~~~~~~~~~~~~~~~~lg~G~fg~Vy~~~~~~-g~~vavK~l~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~-- 507 (747)
+.++..+.+.|++.+.||+|+||.||+|+... ++.+|+|.+... .....++..|+.++.++ +|+||+++++++..
T Consensus 8 ~~~~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~-~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~ 86 (282)
T cd06636 8 LSALRDPAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVT-EDEEEEIKLEINMLKKYSHHRNIATYYGAFIKKS 86 (282)
T ss_pred hhhhcChhhhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecC-hHHHHHHHHHHHHHHHhcCCCcEEEEeeehhccc
Confidence 34444566789999999999999999999754 889999998653 33446788999999998 69999999999863
Q ss_pred ----CCeeEEEEecCCCCChhhHhhhcCCCCcCChhHHHHHHHHHHHHHHHhhhcCCCceEecccCcCcEEEcCCCCceE
Q 004521 508 ----GEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKI 583 (747)
Q Consensus 508 ----~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NIll~~~~~~kl 583 (747)
....++||||+++|+|.+++.... ...+++..+..++.||++||.|||+.+ |+|+||||+||++++++.+||
T Consensus 87 ~~~~~~~~~iv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~qi~~al~~LH~~~---ivH~dl~~~nili~~~~~~~l 162 (282)
T cd06636 87 PPGHDDQLWLVMEFCGAGSVTDLVKNTK-GNALKEDWIAYICREILRGLAHLHAHK---VIHRDIKGQNVLLTENAEVKL 162 (282)
T ss_pred ccCCCCEEEEEEEeCCCCcHHHHHHHcc-CCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEE
Confidence 456799999999999999986533 345788889999999999999999988 999999999999999999999
Q ss_pred ecccCccccCCCCCccc-----cceeeec-------cCCCCCccccchhHHHHHHHHHhCCCCCCCCCCcchhhhhHhHH
Q 004521 584 SDFGLVRTFGGDETEGN-----TNRVVGT-------YDGQFSIKSDVFSFGILLLEIVSGKKNRGFYRSDTKVNLIGHLW 651 (747)
Q Consensus 584 ~DFGla~~~~~~~~~~~-----~~~~~~~-------~~~~~s~ksDVwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~ 651 (747)
+|||+++.......... ....... ....++.++|||||||++|||++|+.|+...... ..+...
T Consensus 163 ~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~---~~~~~~- 238 (282)
T cd06636 163 VDFGVSAQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPM---RALFLI- 238 (282)
T ss_pred eeCcchhhhhccccCCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCHH---hhhhhH-
Confidence 99999876532211100 0000000 1346788999999999999999999997432211 111111
Q ss_pred hcCCcccccchhhhccCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 004521 652 DEGIPLRLIDACIQDSCNLADVIRCIHIGLLCVQQHPEDRPCMPSVIL 699 (747)
Q Consensus 652 ~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dP~~RPt~~~v~~ 699 (747)
.......+.. ... ...+.+++.+||+.||.+||++.+|++
T Consensus 239 ~~~~~~~~~~----~~~----~~~~~~li~~cl~~~p~~Rp~~~ell~ 278 (282)
T cd06636 239 PRNPPPKLKS----KKW----SKKFIDFIEGCLVKNYLSRPSTEQLLK 278 (282)
T ss_pred hhCCCCCCcc----ccc----CHHHHHHHHHHhCCChhhCcCHHHHhc
Confidence 1111111110 011 124667888999999999999999875
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.3e-31 Score=276.72 Aligned_cols=243 Identities=24% Similarity=0.396 Sum_probs=185.3
Q ss_pred CCCccceecccCCeeEEEEEec-CCcEEEEEEeccccc--ccHHHHHHHHHHHhccCCCceeeEEeEEEeCCeeEEEEec
Q 004521 441 NFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKISE--QGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEF 517 (747)
Q Consensus 441 ~~~~~~~lg~G~fg~Vy~~~~~-~g~~vavK~l~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~ 517 (747)
+|.+.+.||+|+||.||+|... +++.+|+|.++.... ...+.+.+|+.++++++|+||+++++++...+..++|+||
T Consensus 1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (264)
T cd06626 1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIFMEY 80 (264)
T ss_pred CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeEecCCEEEEEEec
Confidence 4778899999999999999875 588999999876433 3677899999999999999999999999999999999999
Q ss_pred CCCCChhhHhhhcCCCCcCChhHHHHHHHHHHHHHHHhhhcCCCceEecccCcCcEEEcCCCCceEecccCccccCCCCC
Q 004521 518 MPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDET 597 (747)
Q Consensus 518 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~ 597 (747)
+++++|.+++... ..+++..+..++.+++.||.|||+.+ ++|+||+|+||++++++.+||+|||++........
T Consensus 81 ~~~~~L~~~~~~~---~~~~~~~~~~i~~~i~~~l~~lh~~~---i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~~~~ 154 (264)
T cd06626 81 CSGGTLEELLEHG---RILDEHVIRVYTLQLLEGLAYLHSHG---IVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTT 154 (264)
T ss_pred CCCCcHHHHHhhc---CCCChHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEcccccccccCCCCC
Confidence 9999999998542 34788999999999999999999988 99999999999999999999999999887644322
Q ss_pred cccc---------ceeeec-----cCCCCCccccchhHHHHHHHHHhCCCCCCCCCCcchhhhhHhHHhcCCcccccchh
Q 004521 598 EGNT---------NRVVGT-----YDGQFSIKSDVFSFGILLLEIVSGKKNRGFYRSDTKVNLIGHLWDEGIPLRLIDAC 663 (747)
Q Consensus 598 ~~~~---------~~~~~~-----~~~~~s~ksDVwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 663 (747)
.... ...... ....++.++||||||+++|||++|+.||..... ..... .....+....+.+.
T Consensus 155 ~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~--~~~~~-~~~~~~~~~~~~~~- 230 (264)
T cd06626 155 TMGEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDN--EFQIM-FHVGAGHKPPIPDS- 230 (264)
T ss_pred cccccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcc--hHHHH-HHHhcCCCCCCCcc-
Confidence 1111 000000 012378899999999999999999999753321 11111 11111111111110
Q ss_pred hhccCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 004521 664 IQDSCNLADVIRCIHIGLLCVQQHPEDRPCMPSVIL 699 (747)
Q Consensus 664 l~~~~~~~~~~~~~~l~~~Cl~~dP~~RPt~~~v~~ 699 (747)
. .....+.+++.+||+.+|.+||++.+++.
T Consensus 231 ----~--~~~~~~~~li~~~l~~~p~~R~~~~~i~~ 260 (264)
T cd06626 231 ----L--QLSPEGKDFLDRCLESDPKKRPTASELLQ 260 (264)
T ss_pred ----c--ccCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 0 01223456778999999999999999874
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.2e-31 Score=281.46 Aligned_cols=254 Identities=24% Similarity=0.328 Sum_probs=181.4
Q ss_pred HhcCCCccceecccCCeeEEEEEec-CCcEEEEEEecccc-cccHHHHHHHHHHHhccCCCceeeEEeEEEeCCeeEEEE
Q 004521 438 ATDNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKIS-EQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIY 515 (747)
Q Consensus 438 ~~~~~~~~~~lg~G~fg~Vy~~~~~-~g~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 515 (747)
++++|.+.+.||+|+||.||+|... +++.||+|.+.... ......+.+|+.+++.++|+||+++++++..+...++||
T Consensus 3 ~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~ 82 (291)
T cd07870 3 AATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDIIHTKETLTFVF 82 (291)
T ss_pred ccceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcCCCcHHHHHHHHHHHhcCCCCEeEEEEEEecCCeEEEEE
Confidence 3468999999999999999999875 48899999986532 233456788999999999999999999999999999999
Q ss_pred ecCCCCChhhHhhhcCCCCcCChhHHHHHHHHHHHHHHHhhhcCCCceEecccCcCcEEEcCCCCceEecccCccccCCC
Q 004521 516 EFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGD 595 (747)
Q Consensus 516 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NIll~~~~~~kl~DFGla~~~~~~ 595 (747)
||+. ++|.+++... ...+++..+..++.|++.||.|||+.+ |+|+||||+||+++.++.+||+|||+++.....
T Consensus 83 e~~~-~~l~~~~~~~--~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~ 156 (291)
T cd07870 83 EYMH-TDLAQYMIQH--PGGLHPYNVRLFMFQLLRGLAYIHGQH---ILHRDLKPQNLLISYLGELKLADFGLARAKSIP 156 (291)
T ss_pred eccc-CCHHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChHHEEEcCCCcEEEeccccccccCCC
Confidence 9996 7777776442 234778888899999999999999988 999999999999999999999999998754322
Q ss_pred CCccc-----cceeeec-c--CCCCCccccchhHHHHHHHHHhCCCCCCCCCCcchhhhhHhHHhc-CCc----------
Q 004521 596 ETEGN-----TNRVVGT-Y--DGQFSIKSDVFSFGILLLEIVSGKKNRGFYRSDTKVNLIGHLWDE-GIP---------- 656 (747)
Q Consensus 596 ~~~~~-----~~~~~~~-~--~~~~s~ksDVwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~-~~~---------- 656 (747)
..... ....... . ...++.++|||||||++|||++|+.|+..... ....+...+.. +.+
T Consensus 157 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (291)
T cd07870 157 SQTYSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSD--VFEQLEKIWTVLGVPTEDTWPGVSK 234 (291)
T ss_pred CCCCCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchh--HHHHHHHHHHHcCCCChhhhhhhhh
Confidence 11100 0000011 1 23467899999999999999999999753322 11111111110 000
Q ss_pred -----ccccch----hhhc-cCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 004521 657 -----LRLIDA----CIQD-SCNLADVIRCIHIGLLCVQQHPEDRPCMPSVIL 699 (747)
Q Consensus 657 -----~~~~d~----~l~~-~~~~~~~~~~~~l~~~Cl~~dP~~RPt~~~v~~ 699 (747)
...... .+.. .........+.+++.+|++.||.+|||+.+++.
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l~ 287 (291)
T cd07870 235 LPNYKPEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALL 287 (291)
T ss_pred cccccchhccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCHHHHhc
Confidence 000000 0000 000001234556778999999999999999874
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.2e-31 Score=276.62 Aligned_cols=244 Identities=23% Similarity=0.362 Sum_probs=185.2
Q ss_pred CCCccceecccCCeeEEEEEec-CCcEEEEEEeccc--ccccHHHHHHHHHHHhccCCCceeeEEeEEEe--CCeeEEEE
Q 004521 441 NFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKI--SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQ--GEEKLLIY 515 (747)
Q Consensus 441 ~~~~~~~lg~G~fg~Vy~~~~~-~g~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~--~~~~~lV~ 515 (747)
+|++.+.||+|+||.||++... +++.+|+|.+... .....+.+..|++++++++|+||+++++++.. +...+++|
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 80 (265)
T cd08217 1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIVM 80 (265)
T ss_pred CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEEe
Confidence 4778899999999999999865 4789999998642 33445678899999999999999999998764 34578999
Q ss_pred ecCCCCChhhHhhhcC-CCCcCChhHHHHHHHHHHHHHHHhh-----hcCCCceEecccCcCcEEEcCCCCceEecccCc
Q 004521 516 EFMPNKSLDSFIFDQT-RRTLLDWSQRFHIICGTARGLLYLH-----QDSRLRIIHRDLKASNVLLDQDMNPKISDFGLV 589 (747)
Q Consensus 516 E~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~gl~yLH-----~~~~~~iiHrDlkp~NIll~~~~~~kl~DFGla 589 (747)
||+++++|.+++.... ....+++..++.++.||++||.||| +.+ ++|+||||+||++++++.+||+|||++
T Consensus 81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~---i~h~dl~p~nili~~~~~~kl~d~g~~ 157 (265)
T cd08217 81 EYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNT---VLHRDLKPANIFLDANNNVKLGDFGLA 157 (265)
T ss_pred hhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCc---ceecCCCHHHEEEecCCCEEEeccccc
Confidence 9999999999986532 2456899999999999999999999 555 999999999999999999999999999
Q ss_pred cccCCCCCcccc----ceeee---ccCCCCCccccchhHHHHHHHHHhCCCCCCCCCCcchhhhhHhHHhcCCcccccch
Q 004521 590 RTFGGDETEGNT----NRVVG---TYDGQFSIKSDVFSFGILLLEIVSGKKNRGFYRSDTKVNLIGHLWDEGIPLRLIDA 662 (747)
Q Consensus 590 ~~~~~~~~~~~~----~~~~~---~~~~~~s~ksDVwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 662 (747)
..+......... ..... .....++.++||||||+++|+|++|+.|+.... ..... .....+....+.
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~---~~~~~-~~~~~~~~~~~~-- 231 (265)
T cd08217 158 KILGHDSSFAKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARN---QLQLA-SKIKEGKFRRIP-- 231 (265)
T ss_pred ccccCCcccccccccCCCccChhhhcCCCCCchhHHHHHHHHHHHHHHCCCcccCcC---HHHHH-HHHhcCCCCCCc--
Confidence 876543321100 00000 013457889999999999999999999975432 11111 112222221111
Q ss_pred hhhccCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 004521 663 CIQDSCNLADVIRCIHIGLLCVQQHPEDRPCMPSVILM 700 (747)
Q Consensus 663 ~l~~~~~~~~~~~~~~l~~~Cl~~dP~~RPt~~~v~~~ 700 (747)
. .....+.+++.+|++.+|.+||++.+|+++
T Consensus 232 ---~----~~~~~~~~l~~~~l~~~p~~Rp~~~~il~~ 262 (265)
T cd08217 232 ---Y----RYSSELNEVIKSMLNVDPDKRPSTEELLQL 262 (265)
T ss_pred ---c----ccCHHHHHHHHHHccCCcccCCCHHHHhhC
Confidence 1 112346678889999999999999999874
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.9e-31 Score=278.05 Aligned_cols=244 Identities=25% Similarity=0.416 Sum_probs=184.2
Q ss_pred CCCccceecccCCeeEEEEEe-cCCcEEEEEEecccc------cccHHHHHHHHHHHhccCCCceeeEEeEEEeCCeeEE
Q 004521 441 NFSINNKLGEGGFGPVYKGTL-VDGQEIAVKRLSKIS------EQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLL 513 (747)
Q Consensus 441 ~~~~~~~lg~G~fg~Vy~~~~-~~g~~vavK~l~~~~------~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~l 513 (747)
+|+..+.||+|+||.||+|.. .+++.+|+|.++... ....+.+.+|+.++++++|+||+++++++.+.+..++
T Consensus 1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 80 (268)
T cd06630 1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNL 80 (268)
T ss_pred CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCCeEEE
Confidence 477789999999999999986 458899999986422 1235678999999999999999999999999999999
Q ss_pred EEecCCCCChhhHhhhcCCCCcCChhHHHHHHHHHHHHHHHhhhcCCCceEecccCcCcEEEcCCC-CceEecccCcccc
Q 004521 514 IYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDM-NPKISDFGLVRTF 592 (747)
Q Consensus 514 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NIll~~~~-~~kl~DFGla~~~ 592 (747)
||||+++++|.+++... ..+++..+..++.|++.||.|||+.+ ++|+||||+||+++.++ .+||+|||++..+
T Consensus 81 v~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~ql~~al~~LH~~~---i~H~~i~~~nil~~~~~~~~~l~dfg~~~~~ 154 (268)
T cd06630 81 FVEWMAGGSVSHLLSKY---GAFKEAVIINYTEQLLRGLSYLHENQ---IIHRDVKGANLLIDSTGQRLRIADFGAAARL 154 (268)
T ss_pred EEeccCCCcHHHHHHHh---CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEEccccccccc
Confidence 99999999999998643 35788999999999999999999988 99999999999998776 5999999998776
Q ss_pred CCCCCccc--cceeeec---------cCCCCCccccchhHHHHHHHHHhCCCCCCCCCCcchhhhhHhHHhcCCcccccc
Q 004521 593 GGDETEGN--TNRVVGT---------YDGQFSIKSDVFSFGILLLEIVSGKKNRGFYRSDTKVNLIGHLWDEGIPLRLID 661 (747)
Q Consensus 593 ~~~~~~~~--~~~~~~~---------~~~~~s~ksDVwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~d 661 (747)
........ .....++ ....++.++||||+|+++|||++|+.|+...........+..........
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~---- 230 (268)
T cd06630 155 AAKGTGAGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLALIFKIASATTAP---- 230 (268)
T ss_pred ccccccCCccccccccccceeCHhHhccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcchHHHHHHHhccCCCC----
Confidence 43321100 0001111 13567889999999999999999999975332221111111111111111
Q ss_pred hhhhccCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 004521 662 ACIQDSCNLADVIRCIHIGLLCVQQHPEDRPCMPSVIL 699 (747)
Q Consensus 662 ~~l~~~~~~~~~~~~~~l~~~Cl~~dP~~RPt~~~v~~ 699 (747)
.........+.+++.+|++.+|.+||++.++++
T Consensus 231 -----~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~ll~ 263 (268)
T cd06630 231 -----SIPEHLSPGLRDVTLRCLELQPEDRPPSRELLK 263 (268)
T ss_pred -----CCchhhCHHHHHHHHHHcCCCcccCcCHHHHhc
Confidence 111112234667888999999999999999975
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=99.98 E-value=6.2e-32 Score=284.44 Aligned_cols=251 Identities=20% Similarity=0.266 Sum_probs=180.5
Q ss_pred CCCccceecccCCeeEEEEEec-CCcEEEEEEeccc--ccccHHHHHHHHHHHhccCCCceeeEEeEEEeCCeeEEEEec
Q 004521 441 NFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKI--SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEF 517 (747)
Q Consensus 441 ~~~~~~~lg~G~fg~Vy~~~~~-~g~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~ 517 (747)
+|++.+.||+|+||.||+|+.. +|+.+|+|+++.. .......+.+|+.++++++|+||+++++++.+....++|+||
T Consensus 1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 80 (284)
T cd07839 1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVLHSDKKLTLVFEY 80 (284)
T ss_pred CceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHHhccCCceEEEEec
Confidence 4778899999999999999975 4889999998642 223345678899999999999999999999999999999999
Q ss_pred CCCCChhhHhhhcCCCCcCChhHHHHHHHHHHHHHHHhhhcCCCceEecccCcCcEEEcCCCCceEecccCccccCCCCC
Q 004521 518 MPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDET 597 (747)
Q Consensus 518 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~ 597 (747)
++ ++|.+++... ...+++..+..++.||++||.|||+.+ |+||||||+||+++.++.+||+|||+++.+.....
T Consensus 81 ~~-~~l~~~~~~~--~~~~~~~~~~~~~~qi~~al~~LH~~~---i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~ 154 (284)
T cd07839 81 CD-QDLKKYFDSC--NGDIDPEIVKSFMFQLLKGLAFCHSHN---VLHRDLKPQNLLINKNGELKLADFGLARAFGIPVR 154 (284)
T ss_pred CC-CCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEEcCCCcEEECccchhhccCCCCC
Confidence 97 5788777542 345899999999999999999999988 99999999999999999999999999986543221
Q ss_pred cccc-----ceeeec-c--CCCCCccccchhHHHHHHHHHhCCCCCCCCCCcchhhhhHhHHhc-CC--------ccccc
Q 004521 598 EGNT-----NRVVGT-Y--DGQFSIKSDVFSFGILLLEIVSGKKNRGFYRSDTKVNLIGHLWDE-GI--------PLRLI 660 (747)
Q Consensus 598 ~~~~-----~~~~~~-~--~~~~s~ksDVwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~-~~--------~~~~~ 660 (747)
.... ....+. . ...++.++|||||||++|||++|+.|+..... ....+...... +. .....
T Consensus 155 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (284)
T cd07839 155 CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGND--VDDQLKRIFRLLGTPTEESWPGVSKLP 232 (284)
T ss_pred CcCCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCC--HHHHHHHHHHHhCCCChHHhHHhhhcc
Confidence 1100 000011 1 23468899999999999999999998532211 11111111000 00 00000
Q ss_pred ch----hhhccC-----CHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 004521 661 DA----CIQDSC-----NLADVIRCIHIGLLCVQQHPEDRPCMPSVIL 699 (747)
Q Consensus 661 d~----~l~~~~-----~~~~~~~~~~l~~~Cl~~dP~~RPt~~~v~~ 699 (747)
+. ...... ...-...+.+++.+||+.||.+|||+.++++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~ 280 (284)
T cd07839 233 DYKPYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQ 280 (284)
T ss_pred cccccCCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhc
Confidence 00 000000 0001234557888999999999999999976
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.9e-31 Score=279.63 Aligned_cols=240 Identities=23% Similarity=0.385 Sum_probs=183.9
Q ss_pred CCCccceecccCCeeEEEEEec-CCcEEEEEEeccc-ccccHHHHHHHHHHHhccC---CCceeeEEeEEEeCCeeEEEE
Q 004521 441 NFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKI-SEQGLKELKNEVILFSKLQ---HRNLVKLLGCCIQGEEKLLIY 515 (747)
Q Consensus 441 ~~~~~~~lg~G~fg~Vy~~~~~-~g~~vavK~l~~~-~~~~~~~~~~E~~~l~~l~---H~niv~l~g~~~~~~~~~lV~ 515 (747)
.|++.+.||+|+||.||+|... +++.+|+|.+... .....+++.+|+.++++++ |||++++++++..+...++||
T Consensus 2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~lv~ 81 (277)
T cd06917 2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWIIM 81 (277)
T ss_pred hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCCCchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEEEEE
Confidence 4777899999999999999974 5889999998653 3445677889999999996 999999999999999999999
Q ss_pred ecCCCCChhhHhhhcCCCCcCChhHHHHHHHHHHHHHHHhhhcCCCceEecccCcCcEEEcCCCCceEecccCccccCCC
Q 004521 516 EFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGD 595 (747)
Q Consensus 516 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NIll~~~~~~kl~DFGla~~~~~~ 595 (747)
||+++++|.+++.. ..+++..+..++.|+++||.|||+.+ |+|+||+|+||+++.++.++|+|||++..+...
T Consensus 82 e~~~~~~L~~~~~~----~~l~~~~~~~i~~~i~~~l~~lh~~~---i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~ 154 (277)
T cd06917 82 EYAEGGSVRTLMKA----GPIAEKYISVIIREVLVALKYIHKVG---VIHRDIKAANILVTNTGNVKLCDFGVAALLNQN 154 (277)
T ss_pred ecCCCCcHHHHHHc----cCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCcCHHHEEEcCCCCEEEccCCceeecCCC
Confidence 99999999998843 25889999999999999999999988 999999999999999999999999999876543
Q ss_pred CCccccc-----eeeec--c-CCCCCccccchhHHHHHHHHHhCCCCCCCCCCcchhhhhHhHHhcCCcccccchhhhcc
Q 004521 596 ETEGNTN-----RVVGT--Y-DGQFSIKSDVFSFGILLLEIVSGKKNRGFYRSDTKVNLIGHLWDEGIPLRLIDACIQDS 667 (747)
Q Consensus 596 ~~~~~~~-----~~~~~--~-~~~~s~ksDVwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~ 667 (747)
....... ..... . +..++.++|||||||++|||++|+.|+...... ..... ........+ ...
T Consensus 155 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~---~~~~~-~~~~~~~~~-----~~~ 225 (277)
T cd06917 155 SSKRSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAF---RAMML-IPKSKPPRL-----EDN 225 (277)
T ss_pred ccccccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCChh---hhhhc-cccCCCCCC-----Ccc
Confidence 3211100 00011 0 234688999999999999999999997532211 11111 111111111 111
Q ss_pred CCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 004521 668 CNLADVIRCIHIGLLCVQQHPEDRPCMPSVIL 699 (747)
Q Consensus 668 ~~~~~~~~~~~l~~~Cl~~dP~~RPt~~~v~~ 699 (747)
. ....+.+++.+||+.||++||++.++++
T Consensus 226 ~---~~~~~~~~i~~~l~~~p~~R~~~~~il~ 254 (277)
T cd06917 226 G---YSKLLREFVAACLDEEPKERLSAEELLK 254 (277)
T ss_pred c---CCHHHHHHHHHHcCCCcccCcCHHHHhh
Confidence 0 1234667888999999999999999976
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.4e-31 Score=283.48 Aligned_cols=255 Identities=20% Similarity=0.223 Sum_probs=181.2
Q ss_pred cCCCccceecccCCeeEEEEEec-CCcEEEEEEecccc--cccHHHHHHHHHHHhccC-CCceeeEEeEEEeCCe-----
Q 004521 440 DNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKIS--EQGLKELKNEVILFSKLQ-HRNLVKLLGCCIQGEE----- 510 (747)
Q Consensus 440 ~~~~~~~~lg~G~fg~Vy~~~~~-~g~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~-H~niv~l~g~~~~~~~----- 510 (747)
++|++.+.||+|+||.||+|... +++.||||.++... ......+.+|+.+++++. |+||+++++++...+.
T Consensus 1 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~ 80 (295)
T cd07837 1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPS 80 (295)
T ss_pred CCceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCce
Confidence 46888999999999999999975 48899999976532 223467888999999994 6999999999987666
Q ss_pred eEEEEecCCCCChhhHhhhcCC--CCcCChhHHHHHHHHHHHHHHHhhhcCCCceEecccCcCcEEEcC-CCCceEeccc
Q 004521 511 KLLIYEFMPNKSLDSFIFDQTR--RTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQ-DMNPKISDFG 587 (747)
Q Consensus 511 ~~lV~E~~~~gsL~~~l~~~~~--~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NIll~~-~~~~kl~DFG 587 (747)
.++||||+++ +|.+++..... ...+++..+..++.||++||.|||+.+ |+||||||+||+++. ++.+||+|||
T Consensus 81 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~---i~H~dl~~~nil~~~~~~~~kl~dfg 156 (295)
T cd07837 81 LYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKHG---VMHRDLKPQNLLVDKQKGLLKIADLG 156 (295)
T ss_pred EEEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCChHHEEEecCCCeEEEeecc
Confidence 7999999985 88888865332 346899999999999999999999988 999999999999998 8999999999
Q ss_pred CccccCCCCCcccc-----ceeeec---cCCCCCccccchhHHHHHHHHHhCCCCCCCCCCcchhhhhHhHHhcCCc---
Q 004521 588 LVRTFGGDETEGNT-----NRVVGT---YDGQFSIKSDVFSFGILLLEIVSGKKNRGFYRSDTKVNLIGHLWDEGIP--- 656 (747)
Q Consensus 588 la~~~~~~~~~~~~-----~~~~~~---~~~~~s~ksDVwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~--- 656 (747)
+++.+......... ...... ....++.++||||||+++|||++|..|+...........+.........
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (295)
T cd07837 157 LGRAFSIPVKSYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQLLHIFKLLGTPTEQVW 236 (295)
T ss_pred cceecCCCccccCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHhCCCChhhC
Confidence 98865332111000 000011 1245788999999999999999999987532211110000000000000
Q ss_pred ------------ccccchhhhccCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 004521 657 ------------LRLIDACIQDSCNLADVIRCIHIGLLCVQQHPEDRPCMPSVIL 699 (747)
Q Consensus 657 ------------~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dP~~RPt~~~v~~ 699 (747)
.......+.. ........+.+++.+||+.||.+||++.+++.
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~ 290 (295)
T cd07837 237 PGVSKLRDWHEFPQWKPQDLSR-AVPDLSPEGLDLLQKMLRYDPAKRISAKAALT 290 (295)
T ss_pred cchhhccchhhcCcccchhHHH-hccccCHHHHHHHHHHccCChhhcCCHHHHhc
Confidence 0000000000 00011234667888999999999999999875
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=1e-31 Score=283.25 Aligned_cols=255 Identities=19% Similarity=0.271 Sum_probs=185.3
Q ss_pred cCCCccceecccCCeeEEEEEecC-CcEEEEEEeccc--ccccHHHHHHHHHHHhccCCCceeeEEeEEEeCCeeEEEEe
Q 004521 440 DNFSINNKLGEGGFGPVYKGTLVD-GQEIAVKRLSKI--SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYE 516 (747)
Q Consensus 440 ~~~~~~~~lg~G~fg~Vy~~~~~~-g~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E 516 (747)
++|++.+.||+|+||.||+|...+ ++.||||.++.. .....+.+.+|++++++++|+||+++++++..++..++|||
T Consensus 1 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e 80 (288)
T cd07833 1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLVFE 80 (288)
T ss_pred CceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheEEECCEEEEEEe
Confidence 368889999999999999999864 789999998652 33445789999999999999999999999999999999999
Q ss_pred cCCCCChhhHhhhcCCCCcCChhHHHHHHHHHHHHHHHhhhcCCCceEecccCcCcEEEcCCCCceEecccCccccCCCC
Q 004521 517 FMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDE 596 (747)
Q Consensus 517 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~ 596 (747)
|++++.|..++.. ...+++..+..++.||+.||.|||+.+ ++|+||+|+||++++++.+||+|||++.......
T Consensus 81 ~~~~~~l~~~~~~---~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~~~ 154 (288)
T cd07833 81 YVERTLLELLEAS---PGGLPPDAVRSYIWQLLQAIAYCHSHN---IIHRDIKPENILVSESGVLKLCDFGFARALRARP 154 (288)
T ss_pred cCCCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCCEEEEeeecccccCCCc
Confidence 9998777765532 234889999999999999999999988 9999999999999999999999999988765433
Q ss_pred Cccccc------eeeec--cCC-CCCccccchhHHHHHHHHHhCCCCCCCCCCcchhhhhHhHHhc------------CC
Q 004521 597 TEGNTN------RVVGT--YDG-QFSIKSDVFSFGILLLEIVSGKKNRGFYRSDTKVNLIGHLWDE------------GI 655 (747)
Q Consensus 597 ~~~~~~------~~~~~--~~~-~~s~ksDVwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~------------~~ 655 (747)
...... ..... ... .++.++||||||+++|||++|+.|+...........+...+.. ..
T Consensus 155 ~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (288)
T cd07833 155 ASPLTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPPSHQELFSSNPR 234 (288)
T ss_pred cccccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHhhhcccCcc
Confidence 200000 00000 123 6788999999999999999999987533221111111000000 00
Q ss_pred -----cccccchh-hhccCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 004521 656 -----PLRLIDAC-IQDSCNLADVIRCIHIGLLCVQQHPEDRPCMPSVILM 700 (747)
Q Consensus 656 -----~~~~~d~~-l~~~~~~~~~~~~~~l~~~Cl~~dP~~RPt~~~v~~~ 700 (747)
.....+.. ............+.+++.+||+.+|++||++.+|+++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 285 (288)
T cd07833 235 FAGVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQH 285 (288)
T ss_pred ccccccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhcC
Confidence 00000000 0000011113456788899999999999999998753
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.5e-31 Score=286.47 Aligned_cols=187 Identities=23% Similarity=0.388 Sum_probs=146.6
Q ss_pred cceecccCCeeEEEEEec---CCcEEEEEEecccccccHHHHHHHHHHHhccCCCceeeEEeEEEe--CCeeEEEEecCC
Q 004521 445 NNKLGEGGFGPVYKGTLV---DGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQ--GEEKLLIYEFMP 519 (747)
Q Consensus 445 ~~~lg~G~fg~Vy~~~~~---~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~--~~~~~lV~E~~~ 519 (747)
.++||+|+||.||+|+.. .++.+|+|.+... .....+.+|+.++++++||||+++++++.. +...++||||+.
T Consensus 6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~ 83 (317)
T cd07868 6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGT--GISMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAE 83 (317)
T ss_pred ccccccCCCeEEEEEEEccCCCCceEEEEEECCC--CCcHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEeccC
Confidence 468999999999999865 3578999998652 234567889999999999999999999865 456789999986
Q ss_pred CCChhhHhhhcC------CCCcCChhHHHHHHHHHHHHHHHhhhcCCCceEecccCcCcEEE----cCCCCceEecccCc
Q 004521 520 NKSLDSFIFDQT------RRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLL----DQDMNPKISDFGLV 589 (747)
Q Consensus 520 ~gsL~~~l~~~~------~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NIll----~~~~~~kl~DFGla 589 (747)
++|.+++.... ....+++..+..++.||+.||.|||+.+ |+||||||+|||+ +..+.+||+|||++
T Consensus 84 -~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~---ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~a 159 (317)
T cd07868 84 -HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANW---VLHRDLKPANILVMGEGPERGRVKIADMGFA 159 (317)
T ss_pred -CCHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhCC---EEcCCCCHHHEEEecCCCCcCcEEEeecCce
Confidence 57877764321 1235888999999999999999999988 9999999999999 45678999999999
Q ss_pred cccCCCCCcc-ccceeeec--------c--CCCCCccccchhHHHHHHHHHhCCCCCCC
Q 004521 590 RTFGGDETEG-NTNRVVGT--------Y--DGQFSIKSDVFSFGILLLEIVSGKKNRGF 637 (747)
Q Consensus 590 ~~~~~~~~~~-~~~~~~~~--------~--~~~~s~ksDVwS~Gvvl~elltg~~p~~~ 637 (747)
+.+....... ......++ . ...++.++||||+||++|||++|+.||..
T Consensus 160 ~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~ 218 (317)
T cd07868 160 RLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHC 218 (317)
T ss_pred eccCCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccC
Confidence 8764322110 00001111 1 24578899999999999999999999753
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.8e-31 Score=282.45 Aligned_cols=254 Identities=22% Similarity=0.253 Sum_probs=183.1
Q ss_pred cCCCccceecccCCeeEEEEEecC-CcEEEEEEecccc--cccHHHHHHHHHHHhccCCCceeeEEeEEEeC--CeeEEE
Q 004521 440 DNFSINNKLGEGGFGPVYKGTLVD-GQEIAVKRLSKIS--EQGLKELKNEVILFSKLQHRNLVKLLGCCIQG--EEKLLI 514 (747)
Q Consensus 440 ~~~~~~~~lg~G~fg~Vy~~~~~~-g~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~--~~~~lV 514 (747)
++|++.+.||+|+||.||+|+... ++.+|+|.++... ......+.+|+.++++++||||+++++++... ...++|
T Consensus 5 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~lv 84 (293)
T cd07843 5 DEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKIYMV 84 (293)
T ss_pred hhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEEEE
Confidence 478889999999999999999864 8899999987432 22334677899999999999999999999887 889999
Q ss_pred EecCCCCChhhHhhhcCCCCcCChhHHHHHHHHHHHHHHHhhhcCCCceEecccCcCcEEEcCCCCceEecccCccccCC
Q 004521 515 YEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGG 594 (747)
Q Consensus 515 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NIll~~~~~~kl~DFGla~~~~~ 594 (747)
|||++ ++|.+++.... ..+++..+..++.||+.||+|||+.+ ++|+||||+||+++.++.+||+|||+++.+..
T Consensus 85 ~e~~~-~~L~~~~~~~~--~~l~~~~~~~i~~qi~~aL~~LH~~~---i~H~dl~p~nili~~~~~~~l~d~g~~~~~~~ 158 (293)
T cd07843 85 MEYVE-HDLKSLMETMK--QPFLQSEVKCLMLQLLSGVAHLHDNW---ILHRDLKTSNLLLNNRGILKICDFGLAREYGS 158 (293)
T ss_pred ehhcC-cCHHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCCHHHEEECCCCcEEEeecCceeeccC
Confidence 99997 58988885532 35899999999999999999999988 99999999999999999999999999887654
Q ss_pred CCCccccc-----eeeec-c--CCCCCccccchhHHHHHHHHHhCCCCCCCCCCcchhhhhHhHHhc-------------
Q 004521 595 DETEGNTN-----RVVGT-Y--DGQFSIKSDVFSFGILLLEIVSGKKNRGFYRSDTKVNLIGHLWDE------------- 653 (747)
Q Consensus 595 ~~~~~~~~-----~~~~~-~--~~~~s~ksDVwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~------------- 653 (747)
........ ..... . ...++.++||||||+++|||++|+.|+...........+...+..
T Consensus 159 ~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (293)
T cd07843 159 PLKPYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLGTPTEKIWPGFSELP 238 (293)
T ss_pred CccccccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchHHHHHhhccc
Confidence 32111000 00011 0 234678999999999999999999997643322111111000000
Q ss_pred ----CCcccccchhhhccCCHH-HHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 004521 654 ----GIPLRLIDACIQDSCNLA-DVIRCIHIGLLCVQQHPEDRPCMPSVIL 699 (747)
Q Consensus 654 ----~~~~~~~d~~l~~~~~~~-~~~~~~~l~~~Cl~~dP~~RPt~~~v~~ 699 (747)
..........+....... ....+.+++.+||+.+|++|||+.|+++
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~ell~ 289 (293)
T cd07843 239 GAKKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALK 289 (293)
T ss_pred hhcccccccccchhhhccccccCCChHHHHHHHHHhccCccccCCHHHHhc
Confidence 000000000111100000 1233567888999999999999999975
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=99.98 E-value=3.1e-31 Score=274.34 Aligned_cols=243 Identities=22% Similarity=0.342 Sum_probs=185.0
Q ss_pred CCCccceecccCCeeEEEEEec-CCcEEEEEEeccc--ccccHHHHHHHHHHHhccCCCceeeEEeEEEeCCeeEEEEec
Q 004521 441 NFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKI--SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEF 517 (747)
Q Consensus 441 ~~~~~~~lg~G~fg~Vy~~~~~-~g~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~ 517 (747)
+|++.+.||+|+||.||++... +++.+|||.+... .....+.+.+|+.++++++||||+++++.+..++..++||||
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08220 1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIVMEY 80 (256)
T ss_pred CceEEEEecccCceEEEEEEEcCCCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeEecCCEEEEEEec
Confidence 4788899999999999999875 4889999998652 334567899999999999999999999999999999999999
Q ss_pred CCCCChhhHhhhcCCCCcCChhHHHHHHHHHHHHHHHhhhcCCCceEecccCcCcEEEcCC-CCceEecccCccccCCCC
Q 004521 518 MPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQD-MNPKISDFGLVRTFGGDE 596 (747)
Q Consensus 518 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NIll~~~-~~~kl~DFGla~~~~~~~ 596 (747)
+++++|.+++.... ...+++..+..++.++++||.|||+++ ++|+||||+||+++.+ +.+||+|||+++......
T Consensus 81 ~~~~~L~~~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lh~~~---i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~ 156 (256)
T cd08220 81 APGGTLAEYIQKRC-NSLLDEDTILHFFVQILLALHHVHTKL---ILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKS 156 (256)
T ss_pred CCCCCHHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEEccCCCceecCCCc
Confidence 99999999996532 345889999999999999999999988 9999999999999865 457999999998764332
Q ss_pred Ccccc----ceeee--ccCCCCCccccchhHHHHHHHHHhCCCCCCCCCCcchhhhhHhHHhcCCcccccchhhhccCCH
Q 004521 597 TEGNT----NRVVG--TYDGQFSIKSDVFSFGILLLEIVSGKKNRGFYRSDTKVNLIGHLWDEGIPLRLIDACIQDSCNL 670 (747)
Q Consensus 597 ~~~~~----~~~~~--~~~~~~s~ksDVwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~ 670 (747)
..... ..... .....++.++||||||+++|||++|+.|+..... ........ ......+.+.
T Consensus 157 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~---~~~~~~~~-~~~~~~~~~~-------- 224 (256)
T cd08220 157 KAYTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAANL---PALVLKIM-SGTFAPISDR-------- 224 (256)
T ss_pred cccccccCCcccCchhccCCCCCcccchHHHHHHHHHHHhCCCCcccCch---HHHHHHHH-hcCCCCCCCC--------
Confidence 11100 00000 0134578899999999999999999999653321 11111111 1111111111
Q ss_pred HHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 004521 671 ADVIRCIHIGLLCVQQHPEDRPCMPSVILM 700 (747)
Q Consensus 671 ~~~~~~~~l~~~Cl~~dP~~RPt~~~v~~~ 700 (747)
....+..++.+||+.+|.+|||+.++++.
T Consensus 225 -~~~~l~~li~~~l~~~p~~Rpt~~~ll~~ 253 (256)
T cd08220 225 -YSPDLRQLILSMLNLDPSKRPQLSQIMAQ 253 (256)
T ss_pred -cCHHHHHHHHHHccCChhhCCCHHHHhhC
Confidence 11235678889999999999999999863
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.4e-31 Score=279.86 Aligned_cols=254 Identities=23% Similarity=0.314 Sum_probs=184.8
Q ss_pred CCCccceecccCCeeEEEEEec-CCcEEEEEEecccc-cccHHHHHHHHHHHhccCCCceeeEEeEEEeCCeeEEEEecC
Q 004521 441 NFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKIS-EQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFM 518 (747)
Q Consensus 441 ~~~~~~~lg~G~fg~Vy~~~~~-~g~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~ 518 (747)
+|++.+.||+|++|.||+|+.. +|+.||||.++... ......+.+|+.++++++|+||+++++++...+..++||||+
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (284)
T cd07836 1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVIHTENKLMLVFEYM 80 (284)
T ss_pred CceEeeeeccCCceEEEEEEECCCCeEEEEEEecccccccchHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcEEEEEecC
Confidence 4788899999999999999986 48899999987533 233567788999999999999999999999999999999999
Q ss_pred CCCChhhHhhhcCCCCcCChhHHHHHHHHHHHHHHHhhhcCCCceEecccCcCcEEEcCCCCceEecccCccccCCCCCc
Q 004521 519 PNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETE 598 (747)
Q Consensus 519 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~ 598 (747)
+ ++|.+++........+++..+..++.|++.||.|||+.+ ++||||||+||++++++.+||+|||+++........
T Consensus 81 ~-~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~~~~~ 156 (284)
T cd07836 81 D-KDLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHENR---VLHRDLKPQNLLINKRGELKLADFGLARAFGIPVNT 156 (284)
T ss_pred C-ccHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEECCCCcEEEeecchhhhhcCCccc
Confidence 8 588888866554556899999999999999999999988 999999999999999999999999999765332111
Q ss_pred ccc-----ceeeec---cCCCCCccccchhHHHHHHHHHhCCCCCCCCCCcchhhhhHhHHhcC---------Ccccc--
Q 004521 599 GNT-----NRVVGT---YDGQFSIKSDVFSFGILLLEIVSGKKNRGFYRSDTKVNLIGHLWDEG---------IPLRL-- 659 (747)
Q Consensus 599 ~~~-----~~~~~~---~~~~~s~ksDVwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~---------~~~~~-- 659 (747)
... ...... ....++.++|||||||++|||++|+.|+...........+....... ....+
T Consensus 157 ~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (284)
T cd07836 157 FSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGTPTESTWPGISQLPEYKP 236 (284)
T ss_pred cccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhHHHHhcCchhcc
Confidence 100 000011 12346889999999999999999999975432211111110000000 00000
Q ss_pred -----cchhhhccCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 004521 660 -----IDACIQDSCNLADVIRCIHIGLLCVQQHPEDRPCMPSVIL 699 (747)
Q Consensus 660 -----~d~~l~~~~~~~~~~~~~~l~~~Cl~~dP~~RPt~~~v~~ 699 (747)
.+... ..........+.+++.+|++.||.+||++.+|++
T Consensus 237 ~~~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~ 280 (284)
T cd07836 237 TFPRYPPQDL-QQLFPHADPLGIDLLHRLLQLNPELRISAHDALQ 280 (284)
T ss_pred cccCCChHHH-HHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 00000 0000011234567888999999999999999875
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.7e-31 Score=282.64 Aligned_cols=243 Identities=24% Similarity=0.375 Sum_probs=186.6
Q ss_pred cCCCccceecccCCeeEEEEEec-CCcEEEEEEecccccccHHHHHHHHHHHhccCCCceeeEEeEEEeCCeeEEEEecC
Q 004521 440 DNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFM 518 (747)
Q Consensus 440 ~~~~~~~~lg~G~fg~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~ 518 (747)
++|.+.+.||+|+||.||++... +++.||+|.+........+.+.+|+.++++++||||+++++++...+..++|+||+
T Consensus 19 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~ 98 (293)
T cd06647 19 KKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDSYLVGDELWVVMEYL 98 (293)
T ss_pred hhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEeccccchHHHHHHHHHHHHhhcCCCCeeehhheeeeCCcEEEEEecC
Confidence 67888999999999999999864 57899999987544455677899999999999999999999999999999999999
Q ss_pred CCCChhhHhhhcCCCCcCChhHHHHHHHHHHHHHHHhhhcCCCceEecccCcCcEEEcCCCCceEecccCccccCCCCCc
Q 004521 519 PNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETE 598 (747)
Q Consensus 519 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~ 598 (747)
++++|.+++.. ..+++.++..++.|++.||.|||+.+ ++|+||||+||+++.++.+||+|||++..+......
T Consensus 99 ~~~~L~~~~~~----~~l~~~~~~~i~~~l~~al~~LH~~g---i~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~~~~~ 171 (293)
T cd06647 99 AGGSLTDVVTE----TCMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK 171 (293)
T ss_pred CCCcHHHHHhh----cCCCHHHHHHHHHHHHHHHHHHHhCC---EeeccCCHHHEEEcCCCCEEEccCcceecccccccc
Confidence 99999999853 24788999999999999999999988 999999999999999999999999998765433221
Q ss_pred cccc-----eeee--ccCCCCCccccchhHHHHHHHHHhCCCCCCCCCCcchhhhhHhHHhcCCcccccchhhhccCCHH
Q 004521 599 GNTN-----RVVG--TYDGQFSIKSDVFSFGILLLEIVSGKKNRGFYRSDTKVNLIGHLWDEGIPLRLIDACIQDSCNLA 671 (747)
Q Consensus 599 ~~~~-----~~~~--~~~~~~s~ksDVwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~ 671 (747)
.... .... .....++.++|||||||++||+++|+.||....... ........+... . . ....
T Consensus 172 ~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~---~~~~~~~~~~~~-~-----~--~~~~ 240 (293)
T cd06647 172 RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLR---ALYLIATNGTPE-L-----Q--NPEK 240 (293)
T ss_pred cccccCChhhcCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhh---heeehhcCCCCC-C-----C--Cccc
Confidence 1100 0000 013567889999999999999999999975332211 111111111100 0 0 0001
Q ss_pred HHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 004521 672 DVIRCIHIGLLCVQQHPEDRPCMPSVILM 700 (747)
Q Consensus 672 ~~~~~~~l~~~Cl~~dP~~RPt~~~v~~~ 700 (747)
....+.+++.+||+.+|++||++.+++.+
T Consensus 241 ~~~~l~~li~~~l~~~p~~Rp~~~~il~h 269 (293)
T cd06647 241 LSAIFRDFLNRCLEMDVEKRGSAKELLQH 269 (293)
T ss_pred cCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 11235567889999999999999999875
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.98 E-value=8.9e-32 Score=303.39 Aligned_cols=256 Identities=18% Similarity=0.197 Sum_probs=176.9
Q ss_pred HHHhcCCCccceecccCCeeEEEEEecC-CcEEEEEEecccccccHHHHHHHHHHHhccCC------CceeeEEeEEEeC
Q 004521 436 ANATDNFSINNKLGEGGFGPVYKGTLVD-GQEIAVKRLSKISEQGLKELKNEVILFSKLQH------RNLVKLLGCCIQG 508 (747)
Q Consensus 436 ~~~~~~~~~~~~lg~G~fg~Vy~~~~~~-g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H------~niv~l~g~~~~~ 508 (747)
....++|++.++||+|+||+||+|.... ++.||||+++.. ....+++..|+.+++.++| .+|+++++++...
T Consensus 125 ~~~~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~~~ 203 (467)
T PTZ00284 125 DVSTQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNV-PKYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQNE 203 (467)
T ss_pred ccCCCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecc-hhhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEEEcC
Confidence 3456789999999999999999999754 789999999652 2234456677777777654 4589999988765
Q ss_pred -CeeEEEEecCCCCChhhHhhhcCCCCcCChhHHHHHHHHHHHHHHHhhhc-CCCceEecccCcCcEEEcCCC-------
Q 004521 509 -EEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQD-SRLRIIHRDLKASNVLLDQDM------- 579 (747)
Q Consensus 509 -~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~-~~~~iiHrDlkp~NIll~~~~------- 579 (747)
...++|||++ +++|.+++... ..+++..+..|+.||+.||+|||++ + ||||||||+|||++.++
T Consensus 204 ~~~~~iv~~~~-g~~l~~~l~~~---~~l~~~~~~~i~~qi~~aL~yLH~~~g---IiHrDlKP~NILl~~~~~~~~~~~ 276 (467)
T PTZ00284 204 TGHMCIVMPKY-GPCLLDWIMKH---GPFSHRHLAQIIFQTGVALDYFHTELH---LMHTDLKPENILMETSDTVVDPVT 276 (467)
T ss_pred CceEEEEEecc-CCCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHhcCC---eecCCCCHHHEEEecCCccccccc
Confidence 4678999988 67888888543 3589999999999999999999974 6 99999999999998765
Q ss_pred ---------CceEecccCccccCCCCCccc-c-ceeee--ccCCCCCccccchhHHHHHHHHHhCCCCCCCCCCcchhhh
Q 004521 580 ---------NPKISDFGLVRTFGGDETEGN-T-NRVVG--TYDGQFSIKSDVFSFGILLLEIVSGKKNRGFYRSDTKVNL 646 (747)
Q Consensus 580 ---------~~kl~DFGla~~~~~~~~~~~-~-~~~~~--~~~~~~s~ksDVwS~Gvvl~elltg~~p~~~~~~~~~~~~ 646 (747)
.+||+|||++........... + .+... ..+..++.++|||||||+||||++|+.||...........
T Consensus 277 ~~~~~~~~~~vkl~DfG~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~ 356 (467)
T PTZ00284 277 NRALPPDPCRVRICDLGGCCDERHSRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGKLLYDTHDNLEHLHL 356 (467)
T ss_pred ccccCCCCceEEECCCCccccCccccccccCCccccCcHHhhcCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHH
Confidence 499999998764322211100 0 00000 0145789999999999999999999999864332211111
Q ss_pred hHhHHh-------c--------------CCcccccchh-h---hcc---CCHHHHHHHHHHHHhccCCCCCCCCCHHHHH
Q 004521 647 IGHLWD-------E--------------GIPLRLIDAC-I---QDS---CNLADVIRCIHIGLLCVQQHPEDRPCMPSVI 698 (747)
Q Consensus 647 ~~~~~~-------~--------------~~~~~~~d~~-l---~~~---~~~~~~~~~~~l~~~Cl~~dP~~RPt~~~v~ 698 (747)
+..... . +......++. + ... ........+++|+.+||+.||++|||+.|++
T Consensus 357 i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~ta~e~L 436 (467)
T PTZ00284 357 MEKTLGRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIYGLLHYDRQKRLNARQMT 436 (467)
T ss_pred HHHHcCCCCHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhcccchhhhhchHHHHHHHHHhCCcChhhCCCHHHHh
Confidence 111100 0 0000000000 0 000 0001123456889999999999999999998
Q ss_pred H
Q 004521 699 L 699 (747)
Q Consensus 699 ~ 699 (747)
+
T Consensus 437 ~ 437 (467)
T PTZ00284 437 T 437 (467)
T ss_pred c
Confidence 6
|
|
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.8e-31 Score=283.07 Aligned_cols=238 Identities=25% Similarity=0.372 Sum_probs=181.3
Q ss_pred cceecccCCeeEEEEEec-CCcEEEEEEecccccccHHHHHHHHHHHhccCCCceeeEEeEEEeCCeeEEEEecCCCCCh
Q 004521 445 NNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMPNKSL 523 (747)
Q Consensus 445 ~~~lg~G~fg~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gsL 523 (747)
...||+|+||.||+|... +++.||+|.+........+.+.+|+.+++.++||||+++++++..++..++||||+++++|
T Consensus 26 ~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~iv~e~~~~~~L 105 (297)
T cd06659 26 YIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFLQGGAL 105 (297)
T ss_pred hhhcCCCCceeEEEEEEcCCCCEEEEEEEEecccchHHHHHHHHHHHHhCCCCchhhhhhheeeCCeEEEEEecCCCCCH
Confidence 458999999999999875 5889999998754445567788999999999999999999999999999999999999999
Q ss_pred hhHhhhcCCCCcCChhHHHHHHHHHHHHHHHhhhcCCCceEecccCcCcEEEcCCCCceEecccCccccCCCCCcccc--
Q 004521 524 DSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNT-- 601 (747)
Q Consensus 524 ~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~-- 601 (747)
..++.. ..+++..+..++.|++.||.|||+.+ ++||||||+||+++.++.+||+|||+++.+.........
T Consensus 106 ~~~~~~----~~~~~~~~~~~~~qi~~~L~~LH~~~---ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~~~~~~~~~ 178 (297)
T cd06659 106 TDIVSQ----TRLNEEQIATVCESVLQALCYLHSQG---VIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKSLV 178 (297)
T ss_pred HHHHhh----cCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHeEEccCCcEEEeechhHhhccccccccccee
Confidence 988743 34789999999999999999999988 999999999999999999999999998765432211100
Q ss_pred ---ceeeec--cCCCCCccccchhHHHHHHHHHhCCCCCCCCCCcchhhhhHhHHhcCCcccccchhhhccCCHHHHHHH
Q 004521 602 ---NRVVGT--YDGQFSIKSDVFSFGILLLEIVSGKKNRGFYRSDTKVNLIGHLWDEGIPLRLIDACIQDSCNLADVIRC 676 (747)
Q Consensus 602 ---~~~~~~--~~~~~s~ksDVwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~ 676 (747)
...... ....++.++|||||||++|||++|+.|+..... ...+... .......... ... ....+
T Consensus 179 ~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~---~~~~~~~-~~~~~~~~~~---~~~----~~~~l 247 (297)
T cd06659 179 GTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDSP---VQAMKRL-RDSPPPKLKN---AHK----ISPVL 247 (297)
T ss_pred cCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH---HHHHHHH-hccCCCCccc---cCC----CCHHH
Confidence 000000 145678899999999999999999999753221 1111111 1111111000 000 11235
Q ss_pred HHHHHhccCCCCCCCCCHHHHHHH
Q 004521 677 IHIGLLCVQQHPEDRPCMPSVILM 700 (747)
Q Consensus 677 ~~l~~~Cl~~dP~~RPt~~~v~~~ 700 (747)
.+++.+||+.+|++||++.+|++.
T Consensus 248 ~~~i~~~l~~~P~~Rps~~~ll~~ 271 (297)
T cd06659 248 RDFLERMLTREPQERATAQELLDH 271 (297)
T ss_pred HHHHHHHhcCCcccCcCHHHHhhC
Confidence 567789999999999999999884
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.3e-31 Score=284.79 Aligned_cols=187 Identities=24% Similarity=0.386 Sum_probs=146.2
Q ss_pred cceecccCCeeEEEEEecC---CcEEEEEEecccccccHHHHHHHHHHHhccCCCceeeEEeEEEe--CCeeEEEEecCC
Q 004521 445 NNKLGEGGFGPVYKGTLVD---GQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQ--GEEKLLIYEFMP 519 (747)
Q Consensus 445 ~~~lg~G~fg~Vy~~~~~~---g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~--~~~~~lV~E~~~ 519 (747)
..+||+|+||.||+|+..+ +..||+|.+... .....+.+|+.++++++||||+++++++.. +...++||||++
T Consensus 6 g~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~ 83 (317)
T cd07867 6 GCKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGT--GISMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFDYAE 83 (317)
T ss_pred ceEeccCCCeeEEEEEecCCCccceEEEEEecCC--CCcHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEeeeC
Confidence 3689999999999999754 578999998753 233567899999999999999999999864 456789999987
Q ss_pred CCChhhHhhhc------CCCCcCChhHHHHHHHHHHHHHHHhhhcCCCceEecccCcCcEEE----cCCCCceEecccCc
Q 004521 520 NKSLDSFIFDQ------TRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLL----DQDMNPKISDFGLV 589 (747)
Q Consensus 520 ~gsL~~~l~~~------~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NIll----~~~~~~kl~DFGla 589 (747)
++|.+++... .....+++..+..++.||+.||.|||+.+ |+||||||+|||+ +.++.+||+|||++
T Consensus 84 -~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~a 159 (317)
T cd07867 84 -HDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHANW---VLHRDLKPANILVMGEGPERGRVKIADMGFA 159 (317)
T ss_pred -CcHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCC---EEcCCCCHHHEEEccCCCCCCcEEEeeccce
Confidence 4777776422 12235788899999999999999999988 9999999999999 56678999999999
Q ss_pred cccCCCCCccc-cceeeec--------c--CCCCCccccchhHHHHHHHHHhCCCCCCC
Q 004521 590 RTFGGDETEGN-TNRVVGT--------Y--DGQFSIKSDVFSFGILLLEIVSGKKNRGF 637 (747)
Q Consensus 590 ~~~~~~~~~~~-~~~~~~~--------~--~~~~s~ksDVwS~Gvvl~elltg~~p~~~ 637 (747)
+.+........ .....++ . ...++.++|||||||++|||+||+.||..
T Consensus 160 ~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~ 218 (317)
T cd07867 160 RLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHC 218 (317)
T ss_pred eccCCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCccc
Confidence 87643321110 0011111 1 24578899999999999999999999753
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=99.98 E-value=4.1e-31 Score=277.27 Aligned_cols=240 Identities=24% Similarity=0.389 Sum_probs=183.6
Q ss_pred CCCccceecccCCeeEEEEEec-CCcEEEEEEecccc-cccHHHHHHHHHHHhccCCCceeeEEeEEEeCCeeEEEEecC
Q 004521 441 NFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKIS-EQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFM 518 (747)
Q Consensus 441 ~~~~~~~lg~G~fg~Vy~~~~~-~g~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~ 518 (747)
-|++.+.||+|+||.||+|... +++.+|||.+.... ....+.+.+|+.++.+++||||+++++++..+...++||||+
T Consensus 5 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 84 (277)
T cd06641 5 LFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYL 84 (277)
T ss_pred hhhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeEEEEEEeC
Confidence 4667889999999999999875 58899999976422 334567889999999999999999999999999999999999
Q ss_pred CCCChhhHhhhcCCCCcCChhHHHHHHHHHHHHHHHhhhcCCCceEecccCcCcEEEcCCCCceEecccCccccCCCCCc
Q 004521 519 PNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETE 598 (747)
Q Consensus 519 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~ 598 (747)
++++|.+++.. ..+++..+..++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||+++.+......
T Consensus 85 ~~~~l~~~i~~----~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~~~~~ 157 (277)
T cd06641 85 GGGSALDLLEP----GPLDETQIATILREILKGLDYLHSEK---KIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIK 157 (277)
T ss_pred CCCcHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHccCC---eecCCCCHHhEEECCCCCEEEeecccceecccchhh
Confidence 99999999843 35889999999999999999999988 999999999999999999999999998765432211
Q ss_pred cc----c-ceeeec--cCCCCCccccchhHHHHHHHHHhCCCCCCCCCCcchhhhhHhHHhcCCcccccchhhhccCCHH
Q 004521 599 GN----T-NRVVGT--YDGQFSIKSDVFSFGILLLEIVSGKKNRGFYRSDTKVNLIGHLWDEGIPLRLIDACIQDSCNLA 671 (747)
Q Consensus 599 ~~----~-~~~~~~--~~~~~s~ksDVwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~ 671 (747)
.. . ...... ....++.++|||||||++|||++|..|+..... ...... ........+ ....
T Consensus 158 ~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~---~~~~~~-~~~~~~~~~-----~~~~--- 225 (277)
T cd06641 158 RNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSELHP---MKVLFL-IPKNNPPTL-----EGNY--- 225 (277)
T ss_pred hccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCccch---HHHHHH-HhcCCCCCC-----Cccc---
Confidence 00 0 000011 134678899999999999999999999753221 111111 111111111 1111
Q ss_pred HHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 004521 672 DVIRCIHIGLLCVQQHPEDRPCMPSVILM 700 (747)
Q Consensus 672 ~~~~~~~l~~~Cl~~dP~~RPt~~~v~~~ 700 (747)
...+.+++.+||+.+|.+||++.++++.
T Consensus 226 -~~~~~~~i~~~l~~~p~~Rp~~~~~l~~ 253 (277)
T cd06641 226 -SKPLKEFVEACLNKEPSFRPTAKELLKH 253 (277)
T ss_pred -CHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence 2235677889999999999999999984
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=8.1e-32 Score=290.18 Aligned_cols=233 Identities=21% Similarity=0.229 Sum_probs=169.8
Q ss_pred ecccCCeeEEEEEecC-CcEEEEEEeccc---ccccHHHHHHHHHHHhcc---CCCceeeEEeEEEeCCeeEEEEecCCC
Q 004521 448 LGEGGFGPVYKGTLVD-GQEIAVKRLSKI---SEQGLKELKNEVILFSKL---QHRNLVKLLGCCIQGEEKLLIYEFMPN 520 (747)
Q Consensus 448 lg~G~fg~Vy~~~~~~-g~~vavK~l~~~---~~~~~~~~~~E~~~l~~l---~H~niv~l~g~~~~~~~~~lV~E~~~~ 520 (747)
||+|+||+||+|+... ++.||||++.+. .......+..|..++.+. +||||+++++++......++||||+++
T Consensus 1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~~~ 80 (330)
T cd05586 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMSG 80 (330)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCCCC
Confidence 7999999999999754 899999998642 122334456677777655 699999999999999999999999999
Q ss_pred CChhhHhhhcCCCCcCChhHHHHHHHHHHHHHHHhhhcCCCceEecccCcCcEEEcCCCCceEecccCccccCCCCCccc
Q 004521 521 KSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGN 600 (747)
Q Consensus 521 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~ 600 (747)
|+|..++.. ...+++..+..++.||++||+|||+.+ |+||||||+|||++.++.+||+|||+++..........
T Consensus 81 g~L~~~l~~---~~~~~~~~~~~~~~qil~al~~LH~~~---ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~~~~ 154 (330)
T cd05586 81 GELFWHLQK---EGRFSEDRAKFYIAELVLALEHLHKYD---IVYRDLKPENILLDATGHIALCDFGLSKANLTDNKTTN 154 (330)
T ss_pred ChHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeEECCCCCEEEecCCcCcCCCCCCCCcc
Confidence 999988854 345889999999999999999999988 99999999999999999999999999875432211110
Q ss_pred -----cceeeec-c--CCCCCccccchhHHHHHHHHHhCCCCCCCCCCcchhhhhHhHHhcCCcccccchhhhccCCHHH
Q 004521 601 -----TNRVVGT-Y--DGQFSIKSDVFSFGILLLEIVSGKKNRGFYRSDTKVNLIGHLWDEGIPLRLIDACIQDSCNLAD 672 (747)
Q Consensus 601 -----~~~~~~~-~--~~~~s~ksDVwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~ 672 (747)
....... . ...++.++|||||||++|||++|+.||.... ......... .+.. .+.... .
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~---~~~~~~~i~-~~~~-~~~~~~----~---- 221 (330)
T cd05586 155 TFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAED---TQQMYRNIA-FGKV-RFPKNV----L---- 221 (330)
T ss_pred CccCCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCC---HHHHHHHHH-cCCC-CCCCcc----C----
Confidence 0011111 1 2347899999999999999999999974322 112222211 1111 111110 1
Q ss_pred HHHHHHHHHhccCCCCCCCCC----HHHHHH
Q 004521 673 VIRCIHIGLLCVQQHPEDRPC----MPSVIL 699 (747)
Q Consensus 673 ~~~~~~l~~~Cl~~dP~~RPt----~~~v~~ 699 (747)
...+.+++.+||+.||.+||+ +.++++
T Consensus 222 ~~~~~~li~~~L~~~P~~R~~~~~~~~~ll~ 252 (330)
T cd05586 222 SDEGRQFVKGLLNRNPQHRLGAHRDAVELKE 252 (330)
T ss_pred CHHHHHHHHHHcCCCHHHCCCCCCCHHHHhc
Confidence 122456777999999999995 555544
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.9e-31 Score=280.78 Aligned_cols=250 Identities=23% Similarity=0.326 Sum_probs=184.9
Q ss_pred CCCccceecccCCeeEEEEEec-CCcEEEEEEecccc--cccHHHHHHHHHHHhccCCCceeeEEeEEEeCCeeEEEEec
Q 004521 441 NFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKIS--EQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEF 517 (747)
Q Consensus 441 ~~~~~~~lg~G~fg~Vy~~~~~-~g~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~ 517 (747)
+|++.+.||+|+||.||+|+.. +++.||||++.... ....+.+.+|+.++++++||||+++++++..+...++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~ 80 (286)
T cd07832 1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFPHGSGFVLVMEY 80 (286)
T ss_pred CceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEEecCCeeEEEecc
Confidence 4788899999999999999975 58999999987533 33456899999999999999999999999999999999999
Q ss_pred CCCCChhhHhhhcCCCCcCChhHHHHHHHHHHHHHHHhhhcCCCceEecccCcCcEEEcCCCCceEecccCccccCCCCC
Q 004521 518 MPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDET 597 (747)
Q Consensus 518 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~ 597 (747)
+ +++|.+++.... ..+++.++..++.||++||+|||+.+ ++|+||||+||+++.++.++|+|||++........
T Consensus 81 ~-~~~L~~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~~~~ 154 (286)
T cd07832 81 M-PSDLSEVLRDEE--RPLPEAQVKSYMRMLLKGVAYMHANG---IMHRDLKPANLLISADGVLKIADFGLARLFSEEEP 154 (286)
T ss_pred c-CCCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCcCHHHEEEcCCCcEEEeeeeecccccCCCC
Confidence 9 999999986533 45899999999999999999999988 99999999999999999999999999887654321
Q ss_pred ccc-----c-ceeeec---cCCCCCccccchhHHHHHHHHHhCCCCCCCCCCcchhhhhHhHHhc-CCc--------ccc
Q 004521 598 EGN-----T-NRVVGT---YDGQFSIKSDVFSFGILLLEIVSGKKNRGFYRSDTKVNLIGHLWDE-GIP--------LRL 659 (747)
Q Consensus 598 ~~~-----~-~~~~~~---~~~~~s~ksDVwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~-~~~--------~~~ 659 (747)
... . ...... ....++.++||||+|+++|||++|..++.... ....+...... +.. ..+
T Consensus 155 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (286)
T cd07832 155 RLYSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGEN---DIEQLAIVFRTLGTPNEETWPGLTSL 231 (286)
T ss_pred CccccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCC---HHHHHHHHHHHcCCCChHHHhhccCc
Confidence 000 0 000000 12346889999999999999999976653222 11111111100 000 000
Q ss_pred cc------h-----hhhccCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 004521 660 ID------A-----CIQDSCNLADVIRCIHIGLLCVQQHPEDRPCMPSVILM 700 (747)
Q Consensus 660 ~d------~-----~l~~~~~~~~~~~~~~l~~~Cl~~dP~~RPt~~~v~~~ 700 (747)
.+ . .+.. ........+.+++.+||+.+|++||+++++++.
T Consensus 232 ~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~h 282 (286)
T cd07832 232 PDYNKITFPESKPIPLEE-IFPDASPEALDLLKGLLVYDPSKRLSAAEALRH 282 (286)
T ss_pred chhhcccCCCCCcchHHH-hCCCccHHHHHHHHHHhccChhhCCCHHHHhhC
Confidence 00 0 0000 000112456778889999999999999999864
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=2e-31 Score=280.60 Aligned_cols=252 Identities=23% Similarity=0.300 Sum_probs=183.9
Q ss_pred CCccceecccCCeeEEEEEecC-CcEEEEEEecccc--cccHHHHHHHHHHHhccCCCceeeEEeEEEeC--CeeEEEEe
Q 004521 442 FSINNKLGEGGFGPVYKGTLVD-GQEIAVKRLSKIS--EQGLKELKNEVILFSKLQHRNLVKLLGCCIQG--EEKLLIYE 516 (747)
Q Consensus 442 ~~~~~~lg~G~fg~Vy~~~~~~-g~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~--~~~~lV~E 516 (747)
|++.++||+|+||.||+|+..+ ++.+|+|++.... ....+.+.+|+.++++++|+||+++++++... +..++|||
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e 80 (287)
T cd07840 1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVFE 80 (287)
T ss_pred CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEec
Confidence 5678899999999999999765 8899999998642 34456788999999999999999999999988 88999999
Q ss_pred cCCCCChhhHhhhcCCCCcCChhHHHHHHHHHHHHHHHhhhcCCCceEecccCcCcEEEcCCCCceEecccCccccCCCC
Q 004521 517 FMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDE 596 (747)
Q Consensus 517 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~ 596 (747)
|++ ++|.+++.... ..+++..++.++.||++||+|||+.+ ++|+||||+||++++++.+||+|||++.......
T Consensus 81 ~~~-~~l~~~~~~~~--~~~~~~~~~~i~~~i~~al~~LH~~~---~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~~~ 154 (287)
T cd07840 81 YMD-HDLTGLLDSPE--VKFTESQIKCYMKQLLEGLQYLHSNG---ILHRDIKGSNILINNDGVLKLADFGLARPYTKRN 154 (287)
T ss_pred ccc-ccHHHHHhccC--CCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCcHHHeEEcCCCCEEEccccceeeccCCC
Confidence 997 48888885432 46899999999999999999999988 9999999999999999999999999998765432
Q ss_pred Cccccc------eeeec-c--CCCCCccccchhHHHHHHHHHhCCCCCCCCCCcchhhhhHhHHhcCC---cc-------
Q 004521 597 TEGNTN------RVVGT-Y--DGQFSIKSDVFSFGILLLEIVSGKKNRGFYRSDTKVNLIGHLWDEGI---PL------- 657 (747)
Q Consensus 597 ~~~~~~------~~~~~-~--~~~~s~ksDVwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~---~~------- 657 (747)
...... ..... . ...++.++||||||+++|||++|+.|+...........+........ ..
T Consensus 155 ~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (287)
T cd07840 155 SADYTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQLEKIFELCGSPTDENWPGVSKLPW 234 (287)
T ss_pred cccccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhhccccccchh
Confidence 110000 00000 0 23578899999999999999999999754332111111111000000 00
Q ss_pred -------cccchhhhccCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 004521 658 -------RLIDACIQDSCNLADVIRCIHIGLLCVQQHPEDRPCMPSVIL 699 (747)
Q Consensus 658 -------~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dP~~RPt~~~v~~ 699 (747)
......+...........+.+++.+||+.+|.+||++.++++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~ 283 (287)
T cd07840 235 FENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQ 283 (287)
T ss_pred hhhccccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhh
Confidence 000000000000001345678899999999999999999976
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.3e-31 Score=281.58 Aligned_cols=247 Identities=25% Similarity=0.367 Sum_probs=185.3
Q ss_pred CCCccceecccCCeeEEEEEec-CCcEEEEEEecccc---cccHHHHHHHHHHHhccCCCceeeEEeEEEeCCeeEEEEe
Q 004521 441 NFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKIS---EQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYE 516 (747)
Q Consensus 441 ~~~~~~~lg~G~fg~Vy~~~~~-~g~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E 516 (747)
.|+..+.||+|+||.||+|+.. ++..+|+|.+.... ....+.+.+|++++++++|+|++++++++..+...++|||
T Consensus 26 ~f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 105 (317)
T cd06635 26 LFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVME 105 (317)
T ss_pred hhhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCeEEEEEe
Confidence 3667789999999999999975 48899999986432 2334578899999999999999999999999999999999
Q ss_pred cCCCCChhhHhhhcCCCCcCChhHHHHHHHHHHHHHHHhhhcCCCceEecccCcCcEEEcCCCCceEecccCccccCCCC
Q 004521 517 FMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDE 596 (747)
Q Consensus 517 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~ 596 (747)
|++ |+|.+++... ...+++.++..++.|++.||.|||+.+ |+||||+|+||+++.++.+||+|||++.......
T Consensus 106 ~~~-g~l~~~~~~~--~~~l~~~~~~~i~~~i~~~l~~lH~~~---i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~~~~ 179 (317)
T cd06635 106 YCL-GSASDLLEVH--KKPLQEVEIAAITHGALQGLAYLHSHN---MIHRDIKAGNILLTEPGQVKLADFGSASIASPAN 179 (317)
T ss_pred CCC-CCHHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcccEEECCCCCEEEecCCCccccCCcc
Confidence 997 5777776543 345899999999999999999999988 9999999999999999999999999987654322
Q ss_pred Cccccc-e-----eeeccCCCCCccccchhHHHHHHHHHhCCCCCCCCCCcchhhhhHhHHhcCCcccccchhhhccCCH
Q 004521 597 TEGNTN-R-----VVGTYDGQFSIKSDVFSFGILLLEIVSGKKNRGFYRSDTKVNLIGHLWDEGIPLRLIDACIQDSCNL 670 (747)
Q Consensus 597 ~~~~~~-~-----~~~~~~~~~s~ksDVwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~ 670 (747)
...... . ......+.++.++|||||||++|||++|+.|+.... ....+.......... .. . .
T Consensus 180 ~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~---~~~~~~~~~~~~~~~-~~-----~---~ 247 (317)
T cd06635 180 SFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMN---AMSALYHIAQNESPT-LQ-----S---N 247 (317)
T ss_pred cccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCcc---HHHHHHHHHhccCCC-CC-----C---c
Confidence 211110 0 111123568889999999999999999999964321 111122221111111 00 0 0
Q ss_pred HHHHHHHHHHHhccCCCCCCCCCHHHHHHHhcCCC
Q 004521 671 ADVIRCIHIGLLCVQQHPEDRPCMPSVILMLGSEI 705 (747)
Q Consensus 671 ~~~~~~~~l~~~Cl~~dP~~RPt~~~v~~~L~~~~ 705 (747)
.....+.+++.+||+.+|.+||++.+|++.+-...
T Consensus 248 ~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~~~ 282 (317)
T cd06635 248 EWSDYFRNFVDSCLQKIPQDRPTSEELLKHMFVLR 282 (317)
T ss_pred cccHHHHHHHHHHccCCcccCcCHHHHHhChhhhc
Confidence 11123567888999999999999999998765443
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.4e-31 Score=282.65 Aligned_cols=244 Identities=22% Similarity=0.253 Sum_probs=184.2
Q ss_pred cCCCccceecccCCeeEEEEEecC-CcEEEEEEeccccc---ccHHHHHHHHHHHhccCCCceeeEEeEEEeCCeeEEEE
Q 004521 440 DNFSINNKLGEGGFGPVYKGTLVD-GQEIAVKRLSKISE---QGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIY 515 (747)
Q Consensus 440 ~~~~~~~~lg~G~fg~Vy~~~~~~-g~~vavK~l~~~~~---~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 515 (747)
++|++.+.||+|+||.||++...+ ++.+|+|.+..... ...+.+.+|+++++.++|+||+++++.+......++||
T Consensus 1 ~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 80 (316)
T cd05574 1 KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTETYLCLVM 80 (316)
T ss_pred CceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeecCCEEEEEE
Confidence 368888999999999999999865 89999999875322 24567899999999999999999999999999999999
Q ss_pred ecCCCCChhhHhhhcCCCCcCChhHHHHHHHHHHHHHHHhhhcCCCceEecccCcCcEEEcCCCCceEecccCccccCCC
Q 004521 516 EFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGD 595 (747)
Q Consensus 516 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NIll~~~~~~kl~DFGla~~~~~~ 595 (747)
||+++++|.+++... ....+++..+..++.|+++||+|||+.+ ++|+||||+||+++.++.++|+|||++......
T Consensus 81 e~~~~~~L~~~~~~~-~~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~ 156 (316)
T cd05574 81 DYCPGGELFRLLQRQ-PGKCLSEEVARFYAAEVLLALEYLHLLG---IVYRDLKPENILLHESGHIMLSDFDLSKQSDVE 156 (316)
T ss_pred EecCCCCHHHHHHhC-CCCccCHHHHHHHHHHHHHHHHHHHHCC---eeccCCChHHeEEcCCCCEEEeecchhhccccc
Confidence 999999999998643 2346899999999999999999999988 999999999999999999999999998754322
Q ss_pred CCccc---------------------------cceeeec---------cCCCCCccccchhHHHHHHHHHhCCCCCCCCC
Q 004521 596 ETEGN---------------------------TNRVVGT---------YDGQFSIKSDVFSFGILLLEIVSGKKNRGFYR 639 (747)
Q Consensus 596 ~~~~~---------------------------~~~~~~~---------~~~~~s~ksDVwS~Gvvl~elltg~~p~~~~~ 639 (747)
..... .....++ .+..++.++||||||+++|||++|+.|+....
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~ 236 (316)
T cd05574 157 PPPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTPFKGSN 236 (316)
T ss_pred ccccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCchHHHHHHHHHHHHHhhCCCCCCCCc
Confidence 11000 0000111 13457889999999999999999999975332
Q ss_pred CcchhhhhHhHHhcCCcccccchhhhccCCHHHHHHHHHHHHhccCCCCCCCCC----HHHHHH
Q 004521 640 SDTKVNLIGHLWDEGIPLRLIDACIQDSCNLADVIRCIHIGLLCVQQHPEDRPC----MPSVIL 699 (747)
Q Consensus 640 ~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dP~~RPt----~~~v~~ 699 (747)
.. ........... ... . .......+.+++.+||+.+|++||+ +.++++
T Consensus 237 ~~---~~~~~~~~~~~--~~~-----~--~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~ll~ 288 (316)
T cd05574 237 RD---ETFSNILKKEV--TFP-----G--SPPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQ 288 (316)
T ss_pred hH---HHHHHHhcCCc--cCC-----C--ccccCHHHHHHHHHHccCCHhHCCCchhhHHHHHc
Confidence 11 11111111110 000 0 0002234667888999999999999 555554
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.3e-32 Score=262.91 Aligned_cols=245 Identities=22% Similarity=0.304 Sum_probs=188.8
Q ss_pred HHHhcCCCccceecccCCeeEEEEEecC-CcEEEEEEecccc----c----ccHHHHHHHHHHHhcc-CCCceeeEEeEE
Q 004521 436 ANATDNFSINNKLGEGGFGPVYKGTLVD-GQEIAVKRLSKIS----E----QGLKELKNEVILFSKL-QHRNLVKLLGCC 505 (747)
Q Consensus 436 ~~~~~~~~~~~~lg~G~fg~Vy~~~~~~-g~~vavK~l~~~~----~----~~~~~~~~E~~~l~~l-~H~niv~l~g~~ 505 (747)
....++|...+.||+|..++|.+..++. |++.|+|++.... . .-.+.-..|+.||+++ -||+|+++.+++
T Consensus 13 ~~fy~~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~y 92 (411)
T KOG0599|consen 13 KGFYAKYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVY 92 (411)
T ss_pred hhHHhhcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeec
Confidence 4455678888999999999999987654 8899999986421 1 1234557899999998 699999999999
Q ss_pred EeCCeeEEEEecCCCCChhhHhhhcCCCCcCChhHHHHHHHHHHHHHHHhhhcCCCceEecccCcCcEEEcCCCCceEec
Q 004521 506 IQGEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISD 585 (747)
Q Consensus 506 ~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NIll~~~~~~kl~D 585 (747)
+.+...++|+|.|+.|.|.++|.+ .-.+++.+..+|++|+.+|++|||..+ |+||||||+|||+|++.++||+|
T Consensus 93 es~sF~FlVFdl~prGELFDyLts---~VtlSEK~tR~iMrqlfegVeylHa~~---IVHRDLKpENILlddn~~i~isD 166 (411)
T KOG0599|consen 93 ESDAFVFLVFDLMPRGELFDYLTS---KVTLSEKETRRIMRQLFEGVEYLHARN---IVHRDLKPENILLDDNMNIKISD 166 (411)
T ss_pred cCcchhhhhhhhcccchHHHHhhh---heeecHHHHHHHHHHHHHHHHHHHHhh---hhhcccChhheeeccccceEEec
Confidence 999999999999999999999954 445899999999999999999999988 99999999999999999999999
Q ss_pred ccCccccCCCCCccccceeeecc---------------CCCCCccccchhHHHHHHHHHhCCCCCCCCCCcchhhhhHhH
Q 004521 586 FGLVRTFGGDETEGNTNRVVGTY---------------DGQFSIKSDVFSFGILLLEIVSGKKNRGFYRSDTKVNLIGHL 650 (747)
Q Consensus 586 FGla~~~~~~~~~~~~~~~~~~~---------------~~~~s~ksDVwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~ 650 (747)
||+|+.+...+.... .+|+. ...|+..+|+|+.|||+|-|+.|..||- .... .+.-+.
T Consensus 167 FGFa~~l~~GekLre---lCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFw--HRkQ--mlMLR~ 239 (411)
T KOG0599|consen 167 FGFACQLEPGEKLRE---LCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFW--HRKQ--MLMLRM 239 (411)
T ss_pred cceeeccCCchhHHH---hcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchh--HHHH--HHHHHH
Confidence 999998765433211 11221 4568999999999999999999999963 2211 112222
Q ss_pred HhcCCcccccchhhhccCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 004521 651 WDEGIPLRLIDACIQDSCNLADVIRCIHIGLLCVQQHPEDRPCMPSVIL 699 (747)
Q Consensus 651 ~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dP~~RPt~~~v~~ 699 (747)
..+|...--....-..+ ..+.+++.+||+.||.+|.|..|+++
T Consensus 240 ImeGkyqF~speWadis------~~~KdLIsrlLqVdp~~Ritake~La 282 (411)
T KOG0599|consen 240 IMEGKYQFRSPEWADIS------ATVKDLISRLLQVDPTKRITAKEALA 282 (411)
T ss_pred HHhcccccCCcchhhcc------ccHHHHHHHHHeeCchhcccHHHHhc
Confidence 34444332111111111 12445677999999999999999975
|
|
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.8e-31 Score=277.80 Aligned_cols=247 Identities=24% Similarity=0.341 Sum_probs=187.2
Q ss_pred cCCCccceecccCCeeEEEEEec-CCcEEEEEEecccc-cccHHHHHHHHHHHhccCCCceeeEEeEEEeCCeeEEEEec
Q 004521 440 DNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKIS-EQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEF 517 (747)
Q Consensus 440 ~~~~~~~~lg~G~fg~Vy~~~~~-~g~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~ 517 (747)
++|++.+.||+|+||.||++... +++.+|+|.+.... ....+++.+|++++++++||||+++++.+......++|+||
T Consensus 1 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 80 (265)
T cd06605 1 DDLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAFYNNGDISICMEY 80 (265)
T ss_pred CcchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccChHHHHHHHHHHHHHHHCCCCchhhhheeeecCCEEEEEEEe
Confidence 36778899999999999999986 48899999987632 34556789999999999999999999999999999999999
Q ss_pred CCCCChhhHhhhcCCCCcCChhHHHHHHHHHHHHHHHhhh-cCCCceEecccCcCcEEEcCCCCceEecccCccccCCCC
Q 004521 518 MPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQ-DSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDE 596 (747)
Q Consensus 518 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~-~~~~~iiHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~ 596 (747)
+++++|.+++.... ..++...+..++.|+++||+|||+ .+ ++|+||||+||++++++.+||+|||++..+....
T Consensus 81 ~~~~~L~~~~~~~~--~~~~~~~~~~~~~~l~~~l~~lH~~~~---i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~~~~ 155 (265)
T cd06605 81 MDGGSLDKILKEVQ--GRIPERILGKIAVAVLKGLTYLHEKHK---IIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSL 155 (265)
T ss_pred cCCCcHHHHHHHcc--CCCCHHHHHHHHHHHHHHHHHHcCCCC---eecCCCCHHHEEECCCCCEEEeecccchhhHHHH
Confidence 99999999986532 468889999999999999999999 77 9999999999999999999999999987653221
Q ss_pred Ccc---ccceeee--ccCCCCCccccchhHHHHHHHHHhCCCCCCCCCC--cchhhhhHhHHhcCCcccccchhhhccCC
Q 004521 597 TEG---NTNRVVG--TYDGQFSIKSDVFSFGILLLEIVSGKKNRGFYRS--DTKVNLIGHLWDEGIPLRLIDACIQDSCN 669 (747)
Q Consensus 597 ~~~---~~~~~~~--~~~~~~s~ksDVwS~Gvvl~elltg~~p~~~~~~--~~~~~~~~~~~~~~~~~~~~d~~l~~~~~ 669 (747)
... ....... ..+..++.++||||||+++|||++|+.|+..... ........... ......+....
T Consensus 156 ~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~------ 228 (265)
T cd06605 156 AKTFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPENDPPDGIFELLQYIV-NEPPPRLPSGK------ 228 (265)
T ss_pred hhcccCChhccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCccccccccHHHHHHHHh-cCCCCCCChhh------
Confidence 111 0000000 0145788999999999999999999999754321 11111111111 11111111100
Q ss_pred HHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 004521 670 LADVIRCIHIGLLCVQQHPEDRPCMPSVILM 700 (747)
Q Consensus 670 ~~~~~~~~~l~~~Cl~~dP~~RPt~~~v~~~ 700 (747)
....+.+++.+||+.+|++||++.+++..
T Consensus 229 --~~~~~~~li~~~l~~~p~~Rpt~~~ll~~ 257 (265)
T cd06605 229 --FSPDFQDFVNLCLIKDPRERPSYKELLEH 257 (265)
T ss_pred --cCHHHHHHHHHHcCCCchhCcCHHHHhhC
Confidence 12235677889999999999999999753
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.6e-31 Score=274.94 Aligned_cols=242 Identities=24% Similarity=0.342 Sum_probs=178.7
Q ss_pred cCCCccceecccCCeeEEEEEecC-CcEEEEEEecccc-----cccHHHHHHHHHHHhccCCCceeeEEeEEEeC--Cee
Q 004521 440 DNFSINNKLGEGGFGPVYKGTLVD-GQEIAVKRLSKIS-----EQGLKELKNEVILFSKLQHRNLVKLLGCCIQG--EEK 511 (747)
Q Consensus 440 ~~~~~~~~lg~G~fg~Vy~~~~~~-g~~vavK~l~~~~-----~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~--~~~ 511 (747)
.+|++.+.||+|+||.||+|...+ ++.||||.+.... ....+.+.+|+.++++++||||+++++++.+. ...
T Consensus 2 ~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (265)
T cd06652 2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTL 81 (265)
T ss_pred CcceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceE
Confidence 478889999999999999999755 8899999885311 22346788999999999999999999998764 457
Q ss_pred EEEEecCCCCChhhHhhhcCCCCcCChhHHHHHHHHHHHHHHHhhhcCCCceEecccCcCcEEEcCCCCceEecccCccc
Q 004521 512 LLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRT 591 (747)
Q Consensus 512 ~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NIll~~~~~~kl~DFGla~~ 591 (747)
++||||+++++|.+++... ..+++..+..++.|++.||+|||+.+ ++|+||||+||+++.++.+||+|||+++.
T Consensus 82 ~~v~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~l~Dfg~~~~ 155 (265)
T cd06652 82 SIFMEHMPGGSIKDQLKSY---GALTENVTRKYTRQILEGVSYLHSNM---IVHRDIKGANILRDSVGNVKLGDFGASKR 155 (265)
T ss_pred EEEEEecCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEecCCCCEEECcCccccc
Confidence 8999999999999998543 34788889999999999999999988 99999999999999999999999999876
Q ss_pred cCCCCCcc-ccceeeec---------cCCCCCccccchhHHHHHHHHHhCCCCCCCCCCcchhhhhHhHHhcCCcccccc
Q 004521 592 FGGDETEG-NTNRVVGT---------YDGQFSIKSDVFSFGILLLEIVSGKKNRGFYRSDTKVNLIGHLWDEGIPLRLID 661 (747)
Q Consensus 592 ~~~~~~~~-~~~~~~~~---------~~~~~s~ksDVwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~d 661 (747)
+....... ......++ .+..++.++|||||||++|||++|+.|+.... ....+...........
T Consensus 156 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~---~~~~~~~~~~~~~~~~--- 229 (265)
T cd06652 156 LQTICLSGTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEFE---AMAAIFKIATQPTNPV--- 229 (265)
T ss_pred cccccccccccccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHHhhCCCCCCccc---hHHHHHHHhcCCCCCC---
Confidence 53211100 00000011 14567889999999999999999999975321 1111111111111110
Q ss_pred hhhhccCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 004521 662 ACIQDSCNLADVIRCIHIGLLCVQQHPEDRPCMPSVILM 700 (747)
Q Consensus 662 ~~l~~~~~~~~~~~~~~l~~~Cl~~dP~~RPt~~~v~~~ 700 (747)
........+..++.+|+. +|++||++.+|++.
T Consensus 230 ------~~~~~~~~~~~~i~~~l~-~p~~Rp~~~~il~~ 261 (265)
T cd06652 230 ------LPPHVSDHCRDFLKRIFV-EAKLRPSADELLRH 261 (265)
T ss_pred ------CchhhCHHHHHHHHHHhc-ChhhCCCHHHHhcC
Confidence 111112334566667884 99999999999763
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.3e-31 Score=284.59 Aligned_cols=194 Identities=24% Similarity=0.383 Sum_probs=155.8
Q ss_pred CCCccceecccCCeeEEEEEecC---CcEEEEEEecccc---cccHHHHHHHHHHHhccCCCceeeEEeEEEeC--CeeE
Q 004521 441 NFSINNKLGEGGFGPVYKGTLVD---GQEIAVKRLSKIS---EQGLKELKNEVILFSKLQHRNLVKLLGCCIQG--EEKL 512 (747)
Q Consensus 441 ~~~~~~~lg~G~fg~Vy~~~~~~---g~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~--~~~~ 512 (747)
+|.+.++||+|+||.||+|+... ++.||+|.+.... ....+.+.+|+.++++++||||+++++++... ...+
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 80 (316)
T cd07842 1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVY 80 (316)
T ss_pred CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEE
Confidence 47788999999999999999754 7899999997632 34456788999999999999999999999988 7899
Q ss_pred EEEecCCCCChhhHhhhcCC--CCcCChhHHHHHHHHHHHHHHHhhhcCCCceEecccCcCcEEEcC----CCCceEecc
Q 004521 513 LIYEFMPNKSLDSFIFDQTR--RTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQ----DMNPKISDF 586 (747)
Q Consensus 513 lV~E~~~~gsL~~~l~~~~~--~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NIll~~----~~~~kl~DF 586 (747)
+||||+++ +|.+++..... ...++...+..++.||+.||.|||+.+ |+||||||+||+++. ++.+||+||
T Consensus 81 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~h~dlkp~Nil~~~~~~~~~~~kl~Df 156 (316)
T cd07842 81 LLFDYAEH-DLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSNW---VLHRDLKPANILVMGEGPERGVVKIGDL 156 (316)
T ss_pred EEEeCCCc-CHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhCC---EeeCCCCHHHEEEcCCCCccceEEECCC
Confidence 99999975 67666643322 236888999999999999999999988 999999999999999 999999999
Q ss_pred cCccccCCCCCcc-ccceeeec--------c--CCCCCccccchhHHHHHHHHHhCCCCCCCC
Q 004521 587 GLVRTFGGDETEG-NTNRVVGT--------Y--DGQFSIKSDVFSFGILLLEIVSGKKNRGFY 638 (747)
Q Consensus 587 Gla~~~~~~~~~~-~~~~~~~~--------~--~~~~s~ksDVwS~Gvvl~elltg~~p~~~~ 638 (747)
|+++.+....... ......++ . ...++.++|||||||+||||++|+.|+...
T Consensus 157 g~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~ 219 (316)
T cd07842 157 GLARLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGR 219 (316)
T ss_pred ccccccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCC
Confidence 9998654332210 00000000 1 235788999999999999999999997643
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.6e-31 Score=284.57 Aligned_cols=243 Identities=23% Similarity=0.284 Sum_probs=192.0
Q ss_pred HhcCCCccceecccCCeeEEEEEecC-CcEEEEEEeccccc---ccHHHHHHHHHHHhccC-CCceeeEEeEEEeCCeeE
Q 004521 438 ATDNFSINNKLGEGGFGPVYKGTLVD-GQEIAVKRLSKISE---QGLKELKNEVILFSKLQ-HRNLVKLLGCCIQGEEKL 512 (747)
Q Consensus 438 ~~~~~~~~~~lg~G~fg~Vy~~~~~~-g~~vavK~l~~~~~---~~~~~~~~E~~~l~~l~-H~niv~l~g~~~~~~~~~ 512 (747)
....|++.+.||+|.||.||+++... |+.+|+|.+.+... .....+.+|+.+|+++. |||||++.+.+++....+
T Consensus 33 ~~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~~~~ 112 (382)
T KOG0032|consen 33 IKEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDPDSVY 112 (382)
T ss_pred ccccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCCeEE
Confidence 44678889999999999999999876 99999999976332 34568999999999998 999999999999999999
Q ss_pred EEEecCCCCChhhHhhhcCCCCcCChhHHHHHHHHHHHHHHHhhhcCCCceEecccCcCcEEEcCC----CCceEecccC
Q 004521 513 LIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQD----MNPKISDFGL 588 (747)
Q Consensus 513 lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NIll~~~----~~~kl~DFGl 588 (747)
+|||++.+|.|.+.+... . +++..+..++.||+.++.|||+.+ |+||||||+|+|+... +.+|++|||+
T Consensus 113 lvmEL~~GGeLfd~i~~~---~-~sE~da~~~~~~il~av~~lH~~g---vvHrDlKpEN~L~~~~~~~~~~ik~~DFGl 185 (382)
T KOG0032|consen 113 LVMELCEGGELFDRIVKK---H-YSERDAAGIIRQILEAVKYLHSLG---VVHRDLKPENLLLASKDEGSGRIKLIDFGL 185 (382)
T ss_pred EEEEecCCchHHHHHHHc---c-CCHHHHHHHHHHHHHHHHHHHhCC---ceeccCCHHHeeeccccCCCCcEEEeeCCC
Confidence 999999999999999765 2 899999999999999999999988 9999999999999543 4799999999
Q ss_pred ccccCCCCCccccceeeecc---------CCCCCccccchhHHHHHHHHHhCCCCCCCCCCcchhhhhHhHHhcCCcccc
Q 004521 589 VRTFGGDETEGNTNRVVGTY---------DGQFSIKSDVFSFGILLLEIVSGKKNRGFYRSDTKVNLIGHLWDEGIPLRL 659 (747)
Q Consensus 589 a~~~~~~~~~~~~~~~~~~~---------~~~~s~ksDVwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 659 (747)
++...... .....+|+. ...|+.++||||+||++|.|++|..||.......... ....+.. .+
T Consensus 186 a~~~~~~~---~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~~~~----~i~~~~~-~f 257 (382)
T KOG0032|consen 186 AKFIKPGE---RLHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLSGVPPFWGETEFEIFL----AILRGDF-DF 257 (382)
T ss_pred ceEccCCc---eEeeecCCccccCchhhcCCCCCcccchhHHHHHHHHHhhCCCCCcCCChhHHHH----HHHcCCC-CC
Confidence 99887621 222233432 3689999999999999999999999976443322221 1122221 11
Q ss_pred cchhhhccCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 004521 660 IDACIQDSCNLADVIRCIHIGLLCVQQHPEDRPCMPSVILM 700 (747)
Q Consensus 660 ~d~~l~~~~~~~~~~~~~~l~~~Cl~~dP~~RPt~~~v~~~ 700 (747)
.++... .--..+-.++..++..||.+|+|+.++++.
T Consensus 258 ~~~~w~-----~is~~akd~i~~ll~~dp~~R~ta~~~L~H 293 (382)
T KOG0032|consen 258 TSEPWD-----DISESAKDFIRKLLEFDPRKRLTAAQALQH 293 (382)
T ss_pred CCCCcc-----ccCHHHHHHHHHhcccCcccCCCHHHHhcC
Confidence 111111 112234456678999999999999999984
|
|
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.5e-31 Score=278.28 Aligned_cols=246 Identities=24% Similarity=0.365 Sum_probs=188.9
Q ss_pred HHhcCCCccceecccCCeeEEEEEec-CCcEEEEEEecccccccHHHHHHHHHHHhccCCCceeeEEeEEEeCCeeEEEE
Q 004521 437 NATDNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIY 515 (747)
Q Consensus 437 ~~~~~~~~~~~lg~G~fg~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 515 (747)
...+.|+..+.||+|+||.||+|... +++.+++|.+..... ..+.+.+|++++++++|+||+++++++......++|+
T Consensus 16 ~~~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 94 (286)
T cd06614 16 DPRELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ-NKELIINEILIMKDCKHPNIVDYYDSYLVGDELWVVM 94 (286)
T ss_pred CccccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCch-hHHHHHHHHHHHHHCCCCCeeEEEEEEEECCEEEEEE
Confidence 34567888899999999999999986 588999999976433 5678899999999999999999999999999999999
Q ss_pred ecCCCCChhhHhhhcCCCCcCChhHHHHHHHHHHHHHHHhhhcCCCceEecccCcCcEEEcCCCCceEecccCccccCCC
Q 004521 516 EFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGD 595 (747)
Q Consensus 516 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NIll~~~~~~kl~DFGla~~~~~~ 595 (747)
||+++++|.+++.... ..+++..+..++.|++.||.|||+.+ ++|+||+|+||+++.++.+||+|||++......
T Consensus 95 e~~~~~~L~~~l~~~~--~~l~~~~~~~i~~~i~~~L~~lH~~g---i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~ 169 (286)
T cd06614 95 EYMDGGSLTDIITQNF--VRMNEPQIAYVCREVLQGLEYLHSQN---VIHRDIKSDNILLSKDGSVKLADFGFAAQLTKE 169 (286)
T ss_pred eccCCCcHHHHHHHhc--cCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCChhhEEEcCCCCEEECccchhhhhccc
Confidence 9999999999997643 36899999999999999999999988 999999999999999999999999988755432
Q ss_pred CCccc-----cceeee--ccCCCCCccccchhHHHHHHHHHhCCCCCCCCCCcchhhhhHhHHhcCCcccccchhhhccC
Q 004521 596 ETEGN-----TNRVVG--TYDGQFSIKSDVFSFGILLLEIVSGKKNRGFYRSDTKVNLIGHLWDEGIPLRLIDACIQDSC 668 (747)
Q Consensus 596 ~~~~~-----~~~~~~--~~~~~~s~ksDVwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~ 668 (747)
..... ...... .....++.++|||||||++|||++|+.|+...... ....... ...........
T Consensus 170 ~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~g~~p~~~~~~~---~~~~~~~-~~~~~~~~~~~----- 240 (286)
T cd06614 170 KSKRNSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPPL---RALFLIT-TKGIPPLKNPE----- 240 (286)
T ss_pred hhhhccccCCcccCCHhHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCHH---HHHHHHH-hcCCCCCcchh-----
Confidence 11100 000000 01356789999999999999999999996533221 1111111 11111111110
Q ss_pred CHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 004521 669 NLADVIRCIHIGLLCVQQHPEDRPCMPSVIL 699 (747)
Q Consensus 669 ~~~~~~~~~~l~~~Cl~~dP~~RPt~~~v~~ 699 (747)
.....+.+++.+||+.+|.+||++.+|++
T Consensus 241 --~~~~~l~~li~~~l~~~p~~Rpt~~~il~ 269 (286)
T cd06614 241 --KWSPEFKDFLNKCLVKDPEKRPSAEELLQ 269 (286)
T ss_pred --hCCHHHHHHHHHHhccChhhCcCHHHHhh
Confidence 01123567888999999999999999976
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.1e-31 Score=277.31 Aligned_cols=250 Identities=23% Similarity=0.313 Sum_probs=181.9
Q ss_pred CCccceecccCCeeEEEEEec-CCcEEEEEEecccc--cccHHHHHHHHHHHhccCCCceeeEEeEEEeCCeeEEEEecC
Q 004521 442 FSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKIS--EQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFM 518 (747)
Q Consensus 442 ~~~~~~lg~G~fg~Vy~~~~~-~g~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~ 518 (747)
|++.+.||+|++|.||+|... +|+.||+|++.... ....+.+.+|++++++++||||+++++++.+++..++||||+
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~iv~e~~ 80 (283)
T cd07835 1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVVHSENKLYLVFEFL 80 (283)
T ss_pred CchheEecCCCCeEEEEEEEcCCCCEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhheeccCCeEEEEEecc
Confidence 567789999999999999875 58999999986432 233467889999999999999999999999999999999999
Q ss_pred CCCChhhHhhhcCCCCcCChhHHHHHHHHHHHHHHHhhhcCCCceEecccCcCcEEEcCCCCceEecccCccccCCCCCc
Q 004521 519 PNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETE 598 (747)
Q Consensus 519 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~ 598 (747)
+ ++|.+++..... ..+++..+..++.|+++||+|||+.+ ++||||+|+||+++.++.+||+|||+++.+......
T Consensus 81 ~-~~l~~~~~~~~~-~~~~~~~~~~~~~~i~~~L~~lH~~~---~~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~ 155 (283)
T cd07835 81 D-LDLKKYMDSSPL-TGLDPPLIKSYLYQLLQGIAYCHSHR---VLHRDLKPQNLLIDREGALKLADFGLARAFGVPVRT 155 (283)
T ss_pred C-cCHHHHHhhCCC-CCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCHHHEEEcCCCcEEEeecccccccCCCccc
Confidence 5 689998855332 35899999999999999999999987 999999999999999999999999999765422111
Q ss_pred ccc-----ceeeec---cCCCCCccccchhHHHHHHHHHhCCCCCCCCCCcchhhhhHhHHhc-CCcc------------
Q 004521 599 GNT-----NRVVGT---YDGQFSIKSDVFSFGILLLEIVSGKKNRGFYRSDTKVNLIGHLWDE-GIPL------------ 657 (747)
Q Consensus 599 ~~~-----~~~~~~---~~~~~s~ksDVwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~-~~~~------------ 657 (747)
... ...... ....++.++||||||+++|||++|+.||...... .. ....... +.+.
T Consensus 156 ~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~--~~-~~~~~~~~~~~~~~~~~~~~~~~~ 232 (283)
T cd07835 156 YTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEI--DQ-LFRIFRTLGTPDEDVWPGVTSLPD 232 (283)
T ss_pred cCccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHH--HH-HHHHHHHhCCCChHHhhhhhhchh
Confidence 000 000011 1234688999999999999999999997532211 11 1111000 0000
Q ss_pred ------cccchhhhccCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 004521 658 ------RLIDACIQDSCNLADVIRCIHIGLLCVQQHPEDRPCMPSVILM 700 (747)
Q Consensus 658 ------~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dP~~RPt~~~v~~~ 700 (747)
......... ........+.+++.+|++.+|.+||++.++++.
T Consensus 233 ~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~ 280 (283)
T cd07835 233 YKPTFPKWARQDLSK-VVPNLDEDGLDLLSKMLVYDPAKRISAKAALQH 280 (283)
T ss_pred hhhhcccccccchhh-hcCCCCHHHHHHHHHHhcCChhhCcCHHHHhcC
Confidence 000000000 000011346678889999999999999999753
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.8e-31 Score=270.36 Aligned_cols=242 Identities=25% Similarity=0.401 Sum_probs=187.1
Q ss_pred CCCccceecccCCeeEEEEEec-CCcEEEEEEecccc--cccHHHHHHHHHHHhccCCCceeeEEeEEEeC--CeeEEEE
Q 004521 441 NFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKIS--EQGLKELKNEVILFSKLQHRNLVKLLGCCIQG--EEKLLIY 515 (747)
Q Consensus 441 ~~~~~~~lg~G~fg~Vy~~~~~-~g~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~--~~~~lV~ 515 (747)
+|...+.||+|++|.||+|... +++.|++|.+.... ....+.+.+|+.++++++|+||+++++.+... ...++|+
T Consensus 1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~ 80 (260)
T cd06606 1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIFL 80 (260)
T ss_pred CceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEEE
Confidence 4677899999999999999986 58899999987533 24577899999999999999999999999988 8899999
Q ss_pred ecCCCCChhhHhhhcCCCCcCChhHHHHHHHHHHHHHHHhhhcCCCceEecccCcCcEEEcCCCCceEecccCccccCCC
Q 004521 516 EFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGD 595 (747)
Q Consensus 516 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NIll~~~~~~kl~DFGla~~~~~~ 595 (747)
||+++++|.+++.... .+++..+..++.|+++||+|||+.+ ++|+||+|+||+++.++.+||+|||.+......
T Consensus 81 e~~~~~~L~~~~~~~~---~~~~~~~~~~~~~l~~~l~~lh~~~---~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~ 154 (260)
T cd06606 81 EYVSGGSLSSLLKKFG---KLPEPVIRKYTRQILEGLAYLHSNG---IVHRDIKGANILVDSDGVVKLADFGCAKRLGDI 154 (260)
T ss_pred EecCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEcCCCCEEEcccccEEecccc
Confidence 9999999999986533 6899999999999999999999987 999999999999999999999999998876544
Q ss_pred CCc----c--cc-ceeeec--cCCCCCccccchhHHHHHHHHHhCCCCCCCCCCcchhhhhHhHHhcCCcccccchhhhc
Q 004521 596 ETE----G--NT-NRVVGT--YDGQFSIKSDVFSFGILLLEIVSGKKNRGFYRSDTKVNLIGHLWDEGIPLRLIDACIQD 666 (747)
Q Consensus 596 ~~~----~--~~-~~~~~~--~~~~~s~ksDVwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 666 (747)
... . .. ...... ....++.++||||||+++|||++|..|+.... .................+.+
T Consensus 155 ~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~--~~~~~~~~~~~~~~~~~~~~----- 227 (260)
T cd06606 155 ETGEGTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELG--NPMAALYKIGSSGEPPEIPE----- 227 (260)
T ss_pred cccccccCCCCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC--chHHHHHhccccCCCcCCCc-----
Confidence 321 0 00 000000 13447889999999999999999999975433 11111111111111111111
Q ss_pred cCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 004521 667 SCNLADVIRCIHIGLLCVQQHPEDRPCMPSVIL 699 (747)
Q Consensus 667 ~~~~~~~~~~~~l~~~Cl~~dP~~RPt~~~v~~ 699 (747)
. ....+.+++.+|++.+|.+||++.++++
T Consensus 228 ~----~~~~l~~~i~~~l~~~p~~Rp~~~~ll~ 256 (260)
T cd06606 228 H----LSEEAKDFLRKCLRRDPKKRPTADELLQ 256 (260)
T ss_pred c----cCHHHHHHHHHhCcCChhhCCCHHHHhh
Confidence 1 1234667888999999999999999986
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.1e-31 Score=279.46 Aligned_cols=256 Identities=24% Similarity=0.352 Sum_probs=183.5
Q ss_pred HHhcCCCccceecccCCeeEEEEEecC-CcEEEEEEecccc--cccHHHHHHHHHHHhccCCCceeeEEeEEEeCC----
Q 004521 437 NATDNFSINNKLGEGGFGPVYKGTLVD-GQEIAVKRLSKIS--EQGLKELKNEVILFSKLQHRNLVKLLGCCIQGE---- 509 (747)
Q Consensus 437 ~~~~~~~~~~~lg~G~fg~Vy~~~~~~-g~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~---- 509 (747)
...++|++.+.||+|+||.||+|+... ++.||+|+++... ......+.+|++++++++||||+++++++.+..
T Consensus 4 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~~ 83 (302)
T cd07864 4 RCVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDALD 83 (302)
T ss_pred hhhhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhhh
Confidence 345789999999999999999999864 8899999987532 233457788999999999999999999987655
Q ss_pred ------eeEEEEecCCCCChhhHhhhcCCCCcCChhHHHHHHHHHHHHHHHhhhcCCCceEecccCcCcEEEcCCCCceE
Q 004521 510 ------EKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKI 583 (747)
Q Consensus 510 ------~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NIll~~~~~~kl 583 (747)
..++|+||+++ +|..++... ...+++..+..++.||+.||+|||+.+ |+|+||||+||++++++.+||
T Consensus 84 ~~~~~~~~~lv~e~~~~-~l~~~l~~~--~~~~~~~~~~~i~~qi~~aL~~LH~~~---i~H~dl~p~nili~~~~~~kl 157 (302)
T cd07864 84 FKKDKGAFYLVFEYMDH-DLMGLLESG--LVHFSEDHIKSFMKQLLEGLNYCHKKN---FLHRDIKCSNILLNNKGQIKL 157 (302)
T ss_pred ccccCCcEEEEEcccCc-cHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCcEEe
Confidence 78999999986 677766442 335899999999999999999999988 999999999999999999999
Q ss_pred ecccCccccCCCCCccccc------eeeec-c--CCCCCccccchhHHHHHHHHHhCCCCCCCCCCcchhhhhHhHHhcC
Q 004521 584 SDFGLVRTFGGDETEGNTN------RVVGT-Y--DGQFSIKSDVFSFGILLLEIVSGKKNRGFYRSDTKVNLIGHLWDEG 654 (747)
Q Consensus 584 ~DFGla~~~~~~~~~~~~~------~~~~~-~--~~~~s~ksDVwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~ 654 (747)
+|||++..+.......... ..... . ...++.++|||||||++|||++|+.|+...........+.......
T Consensus 158 ~dfg~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~~~~~~~~~~~~~~~ 237 (302)
T cd07864 158 ADFGLARLYNSEESRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELAQLELISRLCGSP 237 (302)
T ss_pred CcccccccccCCcccccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCC
Confidence 9999998664332111000 00000 1 2346889999999999999999999875332211111111111110
Q ss_pred Cc---cccc--------c------hhhhccCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 004521 655 IP---LRLI--------D------ACIQDSCNLADVIRCIHIGLLCVQQHPEDRPCMPSVIL 699 (747)
Q Consensus 655 ~~---~~~~--------d------~~l~~~~~~~~~~~~~~l~~~Cl~~dP~~RPt~~~v~~ 699 (747)
.. ..+. + ........ .....+.+++.+||+.+|.+||++.+|+.
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~li~~~l~~~P~~Rp~~~~il~ 298 (302)
T cd07864 238 CPAVWPDVIKLPYFNTMKPKKQYRRRLREEFS-FIPTPALDLLDHMLTLDPSKRCTAEEALN 298 (302)
T ss_pred ChhhcccccccccccccccccccccchhhhcC-CCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 00 0000 0 00000000 01234677888999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.2e-30 Score=274.99 Aligned_cols=240 Identities=23% Similarity=0.365 Sum_probs=183.0
Q ss_pred CCccceecccCCeeEEEEEec-CCcEEEEEEecccccccHHHHHHHHHHHhccCCCceeeEEeEEEeCCeeEEEEecCCC
Q 004521 442 FSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMPN 520 (747)
Q Consensus 442 ~~~~~~lg~G~fg~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~ 520 (747)
|...+.||+|++|.||++... +++.+++|++........+.+.+|+.+++.++||||+++++++...+..++|+||+++
T Consensus 21 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~~v~e~~~~ 100 (285)
T cd06648 21 LDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVMEFLEG 100 (285)
T ss_pred hhcceEeccCCCeEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHHcCCCChheEEEEEEcCCeEEEEEeccCC
Confidence 444579999999999999864 5889999998754445566789999999999999999999999999999999999999
Q ss_pred CChhhHhhhcCCCCcCChhHHHHHHHHHHHHHHHhhhcCCCceEecccCcCcEEEcCCCCceEecccCccccCCCCCccc
Q 004521 521 KSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGN 600 (747)
Q Consensus 521 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~ 600 (747)
++|.+++.. ..+++..+..++.|++.||+|||+.+ |+||||+|+||+++.++.+||+|||++...........
T Consensus 101 ~~L~~~~~~----~~~~~~~~~~~~~ql~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~~~~~~~ 173 (285)
T cd06648 101 GALTDIVTH----TRMNEEQIATVCLAVLKALSFLHAQG---VIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVPRRK 173 (285)
T ss_pred CCHHHHHHh----CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCChhhEEEcCCCcEEEcccccchhhccCCcccc
Confidence 999999854 34788999999999999999999988 99999999999999999999999998876543221110
Q ss_pred c-----ceeeec--cCCCCCccccchhHHHHHHHHHhCCCCCCCCCCcchhhhhHhHHhcCCcccccchhhhccCCHHHH
Q 004521 601 T-----NRVVGT--YDGQFSIKSDVFSFGILLLEIVSGKKNRGFYRSDTKVNLIGHLWDEGIPLRLIDACIQDSCNLADV 673 (747)
Q Consensus 601 ~-----~~~~~~--~~~~~s~ksDVwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~ 673 (747)
. ...... ....++.++|||||||++|||++|+.|+.... ......... ......+... . ...
T Consensus 174 ~~~~~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell~g~~p~~~~~---~~~~~~~~~-~~~~~~~~~~---~----~~~ 242 (285)
T cd06648 174 SLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEP---PLQAMKRIR-DNLPPKLKNL---H----KVS 242 (285)
T ss_pred cccCCccccCHHHhcCCCCCCcccHHHHHHHHHHHHhCCCCCcCCC---HHHHHHHHH-hcCCCCCccc---c----cCC
Confidence 0 000000 13567889999999999999999999964321 111222111 1111111110 0 011
Q ss_pred HHHHHHHHhccCCCCCCCCCHHHHHH
Q 004521 674 IRCIHIGLLCVQQHPEDRPCMPSVIL 699 (747)
Q Consensus 674 ~~~~~l~~~Cl~~dP~~RPt~~~v~~ 699 (747)
..+.+++.+||+.+|++||++.++++
T Consensus 243 ~~l~~li~~~l~~~p~~Rpt~~~il~ 268 (285)
T cd06648 243 PRLRSFLDRMLVRDPAQRATAAELLN 268 (285)
T ss_pred HHHHHHHHHHcccChhhCcCHHHHcc
Confidence 34677888999999999999998885
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.7e-31 Score=272.25 Aligned_cols=257 Identities=21% Similarity=0.286 Sum_probs=189.6
Q ss_pred hcCCCccceecccCCeeEEEEEecCCcEEEEEEecccccccHHHHHHHHHHHhc--cCCCceeeEEeEEEeCC----eeE
Q 004521 439 TDNFSINNKLGEGGFGPVYKGTLVDGQEIAVKRLSKISEQGLKELKNEVILFSK--LQHRNLVKLLGCCIQGE----EKL 512 (747)
Q Consensus 439 ~~~~~~~~~lg~G~fg~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~--l~H~niv~l~g~~~~~~----~~~ 512 (747)
.....+.+.||+|.||.||+|.+ .|+.||||++.. .+++.+.+|.+|.+. |+|+||+.|++.-..++ ..+
T Consensus 210 arqI~L~e~IGkGRyGEVwrG~w-rGe~VAVKiF~s---rdE~SWfrEtEIYqTvmLRHENILgFIaaD~~~~gs~TQLw 285 (513)
T KOG2052|consen 210 ARQIVLQEIIGKGRFGEVWRGRW-RGEDVAVKIFSS---RDERSWFRETEIYQTVMLRHENILGFIAADNKDNGSWTQLW 285 (513)
T ss_pred hheeEEEEEecCccccceeeccc-cCCceEEEEecc---cchhhhhhHHHHHHHHHhccchhhhhhhccccCCCceEEEE
Confidence 34677789999999999999998 588999999953 455678888888875 59999999999876654 468
Q ss_pred EEEecCCCCChhhHhhhcCCCCcCChhHHHHHHHHHHHHHHHhhh-----cCCCceEecccCcCcEEEcCCCCceEeccc
Q 004521 513 LIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQ-----DSRLRIIHRDLKASNVLLDQDMNPKISDFG 587 (747)
Q Consensus 513 lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~-----~~~~~iiHrDlkp~NIll~~~~~~kl~DFG 587 (747)
||.+|.++|||.+||.. ..++....++++..+|.||++||. +|++.|.|||||+.|||+..++.+.|+|+|
T Consensus 286 LvTdYHe~GSL~DyL~r----~tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~~C~IADLG 361 (513)
T KOG2052|consen 286 LVTDYHEHGSLYDYLNR----NTVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLG 361 (513)
T ss_pred EeeecccCCcHHHHHhh----ccCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCCcEEEeece
Confidence 99999999999999943 558999999999999999999995 478899999999999999999999999999
Q ss_pred CccccCCCCCc--cccceeeecc--------CCCC-------CccccchhHHHHHHHHHhC----------CCCCCCCC-
Q 004521 588 LVRTFGGDETE--GNTNRVVGTY--------DGQF-------SIKSDVFSFGILLLEIVSG----------KKNRGFYR- 639 (747)
Q Consensus 588 la~~~~~~~~~--~~~~~~~~~~--------~~~~-------s~ksDVwS~Gvvl~elltg----------~~p~~~~~- 639 (747)
||.....+... ......+||- +... -..+||||||.|+||+... ..||....
T Consensus 362 LAv~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~ggi~eey~~Pyyd~Vp 441 (513)
T KOG2052|consen 362 LAVRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGGIVEEYQLPYYDVVP 441 (513)
T ss_pred eeEEecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCEehhhcCCcccCCC
Confidence 99876544221 2222233331 1111 1358999999999999763 23443221
Q ss_pred CcchhhhhHhHHhcCCcccccchhhhccCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhcCCCC
Q 004521 640 SDTKVNLIGHLWDEGIPLRLIDACIQDSCNLADVIRCIHIGLLCVQQHPEDRPCMPSVILMLGSEIL 706 (747)
Q Consensus 640 ~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dP~~RPt~~~v~~~L~~~~~ 706 (747)
.+...+.+....-.......++. ...+-+.+..+.++|..||..+|..|-|+--|-+.|.++..
T Consensus 442 ~DPs~eeMrkVVCv~~~RP~ipn---rW~s~~~l~~m~klMkeCW~~Np~aRltALriKKtl~~l~~ 505 (513)
T KOG2052|consen 442 SDPSFEEMRKVVCVQKLRPNIPN---RWKSDPALRVMAKLMKECWYANPAARLTALRIKKTLAKLSN 505 (513)
T ss_pred CCCCHHHHhcceeecccCCCCCc---ccccCHHHHHHHHHHHHhhcCCchhhhHHHHHHHHHHHHhc
Confidence 12222222211111111111111 12334567778899999999999999999999998887653
|
|
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.3e-31 Score=273.94 Aligned_cols=241 Identities=22% Similarity=0.286 Sum_probs=184.8
Q ss_pred CCCccceecccCCeeEEEEEecC-CcEEEEEEecccc---cccHHHHHHHHHHHhccCCCceeeEEeEEEeCCeeEEEEe
Q 004521 441 NFSINNKLGEGGFGPVYKGTLVD-GQEIAVKRLSKIS---EQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYE 516 (747)
Q Consensus 441 ~~~~~~~lg~G~fg~Vy~~~~~~-g~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E 516 (747)
+|++.+.||.|+||.||+++... ++.+|+|.+.+.. ....+.+.+|++++++++||||+++++++..+...++|+|
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 80 (258)
T cd05578 1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEENMYLVVD 80 (258)
T ss_pred CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCeEEEEEe
Confidence 47888999999999999999864 8899999987532 2456789999999999999999999999999999999999
Q ss_pred cCCCCChhhHhhhcCCCCcCChhHHHHHHHHHHHHHHHhhhcCCCceEecccCcCcEEEcCCCCceEecccCccccCCCC
Q 004521 517 FMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDE 596 (747)
Q Consensus 517 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~ 596 (747)
|+++++|.+++... ..+++..+..++.|+++||.|||+.+ ++|+||+|+||++++++.++|+|||++.......
T Consensus 81 ~~~~~~L~~~l~~~---~~l~~~~~~~~~~~i~~~l~~lh~~~---i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~ 154 (258)
T cd05578 81 LLLGGDLRYHLSQK---VKFSEEQVKFWICEIVLALEYLHSKG---IIHRDIKPDNILLDEQGHVHITDFNIATKVTPDT 154 (258)
T ss_pred CCCCCCHHHHHHhc---CCcCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeEEcCCCCEEEeecccccccCCCc
Confidence 99999999998543 45889999999999999999999988 9999999999999999999999999987664432
Q ss_pred Ccccc----ceeeec--cCCCCCccccchhHHHHHHHHHhCCCCCCCCCCcchhhhhHhHHhcCCcccccchhhhccCCH
Q 004521 597 TEGNT----NRVVGT--YDGQFSIKSDVFSFGILLLEIVSGKKNRGFYRSDTKVNLIGHLWDEGIPLRLIDACIQDSCNL 670 (747)
Q Consensus 597 ~~~~~----~~~~~~--~~~~~s~ksDVwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~ 670 (747)
..... ...... ....++.++||||||+++|+|++|+.|+............ ..... ...... .
T Consensus 155 ~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~-~~~~~-~~~~~~-----~---- 223 (258)
T cd05578 155 LTTSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRTIRDQIR-AKQET-ADVLYP-----A---- 223 (258)
T ss_pred cccccCCChhhcCHHHHcccCCCCcccchhhHHHHHHHHhCCCCCCCCCccHHHHHH-HHhcc-ccccCc-----c----
Confidence 11000 000000 1345788999999999999999999997644332111111 11111 001110 0
Q ss_pred HHHHHHHHHHHhccCCCCCCCCCH--HHHH
Q 004521 671 ADVIRCIHIGLLCVQQHPEDRPCM--PSVI 698 (747)
Q Consensus 671 ~~~~~~~~l~~~Cl~~dP~~RPt~--~~v~ 698 (747)
.....+.+++.+||+.||.+||++ .|++
T Consensus 224 ~~~~~~~~~i~~~l~~~p~~R~~~~~~~l~ 253 (258)
T cd05578 224 TWSTEAIDAINKLLERDPQKRLGDNLKDLK 253 (258)
T ss_pred cCcHHHHHHHHHHccCChhHcCCccHHHHh
Confidence 111446678889999999999999 5543
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.3e-30 Score=268.36 Aligned_cols=244 Identities=29% Similarity=0.424 Sum_probs=188.3
Q ss_pred CCCccceecccCCeeEEEEEec-CCcEEEEEEecccccccHHHHHHHHHHHhccCCCceeeEEeEEEeCCeeEEEEecCC
Q 004521 441 NFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMP 519 (747)
Q Consensus 441 ~~~~~~~lg~G~fg~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~ 519 (747)
+|+..+.||+|++|.||++... +++.+++|++........+.+.+|+.++++++|+||+++++++......++++||++
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l~~e~~~ 80 (253)
T cd05122 1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIVMEFCS 80 (253)
T ss_pred CceeeeeeccCCceEEEEEEECCCCcEEEEEEecccchhHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEecCC
Confidence 4677899999999999999986 588999999987554567889999999999999999999999999999999999999
Q ss_pred CCChhhHhhhcCCCCcCChhHHHHHHHHHHHHHHHhhhcCCCceEecccCcCcEEEcCCCCceEecccCccccCCCCC--
Q 004521 520 NKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDET-- 597 (747)
Q Consensus 520 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~-- 597 (747)
+++|.+++.... ..+++..+..++.|++.||.|||+.+ ++||||+|+||++++++.+||+|||++........
T Consensus 81 ~~~L~~~~~~~~--~~~~~~~~~~i~~~i~~~l~~lh~~~---i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~~ 155 (253)
T cd05122 81 GGSLKDLLKSTN--QTLTESQIAYVCKELLKGLEYLHSNG---IIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKARN 155 (253)
T ss_pred CCcHHHHHhhcC--CCCCHHHHHHHHHHHHHHHHHhhcCC---EecCCCCHHHEEEccCCeEEEeecccccccccccccc
Confidence 999999986532 45899999999999999999999987 99999999999999999999999999887654431
Q ss_pred -ccccceeeec---cCCCCCccccchhHHHHHHHHHhCCCCCCCCCCcchhhhhHhHHhcCCcccccchhhhccCCHHHH
Q 004521 598 -EGNTNRVVGT---YDGQFSIKSDVFSFGILLLEIVSGKKNRGFYRSDTKVNLIGHLWDEGIPLRLIDACIQDSCNLADV 673 (747)
Q Consensus 598 -~~~~~~~~~~---~~~~~s~ksDVwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~ 673 (747)
.........+ ....++.++||||||+++|||++|+.|+...... ..+..... .....+.... .-.
T Consensus 156 ~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~---~~~~~~~~-~~~~~~~~~~-------~~~ 224 (253)
T cd05122 156 TMVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSELPPM---KALFKIAT-NGPPGLRNPE-------KWS 224 (253)
T ss_pred ceecCCcccCHHHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCchH---HHHHHHHh-cCCCCcCccc-------ccC
Confidence 0000000000 1345788999999999999999999996533211 11111111 1111111110 002
Q ss_pred HHHHHHHHhccCCCCCCCCCHHHHHHH
Q 004521 674 IRCIHIGLLCVQQHPEDRPCMPSVILM 700 (747)
Q Consensus 674 ~~~~~l~~~Cl~~dP~~RPt~~~v~~~ 700 (747)
..+.+++.+||+.||++|||+.++++.
T Consensus 225 ~~~~~~i~~~l~~~p~~R~t~~~~l~~ 251 (253)
T cd05122 225 DEFKDFLKKCLQKNPEKRPTAEQLLKH 251 (253)
T ss_pred HHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 336677789999999999999999763
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1e-30 Score=278.87 Aligned_cols=256 Identities=25% Similarity=0.326 Sum_probs=181.7
Q ss_pred hcCCCccceecccCCeeEEEEEecC-CcEEEEEEecccc--cccHHHHHHHHHHHhccCCCceeeEEeEEEeC--CeeEE
Q 004521 439 TDNFSINNKLGEGGFGPVYKGTLVD-GQEIAVKRLSKIS--EQGLKELKNEVILFSKLQHRNLVKLLGCCIQG--EEKLL 513 (747)
Q Consensus 439 ~~~~~~~~~lg~G~fg~Vy~~~~~~-g~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~--~~~~l 513 (747)
.++|++.+.||+|+||.||+|+... |+.||+|.++... ......+.+|+.++++++|+||+++++++... +..++
T Consensus 6 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 85 (309)
T cd07845 6 VTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVGKHLDSIFL 85 (309)
T ss_pred ccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCeEEE
Confidence 4679999999999999999999854 8999999986422 22234567899999999999999999998765 46799
Q ss_pred EEecCCCCChhhHhhhcCCCCcCChhHHHHHHHHHHHHHHHhhhcCCCceEecccCcCcEEEcCCCCceEecccCccccC
Q 004521 514 IYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFG 593 (747)
Q Consensus 514 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NIll~~~~~~kl~DFGla~~~~ 593 (747)
||||+. ++|.+++... ...+++.++..++.||++||+|||+.+ ++||||||+||++++++.+||+|||+++.+.
T Consensus 86 v~e~~~-~~l~~~l~~~--~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~kL~dfg~~~~~~ 159 (309)
T cd07845 86 VMEYCE-QDLASLLDNM--PTPFSESQVKCLMLQLLRGLQYLHENF---IIHRDLKVSNLLLTDKGCLKIADFGLARTYG 159 (309)
T ss_pred EEecCC-CCHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEECccceeeecC
Confidence 999997 5888887543 245899999999999999999999998 9999999999999999999999999998765
Q ss_pred CCCCccccc-----eeeec-c--CCCCCccccchhHHHHHHHHHhCCCCCCCCCCcchhhhhHhHHhcCCcc---cc---
Q 004521 594 GDETEGNTN-----RVVGT-Y--DGQFSIKSDVFSFGILLLEIVSGKKNRGFYRSDTKVNLIGHLWDEGIPL---RL--- 659 (747)
Q Consensus 594 ~~~~~~~~~-----~~~~~-~--~~~~s~ksDVwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~---~~--- 659 (747)
......... ..... . ...++.++|||||||++|||++|+.|+...........+.......... .+
T Consensus 160 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (309)
T cd07845 160 LPAKPMTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQLDLIIQLLGTPNESIWPGFSDL 239 (309)
T ss_pred CccCCCCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChhhchhhhcc
Confidence 432111110 00011 1 2457889999999999999999999975322211111111100000000 00
Q ss_pred --cch-hhhcc--CCH-----HHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 004521 660 --IDA-CIQDS--CNL-----ADVIRCIHIGLLCVQQHPEDRPCMPSVILM 700 (747)
Q Consensus 660 --~d~-~l~~~--~~~-----~~~~~~~~l~~~Cl~~dP~~RPt~~~v~~~ 700 (747)
... .+... ... .....+.+++.+|++.||++|||+.++++.
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il~h 290 (309)
T cd07845 240 PLVGKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALES 290 (309)
T ss_pred cccccccccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcCHHHHhcC
Confidence 000 00000 000 012334568889999999999999999863
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-30 Score=275.93 Aligned_cols=240 Identities=24% Similarity=0.288 Sum_probs=183.9
Q ss_pred cCCCccceecccCCeeEEEEEecC-CcEEEEEEeccc---ccccHHHHHHHHHHHhccCCCceeeEEeEEEeCCeeEEEE
Q 004521 440 DNFSINNKLGEGGFGPVYKGTLVD-GQEIAVKRLSKI---SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIY 515 (747)
Q Consensus 440 ~~~~~~~~lg~G~fg~Vy~~~~~~-g~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 515 (747)
++|++.+.||+|+||.||++.... ++.+|+|.+.+. .....+.+.+|++++++++||||+++++++..+...++||
T Consensus 1 ~~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 80 (290)
T cd05580 1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYLVM 80 (290)
T ss_pred CceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCCeEEEEE
Confidence 468889999999999999999764 899999998652 2234567889999999999999999999999999999999
Q ss_pred ecCCCCChhhHhhhcCCCCcCChhHHHHHHHHHHHHHHHhhhcCCCceEecccCcCcEEEcCCCCceEecccCccccCCC
Q 004521 516 EFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGD 595 (747)
Q Consensus 516 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NIll~~~~~~kl~DFGla~~~~~~ 595 (747)
||+++++|.+++... ..++...+..++.|+++||.|||+.+ ++|+||+|+||+++.++.+||+|||+++.....
T Consensus 81 e~~~~~~L~~~~~~~---~~l~~~~~~~~~~qil~~l~~lH~~~---i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~ 154 (290)
T cd05580 81 EYVPGGELFSHLRKS---GRFPEPVARFYAAQVVLALEYLHSLD---IVYRDLKPENLLLDSDGYIKITDFGFAKRVKGR 154 (290)
T ss_pred ecCCCCCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEECCCCCEEEeeCCCccccCCC
Confidence 999999999998553 45889999999999999999999988 999999999999999999999999999876544
Q ss_pred CCccccc--eeeec--cCCCCCccccchhHHHHHHHHHhCCCCCCCCCCcchhhhhHhHHhcCCcccccchhhhccCCHH
Q 004521 596 ETEGNTN--RVVGT--YDGQFSIKSDVFSFGILLLEIVSGKKNRGFYRSDTKVNLIGHLWDEGIPLRLIDACIQDSCNLA 671 (747)
Q Consensus 596 ~~~~~~~--~~~~~--~~~~~s~ksDVwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~ 671 (747)
....... ..... .....+.++||||||+++|||++|+.|+.... ......... .+.. .+ ....
T Consensus 155 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~---~~~~~~~~~-~~~~-~~-----~~~~--- 221 (290)
T cd05580 155 TYTLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDN---PIQIYEKIL-EGKV-RF-----PSFF--- 221 (290)
T ss_pred CCCCCCCccccChhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCC---HHHHHHHHh-cCCc-cC-----CccC---
Confidence 2211000 00000 13467789999999999999999999965322 111111111 1111 11 1111
Q ss_pred HHHHHHHHHHhccCCCCCCCC-----CHHHHHH
Q 004521 672 DVIRCIHIGLLCVQQHPEDRP-----CMPSVIL 699 (747)
Q Consensus 672 ~~~~~~~l~~~Cl~~dP~~RP-----t~~~v~~ 699 (747)
...+.+++.+||+.+|.+|| ++.++++
T Consensus 222 -~~~l~~li~~~l~~~p~~R~~~~~~~~~~l~~ 253 (290)
T cd05580 222 -SPDAKDLIRNLLQVDLTKRLGNLKNGVNDIKN 253 (290)
T ss_pred -CHHHHHHHHHHccCCHHHccCcccCCHHHHHc
Confidence 13455677899999999999 6666653
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.2e-31 Score=268.80 Aligned_cols=255 Identities=25% Similarity=0.370 Sum_probs=199.6
Q ss_pred HHHHHHhcCCCccceecccCCeeEEEEEec------CCcEEEEEEecc-cccccHHHHHHHHHHHhccCCCceeeEEeEE
Q 004521 433 ATIANATDNFSINNKLGEGGFGPVYKGTLV------DGQEIAVKRLSK-ISEQGLKELKNEVILFSKLQHRNLVKLLGCC 505 (747)
Q Consensus 433 ~~~~~~~~~~~~~~~lg~G~fg~Vy~~~~~------~g~~vavK~l~~-~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~ 505 (747)
+++.....+++....+-+|.||.||+|.+. +.+.|-||.++. .++-....|..|.-++..+.|||+.++.+++
T Consensus 277 ~~l~v~r~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~AS~iQv~~~L~es~lly~~sH~nll~V~~V~ 356 (563)
T KOG1024|consen 277 QELTVQRCRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHASQIQVNLLLQESMLLYGASHPNLLSVLGVS 356 (563)
T ss_pred HhhhhhhhheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhcccHHHHHHHHHHHHHHhcCcCCCccceeEEE
Confidence 344455567888889999999999999654 345788888875 3445567788999999999999999999999
Q ss_pred EeC-CeeEEEEecCCCCChhhHhh-----hcCCCCcCChhHHHHHHHHHHHHHHHhhhcCCCceEecccCcCcEEEcCCC
Q 004521 506 IQG-EEKLLIYEFMPNKSLDSFIF-----DQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDM 579 (747)
Q Consensus 506 ~~~-~~~~lV~E~~~~gsL~~~l~-----~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NIll~~~~ 579 (747)
.+. ...+++|.++.-|+|..||. +......+...+...++.|++.||+|||.++ +||.||.++|++||+..
T Consensus 357 ie~~~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~~---ViHkDiAaRNCvIdd~L 433 (563)
T KOG1024|consen 357 IEDYATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNHG---VIHKDIAARNCVIDDQL 433 (563)
T ss_pred eeccCcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhcC---cccchhhhhcceehhhe
Confidence 875 45688899999999999997 4344455777888899999999999999998 99999999999999999
Q ss_pred CceEecccCccccCCCCCcccc---ceee------eccCCCCCccccchhHHHHHHHHHh-CCCCCCCCCCcchhhhhHh
Q 004521 580 NPKISDFGLVRTFGGDETEGNT---NRVV------GTYDGQFSIKSDVFSFGILLLEIVS-GKKNRGFYRSDTKVNLIGH 649 (747)
Q Consensus 580 ~~kl~DFGla~~~~~~~~~~~~---~~~~------~~~~~~~s~ksDVwS~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~ 649 (747)
++||+|=.++|.+-+.++.... .++. .-.+..|+.++|||||||+||||+| |+.|+... +.....+
T Consensus 434 qVkltDsaLSRDLFP~DYhcLGDnEnRPvkWMslEal~n~~yssasDvWsfGVllWELmtlg~~PyaeI----DPfEm~~ 509 (563)
T KOG1024|consen 434 QVKLTDSALSRDLFPGDYHCLGDNENRPVKWMSLEALQNSHYSSASDVWSFGVLLWELMTLGKLPYAEI----DPFEMEH 509 (563)
T ss_pred eEEeccchhccccCcccccccCCCCCCcccccCHHHHhhhhhcchhhhHHHHHHHHHHHhcCCCCcccc----CHHHHHH
Confidence 9999999999987554443111 1111 1126789999999999999999999 88885422 2233444
Q ss_pred HHhcCCcccccchhhhccCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhcC
Q 004521 650 LWDEGIPLRLIDACIQDSCNLADVIRCIHIGLLCVQQHPEDRPCMPSVILMLGS 703 (747)
Q Consensus 650 ~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dP~~RPt~~~v~~~L~~ 703 (747)
..++|.+...+-. ...+++.+|.-||...|++||++++++.-|..
T Consensus 510 ylkdGyRlaQP~N---------CPDeLf~vMacCWallpeeRPsf~Qlv~cLse 554 (563)
T KOG1024|consen 510 YLKDGYRLAQPFN---------CPDELFTVMACCWALLPEERPSFSQLVICLSE 554 (563)
T ss_pred HHhccceecCCCC---------CcHHHHHHHHHHHhcCcccCCCHHHHHHHHHH
Confidence 4566665443332 23458889999999999999999999998865
|
|
| >KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.5e-32 Score=285.73 Aligned_cols=241 Identities=26% Similarity=0.383 Sum_probs=187.8
Q ss_pred CCCccceecccCCeeEEEEEecC-CcEEEEEEeccccc---ccHHHHHHHHHHHhccCCCceeeEEeEEEeCCeeEEEEe
Q 004521 441 NFSINNKLGEGGFGPVYKGTLVD-GQEIAVKRLSKISE---QGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYE 516 (747)
Q Consensus 441 ~~~~~~~lg~G~fg~Vy~~~~~~-g~~vavK~l~~~~~---~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E 516 (747)
.|...+.||.|+||.||-|+... .+.||||++.-... +....+..|+..|.+++|||+|.+-||+......+||||
T Consensus 27 lf~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~TaWLVME 106 (948)
T KOG0577|consen 27 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHTAWLVME 106 (948)
T ss_pred HHHHHHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeeccchHHHHHH
Confidence 46667899999999999999754 77899999975333 335678999999999999999999999999999999999
Q ss_pred cCCCCChhhHhhhcCCCCcCChhHHHHHHHHHHHHHHHhhhcCCCceEecccCcCcEEEcCCCCceEecccCccccCCCC
Q 004521 517 FMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDE 596 (747)
Q Consensus 517 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~ 596 (747)
||- ||-.++|.-+ ++++.+.++..|..+.+.||+|||+++ .||||||+-||||++.|.|||+|||.|....+..
T Consensus 107 YCl-GSAsDlleVh--kKplqEvEIAAi~~gaL~gLaYLHS~~---~IHRDiKAGNILLse~g~VKLaDFGSAsi~~PAn 180 (948)
T KOG0577|consen 107 YCL-GSASDLLEVH--KKPLQEVEIAAITHGALQGLAYLHSHN---RIHRDIKAGNILLSEPGLVKLADFGSASIMAPAN 180 (948)
T ss_pred HHh-ccHHHHHHHH--hccchHHHHHHHHHHHHHHHHHHHHhh---HHhhhccccceEecCCCeeeeccccchhhcCchh
Confidence 995 7777777543 356889999999999999999999998 9999999999999999999999999998776655
Q ss_pred Cccccceeeec------cCCCCCccccchhHHHHHHHHHhCCCCCCCCCCcchhhhhHhHHhcCCcccccchhhhccCCH
Q 004521 597 TEGNTNRVVGT------YDGQFSIKSDVFSFGILLLEIVSGKKNRGFYRSDTKVNLIGHLWDEGIPLRLIDACIQDSCNL 670 (747)
Q Consensus 597 ~~~~~~~~~~~------~~~~~s~ksDVwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~ 670 (747)
+...+++...+ -.+.|+-|+||||+||+..||.-.++|.- .......+-++..+..+ . +. ..
T Consensus 181 sFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlF---nMNAMSALYHIAQNesP-t-----Lq---s~ 248 (948)
T KOG0577|consen 181 SFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLF---NMNAMSALYHIAQNESP-T-----LQ---SN 248 (948)
T ss_pred cccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCcc---CchHHHHHHHHHhcCCC-C-----CC---Cc
Confidence 54444433332 27899999999999999999999999842 22222222222222211 1 11 11
Q ss_pred HHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 004521 671 ADVIRCIHIGLLCVQQHPEDRPCMPSVIL 699 (747)
Q Consensus 671 ~~~~~~~~l~~~Cl~~dP~~RPt~~~v~~ 699 (747)
+--.....++-.||+.-|.+|||..++++
T Consensus 249 eWS~~F~~Fvd~CLqKipqeRptse~ll~ 277 (948)
T KOG0577|consen 249 EWSDYFRNFVDSCLQKIPQERPTSEELLK 277 (948)
T ss_pred hhHHHHHHHHHHHHhhCcccCCcHHHHhh
Confidence 12223446667899999999999988864
|
|
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1e-30 Score=270.73 Aligned_cols=243 Identities=22% Similarity=0.349 Sum_probs=184.6
Q ss_pred CCCccceecccCCeeEEEEEecC-CcEEEEEEeccc--ccccHHHHHHHHHHHhccCCCceeeEEeEEEeCCeeEEEEec
Q 004521 441 NFSINNKLGEGGFGPVYKGTLVD-GQEIAVKRLSKI--SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEF 517 (747)
Q Consensus 441 ~~~~~~~lg~G~fg~Vy~~~~~~-g~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~ 517 (747)
+|++.+.||+|+||.||+|.... |..+|+|.+... .....+.+.+|+.++++++|+||+++++.+......++|+||
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~ 80 (257)
T cd08225 1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASFQENGRLFIVMEY 80 (257)
T ss_pred CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhheeccCCeEEEEEec
Confidence 47788999999999999999865 889999998652 223456788999999999999999999999999999999999
Q ss_pred CCCCChhhHhhhcCCCCcCChhHHHHHHHHHHHHHHHhhhcCCCceEecccCcCcEEEcCCC-CceEecccCccccCCCC
Q 004521 518 MPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDM-NPKISDFGLVRTFGGDE 596 (747)
Q Consensus 518 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NIll~~~~-~~kl~DFGla~~~~~~~ 596 (747)
+++++|.+++.... ...+++..+..++.|+++||.|||+.+ ++|+||||+||++++++ .+||+|||.+.......
T Consensus 81 ~~~~~L~~~~~~~~-~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~ 156 (257)
T cd08225 81 CDGGDLMKRINRQR-GVLFSEDQILSWFVQISLGLKHIHDRK---ILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSM 156 (257)
T ss_pred CCCCcHHHHHHhcc-CCCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCCHHHEEEcCCCCeEEecccccchhccCCc
Confidence 99999999986532 235789999999999999999999988 99999999999999886 46999999988764332
Q ss_pred Ccccc-----ceeeec--cCCCCCccccchhHHHHHHHHHhCCCCCCCCCCcchhhhhHhHHhcCCcccccchhhhccCC
Q 004521 597 TEGNT-----NRVVGT--YDGQFSIKSDVFSFGILLLEIVSGKKNRGFYRSDTKVNLIGHLWDEGIPLRLIDACIQDSCN 669 (747)
Q Consensus 597 ~~~~~-----~~~~~~--~~~~~s~ksDVwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~ 669 (747)
..... ...... ....++.++|||||||++|||++|..|+.... .......... +...... ...
T Consensus 157 ~~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~---~~~~~~~~~~-~~~~~~~-----~~~- 226 (257)
T cd08225 157 ELAYTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGNN---LHQLVLKICQ-GYFAPIS-----PNF- 226 (257)
T ss_pred ccccccCCCccccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCcc---HHHHHHHHhc-ccCCCCC-----CCC-
Confidence 11110 000000 13567889999999999999999999964321 1111211111 1111110 111
Q ss_pred HHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 004521 670 LADVIRCIHIGLLCVQQHPEDRPCMPSVILM 700 (747)
Q Consensus 670 ~~~~~~~~~l~~~Cl~~dP~~RPt~~~v~~~ 700 (747)
...+.+++.+||+.+|++|||+.+|++.
T Consensus 227 ---~~~~~~~i~~~l~~~p~~Rpt~~~ll~~ 254 (257)
T cd08225 227 ---SRDLRSLISQLFKVSPRDRPSITSILKR 254 (257)
T ss_pred ---CHHHHHHHHHHhccChhhCcCHHHHhhC
Confidence 1236677889999999999999999763
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.5e-31 Score=275.29 Aligned_cols=252 Identities=19% Similarity=0.231 Sum_probs=178.7
Q ss_pred CCccceecccCCeeEEEEEec-CCcEEEEEEecccc-cccHHHHHHHHHHHhccC-CCceeeEEeEEEeC--CeeEEEEe
Q 004521 442 FSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKIS-EQGLKELKNEVILFSKLQ-HRNLVKLLGCCIQG--EEKLLIYE 516 (747)
Q Consensus 442 ~~~~~~lg~G~fg~Vy~~~~~-~g~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~-H~niv~l~g~~~~~--~~~~lV~E 516 (747)
|++.++||+|+||.||+|+.. +++.+|+|+++... ........+|+.++.++. |+||+++++++.+. +..++|||
T Consensus 1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~e 80 (282)
T cd07831 1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALVFE 80 (282)
T ss_pred CceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCchhhhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEEEe
Confidence 567889999999999999975 48899999987532 222334557889999885 99999999999987 88999999
Q ss_pred cCCCCChhhHhhhcCCCCcCChhHHHHHHHHHHHHHHHhhhcCCCceEecccCcCcEEEcCCCCceEecccCccccCCCC
Q 004521 517 FMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDE 596 (747)
Q Consensus 517 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~ 596 (747)
|++ ++|.+++... ...+++.++..++.|++.||+|||+.+ ++||||||+||+++. +.+||+|||+++.+....
T Consensus 81 ~~~-~~l~~~l~~~--~~~~~~~~~~~~~~qi~~~L~~LH~~~---i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~~~~ 153 (282)
T cd07831 81 LMD-MNLYELIKGR--KRPLPEKRVKSYMYQLLKSLDHMHRNG---IFHRDIKPENILIKD-DILKLADFGSCRGIYSKP 153 (282)
T ss_pred cCC-ccHHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecccCHHHEEEcC-CCeEEEecccccccccCC
Confidence 997 5888887543 245899999999999999999999988 999999999999999 999999999998764322
Q ss_pred Cccc---c-ceeeec---cCCCCCccccchhHHHHHHHHHhCCCCCCCCCCcchhhhhHhHHh-----------cCCccc
Q 004521 597 TEGN---T-NRVVGT---YDGQFSIKSDVFSFGILLLEIVSGKKNRGFYRSDTKVNLIGHLWD-----------EGIPLR 658 (747)
Q Consensus 597 ~~~~---~-~~~~~~---~~~~~s~ksDVwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~-----------~~~~~~ 658 (747)
.... . ...... ....++.++|||||||++|||++|..|+...........+..... ......
T Consensus 154 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (282)
T cd07831 154 PYTEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELDQIAKIHDVLGTPDAEVLKKFRKSRHMN 233 (282)
T ss_pred CcCCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCHHHHHHHHHHHcCCCCHHHHHhhccccccc
Confidence 2110 0 000111 134568899999999999999999999754322111111100000 000000
Q ss_pred ccchhhhc----cCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 004521 659 LIDACIQD----SCNLADVIRCIHIGLLCVQQHPEDRPCMPSVILM 700 (747)
Q Consensus 659 ~~d~~l~~----~~~~~~~~~~~~l~~~Cl~~dP~~RPt~~~v~~~ 700 (747)
...+.... .........+.+++.+||+.+|++||++.++++.
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~ 279 (282)
T cd07831 234 YNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALRH 279 (282)
T ss_pred ccCcccccccHHHHcccccHHHHHHHHHHhccCcccccCHHHHhhC
Confidence 00000000 0000113457788899999999999999999763
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.4e-31 Score=279.75 Aligned_cols=255 Identities=20% Similarity=0.301 Sum_probs=180.7
Q ss_pred hcCCCccceecccCCeeEEEEEec-CCcEEEEEEeccc--ccccHHHHHHHHHHHhccCCCceeeEEeEEEeCCe-----
Q 004521 439 TDNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKI--SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEE----- 510 (747)
Q Consensus 439 ~~~~~~~~~lg~G~fg~Vy~~~~~-~g~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~----- 510 (747)
.++|++.++||+|+||.||+|+.. +++.||||.+... .......+.+|+.++++++||||+++++++...+.
T Consensus 11 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 90 (310)
T cd07865 11 VSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPYNRY 90 (310)
T ss_pred hhheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEecccccccCC
Confidence 457999999999999999999975 4889999998642 22234456789999999999999999999876543
Q ss_pred ---eEEEEecCCCCChhhHhhhcCCCCcCChhHHHHHHHHHHHHHHHhhhcCCCceEecccCcCcEEEcCCCCceEeccc
Q 004521 511 ---KLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFG 587 (747)
Q Consensus 511 ---~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NIll~~~~~~kl~DFG 587 (747)
.++||||+. ++|.+++... ...+++.++..++.||++||.|||+++ ++|+||||+||+++.++.+||+|||
T Consensus 91 ~~~~~lv~e~~~-~~l~~~l~~~--~~~~~~~~~~~i~~qi~~al~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg 164 (310)
T cd07865 91 KGSFYLVFEFCE-HDLAGLLSNK--NVKFTLSEIKKVMKMLLNGLYYIHRNK---ILHRDMKAANILITKDGILKLADFG 164 (310)
T ss_pred CceEEEEEcCCC-cCHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEECCCCcEEECcCC
Confidence 499999997 5788777442 235899999999999999999999988 9999999999999999999999999
Q ss_pred CccccCCCCCccc---------cceeeec---cCCCCCccccchhHHHHHHHHHhCCCCCCCCCCcchhhhhHhHHhcCC
Q 004521 588 LVRTFGGDETEGN---------TNRVVGT---YDGQFSIKSDVFSFGILLLEIVSGKKNRGFYRSDTKVNLIGHLWDEGI 655 (747)
Q Consensus 588 la~~~~~~~~~~~---------~~~~~~~---~~~~~s~ksDVwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~ 655 (747)
++..+........ ....... ....++.++||||||+++|||++|+.|+...........+...... .
T Consensus 165 ~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~~~~~~~~~~~~~~-~ 243 (310)
T cd07865 165 LARAFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLTLISQLCGS-I 243 (310)
T ss_pred CcccccCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCC-C
Confidence 9986643221100 0000011 0234678999999999999999999987543322211122211100 0
Q ss_pred cccc---------cch-hhhcc---------CCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 004521 656 PLRL---------IDA-CIQDS---------CNLADVIRCIHIGLLCVQQHPEDRPCMPSVILM 700 (747)
Q Consensus 656 ~~~~---------~d~-~l~~~---------~~~~~~~~~~~l~~~Cl~~dP~~RPt~~~v~~~ 700 (747)
...+ .+. ..... ........+.+++.+||+.||.+||++.++++.
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~t~~e~l~h 307 (310)
T cd07865 244 TPEVWPGVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTALNH 307 (310)
T ss_pred ChhhcccccchhhhhhccCCCccchhhHHhcccccCCHHHHHHHHHHhcCChhhccCHHHHhcC
Confidence 0000 000 00000 000011245678899999999999999999753
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-30 Score=276.49 Aligned_cols=251 Identities=22% Similarity=0.292 Sum_probs=179.9
Q ss_pred cCCCccceecccCCeeEEEEEec-CCcEEEEEEecccc--cccHHHHHHHHHHHhccCCCceeeEEeEEEeCCeeEEEEe
Q 004521 440 DNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKIS--EQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYE 516 (747)
Q Consensus 440 ~~~~~~~~lg~G~fg~Vy~~~~~-~g~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E 516 (747)
++|++.+.||+|++|.||+|+.. +++.||+|.+.... ....+.+.+|++++++++|+||+++++++......++|||
T Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 81 (294)
T PLN00009 2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKRLYLVFE 81 (294)
T ss_pred CceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEEecCCeEEEEEe
Confidence 47888999999999999999975 58899999986532 2334678899999999999999999999999999999999
Q ss_pred cCCCCChhhHhhhcCCCCcCChhHHHHHHHHHHHHHHHhhhcCCCceEecccCcCcEEEcC-CCCceEecccCccccCCC
Q 004521 517 FMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQ-DMNPKISDFGLVRTFGGD 595 (747)
Q Consensus 517 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NIll~~-~~~~kl~DFGla~~~~~~ 595 (747)
|++ ++|.+++.... ...+++..+..++.||+.||+|||+.+ ++||||+|+||+++. ++.+||+|||+++.....
T Consensus 82 ~~~-~~l~~~~~~~~-~~~~~~~~~~~~~~qi~~aL~~LH~~~---i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~~~ 156 (294)
T PLN00009 82 YLD-LDLKKHMDSSP-DFAKNPRLIKTYLYQILRGIAYCHSHR---VLHRDLKPQNLLIDRRTNALKLADFGLARAFGIP 156 (294)
T ss_pred ccc-ccHHHHHHhCC-CCCcCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCcceEEEECCCCEEEEcccccccccCCC
Confidence 996 57877774422 223577888899999999999999988 999999999999985 567899999999765432
Q ss_pred CCcccc-----ceeeec-c--CCCCCccccchhHHHHHHHHHhCCCCCCCCCCcchhhhhHhHHh-cCCc-cc-------
Q 004521 596 ETEGNT-----NRVVGT-Y--DGQFSIKSDVFSFGILLLEIVSGKKNRGFYRSDTKVNLIGHLWD-EGIP-LR------- 658 (747)
Q Consensus 596 ~~~~~~-----~~~~~~-~--~~~~s~ksDVwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~-~~~~-~~------- 658 (747)
...... ...... . ...++.++|||||||++|||++|+.|+...... ..+..... .+.. ..
T Consensus 157 ~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~ 233 (294)
T PLN00009 157 VRTFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEI---DELFKIFRILGTPNEETWPGVTS 233 (294)
T ss_pred ccccccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHH---HHHHHHHHHhCCCChhhcccccc
Confidence 111100 000011 1 235788999999999999999999997532211 11111100 0000 00
Q ss_pred c----------cchhhhccCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 004521 659 L----------IDACIQDSCNLADVIRCIHIGLLCVQQHPEDRPCMPSVIL 699 (747)
Q Consensus 659 ~----------~d~~l~~~~~~~~~~~~~~l~~~Cl~~dP~~RPt~~~v~~ 699 (747)
+ ....... ........+.+++.+|++.+|++||++.++++
T Consensus 234 ~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~ 283 (294)
T PLN00009 234 LPDYKSAFPKWPPKDLAT-VVPTLEPAGVDLLSKMLRLDPSKRITARAALE 283 (294)
T ss_pred chhhhhhcccCCCCCHHH-hCcCCChHHHHHHHHHccCChhhCcCHHHHhc
Confidence 0 0000000 00011233567888999999999999999986
|
|
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.4e-31 Score=276.92 Aligned_cols=248 Identities=25% Similarity=0.354 Sum_probs=179.2
Q ss_pred CCCccceecccCCeeEEEEEecC-CcEEEEEEecccc-cccHHHHHHHHHHHhccC-CCceeeEEeEEEeCCeeEEEEec
Q 004521 441 NFSINNKLGEGGFGPVYKGTLVD-GQEIAVKRLSKIS-EQGLKELKNEVILFSKLQ-HRNLVKLLGCCIQGEEKLLIYEF 517 (747)
Q Consensus 441 ~~~~~~~lg~G~fg~Vy~~~~~~-g~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~-H~niv~l~g~~~~~~~~~lV~E~ 517 (747)
+|...+.||+|+||.||+++... ++.+|+|.+.... ......+.+|+.++.++. |+||+++++++..+...+++|||
T Consensus 5 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~~~e~ 84 (288)
T cd06616 5 DLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWICMEL 84 (288)
T ss_pred HhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccChHHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEEEEec
Confidence 45567899999999999999754 8899999987532 344567899999999996 99999999999999999999999
Q ss_pred CCCCChhhHhhh--cCCCCcCChhHHHHHHHHHHHHHHHhhhc-CCCceEecccCcCcEEEcCCCCceEecccCccccCC
Q 004521 518 MPNKSLDSFIFD--QTRRTLLDWSQRFHIICGTARGLLYLHQD-SRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGG 594 (747)
Q Consensus 518 ~~~gsL~~~l~~--~~~~~~l~~~~~~~i~~~ia~gl~yLH~~-~~~~iiHrDlkp~NIll~~~~~~kl~DFGla~~~~~ 594 (747)
+. ++|.++... ......+++..+..++.+++.||+|||+. + ++||||||+||+++.++.+||+|||+++.+..
T Consensus 85 ~~-~~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~---i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~ 160 (288)
T cd06616 85 MD-ISLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEELK---IIHRDVKPSNILLDRNGNIKLCDFGISGQLVD 160 (288)
T ss_pred cc-CCHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhcCC---eeccCCCHHHEEEccCCcEEEeecchhHHhcc
Confidence 86 455544321 11234589999999999999999999975 5 99999999999999999999999999976543
Q ss_pred CCCcc----ccceeeec-c-C---CCCCccccchhHHHHHHHHHhCCCCCCCCCCcchhhhhHhHHhcCCcccccchhhh
Q 004521 595 DETEG----NTNRVVGT-Y-D---GQFSIKSDVFSFGILLLEIVSGKKNRGFYRSDTKVNLIGHLWDEGIPLRLIDACIQ 665 (747)
Q Consensus 595 ~~~~~----~~~~~~~~-~-~---~~~s~ksDVwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 665 (747)
..... ......+. . . ..++.++|||||||++|||++|+.|+..... ....+.... .+....+ .
T Consensus 161 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~--~~~~~~~~~-~~~~~~~-----~ 232 (288)
T cd06616 161 SIAKTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWNS--VFDQLTQVV-KGDPPIL-----S 232 (288)
T ss_pred CCccccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcch--HHHHHhhhc-CCCCCcC-----C
Confidence 22110 00000000 1 1 3688999999999999999999999754321 111111111 1111111 1
Q ss_pred ccCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 004521 666 DSCNLADVIRCIHIGLLCVQQHPEDRPCMPSVILM 700 (747)
Q Consensus 666 ~~~~~~~~~~~~~l~~~Cl~~dP~~RPt~~~v~~~ 700 (747)
..........+.+++.+||+.+|++||++.+|++.
T Consensus 233 ~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~i~~~ 267 (288)
T cd06616 233 NSEEREFSPSFVNFINLCLIKDESKRPKYKELLEH 267 (288)
T ss_pred CcCCCccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 11111122346678889999999999999999864
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.3e-30 Score=283.43 Aligned_cols=191 Identities=27% Similarity=0.362 Sum_probs=154.5
Q ss_pred HhcCCCccceecccCCeeEEEEEec-CCcEEEEEEeccc--ccccHHHHHHHHHHHhccCCCceeeEEeEEEeC------
Q 004521 438 ATDNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKI--SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQG------ 508 (747)
Q Consensus 438 ~~~~~~~~~~lg~G~fg~Vy~~~~~-~g~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~------ 508 (747)
..++|++.+.||+|+||.||+|+.. +++.||||.+.+. .....+.+.+|+.++++++|+||+++++++...
T Consensus 14 ~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 93 (353)
T cd07850 14 VLKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEEF 93 (353)
T ss_pred hhcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCcccc
Confidence 3468999999999999999999975 5899999998642 233445778899999999999999999998644
Q ss_pred CeeEEEEecCCCCChhhHhhhcCCCCcCChhHHHHHHHHHHHHHHHhhhcCCCceEecccCcCcEEEcCCCCceEecccC
Q 004521 509 EEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGL 588 (747)
Q Consensus 509 ~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NIll~~~~~~kl~DFGl 588 (747)
...++||||+. ++|.+.+.. .++...+..++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||+
T Consensus 94 ~~~~lv~e~~~-~~l~~~~~~-----~l~~~~~~~~~~ql~~aL~~LH~~g---i~H~dlkp~Nil~~~~~~~kL~Dfg~ 164 (353)
T cd07850 94 QDVYLVMELMD-ANLCQVIQM-----DLDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGL 164 (353)
T ss_pred CcEEEEEeccC-CCHHHHHhh-----cCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEECCCCCEEEccCcc
Confidence 34699999996 588877742 1788899999999999999999988 99999999999999999999999999
Q ss_pred ccccCCCCCccc---cceeee---ccCCCCCccccchhHHHHHHHHHhCCCCCCC
Q 004521 589 VRTFGGDETEGN---TNRVVG---TYDGQFSIKSDVFSFGILLLEIVSGKKNRGF 637 (747)
Q Consensus 589 a~~~~~~~~~~~---~~~~~~---~~~~~~s~ksDVwS~Gvvl~elltg~~p~~~ 637 (747)
++.......... ...... ..+..++.++|||||||++|||++|+.||..
T Consensus 165 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~ 219 (353)
T cd07850 165 ARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPG 219 (353)
T ss_pred ceeCCCCCCCCCCcccccccCHHHHhCCCCCCchhhHhHHHHHHHHHHCCCCCCC
Confidence 987643321100 000000 1245688999999999999999999999753
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >KOG0584 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.4e-31 Score=287.07 Aligned_cols=241 Identities=23% Similarity=0.394 Sum_probs=184.5
Q ss_pred CccceecccCCeeEEEEEecC-CcEEEEEEec--c--cccccHHHHHHHHHHHhccCCCceeeEEeEEEeCCe--eEEEE
Q 004521 443 SINNKLGEGGFGPVYKGTLVD-GQEIAVKRLS--K--ISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEE--KLLIY 515 (747)
Q Consensus 443 ~~~~~lg~G~fg~Vy~~~~~~-g~~vavK~l~--~--~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~--~~lV~ 515 (747)
+...+||+|+|-+||+|.+.. |-+||=-.++ . ......+.|..|+.+|+.|+|||||+++.+..+... ..+|+
T Consensus 43 k~~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~in~iT 122 (632)
T KOG0584|consen 43 KFDEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKTINFIT 122 (632)
T ss_pred ehhhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCceeeeee
Confidence 335789999999999998754 6666532222 1 234556889999999999999999999999987765 67899
Q ss_pred ecCCCCChhhHhhhcCCCCcCChhHHHHHHHHHHHHHHHhhhcCCCceEecccCcCcEEEcCC-CCceEecccCccccCC
Q 004521 516 EFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQD-MNPKISDFGLVRTFGG 594 (747)
Q Consensus 516 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NIll~~~-~~~kl~DFGla~~~~~ 594 (747)
|.+..|+|..|+.+..+ ++...+.++++||++||.|||++. ++|||||||-+||+|+.+ |.|||+|+|||..+..
T Consensus 123 EL~TSGtLr~Y~kk~~~---vn~kaik~W~RQILkGL~yLHs~~-PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl~r~ 198 (632)
T KOG0584|consen 123 ELFTSGTLREYRKKHRR---VNIKAIKSWCRQILKGLVYLHSQD-PPIIHRDLKCDNIFVNGNLGEVKIGDLGLATLLRK 198 (632)
T ss_pred ecccCCcHHHHHHHhcc---CCHHHHHHHHHHHHHHhhhhhcCC-CCccccccccceEEEcCCcCceeecchhHHHHhhc
Confidence 99999999999976543 777889999999999999999986 789999999999999865 8999999999998765
Q ss_pred CCCccccceeeec--------cCCCCCccccchhHHHHHHHHHhCCCCCCCCCCcchhhhhHhHHhcCCcccccchhhhc
Q 004521 595 DETEGNTNRVVGT--------YDGQFSIKSDVFSFGILLLEIVSGKKNRGFYRSDTKVNLIGHLWDEGIPLRLIDACIQD 666 (747)
Q Consensus 595 ~~~~~~~~~~~~~--------~~~~~s~ksDVwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 666 (747)
..... +.|| |...|++.+||||||+.++||+|+..|+.... .....+. ....|..+.-+...
T Consensus 199 s~aks----vIGTPEFMAPEmYEE~YnE~VDVYaFGMCmLEMvT~eYPYsEC~--n~AQIYK-KV~SGiKP~sl~kV--- 268 (632)
T KOG0584|consen 199 SHAKS----VIGTPEFMAPEMYEENYNELVDVYAFGMCMLEMVTSEYPYSECT--NPAQIYK-KVTSGIKPAALSKV--- 268 (632)
T ss_pred cccce----eccCccccChHHHhhhcchhhhhhhhhHHHHHHHhccCChhhhC--CHHHHHH-HHHcCCCHHHhhcc---
Confidence 54332 3444 46889999999999999999999999964322 1222222 23333332211111
Q ss_pred cCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH--HhcC
Q 004521 667 SCNLADVIRCIHIGLLCVQQHPEDRPCMPSVIL--MLGS 703 (747)
Q Consensus 667 ~~~~~~~~~~~~l~~~Cl~~dP~~RPt~~~v~~--~L~~ 703 (747)
. ..++.+|+.+|+.. ..+|||+.|+++ +|..
T Consensus 269 -~----dPevr~fIekCl~~-~~~R~sa~eLL~d~Ff~~ 301 (632)
T KOG0584|consen 269 -K----DPEVREFIEKCLAT-KSERLSAKELLKDPFFDE 301 (632)
T ss_pred -C----CHHHHHHHHHHhcC-chhccCHHHHhhChhhcc
Confidence 1 12355677799999 999999999986 5554
|
|
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.7e-30 Score=271.11 Aligned_cols=238 Identities=24% Similarity=0.317 Sum_probs=176.2
Q ss_pred ecccCCeeEEEEEec-CCcEEEEEEeccc---ccccHHHHHHHHHHHhccCCCceeeEEeEEEeCCeeEEEEecCCCCCh
Q 004521 448 LGEGGFGPVYKGTLV-DGQEIAVKRLSKI---SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMPNKSL 523 (747)
Q Consensus 448 lg~G~fg~Vy~~~~~-~g~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gsL 523 (747)
||+|+||+||++... +|+.+|+|.+... .....+.+.+|++++++++||||+++++.+...+..++||||+++++|
T Consensus 1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (277)
T cd05577 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDL 80 (277)
T ss_pred CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecCCCCcH
Confidence 699999999999865 4889999998642 123355678899999999999999999999999999999999999999
Q ss_pred hhHhhhcCCCCcCChhHHHHHHHHHHHHHHHhhhcCCCceEecccCcCcEEEcCCCCceEecccCccccCCCCCcccc--
Q 004521 524 DSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNT-- 601 (747)
Q Consensus 524 ~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~-- 601 (747)
.+++..... ..+++..+..++.|++.||.|||+.+ ++||||+|+||++++++.+||+|||+++...........
T Consensus 81 ~~~l~~~~~-~~~~~~~~~~~~~ql~~~l~~lH~~~---i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~ 156 (277)
T cd05577 81 KYHIYNVGE-PGFPEARAIFYAAQIICGLEHLHQRR---IVYRDLKPENVLLDDHGNVRISDLGLAVELKGGKKIKGRAG 156 (277)
T ss_pred HHHHHHcCc-CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEEccCcchhhhccCCccccccC
Confidence 999865432 35889999999999999999999988 999999999999999999999999998765432111000
Q ss_pred --ceeeec--cCCCCCccccchhHHHHHHHHHhCCCCCCCCCCcchhhhhHhHHhcCCcccccchhhhccCCHHHHHHHH
Q 004521 602 --NRVVGT--YDGQFSIKSDVFSFGILLLEIVSGKKNRGFYRSDTKVNLIGHLWDEGIPLRLIDACIQDSCNLADVIRCI 677 (747)
Q Consensus 602 --~~~~~~--~~~~~s~ksDVwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~ 677 (747)
...... ....++.++|||||||++|||++|+.|+...........+...... .... ..... ...+.
T Consensus 157 ~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~-~~~~-----~~~~~----~~~~~ 226 (277)
T cd05577 157 TPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKVEKEELKRRTLE-MAVE-----YPDKF----SPEAK 226 (277)
T ss_pred CCCcCCHHHhcCCCCCchhhhHHHHHHHHHHhhCCCCCCCCcccccHHHHHhcccc-cccc-----CCccC----CHHHH
Confidence 000000 1345788999999999999999999997543321111111111000 0000 00111 22356
Q ss_pred HHHHhccCCCCCCCC-----CHHHHHH
Q 004521 678 HIGLLCVQQHPEDRP-----CMPSVIL 699 (747)
Q Consensus 678 ~l~~~Cl~~dP~~RP-----t~~~v~~ 699 (747)
+++.+||+.+|.+|| ++.++++
T Consensus 227 ~li~~~l~~~p~~R~~~~~~~~~~ll~ 253 (277)
T cd05577 227 DLCEALLQKDPEKRLGCRGGSADEVRE 253 (277)
T ss_pred HHHHHHccCChhHccCCCcccHHHHHh
Confidence 777899999999999 5555653
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.3e-31 Score=268.28 Aligned_cols=248 Identities=24% Similarity=0.267 Sum_probs=186.7
Q ss_pred cCCCccceecccCCeeEEEEEecC-CcEEEEEEeccc---ccccHHHHHHHHHHHhccCCCceeeEEeEEEeCCeeEEEE
Q 004521 440 DNFSINNKLGEGGFGPVYKGTLVD-GQEIAVKRLSKI---SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIY 515 (747)
Q Consensus 440 ~~~~~~~~lg~G~fg~Vy~~~~~~-g~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 515 (747)
+.|++.+.||.|.-|+||++.+.+ +..+|+|++.+. ........+.|.+||+.++||.|+.|++.++.++..+|||
T Consensus 77 ~~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~~~~cl~m 156 (459)
T KOG0610|consen 77 RHFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFETDKYSCLVM 156 (459)
T ss_pred HHHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeeccceeEEEE
Confidence 356678999999999999999976 589999999763 3445567788999999999999999999999999999999
Q ss_pred ecCCCCChhhHhhhcCCCCcCChhHHHHHHHHHHHHHHHhhhcCCCceEecccCcCcEEEcCCCCceEecccCccccCCC
Q 004521 516 EFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGD 595 (747)
Q Consensus 516 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NIll~~~~~~kl~DFGla~~~~~~ 595 (747)
|||+||+|..+++.+. ...+++..+.-++.+|+-||+|||-.| ||.|||||+||||.++|++-|+||.|+......
T Consensus 157 eyCpGGdL~~LrqkQp-~~~fse~~aRFYaAEvl~ALEYLHmlG---ivYRDLKPENILvredGHIMLsDFDLS~~~~~~ 232 (459)
T KOG0610|consen 157 EYCPGGDLHSLRQKQP-GKRFSESAARFYAAEVLLALEYLHMLG---IVYRDLKPENILVREDGHIMLSDFDLSLRCPVS 232 (459)
T ss_pred ecCCCccHHHHHhhCC-CCccchhhHHHHHHHHHHHHHHHHhhc---eeeccCCcceeEEecCCcEEeeeccccccCCCC
Confidence 9999999999886643 456888888889999999999999988 999999999999999999999999987532110
Q ss_pred CC-----------------------------cc-c------------------------cceeeecc---------CCCC
Q 004521 596 ET-----------------------------EG-N------------------------TNRVVGTY---------DGQF 612 (747)
Q Consensus 596 ~~-----------------------------~~-~------------------------~~~~~~~~---------~~~~ 612 (747)
.+ .. . ....+||. +...
T Consensus 233 Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~G~GH 312 (459)
T KOG0610|consen 233 PTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIRGEGH 312 (459)
T ss_pred CeeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceeeecCCC
Confidence 00 00 0 00011221 4557
Q ss_pred CccccchhHHHHHHHHHhCCCCCCCCCCcchhhhhHhHHhcCCcccccchhhhccCCHHHHHHHHHHHHhccCCCCCCCC
Q 004521 613 SIKSDVFSFGILLLEIVSGKKNRGFYRSDTKVNLIGHLWDEGIPLRLIDACIQDSCNLADVIRCIHIGLLCVQQHPEDRP 692 (747)
Q Consensus 613 s~ksDVwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dP~~RP 692 (747)
+.++|+|+|||+||||+.|+.||....... .+...+.+. ..+.+. .+-...+.+|+.+.|.+||++|.
T Consensus 313 gsAVDWWtfGIflYEmLyG~TPFKG~~~~~--Tl~NIv~~~---l~Fp~~-------~~vs~~akDLIr~LLvKdP~kRl 380 (459)
T KOG0610|consen 313 GSAVDWWTFGIFLYEMLYGTTPFKGSNNKE--TLRNIVGQP---LKFPEE-------PEVSSAAKDLIRKLLVKDPSKRL 380 (459)
T ss_pred CchhhHHHHHHHHHHHHhCCCCcCCCCchh--hHHHHhcCC---CcCCCC-------CcchhHHHHHHHHHhccChhhhh
Confidence 889999999999999999999976443322 111111111 111111 11122345667789999999999
Q ss_pred C----HHHHHH--HhcC
Q 004521 693 C----MPSVIL--MLGS 703 (747)
Q Consensus 693 t----~~~v~~--~L~~ 703 (747)
. +.||-+ ++++
T Consensus 381 g~~rGA~eIK~HpFF~g 397 (459)
T KOG0610|consen 381 GSKRGAAEIKRHPFFEG 397 (459)
T ss_pred ccccchHHhhcCccccC
Confidence 8 778765 3454
|
|
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.5e-30 Score=278.36 Aligned_cols=248 Identities=24% Similarity=0.314 Sum_probs=178.0
Q ss_pred ceeccc--CCeeEEEEEec-CCcEEEEEEeccc--ccccHHHHHHHHHHHhccCCCceeeEEeEEEeCCeeEEEEecCCC
Q 004521 446 NKLGEG--GFGPVYKGTLV-DGQEIAVKRLSKI--SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMPN 520 (747)
Q Consensus 446 ~~lg~G--~fg~Vy~~~~~-~g~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~ 520 (747)
..||+| +||+||+++.. .|+.||||.+... .....+.+.+|+.+++.++||||+++++++..++..++|+||+.+
T Consensus 4 ~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e~~~~ 83 (328)
T cd08226 4 VEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMAY 83 (328)
T ss_pred HHhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEEEecccC
Confidence 456766 99999999975 5899999998642 223456789999999999999999999999999999999999999
Q ss_pred CChhhHhhhcCCCCcCChhHHHHHHHHHHHHHHHhhhcCCCceEecccCcCcEEEcCCCCceEecccCccccCCCCCcc-
Q 004521 521 KSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEG- 599 (747)
Q Consensus 521 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~- 599 (747)
++|.+++..... ..+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+||+.+..........
T Consensus 84 ~~l~~~l~~~~~-~~~~~~~~~~~~~qi~~aL~~lH~~~---ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (328)
T cd08226 84 GSANSLLKTYFP-EGMSEALIGNILFGALRGLNYLHQNG---YIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQKAK 159 (328)
T ss_pred CCHHHHHHhhcc-cCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEeCCCcEEEechHHHhhhhccCcccc
Confidence 999999865332 24788999999999999999999988 9999999999999999999999998654322111000
Q ss_pred -----------ccceeeecc----CCCCCccccchhHHHHHHHHHhCCCCCCCCCCcchhhhhHhHHhcC----------
Q 004521 600 -----------NTNRVVGTY----DGQFSIKSDVFSFGILLLEIVSGKKNRGFYRSDTKVNLIGHLWDEG---------- 654 (747)
Q Consensus 600 -----------~~~~~~~~~----~~~~s~ksDVwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~---------- 654 (747)
......... ...++.++|||||||++|||++|+.|+....... ..........
T Consensus 160 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~--~~~~~~~~~~~~~~~~~~~~ 237 (328)
T cd08226 160 VVYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQ--MLLQKLKGPPYSPLDITTFP 237 (328)
T ss_pred ccccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHH--HHHHHhcCCCCCCccccccc
Confidence 000000000 1346889999999999999999999975332111 1111000000
Q ss_pred -------------------------CcccccchhhhccCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 004521 655 -------------------------IPLRLIDACIQDSCNLADVIRCIHIGLLCVQQHPEDRPCMPSVIL 699 (747)
Q Consensus 655 -------------------------~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dP~~RPt~~~v~~ 699 (747)
....+.+..+...........+.+++.+||+.||++|||+.++++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpta~e~l~ 307 (328)
T cd08226 238 CEESRMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRPSASSLLS 307 (328)
T ss_pred hhhhhhccchhhhhcccccchhccccccccccccccchhhhhhhHHHHHHHHHHccCCcccCCCHHHHhh
Confidence 000011111111112223345778999999999999999999975
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-30 Score=282.26 Aligned_cols=255 Identities=24% Similarity=0.349 Sum_probs=182.2
Q ss_pred HhcCCCccceecccCCeeEEEEEec-CCcEEEEEEeccc--ccccHHHHHHHHHHHhcc-CCCceeeEEeEEEeC--Cee
Q 004521 438 ATDNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKI--SEQGLKELKNEVILFSKL-QHRNLVKLLGCCIQG--EEK 511 (747)
Q Consensus 438 ~~~~~~~~~~lg~G~fg~Vy~~~~~-~g~~vavK~l~~~--~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~--~~~ 511 (747)
..++|++.+.||+|+||.||+|... +++.+|||++... .......+.+|+.+++++ +||||+++++++... ...
T Consensus 5 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~~~ 84 (337)
T cd07852 5 ILRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDKDI 84 (337)
T ss_pred hhhHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCceE
Confidence 3567888999999999999999976 4889999998542 233445678899999999 999999999998654 367
Q ss_pred EEEEecCCCCChhhHhhhcCCCCcCChhHHHHHHHHHHHHHHHhhhcCCCceEecccCcCcEEEcCCCCceEecccCccc
Q 004521 512 LLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRT 591 (747)
Q Consensus 512 ~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NIll~~~~~~kl~DFGla~~ 591 (747)
++||||++ ++|..++... .+++..+..++.||+.||+|||+.+ |+||||||+||+++.++.+||+|||+++.
T Consensus 85 ~lv~e~~~-~~L~~~~~~~----~~~~~~~~~i~~qi~~~L~~LH~~~---i~H~dl~p~nill~~~~~~kl~d~g~~~~ 156 (337)
T cd07852 85 YLVFEYME-TDLHAVIRAN----ILEDVHKRYIMYQLLKALKYIHSGN---VIHRDLKPSNILLNSDCRVKLADFGLARS 156 (337)
T ss_pred EEEecccc-cCHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCcEEEeeccchhc
Confidence 99999997 5898887432 5788999999999999999999988 99999999999999999999999999986
Q ss_pred cCCCCCc---cccceeeec----------cCCCCCccccchhHHHHHHHHHhCCCCCCCCCCcchhhhhHhHHh------
Q 004521 592 FGGDETE---GNTNRVVGT----------YDGQFSIKSDVFSFGILLLEIVSGKKNRGFYRSDTKVNLIGHLWD------ 652 (747)
Q Consensus 592 ~~~~~~~---~~~~~~~~~----------~~~~~s~ksDVwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~------ 652 (747)
+...... .......++ ....++.++||||||+++|||++|+.|+...........+.....
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~ 236 (337)
T cd07852 157 LSELEENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVIGPPSAED 236 (337)
T ss_pred cccccccccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHH
Confidence 6433221 000001111 124578899999999999999999999753322111100000000
Q ss_pred -----cCCcccccchhhh-ccCCHH-----HHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 004521 653 -----EGIPLRLIDACIQ-DSCNLA-----DVIRCIHIGLLCVQQHPEDRPCMPSVILM 700 (747)
Q Consensus 653 -----~~~~~~~~d~~l~-~~~~~~-----~~~~~~~l~~~Cl~~dP~~RPt~~~v~~~ 700 (747)
......+++.... ...... ....+.+++.+||+.+|++|||+.++++.
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~~ 295 (337)
T cd07852 237 IESIKSPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALEH 295 (337)
T ss_pred HHHHHhhhHHHhhhhcccccccchhhhccCCCHHHHHHHHHhccCCcccccCHHHHhhC
Confidence 0000000000000 000000 12346778889999999999999999874
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=1e-30 Score=282.37 Aligned_cols=257 Identities=21% Similarity=0.296 Sum_probs=182.1
Q ss_pred hcCCCccceecccCCeeEEEEEec-CCcEEEEEEeccc-ccccHHHHHHHHHHHhccCCCceeeEEeEEEeCC-----ee
Q 004521 439 TDNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKI-SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGE-----EK 511 (747)
Q Consensus 439 ~~~~~~~~~lg~G~fg~Vy~~~~~-~g~~vavK~l~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~-----~~ 511 (747)
.++|++.++||+|+||.||+|+.. +|+.||||.+... .......+.+|+.++++++|+||+++++++.... ..
T Consensus 4 ~~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 83 (336)
T cd07849 4 GPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFNDV 83 (336)
T ss_pred ccceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccccchhHHHHHHHHHHHHhCCCCCcCchhheeecccccccceE
Confidence 468999999999999999999865 4899999998642 2334567888999999999999999999876543 57
Q ss_pred EEEEecCCCCChhhHhhhcCCCCcCChhHHHHHHHHHHHHHHHhhhcCCCceEecccCcCcEEEcCCCCceEecccCccc
Q 004521 512 LLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRT 591 (747)
Q Consensus 512 ~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NIll~~~~~~kl~DFGla~~ 591 (747)
++|+||++ ++|..++.. ..+++..+..++.|+++||.|||+.+ |+||||||+||+++.++.+||+|||+++.
T Consensus 84 ~lv~e~~~-~~l~~~~~~----~~l~~~~~~~i~~ql~~aL~~LH~~~---ivH~dlkp~Nill~~~~~~kl~dfg~~~~ 155 (336)
T cd07849 84 YIVQELME-TDLYKLIKT----QHLSNDHIQYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTNCDLKICDFGLARI 155 (336)
T ss_pred EEEehhcc-cCHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEECCCCCEEECcccceee
Confidence 99999997 578777632 35889999999999999999999988 99999999999999999999999999976
Q ss_pred cCCCCCcccc-c-------eeeec--c-CCCCCccccchhHHHHHHHHHhCCCCCCCCCCcchhhhhHhHHhcCCcc---
Q 004521 592 FGGDETEGNT-N-------RVVGT--Y-DGQFSIKSDVFSFGILLLEIVSGKKNRGFYRSDTKVNLIGHLWDEGIPL--- 657 (747)
Q Consensus 592 ~~~~~~~~~~-~-------~~~~~--~-~~~~s~ksDVwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~--- 657 (747)
.......... . ..... . ...++.++|||||||++|||++|+.|+...........+..........
T Consensus 156 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (336)
T cd07849 156 ADPEHDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQLNLILGVLGTPSQEDLN 235 (336)
T ss_pred ccccccccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCHHHHH
Confidence 5432211100 0 00011 1 2457889999999999999999999975322111000000000000000
Q ss_pred cccchh-------hh--ccCCH-----HHHHHHHHHHHhccCCCCCCCCCHHHHHHH--hcC
Q 004521 658 RLIDAC-------IQ--DSCNL-----ADVIRCIHIGLLCVQQHPEDRPCMPSVILM--LGS 703 (747)
Q Consensus 658 ~~~d~~-------l~--~~~~~-----~~~~~~~~l~~~Cl~~dP~~RPt~~~v~~~--L~~ 703 (747)
.+.+.. .. ..... .....+.+++.+||+.+|++|||+.++++. |+.
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~hp~~~~ 297 (336)
T cd07849 236 CIISLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAHPYLEQ 297 (336)
T ss_pred HhhchhhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhcCccccc
Confidence 000000 00 00000 112346788899999999999999999886 544
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.3e-30 Score=267.91 Aligned_cols=236 Identities=22% Similarity=0.307 Sum_probs=178.8
Q ss_pred ecccCCeeEEEEEecC-CcEEEEEEecccc---cccHHHHHHHHHHHhccCCCceeeEEeEEEeCCeeEEEEecCCCCCh
Q 004521 448 LGEGGFGPVYKGTLVD-GQEIAVKRLSKIS---EQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMPNKSL 523 (747)
Q Consensus 448 lg~G~fg~Vy~~~~~~-g~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gsL 523 (747)
||+|+||.||+++... ++.+|+|.+.+.. ....+.+.+|+.++++++||||+++++.+.++...++|+||+++++|
T Consensus 1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (262)
T cd05572 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGEL 80 (262)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecCCCCcH
Confidence 6999999999999865 8899999987522 23456799999999999999999999999999999999999999999
Q ss_pred hhHhhhcCCCCcCChhHHHHHHHHHHHHHHHhhhcCCCceEecccCcCcEEEcCCCCceEecccCccccCCCCCcc----
Q 004521 524 DSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEG---- 599 (747)
Q Consensus 524 ~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~---- 599 (747)
.+++... ..+++..+..++.||+.||.|||+.+ ++|+||+|+||+++.++.+||+|||+++.........
T Consensus 81 ~~~l~~~---~~l~~~~~~~~~~~i~~~l~~lH~~~---~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~~~~~~~~ 154 (262)
T cd05572 81 WTILRDR---GLFDEYTARFYIACVVLAFEYLHNRG---IIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQKTWTFCG 154 (262)
T ss_pred HHHHhhc---CCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCHHHEEEcCCCCEEEeeCCcccccCcccccccccC
Confidence 9999543 34888999999999999999999988 9999999999999999999999999998765432110
Q ss_pred ccceeee--ccCCCCCccccchhHHHHHHHHHhCCCCCCCCCCcchhhhhHhHHhcCCcccccchhhhccCCHHHHHHHH
Q 004521 600 NTNRVVG--TYDGQFSIKSDVFSFGILLLEIVSGKKNRGFYRSDTKVNLIGHLWDEGIPLRLIDACIQDSCNLADVIRCI 677 (747)
Q Consensus 600 ~~~~~~~--~~~~~~s~ksDVwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~ 677 (747)
....... .....++.++|+||||+++|||++|..|+.....+ .................. .. ....+.
T Consensus 155 ~~~~~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~-~~~~~~~~~~~~~~~~~~-----~~----~~~~~~ 224 (262)
T cd05572 155 TPEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDDED-PMEIYNDILKGNGKLEFP-----NY----IDKAAK 224 (262)
T ss_pred CcCccChhHhcCCCCCChhhhhhhHHHHHHHHhCCCCcCCCCCC-HHHHHHHHhccCCCCCCC-----cc----cCHHHH
Confidence 0000001 01356788999999999999999999997543321 112222111111111111 00 123467
Q ss_pred HHHHhccCCCCCCCCC-----HHHHHH
Q 004521 678 HIGLLCVQQHPEDRPC-----MPSVIL 699 (747)
Q Consensus 678 ~l~~~Cl~~dP~~RPt-----~~~v~~ 699 (747)
.++.+||+.+|++||+ +.|+++
T Consensus 225 ~~i~~~l~~~p~~R~~~~~~~~~~l~~ 251 (262)
T cd05572 225 DLIKQLLRRNPEERLGNLKGGIKDIKK 251 (262)
T ss_pred HHHHHHccCChhhCcCCcccCHHHHhc
Confidence 7888999999999999 555554
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.1e-30 Score=274.71 Aligned_cols=245 Identities=22% Similarity=0.364 Sum_probs=180.9
Q ss_pred cCCCccceecccCCeeEEEEEecC-CcEEEEEEecccc-cccHHHHHHHHHHHhccC-CCceeeEEeEEEeCCeeEEEEe
Q 004521 440 DNFSINNKLGEGGFGPVYKGTLVD-GQEIAVKRLSKIS-EQGLKELKNEVILFSKLQ-HRNLVKLLGCCIQGEEKLLIYE 516 (747)
Q Consensus 440 ~~~~~~~~lg~G~fg~Vy~~~~~~-g~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~-H~niv~l~g~~~~~~~~~lV~E 516 (747)
++|++.+.||+|+||.||+|+..+ ++.||||.++... .....++..|+.++.+.. |+||+++++++..+...++|||
T Consensus 15 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e 94 (296)
T cd06618 15 NDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCYGYFITDSDVFICME 94 (296)
T ss_pred chheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCChHHHHHHHHHHHHHHhccCCCchHhhheeeecCCeEEEEee
Confidence 578889999999999999999875 8999999997532 234456777887777775 9999999999999999999999
Q ss_pred cCCCCChhhHhhhcCCCCcCChhHHHHHHHHHHHHHHHhhh-cCCCceEecccCcCcEEEcCCCCceEecccCccccCCC
Q 004521 517 FMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQ-DSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGD 595 (747)
Q Consensus 517 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~-~~~~~iiHrDlkp~NIll~~~~~~kl~DFGla~~~~~~ 595 (747)
|+. ++|..++.... ..+++..+..++.||+.||+|||+ .+ |+||||+|+||++++++.+||+|||++..+...
T Consensus 95 ~~~-~~l~~l~~~~~--~~l~~~~~~~i~~~i~~~l~~lH~~~~---i~H~dl~p~nill~~~~~~kL~dfg~~~~~~~~ 168 (296)
T cd06618 95 LMS-TCLDKLLKRIQ--GPIPEDILGKMTVAIVKALHYLKEKHG---VIHRDVKPSNILLDASGNVKLCDFGISGRLVDS 168 (296)
T ss_pred ccC-cCHHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhhCC---EecCCCcHHHEEEcCCCCEEECccccchhccCC
Confidence 985 57777764422 368899999999999999999997 46 999999999999999999999999998765432
Q ss_pred CCccccc---eeeec--c-----CCCCCccccchhHHHHHHHHHhCCCCCCCCCCcchhhhhHhHHhcCCcccccchhhh
Q 004521 596 ETEGNTN---RVVGT--Y-----DGQFSIKSDVFSFGILLLEIVSGKKNRGFYRSDTKVNLIGHLWDEGIPLRLIDACIQ 665 (747)
Q Consensus 596 ~~~~~~~---~~~~~--~-----~~~~s~ksDVwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 665 (747)
....... ....+ . .+.++.++||||||+++|||++|+.|+..... ....+....... ...+....
T Consensus 169 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~--~~~~~~~~~~~~-~~~~~~~~-- 243 (296)
T cd06618 169 KAKTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKT--EFEVLTKILQEE-PPSLPPNE-- 243 (296)
T ss_pred CcccCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchh--HHHHHHHHhcCC-CCCCCCCC--
Confidence 2111100 00000 1 24478899999999999999999999753221 112222222221 11111100
Q ss_pred ccCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 004521 666 DSCNLADVIRCIHIGLLCVQQHPEDRPCMPSVILM 700 (747)
Q Consensus 666 ~~~~~~~~~~~~~l~~~Cl~~dP~~RPt~~~v~~~ 700 (747)
.....+.+++.+||+.||++||++.+++++
T Consensus 244 -----~~~~~l~~li~~~l~~~p~~Rp~~~~il~~ 273 (296)
T cd06618 244 -----GFSPDFCSFVDLCLTKDHRKRPKYRELLQH 273 (296)
T ss_pred -----CCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 112346678889999999999999999865
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.8e-30 Score=265.61 Aligned_cols=240 Identities=25% Similarity=0.392 Sum_probs=185.2
Q ss_pred CCCccceecccCCeeEEEEEec-CCcEEEEEEeccccc--ccHHHHHHHHHHHhccCCCceeeEEeEEEeCCeeEEEEec
Q 004521 441 NFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKISE--QGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEF 517 (747)
Q Consensus 441 ~~~~~~~lg~G~fg~Vy~~~~~-~g~~vavK~l~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~ 517 (747)
+|++.+.||+|++|.||+++.. +++.+++|.+..... ...+.+.+|++++++++|+|++++++++...+..++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 80 (254)
T cd06627 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIILEY 80 (254)
T ss_pred CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEec
Confidence 4778899999999999999876 478999999976433 4567899999999999999999999999999999999999
Q ss_pred CCCCChhhHhhhcCCCCcCChhHHHHHHHHHHHHHHHhhhcCCCceEecccCcCcEEEcCCCCceEecccCccccCCCCC
Q 004521 518 MPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDET 597 (747)
Q Consensus 518 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~ 597 (747)
+++++|.+++... ..+++..+..++.|++.||.|||+.+ |+||||+|+||+++.++.+||+|||++........
T Consensus 81 ~~~~~L~~~~~~~---~~l~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~ 154 (254)
T cd06627 81 AENGSLRQIIKKF---GPFPESLVAVYVYQVLQGLAYLHEQG---VIHRDIKAANILTTKDGVVKLADFGVATKLNDVSK 154 (254)
T ss_pred CCCCcHHHHHHhc---cCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCHHHEEECCCCCEEEeccccceecCCCcc
Confidence 9999999998543 45899999999999999999999988 99999999999999999999999999987654332
Q ss_pred ccc-----cceeeec--cCCCCCccccchhHHHHHHHHHhCCCCCCCCCCcchhhhhHhHHhcCCcccccchhhhccCCH
Q 004521 598 EGN-----TNRVVGT--YDGQFSIKSDVFSFGILLLEIVSGKKNRGFYRSDTKVNLIGHLWDEGIPLRLIDACIQDSCNL 670 (747)
Q Consensus 598 ~~~-----~~~~~~~--~~~~~s~ksDVwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~ 670 (747)
... ....... ....++.++||||+|+++|||++|+.|+..... ....... .......+. ...
T Consensus 155 ~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~---~~~~~~~-~~~~~~~~~-----~~~-- 223 (254)
T cd06627 155 DDASVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYDLNP---MAALFRI-VQDDHPPLP-----EGI-- 223 (254)
T ss_pred cccccccchhhcCHhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCccH---HHHHHHH-hccCCCCCC-----CCC--
Confidence 100 0000000 123478899999999999999999999753321 1111111 111111111 111
Q ss_pred HHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 004521 671 ADVIRCIHIGLLCVQQHPEDRPCMPSVIL 699 (747)
Q Consensus 671 ~~~~~~~~l~~~Cl~~dP~~RPt~~~v~~ 699 (747)
...+..++.+||+.+|++||++.+++.
T Consensus 224 --~~~~~~~i~~~l~~~p~~R~~~~~~l~ 250 (254)
T cd06627 224 --SPELKDFLMQCFQKDPNLRPTAKQLLK 250 (254)
T ss_pred --CHHHHHHHHHHHhCChhhCcCHHHHhc
Confidence 123567888999999999999999874
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.3e-30 Score=273.76 Aligned_cols=237 Identities=23% Similarity=0.351 Sum_probs=179.9
Q ss_pred cceecccCCeeEEEEEec-CCcEEEEEEecccccccHHHHHHHHHHHhccCCCceeeEEeEEEeCCeeEEEEecCCCCCh
Q 004521 445 NNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMPNKSL 523 (747)
Q Consensus 445 ~~~lg~G~fg~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gsL 523 (747)
..+||+|+||.||++... +++.||||++..........+.+|+.+++.++|+||+++++++...+..++||||+++++|
T Consensus 25 ~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L 104 (292)
T cd06657 25 FIKIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGAL 104 (292)
T ss_pred HHHcCCCCCeEEEEEEEcCCCeEEEEEEecccchhHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEEEecCCCCcH
Confidence 368999999999999875 5889999998654445566789999999999999999999999999999999999999999
Q ss_pred hhHhhhcCCCCcCChhHHHHHHHHHHHHHHHhhhcCCCceEecccCcCcEEEcCCCCceEecccCccccCCCCCcccc--
Q 004521 524 DSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNT-- 601 (747)
Q Consensus 524 ~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~-- 601 (747)
.+++.. ..+++..+..++.|++.||+|||+.+ ++|+||+|+||++++++.++|+|||++............
T Consensus 105 ~~~~~~----~~~~~~~~~~~~~ql~~~l~~lH~~g---ivH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~~~~~~~~~ 177 (292)
T cd06657 105 TDIVTH----TRMNEEQIAAVCLAVLKALSVLHAQG---VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKSLV 177 (292)
T ss_pred HHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEEcccccceecccccccccccc
Confidence 998743 24788999999999999999999988 999999999999999999999999998765432211100
Q ss_pred --c-eeeec--cCCCCCccccchhHHHHHHHHHhCCCCCCCCCCcchhhhhHhHHhcCCcccccchhhhccCCHHHHHHH
Q 004521 602 --N-RVVGT--YDGQFSIKSDVFSFGILLLEIVSGKKNRGFYRSDTKVNLIGHLWDEGIPLRLIDACIQDSCNLADVIRC 676 (747)
Q Consensus 602 --~-~~~~~--~~~~~s~ksDVwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~ 676 (747)
. ..... ....++.++|||||||++|||++|..|+...... ..... ........+.. + ... ...+
T Consensus 178 ~~~~y~~pE~~~~~~~~~~~Dv~slGvil~el~tg~~p~~~~~~~---~~~~~-~~~~~~~~~~~--~-~~~----~~~l 246 (292)
T cd06657 178 GTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPL---KAMKM-IRDNLPPKLKN--L-HKV----SPSL 246 (292)
T ss_pred cCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH---HHHHH-HHhhCCcccCC--c-ccC----CHHH
Confidence 0 00000 1356788999999999999999999996532211 11111 11111111100 0 001 1234
Q ss_pred HHHHHhccCCCCCCCCCHHHHHH
Q 004521 677 IHIGLLCVQQHPEDRPCMPSVIL 699 (747)
Q Consensus 677 ~~l~~~Cl~~dP~~RPt~~~v~~ 699 (747)
.+++.+||+.+|.+||++.+|++
T Consensus 247 ~~li~~~l~~~P~~R~~~~~ll~ 269 (292)
T cd06657 247 KGFLDRLLVRDPAQRATAAELLK 269 (292)
T ss_pred HHHHHHHHhCCcccCcCHHHHhc
Confidence 56777999999999999999877
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.3e-30 Score=274.24 Aligned_cols=254 Identities=23% Similarity=0.312 Sum_probs=182.0
Q ss_pred CCccceecccCCeeEEEEEecC-CcEEEEEEeccccc-ccHHHHHHHHHHHhccC-CCceeeEEeEEEeCCeeEEEEecC
Q 004521 442 FSINNKLGEGGFGPVYKGTLVD-GQEIAVKRLSKISE-QGLKELKNEVILFSKLQ-HRNLVKLLGCCIQGEEKLLIYEFM 518 (747)
Q Consensus 442 ~~~~~~lg~G~fg~Vy~~~~~~-g~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~-H~niv~l~g~~~~~~~~~lV~E~~ 518 (747)
|++.+.||+|+||.||+|+..+ ++.|+||++..... .......+|+..+++++ |+||+++++++..++..++||||+
T Consensus 1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (283)
T cd07830 1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFEYM 80 (283)
T ss_pred CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccchhHHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEEEecC
Confidence 5678899999999999999865 78999999875322 22334567999999999 999999999999999999999999
Q ss_pred CCCChhhHhhhcCCCCcCChhHHHHHHHHHHHHHHHhhhcCCCceEecccCcCcEEEcCCCCceEecccCccccCCCCCc
Q 004521 519 PNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETE 598 (747)
Q Consensus 519 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~ 598 (747)
+|+|.+++.... ...+++.++..++.|++.+|.|||+.+ ++|+||+|+||+++.++.++|+|||+++........
T Consensus 81 -~~~l~~~~~~~~-~~~~~~~~~~~~~~~l~~~l~~Lh~~~---i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~~~~~ 155 (283)
T cd07830 81 -EGNLYQLMKDRK-GKPFSESVIRSIIYQILQGLAHIHKHG---FFHRDLKPENLLVSGPEVVKIADFGLAREIRSRPPY 155 (283)
T ss_pred -CCCHHHHHHhcc-cccCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChhhEEEcCCCCEEEeecccceeccCCCCc
Confidence 889998886533 245899999999999999999999988 999999999999999999999999999866432211
Q ss_pred c----ccceeeec---cCCCCCccccchhHHHHHHHHHhCCCCCCCCCCcchhhhhHhH--------HhcCC-cccccch
Q 004521 599 G----NTNRVVGT---YDGQFSIKSDVFSFGILLLEIVSGKKNRGFYRSDTKVNLIGHL--------WDEGI-PLRLIDA 662 (747)
Q Consensus 599 ~----~~~~~~~~---~~~~~s~ksDVwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~--------~~~~~-~~~~~d~ 662 (747)
. ......+. ....++.++||||||+++|||++|+.|+............... +.++. .....+.
T Consensus 156 ~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (283)
T cd07830 156 TDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEGYKLASKLGF 235 (283)
T ss_pred CCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHHHHHHHHHhcCCCChhhhhhHhhhhccccc
Confidence 0 00000011 1345788999999999999999999887533221111100000 00000 0000000
Q ss_pred hhhc--cCCH-----HHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 004521 663 CIQD--SCNL-----ADVIRCIHIGLLCVQQHPEDRPCMPSVILM 700 (747)
Q Consensus 663 ~l~~--~~~~-----~~~~~~~~l~~~Cl~~dP~~RPt~~~v~~~ 700 (747)
.+.. .... .....+.+++.+||+.+|++||++.|++..
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~ 280 (283)
T cd07830 236 RFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQH 280 (283)
T ss_pred cccccccccHHHHcccCCHHHHHHHHHhcccCcccCCCHHHHhhC
Confidence 0000 0000 012457788999999999999999999763
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.1e-31 Score=272.26 Aligned_cols=238 Identities=22% Similarity=0.338 Sum_probs=187.9
Q ss_pred cCCCccceecccCCeeEEEEEec-CCcEEEEEEeccc--ccccHHHHHHHHHHHhccCCCceeeEEeEEEeCCeeEEEEe
Q 004521 440 DNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKI--SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYE 516 (747)
Q Consensus 440 ~~~~~~~~lg~G~fg~Vy~~~~~-~g~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E 516 (747)
.-|.+.+.||+|.|..|-+|++. .|..||||++.+. +.....++..|++-|+.++|||||+|+.+......+|||+|
T Consensus 18 GLYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEViDTQTKlyLiLE 97 (864)
T KOG4717|consen 18 GLYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEVIDTQTKLYLILE 97 (864)
T ss_pred eeehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeehhcccceEEEEEE
Confidence 45777899999999999999864 5999999999763 33445678899999999999999999999999999999999
Q ss_pred cCCCCChhhHhhhcCCCCcCChhHHHHHHHHHHHHHHHhhhcCCCceEecccCcCcEEE-cCCCCceEecccCccccCCC
Q 004521 517 FMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLL-DQDMNPKISDFGLVRTFGGD 595 (747)
Q Consensus 517 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NIll-~~~~~~kl~DFGla~~~~~~ 595 (747)
+-.+|+|.+||.++... +.+....+++.||+.|+.|.|+.. +|||||||+||.+ ..-|-+||+|||++..+.+.
T Consensus 98 LGD~GDl~DyImKHe~G--l~E~La~kYF~QI~~AI~YCHqLH---VVHRDLKPENVVFFEKlGlVKLTDFGFSNkf~PG 172 (864)
T KOG4717|consen 98 LGDGGDLFDYIMKHEEG--LNEDLAKKYFAQIVHAISYCHQLH---VVHRDLKPENVVFFEKLGLVKLTDFGFSNKFQPG 172 (864)
T ss_pred ecCCchHHHHHHhhhcc--ccHHHHHHHHHHHHHHHHHHhhhh---hhcccCCcceeEEeeecCceEeeeccccccCCCc
Confidence 99999999999876654 889999999999999999999877 9999999999975 66789999999999776544
Q ss_pred CCccccceeeec---------cCCCC-CccccchhHHHHHHHHHhCCCCCCCCCCcchhhhhHhHHhcCCcccccchhhh
Q 004521 596 ETEGNTNRVVGT---------YDGQF-SIKSDVFSFGILLLEIVSGKKNRGFYRSDTKVNLIGHLWDEGIPLRLIDACIQ 665 (747)
Q Consensus 596 ~~~~~~~~~~~~---------~~~~~-s~ksDVwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 665 (747)
.... ..+|. .+..| .+++||||+|||||-|++|+.||......+...++ +|=.
T Consensus 173 ~kL~---TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeANDSETLTmI------------mDCK-- 235 (864)
T KOG4717|consen 173 KKLT---TSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEANDSETLTMI------------MDCK-- 235 (864)
T ss_pred chhh---cccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccchhhhhhh------------hccc--
Confidence 3211 11111 13334 46899999999999999999998755443322211 1111
Q ss_pred ccCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 004521 666 DSCNLADVIRCIHIGLLCVQQHPEDRPCMPSVIL 699 (747)
Q Consensus 666 ~~~~~~~~~~~~~l~~~Cl~~dP~~RPt~~~v~~ 699 (747)
...+-.--.+|.+|+..||+.||.+|.+.++|+.
T Consensus 236 YtvPshvS~eCrdLI~sMLvRdPkkRAslEeI~s 269 (864)
T KOG4717|consen 236 YTVPSHVSKECRDLIQSMLVRDPKKRASLEEIVS 269 (864)
T ss_pred ccCchhhhHHHHHHHHHHHhcCchhhccHHHHhc
Confidence 1112222335677888999999999999999975
|
|
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.5e-30 Score=268.54 Aligned_cols=242 Identities=20% Similarity=0.195 Sum_probs=175.7
Q ss_pred ceecccCCeeEEEEEec-CCcEEEEEEecccc---cccHHHHHHHHHHH-hccCCCceeeEEeEEEeCCeeEEEEecCCC
Q 004521 446 NKLGEGGFGPVYKGTLV-DGQEIAVKRLSKIS---EQGLKELKNEVILF-SKLQHRNLVKLLGCCIQGEEKLLIYEFMPN 520 (747)
Q Consensus 446 ~~lg~G~fg~Vy~~~~~-~g~~vavK~l~~~~---~~~~~~~~~E~~~l-~~l~H~niv~l~g~~~~~~~~~lV~E~~~~ 520 (747)
+.||+|+||.||+|+.. +++.||||.+++.. ......+..|..++ ...+|+||+++++++..++..++|+||+++
T Consensus 2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 81 (260)
T cd05611 2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLNG 81 (260)
T ss_pred ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEeccCC
Confidence 57999999999999875 48899999987532 12233445555544 455899999999999999999999999999
Q ss_pred CChhhHhhhcCCCCcCChhHHHHHHHHHHHHHHHhhhcCCCceEecccCcCcEEEcCCCCceEecccCccccCCCCCccc
Q 004521 521 KSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGN 600 (747)
Q Consensus 521 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~ 600 (747)
++|.+++... ..+++..+..++.|++.||.|||+.+ ++||||+|+||++++++.+||+|||+++..........
T Consensus 82 ~~L~~~l~~~---~~~~~~~~~~i~~qi~~aL~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~ 155 (260)
T cd05611 82 GDCASLIKTL---GGLPEDWAKQYIAEVVLGVEDLHQRG---IIHRDIKPENLLIDQTGHLKLTDFGLSRNGLENKKFVG 155 (260)
T ss_pred CCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCcEEEeecccceeccccccCCC
Confidence 9999998543 35889999999999999999999988 99999999999999999999999999876543211111
Q ss_pred cceeee---ccCCCCCccccchhHHHHHHHHHhCCCCCCCCCCcchhhhhHhHHhcCCcccccchhhhccCCHHHHHHHH
Q 004521 601 TNRVVG---TYDGQFSIKSDVFSFGILLLEIVSGKKNRGFYRSDTKVNLIGHLWDEGIPLRLIDACIQDSCNLADVIRCI 677 (747)
Q Consensus 601 ~~~~~~---~~~~~~s~ksDVwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~ 677 (747)
...... ..+..++.++||||||+++|||++|..|+..... ....... ..+... . ...... .....+.
T Consensus 156 ~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~---~~~~~~~-~~~~~~-~-~~~~~~----~~~~~~~ 225 (260)
T cd05611 156 TPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAETP---DAVFDNI-LSRRIN-W-PEEVKE----FCSPEAV 225 (260)
T ss_pred CcCccChhhhcCCCCcchhhhHHHHHHHHHHHHCCCCCCCCCH---HHHHHHH-HhcccC-C-CCcccc----cCCHHHH
Confidence 100000 1134478899999999999999999999753221 1111111 111110 0 000000 1123466
Q ss_pred HHHHhccCCCCCCCCCHHHHHHHhcC
Q 004521 678 HIGLLCVQQHPEDRPCMPSVILMLGS 703 (747)
Q Consensus 678 ~l~~~Cl~~dP~~RPt~~~v~~~L~~ 703 (747)
+++.+||+.+|++||++.++.+.|..
T Consensus 226 ~~i~~~l~~~p~~R~~~~~~~~~l~~ 251 (260)
T cd05611 226 DLINRLLCMDPAKRLGANGYQEIKSH 251 (260)
T ss_pred HHHHHHccCCHHHccCCCcHHHHHcC
Confidence 78889999999999988877776654
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.7e-31 Score=276.88 Aligned_cols=240 Identities=27% Similarity=0.369 Sum_probs=187.7
Q ss_pred cCCCccceecccCCeeEEEEEecCCcEEEEEEecc--cccccHHHHHHHHHHHhccC-CCceeeEEeEEEeCCeeEEEEe
Q 004521 440 DNFSINNKLGEGGFGPVYKGTLVDGQEIAVKRLSK--ISEQGLKELKNEVILFSKLQ-HRNLVKLLGCCIQGEEKLLIYE 516 (747)
Q Consensus 440 ~~~~~~~~lg~G~fg~Vy~~~~~~g~~vavK~l~~--~~~~~~~~~~~E~~~l~~l~-H~niv~l~g~~~~~~~~~lV~E 516 (747)
..|++.++||+||.+.||++...+.+.+|+|++.. .+.+....|++|+.+|.+|+ |.+||+|++|-..++.+|+|||
T Consensus 361 ~~Yeilk~iG~GGSSkV~kV~~s~~~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~~lYmvmE 440 (677)
T KOG0596|consen 361 REYEILKQIGSGGSSKVFKVLNSDKQIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTDGYLYMVME 440 (677)
T ss_pred chhhHHHhhcCCCcceeeeeecCCCcchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccCceEEEEee
Confidence 35888999999999999999988888999998753 45667788999999999995 9999999999999999999999
Q ss_pred cCCCCChhhHhhhcCCCCcCChhHHHHHHHHHHHHHHHhhhcCCCceEecccCcCcEEEcCCCCceEecccCccccCCCC
Q 004521 517 FMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDE 596 (747)
Q Consensus 517 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~ 596 (747)
|= .-+|..+|...... ...| .+..+..|++.++.++|+++ |||.||||.|+|+- .|.+||+|||+|..+..+.
T Consensus 441 ~G-d~DL~kiL~k~~~~-~~~~-~lk~ywkqML~aV~~IH~~g---IVHSDLKPANFLlV-kG~LKLIDFGIA~aI~~DT 513 (677)
T KOG0596|consen 441 CG-DIDLNKILKKKKSI-DPDW-FLKFYWKQMLLAVKTIHQHG---IVHSDLKPANFLLV-KGRLKLIDFGIANAIQPDT 513 (677)
T ss_pred cc-cccHHHHHHhccCC-CchH-HHHHHHHHHHHHHHHHHHhc---eeecCCCcccEEEE-eeeEEeeeechhcccCccc
Confidence 86 47899999654322 2234 67778899999999999999 99999999999984 5679999999999887776
Q ss_pred Cccccceeeecc--------------------CCCCCccccchhHHHHHHHHHhCCCCCCCCCCcchhhhhHhHHhcCCc
Q 004521 597 TEGNTNRVVGTY--------------------DGQFSIKSDVFSFGILLLEIVSGKKNRGFYRSDTKVNLIGHLWDEGIP 656 (747)
Q Consensus 597 ~~~~~~~~~~~~--------------------~~~~s~ksDVwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~ 656 (747)
+.......+||. .-..+.++||||+|||||+|+-|+.||..+. ..+.++
T Consensus 514 TsI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~~-----n~~aKl------ 582 (677)
T KOG0596|consen 514 TSIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQII-----NQIAKL------ 582 (677)
T ss_pred cceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHHH-----HHHHHH------
Confidence 655555555553 1136789999999999999999999976432 112221
Q ss_pred ccccchhh----hccCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 004521 657 LRLIDACI----QDSCNLADVIRCIHIGLLCVQQHPEDRPCMPSVILM 700 (747)
Q Consensus 657 ~~~~d~~l----~~~~~~~~~~~~~~l~~~Cl~~dP~~RPt~~~v~~~ 700 (747)
..+.++.. .......+ ++++|..||+.||.+||+..+|++.
T Consensus 583 ~aI~~P~~~Iefp~~~~~~~---li~~mK~CL~rdPkkR~si~eLLqh 627 (677)
T KOG0596|consen 583 HAITDPNHEIEFPDIPENDE---LIDVMKCCLARDPKKRWSIPELLQH 627 (677)
T ss_pred HhhcCCCccccccCCCCchH---HHHHHHHHHhcCcccCCCcHHHhcC
Confidence 11222211 11111112 7788889999999999999999863
|
|
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.5e-30 Score=277.46 Aligned_cols=255 Identities=22% Similarity=0.329 Sum_probs=180.0
Q ss_pred hcCCCccceecccCCeeEEEEEec-CCcEEEEEEecccc--cccHHHHHHHHHHHhccCCCceeeEEeEEEeCC------
Q 004521 439 TDNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKIS--EQGLKELKNEVILFSKLQHRNLVKLLGCCIQGE------ 509 (747)
Q Consensus 439 ~~~~~~~~~lg~G~fg~Vy~~~~~-~g~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~------ 509 (747)
.++|++.++||+|+||.||+|+.. +++.+|||++.... ......+.+|++++++++|+||+++++++....
T Consensus 7 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 86 (311)
T cd07866 7 LRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKRK 86 (311)
T ss_pred cccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhheeccccccccc
Confidence 478999999999999999999975 48899999986422 223356788999999999999999999876543
Q ss_pred --eeEEEEecCCCCChhhHhhhcCCCCcCChhHHHHHHHHHHHHHHHhhhcCCCceEecccCcCcEEEcCCCCceEeccc
Q 004521 510 --EKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFG 587 (747)
Q Consensus 510 --~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NIll~~~~~~kl~DFG 587 (747)
..++|+||+.. +|...+... ...+++..+..++.|+++||.|||+.+ |+|+||||+||++++++.+||+|||
T Consensus 87 ~~~~~lv~~~~~~-~l~~~~~~~--~~~~~~~~~~~i~~~l~~al~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg 160 (311)
T cd07866 87 RGSVYMVTPYMDH-DLSGLLENP--SVKLTESQIKCYMLQLLEGINYLHENH---ILHRDIKAANILIDNQGILKIADFG 160 (311)
T ss_pred CceEEEEEecCCc-CHHHHHhcc--ccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEECcCc
Confidence 35899999974 676666432 335899999999999999999999988 9999999999999999999999999
Q ss_pred CccccCCCCCcccc---------ceee-------ec-c--CCCCCccccchhHHHHHHHHHhCCCCCCCCCCcchhhhhH
Q 004521 588 LVRTFGGDETEGNT---------NRVV-------GT-Y--DGQFSIKSDVFSFGILLLEIVSGKKNRGFYRSDTKVNLIG 648 (747)
Q Consensus 588 la~~~~~~~~~~~~---------~~~~-------~~-~--~~~~s~ksDVwS~Gvvl~elltg~~p~~~~~~~~~~~~~~ 648 (747)
+++........... .... .. . ...++.++|||||||++|||++|+.|+...........+.
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~~~~~~~~ 240 (311)
T cd07866 161 LARPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQLHLIF 240 (311)
T ss_pred cchhccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence 99865433221110 0000 00 0 2357889999999999999999999975333221111111
Q ss_pred hHHhcCC---------cccccchhh--hccCCH-----HHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 004521 649 HLWDEGI---------PLRLIDACI--QDSCNL-----ADVIRCIHIGLLCVQQHPEDRPCMPSVIL 699 (747)
Q Consensus 649 ~~~~~~~---------~~~~~d~~l--~~~~~~-----~~~~~~~~l~~~Cl~~dP~~RPt~~~v~~ 699 (747)
....... .....+... ...... .....+.+++.+||+.||.+|||+.+++.
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~ell~ 307 (311)
T cd07866 241 KLCGTPTEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYKRLTASDALE 307 (311)
T ss_pred HHhCCCChhhchhhhhcccccccccCCCCCccHHHHcccCChhHHHHHHHHcccCcccCcCHHHHhc
Confidence 1100000 000000000 000000 11145678889999999999999999875
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.9e-30 Score=273.40 Aligned_cols=250 Identities=18% Similarity=0.194 Sum_probs=167.9
Q ss_pred cCCCccceecccCCeeEEEEEecCC----cEEEEEEecccccccH-----------HHHHHHHHHHhccCCCceeeEEeE
Q 004521 440 DNFSINNKLGEGGFGPVYKGTLVDG----QEIAVKRLSKISEQGL-----------KELKNEVILFSKLQHRNLVKLLGC 504 (747)
Q Consensus 440 ~~~~~~~~lg~G~fg~Vy~~~~~~g----~~vavK~l~~~~~~~~-----------~~~~~E~~~l~~l~H~niv~l~g~ 504 (747)
++|.+.++||+|+||.||+|...++ ..+|+|.......... .....+...+..+.|+||++++++
T Consensus 12 ~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~ 91 (294)
T PHA02882 12 KEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKYYGC 91 (294)
T ss_pred CceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcEEEe
Confidence 5799999999999999999997553 4566665432111111 112233445567789999999998
Q ss_pred EEeCC----eeEEEEecCCCCChhhHhhhcCCCCcCChhHHHHHHHHHHHHHHHhhhcCCCceEecccCcCcEEEcCCCC
Q 004521 505 CIQGE----EKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMN 580 (747)
Q Consensus 505 ~~~~~----~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NIll~~~~~ 580 (747)
+.... ..++++|++. .++.+.+... ...++..+..++.|+++||+|||+.+ |+||||||+|||++.++.
T Consensus 92 ~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~---~~~~~~~~~~i~~qi~~~l~~lH~~~---iiHrDiKp~Nill~~~~~ 164 (294)
T PHA02882 92 GSFKRCRMYYRFILLEKLV-ENTKEIFKRI---KCKNKKLIKNIMKDMLTTLEYIHEHG---ISHGDIKPENIMVDGNNR 164 (294)
T ss_pred eeEecCCceEEEEEEehhc-cCHHHHHHhh---ccCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCc
Confidence 76554 3467888764 4565555322 22567888999999999999999988 999999999999999999
Q ss_pred ceEecccCccccCCCCCcc-----ccceeeec---------cCCCCCccccchhHHHHHHHHHhCCCCCCCCCCcchhhh
Q 004521 581 PKISDFGLVRTFGGDETEG-----NTNRVVGT---------YDGQFSIKSDVFSFGILLLEIVSGKKNRGFYRSDTKVNL 646 (747)
Q Consensus 581 ~kl~DFGla~~~~~~~~~~-----~~~~~~~~---------~~~~~s~ksDVwS~Gvvl~elltg~~p~~~~~~~~~~~~ 646 (747)
+||+|||+|+.+....... ......++ .+..++.++|||||||+||||++|+.||........ .
T Consensus 165 ~~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~el~~g~~P~~~~~~~~~--~ 242 (294)
T PHA02882 165 GYIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLPWKGFGHNGN--L 242 (294)
T ss_pred EEEEEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCccccchH--H
Confidence 9999999998764322110 00011122 145689999999999999999999999864422211 1
Q ss_pred hHhHHhcCCcccccchhhhccCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhc
Q 004521 647 IGHLWDEGIPLRLIDACIQDSCNLADVIRCIHIGLLCVQQHPEDRPCMPSVILMLG 702 (747)
Q Consensus 647 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dP~~RPt~~~v~~~L~ 702 (747)
+... ..+....+....+..... ...+.+++..|++.+|++||++.+|++.|+
T Consensus 243 ~~~~-~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~rp~~~~l~~~~~ 294 (294)
T PHA02882 243 IHAA-KCDFIKRLHEGKIKIKNA---NKFIYDFIECVTKLSYEEKPDYDALIKIFD 294 (294)
T ss_pred HHHh-HHHHHHHhhhhhhccCCC---CHHHHHHHHHHHhCCCCCCCCHHHHHHhhC
Confidence 1110 000001111111111111 133567777999999999999999999874
|
|
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.7e-30 Score=266.20 Aligned_cols=244 Identities=19% Similarity=0.241 Sum_probs=175.2
Q ss_pred HHHHHhcCCCcccee--cccCCeeEEEEEec-CCcEEEEEEecccccccHHHHHHHHHHHhcc-CCCceeeEEeEEEeCC
Q 004521 434 TIANATDNFSINNKL--GEGGFGPVYKGTLV-DGQEIAVKRLSKISEQGLKELKNEVILFSKL-QHRNLVKLLGCCIQGE 509 (747)
Q Consensus 434 ~~~~~~~~~~~~~~l--g~G~fg~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~ 509 (747)
+.....++|++.+.+ |+|+||.||+++.. ++..+|+|.+....... . |+.....+ +||||+++++++...+
T Consensus 8 ~~~~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~---~--e~~~~~~~~~h~~iv~~~~~~~~~~ 82 (267)
T PHA03390 8 ELVQFLKNCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNA---I--EPMVHQLMKDNPNFIKLYYSVTTLK 82 (267)
T ss_pred HHHHHHHhhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcch---h--hHHHHHHhhcCCCEEEEEEEEecCC
Confidence 334445677777776 99999999999875 47889999986522111 1 22222222 7999999999999999
Q ss_pred eeEEEEecCCCCChhhHhhhcCCCCcCChhHHHHHHHHHHHHHHHhhhcCCCceEecccCcCcEEEcCCC-CceEecccC
Q 004521 510 EKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDM-NPKISDFGL 588 (747)
Q Consensus 510 ~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NIll~~~~-~~kl~DFGl 588 (747)
..++||||+++++|.+++... ..+++.++..++.||++||.|||+.+ ++||||||+||+++.++ .++|+|||+
T Consensus 83 ~~~iv~e~~~~~~L~~~l~~~---~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~~l~dfg~ 156 (267)
T PHA03390 83 GHVLIMDYIKDGDLFDLLKKE---GKLSEAEVKKIIRQLVEALNDLHKHN---IIHNDIKLENVLYDRAKDRIYLCDYGL 156 (267)
T ss_pred eeEEEEEcCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEEeCCCCeEEEecCcc
Confidence 999999999999999998543 26899999999999999999999988 99999999999999998 999999999
Q ss_pred ccccCCCCCccccceeeec---cCCCCCccccchhHHHHHHHHHhCCCCCCCCCCcchhhhhHhHHhc-CCcccccchhh
Q 004521 589 VRTFGGDETEGNTNRVVGT---YDGQFSIKSDVFSFGILLLEIVSGKKNRGFYRSDTKVNLIGHLWDE-GIPLRLIDACI 664 (747)
Q Consensus 589 a~~~~~~~~~~~~~~~~~~---~~~~~s~ksDVwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~-~~~~~~~d~~l 664 (747)
++................+ ....++.++|||||||++|||++|+.|+....... .. ....... ........
T Consensus 157 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~-~~-~~~~~~~~~~~~~~~~--- 231 (267)
T PHA03390 157 CKIIGTPSCYDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDEE-LD-LESLLKRQQKKLPFIK--- 231 (267)
T ss_pred ceecCCCccCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCcch-hh-HHHHHHhhcccCCccc---
Confidence 8876543322111111111 14567889999999999999999999976322111 11 1111111 11111110
Q ss_pred hccCCHHHHHHHHHHHHhccCCCCCCCCC-HHHHHH
Q 004521 665 QDSCNLADVIRCIHIGLLCVQQHPEDRPC-MPSVIL 699 (747)
Q Consensus 665 ~~~~~~~~~~~~~~l~~~Cl~~dP~~RPt-~~~v~~ 699 (747)
..-..+.+++.+||+.+|.+||+ +.++++
T Consensus 232 ------~~~~~~~~li~~~l~~~p~~R~~~~~~~l~ 261 (267)
T PHA03390 232 ------NVSKNANDFVQSMLKYNINYRLTNYNEIIK 261 (267)
T ss_pred ------ccCHHHHHHHHHHhccChhhCCchHHHHhc
Confidence 11223566778999999999996 688874
|
|
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.6e-30 Score=294.44 Aligned_cols=192 Identities=23% Similarity=0.379 Sum_probs=146.0
Q ss_pred HHhcCCCccceecccCCeeEEEEEecC--CcEEEEE------------------EecccccccHHHHHHHHHHHhccCCC
Q 004521 437 NATDNFSINNKLGEGGFGPVYKGTLVD--GQEIAVK------------------RLSKISEQGLKELKNEVILFSKLQHR 496 (747)
Q Consensus 437 ~~~~~~~~~~~lg~G~fg~Vy~~~~~~--g~~vavK------------------~l~~~~~~~~~~~~~E~~~l~~l~H~ 496 (747)
...++|++.++||+|+||+||++.+.. +...++| .+. ........+.+|+.++++++||
T Consensus 145 ~~~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~-~~~~~~~~~~~Ei~il~~l~Hp 223 (501)
T PHA03210 145 EFLAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVK-AGSRAAIQLENEILALGRLNHE 223 (501)
T ss_pred hhhhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhh-cchHHHHHHHHHHHHHHhCCCC
Confidence 345789999999999999999987643 2222222 111 1223345688999999999999
Q ss_pred ceeeEEeEEEeCCeeEEEEecCCCCChhhHhhhcCC--CCcCChhHHHHHHHHHHHHHHHhhhcCCCceEecccCcCcEE
Q 004521 497 NLVKLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQTR--RTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVL 574 (747)
Q Consensus 497 niv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~--~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NIl 574 (747)
||+++++++...+..++|+|++. ++|.+++..... ........+..|+.||+.||+|||+.+ |+||||||+|||
T Consensus 224 nIv~l~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~g---IiHrDLKP~NIL 299 (501)
T PHA03210 224 NILKIEEILRSEANTYMITQKYD-FDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDKK---LIHRDIKLENIF 299 (501)
T ss_pred CcCcEeEEEEECCeeEEEEeccc-cCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEE
Confidence 99999999999999999999985 677777654221 112335667789999999999999988 999999999999
Q ss_pred EcCCCCceEecccCccccCCCCCccccceeeec---------cCCCCCccccchhHHHHHHHHHhCCCC
Q 004521 575 LDQDMNPKISDFGLVRTFGGDETEGNTNRVVGT---------YDGQFSIKSDVFSFGILLLEIVSGKKN 634 (747)
Q Consensus 575 l~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~~---------~~~~~s~ksDVwS~Gvvl~elltg~~p 634 (747)
|+.++.+||+|||+++.+......... ...|+ ....++.++|||||||+||||++|+.+
T Consensus 300 l~~~~~vkL~DFGla~~~~~~~~~~~~-~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~~~~~ 367 (501)
T PHA03210 300 LNCDGKIVLGDFGTAMPFEKEREAFDY-GWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDFC 367 (501)
T ss_pred ECCCCCEEEEeCCCceecCcccccccc-cccCCcCCCCchhhcCCCCCcHHHHHHHHHHHHHHHHCCCC
Confidence 999999999999999876433221110 01111 145688999999999999999999864
|
|
| >KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.7e-31 Score=287.02 Aligned_cols=194 Identities=28% Similarity=0.435 Sum_probs=164.1
Q ss_pred CCccceecccCCeeEEEEEec-CCcEEEEEEeccc-ccccHHHHHHHHHHHhccCCCceeeEEeEEEeCC------eeEE
Q 004521 442 FSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKI-SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGE------EKLL 513 (747)
Q Consensus 442 ~~~~~~lg~G~fg~Vy~~~~~-~g~~vavK~l~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~------~~~l 513 (747)
+...+.||+|+||.||+|+.+ .|+.||||.+++. .....+...+|+++|++++|+|||++++.-.+.. ...+
T Consensus 15 W~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~~vl 94 (732)
T KOG4250|consen 15 WEMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKESSLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRLPVL 94 (732)
T ss_pred eeehhhhcCCccceeeeecccccccchhHHhhhhhcccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccccceE
Confidence 445688999999999999965 4999999999873 3345567889999999999999999999866544 5689
Q ss_pred EEecCCCCChhhHhhhcCCCCcCChhHHHHHHHHHHHHHHHhhhcCCCceEecccCcCcEEE--cCCC--CceEecccCc
Q 004521 514 IYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLL--DQDM--NPKISDFGLV 589 (747)
Q Consensus 514 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NIll--~~~~--~~kl~DFGla 589 (747)
|||||.+|||...|.+.....-|++.+.+.+..+++.||.|||+++ |+||||||.||++ .++| .-||+|||.|
T Consensus 95 vmEyC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~LrEn~---IvHRDlKP~NIvl~~Gedgq~IyKLtDfG~A 171 (732)
T KOG4250|consen 95 VMEYCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLRENG---IVHRDLKPGNIVLQIGEDGQSIYKLTDFGAA 171 (732)
T ss_pred EEeecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHHHcC---ceeccCCCCcEEEeecCCCceEEeeeccccc
Confidence 9999999999999988877778999999999999999999999998 9999999999998 3334 3699999999
Q ss_pred cccCCCCCccccceeeecc----------CCCCCccccchhHHHHHHHHHhCCCCCCCCCCc
Q 004521 590 RTFGGDETEGNTNRVVGTY----------DGQFSIKSDVFSFGILLLEIVSGKKNRGFYRSD 641 (747)
Q Consensus 590 ~~~~~~~~~~~~~~~~~~~----------~~~~s~ksDVwS~Gvvl~elltg~~p~~~~~~~ 641 (747)
|.+..+. ....++||. .+.|+..+|.|||||++||..||..||......
T Consensus 172 rel~d~s---~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~~~p 230 (732)
T KOG4250|consen 172 RELDDNS---LFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPFGGP 230 (732)
T ss_pred ccCCCCC---eeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcCCCc
Confidence 9886655 233345552 378999999999999999999999998755443
|
|
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.7e-30 Score=275.16 Aligned_cols=248 Identities=20% Similarity=0.216 Sum_probs=175.6
Q ss_pred cceecccCCeeEEEEEecCCcEEEEEEeccc--ccccHHHHHHHHHHHhccCCCceeeEEeEEEeCCeeEEEEecCCCCC
Q 004521 445 NNKLGEGGFGPVYKGTLVDGQEIAVKRLSKI--SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMPNKS 522 (747)
Q Consensus 445 ~~~lg~G~fg~Vy~~~~~~g~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gs 522 (747)
.+.+|.|+++.||+++. +++.||||++... .....+.+.+|++++++++|+||+++++++...+..+++|||+++++
T Consensus 7 ~~~~~~~~~v~~~~~~~-~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~~~~ 85 (314)
T cd08216 7 GKCFEDLMIVHLAKHKP-TNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAYGS 85 (314)
T ss_pred hHhhcCCceEEEEEecC-CCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEeccCCCC
Confidence 34455555555555544 5899999998753 34556789999999999999999999999999999999999999999
Q ss_pred hhhHhhhcCCCCcCChhHHHHHHHHHHHHHHHhhhcCCCceEecccCcCcEEEcCCCCceEecccCccccCCCCCc----
Q 004521 523 LDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETE---- 598 (747)
Q Consensus 523 L~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~---- 598 (747)
|.+++..... ..+++..+..++.|+++||.|||+.+ |+||||||+||+++.++.+||+|||.+..+......
T Consensus 86 l~~~l~~~~~-~~~~~~~~~~~~~~l~~~L~~LH~~~---ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~~~~~ 161 (314)
T cd08216 86 CEDLLKTHFP-EGLPELAIAFILKDVLNALDYIHSKG---FIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVV 161 (314)
T ss_pred HHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCcceEEEecCCceEEecCccceeecccccccccc
Confidence 9999965432 34788899999999999999999988 999999999999999999999999988755322110
Q ss_pred -cccc-------eeeec-c---CCCCCccccchhHHHHHHHHHhCCCCCCCCCCcchhhhhHhHHhcCC-----------
Q 004521 599 -GNTN-------RVVGT-Y---DGQFSIKSDVFSFGILLLEIVSGKKNRGFYRSDTKVNLIGHLWDEGI----------- 655 (747)
Q Consensus 599 -~~~~-------~~~~~-~---~~~~s~ksDVwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~----------- 655 (747)
.... ..... . ...++.++|||||||++|||++|+.||....... ...... ....
T Consensus 162 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~~--~~~~~~-~~~~~~~~~~~~~~~ 238 (314)
T cd08216 162 HDFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQ--MLLEKV-RGTVPCLLDKSTYPL 238 (314)
T ss_pred ccccccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHH--HHHHHH-hccCccccccCchhh
Confidence 0000 00000 0 1347889999999999999999999975322111 111110 0000
Q ss_pred ----ccc----ccchh----hhccCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 004521 656 ----PLR----LIDAC----IQDSCNLADVIRCIHIGLLCVQQHPEDRPCMPSVILM 700 (747)
Q Consensus 656 ----~~~----~~d~~----l~~~~~~~~~~~~~~l~~~Cl~~dP~~RPt~~~v~~~ 700 (747)
... ..+.. .........-..+.+++.+||+.||++|||+.++++.
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~ 295 (314)
T cd08216 239 YEDSMSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLNH 295 (314)
T ss_pred hcCCcCcccccccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhcC
Confidence 000 00000 0001111112356778899999999999999998763
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.1e-30 Score=274.14 Aligned_cols=243 Identities=26% Similarity=0.359 Sum_probs=181.5
Q ss_pred CCCccceecccCCeeEEEEEecC-CcEEEEEEeccc---ccccHHHHHHHHHHHhccCCCceeeEEeEEEeCCeeEEEEe
Q 004521 441 NFSINNKLGEGGFGPVYKGTLVD-GQEIAVKRLSKI---SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYE 516 (747)
Q Consensus 441 ~~~~~~~lg~G~fg~Vy~~~~~~-g~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E 516 (747)
.|+..+.||+|+||.||+|+... ++.+|+|.+... .....+++.+|+++++.++|+|++++++++......++|||
T Consensus 16 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 95 (308)
T cd06634 16 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVME 95 (308)
T ss_pred HHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCCeeEEEEE
Confidence 46667899999999999999754 789999998642 22334578899999999999999999999999999999999
Q ss_pred cCCCCChhhHhhhcCCCCcCChhHHHHHHHHHHHHHHHhhhcCCCceEecccCcCcEEEcCCCCceEecccCccccCCCC
Q 004521 517 FMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDE 596 (747)
Q Consensus 517 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~ 596 (747)
|+. |+|.+++... ...+++.++..++.|++.||.|||+.+ ++||||||+||+++.++.+||+|||++.......
T Consensus 96 ~~~-~~l~~~~~~~--~~~l~~~~~~~~~~~l~~~l~~LH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~ 169 (308)
T cd06634 96 YCL-GSASDLLEVH--KKPLQEVEIAAVTHGALQGLAYLHSHN---MIHRDVKAGNILLSEPGLVKLGDFGSASIMAPAN 169 (308)
T ss_pred ccC-CCHHHHHHHc--CCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHhEEECCCCcEEECCcccceeecCcc
Confidence 996 6887777543 234789999999999999999999988 9999999999999999999999999988654332
Q ss_pred Ccccccee-e-----eccCCCCCccccchhHHHHHHHHHhCCCCCCCCCCcchhhhhHhHHhcCCcccccchhhhccCCH
Q 004521 597 TEGNTNRV-V-----GTYDGQFSIKSDVFSFGILLLEIVSGKKNRGFYRSDTKVNLIGHLWDEGIPLRLIDACIQDSCNL 670 (747)
Q Consensus 597 ~~~~~~~~-~-----~~~~~~~s~ksDVwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~ 670 (747)
........ . +.....++.++|||||||++|||++|+.|+...... ...... ..+....... .
T Consensus 170 ~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~---~~~~~~-~~~~~~~~~~----~---- 237 (308)
T cd06634 170 XFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAM---SALYHI-AQNESPALQS----G---- 237 (308)
T ss_pred cccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccHH---HHHHHH-hhcCCCCcCc----c----
Confidence 21111111 0 111345788999999999999999999996432211 111111 1111111110 0
Q ss_pred HHHHHHHHHHHhccCCCCCCCCCHHHHHHHh
Q 004521 671 ADVIRCIHIGLLCVQQHPEDRPCMPSVILML 701 (747)
Q Consensus 671 ~~~~~~~~l~~~Cl~~dP~~RPt~~~v~~~L 701 (747)
.....+.+++.+||+.+|++||++.+|++..
T Consensus 238 ~~~~~~~~li~~cl~~~P~~Rp~~~~ll~~~ 268 (308)
T cd06634 238 HWSEYFRNFVDSCLQKIPQDRPTSEVLLKHR 268 (308)
T ss_pred cccHHHHHHHHHHhhCCcccCCCHHHHhhCc
Confidence 1112355677899999999999999998764
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.7e-30 Score=263.29 Aligned_cols=244 Identities=23% Similarity=0.339 Sum_probs=188.6
Q ss_pred CCCccceecccCCeeEEEEEec-CCcEEEEEEecccc--cccHHHHHHHHHHHhccCCCceeeEEeEEEeCCeeEEEEec
Q 004521 441 NFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKIS--EQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEF 517 (747)
Q Consensus 441 ~~~~~~~lg~G~fg~Vy~~~~~-~g~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~ 517 (747)
+|.+.+.||+|+||.||++... +++.+|+|++.... ....+.+.+|+++++.++|+|++++++.+......++|+||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~lv~e~ 80 (258)
T cd08215 1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEEKGKLCIVMEY 80 (258)
T ss_pred CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEEecCCEEEEEEEe
Confidence 4778899999999999999975 48899999987532 25567889999999999999999999999999999999999
Q ss_pred CCCCChhhHhhhcC-CCCcCChhHHHHHHHHHHHHHHHhhhcCCCceEecccCcCcEEEcCCCCceEecccCccccCCCC
Q 004521 518 MPNKSLDSFIFDQT-RRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDE 596 (747)
Q Consensus 518 ~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~ 596 (747)
+++++|.+++.... ....+++..+..++.+++.||.|||+.+ ++|+||+|+||+++.++.+||+|||++.......
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~---~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~ 157 (258)
T cd08215 81 ADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSRK---ILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTV 157 (258)
T ss_pred cCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhCC---EecccCChHHeEEcCCCcEEECCccceeecccCc
Confidence 99999999986532 2356899999999999999999999988 9999999999999999999999999998765443
Q ss_pred Cccccce----eee---ccCCCCCccccchhHHHHHHHHHhCCCCCCCCCCcchhhhhHhHHhcCCcccccchhhhccCC
Q 004521 597 TEGNTNR----VVG---TYDGQFSIKSDVFSFGILLLEIVSGKKNRGFYRSDTKVNLIGHLWDEGIPLRLIDACIQDSCN 669 (747)
Q Consensus 597 ~~~~~~~----~~~---~~~~~~s~ksDVwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~ 669 (747)
....... ... .....++.++||||+|+++++|++|+.|+.... ......... ......+.. ..
T Consensus 158 ~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~---~~~~~~~~~-~~~~~~~~~-----~~- 227 (258)
T cd08215 158 DLAKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGEN---LLELALKIL-KGQYPPIPS-----QY- 227 (258)
T ss_pred ceecceeeeecccChhHhccCCCCccccHHHHHHHHHHHHcCCCCCCCCc---HHHHHHHHh-cCCCCCCCC-----CC-
Confidence 1111000 000 014557889999999999999999999964332 112222221 111111111 11
Q ss_pred HHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 004521 670 LADVIRCIHIGLLCVQQHPEDRPCMPSVILM 700 (747)
Q Consensus 670 ~~~~~~~~~l~~~Cl~~dP~~RPt~~~v~~~ 700 (747)
...+.+++.+||+.+|++||++.++++.
T Consensus 228 ---~~~~~~~i~~~l~~~p~~Rp~~~~ll~~ 255 (258)
T cd08215 228 ---SSELRNLVSSLLQKDPEERPSIAQILQS 255 (258)
T ss_pred ---CHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 1235677889999999999999999763
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.1e-30 Score=269.14 Aligned_cols=238 Identities=24% Similarity=0.299 Sum_probs=181.3
Q ss_pred ecccCCeeEEEEEecC-CcEEEEEEeccccc---ccHHHHHHHHHHHhccCCCceeeEEeEEEeCCeeEEEEecCCCCCh
Q 004521 448 LGEGGFGPVYKGTLVD-GQEIAVKRLSKISE---QGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMPNKSL 523 (747)
Q Consensus 448 lg~G~fg~Vy~~~~~~-g~~vavK~l~~~~~---~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gsL 523 (747)
||+|+||.||+++... ++.+++|.+..... ...+.+.+|++++++++||||+++++.+..+...++||||+++++|
T Consensus 1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (265)
T cd05579 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGDL 80 (265)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecCCCCcH
Confidence 6899999999999875 89999999875322 4566789999999999999999999999999999999999999999
Q ss_pred hhHhhhcCCCCcCChhHHHHHHHHHHHHHHHhhhcCCCceEecccCcCcEEEcCCCCceEecccCccccCCCCCcc----
Q 004521 524 DSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEG---- 599 (747)
Q Consensus 524 ~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~---- 599 (747)
.+++.... .+++..+..++.||++||+|||+.+ ++|+||+|+||++++++.+||+|||++..........
T Consensus 81 ~~~l~~~~---~~~~~~~~~i~~qi~~~L~~lH~~~---i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~ 154 (265)
T cd05579 81 ASLLENVG---SLDEDVARIYIAEIVLALEYLHSNG---IIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDD 154 (265)
T ss_pred HHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHcC---eecCCCCHHHeEEcCCCCEEEEecccchhcccCcccccccc
Confidence 99986532 5899999999999999999999988 9999999999999999999999999987643321100
Q ss_pred --ccceeeec---------cCCCCCccccchhHHHHHHHHHhCCCCCCCCCCcchhhhhHhHHhcCCcccccchhhhccC
Q 004521 600 --NTNRVVGT---------YDGQFSIKSDVFSFGILLLEIVSGKKNRGFYRSDTKVNLIGHLWDEGIPLRLIDACIQDSC 668 (747)
Q Consensus 600 --~~~~~~~~---------~~~~~s~ksDVwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~ 668 (747)
......+. .....+.++||||||+++|||++|+.|+..... ....... ..+... ...
T Consensus 155 ~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~---~~~~~~~-~~~~~~-~~~------- 222 (265)
T cd05579 155 EKEDKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGETP---EEIFQNI-LNGKIE-WPE------- 222 (265)
T ss_pred cccccCcccCccccCHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCH---HHHHHHH-hcCCcC-CCc-------
Confidence 00000000 134477899999999999999999999753321 1111111 111111 000
Q ss_pred CHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhcC
Q 004521 669 NLADVIRCIHIGLLCVQQHPEDRPCMPSVILMLGS 703 (747)
Q Consensus 669 ~~~~~~~~~~l~~~Cl~~dP~~RPt~~~v~~~L~~ 703 (747)
.......+..++.+||+.+|.+||++.++.+.|+.
T Consensus 223 ~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~~~~l~~ 257 (265)
T cd05579 223 DVEVSDEAIDLISKLLVPDPEKRLGAKSIEEIKNH 257 (265)
T ss_pred cccCCHHHHHHHHHHhcCCHhhcCCCccHHHHhcC
Confidence 00012345678889999999999999777777764
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.6e-30 Score=271.16 Aligned_cols=243 Identities=22% Similarity=0.260 Sum_probs=179.2
Q ss_pred CCCccceecccCCeeEEEEEec----CCcEEEEEEecccc----cccHHHHHHHHHHHhcc-CCCceeeEEeEEEeCCee
Q 004521 441 NFSINNKLGEGGFGPVYKGTLV----DGQEIAVKRLSKIS----EQGLKELKNEVILFSKL-QHRNLVKLLGCCIQGEEK 511 (747)
Q Consensus 441 ~~~~~~~lg~G~fg~Vy~~~~~----~g~~vavK~l~~~~----~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~ 511 (747)
+|++.+.||+|+||.||+++.. +|+.||+|+++... ....+.+.+|+.++.++ +|+||+++++++..+...
T Consensus 1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (290)
T cd05613 1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKL 80 (290)
T ss_pred CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCeE
Confidence 4778899999999999999863 58899999987522 22346788999999999 599999999999999999
Q ss_pred EEEEecCCCCChhhHhhhcCCCCcCChhHHHHHHHHHHHHHHHhhhcCCCceEecccCcCcEEEcCCCCceEecccCccc
Q 004521 512 LLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRT 591 (747)
Q Consensus 512 ~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NIll~~~~~~kl~DFGla~~ 591 (747)
++||||+++++|.+++... ..+++..+..++.|+++||.|||+.+ ++||||+|+|||++.++.+||+|||+++.
T Consensus 81 ~lv~e~~~~~~L~~~l~~~---~~l~~~~~~~~~~qi~~al~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~ 154 (290)
T cd05613 81 HLILDYINGGELFTHLSQR---ERFKEQEVQIYSGEIVLALEHLHKLG---IIYRDIKLENILLDSNGHVVLTDFGLSKE 154 (290)
T ss_pred EEEEecCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeEECCCCCEEEeeCcccee
Confidence 9999999999999998643 34788899999999999999999988 99999999999999999999999999987
Q ss_pred cCCCCCcccc------ceeeec----cCCCCCccccchhHHHHHHHHHhCCCCCCCCCCcchhhhhHhHHhcCCcccccc
Q 004521 592 FGGDETEGNT------NRVVGT----YDGQFSIKSDVFSFGILLLEIVSGKKNRGFYRSDTKVNLIGHLWDEGIPLRLID 661 (747)
Q Consensus 592 ~~~~~~~~~~------~~~~~~----~~~~~s~ksDVwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~d 661 (747)
+......... ...... ....++.++||||||+++|||++|+.|+...........+......... .
T Consensus 155 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~-~--- 230 (290)
T cd05613 155 FHEDEVERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEP-P--- 230 (290)
T ss_pred cccccccccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCccccHHHHHHHhhccCC-C---
Confidence 6432211100 000000 1234678999999999999999999997533221111111111111100 0
Q ss_pred hhhhccCCHHHHHHHHHHHHhccCCCCCCCC-----CHHHHHH
Q 004521 662 ACIQDSCNLADVIRCIHIGLLCVQQHPEDRP-----CMPSVIL 699 (747)
Q Consensus 662 ~~l~~~~~~~~~~~~~~l~~~Cl~~dP~~RP-----t~~~v~~ 699 (747)
.... ....+..++.+||+.+|++|| +..+++.
T Consensus 231 --~~~~----~~~~~~~ll~~~l~~~p~~R~~~~~~~~~~l~~ 267 (290)
T cd05613 231 --YPQE----MSALAKDIIQRLLMKDPKKRLGCGPSDADEIKK 267 (290)
T ss_pred --CCcc----CCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHc
Confidence 0011 112355777899999999997 5555544
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.8e-30 Score=280.53 Aligned_cols=254 Identities=20% Similarity=0.268 Sum_probs=182.2
Q ss_pred hcCCCccceecccCCeeEEEEEec-CCcEEEEEEeccc--ccccHHHHHHHHHHHhccCCCceeeEEeEEEeC-----Ce
Q 004521 439 TDNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKI--SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQG-----EE 510 (747)
Q Consensus 439 ~~~~~~~~~lg~G~fg~Vy~~~~~-~g~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~-----~~ 510 (747)
.++|.+.+.||+|+||.||+|+.. +++.||||.+... .......+.+|+.+++.++|+||+++++++... ..
T Consensus 4 ~~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~~ 83 (337)
T cd07858 4 DTKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFND 83 (337)
T ss_pred ccceeEEEEeccCCCeEEEEEEecCCCCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHheecccccccCc
Confidence 357889999999999999999975 4899999998752 233456778899999999999999999988654 34
Q ss_pred eEEEEecCCCCChhhHhhhcCCCCcCChhHHHHHHHHHHHHHHHhhhcCCCceEecccCcCcEEEcCCCCceEecccCcc
Q 004521 511 KLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVR 590 (747)
Q Consensus 511 ~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NIll~~~~~~kl~DFGla~ 590 (747)
.++||||+. ++|.+++.. ...+++..+..++.|++.||.|||+.+ ++||||||+||+++.++.+||+|||+++
T Consensus 84 ~~lv~e~~~-~~L~~~~~~---~~~l~~~~~~~i~~qi~~aL~~LH~~~---i~H~dlkp~Nil~~~~~~~kL~Dfg~~~ 156 (337)
T cd07858 84 VYIVYELMD-TDLHQIIRS---SQTLSDDHCQYFLYQLLRGLKYIHSAN---VLHRDLKPSNLLLNANCDLKICDFGLAR 156 (337)
T ss_pred EEEEEeCCC-CCHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCEEECcCcccc
Confidence 799999996 788888753 245899999999999999999999988 9999999999999999999999999998
Q ss_pred ccCCCCCcccc-----ceeeec-c--CCCCCccccchhHHHHHHHHHhCCCCCCCCCCcchhhhhHhHHhcCC-------
Q 004521 591 TFGGDETEGNT-----NRVVGT-Y--DGQFSIKSDVFSFGILLLEIVSGKKNRGFYRSDTKVNLIGHLWDEGI------- 655 (747)
Q Consensus 591 ~~~~~~~~~~~-----~~~~~~-~--~~~~s~ksDVwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~------- 655 (747)
........... ...... . ...++.++|||||||++|||++|+.||...........+........
T Consensus 157 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (337)
T cd07858 157 TTSEKGDFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLITELLGSPSEEDLGFI 236 (337)
T ss_pred ccCCCcccccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCChHHhhhc
Confidence 76433111100 000011 1 24578899999999999999999999753221111111111000000
Q ss_pred ----c-------ccccchhhhccCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 004521 656 ----P-------LRLIDACIQDSCNLADVIRCIHIGLLCVQQHPEDRPCMPSVILM 700 (747)
Q Consensus 656 ----~-------~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dP~~RPt~~~v~~~ 700 (747)
. ....+...... .......+.+++.+||+.+|++||++.++++.
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h 291 (337)
T cd07858 237 RNEKARRYIRSLPYTPRQSFARL-FPHANPLAIDLLEKMLVFDPSKRITVEEALAH 291 (337)
T ss_pred CchhhhHHHHhcCcccccCHHHH-cccCCHHHHHHHHHHhcCChhhccCHHHHHcC
Confidence 0 00000000000 00112346688889999999999999999876
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=99.97 E-value=5e-30 Score=269.44 Aligned_cols=237 Identities=22% Similarity=0.272 Sum_probs=171.5
Q ss_pred eecccCCeeEEEEEecC-CcEEEEEEecccc---cccHHHHHHHHHHH---hccCCCceeeEEeEEEeCCeeEEEEecCC
Q 004521 447 KLGEGGFGPVYKGTLVD-GQEIAVKRLSKIS---EQGLKELKNEVILF---SKLQHRNLVKLLGCCIQGEEKLLIYEFMP 519 (747)
Q Consensus 447 ~lg~G~fg~Vy~~~~~~-g~~vavK~l~~~~---~~~~~~~~~E~~~l---~~l~H~niv~l~g~~~~~~~~~lV~E~~~ 519 (747)
.||+|+||.||++...+ ++.+|+|.+.+.. ......+.+|..++ ...+||||+++++++...+..++||||++
T Consensus 1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~ 80 (279)
T cd05633 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLMN 80 (279)
T ss_pred CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEecCC
Confidence 48999999999999754 8899999986521 12223344454433 34479999999999999999999999999
Q ss_pred CCChhhHhhhcCCCCcCChhHHHHHHHHHHHHHHHhhhcCCCceEecccCcCcEEEcCCCCceEecccCccccCCCCCcc
Q 004521 520 NKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEG 599 (747)
Q Consensus 520 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~ 599 (747)
+++|.+++... ..+++..+..++.|++.||.|||+.+ |+||||||+|||+++++.+||+|||++..........
T Consensus 81 ~~~L~~~i~~~---~~l~~~~~~~i~~qi~~al~~lH~~~---ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~~~~~~ 154 (279)
T cd05633 81 GGDLHYHLSQH---GVFSEKEMRFYATEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHA 154 (279)
T ss_pred CCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---cCCCCCCHHHEEECCCCCEEEccCCcceeccccCccC
Confidence 99999988543 35899999999999999999999988 9999999999999999999999999987653322111
Q ss_pred ---ccceeeec-c--CCCCCccccchhHHHHHHHHHhCCCCCCCCCCcchhhhhHhHHhcCCcccccchhhhccCCHHHH
Q 004521 600 ---NTNRVVGT-Y--DGQFSIKSDVFSFGILLLEIVSGKKNRGFYRSDTKVNLIGHLWDEGIPLRLIDACIQDSCNLADV 673 (747)
Q Consensus 600 ---~~~~~~~~-~--~~~~s~ksDVwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~ 673 (747)
........ . +..++.++|||||||++|||++|..||......... .+..... ..... +.... .
T Consensus 155 ~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~-~~~~~~~-~~~~~-----~~~~~----~ 223 (279)
T cd05633 155 SVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKH-EIDRMTL-TVNVE-----LPDSF----S 223 (279)
T ss_pred cCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCHH-HHHHHhh-cCCcC-----Ccccc----C
Confidence 00000011 1 245788999999999999999999997543322211 1111110 00111 11111 1
Q ss_pred HHHHHHHHhccCCCCCCCC-----CHHHHHHH
Q 004521 674 IRCIHIGLLCVQQHPEDRP-----CMPSVILM 700 (747)
Q Consensus 674 ~~~~~l~~~Cl~~dP~~RP-----t~~~v~~~ 700 (747)
..+.+++.+||+.||.+|| ++.+++++
T Consensus 224 ~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~h 255 (279)
T cd05633 224 PELKSLLEGLLQRDVSKRLGCLGRGAQEVKEH 255 (279)
T ss_pred HHHHHHHHHHhcCCHHHhcCCCCCCHHHHHhC
Confidence 2355677899999999999 59988875
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1e-29 Score=271.70 Aligned_cols=241 Identities=25% Similarity=0.388 Sum_probs=179.2
Q ss_pred CCccceecccCCeeEEEEEec-CCcEEEEEEecccc---cccHHHHHHHHHHHhccCCCceeeEEeEEEeCCeeEEEEec
Q 004521 442 FSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKIS---EQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEF 517 (747)
Q Consensus 442 ~~~~~~lg~G~fg~Vy~~~~~-~g~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~ 517 (747)
|...+.||+|+||.||+|+.. +++.|++|++.... ....+.+.+|+++++.++|||++++++++.+....++||||
T Consensus 23 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 102 (313)
T cd06633 23 FVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVMEY 102 (313)
T ss_pred hhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEEec
Confidence 555678999999999999975 48899999986432 23345788999999999999999999999999999999999
Q ss_pred CCCCChhhHhhhcCCCCcCChhHHHHHHHHHHHHHHHhhhcCCCceEecccCcCcEEEcCCCCceEecccCccccCCCCC
Q 004521 518 MPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDET 597 (747)
Q Consensus 518 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~ 597 (747)
+. ++|.+++... ...+++.++..++.||+.||.|||+.+ ++|+||+|+||+++.++.+||+|||++........
T Consensus 103 ~~-~~l~~~l~~~--~~~l~~~~~~~~~~qi~~al~~LH~~g---i~H~dl~p~nili~~~~~~kL~dfg~~~~~~~~~~ 176 (313)
T cd06633 103 CL-GSASDLLEVH--KKPLQEVEIAAITHGALQGLAYLHSHN---MIHRDIKAGNILLTEPGQVKLADFGSASKSSPANS 176 (313)
T ss_pred CC-CCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCChhhEEECCCCCEEEeecCCCcccCCCCC
Confidence 96 6777777542 345899999999999999999999988 99999999999999999999999999875432221
Q ss_pred ccccc-eeee-----ccCCCCCccccchhHHHHHHHHHhCCCCCCCCCCcchhhhhHhHHhcCCcccccchhhhccCCHH
Q 004521 598 EGNTN-RVVG-----TYDGQFSIKSDVFSFGILLLEIVSGKKNRGFYRSDTKVNLIGHLWDEGIPLRLIDACIQDSCNLA 671 (747)
Q Consensus 598 ~~~~~-~~~~-----~~~~~~s~ksDVwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~ 671 (747)
..... ...+ ...+.++.++|||||||++|||++|..|+..... ........... ....... ..
T Consensus 177 ~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~---~~~~~~~~~~~-~~~~~~~----~~--- 245 (313)
T cd06633 177 FVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNA---MSALYHIAQND-SPTLQSN----EW--- 245 (313)
T ss_pred ccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCh---HHHHHHHHhcC-CCCCCcc----cc---
Confidence 11110 0011 1135678899999999999999999999643221 11111111111 1111111 01
Q ss_pred HHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 004521 672 DVIRCIHIGLLCVQQHPEDRPCMPSVILM 700 (747)
Q Consensus 672 ~~~~~~~l~~~Cl~~dP~~RPt~~~v~~~ 700 (747)
...+.+++.+||+.+|.+||++.++++.
T Consensus 246 -~~~l~~li~~~l~~~P~~Rp~~~~~l~~ 273 (313)
T cd06633 246 -TDSFRGFVDYCLQKIPQERPASAELLRH 273 (313)
T ss_pred -CHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 1235567789999999999999999854
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.7e-30 Score=265.43 Aligned_cols=244 Identities=24% Similarity=0.340 Sum_probs=188.2
Q ss_pred CCCccceecccCCeeEEEEEec-CCcEEEEEEeccc--ccccHHHHHHHHHHHhccCCCceeeEEeEEEeCCeeEEEEec
Q 004521 441 NFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKI--SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEF 517 (747)
Q Consensus 441 ~~~~~~~lg~G~fg~Vy~~~~~-~g~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~ 517 (747)
+|++.+.||+|+||.||+++.. +++.+|+|.+... ......++.+|++++++++|+||+++++++......++||||
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 80 (256)
T cd08530 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLDGNKLCIVMEY 80 (256)
T ss_pred CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhhccCCEEEEEehh
Confidence 4778899999999999999865 4789999998753 233456788999999999999999999999999999999999
Q ss_pred CCCCChhhHhhhcC-CCCcCChhHHHHHHHHHHHHHHHhhhcCCCceEecccCcCcEEEcCCCCceEecccCccccCCCC
Q 004521 518 MPNKSLDSFIFDQT-RRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDE 596 (747)
Q Consensus 518 ~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~ 596 (747)
+++++|.+++.... ....+++..+..++.|++.||.|||+.+ ++|+||+|+||+++.++.+||+|||+++......
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~~---i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~~~~ 157 (256)
T cd08530 81 APFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQK---ILHRDLKSANILLVANDLVKIGDLGISKVLKKNM 157 (256)
T ss_pred cCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCcceEEEecCCcEEEeeccchhhhccCC
Confidence 99999999986532 2345889999999999999999999988 9999999999999999999999999998765432
Q ss_pred Cccccc---eee--eccCCCCCccccchhHHHHHHHHHhCCCCCCCCCCcchhhhhHhHHhcCCcccccchhhhccCCHH
Q 004521 597 TEGNTN---RVV--GTYDGQFSIKSDVFSFGILLLEIVSGKKNRGFYRSDTKVNLIGHLWDEGIPLRLIDACIQDSCNLA 671 (747)
Q Consensus 597 ~~~~~~---~~~--~~~~~~~s~ksDVwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~ 671 (747)
...... ... ...+..++.++|+||||+++|||++|+.|+..... ... ......+....+.. .
T Consensus 158 ~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~---~~~-~~~~~~~~~~~~~~---------~ 224 (256)
T cd08530 158 AKTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSM---QDL-RYKVQRGKYPPIPP---------I 224 (256)
T ss_pred cccccCCccccCHHHHCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH---HHH-HHHHhcCCCCCCch---------h
Confidence 111100 000 01245678899999999999999999999753321 111 11122222222211 1
Q ss_pred HHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 004521 672 DVIRCIHIGLLCVQQHPEDRPCMPSVILM 700 (747)
Q Consensus 672 ~~~~~~~l~~~Cl~~dP~~RPt~~~v~~~ 700 (747)
....+..++.+|++.+|++||++.++++.
T Consensus 225 ~~~~~~~li~~~l~~~p~~Rp~~~~~l~~ 253 (256)
T cd08530 225 YSQDLQNFIRSMLQVKPKLRPNCDKILAS 253 (256)
T ss_pred hCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence 22346778889999999999999999864
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.6e-32 Score=256.40 Aligned_cols=246 Identities=22% Similarity=0.315 Sum_probs=185.0
Q ss_pred HhcCCCccceecccCCeeEEEEEec-CCcEEEEEEec--ccccccHHHHHHHHHHHhccCCCceeeEEeEEEeCCeeEEE
Q 004521 438 ATDNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLS--KISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLI 514 (747)
Q Consensus 438 ~~~~~~~~~~lg~G~fg~Vy~~~~~-~g~~vavK~l~--~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV 514 (747)
..+.|++.+.||+|.|+.||+.... .|+.+|+|++. +......+++.+|++|-+.|+|||||++..........|||
T Consensus 9 f~d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~~~ylv 88 (355)
T KOG0033|consen 9 FSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLV 88 (355)
T ss_pred cchhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhhhcccceeEEE
Confidence 3467888899999999999998764 48899998874 34555788999999999999999999999999999999999
Q ss_pred EecCCCCChhhHhhhcCCCCcCChhHHHHHHHHHHHHHHHhhhcCCCceEecccCcCcEEEcCC---CCceEecccCccc
Q 004521 515 YEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQD---MNPKISDFGLVRT 591 (747)
Q Consensus 515 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NIll~~~---~~~kl~DFGla~~ 591 (747)
+|+|.+++|..-|-. +...++..+-..++||+++|.|.|.++ |||||+||+|++|.+. --+||+|||+|..
T Consensus 89 Fe~m~G~dl~~eIV~---R~~ySEa~aSH~~rQiLeal~yCH~n~---IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~ 162 (355)
T KOG0033|consen 89 FDLVTGGELFEDIVA---REFYSEADASHCIQQILEALAYCHSNG---IVHRDLKPENLLLASKAKGAAVKLADFGLAIE 162 (355)
T ss_pred EecccchHHHHHHHH---HHHHHHHHHHHHHHHHHHHHHHHHhcC---ceeccCChhheeeeeccCCCceeecccceEEE
Confidence 999999999766643 245777888899999999999999998 9999999999999543 4589999999998
Q ss_pred cCCCCCccccceeeec------cCCCCCccccchhHHHHHHHHHhCCCCCCCCCCcchhhhhHhHHhcCCcccccchhhh
Q 004521 592 FGGDETEGNTNRVVGT------YDGQFSIKSDVFSFGILLLEIVSGKKNRGFYRSDTKVNLIGHLWDEGIPLRLIDACIQ 665 (747)
Q Consensus 592 ~~~~~~~~~~~~~~~~------~~~~~s~ksDVwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 665 (747)
+..........-.++- ...+|+..+|||+-|||||-|+.|..||... ....+..++....... ..+...
T Consensus 163 l~~g~~~~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~G~~PF~~~---~~~rlye~I~~g~yd~--~~~~w~ 237 (355)
T KOG0033|consen 163 VNDGEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDE---DQHRLYEQIKAGAYDY--PSPEWD 237 (355)
T ss_pred eCCccccccccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHHhCCCCCCCc---cHHHHHHHHhccccCC--CCcccC
Confidence 8743332221111111 1578999999999999999999999996432 2222333332221110 000000
Q ss_pred ccCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 004521 666 DSCNLADVIRCIHIGLLCVQQHPEDRPCMPSVIL 699 (747)
Q Consensus 666 ~~~~~~~~~~~~~l~~~Cl~~dP~~RPt~~~v~~ 699 (747)
. . -+....++.+||..||.+|.|+.|.++
T Consensus 238 ~-i----s~~Ak~LvrrML~~dP~kRIta~EAL~ 266 (355)
T KOG0033|consen 238 T-V----TPEAKSLIRRMLTVNPKKRITADEALK 266 (355)
T ss_pred c-C----CHHHHHHHHHHhccChhhhccHHHHhC
Confidence 0 0 112345666999999999999998763
|
|
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.6e-30 Score=270.59 Aligned_cols=252 Identities=24% Similarity=0.295 Sum_probs=183.3
Q ss_pred CCccceecccCCeeEEEEEec-CCcEEEEEEeccccc--ccHHHHHHHHHHHhccCCCceeeEEeEEEeCCeeEEEEecC
Q 004521 442 FSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKISE--QGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFM 518 (747)
Q Consensus 442 ~~~~~~lg~G~fg~Vy~~~~~-~g~~vavK~l~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~ 518 (747)
|++.+.||+|++|.||++... +++.+++|++..... .....+..|+.++++++|+||+++++++..+...++|+||+
T Consensus 1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~ 80 (283)
T cd05118 1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVFEFM 80 (283)
T ss_pred CccceeeecCCCceEEEEEcCCCCcEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEEEEEecc
Confidence 566789999999999999975 588999999875322 24567889999999999999999999999999999999999
Q ss_pred CCCChhhHhhhcCCCCcCChhHHHHHHHHHHHHHHHhhhcCCCceEecccCcCcEEEcCCCCceEecccCccccCCCCCc
Q 004521 519 PNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETE 598 (747)
Q Consensus 519 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~ 598 (747)
++ +|.+++.... ..+++..+..++.|+++||.|||+.+ |+|+||||+||+++.++.+||+|||.+..+......
T Consensus 81 ~~-~l~~~l~~~~--~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~~~~ 154 (283)
T cd05118 81 DT-DLYKLIKDRQ--RGLPESLIKSYLYQLLQGLAFCHSHG---ILHRDLKPENLLINTEGVLKLADFGLARSFGSPVRP 154 (283)
T ss_pred CC-CHHHHHHhhc--ccCCHHHHHHHHHHHHHHHHHHHHCC---eeecCcCHHHEEECCCCcEEEeeeeeeEecCCCccc
Confidence 75 8888875532 46899999999999999999999988 999999999999999999999999998876544311
Q ss_pred c----ccceeeec---c-CCCCCccccchhHHHHHHHHHhCCCCCCCCCCcchhhhhHhHHhcCC---cccccc------
Q 004521 599 G----NTNRVVGT---Y-DGQFSIKSDVFSFGILLLEIVSGKKNRGFYRSDTKVNLIGHLWDEGI---PLRLID------ 661 (747)
Q Consensus 599 ~----~~~~~~~~---~-~~~~s~ksDVwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~---~~~~~d------ 661 (747)
. .......+ . ...++.++||||||+++|||++|+.|+...........+........ ...+.+
T Consensus 155 ~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (283)
T cd05118 155 YTHYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKIFRTLGTPDPEVWPKFTSLARNYK 234 (283)
T ss_pred ccCccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCchHhcccchhhhhhhh
Confidence 0 00000000 1 23678999999999999999999988653322111111110000000 000000
Q ss_pred -----hhhh--ccCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 004521 662 -----ACIQ--DSCNLADVIRCIHIGLLCVQQHPEDRPCMPSVIL 699 (747)
Q Consensus 662 -----~~l~--~~~~~~~~~~~~~l~~~Cl~~dP~~RPt~~~v~~ 699 (747)
.... ..........+.+++.+||+.||.+||++.+++.
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~ 279 (283)
T cd05118 235 FSFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALA 279 (283)
T ss_pred hhhccccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhh
Confidence 0000 0000112345678899999999999999999986
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.1e-32 Score=265.99 Aligned_cols=239 Identities=26% Similarity=0.412 Sum_probs=189.4
Q ss_pred CCCccceecccCCeeEEEEEecC-CcEEEEEEecccccccHHHHHHHHHHHhccCCCceeeEEeEEEeCCeeEEEEecCC
Q 004521 441 NFSINNKLGEGGFGPVYKGTLVD-GQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMP 519 (747)
Q Consensus 441 ~~~~~~~lg~G~fg~Vy~~~~~~-g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~ 519 (747)
-|.+..+||+|+||.||+|.++. |+.+|||.+.. +...+++..|+.+|++.+.|++|+++|.+.....+++|||||-
T Consensus 34 VFDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV--~sDLQEIIKEISIMQQC~S~yVVKYYGSYFK~sDLWIVMEYCG 111 (502)
T KOG0574|consen 34 VFDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPV--DTDLQEIIKEISIMQQCKSKYVVKYYGSYFKHSDLWIVMEYCG 111 (502)
T ss_pred HHHHHHHhcCCcchHHHHHHHhccCcEEEEEecCc--cchHHHHHHHHHHHHHcCCchhhhhhhhhccCCceEeehhhcC
Confidence 36667899999999999998865 99999999864 4567899999999999999999999999999999999999999
Q ss_pred CCChhhHhhhcCCCCcCChhHHHHHHHHHHHHHHHhhhcCCCceEecccCcCcEEEcCCCCceEecccCccccCCCCCcc
Q 004521 520 NKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEG 599 (747)
Q Consensus 520 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~ 599 (747)
.|+..++++. +++.|.+.++..+++..++||+|||... -||||||+.||||+.+|.+||+|||.|-.+... ..
T Consensus 112 AGSiSDI~R~--R~K~L~E~EIs~iL~~TLKGL~YLH~~~---KIHRDIKAGNILLNT~G~AKLADFGVAGQLTDT--MA 184 (502)
T KOG0574|consen 112 AGSISDIMRA--RRKPLSEQEISAVLRDTLKGLQYLHDLK---KIHRDIKAGNILLNTDGIAKLADFGVAGQLTDT--MA 184 (502)
T ss_pred CCcHHHHHHH--hcCCccHHHHHHHHHHHHhHHHHHHHHH---HHHhhcccccEEEcccchhhhhhccccchhhhh--HH
Confidence 9999999965 5567999999999999999999999876 799999999999999999999999999766432 22
Q ss_pred ccceeeecc---------CCCCCccccchhHHHHHHHHHhCCCCCCCCCCcchhhhhHhHHhcCCcccccchhhhccCCH
Q 004521 600 NTNRVVGTY---------DGQFSIKSDVFSFGILLLEIVSGKKNRGFYRSDTKVNLIGHLWDEGIPLRLIDACIQDSCNL 670 (747)
Q Consensus 600 ~~~~~~~~~---------~~~~s~ksDVwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~ 670 (747)
....+.|+. .-.|+.++||||+|++..||.-|++|+....+......+ ...-++.+ . .+.
T Consensus 185 KRNTVIGTPFWMAPEVI~EIGY~~~ADIWSLGITaIEMAEG~PPYsDIHPMRAIFMI----PT~PPPTF-----~--KPE 253 (502)
T KOG0574|consen 185 KRNTVIGTPFWMAPEVIEEIGYDTKADIWSLGITAIEMAEGRPPYSDIHPMRAIFMI----PTKPPPTF-----K--KPE 253 (502)
T ss_pred hhCccccCcccccHHHHHHhccchhhhHhhhcchhhhhhcCCCCcccccccceeEec----cCCCCCCC-----C--ChH
Confidence 333455553 346889999999999999999999997544433221111 00001111 0 011
Q ss_pred HHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 004521 671 ADVIRCIHIGLLCVQQHPEDRPCMPSVIL 699 (747)
Q Consensus 671 ~~~~~~~~l~~~Cl~~dP~~RPt~~~v~~ 699 (747)
+--...-+++.+||-..|++|-|+.++++
T Consensus 254 ~WS~~F~DFi~~CLiK~PE~R~TA~~L~~ 282 (502)
T KOG0574|consen 254 EWSSEFNDFIRSCLIKKPEERKTALRLCE 282 (502)
T ss_pred hhhhHHHHHHHHHhcCCHHHHHHHHHHhh
Confidence 11223446777999999999999988765
|
|
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.4e-30 Score=276.27 Aligned_cols=253 Identities=21% Similarity=0.316 Sum_probs=180.4
Q ss_pred hcCCCccceecccCCeeEEEEEec-CCcEEEEEEeccc--ccccHHHHHHHHHHHhccCCCceeeEEeEEEeCC------
Q 004521 439 TDNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKI--SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGE------ 509 (747)
Q Consensus 439 ~~~~~~~~~lg~G~fg~Vy~~~~~-~g~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~------ 509 (747)
.++|.+.+.||+|+||.||+|+.. +++.||||++.+. .......+.+|+.++++++||||+++++++....
T Consensus 14 ~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 93 (342)
T cd07879 14 PERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEFQ 93 (342)
T ss_pred ccceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhheecccccCCCCc
Confidence 368999999999999999999965 5899999998752 2333457889999999999999999999987543
Q ss_pred eeEEEEecCCCCChhhHhhhcCCCCcCChhHHHHHHHHHHHHHHHhhhcCCCceEecccCcCcEEEcCCCCceEecccCc
Q 004521 510 EKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLV 589 (747)
Q Consensus 510 ~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NIll~~~~~~kl~DFGla 589 (747)
..++|+||+. .+|..++ ...+++..+..++.|++.||+|||+.+ ++||||||+||+++.++.+||+|||++
T Consensus 94 ~~~lv~e~~~-~~l~~~~-----~~~~~~~~~~~~~~qi~~aL~~LH~~~---i~H~dlkp~NIll~~~~~~kL~dfg~~ 164 (342)
T cd07879 94 DFYLVMPYMQ-TDLQKIM-----GHPLSEDKVQYLVYQMLCGLKYIHSAG---IIHRDLKPGNLAVNEDCELKILDFGLA 164 (342)
T ss_pred eEEEEecccc-cCHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEeeCCCC
Confidence 4589999996 4676654 124788999999999999999999988 999999999999999999999999999
Q ss_pred cccCCCCCccccc--eeeec-c--CCCCCccccchhHHHHHHHHHhCCCCCCCCCCcchhhhhHhHHh-cCCc-c-----
Q 004521 590 RTFGGDETEGNTN--RVVGT-Y--DGQFSIKSDVFSFGILLLEIVSGKKNRGFYRSDTKVNLIGHLWD-EGIP-L----- 657 (747)
Q Consensus 590 ~~~~~~~~~~~~~--~~~~~-~--~~~~s~ksDVwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~-~~~~-~----- 657 (747)
+............ ..... . ...++.++|||||||++|||++|+.||..... ...+..... .+.. .
T Consensus 165 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~---~~~~~~~~~~~~~~~~~~~~~ 241 (342)
T cd07879 165 RHADAEMTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDY---LDQLTQILKVTGVPGPEFVQK 241 (342)
T ss_pred cCCCCCCCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCCH---HHHHHHHHHhcCCCCHHHHHH
Confidence 8654322111000 00011 1 23578899999999999999999999753221 111111110 0000 0
Q ss_pred --------------cccchhhhccCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH--hcCC
Q 004521 658 --------------RLIDACIQDSCNLADVIRCIHIGLLCVQQHPEDRPCMPSVILM--LGSE 704 (747)
Q Consensus 658 --------------~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dP~~RPt~~~v~~~--L~~~ 704 (747)
......+.... ......+.+++.+||+.||++||++.+++.. ++..
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~li~~~l~~dP~~R~~~~e~l~h~~f~~~ 303 (342)
T cd07879 242 LEDKAAKSYIKSLPKYPRKDFSTLF-PKASPQAVDLLEKMLELDVDKRLTATEALEHPYFDSF 303 (342)
T ss_pred hcccchHHHHhhcCCcccchHHHHh-cCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcchhhc
Confidence 00000000000 0011246678889999999999999999854 5554
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.4e-30 Score=270.38 Aligned_cols=247 Identities=22% Similarity=0.282 Sum_probs=184.4
Q ss_pred CCCccceecccCCeeEEEEEec----CCcEEEEEEecccc----cccHHHHHHHHHHHhcc-CCCceeeEEeEEEeCCee
Q 004521 441 NFSINNKLGEGGFGPVYKGTLV----DGQEIAVKRLSKIS----EQGLKELKNEVILFSKL-QHRNLVKLLGCCIQGEEK 511 (747)
Q Consensus 441 ~~~~~~~lg~G~fg~Vy~~~~~----~g~~vavK~l~~~~----~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~ 511 (747)
+|++.+.||+|+||.||+++.. +++.||||.+++.. ....+.+.+|+.++.++ +||||+++++.+..+...
T Consensus 1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~ 80 (288)
T cd05583 1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKL 80 (288)
T ss_pred CceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCEE
Confidence 4777899999999999999853 46789999987521 23346788999999999 599999999999999999
Q ss_pred EEEEecCCCCChhhHhhhcCCCCcCChhHHHHHHHHHHHHHHHhhhcCCCceEecccCcCcEEEcCCCCceEecccCccc
Q 004521 512 LLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRT 591 (747)
Q Consensus 512 ~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NIll~~~~~~kl~DFGla~~ 591 (747)
++||||+++++|.+++... ..+++..+..++.|+++||.|||+.+ ++||||||+||+++.++.+||+|||+++.
T Consensus 81 ~lv~e~~~~~~L~~~~~~~---~~~~~~~~~~~~~ql~~~l~~lH~~~---~~H~dl~p~nil~~~~~~~~l~dfg~~~~ 154 (288)
T cd05583 81 HLILDYVNGGELFTHLYQR---EHFTESEVRVYIAEIVLALDHLHQLG---IIYRDIKLENILLDSEGHVVLTDFGLSKE 154 (288)
T ss_pred EEEEecCCCCcHHHHHhhc---CCcCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEEEECccccc
Confidence 9999999999999998542 34788999999999999999999987 99999999999999999999999999876
Q ss_pred cCCCCCccccceeeec--------c-C--CCCCccccchhHHHHHHHHHhCCCCCCCCCCcchhhhhHhHHhcCCccccc
Q 004521 592 FGGDETEGNTNRVVGT--------Y-D--GQFSIKSDVFSFGILLLEIVSGKKNRGFYRSDTKVNLIGHLWDEGIPLRLI 660 (747)
Q Consensus 592 ~~~~~~~~~~~~~~~~--------~-~--~~~s~ksDVwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 660 (747)
+......... ...+. . . ...+.++||||||+++|||++|..|+...........+.+....... .
T Consensus 155 ~~~~~~~~~~-~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~-~-- 230 (288)
T cd05583 155 FLAEEEERAY-SFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNSQSEISRRILKSKP-P-- 230 (288)
T ss_pred cccccccccc-cccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCcccchHHHHHHHHHccCC-C--
Confidence 5433211100 00011 0 1 23678999999999999999999997533222111111111111110 0
Q ss_pred chhhhccCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhcCC
Q 004521 661 DACIQDSCNLADVIRCIHIGLLCVQQHPEDRPCMPSVILMLGSE 704 (747)
Q Consensus 661 d~~l~~~~~~~~~~~~~~l~~~Cl~~dP~~RPt~~~v~~~L~~~ 704 (747)
..... ...+.+++.+||+.+|++|||+.++.+.|+..
T Consensus 231 ---~~~~~----~~~l~~li~~~l~~~p~~R~t~~~~~~~l~~~ 267 (288)
T cd05583 231 ---FPKTM----SAEARDFIQKLLEKDPKKRLGANGADEIKNHP 267 (288)
T ss_pred ---CCccc----CHHHHHHHHHHhcCCHhhccCcchHHHHhcCc
Confidence 01111 12355677899999999999999998888764
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=5e-30 Score=275.85 Aligned_cols=256 Identities=22% Similarity=0.320 Sum_probs=182.5
Q ss_pred HHhcCCCccceecccCCeeEEEEEec-CCcEEEEEEeccc--ccccHHHHHHHHHHHhccCCCceeeEEeEEEe-CCeeE
Q 004521 437 NATDNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKI--SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQ-GEEKL 512 (747)
Q Consensus 437 ~~~~~~~~~~~lg~G~fg~Vy~~~~~-~g~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~-~~~~~ 512 (747)
..+++|++.+.||+|+||.||+|... +++.||||++.+. .....+.+..|+.++++++||||+++++++.. ....+
T Consensus 7 ~~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~ 86 (328)
T cd07856 7 EITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFISPLEDIY 86 (328)
T ss_pred ccccceEEEEeecccCCeEEEEEEECCCCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeeeEecCCCcEE
Confidence 45678999999999999999999865 5899999988642 23345678899999999999999999999876 55788
Q ss_pred EEEecCCCCChhhHhhhcCCCCcCChhHHHHHHHHHHHHHHHhhhcCCCceEecccCcCcEEEcCCCCceEecccCcccc
Q 004521 513 LIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTF 592 (747)
Q Consensus 513 lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NIll~~~~~~kl~DFGla~~~ 592 (747)
+|+||+ +++|..++.. ..+++.....++.|+++||.|||+.+ |+||||+|+||++++++.+||+|||+++..
T Consensus 87 lv~e~~-~~~L~~~~~~----~~~~~~~~~~~~~ql~~aL~~LH~~~---iiH~dl~p~Nili~~~~~~~l~dfg~~~~~ 158 (328)
T cd07856 87 FVTELL-GTDLHRLLTS----RPLEKQFIQYFLYQILRGLKYVHSAG---VVHRDLKPSNILINENCDLKICDFGLARIQ 158 (328)
T ss_pred EEeehh-ccCHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEeECCCCCEEeCcccccccc
Confidence 999998 5689888742 34778888899999999999999988 999999999999999999999999998765
Q ss_pred CCCCCcccc--ceeeec--c-CCCCCccccchhHHHHHHHHHhCCCCCCCCCCcchhhhhHhHHh-----------cCCc
Q 004521 593 GGDETEGNT--NRVVGT--Y-DGQFSIKSDVFSFGILLLEIVSGKKNRGFYRSDTKVNLIGHLWD-----------EGIP 656 (747)
Q Consensus 593 ~~~~~~~~~--~~~~~~--~-~~~~s~ksDVwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~-----------~~~~ 656 (747)
......... ....+. . ...++.++||||||+++|||++|+.|+...........+..... ....
T Consensus 159 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (328)
T cd07856 159 DPQMTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDVINTICSENT 238 (328)
T ss_pred CCCcCCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhccchhh
Confidence 332211100 001111 1 24678899999999999999999999754322111100000000 0000
Q ss_pred ccccchh-hhccCCHH-----HHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 004521 657 LRLIDAC-IQDSCNLA-----DVIRCIHIGLLCVQQHPEDRPCMPSVILM 700 (747)
Q Consensus 657 ~~~~d~~-l~~~~~~~-----~~~~~~~l~~~Cl~~dP~~RPt~~~v~~~ 700 (747)
..+.... ........ ....+.+++.+||+.+|++||++.+++..
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~~ 288 (328)
T cd07856 239 LRFVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAH 288 (328)
T ss_pred HHHHhhccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 0000000 00000110 12356678889999999999999998654
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.7e-30 Score=277.78 Aligned_cols=252 Identities=20% Similarity=0.337 Sum_probs=181.5
Q ss_pred cCCCccceecccCCeeEEEEEec-CCcEEEEEEeccc--ccccHHHHHHHHHHHhccCCCceeeEEeEEEe----CCeeE
Q 004521 440 DNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKI--SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQ----GEEKL 512 (747)
Q Consensus 440 ~~~~~~~~lg~G~fg~Vy~~~~~-~g~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~----~~~~~ 512 (747)
++|++.+.||+|+||.||+|+.. +++.||+|++... .....+.+.+|+.++++++||||+++++++.. ....+
T Consensus 5 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 84 (334)
T cd07855 5 SRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKDVY 84 (334)
T ss_pred hceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCceEE
Confidence 68899999999999999999975 4899999998753 22345678889999999999999999998763 34679
Q ss_pred EEEecCCCCChhhHhhhcCCCCcCChhHHHHHHHHHHHHHHHhhhcCCCceEecccCcCcEEEcCCCCceEecccCcccc
Q 004521 513 LIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTF 592 (747)
Q Consensus 513 lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NIll~~~~~~kl~DFGla~~~ 592 (747)
+||||+. ++|.+++.. ...+++..+..++.||+.||.|||+.+ |+||||||+||++++++.+||+|||+++..
T Consensus 85 lv~e~~~-~~l~~~~~~---~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~Nil~~~~~~~kl~dfg~~~~~ 157 (334)
T cd07855 85 VVMDLME-SDLHHIIHS---DQPLTEEHIRYFLYQLLRGLKYIHSAN---VIHRDLKPSNLLVNEDCELRIGDFGMARGL 157 (334)
T ss_pred EEEehhh-hhHHHHhcc---CCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCcEEecccccceee
Confidence 9999996 689888843 234899999999999999999999988 999999999999999999999999999765
Q ss_pred CCCCCcccc--ceeeec----------cCCCCCccccchhHHHHHHHHHhCCCCCCCCCCcchhhhhHhHHhcCCc-ccc
Q 004521 593 GGDETEGNT--NRVVGT----------YDGQFSIKSDVFSFGILLLEIVSGKKNRGFYRSDTKVNLIGHLWDEGIP-LRL 659 (747)
Q Consensus 593 ~~~~~~~~~--~~~~~~----------~~~~~s~ksDVwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~-~~~ 659 (747)
......... ....++ ....++.++|||||||++|||++|+.||...........+... .+.+ ..+
T Consensus 158 ~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~~~~~~~~~--~g~~~~~~ 235 (334)
T cd07855 158 SSSPTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSV--LGSPSEEV 235 (334)
T ss_pred cccCcCCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChHHHHHHHHHH--hCCChhHh
Confidence 332211000 000111 0245788999999999999999999997533221111100000 0000 000
Q ss_pred cc----h-------hh--hccCC-----HHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 004521 660 ID----A-------CI--QDSCN-----LADVIRCIHIGLLCVQQHPEDRPCMPSVILM 700 (747)
Q Consensus 660 ~d----~-------~l--~~~~~-----~~~~~~~~~l~~~Cl~~dP~~RPt~~~v~~~ 700 (747)
.+ . .. ..... ......+.+++.+||+.+|.+||++.++++.
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~ 294 (334)
T cd07855 236 LNRIGSDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQH 294 (334)
T ss_pred hhhhchhhHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence 00 0 00 00000 0113446778889999999999999998874
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.3e-29 Score=266.86 Aligned_cols=250 Identities=21% Similarity=0.318 Sum_probs=178.7
Q ss_pred CCccceecccCCeeEEEEEecC-CcEEEEEEecccc--cccHHHHHHHHHHHhcc---CCCceeeEEeEEEeCCe-----
Q 004521 442 FSINNKLGEGGFGPVYKGTLVD-GQEIAVKRLSKIS--EQGLKELKNEVILFSKL---QHRNLVKLLGCCIQGEE----- 510 (747)
Q Consensus 442 ~~~~~~lg~G~fg~Vy~~~~~~-g~~vavK~l~~~~--~~~~~~~~~E~~~l~~l---~H~niv~l~g~~~~~~~----- 510 (747)
|++.+.||+|+||.||+|+... ++.+|+|+++... ......+.+|+.++.++ +|+||+++++++...+.
T Consensus 1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~ 80 (287)
T cd07838 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELK 80 (287)
T ss_pred CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCce
Confidence 5677899999999999999865 8999999997422 22234566788777665 59999999999998776
Q ss_pred eEEEEecCCCCChhhHhhhcCCCCcCChhHHHHHHHHHHHHHHHhhhcCCCceEecccCcCcEEEcCCCCceEecccCcc
Q 004521 511 KLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVR 590 (747)
Q Consensus 511 ~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NIll~~~~~~kl~DFGla~ 590 (747)
.+++|||+. ++|.+++.... ...+++..+..++.|+++||.|||+.+ ++|+||+|+||+++.++.+||+|||++.
T Consensus 81 ~~l~~e~~~-~~l~~~l~~~~-~~~l~~~~~~~~~~~i~~al~~LH~~~---i~h~~l~~~nili~~~~~~~l~dfg~~~ 155 (287)
T cd07838 81 LTLVFEHVD-QDLATYLSKCP-KPGLPPETIKDLMRQLLRGVDFLHSHR---IVHRDLKPQNILVTSDGQVKIADFGLAR 155 (287)
T ss_pred eEEEehhcc-cCHHHHHHHcc-CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCChhhEEEccCCCEEEeccCcce
Confidence 899999997 58988885532 235899999999999999999999988 9999999999999999999999999998
Q ss_pred ccCCCCCccccc---eeee---ccCCCCCccccchhHHHHHHHHHhCCCCCCCCCCcchhhhhHhHHhcC-C------cc
Q 004521 591 TFGGDETEGNTN---RVVG---TYDGQFSIKSDVFSFGILLLEIVSGKKNRGFYRSDTKVNLIGHLWDEG-I------PL 657 (747)
Q Consensus 591 ~~~~~~~~~~~~---~~~~---~~~~~~s~ksDVwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~-~------~~ 657 (747)
.+.......... .... .....++.++|||||||++|||++|+.|+....... .+......- . ..
T Consensus 156 ~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~ 232 (287)
T cd07838 156 IYSFEMALTSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGTSEAD---QLDKIFDVIGLPSEEEWPR 232 (287)
T ss_pred eccCCcccccccccccccChHHhccCCCCCcchhhhHHHHHHHHHhCCCcccCCChHH---HHHHHHHHcCCCChHhcCC
Confidence 764332211100 0000 114567889999999999999999988865332211 111111100 0 00
Q ss_pred c------ccchhhh---ccCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 004521 658 R------LIDACIQ---DSCNLADVIRCIHIGLLCVQQHPEDRPCMPSVIL 699 (747)
Q Consensus 658 ~------~~d~~l~---~~~~~~~~~~~~~l~~~Cl~~dP~~RPt~~~v~~ 699 (747)
. ....... ......-...+.+++.+||+.||.+||++.++++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~ 283 (287)
T cd07838 233 NVSLPRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQ 283 (287)
T ss_pred CcccchhhcccccccchhhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhc
Confidence 0 0000000 0000111245567888999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.9e-30 Score=276.59 Aligned_cols=252 Identities=22% Similarity=0.299 Sum_probs=181.0
Q ss_pred HHHhcCCCccceecccCCeeEEEEEec-CCcEEEEEEeccc--ccccHHHHHHHHHHHhccCCCceeeEEeEEEeCC---
Q 004521 436 ANATDNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKI--SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGE--- 509 (747)
Q Consensus 436 ~~~~~~~~~~~~lg~G~fg~Vy~~~~~-~g~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~--- 509 (747)
....++|++.+.||+|+||.||+|... +++.||||++... .....+.+.+|+.++++++||||+++++++....
T Consensus 11 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 90 (343)
T cd07880 11 WEVPDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSLD 90 (343)
T ss_pred hccccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeeecCCcccc
Confidence 345678999999999999999999865 5889999998642 2233457889999999999999999999987654
Q ss_pred ---eeEEEEecCCCCChhhHhhhcCCCCcCChhHHHHHHHHHHHHHHHhhhcCCCceEecccCcCcEEEcCCCCceEecc
Q 004521 510 ---EKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDF 586 (747)
Q Consensus 510 ---~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NIll~~~~~~kl~DF 586 (747)
..++||||+ +++|.+++.. ..+++..+..++.||++||+|||+.+ |+||||||+||+++.++.+||+||
T Consensus 91 ~~~~~~lv~e~~-~~~l~~~~~~----~~l~~~~~~~i~~qi~~al~~LH~~g---i~H~dlkp~Nill~~~~~~kl~df 162 (343)
T cd07880 91 RFHDFYLVMPFM-GTDLGKLMKH----EKLSEDRIQFLVYQMLKGLKYIHAAG---IIHRDLKPGNLAVNEDCELKILDF 162 (343)
T ss_pred ccceEEEEEecC-CCCHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeec
Confidence 358999999 6789888743 35889999999999999999999988 999999999999999999999999
Q ss_pred cCccccCCCCCccccce--eeec-c--CCCCCccccchhHHHHHHHHHhCCCCCCCCCCcchhhhhHhHHh-cCCcc-c-
Q 004521 587 GLVRTFGGDETEGNTNR--VVGT-Y--DGQFSIKSDVFSFGILLLEIVSGKKNRGFYRSDTKVNLIGHLWD-EGIPL-R- 658 (747)
Q Consensus 587 Gla~~~~~~~~~~~~~~--~~~~-~--~~~~s~ksDVwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~-~~~~~-~- 658 (747)
|+++............. .... . ...++.++|||||||++|||++|+.|+...... ........ ..... .
T Consensus 163 g~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~---~~~~~~~~~~~~~~~~~ 239 (343)
T cd07880 163 GLARQTDSEMTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHL---DQLMEIMKVTGTPSKEF 239 (343)
T ss_pred ccccccccCccccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHH---HHHHHHHHhcCCCCHHH
Confidence 99986543221110000 0000 0 134788999999999999999999997532211 11111000 00000 0
Q ss_pred ------------------ccchhhhccCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 004521 659 ------------------LIDACIQDSCNLADVIRCIHIGLLCVQQHPEDRPCMPSVIL 699 (747)
Q Consensus 659 ------------------~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dP~~RPt~~~v~~ 699 (747)
.....+.. ........+.+++.+|++.||.+|||+.++++
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l~ 297 (343)
T cd07880 240 VQKLQSEDAKNYVKKLPRFRKKDFRS-LLPNANPLAVNVLEKMLVLDAESRITAAEALA 297 (343)
T ss_pred HHhhcchhHHHHHHhccccCcchHHH-hccCCChHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 00000000 00001123567888999999999999999984
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.4e-29 Score=263.62 Aligned_cols=241 Identities=25% Similarity=0.369 Sum_probs=179.2
Q ss_pred cCCCccceecccCCeeEEEEEecC-CcEEEEEEeccc-----ccccHHHHHHHHHHHhccCCCceeeEEeEEEeC--Cee
Q 004521 440 DNFSINNKLGEGGFGPVYKGTLVD-GQEIAVKRLSKI-----SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQG--EEK 511 (747)
Q Consensus 440 ~~~~~~~~lg~G~fg~Vy~~~~~~-g~~vavK~l~~~-----~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~--~~~ 511 (747)
.+|.+.+.||+|+||.||+|+... ++.+|+|.+... ..+..+.+.+|+.++++++|+||+++++++.+. ...
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (264)
T cd06653 2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKL 81 (264)
T ss_pred CceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEE
Confidence 478889999999999999999754 889999987531 223456789999999999999999999998764 457
Q ss_pred EEEEecCCCCChhhHhhhcCCCCcCChhHHHHHHHHHHHHHHHhhhcCCCceEecccCcCcEEEcCCCCceEecccCccc
Q 004521 512 LLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRT 591 (747)
Q Consensus 512 ~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NIll~~~~~~kl~DFGla~~ 591 (747)
++|+||+++++|.+++... ..+++.....++.|++.||.|||+.+ ++|+||||+||+++.++.++|+|||+++.
T Consensus 82 ~~v~e~~~~~~L~~~~~~~---~~l~~~~~~~~~~~i~~al~~LH~~~---i~H~dl~p~ni~i~~~~~~~l~dfg~~~~ 155 (264)
T cd06653 82 SIFVEYMPGGSIKDQLKAY---GALTENVTRRYTRQILQGVSYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKR 155 (264)
T ss_pred EEEEEeCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCEEECccccccc
Confidence 8999999999999998542 34788899999999999999999988 99999999999999999999999999986
Q ss_pred cCCCCCcc-ccceeeec---------cCCCCCccccchhHHHHHHHHHhCCCCCCCCCCcchhhhhHhHHhcCCcccccc
Q 004521 592 FGGDETEG-NTNRVVGT---------YDGQFSIKSDVFSFGILLLEIVSGKKNRGFYRSDTKVNLIGHLWDEGIPLRLID 661 (747)
Q Consensus 592 ~~~~~~~~-~~~~~~~~---------~~~~~s~ksDVwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~d 661 (747)
........ ......++ ....++.++|||||||++|||++|+.|+.... ....+...........+.
T Consensus 156 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~---~~~~~~~~~~~~~~~~~p- 231 (264)
T cd06653 156 IQTICMSGTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEYE---AMAAIFKIATQPTKPMLP- 231 (264)
T ss_pred cccccccCccccccCCcccccCHhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCccC---HHHHHHHHHcCCCCCCCC-
Confidence 53211100 00001111 13457889999999999999999999975321 111122221111111111
Q ss_pred hhhhccCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 004521 662 ACIQDSCNLADVIRCIHIGLLCVQQHPEDRPCMPSVIL 699 (747)
Q Consensus 662 ~~l~~~~~~~~~~~~~~l~~~Cl~~dP~~RPt~~~v~~ 699 (747)
. .....+.+++.+||+ +|..||+..+++.
T Consensus 232 ----~----~~~~~~~~~i~~~l~-~~~~r~~~~~~~~ 260 (264)
T cd06653 232 ----D----GVSDACRDFLKQIFV-EEKRRPTAEFLLR 260 (264)
T ss_pred ----c----ccCHHHHHHHHHHhc-CcccCccHHHHhc
Confidence 1 111235567779999 5799999998865
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.3e-30 Score=276.66 Aligned_cols=253 Identities=21% Similarity=0.256 Sum_probs=179.6
Q ss_pred cCCCc-cceecccCCeeEEEEEec-CCcEEEEEEeccccccc--------------HHHHHHHHHHHhccCCCceeeEEe
Q 004521 440 DNFSI-NNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKISEQG--------------LKELKNEVILFSKLQHRNLVKLLG 503 (747)
Q Consensus 440 ~~~~~-~~~lg~G~fg~Vy~~~~~-~g~~vavK~l~~~~~~~--------------~~~~~~E~~~l~~l~H~niv~l~g 503 (747)
++|.. .+.||+|+||.||+|... .++.||||.++...... ...+.+|++++++++|+||+++++
T Consensus 8 ~ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~ 87 (335)
T PTZ00024 8 ERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLVD 87 (335)
T ss_pred cchhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeeeE
Confidence 45653 477999999999999975 48999999986522111 125778999999999999999999
Q ss_pred EEEeCCeeEEEEecCCCCChhhHhhhcCCCCcCChhHHHHHHHHHHHHHHHhhhcCCCceEecccCcCcEEEcCCCCceE
Q 004521 504 CCIQGEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKI 583 (747)
Q Consensus 504 ~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NIll~~~~~~kl 583 (747)
++...+..++||||+. ++|.+++.. ...+++.....++.|++.||+|||+.+ ++|+||+|+||+++.++.+||
T Consensus 88 ~~~~~~~~~lv~e~~~-~~l~~~l~~---~~~~~~~~~~~~~~ql~~aL~~LH~~~---i~H~dl~~~nill~~~~~~kl 160 (335)
T PTZ00024 88 VYVEGDFINLVMDIMA-SDLKKVVDR---KIRLTESQVKCILLQILNGLNVLHKWY---FMHRDLSPANIFINSKGICKI 160 (335)
T ss_pred EEecCCcEEEEEeccc-cCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eecccccHHHeEECCCCCEEE
Confidence 9999999999999997 689888853 334889999999999999999999988 999999999999999999999
Q ss_pred ecccCccccCCCCC--------------cccc-----ceeeec--c-CCCCCccccchhHHHHHHHHHhCCCCCCCCCCc
Q 004521 584 SDFGLVRTFGGDET--------------EGNT-----NRVVGT--Y-DGQFSIKSDVFSFGILLLEIVSGKKNRGFYRSD 641 (747)
Q Consensus 584 ~DFGla~~~~~~~~--------------~~~~-----~~~~~~--~-~~~~s~ksDVwS~Gvvl~elltg~~p~~~~~~~ 641 (747)
+|||+++.+..... .... ....+. . ...++.++|||||||++|||++|+.|+......
T Consensus 161 ~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~ 240 (335)
T PTZ00024 161 ADFGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGENEI 240 (335)
T ss_pred CCccceeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHH
Confidence 99999986651110 0000 000000 0 134688999999999999999999997533321
Q ss_pred chhhhhHhHHhcCCccccc---------------chhhhccCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 004521 642 TKVNLIGHLWDEGIPLRLI---------------DACIQDSCNLADVIRCIHIGLLCVQQHPEDRPCMPSVILM 700 (747)
Q Consensus 642 ~~~~~~~~~~~~~~~~~~~---------------d~~l~~~~~~~~~~~~~~l~~~Cl~~dP~~RPt~~~v~~~ 700 (747)
.....+............. ....... .......+.+++.+||+.+|++||++.+++..
T Consensus 241 ~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~~ 313 (335)
T PTZ00024 241 DQLGRIFELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLKTI-FPNASDDAIDLLQSLLKLNPLERISAKEALKH 313 (335)
T ss_pred HHHHHHHHHhCCCchhhCcchhhcccccccCcCCcccHHHh-CcCCChHHHHHHHHHcCCCchhccCHHHHhcC
Confidence 1111111111100000000 0000000 00112346678889999999999999999863
|
|
| >KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-30 Score=252.63 Aligned_cols=245 Identities=22% Similarity=0.344 Sum_probs=182.2
Q ss_pred CCCccceecccCCeeEEEEEecC-CcEEEEEEecc-cccccHHHHHHHHHHHhccC-CCceeeEEeEEEeCCeeEEEEec
Q 004521 441 NFSINNKLGEGGFGPVYKGTLVD-GQEIAVKRLSK-ISEQGLKELKNEVILFSKLQ-HRNLVKLLGCCIQGEEKLLIYEF 517 (747)
Q Consensus 441 ~~~~~~~lg~G~fg~Vy~~~~~~-g~~vavK~l~~-~~~~~~~~~~~E~~~l~~l~-H~niv~l~g~~~~~~~~~lV~E~ 517 (747)
+.+....||.|..|.|++.+... |..+|||.+.+ .+.+..+.+...+.++.+-+ .|+||+.+|+|..+...++.||.
T Consensus 93 dl~~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~dV~IcMel 172 (391)
T KOG0983|consen 93 DLENLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVQCFGYFITNTDVFICMEL 172 (391)
T ss_pred HhhhHHhhcCCCccceEEEEEcccceEEEEEeecccCCHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCchHHHHHHH
Confidence 34456789999999999999865 89999999987 34555677778888777665 89999999999999999999999
Q ss_pred CCCCChhhHhhhcCCCCcCChhHHHHHHHHHHHHHHHhhhcCCCceEecccCcCcEEEcCCCCceEecccCccccCCCCC
Q 004521 518 MPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDET 597 (747)
Q Consensus 518 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~ 597 (747)
|. .-++.+|.. ...++++..+=++...+.+||.||.++. .|||||+||+|||+|+.|++||+|||++-.+.....
T Consensus 173 Ms-~C~ekLlkr--ik~piPE~ilGk~tva~v~AL~YLKeKH--~viHRDvKPSNILlDe~GniKlCDFGIsGrlvdSkA 247 (391)
T KOG0983|consen 173 MS-TCAEKLLKR--IKGPIPERILGKMTVAIVKALYYLKEKH--GVIHRDVKPSNILLDERGNIKLCDFGISGRLVDSKA 247 (391)
T ss_pred HH-HHHHHHHHH--hcCCchHHhhhhhHHHHHHHHHHHHHhc--ceeecccCccceEEccCCCEEeecccccceeecccc
Confidence 84 445555543 2345888888899999999999998754 599999999999999999999999999876643332
Q ss_pred ccc---------cceeeeccCCCCCccccchhHHHHHHHHHhCCCCCCCCCCcchhhhhHhHHhcCCcccccchhhhccC
Q 004521 598 EGN---------TNRVVGTYDGQFSIKSDVFSFGILLLEIVSGKKNRGFYRSDTKVNLIGHLWDEGIPLRLIDACIQDSC 668 (747)
Q Consensus 598 ~~~---------~~~~~~~~~~~~s~ksDVwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~ 668 (747)
... +++....-...|+.++|||||||+|+||.||..||... +.+.+.+..+..+ .++ .++....-+
T Consensus 248 htrsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c--~tdFe~ltkvln~-ePP-~L~~~~gFS- 322 (391)
T KOG0983|consen 248 HTRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGC--KTDFEVLTKVLNE-EPP-LLPGHMGFS- 322 (391)
T ss_pred cccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCC--CccHHHHHHHHhc-CCC-CCCcccCcC-
Confidence 211 11111112467899999999999999999999997532 3344445544442 222 222211111
Q ss_pred CHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 004521 669 NLADVIRCIHIGLLCVQQHPEDRPCMPSVILM 700 (747)
Q Consensus 669 ~~~~~~~~~~l~~~Cl~~dP~~RPt~~~v~~~ 700 (747)
...+++...||+.|+.+||...++++.
T Consensus 323 -----p~F~~fv~~CL~kd~r~RP~Y~~Ll~h 349 (391)
T KOG0983|consen 323 -----PDFQSFVKDCLTKDHRKRPKYNKLLEH 349 (391)
T ss_pred -----HHHHHHHHHHhhcCcccCcchHHHhcC
Confidence 224456668999999999999988763
|
|
| >KOG0586 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.4e-30 Score=277.39 Aligned_cols=242 Identities=23% Similarity=0.328 Sum_probs=184.8
Q ss_pred HhcCCCccceecccCCeeEEEEEecC-CcEEEEEEeccc--ccccHHHHHHHHHHHhccCCCceeeEEeEEEeCCeeEEE
Q 004521 438 ATDNFSINNKLGEGGFGPVYKGTLVD-GQEIAVKRLSKI--SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLI 514 (747)
Q Consensus 438 ~~~~~~~~~~lg~G~fg~Vy~~~~~~-g~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV 514 (747)
....|.+.+.||+|.|++|..|++.. +..||||.+.+. +....+.+.+|+++|..|+|||||+++.+.+.....|+|
T Consensus 54 ~vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v~~t~~~lylV 133 (596)
T KOG0586|consen 54 SVGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSVIETEATLYLV 133 (596)
T ss_pred cccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeeeeeecceeEEE
Confidence 34678999999999999999999754 899999999873 233345689999999999999999999999999999999
Q ss_pred EecCCCCChhhHhhhcCCCCcCChhHHHHHHHHHHHHHHHhhhcCCCceEecccCcCcEEEcCCCCceEecccCccccCC
Q 004521 515 YEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGG 594 (747)
Q Consensus 515 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NIll~~~~~~kl~DFGla~~~~~ 594 (747)
|||+.+|.+.++|..+.+ +....+..++.|+..|++|||+++ |+|||||++||||+.+.++||+|||++..+..
T Consensus 134 ~eya~~ge~~~yl~~~gr---~~e~~ar~~F~q~vsaveYcH~k~---ivHrdLk~eNilL~~~mnikIaDfgfS~~~~~ 207 (596)
T KOG0586|consen 134 MEYASGGELFDYLVKHGR---MKEKEARAKFRQIVSAVEYCHSKN---IVHRDLKAENILLDENMNIKIADFGFSTFFDY 207 (596)
T ss_pred EEeccCchhHHHHHhccc---chhhhhhhhhHHHHHHHHHHhhcc---eeccccchhhcccccccceeeeccccceeecc
Confidence 999999999999976544 455788889999999999999998 99999999999999999999999999987753
Q ss_pred CCCccc----cceeeec-c--CCCCCccccchhHHHHHHHHHhCCCCCCCCCCcchhhhhHhHHhcCCcccccchhhhcc
Q 004521 595 DETEGN----TNRVVGT-Y--DGQFSIKSDVFSFGILLLEIVSGKKNRGFYRSDTKVNLIGHLWDEGIPLRLIDACIQDS 667 (747)
Q Consensus 595 ~~~~~~----~~~~~~~-~--~~~~s~ksDVwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~ 667 (747)
...... ....... + .....+++|+||+||+||-|++|..||+...-.. +- ...+...++..
T Consensus 208 ~~~lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~lk~---Lr---------~rvl~gk~rIp 275 (596)
T KOG0586|consen 208 GLMLQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQNLKE---LR---------PRVLRGKYRIP 275 (596)
T ss_pred cccccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCccccc---cc---------chheeeeeccc
Confidence 322111 1111111 0 2345689999999999999999999976322111 00 11111111111
Q ss_pred CCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 004521 668 CNLADVIRCIHIGLLCVQQHPEDRPCMPSVIL 699 (747)
Q Consensus 668 ~~~~~~~~~~~l~~~Cl~~dP~~RPt~~~v~~ 699 (747)
..+ -..+-+++.+.|-.+|.+|+++.++.+
T Consensus 276 ~~m--s~dce~lLrk~lvl~Pskr~~~dqim~ 305 (596)
T KOG0586|consen 276 FYM--SCDCEDLLRKFLVLNPSKRGPCDQIMK 305 (596)
T ss_pred cee--echhHHHHHHhhccCccccCCHHHhhh
Confidence 110 112345566889999999999999975
|
|
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.3e-29 Score=274.75 Aligned_cols=259 Identities=23% Similarity=0.307 Sum_probs=183.2
Q ss_pred HHHHHHHhcCCCccceecccCCeeEEEEEec-CCcEEEEEEeccc--ccccHHHHHHHHHHHhccCCCceeeEEeEEEeC
Q 004521 432 LATIANATDNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKI--SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQG 508 (747)
Q Consensus 432 ~~~~~~~~~~~~~~~~lg~G~fg~Vy~~~~~-~g~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~ 508 (747)
..++...+++|.+.+.||+|+||.||+|... +++.||+|++... .....+.+.+|+.++++++||||+++++++...
T Consensus 9 ~~~~~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~~ 88 (345)
T cd07877 9 NKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPA 88 (345)
T ss_pred HHHHhhccCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcccceeeeeeec
Confidence 3456667889999999999999999999864 5889999998753 223356788999999999999999999988653
Q ss_pred ------CeeEEEEecCCCCChhhHhhhcCCCCcCChhHHHHHHHHHHHHHHHhhhcCCCceEecccCcCcEEEcCCCCce
Q 004521 509 ------EEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPK 582 (747)
Q Consensus 509 ------~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NIll~~~~~~k 582 (747)
...++++|++ +++|.+++.. ..+++..+..++.|+++||+|||+.+ |+||||||+||++++++.+|
T Consensus 89 ~~~~~~~~~~lv~~~~-~~~L~~~~~~----~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIll~~~~~~k 160 (345)
T cd07877 89 RSLEEFNDVYLVTHLM-GADLNNIVKC----QKLTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELK 160 (345)
T ss_pred ccccccccEEEEehhc-ccCHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCChHHEEEcCCCCEE
Confidence 3357888876 7899888743 24889999999999999999999988 99999999999999999999
Q ss_pred EecccCccccCCCCCccccc--eeeec-c--CCCCCccccchhHHHHHHHHHhCCCCCCCCCCcchhhhhHhHHhcCCc-
Q 004521 583 ISDFGLVRTFGGDETEGNTN--RVVGT-Y--DGQFSIKSDVFSFGILLLEIVSGKKNRGFYRSDTKVNLIGHLWDEGIP- 656 (747)
Q Consensus 583 l~DFGla~~~~~~~~~~~~~--~~~~~-~--~~~~s~ksDVwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~- 656 (747)
|+|||+++............ ..... . ...++.++|||||||++|||++|+.|+...........+.. ..+..
T Consensus 161 l~dfg~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~--~~~~~~ 238 (345)
T cd07877 161 ILDFGLARHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILR--LVGTPG 238 (345)
T ss_pred EecccccccccccccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHH--HhCCCC
Confidence 99999988654322111000 00000 0 14578899999999999999999999753222111111000 00000
Q ss_pred ccc----cch-------hhh--ccCCH-----HHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 004521 657 LRL----IDA-------CIQ--DSCNL-----ADVIRCIHIGLLCVQQHPEDRPCMPSVILM 700 (747)
Q Consensus 657 ~~~----~d~-------~l~--~~~~~-----~~~~~~~~l~~~Cl~~dP~~RPt~~~v~~~ 700 (747)
..+ .+. .+. ..... .....+.+++.+|++.||.+||++.++++.
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h 300 (345)
T cd07877 239 AELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH 300 (345)
T ss_pred HHHHhhcccHhHHHHHHHhcccCCcchhhhcCCCCHHHHHHHHHHcCCChhhcCCHHHHhcC
Confidence 000 000 000 00000 011235678889999999999999988754
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.9e-31 Score=281.04 Aligned_cols=244 Identities=25% Similarity=0.379 Sum_probs=187.2
Q ss_pred cCCCccceecccCCeeEEEEEecC-CcEEEEEEecccccccHHHHHHHHHHHhccCCCceeeEEeEEEeCCeeEEEEecC
Q 004521 440 DNFSINNKLGEGGFGPVYKGTLVD-GQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFM 518 (747)
Q Consensus 440 ~~~~~~~~lg~G~fg~Vy~~~~~~-g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~ 518 (747)
+.|+++..||.|+||.||+|+.++ +-..|.|.+...+.+..+.|+-|++||+..+||+||+|++.|...+.++++.|||
T Consensus 32 d~WeIiGELGDGAFGKVyKA~nket~~lAAaKvIetkseEELEDylVEIeILa~CdHP~ivkLl~ayy~enkLwiliEFC 111 (1187)
T KOG0579|consen 32 DHWEIIGELGDGAFGKVYKAVNKETKLLAAAKVIETKSEEELEDYLVEIEILAECDHPVIVKLLSAYYFENKLWILIEFC 111 (1187)
T ss_pred HHHHHHhhhcCccchhhhhhhcccchhhhhhhhhcccchhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCceEEEEeec
Confidence 456778899999999999999776 4456778887667788899999999999999999999999999999999999999
Q ss_pred CCCChhhHhhhcCCCCcCChhHHHHHHHHHHHHHHHhhhcCCCceEecccCcCcEEEcCCCCceEecccCccccC----C
Q 004521 519 PNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFG----G 594 (747)
Q Consensus 519 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NIll~~~~~~kl~DFGla~~~~----~ 594 (747)
.||-.+.++.... ..|.+.++..+++|++.||.|||++. |||||||+.|||+.-+|.++|+|||.+-... .
T Consensus 112 ~GGAVDaimlEL~--r~LtE~QIqvvc~q~ldALn~LHs~~---iIHRDLKAGNiL~TldGdirLADFGVSAKn~~t~qk 186 (1187)
T KOG0579|consen 112 GGGAVDAIMLELG--RVLTEDQIQVVCYQVLDALNWLHSQN---IIHRDLKAGNILLTLDGDIRLADFGVSAKNKSTRQK 186 (1187)
T ss_pred CCchHhHHHHHhc--cccchHHHHHHHHHHHHHHHHHhhcc---hhhhhccccceEEEecCcEeeecccccccchhHHhh
Confidence 9999999886644 35899999999999999999999998 9999999999999999999999999864321 1
Q ss_pred CCCcccccee-------eecc-CCCCCccccchhHHHHHHHHHhCCCCCCCCCCcchhhhhHhHHhcCCcccccchhhhc
Q 004521 595 DETEGNTNRV-------VGTY-DGQFSIKSDVFSFGILLLEIVSGKKNRGFYRSDTKVNLIGHLWDEGIPLRLIDACIQD 666 (747)
Q Consensus 595 ~~~~~~~~~~-------~~~~-~~~~s~ksDVwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 666 (747)
.+....+++. +.++ +.+|+.++|||||||+|.||..+.+|..... .+..+-.+.+ ..++.++.+
T Consensus 187 RDsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHheln---pMRVllKiaK-SePPTLlqP---- 258 (1187)
T KOG0579|consen 187 RDSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHELN---PMRVLLKIAK-SEPPTLLQP---- 258 (1187)
T ss_pred hccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccccc---hHHHHHHHhh-cCCCcccCc----
Confidence 1111111111 1122 6789999999999999999999999954322 2222222212 222222221
Q ss_pred cCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 004521 667 SCNLADVIRCIHIGLLCVQQHPEDRPCMPSVIL 699 (747)
Q Consensus 667 ~~~~~~~~~~~~l~~~Cl~~dP~~RPt~~~v~~ 699 (747)
+.... ...++...||..||..||+++++++
T Consensus 259 S~Ws~---~F~DfLk~cL~Knp~~Rp~aaqll~ 288 (1187)
T KOG0579|consen 259 SHWSR---SFSDFLKRCLVKNPRNRPPAAQLLK 288 (1187)
T ss_pred chhhh---HHHHHHHHHHhcCCccCCCHHHHhh
Confidence 11111 2334555899999999999999875
|
|
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.2e-30 Score=267.71 Aligned_cols=251 Identities=25% Similarity=0.332 Sum_probs=183.4
Q ss_pred CCccceecccCCeeEEEEEecC-CcEEEEEEecccc--cccHHHHHHHHHHHhccCCCceeeEEeEEEeCCeeEEEEecC
Q 004521 442 FSINNKLGEGGFGPVYKGTLVD-GQEIAVKRLSKIS--EQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFM 518 (747)
Q Consensus 442 ~~~~~~lg~G~fg~Vy~~~~~~-g~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~ 518 (747)
|+..+.||+|+||.||+|+... ++.+|+|.+.... ....+.+..|+.++++++|+||+++++++...+..++||||+
T Consensus 1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~ 80 (282)
T cd07829 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIHTERKLYLVFEYC 80 (282)
T ss_pred CeeehcccccCcceEEEeeecCCCcEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceEEEecCc
Confidence 4567889999999999999865 8999999987642 344567889999999999999999999999999999999999
Q ss_pred CCCChhhHhhhcCCCCcCChhHHHHHHHHHHHHHHHhhhcCCCceEecccCcCcEEEcCCCCceEecccCccccCCCCCc
Q 004521 519 PNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETE 598 (747)
Q Consensus 519 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~ 598 (747)
+ ++|.+++.... ..+++..+..++.|++.||.|||+.+ |+||||+|+||++++++.+||+|||+++........
T Consensus 81 ~-~~l~~~i~~~~--~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~~~~~ 154 (282)
T cd07829 81 D-MDLKKYLDKRP--GPLSPNLIKSIMYQLLRGLAYCHSHR---ILHRDLKPQNILINRDGVLKLADFGLARAFGIPLRT 154 (282)
T ss_pred C-cCHHHHHHhhc--cCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChheEEEcCCCCEEEecCCcccccCCCccc
Confidence 8 58999986532 35899999999999999999999988 999999999999999999999999998876443211
Q ss_pred cccce----eeec---c-CCCCCccccchhHHHHHHHHHhCCCCCCCCCCcchhhhhHhH--------Hh--------cC
Q 004521 599 GNTNR----VVGT---Y-DGQFSIKSDVFSFGILLLEIVSGKKNRGFYRSDTKVNLIGHL--------WD--------EG 654 (747)
Q Consensus 599 ~~~~~----~~~~---~-~~~~s~ksDVwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~--------~~--------~~ 654 (747)
..... ...+ . ...++.++|||||||++|||++|+.|+...........+... |. ..
T Consensus 155 ~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (282)
T cd07829 155 YTHEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGTPTEESWPGVTKLPDYKP 234 (282)
T ss_pred cCccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHHHhCCCcHHHHHhhcccccccc
Confidence 11000 0000 1 236788999999999999999998886432211111000000 00 00
Q ss_pred CcccccchhhhccCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 004521 655 IPLRLIDACIQDSCNLADVIRCIHIGLLCVQQHPEDRPCMPSVIL 699 (747)
Q Consensus 655 ~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dP~~RPt~~~v~~ 699 (747)
............. .......+.+++.+||+.+|++||++.+|+.
T Consensus 235 ~~~~~~~~~~~~~-~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~ 278 (282)
T cd07829 235 TFPKFPPKDLEKV-LPRLDPEGIDLLSKMLQYNPAKRISAKEALK 278 (282)
T ss_pred cccccCccchHHh-cccccHHHHHHHHHhhccCcccCCCHHHHhh
Confidence 0000000000000 0001235678888999999999999999975
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.9e-30 Score=267.86 Aligned_cols=240 Identities=25% Similarity=0.340 Sum_probs=185.2
Q ss_pred cCCCccceecccCCeeEEEEEec-CCcEEEEEEeccc---ccccHHHHHHHHHHHhccC-CCceeeEEeEEEeCCeeEEE
Q 004521 440 DNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKI---SEQGLKELKNEVILFSKLQ-HRNLVKLLGCCIQGEEKLLI 514 (747)
Q Consensus 440 ~~~~~~~~lg~G~fg~Vy~~~~~-~g~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~-H~niv~l~g~~~~~~~~~lV 514 (747)
++|.+.+.||+|+||.||+|+.. +++.||+|.+.+. .....+.+.+|+.++++++ |+||+++++++...+..++|
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv 80 (280)
T cd05581 1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFV 80 (280)
T ss_pred CCceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEEEE
Confidence 46888999999999999999976 5899999998652 2334567889999999998 99999999999999999999
Q ss_pred EecCCCCChhhHhhhcCCCCcCChhHHHHHHHHHHHHHHHhhhcCCCceEecccCcCcEEEcCCCCceEecccCccccCC
Q 004521 515 YEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGG 594 (747)
Q Consensus 515 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NIll~~~~~~kl~DFGla~~~~~ 594 (747)
|||+++++|.+++... ..+++..++.++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++.....
T Consensus 81 ~e~~~~~~L~~~l~~~---~~l~~~~~~~i~~ql~~~l~~Lh~~~---~~H~dl~~~ni~i~~~~~~~l~df~~~~~~~~ 154 (280)
T cd05581 81 LEYAPNGELLQYIRKY---GSLDEKCTRFYAAEILLALEYLHSKG---IIHRDLKPENILLDKDMHIKITDFGTAKVLDP 154 (280)
T ss_pred EcCCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHeEECCCCCEEecCCccccccCC
Confidence 9999999999999653 35899999999999999999999988 99999999999999999999999999887654
Q ss_pred CCCc------------------cccceeeec---------cCCCCCccccchhHHHHHHHHHhCCCCCCCCCCcchhhhh
Q 004521 595 DETE------------------GNTNRVVGT---------YDGQFSIKSDVFSFGILLLEIVSGKKNRGFYRSDTKVNLI 647 (747)
Q Consensus 595 ~~~~------------------~~~~~~~~~---------~~~~~s~ksDVwS~Gvvl~elltg~~p~~~~~~~~~~~~~ 647 (747)
.... .......++ ....++.++||||||++++|+++|+.|+.... .....
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~---~~~~~ 231 (280)
T cd05581 155 NSSPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSN---EYLTF 231 (280)
T ss_pred ccccccCCCCCccccccccccccccccccCCccccCHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCcc---HHHHH
Confidence 3321 000001111 13457889999999999999999999975332 11111
Q ss_pred HhHHhcCCcccccchhhhccCCHHHHHHHHHHHHhccCCCCCCCCCH----HHHHH
Q 004521 648 GHLWDEGIPLRLIDACIQDSCNLADVIRCIHIGLLCVQQHPEDRPCM----PSVIL 699 (747)
Q Consensus 648 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dP~~RPt~----~~v~~ 699 (747)
........ .+ .......+.+++.+||+.+|.+||++ .++++
T Consensus 232 ~~~~~~~~--~~---------~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~ 276 (280)
T cd05581 232 QKILKLEY--SF---------PPNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKA 276 (280)
T ss_pred HHHHhcCC--CC---------CCccCHHHHHHHHHHhcCCHhhCCCcccCHHHHhc
Confidence 11111000 00 00112346678889999999999999 77664
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.9e-30 Score=275.14 Aligned_cols=253 Identities=23% Similarity=0.324 Sum_probs=183.7
Q ss_pred CCCccceecccCCeeEEEEEecC-CcEEEEEEecccc--cccHHHHHHHHHHHhccCCCceeeEEeEEEeCC-----eeE
Q 004521 441 NFSINNKLGEGGFGPVYKGTLVD-GQEIAVKRLSKIS--EQGLKELKNEVILFSKLQHRNLVKLLGCCIQGE-----EKL 512 (747)
Q Consensus 441 ~~~~~~~lg~G~fg~Vy~~~~~~-g~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~-----~~~ 512 (747)
+|.+.+.||+|+||.||+|+... ++.+|||++.... ....+.+.+|+.+++.++|+||+++++++.... ..+
T Consensus 1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 80 (330)
T cd07834 1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVY 80 (330)
T ss_pred CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccceE
Confidence 47888999999999999999765 8899999987633 445678999999999999999999999998875 789
Q ss_pred EEEecCCCCChhhHhhhcCCCCcCChhHHHHHHHHHHHHHHHhhhcCCCceEecccCcCcEEEcCCCCceEecccCcccc
Q 004521 513 LIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTF 592 (747)
Q Consensus 513 lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NIll~~~~~~kl~DFGla~~~ 592 (747)
+||||++ ++|.+++.. ...+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.++|+|||++...
T Consensus 81 lv~e~~~-~~l~~~l~~---~~~l~~~~~~~i~~~l~~~l~~LH~~g---i~H~dlkp~nili~~~~~~~L~dfg~~~~~ 153 (330)
T cd07834 81 IVTELME-TDLHKVIKS---PQPLTDDHIQYFLYQILRGLKYLHSAN---VIHRDLKPSNILVNSNCDLKICDFGLARGV 153 (330)
T ss_pred EEecchh-hhHHHHHhC---CCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEcccCceEee
Confidence 9999998 588888843 236899999999999999999999988 999999999999999999999999999876
Q ss_pred CCCCC---ccc----cceeeec---cCC-CCCccccchhHHHHHHHHHhCCCCCCCCCCcchhhhhHhHHhcCC------
Q 004521 593 GGDET---EGN----TNRVVGT---YDG-QFSIKSDVFSFGILLLEIVSGKKNRGFYRSDTKVNLIGHLWDEGI------ 655 (747)
Q Consensus 593 ~~~~~---~~~----~~~~~~~---~~~-~~s~ksDVwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~------ 655 (747)
..... ... ......+ ... .++.++||||||+++|||++|+.||...........+........
T Consensus 154 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 233 (330)
T cd07834 154 DPDEDEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNLIVEVLGTPSEEDLKF 233 (330)
T ss_pred cccccccccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHhcCCCChhHhhh
Confidence 54321 000 0000000 123 678899999999999999999999754332111111110000000
Q ss_pred -----cccccchh-hhccCCH-----HHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 004521 656 -----PLRLIDAC-IQDSCNL-----ADVIRCIHIGLLCVQQHPEDRPCMPSVILM 700 (747)
Q Consensus 656 -----~~~~~d~~-l~~~~~~-----~~~~~~~~l~~~Cl~~dP~~RPt~~~v~~~ 700 (747)
....+... ....... .....+.+++.+||+.+|.+||++.++++.
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~ 289 (330)
T cd07834 234 ITSEKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAH 289 (330)
T ss_pred ccccchhhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence 00000000 0000000 012345678889999999999999999874
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.7e-30 Score=277.82 Aligned_cols=252 Identities=22% Similarity=0.284 Sum_probs=178.2
Q ss_pred cCCCccceecccCCeeEEEEEecC-CcEEEEEEecccccccHHHHHHHHHHHhccCCCceeeEEeEEEeC----------
Q 004521 440 DNFSINNKLGEGGFGPVYKGTLVD-GQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQG---------- 508 (747)
Q Consensus 440 ~~~~~~~~lg~G~fg~Vy~~~~~~-g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~---------- 508 (747)
.+|.+.+.||+|+||.||+|.... ++.||+|.+........+.+.+|++++++++||||+++++++...
T Consensus 5 ~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~ 84 (342)
T cd07854 5 SRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDVGS 84 (342)
T ss_pred cceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCCchHHHHHHHHHHHHhcCCCcchhhHhhhccccccccccccc
Confidence 578899999999999999999754 889999998765556677899999999999999999999876544
Q ss_pred ----CeeEEEEecCCCCChhhHhhhcCCCCcCChhHHHHHHHHHHHHHHHhhhcCCCceEecccCcCcEEEcC-CCCceE
Q 004521 509 ----EEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQ-DMNPKI 583 (747)
Q Consensus 509 ----~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NIll~~-~~~~kl 583 (747)
...++||||++ ++|.+++.. ..+++..+..++.||++||.|||+.+ |+||||||+||+++. ++.+||
T Consensus 85 ~~~~~~~~lv~e~~~-~~L~~~~~~----~~l~~~~~~~~~~qi~~aL~~LH~~g---ivH~dikp~Nili~~~~~~~kl 156 (342)
T cd07854 85 LTELNSVYIVQEYME-TDLANVLEQ----GPLSEEHARLFMYQLLRGLKYIHSAN---VLHRDLKPANVFINTEDLVLKI 156 (342)
T ss_pred ccccceEEEEeeccc-ccHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEcCCCceEEE
Confidence 35789999997 588888742 34889999999999999999999988 999999999999974 567899
Q ss_pred ecccCccccCCCCCccc-------c-ceeeec---cCCCCCccccchhHHHHHHHHHhCCCCCCCCCCcchhhhhHhHH-
Q 004521 584 SDFGLVRTFGGDETEGN-------T-NRVVGT---YDGQFSIKSDVFSFGILLLEIVSGKKNRGFYRSDTKVNLIGHLW- 651 (747)
Q Consensus 584 ~DFGla~~~~~~~~~~~-------~-~~~~~~---~~~~~s~ksDVwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~- 651 (747)
+|||+++.+........ . ...... ....++.++|||||||++|||++|+.||................
T Consensus 157 ~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~~~~~~~~~~ 236 (342)
T cd07854 157 GDFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQLILESVP 236 (342)
T ss_pred CCcccceecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcC
Confidence 99999976532211100 0 000000 12457889999999999999999999975332111100000000
Q ss_pred ----------hcCCcccccchhhhccCCH-----HHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 004521 652 ----------DEGIPLRLIDACIQDSCNL-----ADVIRCIHIGLLCVQQHPEDRPCMPSVIL 699 (747)
Q Consensus 652 ----------~~~~~~~~~d~~l~~~~~~-----~~~~~~~~l~~~Cl~~dP~~RPt~~~v~~ 699 (747)
................... .....+.+++.+||+.||.+|||+.+|++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~ 299 (342)
T cd07854 237 VVREEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALM 299 (342)
T ss_pred CCChHHhhhhhhhhhhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccCHHHHhC
Confidence 0000000000000000000 01134567888999999999999999985
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.9e-29 Score=262.48 Aligned_cols=236 Identities=23% Similarity=0.271 Sum_probs=171.0
Q ss_pred eecccCCeeEEEEEecC-CcEEEEEEecccc---cccHHHHHHHHH---HHhccCCCceeeEEeEEEeCCeeEEEEecCC
Q 004521 447 KLGEGGFGPVYKGTLVD-GQEIAVKRLSKIS---EQGLKELKNEVI---LFSKLQHRNLVKLLGCCIQGEEKLLIYEFMP 519 (747)
Q Consensus 447 ~lg~G~fg~Vy~~~~~~-g~~vavK~l~~~~---~~~~~~~~~E~~---~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~ 519 (747)
.||+|+||.||+|.... ++.||+|.+.+.. ......+..|.. +++...||||+++++++...+..++||||++
T Consensus 1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 80 (278)
T cd05606 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMN 80 (278)
T ss_pred CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEecCC
Confidence 48999999999998754 8899999986521 112223444443 4445679999999999999999999999999
Q ss_pred CCChhhHhhhcCCCCcCChhHHHHHHHHHHHHHHHhhhcCCCceEecccCcCcEEEcCCCCceEecccCccccCCCCCcc
Q 004521 520 NKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEG 599 (747)
Q Consensus 520 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~ 599 (747)
+++|..++.. ...+++..+..++.|+++||.|||+.+ |+||||||+||++++++.+||+|||+++.+.......
T Consensus 81 g~~L~~~l~~---~~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~di~p~nili~~~~~~kl~dfg~~~~~~~~~~~~ 154 (278)
T cd05606 81 GGDLHYHLSQ---HGVFSEAEMRFYAAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHA 154 (278)
T ss_pred CCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---EEcCCCCHHHEEECCCCCEEEccCcCccccCccCCcC
Confidence 9999988854 345899999999999999999999988 9999999999999999999999999987654322111
Q ss_pred cc---ceeeec-c--CCCCCccccchhHHHHHHHHHhCCCCCCCCCCcchhhhhHhHHhcCCcccccchhhhccCCHHHH
Q 004521 600 NT---NRVVGT-Y--DGQFSIKSDVFSFGILLLEIVSGKKNRGFYRSDTKVNLIGHLWDEGIPLRLIDACIQDSCNLADV 673 (747)
Q Consensus 600 ~~---~~~~~~-~--~~~~s~ksDVwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~ 673 (747)
.. ...... . ...++.++|||||||++|||++|+.|+.......... ........ ... +.... .
T Consensus 155 ~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~~~-~~~~~~~~-~~~-----~~~~~----s 223 (278)
T cd05606 155 SVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHE-IDRMTLTM-AVE-----LPDSF----S 223 (278)
T ss_pred cCCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccchHH-HHHHhhcc-CCC-----CCCcC----C
Confidence 00 000000 1 2357889999999999999999999975432222111 11111110 011 11111 1
Q ss_pred HHHHHHHHhccCCCCCCCC-----CHHHHHH
Q 004521 674 IRCIHIGLLCVQQHPEDRP-----CMPSVIL 699 (747)
Q Consensus 674 ~~~~~l~~~Cl~~dP~~RP-----t~~~v~~ 699 (747)
..+.+++.+|++.+|.+|| ++.++++
T Consensus 224 ~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~ 254 (278)
T cd05606 224 PELRSLLEGLLQRDVNRRLGCLGRGAQEVKE 254 (278)
T ss_pred HHHHHHHHHHhhcCHHhccCCCCCCHHHHHh
Confidence 3456677799999999999 8989875
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.2e-30 Score=293.03 Aligned_cols=245 Identities=26% Similarity=0.416 Sum_probs=176.0
Q ss_pred HhcCCCccceecccCCeeEEEEEec-CCcEEEEEEecc-cccccHHHHHHHHHHHhccCCCceeeEEeEEEe--------
Q 004521 438 ATDNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSK-ISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQ-------- 507 (747)
Q Consensus 438 ~~~~~~~~~~lg~G~fg~Vy~~~~~-~g~~vavK~l~~-~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~-------- 507 (747)
-..+|+..+.||+||||.||+++.+ ||+.+|||++.- .+......+.+|+.++++|+|||||+++....+
T Consensus 477 Y~~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~~~ 556 (1351)
T KOG1035|consen 477 YLNDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKASDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELTVL 556 (1351)
T ss_pred HhhhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCchHHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCccccc
Confidence 4467888999999999999999864 799999999874 344556678899999999999999998754211
Q ss_pred -----------------------------------------------C--------------------------------
Q 004521 508 -----------------------------------------------G-------------------------------- 508 (747)
Q Consensus 508 -----------------------------------------------~-------------------------------- 508 (747)
.
T Consensus 557 ei~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS~~ 636 (1351)
T KOG1035|consen 557 EIVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTSDS 636 (1351)
T ss_pred cccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCccccccccccccccccccc
Confidence 0
Q ss_pred --------------------------------CeeEEEEecCCCCChhhHhhhcCCCCcCChhHHHHHHHHHHHHHHHhh
Q 004521 509 --------------------------------EEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLH 556 (747)
Q Consensus 509 --------------------------------~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH 556 (747)
...||=||||+...|.+++....... .....++++++|++||.|+|
T Consensus 637 e~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~~--~~d~~wrLFreIlEGLaYIH 714 (1351)
T KOG1035|consen 637 EGSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFNS--QRDEAWRLFREILEGLAYIH 714 (1351)
T ss_pred CCccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccch--hhHHHHHHHHHHHHHHHHHH
Confidence 01256689998888888875432211 35778899999999999999
Q ss_pred hcCCCceEecccCcCcEEEcCCCCceEecccCccccC----------C------CCCccccceeeecc------------
Q 004521 557 QDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFG----------G------DETEGNTNRVVGTY------------ 608 (747)
Q Consensus 557 ~~~~~~iiHrDlkp~NIll~~~~~~kl~DFGla~~~~----------~------~~~~~~~~~~~~~~------------ 608 (747)
+.+ ||||||||.||+||++..|||+|||+|.... . .......+...||.
T Consensus 715 ~~g---iIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~~~ 791 (1351)
T KOG1035|consen 715 DQG---IIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSDTS 791 (1351)
T ss_pred hCc---eeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhcccc
Confidence 999 9999999999999999999999999998621 0 00011112223331
Q ss_pred CCCCCccccchhHHHHHHHHHhCCCCCCCCCCcchhhhhHhHHhcCCcccccchhhhccCCHHHHHHHHHHHHhccCCCC
Q 004521 609 DGQFSIKSDVFSFGILLLEIVSGKKNRGFYRSDTKVNLIGHLWDEGIPLRLIDACIQDSCNLADVIRCIHIGLLCVQQHP 688 (747)
Q Consensus 609 ~~~~s~ksDVwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dP 688 (747)
...|+.|+|+||+||||+||+. | |....+....+..+. .+..+... . ....+...-.+++.++++.||
T Consensus 792 ~~~Yn~KiDmYSLGIVlFEM~y---P--F~TsMERa~iL~~LR-~g~iP~~~--~----f~~~~~~~e~slI~~Ll~hdP 859 (1351)
T KOG1035|consen 792 SNKYNSKIDMYSLGIVLFEMLY---P--FGTSMERASILTNLR-KGSIPEPA--D----FFDPEHPEEASLIRWLLSHDP 859 (1351)
T ss_pred cccccchhhhHHHHHHHHHHhc---c--CCchHHHHHHHHhcc-cCCCCCCc--c----cccccchHHHHHHHHHhcCCC
Confidence 2379999999999999999986 3 233444444444332 33322221 1 111122223467789999999
Q ss_pred CCCCCHHHHHH
Q 004521 689 EDRPCMPSVIL 699 (747)
Q Consensus 689 ~~RPt~~~v~~ 699 (747)
.+|||+.|++.
T Consensus 860 ~kRPtA~eLL~ 870 (1351)
T KOG1035|consen 860 SKRPTATELLN 870 (1351)
T ss_pred ccCCCHHHHhh
Confidence 99999999864
|
|
| >KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.2e-31 Score=302.41 Aligned_cols=244 Identities=25% Similarity=0.355 Sum_probs=187.6
Q ss_pred hcCCCccceecccCCeeEEEEEecC-CcEEEEEEecc--cccccHHHHHHHHHHHhccCCCceeeEEeEEEeCCeeEEEE
Q 004521 439 TDNFSINNKLGEGGFGPVYKGTLVD-GQEIAVKRLSK--ISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIY 515 (747)
Q Consensus 439 ~~~~~~~~~lg~G~fg~Vy~~~~~~-g~~vavK~l~~--~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 515 (747)
+-++.-...||.|.||.||-|...+ |...|+|.++- ..........+|+.++..|+|||||+++|+-.+.+..+|.|
T Consensus 1234 ~~rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRekv~IFM 1313 (1509)
T KOG4645|consen 1234 TFRWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREKVYIFM 1313 (1509)
T ss_pred eeeeccccccCCcceeeeEEeecCCccchhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCceeecHHHHHHHH
Confidence 3456666899999999999998654 88999998764 23455677889999999999999999999999999999999
Q ss_pred ecCCCCChhhHhhhcCCCCcCChhHHHHHHHHHHHHHHHhhhcCCCceEecccCcCcEEEcCCCCceEecccCccccCCC
Q 004521 516 EFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGD 595 (747)
Q Consensus 516 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NIll~~~~~~kl~DFGla~~~~~~ 595 (747)
|||++|+|.+.+.. ....++.....+..|++.|+.|||++| ||||||||.||+|+.+|.+|++|||.|+.+...
T Consensus 1314 EyC~~GsLa~ll~~---gri~dE~vt~vyt~qll~gla~LH~~g---IVHRDIK~aNI~Ld~~g~iK~~DFGsa~ki~~~ 1387 (1509)
T KOG4645|consen 1314 EYCEGGSLASLLEH---GRIEDEMVTRVYTKQLLEGLAYLHEHG---IVHRDIKPANILLDFNGLIKYGDFGSAVKIKNN 1387 (1509)
T ss_pred HHhccCcHHHHHHh---cchhhhhHHHHHHHHHHHHHHHHHhcC---ceecCCCccceeeecCCcEEeecccceeEecCc
Confidence 99999999999854 233566666678899999999999999 999999999999999999999999999887654
Q ss_pred CCc--cccceeeec------------cCCCCCccccchhHHHHHHHHHhCCCCCCCCCCcchhhhhHhHHhcCCcccccc
Q 004521 596 ETE--GNTNRVVGT------------YDGQFSIKSDVFSFGILLLEIVSGKKNRGFYRSDTKVNLIGHLWDEGIPLRLID 661 (747)
Q Consensus 596 ~~~--~~~~~~~~~------------~~~~~s~ksDVwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~d 661 (747)
... .......|| -.....-++||||+|||+.||+||++||..... ...+.+....|..+.++.
T Consensus 1388 ~~~~~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dn---e~aIMy~V~~gh~Pq~P~ 1464 (1509)
T KOG4645|consen 1388 AQTMPGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDN---EWAIMYHVAAGHKPQIPE 1464 (1509)
T ss_pred hhcCCHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccc---hhHHHhHHhccCCCCCch
Confidence 211 111112222 234455689999999999999999999754432 233444444555555444
Q ss_pred hhhhccCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 004521 662 ACIQDSCNLADVIRCIHIGLLCVQQHPEDRPCMPSVILM 700 (747)
Q Consensus 662 ~~l~~~~~~~~~~~~~~l~~~Cl~~dP~~RPt~~~v~~~ 700 (747)
. +. ..-.+++-+||+.||++|.++.|+++.
T Consensus 1465 ~-ls--------~~g~dFle~Cl~~dP~~Rw~~~qlle~ 1494 (1509)
T KOG4645|consen 1465 R-LS--------SEGRDFLEHCLEQDPKMRWTASQLLEH 1494 (1509)
T ss_pred h-hh--------HhHHHHHHHHHhcCchhhhHHHHHHHh
Confidence 3 11 112356668999999999998887764
|
|
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=6.2e-30 Score=276.96 Aligned_cols=251 Identities=23% Similarity=0.327 Sum_probs=181.8
Q ss_pred HhcCCCccceecccCCeeEEEEEecC-CcEEEEEEeccc--ccccHHHHHHHHHHHhccCCCceeeEEeEEEeCCe----
Q 004521 438 ATDNFSINNKLGEGGFGPVYKGTLVD-GQEIAVKRLSKI--SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEE---- 510 (747)
Q Consensus 438 ~~~~~~~~~~lg~G~fg~Vy~~~~~~-g~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~---- 510 (747)
..++|++.+.||+|+||.||+|+... ++.||||++... .....+.+.+|+.++++++|+||+++++++...+.
T Consensus 13 ~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 92 (343)
T cd07851 13 VPDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLEDF 92 (343)
T ss_pred ccCceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHhhcccccccc
Confidence 45689999999999999999999864 789999998642 23344667889999999999999999998876655
Q ss_pred --eEEEEecCCCCChhhHhhhcCCCCcCChhHHHHHHHHHHHHHHHhhhcCCCceEecccCcCcEEEcCCCCceEecccC
Q 004521 511 --KLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGL 588 (747)
Q Consensus 511 --~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NIll~~~~~~kl~DFGl 588 (747)
.++|+||+ +++|.+++.. ..+++..+..++.|+++||.|||+.+ |+||||||+||++++++.+||+|||+
T Consensus 93 ~~~~lv~e~~-~~~L~~~~~~----~~l~~~~~~~~~~ql~~aL~~LH~~g---i~H~dlkp~Nill~~~~~~kL~dfg~ 164 (343)
T cd07851 93 QDVYLVTHLM-GADLNNIVKC----QKLSDDHIQFLVYQILRGLKYIHSAG---IIHRDLKPSNIAVNEDCELKILDFGL 164 (343)
T ss_pred ccEEEEEecC-CCCHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCCEEEccccc
Confidence 89999998 5799888853 35899999999999999999999988 99999999999999999999999999
Q ss_pred ccccCCCCCccccc--eeeec---cCCCCCccccchhHHHHHHHHHhCCCCCCCCCCcchhhhhHhHHh-cCCcc-ccc-
Q 004521 589 VRTFGGDETEGNTN--RVVGT---YDGQFSIKSDVFSFGILLLEIVSGKKNRGFYRSDTKVNLIGHLWD-EGIPL-RLI- 660 (747)
Q Consensus 589 a~~~~~~~~~~~~~--~~~~~---~~~~~s~ksDVwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~-~~~~~-~~~- 660 (747)
+............. ..... ....++.++|||||||++|||++|+.|+...... ..+..... .+... .+.
T Consensus 165 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~---~~~~~i~~~~~~~~~~~~~ 241 (343)
T cd07851 165 ARHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHI---DQLKRIMNLVGTPDEELLQ 241 (343)
T ss_pred cccccccccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChH---HHHHHHHHhcCCCCHHHHh
Confidence 98764331111000 00010 0235788999999999999999999997532211 11111100 00000 000
Q ss_pred -----------chhh-hccCCH-----HHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 004521 661 -----------DACI-QDSCNL-----ADVIRCIHIGLLCVQQHPEDRPCMPSVIL 699 (747)
Q Consensus 661 -----------d~~l-~~~~~~-----~~~~~~~~l~~~Cl~~dP~~RPt~~~v~~ 699 (747)
.... ...... .....+.+++.+||+.+|++|||+.+|++
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~ 297 (343)
T cd07851 242 KISSESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALA 297 (343)
T ss_pred hccchhHHHHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCCHHHHhc
Confidence 0000 000000 01235678888999999999999999875
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.9e-29 Score=261.86 Aligned_cols=243 Identities=25% Similarity=0.315 Sum_probs=179.0
Q ss_pred CCCccceecccCCeeEEEEEecC-CcEEEEEEeccc-----ccccHHHHHHHHHHHhccCCCceeeEEeEEEeCCeeEEE
Q 004521 441 NFSINNKLGEGGFGPVYKGTLVD-GQEIAVKRLSKI-----SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLI 514 (747)
Q Consensus 441 ~~~~~~~lg~G~fg~Vy~~~~~~-g~~vavK~l~~~-----~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV 514 (747)
+|.+.+.||+|+||.||+++... +..+++|.++.. ......++..|+.++++++||||+++++++.+.+..++|
T Consensus 1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 80 (260)
T cd08222 1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERDAFCII 80 (260)
T ss_pred CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCCceEEE
Confidence 47788999999999999998754 455666665532 122344677899999999999999999999999999999
Q ss_pred EecCCCCChhhHhhhc-CCCCcCChhHHHHHHHHHHHHHHHhhhcCCCceEecccCcCcEEEcCCCCceEecccCccccC
Q 004521 515 YEFMPNKSLDSFIFDQ-TRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFG 593 (747)
Q Consensus 515 ~E~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NIll~~~~~~kl~DFGla~~~~ 593 (747)
|||+++++|.+++... .....+++..+..++.|+++||.|||+.+ ++|+||||+||+++. +.+||+|||+++.+.
T Consensus 81 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~h~~l~~~nili~~-~~~~l~d~g~~~~~~ 156 (260)
T cd08222 81 TEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQRR---ILHRDLKAKNIFLKN-NLLKIGDFGVSRLLM 156 (260)
T ss_pred EEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHcC---ccccCCChhheEeec-CCEeecccCceeecC
Confidence 9999999999988653 23356899999999999999999999988 999999999999975 569999999987664
Q ss_pred CCCCcccc-----ceeeec--cCCCCCccccchhHHHHHHHHHhCCCCCCCCCCcchhhhhHhHHhcCCcccccchhhhc
Q 004521 594 GDETEGNT-----NRVVGT--YDGQFSIKSDVFSFGILLLEIVSGKKNRGFYRSDTKVNLIGHLWDEGIPLRLIDACIQD 666 (747)
Q Consensus 594 ~~~~~~~~-----~~~~~~--~~~~~s~ksDVwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 666 (747)
........ ...... ....++.++||||||+++|+|++|..|+.... ........ ..+....+.
T Consensus 157 ~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~---~~~~~~~~-~~~~~~~~~------ 226 (260)
T cd08222 157 GSCDLATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQN---FLSVVLRI-VEGPTPSLP------ 226 (260)
T ss_pred CCcccccCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCcc---HHHHHHHH-HcCCCCCCc------
Confidence 32211100 000000 13457789999999999999999999964221 11111111 112111111
Q ss_pred cCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 004521 667 SCNLADVIRCIHIGLLCVQQHPEDRPCMPSVILM 700 (747)
Q Consensus 667 ~~~~~~~~~~~~l~~~Cl~~dP~~RPt~~~v~~~ 700 (747)
......+.+++.+||+.+|++||++.++++.
T Consensus 227 ---~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 257 (260)
T cd08222 227 ---ETYSRQLNSIMQSMLNKDPSLRPSAAEILRN 257 (260)
T ss_pred ---chhcHHHHHHHHHHhcCChhhCcCHHHHhhC
Confidence 1112245678889999999999999999863
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=2e-31 Score=257.01 Aligned_cols=248 Identities=27% Similarity=0.350 Sum_probs=182.4
Q ss_pred CCccceecccCCeeEEEEEecC-CcEEEEEEecccc-cccHHHHHHHHHHHhcc-CCCceeeEEeEEEeCCeeEEEEecC
Q 004521 442 FSINNKLGEGGFGPVYKGTLVD-GQEIAVKRLSKIS-EQGLKELKNEVILFSKL-QHRNLVKLLGCCIQGEEKLLIYEFM 518 (747)
Q Consensus 442 ~~~~~~lg~G~fg~Vy~~~~~~-g~~vavK~l~~~~-~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lV~E~~ 518 (747)
.+....||.|+||+|+|-.++. |+.+|||+++... +...++++.|.+...+- +.||||+++|.+..++..++.||+|
T Consensus 66 Lqdlg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~~keq~rll~e~d~~mks~~cp~IVkfyGa~F~EGdcWiCMELM 145 (361)
T KOG1006|consen 66 LQDLGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNIEKEQKRLLMEHDTVMKSSNCPNIVKFYGALFSEGDCWICMELM 145 (361)
T ss_pred HHHHHHhcCCcchhhhhhhcCccCcEEEEEEeeeccchHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhcCCceeeeHHHH
Confidence 3345789999999999998765 9999999998643 35677888898876655 7999999999999999999999999
Q ss_pred CCCChhhHhhh--cCCCCcCChhHHHHHHHHHHHHHHHhhhcCCCceEecccCcCcEEEcCCCCceEecccCccccCCCC
Q 004521 519 PNKSLDSFIFD--QTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDE 596 (747)
Q Consensus 519 ~~gsL~~~l~~--~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~ 596 (747)
. -||+.+-.. ..++..+++.-.-+|...+.+||.||.+. +.|||||+||+|||||..|.+||+|||++-.+...-
T Consensus 146 d-~SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~--lkiIHRDvKPSNILldr~G~vKLCDFGIcGqLv~Si 222 (361)
T KOG1006|consen 146 D-ISLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEE--LKIIHRDVKPSNILLDRHGDVKLCDFGICGQLVDSI 222 (361)
T ss_pred h-hhHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHH--hhhhhccCChhheEEecCCCEeeecccchHhHHHHH
Confidence 5 666654321 12334588888888999999999999875 369999999999999999999999999986653221
Q ss_pred C---------ccccceeeeccCCCCCccccchhHHHHHHHHHhCCCCCCCCCCcchhhhhHhHHhcCCcccccchhhhcc
Q 004521 597 T---------EGNTNRVVGTYDGQFSIKSDVFSFGILLLEIVSGKKNRGFYRSDTKVNLIGHLWDEGIPLRLIDACIQDS 667 (747)
Q Consensus 597 ~---------~~~~~~~~~~~~~~~s~ksDVwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~ 667 (747)
. ...+++. ...+..|+.++||||+|++|+|+.||+.|+..+.+ ..+.+.++ ..+.++.+..+.
T Consensus 223 AkT~daGCrpYmAPERi-~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~s--vfeql~~V-v~gdpp~l~~~~---- 294 (361)
T KOG1006|consen 223 AKTVDAGCRPYMAPERI-DPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWDS--VFEQLCQV-VIGDPPILLFDK---- 294 (361)
T ss_pred HhhhccCCccccChhcc-CCccCCcchhhhhhhhcceEeeeecCCCCcchHHH--HHHHHHHH-HcCCCCeecCcc----
Confidence 1 1111111 11134589999999999999999999999876654 22223222 233333332211
Q ss_pred CCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 004521 668 CNLADVIRCIHIGLLCVQQHPEDRPCMPSVILM 700 (747)
Q Consensus 668 ~~~~~~~~~~~l~~~Cl~~dP~~RPt~~~v~~~ 700 (747)
...+.-..+..++-.|+..|..+||...++.++
T Consensus 295 ~~~~~s~~~~~fintCl~Kd~~~Rpky~~Lk~~ 327 (361)
T KOG1006|consen 295 ECVHYSFSMVRFINTCLIKDRSDRPKYDDLKKF 327 (361)
T ss_pred cccccCHHHHHHHHHHhhcccccCcchhhhhcC
Confidence 112223346667778999999999999998753
|
|
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=99.96 E-value=8.2e-29 Score=267.02 Aligned_cols=251 Identities=22% Similarity=0.291 Sum_probs=175.0
Q ss_pred CCCccceecccCCeeEEEEEecC---CcEEEEEEeccc--ccccHHHHHHHHHHHhcc-CCCceeeEEeEEEeC----Ce
Q 004521 441 NFSINNKLGEGGFGPVYKGTLVD---GQEIAVKRLSKI--SEQGLKELKNEVILFSKL-QHRNLVKLLGCCIQG----EE 510 (747)
Q Consensus 441 ~~~~~~~lg~G~fg~Vy~~~~~~---g~~vavK~l~~~--~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~----~~ 510 (747)
+|++.+.||+|+||.||+++... +..+|+|++... .....+.+.+|+.+++++ +||||+++++++... ..
T Consensus 1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~ 80 (332)
T cd07857 1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFNE 80 (332)
T ss_pred CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCCc
Confidence 47788999999999999999753 678999998752 222356788999999999 599999999976533 34
Q ss_pred eEEEEecCCCCChhhHhhhcCCCCcCChhHHHHHHHHHHHHHHHhhhcCCCceEecccCcCcEEEcCCCCceEecccCcc
Q 004521 511 KLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVR 590 (747)
Q Consensus 511 ~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NIll~~~~~~kl~DFGla~ 590 (747)
.++++||+. ++|.+++.. ...+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++
T Consensus 81 ~~~~~e~~~-~~L~~~l~~---~~~~~~~~~~~~~~qi~~aL~~LH~~g---ivH~dlkp~Nili~~~~~~kl~Dfg~a~ 153 (332)
T cd07857 81 LYLYEELME-ADLHQIIRS---GQPLTDAHFQSFIYQILCGLKYIHSAN---VLHRDLKPGNLLVNADCELKICDFGLAR 153 (332)
T ss_pred EEEEEeccc-CCHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHeEEcCCCCEEeCcCCCce
Confidence 688889886 689888843 345889999999999999999999988 9999999999999999999999999998
Q ss_pred ccCCCCCccc--cceeeec---------c-CCCCCccccchhHHHHHHHHHhCCCCCCCCCCcchhhhhHhHHh------
Q 004521 591 TFGGDETEGN--TNRVVGT---------Y-DGQFSIKSDVFSFGILLLEIVSGKKNRGFYRSDTKVNLIGHLWD------ 652 (747)
Q Consensus 591 ~~~~~~~~~~--~~~~~~~---------~-~~~~s~ksDVwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~------ 652 (747)
.+........ .....++ . ...++.++|||||||++|||++|+.|+...........+.....
T Consensus 154 ~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 233 (332)
T cd07857 154 GFSENPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQVLGTPDEET 233 (332)
T ss_pred ecccccccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHHHHHHHHHHHhCCCCHHH
Confidence 6543221100 0001111 0 23578899999999999999999998753221110000000000
Q ss_pred -----cCCcc-------cccchhhhccCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 004521 653 -----EGIPL-------RLIDACIQDSCNLADVIRCIHIGLLCVQQHPEDRPCMPSVIL 699 (747)
Q Consensus 653 -----~~~~~-------~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dP~~RPt~~~v~~ 699 (747)
..... ......+... .......+.+++.+|++.||.+|||+.++++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~li~~~l~~~P~~R~t~~~ll~ 291 (332)
T cd07857 234 LSRIGSPKAQNYIRSLPNIPKKPFESI-FPNANPLALDLLEKLLAFDPTKRISVEEALE 291 (332)
T ss_pred HHhhhhhhHHHHHHhccccCCcchHhh-CCCCCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 00000 0000000000 0001134667888999999999999999863
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >PF01453 B_lectin: D-mannose binding lectin; InterPro: IPR001480 A bulb lectin super-family (Amaryllidaceae, Orchidaceae and Aliaceae) contains a ~115-residue-long domain whose overall three dimensional fold is very similar to that of [, ]: Dictyostelium discoideum comitin, an actin binding protein Curculigo latifolia curculin, a sweet tasting and taste-modifying protein This domain generally binds mannose, but in at least one protein, curculin, it is apparently devoid of mannose-binding activity | Back alignment and domain information |
|---|
Probab=99.96 E-value=2e-30 Score=230.68 Aligned_cols=111 Identities=49% Similarity=0.757 Sum_probs=82.0
Q ss_pred CCceEEEcCCCCCCCCC--cceEEEecCCcEEEEcCCCcEEEEe-ccccCcCCceEEEEecccCEEEEeCCCCCCCceee
Q 004521 14 PHEVVWVANRLNPINDS--FGFLMINKTGNLVLTSQSNIVVWSA-YLSKEVQTPVVLQLLDSGNLVLRDEHDGDSETYFW 90 (747)
Q Consensus 14 ~~t~VW~Anr~~p~~~~--~~~l~l~~~G~Lvl~~~~~~~vWst-~~~~~~~~~~~~~lld~GNlVl~~~~~~~~~~~lW 90 (747)
++||||+|||++|+..+ ..+|.|+.||+|+|.|+.++++|++ ++.+.......|.|+|+|||||++.. +.+||
T Consensus 1 ~~tvvW~an~~~p~~~~s~~~~L~l~~dGnLvl~~~~~~~iWss~~t~~~~~~~~~~~L~~~GNlvl~d~~----~~~lW 76 (114)
T PF01453_consen 1 PRTVVWVANRNSPLTSSSGNYTLILQSDGNLVLYDSNGSVIWSSNNTSGRGNSGCYLVLQDDGNLVLYDSS----GNVLW 76 (114)
T ss_dssp ---------TTEEEEECETTEEEEEETTSEEEEEETTTEEEEE--S-TTSS-SSEEEEEETTSEEEEEETT----SEEEE
T ss_pred CcccccccccccccccccccccceECCCCeEEEEcCCCCEEEEecccCCccccCeEEEEeCCCCEEEEeec----ceEEE
Confidence 47999999999999643 3789999999999999999999999 55543125889999999999999964 78999
Q ss_pred eecCCCCCccccCCcccccccccccceEEeccCCCCCC
Q 004521 91 QSFDYPSDTLLPGMKLGWDLKTGLERRVTSWKSFDDPS 128 (747)
Q Consensus 91 qSFd~PtDTlLpg~~l~~~~~~g~~~~l~S~~s~~dps 128 (747)
|||||||||+||||+|+.+..++....++||++.+|||
T Consensus 77 ~Sf~~ptdt~L~~q~l~~~~~~~~~~~~~sw~s~~dps 114 (114)
T PF01453_consen 77 QSFDYPTDTLLPGQKLGDGNVTGKNDSLTSWSSNTDPS 114 (114)
T ss_dssp ESTTSSS-EEEEEET--TSEEEEESTSSEEEESS----
T ss_pred eecCCCccEEEeccCcccCCCccccceEEeECCCCCCC
Confidence 99999999999999999988888777899999999996
|
Each bulb-type lectin domain consists of three sequential beta-sheet subdomains (I, II, III) that are inter-related by pseudo three-fold symmetry. The three subdomains are flat four-stranded, antiparrallel beta-sheets. Together they form a 12-stranded beta-barrel in which the barrel axis coincides with the pseudo 3-fold axis.; GO: 0005529 sugar binding; PDB: 3M7H_A 3M7J_B 3MEZ_D 1DLP_A 1BWU_D 1KJ1_A 1B2P_A 1XD6_A 2DPF_C 2D04_B .... |
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.1e-28 Score=252.16 Aligned_cols=229 Identities=25% Similarity=0.319 Sum_probs=174.9
Q ss_pred ecccCCeeEEEEEecC-CcEEEEEEecccc---cccHHHHHHHHHHHhccCCCceeeEEeEEEeCCeeEEEEecCCCCCh
Q 004521 448 LGEGGFGPVYKGTLVD-GQEIAVKRLSKIS---EQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMPNKSL 523 (747)
Q Consensus 448 lg~G~fg~Vy~~~~~~-g~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gsL 523 (747)
||+|+||.||+++..+ ++.+|+|.+.+.. ......+..|+.++++++|+||+++++.+..+...++||||+++++|
T Consensus 1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L 80 (250)
T cd05123 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGEL 80 (250)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecCCCCcH
Confidence 6999999999999764 8899999987532 22456889999999999999999999999999999999999999999
Q ss_pred hhHhhhcCCCCcCChhHHHHHHHHHHHHHHHhhhcCCCceEecccCcCcEEEcCCCCceEecccCccccCCCCCc--cc-
Q 004521 524 DSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETE--GN- 600 (747)
Q Consensus 524 ~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~--~~- 600 (747)
.+++... ..+++..+..++.|+++||.|||+.+ ++|+||+|+||+++.++.++|+|||++......... ..
T Consensus 81 ~~~l~~~---~~l~~~~~~~~~~qi~~~l~~lh~~~---~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~ 154 (250)
T cd05123 81 FSHLSKE---GRFSEERARFYAAEIVLALEYLHSLG---IIYRDLKPENILLDADGHIKLTDFGLAKELSSEGSRTNTFC 154 (250)
T ss_pred HHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCcceEEEcCCCcEEEeecCcceecccCCCcccCCc
Confidence 9998543 24889999999999999999999987 999999999999999999999999998766443110 00
Q ss_pred -cceeee---ccCCCCCccccchhHHHHHHHHHhCCCCCCCCCCcchhhhhHhHHhcCCcccccchhhhccCCHHHHHHH
Q 004521 601 -TNRVVG---TYDGQFSIKSDVFSFGILLLEIVSGKKNRGFYRSDTKVNLIGHLWDEGIPLRLIDACIQDSCNLADVIRC 676 (747)
Q Consensus 601 -~~~~~~---~~~~~~s~ksDVwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~ 676 (747)
...... ......+.++|+||||+++|||++|+.|+..... ......... .. ..+ .... ...+
T Consensus 155 ~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~---~~~~~~~~~-~~-~~~-----~~~~----~~~l 220 (250)
T cd05123 155 GTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAEDR---KEIYEKILK-DP-LRF-----PEFL----SPEA 220 (250)
T ss_pred CCccccChHHhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCH---HHHHHHHhc-CC-CCC-----CCCC----CHHH
Confidence 000000 0134567899999999999999999999743221 122222111 10 001 0000 2335
Q ss_pred HHHHHhccCCCCCCCCCHHH
Q 004521 677 IHIGLLCVQQHPEDRPCMPS 696 (747)
Q Consensus 677 ~~l~~~Cl~~dP~~RPt~~~ 696 (747)
.+++.+||..||++||++.+
T Consensus 221 ~~~i~~~l~~~p~~R~~~~~ 240 (250)
T cd05123 221 RDLISGLLQKDPTKRLGSGG 240 (250)
T ss_pred HHHHHHHhcCCHhhCCCccc
Confidence 67888999999999999954
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.5e-29 Score=246.20 Aligned_cols=242 Identities=24% Similarity=0.278 Sum_probs=181.6
Q ss_pred ceecccCCeeEEEEE-ecCCcEEEEEEecccccccHHHHHHHHHHHhccC-CCceeeEEeEEEeCCeeEEEEecCCCCCh
Q 004521 446 NKLGEGGFGPVYKGT-LVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQ-HRNLVKLLGCCIQGEEKLLIYEFMPNKSL 523 (747)
Q Consensus 446 ~~lg~G~fg~Vy~~~-~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~-H~niv~l~g~~~~~~~~~lV~E~~~~gsL 523 (747)
+.||+|+|+.|--++ +..|.++|||++.+..........+|++++...+ |+||++|+.+++++...|||||-|.+|+|
T Consensus 84 e~LGeGAyasVqtcv~i~t~~EYAVKiidKq~gHsR~RvfREVe~f~~Cqgh~nilqLiefFEdd~~FYLVfEKm~GGpl 163 (463)
T KOG0607|consen 84 ELLGEGAYASVQTCVSIQTGKEYAVKIIDKQPGHSRSRVFREVETFYQCQGHKNILQLIEFFEDDTRFYLVFEKMRGGPL 163 (463)
T ss_pred HHhcCccceeeeeeeeeccchhhhhhhhhcCCchHHHHHHHHHHHHHHhcCCccHHHHHHHhcccceEEEEEecccCchH
Confidence 689999999999887 5679999999999887788889999999999985 99999999999999999999999999999
Q ss_pred hhHhhhcCCCCcCChhHHHHHHHHHHHHHHHhhhcCCCceEecccCcCcEEEcCCC---CceEecccCccccC--CCCCc
Q 004521 524 DSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDM---NPKISDFGLVRTFG--GDETE 598 (747)
Q Consensus 524 ~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NIll~~~~---~~kl~DFGla~~~~--~~~~~ 598 (747)
..+|..+ ..+++.++.++..+||.||.|||.++ |.||||||+|||-..-. -+||+||.|..-+. .+-..
T Consensus 164 LshI~~~---~~F~E~EAs~vvkdia~aLdFlH~kg---IAHRDlKPENiLC~~pn~vsPvKiCDfDLgSg~k~~~~~sp 237 (463)
T KOG0607|consen 164 LSHIQKR---KHFNEREASRVVKDIASALDFLHTKG---IAHRDLKPENILCESPNKVSPVKICDFDLGSGIKLNNDCSP 237 (463)
T ss_pred HHHHHHh---hhccHHHHHHHHHHHHHHHHHHhhcC---cccccCCccceeecCCCCcCceeeeccccccccccCCCCCC
Confidence 9999653 45899999999999999999999998 99999999999986544 37999998875432 12111
Q ss_pred cccc---eeeecc--------------CCCCCccccchhHHHHHHHHHhCCCCCCCCCCcc-------h----hhhhHhH
Q 004521 599 GNTN---RVVGTY--------------DGQFSIKSDVFSFGILLLEIVSGKKNRGFYRSDT-------K----VNLIGHL 650 (747)
Q Consensus 599 ~~~~---~~~~~~--------------~~~~s~ksDVwS~Gvvl~elltg~~p~~~~~~~~-------~----~~~~~~~ 650 (747)
..+. .++|.. ...|+.+.|.||+|||||-||+|-.||......+ . .+.+...
T Consensus 238 astP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~dCGWdrGe~Cr~CQ~~LFes 317 (463)
T KOG0607|consen 238 ASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFES 317 (463)
T ss_pred CCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCCcCCccCCCccHHHHHHHHHH
Confidence 1111 111210 3468899999999999999999999986433211 0 1122222
Q ss_pred HhcCCcccccchhhhccCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 004521 651 WDEGIPLRLIDACIQDSCNLADVIRCIHIGLLCVQQHPEDRPCMPSVIL 699 (747)
Q Consensus 651 ~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dP~~RPt~~~v~~ 699 (747)
.++|... ++|..... . -....+++...+..++.+|-++.++++
T Consensus 318 IQEGkYe-FPdkdWah---I--S~eakdlisnLlvrda~~rlsa~~vln 360 (463)
T KOG0607|consen 318 IQEGKYE-FPDKDWAH---I--SSEAKDLISNLLVRDAKQRLSAAQVLN 360 (463)
T ss_pred HhccCCc-CChhhhHH---h--hHHHHHHHHHHHhccHHhhhhhhhccC
Confidence 3444432 22222111 0 111223445567799999999988876
|
|
| >KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.2e-29 Score=256.21 Aligned_cols=246 Identities=26% Similarity=0.330 Sum_probs=179.0
Q ss_pred cCCCccceecccCCeeEEEEEe-cCCcEEEEEEeccc-------ccccHHHHHHHHHHHhccCCCceeeEEeEEEeC-Ce
Q 004521 440 DNFSINNKLGEGGFGPVYKGTL-VDGQEIAVKRLSKI-------SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQG-EE 510 (747)
Q Consensus 440 ~~~~~~~~lg~G~fg~Vy~~~~-~~g~~vavK~l~~~-------~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~-~~ 510 (747)
++|-+..+||+|||+.||+|.+ ...+.||||+-... .+...+...+|.+|-+.|.||.||++++++.-+ +.
T Consensus 463 ~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfslDtds 542 (775)
T KOG1151|consen 463 DRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSLDTDS 542 (775)
T ss_pred HHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeeecccc
Confidence 4677778999999999999985 45788999985421 112234577899999999999999999998654 56
Q ss_pred eEEEEecCCCCChhhHhhhcCCCCcCChhHHHHHHHHHHHHHHHhhhcCCCceEecccCcCcEEEcC---CCCceEeccc
Q 004521 511 KLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQ---DMNPKISDFG 587 (747)
Q Consensus 511 ~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NIll~~---~~~~kl~DFG 587 (747)
++-|+|||++.+|+-||.. ...+++.++..|+.||+.||.||.+.. ++|||-||||.||||-+ -|.+||+|||
T Consensus 543 FCTVLEYceGNDLDFYLKQ---hklmSEKEARSIiMQiVnAL~YLNEik-pPIIHYDLKPgNILLv~GtacGeIKITDFG 618 (775)
T KOG1151|consen 543 FCTVLEYCEGNDLDFYLKQ---HKLMSEKEARSIIMQIVNALKYLNEIK-PPIIHYDLKPGNILLVNGTACGEIKITDFG 618 (775)
T ss_pred ceeeeeecCCCchhHHHHh---hhhhhHHHHHHHHHHHHHHHHHHhccC-CCeeeeccCCccEEEecCcccceeEeeecc
Confidence 7899999999999999954 456899999999999999999999874 78999999999999954 4789999999
Q ss_pred CccccCCCCCccc-----cceeeecc-------------CCCCCccccchhHHHHHHHHHhCCCCCCCCCCcchhhhhHh
Q 004521 588 LVRTFGGDETEGN-----TNRVVGTY-------------DGQFSIKSDVFSFGILLLEIVSGKKNRGFYRSDTKVNLIGH 649 (747)
Q Consensus 588 la~~~~~~~~~~~-----~~~~~~~~-------------~~~~s~ksDVwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~ 649 (747)
|++.+.++..... +....|+| ...++.|+||||.|||+|..+.|++||+......+.-....
T Consensus 619 LSKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnqsQQdILqeNT 698 (775)
T KOG1151|consen 619 LSKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQSQQDILQENT 698 (775)
T ss_pred hhhhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCchhHHHHHhhhc
Confidence 9999866543311 11122332 45689999999999999999999999864433222111111
Q ss_pred HHhcCCcccccchhhhccCCHHHHHHHHHHHHhccCCCCCCCCCHHHH
Q 004521 650 LWDEGIPLRLIDACIQDSCNLADVIRCIHIGLLCVQQHPEDRPCMPSV 697 (747)
Q Consensus 650 ~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dP~~RPt~~~v 697 (747)
+.+.....-...+.+ + .....++.+||+..-++|...-++
T Consensus 699 IlkAtEVqFP~KPvV--s------seAkaFIRRCLaYRKeDR~DV~qL 738 (775)
T KOG1151|consen 699 ILKATEVQFPPKPVV--S------SEAKAFIRRCLAYRKEDRIDVQQL 738 (775)
T ss_pred hhcceeccCCCCCcc--C------HHHHHHHHHHHHhhhhhhhhHHHH
Confidence 111111110011111 1 123456679999999999865444
|
|
| >KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription] | Back alignment and domain information |
|---|
Probab=99.96 E-value=6.5e-29 Score=244.40 Aligned_cols=194 Identities=25% Similarity=0.373 Sum_probs=156.0
Q ss_pred hcCCCccceecccCCeeEEEEEecC-----CcEEEEEEeccccc--ccHHHHHHHHHHHhccCCCceeeEEeEEEe-CCe
Q 004521 439 TDNFSINNKLGEGGFGPVYKGTLVD-----GQEIAVKRLSKISE--QGLKELKNEVILFSKLQHRNLVKLLGCCIQ-GEE 510 (747)
Q Consensus 439 ~~~~~~~~~lg~G~fg~Vy~~~~~~-----g~~vavK~l~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~g~~~~-~~~ 510 (747)
...|+....||+|.||.||+|.-.+ ...+|||+++.... .......+|+.+++.|+||||+.+..++.. +..
T Consensus 23 l~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~d~~ 102 (438)
T KOG0666|consen 23 LFEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFLSHDKK 102 (438)
T ss_pred HHHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHhccCce
Confidence 4578889999999999999996433 33799999975322 234567899999999999999999999887 778
Q ss_pred eEEEEecCCCCChhhHhhhcC--CCCcCChhHHHHHHHHHHHHHHHhhhcCCCceEecccCcCcEEEcCC----CCceEe
Q 004521 511 KLLIYEFMPNKSLDSFIFDQT--RRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQD----MNPKIS 584 (747)
Q Consensus 511 ~~lV~E~~~~gsL~~~l~~~~--~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NIll~~~----~~~kl~ 584 (747)
.+|++||.+ -+|..+|+.+. +...++...+..|+.||+.|+.|||++- |+||||||.|||+..+ |.+||+
T Consensus 103 v~l~fdYAE-hDL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~NW---vlHRDLKPaNIlvmgdgperG~VKIa 178 (438)
T KOG0666|consen 103 VWLLFDYAE-HDLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSNW---VLHRDLKPANILVMGDGPERGRVKIA 178 (438)
T ss_pred EEEEehhhh-hhHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhhh---eeeccCCcceEEEeccCCccCeeEee
Confidence 899999997 56777775432 2346888999999999999999999988 9999999999999877 899999
Q ss_pred cccCccccCCCCCcc-ccceeeecc----------CCCCCccccchhHHHHHHHHHhCCCCCC
Q 004521 585 DFGLVRTFGGDETEG-NTNRVVGTY----------DGQFSIKSDVFSFGILLLEIVSGKKNRG 636 (747)
Q Consensus 585 DFGla~~~~~~~~~~-~~~~~~~~~----------~~~~s~ksDVwS~Gvvl~elltg~~p~~ 636 (747)
|||++|.+...-... ....++-|+ ...||.+.|||+.|||+.||++-++.|.
T Consensus 179 DlGlaR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~ 241 (438)
T KOG0666|consen 179 DLGLARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFK 241 (438)
T ss_pred cccHHHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCcccc
Confidence 999999886543322 222222221 4679999999999999999999887764
|
|
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.4e-28 Score=250.21 Aligned_cols=216 Identities=19% Similarity=0.139 Sum_probs=161.6
Q ss_pred cCCeeEEEEEec-CCcEEEEEEecccccccHHHHHHHHHHHhccCCCceeeEEeEEEeCCeeEEEEecCCCCChhhHhhh
Q 004521 451 GGFGPVYKGTLV-DGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMPNKSLDSFIFD 529 (747)
Q Consensus 451 G~fg~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~ 529 (747)
|.||.||+++.. +++.+|+|+++... .+.+|...+....||||+++++++.+.+..++||||+++|+|.+++..
T Consensus 4 g~~~~v~~~~~~~~~~~~~~K~i~~~~-----~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~ 78 (237)
T cd05576 4 GVIDKVLLVMDTRTQQTFILKGLRKSS-----EYSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISK 78 (237)
T ss_pred cccceEEEEEEccCCcEEEEEeecchh-----hhhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCCCHHHHHHH
Confidence 889999999975 48899999997532 334455566667799999999999999999999999999999999865
Q ss_pred cCCCCcCChhHHHHHHHHHHHHHHHhhhcCCCceEecccCcCcEEEcCCCCceEecccCccccCCCCCccccc--eeeec
Q 004521 530 QTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNTN--RVVGT 607 (747)
Q Consensus 530 ~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~--~~~~~ 607 (747)
. ..+++..+..++.|+++||.|||+.+ |+||||||+||+++.++.++|+|||++..+.......... .....
T Consensus 79 ~---~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~y~aPE 152 (237)
T cd05576 79 F---LNIPEECVKRWAAEMVVALDALHREG---IVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDSCDGEAVENMYCAPE 152 (237)
T ss_pred h---cCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEEcCCCCEEEecccchhccccccccCCcCccccCCc
Confidence 3 24889999999999999999999988 9999999999999999999999999876654322111100 00111
Q ss_pred --cCCCCCccccchhHHHHHHHHHhCCCCCCCCCCcchhhhhHhHHhcCCcccccchhhhccCCHHHHHHHHHHHHhccC
Q 004521 608 --YDGQFSIKSDVFSFGILLLEIVSGKKNRGFYRSDTKVNLIGHLWDEGIPLRLIDACIQDSCNLADVIRCIHIGLLCVQ 685 (747)
Q Consensus 608 --~~~~~s~ksDVwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~ 685 (747)
....++.++||||+|+++|||++|+.|+....... ....... +.... ...+.+++.+|++
T Consensus 153 ~~~~~~~~~~~DvwslG~il~el~~g~~~~~~~~~~~---------~~~~~~~-----~~~~~----~~~~~~li~~~l~ 214 (237)
T cd05576 153 VGGISEETEACDWWSLGAILFELLTGKTLVECHPSGI---------NTHTTLN-----IPEWV----SEEARSLLQQLLQ 214 (237)
T ss_pred ccCCCCCCchhhHHHHHHHHHHHHHCcchhhcCchhc---------ccccccC-----CcccC----CHHHHHHHHHHcc
Confidence 13557889999999999999999998754221110 0000000 11111 1235667889999
Q ss_pred CCCCCCCCHH
Q 004521 686 QHPEDRPCMP 695 (747)
Q Consensus 686 ~dP~~RPt~~ 695 (747)
.||++||++.
T Consensus 215 ~dp~~R~~~~ 224 (237)
T cd05576 215 FNPTERLGAG 224 (237)
T ss_pred CCHHHhcCCC
Confidence 9999999973
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=7.1e-28 Score=281.35 Aligned_cols=146 Identities=27% Similarity=0.409 Sum_probs=131.0
Q ss_pred hcCCCccceecccCCeeEEEEEec-CCcEEEEEEecccc---cccHHHHHHHHHHHhccCCCceeeEEeEEEeCCeeEEE
Q 004521 439 TDNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKIS---EQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLI 514 (747)
Q Consensus 439 ~~~~~~~~~lg~G~fg~Vy~~~~~-~g~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV 514 (747)
.++|.+.++||+|+||.||+|... .++.||||+++... ......+..|+.+++.++|+||+++++++......+||
T Consensus 3 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lV 82 (669)
T cd05610 3 IEEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQSANNVYLV 82 (669)
T ss_pred cCCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECCEEEEE
Confidence 357889999999999999999986 48899999987532 23346788999999999999999999999999999999
Q ss_pred EecCCCCChhhHhhhcCCCCcCChhHHHHHHHHHHHHHHHhhhcCCCceEecccCcCcEEEcCCCCceEecccCcc
Q 004521 515 YEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVR 590 (747)
Q Consensus 515 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NIll~~~~~~kl~DFGla~ 590 (747)
|||+++++|.+++... ..+++..++.++.||+.||.|||..+ |+||||||+||||+.++.+||+|||+++
T Consensus 83 mEy~~g~~L~~li~~~---~~l~~~~~~~i~~qil~aL~yLH~~g---IiHrDLKP~NILl~~~g~vkL~DFGls~ 152 (669)
T cd05610 83 MEYLIGGDVKSLLHIY---GYFDEEMAVKYISEVALALDYLHRHG---IIHRDLKPDNMLISNEGHIKLTDFGLSK 152 (669)
T ss_pred EeCCCCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCccHHHEEEcCCCCEEEEeCCCCc
Confidence 9999999999998542 34788899999999999999999987 9999999999999999999999999986
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=7.4e-29 Score=267.34 Aligned_cols=236 Identities=21% Similarity=0.255 Sum_probs=177.9
Q ss_pred HhcCCCccceecccCCeeEEEEEecC-CcEEEEEEecccccccHHHHHHHHHHHhcc-CCCceeeEEeEEEeCCeeEEEE
Q 004521 438 ATDNFSINNKLGEGGFGPVYKGTLVD-GQEIAVKRLSKISEQGLKELKNEVILFSKL-QHRNLVKLLGCCIQGEEKLLIY 515 (747)
Q Consensus 438 ~~~~~~~~~~lg~G~fg~Vy~~~~~~-g~~vavK~l~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lV~ 515 (747)
.++.|++...+|.|+|+.|-++.... ++..+||++.+. ..+-.+|+.++... +||||+++.+.+.++.+.++||
T Consensus 320 ~~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~----~~~~~~e~~~~~~~~~h~niv~~~~v~~~~~~~~~v~ 395 (612)
T KOG0603|consen 320 FTESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKR----ADDNQDEIPISLLVRDHPNIVKSHDVYEDGKEIYLVM 395 (612)
T ss_pred cchhhccccccCCCCccceeeeeccccccchhheecccc----ccccccccchhhhhcCCCcceeecceecCCceeeeee
Confidence 36788888999999999999998654 889999999764 22344567666655 7999999999999999999999
Q ss_pred ecCCCCChhhHhhhcCCCCcCChhHHHHHHHHHHHHHHHhhhcCCCceEecccCcCcEEE-cCCCCceEecccCccccCC
Q 004521 516 EFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLL-DQDMNPKISDFGLVRTFGG 594 (747)
Q Consensus 516 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NIll-~~~~~~kl~DFGla~~~~~ 594 (747)
|++.++-|.+.+.... ....++..|+.+|+.|+.|||+++ +|||||||+|||+ ++.++++|+|||.++....
T Consensus 396 e~l~g~ell~ri~~~~----~~~~e~~~w~~~lv~Av~~LH~~g---vvhRDLkp~NIL~~~~~g~lrltyFG~a~~~~~ 468 (612)
T KOG0603|consen 396 ELLDGGELLRRIRSKP----EFCSEASQWAAELVSAVDYLHEQG---VVHRDLKPGNILLDGSAGHLRLTYFGFWSELER 468 (612)
T ss_pred hhccccHHHHHHHhcc----hhHHHHHHHHHHHHHHHHHHHhcC---eeecCCChhheeecCCCCcEEEEEechhhhCch
Confidence 9999998887775422 222777889999999999999998 9999999999999 6899999999999998766
Q ss_pred CCCc-c-ccceeeec--cCCCCCccccchhHHHHHHHHHhCCCCCCCCCCcchhhhhHhHHhcCCcccccchhhhccCCH
Q 004521 595 DETE-G-NTNRVVGT--YDGQFSIKSDVFSFGILLLEIVSGKKNRGFYRSDTKVNLIGHLWDEGIPLRLIDACIQDSCNL 670 (747)
Q Consensus 595 ~~~~-~-~~~~~~~~--~~~~~s~ksDVwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~ 670 (747)
.... . ........ ....|++++||||||++|||||+|+.|+.....+ .++...+ ..+... ...
T Consensus 469 ~~~tp~~t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~--~ei~~~i-~~~~~s--------~~v-- 535 (612)
T KOG0603|consen 469 SCDTPALTLQYVAPEVLAIQEYTEACDWWSLGVLLYEMLTGRTLFAAHPAG--IEIHTRI-QMPKFS--------ECV-- 535 (612)
T ss_pred hhcccchhhcccChhhhccCCCCcchhhHHHHHHHHHHHhCCCccccCCch--HHHHHhh-cCCccc--------ccc--
Confidence 5111 1 11111111 1568999999999999999999999997654443 2222211 111111 000
Q ss_pred HHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 004521 671 ADVIRCIHIGLLCVQQHPEDRPCMPSVIL 699 (747)
Q Consensus 671 ~~~~~~~~l~~~Cl~~dP~~RPt~~~v~~ 699 (747)
-....+|+.+||+.||.+||+|.++..
T Consensus 536 --S~~AKdLl~~LL~~dP~~Rl~~~~i~~ 562 (612)
T KOG0603|consen 536 --SDEAKDLLQQLLQVDPALRLGADEIGA 562 (612)
T ss_pred --CHHHHHHHHHhccCChhhCcChhhhcc
Confidence 112345666999999999999999875
|
|
| >KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=6.3e-29 Score=255.73 Aligned_cols=238 Identities=25% Similarity=0.322 Sum_probs=188.8
Q ss_pred hcCCCccceecccCCeeEEEEEecC-CcEEEEEEecc---cccccHHHHHHHHHHHhccCCCceeeEEeEEEeCCeeEEE
Q 004521 439 TDNFSINNKLGEGGFGPVYKGTLVD-GQEIAVKRLSK---ISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLI 514 (747)
Q Consensus 439 ~~~~~~~~~lg~G~fg~Vy~~~~~~-g~~vavK~l~~---~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV 514 (747)
.+.|..-++||+||||.||-.+... |+.+|.|++.+ ...++...-.+|-.+|.+++.+.||.+-..++..+.++||
T Consensus 184 ~n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAfeTkd~LClV 263 (591)
T KOG0986|consen 184 KNTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAFETKDALCLV 263 (591)
T ss_pred ccceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeeecCCCceEEE
Confidence 3567778999999999999998765 89999999864 2345667788999999999999999999999999999999
Q ss_pred EecCCCCChhhHhhhcCCCCcCChhHHHHHHHHHHHHHHHhhhcCCCceEecccCcCcEEEcCCCCceEecccCccccCC
Q 004521 515 YEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGG 594 (747)
Q Consensus 515 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NIll~~~~~~kl~DFGla~~~~~ 594 (747)
|..|.+|+|.-+|..... ..+++..+.-++.+|+.||++||... ||.|||||+|||||++|+++|+|.|||..+..
T Consensus 264 LtlMNGGDLkfHiyn~g~-~gF~e~ra~FYAAEi~cGLehlH~~~---iVYRDLKPeNILLDd~GhvRISDLGLAvei~~ 339 (591)
T KOG0986|consen 264 LTLMNGGDLKFHIYNHGN-PGFDEQRARFYAAEIICGLEHLHRRR---IVYRDLKPENILLDDHGHVRISDLGLAVEIPE 339 (591)
T ss_pred EEeecCCceeEEeeccCC-CCCchHHHHHHHHHHHhhHHHHHhcc---eeeccCChhheeeccCCCeEeeccceEEecCC
Confidence 999999999999987654 45899999999999999999999988 99999999999999999999999999998865
Q ss_pred CCCccccceeeec---------cCCCCCccccchhHHHHHHHHHhCCCCCCCCCCcchhhhhHhHHhcCCcccccchhhh
Q 004521 595 DETEGNTNRVVGT---------YDGQFSIKSDVFSFGILLLEIVSGKKNRGFYRSDTKVNLIGHLWDEGIPLRLIDACIQ 665 (747)
Q Consensus 595 ~~~~~~~~~~~~~---------~~~~~s~ksDVwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 665 (747)
....... +|| .++.|+...|.||+||+||||+.|+.||.........+.+.+...+. ..+..|.
T Consensus 340 g~~~~~r---vGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~G~sPFr~~KeKvk~eEvdrr~~~~-~~ey~~k--- 412 (591)
T KOG0986|consen 340 GKPIRGR---VGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIAGHSPFRQRKEKVKREEVDRRTLED-PEEYSDK--- 412 (591)
T ss_pred CCccccc---cCcccccCHHHHcCCcccCCccHHHHHhHHHHHHcccCchhhhhhhhhHHHHHHHHhcc-hhhcccc---
Confidence 5443221 222 15679999999999999999999999987666555544444432221 1111111
Q ss_pred ccCCHHHHHHHHHHHHhccCCCCCCCCC
Q 004521 666 DSCNLADVIRCIHIGLLCVQQHPEDRPC 693 (747)
Q Consensus 666 ~~~~~~~~~~~~~l~~~Cl~~dP~~RPt 693 (747)
--+.+..|....|+.||.+|--
T Consensus 413 ------FS~eakslc~~LL~Kdp~~RLG 434 (591)
T KOG0986|consen 413 ------FSEEAKSLCEGLLTKDPEKRLG 434 (591)
T ss_pred ------cCHHHHHHHHHHHccCHHHhcc
Confidence 1122334555678999999863
|
|
| >KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=3.6e-29 Score=282.36 Aligned_cols=251 Identities=22% Similarity=0.259 Sum_probs=190.8
Q ss_pred HHHHHHHhcCCCccceecccCCeeEEEEEecC-CcEEEEEEecc---cccccHHHHHHHHHHHhccCCCceeeEEeEEEe
Q 004521 432 LATIANATDNFSINNKLGEGGFGPVYKGTLVD-GQEIAVKRLSK---ISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQ 507 (747)
Q Consensus 432 ~~~~~~~~~~~~~~~~lg~G~fg~Vy~~~~~~-g~~vavK~l~~---~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~ 507 (747)
..++.-..++|.+.+.||+|+||.|..++.+. ++.+|+|++.+ .......-|+.|..+|..-+.+-|+++...|.+
T Consensus 67 v~~lrl~~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAFQD 146 (1317)
T KOG0612|consen 67 VKELRLKAEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAFQD 146 (1317)
T ss_pred HHHHhCCHHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHhcC
Confidence 34455556899999999999999999999865 88999999987 345556789999999999999999999999999
Q ss_pred CCeeEEEEecCCCCChhhHhhhcCCCCcCChhHHHHHHHHHHHHHHHhhhcCCCceEecccCcCcEEEcCCCCceEeccc
Q 004521 508 GEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFG 587 (747)
Q Consensus 508 ~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NIll~~~~~~kl~DFG 587 (747)
..++|+|||||+||+|-.++.... .+++..+.-++..|..||.-||+.| +|||||||+|||||..|++||+|||
T Consensus 147 ~~~LYlVMdY~pGGDlltLlSk~~---~~pE~~ArFY~aEiVlAldslH~mg---yVHRDiKPDNvLld~~GHikLADFG 220 (1317)
T KOG0612|consen 147 ERYLYLVMDYMPGGDLLTLLSKFD---RLPEDWARFYTAEIVLALDSLHSMG---YVHRDIKPDNVLLDKSGHIKLADFG 220 (1317)
T ss_pred ccceEEEEecccCchHHHHHhhcC---CChHHHHHHHHHHHHHHHHHHHhcc---ceeccCCcceeEecccCcEeeccch
Confidence 999999999999999999995433 5888888888899999999999988 9999999999999999999999999
Q ss_pred CccccCCCCCccccceeeecc--------------CCCCCccccchhHHHHHHHHHhCCCCCCCCCCcchhhhhHhHHhc
Q 004521 588 LVRTFGGDETEGNTNRVVGTY--------------DGQFSIKSDVFSFGILLLEIVSGKKNRGFYRSDTKVNLIGHLWDE 653 (747)
Q Consensus 588 la~~~~~~~~~~~~~~~~~~~--------------~~~~s~ksDVwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~ 653 (747)
.+-.+..+..-.. ...+||+ .+.|+..+|.||+||++|||+.|..||.. +.....+..+...
T Consensus 221 sClkm~~dG~V~s-~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYa---dslveTY~KIm~h 296 (1317)
T KOG0612|consen 221 SCLKMDADGTVRS-SVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYA---DSLVETYGKIMNH 296 (1317)
T ss_pred hHHhcCCCCcEEe-ccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchH---HHHHHHHHHHhch
Confidence 8877765543221 1233332 37899999999999999999999999642 2223334444333
Q ss_pred CCcccccchhhhccCCHHHHHHHHHHHHhccCCCCCCCCC---HHHHHHH
Q 004521 654 GIPLRLIDACIQDSCNLADVIRCIHIGLLCVQQHPEDRPC---MPSVILM 700 (747)
Q Consensus 654 ~~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dP~~RPt---~~~v~~~ 700 (747)
.....+++.. ..+ +++.. |+.+ +--+|+.|-. +.++...
T Consensus 297 k~~l~FP~~~-~VS---eeakd---LI~~-ll~~~e~RLgrngiedik~H 338 (1317)
T KOG0612|consen 297 KESLSFPDET-DVS---EEAKD---LIEA-LLCDREVRLGRNGIEDIKNH 338 (1317)
T ss_pred hhhcCCCccc-ccC---HHHHH---HHHH-HhcChhhhcccccHHHHHhC
Confidence 2233333211 111 12222 2222 2237777777 8887653
|
|
| >KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=3.5e-28 Score=221.35 Aligned_cols=188 Identities=27% Similarity=0.421 Sum_probs=153.9
Q ss_pred CCCccceecccCCeeEEEEEecC-CcEEEEEEeccc--ccccHHHHHHHHHHHhccCCCceeeEEeEEEeCCeeEEEEec
Q 004521 441 NFSINNKLGEGGFGPVYKGTLVD-GQEIAVKRLSKI--SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEF 517 (747)
Q Consensus 441 ~~~~~~~lg~G~fg~Vy~~~~~~-g~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~ 517 (747)
+|...++||+|.||+||+|+..+ ++.||+|+++-. ++..-....+|+-+++.++|.|||+++++...++..-||+||
T Consensus 3 ~ydkmekigegtygtvfkarn~~t~eivalkrvrlddddegvpssalreicllkelkhknivrl~dvlhsdkkltlvfe~ 82 (292)
T KOG0662|consen 3 KYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEF 82 (292)
T ss_pred chHHHHhhcCCcceeeEecccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhhhccCceeEEeHHH
Confidence 45556899999999999999765 788999998752 223345678999999999999999999999999999999999
Q ss_pred CCCCChhhHhhhcCCCCcCChhHHHHHHHHHHHHHHHhhhcCCCceEecccCcCcEEEcCCCCceEecccCccccCCCCC
Q 004521 518 MPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDET 597 (747)
Q Consensus 518 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~ 597 (747)
|. .+|..+... -.+.++.+....++.|+++||.|.|+++ +.||||||+|.||+.+|+.||+|||++|.++-...
T Consensus 83 cd-qdlkkyfds--lng~~d~~~~rsfmlqllrgl~fchshn---vlhrdlkpqnllin~ngelkladfglarafgipvr 156 (292)
T KOG0662|consen 83 CD-QDLKKYFDS--LNGDLDPEIVRSFMLQLLRGLGFCHSHN---VLHRDLKPQNLLINRNGELKLADFGLARAFGIPVR 156 (292)
T ss_pred hh-HHHHHHHHh--cCCcCCHHHHHHHHHHHHhhhhhhhhhh---hhhccCCcceEEeccCCcEEecccchhhhcCCceE
Confidence 95 677777643 2345888999999999999999999998 99999999999999999999999999998765443
Q ss_pred ccccceeeecc--------CCCCCccccchhHHHHHHHHHhCCCC
Q 004521 598 EGNTNRVVGTY--------DGQFSIKSDVFSFGILLLEIVSGKKN 634 (747)
Q Consensus 598 ~~~~~~~~~~~--------~~~~s~ksDVwS~Gvvl~elltg~~p 634 (747)
....+.+.-.+ ..-|+...|+||-|||+.|+.....|
T Consensus 157 cysaevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrp 201 (292)
T KOG0662|consen 157 CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRP 201 (292)
T ss_pred eeeceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCC
Confidence 22222111111 34588899999999999999986555
|
|
| >KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=2e-28 Score=228.17 Aligned_cols=210 Identities=26% Similarity=0.371 Sum_probs=164.6
Q ss_pred hcCCCccceecccCCeeEEEEEec-CCcEEEEEEecc-cccccHHHHHHHHHHHhcc-CCCceeeEEeEEEeCCeeEEEE
Q 004521 439 TDNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSK-ISEQGLKELKNEVILFSKL-QHRNLVKLLGCCIQGEEKLLIY 515 (747)
Q Consensus 439 ~~~~~~~~~lg~G~fg~Vy~~~~~-~g~~vavK~l~~-~~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lV~ 515 (747)
.++......||+|++|.|-+-++. +|+.+|+|+++. .+.+..+...+|+.+..+- ..|.+|.++|........++.|
T Consensus 45 ad~L~~i~elGrGayG~vekmrh~~sg~imAvKri~~tvn~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~regdvwIcM 124 (282)
T KOG0984|consen 45 ADDLVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATVNSQEQKRLLMDLDIIMRTVDCPFTVHFYGALFREGDVWICM 124 (282)
T ss_pred hhhhhhhhhhcCCccchhhheeeccCCeEEEEeeehhhcChHHHHHHHHhhhhhccCCCCCeEEEeehhhhccccEEEeH
Confidence 345555688999999999888864 599999999975 4566677888899887654 7999999999999999999999
Q ss_pred ecCCCCChhhHhhhc-CCCCcCChhHHHHHHHHHHHHHHHhhhcCCCceEecccCcCcEEEcCCCCceEecccCccccCC
Q 004521 516 EFMPNKSLDSFIFDQ-TRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGG 594 (747)
Q Consensus 516 E~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NIll~~~~~~kl~DFGla~~~~~ 594 (747)
|.|. .||+.+-.+. .+...+++..+=+|+..+.+||.|||++ +.+||||+||+||||+.+|++||+|||++-.+..
T Consensus 125 E~M~-tSldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~k--L~vIHRDvKPsNiLIn~~GqVKiCDFGIsG~L~d 201 (282)
T KOG0984|consen 125 ELMD-TSLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSK--LSVIHRDVKPSNILINYDGQVKICDFGISGYLVD 201 (282)
T ss_pred HHhh-hhHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHH--hhhhhccCCcceEEEccCCcEEEcccccceeehh
Confidence 9995 7887776442 3455688888899999999999999995 4699999999999999999999999998866532
Q ss_pred C---------CCccccceeeecc-CCCCCccccchhHHHHHHHHHhCCCCCCCCCCcchhhhhHhHHhc
Q 004521 595 D---------ETEGNTNRVVGTY-DGQFSIKSDVFSFGILLLEIVSGKKNRGFYRSDTKVNLIGHLWDE 653 (747)
Q Consensus 595 ~---------~~~~~~~~~~~~~-~~~~s~ksDVwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~ 653 (747)
. .....+++..+.. ...|+.|+||||+|+++.||.+++.|++.+. ...+.+.+..++
T Consensus 202 SiAkt~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~w~--tpF~qLkqvVee 268 (282)
T KOG0984|consen 202 SIAKTMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYESWG--TPFQQLKQVVEE 268 (282)
T ss_pred hhHHHHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhccccccccC--CHHHHHHHHhcC
Confidence 2 2222222222222 4479999999999999999999999976543 333444444443
|
|
| >KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.4e-28 Score=242.98 Aligned_cols=190 Identities=24% Similarity=0.313 Sum_probs=161.3
Q ss_pred hcCCCccceecccCCeeEEEEEecC-CcEEEEEEeccc---ccccHHHHHHHHHHHhccCCCceeeEEeEEEeCCeeEEE
Q 004521 439 TDNFSINNKLGEGGFGPVYKGTLVD-GQEIAVKRLSKI---SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLI 514 (747)
Q Consensus 439 ~~~~~~~~~lg~G~fg~Vy~~~~~~-g~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV 514 (747)
.++|...++||+|.||.|.+++-+. ++.+|+|++++. ..+....-..|-++|+..+||.+..+-..+...+.+++|
T Consensus 167 m~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt~drlCFV 246 (516)
T KOG0690|consen 167 MEDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQTQDRLCFV 246 (516)
T ss_pred cchhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhccCceEEEE
Confidence 4688999999999999999998654 899999999873 445566778899999999999999999999999999999
Q ss_pred EecCCCCChhhHhhhcCCCCcCChhHHHHHHHHHHHHHHHhhhcCCCceEecccCcCcEEEcCCCCceEecccCccccCC
Q 004521 515 YEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGG 594 (747)
Q Consensus 515 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NIll~~~~~~kl~DFGla~~~~~ 594 (747)
|||..+|.|.-+|.. ...+++....-....|..||.|||+++ ||.||||.+|.|||.+|++||+||||++.-..
T Consensus 247 MeyanGGeLf~HLsr---er~FsE~RtRFYGaEIvsAL~YLHs~~---ivYRDlKLENLlLDkDGHIKitDFGLCKE~I~ 320 (516)
T KOG0690|consen 247 MEYANGGELFFHLSR---ERVFSEDRTRFYGAEIVSALGYLHSRN---IVYRDLKLENLLLDKDGHIKITDFGLCKEEIK 320 (516)
T ss_pred EEEccCceEeeehhh---hhcccchhhhhhhHHHHHHhhhhhhCC---eeeeechhhhheeccCCceEeeecccchhccc
Confidence 999999999988743 445777777778889999999999988 99999999999999999999999999986432
Q ss_pred CCCccccceeeecc---------CCCCCccccchhHHHHHHHHHhCCCCCC
Q 004521 595 DETEGNTNRVVGTY---------DGQFSIKSDVFSFGILLLEIVSGKKNRG 636 (747)
Q Consensus 595 ~~~~~~~~~~~~~~---------~~~~s~ksDVwS~Gvvl~elltg~~p~~ 636 (747)
... .....+|+. +..|..++|.|.+||++|||++|+.||.
T Consensus 321 ~g~--t~kTFCGTPEYLAPEVleDnDYgraVDWWG~GVVMYEMmCGRLPFy 369 (516)
T KOG0690|consen 321 YGD--TTKTFCGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMMCGRLPFY 369 (516)
T ss_pred ccc--eeccccCChhhcCchhhccccccceeehhhhhHHHHHHHhccCccc
Confidence 221 122344442 5789999999999999999999999964
|
|
| >KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=3.2e-28 Score=238.61 Aligned_cols=247 Identities=20% Similarity=0.207 Sum_probs=176.7
Q ss_pred HhcCCCcc-ceecccCCeeEEEEEecC-CcEEEEEEecccccccHHHHHHHHHHHhcc-CCCceeeEEeEEEeC----Ce
Q 004521 438 ATDNFSIN-NKLGEGGFGPVYKGTLVD-GQEIAVKRLSKISEQGLKELKNEVILFSKL-QHRNLVKLLGCCIQG----EE 510 (747)
Q Consensus 438 ~~~~~~~~-~~lg~G~fg~Vy~~~~~~-g~~vavK~l~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~----~~ 510 (747)
.+++|.+. ++||-|-.|.|.....+. ++.+|+|+|.. ....++|+++--.. .|||||+++++++.. ..
T Consensus 59 itedY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~D-----s~KARrEVeLHw~~s~h~~iV~IidVyeNs~~~rkc 133 (400)
T KOG0604|consen 59 ITEDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLLD-----SPKARREVELHWMASGHPHIVSIIDVYENSYQGRKC 133 (400)
T ss_pred chhhheehhhhhccccCCceEEEEeccchhhhHHHHHhc-----CHHHHhHhhhhhhhcCCCceEEeehhhhhhccCcee
Confidence 45677665 579999999999998765 88999999864 23456788776555 699999999998653 45
Q ss_pred eEEEEecCCCCChhhHhhhcCCCCcCChhHHHHHHHHHHHHHHHhhhcCCCceEecccCcCcEEEcC---CCCceEeccc
Q 004521 511 KLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQ---DMNPKISDFG 587 (747)
Q Consensus 511 ~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NIll~~---~~~~kl~DFG 587 (747)
+++|||.|+||.|...+.++. ...+++.++..|+.||+.|+.|||+.+ |.||||||+|+|... +-.+||+|||
T Consensus 134 LLiVmE~meGGeLfsriq~~g-~~afTErea~eI~~qI~~Av~~lH~~n---IAHRDlKpENLLyt~t~~na~lKLtDfG 209 (400)
T KOG0604|consen 134 LLIVMECMEGGELFSRIQDRG-DQAFTEREASEIMKQIGLAVRYLHSMN---IAHRDLKPENLLYTTTSPNAPLKLTDFG 209 (400)
T ss_pred eEeeeecccchHHHHHHHHcc-cccchHHHHHHHHHHHHHHHHHHHhcc---hhhccCChhheeeecCCCCcceEecccc
Confidence 689999999999999997654 346899999999999999999999988 999999999999964 4568999999
Q ss_pred CccccCCCCCc---cccceeeec---cCCCCCccccchhHHHHHHHHHhCCCCCCCCCCcchhhhhHhHHhcCCcccccc
Q 004521 588 LVRTFGGDETE---GNTNRVVGT---YDGQFSIKSDVFSFGILLLEIVSGKKNRGFYRSDTKVNLIGHLWDEGIPLRLID 661 (747)
Q Consensus 588 la~~~~~~~~~---~~~~~~~~~---~~~~~s~ksDVwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~d 661 (747)
+|+........ ..+.+.... -...|+...|+||+||++|-|++|.+||.......-..-.......+... +.+
T Consensus 210 FAK~t~~~~~L~TPc~TPyYvaPevlg~eKydkscdmwSlgVimYIlLCGyPPFYS~hg~aispgMk~rI~~gqy~-FP~ 288 (400)
T KOG0604|consen 210 FAKETQEPGDLMTPCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKRRIRTGQYE-FPE 288 (400)
T ss_pred cccccCCCccccCCcccccccCHHHhCchhcCCCCCccchhHHHHHhhcCCCcccccCCccCChhHHhHhhccCcc-CCC
Confidence 99976532211 111111111 13568999999999999999999999975433211111111111222211 111
Q ss_pred hhhhccCCHHH-HHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 004521 662 ACIQDSCNLAD-VIRCIHIGLLCVQQHPEDRPCMPSVILM 700 (747)
Q Consensus 662 ~~l~~~~~~~~-~~~~~~l~~~Cl~~dP~~RPt~~~v~~~ 700 (747)
+. ..+ -+...+++...|..+|.+|.|+.+++..
T Consensus 289 pE------Ws~VSe~aKdlIR~LLkt~PteRlTI~~~m~h 322 (400)
T KOG0604|consen 289 PE------WSCVSEAAKDLIRKLLKTEPTERLTIEEVMDH 322 (400)
T ss_pred hh------HhHHHHHHHHHHHHHhcCCchhheeHHHhhcC
Confidence 11 111 1223346667899999999999998763
|
|
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=99.95 E-value=4.9e-27 Score=239.86 Aligned_cols=232 Identities=24% Similarity=0.327 Sum_probs=177.3
Q ss_pred CCeeEEEEEecC-CcEEEEEEeccccccc-HHHHHHHHHHHhccCCCceeeEEeEEEeCCeeEEEEecCCCCChhhHhhh
Q 004521 452 GFGPVYKGTLVD-GQEIAVKRLSKISEQG-LKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMPNKSLDSFIFD 529 (747)
Q Consensus 452 ~fg~Vy~~~~~~-g~~vavK~l~~~~~~~-~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~ 529 (747)
+||.||+|+..+ ++.+|+|++....... .+.+.+|++.+++++|+||+++++++......++++||+++++|.+++..
T Consensus 1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~~~ 80 (244)
T smart00220 1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKKRERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDLLKK 80 (244)
T ss_pred CceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHHHHh
Confidence 589999999865 8999999997644444 68999999999999999999999999999999999999999999999865
Q ss_pred cCCCCcCChhHHHHHHHHHHHHHHHhhhcCCCceEecccCcCcEEEcCCCCceEecccCccccCCCCCc----cccceee
Q 004521 530 QTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETE----GNTNRVV 605 (747)
Q Consensus 530 ~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~----~~~~~~~ 605 (747)
.. .+++..+..++.++++++.|||+.+ ++|+||+|+||++++++.++|+|||.+......... .......
T Consensus 81 ~~---~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~ 154 (244)
T smart00220 81 RG---RLSEDEARFYARQILSALEYLHSNG---IIHRDLKPENILLDEDGHVKLADFGLARQLDPGGLLTTFVGTPEYMA 154 (244)
T ss_pred cc---CCCHHHHHHHHHHHHHHHHHHHHcC---eecCCcCHHHeEECCCCcEEEccccceeeeccccccccccCCcCCCC
Confidence 32 2788999999999999999999987 999999999999999999999999999876543110 0000000
Q ss_pred ec--cCCCCCccccchhHHHHHHHHHhCCCCCCCCCCcchhhhhHhHHhcCCcccccchhhhccCCHHHHHHHHHHHHhc
Q 004521 606 GT--YDGQFSIKSDVFSFGILLLEIVSGKKNRGFYRSDTKVNLIGHLWDEGIPLRLIDACIQDSCNLADVIRCIHIGLLC 683 (747)
Q Consensus 606 ~~--~~~~~s~ksDVwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~C 683 (747)
.. ....++.++||||||++++||++|..|+... ......... ...+........ . .....+.+++.+|
T Consensus 155 pE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~--~~~~~~~~~-~~~~~~~~~~~~----~---~~~~~~~~~i~~~ 224 (244)
T smart00220 155 PEVLLGKGYGKAVDVWSLGVILYELLTGKPPFPGD--DQLLELFKK-IGKPKPPFPPPE----W---KISPEAKDLIRKL 224 (244)
T ss_pred HHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCC--CcHHHHHHH-HhccCCCCcccc----c---cCCHHHHHHHHHH
Confidence 11 1456788999999999999999999996432 111111111 111111110000 0 0123467788899
Q ss_pred cCCCCCCCCCHHHHHH
Q 004521 684 VQQHPEDRPCMPSVIL 699 (747)
Q Consensus 684 l~~dP~~RPt~~~v~~ 699 (747)
+..+|++||++.++++
T Consensus 225 l~~~p~~Rp~~~~~~~ 240 (244)
T smart00220 225 LVKDPEKRLTAEEALQ 240 (244)
T ss_pred ccCCchhccCHHHHhh
Confidence 9999999999999986
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.6e-27 Score=271.72 Aligned_cols=252 Identities=17% Similarity=0.232 Sum_probs=154.4
Q ss_pred HhcCCCccceecccCCeeEEEEEecC-----CcEEEEEEecccccccHHHHHHHHHHHhccCCCceeeEEeE------EE
Q 004521 438 ATDNFSINNKLGEGGFGPVYKGTLVD-----GQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGC------CI 506 (747)
Q Consensus 438 ~~~~~~~~~~lg~G~fg~Vy~~~~~~-----g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~------~~ 506 (747)
..++|++.++||+|+||.||+|++.+ +..||||++..... .+.+..| .+....+.+++.++.. +.
T Consensus 130 ~~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~--~e~~~~e--~l~~~~~~~~~~~~~~~~~~~~~~ 205 (566)
T PLN03225 130 KKDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGA--VEIWMNE--RVRRACPNSCADFVYGFLEPVSSK 205 (566)
T ss_pred ccCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccch--hHHHHHH--HHHhhchhhHHHHHHhhhcccccc
Confidence 45789999999999999999999754 58999999864221 1111111 1222222222222211 24
Q ss_pred eCCeeEEEEecCCCCChhhHhhhcCCC-----------------CcCChhHHHHHHHHHHHHHHHhhhcCCCceEecccC
Q 004521 507 QGEEKLLIYEFMPNKSLDSFIFDQTRR-----------------TLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLK 569 (747)
Q Consensus 507 ~~~~~~lV~E~~~~gsL~~~l~~~~~~-----------------~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlk 569 (747)
.....++||||+++++|.+++...... .......+..++.||+.||+|||+.+ |+|||||
T Consensus 206 ~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~g---IiHRDLK 282 (566)
T PLN03225 206 KEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHSTG---IVHRDVK 282 (566)
T ss_pred cCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHCC---EEeCcCC
Confidence 566789999999999999998643210 01122345679999999999999988 9999999
Q ss_pred cCcEEEcC-CCCceEecccCccccCCCCCccc------cceeeec------------------------cCCCCCccccc
Q 004521 570 ASNVLLDQ-DMNPKISDFGLVRTFGGDETEGN------TNRVVGT------------------------YDGQFSIKSDV 618 (747)
Q Consensus 570 p~NIll~~-~~~~kl~DFGla~~~~~~~~~~~------~~~~~~~------------------------~~~~~s~ksDV 618 (747)
|+|||++. ++.+||+|||+|+.+........ ..+..+. +...++.++||
T Consensus 283 P~NILl~~~~~~~KL~DFGlA~~l~~~~~~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k~DV 362 (566)
T PLN03225 283 PQNIIFSEGSGSFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDI 362 (566)
T ss_pred HHHEEEeCCCCcEEEEeCCCccccccccccCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCCccc
Confidence 99999986 57999999999986532211100 0000000 01235567899
Q ss_pred hhHHHHHHHHHhCCCCCCCCCCcchhhhhHhHHhcCCcc----cccchh----hhccCCH--HHHHHHHHHHHhccCCCC
Q 004521 619 FSFGILLLEIVSGKKNRGFYRSDTKVNLIGHLWDEGIPL----RLIDAC----IQDSCNL--ADVIRCIHIGLLCVQQHP 688 (747)
Q Consensus 619 wS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~----~~~d~~----l~~~~~~--~~~~~~~~l~~~Cl~~dP 688 (747)
|||||+||||+++..+... ....+...+...+... ....+. +...... .+.....+|+.+||+.||
T Consensus 363 wSlGviL~el~~~~~~~~~----~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~dLi~~mL~~dP 438 (566)
T PLN03225 363 YSAGLIFLQMAFPNLRSDS----NLIQFNRQLKRNDYDLVAWRKLVEPRASPDLRRGFEVLDLDGGAGWELLKSMMRFKG 438 (566)
T ss_pred HHHHHHHHHHHhCcCCCch----HHHHHHHHHHhcCCcHHHHHHhhccccchhhhhhhhhccccchHHHHHHHHHccCCc
Confidence 9999999999997765321 1111111110000000 000000 0000000 001123468889999999
Q ss_pred CCCCCHHHHHHH
Q 004521 689 EDRPCMPSVILM 700 (747)
Q Consensus 689 ~~RPt~~~v~~~ 700 (747)
++|||+.++++.
T Consensus 439 ~kR~ta~e~L~H 450 (566)
T PLN03225 439 RQRISAKAALAH 450 (566)
T ss_pred ccCCCHHHHhCC
Confidence 999999999874
|
|
| >KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.9e-29 Score=240.05 Aligned_cols=253 Identities=24% Similarity=0.402 Sum_probs=179.5
Q ss_pred CCCccceecccCCeeEEEEEecC-CcEEEEEEecc--cccccHHHHHHHHHHHhccCCCceeeEEeEEEeC--------C
Q 004521 441 NFSINNKLGEGGFGPVYKGTLVD-GQEIAVKRLSK--ISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQG--------E 509 (747)
Q Consensus 441 ~~~~~~~lg~G~fg~Vy~~~~~~-g~~vavK~l~~--~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~--------~ 509 (747)
.|+-..+||+|.||.||+|+..+ |+.||+|+.-- .....-..-.+|+++|..++|+|++.++..|... .
T Consensus 18 ~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~~r~r~ 97 (376)
T KOG0669|consen 18 KYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPTNRDRA 97 (376)
T ss_pred HHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCcccccc
Confidence 45556899999999999999755 78899987542 1222234567899999999999999999888642 3
Q ss_pred eeEEEEecCCCCChhhHhhhcCCCCcCChhHHHHHHHHHHHHHHHhhhcCCCceEecccCcCcEEEcCCCCceEecccCc
Q 004521 510 EKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLV 589 (747)
Q Consensus 510 ~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NIll~~~~~~kl~DFGla 589 (747)
..|||+.+|+ -+|..+|.+.. ..++..++.+++.++..||.|+|... |+|||+||+|+||+.++.+||+|||++
T Consensus 98 t~ylVf~~ce-hDLaGlLsn~~--vr~sls~Ikk~Mk~Lm~GL~~iHr~k---ilHRDmKaaNvLIt~dgilklADFGla 171 (376)
T KOG0669|consen 98 TFYLVFDFCE-HDLAGLLSNRK--VRFSLSEIKKVMKGLMNGLYYIHRNK---ILHRDMKAANVLITKDGILKLADFGLA 171 (376)
T ss_pred eeeeeHHHhh-hhHHHHhcCcc--ccccHHHHHHHHHHHHHHHHHHHHhh---HHhhcccHhhEEEcCCceEEeeccccc
Confidence 4799999997 57888875432 34888999999999999999999877 999999999999999999999999999
Q ss_pred cccCCCCCcccc---ceeeecc---------CCCCCccccchhHHHHHHHHHhCCCCCCCCCCcchhhhhHhH-------
Q 004521 590 RTFGGDETEGNT---NRVVGTY---------DGQFSIKSDVFSFGILLLEIVSGKKNRGFYRSDTKVNLIGHL------- 650 (747)
Q Consensus 590 ~~~~~~~~~~~~---~~~~~~~---------~~~~s~ksDVwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~------- 650 (747)
|.+........+ .+++..+ ...|+++.|||.-|||+.||++|.+.+..........++..+
T Consensus 172 r~fs~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnteqqql~~Is~LcGs~tke 251 (376)
T KOG0669|consen 172 RAFSTSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQQQLHLISQLCGSITKE 251 (376)
T ss_pred cceecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCChHHHHHHHHHHHhccCCcc
Confidence 877554433222 2222111 567999999999999999999998876543333333333333
Q ss_pred -HhcCCcccccchh----h-hccCC--HHH------HHHHHHHHHhccCCCCCCCCCHHHHHH
Q 004521 651 -WDEGIPLRLIDAC----I-QDSCN--LAD------VIRCIHIGLLCVQQHPEDRPCMPSVIL 699 (747)
Q Consensus 651 -~~~~~~~~~~d~~----l-~~~~~--~~~------~~~~~~l~~~Cl~~dP~~RPt~~~v~~ 699 (747)
|.+-.-..+.... + ..... .+. -...++++-+.+..||.+||.+.+++.
T Consensus 252 vWP~~d~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~ad~aln 314 (376)
T KOG0669|consen 252 VWPNVDNLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRIDADQALN 314 (376)
T ss_pred cCCCcccchHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHHhccCcccCcchHhhhc
Confidence 1111000010000 0 00000 000 113556777899999999999998865
|
|
| >KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=4.7e-28 Score=252.34 Aligned_cols=184 Identities=29% Similarity=0.453 Sum_probs=155.6
Q ss_pred cceecccCCeeEEEEEec-CCcEEEEEEecc--cccccHHHHHHHHHHHhccCCCceeeEEeEEEeCCeeEEEEecCCCC
Q 004521 445 NNKLGEGGFGPVYKGTLV-DGQEIAVKRLSK--ISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMPNK 521 (747)
Q Consensus 445 ~~~lg~G~fg~Vy~~~~~-~g~~vavK~l~~--~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~g 521 (747)
.+.||+|.||+||-|++. .|+.||||.+.+ .......++++|+.||++++||.||.+.-.|+..+..++|||-+. |
T Consensus 569 devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M~ET~ervFVVMEKl~-G 647 (888)
T KOG4236|consen 569 DEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECMFETPERVFVVMEKLH-G 647 (888)
T ss_pred HhhccCCcceeeecceecccCceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEeecCCceEEEEehhhc-c
Confidence 378999999999999975 499999999976 344556889999999999999999999999999999999999996 5
Q ss_pred ChhhHhhhcCCCCcCChhHHHHHHHHHHHHHHHhhhcCCCceEecccCcCcEEEcCC---CCceEecccCccccCCCCCc
Q 004521 522 SLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQD---MNPKISDFGLVRTFGGDETE 598 (747)
Q Consensus 522 sL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NIll~~~---~~~kl~DFGla~~~~~~~~~ 598 (747)
++.+.|... .++.|++....-++.||+.||.|||.++ |+|+||||+||||.+. -++||+|||+||.++.....
T Consensus 648 DMLEMILSs-EkgRL~er~TkFlvtQIL~ALr~LH~kn---IvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgEksFR 723 (888)
T KOG4236|consen 648 DMLEMILSS-EKGRLPERITKFLVTQILVALRYLHFKN---IVHCDLKPENVLLASASPFPQVKLCDFGFARIIGEKSFR 723 (888)
T ss_pred hHHHHHHHh-hcccchHHHHHHHHHHHHHHHHHhhhcc---eeeccCCchheeeccCCCCCceeeccccceeecchhhhh
Confidence 555555443 3445888888888999999999999988 9999999999999654 47999999999998766543
Q ss_pred cccceeeecc---------CCCCCccccchhHHHHHHHHHhCCCCCC
Q 004521 599 GNTNRVVGTY---------DGQFSIKSDVFSFGILLLEIVSGKKNRG 636 (747)
Q Consensus 599 ~~~~~~~~~~---------~~~~s~ksDVwS~Gvvl~elltg~~p~~ 636 (747)
..++|+. +..|+..-|+||.|||+|--++|..||.
T Consensus 724 ---rsVVGTPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsLSGTFPFN 767 (888)
T KOG4236|consen 724 ---RSVVGTPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSGTFPFN 767 (888)
T ss_pred ---hhhcCCccccCHHHHhhccccccccceeeeEEEEEEecccccCC
Confidence 2234442 6778999999999999999999999974
|
|
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.95 E-value=3.5e-27 Score=262.15 Aligned_cols=195 Identities=21% Similarity=0.294 Sum_probs=141.9
Q ss_pred HhcCCCccceecccCCeeEEEEEe-----------------cCCcEEEEEEecccccccHHH--------------HHHH
Q 004521 438 ATDNFSINNKLGEGGFGPVYKGTL-----------------VDGQEIAVKRLSKISEQGLKE--------------LKNE 486 (747)
Q Consensus 438 ~~~~~~~~~~lg~G~fg~Vy~~~~-----------------~~g~~vavK~l~~~~~~~~~~--------------~~~E 486 (747)
..++|++.++||+|+||.||+|.+ ..++.||||++........++ +..|
T Consensus 143 ~~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE 222 (507)
T PLN03224 143 SSDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVE 222 (507)
T ss_pred cccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHH
Confidence 467899999999999999999964 235689999986533222223 3447
Q ss_pred HHHHhccCCCce-----eeEEeEEEe--------CCeeEEEEecCCCCChhhHhhhcCC---------------------
Q 004521 487 VILFSKLQHRNL-----VKLLGCCIQ--------GEEKLLIYEFMPNKSLDSFIFDQTR--------------------- 532 (747)
Q Consensus 487 ~~~l~~l~H~ni-----v~l~g~~~~--------~~~~~lV~E~~~~gsL~~~l~~~~~--------------------- 532 (747)
+.++.+++|.++ ++++++|.. .+..+|||||+++++|.++|+....
T Consensus 223 ~~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~ 302 (507)
T PLN03224 223 AYMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMP 302 (507)
T ss_pred HHHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhcc
Confidence 777778876654 678888754 3567999999999999999864211
Q ss_pred CCcCChhHHHHHHHHHHHHHHHhhhcCCCceEecccCcCcEEEcCCCCceEecccCccccCCCCCccc------cceeee
Q 004521 533 RTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGN------TNRVVG 606 (747)
Q Consensus 533 ~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~------~~~~~~ 606 (747)
...+++..+..++.|+++||.|||+.+ |+||||||+|||++.++.+||+|||+++.+........ ..+...
T Consensus 303 ~~~~~~~~~~~i~~ql~~aL~~lH~~~---ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~g~~tp~Y~aP 379 (507)
T PLN03224 303 QDKRDINVIKGVMRQVLTGLRKLHRIG---IVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGINFNPLYGMLDPRYSPP 379 (507)
T ss_pred cccCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCchHhEEECCCCcEEEEeCcCccccccCCccCccccCCCcceeCh
Confidence 123467788899999999999999988 99999999999999999999999999976432211000 000000
Q ss_pred c-c-C----------------------CCCCccccchhHHHHHHHHHhCCC-CC
Q 004521 607 T-Y-D----------------------GQFSIKSDVFSFGILLLEIVSGKK-NR 635 (747)
Q Consensus 607 ~-~-~----------------------~~~s~ksDVwS~Gvvl~elltg~~-p~ 635 (747)
. . . .....+.||||+||+|+||++|.. |+
T Consensus 380 E~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~ 433 (507)
T PLN03224 380 EELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPV 433 (507)
T ss_pred hhhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCc
Confidence 0 0 0 011235799999999999999885 54
|
|
| >KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=6.4e-28 Score=244.59 Aligned_cols=254 Identities=18% Similarity=0.232 Sum_probs=187.6
Q ss_pred hcCCCccceecccCCeeEEEEEecC-CcEEEEEEecccccccHHHHHHHHHHHhccC-C-Cc----eeeEEeEEEeCCee
Q 004521 439 TDNFSINNKLGEGGFGPVYKGTLVD-GQEIAVKRLSKISEQGLKELKNEVILFSKLQ-H-RN----LVKLLGCCIQGEEK 511 (747)
Q Consensus 439 ~~~~~~~~~lg~G~fg~Vy~~~~~~-g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~-H-~n----iv~l~g~~~~~~~~ 511 (747)
+++|.+...+|+|.||.|-+..... +..||||+++... ...+.-+-|++++++|. + |+ +|++.+|+...++.
T Consensus 88 ~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V~-kYreAa~iEi~vLqki~~~DP~g~~rcv~m~~wFdyrghi 166 (415)
T KOG0671|consen 88 TNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNVD-KYREAALIEIEVLQKINESDPNGKFRCVQMRDWFDYRGHI 166 (415)
T ss_pred ccceehhhhhcCCcccceEEEeecCCCceehHHHHHHHH-HHhhHHHHHHHHHHHHHhcCCCCceEEEeeehhhhccCce
Confidence 6789999999999999999998755 6899999998633 33445677999999993 2 33 78999999999999
Q ss_pred EEEEecCCCCChhhHhhhcCCCCcCChhHHHHHHHHHHHHHHHhhhcCCCceEecccCcCcEEEcC--------------
Q 004521 512 LLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQ-------------- 577 (747)
Q Consensus 512 ~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NIll~~-------------- 577 (747)
++|+|.+ +-|+.++|... ...+++...+..|+.|++++++|||+.. ++|-||||+|||+-+
T Consensus 167 Civfell-G~S~~dFlk~N-~y~~fpi~~ir~m~~QL~~sv~fLh~~k---l~HTDLKPENILfvss~~~~~~~~k~~~~ 241 (415)
T KOG0671|consen 167 CIVFELL-GLSTFDFLKEN-NYIPFPIDHIRHMGYQLLESVAFLHDLK---LTHTDLKPENILFVSSEYFKTYNPKKKVC 241 (415)
T ss_pred EEEEecc-ChhHHHHhccC-CccccchHHHHHHHHHHHHHHHHHHhcc---eeecCCChheEEEeccceEEEeccCCccc
Confidence 9999998 56999999653 3446888999999999999999999988 999999999999832
Q ss_pred ------CCCceEecccCccccCCCCCccccceeeec----cCCCCCccccchhHHHHHHHHHhCCCCCCCCCCcchhhhh
Q 004521 578 ------DMNPKISDFGLVRTFGGDETEGNTNRVVGT----YDGQFSIKSDVFSFGILLLEIVSGKKNRGFYRSDTKVNLI 647 (747)
Q Consensus 578 ------~~~~kl~DFGla~~~~~~~~~~~~~~~~~~----~~~~~s~ksDVwS~Gvvl~elltg~~p~~~~~~~~~~~~~ 647 (747)
+..+||+|||.|+.-.........++-... .+-.++.++||||+||||.|+.+|...|......+...+.
T Consensus 242 ~~r~~ks~~I~vIDFGsAtf~~e~hs~iVsTRHYRAPEViLgLGwS~pCDvWSiGCIL~ElytG~~LFqtHen~EHLaMM 321 (415)
T KOG0671|consen 242 FIRPLKSTAIKVIDFGSATFDHEHHSTIVSTRHYRAPEVILGLGWSQPCDVWSIGCILVELYTGETLFQTHENLEHLAMM 321 (415)
T ss_pred eeccCCCcceEEEecCCcceeccCcceeeeccccCCchheeccCcCCccCceeeeeEEEEeeccceecccCCcHHHHHHH
Confidence 335899999999876554432221111111 1557899999999999999999999987544322222222
Q ss_pred HhHHhcCCcccccchh---------------------------------hhccCCHHHHHHHHHHHHhccCCCCCCCCCH
Q 004521 648 GHLWDEGIPLRLIDAC---------------------------------IQDSCNLADVIRCIHIGLLCVQQHPEDRPCM 694 (747)
Q Consensus 648 ~~~~~~~~~~~~~d~~---------------------------------l~~~~~~~~~~~~~~l~~~Cl~~dP~~RPt~ 694 (747)
..+.. ..+..++... ..-...-.+..++++|+..+|..||.+|+|+
T Consensus 322 erIlG-p~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~LfDLl~~mL~fDP~~RiTl 400 (415)
T KOG0671|consen 322 ERILG-PIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQLFDLLRRMLEFDPARRITL 400 (415)
T ss_pred HHhhC-CCcHHHhhhhhhHhhhhcccccCccccccccchhhhcCCccHHHHhccCcHHHhHHHHHHHHHHccCccccccH
Confidence 22211 1111111100 0012233456778999999999999999999
Q ss_pred HHHHH
Q 004521 695 PSVIL 699 (747)
Q Consensus 695 ~~v~~ 699 (747)
.|+++
T Consensus 401 ~EAL~ 405 (415)
T KOG0671|consen 401 REALS 405 (415)
T ss_pred HHHhc
Confidence 99875
|
|
| >KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=4.4e-27 Score=259.99 Aligned_cols=250 Identities=26% Similarity=0.417 Sum_probs=194.7
Q ss_pred HHHHHHHhcCCCccceecccCCeeEEEEEec-CCcEEEEEEecccccccHHHHHHHHHHHhcc-CCCceeeEEeEEEe--
Q 004521 432 LATIANATDNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKISEQGLKELKNEVILFSKL-QHRNLVKLLGCCIQ-- 507 (747)
Q Consensus 432 ~~~~~~~~~~~~~~~~lg~G~fg~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~-- 507 (747)
++.+...++.|++.+.||.|.+|.||+++.. +++.+|||++.. ..+..+++..|.++++.. +|||++.++|++..
T Consensus 11 ~~~lpdp~d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~-~~d~deEiE~eynil~~~~~hpnv~~fyg~~~k~~ 89 (953)
T KOG0587|consen 11 LSSLPDPADIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDP-TEDEEEEIELEYNMLKKYSHHPNVATFYGAFIKKD 89 (953)
T ss_pred hhhCCCCCCccEEEEEEeeccceeEEEEeeeecCceeeeEeecC-CccccHHHHHHHHHHHhccCCCCcceEEEEEEEec
Confidence 3444556678999999999999999999864 588999999865 445567888899999988 69999999999875
Q ss_pred ---CCeeEEEEecCCCCChhhHhhhcCCCCcCChhHHHHHHHHHHHHHHHhhhcCCCceEecccCcCcEEEcCCCCceEe
Q 004521 508 ---GEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKIS 584 (747)
Q Consensus 508 ---~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NIll~~~~~~kl~ 584 (747)
++.++||||||.+||..+++.... ...+.|..+..|++.++.||.+||.+. +||||||=.||||+.++.+||.
T Consensus 90 ~~~~DqLWLVMEfC~gGSVTDLVKn~~-g~rl~E~~IaYI~re~lrgl~HLH~nk---viHRDikG~NiLLT~e~~VKLv 165 (953)
T KOG0587|consen 90 PGNGDQLWLVMEFCGGGSVTDLVKNTK-GNRLKEEWIAYILREILRGLAHLHNNK---VIHRDIKGQNVLLTENAEVKLV 165 (953)
T ss_pred CCCCCeEEEEeeccCCccHHHHHhhhc-ccchhhHHHHHHHHHHHHHHHHHhhcc---eeeecccCceEEEeccCcEEEe
Confidence 467899999999999999997765 667999999999999999999999887 9999999999999999999999
Q ss_pred cccCccccCCCCCccccceeeec--------------cCCCCCccccchhHHHHHHHHHhCCCCCCCCCCcchhhhhHhH
Q 004521 585 DFGLVRTFGGDETEGNTNRVVGT--------------YDGQFSIKSDVFSFGILLLEIVSGKKNRGFYRSDTKVNLIGHL 650 (747)
Q Consensus 585 DFGla~~~~~~~~~~~~~~~~~~--------------~~~~~s~ksDVwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~ 650 (747)
|||++..+..... .+....|+ ++..|+..+|+||+|++..||--|.+|+-...+.. .+..+
T Consensus 166 DFGvSaQldsT~g--rRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHPmr---aLF~I 240 (953)
T KOG0587|consen 166 DFGVSAQLDSTVG--RRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHPMR---ALFLI 240 (953)
T ss_pred eeeeeeeeecccc--cccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcchhh---hhccC
Confidence 9999876633221 12222222 25678999999999999999999999954322221 11111
Q ss_pred HhcCCcccccchhhhccCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 004521 651 WDEGIPLRLIDACIQDSCNLADVIRCIHIGLLCVQQHPEDRPCMPSVIL 699 (747)
Q Consensus 651 ~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dP~~RPt~~~v~~ 699 (747)
...-++.+ -.+..-..+..+++..||..|.++||++.++++
T Consensus 241 -pRNPPPkL-------krp~kWs~~FndFIs~cL~Kd~e~RP~~~~ll~ 281 (953)
T KOG0587|consen 241 -PRNPPPKL-------KRPKKWSKKFNDFISTCLVKDYEQRPSTEELLK 281 (953)
T ss_pred -CCCCCccc-------cchhhHHHHHHHHHHHHHhhccccCcchhhhcc
Confidence 01111111 123344566778999999999999999998875
|
|
| >PF00954 S_locus_glycop: S-locus glycoprotein family; InterPro: IPR000858 In Brassicaceae, self-incompatible plants have a self/non-self recognition system, which involves the inability of flowering plants to achieve self-fertilisation | Back alignment and domain information |
|---|
Probab=99.94 E-value=3.9e-27 Score=209.27 Aligned_cols=109 Identities=50% Similarity=1.149 Sum_probs=104.7
Q ss_pred EecCCCCCccee-cCCCCCCCceEEEEeecCceEEEEEEecCCccEEEEEEeeeeeEEEEEEEecCCCceEEEeecCCCC
Q 004521 154 YRTGPWNGLRFS-APSLRPNPIFSFSFVSNDVELYYTFNITNKAVISRIVMNQTLYVRRRFIWNKATQSWELYSDVPRDQ 232 (747)
Q Consensus 154 ~~~g~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~l~~~G~l~~~~~~~~~~~~W~~~~~~p~~~ 232 (747)
||+|+|||..|+ +|+|....++.+.|+.++++.+|+|...+.+.++|++||.+|+++ +|.|++.++.|.++|.+|.|+
T Consensus 1 wrsG~WnG~~f~g~p~~~~~~~~~~~fv~~~~e~~~t~~~~~~s~~~r~~ld~~G~l~-~~~w~~~~~~W~~~~~~p~d~ 79 (110)
T PF00954_consen 1 WRSGPWNGQRFSGIPEMSSNSLYNYSFVSNNEEVYYTYSLSNSSVLSRLVLDSDGQLQ-RYIWNESTQSWSVFWSAPKDQ 79 (110)
T ss_pred CCccccCCeEECCcccccccceeEEEEEECCCeEEEEEecCCCceEEEEEEeeeeEEE-EEEEecCCCcEEEEEEecccC
Confidence 899999999999 999998888999999999999999999999999999999999999 999999999999999999999
Q ss_pred CCcccCCCCccccccCCCCccccCCCceeCC
Q 004521 233 CDTYGLCGAYGICIIGQSPVCQCLKGFKPKS 263 (747)
Q Consensus 233 C~~~~~CG~~giC~~~~~~~C~C~~gf~~~~ 263 (747)
||+|+.||+||+|+.+..+.|.||+||+|++
T Consensus 80 Cd~y~~CG~~g~C~~~~~~~C~Cl~GF~P~n 110 (110)
T PF00954_consen 80 CDVYGFCGPNGICNSNNSPKCSCLPGFEPKN 110 (110)
T ss_pred CCCccccCCccEeCCCCCCceECCCCcCCCc
Confidence 9999999999999988889999999999975
|
This is sporophytically controlled by multiple alleles at a single locus (S). There are a total of 50 different S alleles in Brassica oleracea. S-locus glycoproteins, as well as S-receptor kinases, are in linkage with the S-alleles []. Most of the proteins within this family contain apple-like domain (IPR003609 from INTERPRO), which is predicted to possess protein- and/or carbohydrate-binding functions.; GO: 0048544 recognition of pollen |
| >KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=3.9e-27 Score=239.25 Aligned_cols=231 Identities=25% Similarity=0.311 Sum_probs=174.3
Q ss_pred cCCCccceecccCCeeEEEEEecC-CcEEEEEEeccc---ccccHHHHHHHHHHHhcc-CCCceeeEEeEEEeCCeeEEE
Q 004521 440 DNFSINNKLGEGGFGPVYKGTLVD-GQEIAVKRLSKI---SEQGLKELKNEVILFSKL-QHRNLVKLLGCCIQGEEKLLI 514 (747)
Q Consensus 440 ~~~~~~~~lg~G~fg~Vy~~~~~~-g~~vavK~l~~~---~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lV 514 (747)
.+|.+...||+|+||.|.+|..+. .+.+|||+|++. ..+..+--+.|-++|+.. +-|.++++..++..-+.+|+|
T Consensus 349 tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTmDRLyFV 428 (683)
T KOG0696|consen 349 TDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTMDRLYFV 428 (683)
T ss_pred cccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhhhheeeE
Confidence 468889999999999999998765 567999999872 334455566788888876 578999999999999999999
Q ss_pred EecCCCCChhhHhhhcCCCCcCChhHHHHHHHHHHHHHHHhhhcCCCceEecccCcCcEEEcCCCCceEecccCccccCC
Q 004521 515 YEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGG 594 (747)
Q Consensus 515 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NIll~~~~~~kl~DFGla~~~~~ 594 (747)
|||+.+|+|.-.+..- +.+-+..+.-+|..||-||-+||+++ ||.||||..|||||.+|++||+|||+++.-.-
T Consensus 429 MEyvnGGDLMyhiQQ~---GkFKEp~AvFYAaEiaigLFFLh~kg---IiYRDLKLDNvmLd~eGHiKi~DFGmcKEni~ 502 (683)
T KOG0696|consen 429 MEYVNGGDLMYHIQQV---GKFKEPVAVFYAAEIAIGLFFLHSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKENIF 502 (683)
T ss_pred EEEecCchhhhHHHHh---cccCCchhhhhhHHHHHHhhhhhcCC---eeeeeccccceEeccCCceEeeeccccccccc
Confidence 9999999999888543 33667778888999999999999999 99999999999999999999999999985322
Q ss_pred CCCccccceeeecc---------CCCCCccccchhHHHHHHHHHhCCCCCCCCCCcchhhhhHhHHhcCCcccccchhhh
Q 004521 595 DETEGNTNRVVGTY---------DGQFSIKSDVFSFGILLLEIVSGKKNRGFYRSDTKVNLIGHLWDEGIPLRLIDACIQ 665 (747)
Q Consensus 595 ~~~~~~~~~~~~~~---------~~~~s~ksDVwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 665 (747)
+.. .+....|+. -.+|+..+|.|||||+||||+.|..||+....+ ++...+ .+.. .
T Consensus 503 ~~~--TTkTFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEmlaGQpPFdGeDE~---elF~aI-~ehn--------v- 567 (683)
T KOG0696|consen 503 DGV--TTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDED---ELFQAI-MEHN--------V- 567 (683)
T ss_pred CCc--ceeeecCCCcccccceEEecccccchhHHHHHHHHHHHHcCCCCCCCCCHH---HHHHHH-HHcc--------C-
Confidence 221 223344443 367899999999999999999999997643322 222221 1111 1
Q ss_pred ccCCHHHHHHHHHHHHhccCCCCCCCC
Q 004521 666 DSCNLADVIRCIHIGLLCVQQHPEDRP 692 (747)
Q Consensus 666 ~~~~~~~~~~~~~l~~~Cl~~dP~~RP 692 (747)
.++..--.+.+.++..-+...|.+|.
T Consensus 568 -syPKslSkEAv~ickg~ltK~P~kRL 593 (683)
T KOG0696|consen 568 -SYPKSLSKEAVAICKGLLTKHPGKRL 593 (683)
T ss_pred -cCcccccHHHHHHHHHHhhcCCcccc
Confidence 11111122344555567888998884
|
|
| >KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=9.8e-28 Score=231.81 Aligned_cols=252 Identities=24% Similarity=0.354 Sum_probs=182.7
Q ss_pred CccceecccCCeeEEEEEec-CCcEEEEEEeccc--ccccHHHHHHHHHHHhccCCCceeeEEeEEEeCC-----eeEEE
Q 004521 443 SINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKI--SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGE-----EKLLI 514 (747)
Q Consensus 443 ~~~~~lg~G~fg~Vy~~~~~-~g~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~-----~~~lV 514 (747)
+..+.||-|+||.||..++. +|+.||+|++... +-...+.+.+|++++..++|.|++..++...... +.|+|
T Consensus 56 ~PDRPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEiYV~ 135 (449)
T KOG0664|consen 56 QPDRPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQELYVL 135 (449)
T ss_pred CCCCcccccceeEEEeccCCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHHHHH
Confidence 34588999999999999875 5999999998753 2234567889999999999999999998876543 56788
Q ss_pred EecCCCCChhhHhhhcCCCCcCChhHHHHHHHHHHHHHHHhhhcCCCceEecccCcCcEEEcCCCCceEecccCccccCC
Q 004521 515 YEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGG 594 (747)
Q Consensus 515 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NIll~~~~~~kl~DFGla~~~~~ 594 (747)
.|.|. .+|.++|-. ...++...+.-+.+||++||+|||+.+ |.||||||.|.|++++...||+|||+||.-..
T Consensus 136 TELmQ-SDLHKIIVS---PQ~Ls~DHvKVFlYQILRGLKYLHsA~---ILHRDIKPGNLLVNSNCvLKICDFGLARvee~ 208 (449)
T KOG0664|consen 136 TELMQ-SDLHKIIVS---PQALTPDHVKVFVYQILRGLKYLHTAN---ILHRDIKPGNLLVNSNCILKICDFGLARTWDQ 208 (449)
T ss_pred HHHHH-hhhhheecc---CCCCCcchhhhhHHHHHhhhHHHhhcc---hhhccCCCccEEeccCceEEecccccccccch
Confidence 99985 788888744 345777888889999999999999988 99999999999999999999999999998766
Q ss_pred CCCccccceeeecc---------CCCCCccccchhHHHHHHHHHhCCCCCCCCCCcchhhhhHhHH-----------hcC
Q 004521 595 DETEGNTNRVVGTY---------DGQFSIKSDVFSFGILLLEIVSGKKNRGFYRSDTKVNLIGHLW-----------DEG 654 (747)
Q Consensus 595 ~~~~~~~~~~~~~~---------~~~~s~ksDVwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~-----------~~~ 654 (747)
++....+..+...| ...|+.+.||||.|||+.||+..+..|....+-...+++..+. .+|
T Consensus 209 d~~~hMTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~PiqQL~lItdLLGTPs~EaMr~ACEG 288 (449)
T KOG0664|consen 209 RDRLNMTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGPIEQLQMIIDLLGTPSQEAMKYACEG 288 (449)
T ss_pred hhhhhhHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccChHHHHHHHHHHhCCCcHHHHHHHhhh
Confidence 65544433332221 3579999999999999999999888765444433333332221 111
Q ss_pred Ccccccchhhh----------ccCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhc
Q 004521 655 IPLRLIDACIQ----------DSCNLADVIRCIHIGLLCVQQHPEDRPCMPSVILMLG 702 (747)
Q Consensus 655 ~~~~~~d~~l~----------~~~~~~~~~~~~~l~~~Cl~~dP~~RPt~~~v~~~L~ 702 (747)
....++..... .+.+.. -...+.+..+++..||.+|.+..+.+..+-
T Consensus 289 Ak~H~LR~~~k~Ps~~vLYtlsS~~~~-~heav~~~~~~l~~d~dkris~~~A~~~~~ 345 (449)
T KOG0664|consen 289 AKNHVLRAGLRAPDTQRLYKIASPDDK-NHEAVDLLQKLLHFDPDKRISVEEALQHRY 345 (449)
T ss_pred hHHHhhccCCCCCCccceeeecCCccc-chHHHHHHHHHhCCCCcccccHhhhccccc
Confidence 11111111000 111111 122345556789999999999988887663
|
|
| >KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.94 E-value=4e-26 Score=242.69 Aligned_cols=196 Identities=23% Similarity=0.368 Sum_probs=159.4
Q ss_pred hcCCCccceecccCCeeEEEEEecC-CcEEEEEEeccc---ccccHHHHHHHHHHHhccCCCceeeEEeEEEeCCeeEEE
Q 004521 439 TDNFSINNKLGEGGFGPVYKGTLVD-GQEIAVKRLSKI---SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLI 514 (747)
Q Consensus 439 ~~~~~~~~~lg~G~fg~Vy~~~~~~-g~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV 514 (747)
..-|..++.||-|+||.|-++...| ...+|.|.|++. ........+.|..||+....+-||+|+..|.+++.+|+|
T Consensus 628 KSmFvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySFQDkdnLYFV 707 (1034)
T KOG0608|consen 628 KSMFVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFV 707 (1034)
T ss_pred ccceEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEeccCCceEEE
Confidence 3457778899999999999998655 567999999873 345567789999999999999999999999999999999
Q ss_pred EecCCCCChhhHhhhcCCCCcCChhHHHHHHHHHHHHHHHhhhcCCCceEecccCcCcEEEcCCCCceEecccCcccc--
Q 004521 515 YEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTF-- 592 (747)
Q Consensus 515 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NIll~~~~~~kl~DFGla~~~-- 592 (747)
|||+++|++..+|.. .+.+++..+.-++.++..|+++.|..| +|||||||+|||||.+|++||+||||+.-+
T Consensus 708 MdYIPGGDmMSLLIr---mgIFeE~LARFYIAEltcAiesVHkmG---FIHRDiKPDNILIDrdGHIKLTDFGLCTGfRW 781 (1034)
T KOG0608|consen 708 MDYIPGGDMMSLLIR---MGIFEEDLARFYIAELTCAIESVHKMG---FIHRDIKPDNILIDRDGHIKLTDFGLCTGFRW 781 (1034)
T ss_pred EeccCCccHHHHHHH---hccCHHHHHHHHHHHHHHHHHHHHhcc---ceecccCccceEEccCCceeeeecccccccee
Confidence 999999999999854 456788888888889999999999988 999999999999999999999999998532
Q ss_pred -------C-CCCCccccc------------------------------eeeecc---------CCCCCccccchhHHHHH
Q 004521 593 -------G-GDETEGNTN------------------------------RVVGTY---------DGQFSIKSDVFSFGILL 625 (747)
Q Consensus 593 -------~-~~~~~~~~~------------------------------~~~~~~---------~~~~s~ksDVwS~Gvvl 625 (747)
. ++....... ..+|+. ...|+..+|.||.||||
T Consensus 782 THdskYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~q~cdwws~gvil 861 (1034)
T KOG0608|consen 782 THDSKYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYTQLCDWWSVGVIL 861 (1034)
T ss_pred ccccccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCccccchhhHhhHHH
Confidence 1 110000000 011111 35688999999999999
Q ss_pred HHHHhCCCCCCCCCC
Q 004521 626 LEIVSGKKNRGFYRS 640 (747)
Q Consensus 626 ~elltg~~p~~~~~~ 640 (747)
|||+.|+.||.....
T Consensus 862 ~em~~g~~pf~~~tp 876 (1034)
T KOG0608|consen 862 YEMLVGQPPFLADTP 876 (1034)
T ss_pred HHHhhCCCCccCCCC
Confidence 999999999864443
|
|
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=99.93 E-value=6.3e-25 Score=218.56 Aligned_cols=204 Identities=33% Similarity=0.548 Sum_probs=168.7
Q ss_pred ecccCCeeEEEEEecC-CcEEEEEEecccccc-cHHHHHHHHHHHhccCCCceeeEEeEEEeCCeeEEEEecCCCCChhh
Q 004521 448 LGEGGFGPVYKGTLVD-GQEIAVKRLSKISEQ-GLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMPNKSLDS 525 (747)
Q Consensus 448 lg~G~fg~Vy~~~~~~-g~~vavK~l~~~~~~-~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gsL~~ 525 (747)
||+|++|.||++...+ ++.+++|++...... ..+.+.+|+..++.++|++|+++++++......++++||+++++|.+
T Consensus 1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~ 80 (215)
T cd00180 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSLKD 80 (215)
T ss_pred CCcCCceEEEEEEecCCCcEEEEEEeccccchhHHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecCCCCcHHH
Confidence 6899999999999865 899999998763322 35789999999999999999999999999999999999999999999
Q ss_pred HhhhcCCCCcCChhHHHHHHHHHHHHHHHhhhcCCCceEecccCcCcEEEcC-CCCceEecccCccccCCCCC--c---c
Q 004521 526 FIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQ-DMNPKISDFGLVRTFGGDET--E---G 599 (747)
Q Consensus 526 ~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NIll~~-~~~~kl~DFGla~~~~~~~~--~---~ 599 (747)
++.... ..+++..+..++.++++++.|||+.+ ++|+||+|.||+++. ++.++|+|||.+........ . .
T Consensus 81 ~~~~~~--~~~~~~~~~~~~~~l~~~l~~lh~~~---~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~ 155 (215)
T cd00180 81 LLKENE--GKLSEDEILRILLQILEGLEYLHSNG---IIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKSLLKTIVG 155 (215)
T ss_pred HHHhcc--CCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcchhhcccC
Confidence 986532 35789999999999999999999988 999999999999999 89999999999986644320 0 0
Q ss_pred ccceeeec--cCC-CCCccccchhHHHHHHHHHhCCCCCCCCCCcchhhhhHhHHhcCCcccccchhhhccCCHHHHHHH
Q 004521 600 NTNRVVGT--YDG-QFSIKSDVFSFGILLLEIVSGKKNRGFYRSDTKVNLIGHLWDEGIPLRLIDACIQDSCNLADVIRC 676 (747)
Q Consensus 600 ~~~~~~~~--~~~-~~s~ksDVwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~ 676 (747)
........ ... .++.++|+|++|+++++| ..+
T Consensus 156 ~~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l---------------------------------------------~~~ 190 (215)
T cd00180 156 TPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL---------------------------------------------PEL 190 (215)
T ss_pred CCCccChhHhcccCCCCchhhhHHHHHHHHHH---------------------------------------------HHH
Confidence 00000000 122 677899999999999999 335
Q ss_pred HHHHHhccCCCCCCCCCHHHHHHHh
Q 004521 677 IHIGLLCVQQHPEDRPCMPSVILML 701 (747)
Q Consensus 677 ~~l~~~Cl~~dP~~RPt~~~v~~~L 701 (747)
.+++..|++.+|.+||++.++++.|
T Consensus 191 ~~~l~~~l~~~p~~R~~~~~l~~~~ 215 (215)
T cd00180 191 KDLIRKMLQKDPEKRPSAKEILEHL 215 (215)
T ss_pred HHHHHHHhhCCcccCcCHHHHhhCC
Confidence 6777899999999999999998753
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=6.2e-27 Score=243.56 Aligned_cols=240 Identities=20% Similarity=0.251 Sum_probs=186.4
Q ss_pred cCCCccceecccCCeeEEEEEecCCc-EEEEEEecc---cccccHHHHHHHHHHHhccCCCceeeEEeEEEeCCeeEEEE
Q 004521 440 DNFSINNKLGEGGFGPVYKGTLVDGQ-EIAVKRLSK---ISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIY 515 (747)
Q Consensus 440 ~~~~~~~~lg~G~fg~Vy~~~~~~g~-~vavK~l~~---~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 515 (747)
.+++....||-||||.|-+...+... .+|+|.+++ ......+.+..|-.||...+.|.||+++-.+.+.+..|++|
T Consensus 420 ~dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~kyvYmLm 499 (732)
T KOG0614|consen 420 SDLKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRDSKYVYMLM 499 (732)
T ss_pred hhhhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhccchhhhhhH
Confidence 35666788999999999999876533 489998876 34556678899999999999999999999999999999999
Q ss_pred ecCCCCChhhHhhhcCCCCcCChhHHHHHHHHHHHHHHHhhhcCCCceEecccCcCcEEEcCCCCceEecccCccccCCC
Q 004521 516 EFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGD 595 (747)
Q Consensus 516 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NIll~~~~~~kl~DFGla~~~~~~ 595 (747)
|-|-+|.|...|.+ ++.++.....-++..+.+|++|||.++ ||.|||||+|.|||.+|-+||.|||+|+.++..
T Consensus 500 EaClGGElWTiLrd---Rg~Fdd~tarF~~acv~EAfeYLH~k~---iIYRDLKPENllLd~~Gy~KLVDFGFAKki~~g 573 (732)
T KOG0614|consen 500 EACLGGELWTILRD---RGSFDDYTARFYVACVLEAFEYLHRKG---IIYRDLKPENLLLDNRGYLKLVDFGFAKKIGSG 573 (732)
T ss_pred HhhcCchhhhhhhh---cCCcccchhhhhHHHHHHHHHHHHhcC---ceeccCChhheeeccCCceEEeehhhHHHhccC
Confidence 99999999999965 345777888888889999999999998 999999999999999999999999999998655
Q ss_pred CCccccceeeecc---------CCCCCccccchhHHHHHHHHHhCCCCCCCCCCcchhhhhHhHHhcCCcccccchhhhc
Q 004521 596 ETEGNTNRVVGTY---------DGQFSIKSDVFSFGILLLEIVSGKKNRGFYRSDTKVNLIGHLWDEGIPLRLIDACIQD 666 (747)
Q Consensus 596 ~~~~~~~~~~~~~---------~~~~s~ksDVwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 666 (747)
.. +..++|+. +...+.++|.||+|+++|||++|.+||....+.. .+..+.+.-....++ ..+
T Consensus 574 ~K---TwTFcGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~G~pPFs~~dpmk---tYn~ILkGid~i~~P-r~I-- 644 (732)
T KOG0614|consen 574 RK---TWTFCGTPEYVAPEIILNKGHDRAVDYWALGILIYELLTGSPPFSGVDPMK---TYNLILKGIDKIEFP-RRI-- 644 (732)
T ss_pred Cc---eeeecCCcccccchhhhccCcchhhHHHHHHHHHHHHHcCCCCCCCCchHH---HHHHHHhhhhhhhcc-ccc--
Confidence 43 33344443 5678889999999999999999999976443332 222222221111111 111
Q ss_pred cCCHHHHHHHHHHHHhccCCCCCCCCC-----HHHHHHH
Q 004521 667 SCNLADVIRCIHIGLLCVQQHPEDRPC-----MPSVILM 700 (747)
Q Consensus 667 ~~~~~~~~~~~~l~~~Cl~~dP~~RPt-----~~~v~~~ 700 (747)
.....+++.+.+..+|.+|.- +.+|.+.
T Consensus 645 ------~k~a~~Lik~LCr~~P~ERLG~~~~gI~DIkkH 677 (732)
T KOG0614|consen 645 ------TKTATDLIKKLCRDNPTERLGYQKGGINDIKKH 677 (732)
T ss_pred ------chhHHHHHHHHHhcCcHhhhccccCChHHHHhh
Confidence 112445666778899999975 5666543
|
|
| >KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=2.2e-26 Score=253.35 Aligned_cols=237 Identities=25% Similarity=0.366 Sum_probs=170.8
Q ss_pred CCccceecccCCe-eEEEEEecCCcEEEEEEecccccccHHHHHHHHHHHhcc-CCCceeeEEeEEEeCCeeEEEEecCC
Q 004521 442 FSINNKLGEGGFG-PVYKGTLVDGQEIAVKRLSKISEQGLKELKNEVILFSKL-QHRNLVKLLGCCIQGEEKLLIYEFMP 519 (747)
Q Consensus 442 ~~~~~~lg~G~fg-~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lV~E~~~ 519 (747)
|...+.+|.|+.| .||+|.. +|++||||++-. ....-..+|+..++.- +|||||++++.-.++...|+..|.|.
T Consensus 511 ~~~~eilG~Gs~Gt~Vf~G~y-e~R~VAVKrll~---e~~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIalELC~ 586 (903)
T KOG1027|consen 511 FSPKEILGYGSNGTVVFRGVY-EGREVAVKRLLE---EFFDFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIALELCA 586 (903)
T ss_pred eccHHHcccCCCCcEEEEEee-CCceehHHHHhh---HhHHHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEehHhh
Confidence 4445678999988 4799988 689999999853 3344567899999887 69999999999999999999999995
Q ss_pred CCChhhHhhhcCCCCc-CChhHHHHHHHHHHHHHHHhhhcCCCceEecccCcCcEEEcC---C--CCceEecccCccccC
Q 004521 520 NKSLDSFIFDQTRRTL-LDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQ---D--MNPKISDFGLVRTFG 593 (747)
Q Consensus 520 ~gsL~~~l~~~~~~~~-l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NIll~~---~--~~~kl~DFGla~~~~ 593 (747)
-+|.+++........ ..-...+.+..|+++||++||+.+ ||||||||+||||+. + ..++|+|||+++.+.
T Consensus 587 -~sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHsl~---iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl~ 662 (903)
T KOG1027|consen 587 -CSLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHSLK---IVHRDLKPQNILISVPSADGTLRAKISDFGLSKKLA 662 (903)
T ss_pred -hhHHHHHhccccchhhcccccHHHHHHHHHHHHHHHHhcc---cccccCCCceEEEEccCCCcceeEEecccccccccC
Confidence 899999966311111 111445678899999999999977 999999999999976 3 568999999999987
Q ss_pred CCCCcccc-ceeeecc---------CCCCCccccchhHHHHHHHHHhC-CCCCCCCCCcchhhhhHhHHhcCCcccccch
Q 004521 594 GDETEGNT-NRVVGTY---------DGQFSIKSDVFSFGILLLEIVSG-KKNRGFYRSDTKVNLIGHLWDEGIPLRLIDA 662 (747)
Q Consensus 594 ~~~~~~~~-~~~~~~~---------~~~~s~ksDVwS~Gvvl~elltg-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 662 (747)
.+...... ....|+. ...-+.++||||+|||+|..++| .+||+..... ..+.+ ........
T Consensus 663 ~~~sS~~r~s~~sGt~GW~APE~L~~~~~~~avDiFslGCvfyYvltgG~HpFGd~~~R-~~NIl----~~~~~L~~--- 734 (903)
T KOG1027|consen 663 GGKSSFSRLSGGSGTSGWQAPEQLREDRKTQAVDIFSLGCVFYYVLTGGSHPFGDSLER-QANIL----TGNYTLVH--- 734 (903)
T ss_pred CCcchhhcccCCCCcccccCHHHHhccccCcccchhhcCceEEEEecCCccCCCchHHh-hhhhh----cCccceee---
Confidence 76654333 2233332 23446689999999999999997 7897632211 11111 11111111
Q ss_pred hhhccCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 004521 663 CIQDSCNLADVIRCIHIGLLCVQQHPEDRPCMPSVIL 699 (747)
Q Consensus 663 ~l~~~~~~~~~~~~~~l~~~Cl~~dP~~RPt~~~v~~ 699 (747)
+....+ . ...+|+-++++++|..||++.+|+.
T Consensus 735 -L~~~~d--~--eA~dLI~~ml~~dP~~RPsa~~VL~ 766 (903)
T KOG1027|consen 735 -LEPLPD--C--EAKDLISRMLNPDPQLRPSATDVLN 766 (903)
T ss_pred -eccCch--H--HHHHHHHHhcCCCcccCCCHHHHhC
Confidence 111110 1 3556777999999999999999973
|
|
| >KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription] | Back alignment and domain information |
|---|
Probab=99.93 E-value=6.1e-26 Score=214.51 Aligned_cols=186 Identities=24% Similarity=0.405 Sum_probs=152.3
Q ss_pred hcCCCccceecccCCeeEEEEEe-cCCcEEEEEEecccccccHHHHHHHHHHHhccC-CCceeeEEeEEEeCC--eeEEE
Q 004521 439 TDNFSINNKLGEGGFGPVYKGTL-VDGQEIAVKRLSKISEQGLKELKNEVILFSKLQ-HRNLVKLLGCCIQGE--EKLLI 514 (747)
Q Consensus 439 ~~~~~~~~~lg~G~fg~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~-H~niv~l~g~~~~~~--~~~lV 514 (747)
.++|++.+++|+|.++.||.|.. .+.+.++||+++.. ..+.+.+|+.||+.|. ||||+++++...+.. ...||
T Consensus 37 ~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKPV---kkkKIkREikIL~nL~gg~NIi~L~DiV~Dp~SktpaLi 113 (338)
T KOG0668|consen 37 QDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKPV---KKKKIKREIKILQNLRGGPNIIKLLDIVKDPESKTPSLI 113 (338)
T ss_pred cchHHHHHHHcCccHhhHhcccccCCCceEEEeeechH---HHHHHHHHHHHHHhccCCCCeeehhhhhcCccccCchhH
Confidence 46899999999999999999984 56789999999753 3467899999999997 999999999998764 45799
Q ss_pred EecCCCCChhhHhhhcCCCCcCChhHHHHHHHHHHHHHHHhhhcCCCceEecccCcCcEEEcCC-CCceEecccCccccC
Q 004521 515 YEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQD-MNPKISDFGLVRTFG 593 (747)
Q Consensus 515 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NIll~~~-~~~kl~DFGla~~~~ 593 (747)
+||+.+.+...+- ..++..++...+.++++||.|+|+.| |+|||+||.|++||.. -..+|+|+|+|..+.
T Consensus 114 FE~v~n~Dfk~ly------~tl~d~dIryY~~elLkALdyCHS~G---ImHRDVKPhNvmIdh~~rkLrlIDWGLAEFYH 184 (338)
T KOG0668|consen 114 FEYVNNTDFKQLY------PTLTDYDIRYYIYELLKALDYCHSMG---IMHRDVKPHNVMIDHELRKLRLIDWGLAEFYH 184 (338)
T ss_pred hhhhccccHHHHh------hhhchhhHHHHHHHHHHHHhHHHhcC---cccccCCcceeeechhhceeeeeecchHhhcC
Confidence 9999998887654 23667788889999999999999999 9999999999999865 568999999999876
Q ss_pred CCCCcc---ccceeeecc----CCCCCccccchhHHHHHHHHHhCCCCCC
Q 004521 594 GDETEG---NTNRVVGTY----DGQFSIKSDVFSFGILLLEIVSGKKNRG 636 (747)
Q Consensus 594 ~~~~~~---~~~~~~~~~----~~~~s~ksDVwS~Gvvl~elltg~~p~~ 636 (747)
+..... .....-|+. -..|+..-|+|||||+|.+|+..+.||-
T Consensus 185 p~~eYnVRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFF 234 (338)
T KOG0668|consen 185 PGKEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFF 234 (338)
T ss_pred CCceeeeeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCccc
Confidence 543321 111111221 2457788999999999999999999974
|
|
| >KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.7e-25 Score=216.68 Aligned_cols=248 Identities=20% Similarity=0.257 Sum_probs=178.6
Q ss_pred cCCCccceecccCCeeEEEEEecC-CcEEEEEEecccccccHHHHHHHHHHHhcc-CCCceeeEEeE-EEeCCeeEEEEe
Q 004521 440 DNFSINNKLGEGGFGPVYKGTLVD-GQEIAVKRLSKISEQGLKELKNEVILFSKL-QHRNLVKLLGC-CIQGEEKLLIYE 516 (747)
Q Consensus 440 ~~~~~~~~lg~G~fg~Vy~~~~~~-g~~vavK~l~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~g~-~~~~~~~~lV~E 516 (747)
+.|.+.+.||+|.||.+-++.++. .+.+++|.+.+ .....++|.+|...--.| .|.||+.-++. +...+..++++|
T Consensus 24 d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~-p~tt~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d~YvF~qE 102 (378)
T KOG1345|consen 24 DVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPR-PQTTQADFVREFHYSFFLSPHQHIIDTYEVAFQTSDAYVFVQE 102 (378)
T ss_pred hhhhHHHHhcccceeeEEeeeccCCceEEEeeccCc-chhhHHHHHHHhccceeeccchhhhHHHHHHhhcCceEEEeec
Confidence 468889999999999999999865 67899999875 334567899998876666 59999987755 556667789999
Q ss_pred cCCCCChhhHhhhcCCCCcCChhHHHHHHHHHHHHHHHhhhcCCCceEecccCcCcEEE-cC-CCCceEecccCccccCC
Q 004521 517 FMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLL-DQ-DMNPKISDFGLVRTFGG 594 (747)
Q Consensus 517 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NIll-~~-~~~~kl~DFGla~~~~~ 594 (747)
|++.|+|.+-+.. .-+.+....+++.|++.|+.|+|+.+ +||||||.+|||| +. ...+||+|||+.+..+.
T Consensus 103 ~aP~gdL~snv~~----~GigE~~~K~v~~ql~SAi~fMHskn---lVHRdlK~eNiLif~~df~rvKlcDFG~t~k~g~ 175 (378)
T KOG1345|consen 103 FAPRGDLRSNVEA----AGIGEANTKKVFAQLLSAIEFMHSKN---LVHRDLKAENILIFDADFYRVKLCDFGLTRKVGT 175 (378)
T ss_pred cCccchhhhhcCc----ccccHHHHHHHHHHHHHHHHHhhccc---hhhcccccceEEEecCCccEEEeeecccccccCc
Confidence 9999999877633 33677778899999999999999998 9999999999998 33 45799999999886543
Q ss_pred CCCccccce------eeec---cCCCCCccccchhHHHHHHHHHhCCCCCCCCCCcchhhhhHhHHhcCCcccccchhhh
Q 004521 595 DETEGNTNR------VVGT---YDGQFSIKSDVFSFGILLLEIVSGKKNRGFYRSDTKVNLIGHLWDEGIPLRLIDACIQ 665 (747)
Q Consensus 595 ~~~~~~~~~------~~~~---~~~~~s~ksDVwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 665 (747)
......... ...+ ..-...+.+|||.||++++.++||+.|+.....+.....--..|..+....+++..-.
T Consensus 176 tV~~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~~~d~~Y~~~~~w~~rk~~~~P~~F~~ 255 (378)
T KOG1345|consen 176 TVKYLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKASIMDKPYWEWEQWLKRKNPALPKKFNP 255 (378)
T ss_pred eehhhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhhccCchHHHHHHHhcccCccCchhhcc
Confidence 322111100 0000 1224567899999999999999999998744444443333333566655544443211
Q ss_pred ccCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHh
Q 004521 666 DSCNLADVIRCIHIGLLCVQQHPEDRPCMPSVILML 701 (747)
Q Consensus 666 ~~~~~~~~~~~~~l~~~Cl~~dP~~RPt~~~v~~~L 701 (747)
- . .+++++-.+-+..+|++|=...++.++.
T Consensus 256 f--s----~~a~r~Fkk~lt~~~~drcki~~~kk~r 285 (378)
T KOG1345|consen 256 F--S----EKALRLFKKSLTPRFKDRCKIWTAKKMR 285 (378)
T ss_pred c--C----HHHHHHHHHhcCCcccccchhHHHHHHH
Confidence 1 1 2233444478899999996666665554
|
|
| >KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=6.1e-25 Score=217.85 Aligned_cols=193 Identities=23% Similarity=0.364 Sum_probs=161.3
Q ss_pred hcCCCccceecccCCeeEEEEEecC-CcEEEEEEecc---cccccHHHHHHHHHHHhcc-CCCceeeEEeEEEeCCeeEE
Q 004521 439 TDNFSINNKLGEGGFGPVYKGTLVD-GQEIAVKRLSK---ISEQGLKELKNEVILFSKL-QHRNLVKLLGCCIQGEEKLL 513 (747)
Q Consensus 439 ~~~~~~~~~lg~G~fg~Vy~~~~~~-g~~vavK~l~~---~~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~l 513 (747)
.++|.+.+.||+|+|..|..++++. .+.+|+|++++ ...+...-.+.|-.+..+. +||.+|-+..++......++
T Consensus 249 l~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqtesrlff 328 (593)
T KOG0695|consen 249 LQDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQTESRLFF 328 (593)
T ss_pred cccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcccceEEE
Confidence 4678889999999999999999865 77899999986 2344556677888888776 79999999999999999999
Q ss_pred EEecCCCCChhhHhhhcCCCCcCChhHHHHHHHHHHHHHHHhhhcCCCceEecccCcCcEEEcCCCCceEecccCccccC
Q 004521 514 IYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFG 593 (747)
Q Consensus 514 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NIll~~~~~~kl~DFGla~~~~ 593 (747)
|.||+++|+|.-++.. ...++++.+.-+...|.-||.|||+.| ||.||||..|||||.+|++||+|+|+++.--
T Consensus 329 vieyv~ggdlmfhmqr---qrklpeeharfys~ei~lal~flh~rg---iiyrdlkldnvlldaeghikltdygmcke~l 402 (593)
T KOG0695|consen 329 VIEYVNGGDLMFHMQR---QRKLPEEHARFYSAEICLALNFLHERG---IIYRDLKLDNVLLDAEGHIKLTDYGMCKEGL 402 (593)
T ss_pred EEEEecCcceeeehhh---hhcCcHHHhhhhhHHHHHHHHHHhhcC---eeeeeccccceEEccCCceeecccchhhcCC
Confidence 9999999999876643 334888888888899999999999999 9999999999999999999999999998643
Q ss_pred CCCCccccceeeecc---------CCCCCccccchhHHHHHHHHHhCCCCCCCCC
Q 004521 594 GDETEGNTNRVVGTY---------DGQFSIKSDVFSFGILLLEIVSGKKNRGFYR 639 (747)
Q Consensus 594 ~~~~~~~~~~~~~~~---------~~~~s~ksDVwS~Gvvl~elltg~~p~~~~~ 639 (747)
.+.. .+..+.|+. +..|...+|.|++||+++||+.|+.||....
T Consensus 403 ~~gd--~tstfcgtpnyiapeilrgeeygfsvdwwalgvlmfemmagrspfdivg 455 (593)
T KOG0695|consen 403 GPGD--TTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIVG 455 (593)
T ss_pred CCCc--ccccccCCCcccchhhhcccccCceehHHHHHHHHHHHHcCCCCcceec
Confidence 2221 122234432 5789999999999999999999999997543
|
|
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.91 E-value=6.7e-24 Score=214.42 Aligned_cols=190 Identities=31% Similarity=0.444 Sum_probs=158.4
Q ss_pred CCccceecccCCeeEEEEEecC-CcEEEEEEecccccc-cHHHHHHHHHHHhccCCCceeeEEeEEEeCCeeEEEEecCC
Q 004521 442 FSINNKLGEGGFGPVYKGTLVD-GQEIAVKRLSKISEQ-GLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMP 519 (747)
Q Consensus 442 ~~~~~~lg~G~fg~Vy~~~~~~-g~~vavK~l~~~~~~-~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~ 519 (747)
|.+.+.||+|++|.||++...+ ++.+|+|.+...... ..+.+.+|++.+++++|+|++++++++......++++||++
T Consensus 1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 80 (225)
T smart00221 1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTEKQREEFLREIRILKKLKHPNIVKLYGVFEDPEPLYLVMEYCE 80 (225)
T ss_pred CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccchHHHHHHHHHHHHHHhCCCCChhhheeeeecCCceEEEEeccC
Confidence 4567899999999999999876 889999999864443 57789999999999999999999999999999999999999
Q ss_pred CCChhhHhhhcCCCCcCChhHHHHHHHHHHHHHHHhhhcCCCceEecccCcCcEEEcCCCCceEecccCccccCCCC---
Q 004521 520 NKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDE--- 596 (747)
Q Consensus 520 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~--- 596 (747)
+++|.+++..... .+++..+..++.+++.++.|||+.+ ++|+||+|+||+++.++.++|+|||++..+....
T Consensus 81 ~~~L~~~~~~~~~--~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~~~~~ 155 (225)
T smart00221 81 GGDLFDYLRKKGG--KLSEEEARFYLRQILEALEYLHSLG---IVHRDLKPENILLGMDGLVKLADFGLARFIHRDLAAL 155 (225)
T ss_pred CCCHHHHHHhccc--CCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeeCceeeEecCccccc
Confidence 9999999865322 1788999999999999999999987 9999999999999999999999999988775442
Q ss_pred -C-ccccc-eeeec---cCCCCCccccchhHHHHHHHHHhCCCCCC
Q 004521 597 -T-EGNTN-RVVGT---YDGQFSIKSDVFSFGILLLEIVSGKKNRG 636 (747)
Q Consensus 597 -~-~~~~~-~~~~~---~~~~~s~ksDVwS~Gvvl~elltg~~p~~ 636 (747)
. ..... ..... -...++.++|||+||++++||++|+.||.
T Consensus 156 ~~~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~ 201 (225)
T smart00221 156 LKTVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFS 201 (225)
T ss_pred ccceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCcc
Confidence 0 00000 00000 13556779999999999999999999963
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.90 E-value=3.2e-23 Score=215.87 Aligned_cols=132 Identities=27% Similarity=0.386 Sum_probs=111.2
Q ss_pred cCCCccceecccCCeeEEEEEecC-CcEEEEEEecccccccHHHHHHHHHHHhccC-----C---CceeeEEeEEEe---
Q 004521 440 DNFSINNKLGEGGFGPVYKGTLVD-GQEIAVKRLSKISEQGLKELKNEVILFSKLQ-----H---RNLVKLLGCCIQ--- 507 (747)
Q Consensus 440 ~~~~~~~~lg~G~fg~Vy~~~~~~-g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~-----H---~niv~l~g~~~~--- 507 (747)
.+|.+.++||-|.|++||++.+.. .+.||+|+.+. .....+.-+.|+++|++++ | .+||+|++.|..
T Consensus 78 gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKS-AqhYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~FkhsGp 156 (590)
T KOG1290|consen 78 GRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKS-AQHYTEAALDEIKLLQQVREGDPNDPGKKCVVQLLDHFKHSGP 156 (590)
T ss_pred ceEEEEEeccccccceeEEEeeccCCeEEEEEEEeh-hhHHHHHHHHHHHHHHHHHhcCCCCCCCceeeeeeccceecCC
Confidence 578899999999999999998754 67899999875 3444556788999999884 3 369999999976
Q ss_pred -CCeeEEEEecCCCCChhhHhhhcCCCCcCChhHHHHHHHHHHHHHHHhhhcCCCceEecccCcCcEEEc
Q 004521 508 -GEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLD 576 (747)
Q Consensus 508 -~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NIll~ 576 (747)
+.+.++|+|++ +-+|..+|....-+ -++...+.+|++||+.||.|||..+ +|||-||||+||||.
T Consensus 157 NG~HVCMVfEvL-GdnLLklI~~s~Yr-Glpl~~VK~I~~qvL~GLdYLH~ec--gIIHTDlKPENvLl~ 222 (590)
T KOG1290|consen 157 NGQHVCMVFEVL-GDNLLKLIKYSNYR-GLPLSCVKEICRQVLTGLDYLHREC--GIIHTDLKPENVLLC 222 (590)
T ss_pred CCcEEEEEehhh-hhHHHHHHHHhCCC-CCcHHHHHHHHHHHHHHHHHHHHhc--CccccCCCcceeeee
Confidence 45789999999 67888888654433 4889999999999999999999987 699999999999994
|
|
| >KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.90 E-value=3e-24 Score=227.04 Aligned_cols=186 Identities=26% Similarity=0.381 Sum_probs=151.9
Q ss_pred cCCCccceecccCCeeEEEEEecC-CcEEEEEEecccc--------cccHHHHHHHHHHHhccC---CCceeeEEeEEEe
Q 004521 440 DNFSINNKLGEGGFGPVYKGTLVD-GQEIAVKRLSKIS--------EQGLKELKNEVILFSKLQ---HRNLVKLLGCCIQ 507 (747)
Q Consensus 440 ~~~~~~~~lg~G~fg~Vy~~~~~~-g~~vavK~l~~~~--------~~~~~~~~~E~~~l~~l~---H~niv~l~g~~~~ 507 (747)
.+|...+.+|+|+||.|+.|.++. ..+|+||.+.+.. ....-..-.|++||..++ |+||+|++++|++
T Consensus 561 s~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfFEd 640 (772)
T KOG1152|consen 561 SDYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFFED 640 (772)
T ss_pred ccceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhheeec
Confidence 458889999999999999999876 6789999987621 112223557999999997 9999999999999
Q ss_pred CCeeEEEEecC-CCCChhhHhhhcCCCCcCChhHHHHHHHHHHHHHHHhhhcCCCceEecccCcCcEEEcCCCCceEecc
Q 004521 508 GEEKLLIYEFM-PNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDF 586 (747)
Q Consensus 508 ~~~~~lV~E~~-~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NIll~~~~~~kl~DF 586 (747)
++..||+||-. ++-+|.++|.- +..+++.++..|+.||+.|+++||+++ |||||||-+||+++.+|-+||+||
T Consensus 641 dd~yyl~te~hg~gIDLFd~IE~---kp~m~E~eAk~IFkQV~agi~hlh~~~---ivhrdikdenvivd~~g~~klidf 714 (772)
T KOG1152|consen 641 DDYYYLETEVHGEGIDLFDFIEF---KPRMDEPEAKLIFKQVVAGIKHLHDQG---IVHRDIKDENVIVDSNGFVKLIDF 714 (772)
T ss_pred CCeeEEEecCCCCCcchhhhhhc---cCccchHHHHHHHHHHHhccccccccC---ceecccccccEEEecCCeEEEeec
Confidence 99999999975 45688898843 345899999999999999999999999 999999999999999999999999
Q ss_pred cCccccCCCCCccccceeeecc----------CCCCCccccchhHHHHHHHHHhCCCCC
Q 004521 587 GLVRTFGGDETEGNTNRVVGTY----------DGQFSIKSDVFSFGILLLEIVSGKKNR 635 (747)
Q Consensus 587 Gla~~~~~~~~~~~~~~~~~~~----------~~~~s~ksDVwS~Gvvl~elltg~~p~ 635 (747)
|.|........ ..++|+. ..-....-|||++||+||-++..+.|+
T Consensus 715 gsaa~~ksgpf----d~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpy 769 (772)
T KOG1152|consen 715 GSAAYTKSGPF----DVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPY 769 (772)
T ss_pred cchhhhcCCCc----ceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCC
Confidence 98876543322 1223331 122355789999999999999988885
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.90 E-value=1.3e-24 Score=233.49 Aligned_cols=244 Identities=21% Similarity=0.327 Sum_probs=186.8
Q ss_pred HhcCCCccceecccCCeeEEEEEecC-CcEEEEEEecccccccHHHHHHHHHHHhccCCCceeeEEeEEEeCCeeEEEEe
Q 004521 438 ATDNFSINNKLGEGGFGPVYKGTLVD-GQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYE 516 (747)
Q Consensus 438 ~~~~~~~~~~lg~G~fg~Vy~~~~~~-g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E 516 (747)
..++|+..+.+|+|.||.|||++... ++..|||.++-...+..+-.+.|+-+++..+|||||.++|.+......++.||
T Consensus 13 P~ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep~dd~~~iqqei~~~~dc~h~nivay~gsylr~dklwicME 92 (829)
T KOG0576|consen 13 PQDDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPGDDFSGIQQEIGMLRDCRHPNIVAYFGSYLRRDKLWICME 92 (829)
T ss_pred CccchhheeeecCCcccchhhhcccccCchhhheeeeccCCccccccccceeeeecCCCcChHHHHhhhhhhcCcEEEEE
Confidence 34688999999999999999999754 88999999988777888889999999999999999999999999999999999
Q ss_pred cCCCCChhhHhhhcCCCCcCChhHHHHHHHHHHHHHHHhhhcCCCceEecccCcCcEEEcCCCCceEecccCccccCCCC
Q 004521 517 FMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDE 596 (747)
Q Consensus 517 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~ 596 (747)
|+.+|+|++.-+. -.++++.++..+++..++||+|||+.+ -+|||||=.|||+++.+.+|++|||.+-.+....
T Consensus 93 ycgggslQdiy~~---TgplselqiayvcRetl~gl~ylhs~g---k~hRdiKGanilltd~gDvklaDfgvsaqitati 166 (829)
T KOG0576|consen 93 YCGGGSLQDIYHV---TGPLSELQIAYVCRETLQGLKYLHSQG---KIHRDIKGANILLTDEGDVKLADFGVSAQITATI 166 (829)
T ss_pred ecCCCcccceeee---cccchhHHHHHHHhhhhccchhhhcCC---cccccccccceeecccCceeecccCchhhhhhhh
Confidence 9999999988643 346889999999999999999999998 7999999999999999999999999876543211
Q ss_pred Cccccceeeec------------cCCCCCccccchhHHHHHHHHHhCCCCCCCCCCcchhhhhHhHHhcCCc-ccccchh
Q 004521 597 TEGNTNRVVGT------------YDGQFSIKSDVFSFGILLLEIVSGKKNRGFYRSDTKVNLIGHLWDEGIP-LRLIDAC 663 (747)
Q Consensus 597 ~~~~~~~~~~~------------~~~~~s~ksDVwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~-~~~~d~~ 663 (747)
. ......|+ ..+.|..++|||+.|+..-|+---..|.-....... +...-+.+.. +.+-|+
T Consensus 167 ~--KrksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlhpmr~---l~LmTkS~~qpp~lkDk- 240 (829)
T KOG0576|consen 167 A--KRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLHPMRA---LFLMTKSGFQPPTLKDK- 240 (829)
T ss_pred h--hhhcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccccchHHH---HHHhhccCCCCCcccCC-
Confidence 1 11112222 267899999999999999998766666321111111 1111122221 122121
Q ss_pred hhccCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 004521 664 IQDSCNLADVIRCIHIGLLCVQQHPEDRPCMPSVIL 699 (747)
Q Consensus 664 l~~~~~~~~~~~~~~l~~~Cl~~dP~~RPt~~~v~~ 699 (747)
-.. -.-+-+++..|+..+|++||++..+++
T Consensus 241 ~kw------s~~fh~fvK~altknpKkRptaeklL~ 270 (829)
T KOG0576|consen 241 TKW------SEFFHNFVKGALTKNPKKRPTAEKLLQ 270 (829)
T ss_pred ccc------hHHHHHHHHHHhcCCCccCCChhhhee
Confidence 111 112335666899999999999988764
|
|
| >KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.90 E-value=4.9e-24 Score=222.64 Aligned_cols=197 Identities=20% Similarity=0.240 Sum_probs=161.0
Q ss_pred HhcCCCccceecccCCeeEEEEEecC-CcEEEEEEecccccccHHHHHHHHHHHhccC------CCceeeEEeEEEeCCe
Q 004521 438 ATDNFSINNKLGEGGFGPVYKGTLVD-GQEIAVKRLSKISEQGLKELKNEVILFSKLQ------HRNLVKLLGCCIQGEE 510 (747)
Q Consensus 438 ~~~~~~~~~~lg~G~fg~Vy~~~~~~-g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~------H~niv~l~g~~~~~~~ 510 (747)
.-.+|.+....|+|-|++|.+|.... |+.||||+++. ++--.+.=+.|+++|++|+ --|+++|+-.|...++
T Consensus 430 LD~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRn-NE~M~KtGl~EleiLkKL~~AD~Edk~Hclrl~r~F~hknH 508 (752)
T KOG0670|consen 430 LDSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRN-NEVMHKTGLKELEILKKLNDADPEDKFHCLRLFRHFKHKNH 508 (752)
T ss_pred hcceeEEEeccccceeeeeeeccccCCCCeeEEEEeec-chHHhhhhhHHHHHHHHhhccCchhhhHHHHHHHHhhhcce
Confidence 34678888899999999999999754 88999999986 3333445568999999995 3589999999999999
Q ss_pred eEEEEecCCCCChhhHhhhcCCCCcCChhHHHHHHHHHHHHHHHhhhcCCCceEecccCcCcEEEcCC-CCceEecccCc
Q 004521 511 KLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQD-MNPKISDFGLV 589 (747)
Q Consensus 511 ~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NIll~~~-~~~kl~DFGla 589 (747)
+|||+|-+ ..+|.+.|..-...--|....+..++.|+.-||..|...+ |+|.||||.|||+++. ..+||||||.|
T Consensus 509 LClVFE~L-slNLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK~c~---vlHaDIKPDNiLVNE~k~iLKLCDfGSA 584 (752)
T KOG0670|consen 509 LCLVFEPL-SLNLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLKKCG---VLHADIKPDNILVNESKNILKLCDFGSA 584 (752)
T ss_pred eEEEehhh-hchHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHHhcC---eeecccCccceEeccCcceeeeccCccc
Confidence 99999988 4899999988777767888899999999999999999888 9999999999999876 45799999999
Q ss_pred cccCCCCCccc-cceeeec----cCCCCCccccchhHHHHHHHHHhCCCCCCCCC
Q 004521 590 RTFGGDETEGN-TNRVVGT----YDGQFSIKSDVFSFGILLLEIVSGKKNRGFYR 639 (747)
Q Consensus 590 ~~~~~~~~~~~-~~~~~~~----~~~~~s~ksDVwS~Gvvl~elltg~~p~~~~~ 639 (747)
......+.... -..+... .+-+|+...|+||.||+||||.||+..|+...
T Consensus 585 ~~~~eneitPYLVSRFYRaPEIiLG~~yd~~iD~WSvgctLYElYtGkIlFpG~T 639 (752)
T KOG0670|consen 585 SFASENEITPYLVSRFYRAPEIILGLPYDYPIDTWSVGCTLYELYTGKILFPGRT 639 (752)
T ss_pred cccccccccHHHHHHhccCcceeecCcccCCccceeeceeeEEeeccceecCCCC
Confidence 77655443211 1111111 25689999999999999999999998876543
|
|
| >KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.89 E-value=2.1e-23 Score=207.13 Aligned_cols=249 Identities=25% Similarity=0.283 Sum_probs=173.8
Q ss_pred cCCCccceecccCCeeEEEEEe-cCCcEEEEEEecc--cccccHHHHHHHHHHHhccCCCceeeEEeEEEeCC------e
Q 004521 440 DNFSINNKLGEGGFGPVYKGTL-VDGQEIAVKRLSK--ISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGE------E 510 (747)
Q Consensus 440 ~~~~~~~~lg~G~fg~Vy~~~~-~~g~~vavK~l~~--~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~------~ 510 (747)
.+|.-.+.+|.|.- .|-.+.+ -.++.||+|++.. ......+.-.+|..++..++|+||++++.++.-.+ +
T Consensus 17 ~Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~~e 95 (369)
T KOG0665|consen 17 KRYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEFQE 95 (369)
T ss_pred eeeeeecccCCCCc-eEEecchhhccCceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeeccCccccHHHHHh
Confidence 35555677888887 4554443 2488999999864 23445567788999999999999999999987543 5
Q ss_pred eEEEEecCCCCChhhHhhhcCCCCcCChhHHHHHHHHHHHHHHHhhhcCCCceEecccCcCcEEEcCCCCceEecccCcc
Q 004521 511 KLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVR 590 (747)
Q Consensus 511 ~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NIll~~~~~~kl~DFGla~ 590 (747)
.|+|||||. .+|...+.. .++-.....|..|++.|++|||+.+ |+||||||+||++..+...||.|||+|+
T Consensus 96 ~y~v~e~m~-~nl~~vi~~-----elDH~tis~i~yq~~~~ik~lhs~~---IihRdLkPsnivv~~~~~lKi~dfg~ar 166 (369)
T KOG0665|consen 96 VYLVMELMD-ANLCQVILM-----ELDHETISYILYQMLCGIKHLHSAG---IIHRDLKPSNIVVNSDCTLKILDFGLAR 166 (369)
T ss_pred HHHHHHhhh-hHHHHHHHH-----hcchHHHHHHHHHHHHHHHHHHhcc---eeecccCcccceecchhheeeccchhhc
Confidence 689999995 788887752 3667888899999999999999998 9999999999999999999999999998
Q ss_pred ccCCCCCccccceeeec--------cCCCCCccccchhHHHHHHHHHhCCCCCCCCCCc------------chhhhhHhH
Q 004521 591 TFGGDETEGNTNRVVGT--------YDGQFSIKSDVFSFGILLLEIVSGKKNRGFYRSD------------TKVNLIGHL 650 (747)
Q Consensus 591 ~~~~~~~~~~~~~~~~~--------~~~~~s~ksDVwS~Gvvl~elltg~~p~~~~~~~------------~~~~~~~~~ 650 (747)
.-..+. ..+.++... .+..+.+.+||||.||++.||++|+--|.....- .+..++.++
T Consensus 167 ~e~~~~--~mtpyVvtRyyrapevil~~~~ke~vdiwSvGci~gEli~~~Vlf~g~d~idQ~~ki~~~lgtpd~~F~~qL 244 (369)
T KOG0665|consen 167 TEDTDF--MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELILGTVLFPGKDHIDQWNKIIEQLGTPDPSFMKQL 244 (369)
T ss_pred ccCccc--ccCchhheeeccCchheeccCCcccchhhhhhhHHHHHhhceEEecCchHHHHHHHHHHHhcCCCHHHHHHh
Confidence 765441 111111111 1445899999999999999999999776422110 001111111
Q ss_pred ------HhcC--------Ccccccchhhhc--cCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 004521 651 ------WDEG--------IPLRLIDACIQD--SCNLADVIRCIHIGLLCVQQHPEDRPCMPSVILM 700 (747)
Q Consensus 651 ------~~~~--------~~~~~~d~~l~~--~~~~~~~~~~~~l~~~Cl~~dP~~RPt~~~v~~~ 700 (747)
.-+. ....+.|...+. +.+..+...+-.++.++|-.||++|.+..++++.
T Consensus 245 ~~~~r~yv~~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~pe~Risv~daL~H 310 (369)
T KOG0665|consen 245 QPTVRNYVENRPQYQAISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLVIDPEKRISVDDALRH 310 (369)
T ss_pred hHHHHHHhhcChHhhccchhhhCCcccccccccCCccchHHHHHHHHHhhccChhhcccHHHHhcC
Confidence 0000 001112221111 1112233344568889999999999999999874
|
|
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.87 E-value=1.1e-22 Score=243.63 Aligned_cols=187 Identities=18% Similarity=0.239 Sum_probs=126.3
Q ss_pred ccCC-CceeeEEeEE-------EeCCeeEEEEecCCCCChhhHhhhcCCCCcCChhHHHHHHHHHHHHHHHhhhcCCCce
Q 004521 492 KLQH-RNLVKLLGCC-------IQGEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRI 563 (747)
Q Consensus 492 ~l~H-~niv~l~g~~-------~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~i 563 (747)
.++| .||.+++++| .+.+..++++||+ .++|.++|... ...+++.+++.++.||++||.|||+++ |
T Consensus 28 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~al~~lH~~g---I 101 (793)
T PLN00181 28 SLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDNP--DRSVDAFECFHVFRQIVEIVNAAHSQG---I 101 (793)
T ss_pred hhhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhcc--cccccHHHHHHHHHHHHHHHHHHHhCC---e
Confidence 4556 6888888887 3334567888987 56999999642 345899999999999999999999988 9
Q ss_pred EecccCcCcEEEcC-------------------CCCceEecccCccccCCCCC---------cc------------ccce
Q 004521 564 IHRDLKASNVLLDQ-------------------DMNPKISDFGLVRTFGGDET---------EG------------NTNR 603 (747)
Q Consensus 564 iHrDlkp~NIll~~-------------------~~~~kl~DFGla~~~~~~~~---------~~------------~~~~ 603 (747)
+||||||+||||+. ++.+||+|||+++....... .. ...+
T Consensus 102 vHrDlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y 181 (793)
T PLN00181 102 VVHNVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWY 181 (793)
T ss_pred eeccCCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcce
Confidence 99999999999954 45667777777764321000 00 0001
Q ss_pred eeec--cCCCCCccccchhHHHHHHHHHhCCCCCCCCCCcchhhhhHhHHhcCCcccccchhhhccCCHHHHHHHHHHHH
Q 004521 604 VVGT--YDGQFSIKSDVFSFGILLLEIVSGKKNRGFYRSDTKVNLIGHLWDEGIPLRLIDACIQDSCNLADVIRCIHIGL 681 (747)
Q Consensus 604 ~~~~--~~~~~s~ksDVwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~ 681 (747)
..+. ....++.++|||||||+||||++|..|+... ...+... .... ..+.. .....+...++.
T Consensus 182 ~APE~~~~~~~~~~sDVwSlGviL~ELl~~~~~~~~~-----~~~~~~~-~~~~----~~~~~-----~~~~~~~~~~~~ 246 (793)
T PLN00181 182 TSPEEDNGSSSNCASDVYRLGVLLFELFCPVSSREEK-----SRTMSSL-RHRV----LPPQI-----LLNWPKEASFCL 246 (793)
T ss_pred EChhhhccCCCCchhhhhhHHHHHHHHhhCCCchhhH-----HHHHHHH-HHhh----cChhh-----hhcCHHHHHHHH
Confidence 1111 1466899999999999999999988774311 1111111 1111 11110 111233456778
Q ss_pred hccCCCCCCCCCHHHHHH
Q 004521 682 LCVQQHPEDRPCMPSVIL 699 (747)
Q Consensus 682 ~Cl~~dP~~RPt~~~v~~ 699 (747)
+||+.+|.+||+|.||++
T Consensus 247 ~~L~~~P~~Rps~~eil~ 264 (793)
T PLN00181 247 WLLHPEPSCRPSMSELLQ 264 (793)
T ss_pred HhCCCChhhCcChHHHhh
Confidence 999999999999999976
|
|
| >KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=99.85 E-value=8.9e-22 Score=202.93 Aligned_cols=192 Identities=24% Similarity=0.425 Sum_probs=153.0
Q ss_pred HHHhcCCCccceecccCCeeEEEEEecC----CcEEEEEEecccccccHHHHHHHHHHHhcc-CCCceeeEEeEEEeCCe
Q 004521 436 ANATDNFSINNKLGEGGFGPVYKGTLVD----GQEIAVKRLSKISEQGLKELKNEVILFSKL-QHRNLVKLLGCCIQGEE 510 (747)
Q Consensus 436 ~~~~~~~~~~~~lg~G~fg~Vy~~~~~~----g~~vavK~l~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~ 510 (747)
....+.|...++||+|.|++||++++.. .+.||+|.+...+ ....+.+|+++|..+ -|.||+++.+++...+.
T Consensus 32 p~~~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts--~p~ri~~El~~L~~~gG~~ni~~~~~~~rnnd~ 109 (418)
T KOG1167|consen 32 PFISNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTS--SPSRILNELEMLYRLGGSDNIIKLNGCFRNNDQ 109 (418)
T ss_pred hhhhhhhhhhccccccchhhhhhhhHhhhccccceEeeeeccccc--CchHHHHHHHHHHHhccchhhhcchhhhccCCe
Confidence 3445678889999999999999998643 5789999997533 335688999999999 59999999999999999
Q ss_pred eEEEEecCCCCChhhHhhhcCCCCcCChhHHHHHHHHHHHHHHHhhhcCCCceEecccCcCcEEEcCC-CCceEecccCc
Q 004521 511 KLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQD-MNPKISDFGLV 589 (747)
Q Consensus 511 ~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NIll~~~-~~~kl~DFGla 589 (747)
..+|+||++.-...+++.+ ++..++...++.++.||.++|.+| ||||||||+|+|.+.. +.-.|.|||+|
T Consensus 110 v~ivlp~~~H~~f~~l~~~------l~~~~i~~Yl~~ll~Al~~~h~~G---IvHRDiKpsNFL~n~~t~rg~LvDFgLA 180 (418)
T KOG1167|consen 110 VAIVLPYFEHDRFRDLYRS------LSLAEIRWYLRNLLKALAHLHKNG---IVHRDIKPSNFLYNRRTQRGVLVDFGLA 180 (418)
T ss_pred eEEEecccCccCHHHHHhc------CCHHHHHHHHHHHHHHhhhhhccC---ccccCCCccccccccccCCceEEechhH
Confidence 9999999999999998854 678889999999999999999999 9999999999999865 56789999999
Q ss_pred cccCCCC----Ccc------cc------------------ce--------------eeecc----------CCCCCcccc
Q 004521 590 RTFGGDE----TEG------NT------------------NR--------------VVGTY----------DGQFSIKSD 617 (747)
Q Consensus 590 ~~~~~~~----~~~------~~------------------~~--------------~~~~~----------~~~~s~ksD 617 (747)
....... ... .. .. ..|+. -..-+.++|
T Consensus 181 ~~~d~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~QttaiD 260 (418)
T KOG1167|consen 181 QRYDGYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQTTAID 260 (418)
T ss_pred HHHHhhhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcCCccc
Confidence 7321110 000 00 00 00111 134577899
Q ss_pred chhHHHHHHHHHhCCCCCCCC
Q 004521 618 VFSFGILLLEIVSGKKNRGFY 638 (747)
Q Consensus 618 VwS~Gvvl~elltg~~p~~~~ 638 (747)
|||.|||++-+++++.||-..
T Consensus 261 iws~GVI~Lslls~~~PFf~a 281 (418)
T KOG1167|consen 261 IWSAGVILLSLLSRRYPFFKA 281 (418)
T ss_pred eeeccceeehhhccccccccC
Confidence 999999999999999997533
|
|
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.85 E-value=4.8e-21 Score=204.51 Aligned_cols=143 Identities=22% Similarity=0.238 Sum_probs=115.4
Q ss_pred HHHhcCCCccceecccCCeeEEEEEec--CCcEEEEEEeccc-----ccccHHHHHHHHHHHhccCCCceee-EEeEEEe
Q 004521 436 ANATDNFSINNKLGEGGFGPVYKGTLV--DGQEIAVKRLSKI-----SEQGLKELKNEVILFSKLQHRNLVK-LLGCCIQ 507 (747)
Q Consensus 436 ~~~~~~~~~~~~lg~G~fg~Vy~~~~~--~g~~vavK~l~~~-----~~~~~~~~~~E~~~l~~l~H~niv~-l~g~~~~ 507 (747)
....++|.+.+.||+|+||+||+|.+. +++.+|||++... .....+.|.+|++++++++|+|+++ +++
T Consensus 14 ~~~~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~---- 89 (365)
T PRK09188 14 PALSARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLA---- 89 (365)
T ss_pred ccccCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEE----
Confidence 344578999999999999999999875 4778899987532 1223556999999999999999985 443
Q ss_pred CCeeEEEEecCCCCChhhHhhhcCCCCcCChhHHHHHHHHHHHHHHHhhhcCCCceEeccc-CcCcEEEcCCCCceEecc
Q 004521 508 GEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDL-KASNVLLDQDMNPKISDF 586 (747)
Q Consensus 508 ~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDl-kp~NIll~~~~~~kl~DF 586 (747)
.+..+|||||+++++|.... .. . ...++.++++||.|||+.+ |+|||| ||+|||++.++.+||+||
T Consensus 90 ~~~~~LVmE~~~G~~L~~~~----~~---~---~~~~~~~i~~aL~~lH~~g---IiHrDL~KP~NILv~~~~~ikLiDF 156 (365)
T PRK09188 90 TGKDGLVRGWTEGVPLHLAR----PH---G---DPAWFRSAHRALRDLHRAG---ITHNDLAKPQNWLMGPDGEAAVIDF 156 (365)
T ss_pred cCCcEEEEEccCCCCHHHhC----cc---c---hHHHHHHHHHHHHHHHHCC---CeeCCCCCcceEEEcCCCCEEEEEC
Confidence 24579999999999996321 11 1 1467889999999999988 999999 999999999999999999
Q ss_pred cCccccCCC
Q 004521 587 GLVRTFGGD 595 (747)
Q Consensus 587 Gla~~~~~~ 595 (747)
|+|+.+...
T Consensus 157 GlA~~~~~~ 165 (365)
T PRK09188 157 QLASVFRRR 165 (365)
T ss_pred ccceecccC
Confidence 999976543
|
|
| >KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.84 E-value=1.1e-19 Score=194.63 Aligned_cols=250 Identities=22% Similarity=0.252 Sum_probs=179.3
Q ss_pred CCCccceecccCCeeEEEEEecCC--cEEEEEEecccccccHHHHHHHHHHHhccCC----CceeeEEeEE-EeCCeeEE
Q 004521 441 NFSINNKLGEGGFGPVYKGTLVDG--QEIAVKRLSKISEQGLKELKNEVILFSKLQH----RNLVKLLGCC-IQGEEKLL 513 (747)
Q Consensus 441 ~~~~~~~lg~G~fg~Vy~~~~~~g--~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H----~niv~l~g~~-~~~~~~~l 513 (747)
+|.+.++||+|+||.||++..... ..+|+|............+..|+.++..+.+ +++.++++.. ......++
T Consensus 19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~~~i 98 (322)
T KOG1164|consen 19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKPSVLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDFNFI 98 (322)
T ss_pred ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCCccchhHHHHHHHHhhhcCCCCCCEEEEeccCCCceeEE
Confidence 799999999999999999997653 4788888765433333378889999998873 6888999888 47778899
Q ss_pred EEecCCCCChhhHhhhcCCCCcCChhHHHHHHHHHHHHHHHhhhcCCCceEecccCcCcEEEcCC-----CCceEecccC
Q 004521 514 IYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQD-----MNPKISDFGL 588 (747)
Q Consensus 514 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NIll~~~-----~~~kl~DFGl 588 (747)
||+.+ +.+|.++..... ...++..+.++|+.|++.+|++||+.| ++||||||.|+++... ..+.|.|||+
T Consensus 99 VM~l~-G~sL~dl~~~~~-~~~fs~~T~l~ia~q~l~~l~~lH~~G---~iHRDiKp~N~~~g~~~~~~~~~~~llDfGl 173 (322)
T KOG1164|consen 99 VMSLL-GPSLEDLRKRNP-PGRFSRKTVLRIAIQNLNALEDLHSKG---FIHRDIKPENFVVGQSSRSEVRTLYLLDFGL 173 (322)
T ss_pred EEecc-CccHHHHHHhCC-CCCcCHhHHHHHHHHHHHHHHHHHhcC---cccCCcCHHHeeecCCCCcccceEEEEecCC
Confidence 99987 789999875544 456899999999999999999999998 9999999999999765 4689999999
Q ss_pred cc--ccCCCCCc----cc--cceeeecc---------CCCCCccccchhHHHHHHHHHhCCCCCCCCCCcchhhhhHhHH
Q 004521 589 VR--TFGGDETE----GN--TNRVVGTY---------DGQFSIKSDVFSFGILLLEIVSGKKNRGFYRSDTKVNLIGHLW 651 (747)
Q Consensus 589 a~--~~~~~~~~----~~--~~~~~~~~---------~~~~s~ksDVwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~ 651 (747)
++ .+...... .. .....|+. +...+.+.|+||++.++.|++.|..|+................
T Consensus 174 ar~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDles~~Y~l~el~~g~LPW~~~~~~~~~~~~~~~~ 253 (322)
T KOG1164|consen 174 ARRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRRDDLESLFYMLLELLKGSLPWEALEMTDLKSKFEKDP 253 (322)
T ss_pred CccccccCCCCcccccCCCCccCCCCccccccHHHhCCCccCCchhhhhHHHHHHHHhcCCCCCccccccchHHHHHHHh
Confidence 99 43322221 10 11122432 5667889999999999999999999975433322222221111
Q ss_pred hcCCcccccchhhhccCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhcCC
Q 004521 652 DEGIPLRLIDACIQDSCNLADVIRCIHIGLLCVQQHPEDRPCMPSVILMLGSE 704 (747)
Q Consensus 652 ~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dP~~RPt~~~v~~~L~~~ 704 (747)
....... .......++.. +...+-..+..++|....+...|...
T Consensus 254 ~~~~~~~------~~~~~~~~~~~---~~~~~~~~~~~~~Pdy~~~~~~l~~~ 297 (322)
T KOG1164|consen 254 RKLLTDR------FGDLKPEEFAK---ILEYIDSLDYEDKPDYEKLAELLKDV 297 (322)
T ss_pred hhhcccc------ccCCChHHHHH---HHHHhhccCCcCCCCHHHHHHHHHHH
Confidence 1111110 11122233333 33344458999999999999887654
|
|
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.83 E-value=1.6e-20 Score=184.40 Aligned_cols=140 Identities=18% Similarity=0.176 Sum_probs=108.5
Q ss_pred cceecccCCeeEEEEEecCCcEEEEEEeccccc--cc-------HHH-----------------HHHHHHHHhccCCCce
Q 004521 445 NNKLGEGGFGPVYKGTLVDGQEIAVKRLSKISE--QG-------LKE-----------------LKNEVILFSKLQHRNL 498 (747)
Q Consensus 445 ~~~lg~G~fg~Vy~~~~~~g~~vavK~l~~~~~--~~-------~~~-----------------~~~E~~~l~~l~H~ni 498 (747)
...||+|+||.||+|...+|+.||||+++.... .. ... ...|+.++.++.|+++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~v 81 (190)
T cd05147 2 NGCISTGKEANVYHATTANGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAGI 81 (190)
T ss_pred CCccccccceEEEEEECCCCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCCC
Confidence 468999999999999988899999999975311 01 112 2349999999988776
Q ss_pred eeEEeEEEeCCeeEEEEecCCCCChhhHhhhcCCCCcCChhHHHHHHHHHHHHHHHh-hhcCCCceEecccCcCcEEEcC
Q 004521 499 VKLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYL-HQDSRLRIIHRDLKASNVLLDQ 577 (747)
Q Consensus 499 v~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yL-H~~~~~~iiHrDlkp~NIll~~ 577 (747)
.....+.. ...+|||||+++++|...+.. ...++..+...++.|++.+|.|| |+.+ |+||||||+|||++
T Consensus 82 ~~p~~~~~--~~~~iVmE~i~g~~l~~~~~~---~~~~~~~~~~~i~~qi~~~L~~l~H~~g---iiHrDlkP~NIli~- 152 (190)
T cd05147 82 PCPEPILL--KSHVLVMEFIGDDGWAAPRLK---DAPLSESKARELYLQVIQIMRILYQDCR---LVHADLSEYNLLYH- 152 (190)
T ss_pred CCCcEEEe--cCCEEEEEEeCCCCCcchhhh---cCCCCHHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEE-
Confidence 43332222 234899999998877655322 23578899999999999999999 6777 99999999999998
Q ss_pred CCCceEecccCccccC
Q 004521 578 DMNPKISDFGLVRTFG 593 (747)
Q Consensus 578 ~~~~kl~DFGla~~~~ 593 (747)
++.++|+|||+|....
T Consensus 153 ~~~v~LiDFG~a~~~~ 168 (190)
T cd05147 153 DGKLYIIDVSQSVEHD 168 (190)
T ss_pred CCcEEEEEccccccCC
Confidence 4789999999997643
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.83 E-value=2.9e-21 Score=187.11 Aligned_cols=247 Identities=21% Similarity=0.333 Sum_probs=178.5
Q ss_pred CCccceecccCCeeEEEEEecCCcEEEEEEecc--cccccHHHHHHHHHHHhccCCCceeeEEeEEEeCCeeEEEEecCC
Q 004521 442 FSINNKLGEGGFGPVYKGTLVDGQEIAVKRLSK--ISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMP 519 (747)
Q Consensus 442 ~~~~~~lg~G~fg~Vy~~~~~~g~~vavK~l~~--~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~ 519 (747)
..+..+|.+...|..|+|++. |..+++|++.. ......+.|..|.-.++-+.||||+.++|.|....+..++..||+
T Consensus 192 lnl~tkl~e~hsgelwrgrwq-gndivakil~vr~~t~risrdfneefp~lrifshpnilpvlgacnsppnlv~isq~mp 270 (448)
T KOG0195|consen 192 LNLITKLAESHSGELWRGRWQ-GNDIVAKILNVREVTARISRDFNEEFPALRIFSHPNILPVLGACNSPPNLVIISQYMP 270 (448)
T ss_pred hhhhhhhccCCCccccccccc-CcchhhhhhhhhhcchhhcchhhhhCcceeeecCCchhhhhhhccCCCCceEeeeecc
Confidence 344678999999999999995 44566677653 344556789999999999999999999999999999999999999
Q ss_pred CCChhhHhhhcCCCCcCChhHHHHHHHHHHHHHHHhhhcCCCceEecccCcCcEEEcCCCCceEe--cccCccccCCCCC
Q 004521 520 NKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKIS--DFGLVRTFGGDET 597 (747)
Q Consensus 520 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NIll~~~~~~kl~--DFGla~~~~~~~~ 597 (747)
.|+|+..|++.. .-.++..++.+++.+||+||+|||+..+. |.---|.+..++||++.+++|+ |--++-.-.+..+
T Consensus 271 ~gslynvlhe~t-~vvvd~sqav~faldiargmaflhslep~-ipr~~lns~hvmidedltarismad~kfsfqe~gr~y 348 (448)
T KOG0195|consen 271 FGSLYNVLHEQT-SVVVDHSQAVRFALDIARGMAFLHSLEPM-IPRFYLNSKHVMIDEDLTARISMADTKFSFQEVGRAY 348 (448)
T ss_pred chHHHHHHhcCc-cEEEecchHHHHHHHHHhhHHHHhhcchh-hhhhhcccceEEecchhhhheecccceeeeecccccc
Confidence 999999997744 34678899999999999999999997631 3344699999999999998875 3222221111111
Q ss_pred ccc---cceeeeccCCCCCccccchhHHHHHHHHHhCCCCCCCCCCcchhhhhHhHHhcCCcccccchhhhccCCHHHHH
Q 004521 598 EGN---TNRVVGTYDGQFSIKSDVFSFGILLLEIVSGKKNRGFYRSDTKVNLIGHLWDEGIPLRLIDACIQDSCNLADVI 674 (747)
Q Consensus 598 ~~~---~~~~~~~~~~~~s~ksDVwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~ 674 (747)
... ++.........--.++|+|||.|+||||.|.+.||...++.+-- .++.-++....+.... ..
T Consensus 349 ~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspmecg---mkialeglrv~ippgi---------s~ 416 (448)
T KOG0195|consen 349 SPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPMECG---MKIALEGLRVHIPPGI---------SR 416 (448)
T ss_pred CcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchhhh---hhhhhccccccCCCCc---------cH
Confidence 110 00011111223345799999999999999999998765544322 1222344433332221 12
Q ss_pred HHHHHHHhccCCCCCCCCCHHHHHHHhcC
Q 004521 675 RCIHIGLLCVQQHPEDRPCMPSVILMLGS 703 (747)
Q Consensus 675 ~~~~l~~~Cl~~dP~~RPt~~~v~~~L~~ 703 (747)
.+.+++.-|...||.+||.+..|+-.||.
T Consensus 417 hm~klm~icmnedpgkrpkfdmivpilek 445 (448)
T KOG0195|consen 417 HMNKLMNICMNEDPGKRPKFDMIVPILEK 445 (448)
T ss_pred HHHHHHHHHhcCCCCcCCCcceehhhHHH
Confidence 36677778999999999999999999875
|
|
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.83 E-value=1e-20 Score=187.90 Aligned_cols=171 Identities=13% Similarity=0.163 Sum_probs=132.3
Q ss_pred HhcCCCccceecccCCeeEEEEEecCCcEEEEEEecccccccH---HH------HHHHHHHHhccCCCceeeEEeEEEeC
Q 004521 438 ATDNFSINNKLGEGGFGPVYKGTLVDGQEIAVKRLSKISEQGL---KE------LKNEVILFSKLQHRNLVKLLGCCIQG 508 (747)
Q Consensus 438 ~~~~~~~~~~lg~G~fg~Vy~~~~~~g~~vavK~l~~~~~~~~---~~------~~~E~~~l~~l~H~niv~l~g~~~~~ 508 (747)
..++|...++||.|+||.||+... ++..+|||.++....... .. +.+|+..+.+++|++|..+..++...
T Consensus 29 l~~~y~~~~~l~~~~f~~v~l~~~-~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~~~ 107 (232)
T PRK10359 29 LSYNIKTIKVFRNIDDTKVSLIDT-DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYLLA 107 (232)
T ss_pred hhCceEEEEEecCCCceEEEEEec-CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeeeec
Confidence 357899999999999999999765 577899999975322222 22 68999999999999999999886643
Q ss_pred --------CeeEEEEecCCCCChhhHhhhcCCCCcCChhHHHHHHHHHHHHHHHhhhcCCCceEecccCcCcEEEcCCCC
Q 004521 509 --------EEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMN 580 (747)
Q Consensus 509 --------~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NIll~~~~~ 580 (747)
...+|||||+++.+|.++.. ++. ....+++.+|..+|+.+ ++||||||+||+++.++
T Consensus 108 ~~~~~~~~~~~~lvmEyi~G~tL~~~~~-------~~~----~~~~~i~~~l~~lH~~g---i~H~Dikp~Nili~~~g- 172 (232)
T PRK10359 108 ERKTLRYAHTYIMLIEYIEGVELNDMPE-------ISE----DVKAKIKASIESLHQHG---MVSGDPHKGNFIVSKNG- 172 (232)
T ss_pred ccccccccCCeEEEEEEECCccHHHhhh-------ccH----HHHHHHHHHHHHHHHcC---CccCCCChHHEEEeCCC-
Confidence 35789999999999987741 222 24568999999999998 99999999999999988
Q ss_pred ceEecccCccccCCCCCccccceeeeccCCCCCccccchhHHHHHHHHH
Q 004521 581 PKISDFGLVRTFGGDETEGNTNRVVGTYDGQFSIKSDVFSFGILLLEIV 629 (747)
Q Consensus 581 ~kl~DFGla~~~~~~~~~~~~~~~~~~~~~~~s~ksDVwS~Gvvl~ell 629 (747)
++|+|||..+....+..... -.....|..++|+||||+++.-..
T Consensus 173 i~liDfg~~~~~~e~~a~d~-----~vler~y~~~~di~~lg~~~~~~~ 216 (232)
T PRK10359 173 LRIIDLSGKRCTAQRKAKDR-----IDLERHYGIKNEIKDLGYYLLIYK 216 (232)
T ss_pred EEEEECCCcccccchhhHHH-----HHHHhHhcccccccceeEeehHHH
Confidence 99999998876532222111 111334667999999999887653
|
|
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=99.83 E-value=4.2e-20 Score=179.88 Aligned_cols=163 Identities=20% Similarity=0.207 Sum_probs=112.4
Q ss_pred CChhhHhhhcCCCCcCChhHHHHHHHHHHHHHHHhhhcCCCceEecccCcCcEEEcCCCCceEecccCccccCCCCCccc
Q 004521 521 KSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGN 600 (747)
Q Consensus 521 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~ 600 (747)
|+|.+++... ...+++.+++.++.||++||.|||+.+ ||+|||++.++.+|+ ||+++..........
T Consensus 1 GsL~~~l~~~--~~~l~~~~~~~i~~qi~~~L~~lH~~~---------kp~Nil~~~~~~~~~--fG~~~~~~~~~~~g~ 67 (176)
T smart00750 1 VSLADILEVR--GRPLNEEEIWAVCLQCLRALRELHRQA---------KSGNILLTWDGLLKL--DGSVAFKTPEQSRVD 67 (176)
T ss_pred CcHHHHHHHh--CCCCCHHHHHHHHHHHHHHHHHHHhcC---------CcccEeEcCccceee--ccceEeeccccCCCc
Confidence 7899998643 345999999999999999999999865 999999999999999 999987654332221
Q ss_pred cceeeec--cCCCCCccccchhHHHHHHHHHhCCCCCCCCCCcchhhhhHhHHhcCCcccccchhhhccCCHHHH---HH
Q 004521 601 TNRVVGT--YDGQFSIKSDVFSFGILLLEIVSGKKNRGFYRSDTKVNLIGHLWDEGIPLRLIDACIQDSCNLADV---IR 675 (747)
Q Consensus 601 ~~~~~~~--~~~~~s~ksDVwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~---~~ 675 (747)
.....+. .+..++.++|||||||++|||++|+.|+...... ...+...... ....... ........ ..
T Consensus 68 ~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~--~~~~~~~~~~-~~~~~~~----~~~~~~~~~~~~~ 140 (176)
T smart00750 68 PYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEEREL--SAILEILLNG-MPADDPR----DRSNLESVSAARS 140 (176)
T ss_pred ccccChHHhcCCCCcchhhHHHHHHHHHHHHhCCCCccccchh--cHHHHHHHHH-hccCCcc----ccccHHHHHhhhh
Confidence 1111111 2567889999999999999999999997432211 1111111111 1111000 00111111 24
Q ss_pred HHHHHHhccCCCCCCCCCHHHHHHHhcC
Q 004521 676 CIHIGLLCVQQHPEDRPCMPSVILMLGS 703 (747)
Q Consensus 676 ~~~l~~~Cl~~dP~~RPt~~~v~~~L~~ 703 (747)
+.+++.+||+.+|.+||++.++++.+..
T Consensus 141 ~~~~i~~cl~~~p~~Rp~~~~ll~~~~~ 168 (176)
T smart00750 141 FADFMRVCASRLPQRREAANHYLAHCRA 168 (176)
T ss_pred HHHHHHHHHhcccccccCHHHHHHHHHH
Confidence 7788999999999999999999998753
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.82 E-value=1.3e-19 Score=178.71 Aligned_cols=141 Identities=19% Similarity=0.223 Sum_probs=111.3
Q ss_pred cceecccCCeeEEEEEecCCcEEEEEEecccccc---------------------c-----HHHHHHHHHHHhccCCCce
Q 004521 445 NNKLGEGGFGPVYKGTLVDGQEIAVKRLSKISEQ---------------------G-----LKELKNEVILFSKLQHRNL 498 (747)
Q Consensus 445 ~~~lg~G~fg~Vy~~~~~~g~~vavK~l~~~~~~---------------------~-----~~~~~~E~~~l~~l~H~ni 498 (747)
...||+|+||.||+|+..+|+.||||+++..... . ...+..|...+.++.|+++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i 81 (190)
T cd05145 2 NGCISTGKEANVYHARTGDGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAGV 81 (190)
T ss_pred CceeecCCCcEEEEEEcCCCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCCC
Confidence 4789999999999999878999999998753210 0 1224678999999999987
Q ss_pred eeEEeEEEeCCeeEEEEecCCCCChhhHhhhcCCCCcCChhHHHHHHHHHHHHHHHhhh-cCCCceEecccCcCcEEEcC
Q 004521 499 VKLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQ-DSRLRIIHRDLKASNVLLDQ 577 (747)
Q Consensus 499 v~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~-~~~~~iiHrDlkp~NIll~~ 577 (747)
.....+... ..+|||||++++++...... ...++......++.|++.+|.+||+ .+ |+||||||+|||++
T Consensus 82 ~~p~~~~~~--~~~lVmE~~~g~~~~~~~l~---~~~~~~~~~~~i~~~l~~~l~~lH~~~g---ivHrDlkP~NIll~- 152 (190)
T cd05145 82 PVPEPILLK--KNVLVMEFIGDDGSPAPRLK---DVPLEEEEAEELYEQVVEQMRRLYQEAG---LVHGDLSEYNILYH- 152 (190)
T ss_pred CCceEEEec--CCEEEEEEecCCCchhhhhh---hccCCHHHHHHHHHHHHHHHHHHHHhCC---EecCCCChhhEEEE-
Confidence 544443332 34899999998865443221 2346778899999999999999999 87 99999999999999
Q ss_pred CCCceEecccCccccCC
Q 004521 578 DMNPKISDFGLVRTFGG 594 (747)
Q Consensus 578 ~~~~kl~DFGla~~~~~ 594 (747)
++.++|+|||+++.+..
T Consensus 153 ~~~~~liDFG~a~~~~~ 169 (190)
T cd05145 153 DGKPYIIDVSQAVELDH 169 (190)
T ss_pred CCCEEEEEcccceecCC
Confidence 89999999999987654
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.79 E-value=7.1e-18 Score=179.54 Aligned_cols=252 Identities=27% Similarity=0.367 Sum_probs=182.5
Q ss_pred CCccceecccCCeeEEEEEecCCcEEEEEEecccccc---cHHHHHHHHHHHhccCCC-ceeeEEeEEEeCCeeEEEEec
Q 004521 442 FSINNKLGEGGFGPVYKGTLVDGQEIAVKRLSKISEQ---GLKELKNEVILFSKLQHR-NLVKLLGCCIQGEEKLLIYEF 517 (747)
Q Consensus 442 ~~~~~~lg~G~fg~Vy~~~~~~g~~vavK~l~~~~~~---~~~~~~~E~~~l~~l~H~-niv~l~g~~~~~~~~~lV~E~ 517 (747)
|.+.+.||.|+||.||++... ..+++|.+...... ....+.+|+.+++.+.|+ +|+++.+.+......++++|+
T Consensus 2 ~~~~~~l~~g~~~~v~~~~~~--~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 79 (384)
T COG0515 2 YRILRKLGEGSFGEVYLARDR--KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVMEY 79 (384)
T ss_pred ceeEEeecCCCCeEEEEEEec--cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEEEec
Confidence 566789999999999999986 88999998763322 467899999999999988 799999999777778999999
Q ss_pred CCCCChhhHhhhcCCCCcCChhHHHHHHHHHHHHHHHhhhcCCCceEecccCcCcEEEcCCC-CceEecccCccccCCCC
Q 004521 518 MPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDM-NPKISDFGLVRTFGGDE 596 (747)
Q Consensus 518 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NIll~~~~-~~kl~DFGla~~~~~~~ 596 (747)
+.+++|.+++........+.......++.|++.++.|+|+.+ ++||||||+||+++... .++++|||+++.+....
T Consensus 80 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H~~~---~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~~~~ 156 (384)
T COG0515 80 VDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSKG---IIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPG 156 (384)
T ss_pred CCCCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeeecCCCCeEEEeccCcceecCCCC
Confidence 999999977644221125888999999999999999999998 99999999999999998 79999999998655433
Q ss_pred Cccc----cceeeecc---------C---CCCCccccchhHHHHHHHHHhCCCCCCCCCCc-chhhhhHhHHhcCCcccc
Q 004521 597 TEGN----TNRVVGTY---------D---GQFSIKSDVFSFGILLLEIVSGKKNRGFYRSD-TKVNLIGHLWDEGIPLRL 659 (747)
Q Consensus 597 ~~~~----~~~~~~~~---------~---~~~s~ksDVwS~Gvvl~elltg~~p~~~~~~~-~~~~~~~~~~~~~~~~~~ 659 (747)
.... .....++. . ..++...|+||+|++++++++|..|+...... ............... .
T Consensus 157 ~~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~--~ 234 (384)
T COG0515 157 STSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPTP--S 234 (384)
T ss_pred ccccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccccHHHHHHHHHhcCCc--c
Confidence 2211 11122211 2 47888999999999999999999995443321 111222222222211 0
Q ss_pred cchhhhccCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 004521 660 IDACIQDSCNLADVIRCIHIGLLCVQQHPEDRPCMPSVILM 700 (747)
Q Consensus 660 ~d~~l~~~~~~~~~~~~~~l~~~Cl~~dP~~RPt~~~v~~~ 700 (747)
................+.++...|+..+|..|.++.+....
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~ 275 (384)
T COG0515 235 LASPLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSH 275 (384)
T ss_pred cccccCccccchhhHHHHHHHHHHHhcCchhcCCHHHHhhc
Confidence 00000000001112345567778999999999999887764
|
|
| >KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.79 E-value=5.7e-19 Score=168.84 Aligned_cols=198 Identities=23% Similarity=0.344 Sum_probs=155.2
Q ss_pred hcCCCccceecccCCeeEEEEEe-cCCcEEEEEEecccccccHHHHHHHHHHHhccCC-CceeeEEeEEEeCCeeEEEEe
Q 004521 439 TDNFSINNKLGEGGFGPVYKGTL-VDGQEIAVKRLSKISEQGLKELKNEVILFSKLQH-RNLVKLLGCCIQGEEKLLIYE 516 (747)
Q Consensus 439 ~~~~~~~~~lg~G~fg~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H-~niv~l~g~~~~~~~~~lV~E 516 (747)
.++|.+.++||+|+||.+|.|.. .+|.+||||.-+.... .-++..|..+...|+| ..|..+.-+..++....+|||
T Consensus 14 ~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~a~--hpqL~yEskvY~iL~~g~GiP~i~~y~~e~~ynvlVMd 91 (341)
T KOG1163|consen 14 GGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSKAK--HPQLLYESKVYRILQGGVGIPHIRHYGTEKDYNVLVMD 91 (341)
T ss_pred ccceEEEEeecCCchhheeeeeeccCCceEEEEeecccCC--CcchhHHHHHHHHhccCCCCchhhhhccccccceeeee
Confidence 46899999999999999999985 5699999998765322 2467789999999975 667778888888889999999
Q ss_pred cCCCCChhhHhhhcCCCCcCChhHHHHHHHHHHHHHHHhhhcCCCceEecccCcCcEEEcCC---CCceEecccCccccC
Q 004521 517 FMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQD---MNPKISDFGLVRTFG 593 (747)
Q Consensus 517 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NIll~~~---~~~kl~DFGla~~~~ 593 (747)
.+ +-+|+++..-..++ ++..+.+-++.|++.-++|+|.++ +|||||||+|.|..-+ ..+.|+|||+|+.+.
T Consensus 92 LL-GPsLEdLfnfC~R~--ftmkTvLMLaDQml~RiEyvH~r~---fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaKky~ 165 (341)
T KOG1163|consen 92 LL-GPSLEDLFNFCSRR--FTMKTVLMLADQMLSRIEYVHLRN---FIHRDIKPDNFLMGLGRHCNKLYLIDFGLAKKYR 165 (341)
T ss_pred cc-CccHHHHHHHHhhh--hhHHhHHHHHHHHHHHHHHHHhhc---cccccCCccceeeccccccceEEEEeccchhhhc
Confidence 98 68898887544433 788899999999999999999998 9999999999998643 457899999999875
Q ss_pred CCCCccccc-----eeeecc---------CCCCCccccchhHHHHHHHHHhCCCCCCCCCCcchh
Q 004521 594 GDETEGNTN-----RVVGTY---------DGQFSIKSDVFSFGILLLEIVSGKKNRGFYRSDTKV 644 (747)
Q Consensus 594 ~~~~~~~~~-----~~~~~~---------~~~~s~ksDVwS~Gvvl~elltg~~p~~~~~~~~~~ 644 (747)
...+..... ...||. +..-+..-|+=|+|.+|....-|..||.........
T Consensus 166 d~~t~~HIpyre~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYvLmYfnrG~LPWQglka~tk~ 230 (341)
T KOG1163|consen 166 DIRTRQHIPYREDRNLTGTARYASINAHLGIEQSRRDDMESVGYVLMYFNRGSLPWQGLKAATKK 230 (341)
T ss_pred cccccccCccccCCccceeeeehhhhhhhhhhhhhhhhhhhhcceeeeeecCCCcccccchhhHH
Confidence 443321111 122221 334567889999999999999999998755444433
|
|
| >KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.78 E-value=9.3e-19 Score=190.08 Aligned_cols=207 Identities=24% Similarity=0.353 Sum_probs=151.4
Q ss_pred HhccCCCceeeEEeEEEeCCeeEEEEecCCCCChhhHhhhcCCCCcCChhHHHHHHHHHHHHHHHhhhcCCCceEecccC
Q 004521 490 FSKLQHRNLVKLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLK 569 (747)
Q Consensus 490 l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlk 569 (747)
|+.+.|.|+.+++|.+.++...++|.+|+..|+|.+.+.. ....+++.....++++|++||.|||... -..|+.|+
T Consensus 1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~--~~~~~d~~F~~s~~rdi~~Gl~ylh~s~--i~~hg~l~ 76 (484)
T KOG1023|consen 1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSN--EDIKLDYFFILSFIRDISKGLAYLHNSP--IGYHGALK 76 (484)
T ss_pred CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhc--cccCccHHHHHHHHHHHHHHHHHHhcCc--ceeeeeec
Confidence 4678999999999999999999999999999999999976 3345899999999999999999999865 23999999
Q ss_pred cCcEEEcCCCCceEecccCccccCCCC----Cccc--------cceeeec-c---CCCCCccccchhHHHHHHHHHhCCC
Q 004521 570 ASNVLLDQDMNPKISDFGLVRTFGGDE----TEGN--------TNRVVGT-Y---DGQFSIKSDVFSFGILLLEIVSGKK 633 (747)
Q Consensus 570 p~NIll~~~~~~kl~DFGla~~~~~~~----~~~~--------~~~~~~~-~---~~~~s~ksDVwS~Gvvl~elltg~~ 633 (747)
++|+++|..+.+||+|||+........ .... +....+. . ....+.+.||||||++++||++.+.
T Consensus 77 s~nClvd~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r~~ 156 (484)
T KOG1023|consen 77 SSNCLVDSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFRSG 156 (484)
T ss_pred cccceeeeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhccC
Confidence 999999999999999999987664210 0000 0000010 0 1236889999999999999999999
Q ss_pred CCCCCCCcchh-hhhHhHHhcCCcccccchhhhccCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhcCC
Q 004521 634 NRGFYRSDTKV-NLIGHLWDEGIPLRLIDACIQDSCNLADVIRCIHIGLLCVQQHPEDRPCMPSVILMLGSE 704 (747)
Q Consensus 634 p~~~~~~~~~~-~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dP~~RPt~~~v~~~L~~~ 704 (747)
||......... +.+.++.+.+. ....+.+.... +....++.++..||..+|.+||++.+|-..++..
T Consensus 157 ~~~~~~~~~~~~eii~~~~~~~~--~~~rP~i~~~~--e~~~~l~~l~~~cw~e~P~~rPs~~~i~~~~~~~ 224 (484)
T KOG1023|consen 157 PFDLRNLVEDPDEIILRVKKGGS--NPFRPSIELLN--ELPPELLLLVARCWEEIPEKRPSIEQIRSKLLTI 224 (484)
T ss_pred ccccccccCChHHHHHHHHhcCC--CCcCcchhhhh--hcchHHHHHHHHhcccChhhCccHHHHHhhhhhh
Confidence 98764433332 23333222111 11222221110 1222577888899999999999999999888764
|
|
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.77 E-value=3.2e-18 Score=169.71 Aligned_cols=137 Identities=20% Similarity=0.271 Sum_probs=106.6
Q ss_pred CccceecccCCeeEEEEEecCCcEEEEEEecccccccHHHHHHHHHHHhcc-----CCCceeeEEeEEEeCC---e-eEE
Q 004521 443 SINNKLGEGGFGPVYKGTLVDGQEIAVKRLSKISEQGLKELKNEVILFSKL-----QHRNLVKLLGCCIQGE---E-KLL 513 (747)
Q Consensus 443 ~~~~~lg~G~fg~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l-----~H~niv~l~g~~~~~~---~-~~l 513 (747)
.-.+.||+|+||.||. +++....+||++........+.+.+|+.+++.+ .||||++++|++.++. . ..+
T Consensus 5 ~~~~~LG~G~~~~Vy~--hp~~~~k~IKv~~~~~~~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v~~~ 82 (210)
T PRK10345 5 SEQSPLGTGRHRKCYA--HPEDAQRCIKIVYHRGDGGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYVYDV 82 (210)
T ss_pred CCcceecCCCceEEEE--CCCCcCeEEEEEeccccchHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEEEEE
Confidence 3457999999999996 443333479988764444567899999999999 5799999999998874 3 337
Q ss_pred EEec--CCCCChhhHhhhcCCCCcCChhHHHHHHHHHHHHH-HHhhhcCCCceEecccCcCcEEEcC----CCCceEecc
Q 004521 514 IYEF--MPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGL-LYLHQDSRLRIIHRDLKASNVLLDQ----DMNPKISDF 586 (747)
Q Consensus 514 V~E~--~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl-~yLH~~~~~~iiHrDlkp~NIll~~----~~~~kl~DF 586 (747)
|+|| +++++|.+++... .+++. ..++.+++.++ +|||+++ |+||||||+|||++. +..++|+||
T Consensus 83 I~e~~G~~~~tL~~~l~~~----~~~e~--~~~~~~~L~~l~~yLh~~~---IvhrDlKp~NILl~~~~~~~~~~~LiDg 153 (210)
T PRK10345 83 IADFDGKPSITLTEFAEQC----RYEED--VAQLRQLLKKLKRYLLDNR---IVTMELKPQNILCQRISESEVIPVVCDN 153 (210)
T ss_pred EecCCCCcchhHHHHHHcc----cccHh--HHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEeccCCCCCcEEEEEC
Confidence 8999 6689999999442 24444 35677888777 9999998 999999999999974 347999995
Q ss_pred cCcc
Q 004521 587 GLVR 590 (747)
Q Consensus 587 Gla~ 590 (747)
+.++
T Consensus 154 ~G~~ 157 (210)
T PRK10345 154 IGES 157 (210)
T ss_pred CCCc
Confidence 5443
|
|
| >KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.77 E-value=5.8e-18 Score=169.09 Aligned_cols=199 Identities=21% Similarity=0.348 Sum_probs=158.7
Q ss_pred CCCccceecccCCeeEEEEE-ecCCcEEEEEEecccccccHHHHHHHHHHHhcc-CCCceeeEEeEEEeCCeeEEEEecC
Q 004521 441 NFSINNKLGEGGFGPVYKGT-LVDGQEIAVKRLSKISEQGLKELKNEVILFSKL-QHRNLVKLLGCCIQGEEKLLIYEFM 518 (747)
Q Consensus 441 ~~~~~~~lg~G~fg~Vy~~~-~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lV~E~~ 518 (747)
+|.+.++||+|+||.++.|+ +-+++.||||.-...+ ..-++..|.+..+.| ..++|.+++.+-.++.+..||+|++
T Consensus 29 hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrkS--~APQLrdEYr~YKlL~g~~GIP~vYYFGqeG~~NiLVidLL 106 (449)
T KOG1165|consen 29 HYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRKS--EAPQLRDEYRTYKLLGGTEGIPQVYYFGQEGKYNILVIDLL 106 (449)
T ss_pred cceeccccccCcceeeecccccccCceEEEEeccccC--CcchHHHHHHHHHHHcCCCCCCceeeeccccchhhhhhhhh
Confidence 78999999999999999998 4579999999865422 234677788888877 4799999999989999999999998
Q ss_pred CCCChhhHhhhcCCCCcCChhHHHHHHHHHHHHHHHhhhcCCCceEecccCcCcEEEcCC-----CCceEecccCccccC
Q 004521 519 PNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQD-----MNPKISDFGLVRTFG 593 (747)
Q Consensus 519 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NIll~~~-----~~~kl~DFGla~~~~ 593 (747)
+-||+++..-..+ .++..++.-+|.|++.-++|+|++. +|.|||||+|+||..- ..+.|+|||+|+.+.
T Consensus 107 -GPSLEDLFD~CgR--~FSvKTV~miA~Qmi~rie~vH~k~---LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK~Yr 180 (449)
T KOG1165|consen 107 -GPSLEDLFDLCGR--RFSVKTVAMIAKQMITRIEYVHEKD---LIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAKEYR 180 (449)
T ss_pred -CcCHHHHHHHhcC--cccHHhHHHHHHHHHHHHHHHHhcc---eeecccCccceeecCCCCCCCceEEEEeccchhhhc
Confidence 6788887644333 3888999999999999999999998 9999999999999643 458899999999887
Q ss_pred CCCCccccce-----eeec---------cCCCCCccccchhHHHHHHHHHhCCCCCCCCCCcchhhhh
Q 004521 594 GDETEGNTNR-----VVGT---------YDGQFSIKSDVFSFGILLLEIVSGKKNRGFYRSDTKVNLI 647 (747)
Q Consensus 594 ~~~~~~~~~~-----~~~~---------~~~~~s~ksDVwS~Gvvl~elltg~~p~~~~~~~~~~~~~ 647 (747)
...+....++ ..|+ .+.+-+..-|+=|+|-++...|-|..||.....+...+..
T Consensus 181 Dp~TkqHIPYrE~KSLsGTARYMSINTHlGrEQSRRDDLEaLGHvFmYFLRGsLPWQGLKA~tnK~kY 248 (449)
T KOG1165|consen 181 DPKTKQHIPYREHKSLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKADTNKEKY 248 (449)
T ss_pred CccccccCccccccccccceeeeEeeccccchhhhhhhHHHhhhhhhhhccCCCccccccCcchHHHH
Confidence 6554332221 1222 2566778899999999999999999998765554444333
|
|
| >cd00028 B_lectin Bulb-type mannose-specific lectin | Back alignment and domain information |
|---|
Probab=99.76 E-value=2.7e-18 Score=154.28 Aligned_cols=76 Identities=51% Similarity=0.825 Sum_probs=67.7
Q ss_pred CceEEEcCCCCCCCCCcceEEEecCCcEEEEcCCCcEEEEeccccCcCCceEEEEecccCEEEEeCCCCCCCceeeeecC
Q 004521 15 HEVVWVANRLNPINDSFGFLMINKTGNLVLTSQSNIVVWSAYLSKEVQTPVVLQLLDSGNLVLRDEHDGDSETYFWQSFD 94 (747)
Q Consensus 15 ~t~VW~Anr~~p~~~~~~~l~l~~~G~Lvl~~~~~~~vWst~~~~~~~~~~~~~lld~GNlVl~~~~~~~~~~~lWqSFd 94 (747)
+++||.||++.|. ...+.|.|+.||+|+|.|.+|.++|+|++.+ .....+|.|+|+|||||++.+ +.++|||||
T Consensus 41 ~~~vW~snt~~~~-~~~~~l~l~~dGnLvl~~~~g~~vW~S~~~~-~~~~~~~~L~ddGnlvl~~~~----~~~~W~Sf~ 114 (116)
T cd00028 41 RTVVWVANRDNPS-GSSCTLTLQSDGNLVIYDGSGTVVWSSNTTR-VNGNYVLVLLDDGNLVLYDSD----GNFLWQSFD 114 (116)
T ss_pred CeEEEECCCCCCC-CCCEEEEEecCCCeEEEcCCCcEEEEecccC-CCCceEEEEeCCCCEEEECCC----CCEEEcCCC
Confidence 6899999999994 4557899999999999999999999999875 256788999999999999975 789999999
Q ss_pred CC
Q 004521 95 YP 96 (747)
Q Consensus 95 ~P 96 (747)
||
T Consensus 115 ~P 116 (116)
T cd00028 115 YP 116 (116)
T ss_pred CC
Confidence 99
|
The domain contains a three-fold internal repeat (beta-prism architecture). The consensus sequence motif QXDXNXVXY is involved in alpha-D-mannose recognition. Lectins are carbohydrate-binding proteins which specifically recognize diverse carbohydrates and mediate a wide variety of biological processes, such as cell-cell and host-pathogen interactions, serum glycoprotein turnover, and innate immune responses. |
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.75 E-value=7.3e-18 Score=163.83 Aligned_cols=174 Identities=18% Similarity=0.159 Sum_probs=128.1
Q ss_pred ccceecccCCeeEEEEEecCCcEEEEEEecccccc----cHHHHHHHHHHHhccC-CCceeeEEeEEEeCCeeEEEEecC
Q 004521 444 INNKLGEGGFGPVYKGTLVDGQEIAVKRLSKISEQ----GLKELKNEVILFSKLQ-HRNLVKLLGCCIQGEEKLLIYEFM 518 (747)
Q Consensus 444 ~~~~lg~G~fg~Vy~~~~~~g~~vavK~l~~~~~~----~~~~~~~E~~~l~~l~-H~niv~l~g~~~~~~~~~lV~E~~ 518 (747)
+...|++|+||+||.+.. ++..++.+.+.....- ....|.+|+++|++|+ |+++++++++ +..+++|||+
T Consensus 6 ~~~~l~~~~f~~v~~~~~-~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~----~~~~lvmeyI 80 (218)
T PRK12274 6 VNEPLKSDTFGRILLVRG-GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW----DGRHLDRSYL 80 (218)
T ss_pred cceeecCCCcceEEEeec-CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE----cCEEEEEeee
Confidence 457899999999997765 6788888877653221 1225889999999995 5889999886 3469999999
Q ss_pred CCCChhhHhhhcCCCCcCChhHHHHHHHHHHHHHHHhhhcCCCceEeccc-CcCcEEEcCCCCceEecccCccccCCCCC
Q 004521 519 PNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDL-KASNVLLDQDMNPKISDFGLVRTFGGDET 597 (747)
Q Consensus 519 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDl-kp~NIll~~~~~~kl~DFGla~~~~~~~~ 597 (747)
++.+|...+.. ....++.|++++|+++|+.+ |+|||| ||+|||++.++.++|+|||+|........
T Consensus 81 ~G~~L~~~~~~----------~~~~~~~qi~~~L~~lH~~G---IvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~~~~~ 147 (218)
T PRK12274 81 AGAAMYQRPPR----------GDLAYFRAARRLLQQLHRCG---VAHNDLAKEANWLVQEDGSPAVIDFQLAVRGNPRAR 147 (218)
T ss_pred cCccHHhhhhh----------hhHHHHHHHHHHHHHHHHCc---CccCCCCCcceEEEcCCCCEEEEECCCceecCCcch
Confidence 99998654311 11357789999999999998 999999 79999999999999999999985443221
Q ss_pred cc---ccc----------eeeecc--------CCCCC-ccccchhHHHHHHHHHhCCCCC
Q 004521 598 EG---NTN----------RVVGTY--------DGQFS-IKSDVFSFGILLLEIVSGKKNR 635 (747)
Q Consensus 598 ~~---~~~----------~~~~~~--------~~~~s-~ksDVwS~Gvvl~elltg~~p~ 635 (747)
.. ... ...+.+ -...+ ...+.++-|.-+|.++|++.+.
T Consensus 148 ~~r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~ 207 (218)
T PRK12274 148 WMRLLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLH 207 (218)
T ss_pred HHHHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCc
Confidence 00 000 000000 11222 4568999999999999999874
|
|
| >KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.73 E-value=2.2e-18 Score=195.15 Aligned_cols=243 Identities=16% Similarity=0.183 Sum_probs=172.1
Q ss_pred CCCccceecccCCeeEEEEEecCCcEEEEEEecccc-cccHHHHHHHHHH--HhccCCCceeeEEeEEEeCCeeEEEEec
Q 004521 441 NFSINNKLGEGGFGPVYKGTLVDGQEIAVKRLSKIS-EQGLKELKNEVIL--FSKLQHRNLVKLLGCCIQGEEKLLIYEF 517 (747)
Q Consensus 441 ~~~~~~~lg~G~fg~Vy~~~~~~g~~vavK~l~~~~-~~~~~~~~~E~~~--l~~l~H~niv~l~g~~~~~~~~~lV~E~ 517 (747)
++...+.||++.|=.|.+|+++.|. |+||++-+.. .-..+.|.++++- ...++|||.+.+.-+.+.....|||-+|
T Consensus 24 e~~~~~~LGstRFlKv~r~k~~eG~-vVvKVFvk~~p~~sL~~~~qrL~~ik~~l~~~pn~lPfqk~~~t~kAAylvRqy 102 (1431)
T KOG1240|consen 24 ECHYVENLGSTRFLKVARAKDREGL-VVVKVFVKQDPTISLRPFKQRLEEIKFALMKAPNCLPFQKVLVTDKAAYLVRQY 102 (1431)
T ss_pred ceeeecccCchhhhhhhhccCCCce-EEEEEEeccCCCCCchHHHHHHHHHHHHhhcCCcccchHHHHHhhHHHHHHHHH
Confidence 5666789999999999999998887 8999876533 4445555554443 4456899999998887777888899898
Q ss_pred CCCCChhhHhhhcCCCCcCChhHHHHHHHHHHHHHHHhhhcCCCceEecccCcCcEEEcCCCCceEecccCcccc-CCCC
Q 004521 518 MPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTF-GGDE 596 (747)
Q Consensus 518 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NIll~~~~~~kl~DFGla~~~-~~~~ 596 (747)
.. -+|++.| ..+..+...+..-|+.|++.||...|..+ |+|||||.+||||+.-.-+.|+||..-|.. -+.+
T Consensus 103 vk-hnLyDRl---STRPFL~~iEKkWiaFQLL~al~qcH~~g---VcHGDIKsENILiTSWNW~~LtDFAsFKPtYLPeD 175 (1431)
T KOG1240|consen 103 VK-HNLYDRL---STRPFLVLIEKKWIAFQLLKALSQCHKLG---VCHGDIKSENILITSWNWLYLTDFASFKPTYLPED 175 (1431)
T ss_pred Hh-hhhhhhh---ccchHHHHHHHHHHHHHHHHHHHHHHHcC---ccccccccceEEEeeechhhhhcccccCCccCCCC
Confidence 85 6788777 34566888888999999999999999988 999999999999999999999999866532 1222
Q ss_pred Cccccceeeec------------------------cCCCCCccccchhHHHHHHHHHhC-CCCCCCCCCcchhhhhHhHH
Q 004521 597 TEGNTNRVVGT------------------------YDGQFSIKSDVFSFGILLLEIVSG-KKNRGFYRSDTKVNLIGHLW 651 (747)
Q Consensus 597 ~~~~~~~~~~~------------------------~~~~~s~ksDVwS~Gvvl~elltg-~~p~~~~~~~~~~~~~~~~~ 651 (747)
.......+..| .....+++.||||+||++.||++- +++|. ..++..+.-
T Consensus 176 NPadf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~------LSQL~aYr~ 249 (1431)
T KOG1240|consen 176 NPADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFT------LSQLLAYRS 249 (1431)
T ss_pred CcccceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCccc------HHHHHhHhc
Confidence 22211111111 022378899999999999999994 56643 112222221
Q ss_pred hcCCcccccchhhhccCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhcCC
Q 004521 652 DEGIPLRLIDACIQDSCNLADVIRCIHIGLLCVQQHPEDRPCMPSVILMLGSE 704 (747)
Q Consensus 652 ~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dP~~RPt~~~v~~~L~~~ 704 (747)
.+....+.+-..+++ ..+.++++.|++.||++|-++.++++.-.+.
T Consensus 250 ~~~~~~e~~Le~Ied-------~~~Rnlil~Mi~rdPs~RlSAedyL~~yrG~ 295 (1431)
T KOG1240|consen 250 GNADDPEQLLEKIED-------VSLRNLILSMIQRDPSKRLSAEDYLQKYRGL 295 (1431)
T ss_pred cCccCHHHHHHhCcC-------ccHHHHHHHHHccCchhccCHHHHHHhhhcc
Confidence 111111111111111 1245678899999999999999999886654
|
|
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.71 E-value=4.3e-17 Score=165.71 Aligned_cols=143 Identities=18% Similarity=0.181 Sum_probs=111.3
Q ss_pred CCCccceecccCCeeEEEEE--ecCCcEEEEEEecccccc------------------------cHHHHHHHHHHHhccC
Q 004521 441 NFSINNKLGEGGFGPVYKGT--LVDGQEIAVKRLSKISEQ------------------------GLKELKNEVILFSKLQ 494 (747)
Q Consensus 441 ~~~~~~~lg~G~fg~Vy~~~--~~~g~~vavK~l~~~~~~------------------------~~~~~~~E~~~l~~l~ 494 (747)
.|.+.+.||+|+||.||+|+ ..+|+.||||+++..... ....+..|+.++.++.
T Consensus 29 ~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L~ 108 (237)
T smart00090 29 LSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRLY 108 (237)
T ss_pred hHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHHH
Confidence 47888999999999999998 467999999998742210 0123578999999997
Q ss_pred CC--ceeeEEeEEEeCCeeEEEEecCCCCChhhHhhhcCCCCcCChhHHHHHHHHHHHHHHHhhhcCCCceEecccCcCc
Q 004521 495 HR--NLVKLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASN 572 (747)
Q Consensus 495 H~--niv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~N 572 (747)
|. .+.+++++ ...++||||+++.+|...+.. ...+...+...++.||+.++.+||+.+ .|+||||||+|
T Consensus 109 ~~~i~~p~~~~~----~~~~lV~E~~~g~~L~~~~~~---~~~~~~~~~~~i~~qi~~~l~~LH~~g--~iiH~Dikp~N 179 (237)
T smart00090 109 EAGVPVPKPIAW----RRNVLVMEFIGGDGLPAPRLK---DVEPEEEEEFELYDDILEEMRKLYKEG--ELVHGDLSEYN 179 (237)
T ss_pred hcCCCCCeeeEe----cCceEEEEEecCCcccccccc---cCCcchHHHHHHHHHHHHHHHHHHhcC--CEEeCCCChhh
Confidence 53 34455543 235899999999888765422 223555667889999999999999876 39999999999
Q ss_pred EEEcCCCCceEecccCccccC
Q 004521 573 VLLDQDMNPKISDFGLVRTFG 593 (747)
Q Consensus 573 Ill~~~~~~kl~DFGla~~~~ 593 (747)
|+++ ++.++|+|||++....
T Consensus 180 Ili~-~~~i~LiDFg~a~~~~ 199 (237)
T smart00090 180 ILVH-DGKVVIIDVSQSVELD 199 (237)
T ss_pred EEEE-CCCEEEEEChhhhccC
Confidence 9999 8899999999987653
|
|
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.71 E-value=6.2e-17 Score=162.52 Aligned_cols=134 Identities=19% Similarity=0.275 Sum_probs=113.5
Q ss_pred ceecccCCeeEEEEEecCCcEEEEEEeccccc--------ccHHHHHHHHHHHhccCCCceeeEEeEEEeCCeeEEEEec
Q 004521 446 NKLGEGGFGPVYKGTLVDGQEIAVKRLSKISE--------QGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEF 517 (747)
Q Consensus 446 ~~lg~G~fg~Vy~~~~~~g~~vavK~l~~~~~--------~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~ 517 (747)
+.||+|++|.||+|.. .|..++||+...... .....+.+|+.++..++|++|.....++......++||||
T Consensus 2 ~~l~~G~~~~vy~~~~-~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~ 80 (211)
T PRK14879 2 KLIKRGAEAEIYLGDF-LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPENFIIVMEY 80 (211)
T ss_pred cccccCceEEEEEEee-CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCCEEEEEE
Confidence 5799999999999987 677899998653211 1124578899999999999998877777778888999999
Q ss_pred CCCCChhhHhhhcCCCCcCChhHHHHHHHHHHHHHHHhhhcCCCceEecccCcCcEEEcCCCCceEecccCccc
Q 004521 518 MPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRT 591 (747)
Q Consensus 518 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NIll~~~~~~kl~DFGla~~ 591 (747)
+++++|.+++... .. .+..++.+++.+|.+||+.+ ++|||++|.|||++ ++.++|+|||+++.
T Consensus 81 ~~G~~L~~~~~~~------~~-~~~~i~~~i~~~l~~lH~~~---i~H~Dl~p~Nil~~-~~~~~liDf~~a~~ 143 (211)
T PRK14879 81 IEGEPLKDLINSN------GM-EELELSREIGRLVGKLHSAG---IIHGDLTTSNMILS-GGKIYLIDFGLAEF 143 (211)
T ss_pred eCCcCHHHHHHhc------cH-HHHHHHHHHHHHHHHHHhCC---cccCCCCcccEEEE-CCCEEEEECCcccC
Confidence 9999999988432 12 78899999999999999988 99999999999999 78899999998865
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.71 E-value=5.1e-18 Score=193.22 Aligned_cols=244 Identities=20% Similarity=0.210 Sum_probs=163.1
Q ss_pred ccceecccCCeeEEEEEecC-CcEEEEEEec----c-ccc-ccHHHHHHHHHHHhccCCCceeeEEeEEEeCCeeEEEEe
Q 004521 444 INNKLGEGGFGPVYKGTLVD-GQEIAVKRLS----K-ISE-QGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYE 516 (747)
Q Consensus 444 ~~~~lg~G~fg~Vy~~~~~~-g~~vavK~l~----~-~~~-~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E 516 (747)
....+|.|++|.|+...... ....+.|..+ . ... +....+..|+-+-..++|+|++..+..+.+....+-+||
T Consensus 322 ~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~~~~~mE 401 (601)
T KOG0590|consen 322 PGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDGILQSME 401 (601)
T ss_pred ccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcccchhhhh
Confidence 35789999999888776432 3334444322 1 111 111225667788888999999888888777777777799
Q ss_pred cCCCCChhhHhhhcCCCCcCChhHHHHHHHHHHHHHHHhhhcCCCceEecccCcCcEEEcCCCCceEecccCccccCCCC
Q 004521 517 FMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDE 596 (747)
Q Consensus 517 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~ 596 (747)
|+++ +|..++... ..+...++..++.|++.|+.|+|+.| |.|||||++|+++..++.+||+|||.+..+....
T Consensus 402 ~~~~-Dlf~~~~~~---~~~~~~e~~c~fKqL~~Gv~y~h~~G---iahrdlK~enll~~~~g~lki~Dfg~~~vf~~~~ 474 (601)
T KOG0590|consen 402 YCPY-DLFSLVMSN---GKLTPLEADCFFKQLLRGVKYLHSMG---LAHRDLKLENLLVTENGILKIIDFGAASVFRYPW 474 (601)
T ss_pred cccH-HHHHHHhcc---cccchhhhhHHHHHHHHHHHHHHhcC---ceeccCccccEEEecCCceEEeecCcceeeccCc
Confidence 9999 999988542 35788889999999999999999999 9999999999999999999999999987553222
Q ss_pred Cc--cccceeeec---------cCCCCC-ccccchhHHHHHHHHHhCCCCCCCCCCcchhhhhHhHHhcCCcccccchhh
Q 004521 597 TE--GNTNRVVGT---------YDGQFS-IKSDVFSFGILLLEIVSGKKNRGFYRSDTKVNLIGHLWDEGIPLRLIDACI 664 (747)
Q Consensus 597 ~~--~~~~~~~~~---------~~~~~s-~ksDVwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 664 (747)
.. .......|. ....|. ...||||.||++..|++|+.||.......... .... ..........+.
T Consensus 475 e~~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~-~~~~-~~~~~~~~~~~~- 551 (601)
T KOG0590|consen 475 EKNIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSF-KTNN-YSDQRNIFEGPN- 551 (601)
T ss_pred chhhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccccccch-hhhc-cccccccccChH-
Confidence 11 111111111 123344 36899999999999999999986443332211 0000 000000000000
Q ss_pred hccCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 004521 665 QDSCNLADVIRCIHIGLLCVQQHPEDRPCMPSVIL 699 (747)
Q Consensus 665 ~~~~~~~~~~~~~~l~~~Cl~~dP~~RPt~~~v~~ 699 (747)
.....-..+...++.++|+.||.+|.|+.+|++
T Consensus 552 --~~~~~lp~~~~~~~~~~l~~~P~~R~ti~~i~~ 584 (601)
T KOG0590|consen 552 --RLLSLLPRETRIIIYRMLQLDPTKRITIEQILN 584 (601)
T ss_pred --HHHHhchhhHHHHHHHHccCChhheecHHHHhh
Confidence 000011223456888999999999999999975
|
|
| >smart00108 B_lectin Bulb-type mannose-specific lectin | Back alignment and domain information |
|---|
Probab=99.71 E-value=4e-17 Score=146.25 Aligned_cols=75 Identities=49% Similarity=0.813 Sum_probs=66.8
Q ss_pred CceEEEcCCCCCCCCCcceEEEecCCcEEEEcCCCcEEEEeccccCcCCceEEEEecccCEEEEeCCCCCCCceeeeecC
Q 004521 15 HEVVWVANRLNPINDSFGFLMINKTGNLVLTSQSNIVVWSAYLSKEVQTPVVLQLLDSGNLVLRDEHDGDSETYFWQSFD 94 (747)
Q Consensus 15 ~t~VW~Anr~~p~~~~~~~l~l~~~G~Lvl~~~~~~~vWst~~~~~~~~~~~~~lld~GNlVl~~~~~~~~~~~lWqSFd 94 (747)
+++||.|||+.|+..+ +.|.++.||+|+|.|.+|.++|+|++... ....++.|+|+|||||++.. +.++|||||
T Consensus 40 ~~~vW~snt~~~~~~~-~~l~l~~dGnLvl~~~~g~~vW~S~t~~~-~~~~~~~L~ddGnlvl~~~~----~~~~W~Sf~ 113 (114)
T smart00108 40 RTVVWVANRDNPVSDS-CTLTLQSDGNLVLYDGDGRVVWSSNTTGA-NGNYVLVLLDDGNLVIYDSD----GNFLWQSFD 113 (114)
T ss_pred CcEEEECCCCCCCCCC-EEEEEeCCCCEEEEeCCCCEEEEecccCC-CCceEEEEeCCCCEEEECCC----CCEEeCCCC
Confidence 6899999999998765 88999999999999999999999998622 56778999999999999875 679999999
Q ss_pred C
Q 004521 95 Y 95 (747)
Q Consensus 95 ~ 95 (747)
|
T Consensus 114 ~ 114 (114)
T smart00108 114 Y 114 (114)
T ss_pred C
Confidence 7
|
|
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=99.70 E-value=7.4e-17 Score=160.24 Aligned_cols=145 Identities=18% Similarity=0.188 Sum_probs=112.8
Q ss_pred HHHHhcCCCccceecccCCeeEEEEEecCCcEEEEEEeccccc----------------------ccHHHHHHHHHHHhc
Q 004521 435 IANATDNFSINNKLGEGGFGPVYKGTLVDGQEIAVKRLSKISE----------------------QGLKELKNEVILFSK 492 (747)
Q Consensus 435 ~~~~~~~~~~~~~lg~G~fg~Vy~~~~~~g~~vavK~l~~~~~----------------------~~~~~~~~E~~~l~~ 492 (747)
+......|.+.+.||+|+||.||++...+|+.||||+++.... .....+..|..++..
T Consensus 10 ~~~~~~~~~~~~~i~~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~ 89 (198)
T cd05144 10 LVKRGVVESLGNQIGVGKESDVYLALDPDGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKA 89 (198)
T ss_pred HHHcCchhhcCCccccCcceEEEEEEcCCCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHH
Confidence 3333334777899999999999999988899999998754210 011236778999999
Q ss_pred cCCCc--eeeEEeEEEeCCeeEEEEecCCCCChhhHhhhcCCCCcCChhHHHHHHHHHHHHHHHhhhcCCCceEecccCc
Q 004521 493 LQHRN--LVKLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKA 570 (747)
Q Consensus 493 l~H~n--iv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp 570 (747)
+.|++ +.+.++. ...++||||+++++|..+.. ......++.++++++.++|+.+ |+||||||
T Consensus 90 l~~~~i~v~~~~~~----~~~~lv~e~~~g~~L~~~~~---------~~~~~~~~~~i~~~l~~lh~~g---i~H~Dl~p 153 (198)
T cd05144 90 LYEEGFPVPKPIDW----NRHAVVMEYIDGVELYRVRV---------LEDPEEVLDEILEEIVKAYKHG---IIHGDLSE 153 (198)
T ss_pred HHHcCCCCCceeec----CCceEEEEEeCCcchhhccc---------cccHHHHHHHHHHHHHHHHHCC---CCcCCCCc
Confidence 98874 4455442 45589999999999876542 1345678899999999999988 99999999
Q ss_pred CcEEEcCCCCceEecccCccccCCC
Q 004521 571 SNVLLDQDMNPKISDFGLVRTFGGD 595 (747)
Q Consensus 571 ~NIll~~~~~~kl~DFGla~~~~~~ 595 (747)
+||++++++.++|+|||++......
T Consensus 154 ~Nill~~~~~~~liDfg~~~~~~~~ 178 (198)
T cd05144 154 FNILVDDDEKIYIIDWPQMVSTDHP 178 (198)
T ss_pred ccEEEcCCCcEEEEECCccccCCCc
Confidence 9999999999999999999766543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.70 E-value=1e-16 Score=164.22 Aligned_cols=228 Identities=21% Similarity=0.331 Sum_probs=140.5
Q ss_pred CCccceecccCCeeEEEEEecC-CcEEEEEEecc---cccccHHHHHHHHHHHhccCC----------CceeeEEeEEE-
Q 004521 442 FSINNKLGEGGFGPVYKGTLVD-GQEIAVKRLSK---ISEQGLKELKNEVILFSKLQH----------RNLVKLLGCCI- 506 (747)
Q Consensus 442 ~~~~~~lg~G~fg~Vy~~~~~~-g~~vavK~l~~---~~~~~~~~~~~E~~~l~~l~H----------~niv~l~g~~~- 506 (747)
+...+.||.|+++.||.+++.+ ++++|||.... ......+++++|.-.+..+.+ -.++.-++...
T Consensus 14 l~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~~i 93 (288)
T PF14531_consen 14 LVRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLLRI 93 (288)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEEEE
T ss_pred EEEccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEEEE
Confidence 4456899999999999999876 89999999753 334456778888776666433 22222222221
Q ss_pred --------eCC--------eeEEEEecCCCCChhhHhh---hcCC-CCcCChhHHHHHHHHHHHHHHHhhhcCCCceEec
Q 004521 507 --------QGE--------EKLLIYEFMPNKSLDSFIF---DQTR-RTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHR 566 (747)
Q Consensus 507 --------~~~--------~~~lV~E~~~~gsL~~~l~---~~~~-~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHr 566 (747)
... +.+++|+-+ -++|.+++. .... ...+....++.+..|+++.+++||+.| ++|+
T Consensus 94 ~~~~~~~~~~~~~~~~~v~n~~~l~P~~-~~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~G---lVHg 169 (288)
T PF14531_consen 94 PGKPPFFERGPGQSIYWVLNRFLLMPRA-QGDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSYG---LVHG 169 (288)
T ss_dssp TTS-SEEEECETTEEEEEESEEEEEE---SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTT---EEES
T ss_pred cCCCcceecCCCCccceeehhhhccchh-hhcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhcc---eEec
Confidence 111 235677777 478877753 2222 233445566778899999999999999 9999
Q ss_pred ccCcCcEEEcCCCCceEecccCccccCCCCCccccc------eeeec------cCCCCCccccchhHHHHHHHHHhCCCC
Q 004521 567 DLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNTN------RVVGT------YDGQFSIKSDVFSFGILLLEIVSGKKN 634 (747)
Q Consensus 567 Dlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~------~~~~~------~~~~~s~ksDVwS~Gvvl~elltg~~p 634 (747)
||+|+|++++.+|.++|+||+.....+......... ..... ..-.++.+.|.|++|++||.|++|+.|
T Consensus 170 di~~~nfll~~~G~v~Lg~F~~~~r~g~~~~~~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~lWC~~lP 249 (288)
T PF14531_consen 170 DIKPENFLLDQDGGVFLGDFSSLVRAGTRYRCSEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYSLWCGRLP 249 (288)
T ss_dssp T-SGGGEEE-TTS-EEE--GGGEEETTEEEEGGGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHHHHHSS-S
T ss_pred ccceeeEEEcCCCCEEEcChHHHeecCceeeccCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHHHHHccCC
Confidence 999999999999999999999776543322210000 00000 123578899999999999999999999
Q ss_pred CCCCCCcchhhhhHhHHhcCCcccccchhhhccCCHHHHHHHHHHHHhccCCCCCCC
Q 004521 635 RGFYRSDTKVNLIGHLWDEGIPLRLIDACIQDSCNLADVIRCIHIGLLCVQQHPEDR 691 (747)
Q Consensus 635 ~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dP~~R 691 (747)
+........... .+ ..+. .-.+.+..++...|+.+|.+|
T Consensus 250 f~~~~~~~~~~~----------------~f-~~C~-~~Pe~v~~LI~~lL~~~~~~R 288 (288)
T PF14531_consen 250 FGLSSPEADPEW----------------DF-SRCR-DMPEPVQFLIRGLLQRNPEDR 288 (288)
T ss_dssp TCCCGGGSTSGG----------------GG-TTSS----HHHHHHHHHHT-SSGGGS
T ss_pred CCCCCccccccc----------------cc-hhcC-CcCHHHHHHHHHHccCCcccC
Confidence 875433322211 11 1122 223344566778999999988
|
|
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=99.69 E-value=9.7e-17 Score=183.47 Aligned_cols=138 Identities=20% Similarity=0.286 Sum_probs=112.8
Q ss_pred hcCCCccceecccCCeeEEEEEecCCcEEEEEE-eccc-c------cccHHHHHHHHHHHhccCCCceeeEEeEEEeCCe
Q 004521 439 TDNFSINNKLGEGGFGPVYKGTLVDGQEIAVKR-LSKI-S------EQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEE 510 (747)
Q Consensus 439 ~~~~~~~~~lg~G~fg~Vy~~~~~~g~~vavK~-l~~~-~------~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~ 510 (747)
...|...+.||+|+||.||+|.+.+.. +++|+ +.+. . ....+.+.+|++++..++|++++....++.....
T Consensus 332 ~~~~~~~~~iG~G~~g~Vy~~~~~~~~-~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~ 410 (535)
T PRK09605 332 KRRKIPDHLIGKGAEADIKKGEYLGRD-AVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVDPEE 410 (535)
T ss_pred ccccCccceeccCCcEEEEEEeecCcc-ceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEeCCC
Confidence 345566789999999999999875543 34443 2221 1 1123568899999999999999988888888888
Q ss_pred eEEEEecCCCCChhhHhhhcCCCCcCChhHHHHHHHHHHHHHHHhhhcCCCceEecccCcCcEEEcCCCCceEecccCcc
Q 004521 511 KLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVR 590 (747)
Q Consensus 511 ~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NIll~~~~~~kl~DFGla~ 590 (747)
.++||||+++++|.+++. ....++.+++++|.|||+.+ ++||||||+|||+ .++.++|+|||+++
T Consensus 411 ~~lv~E~~~g~~L~~~l~-----------~~~~~~~~i~~~L~~lH~~g---iiHrDlkp~NILl-~~~~~~liDFGla~ 475 (535)
T PRK09605 411 KTIVMEYIGGKDLKDVLE-----------GNPELVRKVGEIVAKLHKAG---IVHGDLTTSNFIV-RDDRLYLIDFGLGK 475 (535)
T ss_pred CEEEEEecCCCcHHHHHH-----------HHHHHHHHHHHHHHHHHhCC---CccCCCChHHEEE-ECCcEEEEeCcccc
Confidence 899999999999998873 35678999999999999988 9999999999999 67899999999997
Q ss_pred cc
Q 004521 591 TF 592 (747)
Q Consensus 591 ~~ 592 (747)
..
T Consensus 476 ~~ 477 (535)
T PRK09605 476 YS 477 (535)
T ss_pred cC
Confidence 63
|
|
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=99.69 E-value=1.3e-16 Score=158.53 Aligned_cols=130 Identities=22% Similarity=0.329 Sum_probs=106.9
Q ss_pred eecccCCeeEEEEEecCCcEEEEEEecccc-c-------ccHHHHHHHHHHHhccCCCceeeEEeEEEeCCeeEEEEecC
Q 004521 447 KLGEGGFGPVYKGTLVDGQEIAVKRLSKIS-E-------QGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFM 518 (747)
Q Consensus 447 ~lg~G~fg~Vy~~~~~~g~~vavK~l~~~~-~-------~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~ 518 (747)
.||+|+||.||+|.. ++..+++|...... . .....+.+|++++..++|+++.....++......++||||+
T Consensus 1 ~ig~G~~~~vy~~~~-~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~~ 79 (199)
T TIGR03724 1 LIAKGAEAIIYLGDF-LGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDNKTIVMEYI 79 (199)
T ss_pred CCCCCceEEEEEeec-CCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCCCEEEEEEE
Confidence 489999999999985 57889999865321 1 11356788999999999887666555666677789999999
Q ss_pred CCCChhhHhhhcCCCCcCChhHHHHHHHHHHHHHHHhhhcCCCceEecccCcCcEEEcCCCCceEecccCccc
Q 004521 519 PNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRT 591 (747)
Q Consensus 519 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NIll~~~~~~kl~DFGla~~ 591 (747)
++++|.+++.... ..++.+++.+|.+||+.+ ++|+|++|.||+++ ++.++|+|||+++.
T Consensus 80 ~g~~l~~~~~~~~----------~~~~~~i~~~l~~lH~~g---i~H~Dl~~~Nil~~-~~~~~liDfg~a~~ 138 (199)
T TIGR03724 80 EGKPLKDVIEEGN----------DELLREIGRLVGKLHKAG---IVHGDLTTSNIIVR-DDKLYLIDFGLGKY 138 (199)
T ss_pred CCccHHHHHhhcH----------HHHHHHHHHHHHHHHHCC---eecCCCCcceEEEE-CCcEEEEECCCCcC
Confidence 9999998874311 078999999999999988 99999999999999 89999999999875
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.67 E-value=9.9e-17 Score=185.86 Aligned_cols=188 Identities=22% Similarity=0.303 Sum_probs=143.0
Q ss_pred HhcCCCccceecccCCeeEEEEEecCCcEEEEEEecccccccHHHHHHHHHHHhccC---CCceeeEEeEEEeCCeeEEE
Q 004521 438 ATDNFSINNKLGEGGFGPVYKGTLVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQ---HRNLVKLLGCCIQGEEKLLI 514 (747)
Q Consensus 438 ~~~~~~~~~~lg~G~fg~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~---H~niv~l~g~~~~~~~~~lV 514 (747)
..+.|.+.+.||+|+||+||+|+..+|+.||+|.-+....- +|.-=.+++.+|+ -+-|+.+..++.-.+..+||
T Consensus 696 ~~~~~~I~~e~G~g~y~~vy~a~~~~~~~~alK~e~P~~~W---EfYI~~q~~~RLk~~~~~~~~~~~~a~~~~~~S~lv 772 (974)
T KOG1166|consen 696 GGEKFCISKEIGEGSYGSVYVATHSNGKLVALKVEKPPNPW---EFYICLQVMERLKPQMLPSIMHISSAHVFQNASVLV 772 (974)
T ss_pred cceeEEEEeeeccccceEEEEeecCCCcEEEEEeecCCCce---eeeehHHHHHhhchhhhcchHHHHHHHccCCcceee
Confidence 34678889999999999999999988999999998764332 1111223333443 23455666666777888999
Q ss_pred EecCCCCChhhHhhhcCCCCcCChhHHHHHHHHHHHHHHHhhhcCCCceEecccCcCcEEEcC-------CCCceEeccc
Q 004521 515 YEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQ-------DMNPKISDFG 587 (747)
Q Consensus 515 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NIll~~-------~~~~kl~DFG 587 (747)
+||.+.|+|.+++. ..+.++|.....++.|++.-+++||..+ |||+||||+|.||.. ...++|+|||
T Consensus 773 ~ey~~~Gtlld~~N---~~~~m~e~lv~~~~~qml~ive~lH~~~---IIHgDiKPDNfll~~~~~~~~~~~~l~lIDfG 846 (974)
T KOG1166|consen 773 SEYSPYGTLLDLIN---TNKVMDEYLVMFFSCQMLRIVEHLHAMG---IIHGDIKPDNFLLRREICADSDSKGLYLIDFG 846 (974)
T ss_pred eeccccccHHHhhc---cCCCCCchhhhHHHHHHHHHHHHHHhcc---eecccCCcceeEeecccCCCCcccceEEEecc
Confidence 99999999999996 4456999999999999999999999998 999999999999942 3458999999
Q ss_pred CccccCCCCCccccceeeec---------cCCCCCccccchhHHHHHHHHHhCCCC
Q 004521 588 LVRTFGGDETEGNTNRVVGT---------YDGQFSIKSDVFSFGILLLEIVSGKKN 634 (747)
Q Consensus 588 la~~~~~~~~~~~~~~~~~~---------~~~~~s~ksDVwS~Gvvl~elltg~~p 634 (747)
-+-.+.--...........+ .+..++.++|-|.|+-+++-||.|+..
T Consensus 847 ~siDm~lfp~~~~F~~~~~td~f~C~EM~~grpWtYq~DyfGlAa~~h~mLFG~y~ 902 (974)
T KOG1166|consen 847 RSIDMKLFPDGTKFKAVWHTDLFDCIEMREGRPWTYQIDYFGLAATVHVMLFGKYM 902 (974)
T ss_pred cceeeeEcCCCcEEeeeeccccchhHHHhcCCCCchhhhhHHHHHHHHHHHHHHHH
Confidence 88654221111111111111 167899999999999999999999875
|
|
| >KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.66 E-value=1.9e-16 Score=161.65 Aligned_cols=189 Identities=19% Similarity=0.220 Sum_probs=124.0
Q ss_pred CCCceeeEEeEEEe---------------------------CCeeEEEEecCCCCChhhHhhhcCCCCcCChhHHHHHHH
Q 004521 494 QHRNLVKLLGCCIQ---------------------------GEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIIC 546 (747)
Q Consensus 494 ~H~niv~l~g~~~~---------------------------~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~ 546 (747)
+|||||++.++|.+ ....|+||.-.+ -+|.+++.... .+.....-|+.
T Consensus 274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY~-~tLr~yl~~~~----~s~r~~~~~la 348 (598)
T KOG4158|consen 274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRYR-QTLREYLWTRH----RSYRTGRVILA 348 (598)
T ss_pred CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcch-hhHHHHHhcCC----CchHHHHHHHH
Confidence 59999999998764 224578887764 68888885432 45566777899
Q ss_pred HHHHHHHHhhhcCCCceEecccCcCcEEE--cCCC--CceEecccCccccCC--CCCccc-----------------cce
Q 004521 547 GTARGLLYLHQDSRLRIIHRDLKASNVLL--DQDM--NPKISDFGLVRTFGG--DETEGN-----------------TNR 603 (747)
Q Consensus 547 ~ia~gl~yLH~~~~~~iiHrDlkp~NIll--~~~~--~~kl~DFGla~~~~~--~~~~~~-----------------~~~ 603 (747)
|+++|+.|||.++ |.|||||++|||| |++. ...|+|||.+-.-.. -+-... .+.
T Consensus 349 QlLEav~hL~~hg---vAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~ta 425 (598)
T KOG4158|consen 349 QLLEAVTHLHKHG---VAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIATA 425 (598)
T ss_pred HHHHHHHHHHHcc---chhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecchhhhhc
Confidence 9999999999999 9999999999998 4444 357899997632111 000000 001
Q ss_pred eeeccCCCCCccccchhHHHHHHHHHhCCCCCCCCCCcchhhhhHhHHhcCCcccccchhhhccCCHHHHHHHHHHHHhc
Q 004521 604 VVGTYDGQFSIKSDVFSFGILLLEIVSGKKNRGFYRSDTKVNLIGHLWDEGIPLRLIDACIQDSCNLADVIRCIHIGLLC 683 (747)
Q Consensus 604 ~~~~~~~~~s~ksDVwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~C 683 (747)
.+|..-..--.|+|.|+.|-+.||++....||..... ..+-....++...+.+.+.... .+.+++...
T Consensus 426 ~PGp~avvny~kAD~WA~GalaYEIfg~~NPFY~rGe---m~L~~r~Yqe~qLPalp~~vpp---------~~rqlV~~l 493 (598)
T KOG4158|consen 426 VPGPNAVVNYEKADTWAAGALAYEIFGRSNPFYKRGE---MLLDTRTYQESQLPALPSRVPP---------VARQLVFDL 493 (598)
T ss_pred CCCCceeeccchhhhhhhhhhHHHHhccCCcccccch---heechhhhhhhhCCCCcccCCh---------HHHHHHHHH
Confidence 1111111123589999999999999999999643111 1111111334444444443222 134566788
Q ss_pred cCCCCCCCCCHHHHHHHhc
Q 004521 684 VQQHPEDRPCMPSVILMLG 702 (747)
Q Consensus 684 l~~dP~~RPt~~~v~~~L~ 702 (747)
|+.||++||+..-....|+
T Consensus 494 L~r~pskRvsp~iAANvl~ 512 (598)
T KOG4158|consen 494 LKRDPSKRVSPNIAANVLN 512 (598)
T ss_pred hcCCccccCCccHHHhHHH
Confidence 9999999998876666664
|
|
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=99.61 E-value=2.7e-15 Score=147.56 Aligned_cols=138 Identities=20% Similarity=0.225 Sum_probs=99.4
Q ss_pred cceecccCCeeEEEEEecCCcEEEEEEecccccc--cHHH----------------------HHHHHHHHhccCCCc--e
Q 004521 445 NNKLGEGGFGPVYKGTLVDGQEIAVKRLSKISEQ--GLKE----------------------LKNEVILFSKLQHRN--L 498 (747)
Q Consensus 445 ~~~lg~G~fg~Vy~~~~~~g~~vavK~l~~~~~~--~~~~----------------------~~~E~~~l~~l~H~n--i 498 (747)
.+.||+|+||.||+|...+++.||||+++..... .... ...|...+.++.+.. +
T Consensus 2 ~~~lg~G~~g~Vy~a~~~~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~ 81 (187)
T cd05119 2 GGPIGTGKEADVYLALDGDGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVPV 81 (187)
T ss_pred CcccccccceeEEEEECCCCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCCC
Confidence 4689999999999999888999999998652111 1111 135666666664432 4
Q ss_pred eeEEeEEEeCCeeEEEEecCCCCChhhHhhhcCCCCcCChhHHHHHHHHHHHHHHHhhh-cCCCceEecccCcCcEEEcC
Q 004521 499 VKLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQ-DSRLRIIHRDLKASNVLLDQ 577 (747)
Q Consensus 499 v~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~-~~~~~iiHrDlkp~NIll~~ 577 (747)
.+.+++ ...++||||++++.+......... .. .+...++.+++.++.++|. .+ |+||||||+||+++
T Consensus 82 ~~~~~~----~~~~lv~e~~~g~~~~~~~l~~~~---~~-~~~~~~~~~~~~~l~~lh~~~~---ivH~Dl~p~Nili~- 149 (187)
T cd05119 82 PKPIDL----NRHVLVMEFIGGDGIPAPRLKDVR---LL-EDPEELYDQILELMRKLYREAG---LVHGDLSEYNILVD- 149 (187)
T ss_pred CceEec----CCCEEEEEEeCCCCccChhhhhhh---hc-ccHHHHHHHHHHHHHHHhhccC---cCcCCCChhhEEEE-
Confidence 444443 246899999998554322111000 11 5677899999999999998 77 99999999999999
Q ss_pred CCCceEecccCccccCC
Q 004521 578 DMNPKISDFGLVRTFGG 594 (747)
Q Consensus 578 ~~~~kl~DFGla~~~~~ 594 (747)
++.++|+|||.+.....
T Consensus 150 ~~~~~liDfg~a~~~~~ 166 (187)
T cd05119 150 DGKVYIIDVPQAVEIDH 166 (187)
T ss_pred CCcEEEEECcccccccC
Confidence 99999999999976544
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=99.60 E-value=5.8e-15 Score=139.06 Aligned_cols=135 Identities=22% Similarity=0.193 Sum_probs=114.7
Q ss_pred ccceecccCCeeEEEEEecCCcEEEEEEecccccccHHHHHHHHHHHhccCC--CceeeEEeEEEeCCeeEEEEecCCCC
Q 004521 444 INNKLGEGGFGPVYKGTLVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQH--RNLVKLLGCCIQGEEKLLIYEFMPNK 521 (747)
Q Consensus 444 ~~~~lg~G~fg~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H--~niv~l~g~~~~~~~~~lV~E~~~~g 521 (747)
+.+.||+|.++.||+++..+ ..+++|....... ...+.+|+.++..++| .++++++++....+..+++|||++++
T Consensus 2 ~~~~i~~g~~~~v~~~~~~~-~~~~iK~~~~~~~--~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~~~g~ 78 (155)
T cd05120 2 SIKLLKGGLTNRVYLLGTKD-EDYVLKINPSREK--GADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEWIEGE 78 (155)
T ss_pred cceecccccccceEEEEecC-CeEEEEecCCCCc--hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEecCCe
Confidence 35789999999999999854 7899999865332 5678999999999976 58999999988888899999999988
Q ss_pred ChhhHhhhcCCCCcCChhHHHHHHHHHHHHHHHhhhcCCCceEecccCcCcEEEcCCCCceEecccCccc
Q 004521 522 SLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRT 591 (747)
Q Consensus 522 sL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NIll~~~~~~kl~DFGla~~ 591 (747)
.+..+ +......++.+++++|++||.....+++|+||+|+||+++..+.+++.|||.++.
T Consensus 79 ~~~~~----------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~ 138 (155)
T cd05120 79 TLDEV----------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGY 138 (155)
T ss_pred ecccC----------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccC
Confidence 77543 4456677899999999999986545699999999999999999999999998864
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >PF08276 PAN_2: PAN-like domain; InterPro: IPR013227 PAN domains have significant functional versatility fulfilling diverse biological functions by mediating protein-protein or protein-carbohydrate interactions [] | Back alignment and domain information |
|---|
Probab=99.59 E-value=1.4e-15 Score=121.04 Aligned_cols=66 Identities=44% Similarity=1.024 Sum_probs=58.1
Q ss_pred cCCCCceEEeeccCCCCCCccccccccChHHHHHhhccCCceeEEeeecccCCCcceeeeecccccc
Q 004521 281 YSRQDGFIKFTELKLPDATSSWVSKSMNLKECREGCLENSSCMAYTNSDIRGGGSGCAMWFGELIDM 347 (747)
Q Consensus 281 C~~~~~f~~~~~~~~p~~~~~~~~~~~s~~~C~~~Cl~nCsC~a~~~~~~~~~~~~C~~~~~~l~d~ 347 (747)
|+.+|+|+++.+|++|++....+..++++++|++.||+||||+||+|.++. ++++|.+|+++|+|+
T Consensus 1 C~~~d~F~~l~~~~~p~~~~~~~~~~~s~~~C~~~Cl~nCsC~Ayay~~~~-~~~~C~lW~~~L~d~ 66 (66)
T PF08276_consen 1 CGSGDGFLKLPNMKLPDFDNAIVDSSVSLEECEKACLSNCSCTAYAYSNLS-GGGGCLLWYGDLVDL 66 (66)
T ss_pred CcCCCEEEEECCeeCCCCcceeeecCCCHHHHHhhcCCCCCEeeEEeeccC-CCCEEEEEcCEeecC
Confidence 445799999999999999877666779999999999999999999997655 668999999999874
|
These domains contain a hair-pin loop like structure, similar to knottins, but the pattern of disulphide bonds differs |
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.56 E-value=6.8e-16 Score=167.57 Aligned_cols=185 Identities=26% Similarity=0.292 Sum_probs=144.4
Q ss_pred eecccCCeeEEEEEe----cCCcEEEEEEeccccc--ccHHHHHHHHHHHhccC-CCceeeEEeEEEeCCeeEEEEecCC
Q 004521 447 KLGEGGFGPVYKGTL----VDGQEIAVKRLSKISE--QGLKELKNEVILFSKLQ-HRNLVKLLGCCIQGEEKLLIYEFMP 519 (747)
Q Consensus 447 ~lg~G~fg~Vy~~~~----~~g~~vavK~l~~~~~--~~~~~~~~E~~~l~~l~-H~niv~l~g~~~~~~~~~lV~E~~~ 519 (747)
.+|+|.||.|++..- ..|..+|+|.+++... ......+.|..++..++ ||.+|++...+..+...+++++|..
T Consensus 1 vlg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~~r 80 (612)
T KOG0603|consen 1 VLGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDFLR 80 (612)
T ss_pred CCCcCCCcchHHHHHhccccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeeeccccchhHhhhhcc
Confidence 379999999997642 2377889999876321 11226677889999997 9999999999999999999999999
Q ss_pred CCChhhHhhhcCCCCcCChhHHHHHHHHHHHHHHHhhhcCCCceEecccCcCcEEEcCCCCceEecccCccccCCCCCc-
Q 004521 520 NKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETE- 598 (747)
Q Consensus 520 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~- 598 (747)
+|.|...+.. ...+.+.........++-+++++|+.+ |+|||+|++||+++.+|++|+.|||+++........
T Consensus 81 gg~lft~l~~---~~~f~~~~~~~~~aelaLald~lh~l~---iiyrd~k~enilld~~Ghi~~tdfglske~v~~~~~c 154 (612)
T KOG0603|consen 81 GGDLFTRLSK---EVMFDELDVAFYLAELALALDHLHKLG---IAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKEKIAC 154 (612)
T ss_pred cchhhhcccc---CCchHHHHHHHHHHHHHHHHhhcchhH---HHHhcccccceeecccCccccCCchhhhHhHhhhhcc
Confidence 9999877743 233556666667778899999999988 999999999999999999999999999876443322
Q ss_pred cccceeeeccCCCCCccccchhHHHHHHHHHhCCCCCCC
Q 004521 599 GNTNRVVGTYDGQFSIKSDVFSFGILLLEIVSGKKNRGF 637 (747)
Q Consensus 599 ~~~~~~~~~~~~~~s~ksDVwS~Gvvl~elltg~~p~~~ 637 (747)
....+.....-......+|.||||++.+||+||..||..
T Consensus 155 gt~eymApEI~~gh~~a~D~ws~gvl~felltg~~pf~~ 193 (612)
T KOG0603|consen 155 GTYEYRAPEIINGHLSAADWWSFGVLAFELLTGTLPFGG 193 (612)
T ss_pred cchhhhhhHhhhccCCcccchhhhhhHHHHhhCCCCCch
Confidence 111111111223577899999999999999999999753
|
|
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.56 E-value=2.6e-14 Score=145.60 Aligned_cols=135 Identities=17% Similarity=0.186 Sum_probs=105.5
Q ss_pred ceec-ccCCeeEEEEEecCCcEEEEEEecccc-------------cccHHHHHHHHHHHhccCCCce--eeEEeEEEeCC
Q 004521 446 NKLG-EGGFGPVYKGTLVDGQEIAVKRLSKIS-------------EQGLKELKNEVILFSKLQHRNL--VKLLGCCIQGE 509 (747)
Q Consensus 446 ~~lg-~G~fg~Vy~~~~~~g~~vavK~l~~~~-------------~~~~~~~~~E~~~l~~l~H~ni--v~l~g~~~~~~ 509 (747)
..|| .||.|+||+.... +..++||+..... ......+.+|+.++.+|+|++| ++.+++.....
T Consensus 37 ~~lg~~~g~gtv~~v~~~-~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~~ 115 (239)
T PRK01723 37 RVVGSAKGRGTTWFVQTP-GVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVVRH 115 (239)
T ss_pred ceeecCCCCccEEEEEeC-CceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeeeec
Confidence 5787 8999999999874 7789999875311 1223567889999999998875 67777754432
Q ss_pred e----eEEEEecCCC-CChhhHhhhcCCCCcCChhHHHHHHHHHHHHHHHhhhcCCCceEecccCcCcEEEcCCCCceEe
Q 004521 510 E----KLLIYEFMPN-KSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKIS 584 (747)
Q Consensus 510 ~----~~lV~E~~~~-gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NIll~~~~~~kl~ 584 (747)
. .++|||++++ .+|.+++.. ..++.. .+.+|+.+|.+||+.+ |+||||||.|||++.++.++|+
T Consensus 116 ~~~~~~~lV~e~l~G~~~L~~~l~~----~~l~~~----~~~~i~~~l~~lH~~G---I~HrDlkp~NILv~~~~~v~LI 184 (239)
T PRK01723 116 GLFYRADILIERIEGARDLVALLQE----APLSEE----QWQAIGQLIARFHDAG---VYHADLNAHNILLDPDGKFWLI 184 (239)
T ss_pred CcceeeeEEEEecCCCCCHHHHHhc----CCCCHH----HHHHHHHHHHHHHHCC---CCCCCCCchhEEEcCCCCEEEE
Confidence 2 2599999997 689888743 123332 3678999999999998 9999999999999999999999
Q ss_pred cccCcccc
Q 004521 585 DFGLVRTF 592 (747)
Q Consensus 585 DFGla~~~ 592 (747)
|||.++..
T Consensus 185 Dfg~~~~~ 192 (239)
T PRK01723 185 DFDRGELR 192 (239)
T ss_pred ECCCcccC
Confidence 99998764
|
|
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=99.46 E-value=2.7e-13 Score=150.03 Aligned_cols=142 Identities=25% Similarity=0.306 Sum_probs=101.8
Q ss_pred cceecccCCeeEEEEEecCCcEEEEEEeccccccc------------------------------H----------HHHH
Q 004521 445 NNKLGEGGFGPVYKGTLVDGQEIAVKRLSKISEQG------------------------------L----------KELK 484 (747)
Q Consensus 445 ~~~lg~G~fg~Vy~~~~~~g~~vavK~l~~~~~~~------------------------------~----------~~~~ 484 (747)
.+.||+|++|.||+|++.+|+.||||+.+...... . -.|.
T Consensus 122 ~~plasaSigQVh~A~l~~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf~ 201 (437)
T TIGR01982 122 EKPLAAASIAQVHRARLVDGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDLR 201 (437)
T ss_pred CcceeeeehhheEEEEecCCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCHH
Confidence 36899999999999999999999999986521100 0 0244
Q ss_pred HHHHHHhcc----CCCceeeEEeEEE-eCCeeEEEEecCCCCChhhHhhhcCCCCcCChhHHHHHHHHHHH-HHHHhhhc
Q 004521 485 NEVILFSKL----QHRNLVKLLGCCI-QGEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTAR-GLLYLHQD 558 (747)
Q Consensus 485 ~E~~~l~~l----~H~niv~l~g~~~-~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~-gl~yLH~~ 558 (747)
+|...+.++ +|.+-+.+-.++. .....+|||||+++++|.++....... . .+..++..++. .+..+|..
T Consensus 202 ~Ea~n~~~~~~~~~~~~~v~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~~~~--~---~~~~ia~~~~~~~l~ql~~~ 276 (437)
T TIGR01982 202 REAANASELGENFKNDPGVYVPEVYWDRTSERVLTMEWIDGIPLSDIAALDEAG--L---DRKALAENLARSFLNQVLRD 276 (437)
T ss_pred HHHHHHHHHHHhcCCCCCEEeCCEehhhcCCceEEEEeECCcccccHHHHHhcC--C---CHHHHHHHHHHHHHHHHHhC
Confidence 566655555 2333333333332 234579999999999998876432111 1 34557777666 47888988
Q ss_pred CCCceEecccCcCcEEEcCCCCceEecccCccccCC
Q 004521 559 SRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGG 594 (747)
Q Consensus 559 ~~~~iiHrDlkp~NIll~~~~~~kl~DFGla~~~~~ 594 (747)
+ ++|+|+||.||+++.++.++|.|||++..+..
T Consensus 277 g---~~H~D~hPgNilv~~~g~i~liDfG~~~~l~~ 309 (437)
T TIGR01982 277 G---FFHADLHPGNIFVLKDGKIIALDFGIVGRLSE 309 (437)
T ss_pred C---ceeCCCCcccEEECCCCcEEEEeCCCeeECCH
Confidence 8 99999999999999999999999999987643
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.45 E-value=4.9e-14 Score=150.47 Aligned_cols=181 Identities=24% Similarity=0.304 Sum_probs=121.9
Q ss_pred CccceecccCCeeEEEEEecCC----cEEEEEEecccccccHHHHHHHHHHHhcc-CCCceeeEEe-------EEE----
Q 004521 443 SINNKLGEGGFGPVYKGTLVDG----QEIAVKRLSKISEQGLKELKNEVILFSKL-QHRNLVKLLG-------CCI---- 506 (747)
Q Consensus 443 ~~~~~lg~G~fg~Vy~~~~~~g----~~vavK~l~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~g-------~~~---- 506 (747)
.+.+..++.+++.++......+ ..++.|.....+-.......+++-.+... +|+..+ +.. ...
T Consensus 247 ~~~k~~~~~~~~~~~~~q~~~~~s~~E~~~s~~~~~d~~~~~~~~~r~~~~l~~~~~~~~s~-~~d~~~s~~~~~~~~~v 325 (516)
T KOG1033|consen 247 SISKSSERVSSGIVFEKQGKNNSSLREWLKSKRADVDSLCACKYTFRQLGVLVDSSHSNRSI-LEDLRPSLFESSKRNKV 325 (516)
T ss_pred cccccccccccCCchhhhhcccchhhhhccchhhhccchhhhhhhhhhhhheeccccCCccc-ccCCCCchhhhcccccc
Confidence 3445667777777766554332 23344443332212222333444444444 344433 222 011
Q ss_pred -eCCeeEEEEecCCCCChhhHhhhcCCCCcCChhHHHHHHHHHHHHHHHhhhcCCCceEecccCcCcEEEcCCCCceEec
Q 004521 507 -QGEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISD 585 (747)
Q Consensus 507 -~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NIll~~~~~~kl~D 585 (747)
.....++.|+++...+|.+||.........++...+.++.|++.|++| ++ .+|||+||.||+...+..+||.|
T Consensus 326 ~~~~~lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y---k~---~ihrdlkp~nif~~~d~q~kIgD 399 (516)
T KOG1033|consen 326 GKKVYLYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY---KG---LIHRDLKPSNIFFSDDDQLKIGD 399 (516)
T ss_pred ccccchhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh---cc---chhhhccccccccccchhhhhhh
Confidence 123468999999999999999766656667888999999999999999 55 89999999999999999999999
Q ss_pred ccCccccCCCCC----ccccceeeec---------cCCCCCccccchhHHHHHHHHHh
Q 004521 586 FGLVRTFGGDET----EGNTNRVVGT---------YDGQFSIKSDVFSFGILLLEIVS 630 (747)
Q Consensus 586 FGla~~~~~~~~----~~~~~~~~~~---------~~~~~s~ksDVwS~Gvvl~ellt 630 (747)
||+......... ........++ .+..|+.|+||||+|+||+|++.
T Consensus 400 Fgl~ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~EL~~ 457 (516)
T KOG1033|consen 400 FGLVTSQDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILAELLI 457 (516)
T ss_pred hhheeecccCCcccchhhhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHHHHHH
Confidence 999887665541 1111112222 15789999999999999999998
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.35 E-value=9e-13 Score=150.26 Aligned_cols=205 Identities=22% Similarity=0.254 Sum_probs=126.8
Q ss_pred hcCCCccceecccCCeeEEEEEecC-CcEEEEEEecccccccHHHHHHHHHHHhccCCCceeeEEeEEEeCCeeEEEEec
Q 004521 439 TDNFSINNKLGEGGFGPVYKGTLVD-GQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEF 517 (747)
Q Consensus 439 ~~~~~~~~~lg~G~fg~Vy~~~~~~-g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~ 517 (747)
..+|+.++.|..|+||.||..+++. .+.+|+|+-++ + . -+++ ++.....|.+|
T Consensus 82 e~df~~IklisngAygavylvrh~~trqrfa~kiNkq-~-l---ilRn---ilt~a~npfvv------------------ 135 (1205)
T KOG0606|consen 82 ESDFNTIKLISNGAYGAVYLVRHKETRQRFAMKINKQ-N-L---ILRN---ILTFAGNPFVV------------------ 135 (1205)
T ss_pred ccccceeEeeccCCCCceeeeeccccccchhhccccc-c-h---hhhc---cccccCCccee------------------
Confidence 3588889999999999999998865 56788843221 1 0 0011 33333444443
Q ss_pred CCCCChhhHhhhcCCCCcCChhHHHHHHHHHHHHHHHhhhcCCCceEecccCcCcEEEcCCCCceEecccCccccCCCC-
Q 004521 518 MPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDE- 596 (747)
Q Consensus 518 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~- 596 (747)
|+-...+.. -+.++.. ++.+++|||+.+ |+|||+||+|.+|..-|++|++|||+++......
T Consensus 136 ---gDc~tllk~---~g~lPvd--------mvla~Eylh~yg---ivhrdlkpdnllIT~mGhiKlTDfgLsk~GLms~a 198 (1205)
T KOG0606|consen 136 ---GDCATLLKN---IGPLPVD--------MVLAVEYLHSYG---IVHRDLKPDNLLITSMGHIKLTDFGLSKKGLMSLA 198 (1205)
T ss_pred ---chhhhhccc---CCCCcch--------hhHHhHhhccCC---eecCCCCCCcceeeecccccccchhhhhhhhhhcc
Confidence 444444422 1223322 267899999988 9999999999999999999999999987432111
Q ss_pred ------------Cccccceeeecc---------CCCCCccccchhHHHHHHHHHhCCCCCCCCCCcchhhhhHhHHhcC-
Q 004521 597 ------------TEGNTNRVVGTY---------DGQFSIKSDVFSFGILLLEIVSGKKNRGFYRSDTKVNLIGHLWDEG- 654 (747)
Q Consensus 597 ------------~~~~~~~~~~~~---------~~~~s~ksDVwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~- 654 (747)
.+.....++|+. ...|...+|+|++|+|+||.+-|+.||.. +...++..++..+.
T Consensus 199 tnl~eg~I~k~t~Ef~dKqvcgTPeyiaPeVilrqgygkpvdwwamGiIlyeFLVgcvpffG---dtpeelfg~visd~i 275 (1205)
T KOG0606|consen 199 TNLKEGHIEKDTHEFQDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFG---DTPEELFGQVISDDI 275 (1205)
T ss_pred chhhhcchHHHHHHhhhccccCCccccChhhhhhhccCCCccHHHHHHHHHHHheeeeeccC---CCHHHHHhhhhhhhc
Confidence 111112233332 45688999999999999999999999643 33334444442221
Q ss_pred CcccccchhhhccCCHHHHHHHHHHHHhccCCCCCCCCCHHHHH
Q 004521 655 IPLRLIDACIQDSCNLADVIRCIHIGLLCVQQHPEDRPCMPSVI 698 (747)
Q Consensus 655 ~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dP~~RPt~~~v~ 698 (747)
..++- |.. ...+ +..++-+.|+.+|..|---...+
T Consensus 276 ~wpE~-dea-----~p~E---a~dli~~LL~qnp~~Rlgt~ga~ 310 (1205)
T KOG0606|consen 276 EWPEE-DEA-----LPPE---AQDLIEQLLRQNPLCRLGTGGAL 310 (1205)
T ss_pred ccccc-CcC-----CCHH---HHHHHHHHHHhChHhhcccchhh
Confidence 11111 111 1122 33444577889999995333333
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.33 E-value=2.3e-13 Score=155.29 Aligned_cols=247 Identities=23% Similarity=0.287 Sum_probs=171.7
Q ss_pred cCCCccceecccCCeeEEEEEecC--CcEEEEEEecccc--cccHHHHHHHHHHHhccC-CCceeeEEeEEEeCCeeEEE
Q 004521 440 DNFSINNKLGEGGFGPVYKGTLVD--GQEIAVKRLSKIS--EQGLKELKNEVILFSKLQ-HRNLVKLLGCCIQGEEKLLI 514 (747)
Q Consensus 440 ~~~~~~~~lg~G~fg~Vy~~~~~~--g~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~-H~niv~l~g~~~~~~~~~lV 514 (747)
..|.+.+.||+|+|+.|-...... ...+|+|.+.... .........|..+-..+. |+|++++++...+.+..+++
T Consensus 20 ~~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~~~~ 99 (601)
T KOG0590|consen 20 SQYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSYLLS 99 (601)
T ss_pred ccccccccccccccchhhhhhhcCCCcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCccCCCcccccc
Confidence 457777889999999999887644 4467777765432 333445556777777776 99999999999999999999
Q ss_pred EecCCCCChhhHhhhcCCCCcCChhHHHHHHHHHHHHHHHhh-hcCCCceEecccCcCcEEEcCCC-CceEecccCcccc
Q 004521 515 YEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLH-QDSRLRIIHRDLKASNVLLDQDM-NPKISDFGLVRTF 592 (747)
Q Consensus 515 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH-~~~~~~iiHrDlkp~NIll~~~~-~~kl~DFGla~~~ 592 (747)
+||..++++.+.+.. ......+.........|+..++.|+| ..+ +.||||||+|.+++..+ ..|++|||+|..+
T Consensus 100 ~~~s~g~~~f~~i~~-~~~~~~~~~~~~~~~~ql~s~l~~~H~~~~---~~h~~ikP~n~~l~~s~~~l~~~df~~At~~ 175 (601)
T KOG0590|consen 100 LSYSDGGSLFSKISH-PDSTGTSSSSASRYLPQLNSGLSYLHPENG---VTHRDIKPSNSLLDESGSALKIADFGLATAY 175 (601)
T ss_pred cCccccccccccccc-CCccCCCCcchhhhhhhhccCccccCcccc---cccCCCCCccchhccCCCcccCCCchhhccc
Confidence 999999999888732 11113556667778999999999999 777 99999999999999999 9999999999877
Q ss_pred CC-CCCccccceeee-cc---------C-CCCCccccchhHHHHHHHHHhCCCCCCCCCCcchhhhhHhHHhcCCccccc
Q 004521 593 GG-DETEGNTNRVVG-TY---------D-GQFSIKSDVFSFGILLLEIVSGKKNRGFYRSDTKVNLIGHLWDEGIPLRLI 660 (747)
Q Consensus 593 ~~-~~~~~~~~~~~~-~~---------~-~~~s~ksDVwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 660 (747)
.. ...........| .. + ....+..|+||.|+++.-+++|..|+......... ...+..........+
T Consensus 176 ~~~~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~~~-~~~~~~~~~~~~~~~ 254 (601)
T KOG0590|consen 176 RNKNGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKDGR-YSSWKSNKGRFTQLP 254 (601)
T ss_pred cccCCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCcccccccccc-ceeecccccccccCc
Confidence 65 333322222233 21 1 23456899999999999999999997654333211 111110111101111
Q ss_pred chhhhccCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 004521 661 DACIQDSCNLADVIRCIHIGLLCVQQHPEDRPCMPSVIL 699 (747)
Q Consensus 661 d~~l~~~~~~~~~~~~~~l~~~Cl~~dP~~RPt~~~v~~ 699 (747)
-..+ -.....+..+++..+|..|.+.+++..
T Consensus 255 ~~~~--------~~~~~~~l~k~l~~~~~~r~s~~~~~~ 285 (601)
T KOG0590|consen 255 WNSI--------SDQAHDLLHKILKENPSNRLSIEELKL 285 (601)
T ss_pred cccC--------ChhhhhcccccccCCchhccccccccc
Confidence 1111 012334455788899999998887743
|
|
| >cd00129 PAN_APPLE PAN/APPLE-like domain; present in N-terminal (N) domains of plasminogen/ hepatocyte growth factor proteins, plasma prekallikrein/coagulation factor XI and microneme antigen proteins, plant receptor-like protein kinases, and various nematode and leech anti-platelet proteins | Back alignment and domain information |
|---|
Probab=99.33 E-value=1.8e-12 Score=106.47 Aligned_cols=71 Identities=18% Similarity=0.251 Sum_probs=61.4
Q ss_pred cCCCCceEEeeccCCCCCCccccccccChHHHHHhhcc---CCceeEEeeecccCCCcceeeeeccc-cccccCCCCCcc
Q 004521 281 YSRQDGFIKFTELKLPDATSSWVSKSMNLKECREGCLE---NSSCMAYTNSDIRGGGSGCAMWFGEL-IDMRDFPGGGQD 356 (747)
Q Consensus 281 C~~~~~f~~~~~~~~p~~~~~~~~~~~s~~~C~~~Cl~---nCsC~a~~~~~~~~~~~~C~~~~~~l-~d~~~~~~~~~~ 356 (747)
|....+|+.+.++++|++.. .++++|++.|++ ||||.||+|.+. +++|.+|.++| .|++.....+.+
T Consensus 5 ~~~~g~fl~~~~~klpd~~~------~s~~eC~~~Cl~~~~nCsC~Aya~~~~---~~gC~~W~~~l~~d~~~~~~~g~~ 75 (80)
T cd00129 5 CKSAGTTLIKIALKIKTTKA------NTADECANRCEKNGLPFSCKAFVFAKA---RKQCLWFPFNSMSGVRKEFSHGFD 75 (80)
T ss_pred eecCCeEEEeecccCCcccc------cCHHHHHHHHhcCCCCCCceeeeccCC---CCCeEEecCcchhhHHhccCCCce
Confidence 33467899999999998765 589999999999 999999999642 45899999999 999988777899
Q ss_pred eeee
Q 004521 357 FYIR 360 (747)
Q Consensus 357 lylr 360 (747)
+|+|
T Consensus 76 Ly~r 79 (80)
T cd00129 76 LYEN 79 (80)
T ss_pred eEeE
Confidence 9997
|
Common structural features include two disulfide bonds that link the alpha-helix to the central region of the protein. PAN domains have significant functional versatility, fulfilling diverse biological functions by mediating protein-protein or protein-carbohydrate interactions. |
| >cd01098 PAN_AP_plant Plant PAN/APPLE-like domain; present in plant S-receptor protein kinases and secreted glycoproteins | Back alignment and domain information |
|---|
Probab=99.28 E-value=6.3e-12 Score=106.12 Aligned_cols=80 Identities=44% Similarity=0.982 Sum_probs=65.2
Q ss_pred CCCcCCC---CceEEeeccCCCCCCccccccccChHHHHHhhccCCceeEEeeecccCCCcceeeeeccccccccCCCCC
Q 004521 278 PLNYSRQ---DGFIKFTELKLPDATSSWVSKSMNLKECREGCLENSSCMAYTNSDIRGGGSGCAMWFGELIDMRDFPGGG 354 (747)
Q Consensus 278 ~l~C~~~---~~f~~~~~~~~p~~~~~~~~~~~s~~~C~~~Cl~nCsC~a~~~~~~~~~~~~C~~~~~~l~d~~~~~~~~ 354 (747)
+++|... +.|+.+.++++|+..+.. ..+++++|++.||+||+|.||+|.+ ++++|.+|.+.+.+.+.....+
T Consensus 2 ~~~C~~~~~~~~f~~~~~~~~~~~~~~~--~~~s~~~C~~~Cl~nCsC~a~~~~~---~~~~C~~~~~~~~~~~~~~~~~ 76 (84)
T cd01098 2 PLNCGGDGSTDGFLKLPDVKLPDNASAI--TAISLEECREACLSNCSCTAYAYNN---GSGGCLLWNGLLNNLRSLSSGG 76 (84)
T ss_pred CcccCCCCCCCEEEEeCCeeCCCchhhh--ccCCHHHHHHHHhcCCCcceeeecC---CCCeEEEEeceecceEeecCCC
Confidence 4567543 689999999999886653 6789999999999999999999963 4678999999998887655556
Q ss_pred cceeeecc
Q 004521 355 QDFYIRMS 362 (747)
Q Consensus 355 ~~lylrl~ 362 (747)
..+|||++
T Consensus 77 ~~~yiKv~ 84 (84)
T cd01098 77 GTLYLRLA 84 (84)
T ss_pred cEEEEEeC
Confidence 78999874
|
PAN/APPLE domains fulfill diverse biological functions by mediating protein-protein or protein-carbohydrate interactions. S-receptor protein kinases and S-locus glycoproteins are involved in sporophytic self-incompatibility response in Brassica, one of probably many molecular mechanisms, by which hermaphrodite flowering plants avoid self-fertilization. |
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=99.27 E-value=1.8e-11 Score=137.15 Aligned_cols=144 Identities=22% Similarity=0.258 Sum_probs=94.4
Q ss_pred cCCCccceecccCCeeEEEEEecC-CcEEEEEEeccccc----------------------------------ccHH---
Q 004521 440 DNFSINNKLGEGGFGPVYKGTLVD-GQEIAVKRLSKISE----------------------------------QGLK--- 481 (747)
Q Consensus 440 ~~~~~~~~lg~G~fg~Vy~~~~~~-g~~vavK~l~~~~~----------------------------------~~~~--- 481 (747)
..|+. +.||+|++|.||+|++++ |+.||||++++.-. +..+
T Consensus 120 ~~fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l~ 198 (537)
T PRK04750 120 DDFDI-KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTLH 198 (537)
T ss_pred HhcCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHHH
Confidence 45665 789999999999999988 99999999975210 0011
Q ss_pred ---HHHHHHHHHhccC----CCceeeEEeEEEe-CCeeEEEEecCCCCChhhHhhhcCCC---CcCChhHHHHHHHHHHH
Q 004521 482 ---ELKNEVILFSKLQ----HRNLVKLLGCCIQ-GEEKLLIYEFMPNKSLDSFIFDQTRR---TLLDWSQRFHIICGTAR 550 (747)
Q Consensus 482 ---~~~~E~~~l~~l~----H~niv~l~g~~~~-~~~~~lV~E~~~~gsL~~~l~~~~~~---~~l~~~~~~~i~~~ia~ 550 (747)
+|.+|+..+.+++ +.+.+.+-.++.+ ....+|||||++|+.+.++-.-.... ..+.......++
T Consensus 199 ~ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~~g~d~~~la~~~v~~~~----- 273 (537)
T PRK04750 199 DELDLMREAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRAAGTDMKLLAERGVEVFF----- 273 (537)
T ss_pred HhhCHHHHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHhcCCCHHHHHHHHHHHHH-----
Confidence 1344444444442 4444444444433 45678999999999998753211111 112222222222
Q ss_pred HHHHhhhcCCCceEecccCcCcEEEcCCC----CceEecccCccccCC
Q 004521 551 GLLYLHQDSRLRIIHRDLKASNVLLDQDM----NPKISDFGLVRTFGG 594 (747)
Q Consensus 551 gl~yLH~~~~~~iiHrDlkp~NIll~~~~----~~kl~DFGla~~~~~ 594 (747)
..++..| ++|+|+||.||+++.++ .+++.|||++..+..
T Consensus 274 --~Qif~~G---ffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~~ 316 (537)
T PRK04750 274 --TQVFRDG---FFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLNK 316 (537)
T ss_pred --HHHHhCC---eeeCCCChHHeEEecCCCCCCeEEEEecceEEECCH
Confidence 3334456 99999999999999988 999999999876643
|
|
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=99.27 E-value=1.8e-11 Score=118.16 Aligned_cols=131 Identities=23% Similarity=0.134 Sum_probs=97.9
Q ss_pred cceecccCCeeEEEEEecCCcEEEEEEecccccccHHHHHHHHHHHhccCCCcee-eEEeEEEeCCeeEEEEecCCCCCh
Q 004521 445 NNKLGEGGFGPVYKGTLVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLV-KLLGCCIQGEEKLLIYEFMPNKSL 523 (747)
Q Consensus 445 ~~~lg~G~fg~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv-~l~g~~~~~~~~~lV~E~~~~gsL 523 (747)
.+.|+.|.++.||+++.. ++.+++|....... ....+.+|+.+++.+.+.+++ +++++. ....++||||+++.++
T Consensus 3 ~~~l~~G~~~~vy~~~~~-~~~~~lK~~~~~~~-~~~~~~~E~~~l~~l~~~~~~P~~~~~~--~~~~~lv~e~i~G~~l 78 (170)
T cd05151 3 ISPLKGGMTNKNYRVEVA-NKKYVVRIPGNGTE-LLINRENEAENSKLAAEAGIGPKLYYFD--PETGVLITEFIEGSEL 78 (170)
T ss_pred eeecCCcccCceEEEEEC-CeEEEEEeCCCCcc-cccCHHHHHHHHHHHHHhCCCCceEEEe--CCCCeEEEEecCCCcc
Confidence 367899999999999874 77899998764321 233567899999988665544 455443 3346899999999887
Q ss_pred hhHhhhcCCCCcCChhHHHHHHHHHHHHHHHhhhcC--CCceEecccCcCcEEEcCCCCceEecccCccc
Q 004521 524 DSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDS--RLRIIHRDLKASNVLLDQDMNPKISDFGLVRT 591 (747)
Q Consensus 524 ~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~--~~~iiHrDlkp~NIll~~~~~~kl~DFGla~~ 591 (747)
.... .....++.+++++|+.||+.+ ...++|+|++|.||+++ ++.++|+|||.+..
T Consensus 79 ~~~~-----------~~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~~ 136 (170)
T cd05151 79 LTED-----------FSDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAGM 136 (170)
T ss_pred cccc-----------ccCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEecccccC
Confidence 6430 111345678999999999876 23469999999999999 67899999998753
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >KOG1266 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.17 E-value=4.3e-11 Score=120.32 Aligned_cols=195 Identities=19% Similarity=0.199 Sum_probs=124.9
Q ss_pred HHHHhccCCCceeeEEeEEEeCC-----eeEEEEecCCCCChhhHhhhcCC-CCcCChhHHHHHHHHHHHHHHHhhhcCC
Q 004521 487 VILFSKLQHRNLVKLLGCCIQGE-----EKLLIYEFMPNKSLDSFIFDQTR-RTLLDWSQRFHIICGTARGLLYLHQDSR 560 (747)
Q Consensus 487 ~~~l~~l~H~niv~l~g~~~~~~-----~~~lV~E~~~~gsL~~~l~~~~~-~~~l~~~~~~~i~~~ia~gl~yLH~~~~ 560 (747)
..-|-.+-|.|||+++.|..+.+ ...++.|||..|+|..+|+...+ ...+......+++.||+.||.|||+..
T Consensus 118 FdnllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs~~- 196 (458)
T KOG1266|consen 118 FDNLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHSCD- 196 (458)
T ss_pred HHHHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhccC-
Confidence 34455667999999999876543 46789999999999999976543 344677777889999999999999975
Q ss_pred CceEecccCcCcEEEcCCCCceEecccCccc------cCCCCC---ccccceeeecc--CCCCCccccchhHHHHHHHHH
Q 004521 561 LRIIHRDLKASNVLLDQDMNPKISDFGLVRT------FGGDET---EGNTNRVVGTY--DGQFSIKSDVFSFGILLLEIV 629 (747)
Q Consensus 561 ~~iiHrDlkp~NIll~~~~~~kl~DFGla~~------~~~~~~---~~~~~~~~~~~--~~~~s~ksDVwS~Gvvl~ell 629 (747)
++|+|+++.-+-|++..++.+||.--..... ....+. ..........+ ....+.++|||+||+..+||-
T Consensus 197 PpiihgnlTc~tifiq~ngLIkig~~ap~s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~tn~~~a~dIy~fgmcAlema 276 (458)
T KOG1266|consen 197 PPIIHGNLTCDTIFIQHNGLIKIGSVAPDSTHPSVNSTREAEKSVNTSLPGFSAPESGTTTNTTGASDIYKFGMCALEMA 276 (458)
T ss_pred CccccCCcchhheeecCCceEEecccCccccchhhhhhhHhhhhccccCCccccCCcCcccccccchhhhhhhHHHHHHH
Confidence 7899999999999999999998853221110 000000 00000000001 123456899999999999998
Q ss_pred hCCCC-CCCCCCcchhhhhHhHHhcCCcccccchhhhccCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 004521 630 SGKKN-RGFYRSDTKVNLIGHLWDEGIPLRLIDACIQDSCNLADVIRCIHIGLLCVQQHPEDRPCMPSVIL 699 (747)
Q Consensus 630 tg~~p-~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dP~~RPt~~~v~~ 699 (747)
-++.- ....+......-+... ...+-+..-+ .++..|++.+|..||+|.+++.
T Consensus 277 ilEiq~tnseS~~~~ee~ia~~-----i~~len~lqr------------~~i~kcl~~eP~~rp~ar~llf 330 (458)
T KOG1266|consen 277 ILEIQSTNSESKVEVEENIANV-----IIGLENGLQR------------GSITKCLEGEPNGRPDARLLLF 330 (458)
T ss_pred HheeccCCCcceeehhhhhhhh-----eeeccCcccc------------CcCcccccCCCCCCcchhhhhc
Confidence 88753 2211111111111111 0111111111 2233799999999999998864
|
|
| >KOG1243 consensus Protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.15 E-value=2.7e-10 Score=125.46 Aligned_cols=163 Identities=17% Similarity=0.269 Sum_probs=121.9
Q ss_pred ecCCcEEEEEEecccccccHHHHHHHHHHHhccCCCceeeEEeEEEeCCeeEEEEecCCCCChhhHhhhcCCCCcCChhH
Q 004521 461 LVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQ 540 (747)
Q Consensus 461 ~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~ 540 (747)
..++.+|.|...+..+........+-++.|+.++||||++++...+..+..|||+|-+ ..|..++.. +....
T Consensus 34 k~~~~~vsVF~~~~~~~~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTErV--~Pl~~~lk~------l~~~~ 105 (690)
T KOG1243|consen 34 KADGGPVSVFVYKRSNGEVTELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTERV--RPLETVLKE------LGKEE 105 (690)
T ss_pred eccCCceEEEEEeCCCchhhHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEeecc--ccHHHHHHH------hHHHH
Confidence 3458888888887655544556788899999999999999999999999999999987 466666644 23456
Q ss_pred HHHHHHHHHHHHHHhhhcCCCceEecccCcCcEEEcCCCCceEecccCccccCCCCCccccceeeeccC-----CCCCcc
Q 004521 541 RFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNTNRVVGTYD-----GQFSIK 615 (747)
Q Consensus 541 ~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~~~~-----~~~s~k 615 (747)
....+.||+.||.|||..+ +++|++|.-..|++++.|+.||++|-++....+-............+. .+-.-.
T Consensus 106 v~~Gl~qIl~AL~FL~~d~--~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~~~~~~~~~~s~~~P~~~~~s~~s 183 (690)
T KOG1243|consen 106 VCLGLFQILAALSFLNDDC--NLVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNAPAKSLYLIESFDDPEEIDPSEWS 183 (690)
T ss_pred HHHHHHHHHHHHHHHhccC--CeeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCcccccchhhhcccChhhcCccccc
Confidence 6677899999999999766 599999999999999999999999988765433222111111111111 111123
Q ss_pred ccchhHHHHHHHHHhCCC
Q 004521 616 SDVFSFGILLLEIVSGKK 633 (747)
Q Consensus 616 sDVwS~Gvvl~elltg~~ 633 (747)
.|.|-||++++|++.|..
T Consensus 184 ~D~~~Lg~li~el~ng~~ 201 (690)
T KOG1243|consen 184 IDSWGLGCLIEELFNGSL 201 (690)
T ss_pred hhhhhHHHHHHHHhCccc
Confidence 599999999999999943
|
|
| >cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain | Back alignment and domain information |
|---|
Probab=99.14 E-value=6.7e-10 Score=108.33 Aligned_cols=138 Identities=14% Similarity=0.129 Sum_probs=99.8
Q ss_pred cceecccCCeeEEEEEecC-------CcEEEEEEeccc-------------cc---------ccHHHHH----HHHHHHh
Q 004521 445 NNKLGEGGFGPVYKGTLVD-------GQEIAVKRLSKI-------------SE---------QGLKELK----NEVILFS 491 (747)
Q Consensus 445 ~~~lg~G~fg~Vy~~~~~~-------g~~vavK~l~~~-------------~~---------~~~~~~~----~E~~~l~ 491 (747)
...||.|.-+.||.|...+ +..+|||+.+.. .. ...+.+. +|.+.|.
T Consensus 2 ~g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~ 81 (197)
T cd05146 2 NGCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLK 81 (197)
T ss_pred CCccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHH
Confidence 3578999999999998653 479999986421 00 0122333 7999999
Q ss_pred ccCC--CceeeEEeEEEeCCeeEEEEecCCCCChhhHhhhcCCCCcCChhHHHHHHHHHHHHHHHh-hhcCCCceEeccc
Q 004521 492 KLQH--RNLVKLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYL-HQDSRLRIIHRDL 568 (747)
Q Consensus 492 ~l~H--~niv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yL-H~~~~~~iiHrDl 568 (747)
++.. -++.+.+++ ...+|||||+.+..+..... +...++..+...+..+++.+|..| |..+ ++|+||
T Consensus 82 rl~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~L---kd~~~~~~~~~~i~~~i~~~l~~l~H~~g---lVHGDL 151 (197)
T cd05146 82 RMQKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPKL---KDAKLNDEEMKNAYYQVLSMMKQLYKECN---LVHADL 151 (197)
T ss_pred HHHHcCCCCCeEEEe----cCCEEEEEEcCCCCccchhh---hccccCHHHHHHHHHHHHHHHHHHHHhCC---eecCCC
Confidence 9853 466677764 46789999998654432211 112244456677889999999999 7777 999999
Q ss_pred CcCcEEEcCCCCceEecccCccccC
Q 004521 569 KASNVLLDQDMNPKISDFGLVRTFG 593 (747)
Q Consensus 569 kp~NIll~~~~~~kl~DFGla~~~~ 593 (747)
++.|||++ ++.+.|+|||.+....
T Consensus 152 s~~NIL~~-~~~v~iIDF~qav~~~ 175 (197)
T cd05146 152 SEYNMLWH-DGKVWFIDVSQSVEPT 175 (197)
T ss_pred CHHHEEEE-CCcEEEEECCCceeCC
Confidence 99999997 4679999999887654
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown. |
| >cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins | Back alignment and domain information |
|---|
Probab=99.08 E-value=7.6e-10 Score=111.71 Aligned_cols=142 Identities=19% Similarity=0.232 Sum_probs=109.8
Q ss_pred ceecccCCeeEEEEEecCCcEEEEEEeccccc-ccHHHHHHHHHHHhccCC--CceeeEEeEEEeCC---eeEEEEecCC
Q 004521 446 NKLGEGGFGPVYKGTLVDGQEIAVKRLSKISE-QGLKELKNEVILFSKLQH--RNLVKLLGCCIQGE---EKLLIYEFMP 519 (747)
Q Consensus 446 ~~lg~G~fg~Vy~~~~~~g~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~H--~niv~l~g~~~~~~---~~~lV~E~~~ 519 (747)
+.|+.|..+.||+++..+|+.+++|....... .....+..|+++++.+++ .++.+++.+..... ..++||||++
T Consensus 4 ~~l~~G~~n~~~~v~~~~g~~~ilK~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e~i~ 83 (223)
T cd05154 4 RQLSGGQSNLTYLLTAGGGRRLVLRRPPPGALLPSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVMERVD 83 (223)
T ss_pred eecCCCccceEEEEEecCCcceEEEeCCCcccCcccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEEEeC
Confidence 67899999999999987778999999765322 245678999999999975 44677887776543 5689999999
Q ss_pred CCChhhHhhhcCCCCcCChhHHHHHHHHHHHHHHHhhhcC----------------------------------------
Q 004521 520 NKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDS---------------------------------------- 559 (747)
Q Consensus 520 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~---------------------------------------- 559 (747)
+.++.+.+.. ..++..++..++.+++++|.+||+..
T Consensus 84 G~~l~~~~~~----~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (223)
T cd05154 84 GRVLRDRLLR----PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAMER 159 (223)
T ss_pred CEecCCCCCC----CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHHHH
Confidence 9988765521 23566777788888888888888521
Q ss_pred -------------CCceEecccCcCcEEEcC--CCCceEecccCccc
Q 004521 560 -------------RLRIIHRDLKASNVLLDQ--DMNPKISDFGLVRT 591 (747)
Q Consensus 560 -------------~~~iiHrDlkp~NIll~~--~~~~kl~DFGla~~ 591 (747)
...++|+|++|.||+++. ++.+.|+||+.+..
T Consensus 160 ~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~ 206 (223)
T cd05154 160 LLRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATL 206 (223)
T ss_pred HHHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEecccccc
Confidence 245899999999999998 56689999997753
|
This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain |
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.99 E-value=5.1e-10 Score=122.35 Aligned_cols=240 Identities=20% Similarity=0.258 Sum_probs=164.6
Q ss_pred CCCccceecc--cCCeeEEEEEe---cCCcEEEEEEecc--cccccHHHHHHHHHHHhcc-CCCceeeEEeEEEeCCeeE
Q 004521 441 NFSINNKLGE--GGFGPVYKGTL---VDGQEIAVKRLSK--ISEQGLKELKNEVILFSKL-QHRNLVKLLGCCIQGEEKL 512 (747)
Q Consensus 441 ~~~~~~~lg~--G~fg~Vy~~~~---~~g~~vavK~l~~--~~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~ 512 (747)
.|.+...+|+ |.+|.||.+.. .++..+|+|+-+. ........=.+|+..-.++ .|+|.++.......++..+
T Consensus 115 ~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e~~~~lf 194 (524)
T KOG0601|consen 115 RFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPAWEGSGILF 194 (524)
T ss_pred hcccccccccCCCCCceeecccCCcccCCcccccccccCCCCCccccccccchhhcccccCccccccccCcccccCCcce
Confidence 4566788999 99999999987 3478899998443 1122223334566666666 4999999888888899999
Q ss_pred EEEecCCCCChhhHhhhcCCCCcCChhHHHHHHHHHHH----HHHHhhhcCCCceEecccCcCcEEEcCC-CCceEeccc
Q 004521 513 LIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTAR----GLLYLHQDSRLRIIHRDLKASNVLLDQD-MNPKISDFG 587 (747)
Q Consensus 513 lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~----gl~yLH~~~~~~iiHrDlkp~NIll~~~-~~~kl~DFG 587 (747)
+=+|++. .+|..+... ....++....+....+... ||.++|... ++|-|+||.||++..+ ...+++|||
T Consensus 195 iqtE~~~-~sl~~~~~~--~~~~~p~~~l~~~~~~~~~~~~~al~~~hs~~---~~~~~~kp~~i~~~~~~~s~~~~df~ 268 (524)
T KOG0601|consen 195 IQTELCG-ESLQSYCHT--PCNFLPDNLLWNSLRDWLSRDVTALSHLHSNN---IVHDDLKPANIFTTSDWTSCKLTDFG 268 (524)
T ss_pred eeecccc-chhHHhhhc--ccccCCchhhhhHHhhhhhcccccccccCCCc---ccccccchhheecccccceeecCCcc
Confidence 9999885 778777744 3334677777888888888 999999988 9999999999999999 889999999
Q ss_pred CccccCCCCCccccceee-----------eccCCCCCccccchhHHHHHHHHHhCCCCCCCCCCcchhhhhHhHHhcCCc
Q 004521 588 LVRTFGGDETEGNTNRVV-----------GTYDGQFSIKSDVFSFGILLLEIVSGKKNRGFYRSDTKVNLIGHLWDEGIP 656 (747)
Q Consensus 588 la~~~~~~~~~~~~~~~~-----------~~~~~~~s~ksDVwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~ 656 (747)
+...++............ ...++.++.+.|+||+|.+..|..++-.......... |.+...
T Consensus 269 ~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~--------W~~~r~ 340 (524)
T KOG0601|consen 269 LVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSS--------WSQLRQ 340 (524)
T ss_pred eeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCC--------cccccc
Confidence 998876554322211100 1126778899999999999999999876532110000 111000
Q ss_pred ccccchhhhccCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 004521 657 LRLIDACIQDSCNLADVIRCIHIGLLCVQQHPEDRPCMPSVIL 699 (747)
Q Consensus 657 ~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dP~~RPt~~~v~~ 699 (747)
.-+.+..... .. .++..+..++++.+|..|++...++.
T Consensus 341 ~~ip~e~~~~-~s----~~l~~~~~~~~d~~~~~~~~~q~~~~ 378 (524)
T KOG0601|consen 341 GYIPLEFCEG-GS----SSLRSVTSQMLDEDPRLRLTAQILTA 378 (524)
T ss_pred ccCchhhhcC-cc----hhhhhHHHHhcCcchhhhhHHHHHhc
Confidence 0011111111 01 11222566799999999998866654
|
|
| >COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.99 E-value=3e-09 Score=100.08 Aligned_cols=131 Identities=20% Similarity=0.302 Sum_probs=100.0
Q ss_pred ceecccCCeeEEEEEecCCcEEEEEE-eccccc-------ccHHHHHHHHHHHhccCCCceeeEEeEEEeCCeeEEEEec
Q 004521 446 NKLGEGGFGPVYKGTLVDGQEIAVKR-LSKISE-------QGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEF 517 (747)
Q Consensus 446 ~~lg~G~fg~Vy~~~~~~g~~vavK~-l~~~~~-------~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~ 517 (747)
..+++|+-+.+|.+.+. |..+++|. +++.-. -......+|+.++.+++--.|.--+=+..+.....|+|||
T Consensus 2 ~~i~~GAEa~i~~~~~~-g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~~~~~I~me~ 80 (204)
T COG3642 2 DLIKQGAEAIIYLTDFL-GLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDPDNGLIVMEY 80 (204)
T ss_pred chhhCCcceeEEeeecc-CcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCEEEEEE
Confidence 46789999999999764 34466664 333111 1134567899999998766665555566778888999999
Q ss_pred CCCCChhhHhhhcCCCCcCChhHHHHHHHHHHHHHHHhhhcCCCceEecccCcCcEEEcCCCCceEecccCccc
Q 004521 518 MPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRT 591 (747)
Q Consensus 518 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NIll~~~~~~kl~DFGla~~ 591 (747)
+++-.|.+++... ...++..+-.-+.-||..+ |+|+||.++||++..+. +.++||||+..
T Consensus 81 I~G~~lkd~l~~~----------~~~~~r~vG~~vg~lH~~g---ivHGDLTtsNiIl~~~~-i~~IDfGLg~~ 140 (204)
T COG3642 81 IEGELLKDALEEA----------RPDLLREVGRLVGKLHKAG---IVHGDLTTSNIILSGGR-IYFIDFGLGEF 140 (204)
T ss_pred eCChhHHHHHHhc----------chHHHHHHHHHHHHHHhcC---eecCCCccceEEEeCCc-EEEEECCcccc
Confidence 9999999888543 2456777777888899998 99999999999998777 99999999874
|
|
| >KOG3087 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.91 E-value=1.5e-08 Score=94.90 Aligned_cols=144 Identities=24% Similarity=0.284 Sum_probs=106.7
Q ss_pred ccceecccCCeeEEEEEecCCcEEEEEE-eccc-------ccccHHHHHHHHHHHhccCCCceeeEEeEEEeCCeeEEEE
Q 004521 444 INNKLGEGGFGPVYKGTLVDGQEIAVKR-LSKI-------SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIY 515 (747)
Q Consensus 444 ~~~~lg~G~fg~Vy~~~~~~g~~vavK~-l~~~-------~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 515 (747)
....|-+|+-+.|+++.. .|+...||. +.+. ..-..+..++|++++.+++--.|.--.-++.+...-.|+|
T Consensus 11 ~l~likQGAEArv~~~~~-~Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~~~i~M 89 (229)
T KOG3087|consen 11 SLELIKQGAEARVPRGSF-SGEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTYGGQIYM 89 (229)
T ss_pred cceeeeccceeeEeeecc-CCceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecCCCeEEE
Confidence 457899999999999988 466666664 3331 1123456788999999987656555555667777778999
Q ss_pred ecCCC-CChhhHhhhcCCCCcCChhHHHHHHHHHHHHHHHhhhcCCCceEecccCcCcEEEcCCCC---ceEecccCccc
Q 004521 516 EFMPN-KSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMN---PKISDFGLVRT 591 (747)
Q Consensus 516 E~~~~-gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NIll~~~~~---~kl~DFGla~~ 591 (747)
||+++ .++.+++...-..... ......++..|-+.+.-||.+. |||+||..+||+|..++. +.|+|||++..
T Consensus 90 E~~~g~~~vk~~i~~~~~~~~~-d~~~~~~~~~iG~~igklH~nd---iiHGDLTTSNill~~~~~~~~~~lIdfgls~~ 165 (229)
T KOG3087|consen 90 EFIDGASTVKDFILSTMEDESE-DEGLAELARRIGELIGKLHDND---IIHGDLTTSNILLRSDGNQITPILIDFGLSSV 165 (229)
T ss_pred EeccchhHHHHHHHHHccCccc-chhHHHHHHHHHHHHHHhhhCC---eecccccccceEEecCCCcCceEEEeecchhc
Confidence 99986 4788888765443222 2233678888999999999988 999999999999976653 57999999765
Q ss_pred c
Q 004521 592 F 592 (747)
Q Consensus 592 ~ 592 (747)
-
T Consensus 166 s 166 (229)
T KOG3087|consen 166 S 166 (229)
T ss_pred c
Confidence 3
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.89 E-value=2e-09 Score=117.84 Aligned_cols=243 Identities=20% Similarity=0.189 Sum_probs=163.6
Q ss_pred HhcCCCccceecccCCeeEEEEEec--CCcEEEEEEecccccccHHHH--HHHHHHHhcc-CCCceeeEEeEEEeCCeeE
Q 004521 438 ATDNFSINNKLGEGGFGPVYKGTLV--DGQEIAVKRLSKISEQGLKEL--KNEVILFSKL-QHRNLVKLLGCCIQGEEKL 512 (747)
Q Consensus 438 ~~~~~~~~~~lg~G~fg~Vy~~~~~--~g~~vavK~l~~~~~~~~~~~--~~E~~~l~~l-~H~niv~l~g~~~~~~~~~ 512 (747)
-..+|..+..||.|.|+.|++.... ++..+++|.+.+.......+. ..|+.+...+ .|.++++........+..+
T Consensus 263 ~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~~~ 342 (524)
T KOG0601|consen 263 KLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLRQGY 342 (524)
T ss_pred ecCCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCCcccccccc
Confidence 3457888899999999999998754 477899998876332222221 3455555555 5888888777777777778
Q ss_pred EEEecCCCCChhhHhhhcCCCCcCChhHHHHHHHHHHHHHHHhhhcCCCceEecccCcCcEEEcCC-CCceEecccCccc
Q 004521 513 LIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQD-MNPKISDFGLVRT 591 (747)
Q Consensus 513 lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NIll~~~-~~~kl~DFGla~~ 591 (747)
+=.||++++++...+. -...++...++++..|++.++.++|+.. ++|+|+||+||++..+ +.-++.|||.+..
T Consensus 343 ip~e~~~~~s~~l~~~---~~~~~d~~~~~~~~~q~~~~l~~i~s~~---~~~~d~~psni~i~~~~~~~~~~~~~~~t~ 416 (524)
T KOG0601|consen 343 IPLEFCEGGSSSLRSV---TSQMLDEDPRLRLTAQILTALNVIHSKL---FVHLDVKPSNILISNDGFFSKLGDFGCWTR 416 (524)
T ss_pred CchhhhcCcchhhhhH---HHHhcCcchhhhhHHHHHhccccccchh---hhcccccccceeeccchhhhhccccccccc
Confidence 8899999999876662 2334778889999999999999999877 9999999999999886 8889999999864
Q ss_pred cCCCC---Cccccce---eeeccCCCCCccccchhHHHHHHHHHhCCCCCCCCCCcchhhhhHhHHhcCCcccccchhhh
Q 004521 592 FGGDE---TEGNTNR---VVGTYDGQFSIKSDVFSFGILLLEIVSGKKNRGFYRSDTKVNLIGHLWDEGIPLRLIDACIQ 665 (747)
Q Consensus 592 ~~~~~---~~~~~~~---~~~~~~~~~s~ksDVwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 665 (747)
+.-.. .....-. ..-.....+..+.|++|||..+.|.+++..-...... +. ....+.....
T Consensus 417 ~~~~~~~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls~~~~~-----~~--~i~~~~~p~~------ 483 (524)
T KOG0601|consen 417 LAFSSGVFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPLSESGVQ-----SL--TIRSGDTPNL------ 483 (524)
T ss_pred cceecccccccccccccchhhccccccccccccccccccccccccCcccCccccc-----ce--eeecccccCC------
Confidence 32111 1111111 1111245677899999999999999998765321110 00 0111211111
Q ss_pred ccCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhcC
Q 004521 666 DSCNLADVIRCIHIGLLCVQQHPEDRPCMPSVILMLGS 703 (747)
Q Consensus 666 ~~~~~~~~~~~~~l~~~Cl~~dP~~RPt~~~v~~~L~~ 703 (747)
.....+.. .+.......++..||.+.++..+.+-
T Consensus 484 -~~~~~~~q---~~~kv~~~~~~~~~~l~~~l~~~~~~ 517 (524)
T KOG0601|consen 484 -PGLKLQLQ---VLLKVMINPDRKRRPSAVELSLHSEF 517 (524)
T ss_pred -CchHHhhh---hhhhhhcCCccccchhhhhhcccchh
Confidence 11112222 23335778999999999888776554
|
|
| >PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.79 E-value=4.5e-08 Score=95.20 Aligned_cols=126 Identities=23% Similarity=0.272 Sum_probs=83.9
Q ss_pred eEEEEEecCCcEEEEEEecccc-------------cc-------------cHHHHHHHHHHHhccCCC--ceeeEEeEEE
Q 004521 455 PVYKGTLVDGQEIAVKRLSKIS-------------EQ-------------GLKELKNEVILFSKLQHR--NLVKLLGCCI 506 (747)
Q Consensus 455 ~Vy~~~~~~g~~vavK~l~~~~-------------~~-------------~~~~~~~E~~~l~~l~H~--niv~l~g~~~ 506 (747)
.||.|...+|..+|||+-+... .. .....++|.+.|.++... ++.+.+++.
T Consensus 1 ~Vy~~~~~~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~~- 79 (188)
T PF01163_consen 1 DVYHAIDPDGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDYN- 79 (188)
T ss_dssp EEEEEEECTTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEEE-
T ss_pred CEEEEECCCCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEEe-
Confidence 3899999899999999865310 00 123467899999999765 566666552
Q ss_pred eCCeeEEEEecCC--CCChhhHhhhcCCCCcCChhHHHHHHHHHHHHHHH-hhhcCCCceEecccCcCcEEEcCCCCceE
Q 004521 507 QGEEKLLIYEFMP--NKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLY-LHQDSRLRIIHRDLKASNVLLDQDMNPKI 583 (747)
Q Consensus 507 ~~~~~~lV~E~~~--~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~y-LH~~~~~~iiHrDlkp~NIll~~~~~~kl 583 (747)
...|||||++ +..+..+. .. .++......++.+++..+.. +|..+ |+|+||.+.|||++++ .+.|
T Consensus 80 ---~~~ivME~I~~~G~~~~~l~-~~----~~~~~~~~~~~~~il~~~~~~~~~~g---ivHGDLs~~NIlv~~~-~~~i 147 (188)
T PF01163_consen 80 ---RNVIVMEYIGEDGVPLPRLK-DV----DLSPEEPKELLEEILEEIIKMLHKAG---IVHGDLSEYNILVDDG-KVYI 147 (188)
T ss_dssp ---TTEEEEE--EETTEEGGCHH-HC----GGGGSTHHHHHHHHHHHHHHHHHCTT---EEESS-STTSEEEETT-CEEE
T ss_pred ---CCEEEEEecCCCccchhhHH-hc----cccchhHHHHHHHHHHHHHHHHHhcC---ceecCCChhhEEeecc-eEEE
Confidence 4589999998 55554433 21 12234556777888886666 46777 9999999999999988 9999
Q ss_pred ecccCccccC
Q 004521 584 SDFGLVRTFG 593 (747)
Q Consensus 584 ~DFGla~~~~ 593 (747)
+|||.+....
T Consensus 148 IDf~qav~~~ 157 (188)
T PF01163_consen 148 IDFGQAVDSS 157 (188)
T ss_dssp --GTTEEETT
T ss_pred EecCcceecC
Confidence 9999887654
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A. |
| >PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional | Back alignment and domain information |
|---|
Probab=98.78 E-value=1e-07 Score=98.30 Aligned_cols=141 Identities=17% Similarity=0.121 Sum_probs=100.8
Q ss_pred ceecccCCeeEEEEEecCCcEEEEEEeccccc-----------ccHHHHHHHHHHHhccCCC--ceeeEEeEEEeC----
Q 004521 446 NKLGEGGFGPVYKGTLVDGQEIAVKRLSKISE-----------QGLKELKNEVILFSKLQHR--NLVKLLGCCIQG---- 508 (747)
Q Consensus 446 ~~lg~G~fg~Vy~~~~~~g~~vavK~l~~~~~-----------~~~~~~~~E~~~l~~l~H~--niv~l~g~~~~~---- 508 (747)
+.+-+-....|++..+ +|+.+.||+...... .....+.+|...+.++... ..++.+++.+..
T Consensus 28 e~v~~~~~rrvvr~~~-~g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~ 106 (268)
T PRK15123 28 EVFRELEGRRTLRFEL-AGKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPA 106 (268)
T ss_pred cEEecCCCceEEEEEE-CCEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCc
Confidence 3444444445777666 678899997643211 1112478899999888543 344556666542
Q ss_pred -CeeEEEEecCCCC-ChhhHhhhcCCCCcCChhHHHHHHHHHHHHHHHhhhcCCCceEecccCcCcEEEcC-------CC
Q 004521 509 -EEKLLIYEFMPNK-SLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQ-------DM 579 (747)
Q Consensus 509 -~~~~lV~E~~~~g-sL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NIll~~-------~~ 579 (747)
...+||+|++++. +|.+++.... ....+...+..++.+++..+.-||..| |+|+||++.|||++. +.
T Consensus 107 ~~~s~LVte~l~~~~sL~~~~~~~~-~~~~~~~~~~~ll~~la~~i~~LH~~G---i~HgDL~~~NiLl~~~~~~~~~~~ 182 (268)
T PRK15123 107 TRTSFIITEDLAPTISLEDYCADWA-TNPPDPRLKRMLIKRVATMVRDMHAAG---INHRDCYICHFLLHLPFPGREEDL 182 (268)
T ss_pred cceeEEEEeeCCCCccHHHHHHhhc-ccCCCHHHHHHHHHHHHHHHHHHHHCc---CccCCCChhhEEEeccccCCCCCc
Confidence 3468999999986 8998885322 123455677789999999999999999 999999999999975 46
Q ss_pred CceEecccCccc
Q 004521 580 NPKISDFGLVRT 591 (747)
Q Consensus 580 ~~kl~DFGla~~ 591 (747)
.+.|+||+.++.
T Consensus 183 ~~~LIDl~r~~~ 194 (268)
T PRK15123 183 KLSVIDLHRAQI 194 (268)
T ss_pred eEEEEECCcccc
Confidence 789999998754
|
|
| >KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=98.76 E-value=1.5e-07 Score=100.92 Aligned_cols=169 Identities=24% Similarity=0.357 Sum_probs=130.0
Q ss_pred CeeEEEEEe-cCCcEEEEEEecccccccHHHHHHHHHHHhccCCCceeeEEeEEEe----CCeeEEEEecCCC-CChhhH
Q 004521 453 FGPVYKGTL-VDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQ----GEEKLLIYEFMPN-KSLDSF 526 (747)
Q Consensus 453 fg~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~----~~~~~lV~E~~~~-gsL~~~ 526 (747)
-.+.|++.. .||..+++|+++....+.......-+++++++.|+|+|+|..++.. +..+++||+|.++ ++|.++
T Consensus 289 ~~Ttyk~~s~~DG~~YvLkRlhg~r~~~~nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL~d~ 368 (655)
T KOG3741|consen 289 SITTYKATSNVDGNAYVLKRLHGDRDQSTNKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTLYDL 368 (655)
T ss_pred cceeEeeeeccCCceeeeeeeccccccCcccchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCchHHHH
Confidence 357899875 4699999999954333333333456788999999999999988863 4567899999885 578777
Q ss_pred hhhcCC------------CCcCChhHHHHHHHHHHHHHHHhhhcCCCceEecccCcCcEEEcCCCCceEecccCccccCC
Q 004521 527 IFDQTR------------RTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGG 594 (747)
Q Consensus 527 l~~~~~------------~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NIll~~~~~~kl~DFGla~~~~~ 594 (747)
-+.... ....++..++.++.|+..||.++|+.| +.-+-|.|++||++.+..++|+..|+...+..
T Consensus 369 ~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHssG---LAck~L~~~kIlv~G~~RIriS~C~i~Dvl~~ 445 (655)
T KOG3741|consen 369 YFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSSG---LACKTLDLKKILVTGKMRIRISGCGIMDVLQE 445 (655)
T ss_pred HccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhcC---ceeecccHhHeEeeCcceEEEecccceeeecC
Confidence 654322 234678899999999999999999999 88899999999999999999999998776655
Q ss_pred CCCccccceeeeccCCCCCccccchhHHHHHHHHHhCCCC
Q 004521 595 DETEGNTNRVVGTYDGQFSIKSDVFSFGILLLEIVSGKKN 634 (747)
Q Consensus 595 ~~~~~~~~~~~~~~~~~~s~ksDVwS~Gvvl~elltg~~p 634 (747)
+..... .--.+-|.=-||.+|+.|.||...
T Consensus 446 d~~~~l----------e~~Qq~D~~~lG~ll~aLAt~~~n 475 (655)
T KOG3741|consen 446 DPTEPL----------ESQQQNDLRDLGLLLLALATGTEN 475 (655)
T ss_pred CCCcch----------hHHhhhhHHHHHHHHHHHhhcccc
Confidence 541111 112366888999999999999765
|
|
| >COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.55 E-value=4.3e-07 Score=90.73 Aligned_cols=136 Identities=19% Similarity=0.206 Sum_probs=96.3
Q ss_pred CCccceecccCCeeEEEEEecCCcEEEEEEeccccc----------------------ccHHHHHHHHHHHhccCCC--c
Q 004521 442 FSINNKLGEGGFGPVYKGTLVDGQEIAVKRLSKISE----------------------QGLKELKNEVILFSKLQHR--N 497 (747)
Q Consensus 442 ~~~~~~lg~G~fg~Vy~~~~~~g~~vavK~l~~~~~----------------------~~~~~~~~E~~~l~~l~H~--n 497 (747)
..+.++||-|.-+.||.|....|.++|||.-+.... ......++|.++|.+|.-. .
T Consensus 93 e~iG~~IGvGKEsdVY~~~~~~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~~ 172 (304)
T COG0478 93 EAIGTKIGVGKESDVYVAIDPKGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGVK 172 (304)
T ss_pred HhhccccccCccceEEEEECCCCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCCC
Confidence 345689999999999999999999999997542100 0122356789999998654 6
Q ss_pred eeeEEeEEEeCCeeEEEEecCCCCChhhHhhhcCCCCcCChhHHHHHHHHHHHHHHHhhhcCCCceEecccCcCcEEEcC
Q 004521 498 LVKLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQ 577 (747)
Q Consensus 498 iv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NIll~~ 577 (747)
+.+.+++ +...+||||+++-.|...- ++....-.|+..|++-+.-+-..| |||+|+.+=||++++
T Consensus 173 VP~P~~~----nRHaVvMe~ieG~eL~~~r--------~~~en~~~il~~il~~~~~~~~~G---iVHGDlSefNIlV~~ 237 (304)
T COG0478 173 VPKPIAW----NRHAVVMEYIEGVELYRLR--------LDVENPDEILDKILEEVRKAYRRG---IVHGDLSEFNILVTE 237 (304)
T ss_pred CCCcccc----ccceeeeehcccceeeccc--------CcccCHHHHHHHHHHHHHHHHHcC---ccccCCchheEEEec
Confidence 6666654 3457999999987665432 122333334444444444444555 999999999999999
Q ss_pred CCCceEecccCcccc
Q 004521 578 DMNPKISDFGLVRTF 592 (747)
Q Consensus 578 ~~~~kl~DFGla~~~ 592 (747)
+|.+.++||--+...
T Consensus 238 dg~~~vIDwPQ~v~~ 252 (304)
T COG0478 238 DGDIVVIDWPQAVPI 252 (304)
T ss_pred CCCEEEEeCcccccC
Confidence 999999999766544
|
|
| >smart00108 B_lectin Bulb-type mannose-specific lectin | Back alignment and domain information |
|---|
Probab=98.50 E-value=5.4e-07 Score=80.66 Aligned_cols=89 Identities=26% Similarity=0.375 Sum_probs=63.6
Q ss_pred eEEEecCCcEEEEcCC-CcEEEEeccccCcCCceEEEEecccCEEEEeCCCCCCCceeeeecCCCCCccccCCccccccc
Q 004521 33 FLMINKTGNLVLTSQS-NIVVWSAYLSKEVQTPVVLQLLDSGNLVLRDEHDGDSETYFWQSFDYPSDTLLPGMKLGWDLK 111 (747)
Q Consensus 33 ~l~l~~~G~Lvl~~~~-~~~vWst~~~~~~~~~~~~~lld~GNlVl~~~~~~~~~~~lWqSFd~PtDTlLpg~~l~~~~~ 111 (747)
.+....||+||+.+.. +.+||++++.........+.|.++|||||++.+ +.++|+|= |-
T Consensus 23 ~~~~q~dgnlV~~~~~~~~~vW~snt~~~~~~~~~l~l~~dGnLvl~~~~----g~~vW~S~-----t~----------- 82 (114)
T smart00108 23 TLIMQNDYNLILYKSSSRTVVWVANRDNPVSDSCTLTLQSDGNLVLYDGD----GRVVWSSN-----TT----------- 82 (114)
T ss_pred ccCCCCCEEEEEEECCCCcEEEECCCCCCCCCCEEEEEeCCCCEEEEeCC----CCEEEEec-----cc-----------
Confidence 3555679999999765 589999997643233478899999999999875 67899871 10
Q ss_pred ccccceEEeccCCCCCCCcceEEEEecCCCceEEEEeCCeeEEecC
Q 004521 112 TGLERRVTSWKSFDDPSPGDFIWAIERQDNPEVVMWKGSRKFYRTG 157 (747)
Q Consensus 112 ~g~~~~l~S~~s~~dps~G~~~~~~~~~g~~~~~~~~~~~~~~~~g 157 (747)
...|.|.+.|+.+|+..++-- ...+.|.+.
T Consensus 83 ---------------~~~~~~~~~L~ddGnlvl~~~-~~~~~W~Sf 112 (114)
T smart00108 83 ---------------GANGNYVLVLLDDGNLVIYDS-DGNFLWQSF 112 (114)
T ss_pred ---------------CCCCceEEEEeCCCCEEEECC-CCCEEeCCC
Confidence 124567889999998765422 345778764
|
|
| >COG0661 AarF Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.48 E-value=7.2e-07 Score=99.67 Aligned_cols=145 Identities=18% Similarity=0.253 Sum_probs=94.8
Q ss_pred CCCccceecccCCeeEEEEEecCCcEEEEEEecccccc------------------------------cHH---------
Q 004521 441 NFSINNKLGEGGFGPVYKGTLVDGQEIAVKRLSKISEQ------------------------------GLK--------- 481 (747)
Q Consensus 441 ~~~~~~~lg~G~fg~Vy~~~~~~g~~vavK~l~~~~~~------------------------------~~~--------- 481 (747)
.|+ .+.|+.++-|.||+|++++|+.||||+.+..-.+ ..+
T Consensus 127 eF~-~~PiAsASIaQVH~A~L~sG~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~E 205 (517)
T COG0661 127 EFE-PEPIASASIAQVHRAVLKSGEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLREE 205 (517)
T ss_pred HcC-CCchhhhhHhhheeEEecCCCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHHH
Confidence 444 2689999999999999999999999998652110 011
Q ss_pred -HHHHHHHHHhcc----CCCceeeEEeEEEe-CCeeEEEEecCCCCChhhHhhhcCCCCcCChhHHHHHHHHHHHH-HHH
Q 004521 482 -ELKNEVILFSKL----QHRNLVKLLGCCIQ-GEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARG-LLY 554 (747)
Q Consensus 482 -~~~~E~~~l~~l----~H~niv~l~g~~~~-~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~g-l~y 554 (747)
.+.+|..-+.++ ++..=+++=.++.+ .....|+|||++|-.+.++...... .++... ++..++++ +..
T Consensus 206 lDy~~EA~n~~~~~~nf~~~~~v~VP~V~we~t~~~VLtmE~i~Gi~i~d~~~l~~~--g~d~k~---ia~~~~~~f~~q 280 (517)
T COG0661 206 LDYRREAANAERFRENFKDDPDVYVPKVYWEYTTRRVLTMEWIDGIKISDIAALKSA--GIDRKE---LAELLVRAFLRQ 280 (517)
T ss_pred hCHHHHHHHHHHHHHHcCCCCCeEeceeehhccCCcEEEEEeeCCEecccHHHHHhc--CCCHHH---HHHHHHHHHHHH
Confidence 134455555444 22222333333432 4677999999999999888533221 234223 33322222 233
Q ss_pred hhhcCCCceEecccCcCcEEEcCCCCceEecccCccccCC
Q 004521 555 LHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGG 594 (747)
Q Consensus 555 LH~~~~~~iiHrDlkp~NIll~~~~~~kl~DFGla~~~~~ 594 (747)
+-..+ ++|.|..|-||+++.++.+.+.|||+...+..
T Consensus 281 ~~~dg---ffHaDpHpGNi~v~~~g~i~~lDfGi~g~l~~ 317 (517)
T COG0661 281 LLRDG---FFHADPHPGNILVRSDGRIVLLDFGIVGRLDP 317 (517)
T ss_pred HHhcC---ccccCCCccceEEecCCcEEEEcCcceecCCH
Confidence 33345 99999999999999999999999999876643
|
|
| >PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.45 E-value=1.1e-06 Score=87.51 Aligned_cols=107 Identities=26% Similarity=0.275 Sum_probs=85.3
Q ss_pred HHHHHHHHHHHhccC--CCceeeEEeEEEeCC----eeEEEEecCCCC-ChhhHhhhcCCCCcCChhHHHHHHHHHHHHH
Q 004521 480 LKELKNEVILFSKLQ--HRNLVKLLGCCIQGE----EKLLIYEFMPNK-SLDSFIFDQTRRTLLDWSQRFHIICGTARGL 552 (747)
Q Consensus 480 ~~~~~~E~~~l~~l~--H~niv~l~g~~~~~~----~~~lV~E~~~~g-sL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl 552 (747)
.....+|...+.++. .-...+.+++.+... ..+||+|++++. +|.+++..... ++......++.++++.+
T Consensus 55 ~~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~~~---~~~~~~~~ll~~l~~~i 131 (206)
T PF06293_consen 55 RSRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQWEQ---LDPSQRRELLRALARLI 131 (206)
T ss_pred chHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhhcc---cchhhHHHHHHHHHHHH
Confidence 346788888888885 344567777776643 348999999974 89998855222 55667788999999999
Q ss_pred HHhhhcCCCceEecccCcCcEEEcCCC---CceEecccCcccc
Q 004521 553 LYLHQDSRLRIIHRDLKASNVLLDQDM---NPKISDFGLVRTF 592 (747)
Q Consensus 553 ~yLH~~~~~~iiHrDlkp~NIll~~~~---~~kl~DFGla~~~ 592 (747)
.-||+.+ |+|+|+++.|||++.+. .+.|+||+-++..
T Consensus 132 ~~lH~~g---i~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~~ 171 (206)
T PF06293_consen 132 AKLHDAG---IYHGDLNPSNILVDPDDGQYRFYLIDLDRMRFR 171 (206)
T ss_pred HHHHHCc---CCCCCCCcccEEEeCCCCceeEEEEcchhceeC
Confidence 9999999 99999999999999887 8999999987653
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane |
| >PRK09902 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.44 E-value=3.3e-06 Score=82.68 Aligned_cols=139 Identities=16% Similarity=0.137 Sum_probs=103.6
Q ss_pred ecccCCeeEEEEEecCCcEEEEEEeccc------ccccHHHHHHHHHHHhccCC--CceeeEEeEEEeCC----eeEEEE
Q 004521 448 LGEGGFGPVYKGTLVDGQEIAVKRLSKI------SEQGLKELKNEVILFSKLQH--RNLVKLLGCCIQGE----EKLLIY 515 (747)
Q Consensus 448 lg~G~fg~Vy~~~~~~g~~vavK~l~~~------~~~~~~~~~~E~~~l~~l~H--~niv~l~g~~~~~~----~~~lV~ 515 (747)
-|+||.+.|++-.+ +|+.+-+|+-... ..-....|.+|...|.++.. -.+.+.+.+..... .-+||+
T Consensus 26 ~~rgG~SgV~r~~~-~g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pvf~~~~k~~~~~rA~LVT 104 (216)
T PRK09902 26 YRRNGMSGVQCVER-NGKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIVFGEAVKIEGEWRALLVT 104 (216)
T ss_pred cCCCCcceEEEEEe-CCcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccceeeeeccCCceEEEEEE
Confidence 46789999999776 4457889987521 13467789999999999953 33555553322222 257999
Q ss_pred ecCCC-CChhhHhhhcCCCCcCChhHHHHHHHHHHHHHHHhhhcCCCceEecccCcCcEEEcCCCC--ceEecccCccc
Q 004521 516 EFMPN-KSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMN--PKISDFGLVRT 591 (747)
Q Consensus 516 E~~~~-gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NIll~~~~~--~kl~DFGla~~ 591 (747)
|-+++ -+|.+++.+.. ....+...+..++.++++.+.-||..+ +.|+|+.+.||+++.++. ++++||--++.
T Consensus 105 e~L~g~~~L~~~l~~~~-~~~~~~~~k~~il~~va~~ia~LH~~G---v~Hgdly~khIll~~~g~~~v~lIDlEk~r~ 179 (216)
T PRK09902 105 EDMAGFISIADWYAQHA-VSPYSDEVRQAMLKAVALAFKKMHSVN---RQHGCCYVRHIYVKTEGKAEAGFLDLEKSRR 179 (216)
T ss_pred EeCCCCccHHHHHhcCC-cCCcchHHHHHHHHHHHHHHHHHHHCC---CcCCCCCHhheeecCCCCeeEEEEEhhccch
Confidence 97764 68988885432 224567778899999999999999998 999999999999986666 99999986653
|
|
| >cd00028 B_lectin Bulb-type mannose-specific lectin | Back alignment and domain information |
|---|
Probab=98.44 E-value=9.3e-07 Score=79.36 Aligned_cols=89 Identities=24% Similarity=0.340 Sum_probs=64.3
Q ss_pred EEEec-CCcEEEEcCC-CcEEEEeccccCcCCceEEEEecccCEEEEeCCCCCCCceeeeecCCCCCccccCCccccccc
Q 004521 34 LMINK-TGNLVLTSQS-NIVVWSAYLSKEVQTPVVLQLLDSGNLVLRDEHDGDSETYFWQSFDYPSDTLLPGMKLGWDLK 111 (747)
Q Consensus 34 l~l~~-~G~Lvl~~~~-~~~vWst~~~~~~~~~~~~~lld~GNlVl~~~~~~~~~~~lWqSFd~PtDTlLpg~~l~~~~~ 111 (747)
+.... ||+||+.+.. +.++|++++.........+.|.++|||||++.+ +.++|+|=-.
T Consensus 24 ~~~q~~dgnlv~~~~~~~~~vW~snt~~~~~~~~~l~l~~dGnLvl~~~~----g~~vW~S~~~---------------- 83 (116)
T cd00028 24 LIMQSRDYNLILYKGSSRTVVWVANRDNPSGSSCTLTLQSDGNLVIYDGS----GTVVWSSNTT---------------- 83 (116)
T ss_pred CCCCCCeEEEEEEeCCCCeEEEECCCCCCCCCCEEEEEecCCCeEEEcCC----CcEEEEeccc----------------
Confidence 44455 8999998765 589999997653245678899999999999875 6789976321
Q ss_pred ccccceEEeccCCCCCCCcceEEEEecCCCceEEEEeCCeeEEecCC
Q 004521 112 TGLERRVTSWKSFDDPSPGDFIWAIERQDNPEVVMWKGSRKFYRTGP 158 (747)
Q Consensus 112 ~g~~~~l~S~~s~~dps~G~~~~~~~~~g~~~~~~~~~~~~~~~~g~ 158 (747)
.+.+.+.+.|+.+|+..++-- ...+.|.+..
T Consensus 84 ---------------~~~~~~~~~L~ddGnlvl~~~-~~~~~W~Sf~ 114 (116)
T cd00028 84 ---------------RVNGNYVLVLLDDGNLVLYDS-DGNFLWQSFD 114 (116)
T ss_pred ---------------CCCCceEEEEeCCCCEEEECC-CCCEEEcCCC
Confidence 024668889999998766532 3467787754
|
The domain contains a three-fold internal repeat (beta-prism architecture). The consensus sequence motif QXDXNXVXY is involved in alpha-D-mannose recognition. Lectins are carbohydrate-binding proteins which specifically recognize diverse carbohydrates and mediate a wide variety of biological processes, such as cell-cell and host-pathogen interactions, serum glycoprotein turnover, and innate immune responses. |
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=98.39 E-value=1.4e-07 Score=108.70 Aligned_cols=196 Identities=19% Similarity=0.245 Sum_probs=133.7
Q ss_pred HHhcCCCccceecccCCeeEEEEEecC-CcEEEEEEecc---cccccHHHHHHHHHHHhccCCCceeeEEeEEEeCCeeE
Q 004521 437 NATDNFSINNKLGEGGFGPVYKGTLVD-GQEIAVKRLSK---ISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKL 512 (747)
Q Consensus 437 ~~~~~~~~~~~lg~G~fg~Vy~~~~~~-g~~vavK~l~~---~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~ 512 (747)
...+.+.+.+-+-+|.++.++.++-.. |...++|.... ......+....+-.+.-..+||-++....-+....+.+
T Consensus 801 sS~d~~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s~~~rsP~~ 880 (1205)
T KOG0606|consen 801 SSPDGFEITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPSFPCRSPLP 880 (1205)
T ss_pred CCCccceecccccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCccccCCCCceecccCCCCCCCCcc
Confidence 455778888899999999999876433 44444444332 22223334444444444456677776666666678889
Q ss_pred EEEecCCCCChhhHhhhcCCCCcCChhHHHHHHHHHHHHHHHhhhcCCCceEecccCcCcEEEcCCCCceEecccCcccc
Q 004521 513 LIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTF 592 (747)
Q Consensus 513 lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NIll~~~~~~kl~DFGla~~~ 592 (747)
||++|..+++|...|+... ..+..-....+..+..+++|||... ++|+|++|.|+++..++..+++|||.....
T Consensus 881 L~~~~~~~~~~~Skl~~~~---~~saepaRs~i~~~vqs~e~L~s~~---r~h~~~~p~~~l~~~~gh~~l~~~~t~~~v 954 (1205)
T KOG0606|consen 881 LVGHYLNGGDLPSKLHNSG---CLSAEPARSPILERVQSLESLHSSL---RKHRDLKPDSLLIAYDGHRPLTDFGTLSKV 954 (1205)
T ss_pred hhhHHhccCCchhhhhcCC---CcccccccchhHHHHhhhhccccch---hhcccccccchhhcccCCcccCcccccccc
Confidence 9999999999998886533 2444444556667888999999876 899999999999999999999999854322
Q ss_pred CCC---------CC------------ccc--------cceeeec---------cCCCCCccccchhHHHHHHHHHhCCCC
Q 004521 593 GGD---------ET------------EGN--------TNRVVGT---------YDGQFSIKSDVFSFGILLLEIVSGKKN 634 (747)
Q Consensus 593 ~~~---------~~------------~~~--------~~~~~~~---------~~~~~s~ksDVwS~Gvvl~elltg~~p 634 (747)
+-- .. ... .....++ .+......+|+|++|++++|.++|..|
T Consensus 955 g~~~p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hgs~ad~~~~g~~l~e~l~g~pp 1034 (1205)
T KOG0606|consen 955 GLIPPTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHGSAADWWSSGVCLFEVLTGIPP 1034 (1205)
T ss_pred ccccCcCCcccccccCccccccccccccccccchhhccccccCCCcccCCcccccccCCCcchhhhhhhhhhhhhcCCCC
Confidence 100 00 000 0001111 134567789999999999999999999
Q ss_pred CCCC
Q 004521 635 RGFY 638 (747)
Q Consensus 635 ~~~~ 638 (747)
+...
T Consensus 1035 ~na~ 1038 (1205)
T KOG0606|consen 1035 FNAE 1038 (1205)
T ss_pred CCCc
Confidence 7543
|
|
| >TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172 | Back alignment and domain information |
|---|
Probab=98.25 E-value=1.2e-05 Score=81.27 Aligned_cols=139 Identities=17% Similarity=0.183 Sum_probs=85.2
Q ss_pred ceecccCCeeEEEEEecCCcEEEEEEecccccccHHHHHHHHHHHhccCCCc--eeeEEeEEEeCCeeEEEEecCCCCC-
Q 004521 446 NKLGEGGFGPVYKGTLVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRN--LVKLLGCCIQGEEKLLIYEFMPNKS- 522 (747)
Q Consensus 446 ~~lg~G~fg~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~n--iv~l~g~~~~~~~~~lV~E~~~~gs- 522 (747)
.+||+|..+.||+. .+..+++|..... .......+|.++++.+..-. +.+.+++....+...+|||+++|..
T Consensus 7 ~~i~~G~t~~~y~~---~~~~~VlR~~~~~--~~~~~i~~E~~~l~~l~~~glpvP~~~~~~~~~~~~glv~e~i~G~~~ 81 (226)
T TIGR02172 7 TQTGEGGNGESYTH---KTGKWMLKLYNPG--FDKETIKREFDASRKVFSLGIPTPHPFDLVEDGGRLGLIYELIVGKRS 81 (226)
T ss_pred eeecCCCCcceeEe---cCCCEEEEeCCCC--CCHHHHHHHHHHHHHHHHcCCCCCceEEEEecCCeeeeeeeecCCccc
Confidence 68999999999983 2556778887642 23456788999999886443 4677888877778889999999863
Q ss_pred hhhHhh--------------h-----cC-CCCcCChhHHH-HHHH----------HHHH-HHHHhhh-cCCCceEecccC
Q 004521 523 LDSFIF--------------D-----QT-RRTLLDWSQRF-HIIC----------GTAR-GLLYLHQ-DSRLRIIHRDLK 569 (747)
Q Consensus 523 L~~~l~--------------~-----~~-~~~~l~~~~~~-~i~~----------~ia~-gl~yLH~-~~~~~iiHrDlk 569 (747)
+...+. . +. ........... .+.. .+.+ ...+|.. .....++|+|+.
T Consensus 82 ~~~~~~~~~~~~~~l~~~la~~l~~lH~~~~~~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~l~~~~~~~~~~HgD~~ 161 (226)
T TIGR02172 82 FSRIISDNPSRLEEIAKIFAEMAKKLHSTKCDTSTFQSYKEKIRKFIEEKDFVPKDYKEKARAFIKEVPDTSTCLHGDFQ 161 (226)
T ss_pred hhhhhcCCHHHHHHHHHHHHHHHHHHhCCCCCCCcHHHHHHHHHHHHHhccCCCHHHHHHHHHHHHhCCCCCceEecCCC
Confidence 211110 0 00 00000100000 0000 0001 1112211 123457899999
Q ss_pred cCcEEEcCCCCceEecccCcc
Q 004521 570 ASNVLLDQDMNPKISDFGLVR 590 (747)
Q Consensus 570 p~NIll~~~~~~kl~DFGla~ 590 (747)
|.||++++++ +.|+||+.+.
T Consensus 162 ~~Nii~~~~~-~~iIDwe~a~ 181 (226)
T TIGR02172 162 IGNLITSGKG-TYWIDLGDFG 181 (226)
T ss_pred CCcEEEcCCC-cEEEechhcC
Confidence 9999999888 9999999764
|
This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636. |
| >smart00473 PAN_AP divergent subfamily of APPLE domains | Back alignment and domain information |
|---|
Probab=98.22 E-value=3.6e-06 Score=69.44 Aligned_cols=73 Identities=37% Similarity=0.773 Sum_probs=55.3
Q ss_pred CCceEEeeccCCCCCCccccccccChHHHHHhhcc-CCceeEEeeecccCCCcceeeee-ccccccccCCCCCcceeee
Q 004521 284 QDGFIKFTELKLPDATSSWVSKSMNLKECREGCLE-NSSCMAYTNSDIRGGGSGCAMWF-GELIDMRDFPGGGQDFYIR 360 (747)
Q Consensus 284 ~~~f~~~~~~~~p~~~~~~~~~~~s~~~C~~~Cl~-nCsC~a~~~~~~~~~~~~C~~~~-~~l~d~~~~~~~~~~lylr 360 (747)
...|..+.++.+++..... ....++++|++.|++ +|+|.||.|.. +..+|.+|. +.+.+.......+.++|.+
T Consensus 3 ~~~f~~~~~~~l~~~~~~~-~~~~s~~~C~~~C~~~~~~C~s~~y~~---~~~~C~l~~~~~~~~~~~~~~~~~~~y~~ 77 (78)
T smart00473 3 DDCFVRLPNTKLPGFSRIV-ISVASLEECASKCLNSNCSCRSFTYNN---GTKGCLLWSESSLGDARLFPSGGVDLYEK 77 (78)
T ss_pred CceeEEecCccCCCCccee-EcCCCHHHHHHHhCCCCCceEEEEEcC---CCCEEEEeeCCccccceecccCCceeEEe
Confidence 3568999999998655432 356799999999999 99999999953 456899999 7777776444555566654
|
Apple-like domains present in Plasminogen, C. elegans hypothetical ORFs and the extracellular portion of plant receptor-like protein kinases. Predicted to possess protein- and/or carbohydrate-binding functions. |
| >PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY) | Back alignment and domain information |
|---|
Probab=98.14 E-value=2.7e-05 Score=76.59 Aligned_cols=138 Identities=14% Similarity=0.149 Sum_probs=91.9
Q ss_pred HhcCCCccceecccCCeeEEEEEecCCcEEEEEEecccccccHHHH---------HHHHHHHhccC---CCceeeEEeEE
Q 004521 438 ATDNFSINNKLGEGGFGPVYKGTLVDGQEIAVKRLSKISEQGLKEL---------KNEVILFSKLQ---HRNLVKLLGCC 505 (747)
Q Consensus 438 ~~~~~~~~~~lg~G~fg~Vy~~~~~~g~~vavK~l~~~~~~~~~~~---------~~E~~~l~~l~---H~niv~l~g~~ 505 (747)
..++|.+.+.+-.....-|.+-.. +|+..++|..+.......+.| .+++..+.+++ -..+..++.+.
T Consensus 29 ~~~~~~~~kv~k~~~r~~ValIei-~~~kyIlK~pr~~~~r~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~~~yl~~ 107 (229)
T PF06176_consen 29 LDNNYKIIKVFKNTKRNYVALIEI-DGKKYILKEPREENRRPERRFKSFFKGSEYSRLINNTDKIRNEGFTEPADPYLAA 107 (229)
T ss_pred HhCCceEEEeecCCCccEEEEEEE-CCcEEEEeccchhhhhHHHHHHHHhccHHHHHHHHHHHHHHHcCccccccceeee
Confidence 346788878888877777777665 578899998875333222222 23344444443 22333333333
Q ss_pred Ee-----CCeeEEEEecCCCCChhhHhhhcCCCCcCChhHHHHHHHHHHHHHHHhhhcCCCceEecccCcCcEEEcCCCC
Q 004521 506 IQ-----GEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMN 580 (747)
Q Consensus 506 ~~-----~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NIll~~~~~ 580 (747)
+. ....+|||||++|..|.++.. ++. .++..+++++.-||+.| +.|+|..|.|++++.++
T Consensus 108 ekk~~~~~~~~~ll~EYIeG~~l~d~~~-------i~e----~~~~ki~~~ikqlH~~G---~~HGD~hpgNFlv~~~~- 172 (229)
T PF06176_consen 108 EKKIFRYTSSYVLLMEYIEGVELNDIED-------IDE----DLAEKIVEAIKQLHKHG---FYHGDPHPGNFLVSNNG- 172 (229)
T ss_pred eeeeccceeEEEEEEEEecCeecccchh-------cCH----HHHHHHHHHHHHHHHcC---CccCCCCcCcEEEECCc-
Confidence 32 234568999999988866531 221 25566788899999999 99999999999998655
Q ss_pred ceEecccCccc
Q 004521 581 PKISDFGLVRT 591 (747)
Q Consensus 581 ~kl~DFGla~~ 591 (747)
+++.||+..+.
T Consensus 173 i~iID~~~k~~ 183 (229)
T PF06176_consen 173 IRIIDTQGKRM 183 (229)
T ss_pred EEEEECccccc
Confidence 99999987654
|
The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process |
| >KOG1235 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.07 E-value=2.6e-05 Score=87.03 Aligned_cols=144 Identities=15% Similarity=0.225 Sum_probs=91.7
Q ss_pred cceecccCCeeEEEEEecCCcEEEEEEeccccccc-------------------------------HH------HHHHHH
Q 004521 445 NNKLGEGGFGPVYKGTLVDGQEIAVKRLSKISEQG-------------------------------LK------ELKNEV 487 (747)
Q Consensus 445 ~~~lg~G~fg~Vy~~~~~~g~~vavK~l~~~~~~~-------------------------------~~------~~~~E~ 487 (747)
.+.||..+.|.||+|++++|+.||||+-+..-++. .+ .|.+|.
T Consensus 166 ~~piaaASlaQVhrA~L~~G~~VaVKVQ~P~l~~~~~~Dl~~~~~~~~~l~k~~p~~~~~~lvdE~~~~L~~ELDF~~EA 245 (538)
T KOG1235|consen 166 EEPIAAASLAQVHRARLKNGEDVAVKVQHPGLEKLIMLDLRNLRLLAKVLQKFFPDFDLVWLVDEIAKSLPQELDFTKEA 245 (538)
T ss_pred cchhhhcchhheEEEEecCCCEEEEEecCcChHHHHHHHHHHHHHHHHHHHHhCcCCchhhHHHHHHhhhHhhcchHHHH
Confidence 37899999999999999999999999876421110 01 134454
Q ss_pred HHHhc----cCCCce---eeEEeEEEe-CCeeEEEEecCCCCChhhHhhhcCCCCcCChhHHHHHHHHHHHHHHHhhhcC
Q 004521 488 ILFSK----LQHRNL---VKLLGCCIQ-GEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDS 559 (747)
Q Consensus 488 ~~l~~----l~H~ni---v~l~g~~~~-~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~ 559 (747)
+-..+ ++|-++ |++=.++.+ ...+.|+||||+|..+.+.-.-... .++...+..-+.++..-+-+ ..|
T Consensus 246 ~Nae~~~~~f~~~~~~~~V~VP~Vy~~~st~RVLtME~~~G~~i~Dl~~i~~~--gi~~~~i~~~l~~~~~~qIf--~~G 321 (538)
T KOG1235|consen 246 KNAERFRENFKDFSLLTYVLVPKVYWDLSTKRVLTMEYVDGIKINDLDAIDKR--GISPHDILNKLVEAYLEQIF--KTG 321 (538)
T ss_pred HhHHHHHHHHHhcccccceeCCeehhhcCcceEEEEEecCCccCCCHHHHHHc--CCCHHHHHHHHHHHHHHHHH--hcC
Confidence 44333 345551 222223322 3467999999999888766432222 24444444333333322222 234
Q ss_pred CCceEecccCcCcEEEcC----CCCceEecccCccccCCC
Q 004521 560 RLRIIHRDLKASNVLLDQ----DMNPKISDFGLVRTFGGD 595 (747)
Q Consensus 560 ~~~iiHrDlkp~NIll~~----~~~~kl~DFGla~~~~~~ 595 (747)
++|+|=.|-||++.. ++.+.+-|||+...+...
T Consensus 322 ---ffHaDPHPGNilv~~~~~~~~~ivllDhGl~~~is~~ 358 (538)
T KOG1235|consen 322 ---FFHADPHPGNILVRPNPEGDEEIVLLDHGLYAVISHK 358 (538)
T ss_pred ---CccCCCCCCcEEEecCCCCCccEEEEcccccccccHH
Confidence 999999999999983 678999999998766433
|
|
| >PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily | Back alignment and domain information |
|---|
Probab=98.07 E-value=3.9e-05 Score=77.75 Aligned_cols=144 Identities=20% Similarity=0.180 Sum_probs=85.8
Q ss_pred cceecccCCeeEEEEEecCCcEEEEEEecccccccHHHHHHHHHHHhccCCC--ceeeEEeEEEeC---CeeEEEEecCC
Q 004521 445 NNKLGEGGFGPVYKGTLVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHR--NLVKLLGCCIQG---EEKLLIYEFMP 519 (747)
Q Consensus 445 ~~~lg~G~fg~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~--niv~l~g~~~~~---~~~~lV~E~~~ 519 (747)
.+.|+.|..+.||+....+ ..+++|..... .....+.+|..+++.+... .+.+++.+.... ...+++||+++
T Consensus 2 i~~l~~G~~n~~~~v~~~~-~~~vlK~~~~~--~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~~~~~~~~~~~i~ 78 (239)
T PF01636_consen 2 IRPLSGGFSNRVYRVTTDD-GRYVLKFYRPP--DAAERLRREAAVLRQLAEHGIPVPRVLAFDTSDEFNGFPYLLMEYIP 78 (239)
T ss_dssp EEEEEESSSSEEEEEEETT-SEEEEEEESSH--HHHHHHHHHHHHHHHHHHTTSBS--EEEEEEETEETSEEEEEEEEES
T ss_pred CccCCCCCeeeEEEEEECC-cEEEEEEeCCC--CCHHHHHHHHHHHHHHHhcCCCCceEEeecccccccccceEEEEEec
Confidence 3679999999999999876 69999997653 4556788899998888533 356777655433 34689999999
Q ss_pred CCChhh----------------Hhh---hc-CCCCcCChhH---------HHHH------------HHHHHH-HHHHhhh
Q 004521 520 NKSLDS----------------FIF---DQ-TRRTLLDWSQ---------RFHI------------ICGTAR-GLLYLHQ 557 (747)
Q Consensus 520 ~gsL~~----------------~l~---~~-~~~~~l~~~~---------~~~i------------~~~ia~-gl~yLH~ 557 (747)
+..+.. .+. .. .....+.... .... ...+.+ .+..+++
T Consensus 79 g~~~~~~~~~~~~~~~~~~~~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 158 (239)
T PF01636_consen 79 GRPLDDELSPEQRPELLRQLGRALAQLHQVPPPFSPFADWPEWRLEFLRQLESWTARLRASELFDDLEELEERLLQELEA 158 (239)
T ss_dssp SEEHHHTSTHHHHHHHHHHHHHHHHHHHHSHTTCCCHTHHHHHHHHHHHHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHH
T ss_pred cccccccccccccccccccchhhhhhcccccccccccccccccccccccccccccccccchhhhhhhHHHHHHHHHHHHh
Confidence 988877 111 11 0111111100 0000 111222 2333332
Q ss_pred ----cCCCceEecccCcCcEEEc-CCCCceEecccCccc
Q 004521 558 ----DSRLRIIHRDLKASNVLLD-QDMNPKISDFGLVRT 591 (747)
Q Consensus 558 ----~~~~~iiHrDlkp~NIll~-~~~~~kl~DFGla~~ 591 (747)
.....++|+|+.|.|||++ +++.+.|.||+.+..
T Consensus 159 ~~~~~~~~~~~HgD~~~~Nil~~~~~~~i~iID~e~a~~ 197 (239)
T PF01636_consen 159 LLPKPLPPVLIHGDLHPGNILVDPSDGRIGIIDFEDAGW 197 (239)
T ss_dssp HHHCCSCEEEE-SS-SGGGEEEESSTTEEEE--GTT-EE
T ss_pred hhccCCCcEEEEeccccccceeeeccceeEEEecccceE
Confidence 2345699999999999999 556668999987653
|
; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B .... |
| >cd05150 APH Aminoglycoside 3'-phosphotransferase (APH) | Back alignment and domain information |
|---|
Probab=98.06 E-value=3.6e-05 Score=78.94 Aligned_cols=141 Identities=15% Similarity=0.135 Sum_probs=86.8
Q ss_pred ceecccCC-eeEEEEEecCCcEEEEEEecccccccHHHHHHHHHHHhccC-CCceeeEEeEEEeCCeeEEEEecCCCCCh
Q 004521 446 NKLGEGGF-GPVYKGTLVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQ-HRNLVKLLGCCIQGEEKLLIYEFMPNKSL 523 (747)
Q Consensus 446 ~~lg~G~f-g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~-H~niv~l~g~~~~~~~~~lV~E~~~~gsL 523 (747)
..|..|.. ..||+.... +..+.||+..... ...+.+|++++..+. +--+.+++++....+..++|||++++.+|
T Consensus 4 ~~~~~g~~~~~v~~~~~~-~~~~~vk~~~~~~---~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~G~~l 79 (244)
T cd05150 4 ERVTEGQSGATVYRLDGK-NPGLYLKIAPSGP---TYELEREAERLRWLAGKLPVPEVIDYGSDDGRAWLLTSAVPGVPA 79 (244)
T ss_pred eecCCCCCcCeEEEEcCC-CCcEEEEecCCCc---ccchHHHHHHHHHHHhcCCCCeEEEEEecCCccEEEEEeeCCccH
Confidence 45666666 688998764 4778888876432 345778999988884 44566788887776678999999999877
Q ss_pred hhHhh-------------------hcCC-CCcCCh--hHHHHHHH--------------------HHHHHHHHhhh----
Q 004521 524 DSFIF-------------------DQTR-RTLLDW--SQRFHIIC--------------------GTARGLLYLHQ---- 557 (747)
Q Consensus 524 ~~~l~-------------------~~~~-~~~l~~--~~~~~i~~--------------------~ia~gl~yLH~---- 557 (747)
..... .... ...+.. ...+.... .+...+..|-.
T Consensus 80 ~~~~~~~~~~~~~~~l~~~l~~lH~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~ 159 (244)
T cd05150 80 AALWEELEPERLVDALAEALRRLHALPVADCPFDRRLDRRLAEARARVENGLVDEDDFDDERRGWSAEELYAELEATRPA 159 (244)
T ss_pred hHhhcccCHHHHHHHHHHHHHHHhcCCcccCCcchhHHHHHHHHHHHHhcCCcChhhCcHhhcCCCHHHHHHHHHhhCCC
Confidence 64321 0000 000100 00000000 01111122211
Q ss_pred cCCCceEecccCcCcEEEcCCCCceEecccCcc
Q 004521 558 DSRLRIIHRDLKASNVLLDQDMNPKISDFGLVR 590 (747)
Q Consensus 558 ~~~~~iiHrDlkp~NIll~~~~~~kl~DFGla~ 590 (747)
...+.++|+|+.|.|||++++..+.|+||+.+.
T Consensus 160 ~~~~~l~HgD~~~~Nil~~~~~~~~iIDwe~a~ 192 (244)
T cd05150 160 EEDLVVTHGDACLPNIIVDPGKFSGFIDLGRLG 192 (244)
T ss_pred cCceEEECCCCCCccEEEeCCcEEEEEEccccc
Confidence 123459999999999999998878999999764
|
The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio |
| >PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C) | Back alignment and domain information |
|---|
Probab=98.03 E-value=1.6e-05 Score=77.80 Aligned_cols=104 Identities=24% Similarity=0.237 Sum_probs=81.7
Q ss_pred HHHHHHHhccCC-CceeeEEeEEEeCCeeEEEEecCCCCChhhHhhhcCCCCcCChhHHHHHHHHHHHHHHHhhhcCCCc
Q 004521 484 KNEVILFSKLQH-RNLVKLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLR 562 (747)
Q Consensus 484 ~~E~~~l~~l~H-~niv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ 562 (747)
..|.-+++.+++ +++.+++|+|- .++|.||...+++...-.....-...+|..|.+||.++++.+++|++.....
T Consensus 7 ~~E~lll~~l~~~~~~pk~lG~CG----~~~v~E~~~~~~~~~~~~~l~~~~~~~w~~R~~iA~~lL~~l~~l~~~~~~~ 82 (188)
T PF12260_consen 7 NNEPLLLQLLQGSEPFPKLLGSCG----RFYVVEYVGAGSLYGIYRPLSQFLQSPWEQRAKIALQLLELLEELDHGPLGF 82 (188)
T ss_pred ccHHHHHHHcCCCCCCCCeeeECC----CEEEEEeecCccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCCCc
Confidence 357888899976 69999999993 4789999987766422100011123689999999999999999999865445
Q ss_pred eEecccCcCcEEEcCCCCceEecccCccc
Q 004521 563 IIHRDLKASNVLLDQDMNPKISDFGLVRT 591 (747)
Q Consensus 563 iiHrDlkp~NIll~~~~~~kl~DFGla~~ 591 (747)
+.-+|++|+|+-+++++.+|+.|...+..
T Consensus 83 ~~lcDv~~~nfgv~~~~~lk~iDld~v~~ 111 (188)
T PF12260_consen 83 FYLCDVSPDNFGVNDDGRLKLIDLDDVFV 111 (188)
T ss_pred EEEeecchHHeEEeCCCcEEEEechhcch
Confidence 88899999999999999999999986644
|
Proteins in this uncharacterised family are described as transmembrane proteins. |
| >COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.00 E-value=5.5e-05 Score=75.24 Aligned_cols=152 Identities=18% Similarity=0.248 Sum_probs=98.4
Q ss_pred cHHHHHHHhcCCCccc---eecccCCeeEEEEEecCCcEEEEEEecccccc-------------------cHHH-----H
Q 004521 431 ELATIANATDNFSINN---KLGEGGFGPVYKGTLVDGQEIAVKRLSKISEQ-------------------GLKE-----L 483 (747)
Q Consensus 431 ~~~~~~~~~~~~~~~~---~lg~G~fg~Vy~~~~~~g~~vavK~l~~~~~~-------------------~~~~-----~ 483 (747)
+...+........+.. .|..|.-+.||+|.-.++..+|||+.+..... ..++ .
T Consensus 36 t~~~l~~L~~rg~i~~~~g~istGKEA~Vy~a~~~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~~W~ 115 (268)
T COG1718 36 TLETLRRLLSRGVITELVGCISTGKEANVYLAETGDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFAWA 115 (268)
T ss_pred HHHHHHHHhcCCceeeeEeeecCCcceEEEeeccCCCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHHHHH
Confidence 4445555555555544 45667777999999888999999998642111 0111 2
Q ss_pred HHHHHHHhccC--CCceeeEEeEEEeCCeeEEEEecCCCCCh-hhHhhhcCCCCcCChhHHHHHHHHHHHHHHHhhhcCC
Q 004521 484 KNEVILFSKLQ--HRNLVKLLGCCIQGEEKLLIYEFMPNKSL-DSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSR 560 (747)
Q Consensus 484 ~~E~~~l~~l~--H~niv~l~g~~~~~~~~~lV~E~~~~gsL-~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~ 560 (747)
.+|..-|.++. +-.+.+-+++. +..|||||+....+ .-.| +...+...+...+..++++.|.-|-...
T Consensus 116 ~kEf~NL~R~~eAGVrvP~Pi~~~----~nVLvMEfIg~~g~pAP~L----kDv~~e~~e~~~~~~~~v~~~~~l~~~a- 186 (268)
T COG1718 116 RKEFRNLKRAYEAGVRVPEPIAFR----NNVLVMEFIGDDGLPAPRL----KDVPLELEEAEGLYEDVVEYMRRLYKEA- 186 (268)
T ss_pred HHHHHHHHHHHHcCCCCCCceeec----CCeEEEEeccCCCCCCCCc----ccCCcCchhHHHHHHHHHHHHHHHHHhc-
Confidence 35666666663 33344444442 34799999865421 1111 1122333356677788888888887633
Q ss_pred CceEecccCcCcEEEcCCCCceEecccCccccC
Q 004521 561 LRIIHRDLKASNVLLDQDMNPKISDFGLVRTFG 593 (747)
Q Consensus 561 ~~iiHrDlkp~NIll~~~~~~kl~DFGla~~~~ 593 (747)
++||+||..=|||+. ++.+.|+|||-|....
T Consensus 187 -~LVHgDLSEyNiL~~-~~~p~iID~~QaV~~~ 217 (268)
T COG1718 187 -GLVHGDLSEYNILVH-DGEPYIIDVSQAVTID 217 (268)
T ss_pred -CcccccchhhheEEE-CCeEEEEECccccccC
Confidence 399999999999999 8999999999887654
|
|
| >COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only] | Back alignment and domain information |
|---|
Probab=97.88 E-value=0.00023 Score=75.11 Aligned_cols=186 Identities=12% Similarity=0.135 Sum_probs=108.4
Q ss_pred ccceecccCCeeEEEEEecCCcEEEEEEecccccccHHHHHHHHHHHhcc-CCCceeeEEeEE------EeCCe-eEEEE
Q 004521 444 INNKLGEGGFGPVYKGTLVDGQEIAVKRLSKISEQGLKELKNEVILFSKL-QHRNLVKLLGCC------IQGEE-KLLIY 515 (747)
Q Consensus 444 ~~~~lg~G~fg~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~------~~~~~-~~lV~ 515 (747)
....||+|+-+.+|--- .-...+.|+..........+ .+..|... .||-+-.=+.+= -++.. .-+.|
T Consensus 15 ~gr~LgqGgea~ly~l~--e~~d~VAKIYh~Pppa~~aq---k~a~la~~p~~p~~~~rvaWPqa~L~G~~~~~~iGflm 89 (637)
T COG4248 15 PGRPLGQGGEADLYTLG--EVRDQVAKIYHAPPPAAQAQ---KVAELAATPDAPLLNYRVAWPQATLHGGRRGKVIGFLM 89 (637)
T ss_pred CCccccCCccceeeecc--hhhchhheeecCCCchHHHH---HHHHhccCCCCcchhhhhcccHHHhhCCCccceeEEec
Confidence 45789999999999532 21223345544322221111 12233333 455443211111 11122 45667
Q ss_pred ecCCCCC-hhhHhhh---cCCCCcCChhHHHHHHHHHHHHHHHhhhcCCCceEecccCcCcEEEcCCCCceEecccCccc
Q 004521 516 EFMPNKS-LDSFIFD---QTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRT 591 (747)
Q Consensus 516 E~~~~gs-L~~~l~~---~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NIll~~~~~~kl~DFGla~~ 591 (747)
..+.+.. ...++.. ........|...++.++.+|.+.+.||+.| .+-+|+.++|+|+++++.+.|.|=..-..
T Consensus 90 P~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~G---h~vGDVn~~~~lVsd~~~V~LVdsDsfqi 166 (637)
T COG4248 90 PKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEHG---HVVGDVNQNSFLVSDDSKVVLVDSDSFQI 166 (637)
T ss_pred ccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhcC---CcccccCccceeeecCceEEEEcccceee
Confidence 7766542 2223221 122345789999999999999999999999 88999999999999999999886331110
Q ss_pred -c---------CCCCCccccceeeec-cCCCCCccccchhHHHHHHHHHhC-CCCCCC
Q 004521 592 -F---------GGDETEGNTNRVVGT-YDGQFSIKSDVFSFGILLLEIVSG-KKNRGF 637 (747)
Q Consensus 592 -~---------~~~~~~~~~~~~~~~-~~~~~s~ksDVwS~Gvvl~elltg-~~p~~~ 637 (747)
. +..+.........+. .+-.-+...|-|.+||++++++.| ++||..
T Consensus 167 ~~ng~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysG 224 (637)
T COG4248 167 NANGTLHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSG 224 (637)
T ss_pred ccCCceEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCc
Confidence 0 000000000000011 123446789999999999999997 889764
|
|
| >PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP | Back alignment and domain information |
|---|
Probab=97.87 E-value=0.00014 Score=71.38 Aligned_cols=128 Identities=16% Similarity=0.264 Sum_probs=90.6
Q ss_pred cceecccCCeeEEEEEecCCcEEEEEEecccc----------------cccHHHHHHHHHHHhccC------CCceeeEE
Q 004521 445 NNKLGEGGFGPVYKGTLVDGQEIAVKRLSKIS----------------EQGLKELKNEVILFSKLQ------HRNLVKLL 502 (747)
Q Consensus 445 ~~~lg~G~fg~Vy~~~~~~g~~vavK~l~~~~----------------~~~~~~~~~E~~~l~~l~------H~niv~l~ 502 (747)
...||+|+.-.||. +++.....||+..... ....+++.+|+.-...+. +.+|.+++
T Consensus 6 ~~~i~~G~~R~cy~--HP~dp~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~~~~~~i~r~~ 83 (199)
T PF10707_consen 6 SDLIAQGGERDCYQ--HPDDPNLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRGVDWSHIPRFY 83 (199)
T ss_pred CcccccCCCceEEE--CCCCCCeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccCCcccccccEe
Confidence 57899999999995 5566778899887643 223566777777666665 88999999
Q ss_pred eEEEeCCeeEEEEecCCC------CChhhHhhhcCCCCcCChhHHHHHHHHHHHHHHHhhhcCCCceEecccCcCcEEEc
Q 004521 503 GCCIQGEEKLLIYEFMPN------KSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLD 576 (747)
Q Consensus 503 g~~~~~~~~~lV~E~~~~------gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NIll~ 576 (747)
|+..++...-+|+|.+.+ -+|.+++.. ..++. ...+.+.+ -..||-++. |+.+||+|.||++.
T Consensus 84 G~veT~~G~Glv~e~I~d~dG~~s~TL~~~l~~----~~~~~-~~~~~L~~---f~~~l~~~~---Iv~~dl~~~NIv~~ 152 (199)
T PF10707_consen 84 GFVETNLGLGLVVELIRDADGNISPTLEDYLKE----GGLTE-ELRQALDE---FKRYLLDHH---IVIRDLNPHNIVVQ 152 (199)
T ss_pred EEEecCCceEEEEEEEECCCCCcCccHHHHHHc----CCccH-HHHHHHHH---HHHHHHHcC---CeecCCCcccEEEE
Confidence 999999999999998653 257777732 23444 33333333 345555555 99999999999995
Q ss_pred CC--C--CceEec
Q 004521 577 QD--M--NPKISD 585 (747)
Q Consensus 577 ~~--~--~~kl~D 585 (747)
.. + .+.|+|
T Consensus 153 ~~~~~~~~lvlID 165 (199)
T PF10707_consen 153 RRDSGEFRLVLID 165 (199)
T ss_pred ecCCCceEEEEEe
Confidence 33 2 466666
|
PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner []. |
| >PLN02876 acyl-CoA dehydrogenase | Back alignment and domain information |
|---|
Probab=97.80 E-value=0.0002 Score=86.44 Aligned_cols=79 Identities=15% Similarity=0.330 Sum_probs=58.6
Q ss_pred cceecccCCeeEEEEEecCC---cEEEEEEecccc-cccHHHHHHHHHHHhccC-CCce--eeEEeEEEeC---CeeEEE
Q 004521 445 NNKLGEGGFGPVYKGTLVDG---QEIAVKRLSKIS-EQGLKELKNEVILFSKLQ-HRNL--VKLLGCCIQG---EEKLLI 514 (747)
Q Consensus 445 ~~~lg~G~fg~Vy~~~~~~g---~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~-H~ni--v~l~g~~~~~---~~~~lV 514 (747)
.++++.|.+..+|+....++ ..+++|+..... ......+.+|+++++.+. |.++ .+++++|.+. +..++|
T Consensus 43 v~~l~gG~sn~ty~l~~~~~~~~~~~VLR~~p~~~~~~~~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~~v~G~~flV 122 (822)
T PLN02876 43 VSQFGHGQSNPTFLLEVGNGGSVKRYVLRKKPPGKLLQSAHAVEREYQVLRALGEHTDVPVPKVYCLCTDASVIGTAFYI 122 (822)
T ss_pred EEEeCCCCcCceEEEEECCCCcceeEEEEeCCCCccCccHHHHHHHHHHHHHHhhcCCCCCCcEEEEecCCCcCCCceEE
Confidence 47889999999999877553 467778764322 123457889999999995 6665 7888888764 457899
Q ss_pred EecCCCCCh
Q 004521 515 YEFMPNKSL 523 (747)
Q Consensus 515 ~E~~~~gsL 523 (747)
|||+++..+
T Consensus 123 ME~v~G~~~ 131 (822)
T PLN02876 123 MEYLEGRIF 131 (822)
T ss_pred EEecCCccc
Confidence 999997654
|
|
| >cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members | Back alignment and domain information |
|---|
Probab=97.70 E-value=0.00022 Score=72.69 Aligned_cols=73 Identities=16% Similarity=0.294 Sum_probs=46.8
Q ss_pred ceecccCCe-eEEEEEecCCcEEEEEEecccccccHHHHHHHHHHHhccCCC---ceeeEEeEEEeCC---eeEEEEecC
Q 004521 446 NKLGEGGFG-PVYKGTLVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHR---NLVKLLGCCIQGE---EKLLIYEFM 518 (747)
Q Consensus 446 ~~lg~G~fg-~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~---niv~l~g~~~~~~---~~~lV~E~~ 518 (747)
+.|+.|+.. .||+. +..+++|..+. ......+.+|.+++..+... .+.++++.....+ ..++|||++
T Consensus 3 ~~~~~gG~~n~vy~~----~~~~VlR~~~~--~~~~~~~~~E~~~l~~L~~~~~v~vP~~~~~~~~~~~~~~~~~l~~~i 76 (235)
T cd05155 3 EPVDSGGTDNATFRL----GDDMSVRLPSA--AGYAGQVRKEQRWLPRLAPHLPLPVPEPLGKGEPGEGYPWPWSVYRWL 76 (235)
T ss_pred eeccCCCcccceEEc----CCceEEEcCCc--cchHHHHHHHHHHHHHHhccCCCCCCceeecCCCccCCCcceEEEEee
Confidence 567877777 48874 24577776543 22345788999999887532 3444454433322 347899999
Q ss_pred CCCChh
Q 004521 519 PNKSLD 524 (747)
Q Consensus 519 ~~gsL~ 524 (747)
+|.++.
T Consensus 77 ~G~~l~ 82 (235)
T cd05155 77 EGETAT 82 (235)
T ss_pred cCCCCC
Confidence 987764
|
The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista |
| >PRK10593 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=97.69 E-value=0.00049 Score=72.70 Aligned_cols=76 Identities=12% Similarity=0.071 Sum_probs=57.1
Q ss_pred cceecccCCeeEEEEEecCCcEEEEEEecccccccHHHHHHHHHHHhccCC---CceeeEEeEEEeC---CeeEEEEecC
Q 004521 445 NNKLGEGGFGPVYKGTLVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQH---RNLVKLLGCCIQG---EEKLLIYEFM 518 (747)
Q Consensus 445 ~~~lg~G~fg~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H---~niv~l~g~~~~~---~~~~lV~E~~ 518 (747)
.+.||.|..+.||+....+++ +.+|..+. ......|.+|...++.|.- ..+.++++++... +..+||||++
T Consensus 19 ~~~i~~G~~~~vy~~~~~~~~-~~~k~~~~--~~~~~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~~~~g~~~LVmE~i 95 (297)
T PRK10593 19 VECISEQPYAALWALYDSQGN-PMPLMARS--FSTPGVAQQEAWKLSMLARSGTVRMPTVYGVMTHEQSPGPDVLLLERL 95 (297)
T ss_pred eeecCCccceeEEEEEcCCCC-EEEEEecc--cccchHHHHHHHHHHHHccCCCCCcCcEEEEeccCCcCCCeEEEEecc
Confidence 578999999999998765554 66676432 1133588999999998853 4678889888653 5689999999
Q ss_pred CCCCh
Q 004521 519 PNKSL 523 (747)
Q Consensus 519 ~~gsL 523 (747)
+++++
T Consensus 96 ~G~~~ 100 (297)
T PRK10593 96 RGVSV 100 (297)
T ss_pred CCEec
Confidence 98765
|
|
| >KOG2137 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=97.64 E-value=3e-05 Score=86.67 Aligned_cols=89 Identities=21% Similarity=0.385 Sum_probs=63.8
Q ss_pred HHHHHHHHHHHhhhcCCCceEecccCcCcEEEcCCCCceEecccCccccCCCCCccccceee---------ec-------
Q 004521 544 IICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNTNRVV---------GT------- 607 (747)
Q Consensus 544 i~~~ia~gl~yLH~~~~~~iiHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~---------~~------- 607 (747)
=+.+++.||.|+|... .+||++|.|++|.++..+..||+.|+++....+.....-..+-. ..
T Consensus 104 nl~~v~dgl~flh~sA--k~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~ 181 (700)
T KOG2137|consen 104 NLGNVADGLAFLHRSA--KVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYL 181 (700)
T ss_pred hhhcccchhhhhccCc--ceeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhh
Confidence 3455669999999865 69999999999999999999999999876544311100000000 00
Q ss_pred cCCCCCccccchhHHHHHHHHHhCCCC
Q 004521 608 YDGQFSIKSDVFSFGILLLEIVSGKKN 634 (747)
Q Consensus 608 ~~~~~s~ksDVwS~Gvvl~elltg~~p 634 (747)
.....+.++|+||+||++|-+..|.++
T Consensus 182 ~~~~~~~~sd~fSlG~li~~i~~~gk~ 208 (700)
T KOG2137|consen 182 LGTTNTPASDVFSLGVLIYTIYNGGKS 208 (700)
T ss_pred ccccccccccceeeeeEEEEEecCCcc
Confidence 034567899999999999999965555
|
|
| >PF11883 DUF3403: Domain of unknown function (DUF3403); InterPro: IPR021820 This functionally uncharacterised domain of around 50 amino acids is found in the C terminus of eukaryotic S-locus receptor kinase proteins | Back alignment and domain information |
|---|
Probab=97.59 E-value=7.9e-05 Score=54.29 Aligned_cols=44 Identities=55% Similarity=0.733 Sum_probs=37.8
Q ss_pred CCCCCCCCCCccccccCCCCCCCCCCCC--CCCCCcceeeeeccCC
Q 004521 704 EILLPQPKQPGYLADRKSTEPYSSSSMP--ESSSTNTLTISELEAR 747 (747)
Q Consensus 704 ~~~~~~p~~p~~~~~~~~~~~~~~~~~~--~~~s~~~~~~~~~~~r 747 (747)
...+|.|++|+|+..+...+..+++... ..+|+|++|+|.++||
T Consensus 3 ~~~LP~PKqPgF~~~r~~~e~~sSss~~~~~~~SvNevTiT~l~~R 48 (48)
T PF11883_consen 3 TATLPQPKQPGFFTGRSPSETDSSSSKQRDESCSVNEVTITMLEAR 48 (48)
T ss_pred cccCCCCCCCCEEeEcCCCCcCCCcccccCCCCCeeeEEEEeEecC
Confidence 4679999999999998887776665554 8899999999999998
|
; GO: 0004674 protein serine/threonine kinase activity |
| >PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2 | Back alignment and domain information |
|---|
Probab=97.54 E-value=0.00074 Score=65.84 Aligned_cols=125 Identities=27% Similarity=0.393 Sum_probs=90.6
Q ss_pred cCCCccceecccCC-eeEEEEEecCCcEEEEEEecc---c---------cc---------ccHHHHHHHHHHHhccC---
Q 004521 440 DNFSINNKLGEGGF-GPVYKGTLVDGQEIAVKRLSK---I---------SE---------QGLKELKNEVILFSKLQ--- 494 (747)
Q Consensus 440 ~~~~~~~~lg~G~f-g~Vy~~~~~~g~~vavK~l~~---~---------~~---------~~~~~~~~E~~~l~~l~--- 494 (747)
.+++..+.||.|.- |.||++++ +|+.+|+|..+. . .. .....|..|.+..++|+
T Consensus 37 ~~I~flefLg~g~~~~~V~kv~I-~g~~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PF~~ECRAfgRLke~~ 115 (207)
T PF13095_consen 37 DDIEFLEFLGHGSHDGYVFKVEI-DGRIYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHYADPFNCECRAFGRLKEAG 115 (207)
T ss_pred CcEeeeeecCCCCceeEEEEEEE-CCeEEEEEEeeccccCCCccccccccccccccchhhhhcChHHHHHHhhHHHHhcc
Confidence 67888999999999 99999998 678999999432 0 00 11235788999888885
Q ss_pred CCce--eeEEeEEEeCC------------------eeEEEEecCCCCChhhHhhhcCCCCcCChhHHHHHHHHHHHHHHH
Q 004521 495 HRNL--VKLLGCCIQGE------------------EKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLY 554 (747)
Q Consensus 495 H~ni--v~l~g~~~~~~------------------~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~y 554 (747)
+.++ |+.+||..-.. ...||.||++... ....+-+.+|.+-|..
T Consensus 116 ~e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~----------------~~~~~~~~~~~~dl~~ 179 (207)
T PF13095_consen 116 REGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP----------------PLQIRDIPQMLRDLKI 179 (207)
T ss_pred ccCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc----------------ccchhHHHHHHHHHHH
Confidence 4456 89999974321 1246777765432 1122345677888899
Q ss_pred hhhcCCCceEecccCcCcEEEcCCCCceEecccCc
Q 004521 555 LHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLV 589 (747)
Q Consensus 555 LH~~~~~~iiHrDlkp~NIll~~~~~~kl~DFGla 589 (747)
+|..+ |+-+|+++.|.. .-||+|||.+
T Consensus 180 ~~k~g---I~~~Dv~~~ny~-----~G~lvDfs~~ 206 (207)
T PF13095_consen 180 LHKLG---IVPRDVKPRNYR-----GGKLVDFSSS 206 (207)
T ss_pred HHHCC---eeeccCcccccc-----CCEEEecccC
Confidence 99888 999999999986 4589999854
|
|
| >TIGR02721 ycfN_thiK thiamine kinase | Back alignment and domain information |
|---|
Probab=97.49 E-value=0.00061 Score=70.41 Aligned_cols=138 Identities=16% Similarity=0.113 Sum_probs=77.8
Q ss_pred eecccCCeeEEEEEecCCcEEEEEEecccccccHHHHHHHHHHHhccCCCce-eeEEeEEEeCCeeEEEEecCCCCChhh
Q 004521 447 KLGEGGFGPVYKGTLVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNL-VKLLGCCIQGEEKLLIYEFMPNKSLDS 525 (747)
Q Consensus 447 ~lg~G~fg~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~ni-v~l~g~~~~~~~~~lV~E~~~~gsL~~ 525 (747)
.+..|-...+|+... +++.+++|..........-...+|..+++.+....+ .++++... ..+||||+++..+..
T Consensus 3 ~~~~G~tn~~y~~~~-~~~~~vlR~~~~~~~~~~~~r~~E~~~l~~l~~~g~~P~~i~~~~----~~~v~e~i~G~~~~~ 77 (256)
T TIGR02721 3 TLSGGLTNRSWRIEH-PGISFVWRPQSPVCKALGVDRQREYQILQALSALGLAPKPILVNE----HWLLVEWLEGEVITL 77 (256)
T ss_pred cCCCcCcCCeEEEEe-CCccEEEeeCCcccccccCcHHHHHHHHHHHHhcCCCCceEEEeC----CEEEEEeccCccccc
Confidence 455677788998873 567888887654322211235778888888864333 34444432 378999999876542
Q ss_pred H-----------------hhhcC-CCCcCChhHH-HHHHHH---------HHHHHHHhhhc-----CCCceEecccCcCc
Q 004521 526 F-----------------IFDQT-RRTLLDWSQR-FHIICG---------TARGLLYLHQD-----SRLRIIHRDLKASN 572 (747)
Q Consensus 526 ~-----------------l~~~~-~~~~l~~~~~-~~i~~~---------ia~gl~yLH~~-----~~~~iiHrDlkp~N 572 (747)
. |+... ....++.... .....+ +..-+..+-.. ....++|+|+.|.|
T Consensus 78 ~~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~H~Dl~~~N 157 (256)
T TIGR02721 78 DQFVALDLLLELAALLHQLHSQPRFGYPLSLKARIAHYWLQIDPARRTPEWLRLYKQFRSAPEPAPLPLAPLHMDVHAYN 157 (256)
T ss_pred ccccCchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhcccccCChHHHHHHHHHHhccCCCCCCCeeecCCCCcCc
Confidence 1 11111 0111111111 111101 11112222111 12358999999999
Q ss_pred EEEcCCCCceEecccCcc
Q 004521 573 VLLDQDMNPKISDFGLVR 590 (747)
Q Consensus 573 Ill~~~~~~kl~DFGla~ 590 (747)
|++++++ +.|+||..|.
T Consensus 158 il~~~~~-~~lIDwE~a~ 174 (256)
T TIGR02721 158 LVVTPQG-LKLIDWEYAS 174 (256)
T ss_pred EEEeCCC-CEEEeccccC
Confidence 9999877 7899998764
|
Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function. |
| >cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes | Back alignment and domain information |
|---|
Probab=97.44 E-value=0.001 Score=67.76 Aligned_cols=74 Identities=20% Similarity=0.303 Sum_probs=48.5
Q ss_pred ceecccCCeeEEEEEecC--CcEEEEEEecccccccHHHHHHHHHHHhccCCCc-eeeEEeEEEeCCeeEEEEecCCCCC
Q 004521 446 NKLGEGGFGPVYKGTLVD--GQEIAVKRLSKISEQGLKELKNEVILFSKLQHRN-LVKLLGCCIQGEEKLLIYEFMPNKS 522 (747)
Q Consensus 446 ~~lg~G~fg~Vy~~~~~~--g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~n-iv~l~g~~~~~~~~~lV~E~~~~gs 522 (747)
+.|..|-...+|+....+ ++.+++|....... ......+|+.++..+.... ..++++... ..+||||+++.+
T Consensus 4 ~~l~gG~tN~~~~v~~~~~~~~~~vlR~~~~~~~-~~~d~~~E~~~~~~l~~~gl~P~v~~~~~----~~~l~e~i~G~~ 78 (235)
T cd05157 4 KRFTGGITNKLVKVSNKEDNQDAVLVRVYGNKTE-LIIDRERELRIHKLLSKHGLAPKLYATFQ----NGLIYEFIPGRT 78 (235)
T ss_pred EEcCCcccceEEEEEcCCCCCCeEEEEEccCCcc-ceecHHHHHHHHHHHHhCCCCCeEEEEeC----CcEEEEeeCCCc
Confidence 567778888999988764 67888997654222 1223357888888885433 344544332 248999999877
Q ss_pred hh
Q 004521 523 LD 524 (747)
Q Consensus 523 L~ 524 (747)
+.
T Consensus 79 l~ 80 (235)
T cd05157 79 LE 80 (235)
T ss_pred CC
Confidence 63
|
ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo |
| >PRK09550 mtnK methylthioribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=97.40 E-value=0.0021 Score=70.05 Aligned_cols=75 Identities=15% Similarity=0.222 Sum_probs=55.1
Q ss_pred ceecccCCeeEEEEEecCC-cEEEEEEeccc----c---cccHHHHHHHHHHHhccC---CCceeeEEeEEEeCCeeEEE
Q 004521 446 NKLGEGGFGPVYKGTLVDG-QEIAVKRLSKI----S---EQGLKELKNEVILFSKLQ---HRNLVKLLGCCIQGEEKLLI 514 (747)
Q Consensus 446 ~~lg~G~fg~Vy~~~~~~g-~~vavK~l~~~----~---~~~~~~~~~E~~~l~~l~---H~niv~l~g~~~~~~~~~lV 514 (747)
+.||.|.+..||+....+| +.++||.-... . ....+.+..|.+.|..+. -.++.+++.+ +.+..++|
T Consensus 32 ~elggGn~N~VyrV~~~~g~~svIVKqa~p~~r~~g~~wpl~~eR~~~Eae~L~~l~~~~p~~VPkV~~~--D~~~~~lV 109 (401)
T PRK09550 32 REIGDGNLNLVFRVSDTEGGKSVIVKQALPYVRVVGESWPLTLDRARIEAEALKIQAKYVPDLVPKVYHY--DEELAVTV 109 (401)
T ss_pred eEcCCCceEEEEEEEeCCCCeEEEEEecCcccccccccccccHHHHHHHHHHHHHHHhhCCCCCCeEEEE--CCCCCEEE
Confidence 6899999999999998877 58999985421 1 124566778888888763 2456777776 44567899
Q ss_pred EecCCCCC
Q 004521 515 YEFMPNKS 522 (747)
Q Consensus 515 ~E~~~~gs 522 (747)
|||+++..
T Consensus 110 ME~L~~~~ 117 (401)
T PRK09550 110 MEDLSDHK 117 (401)
T ss_pred EecCCCcc
Confidence 99998643
|
|
| >PF01453 B_lectin: D-mannose binding lectin; InterPro: IPR001480 A bulb lectin super-family (Amaryllidaceae, Orchidaceae and Aliaceae) contains a ~115-residue-long domain whose overall three dimensional fold is very similar to that of [, ]: Dictyostelium discoideum comitin, an actin binding protein Curculigo latifolia curculin, a sweet tasting and taste-modifying protein This domain generally binds mannose, but in at least one protein, curculin, it is apparently devoid of mannose-binding activity | Back alignment and domain information |
|---|
Probab=97.40 E-value=0.00093 Score=59.54 Aligned_cols=73 Identities=29% Similarity=0.447 Sum_probs=50.2
Q ss_pred CceEEEc-CCCCCCCCCcceEEEecCCcEEEEcCCCcEEEEeccccCcCCceEEEEec--ccCEEEEeCCCCCCCceeee
Q 004521 15 HEVVWVA-NRLNPINDSFGFLMINKTGNLVLTSQSNIVVWSAYLSKEVQTPVVLQLLD--SGNLVLRDEHDGDSETYFWQ 91 (747)
Q Consensus 15 ~t~VW~A-nr~~p~~~~~~~l~l~~~G~Lvl~~~~~~~vWst~~~~~~~~~~~~~lld--~GNlVl~~~~~~~~~~~lWq 91 (747)
.++||.. +...... ....+.|..+|||||.|..+.++|++... ++.+.+..++ .||++ .... ..+.|.
T Consensus 38 ~~~iWss~~t~~~~~-~~~~~~L~~~GNlvl~d~~~~~lW~Sf~~---ptdt~L~~q~l~~~~~~-~~~~----~~~sw~ 108 (114)
T PF01453_consen 38 GSVIWSSNNTSGRGN-SGCYLVLQDDGNLVLYDSSGNVLWQSFDY---PTDTLLPGQKLGDGNVT-GKND----SLTSWS 108 (114)
T ss_dssp TEEEEE--S-TTSS--SSEEEEEETTSEEEEEETTSEEEEESTTS---SS-EEEEEET--TSEEE-EEST----SSEEEE
T ss_pred CCEEEEecccCCccc-cCeEEEEeCCCCEEEEeecceEEEeecCC---CccEEEeccCcccCCCc-cccc----eEEeEC
Confidence 4679999 4343332 44789999999999999999999999433 4556677777 88888 5442 468898
Q ss_pred ecCCC
Q 004521 92 SFDYP 96 (747)
Q Consensus 92 SFd~P 96 (747)
|=+.|
T Consensus 109 s~~dp 113 (114)
T PF01453_consen 109 SNTDP 113 (114)
T ss_dssp SS---
T ss_pred CCCCC
Confidence 86665
|
Each bulb-type lectin domain consists of three sequential beta-sheet subdomains (I, II, III) that are inter-related by pseudo three-fold symmetry. The three subdomains are flat four-stranded, antiparrallel beta-sheets. Together they form a 12-stranded beta-barrel in which the barrel axis coincides with the pseudo 3-fold axis.; GO: 0005529 sugar binding; PDB: 3M7H_A 3M7J_B 3MEZ_D 1DLP_A 1BWU_D 1KJ1_A 1B2P_A 1XD6_A 2DPF_C 2D04_B .... |
| >COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=97.31 E-value=0.0012 Score=62.44 Aligned_cols=128 Identities=20% Similarity=0.267 Sum_probs=87.3
Q ss_pred ccceecccCCeeEEEEEecCCcEEEEEEecccccccHHHHHHHHHHHhccCCCcee-eEEeEEEeCCeeEEEEecCCCCC
Q 004521 444 INNKLGEGGFGPVYKGTLVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLV-KLLGCCIQGEEKLLIYEFMPNKS 522 (747)
Q Consensus 444 ~~~~lg~G~fg~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv-~l~g~~~~~~~~~lV~E~~~~gs 522 (747)
..+.|++|.+|.||++.+. |..+|+|+-+. +.....+..|++++..++-.++. +++.|- ...+.|||+.+-.
T Consensus 26 v~~~L~KG~~s~Vyl~~~~-~~~~a~Kvrr~--ds~r~~l~kEakiLeil~g~~~~p~vy~yg----~~~i~me~i~G~~ 98 (201)
T COG2112 26 VEKELAKGTTSVVYLGEWR-GGEVALKVRRR--DSPRRNLEKEAKILEILAGEGVTPEVYFYG----EDFIRMEYIDGRP 98 (201)
T ss_pred hhhhhhcccccEEEEeecc-CceEEEEEecC--CcchhhHHHHHHHHHHhhhcCCCceEEEec----hhhhhhhhhcCcc
Confidence 3578999999999999984 55899998764 34457899999999998866654 344442 2345699999888
Q ss_pred hhhHhhhcCCCCcCChhHHHHHHHHHHHHHHHhhhcCCCceEecccC-cCcEEEcCCCCceEecccCccc
Q 004521 523 LDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLK-ASNVLLDQDMNPKISDFGLVRT 591 (747)
Q Consensus 523 L~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlk-p~NIll~~~~~~kl~DFGla~~ 591 (747)
|.+.-... +.... ..+++.---|-..| |-|+.|. |..++|-++..+.|+||--|+.
T Consensus 99 L~~~~~~~------~rk~l----~~vlE~a~~LD~~G---I~H~El~~~~k~vlv~~~~~~iIDFd~At~ 155 (201)
T COG2112 99 LGKLEIGG------DRKHL----LRVLEKAYKLDRLG---IEHGELSRPWKNVLVNDRDVYIIDFDSATF 155 (201)
T ss_pred hhhhhhcc------cHHHH----HHHHHHHHHHHHhc---cchhhhcCCceeEEecCCcEEEEEccchhh
Confidence 87654211 22222 33444433334334 8888884 6656666666999999998863
|
|
| >cd05153 HomoserineK_II Homoserine Kinase, type II | Back alignment and domain information |
|---|
Probab=97.21 E-value=0.0019 Score=68.28 Aligned_cols=142 Identities=20% Similarity=0.176 Sum_probs=85.1
Q ss_pred cceecccCCeeEEEEEecCCcEEEEEEecccccccHHHHHHHHHHHhccCCCc--eeeEEeE------EEeCCeeEEEEe
Q 004521 445 NNKLGEGGFGPVYKGTLVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRN--LVKLLGC------CIQGEEKLLIYE 516 (747)
Q Consensus 445 ~~~lg~G~fg~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~n--iv~l~g~------~~~~~~~~lV~E 516 (747)
.+.|..|....+|+.... +..+++|+... .....+..|+.++..+.+.. +.+++.. ....+..++|+|
T Consensus 19 i~~i~~G~~n~~y~v~~~-~~~~vLr~~~~---~~~~~~~~e~~~l~~L~~~g~~vp~~i~~~~g~~~~~~~~~~~~l~~ 94 (296)
T cd05153 19 FEGISAGIENTNYFVTTD-SGRYVLTLFEK---VSAEELPFFLALLDHLAERGLPVPRPIADRDGEYLSELAGKPAALVE 94 (296)
T ss_pred eecccCccccceEEEEeC-CCcEEEEEcCC---CChHhccHHHHHHHHHHHCCCCCCccccCCCCcEeeeeCCceEEEEE
Confidence 456777877899998764 44688888754 33456777888888875332 4444432 123345689999
Q ss_pred cCCCCChhh----Hh----------hhcCCC--------CcCChhHHH----------HHHHHHHHHHHHhhh----cCC
Q 004521 517 FMPNKSLDS----FI----------FDQTRR--------TLLDWSQRF----------HIICGTARGLLYLHQ----DSR 560 (747)
Q Consensus 517 ~~~~gsL~~----~l----------~~~~~~--------~~l~~~~~~----------~i~~~ia~gl~yLH~----~~~ 560 (747)
|++|..+.. .. +..... ....|.... .....+...+.++.. .-.
T Consensus 95 ~i~G~~~~~~~~~~~~~lg~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~~~~~~~ 174 (296)
T cd05153 95 FLAGEHLTRPTAAHCRQIGEALARLHLAAQSFPGERNNLRGLAWIRELGKDLLPLLSAEDRALLADELARQDAFDPSDLP 174 (296)
T ss_pred eCCCCCCCCCCHHHHHHHHHHHHHHHHHhccCCccCCCcCCcHHHHHHHHHhccccCHHHHHHHHHHHHHHHhhhhhcCC
Confidence 999877532 11 110000 011221110 011123344455443 112
Q ss_pred CceEecccCcCcEEEcCCCCceEecccCcc
Q 004521 561 LRIIHRDLKASNVLLDQDMNPKISDFGLVR 590 (747)
Q Consensus 561 ~~iiHrDlkp~NIll~~~~~~kl~DFGla~ 590 (747)
..++|+|+.|.|||++++..+.|.||+.+.
T Consensus 175 ~~l~HgD~~~~Nil~~~~~~~~iIDfe~a~ 204 (296)
T cd05153 175 RGVIHADLFRDNVLFDGDELSGVIDFYFAC 204 (296)
T ss_pred CcCCccCcCcccEEEeCCceEEEeehhhhc
Confidence 359999999999999998778999998764
|
Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine. |
| >cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes | Back alignment and domain information |
|---|
Probab=96.97 E-value=0.0039 Score=66.16 Aligned_cols=140 Identities=26% Similarity=0.362 Sum_probs=82.7
Q ss_pred ceecccCCeeEEEEEecC-------CcEEEEEEecccccccHHHHHHHHHHHhccCCCce-eeEEeEEEeCCeeEEEEec
Q 004521 446 NKLGEGGFGPVYKGTLVD-------GQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNL-VKLLGCCIQGEEKLLIYEF 517 (747)
Q Consensus 446 ~~lg~G~fg~Vy~~~~~~-------g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~ni-v~l~g~~~~~~~~~lV~E~ 517 (747)
+.|..|--..+|+....+ ++.+++|+..... .......+|..++..+....+ .++++++.. .+|+||
T Consensus 4 ~~l~gGltN~~y~v~~~~~~~~~~~~~~~vlRi~~~~~-~~~~~r~~E~~~~~~l~~~g~~P~~~~~~~~----~~v~e~ 78 (302)
T cd05156 4 SKISGGLTNAVYKVSLPDEDALSDEPRKVLLRVYGQSV-ELLIDRERELVVFARLSERNLGPKLYGIFPN----GRIEEF 78 (302)
T ss_pred EEecCcccceeEEEEcCCcccccCCCCeEEEEEecCCC-cceechHHHHHHHHHHHhCCCCCceEEEeCC----Cchhhe
Confidence 456666667899888655 4788899865432 233456778888888753333 355555532 368999
Q ss_pred CCCCChhhHh-----------------hhcCCCC------cCC--hhHHHH--------------------------HHH
Q 004521 518 MPNKSLDSFI-----------------FDQTRRT------LLD--WSQRFH--------------------------IIC 546 (747)
Q Consensus 518 ~~~gsL~~~l-----------------~~~~~~~------~l~--~~~~~~--------------------------i~~ 546 (747)
++|..+.... +...... ..+ +..... +..
T Consensus 79 i~G~~l~~~~~~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 158 (302)
T cd05156 79 IPSRTLTTEELRDPDISAEIARRMAKLHSIVVPLSPEERDLTPAIWKLLKQWLDLAETVIEIVDSDSEKLLEVELSLFLE 158 (302)
T ss_pred eCCCcCCHhHcCCcHHHHHHHHHHHHhhCCCCCCCCCcCcccchHHHHHHHHHHHhhhhhhhcccchhhhhhhhHHHHHH
Confidence 9987764321 1100000 000 111100 111
Q ss_pred HHHHHHHHhhh------cCCCceEecccCcCcEEEcCC----CCceEecccCcc
Q 004521 547 GTARGLLYLHQ------DSRLRIIHRDLKASNVLLDQD----MNPKISDFGLVR 590 (747)
Q Consensus 547 ~ia~gl~yLH~------~~~~~iiHrDlkp~NIll~~~----~~~kl~DFGla~ 590 (747)
.+..-+.+|.. .....++|+|+.|.|||++++ +.++|+||..|.
T Consensus 159 ~~~~~~~~l~~~~~~~~~~~~~lcH~Dl~~~Nil~~~~~~~~~~i~lIDwEya~ 212 (302)
T cd05156 159 DEAKYLRFLLESTSEESGSPVVFCHNDLQEGNILLLNPSSETKKLVLIDFEYAS 212 (302)
T ss_pred HHHHHHHHHHhhccCCCCCCceEEecCCCcCeEEecCCCCCCCcEEEEeeCCCC
Confidence 22233334432 234569999999999999985 889999998775
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer |
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=96.93 E-value=0.0036 Score=74.31 Aligned_cols=191 Identities=20% Similarity=0.215 Sum_probs=124.1
Q ss_pred HHHHHHHHHhccCCCceeeEEeEEEeCCeeE----EEEecCCCCChhhHhhhcCCCCcCChhHHHHHHHHHHHHHHHhhh
Q 004521 482 ELKNEVILFSKLQHRNLVKLLGCCIQGEEKL----LIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQ 557 (747)
Q Consensus 482 ~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~----lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~ 557 (747)
....|...+.++.|+|++.+++|..+....- +..|++..-++...+.. -..++....+.+..++.+||.|+|+
T Consensus 228 ~~E~e~~~l~k~~~~n~~~~~~~~le~~~~g~~~~v~~~~~s~~~~~~~~q~---v~~i~~~~~r~~~~~~~~GL~~~h~ 304 (1351)
T KOG1035|consen 228 TTEIELESLSKIAHDNLGGYFVYGLERLFRGIVLDVLQEICSKVELRSLLQS---VGSIPLETLRILHQKLLEGLAYLHS 304 (1351)
T ss_pred HHHHHHHHHHhhccccccceeEEeehhhcchHHHHHHHhhcCccchHHHHhh---ccccCHHHHHHHHHHHhhhHHHHHH
Confidence 3455777888999999999999987654432 34577888888877744 3457788888899999999999998
Q ss_pred cCCCceEecccCcC---cEEEcCCCCceEe--cccCccccCCCCCccccce-----eeecc---CCCCCccccchhHHHH
Q 004521 558 DSRLRIIHRDLKAS---NVLLDQDMNPKIS--DFGLVRTFGGDETEGNTNR-----VVGTY---DGQFSIKSDVFSFGIL 624 (747)
Q Consensus 558 ~~~~~iiHrDlkp~---NIll~~~~~~kl~--DFGla~~~~~~~~~~~~~~-----~~~~~---~~~~s~ksDVwS~Gvv 624 (747)
.. ..|.-|..+ +--.+.++.+.++ ||+..+.+........... ..... ........|+|.+|..
T Consensus 305 ~~---l~~v~L~~s~~~~~~~~~e~~~~~sl~~~~ss~~l~d~~~~~~~~~~~~~~~~e~~~~~~~~~~r~~dL~~lgll 381 (1351)
T KOG1035|consen 305 LS---LEHVVLSASSSKESTVDGEGVVAISLSDFDSSKPLPDNEKSFSDLLAEIRNADEDLKENTAKKSRLTDLWCLGLL 381 (1351)
T ss_pred hc---cceeEEecccccccccCccceeecchhhhcccccCCCcccchhhcCccccccccccccccchhhhhhHHHHHHHH
Confidence 75 666655555 4555667777777 9988876654332211100 00011 1223345799999999
Q ss_pred HHHHHhCCCCCCCCCCcchhhhhHhHHhcCCcccccchhhhccCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHh
Q 004521 625 LLEIVSGKKNRGFYRSDTKVNLIGHLWDEGIPLRLIDACIQDSCNLADVIRCIHIGLLCVQQHPEDRPCMPSVILML 701 (747)
Q Consensus 625 l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dP~~RPt~~~v~~~L 701 (747)
+.-+..|..+..... .+..+++..... ........|+..++++|++..+++.+.
T Consensus 382 ~~~~~~~~~i~~~~~---------------~~~~~l~~~~~~--------~~~d~~~~~~~~~~~~Rl~~~~ll~~~ 435 (1351)
T KOG1035|consen 382 LLQLSQGEDISEKSA---------------VPVSLLDVLSTS--------ELLDALPKCLDEDSEERLSALELLTHP 435 (1351)
T ss_pred HhhhhhcCccccccc---------------chhhhhccccch--------hhhhhhhhhcchhhhhccchhhhhhch
Confidence 999999887632110 011111111100 122334479999999999999998755
|
|
| >PRK05231 homoserine kinase; Provisional | Back alignment and domain information |
|---|
Probab=96.84 E-value=0.023 Score=60.70 Aligned_cols=141 Identities=20% Similarity=0.201 Sum_probs=76.5
Q ss_pred ceecccCCeeEEEEEecCCcEEEEEEecccccccHHHHHHHHHHHhccCCC--ceeeEEe------EEEeCCeeEEEEec
Q 004521 446 NKLGEGGFGPVYKGTLVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHR--NLVKLLG------CCIQGEEKLLIYEF 517 (747)
Q Consensus 446 ~~lg~G~fg~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~--niv~l~g------~~~~~~~~~lV~E~ 517 (747)
+.|+.|....+|+....+| .+++|+... ...+.+..|+.++..|... .+.+.+. +....+..++++||
T Consensus 28 ~~l~~G~~n~~y~v~t~~g-~~vLK~~~~---~~~~~l~~~~~~l~~L~~~glpvP~~i~~~~G~~~~~~~g~~~~l~~~ 103 (319)
T PRK05231 28 KGIAEGIENSNFFLTTTQG-EYVLTLFER---LTAEDLPFFLGLMQHLAARGVPVPAPVARRDGAALGELAGKPAAIVTF 103 (319)
T ss_pred chhccccccceEEEEeCCC-cEEEEEecc---CChHHhHHHHHHHHHHHHCCCCCCcceeCCCCCEeeeeCCEEEEEEEe
Confidence 5567777789999876555 688888752 1233444555666655321 2333332 12234567899999
Q ss_pred CCCCChhh-----------Hh---hhcCCC------C--cCCh-hHHHH------------HHHH-HHHHHHHhhhc---
Q 004521 518 MPNKSLDS-----------FI---FDQTRR------T--LLDW-SQRFH------------IICG-TARGLLYLHQD--- 558 (747)
Q Consensus 518 ~~~gsL~~-----------~l---~~~~~~------~--~l~~-~~~~~------------i~~~-ia~gl~yLH~~--- 558 (747)
++|..+.. .| +..... . .+.| ..... ...+ +...+..+...
T Consensus 104 l~G~~~~~~~~~~~~~~G~~LA~lH~~~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 183 (319)
T PRK05231 104 LEGKWPRAPTAAHCAEVGEMLARMHLAGRDFPLERPNLRGLAWWRELAPRLLPFLADEQAALLEAELAAQLAFLASAAWP 183 (319)
T ss_pred cCCCCCCCCCHHHHHHHHHHHHHHHhhhhcCCccCCCCCChHHHHHHHHHHhhccChhHHHHHHHHHHHHHHhhhccccc
Confidence 99875421 11 111100 0 1111 11111 1111 11122233211
Q ss_pred -CCCceEecccCcCcEEEcCCCCceEecccCcc
Q 004521 559 -SRLRIIHRDLKASNVLLDQDMNPKISDFGLVR 590 (747)
Q Consensus 559 -~~~~iiHrDlkp~NIll~~~~~~kl~DFGla~ 590 (747)
-...+||+|+.|.|||++.+...-|+||+.+.
T Consensus 184 ~lp~~liHgD~~~~Nil~~~~~~~~iIDf~~~~ 216 (319)
T PRK05231 184 ALPRGVIHADLFRDNVLFEGDRLSGFIDFYFAC 216 (319)
T ss_pred cCCcccCCCCCCCCcEEEECCceEEEEeccccc
Confidence 23459999999999999977666899999764
|
|
| >TIGR00938 thrB_alt homoserine kinase, Neisseria type | Back alignment and domain information |
|---|
Probab=96.83 E-value=0.023 Score=60.42 Aligned_cols=143 Identities=23% Similarity=0.217 Sum_probs=81.8
Q ss_pred cceecccCCeeEEEEEecCCcEEEEEEecccccccHHHHHHHHHHHhccCCC--ceeeEEeEE------EeCCeeEEEEe
Q 004521 445 NNKLGEGGFGPVYKGTLVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHR--NLVKLLGCC------IQGEEKLLIYE 516 (747)
Q Consensus 445 ~~~lg~G~fg~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~--niv~l~g~~------~~~~~~~lV~E 516 (747)
.+.++.|.-..+|+....++ .+++|+..... ...++..|.+++..|... .+.+++... ...+..++|+|
T Consensus 27 i~~~~~G~~n~~y~v~t~~~-~~vLK~~~~~~--~~~~i~~e~~~l~~L~~~g~pvp~~i~t~~g~~~~~~~g~~~~l~e 103 (307)
T TIGR00938 27 LKGIAEGVENSNYLLTTDVG-RYILTLYEKRV--KAEELPFFLALTTHLAARGLPVPKPVKSRDGRQLSTLAGKPACLVE 103 (307)
T ss_pred ccccCCccccceEEEEeCCC-cEEEEEecCCC--CHHHHHHHHHHHHHHHHCCCCCCccccCCCCCeehhcCCeEEEEEE
Confidence 35677777789998875444 57788765421 234556677777777422 234444321 12345689999
Q ss_pred cCCCCChhh-----------H---hhhcCCC------C---cCChhHHH------------HHHHHHHHHHHHhhh----
Q 004521 517 FMPNKSLDS-----------F---IFDQTRR------T---LLDWSQRF------------HIICGTARGLLYLHQ---- 557 (747)
Q Consensus 517 ~~~~gsL~~-----------~---l~~~~~~------~---~l~~~~~~------------~i~~~ia~gl~yLH~---- 557 (747)
|++|..+.. . ++..... . .-.|.... .....+.+.++++..
T Consensus 104 ~i~G~~~~~~~~~~~~~~G~~LA~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~l~~~~~~~l~~~~~~l~~~~~~ 183 (307)
T TIGR00938 104 FLQGLSVGRPTAMHCRPVGEVLAWMHLAGAHFPENRKNSLRLEAWHILAEKCFEAAPQLEAHMGAELDKELDYLDKFWPR 183 (307)
T ss_pred eCCCCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCCCCCCChHHHHHHHHhhhhcccccCHHHHHHHHHHHHHHHhhhhh
Confidence 999865421 0 1110010 0 01111110 011223345555543
Q ss_pred cCCCceEecccCcCcEEEcCCCCceEecccCcc
Q 004521 558 DSRLRIIHRDLKASNVLLDQDMNPKISDFGLVR 590 (747)
Q Consensus 558 ~~~~~iiHrDlkp~NIll~~~~~~kl~DFGla~ 590 (747)
.....++|+|+.+.||+++.++...|.||+.+.
T Consensus 184 ~~~~~l~HgD~~~~Nvl~~~~~~~~vIDfd~~~ 216 (307)
T TIGR00938 184 DLPRGVIHADLFPDNVLFDGDSVKGVIDFYFAC 216 (307)
T ss_pred cCCCccCCCCCCcCcEEEECCceEEEeeccccc
Confidence 223469999999999999988877899999764
|
Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase. |
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=96.82 E-value=0.00019 Score=79.50 Aligned_cols=181 Identities=15% Similarity=0.099 Sum_probs=120.0
Q ss_pred cCCCccceecccCCeeEEEEEecCCcEEEEEEecccccccHHHHHHHHHHHhccCCCc-eeeEEeEEEeCCeeEEEEecC
Q 004521 440 DNFSINNKLGEGGFGPVYKGTLVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRN-LVKLLGCCIQGEEKLLIYEFM 518 (747)
Q Consensus 440 ~~~~~~~~lg~G~fg~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~n-iv~l~g~~~~~~~~~lV~E~~ 518 (747)
.-+...+.+++++++.++|.+....+...++.+... .+..-++++|.+++||| .+..++-+..+...+++++++
T Consensus 242 kws~~fh~fvK~altknpKkRptaeklL~h~fvs~~-----l~~rl~~eLLdK~n~P~~~v~~~~d~~~E~~~~i~~~i~ 316 (829)
T KOG0576|consen 242 KWSEFFHNFVKGALTKNPKKRPTAEKLLQHPFVSQT-----LSRRLAIELLDKVNNPNPVVRYLEDYDGEDYLWIPMRIC 316 (829)
T ss_pred cchHHHHHHHHHHhcCCCccCCChhhheeceeeccc-----hhhHHHHHHHHHccCCCCcccccccCCcccccchhhhhh
Confidence 334445678999999999987655555556665432 45567899999999999 666666666677788999998
Q ss_pred CCC-ChhhHhhhcCCCCcCChhHHHHHHHHHHHHHHHhhhcCCCceEecccCcCcEEEcCCCCceEecccCccccCCCCC
Q 004521 519 PNK-SLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDET 597 (747)
Q Consensus 519 ~~g-sL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~ 597 (747)
..+ +-..... ...-.+..-+...+.+.-+++++|||+.. -+|+| ||+..+ +..|..||+....+.....
T Consensus 317 s~~rs~~~~~~--~se~~~~~~~~~~~~r~et~~l~~l~~~~---~~~~d----~~l~s~-~~~~~~~~~v~~~L~~~~~ 386 (829)
T KOG0576|consen 317 STGRSSALEMT--VSEIALEQYQFAYPLRKETRPLAELHSSY---KVHRD----NILGSE-EEVKLLDFAVPPQLTRTMK 386 (829)
T ss_pred cCCccccccCC--hhhHhhhhhhhhhhhhhhccccccccccc---ccCcc----cccccc-cccccccccCCcccCcccc
Confidence 876 2211110 01111333444556677788999999864 48999 777665 7789999998876654321
Q ss_pred c---cccceeee---ccCCCCCccccchhHHHHHHHHHhCCCCC
Q 004521 598 E---GNTNRVVG---TYDGQFSIKSDVFSFGILLLEIVSGKKNR 635 (747)
Q Consensus 598 ~---~~~~~~~~---~~~~~~s~ksDVwS~Gvvl~elltg~~p~ 635 (747)
. ..+..... ...+.+..+.|+|+.|+---++--|..|.
T Consensus 387 ~~t~~~~~~~~~pev~~~~~~~~~p~~~~~~~~~~~~ap~~pPr 430 (829)
T KOG0576|consen 387 PRTAIGTPEPLAPEVIQENTIDGCPDSGSLAVSAIQMAPGLPPR 430 (829)
T ss_pred cccCCCCCCCCCchhhcccccccCCCccCCCcchhhcCCCCCCC
Confidence 1 00110111 12567888999999999777777777764
|
|
| >COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only] | Back alignment and domain information |
|---|
Probab=96.51 E-value=0.021 Score=60.13 Aligned_cols=128 Identities=16% Similarity=0.227 Sum_probs=77.4
Q ss_pred eEEEEEecCCcEEEEEEec-ccccccHHHHHHHHHHHhccCC--CceeeEEeEEEeCC--eeEEEEecCCCCChhhHhhh
Q 004521 455 PVYKGTLVDGQEIAVKRLS-KISEQGLKELKNEVILFSKLQH--RNLVKLLGCCIQGE--EKLLIYEFMPNKSLDSFIFD 529 (747)
Q Consensus 455 ~Vy~~~~~~g~~vavK~l~-~~~~~~~~~~~~E~~~l~~l~H--~niv~l~g~~~~~~--~~~lV~E~~~~gsL~~~l~~ 529 (747)
.+|..... ++.+++.+-. ...........+|..+|+.+.- .-..+.+++|.++. ..+.||+|+++..+...+..
T Consensus 40 ~t~~~~~~-~~~~vlR~P~~~~~~~~~~~~~re~~~i~~l~~~~vP~p~~~~~~~~~~~g~pf~v~~~veGe~~~~~~~~ 118 (321)
T COG3173 40 DTFRLGDT-GQKYVLRKPPRGDPVESAHDEKREYRVIAALLDVDVPVPRAFGLCGEGYLGTPFYVMEWVEGEVVWSALPP 118 (321)
T ss_pred ceEEEecC-CceEEEecCCccccchhhhHHHhHHHHHHHhcCCCCCCcccccccccCCCCCceEEEEEecceeccCcCCc
Confidence 44444332 7778887221 1223344566778888887743 34456677777766 66999999988433222210
Q ss_pred cCCCCcCChhHHHHHH-HHHHHHHHHhh--------------------------------------------------hc
Q 004521 530 QTRRTLLDWSQRFHII-CGTARGLLYLH--------------------------------------------------QD 558 (747)
Q Consensus 530 ~~~~~~l~~~~~~~i~-~~ia~gl~yLH--------------------------------------------------~~ 558 (747)
. ... .+++ ..+++.|.-|| ++
T Consensus 119 ~------~~~--~~~~~~~l~~~La~LH~ida~~~~~~g~~~~~~~rql~~~~~~~~~~~~~~~~~~p~~~~~~~Wl~~~ 190 (321)
T COG3173 119 E------SLG--RQFALDALADFLAELHSIDAAGLPDPGKPNAYRGRQLARWDDEYRRAKKELGGRIPLADRLIKWLEAN 190 (321)
T ss_pred c------cch--HHHHHHHHHHHHHHHhCCCCcCCCCCCccCccccchhhHHHHHHHHHHHhccCCCchHHHHHHHHHhc
Confidence 0 000 0111 13333333333 22
Q ss_pred -----CCCceEecccCcCcEEEcCCCCceEecccCccc
Q 004521 559 -----SRLRIIHRDLKASNVLLDQDMNPKISDFGLVRT 591 (747)
Q Consensus 559 -----~~~~iiHrDlkp~NIll~~~~~~kl~DFGla~~ 591 (747)
++..++|+|+.+.||+++.+.-+-|.||+++..
T Consensus 191 ~p~~~~~~~lvHGD~~~gNlii~~~~~~gVlDwe~~~l 228 (321)
T COG3173 191 RPPWAGPPVLVHGDYRPGNLIIDPGRPTGVLDWELATL 228 (321)
T ss_pred CCCcCCCceeeeCCcccCCEEEeCCCeeEEEecccccc
Confidence 245699999999999999998899999998764
|
|
| >cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2') | Back alignment and domain information |
|---|
Probab=96.51 E-value=0.019 Score=59.86 Aligned_cols=31 Identities=23% Similarity=0.502 Sum_probs=25.5
Q ss_pred CceEecccCcCcEEEcCCCC-ceEecccCccc
Q 004521 561 LRIIHRDLKASNVLLDQDMN-PKISDFGLVRT 591 (747)
Q Consensus 561 ~~iiHrDlkp~NIll~~~~~-~kl~DFGla~~ 591 (747)
..++|+|++|.|||+++++. .-|.||+.+..
T Consensus 185 ~~lvHGD~~~~Nilv~~~~~~~gviDWe~a~i 216 (276)
T cd05152 185 TVLVHGDLHPGHILIDEDARVTGLIDWTEAKV 216 (276)
T ss_pred CeeEeCCCCCCcEEEeCCCCEEEEECcHhccc
Confidence 45899999999999997555 46999998754
|
MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported |
| >cd01100 APPLE_Factor_XI_like Subfamily of PAN/APPLE-like domains; present in plasma prekallikrein/coagulation factor XI, microneme antigen proteins, and a few prokaryotic proteins | Back alignment and domain information |
|---|
Probab=96.50 E-value=0.0032 Score=51.13 Aligned_cols=48 Identities=17% Similarity=0.420 Sum_probs=34.6
Q ss_pred eccCCCCCCccccccccChHHHHHhhccCCceeEEeeecccCCCcceeeeec
Q 004521 291 TELKLPDATSSWVSKSMNLKECREGCLENSSCMAYTNSDIRGGGSGCAMWFG 342 (747)
Q Consensus 291 ~~~~~p~~~~~~~~~~~s~~~C~~~Cl~nCsC~a~~~~~~~~~~~~C~~~~~ 342 (747)
.+++++..+.... ...+.++|++.|+.+|+|.||.|.. +...|+++..
T Consensus 10 ~~~~~~g~d~~~~-~~~s~~~Cq~~C~~~~~C~afT~~~---~~~~C~lk~~ 57 (73)
T cd01100 10 SNVDFRGGDLSTV-FASSAEQCQAACTADPGCLAFTYNT---KSKKCFLKSS 57 (73)
T ss_pred CCCccccCCccee-ecCCHHHHHHHcCCCCCceEEEEEC---CCCeEEcccC
Confidence 4566665554423 3458999999999999999999952 3456977654
|
PAN/APPLE domains fulfill diverse biological functions by mediating protein-protein or protein-carbohydrate interactions. |
| >PF03881 Fructosamin_kin: Fructosamine kinase; InterPro: IPR016477 Ketosamines derive from a non-enzymatic reaction between a sugar and a protein [] | Back alignment and domain information |
|---|
Probab=96.37 E-value=0.038 Score=57.84 Aligned_cols=73 Identities=19% Similarity=0.254 Sum_probs=48.7
Q ss_pred cceecccCCeeEEEEEecCCcEEEEEEecccccccHHHHHHHHHHHhccC---CCceeeEEeEEEeCCeeEEEEecCCCC
Q 004521 445 NNKLGEGGFGPVYKGTLVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQ---HRNLVKLLGCCIQGEEKLLIYEFMPNK 521 (747)
Q Consensus 445 ~~~lg~G~fg~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~---H~niv~l~g~~~~~~~~~lV~E~~~~g 521 (747)
.+.|+-|....+|+.. .+++.+-||.-.. .....|..|..-|+.|. --.+.+.+++....+..+|||||++.+
T Consensus 22 ~~~v~GG~i~~a~~~~-~~~~~~FvK~~~~---~~~~~f~~Ea~gL~~L~~~~~~~vP~vi~~G~~~~~~fLlle~l~~~ 97 (288)
T PF03881_consen 22 IEPVSGGDINEAYRLD-TDGGSYFVKVNSE---SGRDMFEGEAEGLKALAEANPIRVPKVIAWGEYDDDAFLLLEFLEMG 97 (288)
T ss_dssp EEEE--SSSSEEEEEE-TTS-EEEEEEEEG---GGCCHHHHHHHHHHHHCHTTTSBS--EEEEEE-SSCCEEEEE-----
T ss_pred eEecCCCChhheEEEE-CCCccEEEEecCh---hhHHHHHHHHHHHHHHHhcCCCCCCeEEEEEeecCCceEEEEeecCC
Confidence 4678889999999877 5688899998752 33457888888888773 456789999988888889999999877
|
Ketosamine-3-kinases (KT3K), of which fructosamine-3-kinase (FN3K) is the best-known example, catalyse the phosphorylation of the ketosamine moiety of glycated proteins. The instability of a phosphorylated ketosamine leads to its degradation, and KT3K is thus thought to be involved in protein repair []. The function of the prokaryotic members of this group has not been established. However, several lines of evidence indicate that they may function as fructosamine-3-kinases (FN3K). First, they are similar to characterised FN3K from mouse and human. Second, the Escherichia coli members are found in close proximity on the genome to fructose-6-phosphate kinase (PfkB). Last, FN3K activity has been found in a Anacystis montana (Gloeocapsa montana Kutzing 1843) [], indicating such activity-directly demonstrated in eukaryotes-is nonetheless not confined to eukaryotes. This family includes eukaryotic fructosamine-3-kinase enzymes [] which may initiate a process leading to the deglycation of fructoselysine and of glycated proteins and in the phosphorylation of 1-deoxy-1-morpholinofructose, fructoselysine, fructoseglycine, fructose and glycated lysozyme. The family also includes bacterial members that have not been characterised but probably have a similar or identical function. For additional information please see [].; PDB: 3JR1_B 3F7W_A. |
| >PLN02236 choline kinase | Back alignment and domain information |
|---|
Probab=96.27 E-value=0.026 Score=60.91 Aligned_cols=140 Identities=18% Similarity=0.266 Sum_probs=79.2
Q ss_pred ceecccCCeeEEEEEecC-----CcEEEEEEecccccccHHHHHHHHHHHhccCCCcee-eEEeEEEeCCeeEEEEecCC
Q 004521 446 NKLGEGGFGPVYKGTLVD-----GQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLV-KLLGCCIQGEEKLLIYEFMP 519 (747)
Q Consensus 446 ~~lg~G~fg~Vy~~~~~~-----g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv-~l~g~~~~~~~~~lV~E~~~ 519 (747)
+.|-.|-.-.+|+....+ ++.+++|.......... .-..|..+++.+...++. ++++.+..+ .|+||++
T Consensus 42 ~~l~gGlTN~~y~v~~~~~~~~~~~~~v~Ri~g~~t~~~i-dR~~E~~~~~~l~~~gl~P~~~~~~~~g----~v~efi~ 116 (344)
T PLN02236 42 IPLKGAMTNEVFQIKWPTKEGNLGRKVLVRIYGEGVELFF-DRDDEIRTFECMSRHGQGPRLLGRFPNG----RVEEFIH 116 (344)
T ss_pred EEcCCcccceeEEEEeCCCCCCCCCeEEEEEccCCCCeee-chHHHHHHHHHHHHcCCCCceEEEECCc----eEEEeeC
Confidence 455556667888887533 35788888765333222 236788888888644443 556655332 5899998
Q ss_pred CCChhhH-------h----------hhcC-C--CCcCChhHHHHHHHH-----------------HHHHHHHh----hh-
Q 004521 520 NKSLDSF-------I----------FDQT-R--RTLLDWSQRFHIICG-----------------TARGLLYL----HQ- 557 (747)
Q Consensus 520 ~gsL~~~-------l----------~~~~-~--~~~l~~~~~~~i~~~-----------------ia~gl~yL----H~- 557 (747)
+.+|... + +... . .....+.+..+...+ +...+..| ..
T Consensus 117 g~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~~~~~~~~l~~~~~~~~~~~~~l~~~~~~L~~~~~~~ 196 (344)
T PLN02236 117 ARTLSAADLRDPEISALIAAKLREFHSLDMPGPKNVLLWDRLRNWLKEAKNLCSPEEAKEFRLDSLEDEINLLEKELSGD 196 (344)
T ss_pred CCCCCHHHcCChHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhhcCcchhhhcCHHHHHHHHHHHHHHhccc
Confidence 7776421 0 1100 0 001112222222211 11111122 21
Q ss_pred cCCCceEecccCcCcEEEcC-CCCceEecccCcc
Q 004521 558 DSRLRIIHRDLKASNVLLDQ-DMNPKISDFGLVR 590 (747)
Q Consensus 558 ~~~~~iiHrDlkp~NIll~~-~~~~kl~DFGla~ 590 (747)
.....++|+|+++.|||+++ ++.+.|+||..+.
T Consensus 197 ~~~~~~cH~Dl~~~Nil~~~~~~~~~lID~Eya~ 230 (344)
T PLN02236 197 DQEIGFCHNDLQYGNIMIDEETRAITIIDYEYAS 230 (344)
T ss_pred CCCceEEeCCCCcCcEEEeCCCCcEEEEeehhcc
Confidence 22345899999999999986 4789999998765
|
|
| >KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=96.24 E-value=0.0046 Score=63.79 Aligned_cols=134 Identities=16% Similarity=0.164 Sum_probs=91.1
Q ss_pred CCCccceecccCCeeEEEEEecCCcEEEEEEeccc---------ccc-----------c--HHHHHHHHHHHhccC-C-C
Q 004521 441 NFSINNKLGEGGFGPVYKGTLVDGQEIAVKRLSKI---------SEQ-----------G--LKELKNEVILFSKLQ-H-R 496 (747)
Q Consensus 441 ~~~~~~~lg~G~fg~Vy~~~~~~g~~vavK~l~~~---------~~~-----------~--~~~~~~E~~~l~~l~-H-~ 496 (747)
-+.+.++||-|.-+.||.+...+|++.++|.-+-. ..+ . .-...+|...|+.|. | -
T Consensus 93 v~svGnqIGVGKESDIY~v~d~~G~~~~lK~HRLGRtSFR~Vk~kRDY~r~r~~~sWlyLSRlaa~kEfafmkaL~e~gf 172 (465)
T KOG2268|consen 93 VESVGNQIGVGKESDIYVVADEEGNPLILKLHRLGRTSFRNVKNKRDYLRKRKSGSWLYLSRLAATKEFAFMKALYERGF 172 (465)
T ss_pred hhhhccccccccccceEEEecCCCCchhHHHHhhhhhhHHHhhhhhhhHhcCCccchhhhHHHHHHHHHHHHHHHHHcCC
Confidence 46778999999999999999988999999864310 000 0 112356788888874 3 2
Q ss_pred ceeeEEeEEEeCCeeEEEEecCCCCChhhHhhhcCCCCcCChhHHHHHHHHHHHHHHHhhhcCCCceEecccCcCcEEEc
Q 004521 497 NLVKLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLD 576 (747)
Q Consensus 497 niv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NIll~ 576 (747)
-+.+.++++ ..++|||++.+-.|...-+ ..+...+. ..+..-+.-|..+| +||+|..-=||+++
T Consensus 173 pVPkpiD~~----RH~Vvmelv~g~Pl~~v~~------v~d~~~ly---~~lm~~Iv~la~~G---lIHgDFNEFNimv~ 236 (465)
T KOG2268|consen 173 PVPKPIDHN----RHCVVMELVDGYPLRQVRH------VEDPPTLY---DDLMGLIVRLANHG---LIHGDFNEFNIMVK 236 (465)
T ss_pred CCCCccccc----ceeeHHHhhcccceeeeee------cCChHHHH---HHHHHHHHHHHHcC---ceecccchheeEEe
Confidence 344555543 4589999998887764421 12223332 23333344555666 99999999999999
Q ss_pred CCCCceEecccCcc
Q 004521 577 QDMNPKISDFGLVR 590 (747)
Q Consensus 577 ~~~~~kl~DFGla~ 590 (747)
++..++++||--..
T Consensus 237 dd~~i~vIDFPQmv 250 (465)
T KOG2268|consen 237 DDDKIVVIDFPQMV 250 (465)
T ss_pred cCCCEEEeechHhh
Confidence 99999999997543
|
|
| >PLN02756 S-methyl-5-thioribose kinase | Back alignment and domain information |
|---|
Probab=95.89 E-value=0.099 Score=57.00 Aligned_cols=73 Identities=12% Similarity=0.126 Sum_probs=50.2
Q ss_pred cceecccCCeeEEEEEecCCcEEEEEEecc----ccc---ccHHHHHHHHHHHhccC---CCceeeEEeEEEeCCeeEEE
Q 004521 445 NNKLGEGGFGPVYKGTLVDGQEIAVKRLSK----ISE---QGLKELKNEVILFSKLQ---HRNLVKLLGCCIQGEEKLLI 514 (747)
Q Consensus 445 ~~~lg~G~fg~Vy~~~~~~g~~vavK~l~~----~~~---~~~~~~~~E~~~l~~l~---H~niv~l~g~~~~~~~~~lV 514 (747)
.+.||-|..-.||+... +++.++||+-.. ... .....-..|...|+.+. ..++.+++.++. +..+++
T Consensus 37 ~~eiggGn~N~VyrV~~-~~~svVVKqa~p~~r~vga~wpl~~~R~~~Ea~aL~~~~~~~p~~VPkVy~~de--d~~vlv 113 (418)
T PLN02756 37 IKEVGDGNLNFVYIVVS-SSGSFVIKQALPYIRCIGESWPMTKERAYFEATALREHGRLCPDHVPEVYHFDR--TMALIG 113 (418)
T ss_pred EEEcCCCceeeEEEEEc-CCccEEEEeCCccccCCCccccCCccHHHHHHHHHHHhhhcCCCCCCeEEEECC--CCCEEE
Confidence 47899999999999876 456799998652 111 13334444566666553 357888888876 456889
Q ss_pred EecCCC
Q 004521 515 YEFMPN 520 (747)
Q Consensus 515 ~E~~~~ 520 (747)
|||+++
T Consensus 114 ME~L~~ 119 (418)
T PLN02756 114 MRYLEP 119 (418)
T ss_pred EeecCC
Confidence 999976
|
|
| >KOG1093 consensus Predicted protein kinase (contains TBC and RHOD domains) [General function prediction only] | Back alignment and domain information |
|---|
Probab=95.77 E-value=0.015 Score=63.56 Aligned_cols=70 Identities=17% Similarity=0.216 Sum_probs=46.6
Q ss_pred EEEEEecCCcEEEEEEecccccccHHHHHHHHHHHhccCCCceeeEEeEEEeCCe-eEEEEecCCCCChhhHhhh
Q 004521 456 VYKGTLVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEE-KLLIYEFMPNKSLDSFIFD 529 (747)
Q Consensus 456 Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~-~~lV~E~~~~gsL~~~l~~ 529 (747)
.+.|....|..+ .--+.- .....++.....+++.+.|+|+.+.+.+...... ..+|+|++ +.||++++..
T Consensus 5 ~~~a~~~~~~~c-~nglpl--t~~s~~ilgr~~~lktl~~~~l~~yl~~~r~~~~r~IVV~e~~-~~Sled~~~~ 75 (725)
T KOG1093|consen 5 TFFAQEKPGDVC-SNGLPL--TPNSIQILGRFQYLKSLQHDNLCQYLDFSRGKHERVIVVMEHY-TMSLEDILKT 75 (725)
T ss_pred EEehhcCCCccc-cCCCcC--CCcHHHHhhhhHHHHhhcCccceeeEeeecCccceEEEEehhh-ccchHHHHHh
Confidence 345555555443 222221 1223456667788999999999999998776544 56789988 5899988854
|
|
| >TIGR01767 MTRK 5-methylthioribose kinase | Back alignment and domain information |
|---|
Probab=95.69 E-value=0.091 Score=56.27 Aligned_cols=79 Identities=13% Similarity=0.159 Sum_probs=50.2
Q ss_pred eecccCCeeEEEEEecCC-cEEEEEEecc----cc---cccHHHHHHHHHHHhccC--CC-ceeeEEeEEEeCCeeEEEE
Q 004521 447 KLGEGGFGPVYKGTLVDG-QEIAVKRLSK----IS---EQGLKELKNEVILFSKLQ--HR-NLVKLLGCCIQGEEKLLIY 515 (747)
Q Consensus 447 ~lg~G~fg~Vy~~~~~~g-~~vavK~l~~----~~---~~~~~~~~~E~~~l~~l~--H~-niv~l~g~~~~~~~~~lV~ 515 (747)
.||.|...-||++...+| +.|+||.-.. .. .-.......|...|+... -| .+.+++.+ +.+...+||
T Consensus 2 EigdGnlN~VfrV~~~~g~~svIVKQAlp~vRv~g~~wpl~~~R~~~E~~~L~~~~~~~P~~vP~vy~~--D~e~~~~vM 79 (370)
T TIGR01767 2 EVGDGNLNLVFHVYDQEGDRAAIVKQALPYVRVVGESWPLTLDRARIESSALIRQGEHVPHLVPRIFHF--DTEMAVTVM 79 (370)
T ss_pred cCCCCceEEEEEEEcCCCCeeEEEEEcCHHHhhcCCCCCCCccHHHHHHHHHHHhhccCccccCeEEEE--ccccceehH
Confidence 579999999999998654 6899998542 11 223445556777776653 24 34455443 455667999
Q ss_pred ecCCCC-ChhhHh
Q 004521 516 EFMPNK-SLDSFI 527 (747)
Q Consensus 516 E~~~~g-sL~~~l 527 (747)
|+++.. .|...|
T Consensus 80 EdL~~~~ilR~~L 92 (370)
T TIGR01767 80 EDLSHHKIARKGL 92 (370)
T ss_pred hhCccchHHHHHH
Confidence 998643 343443
|
This enzyme is involved in the methionine salvage pathway in certain bacteria. |
| >TIGR02906 spore_CotS spore coat protein, CotS family | Back alignment and domain information |
|---|
Probab=95.13 E-value=0.23 Score=52.77 Aligned_cols=29 Identities=24% Similarity=0.347 Sum_probs=25.1
Q ss_pred CceEecccCcCcEEEcCCCCceEecccCcc
Q 004521 561 LRIIHRDLKASNVLLDQDMNPKISDFGLVR 590 (747)
Q Consensus 561 ~~iiHrDlkp~NIll~~~~~~kl~DFGla~ 590 (747)
..++|+|+.+.||+++. +.+.|.||+.+.
T Consensus 187 ~~liHgD~~~~Nil~~~-~~i~lIDfd~~~ 215 (313)
T TIGR02906 187 RGFCHQDYAYHNILLKD-NEVYVIDFDYCT 215 (313)
T ss_pred CceEcCCCCcccEEEeC-CcEEEEECcccc
Confidence 45899999999999988 678999999654
|
Members of this family include the spore coat proteins CotS and YtaA from Bacillus subtilis and, from other endospore-forming bacteria, homologs that are more closely related to these two than to the spore coat proteins YutH and YsxE. The CotS family is more broadly distributed than YutH or YsxE, but still is not universal among spore-formers. |
| >PF01633 Choline_kinase: Choline/ethanolamine kinase; InterPro: IPR002573 Choline kinase, (ATP:choline phosphotransferase, 2 | Back alignment and domain information |
|---|
Probab=95.06 E-value=0.053 Score=54.10 Aligned_cols=30 Identities=33% Similarity=0.560 Sum_probs=21.2
Q ss_pred CceEecccCcCcEEE-cCCCCceEecccCcc
Q 004521 561 LRIIHRDLKASNVLL-DQDMNPKISDFGLVR 590 (747)
Q Consensus 561 ~~iiHrDlkp~NIll-~~~~~~kl~DFGla~ 590 (747)
.-++|.||.|.|||+ +.++.++|+||-.|.
T Consensus 143 ~v~cHnDl~~~Nil~~~~~~~~~lIDfEya~ 173 (211)
T PF01633_consen 143 LVFCHNDLNPGNILINNKDGEVKLIDFEYAG 173 (211)
T ss_dssp EEEE-S--SGGGEEETSSSSCEEE--GTT-E
T ss_pred ceEeeccCccccEEeccCCCeEEEecHHHHh
Confidence 348999999999999 889999999998764
|
7.1.32 from EC) belongs to the choline/ethanolamine kinase family. Ethanolamine and choline are major membrane phospholipids, in the form of glycerophosphoethanolamine and glycerophosphocholine. Ethanolamine is also a component of the glycosylphosphatidylinositol (GPI) anchor, which is necessary for cell-surface protein attachment []. The de novo synthesis of these phospholipids begins with the creation of phosphoethanolamine and phosphocholine by ethanolamine and choline kinases in the first step of the CDP-ethanolamine pathway [, ]. There are two putative choline/ethanolamine kinases (C/EKs) in the Trypanosoma brucei genome. Ethanolamine kinase has no choline kinase activity [] and its activity is inhibited by ADP []. Inositol supplementation represses ethanolamine kinase, decreasing the incorporation of ethanolamine into the CDP-ethanolamine pathway and into phosphatidylethanolamine and phosphatidylcholine []. ; GO: 0016773 phosphotransferase activity, alcohol group as acceptor; PDB: 3C5I_A 2IG7_A 3LQ3_A 3FEG_A 2QG7_E 3FI8_A 1NW1_A 3MES_A 3G15_A 2CKP_B .... |
Homologous Structure Templates
Structure Templates Detected by BLAST
Original result of BLAST against Protein Data Bank
| ID | Alignment Graph | Length |
Definition |
E-value | |
| Query | 747 | ||||
| 3tl8_A | 349 | The Avrptob-Bak1 Complex Reveals Two Structurally S | 1e-45 | ||
| 3uim_A | 326 | Structural Basis For The Impact Of Phosphorylation | 6e-45 | ||
| 2nry_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 1e-32 | ||
| 2nru_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 2e-32 | ||
| 3hgk_A | 327 | Crystal Structure Of Effect Protein Avrptob Complex | 2e-32 | ||
| 2oib_A | 301 | Crystal Structure Of Irak4 Kinase Domain Apo Form L | 2e-32 | ||
| 2qkw_B | 321 | Structural Basis For Activation Of Plant Immunity B | 2e-32 | ||
| 2o8y_A | 298 | Apo Irak4 Kinase Domain Length = 298 | 2e-31 | ||
| 3kxz_A | 287 | The Complex Crystal Structure Of Lck With A Probe M | 1e-20 | ||
| 3kmm_A | 288 | Structure Of Human Lck Kinase With A Small Molecule | 1e-20 | ||
| 2zm1_A | 285 | Crystal Structure Of Imidazo Pyrazin 1 Bound To The | 1e-20 | ||
| 1qpe_A | 279 | Structural Analysis Of The Lymphocyte-Specific Kina | 2e-20 | ||
| 3a4o_X | 286 | Lyn Kinase Domain Length = 286 | 2e-20 | ||
| 2zv7_A | 279 | Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | 2e-20 | ||
| 3lck_A | 271 | The Kinase Domain Of Human Lymphocyte Kinase (Lck), | 2e-20 | ||
| 2pl0_A | 289 | Lck Bound To Imatinib Length = 289 | 2e-20 | ||
| 2ofu_A | 273 | X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam | 2e-20 | ||
| 2ofv_A | 277 | Crystal Structure Of Aminoquinazoline 1 Bound To Lc | 2e-20 | ||
| 3bym_A | 272 | X-Ray Co-Crystal Structure Aminobenzimidazole Triaz | 2e-20 | ||
| 3bys_A | 277 | Co-Crystal Structure Of Lck And Aminopyrimidine Ami | 2e-20 | ||
| 2of2_A | 271 | Crystal Structure Of Furanopyrimidine 8 Bound To Lc | 2e-20 | ||
| 2og8_A | 265 | Crystal Structure Of Aminoquinazoline 36 Bound To L | 4e-20 | ||
| 3mpm_A | 267 | Lck Complexed With A Pyrazolopyrimidine Length = 26 | 9e-20 | ||
| 2hk5_A | 270 | Hck Kinase In Complex With Lck Targetted Inhibitor | 2e-19 | ||
| 1qpd_A | 279 | Structural Analysis Of The Lymphocyte-specific Kina | 2e-19 | ||
| 4gt4_A | 308 | Structure Of Unliganded, Inactive Ror2 Kinase Domai | 2e-19 | ||
| 3p86_A | 309 | Crystal Structure Of Ctr1 Kinase Domain Mutant D676 | 3e-19 | ||
| 3q6w_A | 307 | Structure Of Dually-phosphorylated Met Receptor Kin | 3e-19 | ||
| 3zzw_A | 289 | Crystal Structure Of The Kinase Domain Of Ror2 Leng | 3e-19 | ||
| 1qcf_A | 454 | Crystal Structure Of Hck In Complex With A Src Fami | 4e-19 | ||
| 2r4b_A | 321 | Erbb4 Kinase Domain Complexed With A Thienopyrimidi | 4e-19 | ||
| 3q6u_A | 308 | Structure Of The Apo Met Receptor Kinase In The Dua | 4e-19 | ||
| 4gg5_A | 319 | Crystal Structure Of Cmet In Complex With Novel Inh | 4e-19 | ||
| 2wd1_A | 292 | Human C-Met Kinase In Complex With Azaindole Inhibi | 4e-19 | ||
| 3i5n_A | 309 | Crystal Structure Of C-Met With Triazolopyridazine | 4e-19 | ||
| 3f66_A | 298 | Human C-Met Kinase In Complex With Quinoxaline Inhi | 4e-19 | ||
| 2rfn_A | 310 | X-ray Structure Of C-met With Inhibitor. Length = 3 | 4e-19 | ||
| 2wgj_A | 306 | X-Ray Structure Of Pf-02341066 Bound To The Kinase | 4e-19 | ||
| 3lq8_A | 302 | Structure Of The Kinase Domain Of C-Met Bound To Xl | 5e-19 | ||
| 2g15_A | 318 | Structural Characterization Of Autoinhibited C-Met | 5e-19 | ||
| 3bbt_B | 328 | Crystal Structure Of The Erbb4 Kinase In Complex Wi | 5e-19 | ||
| 1y57_A | 452 | Structure Of Unphosphorylated C-Src In Complex With | 5e-19 | ||
| 3c1x_A | 373 | Crystal Structure Of The Tyrosine Kinase Domain Of | 5e-19 | ||
| 1fmk_A | 452 | Crystal Structure Of Human Tyrosine-Protein Kinase | 5e-19 | ||
| 1ad5_A | 438 | Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | 5e-19 | ||
| 3a4p_A | 319 | Human C-Met Kinase Domain Complexed With 6-Benzylox | 5e-19 | ||
| 2h8h_A | 535 | Src Kinase In Complex With A Quinazoline Inhibitor | 6e-19 | ||
| 3cth_A | 314 | Crystal Structure Of The Tyrosine Kinase Domain Of | 6e-19 | ||
| 3miy_A | 266 | X-Ray Crystal Structure Of Itk Complexed With Sunit | 6e-19 | ||
| 1yi6_A | 276 | C-Term Tail Segment Of Human Tyrosine Kinase (258-5 | 6e-19 | ||
| 1r0p_A | 312 | Crystal Structure Of The Tyrosine Kinase Domain Of | 6e-19 | ||
| 3qti_A | 314 | C-Met Kinase In Complex With Nvp-Bvu972 Length = 31 | 7e-19 | ||
| 3dkc_A | 317 | Sgx Clone 5698a65kfg1h1 Length = 317 | 7e-19 | ||
| 4asz_A | 299 | Crystal Structure Of Apo Trkb Kinase Domain Length | 7e-19 | ||
| 3ppz_A | 309 | Crystal Structure Of Ctr1 Kinase Domain In Complex | 8e-19 | ||
| 2bdf_A | 279 | Src Kinase In Complex With Inhibitor Ap23451 Length | 8e-19 | ||
| 3dkg_A | 317 | Sgx Clone 5698a109kfg1h1 Length = 317 | 9e-19 | ||
| 1ksw_A | 452 | Structure Of Human C-Src Tyrosine Kinase (Thr338gly | 9e-19 | ||
| 3dtc_A | 271 | Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp | 1e-18 | ||
| 2dq7_X | 283 | Crystal Structure Of Fyn Kinase Domain Complexed Wi | 1e-18 | ||
| 1yol_A | 283 | Crystal Structure Of Src Kinase Domain In Complex W | 2e-18 | ||
| 4f0f_A | 287 | Crystal Structure Of The Roco4 Kinase Domain Bound | 2e-18 | ||
| 1yoj_A | 283 | Crystal Structure Of Src Kinase Domain Length = 283 | 2e-18 | ||
| 4hct_A | 269 | Crystal Structure Of Itk In Complex With Compound 5 | 4e-18 | ||
| 1sm2_A | 264 | Crystal Structure Of The Phosphorylated Interleukin | 4e-18 | ||
| 3v5j_A | 266 | Crystal Structure Of Interleukin-2 Inducible T-Cell | 4e-18 | ||
| 3d7u_B | 277 | Structural Basis For The Recognition Of C-Src By It | 4e-18 | ||
| 3u4w_A | 275 | Src In Complex With Dna-Templated Macrocyclic Inhib | 5e-18 | ||
| 3dqw_A | 286 | C-Src Kinase Domain Thr338ile Mutant In Complex Wit | 6e-18 | ||
| 2oiq_A | 286 | Crystal Structure Of Chicken C-Src Kinase Domain In | 6e-18 | ||
| 4f1o_A | 287 | Crystal Structure Of The L1180t Mutant Roco4 Kinase | 6e-18 | ||
| 3g6h_A | 286 | Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma | 7e-18 | ||
| 3svv_A | 286 | Crystal Structure Of T338c C-Src Covalently Bound T | 7e-18 | ||
| 3v5q_A | 297 | Discovery Of A Selective Trk Inhibitor With Efficac | 8e-18 | ||
| 4f1m_A | 287 | Crystal Structure Of The G1179s Roco4 Kinase Domain | 9e-18 | ||
| 2ptk_A | 453 | Chicken Src Tyrosine Kinase Length = 453 | 9e-18 | ||
| 3oez_A | 286 | Crystal Structure Of The L317i Mutant Of The Chicke | 1e-17 | ||
| 3geq_A | 286 | Structural Basis For The Chemical Rescue Of Src Kin | 1e-17 | ||
| 3qgw_A | 286 | Crystal Structure Of Itk Kinase Bound To An Inhibit | 1e-17 | ||
| 2i1m_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An | 1e-17 | ||
| 3t9t_A | 267 | Crystal Structure Of Btk Mutant (F435t,K596r) Compl | 1e-17 | ||
| 4f0i_A | 300 | Crystal Structure Of Apo Trka Length = 300 | 2e-17 | ||
| 4gt5_A | 306 | Crystal Structure Of The Inactive Trka Kinase Domai | 2e-17 | ||
| 2qok_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 2e-17 | ||
| 2qq7_A | 286 | Crystal Structure Of Drug Resistant Src Kinase Doma | 2e-17 | ||
| 2hwo_A | 286 | Crystal Structure Of Src Kinase Domain In Complex W | 2e-17 | ||
| 4aoj_A | 329 | Human Trka In Complex With The Inhibitor Az-23 Leng | 2e-17 | ||
| 2qoo_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 2e-17 | ||
| 2qoc_A | 344 | Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp | 2e-17 | ||
| 3fxx_A | 371 | Human Epha3 Kinase And Juxtamembrane Region Bound T | 2e-17 | ||
| 4e6d_A | 298 | Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W | 2e-17 | ||
| 2ogv_A | 317 | Crystal Structure Of The Autoinhibited Human C-Fms | 2e-17 | ||
| 3lcd_A | 329 | Inhibitor Bound To A Dfg-In Structure Of The Kinase | 3e-17 | ||
| 2gsf_A | 373 | The Human Epha3 Receptor Tyrosine Kinase And Juxtam | 3e-17 | ||
| 3dzq_A | 361 | Human Epha3 Kinase Domain In Complex With Inhibitor | 3e-17 | ||
| 2qof_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f | 3e-17 | ||
| 2qod_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y602f | 3e-17 | ||
| 2qoi_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 3e-17 | ||
| 3bea_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P | 4e-17 | ||
| 3omv_A | 307 | Crystal Structure Of C-Raf (Raf-1) Length = 307 | 4e-17 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 4e-17 | ||
| 2qol_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596:y | 5e-17 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 5e-17 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 5e-17 | ||
| 3rvg_A | 303 | Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido | 5e-17 | ||
| 4aqc_A | 301 | Triazolopyridine-Based Inhibitor Of Janus Kinase 2 | 6e-17 | ||
| 3e62_A | 293 | Fragment Based Discovery Of Jak-2 Inhibitors Length | 6e-17 | ||
| 2w1i_A | 326 | Structure Determination Of Aurora Kinase In Complex | 6e-17 | ||
| 4hge_A | 300 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 | 6e-17 | ||
| 3tjc_A | 298 | Co-Crystal Structure Of Jak2 With Thienopyridine 8 | 6e-17 | ||
| 2b7a_A | 293 | The Structural Basis Of Janus Kinase 2 Inhibition B | 6e-17 | ||
| 4e4m_A | 302 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 3 | 7e-17 | ||
| 3q32_A | 301 | Structure Of Janus Kinase 2 With A Pyrrolotriazine | 7e-17 | ||
| 3lpb_A | 295 | Crystal Structure Of Jak2 Complexed With A Potent 2 | 7e-17 | ||
| 3jy9_A | 311 | Janus Kinase 2 Inhibitors Length = 311 | 8e-17 | ||
| 3dk6_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 8e-17 | ||
| 2gqg_A | 278 | X-Ray Crystal Structure Of Dasatinib (Bms-354825) B | 8e-17 | ||
| 3io7_A | 313 | 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel | 8e-17 | ||
| 2qob_A | 344 | Human Epha3 Kinase Domain, Base Structure Length = | 9e-17 | ||
| 2qo7_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Dephos | 9e-17 | ||
| 3qrj_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain T | 9e-17 | ||
| 3qri_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain I | 1e-16 | ||
| 2hzi_A | 277 | Abl Kinase Domain In Complex With Pd180970 Length = | 1e-16 | ||
| 2hz0_A | 270 | Abl Kinase Domain In Complex With Nvp-Aeg082 Length | 1e-16 | ||
| 2v7a_A | 286 | Crystal Structure Of The T315i Abl Mutant In Comple | 1e-16 | ||
| 2hyy_A | 273 | Human Abl Kinase Domain In Complex With Imatinib (S | 1e-16 | ||
| 2qon_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 1e-16 | ||
| 3ugc_A | 295 | Structural Basis Of Jak2 Inhibition By The Type Ii | 1e-16 | ||
| 2xa4_A | 298 | Inhibitors Of Jak2 Kinase Domain Length = 298 | 1e-16 | ||
| 2hiw_A | 287 | Crystal Structure Of Inactive Conformation Abl Kina | 1e-16 | ||
| 2e2b_A | 293 | Crystal Structure Of The C-Abl Kinase Domain In Com | 1e-16 | ||
| 2g1t_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 1e-16 | ||
| 3dk7_A | 277 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 1e-16 | ||
| 3pyy_A | 298 | Discovery And Characterization Of A Cell-Permeable, | 2e-16 | ||
| 3oxz_A | 284 | Crystal Structure Of Abl Kinase Domain Bound With A | 2e-16 | ||
| 1fpu_A | 293 | Crystal Structure Of Abl Kinase Domain In Complex W | 2e-16 | ||
| 2z60_A | 288 | Crystal Structure Of The T315i Mutant Of Abl Kinase | 2e-16 | ||
| 3oy3_A | 284 | Crystal Structure Of Abl T315i Mutant Kinase Domain | 2e-16 | ||
| 2qoh_A | 288 | Crystal Structure Of Abl Kinase Bound With Ppy-a Le | 2e-16 | ||
| 3kul_B | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 2e-16 | ||
| 2f4j_A | 287 | Structure Of The Kinase Domain Of An Imatinib-Resis | 3e-16 | ||
| 2g2f_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 3e-16 | ||
| 2qkr_A | 313 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 3e-16 | ||
| 3dk3_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 3e-16 | ||
| 3kul_A | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 3e-16 | ||
| 4dbn_A | 284 | Crystal Structure Of The Kinase Domain Of Human B-R | 3e-16 | ||
| 3niz_A | 311 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 3e-16 | ||
| 1uwj_A | 276 | The Complex Of Mutant V599e B-raf And Bay439006 Len | 3e-16 | ||
| 2fb8_A | 281 | Structure Of The B-Raf Kinase Domain Bound To Sb-59 | 3e-16 | ||
| 3q96_A | 282 | B-Raf Kinase Domain In Complex With A Tetrahydronap | 3e-16 | ||
| 2i0v_A | 335 | C-Fms Tyrosine Kinase In Complex With A Quinolone I | 3e-16 | ||
| 3gvu_A | 292 | The Crystal Structure Of Human Abl2 In Complex With | 3e-16 | ||
| 4h58_A | 275 | Braf In Complex With Compound 3 Length = 275 | 3e-16 | ||
| 3idp_A | 300 | B-Raf V600e Kinase Domain In Complex With An Aminoi | 3e-16 | ||
| 1uwh_A | 276 | The Complex Of Wild Type B-Raf And Bay439006 Length | 3e-16 | ||
| 4bbe_A | 298 | Aminoalkylpyrimidine Inhibitor Complexes With Jak2 | 3e-16 | ||
| 3ii5_A | 306 | The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi | 4e-16 | ||
| 3d4q_A | 307 | Pyrazole-Based Inhibitors Of B-Raf Kinase Length = | 4e-16 | ||
| 4g9r_A | 307 | B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr | 4e-16 | ||
| 1k3a_A | 299 | Structure Of The Insulin-Like Growth Factor 1 Recep | 4e-16 | ||
| 2zm3_A | 308 | Complex Structure Of Insulin-Like Growth Factor Rec | 5e-16 | ||
| 3lco_A | 324 | Inhibitor Bound To A Dfg-Out Structure Of The Kinas | 6e-16 | ||
| 2fo0_A | 495 | Organization Of The Sh3-Sh2 Unit In Active And Inac | 7e-16 | ||
| 1opl_A | 537 | Structural Basis For The Auto-Inhibition Of C-Abl T | 7e-16 | ||
| 1opk_A | 495 | Structural Basis For The Auto-Inhibition Of C-Abl T | 9e-16 | ||
| 1m7n_A | 322 | Crystal Structure Of Unactivated Apo Insulin-Like G | 9e-16 | ||
| 2oj9_A | 307 | Structure Of Igf-1r Kinase Domain Complexed With A | 1e-15 | ||
| 1jqh_A | 308 | Igf-1 Receptor Kinase Domain Length = 308 | 1e-15 | ||
| 3qqu_A | 301 | Cocrystal Structure Of Unphosphorylated Igf With Py | 1e-15 | ||
| 1p4o_A | 322 | Structure Of Apo Unactivated Igf-1r Kinase Domain A | 1e-15 | ||
| 3i81_A | 315 | Crystal Structure Of Insulin-Like Growth Factor 1 R | 1e-15 | ||
| 3o23_A | 305 | Human Unphosphorylated Igf1-R Kinase Domain In Comp | 1e-15 | ||
| 3lw0_A | 304 | Igf-1rk In Complex With Ligand Msc1609119a-1 Length | 1e-15 | ||
| 3lvp_A | 336 | Crystal Structure Of Bisphosphorylated Igf1-R Kinas | 1e-15 | ||
| 3s95_A | 310 | Crystal Structure Of The Human Limk1 Kinase Domain | 1e-15 | ||
| 1jpa_A | 312 | Crystal Structure Of Unphosphorylated Ephb2 Recepto | 2e-15 | ||
| 2x7f_A | 326 | Crystal Structure Of The Kinase Domain Of Human Tra | 2e-15 | ||
| 1luf_A | 343 | Crystal Structure Of The Musk Tyrosine Kinase: Insi | 2e-15 | ||
| 3d94_A | 301 | Crystal Structure Of The Insulin-Like Growth Factor | 2e-15 | ||
| 2pk9_A | 317 | Structure Of The Pho85-pho80 Cdk-cyclin Complex Of | 2e-15 | ||
| 3l9p_A | 367 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 3e-15 | ||
| 2ivt_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 3e-15 | ||
| 3lct_A | 344 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 3e-15 | ||
| 4fnw_A | 327 | Crystal Structure Of The Apo F1174l Anaplastic Lymp | 3e-15 | ||
| 2yjr_A | 342 | Structure Of F1174l Mutant Anaplastic Lymphoma Kina | 3e-15 | ||
| 1mqb_A | 333 | Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro | 3e-15 | ||
| 2ivs_A | 314 | Crystal Structure Of Non-Phosphorylated Ret Tyrosin | 4e-15 | ||
| 4aw5_A | 291 | Complex Of The Ephb4 Kinase Domain With An Oxindole | 5e-15 | ||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 5e-15 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 6e-15 | ||
| 2vwu_A | 302 | Ephb4 Kinase Domain Inhibitor Complex Length = 302 | 6e-15 | ||
| 2qnj_A | 328 | Kinase And Ubiquitin-Associated Domains Of Mark3PAR | 6e-15 | ||
| 2hak_A | 328 | Catalytic And Ubiqutin-Associated Domains Of Mark1P | 7e-15 | ||
| 2ivv_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 7e-15 | ||
| 2yfx_A | 327 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 7e-15 | ||
| 2r2p_A | 295 | Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep | 7e-15 | ||
| 2xb7_A | 315 | Structure Of Human Anaplastic Lymphoma Kinase In Co | 7e-15 | ||
| 4fnz_A | 327 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 8e-15 | ||
| 2yhv_A | 342 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 8e-15 | ||
| 3ika_A | 331 | Crystal Structure Of Egfr 696-1022 T790m Mutant Cov | 8e-15 | ||
| 3pp0_A | 338 | Crystal Structure Of The Kinase Domain Of Human Her | 8e-15 | ||
| 2xp2_A | 327 | Structure Of The Human Anaplastic Lymphoma Kinase I | 8e-15 | ||
| 2yjs_A | 342 | Structure Of C1156y Mutant Anaplastic Lymphoma Kina | 8e-15 | ||
| 2jiv_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 9e-15 | ||
| 3aox_A | 344 | X-Ray Crystal Structure Of Human Anaplastic Lymphom | 9e-15 | ||
| 2jiu_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 9e-15 | ||
| 4dce_A | 333 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 9e-15 | ||
| 4i24_A | 329 | Structure Of T790m Egfr Kinase Domain Co-crystalliz | 9e-15 | ||
| 4g5p_A | 330 | Crystal Structure Of Egfr Kinase T790m In Complex W | 1e-14 | ||
| 2hen_A | 286 | Crystal Structure Of The Ephb2 Receptor Kinase Doma | 1e-14 | ||
| 2jit_A | 327 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 1e-14 | ||
| 4fob_A | 353 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 1e-14 | ||
| 2gs2_A | 330 | Crystal Structure Of The Active Egfr Kinase Domain | 1e-14 | ||
| 1m14_A | 333 | Tyrosine Kinase Domain From Epidermal Growth Factor | 1e-14 | ||
| 3lzb_A | 327 | Egfr Kinase Domain Complexed With An Imidazo[2,1-B] | 1e-14 | ||
| 4g5j_A | 330 | Crystal Structure Of Egfr Kinase In Complex With Bi | 1e-14 | ||
| 2j5f_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 1e-14 | ||
| 2xyu_A | 285 | Crystal Structure Of Epha4 Kinase Domain In Complex | 1e-14 | ||
| 2gs7_A | 330 | Crystal Structure Of The Inactive Egfr Kinase Domai | 1e-14 | ||
| 4i23_A | 329 | Crystal Structure Of The Wild-type Egfr Kinase Doma | 1e-14 | ||
| 2hel_A | 306 | Crystal Structure Of A Mutant Epha4 Kinase Domain ( | 1e-14 | ||
| 3bel_A | 315 | X-Ray Structure Of Egfr In Complex With Oxime Inhib | 1e-14 | ||
| 4hjo_A | 337 | Crystal Structure Of The Inactive Egfr Tyrosine Kin | 1e-14 | ||
| 3vjo_A | 334 | Crystal Structure Of The Wild-Type Egfr Kinase Doma | 1e-14 | ||
| 2j5e_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 1e-14 | ||
| 3fe3_A | 328 | Crystal Structure Of The Kinase Mark3PAR-1: T211a-S | 1e-14 | ||
| 2y6m_A | 291 | Crystal Structure Of Epha4 Kinase Domain Length = 2 | 1e-14 | ||
| 3gqi_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 1e-14 | ||
| 1xkk_A | 352 | Egfr Kinase Domain Complexed With A Quinazoline Inh | 1e-14 | ||
| 1fvr_A | 327 | Tie2 Kinase Domain Length = 327 | 2e-14 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 2e-14 | ||
| 2oo8_X | 317 | Synthesis, Structural Analysis, And Sar Studies Of | 2e-14 | ||
| 1ir3_A | 306 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 2e-14 | ||
| 2iw6_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com | 2e-14 | ||
| 1gz8_A | 299 | Human Cyclin Dependent Kinase 2 Complexed With The | 2e-14 | ||
| 2z8c_A | 303 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 2e-14 | ||
| 2r0i_A | 327 | Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len | 2e-14 | ||
| 1zmu_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 2e-14 | ||
| 4erw_A | 306 | Cdk2 In Complex With Staurosporine Length = 306 | 2e-14 | ||
| 2rei_A | 318 | Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep | 2e-14 | ||
| 1rqq_A | 306 | Crystal Structure Of The Insulin Receptor Kinase In | 2e-14 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 2e-14 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 2e-14 | ||
| 2rfd_A | 324 | Crystal Structure Of The Complex Between The Egfr K | 2e-14 | ||
| 1k9a_A | 450 | Crystal Structure Analysis Of Full-Length Carboxyl- | 2e-14 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 2e-14 | ||
| 3ezr_A | 300 | Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ | 2e-14 | ||
| 3q4z_A | 306 | Structure Of Unphosphorylated Pak1 Kinase Domain Le | 2e-14 | ||
| 1vyw_A | 309 | Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = | 2e-14 | ||
| 3pxf_A | 306 | Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N | 2e-14 | ||
| 2w17_A | 299 | Cdk2 In Complex With The Imidazole Pyrimidine Amide | 3e-14 | ||
| 2j51_A | 325 | Crystal Structure Of Human Ste20-Like Kinase Bound | 3e-14 | ||
| 1fin_A | 298 | Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = | 3e-14 | ||
| 4e4l_A | 302 | Jak1 Kinase (Jh1 Domain) In Complex With Compound 3 | 3e-14 | ||
| 1pf8_A | 298 | Crystal Structure Of Human Cyclin-dependent Kinase | 3e-14 | ||
| 4fnx_A | 327 | Crystal Structure Of The Apo R1275q Anaplastic Lymp | 3e-14 | ||
| 4eoq_A | 301 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 3e-14 | ||
| 4bcq_A | 301 | Structure Of Cdk2 In Complex With Cyclin A And A 2- | 3e-14 | ||
| 4eop_A | 300 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 3e-14 | ||
| 3d7t_A | 269 | Structural Basis For The Recognition Of C-Src By It | 3e-14 | ||
| 3q4t_A | 322 | Crystal Structure Of Activin Receptor Type-Iia (Acv | 3e-14 | ||
| 4eos_A | 300 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 3e-14 | ||
| 3pj8_A | 299 | Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D] | 3e-14 | ||
| 2wzj_A | 327 | Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82 | 3e-14 | ||
| 1irk_A | 306 | Crystal Structure Of The Tyrosine Kinase Domain Of | 3e-14 | ||
| 2c30_A | 321 | Crystal Structure Of The Human P21-Activated Kinase | 3e-14 | ||
| 1h1p_A | 303 | Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP | 3e-14 | ||
| 3cly_A | 334 | Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase | 3e-14 | ||
| 1ogu_A | 302 | Structure Of Human Thr160-phospho Cdk2/cyclin A Com | 3e-14 | ||
| 4eoo_A | 299 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 3e-14 | ||
| 1w98_A | 298 | The Structural Basis Of Cdk2 Activation By Cyclin E | 3e-14 | ||
| 3eyg_A | 290 | Crystal Structures Of Jak1 And Jak2 Inhibitor Compl | 3e-14 | ||
| 1e9h_A | 297 | Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex | 3e-14 | ||
| 1byg_A | 278 | Kinase Domain Of Human C-Terminal Src Kinase (Csk) | 3e-14 | ||
| 2pvf_A | 334 | Crystal Structure Of Tyrosine Phosphorylated Activa | 3e-14 | ||
| 1qmz_A | 299 | Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com | 3e-14 | ||
| 3bht_A | 300 | Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN | 3e-14 | ||
| 1fgk_A | 310 | Crystal Structure Of The Tyrosine Kinase Domain Of | 3e-14 | ||
| 2pvy_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 3e-14 | ||
| 3js2_A | 317 | Crystal Structure Of Minimal Kinase Domain Of Fibro | 3e-14 | ||
| 4eoi_A | 299 | Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc | 4e-14 | ||
| 4i3z_A | 296 | Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES | 4e-14 | ||
| 3d7u_A | 263 | Structural Basis For The Recognition Of C-Src By It | 4e-14 | ||
| 1jst_A | 298 | Phosphorylated Cyclin-Dependent Kinase-2 Bound To C | 4e-14 | ||
| 3pls_A | 298 | Ron In Complex With Ligand Amp-Pnp Length = 298 | 4e-14 | ||
| 3c4f_A | 302 | Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M | 4e-14 | ||
| 1zmv_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 4e-14 | ||
| 3kxx_A | 317 | Structure Of The Mutant Fibroblast Growth Factor Re | 4e-14 | ||
| 3gql_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 4e-14 | ||
| 1oit_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 4e-14 | ||
| 3rhx_B | 306 | Crystal Structure Of The Catalytic Domain Of Fgfr1 | 4e-14 | ||
| 4f63_A | 309 | Crystal Structure Of Human Fibroblast Growth Factor | 4e-14 | ||
| 3eta_A | 317 | Kinase Domain Of Insulin Receptor Complexed With A | 4e-14 | ||
| 3qhr_A | 298 | Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic | 4e-14 | ||
| 3cd3_A | 377 | Crystal Structure Of Phosphorylated Human Feline Sa | 4e-14 | ||
| 2jgz_A | 289 | Crystal Structure Of Phospho-Cdk2 In Complex With C | 4e-14 | ||
| 3ug1_A | 334 | Crystal Structure Of The Mutated Egfr Kinase Domain | 4e-14 | ||
| 2pzp_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 5e-14 | ||
| 3w2o_A | 331 | Egfr Kinase Domain T790m/l858r Mutant With Tak-285 | 5e-14 | ||
| 4i1z_A | 329 | Crystal Structure Of The Monomeric (v948r) Form Of | 5e-14 | ||
| 2itn_A | 327 | Crystal Structure Of Egfr Kinase Domain G719s Mutat | 5e-14 | ||
| 4i21_A | 329 | Crystal Structure Of L858r + T790m Egfr Kinase Doma | 5e-14 | ||
| 1i44_A | 306 | Crystallographic Studies Of An Activation Loop Muta | 5e-14 | ||
| 3tt0_A | 382 | Co-Structure Of Fibroblast Growth Factor Receptor 1 | 5e-14 | ||
| 2pwl_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 5e-14 | ||
| 2pz5_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 6e-14 | ||
| 2itt_A | 327 | Crystal Structure Of Egfr Kinase Domain L858r Mutat | 6e-14 | ||
| 2eb2_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (G7 | 6e-14 | ||
| 2eb3_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (L8 | 6e-14 | ||
| 2wqb_A | 324 | Structure Of The Tie2 Kinase Domain In Complex With | 6e-14 | ||
| 4eom_A | 301 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 6e-14 | ||
| 2wqm_A | 310 | Structure Of Apo Human Nek7 Length = 310 | 6e-14 | ||
| 3gop_A | 361 | Crystal Structure Of The Egf Receptor Juxtamembrane | 6e-14 | ||
| 1u5q_A | 348 | Crystal Structure Of The Tao2 Kinase Domain: Activa | 6e-14 | ||
| 1zmw_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 7e-14 | ||
| 4i20_A | 329 | Crystal Structure Of Monomeric (v948r) Primary Onco | 7e-14 | ||
| 4eoj_A | 302 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 7e-14 | ||
| 3bkb_A | 377 | Crystal Structure Of Human Feline Sarcoma Viral Onc | 7e-14 | ||
| 3sxr_A | 268 | Crystal Structure Of Bmx Non-Receptor Tyrosine Kina | 7e-14 | ||
| 4eon_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 7e-14 | ||
| 2gcd_A | 309 | Tao2 Kinase Domain-Staurosporine Structure Length = | 7e-14 | ||
| 1u59_A | 287 | Crystal Structure Of The Zap-70 Kinase Domain In Co | 8e-14 | ||
| 4eok_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 8e-14 | ||
| 2jfl_A | 325 | Crystal Structure Of Human Ste20-Like Kinase ( Diph | 1e-13 | ||
| 2psq_A | 370 | Crystal Structure Of Unphosphorylated Unactivated W | 1e-13 | ||
| 2jfm_A | 325 | Crystal Structure Of Human Ste20-Like Kinase (Unlig | 1e-13 | ||
| 1oir_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 1e-13 | ||
| 1h01_A | 298 | Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili | 1e-13 | ||
| 2pzr_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-13 | ||
| 1gjo_A | 316 | The Fgfr2 Tyrosine Kinase Domain Length = 316 | 1e-13 | ||
| 3b2t_A | 311 | Structure Of Phosphotransferase Length = 311 | 1e-13 | ||
| 3ri1_A | 313 | Crystal Structure Of The Catalytic Domain Of Fgfr2 | 1e-13 | ||
| 1p14_A | 306 | Crystal Structure Of A Catalytic-Loop Mutant Of The | 1e-13 | ||
| 3ekk_A | 307 | Insulin Receptor Kinase Complexed With An Inhibitor | 1e-13 | ||
| 3nyx_A | 302 | Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T | 1e-13 | ||
| 1gii_A | 298 | Human Cyclin Dependent Kinase 2 Complexed With The | 2e-13 | ||
| 2j7t_A | 302 | Crystal Structure Of Human Serine Threonine Kinase- | 2e-13 | ||
| 3nz0_A | 302 | Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3 | 2e-13 | ||
| 4bc6_A | 293 | Crystal Structure Of Human Serine Threonine Kinase- | 2e-13 | ||
| 3iec_A | 319 | Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K | 2e-13 | ||
| 3g2f_A | 336 | Crystal Structure Of The Kinase Domain Of Bone Morp | 2e-13 | ||
| 2ozo_A | 613 | Autoinhibited Intact Human Zap-70 Length = 613 | 2e-13 | ||
| 4e1z_A | 291 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 2e-13 | ||
| 2q0b_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-13 | ||
| 4e20_A | 290 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 3e-13 | ||
| 2iw8_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82 | 3e-13 | ||
| 2vwi_A | 303 | Structure Of The Osr1 Kinase, A Hypertension Drug T | 3e-13 | ||
| 3orx_A | 316 | Pdk1 Mutant Bound To Allosteric Disulfide Fragment | 3e-13 | ||
| 3dak_A | 290 | Crystal Structure Of Domain-Swapped Osr1 Kinase Dom | 4e-13 | ||
| 2py3_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 5e-13 | ||
| 1rjb_A | 344 | Crystal Structure Of Flt3 Length = 344 | 6e-13 | ||
| 1y8g_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 7e-13 | ||
| 3cjg_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 7e-13 | ||
| 2q0n_A | 301 | Structure Of Human P21 Activating Kinase 4 (Pak4) I | 9e-13 | ||
| 3p08_A | 267 | Crystal Structure Of The Human Btk Kinase Domain Le | 9e-13 | ||
| 3k54_A | 283 | Structures Of Human Bruton's Tyrosine Kinase In Act | 9e-13 | ||
| 4fif_A | 346 | Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid | 9e-13 | ||
| 4fie_A | 423 | Full-Length Human Pak4 Length = 423 | 9e-13 | ||
| 2x4z_A | 296 | Crystal Structure Of The Human P21-Activated Kinase | 1e-12 | ||
| 2cdz_A | 303 | Crystal Structure Of The Human P21-Activated Kinase | 1e-12 | ||
| 3gen_A | 283 | The 1.6 A Crystal Structure Of Human Bruton's Tyros | 1e-12 | ||
| 2bva_A | 292 | Crystal Structure Of The Human P21-Activated Kinase | 1e-12 | ||
| 3pix_A | 274 | Crystal Structure Of Btk Kinase Domain Complexed Wi | 1e-12 | ||
| 2f57_A | 317 | Crystal Structure Of The Human P21-activated Kinase | 1e-12 | ||
| 3oct_A | 265 | Crystal Structure Of Bruton's Tyrosine Kinase Mutan | 1e-12 | ||
| 3ocs_A | 271 | Crystal Structure Of Bruton's Tyrosine Kinase In Co | 1e-12 | ||
| 3lxn_A | 318 | Structural And Thermodynamic Characterization Of Th | 1e-12 | ||
| 2oh4_A | 316 | Crystal Structure Of Vegfr2 With A Benzimidazole-Ur | 1e-12 | ||
| 1k2p_A | 263 | Crystal Structure Of Bruton's Tyrosine Kinase Domai | 1e-12 | ||
| 3pwy_A | 311 | Crystal Structure Of An Extender (Spd28345)-Modifie | 1e-12 | ||
| 2qlu_A | 314 | Crystal Structure Of Activin Receptor Type Ii Kinas | 1e-12 | ||
| 1v0b_A | 288 | Crystal Structure Of The T198a Mutant Of Pfpk5 Leng | 2e-12 | ||
| 1v0o_A | 288 | Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho | 2e-12 | ||
| 1ob3_A | 288 | Structure Of P. Falciparum Pfpk5 Length = 288 | 2e-12 | ||
| 3kex_A | 325 | Crystal Structure Of The Catalytically Inactive Kin | 2e-12 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 2e-12 | ||
| 1t45_A | 331 | Structural Basis For The Autoinhibition And Sti-571 | 2e-12 | ||
| 3lmg_A | 344 | Crystal Structure Of The Erbb3 Kinase Domain In Com | 2e-12 | ||
| 3g0f_A | 336 | Kit Kinase Domain Mutant D816h In Complex With Suni | 2e-12 | ||
| 1zys_A | 273 | Co-Crystal Structure Of Checkpoint Kinase Chk1 With | 2e-12 | ||
| 1pkg_A | 329 | Structure Of A C-kit Kinase Product Complex Length | 2e-12 | ||
| 3g0e_A | 336 | Kit Kinase Domain In Complex With Sunitinib Length | 2e-12 | ||
| 2p0c_A | 313 | Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro | 3e-12 | ||
| 3vnt_A | 318 | Crystal Structure Of The Kinase Domain Of Human Veg | 3e-12 | ||
| 1t46_A | 313 | Structural Basis For The Autoinhibition And Sti-571 | 3e-12 | ||
| 1ywn_A | 316 | Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p | 3e-12 | ||
| 4fsn_A | 278 | Crystal Structure Of The Chk1 Length = 278 | 3e-12 | ||
| 4gs6_A | 315 | Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz | 3e-12 | ||
| 2p2i_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 3e-12 | ||
| 4fsm_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 3e-12 | ||
| 2eva_A | 307 | Structural Basis For The Interaction Of Tak1 Kinase | 3e-12 | ||
| 1h1w_A | 289 | High Resolution Crystal Structure Of The Human Pdk1 | 4e-12 | ||
| 2r0u_A | 323 | Crystal Structure Of Chek1 In Complex With Inhibito | 4e-12 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 4e-12 | ||
| 2p2h_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 4e-12 | ||
| 1uu9_A | 286 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 4e-12 | ||
| 2r7b_A | 312 | Crystal Structure Of The Phosphoinositide-Dependent | 4e-12 | ||
| 1z5m_A | 286 | Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr | 4e-12 | ||
| 1uu3_A | 310 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 4e-12 | ||
| 4fsy_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 4e-12 | ||
| 2hog_A | 322 | Crystal Structure Of Chek1 In Complex With Inhibito | 4e-12 | ||
| 2x8e_A | 276 | Discovery Of A Novel Class Of Triazolones As Checkp | 4e-12 | ||
| 2br1_A | 297 | Structure-Based Design Of Novel Chk1 Inhibitors: In | 4e-12 | ||
| 1ia8_A | 289 | The 1.7 A Crystal Structure Of Human Cell Cycle Che | 4e-12 | ||
| 3jvr_A | 271 | Characterization Of The Chk1 Allosteric Inhibitor B | 4e-12 | ||
| 1zlt_A | 295 | Crystal Structure Of Chk1 Complexed With A Hymenald | 4e-12 | ||
| 2ayp_A | 269 | Crystal Structure Of Chk1 With An Indol Inhibitor L | 4e-12 | ||
| 4fsw_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 4e-12 | ||
| 2e9v_A | 268 | Structure Of H-Chk1 Complexed With A859017 Length = | 4e-12 | ||
| 2biy_A | 310 | Structure Of Pdk1-S241a Mutant Kinase Domain Length | 4e-12 | ||
| 3rwp_A | 311 | Discovery Of A Novel, Potent And Selective Inhibito | 4e-12 | ||
| 3nus_A | 286 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra | 4e-12 | ||
| 2xir_A | 316 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 4e-12 | ||
| 3iop_A | 312 | Pdk-1 In Complex With The Inhibitor Compound-8i Len | 4e-12 | ||
| 3pjc_A | 315 | Crystal Structure Of Jak3 Complexed With A Potent A | 4e-12 | ||
| 2ydj_A | 276 | Discovery Of Checkpoint Kinase Inhibitor Azd7762 By | 4e-12 | ||
| 3ot3_A | 273 | X-Ray Crystal Structure Of Compound 22k Bound To Hu | 4e-12 | ||
| 3qup_A | 323 | Inhibitor Bound Structure Of The Kinase Domain Of T | 5e-12 | ||
| 3sc1_A | 311 | Novel Isoquinolone Pdk1 Inhibitors Discovered Throu | 5e-12 | ||
| 2ghg_A | 269 | H-Chk1 Complexed With A431994 Length = 269 | 5e-12 | ||
| 3ma6_A | 298 | Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr | 5e-12 | ||
| 3lxk_A | 327 | Structural And Thermodynamic Characterization Of Th | 5e-12 | ||
| 1vr2_A | 316 | Human Vascular Endothelial Growth Factor Receptor 2 | 5e-12 | ||
| 4a07_A | 311 | Human Pdk1 Kinase Domain In Complex With Allosteric | 5e-12 | ||
| 3hrc_A | 311 | Crystal Structure Of A Mutant Of Human Pdk1 Kinase | 5e-12 | ||
| 3h9o_A | 311 | Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) | 5e-12 | ||
| 4hvd_A | 314 | Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h | 5e-12 | ||
| 2xch_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 5e-12 | ||
| 4fst_A | 269 | Crystal Structure Of The Chk1 Length = 269 | 5e-12 | ||
| 4fsz_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 5e-12 | ||
| 3u6j_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 5e-12 | ||
| 3qc4_A | 314 | Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = | 5e-12 | ||
| 3nun_A | 292 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea | 5e-12 | ||
| 3ewh_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 5e-12 | ||
| 2xck_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 5e-12 | ||
| 4ft3_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 5e-12 | ||
| 4agc_A | 353 | Crystal Structure Of Vegfr2 (Juxtamembrane And Kina | 6e-12 | ||
| 3nax_A | 311 | Pdk1 In Complex With Inhibitor Mp7 Length = 311 | 6e-12 | ||
| 3nay_A | 311 | Pdk1 In Complex With Inhibitor Mp6 Length = 311 | 6e-12 | ||
| 1yvj_A | 290 | Crystal Structure Of The Jak3 Kinase Domain In Comp | 7e-12 | ||
| 3ku2_A | 507 | Crystal Structure Of Inactivated Form Of Cdpk1 From | 1e-11 | ||
| 3i79_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 1e-11 | ||
| 2uv2_A | 287 | Crystal Structure Of Human Ste20-Like Kinase Bound | 1e-11 | ||
| 3hx4_A | 508 | Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg | 1e-11 | ||
| 4fsu_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-11 | ||
| 3cjf_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 1e-11 | ||
| 3hyh_A | 275 | Crystal Structure Of The Protein Kinase Domain Of Y | 1e-11 | ||
| 3dae_A | 283 | Crystal Structure Of Phosphorylated Snf1 Kinase Dom | 2e-11 | ||
| 2fh9_A | 274 | Structure And Dimerization Of The Kinase Domain Fro | 2e-11 | ||
| 3mn3_A | 271 | An Inhibited Conformation For The Protein Kinase Do | 2e-11 | ||
| 3tub_A | 293 | Crystal Structure Of Syk Kinase Domain With 1-(5-(6 | 2e-11 | ||
| 3vf8_A | 299 | Crystal Structure Of Spleen Tyrosine Kinase Syk Cat | 2e-11 | ||
| 1ua2_A | 346 | Crystal Structure Of Human Cdk7 Length = 346 | 2e-11 | ||
| 3emg_A | 291 | Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami | 3e-11 | ||
| 3srv_A | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 3e-11 | ||
| 3h4j_B | 336 | Crystal Structure Of Pombe Ampk Kdaid Fragment Leng | 3e-11 | ||
| 1xba_A | 291 | Crystal Structure Of Apo Syk Tyrosine Kinase Domain | 3e-11 | ||
| 3srv_B | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 3e-11 | ||
| 4dfl_A | 274 | Crystal Structure Of Spleen Tyrosine Kinase Complex | 3e-11 | ||
| 4f4p_A | 273 | Syk In Complex With Ligand Lasw836 Length = 273 | 3e-11 | ||
| 3dfa_A | 286 | Crystal Structure Of Kinase Domain Of Calcium-depen | 3e-11 | ||
| 2wei_A | 287 | Crystal Structure Of The Kinase Domain Of Cryptospo | 3e-11 | ||
| 2y4i_B | 319 | Ksr2-Mek1 Heterodimer Length = 319 | 3e-11 | ||
| 3gbz_A | 329 | Structure Of The Cmgc Cdk Kinase From Giardia Lambl | 4e-11 | ||
| 4fl3_A | 635 | Structural And Biophysical Characterization Of The | 4e-11 | ||
| 4fl2_A | 636 | Structural And Biophysical Characterization Of The | 4e-11 | ||
| 3c7q_A | 316 | Structure Of Vegfr2 Kinase Domain In Complex With B | 5e-11 | ||
| 4aaa_A | 331 | Crystal Structure Of The Human Cdkl2 Kinase Domain | 6e-11 | ||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 6e-11 | ||
| 3mdy_A | 337 | Crystal Structure Of The Cytoplasmic Domain Of The | 9e-11 | ||
| 3i7c_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 9e-11 | ||
| 3fzo_A | 277 | Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin | 1e-10 | ||
| 1u54_A | 291 | Crystal Structures Of The Phosphorylated And Unphos | 1e-10 | ||
| 2xik_A | 294 | Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K | 1e-10 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 1e-10 | ||
| 4h1j_A | 293 | Crystal Structure Of Pyk2 With The Pyrazole 13a Len | 1e-10 | ||
| 3igo_A | 486 | Crystal Structure Of Cryptosporidium Parvum Cdpk1, | 1e-10 | ||
| 1zyc_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 1e-10 | ||
| 3cc6_A | 281 | Crystal Structure Of Kinase Domain Of Protein Tyros | 1e-10 | ||
| 1u46_A | 291 | Crystal Structure Of The Unphosphorylated Kinase Do | 1e-10 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 1e-10 | ||
| 3ckx_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 1e-10 | ||
| 2a19_B | 284 | Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng | 1e-10 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 1e-10 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 1e-10 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 1e-10 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 2e-10 | ||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 2e-10 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 2e-10 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 2e-10 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 2e-10 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 2e-10 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 2e-10 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 2e-10 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 2e-10 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 2e-10 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 2e-10 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 2e-10 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 2e-10 | ||
| 4hzs_A | 341 | Crystal Structure Of Ack1 Kinase Domain With C-term | 2e-10 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 2e-10 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 2e-10 | ||
| 4ewh_B | 275 | Co-Crystal Structure Of Ack1 With Inhibitor Length | 2e-10 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 2e-10 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 2e-10 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 2e-10 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 3e-10 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 3e-10 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 3e-10 | ||
| 4hzr_A | 277 | Crystal Structure Of Ack1 Kinase Domain Length = 27 | 3e-10 | ||
| 4id7_A | 273 | Ack1 Kinase In Complex With The Inhibitor Cis-3-[8- | 3e-10 | ||
| 3eqp_B | 276 | Crystal Structure Of Ack1 With Compound T95 Length | 3e-10 | ||
| 4g31_A | 299 | Crystal Structure Of Gsk6414 Bound To Perk (R587-R1 | 3e-10 | ||
| 3d5v_A | 317 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 4e-10 | ||
| 3d5w_A | 317 | Crystal Structure Of A Phosphorylated Polo-Like Kin | 4e-10 | ||
| 3d5u_A | 317 | Crystal Structure Of A Wildtype Polo-Like Kinase 1 | 4e-10 | ||
| 1zy4_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 4e-10 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 4e-10 | ||
| 3db6_A | 301 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 4e-10 | ||
| 3mtl_A | 324 | Crystal Structure Of The Pctaire1 Kinase In Complex | 5e-10 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 5e-10 | ||
| 2h6d_A | 276 | Protein Kinase Domain Of The Human 5'-Amp-Activated | 6e-10 | ||
| 3uiu_A | 306 | Crystal Structure Of Apo-Pkr Kinase Domain Length = | 6e-10 | ||
| 2clq_A | 295 | Structure Of Mitogen-Activated Protein Kinase Kinas | 6e-10 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 6e-10 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 6e-10 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 7e-10 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 7e-10 | ||
| 3vw6_A | 269 | Crystal Structure Of Human Apoptosis Signal-Regulat | 7e-10 | ||
| 3oht_A | 389 | Crystal Structure Of Salmo Salar P38alpha Length = | 9e-10 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 9e-10 | ||
| 2y94_A | 476 | Structure Of An Active Form Of Mammalian Ampk Lengt | 9e-10 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 1e-09 | ||
| 2yza_A | 276 | Crystal Structure Of Kinase Domain Of Human 5'-Amp- | 1e-09 | ||
| 3uto_A | 573 | Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin- | 2e-09 | ||
| 1h4l_A | 292 | Structure And Regulation Of The Cdk5-P25(Nck5a) Com | 2e-09 | ||
| 3nie_A | 429 | Crystal Structure Of Pf11_0147 Length = 429 | 2e-09 | ||
| 1koa_A | 491 | Twitchin Kinase Fragment (C.Elegans), Autoregulated | 3e-09 | ||
| 4ec8_A | 373 | Structure Of Full Length Cdk9 In Complex With Cycli | 3e-09 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 3e-09 | ||
| 3mi9_A | 351 | Crystal Structure Of Hiv-1 Tat Complexed With Human | 3e-09 | ||
| 3is5_A | 285 | Crystal Structure Of Cdpk Kinase Domain From Toxopl | 3e-09 | ||
| 4bcf_A | 331 | Structure Of Cdk9 In Complex With Cyclin T And A 2- | 3e-09 | ||
| 4exu_A | 371 | Mapk13, Inactive Form Length = 371 | 4e-09 | ||
| 2x4f_A | 373 | The Crystal Structure Of The Human Myosin Light Cha | 4e-09 | ||
| 3coi_A | 353 | Crystal Structure Of P38delta Kinase Length = 353 | 4e-09 | ||
| 3blh_A | 331 | Crystal Structure Of Human Cdk9CYCLINT1 Length = 33 | 4e-09 | ||
| 1zxe_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 5e-09 | ||
| 3oz6_A | 388 | Crystal Structure Of Mapk From Cryptosporidium Parv | 5e-09 | ||
| 2jkm_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 6e-09 | ||
| 2w5a_A | 279 | Human Nek2 Kinase Adp-Bound Length = 279 | 6e-09 | ||
| 2v5q_A | 315 | Crystal Structure Of Wild-type Plk-1 Kinase Domain | 7e-09 | ||
| 3thb_A | 333 | Structure Of Plk1 Kinase Domain In Complex With A B | 7e-09 | ||
| 4ebw_A | 304 | Structure Of Focal Adhesion Kinase Catalytic Domain | 7e-09 | ||
| 3ll6_A | 337 | Crystal Structure Of The Human Cyclin G Associated | 7e-09 | ||
| 4agu_A | 311 | Crystal Structure Of The Human Cdkl1 Kinase Domain | 7e-09 | ||
| 2ou7_A | 335 | Structure Of The Catalytic Domain Of Human Polo-Lik | 7e-09 | ||
| 1ung_A | 292 | Structural Mechanism For The Inhibition Of Cdk5-P25 | 7e-09 | ||
| 2yac_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 7e-09 | ||
| 3kb7_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 7e-09 | ||
| 2etm_A | 281 | Crystal Structure Of Focal Adhesion Kinase Domain C | 7e-09 | ||
| 3bz3_A | 276 | Crystal Structure Analysis Of Focal Adhesion Kinase | 8e-09 | ||
| 1bi8_A | 326 | Mechanism Of G1 Cyclin Dependent Kinase Inhibition | 8e-09 | ||
| 1mp8_A | 281 | Crystal Structure Of Focal Adhesion Kinase (Fak) Le | 8e-09 | ||
| 2j0l_A | 276 | Crystal Structure Of A The Active Conformation Of T | 8e-09 | ||
| 2j0m_B | 276 | Crystal Structure A Two-Chain Complex Between The F | 8e-09 | ||
| 1jow_B | 308 | Crystal Structure Of A Complex Of Human Cdk6 And A | 8e-09 | ||
| 3nup_A | 307 | Cdk6 (Monomeric) In Complex With Inhibitor Length = | 9e-09 | ||
| 3vul_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 9e-09 | ||
| 4apc_A | 350 | Crystal Structure Of Human Nima-Related Kinase 1 (N | 9e-09 | ||
| 3pxk_A | 282 | Focal Adhesion Kinase Catalytic Domain In Complex W | 9e-09 | ||
| 2rku_A | 294 | Structure Of Plk1 In Complex With Bi2536 Length = 2 | 9e-09 | ||
| 3vum_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M7 | 9e-09 | ||
| 3fi3_A | 364 | Crystal Structure Of Jnk3 With Indazole Inhibitor, | 9e-09 | ||
| 4a4x_A | 279 | Nek2-Ede Bound To Cct248662 Length = 279 | 1e-08 | ||
| 3gc9_A | 370 | The Structure Of P38beta C119s, C162s In Complex Wi | 1e-08 | ||
| 2gtm_A | 348 | Mutated Mouse P38 Map Kinase Domain In Complex With | 1e-08 | ||
| 2oza_B | 366 | Structure Of P38alpha Complex Length = 366 | 1e-08 | ||
| 2puu_A | 348 | Crystal Structure Of P38 Complex With 1-(5-Tert-But | 1e-08 | ||
| 1lew_A | 360 | Crystal Structure Of Map Kinase P38 Complexed To Th | 1e-08 | ||
| 3tg1_A | 380 | Crystal Structure Of P38alpha In Complex With A Map | 1e-08 | ||
| 1bmk_A | 379 | The Complex Structure Of The Map Kinase P38SB218655 | 1e-08 | ||
| 3aln_A | 327 | Crystal Structure Of Human Non-Phosphorylated Mkk4 | 1e-08 | ||
| 2fso_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a) A | 1e-08 | ||
| 2fsl_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a+f3 | 1e-08 | ||
| 2jkk_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 2e-08 | ||
| 2fst_X | 367 | Mitogen Activated Protein Kinase P38alpha (d176a+f3 | 2e-08 | ||
| 2jed_A | 352 | The Crystal Structure Of The Kinase Domain Of The P | 2e-08 | ||
| 3fi4_A | 372 | P38 Kinase Crystal Structure In Complex With Ro4499 | 2e-08 | ||
| 3gp0_A | 348 | Crystal Structure Of Human Mitogen Activated Protei | 2e-08 | ||
| 3p4k_A | 370 | The Third Conformation Of P38a Map Kinase Observed | 2e-08 | ||
| 2ghl_A | 348 | Mutant Mus Musculus P38 Kinase Domain In Complex Wi | 2e-08 | ||
| 2baq_A | 365 | P38alpha Bound To Ro3201195 Length = 365 | 2e-08 | ||
| 1yw2_A | 360 | Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | 2e-08 | ||
| 1ywr_A | 360 | Crystal Structure Analysis Of Inactive P38 Kinase D | 2e-08 | ||
| 3npc_A | 364 | Crystal Structure Of Jnk2 Complexed With Birb796 Le | 2e-08 | ||
| 3kvx_A | 364 | Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le | 2e-08 | ||
| 2b9f_A | 353 | Crystal Structure Of Non-Phosphorylated Fus3 Length | 2e-08 | ||
| 3py3_A | 380 | Crystal Structure Of Phosphorylated P38alpha Map Ki | 2e-08 | ||
| 2f9g_A | 353 | Crystal Structure Of Fus3 Phosphorylated On Tyr182 | 2e-08 | ||
| 3vuk_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M5 | 2e-08 | ||
| 2b9h_A | 353 | Crystal Structure Of Fus3 With A Docking Motif From | 2e-08 | ||
| 3nnx_A | 354 | Crystal Structure Of Phosphorylated P38 Alpha In Co | 2e-08 | ||
| 2jav_A | 279 | Human Kinase With Pyrrole-Indolinone Ligand Length | 2e-08 | ||
| 2r9s_A | 356 | C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu | 2e-08 | ||
| 3fv8_A | 355 | Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le | 2e-08 | ||
| 2bal_A | 365 | P38alpha Map Kinase Bound To Pyrazoloamine Length = | 2e-08 | ||
| 3fi2_A | 353 | Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib | 2e-08 | ||
| 2npq_A | 367 | A Novel Lipid Binding Site In The P38 Alpha Map Kin | 3e-08 | ||
| 2j0j_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 3e-08 | ||
| 3gc8_A | 370 | The Structure Of P38beta C162s In Complex With A Di | 3e-08 | ||
| 4e5a_X | 360 | The W197a Mutant Of P38a Map Kinase Length = 360 | 3e-08 | ||
| 3d83_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 3e-08 | ||
| 3hvc_A | 362 | Crystal Structure Of Human P38alpha Map Kinase Leng | 3e-08 | ||
| 3s3i_A | 349 | P38 Kinase Crystal Structure In Complex With Small | 3e-08 | ||
| 3hec_A | 348 | P38 In Complex With Imatinib Length = 348 | 3e-08 | ||
| 3e92_A | 371 | Crystal Structure Of P38 Kinase In Complex With A B | 3e-08 | ||
| 2lgc_A | 359 | Joint Nmr And X-Ray Refinement Reveals The Structur | 3e-08 | ||
| 3odz_X | 360 | Crystal Structure Of P38alpha Y323r Active Mutant L | 3e-08 | ||
| 3nnu_A | 354 | Crystal Structure Of P38 Alpha In Complex With Dp13 | 3e-08 | ||
| 3zgw_A | 347 | Crystal Structure Of Maternal Embryonic Leucine Zip | 3e-08 | ||
| 2baj_A | 365 | P38alpha Bound To Pyrazolourea Length = 365 | 3e-08 | ||
| 3hrb_A | 359 | P38 Kinase Crystal Structure In Complex With Small | 3e-08 | ||
| 3k3i_A | 350 | P38alpha Bound To Novel Dgf-Out Compound Pf-0021595 | 3e-08 | ||
| 3gcu_A | 360 | Human P38 Map Kinase In Complex With Rl48 Length = | 3e-08 | ||
| 1di9_A | 360 | The Structure Of P38 Mitogen-Activated Protein Kina | 3e-08 | ||
| 1m7q_A | 366 | Crystal Structure Of P38 Map Kinase In Complex With | 3e-08 | ||
| 3zsg_A | 362 | X-Ray Structure Of P38alpha Bound To Tak-715 Length | 3e-08 | ||
| 3ody_X | 360 | Crystal Structure Of P38alpha Y323q Active Mutant L | 3e-08 | ||
| 3od6_X | 360 | Crystal Structure Of P38alpha Y323t Active Mutant L | 3e-08 | ||
| 3kq7_A | 380 | Structure Of Human P38alpha With N-[4-Methyl-3-(6-{ | 3e-08 | ||
| 3k3j_A | 362 | P38alpha Bound To Novel Dfg-Out Compound Pf-0041612 | 3e-08 | ||
| 1bl6_A | 379 | The Complex Structure Of The Map Kinase P38SB216995 | 3e-08 | ||
| 1ian_A | 366 | Human P38 Map Kinase Inhibitor Complex Length = 366 | 3e-08 | ||
| 1xjd_A | 345 | Crystal Structure Of Pkc-Theta Complexed With Staur | 3e-08 | ||
| 1zzl_A | 351 | Crystal Structure Of P38 With Triazolopyridine Leng | 3e-08 | ||
| 1oz1_A | 372 | P38 Mitogen-Activated Kinase In Complex With 4-Azai | 3e-08 | ||
| 2gfs_A | 372 | P38 Kinase Crystal Structure In Complex With Ro3201 | 3e-08 | ||
| 3d7z_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 3e-08 | ||
| 3dt1_A | 383 | P38 Complexed With A Quinazoline Inhibitor Length = | 3e-08 | ||
| 3vui_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 3e-08 | ||
| 3rp9_A | 458 | Crystal Structure Of The Apo Mapk From Toxoplasma G | 3e-08 | ||
| 3mpt_A | 371 | Crystal Structure Of P38 Kinase In Complex With A P | 3e-08 | ||
| 2y8o_A | 362 | Crystal Structure Of Human P38alpha Complexed With | 3e-08 | ||
| 3oef_X | 360 | Crystal Structure Of Y323f Inactive Mutant Of P38al | 3e-08 | ||
| 3kk9_A | 282 | Camkii Substrate Complex B Length = 282 | 4e-08 | ||
| 1ove_A | 366 | The Structure Of P38 Alpha In Complex With A Dihydr | 4e-08 | ||
| 3txo_A | 353 | Pkc Eta Kinase In Complex With A Naphthyridine Leng | 4e-08 | ||
| 3kk8_A | 284 | Camkii Substrate Complex A Length = 284 | 4e-08 | ||
| 3ttj_A | 464 | Crystal Structure Of Jnk3 Complexed With Cc-359, A | 4e-08 | ||
| 3kl8_A | 269 | Camkiintide Inhibitor Complex Length = 269 | 4e-08 | ||
| 2vrx_A | 285 | Structure Of Aurora B Kinase In Complex With Zm4474 | 4e-08 | ||
| 2bfx_B | 284 | Mechanism Of Aurora-B Activation By Incenp And Inhi | 4e-08 | ||
| 3q5i_A | 504 | Crystal Structure Of Pbanka_031420 Length = 504 | 4e-08 | ||
| 3v3v_A | 379 | Structural And Functional Analysis Of Quercetagetin | 5e-08 | ||
| 3vuh_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M3 | 5e-08 | ||
| 1s9i_A | 354 | X-Ray Structure Of The Human Mitogen-Activated Prot | 5e-08 | ||
| 4fvp_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain ( | 5e-08 | ||
| 1pmn_A | 364 | Crystal Structure Of Jnk3 In Complex With An Imidaz | 5e-08 | ||
| 3gcp_A | 360 | Human P38 Map Kinase In Complex With Sb203580 Lengt | 5e-08 | ||
| 3ptg_A | 363 | Design And Synthesis Of A Novel, Orally Efficacious | 5e-08 | ||
| 3oxi_A | 362 | Design And Synthesis Of Disubstituted Thiophene And | 5e-08 | ||
| 2j0k_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 5e-08 | ||
| 2o0u_A | 364 | Crystal Structure Of Human Jnk3 Complexed With N-{3 | 5e-08 | ||
| 3e7o_A | 360 | Crystal Structure Of Jnk2 Length = 360 | 5e-08 | ||
| 4h36_A | 356 | Crystal Structure Of Jnk3 In Complex With Atf2 Pept | 5e-08 | ||
| 1jnk_A | 423 | The C-Jun N-Terminal Kinase (Jnk3s) Complexed With | 5e-08 | ||
| 2exc_X | 356 | Inhibitor Complex Of Jnk3 Length = 356 | 6e-08 | ||
| 2b1p_A | 355 | Inhibitor Complex Of Jnk3 Length = 355 | 6e-08 | ||
| 2y4i_C | 395 | Ksr2-Mek1 Heterodimer Length = 395 | 6e-08 | ||
| 2ok1_A | 365 | Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3 | 6e-08 | ||
| 4ewq_A | 383 | Human P38 Alpha Mapk In Complex With A Pyridazine B | 6e-08 | ||
| 3orn_A | 307 | Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In | 6e-08 | ||
| 3o17_A | 370 | Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3 | 6e-08 | ||
| 1s9j_A | 341 | X-Ray Structure Of The Human Mitogen-Activated Prot | 6e-08 | ||
| 1ukh_A | 369 | Structural Basis For The Selective Inhibition Of Jn | 6e-08 | ||
| 3my0_A | 305 | Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai | 6e-08 | ||
| 2g01_A | 370 | Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit | 6e-08 | ||
| 3mh2_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 7e-08 | ||
| 3pze_A | 358 | Jnk1 In Complex With Inhibitor Length = 358 | 7e-08 | ||
| 3vug_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 7e-08 | ||
| 2xrw_A | 371 | Linear Binding Motifs For Jnk And For Calcineurin A | 7e-08 | ||
| 2p55_A | 333 | X-Ray Structure Of The Human Mitogen-Activated Prot | 7e-08 | ||
| 3elj_A | 369 | Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine | 7e-08 | ||
| 2xs0_A | 386 | Linear Binding Motifs For Jnk And For Calcineurin A | 7e-08 | ||
| 2bfy_A | 284 | Complex Of Aurora-B With Incenp And Hesperidin. Len | 7e-08 | ||
| 3vud_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 7e-08 | ||
| 3n9x_A | 432 | Crystal Structure Of Map Kinase From Plasmodium Ber | 8e-08 | ||
| 4an2_A | 301 | Crystal Structures Of Human Mek1 With Carboxamide-B | 9e-08 | ||
| 2bdw_A | 362 | Crystal Structure Of The Auto-Inhibited Kinase Doma | 9e-08 | ||
| 3mbl_A | 328 | Crystal Structure Of The Human Mitogen-Activated Pr | 9e-08 | ||
| 3dv3_A | 322 | Mek1 With Pf-04622664 Bound Length = 322 | 9e-08 | ||
| 3gi3_A | 360 | Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana | 1e-07 | ||
| 3lij_A | 494 | Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) | 1e-07 | ||
| 3f69_A | 311 | Crystal Structure Of The Mycobacterium Tuberculosis | 1e-07 | ||
| 1a06_A | 332 | Calmodulin-Dependent Protein Kinase From Rat Length | 1e-07 | ||
| 1vzo_A | 355 | The Structure Of The N-Terminal Kinase Domain Of Ms | 1e-07 | ||
| 3eqc_A | 360 | X-Ray Structure Of The Human Mitogen-Activated Prot | 1e-07 | ||
| 2w99_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 1e-07 | ||
| 2w96_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 1e-07 | ||
| 4af3_A | 292 | Human Aurora B Kinase In Complex With Incenp And Vx | 1e-07 | ||
| 2w9f_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 1e-07 | ||
| 4fg8_A | 315 | Crystal Structure Of Human Calcium/calmodulin-depen | 1e-07 | ||
| 4fg7_A | 293 | Crystal Structure Of Human Calcium/calmodulin-depen | 1e-07 | ||
| 1b6c_B | 342 | Crystal Structure Of The Cytoplasmic Domain Of The | 1e-07 | ||
| 4fg9_A | 320 | Crystal Structure Of Human Calcium/calmodulin-depen | 2e-07 | ||
| 1py5_A | 326 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 2e-07 | ||
| 4fvr_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain M | 2e-07 | ||
| 3bhh_A | 295 | Crystal Structure Of Human Calcium/calmodulin-depen | 2e-07 | ||
| 1cm8_A | 367 | Phosphorylated Map Kinase P38-Gamma Length = 367 | 2e-07 | ||
| 3ori_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain L33d | 2e-07 | ||
| 3h9r_A | 330 | Crystal Structure Of The Kinase Domain Of Type I Ac | 2e-07 | ||
| 3sls_A | 304 | Crystal Structure Of Human Mek-1 Kinase In Complex | 2e-07 | ||
| 3o8p_A | 360 | Conformational Plasticity Of P38 Map Kinase Dfg Mot | 2e-07 | ||
| 3mh0_A | 360 | Mutagenesis Of P38 Map Kinase Eshtablishes Key Role | 3e-07 | ||
| 3mtf_A | 301 | Crystal Structure Of The Acvr1 Kinase In Complex Wi | 3e-07 | ||
| 4dym_A | 301 | Crystal Structure Of The Acvr1 Kinase Domain In Com | 3e-07 | ||
| 3qd2_B | 332 | Crsytal Structure Of Mouse Perk Kinase Domain Lengt | 3e-07 | ||
| 3qa8_A | 676 | Crystal Structure Of Inhibitor Of Kappa B Kinase Be | 3e-07 | ||
| 3rzf_A | 677 | Crystal Structure Of Inhibitor Of Kappab Kinase Bet | 3e-07 | ||
| 1y6a_A | 366 | Crystal Structure Of Vegfr2 In Complex With A 2-Ani | 3e-07 | ||
| 3vhk_A | 368 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 3e-07 | ||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 3e-07 | ||
| 3mh3_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 3e-07 | ||
| 3vhe_A | 359 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 3e-07 | ||
| 3vid_A | 356 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 3e-07 | ||
| 3mh1_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 4e-07 | ||
| 3fme_A | 290 | Crystal Structure Of Human Mitogen-Activated Protei | 4e-07 | ||
| 2vz6_A | 313 | Structure Of Human Calcium Calmodulin Dependent Pro | 4e-07 | ||
| 2buj_A | 317 | Crystal Structure Of The Human Serine-Threonine Kin | 5e-07 | ||
| 3hng_A | 360 | Crystal Structure Of Vegfr1 In Complex With N-(4-ch | 5e-07 | ||
| 3dxn_A | 287 | Crystal Structure Of The Calcium-dependent Kinase F | 5e-07 | ||
| 3vn9_A | 340 | Rifined Crystal Structure Of Non-Phosphorylated Map | 6e-07 | ||
| 3f61_A | 311 | Crystal Structure Of M. Tuberculosis Pknb Leu33aspV | 6e-07 | ||
| 2v7o_A | 336 | Crystal Structure Of Human Calcium-Calmodulin-Depen | 6e-07 | ||
| 3rny_A | 346 | Crystal Structure Of Human Rsk1 C-Terminal Kinase D | 7e-07 | ||
| 4ic7_A | 442 | Crystal Structure Of The Erk5 Kinase Domain In Comp | 7e-07 | ||
| 3soa_A | 444 | Full-Length Human Camkii Length = 444 | 8e-07 | ||
| 2wnt_A | 330 | Crystal Structure Of The Human Ribosomal Protein S6 | 8e-07 | ||
| 3g33_A | 308 | Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | 9e-07 | ||
| 2wtk_C | 305 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 9e-07 | ||
| 4fux_A | 360 | Crystal Structure Of The Erk2 Complexed With E75 Le | 1e-06 | ||
| 2jc6_A | 334 | Crystal Structure Of Human Calmodulin-Dependent Pro | 1e-06 | ||
| 4b99_A | 398 | Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le | 1e-06 | ||
| 2y9q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 1e-06 | ||
| 4fv6_A | 360 | Crystal Structure Of The Erk2 Complexed With E57 Le | 1e-06 | ||
| 2zv2_A | 298 | Crystal Structure Of Human CalciumCALMODULIN-Depend | 1e-06 | ||
| 3uib_A | 362 | Map Kinase Lmampk10 From Leishmania Major In Comple | 1e-06 | ||
| 1h8f_A | 352 | Glycogen Synthase Kinase 3 Beta. Length = 352 | 1e-06 | ||
| 4fv7_A | 360 | Crystal Structure Of The Erk2 Complexed With E94 Le | 1e-06 | ||
| 3sa0_A | 360 | Complex Of Erk2 With Norathyriol Length = 360 | 1e-06 | ||
| 1uv5_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With 6-Br | 1e-06 | ||
| 3f88_A | 349 | Glycogen Synthase Kinase 3beta Inhibitor Complex Le | 1e-06 | ||
| 2ojg_A | 380 | Crystal Structure Of Erk2 In Complex With N,n-dimet | 1e-06 | ||
| 1o9u_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 1e-06 | ||
| 3pg1_A | 362 | Map Kinase Lmampk10 From Leishmania Major (1.95 Ang | 1e-06 | ||
| 3krw_A | 688 | Human Grk2 In Complex With Gbetgamma Subunits And B | 1e-06 | ||
| 3cik_A | 689 | Human Grk2 In Complex With Gbetagamma Subunits Leng | 1e-06 | ||
| 1wzy_A | 368 | Crystal Structure Of Human Erk2 Complexed With A Py | 1e-06 | ||
| 1tvo_A | 368 | The Structure Of Erk2 In Complex With A Small Molec | 1e-06 | ||
| 1omw_A | 689 | Crystal Structure Of The Complex Between G Protein- | 1e-06 | ||
| 3psc_A | 695 | Bovine Grk2 In Complex With Gbetagamma Subunits Len | 1e-06 | ||
| 3hzt_A | 467 | Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4 | 1e-06 | ||
| 4fr4_A | 384 | Crystal Structure Of Human SerineTHREONINE-Protein | 2e-06 | ||
| 1rw8_A | 301 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 2e-06 | ||
| 3tzm_A | 309 | Tgf-Beta Receptor Type 1 In Complex With Sb431542 L | 2e-06 | ||
| 1vjy_A | 303 | Crystal Structure Of A Naphthyridine Inhibitor Of H | 2e-06 | ||
| 3say_A | 430 | Crystal Structure Of Human Glycogen Synthase Kinase | 2e-06 | ||
| 3orm_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain D76a | 2e-06 | ||
| 1pme_A | 380 | Structure Of Penta Mutant Human Erk2 Map Kinase Com | 2e-06 | ||
| 1i09_A | 420 | Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len | 2e-06 | ||
| 1q5k_A | 414 | Crystal Structure Of Glycogen Synthase Kinase 3 In | 2e-06 | ||
| 1pyx_A | 422 | Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | 2e-06 | ||
| 4afj_A | 367 | 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec | 2e-06 | ||
| 2wot_A | 306 | Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl) | 2e-06 | ||
| 3g51_A | 325 | Structural Diversity Of The Active Conformation Of | 2e-06 | ||
| 4dit_A | 382 | Crystal Structure Of Gsk3beta In Complex With A Imi | 2e-06 | ||
| 2o5k_A | 372 | Crystal Structure Of Gsk3beta In Complex With A Ben | 2e-06 | ||
| 1gng_A | 378 | Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With | 2e-06 | ||
| 3gb2_A | 353 | Gsk3beta Inhibitor Complex Length = 353 | 2e-06 | ||
| 4acc_A | 465 | Gsk3b In Complex With Inhibitor Length = 465 | 2e-06 | ||
| 3zrk_A | 371 | Identification Of 2-(4-Pyridyl)thienopyridinones As | 2e-06 | ||
| 1q3d_A | 424 | Gsk-3 Beta Complexed With Staurosporine Length = 42 | 2e-06 | ||
| 2ow3_A | 352 | Glycogen Synthase Kinase-3 Beta In Complex With Bis | 2e-06 | ||
| 3zdi_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 2e-06 | ||
| 3tei_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 2e-06 | ||
| 2phk_A | 277 | The Crystal Structure Of A Phosphorylase Kinase Pep | 2e-06 | ||
| 1ql6_A | 298 | The Catalytic Mechanism Of Phosphorylase Kinase Pro | 2e-06 | ||
| 4gsb_A | 364 | Monoclinic Crystal Form Of The Apo-Erk2 Length = 36 | 2e-06 | ||
| 1phk_A | 298 | Two Structures Of The Catalytic Domain Of Phosphory | 2e-06 | ||
| 1r0e_A | 391 | Glycogen Synthase Kinase-3 Beta In Complex With 3-I | 2e-06 | ||
| 3qyw_A | 364 | Crystal Structure Of Erk2 In Complex With An Inhibi | 2e-06 | ||
| 3sd0_A | 350 | Identification Of A Glycogen Synthase Kinase-3b Inh | 2e-06 | ||
| 3f7z_A | 350 | X-ray Co-crystal Structure Of Glycogen Synthase Kin | 3e-06 | ||
| 3dls_A | 335 | Crystal Structure Of Human Pas Kinase Bound To Adp | 3e-06 | ||
| 4h3q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 3e-06 | ||
| 2wel_A | 327 | Crystal Structure Of Su6656-Bound CalciumCALMODULIN | 3e-06 | ||
| 4el9_A | 305 | Structure Of N-Terminal Kinase Domain Of Rsk2 With | 3e-06 | ||
| 3o71_A | 358 | Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length | 3e-06 | ||
| 3r63_A | 358 | Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | 3e-06 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 3e-06 | ||
| 2vn9_A | 301 | Crystal Structure Of Human Calcium Calmodulin Depen | 3e-06 | ||
| 3zu7_A | 365 | Crystal Structure Of A Designed Selected Ankyrin Re | 3e-06 | ||
| 3enm_A | 316 | The Structure Of The Map2k Mek6 Reveals An Autoinhi | 3e-06 | ||
| 2z7l_A | 366 | Unphosphorylated Mitogen Activated Protein Kinase E | 3e-06 | ||
| 3c9w_A | 357 | Crystal Structure Of Erk-2 With Hypothemycin Covale | 3e-06 | ||
| 2fys_B | 364 | Crystal Structure Of Erk2 Complex With Kim Peptide | 3e-06 | ||
| 2zoq_A | 382 | Structural Dissection Of Human Mitogen-Activated Ki | 3e-06 | ||
| 2xuu_A | 334 | Crystal Structure Of A Dap-Kinase 1 Mutant Length = | 3e-06 | ||
| 3dfc_B | 295 | Crystal Structure Of A Glycine-Rich Loop Mutant Of | 3e-06 | ||
| 1mru_A | 311 | Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob | 3e-06 | ||
| 2qr8_A | 342 | 2.0a X-ray Structure Of C-terminal Kinase Domain Of | 3e-06 | ||
| 1ig1_A | 294 | 1.8a X-Ray Structure Of Ternary Complex Of A Cataly | 4e-06 | ||
| 1p4f_A | 293 | Death Associated Protein Kinase Catalytic Domain Wi | 4e-06 | ||
| 3f5u_A | 295 | Crystal Structure Of The Death Associated Protein K | 4e-06 | ||
| 1yrp_A | 278 | Catalytic Domain Of Human Zip Kinase Phosphorylated | 4e-06 | ||
| 3zuv_A | 364 | Crystal Structure Of A Designed Selected Ankyrin Re | 4e-06 | ||
| 2erk_A | 365 | Phosphorylated Map Kinase Erk2 Length = 365 | 4e-06 | ||
| 1kob_A | 387 | Twitchin Kinase Fragment (Aplysia), Autoregulated P | 4e-06 | ||
| 2xzs_A | 312 | Death Associated Protein Kinase 1 Residues 1-312 Le | 4e-06 | ||
| 2x0g_A | 334 | X-ray Structure Of A Dap-kinase Calmodulin Complex | 4e-06 | ||
| 1o6y_A | 299 | Catalytic Domain Of Pknb Kinase From Mycobacterium | 5e-06 | ||
| 3bhy_A | 283 | Crystal Structure Of Human Death Associated Protein | 5e-06 | ||
| 2j90_A | 304 | Crystal Structure Of Human Zip Kinase In Complex Wi | 5e-06 | ||
| 2gph_A | 364 | Docking Motif Interactions In The Map Kinase Erk2 L | 5e-06 | ||
| 2y0a_A | 326 | Structure Of Dapk1 Construct Residues 1-304 Length | 5e-06 | ||
| 3gu4_A | 295 | Crystal Structure Of Dapkq23v-Amppnp Length = 295 | 5e-06 | ||
| 3cek_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 5e-06 | ||
| 3hmn_A | 342 | Crystal Structure Of Human Mps1 Catalytic Domain In | 5e-06 | ||
| 1gol_A | 364 | Coordinates Of Rat Map Kinase Erk2 With An Arginine | 6e-06 | ||
| 2x9e_A | 317 | Human Mps1 In Complex With Nms-P715 Length = 317 | 6e-06 | ||
| 2w4k_A | 302 | X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | 6e-06 | ||
| 4dc2_A | 396 | Structure Of Pkc In Complex With A Substrate Peptid | 6e-06 | ||
| 2yak_A | 285 | Structure Of Death-Associated Protein Kinase 1 (Dap | 6e-06 | ||
| 3gu8_A | 295 | Crystal Structure Of Dapkl93g With N6-Cyclopentylad | 6e-06 | ||
| 3c4x_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 6e-06 | ||
| 3t8o_A | 543 | Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu | 6e-06 | ||
| 3qc9_A | 543 | Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4 | 6e-06 | ||
| 3c4w_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 6e-06 | ||
| 1wvw_A | 278 | Crystal Structures Of Kinase Domain Of Dap Kinase I | 6e-06 | ||
| 3fpq_A | 290 | Crystal Structure Of The Kinase Domain Of Wnk1 Leng | 6e-06 | ||
| 2w4j_A | 277 | X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | 6e-06 | ||
| 3vqu_A | 320 | Crystal Structure Of Human Mps1 Catalytic Domain In | 7e-06 | ||
| 3dbq_A | 343 | Crystal Structure Of Ttk Kinase Domain Length = 343 | 7e-06 | ||
| 2pml_X | 348 | Crystal Structure Of Pfpk7 In Complex With An Atp A | 7e-06 | ||
| 2i6l_A | 320 | Crystal Structure Of Human Mitogen Activated Protei | 8e-06 | ||
| 2zmc_A | 390 | Crystal Structure Of Human Mitotic Checkpoint Kinas | 9e-06 | ||
| 4e7w_A | 394 | Structure Of Gsk3 From Ustilago Maydis Length = 394 | 9e-06 | ||
| 3p1a_A | 311 | Structure Of Human Membrane-Associated Tyrosine- An | 1e-05 | ||
| 2ycf_A | 322 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 1e-05 | ||
| 2xk9_A | 322 | Structural Analysis Of Checkpoint Kinase 2 (Chk2) I | 1e-05 | ||
| 2w0j_A | 323 | Crystal Structure Of Chk2 In Complex With Nsc 10955 | 1e-05 | ||
| 2f2u_A | 402 | Crystal Structure Of The Rho-Kinase Kinase Domain L | 1e-05 | ||
| 2ycr_A | 323 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 1e-05 | ||
| 2cn5_A | 329 | Crystal Structure Of Human Chk2 In Complex With Adp | 1e-05 | ||
| 2qg5_A | 294 | Cryptosporidium Parvum Calcium Dependent Protein Ki | 1e-05 | ||
| 3a60_A | 327 | Crystal Structure Of Unphosphorylated P70s6k1 (Form | 1e-05 | ||
| 1zrz_A | 364 | Crystal Structure Of The Catalytic Domain Of Atypic | 1e-05 | ||
| 2w4o_A | 349 | Crystal Structure Of Human Camk4 In Complex With 4- | 1e-05 | ||
| 3a8w_A | 345 | Crystal Structure Of Pkciota Kinase Domain Length = | 2e-05 | ||
| 1xh9_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 2e-05 | ||
| 3zh8_A | 349 | A Novel Small Molecule Apkc Inhibitor Length = 349 | 2e-05 | ||
| 3a62_A | 327 | Crystal Structure Of Phosphorylated P70s6k1 Length | 2e-05 | ||
| 1yxs_A | 293 | Crystal Structure Of Kinase Pim1 With P123m Mutatio | 2e-05 | ||
| 3bi6_A | 287 | Wee1 Kinase Complex With Inhibitor Pd352396 Length | 2e-05 | ||
| 1x8b_A | 289 | Structure Of Human Wee1a Kinase: Kinase Domain Comp | 2e-05 | ||
| 2in6_A | 287 | Wee1 Kinase Complex With Inhibitor Pd311839 Length | 2e-05 | ||
| 2gng_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 2e-05 | ||
| 3i6u_A | 419 | Structure And Activation Mechanism Of The Chk2 Dna- | 2e-05 | ||
| 2y7j_A | 365 | Structure Of Human Phosphorylase Kinase, Gamma 2 Le | 2e-05 | ||
| 2jam_A | 304 | Crystal Structure Of Human Calmodulin-Dependent Pro | 2e-05 | ||
| 2z2w_A | 285 | Humand Wee1 Kinase Complexed With Inhibitor Pf03357 | 2e-05 | ||
| 2gnf_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 2e-05 | ||
| 1yhs_A | 273 | Crystal Structure Of Pim-1 Bound To Staurosporine L | 2e-05 | ||
| 3iw4_A | 360 | Crystal Structure Of Pkc Alpha In Complex With Nvp- | 2e-05 | ||
| 3i6w_A | 443 | Structure And Activation Mechanism Of The Chk2 Dna- | 2e-05 | ||
| 3h9f_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 3e-05 | ||
| 2r5t_A | 373 | Crystal Structure Of Inactive Serum And Glucocortic | 3e-05 | ||
| 2zmd_A | 390 | Crystal Structure Of Human Mps1 Catalytic Domain T6 | 3e-05 | ||
| 4euu_A | 319 | Structure Of Bx-795 Complexed With Human Tbk1 Kinas | 3e-05 | ||
| 4eut_A | 396 | Structure Of Bx-795 Complexed With Unphosphorylated | 3e-05 | ||
| 3uix_A | 298 | Crystal Structure Of Pim1 Kinase In Complex With Sm | 4e-05 | ||
| 3jxw_A | 294 | Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4- | 4e-05 | ||
| 2qr7_A | 342 | 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of | 4e-05 | ||
| 1ywv_A | 293 | Crystal Structures Of Proto-Oncogene Kinase Pim1: A | 4e-05 | ||
| 1smh_A | 350 | Protein Kinase A Variant Complex With Completely Or | 4e-05 | ||
| 3f3z_A | 277 | Crystal Structure Of Cryptosporidium Parvum Calcium | 4e-05 | ||
| 2ac5_A | 316 | Structure Of Human Mnk2 Kinase Domain Mutant D228g | 4e-05 | ||
| 3udb_A | 317 | Crystal Structure Of Snrk2.6 Length = 317 | 4e-05 | ||
| 1xqz_A | 300 | Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut | 4e-05 | ||
| 3r00_A | 299 | The Discovery Of Novel Benzofuran-2-Carboxylic Acid | 4e-05 | ||
| 3c4e_A | 273 | Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7 | 4e-05 | ||
| 3f2a_A | 300 | Crystal Structure Of Human Pim-1 In Complex With Da | 4e-05 | ||
| 2xj0_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-4 Fro | 5e-05 | ||
| 2xiy_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-2 Fro | 5e-05 | ||
| 3uc4_A | 362 | The Crystal Structure Of Snf1-Related Kinase 2.6 Le | 5e-05 | ||
| 4dtk_A | 276 | Novel And Selective Pan-Pim Kinase Inhibitor Length | 5e-05 | ||
| 3a99_A | 320 | Structure Of Pim-1 Kinase Crystallized In The Prese | 5e-05 | ||
| 2xix_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-1 Fro | 5e-05 | ||
| 1szm_A | 350 | Dual Binding Mode Of Bisindolylmaleimide 2 To Prote | 6e-05 | ||
| 4alv_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 6e-05 | ||
| 4a7c_A | 308 | Crystal Structure Of Pim1 Kinase With Etp46546 Leng | 6e-05 | ||
| 1xws_A | 313 | Crystal Structure Of The Human Pim1 Kinase Domain L | 7e-05 | ||
| 1q8w_A | 350 | The Catalytic Subunit Of Camp-Dependent Protein Kin | 7e-05 | ||
| 1xh7_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 7e-05 | ||
| 2jds_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 7e-05 | ||
| 2gnj_A | 350 | Pka Three Fold Mutant Model Of Rho-Kinase With Y-27 | 7e-05 | ||
| 4ae9_A | 343 | Structure And Function Of The Human Sperm-specific | 7e-05 | ||
| 1ctp_E | 350 | Structure Of The Mammalian Catalytic Subunit Of Cam | 7e-05 | ||
| 1cdk_A | 350 | Camp-Dependent Protein Kinase Catalytic Subunit (E. | 7e-05 | ||
| 1cmk_E | 350 | Crystal Structures Of The Myristylated Catalytic Su | 8e-05 | ||
| 1tki_A | 321 | Autoinhibited Serine Kinase Domain Of The Giant Mus | 8e-05 | ||
| 3mfr_A | 351 | Cask-4m Cam Kinase Domain, Native Length = 351 | 8e-05 | ||
| 2obj_A | 333 | Crystal Structure Of Human Pim-1 Kinase In Complex | 8e-05 | ||
| 3dcv_A | 328 | Crystal Structure Of Human Pim1 Kinase Complexed Wi | 8e-05 | ||
| 3jpv_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 9e-05 | ||
| 2uzt_A | 336 | Pka Structures Of Akt, Indazole-Pyridine Inhibitors | 9e-05 | ||
| 1q61_A | 350 | Pka Triple Mutant Model Of Pkb Length = 350 | 9e-05 | ||
| 2c1a_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 9e-05 | ||
| 3l9m_A | 351 | Crystal Structure Of Pkab3 (Pka Triple Mutant V123a | 9e-05 | ||
| 1na7_A | 329 | Crystal Structure Of The Catalytic Subunit Of Human | 9e-05 | ||
| 4as0_A | 273 | Cyclometalated Phthalimides As Protein Kinase Inhib | 9e-05 | ||
| 2bil_B | 313 | The Human Protein Kinase Pim1 In Complex With Its C | 9e-05 | ||
| 3ujg_A | 361 | Crystal Structure Of Snrk2.6 In Complex With Hab1 L | 9e-05 | ||
| 3ma3_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 9e-05 | ||
| 3cy3_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 9e-05 | ||
| 2j2i_B | 312 | Crystal Structure Of The Humab Pim1 In Complex With | 9e-05 | ||
| 1svh_A | 350 | Crystal Structure Of Protein Kinase A In Complex Wi | 9e-05 | ||
| 2bik_B | 313 | Human Pim1 Phosphorylated On Ser261 Length = 313 | 1e-04 | ||
| 3cxw_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 1e-04 | ||
| 3dnd_A | 350 | Camp-Dependent Protein Kinase Pka Catalytic Subunit | 1e-04 | ||
| 2f7e_E | 351 | Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu | 1e-04 | ||
| 4ae6_A | 343 | Structure And Function Of The Human Sperm-specific | 1e-04 | ||
| 3agm_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 1e-04 | ||
| 1stc_E | 350 | Camp-Dependent Protein Kinase, Alpha-Catalytic Subu | 1e-04 | ||
| 3agl_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 1e-04 | ||
| 3nyn_A | 576 | Crystal Structure Of G Protein-Coupled Receptor Kin | 1e-04 | ||
| 3nx8_A | 351 | Human Camp Dependent Protein Kinase In Complex With | 1e-04 | ||
| 2acx_A | 576 | Crystal Structure Of G Protein Coupled Receptor Kin | 1e-04 | ||
| 3mvj_A | 371 | Human Cyclic Amp-Dependent Protein Kinase Pka Inhib | 1e-04 | ||
| 2uvy_A | 351 | Structure Of Pka-pkb Chimera Complexed With Methyl- | 2e-04 | ||
| 3ama_A | 351 | Protein Kinase A Sixfold Mutant Model Of Aurora B W | 2e-04 | ||
| 2iwi_A | 312 | Crystal Structure Of The Human Pim2 In Complex With | 2e-04 | ||
| 1q24_A | 350 | Pka Double Mutant Model Of Pkb In Complex With Mgat | 2e-04 | ||
| 2dyl_A | 318 | Crystal Structure Of Human Mitogen-Activated Protei | 2e-04 | ||
| 2ac3_A | 316 | Structure Of Human Mnk2 Kinase Domain Length = 316 | 3e-04 | ||
| 2vo0_A | 351 | Structure Of Pka-Pkb Chimera Complexed With C-(4-(4 | 3e-04 | ||
| 2jdt_A | 351 | Structure Of Pka-Pkb Chimera Complexed With Isoquin | 3e-04 | ||
| 3zut_A | 362 | The Structure Of Ost1 (D160a) Kinase Length = 362 | 5e-04 | ||
| 3zuu_A | 362 | The Structure Of Ost1 (D160a, S175d) Kinase In Comp | 6e-04 | ||
| 3uc3_A | 361 | The Crystal Structure Of Snf1-Related Kinase 2.3 Le | 7e-04 | ||
| 3pfq_A | 674 | Crystal Structure And Allosteric Activation Of Prot | 7e-04 |
| >pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349 | Back alignment and structure |
|
| >pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326 | Back alignment and structure |
|
| >pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327 | Back alignment and structure |
|
| >pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301 | Back alignment and structure |
|
| >pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321 | Back alignment and structure |
|
| >pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287 | Back alignment and structure |
|
| >pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288 | Back alignment and structure |
|
| >pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285 | Back alignment and structure |
|
| >pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286 | Back alignment and structure |
|
| >pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | Back alignment and structure |
|
| >pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271 | Back alignment and structure |
|
| >pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289 | Back alignment and structure |
|
| >pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273 | Back alignment and structure |
|
| >pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277 | Back alignment and structure |
|
| >pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272 | Back alignment and structure |
|
| >pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277 | Back alignment and structure |
|
| >pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271 | Back alignment and structure |
|
| >pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265 | Back alignment and structure |
|
| >pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267 | Back alignment and structure |
|
| >pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270 | Back alignment and structure |
|
| >pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307 | Back alignment and structure |
|
| >pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289 | Back alignment and structure |
|
| >pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454 | Back alignment and structure |
|
| >pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321 | Back alignment and structure |
|
| >pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308 | Back alignment and structure |
|
| >pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292 | Back alignment and structure |
|
| >pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309 | Back alignment and structure |
|
| >pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310 | Back alignment and structure |
|
| >pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306 | Back alignment and structure |
|
| >pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302 | Back alignment and structure |
|
| >pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318 | Back alignment and structure |
|
| >pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328 | Back alignment and structure |
|
| >pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452 | Back alignment and structure |
|
| >pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373 | Back alignment and structure |
|
| >pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452 | Back alignment and structure |
|
| >pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | Back alignment and structure |
|
| >pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535 | Back alignment and structure |
|
| >pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266 | Back alignment and structure |
|
| >pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276 | Back alignment and structure |
|
| >pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312 | Back alignment and structure |
|
| >pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314 | Back alignment and structure |
|
| >pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299 | Back alignment and structure |
|
| >pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279 | Back alignment and structure |
|
| >pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452 | Back alignment and structure |
|
| >pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271 | Back alignment and structure |
|
| >pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283 | Back alignment and structure |
|
| >pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283 | Back alignment and structure |
|
| >pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269 | Back alignment and structure |
|
| >pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264 | Back alignment and structure |
|
| >pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266 | Back alignment and structure |
|
| >pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277 | Back alignment and structure |
|
| >pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275 | Back alignment and structure |
|
| >pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286 | Back alignment and structure |
|
| >pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286 | Back alignment and structure |
|
| >pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287 | Back alignment and structure |
|
| >pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286 | Back alignment and structure |
|
| >pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286 | Back alignment and structure |
|
| >pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297 | Back alignment and structure |
|
| >pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453 | Back alignment and structure |
|
| >pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286 | Back alignment and structure |
|
| >pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286 | Back alignment and structure |
|
| >pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267 | Back alignment and structure |
|
| >pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300 | Back alignment and structure |
|
| >pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329 | Back alignment and structure |
|
| >pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344 | Back alignment and structure |
|
| >pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371 | Back alignment and structure |
|
| >pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298 | Back alignment and structure |
|
| >pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317 | Back alignment and structure |
|
| >pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329 | Back alignment and structure |
|
| >pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373 | Back alignment and structure |
|
| >pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361 | Back alignment and structure |
|
| >pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303 | Back alignment and structure |
|
| >pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301 | Back alignment and structure |
|
| >pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293 | Back alignment and structure |
|
| >pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300 | Back alignment and structure |
|
| >pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298 | Back alignment and structure |
|
| >pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295 | Back alignment and structure |
|
| >pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311 | Back alignment and structure |
|
| >pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278 | Back alignment and structure |
|
| >pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313 | Back alignment and structure |
|
| >pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344 | Back alignment and structure |
|
| >pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373 | Back alignment and structure |
|
| >pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277 | Back alignment and structure |
|
| >pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277 | Back alignment and structure |
|
| >pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277 | Back alignment and structure |
|
| >pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270 | Back alignment and structure |
|
| >pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286 | Back alignment and structure |
|
| >pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273 | Back alignment and structure |
|
| >pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295 | Back alignment and structure |
|
| >pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293 | Back alignment and structure |
|
| >pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277 | Back alignment and structure |
|
| >pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298 | Back alignment and structure |
|
| >pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284 | Back alignment and structure |
|
| >pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288 | Back alignment and structure |
|
| >pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284 | Back alignment and structure |
|
| >pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288 | Back alignment and structure |
|
| >pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287 | Back alignment and structure |
|
| >pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313 | Back alignment and structure |
|
| >pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284 | Back alignment and structure |
|
| >pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311 | Back alignment and structure |
|
| >pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281 | Back alignment and structure |
|
| >pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282 | Back alignment and structure |
|
| >pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292 | Back alignment and structure |
|
| >pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275 | Back alignment and structure |
|
| >pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300 | Back alignment and structure |
|
| >pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298 | Back alignment and structure |
|
| >pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306 | Back alignment and structure |
|
| >pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307 | Back alignment and structure |
|
| >pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299 | Back alignment and structure |
|
| >pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308 | Back alignment and structure |
|
| >pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324 | Back alignment and structure |
|
| >pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537 | Back alignment and structure |
|
| >pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495 | Back alignment and structure |
|
| >pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322 | Back alignment and structure |
|
| >pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301 | Back alignment and structure |
|
| >pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322 | Back alignment and structure |
|
| >pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315 | Back alignment and structure |
|
| >pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305 | Back alignment and structure |
|
| >pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304 | Back alignment and structure |
|
| >pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336 | Back alignment and structure |
|
| >pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310 | Back alignment and structure |
|
| >pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312 | Back alignment and structure |
|
| >pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343 | Back alignment and structure |
|
| >pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301 | Back alignment and structure |
|
| >pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317 | Back alignment and structure |
|
| >pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367 | Back alignment and structure |
|
| >pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344 | Back alignment and structure |
|
| >pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333 | Back alignment and structure |
|
| >pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302 | Back alignment and structure |
|
| >pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314 | Back alignment and structure |
|
| >pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327 | Back alignment and structure |
|
| >pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295 | Back alignment and structure |
|
| >pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315 | Back alignment and structure |
|
| >pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327 | Back alignment and structure |
|
| >pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331 | Back alignment and structure |
|
| >pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338 | Back alignment and structure |
|
| >pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327 | Back alignment and structure |
|
| >pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328 | Back alignment and structure |
|
| >pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344 | Back alignment and structure |
|
| >pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328 | Back alignment and structure |
|
| >pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329 | Back alignment and structure |
|
| >pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286 | Back alignment and structure |
|
| >pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327 | Back alignment and structure |
|
| >pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353 | Back alignment and structure |
|
| >pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330 | Back alignment and structure |
|
| >pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333 | Back alignment and structure |
|
| >pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327 | Back alignment and structure |
|
| >pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327 | Back alignment and structure |
|
| >pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285 | Back alignment and structure |
|
| >pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330 | Back alignment and structure |
|
| >pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329 | Back alignment and structure |
|
| >pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306 | Back alignment and structure |
|
| >pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315 | Back alignment and structure |
|
| >pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337 | Back alignment and structure |
|
| >pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327 | Back alignment and structure |
|
| >pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328 | Back alignment and structure |
|
| >pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352 | Back alignment and structure |
|
| >pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317 | Back alignment and structure |
|
| >pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306 | Back alignment and structure |
|
| >pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299 | Back alignment and structure |
|
| >pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303 | Back alignment and structure |
|
| >pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327 | Back alignment and structure |
|
| >pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327 | Back alignment and structure |
|
| >pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306 | Back alignment and structure |
|
| >pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318 | Back alignment and structure |
|
| >pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324 | Back alignment and structure |
|
| >pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300 | Back alignment and structure |
|
| >pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309 | Back alignment and structure |
|
| >pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306 | Back alignment and structure |
|
| >pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299 | Back alignment and structure |
|
| >pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298 | Back alignment and structure |
|
| >pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269 | Back alignment and structure |
|
| >pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322 | Back alignment and structure |
|
| >pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299 | Back alignment and structure |
|
| >pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327 | Back alignment and structure |
|
| >pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306 | Back alignment and structure |
|
| >pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321 | Back alignment and structure |
|
| >pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303 | Back alignment and structure |
|
| >pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334 | Back alignment and structure |
|
| >pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299 | Back alignment and structure |
|
| >pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298 | Back alignment and structure |
|
| >pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290 | Back alignment and structure |
|
| >pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297 | Back alignment and structure |
|
| >pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278 | Back alignment and structure |
|
| >pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334 | Back alignment and structure |
|
| >pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299 | Back alignment and structure |
|
| >pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300 | Back alignment and structure |
|
| >pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310 | Back alignment and structure |
|
| >pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317 | Back alignment and structure |
|
| >pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299 | Back alignment and structure |
|
| >pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296 | Back alignment and structure |
|
| >pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263 | Back alignment and structure |
|
| >pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298 | Back alignment and structure |
|
| >pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298 | Back alignment and structure |
|
| >pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302 | Back alignment and structure |
|
| >pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327 | Back alignment and structure |
|
| >pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317 | Back alignment and structure |
|
| >pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306 | Back alignment and structure |
|
| >pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309 | Back alignment and structure |
|
| >pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317 | Back alignment and structure |
|
| >pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298 | Back alignment and structure |
|
| >pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377 | Back alignment and structure |
|
| >pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289 | Back alignment and structure |
|
| >pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334 | Back alignment and structure |
|
| >pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331 | Back alignment and structure |
|
| >pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329 | Back alignment and structure |
|
| >pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329 | Back alignment and structure |
|
| >pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382 | Back alignment and structure |
|
| >pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327 | Back alignment and structure |
|
| >pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334 | Back alignment and structure |
|
| >pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324 | Back alignment and structure |
|
| >pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310 | Back alignment and structure |
|
| >pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361 | Back alignment and structure |
|
| >pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348 | Back alignment and structure |
|
| >pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327 | Back alignment and structure |
|
| >pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329 | Back alignment and structure |
|
| >pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302 | Back alignment and structure |
|
| >pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377 | Back alignment and structure |
|
| >pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268 | Back alignment and structure |
|
| >pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309 | Back alignment and structure |
|
| >pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287 | Back alignment and structure |
|
| >pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300 | Back alignment and structure |
|
| >pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370 | Back alignment and structure |
|
| >pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325 | Back alignment and structure |
|
| >pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311 | Back alignment and structure |
|
| >pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313 | Back alignment and structure |
|
| >pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302 | Back alignment and structure |
|
| >pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302 | Back alignment and structure |
|
| >pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293 | Back alignment and structure |
|
| >pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319 | Back alignment and structure |
|
| >pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336 | Back alignment and structure |
|
| >pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613 | Back alignment and structure |
|
| >pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290 | Back alignment and structure |
|
| >pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303 | Back alignment and structure |
|
| >pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316 | Back alignment and structure |
|
| >pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290 | Back alignment and structure |
|
| >pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344 | Back alignment and structure |
|
| >pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327 | Back alignment and structure |
|
| >pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301 | Back alignment and structure |
|
| >pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267 | Back alignment and structure |
|
| >pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283 | Back alignment and structure |
|
| >pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346 | Back alignment and structure |
|
| >pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423 | Back alignment and structure |
|
| >pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296 | Back alignment and structure |
|
| >pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303 | Back alignment and structure |
|
| >pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283 | Back alignment and structure |
|
| >pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292 | Back alignment and structure |
|
| >pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274 | Back alignment and structure |
|
| >pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317 | Back alignment and structure |
|
| >pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265 | Back alignment and structure |
|
| >pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271 | Back alignment and structure |
|
| >pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318 | Back alignment and structure |
|
| >pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316 | Back alignment and structure |
|
| >pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263 | Back alignment and structure |
|
| >pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311 | Back alignment and structure |
|
| >pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314 | Back alignment and structure |
|
| >pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288 | Back alignment and structure |
|
| >pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331 | Back alignment and structure |
|
| >pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344 | Back alignment and structure |
|
| >pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273 | Back alignment and structure |
|
| >pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329 | Back alignment and structure |
|
| >pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313 | Back alignment and structure |
|
| >pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318 | Back alignment and structure |
|
| >pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313 | Back alignment and structure |
|
| >pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316 | Back alignment and structure |
|
| >pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278 | Back alignment and structure |
|
| >pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315 | Back alignment and structure |
|
| >pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307 | Back alignment and structure |
|
| >pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289 | Back alignment and structure |
|
| >pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286 | Back alignment and structure |
|
| >pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312 | Back alignment and structure |
|
| >pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286 | Back alignment and structure |
|
| >pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310 | Back alignment and structure |
|
| >pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322 | Back alignment and structure |
|
| >pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276 | Back alignment and structure |
|
| >pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297 | Back alignment and structure |
|
| >pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289 | Back alignment and structure |
|
| >pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271 | Back alignment and structure |
|
| >pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295 | Back alignment and structure |
|
| >pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268 | Back alignment and structure |
|
| >pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310 | Back alignment and structure |
|
| >pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311 | Back alignment and structure |
|
| >pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286 | Back alignment and structure |
|
| >pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316 | Back alignment and structure |
|
| >pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312 | Back alignment and structure |
|
| >pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315 | Back alignment and structure |
|
| >pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276 | Back alignment and structure |
|
| >pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273 | Back alignment and structure |
|
| >pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323 | Back alignment and structure |
|
| >pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311 | Back alignment and structure |
|
| >pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269 | Back alignment and structure |
|
| >pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298 | Back alignment and structure |
|
| >pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327 | Back alignment and structure |
|
| >pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311 | Back alignment and structure |
|
| >pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311 | Back alignment and structure |
|
| >pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311 | Back alignment and structure |
|
| >pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314 | Back alignment and structure |
|
| >pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269 | Back alignment and structure |
|
| >pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314 | Back alignment and structure |
|
| >pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292 | Back alignment and structure |
|
| >pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353 | Back alignment and structure |
|
| >pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311 | Back alignment and structure |
|
| >pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311 | Back alignment and structure |
|
| >pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290 | Back alignment and structure |
|
| >pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507 | Back alignment and structure |
|
| >pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484 | Back alignment and structure |
|
| >pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508 | Back alignment and structure |
|
| >pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275 | Back alignment and structure |
|
| >pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274 | Back alignment and structure |
|
| >pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271 | Back alignment and structure |
|
| >pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293 | Back alignment and structure |
|
| >pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299 | Back alignment and structure |
|
| >pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346 | Back alignment and structure |
|
| >pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291 | Back alignment and structure |
|
| >pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336 | Back alignment and structure |
|
| >pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274 | Back alignment and structure |
|
| >pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273 | Back alignment and structure |
|
| >pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286 | Back alignment and structure |
|
| >pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287 | Back alignment and structure |
|
| >pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319 | Back alignment and structure |
|
| >pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329 | Back alignment and structure |
|
| >pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635 | Back alignment and structure |
|
| >pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636 | Back alignment and structure |
|
| >pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316 | Back alignment and structure |
|
| >pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331 | Back alignment and structure |
|
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337 | Back alignment and structure |
|
| >pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484 | Back alignment and structure |
|
| >pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277 | Back alignment and structure |
|
| >pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291 | Back alignment and structure |
|
| >pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293 | Back alignment and structure |
|
| >pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486 | Back alignment and structure |
|
| >pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281 | Back alignment and structure |
|
| >pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304 | Back alignment and structure |
|
| >pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277 | Back alignment and structure |
|
| >pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273 | Back alignment and structure |
|
| >pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276 | Back alignment and structure |
|
| >pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299 | Back alignment and structure |
|
| >pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317 | Back alignment and structure |
|
| >pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317 | Back alignment and structure |
|
| >pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317 | Back alignment and structure |
|
| >pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301 | Back alignment and structure |
|
| >pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276 | Back alignment and structure |
|
| >pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276 | Back alignment and structure |
|
| >pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573 | Back alignment and structure |
|
| >pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292 | Back alignment and structure |
|
| >pdb|3NIE|A Chain A, Crystal Structure Of Pf11_0147 Length = 429 | Back alignment and structure |
|
| >pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491 | Back alignment and structure |
|
| >pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351 | Back alignment and structure |
|
| >pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285 | Back alignment and structure |
|
| >pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331 | Back alignment and structure |
|
| >pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371 | Back alignment and structure |
|
| >pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373 | Back alignment and structure |
|
| >pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353 | Back alignment and structure |
|
| >pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331 | Back alignment and structure |
|
| >pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303 | Back alignment and structure |
|
| >pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388 | Back alignment and structure |
|
| >pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279 | Back alignment and structure |
|
| >pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315 | Back alignment and structure |
|
| >pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304 | Back alignment and structure |
|
| >pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337 | Back alignment and structure |
|
| >pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311 | Back alignment and structure |
|
| >pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335 | Back alignment and structure |
|
| >pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292 | Back alignment and structure |
|
| >pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311 | Back alignment and structure |
|
| >pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311 | Back alignment and structure |
|
| >pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281 | Back alignment and structure |
|
| >pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326 | Back alignment and structure |
|
| >pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281 | Back alignment and structure |
|
| >pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276 | Back alignment and structure |
|
| >pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276 | Back alignment and structure |
|
| >pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308 | Back alignment and structure |
|
| >pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350 | Back alignment and structure |
|
| >pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282 | Back alignment and structure |
|
| >pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294 | Back alignment and structure |
|
| >pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364 | Back alignment and structure |
|
| >pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279 | Back alignment and structure |
|
| >pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370 | Back alignment and structure |
|
| >pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348 | Back alignment and structure |
|
| >pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366 | Back alignment and structure |
|
| >pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348 | Back alignment and structure |
|
| >pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360 | Back alignment and structure |
|
| >pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380 | Back alignment and structure |
|
| >pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379 | Back alignment and structure |
|
| >pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367 | Back alignment and structure |
|
| >pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352 | Back alignment and structure |
|
| >pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372 | Back alignment and structure |
|
| >pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348 | Back alignment and structure |
|
| >pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370 | Back alignment and structure |
|
| >pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348 | Back alignment and structure |
|
| >pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365 | Back alignment and structure |
|
| >pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | Back alignment and structure |
|
| >pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364 | Back alignment and structure |
|
| >pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364 | Back alignment and structure |
|
| >pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353 | Back alignment and structure |
|
| >pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353 | Back alignment and structure |
|
| >pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353 | Back alignment and structure |
|
| >pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354 | Back alignment and structure |
|
| >pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279 | Back alignment and structure |
|
| >pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356 | Back alignment and structure |
|
| >pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355 | Back alignment and structure |
|
| >pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365 | Back alignment and structure |
|
| >pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353 | Back alignment and structure |
|
| >pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367 | Back alignment and structure |
|
| >pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656 | Back alignment and structure |
|
| >pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370 | Back alignment and structure |
|
| >pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362 | Back alignment and structure |
|
| >pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348 | Back alignment and structure |
|
| >pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359 | Back alignment and structure |
|
| >pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354 | Back alignment and structure |
|
| >pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365 | Back alignment and structure |
|
| >pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350 | Back alignment and structure |
|
| >pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360 | Back alignment and structure |
|
| >pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360 | Back alignment and structure |
|
| >pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362 | Back alignment and structure |
|
| >pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362 | Back alignment and structure |
|
| >pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379 | Back alignment and structure |
|
| >pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366 | Back alignment and structure |
|
| >pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345 | Back alignment and structure |
|
| >pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351 | Back alignment and structure |
|
| >pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372 | Back alignment and structure |
|
| >pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3RP9|A Chain A, Crystal Structure Of The Apo Mapk From Toxoplasma Gondii, 25.M01780 Or Tgme49_007820 Length = 458 | Back alignment and structure |
|
| >pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282 | Back alignment and structure |
|
| >pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366 | Back alignment and structure |
|
| >pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353 | Back alignment and structure |
|
| >pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284 | Back alignment and structure |
|
| >pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464 | Back alignment and structure |
|
| >pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269 | Back alignment and structure |
|
| >pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285 | Back alignment and structure |
|
| >pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504 | Back alignment and structure |
|
| >pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379 | Back alignment and structure |
|
| >pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354 | Back alignment and structure |
|
| >pdb|4FVP|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain (Apo Form) Length = 289 | Back alignment and structure |
|
| >pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360 | Back alignment and structure |
|
| >pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363 | Back alignment and structure |
|
| >pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362 | Back alignment and structure |
|
| >pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656 | Back alignment and structure |
|
| >pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364 | Back alignment and structure |
|
| >pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360 | Back alignment and structure |
|
| >pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356 | Back alignment and structure |
|
| >pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423 | Back alignment and structure |
|
| >pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356 | Back alignment and structure |
|
| >pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355 | Back alignment and structure |
|
| >pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395 | Back alignment and structure |
|
| >pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365 | Back alignment and structure |
|
| >pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307 | Back alignment and structure |
|
| >pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370 | Back alignment and structure |
|
| >pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341 | Back alignment and structure |
|
| >pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369 | Back alignment and structure |
|
| >pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305 | Back alignment and structure |
|
| >pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370 | Back alignment and structure |
|
| >pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358 | Back alignment and structure |
|
| >pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371 | Back alignment and structure |
|
| >pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333 | Back alignment and structure |
|
| >pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369 | Back alignment and structure |
|
| >pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386 | Back alignment and structure |
|
| >pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284 | Back alignment and structure |
|
| >pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3N9X|A Chain A, Crystal Structure Of Map Kinase From Plasmodium Berghei, Pb000659.00.0 Length = 432 | Back alignment and structure |
|
| >pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301 | Back alignment and structure |
|
| >pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362 | Back alignment and structure |
|
| >pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328 | Back alignment and structure |
|
| >pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322 | Back alignment and structure |
|
| >pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494 | Back alignment and structure |
|
| >pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311 | Back alignment and structure |
|
| >pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332 | Back alignment and structure |
|
| >pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355 | Back alignment and structure |
|
| >pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360 | Back alignment and structure |
|
| >pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292 | Back alignment and structure |
|
| >pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315 | Back alignment and structure |
|
| >pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293 | Back alignment and structure |
|
| >pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342 | Back alignment and structure |
|
| >pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320 | Back alignment and structure |
|
| >pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|4FVR|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain Mutant V617f (Mg- Atp-Bound Form) Length = 289 | Back alignment and structure |
|
| >pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295 | Back alignment and structure |
|
| >pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367 | Back alignment and structure |
|
| >pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311 | Back alignment and structure |
|
| >pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330 | Back alignment and structure |
|
| >pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304 | Back alignment and structure |
|
| >pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360 | Back alignment and structure |
|
| >pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301 | Back alignment and structure |
|
| >pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332 | Back alignment and structure |
|
| >pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676 | Back alignment and structure |
|
| >pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677 | Back alignment and structure |
|
| >pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368 | Back alignment and structure |
|
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356 | Back alignment and structure |
|
| >pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290 | Back alignment and structure |
|
| >pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313 | Back alignment and structure |
|
| >pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317 | Back alignment and structure |
|
| >pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360 | Back alignment and structure |
|
| >pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340 | Back alignment and structure |
|
| >pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311 | Back alignment and structure |
|
| >pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336 | Back alignment and structure |
|
| >pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346 | Back alignment and structure |
|
| >pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442 | Back alignment and structure |
|
| >pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444 | Back alignment and structure |
|
| >pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330 | Back alignment and structure |
|
| >pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | Back alignment and structure |
|
| >pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305 | Back alignment and structure |
|
| >pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360 | Back alignment and structure |
|
| >pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334 | Back alignment and structure |
|
| >pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398 | Back alignment and structure |
|
| >pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360 | Back alignment and structure |
|
| >pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298 | Back alignment and structure |
|
| >pdb|3UIB|A Chain A, Map Kinase Lmampk10 From Leishmania Major In Complex With Sb203580 Length = 362 | Back alignment and structure |
|
| >pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352 | Back alignment and structure |
|
| >pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360 | Back alignment and structure |
|
| >pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360 | Back alignment and structure |
|
| >pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350 | Back alignment and structure |
|
| >pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349 | Back alignment and structure |
|
| >pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350 | Back alignment and structure |
|
| >pdb|3PG1|A Chain A, Map Kinase Lmampk10 From Leishmania Major (1.95 Angs Resolution) Length = 362 | Back alignment and structure |
|
| >pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688 | Back alignment and structure |
|
| >pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689 | Back alignment and structure |
|
| >pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368 | Back alignment and structure |
|
| >pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368 | Back alignment and structure |
|
| >pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695 | Back alignment and structure |
|
| >pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467 | Back alignment and structure |
|
| >pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384 | Back alignment and structure |
|
| >pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309 | Back alignment and structure |
|
| >pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303 | Back alignment and structure |
|
| >pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430 | Back alignment and structure |
|
| >pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311 | Back alignment and structure |
|
| >pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420 | Back alignment and structure |
|
| >pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414 | Back alignment and structure |
|
| >pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | Back alignment and structure |
|
| >pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367 | Back alignment and structure |
|
| >pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306 | Back alignment and structure |
|
| >pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325 | Back alignment and structure |
|
| >pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382 | Back alignment and structure |
|
| >pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378 | Back alignment and structure |
|
| >pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353 | Back alignment and structure |
|
| >pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465 | Back alignment and structure |
|
| >pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371 | Back alignment and structure |
|
| >pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424 | Back alignment and structure |
|
| >pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352 | Back alignment and structure |
|
| >pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350 | Back alignment and structure |
|
| >pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277 | Back alignment and structure |
|
| >pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298 | Back alignment and structure |
|
| >pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298 | Back alignment and structure |
|
| >pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391 | Back alignment and structure |
|
| >pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350 | Back alignment and structure |
|
| >pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350 | Back alignment and structure |
|
| >pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335 | Back alignment and structure |
|
| >pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327 | Back alignment and structure |
|
| >pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305 | Back alignment and structure |
|
| >pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358 | Back alignment and structure |
|
| >pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301 | Back alignment and structure |
|
| >pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316 | Back alignment and structure |
|
| >pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366 | Back alignment and structure |
|
| >pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357 | Back alignment and structure |
|
| >pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364 | Back alignment and structure |
|
| >pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382 | Back alignment and structure |
|
| >pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334 | Back alignment and structure |
|
| >pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311 | Back alignment and structure |
|
| >pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342 | Back alignment and structure |
|
| >pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294 | Back alignment and structure |
|
| >pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295 | Back alignment and structure |
|
| >pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278 | Back alignment and structure |
|
| >pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387 | Back alignment and structure |
|
| >pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312 | Back alignment and structure |
|
| >pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334 | Back alignment and structure |
|
| >pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299 | Back alignment and structure |
|
| >pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283 | Back alignment and structure |
|
| >pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304 | Back alignment and structure |
|
| >pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326 | Back alignment and structure |
|
| >pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|3CEK|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (ttk) Length = 313 | Back alignment and structure |
|
| >pdb|3HMN|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With Atp Length = 342 | Back alignment and structure |
|
| >pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364 | Back alignment and structure |
|
| >pdb|2X9E|A Chain A, Human Mps1 In Complex With Nms-P715 Length = 317 | Back alignment and structure |
|
| >pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | Back alignment and structure |
|
| >pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396 | Back alignment and structure |
|
| >pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285 | Back alignment and structure |
|
| >pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295 | Back alignment and structure |
|
| >pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543 | Back alignment and structure |
|
| >pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543 | Back alignment and structure |
|
| >pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543 | Back alignment and structure |
|
| >pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543 | Back alignment and structure |
|
| >pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278 | Back alignment and structure |
|
| >pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290 | Back alignment and structure |
|
| >pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | Back alignment and structure |
|
| >pdb|3VQU|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With 4- [(4-Amino-5-Cyano-6-Ethoxypyridin-2- Yl)amino]benzamide Length = 320 | Back alignment and structure |
|
| >pdb|3DBQ|A Chain A, Crystal Structure Of Ttk Kinase Domain Length = 343 | Back alignment and structure |
|
| >pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348 | Back alignment and structure |
|
| >pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320 | Back alignment and structure |
|
| >pdb|2ZMC|A Chain A, Crystal Structure Of Human Mitotic Checkpoint Kinase Mps1 Catalytic Domain Apo Form Length = 390 | Back alignment and structure |
|
| >pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394 | Back alignment and structure |
|
| >pdb|3P1A|A Chain A, Structure Of Human Membrane-Associated Tyrosine- And Threonine- Specific Cdc2-Inhibitory Kinase Myt1 (Pkmyt1) Length = 311 | Back alignment and structure |
|
| >pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322 | Back alignment and structure |
|
| >pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322 | Back alignment and structure |
|
| >pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323 | Back alignment and structure |
|
| >pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402 | Back alignment and structure |
|
| >pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323 | Back alignment and structure |
|
| >pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329 | Back alignment and structure |
|
| >pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294 | Back alignment and structure |
|
| >pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327 | Back alignment and structure |
|
| >pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364 | Back alignment and structure |
|
| >pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349 | Back alignment and structure |
|
| >pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345 | Back alignment and structure |
|
| >pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327 | Back alignment and structure |
|
| >pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293 | Back alignment and structure |
|
| >pdb|3BI6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd352396 Length = 287 | Back alignment and structure |
|
| >pdb|1X8B|A Chain A, Structure Of Human Wee1a Kinase: Kinase Domain Complexed With Inhibitor Pd0407824 Length = 289 | Back alignment and structure |
|
| >pdb|2IN6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd311839 Length = 287 | Back alignment and structure |
|
| >pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419 | Back alignment and structure |
|
| >pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365 | Back alignment and structure |
|
| >pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304 | Back alignment and structure |
|
| >pdb|2Z2W|A Chain A, Humand Wee1 Kinase Complexed With Inhibitor Pf0335770 Length = 285 | Back alignment and structure |
|
| >pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350 | Back alignment and structure |
|
| >pdb|1YHS|A Chain A, Crystal Structure Of Pim-1 Bound To Staurosporine Length = 273 | Back alignment and structure |
|
| >pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360 | Back alignment and structure |
|
| >pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443 | Back alignment and structure |
|
| >pdb|3H9F|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (Ttk) In Complex With A Pyrimido-Diazepin Ligand Length = 313 | Back alignment and structure |
|
| >pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373 | Back alignment and structure |
|
| >pdb|2ZMD|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain T686a Mutant In Complex With Sp600125 Inhibitor Length = 390 | Back alignment and structure |
|
| >pdb|4EUU|A Chain A, Structure Of Bx-795 Complexed With Human Tbk1 Kinase Domain Phosphorylated On Ser172 Length = 319 | Back alignment and structure |
|
| >pdb|4EUT|A Chain A, Structure Of Bx-795 Complexed With Unphosphorylated Human Tbk1 Kinase- Uld Domain Length = 396 | Back alignment and structure |
|
| >pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As Potent, Highly Selective And Orally Bioavailable Pim Kinases Inhibitors Length = 294 | Back alignment and structure |
|
| >pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342 | Back alignment and structure |
|
| >pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target Of Aberrant Somatic Hypermutations In Diffuse Large Cell Lymphoma Length = 293 | Back alignment and structure |
|
| >pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350 | Back alignment and structure |
|
| >pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277 | Back alignment and structure |
|
| >pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316 | Back alignment and structure |
|
| >pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317 | Back alignment and structure |
|
| >pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300 | Back alignment and structure |
|
| >pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As Potent Pim-1 Inhibitors Length = 299 | Back alignment and structure |
|
| >pdb|3C4E|A Chain A, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7- Azaindole Length = 273 | Back alignment and structure |
|
| >pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300 | Back alignment and structure |
|
| >pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362 | Back alignment and structure |
|
| >pdb|4DTK|A Chain A, Novel And Selective Pan-Pim Kinase Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3A99|A Chain A, Structure Of Pim-1 Kinase Crystallized In The Presence Of P27kip1 Carboxy-Terminal Peptide Length = 320 | Back alignment and structure |
|
| >pdb|2XIX|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-1 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350 | Back alignment and structure |
|
| >pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|4A7C|A Chain A, Crystal Structure Of Pim1 Kinase With Etp46546 Length = 308 | Back alignment and structure |
|
| >pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313 | Back alignment and structure |
|
| >pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350 | Back alignment and structure |
|
| >pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351 | Back alignment and structure |
|
| >pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350 | Back alignment and structure |
|
| >pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350 | Back alignment and structure |
|
| >pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350 | Back alignment and structure |
|
| >pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350 | Back alignment and structure |
|
| >pdb|1TKI|A Chain A, Autoinhibited Serine Kinase Domain Of The Giant Muscle Protein Titin Length = 321 | Back alignment and structure |
|
| >pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351 | Back alignment and structure |
|
| >pdb|2OBJ|A Chain A, Crystal Structure Of Human Pim-1 Kinase In Complex With Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3DCV|A Chain A, Crystal Structure Of Human Pim1 Kinase Complexed With 4-(4- Hydroxy-3-Methyl-Phenyl)-6-Phenylpyrimidin-2(1h)-One Length = 328 | Back alignment and structure |
|
| >pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313 | Back alignment and structure |
|
| >pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336 | Back alignment and structure |
|
| >pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350 | Back alignment and structure |
|
| >pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351 | Back alignment and structure |
|
| >pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351 | Back alignment and structure |
|
| >pdb|1NA7|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 Length = 329 | Back alignment and structure |
|
| >pdb|4AS0|A Chain A, Cyclometalated Phthalimides As Protein Kinase Inhibitors Length = 273 | Back alignment and structure |
|
| >pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313 | Back alignment and structure |
|
| >pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361 | Back alignment and structure |
|
| >pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Naphtho-Difuran Ligand Length = 313 | Back alignment and structure |
|
| >pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And The Jnk Inhibitor V Length = 314 | Back alignment and structure |
|
| >pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312 | Back alignment and structure |
|
| >pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350 | Back alignment and structure |
|
| >pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261 Length = 313 | Back alignment and structure |
|
| >pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314 | Back alignment and structure |
|
| >pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350 | Back alignment and structure |
|
| >pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351 | Back alignment and structure |
|
| >pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351 | Back alignment and structure |
|
| >pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350 | Back alignment and structure |
|
| >pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351 | Back alignment and structure |
|
| >pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576 | Back alignment and structure |
|
| >pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351 | Back alignment and structure |
|
| >pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576 | Back alignment and structure |
|
| >pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371 | Back alignment and structure |
|
| >pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351 | Back alignment and structure |
|
| >pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351 | Back alignment and structure |
|
| >pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312 | Back alignment and structure |
|
| >pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350 | Back alignment and structure |
|
| >pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318 | Back alignment and structure |
|
| >pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351 | Back alignment and structure |
|
| >pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351 | Back alignment and structure |
|
| >pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362 | Back alignment and structure |
|
| >pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362 | Back alignment and structure |
|
| >pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361 | Back alignment and structure |
|
| >pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST
Original result of RPS-BLAST against PDB70 database
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 384 bits (990), Expect = e-129
Identities = 98/308 (31%), Positives = 151/308 (49%), Gaps = 30/308 (9%)
Query: 417 ENEDQNI-DLELPLFELATIANATDNFS------INNKLGEGGFGPVYKGTLVDGQEIAV 469
EN+ + D F + N T+NF NK+GEGGFG VYKG + + +AV
Sbjct: 1 ENKSLEVSDTRFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAV 59
Query: 470 KRLSKI----SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMPNKSLDS 525
K+L+ + +E+ ++ E+ + +K QH NLV+LLG G++ L+Y +MPN SL
Sbjct: 60 KKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLD 119
Query: 526 FIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISD 585
+ L W R I G A G+ +LH++ IHRD+K++N+LLD+ KISD
Sbjct: 120 RLSCLDGTPPLSWHMRCKIAQGAANGINFLHENH---HIHRDIKSANILLDEAFTAKISD 176
Query: 586 FGLVRTFGGDETEGNTNRVVGTY--------DGQFSIKSDVFSFGILLLEIVSGKKNRGF 637
FGL R T+R+VGT G+ + KSD++SFG++LLEI++G
Sbjct: 177 FGLARASEKFAQTVMTSRIVGTTAYMAPEALRGEITPKSDIYSFGVVLLEIITGLPAVDE 236
Query: 638 YRSDTKVNLIGHLW----DEGIPLRLIDACIQDSCNLADVIRCIHIGLLCVQQHPEDRPC 693
+R L+ +E ID + D + V + C+ + RP
Sbjct: 237 HREP--QLLLDIKEEIEDEEKTIEDYIDKKMND-ADSTSVEAMYSVASQCLHEKKNKRPD 293
Query: 694 MPSVILML 701
+ V +L
Sbjct: 294 IKKVQQLL 301
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326 | Back alignment and structure |
|---|
Score = 362 bits (931), Expect = e-120
Identities = 112/294 (38%), Positives = 163/294 (55%), Gaps = 17/294 (5%)
Query: 430 FELATIANATDNFSINNKLGEGGFGPVYKGTLVDGQEIAVKRLSKISEQGLK-ELKNEVI 488
F L + A+DNFS N LG GGFG VYKG L DG +AVKRL + QG + + + EV
Sbjct: 20 FSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGELQFQTEVE 79
Query: 489 LFSKLQHRNLVKLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQTR-RTLLDWSQRFHIICG 547
+ S HRNL++L G C+ E+LL+Y +M N S+ S + ++ + LDW +R I G
Sbjct: 80 MISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALG 139
Query: 548 TARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNTNRVVGT 607
+ARGL YLH +IIHRD+KA+N+LLD++ + DFGL + +T T V GT
Sbjct: 140 SARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTT-AVRGT 198
Query: 608 Y---------DGQFSIKSDVFSFGILLLEIVSGKKNRGFYRS--DTKVNLIGHLW---DE 653
G+ S K+DVF +G++LLE+++G++ R D V L+ + E
Sbjct: 199 IGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKE 258
Query: 654 GIPLRLIDACIQDSCNLADVIRCIHIGLLCVQQHPEDRPCMPSVILMLGSEILL 707
L+D +Q + +V + I + LLC Q P +RP M V+ ML + L
Sbjct: 259 KKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEGDGLA 312
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 331 bits (851), Expect = e-108
Identities = 101/312 (32%), Positives = 160/312 (51%), Gaps = 22/312 (7%)
Query: 408 TENSRETDQENEDQNIDLELPL----FELATIANATDNFSINNKLGEGGFGPVYKGTLVD 463
++ S+ T+ N+ + +P L + AT+NF +G G FG VYKG L D
Sbjct: 3 SKYSKATNSINDALSSSYLVPFESYRVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRD 62
Query: 464 GQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMPNKSL 523
G ++A+KR + S QG++E + E+ S +H +LV L+G C + E +LIY++M N +L
Sbjct: 63 GAKVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDERNEMILIYKYMENGNL 122
Query: 524 DSFIFDQTRRTL-LDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPK 582
++ T+ + W QR I G ARGL YLH + IIHRD+K+ N+LLD++ PK
Sbjct: 123 KRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTRA---IIHRDVKSINILLDENFVPK 179
Query: 583 ISDFGLVRTF-GGDETEGNTNRVVGTY---------DGQFSIKSDVFSFGILLLEIVSGK 632
I+DFG+ + D+T +T V GT G+ + KSDV+SFG++L E++ +
Sbjct: 180 ITDFGISKKGTELDQTHLST-VVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCAR 238
Query: 633 KNRGFYRSDTKVNLI---GHLWDEGIPLRLIDACIQDSCNLADVIRCIHIGLLCVQQHPE 689
VNL + G +++D + D + + + C+ E
Sbjct: 239 SAIVQSLPREMVNLAEWAVESHNNGQLEQIVDPNLADKIRPESLRKFGDTAVKCLALSSE 298
Query: 690 DRPCMPSVILML 701
DRP M V+ L
Sbjct: 299 DRPSMGDVLWKL 310
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 266 bits (683), Expect = 2e-83
Identities = 64/320 (20%), Positives = 120/320 (37%), Gaps = 43/320 (13%)
Query: 416 QENEDQNIDLELPLFELATIANATDNFSINNKLGEGGFGPVYKGTLVDGQEIAVKRLSKI 475
+ + ++L L + + G FG V+K + + +AVK
Sbjct: 3 HHHHHHSSGVDLGTENLYF---QSMPLQLLEVKARGRFGCVWKAQ-LLNEYVAVKIFPIQ 58
Query: 476 SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGE----EKLLIYEFMPNKSLDSFIFDQT 531
+Q + + EV ++H N+++ +G +G + LI F SL F+
Sbjct: 59 DKQS-WQNEYEVYSLPGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFL---- 113
Query: 532 RRTLLDWSQRFHIICGTARGLLYLHQD-------SRLRIIHRDLKASNVLLDQDMNPKIS 584
+ ++ W++ HI ARGL YLH+D + I HRD+K+ NVLL ++ I+
Sbjct: 114 KANVVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIA 173
Query: 585 DFGLVRTFGGDETEGNTNRVVGTY--------------DGQFSIKSDVFSFGILLLEIVS 630
DFGL F ++ G+T+ VGT ++ D+++ G++L E+ S
Sbjct: 174 DFGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELAS 233
Query: 631 GKKNRGFYRSDTKVNLIGHLWDEGIPLRLIDA--------CIQDSCNLADVIRCI-HIGL 681
+ + + + + ++D + +
Sbjct: 234 RCTAADGPVDEYMLPFEEEIGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIE 293
Query: 682 LCVQQHPEDRPCMPSVILML 701
C E R V +
Sbjct: 294 ECWDHDAEARLSAGCVGERI 313
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 223 bits (571), Expect = 4e-67
Identities = 68/324 (20%), Positives = 111/324 (34%), Gaps = 58/324 (17%)
Query: 438 ATDNFSINNKLGEGGFGPVYKGTLVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRN 497
DN + +G G +G VYKG+L D + +AVK S + Q K + ++H N
Sbjct: 11 DLDNLKLLELIGRGRYGAVYKGSL-DERPVAVKVFSFANRQNFINEK-NIYRVPLMEHDN 68
Query: 498 LVKLLGCCIQGE-----EKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGL 552
+ + + + E LL+ E+ PN SL ++ T DW + RGL
Sbjct: 69 IARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLSLHT----SDWVSSCRLAHSVTRGL 124
Query: 553 LYLHQD------SRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGG------DETEGN 600
YLH + + I HRDL + NVL+ D ISDFGL G E +
Sbjct: 125 AYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNRLVRPGEEDNA 184
Query: 601 TNRVVGTY----------------DGQFSIKSDVFSFGILLLEIVSGKKNRGFYRSDTKV 644
VGT + D+++ G++ EI + S +
Sbjct: 185 AISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGESVPEY 244
Query: 645 NLIGHLWDEGIP-------------LRLIDACIQDSCNLADVIRCIHIGLL--CVQQHPE 689
+ P R ++ + + C Q E
Sbjct: 245 QMAFQTEVGNHPTFEDMQVLVSREKQRPK---FPEAWKENSLAVRSLKETIEDCWDQDAE 301
Query: 690 DRPCMPSVILMLGSEILLPQPKQP 713
R + +E+++ +
Sbjct: 302 ARLTAQXAEERM-AELMMIWERNK 324
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 202 bits (515), Expect = 3e-59
Identities = 75/314 (23%), Positives = 133/314 (42%), Gaps = 45/314 (14%)
Query: 401 RRNIAEKTENSRETDQENEDQNIDLELPLFELATIANATDNFSINNKLGEGGFGPVYKGT 460
+I + + +D +I +L +I K+G G FG V++
Sbjct: 12 DYDIPTTENLYFQGAMDGDDMDIPWC----DL----------NIKEKIGAGSFGTVHRAE 57
Query: 461 LVDGQEIAVKRL--SKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFM 518
G ++AVK L + + E EV + +L+H N+V +G Q ++ E++
Sbjct: 58 W-HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNLSIVTEYL 116
Query: 519 PNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQD 578
SL + R LD +R + A+G+ YLH I+HR+LK+ N+L+D+
Sbjct: 117 SRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHN-RNPPIVHRNLKSPNLLVDKK 175
Query: 579 MNPKISDFGLVRTFGGDETEGNTNRVVGTY---------DGQFSIKSDVFSFGILLLEIV 629
K+ DFGL R T ++ GT D + KSDV+SFG++L E+
Sbjct: 176 YTVKVCDFGLSRLK--ASTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELA 233
Query: 630 SGKKNRGFYRSDTKVNLIGHLWDEGIPLRLIDACIQDSCN--LADVIRCIHIGLLCVQQH 687
+ ++ + + ++ + + RL I + N +A +I C
Sbjct: 234 TLQQ---PWGNLNPAQVVAAVGFKC--KRLE---IPRNLNPQVAAIIE------GCWTNE 279
Query: 688 PEDRPCMPSVILML 701
P RP +++ +L
Sbjct: 280 PWKRPSFATIMDLL 293
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 196 bits (500), Expect = 4e-57
Identities = 77/319 (24%), Positives = 116/319 (36%), Gaps = 47/319 (14%)
Query: 440 DNFSINNKLGEGGFGPVYKGTL-VDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNL 498
+ LG+G FG K T G+ + +K L + E+ + EV + L+H N+
Sbjct: 10 SDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNV 69
Query: 499 VKLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQD 558
+K +G + + I E++ +L I + WSQR A G+ YLH
Sbjct: 70 LKFIGVLYKDKRLNFITEYIKGGTLRGIIKSMDSQ--YPWSQRVSFAKDIASGMAYLHS- 126
Query: 559 SRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNTNR------------VVG 606
+ IIHRDL + N L+ ++ N ++DFGL R ++T+ R VVG
Sbjct: 127 --MNIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVG 184
Query: 607 TY---------DGQFSIKSDVFSFGILLLEIVSGKKNRGFYRSDTKVNLIGHLWDEGIPL 657
+ K DVFSFGI+L EI+ Y T G L
Sbjct: 185 NPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMD--FGLNVRGF--L 240
Query: 658 RLIDACIQDSC--NLADVIRCIHIGLLCVQQHPEDRPCMPSVILMLGS-----EILLPQP 710
+C + + + C PE RP + L + LP
Sbjct: 241 DR---YCPPNCPPSFFPIT------VRCCDLDPEKRPSFVKLEHWLETLRMHLAGHLPLG 291
Query: 711 KQPGYLADRKSTEPYSSSS 729
Q L S
Sbjct: 292 PQLEQLDRGFWETYRRGES 310
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 193 bits (492), Expect = 5e-56
Identities = 67/292 (22%), Positives = 114/292 (39%), Gaps = 41/292 (14%)
Query: 440 DNFSINNKLGEGGFGPVYKGTLVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLV 499
+ +G G FG V K +++A+K++ SE K E+ S++ H N+V
Sbjct: 8 KEIEVEEVVGRGAFGVVCKAKW-RAKDVAIKQI--ESESERKAFIVELRQLSRVNHPNIV 64
Query: 500 KLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDS 559
KL G C+ L+ E+ SL + + + ++G+ YLH
Sbjct: 65 KLYGACLN--PVCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQ 122
Query: 560 RLRIIHRDLKASNVLLDQDMN-PKISDFGLVRTFGGDETEGNTNRVVGTY---------D 609
+IHRDLK N+LL KI DFG + + + G+
Sbjct: 123 PKALIHRDLKPPNLLLVAGGTVLKICDFGTAC-----DIQTHMTNNKGSAAWMAPEVFEG 177
Query: 610 GQFSIKSDVFSFGILLLEIVSGKK-NRGFYRSDTKVNLIGHLWDEGIPLRLIDACIQDSC 668
+S K DVFS+GI+L E+++ +K ++ H G LI +
Sbjct: 178 SNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRIMWAVH---NGTRPPLIKNLPKP-- 232
Query: 669 NLADVIRCIHIGLLCVQQHPEDRPCMPSVILML--------GSEILLPQPKQ 712
+ ++ C + P RP M ++ ++ G++ L P Q
Sbjct: 233 -IESLMTR------CWSKDPSQRPSMEEIVKIMTHLMRYFPGADEPLQYPCQ 277
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 190 bits (484), Expect = 3e-55
Identities = 74/290 (25%), Positives = 131/290 (45%), Gaps = 52/290 (17%)
Query: 440 DNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKISEQG-------LKELKNEVILFS 491
+ ++G+GGFG V+KG LV D +A+K L +G +E + EV + S
Sbjct: 19 NEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMS 78
Query: 492 KLQHRNLVKLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARG 551
L H N+VKL G ++ EF+P L + D+ + WS + ++ A G
Sbjct: 79 NLNHPNIVKLYGLMHNP--PRMVMEFVPCGDLYHRLLDKAHP--IKWSVKLRLMLDIALG 134
Query: 552 LLYLHQDSRLRIIHRDLKASNVLLDQ-----DMNPKISDFGLVRTFGGDETEGNTNRVVG 606
+ Y+ I+HRDL++ N+ L + K++DFGL + ++ + + ++G
Sbjct: 135 IEYMQN-QNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQ-----QSVHSVSGLLG 188
Query: 607 TY-----------DGQFSIKSDVFSFGILLLEIVSGKKNRGFYR--SDTKVNLIGHLWDE 653
+ + ++ K+D +SF ++L I++G+ + S K+ I + +E
Sbjct: 189 NFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEG---PFDEYSYGKIKFINMIREE 245
Query: 654 GIPLRLIDACIQDSCN--LADVIRCIHIGLLCVQQHPEDRPCMPSVILML 701
G LR I + C L +VI LC P+ RP ++ L
Sbjct: 246 G--LRPT---IPEDCPPRLRNVIE------LCWSGDPKKRPHFSYIVKEL 284
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 188 bits (479), Expect = 1e-54
Identities = 73/281 (25%), Positives = 121/281 (43%), Gaps = 46/281 (16%)
Query: 444 INNKLGEGGFGPVYKGTLVDGQEIAVKRLSKISEQ----GLKELKNEVILFSKLQHRNLV 499
+ +G GGFG VY+ G E+AVK ++ ++ ++ E LF+ L+H N++
Sbjct: 11 LEEIIGIGGFGKVYRAFW-IGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNII 69
Query: 500 KLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDS 559
L G C++ L+ EF L+ + + + ARG+ YLH ++
Sbjct: 70 ALRGVCLKEPNLCLVMEFARGGPLNRVL----SGKRIPPDILVNWAVQIARGMNYLHDEA 125
Query: 560 RLRIIHRDLKASNVLLDQDMNP--------KISDFGLVRTFGGDETEGNTNRVVGTY--- 608
+ IIHRDLK+SN+L+ Q + KI+DFGL R + G Y
Sbjct: 126 IVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWHRTTKMSAA----GAYAWM 181
Query: 609 ------DGQFSIKSDVFSFGILLLEIVSGKKNRGFYRSDTKVNLIGHLWDEGIPLRLIDA 662
FS SDV+S+G+LL E+++G+ +R + + + L L
Sbjct: 182 APEVIRASMFSKGSDVWSYGVLLWELLTGEV---PFRGIDGLAVAYGVAMNK--LALP-- 234
Query: 663 CIQDSCN--LADVIRCIHIGLLCVQQHPEDRPCMPSVILML 701
I +C A ++ C P RP +++ L
Sbjct: 235 -IPSTCPEPFAKLME------DCWNPDPHSRPSFTNILDQL 268
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 187 bits (477), Expect = 2e-54
Identities = 59/280 (21%), Positives = 111/280 (39%), Gaps = 42/280 (15%)
Query: 440 DNFSINNKLGEGGFGPVYKGTLVDGQEIAVKRL--SKISEQGLKELKNEVILFSKLQHRN 497
+ KL E G ++KG G +I VK L S + ++ E H N
Sbjct: 10 KQLNFLTKLNENHSGELWKGRW-QGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPN 68
Query: 498 LVKLLGCCIQGEEKLL--IYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYL 555
++ +LG C I +MP SL + + + T + D SQ ARG+ +L
Sbjct: 69 VLPVLGACQSPPAPHPTLITHWMPYGSLYNVLHEGTNFVV-DQSQAVKFALDMARGMAFL 127
Query: 556 HQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNTNRVVGTY------- 608
H L I L + +V++D+DM +IS + +F + +
Sbjct: 128 HTLEPL-IPRHALNSRSVMIDEDMTARISMADVKFSF-------QSPGRMYAPAWVAPEA 179
Query: 609 -----DGQFSIKSDVFSFGILLLEIVSGKKNRGFYRSDTKVNLIGHLWDEGIPLRLIDAC 663
+ +D++SF +LL E+V+ + + + + + + EG LR
Sbjct: 180 LQKKPEDTNRRSADMWSFAVLLWELVTREV---PFADLSNMEIGMKVALEG--LRPT--- 231
Query: 664 IQDSCN--LADVIRCIHIGLLCVQQHPEDRPCMPSVILML 701
I + ++ +++ +C+ + P RP ++ +L
Sbjct: 232 IPPGISPHVSKLMK------ICMNEDPAKRPKFDMIVPIL 265
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 186 bits (475), Expect = 6e-54
Identities = 69/278 (24%), Positives = 126/278 (45%), Gaps = 34/278 (12%)
Query: 440 DNFSINNKLGEGGFGPVYKGTLVDGQEIAVKRL--SKISEQGLKELKNEVILFSKLQHRN 497
++ ++G G FG VYKG ++AVK L + + Q L+ KNEV + K +H N
Sbjct: 24 GQITVGQRIGSGSFGTVYKGKW--HGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVN 81
Query: 498 LVKLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQ 557
++ +G + ++ ++ SL + T + + I TARG+ YLH
Sbjct: 82 ILLFMGYSTA-PQLAIVTQWCEGSSLYHHL--HASETKFEMKKLIDIARQTARGMDYLHA 138
Query: 558 DSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNTNRVVGTY--------- 608
IIHRDLK++N+ L +D KI DFGL ++ G+
Sbjct: 139 ---KSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIR 195
Query: 609 ---DGQFSIKSDVFSFGILLLEIVSGKKNRGFYRSDTKVNLIGHLWDEGIPLRLIDACIQ 665
+S +SDV++FGI+L E+++G+ Y + + I + G L + ++
Sbjct: 196 MQDSNPYSFQSDVYAFGIVLYELMTGQLP---YSNINNRDQIIEMVGRGS-LSPDLSKVR 251
Query: 666 DSCN--LADVIRCIHIGLLCVQQHPEDRPCMPSVILML 701
+C + ++ C+++ ++RP P ++ +
Sbjct: 252 SNCPKRMKRLMA------ECLKKKRDERPSFPRILAEI 283
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 176 bits (447), Expect = 1e-49
Identities = 68/317 (21%), Positives = 125/317 (39%), Gaps = 61/317 (19%)
Query: 410 NSRETDQENEDQNIDLELPLFELATIANATDNFSINNKLGEGGFGPVYKGTLVDGQEIAV 469
+ +T ++ +I E +L I +G+G FG VY G E+A+
Sbjct: 17 KASQTSIFLQEWDIPFE----QL----------EIGELIGKGRFGQVYHGRW--HGEVAI 60
Query: 470 KRL--SKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMPNKSLDSFI 527
+ + + +E LK K EV+ + + +H N+V +G C+ +I ++L S +
Sbjct: 61 RLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMSPPHLAIITSLCKGRTLYSVV 120
Query: 528 FDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFG 587
+ + +LD ++ I +G+ YLH I+H+DLK+ NV D + I+DFG
Sbjct: 121 --RDAKIVLDVNKTRQIAQEIVKGMGYLHA---KGILHKDLKSKNVFYD-NGKVVITDFG 174
Query: 588 LVRTFGGDETEGNTNR---VVGTY------------------DGQFSIKSDVFSFGILLL 626
L G + ++ G FS SDVF+ G +
Sbjct: 175 LFSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWY 234
Query: 627 EIVSGKKNRGFYRSDTKVNLIGHLWDEGIPLRLIDACIQDSCN--LADVIRCIHIGLLCV 684
E+ + + +++ +I + P Q ++D++ C
Sbjct: 235 ELHAREWP---FKTQPAEAIIWQMGTGMKPN-----LSQIGMGKEISDILL------FCW 280
Query: 685 QQHPEDRPCMPSVILML 701
E+RP ++ ML
Sbjct: 281 AFEQEERPTFTKLMDML 297
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 166 bits (422), Expect = 5e-46
Identities = 62/256 (24%), Positives = 109/256 (42%), Gaps = 35/256 (13%)
Query: 407 KTENSRETDQENEDQNIDLELPLFELATIANATDNFSINNKLGEGGFGPVYKGTLVDGQE 466
E+ R+ ++++ LPL TIA + ++G+G +G V+ G G++
Sbjct: 7 PGESLRDLIEQSQSSGSGSGLPLLVQRTIA---KQIQMVKQIGKGRYGEVWMGKW-RGEK 62
Query: 467 IAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEK----LLIYEFMPNKS 522
+AVK E + E+ ++H N++ + I+G LI ++ N S
Sbjct: 63 VAVKVFFTTEEA-SWFRETEIYQTVLMRHENILGFIAADIKGTGSWTQLYLITDYHENGS 121
Query: 523 LDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLR-----IIHRDLKASNVLLDQ 577
L ++ + T LD + + GL +LH + I HRDLK+ N+L+ +
Sbjct: 122 LYDYL----KSTTLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKK 177
Query: 578 DMNPKISDFGLVRTF--GGDETEGNTNRVVGTY---------------DGQFSIKSDVFS 620
+ I+D GL F +E + N VGT Q I +D++S
Sbjct: 178 NGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYS 237
Query: 621 FGILLLEIVSGKKNRG 636
FG++L E+ + G
Sbjct: 238 FGLILWEVARRCVSGG 253
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 162 bits (412), Expect = 5e-45
Identities = 53/231 (22%), Positives = 97/231 (41%), Gaps = 39/231 (16%)
Query: 434 TIANATDNFSINNKLGEGGFGPVYKGTLVDGQEIAVKRLSKISEQGLKELKNEVILF--S 491
T+A + ++ +G+G +G V++G+ G+ +AVK S + K E L+
Sbjct: 5 TVA---RDITLLECVGKGRYGEVWRGSW-QGENVAVK---IFSSRDEKSWFRETELYNTV 57
Query: 492 KLQHRNLVKLLGCCIQGEEK----LLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICG 547
L+H N++ + + LI + SL ++ + T LD I+
Sbjct: 58 MLRHENILGFIASDMTSRHSSTQLWLITHYHEMGSLYDYL----QLTTLDTVSCLRIVLS 113
Query: 548 TARGLLYLHQDSRLR-----IIHRDLKASNVLLDQDMNPKISDFGLVR--TFGGDETEGN 600
A GL +LH + I HRDLK+ N+L+ ++ I+D GL + ++ +
Sbjct: 114 IASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVG 173
Query: 601 TNRVVGTY---------------DGQFSIKSDVFSFGILLLEIVSGKKNRG 636
N VGT + D+++FG++L E+ + G
Sbjct: 174 NNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNG 224
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 163 bits (414), Expect = 2e-44
Identities = 58/206 (28%), Positives = 91/206 (44%), Gaps = 24/206 (11%)
Query: 440 DNFSINNKLGEGGFGPVYKGTL-VDGQEIAVKRL-SKISEQGLKELKNEVILFSKLQHRN 497
++ + ++G G FG V+ G L D +AVK + + E + + H N
Sbjct: 114 EDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPN 173
Query: 498 LVKLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQ 557
+V+L+G C Q + ++ E + +F+ +T L ++ A G+ YL
Sbjct: 174 IVRLIGVCTQKQPIYIVMELVQGGDFLTFL--RTEGARLRVKTLLQMVGDAAAGMEYLES 231
Query: 558 DSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNTNRVVGT---------- 607
IHRDL A N L+ + KISDFG+ R +E +G G
Sbjct: 232 ---KCCIHRDLAARNCLVTEKNVLKISDFGMSR----EEADGVYAASGGLRQVPVKWTAP 284
Query: 608 ---YDGQFSIKSDVFSFGILLLEIVS 630
G++S +SDV+SFGILL E S
Sbjct: 285 EALNYGRYSSESDVWSFGILLWETFS 310
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 160 bits (407), Expect = 7e-44
Identities = 56/260 (21%), Positives = 102/260 (39%), Gaps = 37/260 (14%)
Query: 406 EKTENSRETDQENEDQNIDLELPLFELATIANATDNFSINNKLGEGGFGPVYKGTLVDGQ 465
+ ++ + LPL TIA + +G+G FG V++G G+
Sbjct: 11 SEGTTLKDLIYDMTTSGSGSGLPLLVQRTIA---RTIVLQESIGKGRFGEVWRGKW-RGE 66
Query: 466 EIAVKRLSKISEQG-LKELKNEVILFSKLQHRNLVKLLGCCIQGEEK----LLIYEFMPN 520
E+AVK S E+ +E E+ L+H N++ + + L+ ++ +
Sbjct: 67 EVAVKIFSSREERSWFREA--EIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSDYHEH 124
Query: 521 KSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQD-----SRLRIIHRDLKASNVLL 575
SL ++ R + + TA GL +LH + + I HRDLK+ N+L+
Sbjct: 125 GSLFDYL----NRYTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILV 180
Query: 576 DQDMNPKISDFGLVRTF--GGDETEGNTNRVVGTY---------------DGQFSIKSDV 618
++ I+D GL D + N VGT + ++D+
Sbjct: 181 KKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADI 240
Query: 619 FSFGILLLEIVSGKKNRGFY 638
++ G++ EI G +
Sbjct: 241 YAMGLVFWEIARRCSIGGIH 260
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 154 bits (391), Expect = 4e-42
Identities = 61/223 (27%), Positives = 99/223 (44%), Gaps = 39/223 (17%)
Query: 440 DNFSINNKLGEGGFGPVYKGTLVDG------QEIAVKRLSKISEQGLKELKNEVILFSKL 493
+ + +LGEG FG V+ + +AVK L + K+ + E L + L
Sbjct: 15 RDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNL 74
Query: 494 QHRNLVKLLGCCIQGEEKLLIYEFMPNKSLDSF-------------IFDQTRRTLLDWSQ 540
QH ++VK G C G+ ++++E+M + L+ F + + L SQ
Sbjct: 75 QHEHIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQ 134
Query: 541 RFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGN 600
HI A G++YL + +HRDL N L+ ++ KI DFG+ R D +
Sbjct: 135 MLHIASQIASGMVYL---ASQHFVHRDLATRNCLVGANLLVKIGDFGMSR----DVYSTD 187
Query: 601 TNRVVGT-------------YDGQFSIKSDVFSFGILLLEIVS 630
RV G +F+ +SDV+SFG++L EI +
Sbjct: 188 YYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFT 230
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 155 bits (393), Expect = 4e-42
Identities = 61/222 (27%), Positives = 100/222 (45%), Gaps = 38/222 (17%)
Query: 440 DNFSINNKLGEGGFGPVYKGTLVDGQE------IAVKRLSKISEQGLKELKNEVILFSKL 493
+ + +LGEG FG V+ + +AVK L + SE ++ + E L + L
Sbjct: 41 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTML 100
Query: 494 QHRNLVKLLGCCIQGEEKLLIYEFMPNKSLDSF------------IFDQTRRTLLDWSQR 541
QH+++V+ G C +G L+++E+M + L+ F + L Q
Sbjct: 101 QHQHIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQL 160
Query: 542 FHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNT 601
+ A G++YL + L +HRDL N L+ Q + KI DFG+ R D +
Sbjct: 161 LAVASQVAAGMVYL---AGLHFVHRDLATRNCLVGQGLVVKIGDFGMSR----DIYSTDY 213
Query: 602 NRVVGT-------------YDGQFSIKSDVFSFGILLLEIVS 630
RV G +F+ +SDV+SFG++L EI +
Sbjct: 214 YRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFT 255
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 153 bits (388), Expect = 4e-42
Identities = 56/203 (27%), Positives = 94/203 (46%), Gaps = 22/203 (10%)
Query: 440 DNFSINNKLGEGGFGPVYKGTLVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLV 499
+ ++G G FG V+ G ++ ++A+K + + ++ E + KL H LV
Sbjct: 8 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTI-REGAMSEEDFIEEAEVMMKLSHPKLV 66
Query: 500 KLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDS 559
+L G C++ L+ EFM + L ++ +T+R L + G+ YL
Sbjct: 67 QLYGVCLEQAPICLVTEFMEHGCLSDYL--RTQRGLFAAETLLGMCLDVCEGMAYL---E 121
Query: 560 RLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNTNRVVGT------------ 607
+IHRDL A N L+ ++ K+SDFG+ R D+ GT
Sbjct: 122 EACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYT----SSTGTKFPVKWASPEVF 177
Query: 608 YDGQFSIKSDVFSFGILLLEIVS 630
++S KSDV+SFG+L+ E+ S
Sbjct: 178 SFSRYSSKSDVWSFGVLMWEVFS 200
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 152 bits (387), Expect = 7e-42
Identities = 60/203 (29%), Positives = 95/203 (46%), Gaps = 22/203 (10%)
Query: 440 DNFSINNKLGEGGFGPVYKGTLVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLV 499
+ ++ +LG G FG V G ++AVK + K E E KL H LV
Sbjct: 8 EEITLLKELGSGQFGVVKLGKWKGQYDVAVKMI-KEGSMSEDEFFQEAQTMMKLSHPKLV 66
Query: 500 KLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDS 559
K G C + ++ E++ N L +++ ++ L+ SQ + G+ +L
Sbjct: 67 KFYGVCSKEYPIYIVTEYISNGCLLNYL--RSHGKGLEPSQLLEMCYDVCEGMAFL---E 121
Query: 560 RLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNTNRVVGT------------ 607
+ IHRDL A N L+D+D+ K+SDFG+ R D+ VGT
Sbjct: 122 SHQFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQYV----SSVGTKFPVKWSAPEVF 177
Query: 608 YDGQFSIKSDVFSFGILLLEIVS 630
+ ++S KSDV++FGIL+ E+ S
Sbjct: 178 HYFKYSSKSDVWAFGILMWEVFS 200
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 152 bits (387), Expect = 9e-42
Identities = 57/203 (28%), Positives = 87/203 (42%), Gaps = 22/203 (10%)
Query: 440 DNFSINNKLGEGGFGPVYKGTLVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLV 499
+ + +LG G FG V G ++A+K + K E E + L H LV
Sbjct: 24 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMI-KEGSMSEDEFIEEAKVMMNLSHEKLV 82
Query: 500 KLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDS 559
+L G C + +I E+M N L +++ + R Q + + YL
Sbjct: 83 QLYGVCTKQRPIFIITEYMANGCLLNYL--REMRHRFQTQQLLEMCKDVCEAMEYL---E 137
Query: 560 RLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNTNRVVGT------------ 607
+ +HRDL A N L++ K+SDFGL R DE VG+
Sbjct: 138 SKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYT----SSVGSKFPVRWSPPEVL 193
Query: 608 YDGQFSIKSDVFSFGILLLEIVS 630
+FS KSD+++FG+L+ EI S
Sbjct: 194 MYSKFSSKSDIWAFGVLMWEIYS 216
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 152 bits (385), Expect = 2e-41
Identities = 61/205 (29%), Positives = 94/205 (45%), Gaps = 22/205 (10%)
Query: 443 SINNKLGEGGFGPVYKGTLVDG----QEIAVKRLSKI-SEQGLKELKNEVILFSKLQHRN 497
N +G G FG VY GTL+D AVK L++I + + E I+ H N
Sbjct: 28 HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPN 87
Query: 498 LVKLLGCCIQGEEKLL-IYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLH 556
++ LLG C++ E L + +M + L +FI + A+G+ YL
Sbjct: 88 VLSLLGICLRSEGSPLVVLPYMKHGDLRNFI--RNETHNPTVKDLIGFGLQVAKGMKYL- 144
Query: 557 QDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNTNRVVGT--------- 607
+ + +HRDL A N +LD+ K++DFGL R E N+
Sbjct: 145 --ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALE 202
Query: 608 --YDGQFSIKSDVFSFGILLLEIVS 630
+F+ KSDV+SFG+LL E+++
Sbjct: 203 SLQTQKFTTKSDVWSFGVLLWELMT 227
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 151 bits (384), Expect = 6e-41
Identities = 73/347 (21%), Positives = 128/347 (36%), Gaps = 86/347 (24%)
Query: 440 DNFSINNKLGEGGFGPVYKGTLV-----DGQEIAVKRLSKISEQGLKELKNEVILFSKLQ 494
+ ++LG+G FG V G +AVK+L ++ + E+ + L
Sbjct: 23 RHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALH 82
Query: 495 HRNLVKLLGCCIQGEEK--LLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGL 552
+VK G + L+ E++P+ L F+ Q R LD S+ +G+
Sbjct: 83 SDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFL--QRHRARLDASRLLLYSSQICKGM 140
Query: 553 LYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNTNRVVGTY---- 608
YL R +HRDL A N+L++ + + KI+DFGL + D+ Y
Sbjct: 141 EYLGS---RRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDY---------YVVRE 188
Query: 609 ---------------DGQFSIKSDVFSFGILLLEIVS-GKKNRGFYRSDTKVNLIGHLWD 652
D FS +SDV+SFG++L E+ + K+
Sbjct: 189 PGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKS----------------CS 232
Query: 653 EGIPLRLIDACIQDSCNLADVIRCIHIG-----------------LLCVQQHPEDRPCMP 695
+ C +D L+ ++ + G LC P+DRP
Sbjct: 233 PSAEFLRMMGCERDVPALSRLLELLEEGQRLPAPPACPAEVHELMKLCWAPSPQDRPSFS 292
Query: 696 SVILMLGSEILLPQPKQPGYLADRKSTEPYSSSSMPESSSTNTLTIS 742
++ L + + E ++ ++ PE ++L+ S
Sbjct: 293 ALGPQLDM-----------LWSGSRGCETHAFTAHPEGKH-HSLSFS 327
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 151 bits (383), Expect = 8e-41
Identities = 57/214 (26%), Positives = 99/214 (46%), Gaps = 26/214 (12%)
Query: 440 DNFSINNKLGEGGFGPVYKGTLVDGQE------IAVKRLSKI-SEQGLKELKNEVILFSK 492
+ +++ +LG+G FG VY+G + +A+K +++ S + E NE + +
Sbjct: 25 EKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKE 84
Query: 493 LQHRNLVKLLGCCIQGEEKLLIYEFMPNKSLDSF-------IFDQTRRTLLDWSQRFHII 545
++V+LLG QG+ L+I E M L S+ + + S+ +
Sbjct: 85 FNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMA 144
Query: 546 CGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVR-TFGGDETEGNTNRV 604
A G+ YL + + +HRDL A N ++ +D KI DFG+ R + D +
Sbjct: 145 GEIADGMAYL---NANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGL 201
Query: 605 V--------GTYDGQFSIKSDVFSFGILLLEIVS 630
+ DG F+ SDV+SFG++L EI +
Sbjct: 202 LPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT 235
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 151 bits (383), Expect = 1e-40
Identities = 64/287 (22%), Positives = 113/287 (39%), Gaps = 53/287 (18%)
Query: 440 DNFSINNKLGEGGFGPVYKGTLV-----DGQEIAVKRLSKISEQGLKELKNEVILFSKLQ 494
+ +LG+G FG V G+ +AVK+L +E+ L++ + E+ + LQ
Sbjct: 41 RHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQ 100
Query: 495 HRNLVKLLGCCIQGEEK--LLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGL 552
H N+VK G C + LI E++P SL ++ Q + +D + +G+
Sbjct: 101 HDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYL--QKHKERIDHIKLLQYTSQICKGM 158
Query: 553 LYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDET--EGNTNRVV----- 605
YL R IHRDL N+L++ + KI DFGL + D+ +
Sbjct: 159 EYL---GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEYYKVKEPGESPIFWY 215
Query: 606 ---GTYDGQFSIKSDVFSFGILLLEIVSGKKNRGFYRSDTKVNLIGHLWDEGIPLRLIDA 662
+ +FS+ SDV+SFG++L E+ + + + + +IG+ + +
Sbjct: 216 APESLTESKFSVASDVWSFGVVLYELFTYIE-KSKSPPAEFMRMIGNDKQGQMIVF---- 270
Query: 663 CIQDSCNLADVIRCIHIG-----------------LLCVQQHPEDRP 692
+I + C + RP
Sbjct: 271 ---------HLIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRP 308
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 150 bits (380), Expect = 1e-40
Identities = 65/298 (21%), Positives = 115/298 (38%), Gaps = 57/298 (19%)
Query: 440 DNFSINNKLGEGGFGPVYKGTLV-----DGQEIAVKRLSKISEQGLKELKNEVILFSKLQ 494
+ +LG+G FG V G+ +AVK+L +E+ L++ + E+ + LQ
Sbjct: 10 RHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQ 69
Query: 495 HRNLVKLLGCCIQGEEK--LLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGL 552
H N+VK G C + LI E++P SL ++ Q + +D + +G+
Sbjct: 70 HDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYL--QKHKERIDHIKLLQYTSQICKGM 127
Query: 553 LYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNTNRVVGT----- 607
YL R IHRDL N+L++ + KI DFGL + D+
Sbjct: 128 EYL---GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEFFKVKE--PGESPIF 182
Query: 608 -------YDGQFSIKSDVFSFGILLLEIVSGKKNRGFYRSDTKVNLIGHLWDEGIPLRLI 660
+ +FS+ SDV+SFG++L E+ + + + + +IG+ + +
Sbjct: 183 WYAPESLTESKFSVASDVWSFGVVLYELFTYIE-KSKSPPAEFMRMIGNDKQGQMIVF-- 239
Query: 661 DACIQDSCNLADVIRCIHIG-----------------LLCVQQHPEDRPCMPSVILML 701
+I + C + RP + L +
Sbjct: 240 -----------HLIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRV 286
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 149 bits (379), Expect = 2e-40
Identities = 57/204 (27%), Positives = 93/204 (45%), Gaps = 22/204 (10%)
Query: 444 INNKLGEGGFGPVYKGTLVDGQE----IAVKRLSKI-SEQGLKELKNEVILFSKLQHRNL 498
+ +G+G FG VY G +D + A+K LS+I Q ++ E +L L H N+
Sbjct: 25 SDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNV 84
Query: 499 VKLLGCCIQGEE-KLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQ 557
+ L+G + E ++ +M + L FI ++ + ARG+ YL
Sbjct: 85 LALIGIMLPPEGLPHVLLPYMCHGDLLQFI--RSPQRNPTVKDLISFGLQVARGMEYL-- 140
Query: 558 DSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNTNRVVGT---------- 607
+ + +HRDL A N +LD+ K++DFGL R E
Sbjct: 141 -AEQKFVHRDLAARNCMLDESFTVKVADFGLARDILDREYYSVQQHRHARLPVKWTALES 199
Query: 608 -YDGQFSIKSDVFSFGILLLEIVS 630
+F+ KSDV+SFG+LL E+++
Sbjct: 200 LQTYRFTTKSDVWSFGVLLWELLT 223
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 150 bits (381), Expect = 2e-40
Identities = 59/207 (28%), Positives = 100/207 (48%), Gaps = 22/207 (10%)
Query: 440 DNFSINNKLGEGGFGPVYKGTLV--DGQEI--AVKRL-SKISEQGLKELKNEVILFSKLQ 494
I +G G G V G L +++ A+K L + +E+ ++ +E + +
Sbjct: 49 SRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFD 108
Query: 495 HRNLVKLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLY 554
H N+++L G +G +++ E+M N SLD+F+ +T Q ++ G G+ Y
Sbjct: 109 HPNIIRLEGVVTRGRLAMIVTEYMENGSLDTFL--RTHDGQFTIMQLVGMLRGVGAGMRY 166
Query: 555 LHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNTNRVVGT------- 607
L S L +HRDL A NVL+D ++ K+SDFGL R D+ + G
Sbjct: 167 L---SDLGYVHRDLAARNVLVDSNLVCKVSDFGLSRVL-EDDPDAAYTTTGGKIPIRWTA 222
Query: 608 ----YDGQFSIKSDVFSFGILLLEIVS 630
FS SDV+SFG+++ E+++
Sbjct: 223 PEAIAFRTFSSASDVWSFGVVMWEVLA 249
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 150 bits (381), Expect = 2e-40
Identities = 61/217 (28%), Positives = 102/217 (47%), Gaps = 36/217 (16%)
Query: 440 DNFSINNKLGEGGFGPVYKGTLVDGQE-----IAVKRLSK-ISEQGLKELKNEVILFSKL 493
F LG G FG VYKG + E +A+K L + S + KE+ +E + + +
Sbjct: 15 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 74
Query: 494 QHRNLVKLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQ----TRRTLLDWSQRFHIICGTA 549
+ ++ +LLG C+ LI + MP L ++ + + LL+W A
Sbjct: 75 DNPHVCRLLGICLT-STVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCV------QIA 127
Query: 550 RGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNTNRVVGT-- 607
+G+ YL R++HRDL A NVL+ + KI+DFGL + G +E E + G
Sbjct: 128 KGMNYL---EDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAE---GGKV 181
Query: 608 ----------YDGQFSIKSDVFSFGILLLEIVS-GKK 633
++ +SDV+S+G+ + E+++ G K
Sbjct: 182 PIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSK 218
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 151 bits (383), Expect = 2e-40
Identities = 60/205 (29%), Positives = 95/205 (46%), Gaps = 22/205 (10%)
Query: 443 SINNKLGEGGFGPVYKGTLVDG----QEIAVKRLSKI-SEQGLKELKNEVILFSKLQHRN 497
N +G G FG VY GTL+D AVK L++I + + E I+ H N
Sbjct: 92 HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPN 151
Query: 498 LVKLLGCCIQGEEKLL-IYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLH 556
++ LLG C++ E L + +M + L +FI + A+G+ +L
Sbjct: 152 VLSLLGICLRSEGSPLVVLPYMKHGDLRNFI--RNETHNPTVKDLIGFGLQVAKGMKFL- 208
Query: 557 QDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNTNRVVGT--------- 607
+ + +HRDL A N +LD+ K++DFGL R E + N+
Sbjct: 209 --ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALE 266
Query: 608 --YDGQFSIKSDVFSFGILLLEIVS 630
+F+ KSDV+SFG+LL E+++
Sbjct: 267 SLQTQKFTTKSDVWSFGVLLWELMT 291
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 148 bits (376), Expect = 3e-40
Identities = 59/200 (29%), Positives = 93/200 (46%), Gaps = 20/200 (10%)
Query: 440 DNFSINNKLGEGGFGPVYKGTLVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLV 499
+ +G+G FG V G G ++AVK + + + E + ++L+H NLV
Sbjct: 21 KELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKNDATA--QAFLAEASVMTQLRHSNLV 77
Query: 500 KLLGCCIQGEEKLLI-YEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQD 558
+LLG ++ + L I E+M SL ++ + R++L + YL
Sbjct: 78 QLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSR-GRSVLGGDCLLKFSLDVCEAMEYL--- 133
Query: 559 SRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNTNRVV--------GTYDG 610
+HRDL A NVL+ +D K+SDFGL + + + + +
Sbjct: 134 EGNNFVHRDLAARNVLVSEDNVAKVSDFGLTK----EASSTQDTGKLPVKWTAPEALREK 189
Query: 611 QFSIKSDVFSFGILLLEIVS 630
+FS KSDV+SFGILL EI S
Sbjct: 190 KFSTKSDVWSFGILLWEIYS 209
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 148 bits (375), Expect = 4e-40
Identities = 61/204 (29%), Positives = 98/204 (48%), Gaps = 22/204 (10%)
Query: 440 DNFSINNKLGEGGFGPVYKGTLVDG-QEIAVKRLSKISEQGLKELKNEVILFSKLQHRNL 498
+ ++ +KLG G +G VY+G +AVK L K ++E E + +++H NL
Sbjct: 13 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTL-KEDTMEVEEFLKEAAVMKEIKHPNL 71
Query: 499 VKLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQD 558
V+LLG C + +I EFM +L ++ + R + ++ + + YL
Sbjct: 72 VQLLGVCTREPPFYIITEFMTYGNLLDYLREC-NRQEVSAVVLLYMATQISSAMEYL--- 127
Query: 559 SRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNTNRVVGT----------- 607
+ IHRDL A N L+ ++ K++DFGL R GD + G
Sbjct: 128 EKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHA----GAKFPIKWTAPES 183
Query: 608 -YDGQFSIKSDVFSFGILLLEIVS 630
+FSIKSDV++FG+LL EI +
Sbjct: 184 LAYNKFSIKSDVWAFGVLLWEIAT 207
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 149 bits (378), Expect = 4e-40
Identities = 62/217 (28%), Positives = 96/217 (44%), Gaps = 31/217 (14%)
Query: 440 DNFSINNKLGEGGFGPVYKGTLVDGQE---IAVKRL-SKISEQGLKELKNEVILFSKL-Q 494
++ + +GEG FG V K + A+KR+ S+ ++ E+ + KL
Sbjct: 25 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGH 84
Query: 495 HRNLVKLLGCCIQGEEKLLIYEFMPNKSLDSF-------------IFDQTRRTLLDWSQR 541
H N++ LLG C L E+ P+ +L F + + L Q
Sbjct: 85 HPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQL 144
Query: 542 FHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNT 601
H ARG+ YL S+ + IHRDL A N+L+ ++ KI+DFGL R G + T
Sbjct: 145 LHFAADVARGMDYL---SQKQFIHRDLAARNILVGENYVAKIADFGLSR--GQEVYVKKT 199
Query: 602 NRVV--------GTYDGQFSIKSDVFSFGILLLEIVS 630
+ ++ SDV+S+G+LL EIVS
Sbjct: 200 MGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 236
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 148 bits (375), Expect = 4e-40
Identities = 64/220 (29%), Positives = 103/220 (46%), Gaps = 32/220 (14%)
Query: 440 DNFSINNKLGEGGFGPVYKGTLVDG------QEIAVKRLSKI-SEQGLKELKNEVILFSK 492
+LGE FG VYKG L Q +A+K L +E ++E +L ++
Sbjct: 9 SAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRAR 68
Query: 493 LQHRNLVKLLGCCIQGEEKLLIYEFMPNKSLDSF-------------IFDQTRRTLLDWS 539
LQH N+V LLG + + +I+ + + L F D+T ++ L+
Sbjct: 69 LQHPNVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPP 128
Query: 540 QRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRT-FGGDETE 598
H++ A G+ YL S ++H+DL NVL+ +N KISD GL R + D +
Sbjct: 129 DFVHLVAQIAAGMEYL---SSHHVVHKDLATRNVLVYDKLNVKISDLGLFREVYAADYYK 185
Query: 599 GNTNRVV--------GTYDGQFSIKSDVFSFGILLLEIVS 630
N ++ G+FSI SD++S+G++L E+ S
Sbjct: 186 LLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFS 225
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 147 bits (374), Expect = 5e-40
Identities = 65/203 (32%), Positives = 94/203 (46%), Gaps = 22/203 (10%)
Query: 440 DNFSINNKLGEGGFGPVYKGTLVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLV 499
+ + +LG G FG V+ G ++AVK L K E L +LQH+ LV
Sbjct: 13 ETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSL-KQGSMSPDAFLAEANLMKQLQHQRLV 71
Query: 500 KLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDS 559
+L Q E +I E+M N SL F+ L ++ + A G+ ++
Sbjct: 72 RLYAVVTQ-EPIYIITEYMENGSLVDFL-KTPSGIKLTINKLLDMAAQIAEGMAFI---E 126
Query: 560 RLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNTNRVVGT------------ 607
IHRDL+A+N+L+ ++ KI+DFGL R +E G
Sbjct: 127 ERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYT----AREGAKFPIKWTAPEAI 182
Query: 608 YDGQFSIKSDVFSFGILLLEIVS 630
G F+IKSDV+SFGILL EIV+
Sbjct: 183 NYGTFTIKSDVWSFGILLTEIVT 205
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 148 bits (375), Expect = 8e-40
Identities = 56/214 (26%), Positives = 94/214 (43%), Gaps = 26/214 (12%)
Query: 440 DNFSINNKLGEGGFGPVYKGTLVDGQE----IAVKRLSK--ISEQGLKELKNEVILFSKL 493
+ + LGEG FG V +G L +AVK + S++ ++E +E
Sbjct: 34 NLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDF 93
Query: 494 QHRNLVKLLGCCIQGE-----EKLLIYEFMPNKSLDSFI---FDQTRRTLLDWSQRFHII 545
H N+++LLG CI+ + ++I FM L +++ +T + +
Sbjct: 94 SHPNVIRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFM 153
Query: 546 CGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVR-TFGGDETEGNTNRV 604
A G+ YL S +HRDL A N +L DM ++DFGL + + GD
Sbjct: 154 VDIALGMEYL---SNRNFLHRDLAARNCMLRDDMTVCVADFGLSKKIYSGDYYRQGRIAK 210
Query: 605 V--------GTYDGQFSIKSDVFSFGILLLEIVS 630
+ D ++ KSDV++FG+ + EI +
Sbjct: 211 MPVKWIAIESLADRVYTSKSDVWAFGVTMWEIAT 244
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 151 bits (384), Expect = 8e-40
Identities = 58/200 (29%), Positives = 94/200 (47%), Gaps = 20/200 (10%)
Query: 440 DNFSINNKLGEGGFGPVYKGTLVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLV 499
+ +G+G FG V G G ++AVK + + + E + ++L+H NLV
Sbjct: 193 KELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKNDATA--QAFLAEASVMTQLRHSNLV 249
Query: 500 KLLGCCIQGEEKL-LIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQD 558
+LLG ++ + L ++ E+M SL ++ + R++L + YL
Sbjct: 250 QLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSR-GRSVLGGDCLLKFSLDVCEAMEYL--- 305
Query: 559 SRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNTNRVV--------GTYDG 610
+HRDL A NVL+ +D K+SDFGL + + + + +
Sbjct: 306 EGNNFVHRDLAARNVLVSEDNVAKVSDFGLTK----EASSTQDTGKLPVKWTAPEALREK 361
Query: 611 QFSIKSDVFSFGILLLEIVS 630
+FS KSDV+SFGILL EI S
Sbjct: 362 KFSTKSDVWSFGILLWEIYS 381
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 148 bits (375), Expect = 9e-40
Identities = 72/309 (23%), Positives = 107/309 (34%), Gaps = 57/309 (18%)
Query: 440 DNFSINNKLGEGGFGPVYKGTL---VDGQEI--AVKRL-SKISEQGLKELKNEVILFSKL 493
LGEG FG V DG AVK L + Q K E+ + L
Sbjct: 31 RYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTL 90
Query: 494 QHRNLVKLLGCCIQGEEK--LLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARG 551
H +++K GCC L+ E++P SL ++ R + +Q G
Sbjct: 91 YHEHIIKYKGCCEDAGAASLQLVMEYVPLGSLRDYL----PRHSIGLAQLLLFAQQICEG 146
Query: 552 LLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETE--GNTNRVV---- 605
+ YLH IHRDL A NVLLD D KI DFGL + +
Sbjct: 147 MAYLHA---QHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFW 203
Query: 606 ----GTYDGQFSIKSDVFSFGILLLEIVSGKKNRGFYRSDTKVNLIGHLWDEGIPLRLID 661
+ +F SDV+SFG+ L E+++ + ++ L GI
Sbjct: 204 YAPECLKEYKFYYASDVWSFGVTLYELLT-------HCDSSQSPPTKFLELIGIA----- 251
Query: 662 ACIQDSCNLADVIRCIHIG-----------------LLCVQQHPEDRPCMPSVILMLGSE 704
Q + + + G C + RP ++I +L +
Sbjct: 252 ---QGQMTVLRLTELLERGERLPRPDKCPAEVYHLMKNCWETEASFRPTFENLIPILKTV 308
Query: 705 ILLPQPKQP 713
Q + P
Sbjct: 309 HEKYQGQAP 317
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 147 bits (373), Expect = 9e-40
Identities = 49/213 (23%), Positives = 92/213 (43%), Gaps = 29/213 (13%)
Query: 440 DNFSINNKLGEGGFGPVYKGTLVD--------GQEIAVKRLSKISEQGLKELKNEVILFS 491
++ N LG+G F ++KG + E+ +K L K + + S
Sbjct: 8 EDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMS 67
Query: 492 KLQHRNLVKLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARG 551
KL H++LV G C+ G+E +L+ EF+ SLD+++ + + ++ + + A
Sbjct: 68 KLSHKHLVLNYGVCVCGDENILVQEFVKFGSLDTYL--KKNKNCINILWKLEVAKQLAAA 125
Query: 552 LLYLHQDSRLRIIHRDLKASNVLLDQDMNP--------KISDFGLVRTFGGDETEGNTNR 603
+ +L +IH ++ A N+LL ++ + K+SD G+ T + R
Sbjct: 126 MHFL---EENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITV--LPKDILQER 180
Query: 604 V------VGTYDGQFSIKSDVFSFGILLLEIVS 630
+ ++ +D +SFG L EI S
Sbjct: 181 IPWVPPECIENPKNLNLATDKWSFGTTLWEICS 213
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 148 bits (375), Expect = 1e-39
Identities = 57/208 (27%), Positives = 99/208 (47%), Gaps = 23/208 (11%)
Query: 440 DNFSINNKLGEGGFGPVYKGTLVDGQE-----IAVKRLSK-ISEQGLKELKNEVILFSKL 493
+ +G G FG VYKG L +A+K L +E+ + E + +
Sbjct: 44 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQF 103
Query: 494 QHRNLVKLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLL 553
H N+++L G + + ++I E+M N +LD F+ + + Q ++ G A G+
Sbjct: 104 SHHNIIRLEGVISKYKPMMIITEYMENGALDKFL--REKDGEFSVLQLVGMLRGIAAGMK 161
Query: 554 YLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNTNRVVGT------ 607
YL + + +HRDL A N+L++ ++ K+SDFGL R D+ E G
Sbjct: 162 YL---ANMNYVHRDLAARNILVNSNLVCKVSDFGLSR-VLEDDPEATYTTSGGKIPIRWT 217
Query: 608 -----YDGQFSIKSDVFSFGILLLEIVS 630
+F+ SDV+SFGI++ E+++
Sbjct: 218 APEAISYRKFTSASDVWSFGIVMWEVMT 245
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 149 bits (378), Expect = 1e-39
Identities = 79/340 (23%), Positives = 133/340 (39%), Gaps = 82/340 (24%)
Query: 440 DNFSINNKLGEGGFGPVYKGTLV--DGQEI--AVKRLSK-ISEQGLKELKNEVILFSKLQ 494
N SI+ +G G FG V G L +EI A+K L +E+ ++ E + +
Sbjct: 45 TNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFD 104
Query: 495 HRNLVKLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLY 554
H N+++L G + + +++ E+M N SLDSF+ + Q ++ G A G+ Y
Sbjct: 105 HPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFL--RKHDAQFTVIQLVGMLRGIASGMKY 162
Query: 555 LHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNTNRVVGT------- 607
L S + +HRDL A N+L++ ++ K+SDFGL R D+ E G
Sbjct: 163 L---SDMGYVHRDLAARNILINSNLVCKVSDFGLGRVL-EDDPEAAYTTRGGKIPIRWTS 218
Query: 608 ----YDGQFSIKSDVFSFGILLLEIVS-------GKKNRGFYRSDTKVNLIGHLWDEGIP 656
+F+ SDV+S+GI+L E++S N+
Sbjct: 219 PEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQ--------------------- 257
Query: 657 LRLIDACIQDSCNLADVIRCIHIG-----------------LLCVQQHPEDRPCMPSVIL 699
DVI+ + G L C Q+ +RP ++
Sbjct: 258 ---------------DVIKAVDEGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVS 302
Query: 700 MLGSEILLPQPKQPGYLADRKSTEPYSSSSMPESSSTNTL 739
+L I P + A + + S + ++ T
Sbjct: 303 ILDKLIRNPGSLKIITSAAARPSNLLLDQSNVDITTFRTT 342
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 147 bits (374), Expect = 2e-39
Identities = 57/217 (26%), Positives = 94/217 (43%), Gaps = 31/217 (14%)
Query: 440 DNFSINNKLGEGGFGPVYKGTLVDG----QEIAVKRLSK--ISEQGLKELKNEVILFSKL 493
F++ LG+G FG V + L ++AVK L I+ ++E E +
Sbjct: 23 QQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEF 82
Query: 494 QHRNLVKLLGCCIQGEEK------LLIYEFMPNKSLDSFIFDQTRRTL-----LDWSQRF 542
H ++ KL+G ++ K ++I FM + L +F+ R L
Sbjct: 83 DHPHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFL--LASRIGENPFNLPLQTLV 140
Query: 543 HIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVR-TFGGDETEGNT 601
+ A G+ YL S IHRDL A N +L +DM ++DFGL R + GD
Sbjct: 141 RFMVDIACGMEYL---SSRNFIHRDLAARNCMLAEDMTVCVADFGLSRKIYSGDYYRQGC 197
Query: 602 NRVV--------GTYDGQFSIKSDVFSFGILLLEIVS 630
+ D +++ SDV++FG+ + EI++
Sbjct: 198 ASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMT 234
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 146 bits (371), Expect = 2e-39
Identities = 60/210 (28%), Positives = 94/210 (44%), Gaps = 25/210 (11%)
Query: 440 DNFSINNKLGEGGFGPVYKGTLV-----DGQEIAVKRL-SKISEQGLKELKNEVILFSKL 493
LGEG FG V G+++AVK L + + +LK E+ + L
Sbjct: 21 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNL 80
Query: 494 QHRNLVKLLGCCIQGEEK--LLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARG 551
H N+VK G C + LI EF+P+ SL ++ + ++ Q+ +G
Sbjct: 81 YHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYL--PKNKNKINLKQQLKYAVQICKG 138
Query: 552 LLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNTNRVVGT---- 607
+ YL + +HRDL A NVL++ + KI DFGL + D+ E T +
Sbjct: 139 MDYL---GSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDK-EYYTVKDDRDSPVF 194
Query: 608 -------YDGQFSIKSDVFSFGILLLEIVS 630
+F I SDV+SFG+ L E+++
Sbjct: 195 WYAPECLMQSKFYIASDVWSFGVTLHELLT 224
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 147 bits (373), Expect = 2e-39
Identities = 61/223 (27%), Positives = 100/223 (44%), Gaps = 35/223 (15%)
Query: 440 DNFSINNKLGEGGFGPVYKGTLVD--------GQEIAVKRLSKI-SEQGLKELKNEVILF 490
D ++ LGEG FG V V +AVK L +E+ L +L +E+ +
Sbjct: 35 DKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMM 94
Query: 491 SKL-QHRNLVKLLGCCIQGEEKLLIYEFMPNKSLDSF-------------IFDQTRRTLL 536
+ +H+N++ LLG C Q +I E+ +L + ++ +
Sbjct: 95 KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQM 154
Query: 537 DWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVR-TFGGD 595
+ ARG+ YL + + IHRDL A NVL+ ++ KI+DFGL R D
Sbjct: 155 TFKDLVSCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNID 211
Query: 596 ETEGNTNRVV--------GTYDGQFSIKSDVFSFGILLLEIVS 630
+ TN + +D ++ +SDV+SFG+L+ EI +
Sbjct: 212 YYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 151 bits (382), Expect = 3e-39
Identities = 59/200 (29%), Positives = 97/200 (48%), Gaps = 14/200 (7%)
Query: 440 DNFSINNKLGEGGFGPVYKGTLVD-GQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNL 498
+ ++ +KLG G +G VY+G +AVK L K ++E E + +++H NL
Sbjct: 220 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTL-KEDTMEVEEFLKEAAVMKEIKHPNL 278
Query: 499 VKLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQD 558
V+LLG C + +I EFM +L ++ + R + ++ + + YL
Sbjct: 279 VQLLGVCTREPPFYIITEFMTYGNLLDYLREC-NRQEVSAVVLLYMATQISSAMEYL--- 334
Query: 559 SRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNTNRVV--------GTYDG 610
+ IHR+L A N L+ ++ K++DFGL R GD +
Sbjct: 335 EKKNFIHRNLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYN 394
Query: 611 QFSIKSDVFSFGILLLEIVS 630
+FSIKSDV++FG+LL EI +
Sbjct: 395 KFSIKSDVWAFGVLLWEIAT 414
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 146 bits (371), Expect = 4e-39
Identities = 63/230 (27%), Positives = 101/230 (43%), Gaps = 44/230 (19%)
Query: 440 DNFSINNKLGEGGFGPVYKGTLVDG------QEIAVKRLSKI-SEQGLKELKNEVILFSK 492
N + LGEG FG V K T +AVK L + S L++L +E + +
Sbjct: 23 KNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQ 82
Query: 493 LQHRNLVKLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGT---- 548
+ H +++KL G C Q LLI E+ SL F+ + R + +
Sbjct: 83 VNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFL--RESRKVGPGYLGSGGSRNSSSLD 140
Query: 549 -------------------ARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLV 589
++G+ YL + ++++HRDL A N+L+ + KISDFGL
Sbjct: 141 HPDERALTMGDLISFAWQISQGMQYL---AEMKLVHRDLAARNILVAEGRKMKISDFGLS 197
Query: 590 R-TFGGDETEGNTNRVV--------GTYDGQFSIKSDVFSFGILLLEIVS 630
R + D + + +D ++ +SDV+SFG+LL EIV+
Sbjct: 198 RDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVT 247
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 149 bits (379), Expect = 4e-39
Identities = 63/203 (31%), Positives = 93/203 (45%), Gaps = 22/203 (10%)
Query: 440 DNFSINNKLGEGGFGPVYKGTLVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLV 499
++ + KLG G FG V+ T ++AVK + K ++ E + LQH LV
Sbjct: 188 ESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTM-KPGSMSVEAFLAEANVMKTLQHDKLV 246
Query: 500 KLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDS 559
KL + E +I EFM SL F+ + + A G+ ++
Sbjct: 247 KLHAVVTK-EPIYIITEFMAKGSLLDFLKSD-EGSKQPLPKLIDFSAQIAEGMAFI---E 301
Query: 560 RLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNTNRVVGT------------ 607
+ IHRDL+A+N+L+ + KI+DFGL R +E G
Sbjct: 302 QRNYIHRDLRAANILVSASLVCKIADFGLARVIEDNEYT----AREGAKFPIKWTAPEAI 357
Query: 608 YDGQFSIKSDVFSFGILLLEIVS 630
G F+IKSDV+SFGILL+EIV+
Sbjct: 358 NFGSFTIKSDVWSFGILLMEIVT 380
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 146 bits (371), Expect = 4e-39
Identities = 64/218 (29%), Positives = 96/218 (44%), Gaps = 34/218 (15%)
Query: 440 DNFSINNKLGEGGFGPVYKGTLVDG------QEIAVKRLSKI-SEQGLKELKNEVILFSK 492
N ++ LG G FG VY+G + ++AVK L ++ SEQ + E ++ SK
Sbjct: 30 KNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISK 89
Query: 493 LQHRNLVKLLGCCIQGEEKLLIYEFMPNKSLDSFI----FDQTRRTLLDWSQRFHIICGT 548
H+N+V+ +G +Q + ++ E M L SF+ ++ + L H+
Sbjct: 90 FNHQNIVRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDI 149
Query: 549 ARGLLYLHQDSRLRIIHRDLKASNVLLD---QDMNPKISDFGLVRTFGGDETEGNTNRVV 605
A G YL IHRD+ A N LL KI DFG+ R D + R
Sbjct: 150 ACGCQYL---EENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMAR----DIYRASYYRKG 202
Query: 606 GT-------------YDGQFSIKSDVFSFGILLLEIVS 630
G +G F+ K+D +SFG+LL EI S
Sbjct: 203 GCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 240
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 147 bits (373), Expect = 6e-39
Identities = 61/223 (27%), Positives = 100/223 (44%), Gaps = 35/223 (15%)
Query: 440 DNFSINNKLGEGGFGPVYKGTLVD--------GQEIAVKRL-SKISEQGLKELKNEVILF 490
D ++ LGEG FG V V +AVK L +E+ L +L +E+ +
Sbjct: 81 DKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMM 140
Query: 491 SKL-QHRNLVKLLGCCIQGEEKLLIYEFMPNKSLDSF-------------IFDQTRRTLL 536
+ +H+N++ LLG C Q +I E+ +L + ++ +
Sbjct: 141 KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQM 200
Query: 537 DWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVR-TFGGD 595
+ ARG+ YL + + IHRDL A NVL+ ++ KI+DFGL R D
Sbjct: 201 TFKDLVSCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNID 257
Query: 596 ETEGNTNRVV--------GTYDGQFSIKSDVFSFGILLLEIVS 630
+ TN + +D ++ +SDV+SFG+L+ EI +
Sbjct: 258 YYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 300
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 145 bits (369), Expect = 8e-39
Identities = 48/209 (22%), Positives = 92/209 (44%), Gaps = 27/209 (12%)
Query: 440 DNFSINNKLGEGGFGPVYKGTLVDGQE-----IAVKRL-SKISEQGLKELKNEVILFSKL 493
LG G FG V+KG + E + +K + K Q + + + ++ L
Sbjct: 13 TELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSL 72
Query: 494 QHRNLVKLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLL 553
H ++V+LLG C L+ +++P SL + + R L + A+G+
Sbjct: 73 DHAHIVRLLGLCPG-SSLQLVTQYLPLGSLLDHV--RQHRGALGPQLLLNWGVQIAKGMY 129
Query: 554 YLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNTNRVVGT------ 607
YL ++HR+L A NVLL +++DFG+ D+ + +
Sbjct: 130 YL---EEHGMVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYS---EAKTPIKW 183
Query: 608 ------YDGQFSIKSDVFSFGILLLEIVS 630
+ G+++ +SDV+S+G+ + E+++
Sbjct: 184 MALESIHFGKYTHQSDVWSYGVTVWELMT 212
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 145 bits (369), Expect = 1e-38
Identities = 58/228 (25%), Positives = 99/228 (43%), Gaps = 40/228 (17%)
Query: 440 DNFSINNKLGEGGFGPVYKGTLVDG------QEIAVKRLSKI-SEQGLKELKNEVILFSK 492
+N +GEG FG V++ +AVK L + S + + E L ++
Sbjct: 47 NNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAE 106
Query: 493 LQHRNLVKLLGCCIQGEEKLLIYEFMPNKSLDSF---------------------IFDQT 531
+ N+VKLLG C G+ L++E+M L+ F
Sbjct: 107 FDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSP 166
Query: 532 RRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVR- 590
L +++ I A G+ YL S + +HRDL N L+ ++M KI+DFGL R
Sbjct: 167 GPPPLSCAEQLCIARQVAAGMAYL---SERKFVHRDLATRNCLVGENMVVKIADFGLSRN 223
Query: 591 TFGGDETEGNTNRVV--------GTYDGQFSIKSDVFSFGILLLEIVS 630
+ D + + N + + +++ +SDV+++G++L EI S
Sbjct: 224 IYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFS 271
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 146 bits (370), Expect = 1e-38
Identities = 64/218 (29%), Positives = 95/218 (43%), Gaps = 34/218 (15%)
Query: 440 DNFSINNKLGEGGFGPVYKGTLVDG------QEIAVKRLSKI-SEQGLKELKNEVILFSK 492
N ++ LG G FG VY+G + ++AVK L ++ SEQ + E ++ SK
Sbjct: 71 KNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISK 130
Query: 493 LQHRNLVKLLGCCIQGEEKLLIYEFMPNKSLDSFI----FDQTRRTLLDWSQRFHIICGT 548
H+N+V+ +G +Q + ++ E M L SF+ ++ + L H+
Sbjct: 131 FNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDI 190
Query: 549 ARGLLYLHQDSRLRIIHRDLKASNVLLD---QDMNPKISDFGLVRTFGGDETEGNTNRVV 605
A G YL IHRD+ A N LL KI DFG+ R D R
Sbjct: 191 ACGCQYL---EENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMAR----DIYRAGYYRKG 243
Query: 606 GT-------------YDGQFSIKSDVFSFGILLLEIVS 630
G +G F+ K+D +SFG+LL EI S
Sbjct: 244 GCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 281
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 144 bits (365), Expect = 2e-38
Identities = 61/225 (27%), Positives = 91/225 (40%), Gaps = 39/225 (17%)
Query: 440 DNFSINNKLGEGGFGPVYKGTLVDGQE------IAVKRLSKI-SEQGLKELKNEVILFSK 492
+ S LG G FG V + T + +AVK L + L +E+ + S
Sbjct: 23 NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSY 82
Query: 493 L-QHRNLVKLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGT--- 548
L H N+V LLG C G L+I E+ L +F+ + +R S+ I
Sbjct: 83 LGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFL--RRKRDSFICSKTSPAIMEDDEL 140
Query: 549 --------------ARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVR-TFG 593
A+G+ +L + IHRDL A N+LL KI DFGL R
Sbjct: 141 ALDLEDLLSFSYQVAKGMAFL---ASKNCIHRDLAARNILLTHGRITKICDFGLARDIKN 197
Query: 594 GDETEGNTNRVV--------GTYDGQFSIKSDVFSFGILLLEIVS 630
N + ++ ++ +SDV+S+GI L E+ S
Sbjct: 198 DSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFS 242
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 144 bits (365), Expect = 3e-38
Identities = 56/209 (26%), Positives = 97/209 (46%), Gaps = 27/209 (12%)
Query: 440 DNFSINNKLGEGGFGPVYKGTLVDGQE-----IAVKRL-SKISEQGLKELKNEVILFSKL 493
F LG G FG VYKG + E +A+K L S + KE+ +E + + +
Sbjct: 15 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 74
Query: 494 QHRNLVKLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLL 553
+ ++ +LLG C+ LI + MP L ++ + + + + A+G+
Sbjct: 75 DNPHVCRLLGICLT-STVQLITQLMPFGCLLDYV--REHKDNIGSQYLLNWCVQIAKGMN 131
Query: 554 YLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNTNRVVGT------ 607
YL R++HRDL A NVL+ + KI+DFGL + G +E E + G
Sbjct: 132 YL---EDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAE---GGKVPIKW 185
Query: 608 ------YDGQFSIKSDVFSFGILLLEIVS 630
++ +SDV+S+G+ + E+++
Sbjct: 186 MALESILHRIYTHQSDVWSYGVTVWELMT 214
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 142 bits (361), Expect = 4e-38
Identities = 55/203 (27%), Positives = 92/203 (45%), Gaps = 24/203 (11%)
Query: 444 INNKLGEGGFGPVYKGTLVDGQE---IAVKRLSK-ISEQGLKELKNEVILFSKLQHRNLV 499
+ +LG G FG V +G ++ +A+K L + + +E+ E + +L + +V
Sbjct: 14 ADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIV 73
Query: 500 KLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDS 559
+L+G C Q E +L+ E L F+ +R + S ++ + G+ YL
Sbjct: 74 RLIGVC-QAEALMLVMEMAGGGPLHKFL--VGKREEIPVSNVAELLHQVSMGMKYL---E 127
Query: 560 RLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNTNRVVGT------------ 607
+HRDL A NVLL KISDFGL + G D++
Sbjct: 128 EKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTAR--SAGKWPLKWYAPECI 185
Query: 608 YDGQFSIKSDVFSFGILLLEIVS 630
+FS +SDV+S+G+ + E +S
Sbjct: 186 NFRKFSSRSDVWSYGVTMWEALS 208
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 141 bits (359), Expect = 6e-38
Identities = 51/208 (24%), Positives = 89/208 (42%), Gaps = 27/208 (12%)
Query: 440 DNFSINNKLGEGGFGPVYKGTLV--DGQEI--AVKRLSKI-SEQGLKELKNEVILFSKLQ 494
++ +N LGEG FG VY+G G++I AVK K + ++ +E ++ L
Sbjct: 12 EDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLD 71
Query: 495 HRNLVKLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLY 554
H ++VKL+G + E +I E P L ++ + + L + + Y
Sbjct: 72 HPHIVKLIGII-EEEPTWIIMELYPYGELGHYL--ERNKNSLKVLTLVLYSLQICKAMAY 128
Query: 555 LHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNTNRVVGT------- 607
L + +HRD+ N+L+ K+ DFGL R ++ + T
Sbjct: 129 L---ESINCVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYY----KASVTRLPIKWM 181
Query: 608 -----YDGQFSIKSDVFSFGILLLEIVS 630
+F+ SDV+ F + + EI+S
Sbjct: 182 SPESINFRRFTTASDVWMFAVCMWEILS 209
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 141 bits (358), Expect = 8e-38
Identities = 50/208 (24%), Positives = 85/208 (40%), Gaps = 27/208 (12%)
Query: 440 DNFSINNKLGEGGFGPVYKGTLV--DGQEI--AVKRLSK-ISEQGLKELKNEVILFSKLQ 494
+ + +GEG FG V++G + + + A+K S+ ++ E + +
Sbjct: 15 ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFD 74
Query: 495 HRNLVKLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLY 554
H ++VKL+G + +I E L SF+ Q R+ LD + + L Y
Sbjct: 75 HPHIVKLIGVITE-NPVWIIMELCTLGELRSFL--QVRKYSLDLASLILYAYQLSTALAY 131
Query: 555 LHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNTNRVVGT------- 607
L R +HRD+ A NVL+ + K+ DFGL R +
Sbjct: 132 L---ESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYY----KASKGKLPIKWM 184
Query: 608 -----YDGQFSIKSDVFSFGILLLEIVS 630
+F+ SDV+ FG+ + EI+
Sbjct: 185 APESINFRRFTSASDVWMFGVCMWEILM 212
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 143 bits (362), Expect = 9e-38
Identities = 67/221 (30%), Positives = 97/221 (43%), Gaps = 35/221 (15%)
Query: 440 DNFSINNKLGEGGFGPVYKGTLVDGQE------IAVKRL-SKISEQGLKELKNEVILFSK 492
+N LG G FG V + T + +AVK L S + L +E+ + S
Sbjct: 46 NNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSH 105
Query: 493 L-QHRNLVKLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGT--- 548
L QH N+V LLG C G L+I E+ L +F+ + + +L+ F I T
Sbjct: 106 LGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFL--RRKSRVLETDPAFAIANSTAST 163
Query: 549 ----------ARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVR-TFGGDET 597
A+G+ +L + IHRD+ A NVLL KI DFGL R
Sbjct: 164 RDLLHFSSQVAQGMAFL---ASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNY 220
Query: 598 EGNTNRVV--------GTYDGQFSIKSDVFSFGILLLEIVS 630
N + +D ++++SDV+S+GILL EI S
Sbjct: 221 IVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFS 261
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 145 bits (367), Expect = 2e-37
Identities = 60/199 (30%), Positives = 97/199 (48%), Gaps = 14/199 (7%)
Query: 440 DNFSINNKLGEGGFGPVYKGTLVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLV 499
++ + KLG+G FG V+ GT +A+K L K + E + KL+H LV
Sbjct: 184 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTL-KPGTMSPEAFLQEAQVMKKLRHEKLV 242
Query: 500 KLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDS 559
+L + E ++ E+M SL F+ + L Q + A G+ Y+
Sbjct: 243 QLYAVVSE-EPIYIVTEYMSKGSLLDFLKGE-TGKYLRLPQLVDMAAQIASGMAYV---E 297
Query: 560 RLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNTNRVV--------GTYDGQ 611
R+ +HRDL+A+N+L+ +++ K++DFGL R +E G+
Sbjct: 298 RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGR 357
Query: 612 FSIKSDVFSFGILLLEIVS 630
F+IKSDV+SFGILL E+ +
Sbjct: 358 FTIKSDVWSFGILLTELTT 376
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 143 bits (362), Expect = 2e-37
Identities = 63/223 (28%), Positives = 97/223 (43%), Gaps = 35/223 (15%)
Query: 440 DNFSINNKLGEGGFGPVYKGTLVD--------GQEIAVKRLSKI-SEQGLKELKNEVILF 490
D + LGEG FG V + ++AVK L +E+ L +L +E+ +
Sbjct: 69 DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMM 128
Query: 491 SKL-QHRNLVKLLGCCIQGEEKLLIYEFMPNKSLDSF-------------IFDQTRRTLL 536
+ +H+N++ LLG C Q +I E+ +L + L
Sbjct: 129 KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQL 188
Query: 537 DWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVR-TFGGD 595
ARG+ YL + + IHRDL A NVL+ +D KI+DFGL R D
Sbjct: 189 SSKDLVSCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHID 245
Query: 596 ETEGNTNRVV--------GTYDGQFSIKSDVFSFGILLLEIVS 630
+ TN + +D ++ +SDV+SFG+LL EI +
Sbjct: 246 YYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 288
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 141 bits (357), Expect = 2e-37
Identities = 58/222 (26%), Positives = 93/222 (41%), Gaps = 34/222 (15%)
Query: 440 DNFSINNKLGEGGFGPVYKGTLVD------GQEIAVKRL-SKISEQGLKELKNEVILFSK 492
D + LG G FG V + + +AVK L + + L +E+ +
Sbjct: 27 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIH 86
Query: 493 L-QHRNLVKLLGCCIQGEEKL-LIYEFMPNKSLDSF-------------IFDQTRRTLLD 537
+ H N+V LLG C + L +I EF +L ++ + + L
Sbjct: 87 IGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLT 146
Query: 538 WSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVR-TFGGDE 596
A+G+ +L + + IHRDL A N+LL + KI DFGL R + +
Sbjct: 147 LEHLICYSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPD 203
Query: 597 TEGNTNRVV--------GTYDGQFSIKSDVFSFGILLLEIVS 630
+ + +D ++I+SDV+SFG+LL EI S
Sbjct: 204 YVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 245
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 141 bits (358), Expect = 3e-37
Identities = 61/230 (26%), Positives = 93/230 (40%), Gaps = 44/230 (19%)
Query: 440 DNFSINNKLGEGGFGPVYKGTLVDGQE------IAVKRL-SKISEQGLKELKNEVILFSK 492
+N LG G FG V T + +AVK L K + L +E+ + ++
Sbjct: 45 ENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQ 104
Query: 493 L-QHRNLVKLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGT--- 548
L H N+V LLG C LI+E+ L +++ +++R + +
Sbjct: 105 LGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYL--RSKREKFSEDEIEYENQKRLEE 162
Query: 549 -------------------ARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLV 589
A+G+ +L +HRDL A NVL+ KI DFGL
Sbjct: 163 EEDLNVLTFEDLLCFAYQVAKGMEFL---EFKSCVHRDLAARNVLVTHGKVVKICDFGLA 219
Query: 590 R-TFGGDETEGNTNRVV--------GTYDGQFSIKSDVFSFGILLLEIVS 630
R N + ++G ++IKSDV+S+GILL EI S
Sbjct: 220 RDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFS 269
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 140 bits (354), Expect = 3e-37
Identities = 62/228 (27%), Positives = 88/228 (38%), Gaps = 36/228 (15%)
Query: 426 ELPLFELATIANATDNFSINNKLGEGGFGPVYKGTL--VDGQEI--AVKRL---SKISEQ 478
E PL L + D + KLG+G FG V +G G+ + AVK L +
Sbjct: 5 EGPLQSLTCLIGEKD-LRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPE 63
Query: 479 GLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQTRR----T 534
+ + EV L HRNL++L G + ++ E P SL + T
Sbjct: 64 AMDDFIREVNAMHSLDHRNLIRLYGVVL-TPPMKMVTELAPLGSLLDRLRKHQGHFLLGT 122
Query: 535 LLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGG 594
L ++ A G+ YL R IHRDL A N+LL KI DFGL+R
Sbjct: 123 LSRYAV------QVAEGMGYL---ESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQ 173
Query: 595 DETEGNTNRVVGT------------YDGQFSIKSDVFSFGILLLEIVS 630
++ FS SD + FG+ L E+ +
Sbjct: 174 NDDHYVMQE--HRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFT 219
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 140 bits (356), Expect = 3e-37
Identities = 66/300 (22%), Positives = 113/300 (37%), Gaps = 44/300 (14%)
Query: 441 NFSINNKLGEGGFGPVYKGT-LVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLV 499
++ KLGEGGF V L DG A+KR+ +Q +E + E + H N++
Sbjct: 30 HYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNIL 89
Query: 500 KLLGCCIQ----GEEKLLIYEFMPNKSLDSFIFD-QTRRTLLDWSQRFHIICGTARGLLY 554
+L+ C++ E L+ F +L + I + + L Q ++ G RGL
Sbjct: 90 RLVAYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEA 149
Query: 555 LHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNTNRVV-------GT 607
+H HRDLK +N+LL + P + D G + + T
Sbjct: 150 IHA---KGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQRCT 206
Query: 608 --Y------DGQ----FSIKSDVFSFGILLLEIVSGKK--NRGFYRSDTKVNLIGHLWDE 653
Y Q ++DV+S G +L ++ G+ + F + D+ + +
Sbjct: 207 ISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDSVALAVQNQLSI 266
Query: 654 GIPLRLIDACIQDSCNLADVIRCIHIGLLCVQQHPEDRPCMPSVILMLGSEILLPQPKQP 713
R S L ++ + P RP +P ++ L + P P Q
Sbjct: 267 PQSPRH-------SSALWQLLNS------MMTVDPHQRPHIPLLLSQL-EALQPPAPGQH 312
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 145 bits (368), Expect = 4e-37
Identities = 60/199 (30%), Positives = 97/199 (48%), Gaps = 14/199 (7%)
Query: 440 DNFSINNKLGEGGFGPVYKGTLVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLV 499
++ + KLG+G FG V+ GT +A+K L K + E + KL+H LV
Sbjct: 267 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTL-KPGTMSPEAFLQEAQVMKKLRHEKLV 325
Query: 500 KLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDS 559
+L + E ++ E+M SL F+ + L Q + A G+ Y+
Sbjct: 326 QLYAVVSE-EPIYIVTEYMSKGSLLDFLKGE-TGKYLRLPQLVDMAAQIASGMAYV---E 380
Query: 560 RLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNTNRVV--------GTYDGQ 611
R+ +HRDL+A+N+L+ +++ K++DFGL R +E G+
Sbjct: 381 RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGR 440
Query: 612 FSIKSDVFSFGILLLEIVS 630
F+IKSDV+SFGILL E+ +
Sbjct: 441 FTIKSDVWSFGILLTELTT 459
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 137 bits (347), Expect = 3e-36
Identities = 58/201 (28%), Positives = 84/201 (41%), Gaps = 26/201 (12%)
Query: 447 KLGEGGFGPVYKGTL-VDGQEI--AVKRLSK--ISEQGLKELKNEVILFSKLQHRNLVKL 501
+LG G FG V KG + AVK L EL E + +L + +V++
Sbjct: 24 ELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRM 83
Query: 502 LGCCIQGEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRL 561
+G C + E +L+ E L+ ++ Q R + ++ + G+ YL
Sbjct: 84 IGIC-EAESWMLVMEMAELGPLNKYL--QQNRHV-KDKNIIELVHQVSMGMKYL---EES 136
Query: 562 RIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNTNRVVGT------------YD 609
+HRDL A NVLL KISDFGL + DE
Sbjct: 137 NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQT--HGKWPVKWYAPECINY 194
Query: 610 GQFSIKSDVFSFGILLLEIVS 630
+FS KSDV+SFG+L+ E S
Sbjct: 195 YKFSSKSDVWSFGVLMWEAFS 215
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 137 bits (346), Expect = 3e-36
Identities = 67/285 (23%), Positives = 112/285 (39%), Gaps = 55/285 (19%)
Query: 440 DNFSINNKLGEGGFGPVYKGT-LVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNL 498
+F +G GGFG V+K +DG+ +KR+ +E + + EV +KL H N+
Sbjct: 11 MDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNNE----KAEREVKALAKLDHVNI 66
Query: 499 VKLLGC---------------CIQGEEKLLIY-EFMPNKSLDSFIFDQTRRTLLDWSQRF 542
V GC + L I EF +L+ +I ++ R LD
Sbjct: 67 VHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWI-EKRRGEKLDKVLAL 125
Query: 543 HIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNTN 602
+ +G+ Y+H ++I+RDLK SN+ L KI DFGLV + + +G
Sbjct: 126 ELFEQITKGVDYIHSK---KLINRDLKPSNIFLVDTKQVKIGDFGLVTSL---KNDGKRT 179
Query: 603 RVVGTY---------DGQFSIKSDVFSFGILLLEIVSGKKNRGFYRSDTKVNLIGHLWDE 653
R GT + + D+++ G++L E++ F S L D
Sbjct: 180 RSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCD-TAFETS----KFFTDLRDG 234
Query: 654 GIPLRLIDACIQDSCNLADVIRCIHIGLLCVQQHPEDRPCMPSVI 698
I +++ + + PEDRP ++
Sbjct: 235 IISDIF-------DKKEKTLLQ------KLLSKKPEDRPNTSEIL 266
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 143 bits (362), Expect = 4e-36
Identities = 61/249 (24%), Positives = 102/249 (40%), Gaps = 33/249 (13%)
Query: 398 RKRRRNIAEKTENSRETDQENEDQNIDLELPLFELATIANATDNFSINNKLGEGGFGPVY 457
K R + + E ++ L L L + +LG G FG V
Sbjct: 303 DKPRPMPMDTSVFESPFSDPEELKDKKLFLKRDNLLIA---------DIELGCGNFGSVR 353
Query: 458 KGTL-VDGQEI--AVKRL-SKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLL 513
+G + ++I A+K L + +E+ E + +L + +V+L+G C Q E +L
Sbjct: 354 QGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVC-QAEALML 412
Query: 514 IYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNV 573
+ E L F+ +R + S ++ + G+ YL +HR+L A NV
Sbjct: 413 VMEMAGGGPLHKFL--VGKREEIPVSNVAELLHQVSMGMKYL---EEKNFVHRNLAARNV 467
Query: 574 LLDQDMNPKISDFGLVRTFGGDETEGNTNRVVGT------------YDGQFSIKSDVFSF 621
LL KISDFGL + G D++ +FS +SDV+S+
Sbjct: 468 LLVNRHYAKISDFGLSKALGADDSYYTAR--SAGKWPLKWYAPECINFRKFSSRSDVWSY 525
Query: 622 GILLLEIVS 630
G+ + E +S
Sbjct: 526 GVTMWEALS 534
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 143 bits (361), Expect = 8e-36
Identities = 50/204 (24%), Positives = 87/204 (42%), Gaps = 19/204 (9%)
Query: 440 DNFSINNKLGEGGFGPVYKGTLV--DGQEI--AVKRL-SKISEQGLKELKNEVILFSKLQ 494
+ + +GEG FG V++G + + + A+K + S+ ++ E + +
Sbjct: 390 ERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFD 449
Query: 495 HRNLVKLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLY 554
H ++VKL+G + +I E L SF+ Q R+ LD + + L Y
Sbjct: 450 HPHIVKLIGVITE-NPVWIIMELCTLGELRSFL--QVRKFSLDLASLILYAYQLSTALAY 506
Query: 555 LHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNTNRVV--------G 606
L R +HRD+ A NVL+ + K+ DFGL R + +
Sbjct: 507 L---ESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPES 563
Query: 607 TYDGQFSIKSDVFSFGILLLEIVS 630
+F+ SDV+ FG+ + EI+
Sbjct: 564 INFRRFTSASDVWMFGVCMWEILM 587
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 137 bits (347), Expect = 1e-35
Identities = 60/323 (18%), Positives = 122/323 (37%), Gaps = 45/323 (13%)
Query: 440 DNFSINNKLGEGGFGPVYKGT-LVDGQEIAVK--RLSKISEQGLKELKNEVILFSKLQHR 496
+ + K+GEG FG DG++ +K +S++S + +E + EV + + ++H
Sbjct: 24 EKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHP 83
Query: 497 NLVKLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLH 556
N+V+ + ++ ++ L I Q + L Q L ++H
Sbjct: 84 NIVQYRESFEENGSLYIVMDYCEGGDLFKRINAQ-KGVLFQEDQILDWFVQICLALKHVH 142
Query: 557 QDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNTNRVVGT--Y------ 608
+I+HRD+K+ N+ L +D ++ DFG+ R +GT Y
Sbjct: 143 DR---KILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVELARA--CIGTPYYLSPEIC 197
Query: 609 -DGQFSIKSDVFSFGILLLEIVSGKKNRGFYRSDTK--VNLIGHLWDEGIPLRLIDACIQ 665
+ ++ KSD+++ G +L E+ + K F K V I + L
Sbjct: 198 ENKPYNNKSDIWALGCVLYELCTLK--HAFEAGSMKNLVLKIISGSFPPVSLHY------ 249
Query: 666 DSCNLADVIRCIHIGLLCVQQHPEDRP----------CMPSVILMLGSEILLPQPKQPGY 715
S +L ++ +++P DRP + L +++ + +
Sbjct: 250 -SYDLRSLVS------QLFKRNPRDRPSVNSILEKGFIAKRIEKFLSPQLIAEEFCLKTF 302
Query: 716 LADRKSTEPYSSSSMPESSSTNT 738
P + ++S +
Sbjct: 303 SKFGSQPIPAKRPASGQNSISVM 325
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 134 bits (340), Expect = 3e-35
Identities = 59/302 (19%), Positives = 123/302 (40%), Gaps = 43/302 (14%)
Query: 407 KTENSRETDQENEDQNIDLELPLFELATIANATDNFSINNKLGEGGFGPVYKGT-LVDGQ 465
+ E +++ D E + + ++N + ++G G F VYKG
Sbjct: 1 QEERNQQQDDIEELETKAVG--------MSNDGRFLKFDIEIGRGSFKTVYKGLDTETTV 52
Query: 466 EIAVK--RLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCI---QGEEKLLIY-EFMP 519
E+A + K+++ + K E + LQH N+V+ +G++ +++ E M
Sbjct: 53 EVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVTELMT 112
Query: 520 NKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLD-QD 578
+ +L +++ R ++ +GL +LH + IIHRDLK N+ +
Sbjct: 113 SGTLKTYL---KRFKVMKIKVLRSWCRQILKGLQFLHTRTP-PIIHRDLKCDNIFITGPT 168
Query: 579 MNPKISDFGLVRTFGGDETEGNTNRVVGT--------YDGQFSIKSDVFSFGILLLEIVS 630
+ KI D GL + V+GT Y+ ++ DV++FG+ +LE+ +
Sbjct: 169 GSVKIGDLGLATL----KRASFAKAVIGTPEFMAPEMYEEKYDESVDVYAFGMCMLEMAT 224
Query: 631 GKKNRGFYRSDTKVNLIGHLWDEGIPLRLIDACIQDSCNLADVIRCIHIGLLCVQQHPED 690
+ ++ ++ G+ D + ++I C++Q+ ++
Sbjct: 225 SEYPYSECQNAAQIYRRVT---SGVKPASFDKVA--IPEVKEIIE------GCIRQNKDE 273
Query: 691 RP 692
R
Sbjct: 274 RY 275
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 134 bits (338), Expect = 5e-35
Identities = 66/286 (23%), Positives = 109/286 (38%), Gaps = 51/286 (17%)
Query: 440 DNFSINNKLGEGGFGPVYKGT-LVDGQEIAVKRLS-KISEQGLKELKNEVILFSKLQHRN 497
+F LG GGFG V++ VD A+KR+ E +++ EV +KL+H
Sbjct: 5 TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPG 64
Query: 498 LVKLLGCCI---------QGEEKLLIY---EFMPNKSLDSFIFDQTRRTLLDWSQRFHII 545
+V+ + K+ +Y + ++L ++ + + S HI
Sbjct: 65 IVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIF 124
Query: 546 CGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNTNRV- 604
A + +LH ++HRDLK SN+ D K+ DFGLV DE E
Sbjct: 125 LQIAEAVEFLHS---KGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPM 181
Query: 605 ---------VGT--Y-------DGQFSIKSDVFSFGILLLEIVSGKKNRGFYRSDTKVNL 646
VGT Y +S K D+FS G++L E++ F +V
Sbjct: 182 PAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELL-----YPFSTQMERVRT 236
Query: 647 IGHLWDEGIPLRLIDACIQDSCNLADVIRCIHIGLLCVQQHPEDRP 692
+ + + P L Q +++ + P +RP
Sbjct: 237 LTDVRNLKFP-PLFT---QKYPCEYVMVQ------DMLSPSPMERP 272
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 129 bits (327), Expect = 2e-33
Identities = 65/268 (24%), Positives = 113/268 (42%), Gaps = 31/268 (11%)
Query: 440 DNFSINNKLGEGGFGPVYKGT-LVDGQEIAVKRL---SKISEQGLKELKNEVILFSKLQH 495
NF I K+G G F VY+ L+DG +A+K++ + + + E+ L +L H
Sbjct: 32 ANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNH 91
Query: 496 RNLVKLLGCCIQGEEKLLIY-EFMPNKSLDSFIFDQTRR-TLLDWSQRFHIICGTARGLL 553
N++K I+ + +L I E L I ++ L+ + L
Sbjct: 92 PNVIKYYASFIE-DNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALE 150
Query: 554 YLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNTNRVVGT--Y--- 608
++H R++HRD+K +NV + K+ D GL R F T ++ +VGT Y
Sbjct: 151 HMHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHS--LVGTPYYMSP 205
Query: 609 ----DGQFSIKSDVFSFGILLLEIVSGKKNRGFYRSDTKVNLIGHLWDEGIPLRLIDACI 664
+ ++ KSD++S G LL E+ + + FY + + ++ L
Sbjct: 206 ERIHENGYNFKSDIWSLGCLLYEMAALQ--SPFYGDKMNLYSLCKKIEQCDYPPLPSDHY 263
Query: 665 QDSCNLADVIRCIHIGLLCVQQHPEDRP 692
S L ++ +C+ PE RP
Sbjct: 264 --SEELRQLVN------MCINPDPEKRP 283
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 127 bits (321), Expect = 1e-32
Identities = 62/266 (23%), Positives = 98/266 (36%), Gaps = 38/266 (14%)
Query: 440 DNFSINNKLGEGGFGPVYKGT-LVDGQEIAVKRLSK--ISEQGLKELKNEVILFSKL-QH 495
+F ++LG G +G V+K DG+ AVKR + EV K+ QH
Sbjct: 57 QSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQH 116
Query: 496 RNLVKLLGCCIQGEEKLLIY-EFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLY 554
V+L + L + E SL + L +Q + + T L +
Sbjct: 117 PCCVRLEQA-WEEGGILYLQTELC-GPSLQQHC--EAWGASLPEAQVWGYLRDTLLALAH 172
Query: 555 LHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNTNRVVGT--Y---- 608
LH ++H D+K +N+ L K+ DFGL+ G T G G Y
Sbjct: 173 LHS---QGLVHLDVKPANIFLGPRGRCKLGDFGLLVELG---TAGAGEVQEGDPRYMAPE 226
Query: 609 --DGQFSIKSDVFSFGILLLEIVSGKKNRGFYRSDTKVNLIGHLWDEGIPLRLIDACIQD 666
G + +DVFS G+ +LE+ + + G+L E L
Sbjct: 227 LLQGSYGTAADVFSLGLTILEVACNME-LPHGGEGWQQLRQGYLPPE-FTAGL------- 277
Query: 667 SCNLADVIRCIHIGLLCVQQHPEDRP 692
S L V+ + ++ P+ R
Sbjct: 278 SSELRSVLV------MMLEPDPKLRA 297
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 125 bits (315), Expect = 4e-32
Identities = 59/210 (28%), Positives = 92/210 (43%), Gaps = 19/210 (9%)
Query: 440 DNFSINNKLGEGGFGPVYKGT-LVDGQEIAVK--RLSKISEQGLKELKNEVILFSKLQHR 496
+++ + +G G +G K DG+ + K ++E + L +EV L +L+H
Sbjct: 6 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHP 65
Query: 497 NLVKLLGCCIQGEEKLL--IYEFMPNKSLDSFIFDQTR-RTLLDWSQRFHIICGTARGLL 553
N+V+ I L + E+ L S I T+ R LD ++ L
Sbjct: 66 NIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALK 125
Query: 554 YLHQ--DSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNTNRVVGT--Y- 608
H+ D ++HRDLK +NV LD N K+ DFGL R D + T VGT Y
Sbjct: 126 ECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKT--FVGTPYYM 183
Query: 609 ------DGQFSIKSDVFSFGILLLEIVSGK 632
++ KSD++S G LL E+ +
Sbjct: 184 SPEQMNRMSYNEKSDIWSLGCLLYELCALM 213
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 125 bits (315), Expect = 6e-32
Identities = 54/199 (27%), Positives = 89/199 (44%), Gaps = 20/199 (10%)
Query: 448 LGEGGFGPVYKGT-LVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCI 506
LG+G +G VY G L + IA+K + + + + L E+ L L+H+N+V+ LG
Sbjct: 30 LGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSF- 88
Query: 507 QGEEKLLIY-EFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIH 565
+ I+ E +P SL + + + + GL YLH + +I+H
Sbjct: 89 SENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDN---QIVH 145
Query: 566 RDLKASNVLLDQDM-NPKISDFGLVRTFGGDETEGNTNRVVGT-----------YDGQFS 613
RD+K NVL++ KISDFG + G T GT +
Sbjct: 146 RDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTET--FTGTLQYMAPEIIDKGPRGYG 203
Query: 614 IKSDVFSFGILLLEIVSGK 632
+D++S G ++E+ +GK
Sbjct: 204 KAADIWSLGCTIIEMATGK 222
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 125 bits (315), Expect = 8e-32
Identities = 52/232 (22%), Positives = 92/232 (39%), Gaps = 48/232 (20%)
Query: 439 TDNFSINNKLGEGGFGPVYKGT-LVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRN 497
+F LG+G FG V K +D + A+K++ +E+ L + +EV+L + L H+
Sbjct: 5 ASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRH-TEEKLSTILSEVMLLASLNHQY 63
Query: 498 LVKLLGC----------CIQGEEKLLIY---EFMPNKSLDSFIFDQTRRTLLDWSQRFHI 544
+V+ ++K ++ E+ N +L I + + + +
Sbjct: 64 VVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLI--HSENLNQQRDEYWRL 121
Query: 545 ICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTF------------ 592
L Y+H IIHRDLK N+ +D+ N KI DFGL +
Sbjct: 122 FRQILEALSYIHS---QGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQ 178
Query: 593 GGDETEGNTNRVVGT-------------YDGQFSIKSDVFSFGILLLEIVSG 631
+ N +GT + + K D++S GI+ E++
Sbjct: 179 NLPGSSDNLTSAIGTAMYVATEVLDGTGHYNE---KIDMYSLGIIFFEMIYP 227
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 125 bits (316), Expect = 8e-32
Identities = 62/246 (25%), Positives = 104/246 (42%), Gaps = 33/246 (13%)
Query: 403 NIAEKTENSRETDQENEDQNIDLELPLFELATIANATDNFSINNKLGEGGFGPVYKGT-L 461
+ TEN + L + + K+GEG G V
Sbjct: 10 GVDLGTENLYFQSGVVTHEQFKAALR--MVVDQGDPRLLLDSYVKIGEGSTGIVCLAREK 67
Query: 462 VDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMPNK 521
G+++AVK + +Q + L NEV++ QH N+V++ + GEE ++ EF+
Sbjct: 68 HSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFNVVEMYKSYLVGEELWVLMEFLQGG 127
Query: 522 SLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNP 581
+L D + L+ Q + + L YLH +IHRD+K+ ++LL D
Sbjct: 128 ALT----DIVSQVRLNEEQIATVCEAVLQALAYLHAQ---GVIHRDIKSDSILLTLDGRV 180
Query: 582 KISDFGLVRTFGGDETEGNTNR--VVGT-------------YDGQFSIKSDVFSFGILLL 626
K+SDFG F ++ R +VGT Y + D++S GI+++
Sbjct: 181 KLSDFG----FCAQISKDVPKRKSLVGTPYWMAPEVISRSLYAT----EVDIWSLGIMVI 232
Query: 627 EIVSGK 632
E+V G+
Sbjct: 233 EMVDGE 238
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 124 bits (313), Expect = 1e-31
Identities = 53/220 (24%), Positives = 107/220 (48%), Gaps = 31/220 (14%)
Query: 429 LFELATIANATDNFSINNKLGEGGFGPVYKGT-LVDGQEIAVKRLSKISEQGLKELKNEV 487
L + ++ + ++ K+G+G G VY + GQE+A+++++ + + + NE+
Sbjct: 9 LRSIVSVGDPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEI 68
Query: 488 ILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICG 547
++ + ++ N+V L + G+E ++ E++ SL D T +D Q +
Sbjct: 69 LVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLT----DVVTETCMDEGQIAAVCRE 124
Query: 548 TARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGG--DETEGNTNRVV 605
+ L +LH + ++IHRD+K+ N+LL D + K++DFG F + + +V
Sbjct: 125 CLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFG----FCAQITPEQSKRSTMV 177
Query: 606 GT-------------YDGQFSIKSDVFSFGILLLEIVSGK 632
GT Y K D++S GI+ +E++ G+
Sbjct: 178 GTPYWMAPEVVTRKAYGP----KVDIWSLGIMAIEMIEGE 213
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 124 bits (313), Expect = 2e-31
Identities = 68/332 (20%), Positives = 116/332 (34%), Gaps = 64/332 (19%)
Query: 441 NFSINNKLGEGGFGPVYKGT-LVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQ-HRNL 498
+ L EGGF VY+ + G+E A+KRL E+ + + EV KL H N+
Sbjct: 29 RLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNI 88
Query: 499 VKLLGCCIQGEEK-------LLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARG 551
V+ G+E+ L+ + L F+ R L I T R
Sbjct: 89 VQFCSAASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTVLKIFYQTCRA 148
Query: 552 LLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNTNRVVGTYD-- 609
+ ++H+ + IIHRDLK N+LL K+ DFG T + + +
Sbjct: 149 VQHMHR-QKPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRALVEEE 207
Query: 610 ------------------GQFSI--KSDVFSFGILLLEIVSGKKNRGFYRSDTKVNLIGH 649
F I K D+++ G +L + + H
Sbjct: 208 ITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQ----------------H 251
Query: 650 LWDEGIPLRLIDACIQD------SCNLADVIRCIHIGLLCVQQHPEDRPCMPSVI----L 699
+++G LR+++ +IR +Q +PE+R + V+
Sbjct: 252 PFEDGAKLRIVNGKYSIPPHDTQYTVFHSLIRA------MLQVNPEERLSIAEVVHQLQE 305
Query: 700 MLGSEILLPQPKQPGYLADRKSTEPYSSSSMP 731
+ + + P+ L + S P
Sbjct: 306 IAAARNVNPKSPITELLEQNGGYGSATLSRGP 337
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 123 bits (311), Expect = 3e-31
Identities = 58/223 (26%), Positives = 96/223 (43%), Gaps = 34/223 (15%)
Query: 431 ELATIANATDNFSINNKLGEGGFGPVYKGT-LVDGQEIAVKRLSKISEQGLKELKNEVIL 489
+ + + + I +LG+G FG VYK G A K + SE+ L++ E+ +
Sbjct: 10 HVRRDLDPNEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEI 69
Query: 490 FSKLQHRNLVKLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTA 549
+ H +VKLLG + ++ EF P ++D+ + L Q +
Sbjct: 70 LATCDHPYIVKLLGAYYHDGKLWIMIEFCPGGAVDAIM--LELDRGLTEPQIQVVCRQML 127
Query: 550 RGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGG--DETEGNTNRVVGT 607
L +LH RIIHRDLKA NVL+ + + +++DFG +T + +GT
Sbjct: 128 EALNFLHSK---RIIHRDLKAGNVLMTLEGDIRLADFG----VSAKNLKTLQKRDSFIGT 180
Query: 608 ------------------YDGQFSIKSDVFSFGILLLEIVSGK 632
YD K+D++S GI L+E+ +
Sbjct: 181 PYWMAPEVVMCETMKDTPYDY----KADIWSLGITLIEMAQIE 219
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 122 bits (309), Expect = 6e-31
Identities = 63/220 (28%), Positives = 103/220 (46%), Gaps = 31/220 (14%)
Query: 429 LFELATIANATDNFSINNKLGEGGFGPVYKGT-LVDGQEIAVKRLSKISEQGLKELKNEV 487
L E + + F + KLGEG +G VYK GQ +A+K++ E L+E+ E+
Sbjct: 18 LDEDSLTKQPEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVP--VESDLQEIIKEI 75
Query: 488 ILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICG 547
+ + ++VK G + + ++ E+ S+ I + R L + I+
Sbjct: 76 SIMQQCDSPHVVKYYGSYFKNTDLWIVMEYCGAGSVSDII--RLRNKTLTEDEIATILQS 133
Query: 548 TARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGG--DETEGNTNRVV 605
T +GL YLH R IHRD+KA N+LL+ + + K++DFG G +T N V+
Sbjct: 134 TLKGLEYLHFM---RKIHRDIKAGNILLNTEGHAKLADFG----VAGQLTDTMAKRNTVI 186
Query: 606 GT-------------YDGQFSIKSDVFSFGILLLEIVSGK 632
GT Y+ +D++S GI +E+ GK
Sbjct: 187 GTPFWMAPEVIQEIGYNC----VADIWSLGITAIEMAEGK 222
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 122 bits (308), Expect = 2e-30
Identities = 62/279 (22%), Positives = 113/279 (40%), Gaps = 43/279 (15%)
Query: 441 NFSINNKLGEGGFGPVYKGTLVDGQEIAVKR--LSKISEQGLKELKNEVILFSKLQHRNL 498
+SI ++G GG V++ Q A+K L + Q L +NE+ +KLQ +
Sbjct: 57 IYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSD 116
Query: 499 --VKLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLH 556
++L ++ + + N L+S++ ++ +D +R + +H
Sbjct: 117 KIIRLYD-YEITDQYIYMVMECGNIDLNSWL---KKKKSIDPWERKSYWKNMLEAVHTIH 172
Query: 557 QDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNTNRVVGT--------- 607
Q I+H DLK +N L+ D K+ DFG+ D T + VG
Sbjct: 173 Q---HGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTSVVKDSQVGAVNYMPPEAI 228
Query: 608 -----------YDGQFSIKSDVFSFGILLLEIVSGKKNRGFYRSDTKVNLIGHLWDEGIP 656
+ S KSDV+S G +L + GK F + +++ + + D
Sbjct: 229 KDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTP--FQQIINQISKLHAIIDPNHE 286
Query: 657 LRLIDACIQDSCNLADVIRCIHIGLLCVQQHPEDRPCMP 695
+ D +L DV++C C+++ P+ R +P
Sbjct: 287 IEFPDIP---EKDLQDVLKC------CLKRDPKQRISIP 316
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 121 bits (305), Expect = 3e-30
Identities = 56/256 (21%), Positives = 100/256 (39%), Gaps = 40/256 (15%)
Query: 398 RKRRRNIAEKTENSRETDQENEDQNIDLELPLFELATIANATDNFSINNKLGEGGFGPVY 457
K + + K + ++NE + +L + + ++G G FG V+
Sbjct: 17 AKTWSSGSAKLQRLGPETEDNEGVLLTEKLKPVD-YEYREEVHWMTHQPRVGRGSFGEVH 75
Query: 458 KGT-LVDGQEIAVK--RLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLI 514
+ G + AVK RL + E++ + L +V L G +G + I
Sbjct: 76 RMKDKQTGFQCAVKKVRLEVFRVE-------ELVACAGLSSPRIVPLYGAVREG-PWVNI 127
Query: 515 Y-EFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNV 573
+ E + SL I + L + + + GL YLH RI+H D+KA NV
Sbjct: 128 FMELLEGGSLGQLI---KQMGCLPEDRALYYLGQALEGLEYLHTR---RILHGDVKADNV 181
Query: 574 LLDQDMNP-KISDFGL---VRTFGGDETEGNTNRVVGT-------------YDGQFSIKS 616
LL D + + DFG ++ G ++ + + GT D K
Sbjct: 182 LLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMGKPCDA----KV 237
Query: 617 DVFSFGILLLEIVSGK 632
D++S ++L +++G
Sbjct: 238 DIWSSCCMMLHMLNGC 253
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 120 bits (302), Expect = 3e-30
Identities = 59/315 (18%), Positives = 107/315 (33%), Gaps = 76/315 (24%)
Query: 439 TDNFSINNKLGEGGFGPVYKGT-LVDGQEIAVKR--LSKISEQGLKELKNEVILFSKL-Q 494
T F K+G G FG V+K +DG A+KR + EV + L Q
Sbjct: 10 TTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQ 69
Query: 495 HRNLVKLLGCCIQGEEKLLIY-EFMPNKSLDSFIFDQTRR-TLLDWSQRFHIICGTARGL 552
H ++V+ + + +LI E+ SL I + R + ++ ++ RGL
Sbjct: 70 HSHVVRYFSAWAEDD-HMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGL 128
Query: 553 LYLHQDSRLRIIHRDLKASNVLLDQDMNP-------------------KISDFGLVRTFG 593
Y+H ++H D+K SN+ + + P KI D G V
Sbjct: 129 RYIHSM---SLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRIS 185
Query: 594 GDETEGNTNRVVGT--Y--------DGQFSIKSDVFSFGILLLEIVSGKKNRGFYRSDTK 643
+ E G + + K+D+F+ + ++ +
Sbjct: 186 SPQVE------EGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAE----------- 228
Query: 644 VNLIGHLWDEGIPLRLIDACIQD------SCNLADVIRCIHIGLLCVQQHPEDRPCMPSV 697
L G I S ++++ + + PE R PS
Sbjct: 229 -----PLPRNGDQWHEIRQGRLPRIPQVLSQEFTELLK------VMIHPDPERR---PSA 274
Query: 698 ILMLGSEILLPQPKQ 712
+ ++ +LL ++
Sbjct: 275 MALVKHSVLLSASRK 289
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 120 bits (304), Expect = 4e-30
Identities = 63/280 (22%), Positives = 116/280 (41%), Gaps = 45/280 (16%)
Query: 441 NFSINNKLGEGGFGPVYKGTLVDGQEIAVKRLSK--ISEQGLKELKNEVILFSKLQHRNL 498
+SI ++G GG V++ Q A+K ++ Q L +NE+ +KLQ +
Sbjct: 10 IYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSD 69
Query: 499 --VKLLGCCIQGEEKL-LIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYL 555
++L ++ + ++ E N L+S++ ++ +D +R + +
Sbjct: 70 KIIRLYD-YEITDQYIYMVMEC-GNIDLNSWL---KKKKSIDPWERKSYWKNMLEAVHTI 124
Query: 556 HQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNTNRVVGT-------- 607
HQ I+H DLK +N L+ D K+ DFG+ D T + VGT
Sbjct: 125 HQ---HGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEA 180
Query: 608 ------------YDGQFSIKSDVFSFGILLLEIVSGKKNRGFYRSDTKVNLIGHLWDEGI 655
+ S KSDV+S G +L + GK F + +++ + + D
Sbjct: 181 IKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGK--TPFQQIINQISKLHAIIDPNH 238
Query: 656 PLRLIDACIQDSCNLADVIRCIHIGLLCVQQHPEDRPCMP 695
+ D +L DV++C C+++ P+ R +P
Sbjct: 239 EIEFPDIP---EKDLQDVLKC------CLKRDPKQRISIP 269
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 120 bits (302), Expect = 4e-30
Identities = 53/217 (24%), Positives = 90/217 (41%), Gaps = 34/217 (15%)
Query: 441 NFSINNKLGEGGFGPVYKGTLVDGQEIAVKR--LSKISEQGLKELKNEVILFSKLQHRNL 498
+SI ++G GG V++ Q A+K L + Q L +NE+ +KLQ +
Sbjct: 29 IYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSD 88
Query: 499 --VKLLGCCIQGEEKL-LIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYL 555
++L ++ + ++ E N L+S++ ++ +D +R + +
Sbjct: 89 KIIRLYD-YEITDQYIYMVMECG-NIDLNSWL---KKKKSIDPWERKSYWKNMLEAVHTI 143
Query: 556 HQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNTNRVVGT-------- 607
HQ I+H DLK +N L+ D K+ DFG+ D T + VGT
Sbjct: 144 HQ---HGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEA 199
Query: 608 ------------YDGQFSIKSDVFSFGILLLEIVSGK 632
+ S KSDV+S G +L + GK
Sbjct: 200 IKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGK 236
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 120 bits (304), Expect = 5e-30
Identities = 61/224 (27%), Positives = 98/224 (43%), Gaps = 36/224 (16%)
Query: 429 LFELATIANATDNFSINNKLGEGGFGPVYKGT-LVDGQEIAVKRLS---KISEQGLKELK 484
+ EL + FS ++G G FG VY + + + +A+K++S K S + +++
Sbjct: 43 VAELFFKDDPEKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDII 102
Query: 485 NEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHI 544
EV KL+H N ++ GC ++ L+ E+ + D + + L + +
Sbjct: 103 KEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYCLGSASD---LLEVHKKPLQEVEIAAV 159
Query: 545 ICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNTNRV 604
G +GL YLH +IHRD+KA N+LL + K+ DFG N+
Sbjct: 160 THGALQGLAYLHSH---NMIHRDVKAGNILLSEPGLVKLGDFG----SASIMAPANS--F 210
Query: 605 VGT----------------YDGQFSIKSDVFSFGILLLEIVSGK 632
VGT YDG K DV+S GI +E+ K
Sbjct: 211 VGTPYWMAPEVILAMDEGQYDG----KVDVWSLGITCIELAERK 250
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 118 bits (298), Expect = 1e-29
Identities = 58/219 (26%), Positives = 93/219 (42%), Gaps = 41/219 (18%)
Query: 440 DNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRL-SKISEQGLKELKNEV-ILFSKLQHR 496
D+ +LG G +G V K V GQ +AVKR+ + ++ Q K L ++ I +
Sbjct: 7 DDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCP 66
Query: 497 NLVKLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRF------HIICGTAR 550
V G + + + E M + SLD F + ++D Q I +
Sbjct: 67 FTVTFYGALFREGDVWICMELM-DTSLDKFY-----KQVIDKGQTIPEDILGKIAVSIVK 120
Query: 551 GLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFG----LVRTFGGDETEGNTNRVVG 606
L +LH S+L +IHRD+K SNVL++ K+ DFG LV + G
Sbjct: 121 ALEHLH--SKLSVIHRDVKPSNVLINALGQVKMCDFGISGYLVDDVAK-------DIDAG 171
Query: 607 TY-------------DGQFSIKSDVFSFGILLLEIVSGK 632
+S+KSD++S GI ++E+ +
Sbjct: 172 CKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILR 210
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 116 bits (293), Expect = 5e-29
Identities = 58/212 (27%), Positives = 104/212 (49%), Gaps = 28/212 (13%)
Query: 436 ANATDNFSINNKLGEGGFGPVYKGT-LVDGQEIAVKRLS-KISEQGLKELKNEVILFSKL 493
A+ + F+ K+G+G FG V+KG + +A+K + + +E +++++ E+ + S+
Sbjct: 18 ADPEELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQC 77
Query: 494 QHRNLVKLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLL 553
+ K G ++ + +I E++ S D LD +Q I+ +GL
Sbjct: 78 DSPYVTKYYGSYLKDTKLWIIMEYLGGGSAL----DLLEPGPLDETQIATILREILKGLD 133
Query: 554 YLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNTNRVVGT------ 607
YLH + + IHRD+KA+NVLL + K++DFG+ +T+ N VGT
Sbjct: 134 YLHSE---KKIHRDIKAANVLLSEHGEVKLADFGVAGQL--TDTQIKRNTFVGTPFWMAP 188
Query: 608 -------YDGQFSIKSDVFSFGILLLEIVSGK 632
YD K+D++S GI +E+ G+
Sbjct: 189 EVIKQSAYDS----KADIWSLGITAIELARGE 216
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 117 bits (294), Expect = 7e-29
Identities = 64/225 (28%), Positives = 104/225 (46%), Gaps = 29/225 (12%)
Query: 430 FELATIANATDNFSINNKLGEGGFGPVYKGT-LVDGQEIAVKRLSKISEQGLKELKNEVI 488
+L+ + + F + +G G +G VYKG + GQ A+K + ++ +E+K E+
Sbjct: 14 IDLSALRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVM-DVTGDEEEEIKQEIN 72
Query: 489 LFSKL-QHRNLVKLLGCCIQG-----EEKL-LIYEFMPNKSLDSFIFDQTRRTLLDWSQR 541
+ K HRN+ G I+ +++L L+ EF S+ + T+ L
Sbjct: 73 MLKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTD-LIKNTKGNTLKEEWI 131
Query: 542 FHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNT 601
+I RGL +LHQ ++IHRD+K NVLL ++ K+ DFG+ D T G
Sbjct: 132 AYICREILRGLSHLHQH---KVIHRDIKGQNVLLTENAEVKLVDFGVSAQL--DRTVGRR 186
Query: 602 NRVVGT--------------YDGQFSIKSDVFSFGILLLEIVSGK 632
N +GT D + KSD++S GI +E+ G
Sbjct: 187 NTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGA 231
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 116 bits (293), Expect = 1e-28
Identities = 57/216 (26%), Positives = 94/216 (43%), Gaps = 34/216 (15%)
Query: 440 DNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRL-SKISEQGLKELKNEV-ILFSKLQHR 496
++ ++G G +G V K GQ +AVKR+ S + E+ K+L ++ ++
Sbjct: 22 EDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCP 81
Query: 497 NLVKLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRF------HIICGTAR 550
+V+ G + + + E M + S D F + I T +
Sbjct: 82 YIVQFYGALFREGDCWICMELM-STSFDKFY----KYVYSVLDDVIPEEILGKITLATVK 136
Query: 551 GLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFG----LVRTFGGDETEG------- 599
L +L L+IIHRD+K SN+LLD+ N K+ DFG LV + G
Sbjct: 137 ALNHLK--ENLKIIHRDIKPSNILLDRSGNIKLCDFGISGQLVDSIAKTRDAGCRPYMAP 194
Query: 600 ---NTNRVVGTYDGQFSIKSDVFSFGILLLEIVSGK 632
+ + YD ++SDV+S GI L E+ +G+
Sbjct: 195 ERIDPSASRQGYD----VRSDVWSLGITLYELATGR 226
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 115 bits (291), Expect = 2e-28
Identities = 51/213 (23%), Positives = 93/213 (43%), Gaps = 35/213 (16%)
Query: 440 DNFSINNKLGEGGFGPVYKGTLVD-GQEIAVKRLSK--ISEQGLKE-LKNEVILFSKLQH 495
+ LG+GGF ++ + D + A K + K + + +E + E+ + L H
Sbjct: 41 RRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAH 100
Query: 496 RNLVKLLGCCIQGEEKL-LIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHI--ICGTARGL 552
+++V G + + + ++ E +SL + R+ L + R+++ I G
Sbjct: 101 QHVVGFHGF-FEDNDFVFVVLELCRRRSLLELH--KRRKALTEPEARYYLRQIVL---GC 154
Query: 553 LYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNTNRVVGT----- 607
YLH+ R+IHRDLK N+ L++D+ KI DFGL D + GT
Sbjct: 155 QYLHR---NRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKV--LCGTPNYIA 209
Query: 608 --------YDGQFSIKSDVFSFGILLLEIVSGK 632
+ + DV+S G ++ ++ GK
Sbjct: 210 PEVLSKKGHSF----EVDVWSIGCIMYTLLVGK 238
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 114 bits (287), Expect = 3e-28
Identities = 52/213 (24%), Positives = 93/213 (43%), Gaps = 35/213 (16%)
Query: 440 DNFSINNKLGEGGFGPVYKGTLVD-GQEIAVKRLSK--ISEQGLKE-LKNEVILFSKLQH 495
+ LG+GGF ++ + D + A K + K + + +E + E+ + L H
Sbjct: 15 RRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAH 74
Query: 496 RNLVKLLGCCIQGEEKL-LIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHI--ICGTARGL 552
+++V G + + + ++ E +SL + R+ L + R+++ I G
Sbjct: 75 QHVVGFHGF-FEDNDFVFVVLELCRRRSLLELH--KRRKALTEPEARYYLRQIVL---GC 128
Query: 553 LYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNTNRVVGT----- 607
YLH R R+IHRDLK N+ L++D+ KI DFGL D + GT
Sbjct: 129 QYLH---RNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKV--LCGTPNYIA 183
Query: 608 --------YDGQFSIKSDVFSFGILLLEIVSGK 632
+ + DV+S G ++ ++ GK
Sbjct: 184 PEVLSKKGHSF----EVDVWSIGCIMYTLLVGK 212
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 114 bits (287), Expect = 4e-28
Identities = 46/219 (21%), Positives = 86/219 (39%), Gaps = 27/219 (12%)
Query: 437 NATDNFSINNKLGEGGFGPVYKGT-LVDGQEIAVKRLSKISEQGLKE-LKNEVILFSKLQ 494
+ + +++ LG+G V++G G A+K + IS + E + KL
Sbjct: 6 TSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLN 65
Query: 495 HRNLVKLLGCCIQGEEKLLIY---EFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARG 551
H+N+VKL + EF P SL + + + + L S+ ++ G
Sbjct: 66 HKNIVKLFAI-EEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGG 124
Query: 552 LLYLHQDSRLRIIHRDLKASNVLL----DQDMNPKISDFGLVRTFGGDE-------TEG- 599
+ +L + I+HR++K N++ D K++DFG R DE TE
Sbjct: 125 MNHLRE---NGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVSLYGTEEY 181
Query: 600 ------NTNRVVGTYDGQFSIKSDVFSFGILLLEIVSGK 632
+ + ++ D++S G+ +G
Sbjct: 182 LHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGS 220
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 113 bits (283), Expect = 2e-27
Identities = 63/331 (19%), Positives = 107/331 (32%), Gaps = 96/331 (29%)
Query: 440 DNFSINNKLGEGGFGPVYKGT-LVDGQEIAVKRLS-KISEQGLKELKNEVILFSKLQHRN 497
+F +G GGFG V++ VD A+KR+ E +++ EV +KL+H
Sbjct: 6 TDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPG 65
Query: 498 LVKLLGCCIQG----------------------------------EEKLL-------IYE 516
+V+ ++ + + +
Sbjct: 66 IVRYFNAWLETPPEKWQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVG 125
Query: 517 FMPNKSLDSFIFDQT----RRTLLDWSQR------------FHIICGTARGLLYLHQDSR 560
+ S +++ Q + L DW R HI A + +LH
Sbjct: 126 QLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHGVCLHIFIQIAEAVEFLHS--- 182
Query: 561 LRIIHRDLKASNVLLDQDMNPKISDFGLVR----------TFGGDETEGNTNRVVGTY-- 608
++HRDLK SN+ D K+ DFGLV VGT
Sbjct: 183 KGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLY 242
Query: 609 -------DGQFSIKSDVFSFGILLLEIVSGKKNRGFYRSDTKVNLIGHLWDEGIPLRLID 661
+S K D+FS G++L E++ F +V +I + + P
Sbjct: 243 MSPEQIHGNNYSHKVDIFSLGLILFELLY-----SFSTQMERVRIITDVRNLKFP----L 293
Query: 662 ACIQDSCNLADVIRCIHIGLLCVQQHPEDRP 692
Q +++ + P +RP
Sbjct: 294 LFTQKYPQEHMMVQ------DMLSPSPTERP 318
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 112 bits (281), Expect = 2e-27
Identities = 55/220 (25%), Positives = 97/220 (44%), Gaps = 31/220 (14%)
Query: 437 NATDNFSINNKLGEGGFGPVYKGT-LVDGQEIAVKRLS-KISEQGLKELKNEVILFSKLQ 494
D++ + +G G V +++A+KR++ + + + EL E+ S+
Sbjct: 12 INRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCH 71
Query: 495 HRNLVKLLGCCIQGEEKLLIYEFMPNKSL-----DSFIFDQTRRTLLDWSQRFHIICGTA 549
H N+V + +E L+ + + S+ + + +LD S I+
Sbjct: 72 HPNIVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVL 131
Query: 550 RGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGL---VRTFGGDETEGNTNRVVG 606
GL YLH++ IHRD+KA N+LL +D + +I+DFG+ + T G VG
Sbjct: 132 EGLEYLHKN---GQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVG 188
Query: 607 T--------------YDGQFSIKSDVFSFGILLLEIVSGK 632
T YD K+D++SFGI +E+ +G
Sbjct: 189 TPCWMAPEVMEQVRGYDF----KADIWSFGITAIELATGA 224
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 113 bits (285), Expect = 3e-27
Identities = 40/222 (18%), Positives = 78/222 (35%), Gaps = 25/222 (11%)
Query: 432 LATIANATDNFSINNKLGEG--GFGPVYKGT-LVDGQEIAVKR--LSKISEQGLKELKNE 486
+++ + + +G+G V G+ + V+R L S + + L+ E
Sbjct: 17 MSSFLPEGGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGE 76
Query: 487 VILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIIC 546
+ + H N+V I E ++ FM S + ++ +I+
Sbjct: 77 LHVSKLFNHPNIVPYRATFIADNELWVVTSFMAYGSAKD-LICTHFMDGMNELAIAYILQ 135
Query: 547 GTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFG----LVRTFGGDET-EGNT 601
G + L Y+H +HR +KAS++L+ D +S ++
Sbjct: 136 GVLKALDYIHHM---GYVHRSVKASHILISVDGKVYLSGLRSNLSMISHGQRQRVVHDFP 192
Query: 602 NRVVGT-----------YDGQFSIKSDVFSFGILLLEIVSGK 632
V + KSD++S GI E+ +G
Sbjct: 193 KYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGH 234
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 113 bits (284), Expect = 4e-27
Identities = 46/219 (21%), Positives = 86/219 (39%), Gaps = 27/219 (12%)
Query: 437 NATDNFSINNKLGEGGFGPVYKGT-LVDGQEIAVKRLSKISEQGLKE-LKNEVILFSKLQ 494
+ + +++ LG+G V++G G A+K + IS + E + KL
Sbjct: 6 TSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLN 65
Query: 495 HRNLVKLLGCCIQGEEKLLIY---EFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARG 551
H+N+VKL + EF P SL + + + + L S+ ++ G
Sbjct: 66 HKNIVKLF-AIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGG 124
Query: 552 LLYLHQDSRLRIIHRDLKASNVLL----DQDMNPKISDFGLVRTFGGDE-------TEG- 599
+ +L + I+HR++K N++ D K++DFG R DE TE
Sbjct: 125 MNHLRE---NGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVSLYGTEEY 181
Query: 600 ------NTNRVVGTYDGQFSIKSDVFSFGILLLEIVSGK 632
+ + ++ D++S G+ +G
Sbjct: 182 LHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGS 220
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 109 bits (276), Expect = 8e-27
Identities = 57/209 (27%), Positives = 108/209 (51%), Gaps = 26/209 (12%)
Query: 440 DNFSINNKLGEGGFGPVYKGT-LVDGQEIAVKRLSK--ISEQGLKE-LKNEVILFSKLQH 495
++F + N LG+G F VY+ + G E+A+K + K + + G+ + ++NEV + +L+H
Sbjct: 11 EDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKH 70
Query: 496 RNLVKLLGCCIQGEEKL-LIYEFMPNKSLDSFIFDQTRRTLLDWSQRF--HIICGTARGL 552
++++L + + L+ E N ++ ++ ++ + + ++ F II G +
Sbjct: 71 PSILELYNY-FEDSNYVYLVLEMCHNGEMNRYLKNRVKPFSENEARHFMHQIITG----M 125
Query: 553 LYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNTNRVVGTYD--- 609
LYLH I+HRDL SN+LL ++MN KI+DFGL + T + GT +
Sbjct: 126 LYLH---SHGILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKHYT--LCGTPNYIS 180
Query: 610 ------GQFSIKSDVFSFGILLLEIVSGK 632
++SDV+S G + ++ G+
Sbjct: 181 PEIATRSAHGLESDVWSLGCMFYTLLIGR 209
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 111 bits (279), Expect = 1e-26
Identities = 57/234 (24%), Positives = 98/234 (41%), Gaps = 21/234 (8%)
Query: 411 SRETDQENEDQNIDLELPLFELATIANAT-DNFSINNKLGEGGFGPVYKGTLV-DGQEIA 468
E + +E Q LE L + + D+F ++LG G G V+K + G +A
Sbjct: 3 KLEELELDEQQRKRLEAFLTQKQKVGELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMA 62
Query: 469 VKRLS-KISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMPNKSLDSFI 527
K + +I ++ E+ + + +V G E + E M SLD +
Sbjct: 63 RKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVL 122
Query: 528 FDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFG 587
R + + +GL YL + +I+HRD+K SN+L++ K+ DFG
Sbjct: 123 KKAGR---IPEQILGKVSIAVIKGLTYLR--EKHKIMHRDVKPSNILVNSRGEIKLCDFG 177
Query: 588 LVRTFGGDETEGNTNRVVGTY---------DGQFSIKSDVFSFGILLLEIVSGK 632
G + N VGT +S++SD++S G+ L+E+ G+
Sbjct: 178 ----VSGQLIDSMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGR 227
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 109 bits (274), Expect = 3e-26
Identities = 46/214 (21%), Positives = 84/214 (39%), Gaps = 33/214 (15%)
Query: 440 DNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRL-SKISEQGLKELKNEV-ILFSKLQHR 496
++ ++G G G V+K G IAVK++ +++ K + ++ ++
Sbjct: 25 NDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCP 84
Query: 497 NLVKLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLH 556
+V+ G I + + E M + + + + L YL
Sbjct: 85 YIVQCFGTFITNTDVFIAMELM-GTCAEKLKKRMQGP--IPERILGKMTVAIVKALYYLK 141
Query: 557 QDSRLRIIHRDLKASNVLLDQDMNPKISDFG----LVRTFGGDETEGNTNRVVGTY---- 608
+ +IHRD+K SN+LLD+ K+ DFG LV +R G
Sbjct: 142 --EKHGVIHRDVKPSNILLDERGQIKLCDFGISGRLVDDKAK-------DRSAGCAAYMA 192
Query: 609 ----------DGQFSIKSDVFSFGILLLEIVSGK 632
+ I++DV+S GI L+E+ +G+
Sbjct: 193 PERIDPPDPTKPDYDIRADVWSLGISLVELATGQ 226
|
| >2r3i_A Cell division protein kinase 2; serine/threonine-protein kinase, cell cycle, inhibition, cyclin-dependent kinase, cancer, ATP-binding; HET: SCF; 1.28A {Homo sapiens} PDB: 2r3j_A* 2r3k_A* 2r3l_A* 2r3m_A* 2r3n_A* 2r3o_A* 2r3p_A* 2r3q_A* 1jvp_P* 1buh_A 1ckp_A* 1di8_A* 1dm2_A* 1f5q_A 1fin_A* 1fq1_B* 1fvt_A* 1fvv_A* 1g5s_A* 1gih_A* ... Length = 299 | Back alignment and structure |
|---|
Score = 106 bits (268), Expect = 1e-25
Identities = 56/174 (32%), Positives = 90/174 (51%), Gaps = 19/174 (10%)
Query: 440 DNFSINNKLGEGGFGPVYKGT-LVDGQEIAVKRLSKISEQ------GLKELKNEVILFSK 492
+NF K+GEG +G VYK + G+ +A+K++ +E ++E+ L +
Sbjct: 3 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREIS----LLKE 58
Query: 493 LQHRNLVKLLGCCIQGEEKL-LIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARG 551
L H N+VKLL I E KL L++EF+ + L F+ D + T + + +G
Sbjct: 59 LNHPNIVKLL-DVIHTENKLYLVFEFLH-QDLKKFM-DASALTGIPLPLIKSYLFQLLQG 115
Query: 552 LLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNTNRVV 605
L + H R++HRDLK N+L++ + K++DFGL R F G T+ VV
Sbjct: 116 LAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAF-GVPVRTYTHEVV 165
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 109 bits (274), Expect = 1e-25
Identities = 46/211 (21%), Positives = 83/211 (39%), Gaps = 30/211 (14%)
Query: 441 NFSINNKLGEGGFGPVYKGTLVDGQEIAVKRLSKISEQGLKELKNEVILFSKL-QHRNLV 499
+F + LG G G + + D +++AVKR+ + EV L + +H N++
Sbjct: 25 SFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILP---ECFSFADREVQLLRESDEHPNVI 81
Query: 500 KLLGCCIQGEEKL-LIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQD 558
+ C + + + E +L ++ + + + ++ T GL +LH
Sbjct: 82 RYF-CTEKDRQFQYIAIELCA-ATLQEYV--EQKDFAHLGLEPITLLQQTTSGLAHLHS- 136
Query: 559 SRLRIIHRDLKASNVLL-----DQDMNPKISDFGLVRTFGGDETE-GNTNRVVGT----- 607
L I+HRDLK N+L+ + ISDFGL + + V GT
Sbjct: 137 --LNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGWIA 194
Query: 608 -------YDGQFSIKSDVFSFGILLLEIVSG 631
+ D+FS G + ++S
Sbjct: 195 PEMLSEDCKENPTYTVDIFSAGCVFYYVISE 225
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 108 bits (270), Expect = 2e-25
Identities = 31/333 (9%), Positives = 71/333 (21%), Gaps = 53/333 (15%)
Query: 402 RNIAEKTENSRETDQENEDQNIDLELPLFELATIANATDNFSINNKLGEGGFGPVYKGTL 461
E + + + ++ + L G V+
Sbjct: 24 YCREEALKEPAAMVEAVTATVWPQNAETTVDSLLSQGERKLKLVEPLRVGDRSVVFLVRD 83
Query: 462 VD-GQEIAVKRLSK---ISEQGLKELKNEVILFSKLQHRNLVKLLGCC----------IQ 507
V+ ++ A+K + S L+ L ++L + + +Q
Sbjct: 84 VERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAVAVQ 143
Query: 508 GEEK----------------LLIYEFMP---NKSLDSFIFDQTRRTLLDWSQRFHIICGT 548
+ LL+ + F R +
Sbjct: 144 SQPPFAQLSPGQDDYAVANYLLLMPAASVDLELLFSTLDFVYVFRGDEGILALHILTAQL 203
Query: 549 ARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFG-GDETEGNTNR---- 603
R L ++H N+ + D + D + G
Sbjct: 204 IRLAANLQ---SKGLVHGHFTPDNLFIMPDGRLMLGDVSALWKVGTRGPASSVPVTYAPR 260
Query: 604 -VVGTYDGQFSIKSDVFSFGILLLEIVSGKKNRGFYRSDTKVNLIGHLWDEGIPLR---L 659
+ F+ + + G+ + + F + +P
Sbjct: 261 EFLNASTATFTHALNAWQLGLSIYRVWCLF--LPFGLVTPGIKGSWKRPSLRVPGTDSLA 318
Query: 660 IDACIQDSCNLADVIRCIHIGLLCVQQHPEDRP 692
+C + +I L R
Sbjct: 319 FGSCTPLPDFVKTLIG----RFLNF--DRRRRL 345
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 106 bits (268), Expect = 2e-25
Identities = 54/178 (30%), Positives = 87/178 (48%), Gaps = 18/178 (10%)
Query: 437 NATDNFSINNKLGEGGFGPVYKGT-LVDGQEIAVKRLSKISEQG-----LKELKNEVILF 490
+++ F KLG G + VYKG G +A+K + SE+G ++E+ L
Sbjct: 2 SSSSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREIS----LM 57
Query: 491 SKLQHRNLVKLLGCCIQGEEKL-LIYEFMPN--KSLDSFIFDQTRRTLLDWSQRFHIICG 547
+L+H N+V+L I E KL L++EFM N K L+ + +
Sbjct: 58 KELKHENIVRLY-DVIHTENKLTLVFEFMDNDLKKYMDSRTVGNTPRGLELNLVKYFQWQ 116
Query: 548 TARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNTNRVV 605
+GL + H++ +I+HRDLK N+L+++ K+ DFGL R F G ++ VV
Sbjct: 117 LLQGLAFCHEN---KILHRDLKPQNLLINKRGQLKLGDFGLARAF-GIPVNTFSSEVV 170
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 108 bits (271), Expect = 2e-25
Identities = 50/345 (14%), Positives = 91/345 (26%), Gaps = 76/345 (22%)
Query: 448 LGEGGFGPVYKGT-LVDGQEIAVKRLSK---ISEQGLKELKNEVILFSKLQH-------- 495
LG+ + T G+ V +K++K EV+ L+
Sbjct: 86 LGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAK 145
Query: 496 --------RNLVKLLGCCIQGEEK--------LLIYEFMPNKSLDSFIF------DQTRR 533
+LVK + L + P + F +
Sbjct: 146 VHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTH 205
Query: 534 TLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFG 593
L R + R L LH ++H L+ +++LDQ ++ F +
Sbjct: 206 KSLVHHARLQLTLQVIRLLASLH---HYGLVHTYLRPVDIVLDQRGGVFLTGFEHLVRD- 261
Query: 594 GDETEGNTNRVVGT--------------YDGQFSIKSDVFSFGILLLEIVSGKKNRGFYR 639
G R + + D ++ G+ + I
Sbjct: 262 GASAVSPIGRGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCAD--LPNTD 319
Query: 640 SDTKVNLIGHLWDEGIPLRLIDACIQDSCNLADVIRCIHIGLLCVQQHPEDRPCMPSVIL 699
G + +C + ++ G L + EDR +
Sbjct: 320 DAA----------LGGSEWIFRSCKNIPQPVRALLE----GFL--RYPKEDRLLPLQAME 363
Query: 700 MLGSEILLPQ--PKQPGYLAD----RKSTEPYSSSSMPESSSTNT 738
E L + P Y D R+ P S +S P+ +
Sbjct: 364 TPEYEQLRTELSAALPLYQTDGEPTREGGAPPSGTSQPDEAGAAE 408
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 105 bits (265), Expect = 2e-25
Identities = 58/218 (26%), Positives = 94/218 (43%), Gaps = 47/218 (21%)
Query: 440 DNFSINNKLGEGGFGPVYKGT-LVDGQEIAVKRLSK--ISEQGLKE-LKNEVILFSKLQH 495
++F I LG+G FG VY +A+K L K + + G++ L+ EV + S L+H
Sbjct: 9 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRH 68
Query: 496 RNLVKLLGCCIQGEEKL-LIYEFMPNKSLDSFIFDQTRRTLLDWSQRF------HIICGT 548
N+++L G ++ LI E+ P ++ + + ++ +F I
Sbjct: 69 PNILRLYGY-FHDATRVYLILEYAPLGTV----YRELQK-----LSKFDEQRTATYITEL 118
Query: 549 ARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNTNRVV-GT 607
A L Y H R+IHRD+K N+LL KI+DFG + + GT
Sbjct: 119 ANALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGW-----SVHAPSSRRTDLCGT 170
Query: 608 -------------YDGQFSIKSDVFSFGILLLEIVSGK 632
+D K D++S G+L E + GK
Sbjct: 171 LDYLPPEMIEGRMHDE----KVDLWSLGVLCYEFLVGK 204
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 106 bits (266), Expect = 3e-25
Identities = 58/173 (33%), Positives = 87/173 (50%), Gaps = 19/173 (10%)
Query: 440 DNFSINNKLGEGGFGPVYKGTLVDGQEIAVKRLSKISEQ------GLKELKNEVILFSKL 493
+ + K+GEG +G VYK G+ +A+KR+ +E ++E+ L +L
Sbjct: 21 EKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREIS----LLKEL 76
Query: 494 QHRNLVKLLGCCIQGEEKL-LIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGL 552
H N+V L+ I E L L++EFM K L + +T L SQ + RG+
Sbjct: 77 HHPNIVSLI-DVIHSERCLTLVFEFME-KDLKKVL--DENKTGLQDSQIKIYLYQLLRGV 132
Query: 553 LYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNTNRVV 605
+ HQ RI+HRDLK N+L++ D K++DFGL R F G T+ VV
Sbjct: 133 AHCHQH---RILHRDLKPQNLLINSDGALKLADFGLARAF-GIPVRSYTHEVV 181
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 110 bits (276), Expect = 3e-25
Identities = 54/215 (25%), Positives = 88/215 (40%), Gaps = 28/215 (13%)
Query: 439 TDNFSINNKLGEGGFGPVYKGT-LVDGQEIAVKRLSKISEQGLKE-LKNEVILFSKLQHR 496
+ + +LG GGFG V + G+++A+K+ + +E E+ + KL H
Sbjct: 13 CGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHP 72
Query: 497 NLVKLLGCCIQGEEKL-------LIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTA 549
N+V G +KL L E+ L ++ L ++ +
Sbjct: 73 NVVSAR-EVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDIS 131
Query: 550 RGLLYLHQDSRLRIIHRDLKASNVLLD---QDMNPKISDFGLVRTFGGDETEGNTNRVVG 606
L YLH+ RIIHRDLK N++L Q + KI D G + E VG
Sbjct: 132 SALRYLHE---NRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGE---LCTEFVG 185
Query: 607 T--------YDGQ-FSIKSDVFSFGILLLEIVSGK 632
T + + +++ D +SFG L E ++G
Sbjct: 186 TLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGF 220
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 106 bits (266), Expect = 4e-25
Identities = 54/173 (31%), Positives = 86/173 (49%), Gaps = 15/173 (8%)
Query: 440 DNFSINNKLGEGGFGPVYKGT-LVDGQEIAVKRLSKISEQGLKELKN-----EVILFSKL 493
+ + LGEG F VYK Q +A+K++ K+ N E+ L +L
Sbjct: 10 KRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQEL 69
Query: 494 QHRNLVKLLGCCIQGEEKL-LIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGL 552
H N++ LL + + L+++FM L+ I + +L S + T +GL
Sbjct: 70 SHPNIIGLLDA-FGHKSNISLVFDFME-TDLEVII--KDNSLVLTPSHIKAYMLMTLQGL 125
Query: 553 LYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNTNRVV 605
YLHQ I+HRDLK +N+LLD++ K++DFGL ++F G T++VV
Sbjct: 126 EYLHQH---WILHRDLKPNNLLLDENGVLKLADFGLAKSF-GSPNRAYTHQVV 174
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 7e-25
Identities = 50/232 (21%), Positives = 88/232 (37%), Gaps = 52/232 (22%)
Query: 440 DNFSINNKLGEGGFGPVYKGTLV--DGQEIAVKRLSK-----------------ISEQGL 480
+++ I L +G F + L D + A+K+ K +
Sbjct: 31 NDYRIIRTLNQGKFNKII---LCEKDNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKY 87
Query: 481 KELKNEVILFSKLQHRNLVKLLGCCIQGEEKL-LIYEFMPNKSLDSFI-----FDQTRRT 534
+ KNE+ + + +++ + G I +++ +IYE+M N S+ F D+
Sbjct: 88 DDFKNELQIITDIKNEYCLTCEGI-ITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTC 146
Query: 535 LLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGG 594
+ II Y+H + I HRD+K SN+L+D++ K+SDFG
Sbjct: 147 FIPIQVIKCIIKSVLNSFSYIH--NEKNICHRDVKPSNILMDKNGRVKLSDFGESEYM-- 202
Query: 595 DETEGNTNRVVGT--------------YDGQFSIKSDVFSFGILLLEIVSGK 632
+ GT Y+G K D++S GI L +
Sbjct: 203 --VDKKIKGSRGTYEFMPPEFFSNESSYNGA---KVDIWSLGICLYVMFYNV 249
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 2e-24
Identities = 49/173 (28%), Positives = 86/173 (49%), Gaps = 19/173 (10%)
Query: 440 DNFSINNKLGEGGFGPVYKGT-LVDGQEIAVKRLSKISEQG-----LKELKNEVILFSKL 493
+ + +KLGEG + VYKG + +A+K + E+G ++E+ L L
Sbjct: 2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVS----LLKDL 57
Query: 494 QHRNLVKLLGCCIQGEEKL-LIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGL 552
+H N+V L I E+ L L++E++ +K L ++ +++ + RGL
Sbjct: 58 KHANIVTLH-DIIHTEKSLTLVFEYL-DKDLKQYL--DDCGNIINMHNVKLFLFQLLRGL 113
Query: 553 LYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNTNRVV 605
Y H+ +++HRDLK N+L+++ K++DFGL R T+ N VV
Sbjct: 114 AYCHRQ---KVLHRDLKPQNLLINERGELKLADFGLARAK-SIPTKTYDNEVV 162
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 2e-24
Identities = 45/174 (25%), Positives = 83/174 (47%), Gaps = 20/174 (11%)
Query: 440 DNFSINNKLGEGGFGPVYKGT-LVDGQEIAVKRLSKISEQ------GLKELKNEVILFSK 492
+ K+GEG +G V+K + +A+KR+ + L+E+ L +
Sbjct: 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREIC----LLKE 57
Query: 493 LQHRNLVKLLGCCIQGEEKL-LIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARG 551
L+H+N+V+L + ++KL L++EF + L + + LD + +G
Sbjct: 58 LKHKNIVRLH-DVLHSDKKLTLVFEFCD-QDLKKYF--DSCNGDLDPEIVKSFLFQLLKG 113
Query: 552 LLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNTNRVV 605
L + H ++HRDLK N+L++++ K+++FGL R F G + VV
Sbjct: 114 LGFCHSR---NVLHRDLKPQNLLINRNGELKLANFGLARAF-GIPVRCYSAEVV 163
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 102 bits (257), Expect = 3e-24
Identities = 47/173 (27%), Positives = 83/173 (47%), Gaps = 19/173 (10%)
Query: 440 DNFSINNKLGEGGFGPVYKGTLVDGQEIAVKRLSKISEQ------GLKELKNEVILFSKL 493
+ + K+GEG +G VYK G+ A+K++ E ++E+ + +L
Sbjct: 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREIS----ILKEL 57
Query: 494 QHRNLVKLLGCCIQGEEKL-LIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGL 552
+H N+VKL I +++L L++E + + L + L+ + G+
Sbjct: 58 KHSNIVKLY-DVIHTKKRLVLVFEHLD-QDLKKLL--DVCEGGLESVTAKSFLLQLLNGI 113
Query: 553 LYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNTNRVV 605
Y H R++HRDLK N+L++++ KI+DFGL R F G T+ +V
Sbjct: 114 AYCHDR---RVLHRDLKPQNLLINREGELKIADFGLARAF-GIPVRKYTHEIV 162
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 101 bits (255), Expect = 5e-24
Identities = 74/302 (24%), Positives = 130/302 (43%), Gaps = 44/302 (14%)
Query: 444 INNKLGEGGFGPVYKGT-LVDGQEIAVKRLS---KISEQGLKELKNEVILFSKLQHRNLV 499
I +KLG GG VY + ++A+K + + E+ LK + EV S+L H+N+V
Sbjct: 15 IVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIV 74
Query: 500 KLLGCCIQGEEKLLIY---EFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLH 556
++ EE Y E++ +L +I L + G+ + H
Sbjct: 75 SMID---VDEEDDCYYLVMEYIEGPTLSEYIESHGP---LSVDTAINFTNQILDGIKHAH 128
Query: 557 QDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNTNRVVGT--Y------ 608
+RI+HRD+K N+L+D + KI DFG+ + + + TN V+GT Y
Sbjct: 129 ---DMRIVHRDIKPQNILIDSNKTLKIFDFGIAKAL-SETSLTQTNHVLGTVQYFSPEQA 184
Query: 609 -DGQFSIKSDVFSFGILLLEIVSGKKNRGFYRSDTKVNL-IGHLWDEG-IPLRLIDACIQ 665
+D++S GI+L E++ G+ + +T V++ I H+ D + I
Sbjct: 185 KGEATDECTDIYSIGIVLYEMLVGEPP---FNGETAVSIAIKHIQDSVPNVTTDVRKDIP 241
Query: 666 DSCNLADVIRCIHIGLLCVQQHPEDRPCMPSVILMLG--SEILLP-QPKQPGYLADRKST 722
S L++VI L ++ +R ++ M S +L + + Y D+ T
Sbjct: 242 QS--LSNVI------LRATEKDKANRY--KTIQEMKDDLSSVLHENRANEDVYELDKMKT 291
Query: 723 EP 724
Sbjct: 292 IA 293
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 102 bits (255), Expect = 1e-23
Identities = 32/222 (14%), Positives = 62/222 (27%), Gaps = 31/222 (13%)
Query: 439 TDNFSINNKLGEGGFGPVYKGTLVD------GQEIAVKRLSKISEQGLKELKNEVILFSK 492
+ +++ LGEG F VY+ T D Q+ +K + +
Sbjct: 64 SKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKP 123
Query: 493 LQHRNLVKLLGCCIQGEEKLLIYEFMPNKSLDSFI--FDQTRRTLLDWSQRFHIICGTAR 550
+K + +L+ E +L + I + T ++
Sbjct: 124 SMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLY 183
Query: 551 GLLYLHQDSRLRIIHRDLKASNVLL-----------DQDMNPKISDFGLVRTFGGDETEG 599
+ +H IIH D+K N +L D + D G
Sbjct: 184 MIEQVHD---CEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGT 240
Query: 600 NTNRVVGT--YDGQ-------FSIKSDVFSFGILLLEIVSGK 632
T + ++ + D F + ++ G
Sbjct: 241 IFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGT 282
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 99 bits (250), Expect = 2e-23
Identities = 54/218 (24%), Positives = 92/218 (42%), Gaps = 47/218 (21%)
Query: 440 DNFSINNKLGEGGFGPVYKGTLVD-GQEIAVKRLSK--ISEQGLKE-LKNEVILFSKLQH 495
D+F I LG+G FG VY +A+K L K + ++G++ L+ E+ + S L+H
Sbjct: 14 DDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRH 73
Query: 496 RNLVKLLGCCIQGEEKL-LIYEFMPNKSLDSFIFDQTRRTLLDWSQRF------HIICGT 548
N++++ +++ L+ EF P L + + ++ RF +
Sbjct: 74 PNILRMYNY-FHDRKRIYLMLEFAPRGEL----YKELQK-----HGRFDEQRSATFMEEL 123
Query: 549 ARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGL-VRTFGGDETEGNTNRVVGT 607
A L Y H ++IHRD+K N+L+ KI+DFG V + GT
Sbjct: 124 ADALHYCH---ERKVIHRDIKPENLLMGYKGELKIADFGWSVHAPS-----LRRRTMCGT 175
Query: 608 -------------YDGQFSIKSDVFSFGILLLEIVSGK 632
+D K D++ G+L E + G
Sbjct: 176 LDYLPPEMIEGKTHDE----KVDLWCAGVLCYEFLVGM 209
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 2e-23
Identities = 40/173 (23%), Positives = 76/173 (43%), Gaps = 18/173 (10%)
Query: 440 DNFSINNKLGEGGFGPVYKGT-LVDGQEIAVKRLSKISEQGLKELKN-----EVILFSKL 493
+ + K+GEG +G V+K GQ +A+K K E + E+ + +L
Sbjct: 3 EKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIK---KFLESEDDPVIKKIALREIRMLKQL 59
Query: 494 QHRNLVKLLGCCIQGEEKL-LIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGL 552
+H NLV LL + + +L L++E+ + ++ + + + I T + +
Sbjct: 60 KHPNLVNLL-EVFRRKRRLHLVFEYC-DHTVLHEL--DRYQRGVPEHLVKSITWQTLQAV 115
Query: 553 LYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNTNRVV 605
+ H+ IHRD+K N+L+ + K+ DFG R ++ + V
Sbjct: 116 NFCHKH---NCIHRDVKPENILITKHSVIKLCDFGFARLL-TGPSDYYDDEVA 164
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 102 bits (255), Expect = 6e-23
Identities = 58/240 (24%), Positives = 98/240 (40%), Gaps = 23/240 (9%)
Query: 407 KTENSRETDQENEDQNIDLELPLFELATIANATDNFSINNKLGEGGFGPVYKGT-LVDGQ 465
+S + ++ +F + + ++ + KLG G +G V V
Sbjct: 4 HHHHSSGRENLYFQGDLQATPGMFITSKKGHLSEMYQRVKKLGSGAYGEVLLCRDKVTHV 63
Query: 466 EIAVKRLSK--ISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMPNKSL 523
E A+K + K +S +L EV + L H N++KL L+ E L
Sbjct: 64 ERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLVMECYKGGEL 123
Query: 524 DSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLL---DQDMN 580
I + + +D + + G+ YLH+ I+HRDLK N+LL ++D
Sbjct: 124 FDEIIHRMKFNEVDAAVIIKQVLS---GVTYLHK---HNIVHRDLKPENLLLESKEKDAL 177
Query: 581 PKISDFGLVRTFGGDETEGNTNRVVGT--Y------DGQFSIKSDVFSFGILLLEIVSGK 632
KI DFGL F + +GT Y ++ K DV+S G++L +++G
Sbjct: 178 IKIVDFGLSAVFENQKK---MKERLGTAYYIAPEVLRKKYDEKCDVWSIGVILFILLAGY 234
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 99.2 bits (248), Expect = 7e-23
Identities = 51/185 (27%), Positives = 79/185 (42%), Gaps = 38/185 (20%)
Query: 440 DNFSINNKLGEGGFGPVYKGT-LVDGQEIAVKRLSKISEQ------GLKELKNEVILFSK 492
D + KLGEG +G VYK V + +A+KR+ E+ ++E+ L +
Sbjct: 34 DRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVS----LLKE 89
Query: 493 LQHRNLVKLLGCCIQGEEKL-LIYEFMPNKSLDSFIFDQTRRTLLDWSQRF---HIICGT 548
LQHRN+++L I +L LI+E+ + + +D + I
Sbjct: 90 LQHRNIIELK-SVIHHNHRLHLIFEYA----------ENDLKKYMDKNPDVSMRVIKSFL 138
Query: 549 A---RGLLYLHQDSRLRIIHRDLKASNVLLDQDMNP-----KISDFGLVRTFGGDETEGN 600
G+ + H R +HRDLK N+LL KI DFGL R F G
Sbjct: 139 YQLINGVNFCHSR---RCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAF-GIPIRQF 194
Query: 601 TNRVV 605
T+ ++
Sbjct: 195 THEII 199
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 98.8 bits (247), Expect = 1e-22
Identities = 45/185 (24%), Positives = 82/185 (44%), Gaps = 33/185 (17%)
Query: 440 DNFSINNKLGEGGFGPVYKG--TLVDGQEIAVKRLSKISEQG------------LKELKN 485
+ ++GEG +G V+K G+ +A+KR+ + + L+ L+
Sbjct: 11 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLET 70
Query: 486 EVILFSKLQHRNLVKLL----GCCIQGEEKL-LIYEFMPNKSLDSFIFDQTRRTLLDWSQ 540
+H N+V+L E KL L++E + ++ L +++ D+ +
Sbjct: 71 F-------EHPNVVRLFDVCTVSRTDRETKLTLVFEHV-DQDLTTYL-DKVPEPGVPTET 121
Query: 541 RFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGN 600
++ RGL +LH R++HRDLK N+L+ K++DFGL R +
Sbjct: 122 IKDMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMAL-- 176
Query: 601 TNRVV 605
T+ VV
Sbjct: 177 TSVVV 181
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 102 bits (255), Expect = 1e-22
Identities = 35/208 (16%), Positives = 79/208 (37%), Gaps = 37/208 (17%)
Query: 444 INNKLGEGGFGPVYKG--TLVDGQEIAVKRLSKISEQGLKE-LKNEVILFSKLQHRNLVK 500
+ + GG G +Y V+G+ + +K L + + E +++ H ++V+
Sbjct: 84 VKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQ 143
Query: 501 LLGCCIQGEE-----KLLIY---EFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGL 552
+ E + Y E++ +SL +++ L ++ + L
Sbjct: 144 IFN---FVEHTDRHGDPVGYIVMEYVGGQSLK-----RSKGQKLPVAEAIAYLLEILPAL 195
Query: 553 LYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNTNRVVGT--Y-- 608
YLH + +++ DLK N++L ++ K+ D G V + GT +
Sbjct: 196 SYLH---SIGLVYNDLKPENIMLTEE-QLKLIDLGAVSRINS------FGYLYGTPGFQA 245
Query: 609 ----DGQFSIKSDVFSFGILLLEIVSGK 632
++ +D+++ G L +
Sbjct: 246 PEIVRTGPTVATDIYTVGRTLAALTLDL 273
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 99.3 bits (247), Expect = 2e-22
Identities = 42/358 (11%), Positives = 91/358 (25%), Gaps = 70/358 (19%)
Query: 390 VLIAGYLIRKRRRNIAEKTENSRE-TDQENEDQNIDLELPLFELATIANATDNFSINNKL 448
V+I R + N+ +E + D + P + + L
Sbjct: 22 VVIEELFNRIPQANVRTTSEYMQSAADSLVSTSLWNTGQPFRVESELGERPRTLVRGTVL 81
Query: 449 GEGGFGPVYKGT-LVDGQEIAVKRLSK---ISEQGLKELKNEVILFSKLQ---------- 494
G+ + T G+ V +K++K EV+ L+
Sbjct: 82 GQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKV 141
Query: 495 ---------------HRNLVKLLGCCIQGEEK--LLIYEFMPNKSLDSF--IFDQTR-RT 534
+ ++++ +Y M + + +
Sbjct: 142 HLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTHK 201
Query: 535 LLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGG 594
L R + R L LH ++H L+ +++LDQ ++ F + G
Sbjct: 202 SLVHHARLQLTLQVIRLLASLH---HYGLVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGA 258
Query: 595 DETEGNTNRVV--------------GTYDGQFSIKSDVFSFGILLLEIVSGKKNRGFYRS 640
+ + D ++ G+++ I +
Sbjct: 259 RVVSSVSRGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIWCAD--LPITKD 316
Query: 641 DTKVNLIGHLWDEGIPLRLIDACIQDSCNLADVIRCIHIGLLCVQQHPEDRPCMPSVI 698
G + +C + ++ G L EDR +
Sbjct: 317 A----------ALGGSEWIFRSCKNIPQPVRALLE----GFLRY--PKEDRLLPLQAM 358
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 97.6 bits (244), Expect = 2e-22
Identities = 47/189 (24%), Positives = 81/189 (42%), Gaps = 35/189 (18%)
Query: 438 ATDNFSINNKLGEGGFGPVYKGT-LVDGQEIAVKRLSKISEQG---------------LK 481
AT + ++G G +G VYK G +A+K + + G L+
Sbjct: 7 ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLR 66
Query: 482 ELKNEVILFSKLQHRNLVKLL----GCCIQGEEKL-LIYEFMPNKSLDSFIFDQTRRTLL 536
L+ +H N+V+L+ E K+ L++E + ++ L +++ D+ L
Sbjct: 67 RLEAF-------EHPNVVRLMDVCATSRTDREIKVTLVFEHV-DQDLRTYL-DKAPPPGL 117
Query: 537 DWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDE 596
++ RGL +LH + I+HRDLK N+L+ K++DFGL R +
Sbjct: 118 PAETIKDLMRQFLRGLDFLHAN---CIVHRDLKPENILVTSGGTVKLADFGLARIYSYQM 174
Query: 597 TEGNTNRVV 605
T VV
Sbjct: 175 A--LTPVVV 181
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 98.1 bits (245), Expect = 2e-22
Identities = 44/173 (25%), Positives = 77/173 (44%), Gaps = 18/173 (10%)
Query: 440 DNFSINNKLGEGGFGPVYKGT-LVDGQEIAVKRLSKISEQGLKELKN-----EVILFSKL 493
+ + +GEG +G V K G+ +A+K K E ++ E+ L +L
Sbjct: 25 EKYENLGLVGEGSYGMVMKCRNKDTGRIVAIK---KFLESDDDKMVKKIAMREIKLLKQL 81
Query: 494 QHRNLVKLLGCCIQGEEKL-LIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGL 552
+H NLV LL + +++ L++EF+ + ++ + + LD+ + G+
Sbjct: 82 RHENLVNLL-EVCKKKKRWYLVFEFV-DHTILDDL--ELFPNGLDYQVVQKYLFQIINGI 137
Query: 553 LYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNTNRVV 605
+ H IIHRD+K N+L+ Q K+ DFG RT E + V
Sbjct: 138 GFCHSH---NIIHRDIKPENILVSQSGVVKLCDFGFARTL-AAPGEVYDDEVA 186
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 98.9 bits (247), Expect = 2e-22
Identities = 47/219 (21%), Positives = 91/219 (41%), Gaps = 43/219 (19%)
Query: 439 TDNFSINNKLGEGGFGPVYKGTLVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNL 498
++ +G G FG V++ LV+ E+A+K++ + +EL+ + ++H N+
Sbjct: 39 EIAYTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQDKRFKNRELQ----IMRIVKHPNV 94
Query: 499 VKLLGCCIQGEEKL------LIYEFMP---NKSLDSFIFDQTRRTLLDWSQRFHI----- 544
V L +K L+ E++P ++ + + +L I
Sbjct: 95 VDLKAFFYSNGDKKDEVFLNLVLEYVPETVYRASRHYAKLKQTMPML------LIKLYMY 148
Query: 545 -ICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNP-KISDFGLVRTFGGDETEGNTN 602
+ R L Y+H + I HRD+K N+LLD K+ DFG + E N +
Sbjct: 149 QLL---RSLAYIHS---IGICHRDIKPQNLLLDPPSGVLKLIDFGSAKIL--IAGEPNVS 200
Query: 603 RVVGTY---------DGQFSIKSDVFSFGILLLEIVSGK 632
+ Y ++ D++S G ++ E++ G+
Sbjct: 201 YICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQ 239
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 97.3 bits (243), Expect = 2e-22
Identities = 67/316 (21%), Positives = 128/316 (40%), Gaps = 49/316 (15%)
Query: 444 INNKLGEGGFGPVYKGT-LVDGQEIAVK----RLSKISEQGLKELKNEVILFSKLQHRNL 498
+ LG GG V+ L D +++AVK L++ + E + L H +
Sbjct: 16 LGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLAR-DPSFYLRFRREAQNAAALNHPAI 74
Query: 499 VKLLGCCIQGEEKL-------LIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARG 551
V + GE + ++ E++ +L + + + + +I +
Sbjct: 75 VAVYD---TGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGP---MTPKRAIEVIADACQA 128
Query: 552 LLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDE-TEGNTNRVVGT--Y 608
L + H + IIHRD+K +N+++ K+ DFG+ R + T V+GT Y
Sbjct: 129 LNFSH---QNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQY 185
Query: 609 -------DGQFSIKSDVFSFGILLLEIVSGKKNRGFYRSDTKVNL-IGHLWDEGIPLRLI 660
+SDV+S G +L E+++G+ + D+ V++ H+ ++ IP
Sbjct: 186 LSPEQARGDSVDARSDVYSLGCVLYEVLTGEPP---FTGDSPVSVAYQHVREDPIPPSAR 242
Query: 661 DACIQDSCNLADVIRCIHIGLLCVQQHPEDRPCMPSVILMLG--SEILLPQPKQ-PGYLA 717
+ L V+ L + ++PE+R + M + +P + P L
Sbjct: 243 HEGLSAD--LDAVV------LKALAKNPENRY--QTAAEMRADLVRVHNGEPPEAPKVLT 292
Query: 718 DRKSTEPYSSSSMPES 733
D + T SS++ S
Sbjct: 293 DAERTSLLSSAAGNLS 308
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 97.3 bits (243), Expect = 3e-22
Identities = 60/215 (27%), Positives = 89/215 (41%), Gaps = 37/215 (17%)
Query: 440 DNFSINNKLGEGGFGPVYKGTLVDGQEI-AVKRLSK---ISEQGLKELKNEVILFSKLQH 495
++F LGEG F V + A+K L K I E + + E + S+L H
Sbjct: 30 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 89
Query: 496 RNLVKLLGCCIQGEEKL-LIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTAR---- 550
VKL Q +EKL + N L R+ F C R
Sbjct: 90 PFFVKLYFTF-QDDEKLYFGLSYAKNGEL----LKYIRK-----IGSFDETC--TRFYTA 137
Query: 551 ----GLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNTNRVVG 606
L YLH IIHRDLK N+LL++DM+ +I+DFG + + + N VG
Sbjct: 138 EIVSALEYLHG---KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVG 194
Query: 607 T--Y-------DGQFSIKSDVFSFGILLLEIVSGK 632
T Y + SD+++ G ++ ++V+G
Sbjct: 195 TAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGL 229
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 96.9 bits (242), Expect = 3e-22
Identities = 50/209 (23%), Positives = 82/209 (39%), Gaps = 35/209 (16%)
Query: 448 LGEGGFGPVYKGT-LVDGQEIAVKRLSK----ISEQGLKELKNEVILFSKLQHRNLVKLL 502
LGEG +G V + AVK L K G +K E+ L +L+H+N+++L+
Sbjct: 13 LGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLV 72
Query: 503 GCCIQGEEKLLIY---EFMPNKSLDSFIFDQTRRTLLDWSQRF--HIICGTARGLLYLHQ 557
+ EEK +Y E+ + +R + + + +I G YLH
Sbjct: 73 DV-LYNEEKQKMYMVMEYCVCGMQEMLDSVPEKRFPVCQAHGYFCQLIDGLE----YLH- 126
Query: 558 DSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNTNRVVGT---------- 607
I+H+D+K N+LL KIS G+ + G+
Sbjct: 127 --SQGIVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCRTSQGSPAFQPPEIAN 184
Query: 608 ----YDGQFSIKSDVFSFGILLLEIVSGK 632
+ G K D++S G+ L I +G
Sbjct: 185 GLDTFSGF---KVDIWSAGVTLYNITTGL 210
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 99.4 bits (248), Expect = 4e-22
Identities = 62/209 (29%), Positives = 97/209 (46%), Gaps = 26/209 (12%)
Query: 439 TDNFSINNKLGEGGFGPVYKGT-LVDGQEIAVKRLSK---ISEQGLKELKNEVILFSKLQ 494
+D + LG+G FG V + GQE AVK +SK + + L EV L +L
Sbjct: 25 SDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLD 84
Query: 495 HRNLVKLLGCCIQGEEKL-LIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLL 553
H N++KL + + L+ E L I + R + +D ++ + G+
Sbjct: 85 HPNIMKLYEFF-EDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAARIIRQVLS---GIT 140
Query: 554 YLHQDSRLRIIHRDLKASNVLL---DQDMNPKISDFGLVRTFGGDETEGNTNRVVGT--Y 608
Y+H+ +I+HRDLK N+LL +D N +I DFGL F + +GT Y
Sbjct: 141 YMHK---NKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKK---MKDKIGTAYY 194
Query: 609 ------DGQFSIKSDVFSFGILLLEIVSG 631
G + K DV+S G++L ++SG
Sbjct: 195 IAPEVLHGTYDEKCDVWSTGVILYILLSG 223
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 98.3 bits (245), Expect = 6e-22
Identities = 50/229 (21%), Positives = 81/229 (35%), Gaps = 45/229 (19%)
Query: 440 DNFSINNKLGEGGFGPVYKGTLVDGQEIAVKRLSKISEQGLKELKNEV-ILFSKLQHRNL 498
+ LG G G V G+ +AVKR+ E+ +L H N+
Sbjct: 15 NLVVSEKILGYGSSGTVVFQGSFQGRPVAVKRMLI---DFCDIALMEIKLLTESDDHPNV 71
Query: 499 VKLLGCCIQGEEKL-LIYEFMPNKSLDSFI----FDQTRRTLLDWSQRFHIICGTARGLL 553
++ C + L + E N +L + L ++ A G+
Sbjct: 72 IRYY-CSETTDRFLYIALELC-NLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVA 129
Query: 554 YLHQDSRLRIIHRDLKASNVLLD-------------QDMNPKISDFGLVRTFGGDET--E 598
+LH L+IIHRDLK N+L+ +++ ISDFGL + ++
Sbjct: 130 HLHS---LKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSFR 186
Query: 599 GNTNRVVGT----------------YDGQFSIKSDVFSFGILLLEIVSG 631
N N GT + + D+FS G + I+S
Sbjct: 187 TNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSK 235
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 96.6 bits (241), Expect = 7e-22
Identities = 63/210 (30%), Positives = 100/210 (47%), Gaps = 32/210 (15%)
Query: 441 NFSINNKLGEGGFGPVYKGT-LVDGQEIAVKRL--SKISEQGLKELKNEVILFSKLQHRN 497
N+ + +G+G F V ++ G+E+A+K + ++++ L++L EV + L H N
Sbjct: 16 NYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPN 75
Query: 498 LVKLLGCCIQGEEKL-LIYEFMPNKSLDSFIFDQTRRTLLDWSQRFH-IICGTARGLLYL 555
+VKL I+ E+ L LI E+ + ++ R + +F I+ Y
Sbjct: 76 IVKLFEV-IETEKTLYLIMEYASGGEVFDYLVAHGRMKEKEARSKFRQIVSAVQ----YC 130
Query: 556 HQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNTNRVVGT-------- 607
H + RI+HRDLKA N+LLD DMN KI+DFG F + G
Sbjct: 131 H---QKRIVHRDLKAENLLLDADMNIKIADFGFSNEFTVGGKL---DAFCGAPPYAAPEL 184
Query: 608 -----YDGQFSIKSDVFSFGILLLEIVSGK 632
YDG + DV+S G++L +VSG
Sbjct: 185 FQGKKYDGP---EVDVWSLGVILYTLVSGS 211
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 95.3 bits (238), Expect = 7e-22
Identities = 60/205 (29%), Positives = 87/205 (42%), Gaps = 36/205 (17%)
Query: 448 LGEGGFGPVYKGT-LVDGQEIAVKRLSKISEQGLKE-LKNEVILFSKLQHRNLVKLLGCC 505
LGEG +G V V + +AVK + E +K E+ + L H N+VK G
Sbjct: 15 LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGH- 73
Query: 506 IQGEEKL-LIYEFMPNKSLDSFIFD---QTRRTLLDWSQRF--HIICGTARGLLYLHQDS 559
+ L E+ L FD +QRF ++ G YLH
Sbjct: 74 RREGNIQYLFLEYCSGGEL----FDRIEPDIGMPEPDAQRFFHQLMAGVV----YLH--- 122
Query: 560 RLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNTNRVVGT------------ 607
+ I HRD+K N+LLD+ N KISDFGL F + E N++ GT
Sbjct: 123 GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRR 182
Query: 608 -YDGQFSIKSDVFSFGILLLEIVSG 631
+ + DV+S GI+L +++G
Sbjct: 183 EFHAE---PVDVWSCGIVLTAMLAG 204
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 95.1 bits (237), Expect = 2e-21
Identities = 60/205 (29%), Positives = 87/205 (42%), Gaps = 36/205 (17%)
Query: 448 LGEGGFGPVYKGT-LVDGQEIAVKRLSKISEQGLKE-LKNEVILFSKLQHRNLVKLLGCC 505
LGEG +G V V + +AVK + E +K E+ + L H N+VK G
Sbjct: 15 LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGH- 73
Query: 506 IQGEEKL-LIYEFMPNKSLDSFIFD---QTRRTLLDWSQRF--HIICGTARGLLYLHQDS 559
+ L E+ L FD +QRF ++ G YLH
Sbjct: 74 RREGNIQYLFLEYCSGGEL----FDRIEPDIGMPEPDAQRFFHQLMAGVV----YLH--- 122
Query: 560 RLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNTNRVVGT------------ 607
+ I HRD+K N+LLD+ N KISDFGL F + E N++ GT
Sbjct: 123 GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRR 182
Query: 608 -YDGQFSIKSDVFSFGILLLEIVSG 631
+ + DV+S GI+L +++G
Sbjct: 183 EFHAE---PVDVWSCGIVLTAMLAG 204
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 94.6 bits (236), Expect = 2e-21
Identities = 53/265 (20%), Positives = 99/265 (37%), Gaps = 37/265 (13%)
Query: 444 INNKLGEGGFGPVYKGT-LVDGQEIAVKRLSK--ISEQGLKE-LKNEVILFSKLQHRNLV 499
+ +G GG G VY+ V + +A+K +S+ S+ + ++ E +LQ ++V
Sbjct: 38 LRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVV 97
Query: 500 KLLGCCIQGEEKLLIY---EFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLH 556
+ GE +Y + L + + R+ L + I+ L H
Sbjct: 98 PIHD---FGEIDGQLYVDMRLINGVDLAAML---RRQGPLAPPRAVAIVRQIGSALDAAH 151
Query: 557 QDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNTNRVVGTY-------- 608
HRD+K N+L+ D + DFG+ DE VGT
Sbjct: 152 AA---GATHRDVKPENILVSADDFAYLVDFGIASA-TTDEKLTQLGNTVGTLYYMAPERF 207
Query: 609 -DGQFSIKSDVFSFGILLLEIVSGKKNRGFYRSDTKVNLIGHLWDEGIPLRLIDACIQDS 667
+ + ++D+++ +L E ++G Y+ D + H+ + I +
Sbjct: 208 SESHATYRADIYALTCVLYECLTGSPP---YQGDQLSVMGAHINQAIPRPSTVRPGIPVA 264
Query: 668 CNLADVIRCIHIGLLCVQQHPEDRP 692
VI + ++PEDR
Sbjct: 265 --FDAVI------ARGMAKNPEDRY 281
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 97.1 bits (242), Expect = 2e-21
Identities = 62/210 (29%), Positives = 95/210 (45%), Gaps = 29/210 (13%)
Query: 439 TDNFSINNKLGEGGFGPVYKGT-LVDGQEIAVKRLSK--ISEQGLKELKNEVILFSKLQH 495
+ ++I LG+G FG V K + QE AVK ++K + + EV L KL H
Sbjct: 21 AERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDH 80
Query: 496 RNLVKLLGCCIQGEEKLLIY---EFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGL 552
N++KL E+ Y E L I + R + D ++ + G+
Sbjct: 81 PNIMKLFEIL---EDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFS---GI 134
Query: 553 LYLHQDSRLRIIHRDLKASNVLL---DQDMNPKISDFGLVRTFGGDETEGNTNRVVGT-- 607
Y+H+ I+HRDLK N+LL ++D + KI DFGL F + +GT
Sbjct: 135 TYMHK---HNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTK---MKDRIGTAY 188
Query: 608 Y------DGQFSIKSDVFSFGILLLEIVSG 631
Y G + K DV+S G++L ++SG
Sbjct: 189 YIAPEVLRGTYDEKCDVWSAGVILYILLSG 218
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 94.8 bits (236), Expect = 3e-21
Identities = 53/248 (21%), Positives = 93/248 (37%), Gaps = 52/248 (20%)
Query: 441 NFSINNKLGEGGFGPVYKGT-LVDGQEIAVKRLSK--------ISEQGLKELKNEVILFS 491
+S + LG G FG V+ +E+ VK + K I + L ++ E+ + S
Sbjct: 25 KYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILS 84
Query: 492 KLQHRNLVKLLGCCIQGEEKL-LIYEFMPN-KSLDSFIFDQTRRTLLDWSQRFH-IICGT 548
+++H N++K+L + + L+ E + L +FI R S F ++
Sbjct: 85 RVEHANIIKVLDI-FENQGFFQLVMEKHGSGLDLFAFIDRHPRLDEPLASYIFRQLVSAV 143
Query: 549 ARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNTNRVVGT- 607
YL IIHRD+K N+++ +D K+ DFG E GT
Sbjct: 144 G----YLR---LKDIIHRDIKDENIVIAEDFTIKLIDFGSAAYL---ERGKLFYTFCGTI 193
Query: 608 ------------YDGQFSIKSDVFSFGILLLEIVSG--------KKNRGFYR-----SDT 642
Y G + +++S G+ L +V + S
Sbjct: 194 EYCAPEVLMGNPYRGP---ELEMWSLGVTLYTLVFEENPFCELEETVEAAIHPPYLVSKE 250
Query: 643 KVNLIGHL 650
++L+ L
Sbjct: 251 LMSLVSGL 258
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 94.6 bits (236), Expect = 4e-21
Identities = 53/187 (28%), Positives = 89/187 (47%), Gaps = 34/187 (18%)
Query: 440 DNFSINNKLGEGGFGPVYKGT-LVDGQEIAVKRLSKISEQ------GLKELKNEVILFSK 492
+ K+G+G FG V+K GQ++A+K++ +E+ L+E+K IL
Sbjct: 17 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIK---IL-QL 72
Query: 493 LQHRNLVKLLGCCIQGEEKL--------LIYEFMPN---KSLDSFIFDQTRRTLLDWSQR 541
L+H N+V L+ C L+++F + L + S+
Sbjct: 73 LKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSN------VLVKFTLSEI 126
Query: 542 FHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGN- 600
++ GL Y+H++ +I+HRD+KA+NVL+ +D K++DFGL R F +
Sbjct: 127 KRVMQMLLNGLYYIHRN---KILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPN 183
Query: 601 --TNRVV 605
TNRVV
Sbjct: 184 RYTNRVV 190
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 95.2 bits (237), Expect = 6e-21
Identities = 53/219 (24%), Positives = 97/219 (44%), Gaps = 42/219 (19%)
Query: 439 TDNFSINNKLGEGGFGPVYKGTLVD-GQEIAVKRLSKISEQGLKELKNEVILFSKLQHRN 497
+++ +G G FG VY+ L D G+ +A+K++ + +EL+ + KL H N
Sbjct: 53 EVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQ----IMRKLDHCN 108
Query: 498 LVKLLGCCIQGEEKL------LIYEFMPNKSLDSFI--FDQTRRTLLDWSQRFHI----- 544
+V+L EK L+ +++P +++ + + ++TL ++
Sbjct: 109 IVRLRYFFYSSGEKKDEVYLNLVLDYVP-ETVYRVARHYSRAKQTLPV----IYVKLYMY 163
Query: 545 -ICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNP-KISDFGLVRTFGGDETEGNTN 602
+ R L Y+H I HRD+K N+LLD D K+ DFG + E N +
Sbjct: 164 QLF---RSLAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL--VRGEPNVS 215
Query: 603 RVVGTY---------DGQFSIKSDVFSFGILLLEIVSGK 632
+ Y ++ DV+S G +L E++ G+
Sbjct: 216 YICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 254
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 92.3 bits (230), Expect = 9e-21
Identities = 62/208 (29%), Positives = 91/208 (43%), Gaps = 33/208 (15%)
Query: 439 TDNFSINNKLGEGGFGPVYKGT-LVDGQEIAVKRLSK--ISEQGLKELKNEVILFSKLQH 495
+ ++I LG+G FG V K + QE AVK ++K + + EV L KL H
Sbjct: 21 AERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDH 80
Query: 496 RNLVKLLGCCIQGEEKLLIY---EFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGL 552
N++KL E+ Y E L I + R + D ++ + G+
Sbjct: 81 PNIMKLFEIL---EDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFS---GI 134
Query: 553 LYLHQDSRLRIIHRDLKASNVLL---DQDMNPKISDFGLVRTFGGDETEGNTNRVVGT-- 607
Y+H+ I+HRDLK N+LL ++D + KI DFGL F + +GT
Sbjct: 135 TYMHK---HNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTK---MKDRIGTAY 188
Query: 608 Y------DGQFSIKSDVFSFG----ILL 625
Y G + K DV+S G ILL
Sbjct: 189 YIAPEVLRGTYDEKCDVWSAGVILYILL 216
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 94.8 bits (236), Expect = 1e-20
Identities = 59/252 (23%), Positives = 101/252 (40%), Gaps = 36/252 (14%)
Query: 406 EKTENSRETDQENEDQNIDLELPLFELATIANATDNFSINNKLGEGGFGPVYKGT-LVDG 464
+ + Q I + ++ +++ KLG G +G V
Sbjct: 2 HHHHHHSSGRENLYFQGIAINPGMYVRKKEGKIGESYFKVRKLGSGAYGEVLLCKEKNGH 61
Query: 465 QEIAVKRLSK-------------ISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEK 511
E A+K + K E+ +E+ NE+ L L H N++KL + ++
Sbjct: 62 SEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFDVF-EDKKY 120
Query: 512 L-LIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKA 570
L+ EF L I ++ + D + I G+ YLH+ I+HRD+K
Sbjct: 121 FYLVTEFYEGGELFEQIINRHKFDECDAANIMKQILS---GICYLHK---HNIVHRDIKP 174
Query: 571 SNVLL---DQDMNPKISDFGLVRTFGGDETEGNTNRVVGT--Y------DGQFSIKSDVF 619
N+LL + +N KI DFGL F D +GT Y +++ K DV+
Sbjct: 175 ENILLENKNSLLNIKIVDFGLSSFFSKDYK---LRDRLGTAYYIAPEVLKKKYNEKCDVW 231
Query: 620 SFGILLLEIVSG 631
S G+++ ++ G
Sbjct: 232 SCGVIMYILLCG 243
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 91.1 bits (227), Expect = 2e-20
Identities = 47/209 (22%), Positives = 78/209 (37%), Gaps = 31/209 (14%)
Query: 436 ANATDNFSINNKLGEGGFGPVYKGT-LVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQ 494
+ +++ N +G G +G V A K++ K + + K E+ + L
Sbjct: 5 GDINQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLD 64
Query: 495 HRNLVKLLGCCIQGEEKLLIY---EFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARG 551
H N+++L E+ IY E L + + D ++ +
Sbjct: 65 HPNIIRLYETF---EDNTDIYLVMELCTGGELFERVVHKRVFRESDAARIMKDVLS---A 118
Query: 552 LLYLHQDSRLRIIHRDLKASNVLL---DQDMNPKISDFGLVRTFGGDETEGNTNRVVGT- 607
+ Y H+ L + HRDLK N L D K+ DFGL F + VGT
Sbjct: 119 VAYCHK---LNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKM---MRTKVGTP 172
Query: 608 -Y------DGQFSIKSDVFSFG----ILL 625
Y +G + + D +S G +LL
Sbjct: 173 YYVSPQVLEGLYGPECDEWSAGVMMYVLL 201
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 90.0 bits (224), Expect = 6e-20
Identities = 56/254 (22%), Positives = 100/254 (39%), Gaps = 71/254 (27%)
Query: 433 ATIANATDNFSINN-----KLGEGGFGPVYKGT-LVDGQEIAVKRLSK------------ 474
+ ++ D +N ++G+G +G V D A+K LSK
Sbjct: 1 GSSGSSGDCVQLNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRR 60
Query: 475 --------------ISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIY---EF 517
++++ E+ + KL H N+VKL+ + + +Y E
Sbjct: 61 PPPRGTRPAPGGCIQPRGPIEQVYQEIAILKKLDHPNVVKLV-EVLDDPNEDHLYMVFEL 119
Query: 518 MPNKSLDSFIFDQTRRTLL--DWSQRFH--IICGTARGLLYLHQDSRLRIIHRDLKASNV 573
+ + + L D ++ + +I G + YLH +IIHRD+K SN+
Sbjct: 120 VNQGPV----MEVPTLKPLSEDQARFYFQDLIKG----IEYLH---YQKIIHRDIKPSNL 168
Query: 574 LLDQDMNPKISDFGLVRTFGGDETEGNTNRVVGT---------------YDGQFSIKSDV 618
L+ +D + KI+DFG+ F G + + VGT + G+ DV
Sbjct: 169 LVGEDGHIKIADFGVSNEFKGSDALLSN--TVGTPAFMAPESLSETRKIFSGK---ALDV 223
Query: 619 FSFGILLLEIVSGK 632
++ G+ L V G+
Sbjct: 224 WAMGVTLYCFVFGQ 237
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 91.8 bits (228), Expect = 7e-20
Identities = 39/167 (23%), Positives = 71/167 (42%), Gaps = 25/167 (14%)
Query: 444 INNKLGEGGFGPVYKG---TLVDGQEIAVKRLSK--ISEQGLKELKNEVILFSKLQHRNL 498
K+G G +G VYK D ++ A+K++ IS +E + L +L+H N+
Sbjct: 25 EGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGISMSACRE----IALLRELKHPNV 80
Query: 499 VKLLGCCIQ-GEEKL-LIYEFMPNKSLDSFIFDQTRRTLLDWSQRF------HIICGTAR 550
+ L + + K+ L++++ L I + ++
Sbjct: 81 ISLQKVFLSHADRKVWLLFDYA-EHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILD 139
Query: 551 GLLYLHQDSRLRIIHRDLKASNVLLDQDMNP----KISDFGLVRTFG 593
G+ YLH + ++HRDLK +N+L+ + KI+D G R F
Sbjct: 140 GIHYLHAN---WVLHRDLKPANILVMGEGPERGRVKIADMGFARLFN 183
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 89.2 bits (222), Expect = 8e-20
Identities = 51/210 (24%), Positives = 79/210 (37%), Gaps = 32/210 (15%)
Query: 436 ANATDNFSINNKLGEGGFGPVYKGT-LVDGQEIAVKRLSKISEQGLKE-LKNEVILFSKL 493
D F KLG G FG V+ G E +K ++K Q E ++ E+ + L
Sbjct: 18 GTIDDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSL 77
Query: 494 QHRNLVKLLGCCIQGEEKLLIY---EFMPNKSLDSFIFDQTRR----TLLDWSQRFHIIC 546
H N++K+ E+ +Y E L I R + ++ +
Sbjct: 78 DHPNIIKIFEVF---EDYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMM 134
Query: 547 GTARGLLYLHQDSRLRIIHRDLKASNVLL---DQDMNPKISDFGLVRTFGGDETEGNTNR 603
L Y H ++H+DLK N+L KI DFGL F DE +
Sbjct: 135 N---ALAYFHS---QHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDEH---STN 185
Query: 604 VVGT--Y------DGQFSIKSDVFSFGILL 625
GT Y + K D++S G+++
Sbjct: 186 AAGTALYMAPEVFKRDVTFKCDIWSAGVVM 215
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 88.8 bits (221), Expect = 1e-19
Identities = 57/201 (28%), Positives = 91/201 (45%), Gaps = 27/201 (13%)
Query: 448 LGEGGFGPVYKGT-LVDGQEIAVKRLSK--ISEQGLKE-LKNEVILFSKLQHRNLVKLLG 503
LG G FG V G + G ++AVK L++ I + +K E+ +H +++KL
Sbjct: 19 LGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQ 78
Query: 504 CCIQGEEKL-LIYEFMPNKSLDSFIFDQTRRTLLDWSQRFH-IICGTARGLLYLHQDSRL 561
I ++ E++ L +I R ++ + F I+ Y H R
Sbjct: 79 V-ISTPTDFFMVMEYVSGGELFDYICKHGRVEEMEARRLFQQILSAVD----YCH---RH 130
Query: 562 RIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDE----TEGNTN----RVVG--TYDGQ 611
++HRDLK NVLLD MN KI+DFGL E + G+ N V+ Y G
Sbjct: 131 MVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRTSCGSPNYAAPEVISGRLYAGP 190
Query: 612 FSIKSDVFSFGILLLEIVSGK 632
+ D++S G++L ++ G
Sbjct: 191 ---EVDIWSCGVILYALLCGT 208
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 90.4 bits (225), Expect = 1e-19
Identities = 47/227 (20%), Positives = 87/227 (38%), Gaps = 48/227 (21%)
Query: 437 NATDNFSINNKLGEGGFGPVYKGTLVD-GQEIAVKRLSKISEQGLKELKN----EVILFS 491
D F + G+G FG V G G +A+K K+ + +N + +
Sbjct: 20 KEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIK---KVIQD--PRFRNRELQIMQDLA 74
Query: 492 KLQHRNLVKLLGC-CIQGEEKL------LIYEFMP---NKSLDSFIFDQTRRTLLDWSQR 541
L H N+V+L GE ++ E++P ++ ++ Q +
Sbjct: 75 VLHHPNIVQLQSYFYTLGERDRRDIYLNVVMEYVPDTLHRCCRNYYRRQVAPPPI----- 129
Query: 542 FHI------ICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNP-KISDFGLVRTFGG 594
I + R + LH S + + HRD+K NVL+++ K+ DFG +
Sbjct: 130 -LIKVFLFQLI---RSIGCLHLPS-VNVCHRDIKPHNVLVNEADGTLKLCDFGSAKKLSP 184
Query: 595 DETEGNTNRVVGTY---------DGQFSIKSDVFSFGILLLEIVSGK 632
E N + Y + ++ D++S G + E++ G+
Sbjct: 185 SEP--NVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGE 229
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 92.2 bits (229), Expect = 1e-19
Identities = 62/219 (28%), Positives = 92/219 (42%), Gaps = 43/219 (19%)
Query: 440 DNFSINNKLGEGGFGPVYKGTLVDGQEI-AVKRLSK---ISEQGLKELKNEVILFSKLQH 495
D F LG GGFG V+ + ++ A K+L+K +G + E + +K+
Sbjct: 185 DWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHS 244
Query: 496 RNLVKLLGCCIQGEEKL-LIYEFMP---------NKSLDSFIFDQTRRTLLDWSQRF--- 542
R +V L + + L L+ M N D+ F + R F
Sbjct: 245 RFIVSLA-YAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPR-------AIFYTA 296
Query: 543 HIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNTN 602
I+ G L +LHQ II+RDLK NVLLD D N +ISD GL +T+ T
Sbjct: 297 QIVSG----LEHLHQ---RNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTK--TK 347
Query: 603 RVVGTYD--------GQFSIKS-DVFSFGILLLEIVSGK 632
GT G+ S D F+ G+ L E+++ +
Sbjct: 348 GYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAAR 386
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 90.2 bits (224), Expect = 2e-19
Identities = 49/239 (20%), Positives = 90/239 (37%), Gaps = 25/239 (10%)
Query: 402 RNIAEKTENSRETDQENEDQNIDLEL-PLFELATIANATDNFSINNKLGEGGFGPVYKGT 460
+ K + + D + ++I + P + D + I +LG G FG V++
Sbjct: 12 SKVRGKYDGPKINDYDKFYEDIWKKYVPQPVEVKQGSVYDYYDILEELGSGAFGVVHRCV 71
Query: 461 -LVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMP 519
G+ K ++ +KNE+ + ++L H L+ L E +LI EF+
Sbjct: 72 EKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFLS 131
Query: 520 NKSL-DSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQD 578
L D + + + + C GL ++H+ I+H D+K N++ +
Sbjct: 132 GGELFDRIAAEDYKMSEAEVINYMRQACE---GLKHMHE---HSIVHLDIKPENIMCETK 185
Query: 579 MNP--KISDFGLVRTFGGDETEGNTNRVVGT----------YDGQFSIKSDVFSFGILL 625
KI DFGL DE T + +D+++ G+L
Sbjct: 186 KASSVKIIDFGLATKLNPDE---IVKVTTATAEFAAPEIVDREP-VGFYTDMWAIGVLG 240
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 91.4 bits (227), Expect = 2e-19
Identities = 60/222 (27%), Positives = 92/222 (41%), Gaps = 30/222 (13%)
Query: 440 DNFSINNKLGEGGFGPVYKGTLVDGQEI-AVKRLSK---ISEQGLKELKNEVILFSKLQH 495
+ F LG+GGFG V + ++ A K+L K +G NE + K+
Sbjct: 184 NTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNS 243
Query: 496 RNLVKLLGCCIQGEEKL-LIYEFMPNKSLDSFIFDQTRRTLLDWSQRF---HIICGTARG 551
R +V L + ++ L L+ M L I+ + + F I CG
Sbjct: 244 RFVVSL-AYAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCG---- 298
Query: 552 LLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNTNRVVGTYD-- 609
L LH R RI++RDLK N+LLD + +ISD GL +T VGT
Sbjct: 299 LEDLH---RERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQT---IKGRVGTVGYM 352
Query: 610 ------GQFSIKS-DVFSFGILLLEIVSGKKNRGFYRSDTKV 644
+ S D ++ G LL E+++G+ F + K+
Sbjct: 353 APEVVKNERYTFSPDWWALGCLLYEMIAGQSP--FQQRKKKI 392
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 91.1 bits (226), Expect = 3e-19
Identities = 52/246 (21%), Positives = 91/246 (36%), Gaps = 28/246 (11%)
Query: 398 RKRRRNIAEKTENSRETDQENEDQNIDLELPLFELATIANATDNFS----INNKLGEGGF 453
R + K + T N D + + + D+ I+ +LG G F
Sbjct: 111 RGYDVDEQGKIVRGKGTVSSNYDNYVFDIWKQYYPQPVEIKHDHVLDHYDIHEELGTGAF 170
Query: 454 GPVYKGT-LVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKL 512
G V++ T G A K + E + ++ E+ S L+H LV L E +
Sbjct: 171 GVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMV 230
Query: 513 LIYEFMPNKSL-DSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKAS 571
+IYEFM L + + + + + + +C GL ++H+ +H DLK
Sbjct: 231 MIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCK---GLCHMHE---NNYVHLDLKPE 284
Query: 572 NVLLDQDMNP--KISDFGLVRTFGGDETEGNTNRVVGT----------YDGQFSIKSDVF 619
N++ + K+ DFGL + + GT +D++
Sbjct: 285 NIMFTTKRSNELKLIDFGLTAHLDPKQ---SVKVTTGTAEFAAPEVAEGKP-VGYYTDMW 340
Query: 620 SFGILL 625
S G+L
Sbjct: 341 SVGVLS 346
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 88.2 bits (219), Expect = 4e-19
Identities = 64/291 (21%), Positives = 100/291 (34%), Gaps = 73/291 (25%)
Query: 440 DNFSINNKLGEGGFGPVYKGT-LVDGQEIAVKRLSK------ISEQGLKELKNEVILFSK 492
+ + LG GGFG VY G + D +A+K + K + EV+L K
Sbjct: 43 SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKK 102
Query: 493 LQHR--NLVKLLGCCIQGEEKLLIYEF-MPNKSLDSFIFDQTRRTLLDWSQRFHIICGTA 549
+ +++LL + + +LI E P + L FI T R L
Sbjct: 103 VSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFI---TERGALQEELARSFFWQVL 159
Query: 550 RGLLYLHQDSRLRIIHRDLKASNVLLDQD-MNPKISDFGLVRTFGGDETEGNTNRVVGT- 607
+ + H ++HRD+K N+L+D + K+ DFG + GT
Sbjct: 160 EAVRHCH---NCGVLHRDIKDENILIDLNRGELKLIDFGSGALL----KDTVYTDFDGTR 212
Query: 608 ------------YDGQFSIKSDVFSFGILLLEIVSG--------KKNRGFYRSDTKVNLI 647
Y G+ + V+S GILL ++V G + RG
Sbjct: 213 VYSPPEWIRYHRYHGR---SAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVF-------- 261
Query: 648 GHLWDEGIPLRLIDACIQDSCNLADVIRCIHIGLLCVQQHPEDRPCMPSVI 698
R+ S +IR C+ P DRP +
Sbjct: 262 -------FRQRV-------SSECQHLIRW------CLALRPSDRPTFEEIQ 292
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 88.2 bits (219), Expect = 7e-19
Identities = 41/215 (19%), Positives = 78/215 (36%), Gaps = 25/215 (11%)
Query: 406 EKTENSRETDQENEDQNIDLELPLFELATIANATDNFSINNKLGEGGFGPVYKGT-LVDG 464
+ + + + Q++ E L + A + + +G G V + G
Sbjct: 60 KLNDAQPKGTENLYFQSMGPEDELPDWAAAKEFYQKYDPKDVIGRGVSSVVRRCVHRATG 119
Query: 465 QEIAVKRLSK--------ISEQGLKELKNEV-ILFSKLQHRNLVKLLGCCIQGEEKLLIY 515
E AVK + E+ + + E IL H +++ L+ E ++
Sbjct: 120 HEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSY---ESSSFMF 176
Query: 516 ---EFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASN 572
+ M L ++ ++ + + + + +LH I+HRDLK N
Sbjct: 177 LVFDLMRKGELFDYLTEKVALSEKETRSIMRSLLE---AVSFLHA---NNIVHRDLKPEN 230
Query: 573 VLLDQDMNPKISDFGLVRTFGGDETEGNTNRVVGT 607
+LLD +M ++SDFG E + GT
Sbjct: 231 ILLDDNMQIRLSDFGFSCHLEPGEK---LRELCGT 262
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 87.3 bits (217), Expect = 9e-19
Identities = 60/213 (28%), Positives = 97/213 (45%), Gaps = 52/213 (24%)
Query: 448 LGEGGFGPVYKGT-LVDGQEIAVKRLSK--ISEQGLKE-LKNEVILFSKLQHRNLVKLLG 503
LGEG FG V T Q++A+K +S+ + + + ++ E+ L+H +++KL
Sbjct: 17 LGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKL-- 74
Query: 504 CCIQGEEKLLIYEFMPNKSLDSFI---------FD---QTRRTLLDWSQRF--HIICGTA 549
Y+ + + D + FD + +R D +RF IIC
Sbjct: 75 -----------YDVITTPT-DIVMVIEYAGGELFDYIVEKKRMTEDEGRRFFQQIICAIE 122
Query: 550 RGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDE----TEGNTN--- 602
Y H R +I+HRDLK N+LLD ++N KI+DFGL + G+ N
Sbjct: 123 ----YCH---RHKIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGNFLKTSCGSPNYAA 175
Query: 603 -RVVG--TYDGQFSIKSDVFSFGILLLEIVSGK 632
V+ Y G + DV+S GI+L ++ G+
Sbjct: 176 PEVINGKLYAGP---EVDVWSCGIVLYVMLVGR 205
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 85.8 bits (213), Expect = 2e-18
Identities = 63/333 (18%), Positives = 113/333 (33%), Gaps = 92/333 (27%)
Query: 440 DNFSINNKLGEGGFGPVYKGT-LVDGQEIAVKRLSK------ISEQGLKELKNEV----I 488
+ + LG+GGFG V+ G L D ++A+K + + EV
Sbjct: 31 AEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWK 90
Query: 489 LFSKLQHRNLVKLLGCCIQGEEKL-LIYEFMPNKSLDSFIFDQTRRTLL-DWSQRF--HI 544
+ + H +++LL + +E L+ E P + D F + + L S+ F +
Sbjct: 91 VGAGGGHPGVIRLLDW-FETQEGFMLVLER-PLPAQDLFDYITEKGPLGEGPSRCFFGQV 148
Query: 545 ICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNP-KISDFGLVRTFGGDETEGNTNR 603
+ + + H ++HRD+K N+L+D K+ DFG G +
Sbjct: 149 VAA----IQHCH---SRGVVHRDIKDENILIDLRRGCAKLIDFGS----GALLHDEPYTD 197
Query: 604 VVGT-------------YDGQFSIKSDVFSFGILLLEIVSG--------KKNRGFYRSDT 642
GT Y + V+S GILL ++V G +
Sbjct: 198 FDGTRVYSPPEWISRHQYHAL---PATVWSLGILLYDMVCGDIPFERDQEILEAELH--- 251
Query: 643 KVNLIGHLWDEGIPLRLIDACIQDSCNLADVIRCIHIGLLCVQQHPEDRPCMPSVI---- 698
P + S + +IR C+ P RP + ++
Sbjct: 252 ------------FPAHV-------SPDCCALIRR------CLAPKPSSRPSLEEILLDPW 286
Query: 699 LMLGSEILLPQPKQPGYLADRKSTEPYSSSSMP 731
+ +E + P + P + S +P
Sbjct: 287 MQTPAEDVPLNPSKG-------GPAPLAWSLLP 312
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 87.4 bits (217), Expect = 2e-18
Identities = 43/181 (23%), Positives = 72/181 (39%), Gaps = 22/181 (12%)
Query: 439 TDNFSINNKLGEGGFGPVYKGT-LVDGQEIAVKRLSK--------ISEQGLKELKNEVIL 489
D + ++ LG G G V +++A++ +SK ++ E+ +
Sbjct: 134 RDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEI 193
Query: 490 FSKLQHRNLVKLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTA 549
KL H ++K+ E+ ++ E M L + R F+ +
Sbjct: 194 LKKLNHPCIIKIKNF-FDAEDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLL-- 250
Query: 550 RGLLYLHQDSRLRIIHRDLKASNVLL---DQDMNPKISDFGLVRTFGGDETEGNTNRVVG 606
+ YLH+ IIHRDLK NVLL ++D KI+DFG + G + G
Sbjct: 251 -AVQYLHE---NGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSL---MRTLCG 303
Query: 607 T 607
T
Sbjct: 304 T 304
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 86.0 bits (213), Expect = 3e-18
Identities = 47/253 (18%), Positives = 83/253 (32%), Gaps = 63/253 (24%)
Query: 439 TDNFSINNKLGEGGFGPVYKGT-LVDGQEIAVK-----RLSKISEQGLKELKNEVILFSK 492
+ + +G+G +G V A+K ++ +I+ + ++ +K EV L K
Sbjct: 25 QKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKK 84
Query: 493 LQHRNLVKLLGCCIQGEEKL-LIYEFMPNKSLDSFIFDQTRRTLLDWSQRF--------- 542
L H N+ +L + E+ + L+ E L + + +
Sbjct: 85 LHHPNIARLYEV-YEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCP 143
Query: 543 ----------------------------HIICGTARGLLYLHQDSRLRIIHRDLKASNVL 574
+I+ L YLH I HRD+K N L
Sbjct: 144 ECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLHN---QGICHRDIKPENFL 200
Query: 575 L--DQDMNPKISDFGLVRTFGGDETEGNT--NRVVGT-----------YDGQFSIKSDVF 619
++ K+ DFGL + F GT + + K D +
Sbjct: 201 FSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAW 260
Query: 620 SFGILLLEIVSGK 632
S G+LL ++ G
Sbjct: 261 SAGVLLHLLLMGA 273
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 86.3 bits (214), Expect = 3e-18
Identities = 64/247 (25%), Positives = 106/247 (42%), Gaps = 36/247 (14%)
Query: 405 AEKTENSRETDQENEDQNIDLELP--LFELATI----ANATDNFSINNK--LGEGGFGPV 456
A+ TE + +D+ P F+ + ++++ LG G FG V
Sbjct: 46 ADLTERMPVKSKRTSALAVDIPAPPAPFDHRIVTAKQGAVNSFYTVSKTEILGGGRFGQV 105
Query: 457 YKGT-LVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIY 515
+K G ++A K + + +E+KNE+ + ++L H NL++L + +L+
Sbjct: 106 HKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVM 165
Query: 516 EFMPNKSL-DSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVL 574
E++ L D I + T LD IC G+ ++HQ + I+H DLK N+L
Sbjct: 166 EYVDGGELFDRIIDESYNLTELDTILFMKQICE---GIRHMHQ---MYILHLDLKPENIL 219
Query: 575 L-DQDMNP-KISDFGLVRTFGGDETEGNTNRVVGT----------YDGQFSIKSDVFSFG 622
++D KI DFGL R + E GT YD S +D++S G
Sbjct: 220 CVNRDAKQIKIIDFGLARRYKPRE---KLKVNFGTPEFLAPEVVNYDF-VSFPTDMWSVG 275
Query: 623 ----ILL 625
+LL
Sbjct: 276 VIAYMLL 282
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 85.4 bits (212), Expect = 4e-18
Identities = 49/217 (22%), Positives = 95/217 (43%), Gaps = 40/217 (18%)
Query: 437 NATDNFSINNKLGEGGFGPVYKGT-LVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQ- 494
D++ + KLG G + V++ + + +++ VK L + + K++K E+ + L+
Sbjct: 33 GNQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKK---KKIKREIKILENLRG 89
Query: 495 HRNLVKLLGCCIQGEEK--LLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHI--ICGTAR 550
N++ L + L++E + N +TL D+ RF++ I +
Sbjct: 90 GPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLY-----QTLTDYDIRFYMYEIL---K 141
Query: 551 GLLYLHQDSRLRIIHRDLKASNVLLD-QDMNPKISDFGLVRTFGGDETEGNTNRVV---- 605
L Y H S I+HRD+K NV++D + ++ D+GL + RV
Sbjct: 142 ALDYCH--SM-GIMHRDVKPHNVMIDHEHRKLRLIDWGLAE--FYHPGQEYNVRVASRYF 196
Query: 606 ---------GTYDGQFSIKSDVFSFGILLLEIVSGKK 633
YD +S+ D++S G +L ++ K+
Sbjct: 197 KGPELLVDYQMYD--YSL--DMWSLGCMLASMIFRKE 229
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 84.5 bits (210), Expect = 4e-18
Identities = 46/178 (25%), Positives = 76/178 (42%), Gaps = 21/178 (11%)
Query: 439 TDNFSINNKLGEGGFGPVYKGT-LVDGQEIAVKRLSK--ISEQGLKELKNEVILFSKLQH 495
+DN+ + +LG+G F V + G E A K ++ +S + ++L+ E + KLQH
Sbjct: 5 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQH 64
Query: 496 RNLVKLLGCCIQGEEKLLIY---EFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGL 552
N+V+L +E+ Y + + L I + + D S I +
Sbjct: 65 PNIVRLHDSI---QEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILE---SI 118
Query: 553 LYLHQDSRLRIIHRDLKASNVLL---DQDMNPKISDFGLVRTFGGDETEGNTNRVVGT 607
Y H I+HR+LK N+LL + K++DFGL E + GT
Sbjct: 119 AYCHS---NGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEA---WHGFAGT 170
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 86.8 bits (215), Expect = 5e-18
Identities = 57/201 (28%), Positives = 92/201 (45%), Gaps = 27/201 (13%)
Query: 448 LGEGGFGPVYKGT-LVDGQEIAVKRLSK--ISEQGLKE-LKNEVILFSKLQHRNLVKLLG 503
LG G FG V G + G ++AVK L++ I + ++ E+ +H +++KL
Sbjct: 24 LGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQ 83
Query: 504 CCIQGEEKL-LIYEFMPNKSLDSFIFDQTRRTLLDWSQRFH-IICGTARGLLYLHQDSRL 561
I + ++ E++ L +I R + + F I+ G Y H R
Sbjct: 84 V-ISTPSDIFMVMEYVSGGELFDYICKNGRLDEKESRRLFQQILSGVD----YCH---RH 135
Query: 562 RIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDE----TEGNTN----RVVG--TYDGQ 611
++HRDLK NVLLD MN KI+DFGL E + G+ N V+ Y G
Sbjct: 136 MVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRTSCGSPNYAAPEVISGRLYAGP 195
Query: 612 FSIKSDVFSFGILLLEIVSGK 632
+ D++S G++L ++ G
Sbjct: 196 ---EVDIWSSGVILYALLCGT 213
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 84.7 bits (210), Expect = 6e-18
Identities = 44/181 (24%), Positives = 71/181 (39%), Gaps = 22/181 (12%)
Query: 439 TDNFSINNKLGEGGFGPVYKGT-LVDGQEIAVKRLSK--------ISEQGLKELKNEVIL 489
D + ++ LG G G V +++A+K +SK ++ E+ +
Sbjct: 9 RDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEI 68
Query: 490 FSKLQHRNLVKLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTA 549
KL H ++K+ E+ ++ E M L + R F+ +
Sbjct: 69 LKKLNHPCIIKIKNF-FDAEDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLL-- 125
Query: 550 RGLLYLHQDSRLRIIHRDLKASNVLL---DQDMNPKISDFGLVRTFGGDETEGNTNRVVG 606
+ YLH IIHRDLK NVLL ++D KI+DFG + G + G
Sbjct: 126 -AVQYLH---ENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSL---MRTLCG 178
Query: 607 T 607
T
Sbjct: 179 T 179
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 83.8 bits (208), Expect = 8e-18
Identities = 43/180 (23%), Positives = 68/180 (37%), Gaps = 20/180 (11%)
Query: 439 TDNFSINNKLGEGGFGPVYKGT-LVDGQEIAVKRLSKISEQGLKE---------LKNEV- 487
+N+ LG G V + +E AVK + EV
Sbjct: 16 YENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVD 75
Query: 488 ILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICG 547
IL H N+++L L+++ M L ++ ++ + + + +
Sbjct: 76 ILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLE 135
Query: 548 TARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNTNRVVGT 607
+ LH+ L I+HRDLK N+LLD DMN K++DFG E V GT
Sbjct: 136 ---VICALHK---LNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEK---LREVCGT 186
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 83.8 bits (208), Expect = 8e-18
Identities = 44/176 (25%), Positives = 70/176 (39%), Gaps = 20/176 (11%)
Query: 439 TDNFSINNKLGEGGFGPVYKGT-LVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRN 497
F LG G F V+ + G+ A+K + K L+NE+ + K++H N
Sbjct: 8 RKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHEN 67
Query: 498 LVKLLGCCIQGEEKLLIY---EFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLY 554
+V L E Y + + L I ++ T D S + + Y
Sbjct: 68 IVTLEDIY---ESTTHYYLVMQLVSGGELFDRILERGVYTEKDASLVIQQVLS---AVKY 121
Query: 555 LHQDSRLRIIHRDLKASNVLL---DQDMNPKISDFGLVRTFGGDETEGNTNRVVGT 607
LH+ I+HRDLK N+L +++ I+DFGL + G + GT
Sbjct: 122 LHE---NGIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQ----NGIMSTACGT 170
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 86.9 bits (215), Expect = 8e-18
Identities = 65/253 (25%), Positives = 108/253 (42%), Gaps = 43/253 (16%)
Query: 401 RRNIAEKTENSRETDQENEDQNIDLELPLFELATIANATDNFSINNKLGEGGFGPVYKGT 460
R ++ +K S + + + +N++L + L ++FS++ +G GGFG VY
Sbjct: 158 RGDVFQKFIESDKFTRFCQWKNVELNIHL--------TMNDFSVHRIIGRGGFGEVYGCR 209
Query: 461 LVDGQEI-AVKRLSK---ISEQGLKELKNEVILFSKL---QHRNLVKLLGCCIQGEEKL- 512
D ++ A+K L K +QG NE I+ S + +V + +KL
Sbjct: 210 KADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCM-SYAFHTPDKLS 268
Query: 513 LIYEFMPNKSLDSFIFDQTRRTLLDWSQRFH---IICGTARGLLYLHQDSRLRIIHRDLK 569
I + M L + + RF+ II G L ++H +++RDLK
Sbjct: 269 FILDLMNGGDLHYHL--SQHGVFSEADMRFYAAEIILG----LEHMHN---RFVVYRDLK 319
Query: 570 ASNVLLDQDMNPKISDFGLVRTFGGDETEGNTNRVVGT--Y-------DGQFSIKS-DVF 619
+N+LLD+ + +ISD GL F + VGT Y G S D F
Sbjct: 320 PANILLDEHGHVRISDLGLACDFSKKKPHA----SVGTHGYMAPEVLQKGVAYDSSADWF 375
Query: 620 SFGILLLEIVSGK 632
S G +L +++ G
Sbjct: 376 SLGCMLFKLLRGH 388
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 83.4 bits (207), Expect = 9e-18
Identities = 48/211 (22%), Positives = 87/211 (41%), Gaps = 31/211 (14%)
Query: 436 ANATDNFSINNKLGEGGFGPVYKGT-LVDGQEIAVKRLSK------ISEQGLKELKNEVI 488
+ D++ + +LG G F V K G+E A K + K +E++ EV
Sbjct: 1 SMVEDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVN 60
Query: 489 LFSKLQHRNLVKLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGT 548
+ +++H N++ L + +LI E + L F+ ++ T + +Q I
Sbjct: 61 ILREIRHPNIITLHDIFENKTDVVLILELVSGGELFDFLAEKESLTEDEATQFLKQILD- 119
Query: 549 ARGLLYLHQDSRLRIIHRDLKASNVLL----DQDMNPKISDFGLVRTFGGDETEGNTNRV 604
G+ YLH RI H DLK N++L + K+ DFG+ +
Sbjct: 120 --GVHYLHS---KRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNE---FKNI 171
Query: 605 VGT----------YDGQFSIKSDVFSFGILL 625
GT Y+ +++D++S G++
Sbjct: 172 FGTPEFVAPEIVNYEP-LGLEADMWSIGVIT 201
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 83.1 bits (206), Expect = 2e-17
Identities = 49/210 (23%), Positives = 84/210 (40%), Gaps = 31/210 (14%)
Query: 437 NATDNFSINNKLGEGGFGPVYKGT-LVDGQEIAVKRLSK------ISEQGLKELKNEVIL 489
N D + +LG G F V K G + A K + K ++++ EV +
Sbjct: 8 NVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSI 67
Query: 490 FSKLQHRNLVKLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTA 549
++QH N++ L + +LI E + L F+ ++ T + ++ I
Sbjct: 68 LKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILN-- 125
Query: 550 RGLLYLHQDSRLRIIHRDLKASNVLL----DQDMNPKISDFGLVRTFGGDETEGNTNRVV 605
G+ YLH L+I H DLK N++L KI DFGL +
Sbjct: 126 -GVYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNE---FKNIF 178
Query: 606 GT----------YDGQFSIKSDVFSFGILL 625
GT Y+ +++D++S G++
Sbjct: 179 GTPEFVAPEIVNYEP-LGLEADMWSIGVIT 207
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 83.1 bits (206), Expect = 2e-17
Identities = 48/211 (22%), Positives = 81/211 (38%), Gaps = 31/211 (14%)
Query: 436 ANATDNFSINNKLGEGGFGPVYKGT-LVDGQEIAVKRLSK------ISEQGLKELKNEVI 488
D + I +LG G F V K G E A K + K +E++ EV
Sbjct: 8 QKVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVS 67
Query: 489 LFSKLQHRNLVKLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGT 548
+ ++ H N++ L + +LI E + L F+ + + + + I
Sbjct: 68 ILRQVLHHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILD- 126
Query: 549 ARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNP----KISDFGLVRTFGGDETEGNTNRV 604
G+ YLH +I H DLK N++L P K+ DFGL +
Sbjct: 127 --GVNYLHT---KKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVE---FKNI 178
Query: 605 VGT----------YDGQFSIKSDVFSFGILL 625
GT Y+ +++D++S G++
Sbjct: 179 FGTPEFVAPEIVNYEP-LGLEADMWSIGVIT 208
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 83.1 bits (206), Expect = 2e-17
Identities = 39/203 (19%), Positives = 74/203 (36%), Gaps = 25/203 (12%)
Query: 437 NATDNFSINNKLGEGGFGPVYKGT-LVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQH 495
+ + I LG G FG V++ + K + +K E+ + + +H
Sbjct: 2 ELYEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKV-KGTDQVLVKKEISILNIARH 60
Query: 496 RNLVKLLGCCIQGEEKLLIYEFMPNKSL-DSFIFDQTRRTLLDWSQRFHIICGTARGLLY 554
RN++ L EE ++I+EF+ + + + H +C L +
Sbjct: 61 RNILHLHESFESMEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCE---ALQF 117
Query: 555 LHQDSRLRIIHRDLKASNVLLDQDMNP--KISDFGLVRTFGGDETEGNTNRVVGT----- 607
LH I H D++ N++ + KI +FG R + +
Sbjct: 118 LHS---HNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDN---FRLLFTAPEYYA 171
Query: 608 -----YDGQFSIKSDVFSFGILL 625
+D S +D++S G L+
Sbjct: 172 PEVHQHDV-VSTATDMWSLGTLV 193
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 83.5 bits (207), Expect = 2e-17
Identities = 44/182 (24%), Positives = 68/182 (37%), Gaps = 21/182 (11%)
Query: 439 TDNFSINNKLGEGGFGPVYKGT-LVDGQEIAVK-----RLSKISEQGLKELKNEVILFSK 492
D + + +G+G F V + GQ+ AVK + + ++LK E +
Sbjct: 23 EDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHM 82
Query: 493 LQHRNLVKLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQTRRTLL----DWSQRFHIICGT 548
L+H ++V+LL +++EFM L I + + S I
Sbjct: 83 LKHPHIVELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILE- 141
Query: 549 ARGLLYLHQDSRLRIIHRDLKASNVLL---DQDMNPKISDFGLVRTFGGDETEGNTNRVV 605
L Y H IIHRD+K VLL + K+ FG+ G V
Sbjct: 142 --ALRYCHD---NNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLVAGG--RV 194
Query: 606 GT 607
GT
Sbjct: 195 GT 196
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 83.1 bits (206), Expect = 2e-17
Identities = 44/174 (25%), Positives = 68/174 (39%), Gaps = 16/174 (9%)
Query: 439 TDNFSINNKLGEGGFGPVYKGT-LVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRN 497
TD + + +G G + + E AVK + K +E++ IL QH N
Sbjct: 21 TDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKRDPTEEIE---ILLRYGQHPN 77
Query: 498 LVKLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQ 557
++ L G+ ++ E M L I Q + + S I + YLH
Sbjct: 78 IITLKDVYDDGKYVYVVTELMKGGELLDKILRQKFFSEREASAVLFTITK---TVEYLHA 134
Query: 558 DSRLRIIHRDLKASNVLL-DQDMNP---KISDFGLVRTFGGDETEGNTNRVVGT 607
++HRDLK SN+L D+ NP +I DFG + + T T
Sbjct: 135 ---QGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGLLMT--PCYT 183
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 82.3 bits (204), Expect = 3e-17
Identities = 49/180 (27%), Positives = 74/180 (41%), Gaps = 17/180 (9%)
Query: 439 TDNFSINNK-LGEGGFGPVYKGT-LVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQ-H 495
D + + LGEG V L+ QE AVK + K + EV + + Q H
Sbjct: 11 EDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGH 70
Query: 496 RNLVKLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYL 555
RN+++L+ + + L++E M S+ S I + L+ S + L +L
Sbjct: 71 RNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVAS---ALDFL 127
Query: 556 HQDSRLRIIHRDLKASNVLL---DQDMNPKISDFGLVRTF--GGDETEGNTNR---VVGT 607
H I HRDLK N+L +Q KI DF L GD + +T G+
Sbjct: 128 HN---KGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGS 184
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 82.8 bits (205), Expect = 4e-17
Identities = 47/211 (22%), Positives = 81/211 (38%), Gaps = 31/211 (14%)
Query: 436 ANATDNFSINNKLGEGGFGPVYKGT-LVDGQEIAVKRLSKIS------EQGLKELKNEVI 488
D + I +LG G F V K G E A K + K +E++ EV
Sbjct: 8 QKVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVS 67
Query: 489 LFSKLQHRNLVKLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGT 548
+ ++ H N++ L + +LI E + L F+ + + + + I
Sbjct: 68 ILRQVLHPNIITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILD- 126
Query: 549 ARGLLYLHQDSRLRIIHRDLKASNVLL----DQDMNPKISDFGLVRTFGGDETEGNTNRV 604
G+ YLH +I H DLK N++L + K+ DFGL +
Sbjct: 127 --GVNYLHT---KKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVE---FKNI 178
Query: 605 VGT----------YDGQFSIKSDVFSFGILL 625
GT Y+ +++D++S G++
Sbjct: 179 FGTPEFVAPEIVNYEP-LGLEADMWSIGVIT 208
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 82.7 bits (205), Expect = 4e-17
Identities = 48/176 (27%), Positives = 78/176 (44%), Gaps = 17/176 (9%)
Query: 439 TDNFSINNKLGEGGFGPVYKGT-LVDGQEIAVKRLSK--ISEQGLKELKNEVILFSKLQH 495
+DN+ + +LG+G F V + G E A K ++ +S + ++L+ E + KLQH
Sbjct: 28 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQH 87
Query: 496 RNLVKLLGCCIQGEEKL-LIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLY 554
N+V+L IQ E L+++ + L I + + D S I + Y
Sbjct: 88 PNIVRLHD-SIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILE---SIAY 143
Query: 555 LHQDSRLRIIHRDLKASNVLL---DQDMNPKISDFGLVRTFGGDETEGNTNRVVGT 607
H I+HR+LK N+LL + K++DFGL E + GT
Sbjct: 144 CHS---NGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEA---WHGFAGT 193
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 82.7 bits (205), Expect = 8e-17
Identities = 46/187 (24%), Positives = 83/187 (44%), Gaps = 22/187 (11%)
Query: 432 LATI--ANATDNFSINNKLGEGGFGPVYKGT-LVDGQEIAVKRLSK--ISEQGLKELKNE 486
+ATI T+ + + +LG+G F V + ++ GQE A ++ +S + ++L+ E
Sbjct: 1 MATITCTRFTEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLERE 60
Query: 487 VILFSKLQHRNLVKLLGCCIQGEEKLLIY---EFMPNKSLDSFIFDQTRRTLLDWSQRFH 543
+ L+H N+V+L E+ Y + + L I + + D S
Sbjct: 61 ARICRLLKHPNIVRLHDSI---SEEGHHYLIFDLVTGGELFEDIVAREYYSEADASHCIQ 117
Query: 544 IICGTARGLLYLHQDSRLRIIHRDLKASNVLL---DQDMNPKISDFGLVRTFGGDETEGN 600
I +L+ HQ + ++HR+LK N+LL + K++DFGL G++
Sbjct: 118 QILE---AVLHCHQ---MGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWF 171
Query: 601 TNRVVGT 607
GT
Sbjct: 172 G--FAGT 176
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458 | Back alignment and structure |
|---|
Score = 82.6 bits (204), Expect = 9e-17
Identities = 42/176 (23%), Positives = 82/176 (46%), Gaps = 23/176 (13%)
Query: 439 TDNFSINNKLGEGGFGPVYKGT-LVDGQEIAVKRLSKISEQG------LKELKNEVILFS 491
D + I + +G G +G V + ++ + +A+K++ ++ E L+E+ + +
Sbjct: 52 PDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIA----ILN 107
Query: 492 KLQHRNLVKLLGCCIQGEEKL-----LIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIIC 546
+L H ++VK+L I + + ++ E +T L + + ++
Sbjct: 108 RLNHDHVVKVLDIVIPKDVEKFDELYVVLEIAD-SDFKKLF--RTPVYLTELHIKT-LLY 163
Query: 547 GTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNTN 602
G+ Y+H S I+HRDLK +N L++QD + K+ DFGL RT E +
Sbjct: 164 NLLVGVKYVH--SA-GILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPENGNSQL 216
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 80.0 bits (198), Expect = 2e-16
Identities = 53/230 (23%), Positives = 89/230 (38%), Gaps = 30/230 (13%)
Query: 416 QENEDQNIDLELPLFELATIANATDNFSINNK-LGEGGFGPVYKGT-LVDGQEIAVKRLS 473
+ +DL ++ N + + + +K LG G F V + GQE A K L
Sbjct: 4 HHHHSSGVDLGTENLYFQSMENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLK 63
Query: 474 K--ISEQGLKELKNEVILFSKLQHR-NLVKLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQ 530
K + E+ +E+ + + ++ L E +LI E+ + S +
Sbjct: 64 KRRRGQDCRAEILHEIAVLELAKSCPRVINLHEVYENTSEIILILEYAAGGEIFSLCLPE 123
Query: 531 TRRTL--LDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLL---DQDMNPKISD 585
+ D + I G+ YLHQ I+H DLK N+LL + KI D
Sbjct: 124 LAEMVSENDVIRLIKQILE---GVYYLHQ---NNIVHLDLKPQNILLSSIYPLGDIKIVD 177
Query: 586 FGLVRTFGGDETEGNTNRVVGT----------YDGQFSIKSDVFSFGILL 625
FG+ R G ++GT YD + +D+++ GI+
Sbjct: 178 FGMSRKIGHACE---LREIMGTPEYLAPEILNYDP-ITTATDMWNIGIIA 223
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 80.2 bits (198), Expect = 4e-16
Identities = 46/249 (18%), Positives = 97/249 (38%), Gaps = 66/249 (26%)
Query: 437 NATDNFSINNKLGEGGFGPVYKGTLVD-GQEIAVKRLSKISEQGLKELKNEVILFSKLQH 495
++ +S+ LG G FG V + ++ G+ A+K++ + +EL + L H
Sbjct: 4 TSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPRYKNRELD----IMKVLDH 59
Query: 496 RNLVKLLGCCIQGEEKL--------------------------------------LIYEF 517
N++KL+ ++ +I E+
Sbjct: 60 VNIIKLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEY 119
Query: 518 MPNKSLDSFI--FDQTRRTLLDWSQRFHI--ICGTARGLLYLHQDSRLRIIHRDLKASNV 573
+P +L + F ++ R++ +I + R + ++H L I HRD+K N+
Sbjct: 120 VP-DTLHKVLKSFIRSGRSIPMNLISIYIYQLF---RAVGFIHS---LGICHRDIKPQNL 172
Query: 574 LLDQDMNP-KISDFGLVRTFGGDETEGNTNRVVGTY---------DGQFSIKSDVFSFGI 623
L++ N K+ DFG + +E + + + +++ D++S G
Sbjct: 173 LVNSKDNTLKLCDFGSAKKL--IPSEPSVAYICSRFYRAPELMLGATEYTPSIDLWSIGC 230
Query: 624 LLLEIVSGK 632
+ E++ GK
Sbjct: 231 VFGELILGK 239
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 78.9 bits (195), Expect = 6e-16
Identities = 52/210 (24%), Positives = 85/210 (40%), Gaps = 49/210 (23%)
Query: 448 LGEGGFGPVYKGT-LVDGQEIAVKRLSKISEQGLKE-LKNEVILFSKLQHRNLVKLLGCC 505
+G G FG + + +AVK + + + E ++ E+I L+H N+V+
Sbjct: 28 IGSGNFGVARLMRDKLTKELVAVKYIER--GAAIDENVQREIINHRSLRHPNIVRFKEV- 84
Query: 506 IQGEEKL-LIYEFMPNKSLDSFIFD---QTRRTLLDWSQRF--HIICGTARGLLYLHQDS 559
I L +I E+ L ++ R D ++ F ++ G + Y H
Sbjct: 85 ILTPTHLAIIMEYASGGEL----YERICNAGRFSEDEARFFFQQLLSGVS----YCH--- 133
Query: 560 RLRIIHRDLKASNVLLDQD--MNPKISDFGLVRTFGGDE---TEGNTNRVVGT------- 607
++I HRDLK N LLD KI DFG ++ + VGT
Sbjct: 134 SMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKS------TVGTPAYIAPE 187
Query: 608 ------YDGQFSIKSDVFSFGILLLEIVSG 631
YDG+ +DV+S G+ L ++ G
Sbjct: 188 VLLRQEYDGK---IADVWSCGVTLYVMLVG 214
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 79.0 bits (195), Expect = 9e-16
Identities = 66/320 (20%), Positives = 117/320 (36%), Gaps = 64/320 (20%)
Query: 399 KRRRNIAEKTENSRETDQENEDQNIDLELPLFELATIANATDNFSINNKLGEGGFGPVY- 457
+ + +A+ + + ++ + D+F I +G G F V
Sbjct: 34 AQDKYVADFLQWAEPIVVRLKEVRLQR--------------DDFEILKVIGRGAFSEVAV 79
Query: 458 ---KGTLVDGQEIAVKRLSK---ISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEK 511
K T GQ A+K ++K + + + E + R + +L Q E
Sbjct: 80 VKMKQT---GQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLH-FAFQDENY 135
Query: 512 L-LIYEFMPNKSLDSFIFDQTRRTLLDWSQRFH---IICGTARGLLYLHQDSRLRIIHRD 567
L L+ E+ L + + R + + RF+ I+ + +H+ L +HRD
Sbjct: 136 LYLVMEYYVGGDLLTLLSKFGERIPAEMA-RFYLAEIVMA----IDSVHR---LGYVHRD 187
Query: 568 LKASNVLLDQDMNPKISDFGLVRTFGGDETEGNTNRVVGTYD----------------GQ 611
+K N+LLD+ + +++DFG D T + VGT D G
Sbjct: 188 IKPDNILLDRCGHIRLADFGSCLKLRADGTVR-SLVAVGTPDYLSPEILQAVGGGPGTGS 246
Query: 612 FSIKSDVFSFGILLLEIVSGKKNRGFYRSDTKVNLIGHLWDEGIPLRLIDACIQDSCNLA 671
+ + D ++ G+ E+ G+ FY +D+ G + L L
Sbjct: 247 YGPECDWWALGVFAYEMFYGQTP--FY-ADSTAETYGKIVHYKEHLSLPLVDEGVPEEAR 303
Query: 672 DVIRCIHIGLLCVQQHPEDR 691
D I+ LLC PE R
Sbjct: 304 DFIQ----RLLC---PPETR 316
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 78.5 bits (194), Expect = 1e-15
Identities = 46/176 (26%), Positives = 73/176 (41%), Gaps = 21/176 (11%)
Query: 439 TDNFSINNKLGEGGFGPVYKGT-LVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRN 497
+D F + ++LG G VY+ + A+K L K ++ K ++ E+ + +L H N
Sbjct: 52 SDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTVDK--KIVRTEIGVLLRLSHPN 109
Query: 498 LVKLLGCCIQGEEKLLIY---EFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLY 554
++KL E I E + L I ++ + D + I + Y
Sbjct: 110 IIKLKEIF---ETPTEISLVLELVTGGELFDRIVEKGYYSERDAADAVKQILE---AVAY 163
Query: 555 LHQDSRLRIIHRDLKASNVLL---DQDMNPKISDFGLVRTFGGDETEGNTNRVVGT 607
LH+ I+HRDLK N+L D KI+DFGL + V GT
Sbjct: 164 LHE---NGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQVL---MKTVCGT 213
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 78.6 bits (194), Expect = 1e-15
Identities = 64/311 (20%), Positives = 126/311 (40%), Gaps = 53/311 (17%)
Query: 399 KRRRNIAEKTENSRETDQENEDQNIDLELPLFELATIANATDNFSINNKLGEGGFGPVYK 458
+R +NI E E ++ + + + ++F I +G G FG V
Sbjct: 47 RREKNILEYLEWAKPFTSKVKQMRLHR--------------EDFEILKVIGRGAFGEVAV 92
Query: 459 GTLVDGQEI-AVKRLSKISEQGLKEL---KNEVILFSKLQHRNLVKLLGCCIQGEEKL-L 513
L + ++ A+K L+K E + E + + + L Q + L L
Sbjct: 93 VKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLH-YAFQDDNNLYL 151
Query: 514 IYEFMPNKSLDSFIFDQTRRTLLDWSQRFH---IICGTARGLLYLHQDSRLRIIHRDLKA 570
+ ++ L + + R + + RF+ ++ + +HQ L +HRD+K
Sbjct: 152 VMDYYVGGDLLTLLSKFEDRLPEEMA-RFYLAEMVIA----IDSVHQ---LHYVHRDIKP 203
Query: 571 SNVLLDQDMNPKISDFGLVRTFGGDETEGNTNRVVGTYD--------------GQFSIKS 616
N+L+D + + +++DFG D T ++ VGT D G++ +
Sbjct: 204 DNILMDMNGHIRLADFGSCLKLMEDGT-VQSSVAVGTPDYISPEILQAMEGGKGRYGPEC 262
Query: 617 DVFSFGILLLEIVSGKKNRGFYRSDTKVNLIGHLWDEGIPLRLIDACIQDSCNLADVIRC 676
D +S G+ + E++ G+ FY +++ V G + + + S N D+IR
Sbjct: 263 DWWSLGVCMYEMLYGETP--FY-AESLVETYGKIMNHKERFQFPTQVTDVSENAKDLIR- 318
Query: 677 IHIGLLCVQQH 687
L+C ++H
Sbjct: 319 ---RLICSREH 326
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 77.7 bits (192), Expect = 1e-15
Identities = 48/213 (22%), Positives = 91/213 (42%), Gaps = 33/213 (15%)
Query: 439 TDNFSINNKLGEGGFGPVYKGT-LVDGQEIAVKRLSKISEQG------LKELKNEVILFS 491
+ +G G +G V G+++A+K+LS+ + +EL L
Sbjct: 23 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELL----LLK 78
Query: 492 KLQHRNLVKLL------GCCIQGEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHII 545
+QH N++ LL + L+ FM L + + ++ ++
Sbjct: 79 HMQHENVIGLLDVFTPASSLRNFYDFYLVMPFMQ-TDLQKIM----GLKFSEEKIQY-LV 132
Query: 546 CGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNTNR-- 603
+GL Y+H ++HRDLK N+ +++D KI DFGL R + T R
Sbjct: 133 YQMLKGLKYIHSAG---VVHRDLKPGNLAVNEDCELKILDFGLARHADAEMTGYVVTRWY 189
Query: 604 ----VVGTYDGQFSIKSDVFSFGILLLEIVSGK 632
V+ ++ ++ D++S G ++ E+++GK
Sbjct: 190 RAPEVILSW-MHYNQTVDIWSVGCIMAEMLTGK 221
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 77.7 bits (192), Expect = 2e-15
Identities = 63/255 (24%), Positives = 101/255 (39%), Gaps = 53/255 (20%)
Query: 405 AEKTENSRETDQENEDQNIDLELPLFELATIANAT-DNFSINNKLGEGGFGPVYKGTLVD 463
A K + +E+ +E + + L +E + A D F LG G FG V +
Sbjct: 5 AAKKGSEQESVKEFLAKAKEDFLKKWETPSQNTAQLDQFDRIKTLGTGSFGRVMLVKHKE 64
Query: 464 GQEI-AVKRLSKISEQGLKEL---KNEVILFSKLQHRNLVKLLGCCIQGEEKL-LIYEFM 518
A+K L K LK++ NE + + LVKL + L ++ E++
Sbjct: 65 SGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSF-KDNSNLYMVMEYV 123
Query: 519 PNKSLDSFIFDQTRRTLLDWSQRFHIICGTAR--------GLLYLHQDSRLRIIHRDLKA 570
+ F RR RF AR YLH L +I+RDLK
Sbjct: 124 AGGEM----FSHLRR-----IGRFSE--PHARFYAAQIVLTFEYLHS---LDLIYRDLKP 169
Query: 571 SNVLLDQDMNPKISDFGLVRTFGGDETEGNTNRVVGT-------------YDGQFSIKS- 616
N+L+DQ +++DFG + +G T + GT Y+ K+
Sbjct: 170 ENLLIDQQGYIQVTDFGFAK-----RVKGRTWTLCGTPEALAPEIILSKGYN-----KAV 219
Query: 617 DVFSFGILLLEIVSG 631
D ++ G+L+ E+ +G
Sbjct: 220 DWWALGVLIYEMAAG 234
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 76.9 bits (189), Expect = 3e-15
Identities = 42/140 (30%), Positives = 60/140 (42%), Gaps = 26/140 (18%)
Query: 504 CCIQGEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRI 563
EEK L D + T L+ +S + A+G+ +L + +
Sbjct: 164 SSGFVEEKSLSDVEEEEAPEDLYKDFLTLEHLICYSFQ------VAKGMEFL---ASRKC 214
Query: 564 IHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNTNRVVGT-------------YDG 610
IHRDL A N+LL + KI DFGL R D + G +D
Sbjct: 215 IHRDLAARNILLSEKNVVKICDFGLAR----DIYKDPDYVRKGDARLPLKWMAPETIFDR 270
Query: 611 QFSIKSDVFSFGILLLEIVS 630
++I+SDV+SFG+LL EI S
Sbjct: 271 VYTIQSDVWSFGVLLWEIFS 290
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 67.3 bits (164), Expect = 4e-12
Identities = 34/162 (20%), Positives = 61/162 (37%), Gaps = 19/162 (11%)
Query: 440 DNFSINNKLGEGGFGPVYKGTLVD------GQEIAVKRL-SKISEQGLKELKNEVILFSK 492
D + LG G FG V + + +AVK L + + L +E+ +
Sbjct: 22 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIH 81
Query: 493 L-QHRNLVKLLGCCIQ-GEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTAR 550
+ H N+V LLG C + G ++I EF +L +++ S+R + +
Sbjct: 82 IGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYL----------RSKRNEFVPYKTK 131
Query: 551 GLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTF 592
G + + I DLK + + S F ++
Sbjct: 132 GARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSL 173
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 77.4 bits (191), Expect = 3e-15
Identities = 53/227 (23%), Positives = 92/227 (40%), Gaps = 41/227 (18%)
Query: 440 DNFSINNKLGEGGFGPVYKGTLVDGQEI-AVKRLSK---ISEQGLKELKNEVILFSKLQH 495
D+F I +G+G FG V D +++ A+K ++K + ++ + E+ + L+H
Sbjct: 15 DHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEH 74
Query: 496 RNLVKLLGCCIQGEEKL-LIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHI------ICGT 548
LV L Q EE + ++ + + L R L + F IC
Sbjct: 75 PFLVNLW-YSFQDEEDMFMVVDLLLGGDL---------RYHLQQNVHFKEETVKLFICEL 124
Query: 549 ARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNTNRVVGTY 608
L YL RIIHRD+K N+LLD+ + I+DF + + + GT
Sbjct: 125 VMALDYLQN---QRIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRETQ---ITTMAGTK 178
Query: 609 D------------GQFSIKSDVFSFGILLLEIVSGKKNRGFYRSDTK 643
+S D +S G+ E++ G+ R ++ +
Sbjct: 179 PYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGR--RPYHIRSST 223
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 76.6 bits (189), Expect = 4e-15
Identities = 47/216 (21%), Positives = 82/216 (37%), Gaps = 52/216 (24%)
Query: 439 TDNFSINNK-LGEGGFGPVYKGT-LVDGQEIAVKRLSKISEQGLKELKNEV-ILFSKLQH 495
TD++ ++ + LG G G V + GQ+ A+K L + + EV +
Sbjct: 27 TDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDS-----PKARQEVDHHWQASGG 81
Query: 496 RNLVKLLGCC---IQGEEKL-LIYEFMPNKSLDSFIFDQ-TRRTLLDWSQR-----FHII 545
++V +L G+ L +I E M L F + R +++R I
Sbjct: 82 PHIVCILDVYENMHHGKRCLLIIMECMEGGEL----FSRIQERGDQAFTEREAAEIMRDI 137
Query: 546 CGTARGLLYLHQDSRLRIIHRDLKASNVLL---DQDMNPKISDFGLVRTFGGDETEGNTN 602
+ +LH I HRD+K N+L ++D K++DFG + T+
Sbjct: 138 GT---AIQFLHS---HNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKET----TQNALQ 187
Query: 603 RVVGT-------------YDGQFSIKSDVFSFGILL 625
T YD D++S G+++
Sbjct: 188 TPCYTPYYVAPEVLGPEKYDK----SCDMWSLGVIM 219
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 75.4 bits (186), Expect = 8e-15
Identities = 46/197 (23%), Positives = 72/197 (36%), Gaps = 33/197 (16%)
Query: 447 KLGEGGFGPVYKGT-LVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQ-HRNLVKLLGC 504
LGEG F K Q AVK +SK + + E+ + H N+VKL
Sbjct: 18 PLGEGSFSICRKCVHKKSNQAFAVKIISK---RMEANTQKEITALKLCEGHPNIVKLHEV 74
Query: 505 CIQGEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRII 564
L+ E + L I + + + S + + ++H + ++
Sbjct: 75 FHDQLHTFLVMELLNGGELFERIKKKKHFSETEASYIMRKLVS---AVSHMHD---VGVV 128
Query: 565 HRDLKASNVLL---DQDMNPKISDFGLVRTFGGDETEGNTNRVVGT-------------Y 608
HRDLK N+L + ++ KI DFG R D T T Y
Sbjct: 129 HRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKT--PCFTLHYAAPELLNQNGY 186
Query: 609 DGQFSIKSDVFSFGILL 625
D D++S G++L
Sbjct: 187 DE----SCDLWSLGVIL 199
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336 | Back alignment and structure |
|---|
Score = 75.3 bits (184), Expect = 8e-15
Identities = 35/202 (17%), Positives = 62/202 (30%), Gaps = 52/202 (25%)
Query: 438 ATDNFSINNKLGEGGFGPVYKGTLVDGQEIAVKRL--------SKISEQGLKELKNEVIL 489
T+ K+GEG FG V++ D +A+K + + ++ +E+ E+I+
Sbjct: 18 PTEKLQRCEKIGEGVFGEVFQTIA-DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIII 76
Query: 490 FSKLQ---------HRNLVKLLGCCI-----------------------------QGEEK 511
+L + L +++
Sbjct: 77 SKELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQ 136
Query: 512 LLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKAS 571
L I +D +Q R L + I+ L LR HRDL
Sbjct: 137 LFIVLEFEFGGID---LEQMRTKLSSLATAKSILHQLTASLAVAEA--SLRFEHRDLHWG 191
Query: 572 NVLLDQDMNPKISDFGLVRTFG 593
NVLL + K+ ++
Sbjct: 192 NVLLKKTSLKKLHYTLNGKSST 213
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 76.0 bits (187), Expect = 1e-14
Identities = 53/215 (24%), Positives = 86/215 (40%), Gaps = 36/215 (16%)
Query: 439 TDNFSINNKLGEGGFGPVYKGT-LVDGQEIAVKRLSKISEQG------LKELKNEVILFS 491
+ +G G G V V + +A+K+LS+ + +EL L
Sbjct: 61 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELV----LMK 116
Query: 492 KLQHRNLVKLL------GCCIQGEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHII 545
+ H+N++ LL + ++ L+ E M L I + L + ++
Sbjct: 117 CVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDAN-LCQVI----QMELDHERMSY-LL 170
Query: 546 CGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNTNRVV 605
G+ +LH IIHRDLK SN+++ D KI DFGL RT + T VV
Sbjct: 171 YQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLARTA--GTSFMMTPYVV 225
Query: 606 GTY--------DGQFSIKSDVFSFGILLLEIVSGK 632
Y + D++S G ++ E+V K
Sbjct: 226 TRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHK 260
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 74.1 bits (183), Expect = 2e-14
Identities = 60/221 (27%), Positives = 96/221 (43%), Gaps = 56/221 (25%)
Query: 440 DNFSINNKLGEGGFGPVYKGTLVDGQEI-AVKRLSKISEQGLKEL---KNEVILFSKLQH 495
+F I LG G FG V+ A+K L K LK++ +E ++ S + H
Sbjct: 6 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTH 65
Query: 496 RNLVKLLGCCIQGEEKL-LIYEFMPNKSLDSFIFDQTRRTLLDWSQRFH----------I 544
++++ G Q +++ +I +++ L F R+ SQRF +
Sbjct: 66 PFIIRMWGTF-QDAQQIFMIMDYIEGGEL----FSLLRK-----SQRFPNPVAKFYAAEV 115
Query: 545 ICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNTNRV 604
L YLH II+RDLK N+LLD++ + KI+DFG + T +
Sbjct: 116 CLA----LEYLHS---KDIIYRDLKPENILLDKNGHIKITDFGFAK-----YVPDVTYTL 163
Query: 605 VGT-------------YDGQFSIKS-DVFSFGILLLEIVSG 631
GT Y+ KS D +SFGIL+ E+++G
Sbjct: 164 CGTPDYIAPEVVSTKPYN-----KSIDWWSFGILIYEMLAG 199
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 74.2 bits (183), Expect = 2e-14
Identities = 50/216 (23%), Positives = 93/216 (43%), Gaps = 34/216 (15%)
Query: 439 TDNFSINNKLGEGGFGPVYKGT-LVDGQEIAVKRLSKISEQG-----LKELKNEVILFSK 492
++ + +GEG +G V ++ +A+K++S Q L+E+K + +
Sbjct: 26 GPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIK----ILLR 81
Query: 493 LQHRNLVKLLGCCI-QGEEKL----LIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICG 547
+H N++ + E++ ++ + M L + Q L + + +
Sbjct: 82 FRHENIIGINDIIRAPTIEQMKDVYIVQDLME-TDLYKLLKTQ---HLSNDHICY-FLYQ 136
Query: 548 TARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGN--TNRVV 605
RGL Y+H S ++HRDLK SN+LL+ + KI DFGL R D T V
Sbjct: 137 ILRGLKYIH--SA-NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVA 193
Query: 606 GTY---------DGQFSIKSDVFSFGILLLEIVSGK 632
+ ++ D++S G +L E++S +
Sbjct: 194 TRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 229
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 73.5 bits (181), Expect = 2e-14
Identities = 36/176 (20%), Positives = 67/176 (38%), Gaps = 30/176 (17%)
Query: 428 PLFELATIANATDNFSINNKLGEGGFGPVYKGT-LVDGQEIAVKRLSKISEQGLKELKNE 486
++ A D + LG G G V + ++ A+K L + + E
Sbjct: 6 SGLQIKKNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARRE 60
Query: 487 V-ILFSKLQHRNLVKLLGCC---IQGEEKL-LIYEFMPNKSLDSFIFDQ-TRRTLLDWSQ 540
V + + Q ++V+++ G + L ++ E + L F + R +++
Sbjct: 61 VELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGEL----FSRIQDRGDQAFTE 116
Query: 541 R-----FHIICGTARGLLYLHQDSRLRIIHRDLKASNVLL---DQDMNPKISDFGL 588
R I + YLH + I HRD+K N+L + K++DFG
Sbjct: 117 REASEIMKSIGEA---IQYLHS---INIAHRDVKPENLLYTSKRPNAILKLTDFGF 166
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 74.3 bits (183), Expect = 3e-14
Identities = 47/223 (21%), Positives = 86/223 (38%), Gaps = 41/223 (18%)
Query: 439 TDNFSINNKLGEGGFGPVYKGTLVDGQEIAVKRLSKISEQG---------------LKEL 483
+++ + G +G V G +G +A+KR+ G L+E+
Sbjct: 21 QSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREI 80
Query: 484 KNEVILFSKLQHRNLVKLLGCCI-QGEEKL----LIYEFMPNKSLDSFIFDQTRRTLLDW 538
+ L + H N++ L + E + L+ E M L I +R ++
Sbjct: 81 R----LLNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELMRT-DLAQVI--HDQRIVISP 133
Query: 539 SQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETE 598
+ + GL LH+ ++HRDL N+LL + + I DF L R D +
Sbjct: 134 QHIQYFMYHILLGLHVLHEAG---VVHRDLHPGNILLADNNDITICDFNLAREDTADANK 190
Query: 599 GNTNRVVGTY---------DGQFSIKSDVFSFGILLLEIVSGK 632
T+ V + F+ D++S G ++ E+ + K
Sbjct: 191 --THYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRK 231
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 74.3 bits (183), Expect = 3e-14
Identities = 53/254 (20%), Positives = 97/254 (38%), Gaps = 47/254 (18%)
Query: 399 KRRRNIAEKTENSRETDQENEDQNIDLELPLFELATIANATDNFSINNKLGEGGFGPVYK 458
++ +NI ++T + D + +++ + +G G FG V
Sbjct: 42 RKNKNIDNFLSRYKDTINKIRDLRMKA--------------EDYEVVKVIGRGAFGEVQL 87
Query: 459 GTLVDGQEI-AVKRLSK---ISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKL-L 513
+++ A+K LSK I E + + +V+L Q + L +
Sbjct: 88 VRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLF-YAFQDDRYLYM 146
Query: 514 IYEFMPNKSLDSFIFDQTRRTLLDWSQRFH---IICGTARGLLYLHQDSRLRIIHRDLKA 570
+ E+MP L W+ RF+ ++ L +H + IHRD+K
Sbjct: 147 VMEYMPGGDL--VNLMSNYDVPEKWA-RFYTAEVVLA----LDAIHS---MGFIHRDVKP 196
Query: 571 SNVLLDQDMNPKISDFGLVRTFGGDETEGNTNRVVGT-------------YDGQFSIKSD 617
N+LLD+ + K++DFG + + VGT DG + + D
Sbjct: 197 DNMLLDKSGHLKLADFGTCMKMNKEGMVR-CDTAVGTPDYISPEVLKSQGGDGYYGRECD 255
Query: 618 VFSFGILLLEIVSG 631
+S G+ L E++ G
Sbjct: 256 WWSVGVFLYEMLVG 269
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 74.4 bits (183), Expect = 3e-14
Identities = 35/175 (20%), Positives = 70/175 (40%), Gaps = 31/175 (17%)
Query: 439 TDNFSINNK-LGEGGFGPVYKGT-LVDGQEIAVKRLSKISEQGLKELKNEV-ILFSKLQH 495
D++ + ++ LG G G V + ++ A+K L + + EV + + Q
Sbjct: 60 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQC 114
Query: 496 RNLVKLLGCC---IQGEEKL-LIYEFMPNKSLDSFIFDQ-TRRTLLDWSQR-----FHII 545
++V+++ G + L ++ E + L F + R +++R I
Sbjct: 115 PHIVRIVDVYENLYAGRKCLLIVMECLDGGEL----FSRIQDRGDQAFTEREASEIMKSI 170
Query: 546 CGTARGLLYLHQDSRLRIIHRDLKASNVLL---DQDMNPKISDFGLVRTFGGDET 597
+ YLH + I HRD+K N+L + K++DFG + +
Sbjct: 171 GEA---IQYLHS---INIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNS 219
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432 | Back alignment and structure |
|---|
Score = 74.0 bits (182), Expect = 4e-14
Identities = 45/191 (23%), Positives = 83/191 (43%), Gaps = 23/191 (12%)
Query: 439 TDNFSINNKLGEGGFGPVYKGT-LVDGQEIAVKRLSKISEQG------LKELKNEVILFS 491
DN+ I + +G G +G VY + +A+K+++++ E L+E+ + +
Sbjct: 25 PDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREIT----ILN 80
Query: 492 KLQHRNLVKLLGCCI-QGEEKL----LIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIIC 546
+L+ +++L I K ++ E L +T L + + I+
Sbjct: 81 RLKSDYIIRLYDLIIPDDLLKFDELYIVLEIAD-SDLKKLF--KTPIFLTEEHIKT-ILY 136
Query: 547 GTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNTNRVVG 606
G ++H IIHRDLK +N LL+QD + K+ DFGL RT ++ N +
Sbjct: 137 NLLLGENFIH--ES-GIIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKDTNIVNDLEE 193
Query: 607 TYDGQFSIKSD 617
+ K+
Sbjct: 194 NEEPGPHNKNL 204
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 73.2 bits (180), Expect = 5e-14
Identities = 50/215 (23%), Positives = 87/215 (40%), Gaps = 36/215 (16%)
Query: 439 TDNFSINNKLGEGGFGPVYKGT-LVDGQEIAVKRLSKISEQG------LKELKNEVILFS 491
+ +G G G V + + +A+K+LS+ + +EL L
Sbjct: 24 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELV----LMK 79
Query: 492 KLQHRNLVKLL------GCCIQGEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHII 545
+ H+N++ LL + ++ ++ E M +L I + L + ++
Sbjct: 80 CVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDA-NLCQVI----QMELDHERMSY-LL 133
Query: 546 CGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNTNRVV 605
G+ +LH IIHRDLK SN+++ D KI DFGL RT + T VV
Sbjct: 134 YQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTA--GTSFMMTPYVV 188
Query: 606 GTY--------DGQFSIKSDVFSFGILLLEIVSGK 632
Y + D++S G ++ E++ G
Sbjct: 189 TRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGG 223
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 73.1 bits (180), Expect = 6e-14
Identities = 49/213 (23%), Positives = 90/213 (42%), Gaps = 32/213 (15%)
Query: 439 TDNFSINNKLGEGGFGPVYKGT-LVDGQEIAVKRLSKISEQG------LKELKNEVILFS 491
+ +G G +G V G ++A+K+L + + +EL+ L
Sbjct: 24 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELR----LLK 79
Query: 492 KLQHRNLVKLL------GCCIQGEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHII 545
++H N++ LL + L+ FM L + + L + ++
Sbjct: 80 HMRHENVIGLLDVFTPDETLDDFTDFYLVMPFM-GTDLGKLMKHEK----LGEDRIQFLV 134
Query: 546 CGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNTNR-- 603
+GL Y+H IIHRDLK N+ +++D KI DFGL R + T R
Sbjct: 135 YQMLKGLRYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGLARQADSEMTGYVVTRWY 191
Query: 604 ----VVGTYDGQFSIKSDVFSFGILLLEIVSGK 632
V+ + +++ D++S G ++ E+++GK
Sbjct: 192 RAPEVILNWM-RYTQTVDIWSVGCIMAEMITGK 223
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 72.6 bits (179), Expect = 6e-14
Identities = 48/159 (30%), Positives = 76/159 (47%), Gaps = 20/159 (12%)
Query: 440 DNFSINNKLGEGGFGPVY---KGTLVDGQEI-AVKRLSK--ISEQGLKELKNEVILFSKL 493
F + LG+G FG V+ K + D +++ A+K L K + + K E + ++
Sbjct: 24 SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEV 83
Query: 494 QHRNLVKLLGCCIQGEEKL-LIYEFMPNKSLDSFIFDQTRRTLLDWSQRFH---IICGTA 549
H +VKL Q E KL LI +F+ L F + +F+ +
Sbjct: 84 NHPFIVKLH-YAFQTEGKLYLILDFLRGGDL--FTRLSKEVMFTEEDVKFYLAELALA-- 138
Query: 550 RGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGL 588
L +LH L II+RDLK N+LLD++ + K++DFGL
Sbjct: 139 --LDHLHS---LGIIYRDLKPENILLDEEGHIKLTDFGL 172
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 73.2 bits (180), Expect = 9e-14
Identities = 44/198 (22%), Positives = 75/198 (37%), Gaps = 17/198 (8%)
Query: 402 RNIAEKTENSRETDQENEDQNIDLELPLFELATIANAT------DNFSINNKLGEGGFGP 455
+ +A+ + + + + E+ + F LG+G FG
Sbjct: 104 QTVADGLKKQAAAEMDFRSGSPSDNSGAEEMEVSLAKPKHRVTMNEFEYLKLLGKGTFGK 163
Query: 456 VYKGTLVDGQEI-AVKRLSK---ISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEK 511
V A+K L K +++ + E + +H L L Q ++
Sbjct: 164 VILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALK-YSFQTHDR 222
Query: 512 L-LIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKA 570
L + E+ L F R + RF+ L YLH S +++RDLK
Sbjct: 223 LCFVMEYANGGEL--FFHLSRERVFSEDRARFYGAE-IVSALDYLH--SEKNVVYRDLKL 277
Query: 571 SNVLLDQDMNPKISDFGL 588
N++LD+D + KI+DFGL
Sbjct: 278 ENLMLDKDGHIKITDFGL 295
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 69.8 bits (171), Expect = 3e-13
Identities = 30/254 (11%), Positives = 66/254 (25%), Gaps = 47/254 (18%)
Query: 447 KLGEGGFGPVYKGT-LVDGQEIAVKRL---SKISEQGLKELKNEVILFSKLQHRNLVKLL 502
G ++ +++A+ + + + L+E + + S++ + ++L
Sbjct: 38 FHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVL 97
Query: 503 GCCIQGEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLR 562
L++ E++ SL T + A H R
Sbjct: 98 DVVHTRAGGLVVAEWIRGGSLQEVA-----DTSPSPVGAIRAMQSLAAAADAAH---RAG 149
Query: 563 IIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNTNRVVGTYDGQFSIKSDVFSFG 622
+ S V + D + ++ D + D+ G
Sbjct: 150 VALSIDHPSRVRVSIDGDVVLAYPA----TMPDANP----------------QDDIRGIG 189
Query: 623 ILLLEIVSGKKNRGFYRSDTKVNLIG----HLWDEGIPLRLIDACIQDSCNLADVIRCIH 678
L ++ R + + + I ID I ++ V
Sbjct: 190 ASLYALLVN---RWPLPEAGVRSGLAPAERDTAGQPIEPADIDRDIPFQ--ISAVA---- 240
Query: 679 IGLLCVQQHPEDRP 692
VQ R
Sbjct: 241 --ARSVQGDGGIRS 252
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 70.8 bits (174), Expect = 3e-13
Identities = 54/213 (25%), Positives = 96/213 (45%), Gaps = 32/213 (15%)
Query: 439 TDNFSINNKLGEGGFGPVYKGT-LVDGQEIAVKRLSKISEQG------LKELKNEVILFS 491
+ + + +G G +G V G +AVK+LS+ + +EL+ L
Sbjct: 28 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELR----LLK 83
Query: 492 KLQHRNLVKLL------GCCIQGEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHII 545
++H N++ LL + + L+ M L++ + Q L D +F +I
Sbjct: 84 HMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMG-ADLNNIVKCQK---LTDDHVQF-LI 138
Query: 546 CGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNTNR-- 603
RGL Y+H IIHRDLK SN+ +++D KI DFGL R + T R
Sbjct: 139 YQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARHTADEMTGYVATRWY 195
Query: 604 ----VVGTYDGQFSIKSDVFSFGILLLEIVSGK 632
++ + ++ D++S G ++ E+++G+
Sbjct: 196 RAPEIMLNW-MHYNQTVDIWSVGCIMAELLTGR 227
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 70.8 bits (174), Expect = 4e-13
Identities = 49/205 (23%), Positives = 74/205 (36%), Gaps = 41/205 (20%)
Query: 404 IAEKTENSRETDQENEDQNIDLELPLFELATIANATDNFSINNKLGEGGFGPVYKGTLVD 463
I++ E ++ L + +F +G+G FG V
Sbjct: 2 ISQPQEPELMNANPAPPPAPSQQINLGPSSNPHAKPSDFHFLKVIGKGSFGKVLLARHKA 61
Query: 464 GQEI-AVKRLSK--ISEQGLKELKNEV--------ILFSKLQHRNLVKLLGCCIQGEEKL 512
+ AVK L K I + K E +L ++H LV L Q +KL
Sbjct: 62 EEVFYAVKVLQKKAILK------KKEEKHIMSERNVLLKNVKHPFLVGLH-FSFQTADKL 114
Query: 513 -LIYEFMPNKSL-----DSFIFDQTRRTLLDWSQRF---HIICGTARGLLYLHQDSRLRI 563
+ +++ L F + R RF I L YLH L I
Sbjct: 115 YFVLDYINGGELFYHLQRERCFLEPR-------ARFYAAEIASA----LGYLHS---LNI 160
Query: 564 IHRDLKASNVLLDQDMNPKISDFGL 588
++RDLK N+LLD + ++DFGL
Sbjct: 161 VYRDLKPENILLDSQGHIVLTDFGL 185
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 69.9 bits (172), Expect = 4e-13
Identities = 41/154 (26%), Positives = 65/154 (42%), Gaps = 12/154 (7%)
Query: 440 DNFSINNKLGEGGFGPVYKGTLVDGQEI-AVKRLSK---ISEQGLKELKNEVILFSKLQH 495
++F LG+G FG V A+K L K I++ + E + +H
Sbjct: 5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRH 64
Query: 496 RNLVKLLGCCIQGEEKL-LIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLY 554
L L Q ++L + E+ L F R + RF+ L Y
Sbjct: 65 PFLTALK-YAFQTHDRLCFVMEYANGGEL--FFHLSRERVFTEERARFYGAE-IVSALEY 120
Query: 555 LHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGL 588
LH +++RD+K N++LD+D + KI+DFGL
Sbjct: 121 LHS---RDVVYRDIKLENLMLDKDGHIKITDFGL 151
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 70.8 bits (173), Expect = 8e-13
Identities = 45/155 (29%), Positives = 70/155 (45%), Gaps = 13/155 (8%)
Query: 440 DNFSINNKLGEGGFGPVYKGTLVDGQEI-AVKRLSK---ISEQGLKELKNE-VILFSKLQ 494
+F+ LG+G FG V E+ AVK L K I + ++ E +L +
Sbjct: 341 TDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGK 400
Query: 495 HRNLVKLLGCCIQGEEKL-LIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLL 553
L +L C Q ++L + E++ L + Q R + F+ A GL
Sbjct: 401 PPFLTQLH-SCFQTMDRLYFVMEYVNGGDL-MYHIQQVGRFKEPHA-VFYAAE-IAIGLF 456
Query: 554 YLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGL 588
+L II+RDLK NV+LD + + KI+DFG+
Sbjct: 457 FLQS---KGIIYRDLKLDNVMLDSEGHIKIADFGM 488
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 68.8 bits (169), Expect = 1e-12
Identities = 49/224 (21%), Positives = 94/224 (41%), Gaps = 41/224 (18%)
Query: 439 TDNFSINNKLGEGGFGPVYKGT-LVDGQEIAVKRLSKISEQGLKELKN---EVILFSKLQ 494
+ LG GG G V+ + +A+K KI + +K+ E+ + +L
Sbjct: 10 GSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIK---KIVLTDPQSVKHALREIKIIRRLD 66
Query: 495 HRNLVKLL----------GCCIQGEEKL----LIYEFMPNKSLDSFIFDQTRRTLLDWSQ 540
H N+VK+ + +L ++ E+M L + + LL+
Sbjct: 67 HDNIVKVFEILGPSGSQLTDDVGSLTELNSVYIVQEYME-TDLANVLEQGP---LLEEHA 122
Query: 541 RFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLD-QDMNPKISDFGLVRTFGGDETEG 599
R + RGL Y+H + ++HRDLK +N+ ++ +D+ KI DFGL R +
Sbjct: 123 RL-FMYQLLRGLKYIHSAN---VLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYSHK 178
Query: 600 N--TNRVVGTY---------DGQFSIKSDVFSFGILLLEIVSGK 632
+ +V + ++ D+++ G + E+++GK
Sbjct: 179 GHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGK 222
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 69.2 bits (170), Expect = 1e-12
Identities = 44/164 (26%), Positives = 70/164 (42%), Gaps = 31/164 (18%)
Query: 440 DNFSINNKLGEGGFGPVYKGTLVDGQEI-AVKRLSK--ISEQGLKELKNEV--------I 488
+F+ LG+G FG V E+ AVK L K + + ++V +
Sbjct: 20 TDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQ------DDDVECTMVEKRV 73
Query: 489 LFSKLQHRNLVKLLGCCIQGEEKL-LIYEFMPNKSLDSFIFDQTRRTLLDWSQRFH---I 544
L + L +L C Q ++L + E++ L + Q R + F+ I
Sbjct: 74 LALPGKPPFLTQLH-SCFQTMDRLYFVMEYVNGGDL-MYHIQQVGRFKEPHA-VFYAAEI 130
Query: 545 ICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGL 588
G L +L II+RDLK NV+LD + + KI+DFG+
Sbjct: 131 AIG----LFFLQS---KGIIYRDLKLDNVMLDSEGHIKIADFGM 167
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 68.7 bits (169), Expect = 1e-12
Identities = 46/161 (28%), Positives = 76/161 (47%), Gaps = 22/161 (13%)
Query: 440 DNFSINNKLGEGGFGPVY---KGTLVDGQEI-AVKRLSK---ISEQGLKE-LKNEVILFS 491
+ F + LG+GG+G V+ K T + +I A+K L K + K E +
Sbjct: 17 ECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILE 76
Query: 492 KLQHRNLVKLLGCCIQGEEKL-LIYEFMPNKSLDSFIFDQTRRTLLDWSQRF---HIICG 547
+++H +V L+ Q KL LI E++ L F+ + ++ + F I
Sbjct: 77 EVKHPFIVDLI-YAFQTGGKLYLILEYLSGGEL--FMQLEREGIFMEDTACFYLAEISMA 133
Query: 548 TARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGL 588
L +LHQ II+RDLK N++L+ + K++DFGL
Sbjct: 134 ----LGHLHQ---KGIIYRDLKPENIMLNHQGHVKLTDFGL 167
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 68.8 bits (169), Expect = 1e-12
Identities = 44/158 (27%), Positives = 71/158 (44%), Gaps = 19/158 (12%)
Query: 440 DNFSINNKLGEGGFGPVYKGTLVDGQEI-AVKRLSK---ISEQGLKELKNE-VILFSKLQ 494
+F + +G G + V L I A+K + K ++ + ++ E +
Sbjct: 9 QDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASN 68
Query: 495 HRNLVKLLGCCIQGEEKL-LIYEFMPNKSLDSFIFDQTRRTLLDWSQRFH---IICGTAR 550
H LV L C Q E +L + E++ L Q +R L + RF+ I
Sbjct: 69 HPFLVGLH-SCFQTESRLFFVIEYVNGGDL--MFHMQRQRKLPEEHARFYSAEISLA--- 122
Query: 551 GLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGL 588
L YLH+ II+RDLK NVLLD + + K++D+G+
Sbjct: 123 -LNYLHE---RGIIYRDLKLDNVLLDSEGHIKLTDYGM 156
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 68.8 bits (169), Expect = 1e-12
Identities = 42/155 (27%), Positives = 71/155 (45%), Gaps = 13/155 (8%)
Query: 440 DNFSINNKLGEGGFGPVYKGTLVDGQEI-AVKRLSK---ISEQGLKELKNE-VILFSKLQ 494
++F ++ LG+G FG V+ + A+K L K + + ++ E +L +
Sbjct: 17 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWE 76
Query: 495 HRNLVKLLGCCIQGEEKL-LIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLL 553
H L + C Q +E L + E++ L Q+ F+ GL
Sbjct: 77 HPFLTHMF-CTFQTKENLFFVMEYLNGGDL--MYHIQSCHKFDLSRATFYAAE-IILGLQ 132
Query: 554 YLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGL 588
+LH I++RDLK N+LLD+D + KI+DFG+
Sbjct: 133 FLHS---KGIVYRDLKLDNILLDKDGHIKIADFGM 164
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 68.9 bits (169), Expect = 1e-12
Identities = 47/195 (24%), Positives = 80/195 (41%), Gaps = 23/195 (11%)
Query: 403 NIAEKTENSRETDQENEDQNIDLELPLFELATIANATDNFSINNKLGEGGFGPVYKGTLV 462
N+ + ++E E N + +F + +G G + V L
Sbjct: 19 NLYFQGAMGSGIEEEKEAMNTRESGKASSSLGL----QDFDLLRVIGRGSYAKVLLVRLK 74
Query: 463 DGQEI-AVKRLSK---ISEQGLKELKNE-VILFSKLQHRNLVKLLGCCIQGEEKL-LIYE 516
I A++ + K ++ + ++ E + H LV L C Q E +L + E
Sbjct: 75 KTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLH-SCFQTESRLFFVIE 133
Query: 517 FMPNKSLDSFIFDQTRRTLLDWSQRFH---IICGTARGLLYLHQDSRLRIIHRDLKASNV 573
++ L Q +R L + RF+ I L YLH+ II+RDLK NV
Sbjct: 134 YVNGGDL--MFHMQRQRKLPEEHARFYSAEISLA----LNYLHE---RGIIYRDLKLDNV 184
Query: 574 LLDQDMNPKISDFGL 588
LLD + + K++D+G+
Sbjct: 185 LLDSEGHIKLTDYGM 199
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 68.4 bits (168), Expect = 2e-12
Identities = 51/161 (31%), Positives = 76/161 (47%), Gaps = 25/161 (15%)
Query: 440 DNFSINNKLGEGGFGPVYKGTLVDGQEI-AVKRLSK--ISEQGLKELKNEV--------I 488
DNF LG+G FG V + + ++ AVK L K I + ++V I
Sbjct: 23 DNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQ------DDDVECTMTEKRI 76
Query: 489 LFSKLQHRNLVKLLGCCIQGEEKL-LIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICG 547
L H L +L CC Q ++L + EF+ L F ++RR + RF+
Sbjct: 77 LSLARNHPFLTQLF-CCFQTPDRLFFVMEFVNGGDL-MFHIQKSRRFDEARA-RFYAAE- 132
Query: 548 TARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGL 588
L++LH II+RDLK NVLLD + + K++DFG+
Sbjct: 133 IISALMFLHD---KGIIYRDLKLDNVLLDHEGHCKLADFGM 170
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388 | Back alignment and structure |
|---|
Score = 68.6 bits (168), Expect = 2e-12
Identities = 44/190 (23%), Positives = 83/190 (43%), Gaps = 20/190 (10%)
Query: 439 TDNFSINNKLGEGGFGPVYKGT-LVDGQEIAVKRLSKISEQG------LKELKNEVILFS 491
+ + KLG+G +G V+K G+ +AVK++ + +E+ IL
Sbjct: 8 LRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIM---ILTE 64
Query: 492 KLQHRNLVKLLGCCI--QGEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTA 549
H N+V LL + L++++M L + I L +++ ++
Sbjct: 65 LSGHENIVNLLNVLRADNDRDVYLVFDYME-TDLHAVIRANI---LEPVHKQY-VVYQLI 119
Query: 550 RGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNTNRVVGTYD 609
+ + YLH S ++HRD+K SN+LL+ + + K++DFGL R+F N + +
Sbjct: 120 KVIKYLH--SG-GLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLSINEN 176
Query: 610 GQFSIKSDVF 619
+
Sbjct: 177 TENFDDDQPI 186
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 67.7 bits (166), Expect = 4e-12
Identities = 45/175 (25%), Positives = 77/175 (44%), Gaps = 23/175 (13%)
Query: 439 TDNFSINNKLGEGGFGPVYKGT-LVDGQEIAVKRLSKISEQG-----LKELKNEVILFSK 492
+ +F + + LGEG +G V T G+ +A+K++ + L+E+K +
Sbjct: 10 SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIK----ILKH 65
Query: 493 LQHRNLVKLLGCCI-QGEEKL----LIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICG 547
+H N++ + E +I E M L I Q L D ++ I
Sbjct: 66 FKHENIITIFNIQRPDSFENFNEVYIIQELMQ-TDLHRVISTQM---LSDDHIQY-FIYQ 120
Query: 548 TARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNTN 602
T R + LH + +IHRDLK SN+L++ + + K+ DFGL R + +
Sbjct: 121 TLRAVKVLHGSN---VIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEP 172
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 66.5 bits (163), Expect = 8e-12
Identities = 61/217 (28%), Positives = 97/217 (44%), Gaps = 35/217 (16%)
Query: 440 DNFSINNKLGEGGFGPVY---KGTLVDGQEI-AVKRLSK---ISEQGLKE-LKNE-VILF 490
+NF + LG G +G V+ K + D ++ A+K L K + + E + E +L
Sbjct: 54 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLE 113
Query: 491 SKLQHRNLVKLLGCCIQGEEKL-LIYEFMPNKSLDSFIFDQTRRTLLDWSQRFH---IIC 546
Q LV L Q E KL LI +++ L F R + + + I+
Sbjct: 114 HIRQSPFLVTLH-YAFQTETKLHLILDYINGGEL--FTHLSQRERFTEHEVQIYVGEIVL 170
Query: 547 GTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNTNRVVG 606
L +LH+ L II+RD+K N+LLD + + ++DFGL + F DETE G
Sbjct: 171 A----LEHLHK---LGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETER-AYDFCG 222
Query: 607 T----------YDGQFSIKS-DVFSFGILLLEIVSGK 632
T K+ D +S G+L+ E+++G
Sbjct: 223 TIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGA 259
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296 | Back alignment and structure |
|---|
Score = 60.5 bits (147), Expect = 5e-10
Identities = 37/162 (22%), Positives = 71/162 (43%), Gaps = 21/162 (12%)
Query: 440 DNFSINNKLGEGGFGPVYKGT-LVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQH-RN 497
+ + + K+G G FG +Y GT + G+E+A+K ++ L E ++ +Q
Sbjct: 9 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQ--LHIESKIYKMMQGGVG 66
Query: 498 LVKLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLL---- 553
+ + C +G+ +++ E + SL+ +F+ R + A ++
Sbjct: 67 IPTIRWCGAEGDYNVMVMELL-GPSLED-LFNFCSRKF-----SLKTVLLLADQMISRIE 119
Query: 554 YLHQDSRLRIIHRDLKASNVLLDQDMNPK---ISDFGLVRTF 592
Y+H + IHRD+K N L+ I DFGL + +
Sbjct: 120 YIHSKN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKY 158
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483 | Back alignment and structure |
|---|
Score = 57.3 bits (138), Expect = 1e-08
Identities = 37/162 (22%), Positives = 72/162 (44%), Gaps = 21/162 (12%)
Query: 440 DNFSINNKLGEGGFGPVYKGT-LVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNL 498
+ F + K+G G FG +Y GT + +E+A+K + ++ L E ++ LQ
Sbjct: 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQ--LLYESKIYRILQGGTG 64
Query: 499 V-KLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLL---- 553
+ + ++G+ +L+ + + SL+ +F+ R L + A ++
Sbjct: 65 IPNVRWFGVEGDYNVLVMDLL-GPSLED-LFNFCSRKL-----SLKTVLMLADQMINRVE 117
Query: 554 YLHQDSRLRIIHRDLKASNVLLDQDMNPK---ISDFGLVRTF 592
++H S +HRD+K N L+ I DFGL + +
Sbjct: 118 FVHSKS---FLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKY 156
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298 | Back alignment and structure |
|---|
Score = 55.4 bits (134), Expect = 2e-08
Identities = 35/166 (21%), Positives = 80/166 (48%), Gaps = 27/166 (16%)
Query: 440 DNFSINNKLGEGGFGPVYKGT-LVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQH-RN 497
++ + ++GEG FG +++GT L++ Q++A+K + S+ L++E + L
Sbjct: 10 VHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAPQ--LRDEYRTYKLLAGCTG 67
Query: 498 LVKLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHI--ICGTARGLL-- 553
+ + +G +L+ + + SL+ + D R +F + + A+ +L
Sbjct: 68 IPNVYYFGQEGLHNVLVIDLLG-PSLED-LLDLCGR-------KFSVKTVAMAAKQMLAR 118
Query: 554 --YLHQDSRLRIIHRDLKASNVLLDQDMNPK-----ISDFGLVRTF 592
+H+ S +++RD+K N L+ + + + DFG+V+ +
Sbjct: 119 VQSIHEKS---LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFY 161
|
| >1kj1_A Lectin I, lecgna 1; BULB lectin, mannose, plant protein; HET: MAN; 2.20A {Allium sativum} SCOP: b.78.1.1 PDB: 1bwu_P* 1kj1_D* 1bwu_Q* 1bwu_A* 1bwu_D* Length = 109 | Back alignment and structure |
|---|
Score = 51.4 bits (123), Expect = 2e-08
Identities = 16/84 (19%), Positives = 29/84 (34%), Gaps = 9/84 (10%)
Query: 12 YPPHEVVWVANRLNPINDSFGFLMINKTGNLVLTSQSNIVVWSAYLSKEVQTPVVLQLLD 71
Y VW +N ++ GN V+ +W+++ + VL L +
Sbjct: 34 YDHSTSVWASNTGILGKKGC-KAVLQSDGNFVVYDAEGRSLWASHSVRG-NGNYVLVLQE 91
Query: 72 SGNLVLRDEHDGDSETYFWQSFDY 95
GN+V+ W + Y
Sbjct: 92 DGNVVIYGSD-------IWSTGTY 108
|
| >1kj1_A Lectin I, lecgna 1; BULB lectin, mannose, plant protein; HET: MAN; 2.20A {Allium sativum} SCOP: b.78.1.1 PDB: 1bwu_P* 1kj1_D* 1bwu_Q* 1bwu_A* 1bwu_D* Length = 109 | Back alignment and structure |
|---|
Score = 40.6 bits (95), Expect = 2e-04
Identities = 13/68 (19%), Positives = 23/68 (33%), Gaps = 5/68 (7%)
Query: 25 NPINDSFGFLMINKTGNLVLTSQSNIVVWSAYLSKEVQTPVVLQLLDSGNLVLRDEHDGD 84
++ ++ + NLVL + VW++ + L GN V+ D
Sbjct: 14 QSLDVEPYHFIMQEDCNLVLYD-HSTSVWASNTGILGKKGCKAVLQSDGNFVVYDAEG-- 70
Query: 85 SETYFWQS 92
W S
Sbjct: 71 --RSLWAS 76
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330 | Back alignment and structure |
|---|
Score = 53.9 bits (130), Expect = 7e-08
Identities = 38/165 (23%), Positives = 68/165 (41%), Gaps = 27/165 (16%)
Query: 441 NFSINNKLGEGGFGPVYKGT-LVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQH-RNL 498
NF + K+G G FG + G L + +A+K S +L E + +L +
Sbjct: 10 NFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSRA--PQLHLEYRFYKQLGSGDGI 67
Query: 499 VKLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHI--ICGTARGLL--- 553
++ G+ ++ E + SL+ +FD R F + + A L+
Sbjct: 68 PQVYYFGPCGKYNAMVLELL-GPSLED-LFDLCDR-------TFSLKTVLMIAIQLISRM 118
Query: 554 -YLHQDSRLRIIHRDLKASNVLLDQDMNPK-----ISDFGLVRTF 592
Y+H + +I+RD+K N L+ + N I DF L + +
Sbjct: 119 EYVHSKN---LIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEY 160
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382 | Back alignment and structure |
|---|
Score = 53.9 bits (130), Expect = 9e-08
Identities = 42/171 (24%), Positives = 66/171 (38%), Gaps = 39/171 (22%)
Query: 439 TDNFSINNKLGEGGFGPVYKGT-LVDGQEIAVK---RLSKISEQGLKELKNEVILFSKLQ 494
D + I++ +G+G FG V K V+ + +A+K Q E++ +L +
Sbjct: 53 MDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFLNQAQIEVR---LL-ELMN 108
Query: 495 HR------NLVKLLGC-------CIQGEEKLL---IYEFMPNKSLDSFIFDQTRRTLLDW 538
+V L C+ E +L +Y+ + N + + TR+
Sbjct: 109 KHDTEMKYYIVHLKRHFMFRNHLCLVFE--MLSYNLYDLLRNTNFRGVSLNLTRKFA--- 163
Query: 539 SQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNP--KISDFG 587
Q LL+L L IIH DLK N+LL KI DFG
Sbjct: 164 QQMC-------TALLFLA-TPELSIIHCDLKPENILLCNPKRSAIKIVDFG 206
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429 | Back alignment and structure |
|---|
Score = 53.2 bits (128), Expect = 2e-07
Identities = 51/226 (22%), Positives = 86/226 (38%), Gaps = 63/226 (27%)
Query: 442 FSINNKLGEGGFGPVYKGT-LVDGQEIAVKRL---SKISEQGLKELKNEVILFSKLQHR- 496
+ + +G+G FG V K Q +A+K + + Q +E++ IL L+ +
Sbjct: 99 YEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNEKRFHRQAAEEIR---IL-EHLRKQD 154
Query: 497 -----NLVKLLGC-------CIQGEEKLL---IYEFMPNKSLDSFIFDQTRRTLLDWSQR 541
N++ +L C+ E LL +YE + F R
Sbjct: 155 KDNTMNVIHMLENFTFRNHICMTFE--LLSMNLYELIKKNKFQGFSLPLVR--------- 203
Query: 542 FHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNP--KISDFGLVRTFGGDETEG 599
+ L LH + RIIH DLK N+LL Q K+ DFG +
Sbjct: 204 -KFAHSILQCLDALH---KNRIIHCDLKPENILLKQQGRSGIKVIDFGSS-CY------- 251
Query: 600 NTNRVVGTY-------------DGQFSIKSDVFSFGILLLEIVSGK 632
++ V TY ++ + D++S G +L E+++G
Sbjct: 252 -EHQRVYTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGY 296
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373 | Back alignment and structure |
|---|
Score = 52.8 bits (127), Expect = 2e-07
Identities = 44/228 (19%), Positives = 89/228 (39%), Gaps = 57/228 (25%)
Query: 444 INNKLGEGGFGPVYKGT-LVDGQEIAVKRL---SKISEQGLKELK-------NEVILFSK 492
+ KLG G F V+ +V+ +A+K + +E E+K +
Sbjct: 23 LVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKEDS 82
Query: 493 LQHRNLVKLLGC-CIQGEEKL---LIYEFMPNKSLDSFIFDQTRRTL-LDWSQRFHIICG 547
+ +++KLL +G + +++E + ++L + I R + L + ++
Sbjct: 83 MGANHILKLLDHFNHKGPNGVHVVMVFEVL-GENLLALIKKYEHRGIPLIYVKQI----- 136
Query: 548 TAR----GLLYLHQDSRLRIIHRDLKASNVLLDQDMNP------KISDFGLVRTFGGDET 597
++ GL Y+H R IIH D+K NVL++ +P KI+D G + +
Sbjct: 137 -SKQLLLGLDYMH--RRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLG-NACWYDEH- 191
Query: 598 EGNTNRVVGTY-------------DGQFSIKSDVFSFGILLLEIVSGK 632
+ +D++S L+ E+++G
Sbjct: 192 -------YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGD 232
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364 | Back alignment and structure |
|---|
Score = 52.8 bits (127), Expect = 2e-07
Identities = 32/181 (17%), Positives = 63/181 (34%), Gaps = 41/181 (22%)
Query: 441 NFSINNKLGEGGFGPVYKGTLVDGQEIAVKRLS--KISEQGLKELKNEVILFSKLQHRNL 498
+ + +G+GGFG +Y + + + K+ L E+ + +
Sbjct: 36 AWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQ 95
Query: 499 V---------------KLLGCCIQGEEKLLIYEFMP----NKSLDSFIFDQTRRTLLDWS 539
+ K G + + Y FM L I++ +
Sbjct: 96 IQKWIRTRKLKYLGVPKYWGSGLHDKNGKS-YRFMIMDRFGSDLQK-IYEANAK------ 147
Query: 540 QRFHI--ICGTARGLL----YLHQDSRLRIIHRDLKASNVLLDQDMNPKI--SDFGLVRT 591
RF + + +L Y+H+ +H D+KASN+LL+ ++ D+GL
Sbjct: 148 -RFSRKTVLQLSLRILDILEYIHEHE---YVHGDIKASNLLLNYKNPDQVYLVDYGLAYR 203
Query: 592 F 592
+
Sbjct: 204 Y 204
|
| >3a0c_A Mannose/sialic acid-binding lectin; beta-prism II, sugar binding protein; 2.00A {Polygonatum cyrtonema} PDB: 3a0d_A* 3a0e_A* Length = 110 | Back alignment and structure |
|---|
Score = 48.6 bits (116), Expect = 3e-07
Identities = 20/81 (24%), Positives = 32/81 (39%), Gaps = 10/81 (12%)
Query: 12 YPPHEVVWVANRLNPINDSFGFLMINKTGNLVLTSQSNIVVWSAYLSKEVQTPVVLQLLD 71
Y + VW +N + L + GNLV+ QSN V+W + + + VL L
Sbjct: 35 YDSGKPVWASNTGGLGSGCRLTL--HNNGNLVIYDQSNRVIWQTKTNGK-EDHYVLVLQQ 91
Query: 72 SGNLVLRDEHDGDSETYFWQS 92
N+V+ W +
Sbjct: 92 DRNVVIYG-------PVVWAT 105
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345 | Back alignment and structure |
|---|
Score = 52.0 bits (125), Expect = 4e-07
Identities = 34/184 (18%), Positives = 67/184 (36%), Gaps = 40/184 (21%)
Query: 441 NFSINNKLGEGGFGPVYKGT-LVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLV 499
+ + K+G GGFG +Y ++ A + K+ Q L +E+ + ++ ++ +
Sbjct: 38 QWVLGKKIGSGGFGLIYLAFPTNKPEKDARH-VVKVEYQENGPLFSELKFYQRVAKKDCI 96
Query: 500 ---------KLLG-----CCIQGEEKLLIYEFMP----NKSLDSFIFDQTRRTLLDWSQR 541
LG E K Y FM L + +
Sbjct: 97 KKWIERKQLDYLGIPLFYGSGLTEFKGRSYRFMVMERLGIDLQK---------ISGQNGT 147
Query: 542 FHI--ICGTARGLL----YLHQDSRLRIIHRDLKASNVLLDQDMNPKI--SDFGLVRTFG 593
F + +L Y+H++ +H D+KA+N+LL ++ +D+GL +
Sbjct: 148 FKKSTVLQLGIRMLDVLEYIHENE---YVHGDIKAANLLLGYKNPDQVYLADYGLSYRYC 204
Query: 594 GDET 597
+
Sbjct: 205 PNGN 208
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 51.8 bits (123), Expect = 8e-07
Identities = 56/384 (14%), Positives = 112/384 (29%), Gaps = 103/384 (26%)
Query: 379 IVISTAALLAVVLIAGYLIRKRRRNIAEKTENSRETDQENEDQNIDLELPLFELATIANA 438
I++S A+ + + L+ K+ + + E + + F ++ I
Sbjct: 54 IIMSKDAVSGTLRLFWTLLSKQEEMVQKFVEEVLRINYK------------FLMSPIKTE 101
Query: 439 TDNFSINNKLGEGGFGPVYKGTLVDGQEIA---VKRLSKISE--QGLKELK--------- 484
S+ ++ +Y D Q A V RL + Q L EL+
Sbjct: 102 QRQPSMMTRMYIEQRDRLYN----DNQVFAKYNVSRLQPYLKLRQALLELRPAKNVLIDG 157
Query: 485 ----------NEVILFSKLQHRNLVKL----LGCCIQGEEKL-----LIYEFMPNKSLDS 525
+V L K+Q + K+ L C E L L+Y+ PN + S
Sbjct: 158 VLGSGKTWVALDVCLSYKVQCKMDFKIFWLNLKNCNSPETVLEMLQKLLYQIDPNWTSRS 217
Query: 526 FIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISD 585
+ + R LL ++ +++ + +++ KI
Sbjct: 218 DHSSNIKLRIHSIQAEL-------RRLLKSKPYENCLLVLLNVQNAKAWNAFNLSCKI-- 268
Query: 586 FGLVRTFGGDETEGNTNRVVGTYDGQFSIKSDVFSFGI-----LLLEIVSGKKNRGFYRS 640
L+ T + T+ + S+ + LLL+ +
Sbjct: 269 --LLTT----RFKQVTDFLSAATTTHISLDHHSMTLTPDEVKSLLLKYL----------- 311
Query: 641 DTKVNLIGHLWDEGIPLR--LIDACIQDSCNLAD---------VIRCIHIGLLC-----V 684
D + + P R +I I+D D + I L
Sbjct: 312 DCRPQDLPREVLTTNPRRLSIIAESIRDGLATWDNWKHVNCDKLTTIIESSLNVLEPAEY 371
Query: 685 QQH-------PEDRPCMPSVILML 701
++ P ++ ++
Sbjct: 372 RKMFDRLSVFPPSAHIPTILLSLI 395
|
| >1b2p_A Protein (lectin); mannose-binding lectin, monocot, aglutinin, bluebell bulbs, carbohydrate interactions, sugar binding protein; 1.70A {Hyacinthoides hispanica} SCOP: b.78.1.1 Length = 119 | Back alignment and structure |
|---|
Score = 47.2 bits (112), Expect = 1e-06
Identities = 15/66 (22%), Positives = 28/66 (42%), Gaps = 3/66 (4%)
Query: 12 YPPHEVVWVANRLNPINDSFGFLMINKTGNLVLTSQSNIVVWSAYLSKEVQTPVVLQLLD 71
Y + +W N N ++ G LV+ + N+ VW + ++ + VL L
Sbjct: 45 YDNNNPIWATNTGGLGNGCR--AVLQPDGVLVVITNENVTVWQSPVAGK-AGHYVLVLQP 101
Query: 72 SGNLVL 77
N+V+
Sbjct: 102 DRNVVI 107
|
| >1b2p_A Protein (lectin); mannose-binding lectin, monocot, aglutinin, bluebell bulbs, carbohydrate interactions, sugar binding protein; 1.70A {Hyacinthoides hispanica} SCOP: b.78.1.1 Length = 119 | Back alignment and structure |
|---|
Score = 40.7 bits (95), Expect = 2e-04
Identities = 19/92 (20%), Positives = 39/92 (42%), Gaps = 9/92 (9%)
Query: 2 MLADKEPNKSYPPHEVVWVANRLNPINDSFGFLMINKT-GNLVLTSQSNIVVWSAYLSKE 60
++ K+P+ ++P +++ L + + + I +T NLVL +N +W+ +
Sbjct: 3 IIFSKQPDDNHP--QILHATESLEILFGTHVYRFIMQTDCNLVLY-DNNNPIWATN-TGG 58
Query: 61 VQTPVVLQLLDSGNLVLRDEHDGDSETYFWQS 92
+ L G LV+ + WQS
Sbjct: 59 LGNGCRAVLQPDGVLVVITNEN----VTVWQS 86
|
| >2dpf_A Curculin; sweet taste, taste modifying, plant protein; 1.50A {Curculigo latifolia} PDB: 2d04_B* 2d04_A* Length = 115 | Back alignment and structure |
|---|
Score = 46.8 bits (111), Expect = 1e-06
Identities = 17/81 (20%), Positives = 25/81 (30%), Gaps = 10/81 (12%)
Query: 12 YPPHEVVWVANRLNPINDSFGFLMINKTGNLVLTSQSNIVVWSAYLSKEVQTPVVLQLLD 71
Y +W +N S L + GNLV+ +N VW + + L L
Sbjct: 35 YQNGRQIWASNTDR--RGSGCRLTLLSDGNLVIYDHNNNDVWGSACWGD-NGKYALVLQK 91
Query: 72 SGNLVLRDEHDGDSETYFWQS 92
G V+ W
Sbjct: 92 DGRFVIYG-------PVLWSL 105
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360 | Back alignment and structure |
|---|
Score = 49.6 bits (119), Expect = 2e-06
Identities = 50/239 (20%), Positives = 81/239 (33%), Gaps = 67/239 (28%)
Query: 442 FSINNKLGEGGFGPVYKGT-LVDGQEIAVK---RLSKISEQGLKELKNEVILFSKLQHR- 496
F + K+G+G FG V + + + AVK + K + E IL K+Q+
Sbjct: 37 FLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNIKKYTRSAKIEAD---IL-KKIQNDD 92
Query: 497 ----NLVKLLGC-------CIQGEEKLL---IYEFMPNKSLDSFIFDQTRRTLLDWSQRF 542
N+VK G C+ E L +YE + + + F + +
Sbjct: 93 INNNNIVKYHGKFMYYDHMCLIFE--PLGPSLYEIITRNNYNGFHIEDIK---------- 140
Query: 543 HIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNTN 602
+ L YL ++ + H DLK N+LLD K T G T
Sbjct: 141 LYCIEILKALNYLR---KMSLTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTK 197
Query: 603 RVV--------GTYDGQ---------------------FSIKSDVFSFGILLLEIVSGK 632
T+ + + SD++SFG +L E+ +G
Sbjct: 198 STGIKLIDFGCATFKSDYHGSIINTRQYRAPEVILNLGWDVSSDMWSFGCVLAELYTGS 256
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352 | Back alignment and structure |
|---|
Score = 49.4 bits (118), Expect = 2e-06
Identities = 27/178 (15%), Positives = 63/178 (35%), Gaps = 35/178 (19%)
Query: 441 NFSINNKLGEGGFGPVYKGT---------LVDGQEIAVKRLSKISEQGLKELK------- 484
+ + + G +Y+ Q+ ++K L + E
Sbjct: 43 QWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLK-LDAKDGRLFNEQNFFQRAAK 101
Query: 485 -NEVILFSKLQHRNLV---KLLGCCIQGEEKLLIYEFMP----NKSLDSFIFDQTRRTLL 536
+V + KL L+ +G + ++ Y F+ +SL S D + + +L
Sbjct: 102 PLQVNKWKKLYSTPLLAIPTCMGFGVHQDK----YRFLVLPSLGRSLQS-ALDVSPKHVL 156
Query: 537 DWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKI--SDFGLVRTF 592
+ C L +LH++ +H ++ A N+ +D + ++ + +G +
Sbjct: 157 SERSVLQVACRLLDALEFLHENE---YVHGNVTAENIFVDPEDQSQVTLAGYGFAFRY 211
|
| >1xd5_A Gastrodianin-1, antifungal protein GAFP-1; monocot mannose binding lectin, monomer, homogeneous beta- sheet; 2.00A {Gastrodia elata} SCOP: b.78.1.1 PDB: 1xd6_A Length = 112 | Back alignment and structure |
|---|
Score = 45.7 bits (108), Expect = 3e-06
Identities = 17/81 (20%), Positives = 30/81 (37%), Gaps = 8/81 (9%)
Query: 12 YPPHEVVWVANRLNPINDSFGFLMINKTGNLVLTSQSNIVVWSAYLSKEVQTPVVLQLLD 71
Y + VW + + L + GNLV+ S S +W++ + L L
Sbjct: 34 YDNNRAVWASGTNGKASGCV--LKMQNDGNLVIYSGSR-AIWASN-TNRQNGNYYLILQR 89
Query: 72 SGNLVLRDEHDGDSETYFWQS 92
N+V+ D + W +
Sbjct: 90 DRNVVIYDNSN----NAIWAT 106
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339 | Back alignment and structure |
|---|
Score = 47.3 bits (113), Expect = 1e-05
Identities = 51/241 (21%), Positives = 84/241 (34%), Gaps = 75/241 (31%)
Query: 442 FSINNKLGEGGFGPVYKG--TLVDGQEIAVK---RLSKISEQGLKELKNEVILFSKLQHR 496
+ I + LGEG FG V + G+ +AVK + + E E++ +L L
Sbjct: 16 YEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNVDRYCEAARSEIQ---VL-EHLNTT 71
Query: 497 ------NLVKLLGC-------CIQGEEKLL---IYEFMPNKSLDSFIFDQTR---RTLLD 537
V++L CI E LL Y+F+ F D R +
Sbjct: 72 DPNSTFRCVQMLEWFEHHGHICIVFE--LLGLSTYDFIKENGFLPFRLDHIRKMAYQIC- 128
Query: 538 WSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDET 597
+ + +LH ++ H DLK N+L + ++ + + T
Sbjct: 129 ------------KSVNFLH---SNKLTHTDLKPENILF---VQSDYTEAYNPKIKRDERT 170
Query: 598 EGNTN-RVV----GTYDGQ---------------------FSIKSDVFSFGILLLEIVSG 631
N + +VV TYD + +S DV+S G +L+E G
Sbjct: 171 LINPDIKVVDFGSATYDDEHHSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLG 230
Query: 632 K 632
Sbjct: 231 F 231
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355 | Back alignment and structure |
|---|
Score = 46.9 bits (112), Expect = 1e-05
Identities = 48/241 (19%), Positives = 82/241 (34%), Gaps = 69/241 (28%)
Query: 439 TDNFSINNKLGEGGFGPVYKG--TLVDGQEIAVK---RLSKISEQGLKELKNEVILFSKL 493
+ + I LGEG FG V + ++A+K + K E E+ +L K+
Sbjct: 18 QERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNVGKYREAARLEIN---VL-KKI 73
Query: 494 QHR------NLVKLLGC-------CIQGEEKLL---IYEFMPNKSLDSFIFDQTRRTLLD 537
+ + V + CI E LL +EF+ + + R
Sbjct: 74 KEKDKENKFLCVLMSDWFNFHGHMCIAFE--LLGKNTFEFLKENNFQPYPLPHVR----- 126
Query: 538 WSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDET 597
H+ L +LH ++ H DLK N+L +N + +++
Sbjct: 127 -----HMAYQLCHALRFLH---ENQLTHTDLKPENILF---VNSEFETLYNEHKSCEEKS 175
Query: 598 EGNTN-RVV----GTYDGQ---------------------FSIKSDVFSFGILLLEIVSG 631
NT+ RV T+D + ++ DV+S G +L E G
Sbjct: 176 VKNTSIRVADFGSATFDHEHHTTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRG 235
Query: 632 K 632
Sbjct: 236 F 236
|
| >3dzw_A Agglutinin; lectin, mannobiose, mannose-alpha1, 3-mannose, D sugar binding protein; HET: MAN; 1.70A {Narcissus pseudonarcissus} PDB: 1npl_A* 1jpc_A* 1msa_A* 1niv_A* Length = 109 | Back alignment and structure |
|---|
Score = 42.2 bits (99), Expect = 5e-05
Identities = 19/81 (23%), Positives = 29/81 (35%), Gaps = 10/81 (12%)
Query: 12 YPPHEVVWVANRLNPINDSFGFLMINKTGNLVLTSQSNIVVWSAYLSKEVQTPVVLQLLD 71
Y + +W N D L + GNLV+ S N +W++ E V L
Sbjct: 34 YDVDKPIWATNTGG--LDRRCHLSMQSDGNLVVYSPRNNPIWASNTGGE-NGNYVCVLQK 90
Query: 72 SGNLVLRDEHDGDSETYFWQS 92
N+V+ T W +
Sbjct: 91 DRNVVIYG-------TARWAT 104
|
| >3r0e_B Lectin; carbohydrate binding, carbohydrate, sugar binding protein; 2.40A {Remusatia vivipara} Length = 110 | Back alignment and structure |
|---|
Score = 41.8 bits (98), Expect = 6e-05
Identities = 18/64 (28%), Positives = 27/64 (42%), Gaps = 3/64 (4%)
Query: 14 PHEVVWVANRLNPINDSFGFLMINKTGNLVLTSQSNIVVWSAYLSKEVQTPVVLQLLDSG 73
+ W +N N FL +N G L++ +WS+ S + Q VL L D G
Sbjct: 40 GGKYGWQSNTHG--NGEHCFLRLNHKGELIIKDDDFKTIWSSRSSSK-QGEYVLILQDDG 96
Query: 74 NLVL 77
V+
Sbjct: 97 FGVI 100
|
| >3r0e_A Lectin; carbohydrate binding, carbohydrate, sugar binding protein; 2.40A {Remusatia vivipara} Length = 109 | Back alignment and structure |
|---|
Score = 41.0 bits (96), Expect = 1e-04
Identities = 14/73 (19%), Positives = 26/73 (35%), Gaps = 3/73 (4%)
Query: 16 EVVWVANRLNPINDSFGFLMINKTGNLVLTSQSNIVVWSAYLSKEVQTPVVLQLLDSGNL 75
W +N N N L + G LV+ + VW + ++ V+ + G L
Sbjct: 37 NGNWQSNTAN--NGRDCKLTLTDYGELVIKNGDGSTVWKSG-AQSVKGNYAAVVHPDGRL 93
Query: 76 VLRDEHDGDSETY 88
V+ + +
Sbjct: 94 VVFGPSVFKIDPW 106
|
| >1dlp_A Lectin scafet precursor; two-domain lectin, beta prism II fold, native, sugar binding protein; 3.30A {Hyacinthoides hispanica} SCOP: b.78.1.1 b.78.1.1 Length = 236 | Back alignment and structure |
|---|
Score = 43.0 bits (100), Expect = 1e-04
Identities = 12/66 (18%), Positives = 23/66 (34%), Gaps = 3/66 (4%)
Query: 12 YPPHEVVWVANRLNPINDSFGFLMINKTGNLVLTSQSNIVVWSAYLSKEVQTPVVLQLLD 71
+ + VW N ++ G + + + NI VW++ + V L
Sbjct: 165 FDRDDRVWSTNTAGKGTGCR--AVLQPNGRMDVLTNQNIAVWTSG-NSRSAGRYVFVLQP 221
Query: 72 SGNLVL 77
NL +
Sbjct: 222 DRNLAI 227
|
| >1dlp_A Lectin scafet precursor; two-domain lectin, beta prism II fold, native, sugar binding protein; 3.30A {Hyacinthoides hispanica} SCOP: b.78.1.1 b.78.1.1 Length = 236 | Back alignment and structure |
|---|
Score = 42.2 bits (98), Expect = 3e-04
Identities = 19/149 (12%), Positives = 42/149 (28%), Gaps = 11/149 (7%)
Query: 12 YPPHEVVWVANRLNPINDSFGFLMINKTGNLVLTSQSNIVVWSAYLSKEVQTPVVLQLLD 71
+ VW +N + ++ G LV+ + N + WS+ VL L
Sbjct: 41 FDSDVRVWASNTAGA---TGCRAVLQSDGLLVILTAQNTIRWSSGTKGS-IGNYVLVLQP 96
Query: 72 SGNLVLRDEHDGDSETYFWQSFDYPSDTLLPGMKLGWDLKTGLERRVTSWKSFDDPSPGD 131
+ + DS T S ++ + S
Sbjct: 97 DRTVTIYGPGLWDSGTSNKGSVVVANNGNSILYSTQGNDNHP-------QTLHATQSLQL 149
Query: 132 FIWAIERQDNPEVVMWKGSRKFYRTGPWN 160
+ + + + +V++ + + T
Sbjct: 150 SPYRLSMETDCNLVLFDRDDRVWSTNTAG 178
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397 | Back alignment and structure |
|---|
Score = 42.6 bits (100), Expect = 4e-04
Identities = 38/151 (25%), Positives = 67/151 (44%), Gaps = 20/151 (13%)
Query: 439 TDNFSINNKLGEGGFGPVYKG-TLVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQ--- 494
+ + KLG G F V+ + + +A+K + K +E + +E+ L ++
Sbjct: 36 NGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMK-VVKSAEHYTETALDEIRLLKSVRNSD 94
Query: 495 -----HRNLVKLLGC-CIQGEE---KLLIYEFMPNKSLDSFIFDQTRRTL-LDWSQRFHI 544
+V+LL I G +++E + L +I + L L ++ I
Sbjct: 95 PNDPNREMVVQLLDDFKISGVNGTHICMVFEVL-GHHLLKWIIKSNYQGLPLPCVKK--I 151
Query: 545 ICGTARGLLYLHQDSRLRIIHRDLKASNVLL 575
I +GL YLH ++ RIIH D+K N+LL
Sbjct: 152 IQQVLQGLDYLH--TKCRIIHTDIKPENILL 180
|
| >3mez_B Mannose-specific lectin 3 chain 2; heterotetramer, sugar binding protein; 1.94A {Crocus vernus} Length = 113 | Back alignment and structure |
|---|
Score = 39.1 bits (91), Expect = 7e-04
Identities = 12/61 (19%), Positives = 24/61 (39%), Gaps = 3/61 (4%)
Query: 17 VVWVANRLNPINDSFGFLMINKTGNLVLTSQSNIVVWSAYLSKEVQTPVVLQLLDSGNLV 76
+VW + F+ + +G L +T V+ + + + VL L +G V
Sbjct: 46 IVWESGTSG--RGQHCFMRLGHSGELDITDDRLNTVFVSNTVGQ-EGDYVLILQINGQAV 102
Query: 77 L 77
+
Sbjct: 103 V 103
|
Structure Templates Detected by HHsearch
Original result of HHsearch against PDB70 database
No hit with probability above 80.00
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST
Original result of RPS-BLAST against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
E-value |
| 747 | ||||
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 6e-65 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 5e-60 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 2e-57 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 2e-57 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 2e-56 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 3e-56 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 2e-55 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 2e-55 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 8e-55 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 9e-55 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 1e-54 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 1e-54 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 1e-54 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 3e-54 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 6e-54 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 9e-54 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 1e-53 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 1e-53 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 2e-53 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 2e-52 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 7e-52 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 7e-52 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 1e-51 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 3e-51 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 3e-51 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 2e-50 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 2e-50 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 7e-50 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 6e-48 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 2e-47 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 5e-47 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 8e-46 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 2e-43 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 3e-43 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 2e-42 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 8e-42 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 6e-41 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 7e-40 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 3e-39 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 7e-39 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 1e-38 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 3e-38 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 5e-38 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 2e-37 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 2e-37 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 1e-36 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 1e-36 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 1e-35 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 7e-34 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 9e-34 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 1e-33 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 3e-33 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 8e-33 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 2e-32 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 4e-32 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 4e-32 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 4e-31 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 8e-31 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 4e-27 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 6e-27 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 5e-26 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 6e-26 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 3e-22 | |
| d1kj1a_ | 109 | b.78.1.1 (A:) Lectin (agglutinin) {Garlic (Allium | 5e-14 | |
| d1dlpa2 | 120 | b.78.1.1 (A:116-235) Fetuin-binding protein Scafet | 4e-10 | |
| d1dlpa2 | 120 | b.78.1.1 (A:116-235) Fetuin-binding protein Scafet | 7e-05 | |
| d1xd5a_ | 112 | b.78.1.1 (A:) Gastrodianin (antifungal protein) {G | 3e-09 | |
| d1jpca_ | 108 | b.78.1.1 (A:) Lectin (agglutinin) {Snowdrop (Galan | 5e-09 | |
| d1b2pa_ | 119 | b.78.1.1 (A:) Lectin (agglutinin) {Bluebell (Scill | 4e-08 | |
| d1dlpa1 | 115 | b.78.1.1 (A:1-115) Fetuin-binding protein Scafet p | 6e-06 |
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 215 bits (548), Expect = 6e-65
Identities = 62/274 (22%), Positives = 121/274 (44%), Gaps = 26/274 (9%)
Query: 440 DNFSINNKLGEGGFGPVYKGTLVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLV 499
++ ++G G FG VYKG + + ++ + Q L+ KNEV + K +H N++
Sbjct: 8 GQITVGQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNIL 67
Query: 500 KLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDS 559
+G + ++ ++ SL + T + + I TA+G+ YLH S
Sbjct: 68 LFMGYSTAP-QLAIVTQWCEGSSLYHHLHI--IETKFEMIKLIDIARQTAQGMDYLHAKS 124
Query: 560 RLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNTNRVVGTY----------- 608
IIHRDLK++N+ L +D+ KI DFGL ++ G+
Sbjct: 125 ---IIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQ 181
Query: 609 -DGQFSIKSDVFSFGILLLEIVSGKKNRGFYRSDTKVNLIGHLWDEGIPLRLIDACIQDS 667
+S +SDV++FGI+L E+++G+ + + + +I + + L
Sbjct: 182 DKNPYSFQSDVYAFGIVLYELMTGQLP--YSNINNRDQIIFMVGRGYLSPDLSKVRSNCP 239
Query: 668 CNLADVIRCIHIGLLCVQQHPEDRPCMPSVILML 701
+ ++ C+++ ++RP P ++ +
Sbjct: 240 KAMKRLMA------ECLKKKRDERPLFPQILASI 267
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 201 bits (513), Expect = 5e-60
Identities = 78/270 (28%), Positives = 122/270 (45%), Gaps = 26/270 (9%)
Query: 440 DNFSINNKLGEGGFGPVYKGTLVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLV 499
+ + +LG G FG V+ G ++AVK L + E L +LQH+ LV
Sbjct: 13 ETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQ-GSMSPDAFLAEANLMKQLQHQRLV 71
Query: 500 KLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDS 559
+L Q E +I E+M N SL F+ L ++ + A G+ ++ + +
Sbjct: 72 RLYAVVTQ-EPIYIITEYMENGSLVDFLKTP-SGIKLTINKLLDMAAQIAEGMAFIEERN 129
Query: 560 RLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNTNRVVGTY--------DGQ 611
IHRDL+A+N+L+ ++ KI+DFGL R +E G
Sbjct: 130 ---YIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGT 186
Query: 612 FSIKSDVFSFGILLLEIVSGKKNRGFYRSDTKVNLIGHLWDEGIPLRLIDACIQDSCNLA 671
F+IKSDV+SFGILL EIV+ + Y T +I +L + G + D C ++
Sbjct: 187 FTIKSDVWSFGILLTEIVTHGRI--PYPGMTNPEVIQNL-ERGYRMVRPDNCPEE----- 238
Query: 672 DVIRCIHIGLLCVQQHPEDRPCMPSVILML 701
+ LC ++ PEDRP + +L
Sbjct: 239 ----LYQLMRLCWKERPEDRPTFDYLRSVL 264
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 194 bits (494), Expect = 2e-57
Identities = 70/277 (25%), Positives = 119/277 (42%), Gaps = 31/277 (11%)
Query: 440 DNFSINNKLGEGGFGPVYKGTLVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLV 499
+ ++G G FG V+ G ++ ++A+K + + ++ E + KL H LV
Sbjct: 5 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIRE-GAMSEEDFIEEAEVMMKLSHPKLV 63
Query: 500 KLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDS 559
+L G C++ L++EFM + L ++ Q + G+ YL +
Sbjct: 64 QLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLF--AAETLLGMCLDVCEGMAYLEE-- 119
Query: 560 RLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNTNRVVGTY---------DG 610
+IHRDL A N L+ ++ K+SDFG+ R D+ ++
Sbjct: 120 -ACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYT-SSTGTKFPVKWASPEVFSFS 177
Query: 611 QFSIKSDVFSFGILLLEIVSGKKNRGFYRSDTKV-NLIGHLWDEGIPLRLIDACIQDSCN 669
++S KSDV+SFG+L+ E+ S K RS+++V I + P RL
Sbjct: 178 RYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYKP-RLAST------- 229
Query: 670 LADVIRCIHIGLLCVQQHPEDRPCMPSVILMLGSEIL 706
I C ++ PEDRP ++ L +EI
Sbjct: 230 -----HVYQIMNHCWKERPEDRPAFSRLLRQL-AEIA 260
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 195 bits (496), Expect = 2e-57
Identities = 72/284 (25%), Positives = 125/284 (44%), Gaps = 27/284 (9%)
Query: 440 DNFSINNKLGEGGFGPVYKGTLVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLV 499
++ + KLG+G FG V+ GT +A+K L + E + KL+H LV
Sbjct: 17 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKP-GTMSPEAFLQEAQVMKKLRHEKLV 75
Query: 500 KLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDS 559
+L + E ++ E+M SL F+ +T + L Q + A G+ Y+ +
Sbjct: 76 QLYAVVSE-EPIYIVTEYMSKGSLLDFLKGETGKYL-RLPQLVDMAAQIASGMAYVER-- 131
Query: 560 RLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNTNRVVGTY--------DGQ 611
+ +HRDL+A+N+L+ +++ K++DFGL R +E G+
Sbjct: 132 -MNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGR 190
Query: 612 FSIKSDVFSFGILLLEIVSGKKNRGFYRSDTKVNLIGHLWDEGIPLRLIDACIQDSCNLA 671
F+IKSDV+SFGILL E+ + + Y ++ + + G + C +
Sbjct: 191 FTIKSDVWSFGILLTELTTKGRV--PYPGMVNREVLDQV-ERGYRMPCPPECPES----- 242
Query: 672 DVIRCIHIGLLCVQQHPEDRPCMPSVILMLGSEILLPQPK-QPG 714
+ C ++ PE+RP + L +P+ QPG
Sbjct: 243 ----LHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTEPQYQPG 282
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 192 bits (489), Expect = 2e-56
Identities = 71/308 (23%), Positives = 125/308 (40%), Gaps = 52/308 (16%)
Query: 431 ELATIANATDNFSINNKLGEGGFGPVYKGTL------VDGQEIAVKRLSK-ISEQGLKEL 483
+L ++ +N +GEG FG V++ +AVK L + S +
Sbjct: 4 KLLSLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADF 63
Query: 484 KNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQTRRTL-------- 535
+ E L ++ + N+VKLLG C G+ L++E+M L+ F+ + T+
Sbjct: 64 QREAALMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDL 123
Query: 536 -------------LDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPK 582
L +++ I A G+ YL + + +HRDL N L+ ++M K
Sbjct: 124 STRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSER---KFVHRDLATRNCLVGENMVVK 180
Query: 583 ISDFGLVRTFGGDETEGNTNRVVGTY---------DGQFSIKSDVFSFGILLLEIVSGKK 633
I+DFGL R + +++ +SDV+++G++L EI S
Sbjct: 181 IADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGL 240
Query: 634 NRGFYRSDTKVNLIGHLWDEGIPLRLIDACIQDSCNLADVIRCIHIGLLCVQQHPEDRPC 693
Y +I ++ D G L + C + ++ LC + P DRP
Sbjct: 241 Q--PYYGMAHEEVIYYVRD-GNILACPENCPLE---------LYNLMRLCWSKLPADRPS 288
Query: 694 MPSVILML 701
S+ +L
Sbjct: 289 FCSIHRIL 296
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 191 bits (487), Expect = 3e-56
Identities = 67/271 (24%), Positives = 118/271 (43%), Gaps = 26/271 (9%)
Query: 440 DNFSINNKLGEGGFGPVYKGTLVD-GQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNL 498
+ ++ +KLG G +G VY+G +AVK L + ++E E + +++H NL
Sbjct: 17 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKE-DTMEVEEFLKEAAVMKEIKHPNL 75
Query: 499 VKLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQD 558
V+LLG C + +I EFM +L ++ + R+ + ++ + + YL
Sbjct: 76 VQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQE-VSAVVLLYMATQISSAMEYLE-- 132
Query: 559 SRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNTNRVVGTY--------DG 610
+ IHRDL A N L+ ++ K++DFGL R GD +
Sbjct: 133 -KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYN 191
Query: 611 QFSIKSDVFSFGILLLEIVSGKKNRGFYRSDTKVNLIGHLWDEGIPLRLIDACIQDSCNL 670
+FSIKSDV++FG+LL EI + + ++ + L ++ + + C +
Sbjct: 192 KFSIKSDVWAFGVLLWEIATYGMS---PYPGIDLSQVYELLEKDYRMERPEGCPEK---- 244
Query: 671 ADVIRCIHIGLLCVQQHPEDRPCMPSVILML 701
+ C Q +P DRP +
Sbjct: 245 -----VYELMRACWQWNPSDRPSFAEIHQAF 270
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 189 bits (480), Expect = 2e-55
Identities = 67/267 (25%), Positives = 110/267 (41%), Gaps = 24/267 (8%)
Query: 440 DNFSINNKLGEGGFGPVYKGTLVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLV 499
+ +G+G FG V G G ++AVK + + + E + ++L+H NLV
Sbjct: 7 KELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKN--DATAQAFLAEASVMTQLRHSNLV 63
Query: 500 KLLGCCIQGEEKL-LIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQD 558
+LLG ++ + L ++ E+M SL ++ + R++L + YL
Sbjct: 64 QLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSR-GRSVLGGDCLLKFSLDVCEAMEYLE-- 120
Query: 559 SRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNTNRVVGT----YDGQFSI 614
+HRDL A NVL+ +D K+SDFGL + + G + +FS
Sbjct: 121 -GNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPVKWTAPEALREKKFST 179
Query: 615 KSDVFSFGILLLEIVSGKKNRGFYRSDTKVNLIGHLWDEGIPLRLIDACIQDSCNLADVI 674
KSDV+SFGILL EI S + Y +++ ++G + D C
Sbjct: 180 KSDVWSFGILLWEIYSFGRV--PYPRIPLKDVV-PRVEKGYKMDAPDGCPPA-------- 228
Query: 675 RCIHIGLLCVQQHPEDRPCMPSVILML 701
+ C RP + L
Sbjct: 229 -VYEVMKNCWHLDAAMRPSFLQLREQL 254
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 190 bits (482), Expect = 2e-55
Identities = 56/296 (18%), Positives = 108/296 (36%), Gaps = 40/296 (13%)
Query: 440 DNFSINNKLGEGGFGPVYKGTLVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLV 499
+ +G+G FG V++G G+E+AVK S E+ + E+ L+H N++
Sbjct: 3 RTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSREERS-WFREAEIYQTVMLRHENIL 60
Query: 500 KLLGCCIQGEEKL----LIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYL 555
+ + L+ ++ + SL ++ R + + TA GL +L
Sbjct: 61 GFIAADNKDNGTWTQLWLVSDYHEHGSLFDYL----NRYTVTVEGMIKLALSTASGLAHL 116
Query: 556 HQD-----SRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTF--GGDETEGNTNRVVGTY 608
H + + I HRDLK+ N+L+ ++ I+D GL D + N VGT
Sbjct: 117 HMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTK 176
Query: 609 ---------------DGQFSIKSDVFSFGILLLEIVSGKKNRGF-------YRSDTKVNL 646
+ ++D+++ G++ EI G Y +
Sbjct: 177 RYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDP 236
Query: 647 IGHLWDEGIPLRLIDACIQDSCNLADVIRCIH-IGLLCVQQHPEDRPCMPSVILML 701
+ + + + I + + +R + I C + R + L
Sbjct: 237 SVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTL 292
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 188 bits (478), Expect = 8e-55
Identities = 67/271 (24%), Positives = 112/271 (41%), Gaps = 29/271 (10%)
Query: 437 NATDNFSINNKLGEGGFGPVYKGTLVD-GQEIAVKRLSKISEQGLKELKNEVILFSKLQH 495
N D + I +LG+G FG VYK + A K + SE+ L++ E+ + + H
Sbjct: 9 NPEDFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDH 68
Query: 496 RNLVKLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYL 555
N+VKLL ++ EF ++D+ + + R L SQ + T L YL
Sbjct: 69 PNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERP--LTESQIQVVCKQTLDALNYL 126
Query: 556 HQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNTNRVVGTY------- 608
H +IIHRDLKA N+L D + K++DFG+ ++ +
Sbjct: 127 HD---NKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFIGTPYWMAPEVVM 183
Query: 609 -----DGQFSIKSDVFSFGILLLEIVSGKKNRGFYRSDTKVNLIGHLWDEGIPLRLIDAC 663
D + K+DV+S GI L+E+ + + + L+ E L
Sbjct: 184 CETSKDRPYDYKADVWSLGITLIEMAEIE--PPHHELNPMRVLLKIAKSEPPTLAQPSRW 241
Query: 664 IQDSCNLADVIRCIHIGLLCVQQHPEDRPCM 694
S N D ++ C++++ + R
Sbjct: 242 ---SSNFKDFLKK------CLEKNVDARWTT 263
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 188 bits (478), Expect = 9e-55
Identities = 72/298 (24%), Positives = 122/298 (40%), Gaps = 43/298 (14%)
Query: 430 FELATIANATDNFS---------INNKLGEGGFGPVYKGTLV----DGQEIAVKRLSK-I 475
F A F+ I +G G FG V G L +A+K L
Sbjct: 7 FTFEDPNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGY 66
Query: 476 SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQTRRTL 535
+E+ ++ +E + + H N++ L G + ++I EFM N SLDSF+ +
Sbjct: 67 TEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQF- 125
Query: 536 LDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGD 595
Q ++ G A G+ YL + +HRDL A N+L++ ++ K+SDFGL R D
Sbjct: 126 -TVIQLVGMLRGIAAGMKYLAD---MNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDD 181
Query: 596 ETEGNTNRVVGTY------------DGQFSIKSDVFSFGILLLEIVSGKKNRGFYRSDTK 643
++ +G +F+ SDV+S+GI++ E++S + Y T
Sbjct: 182 TSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGER--PYWDMTN 239
Query: 644 VNLIGHLWDEGIPLRLIDACIQDSCNLADVIRCIHIGLLCVQQHPEDRPCMPSVILML 701
++I + ++ L C + L C Q+ RP ++ L
Sbjct: 240 QDVINAI-EQDYRLPPPMDCPSA---------LHQLMLDCWQKDRNHRPKFGQIVNTL 287
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 188 bits (479), Expect = 1e-54
Identities = 71/303 (23%), Positives = 110/303 (36%), Gaps = 51/303 (16%)
Query: 440 DNFSINNKLGEGGFGPVYKGTLVD------GQEIAVKRLSKISEQG-LKELKNEVILFSK 492
+N LG G FG V T ++AVK L + ++ + L +E+ + ++
Sbjct: 37 ENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQ 96
Query: 493 L-QHRNLVKLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQTRR------------------ 533
L H N+V LLG C LI+E+ L +++ + +
Sbjct: 97 LGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEE 156
Query: 534 --TLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRT 591
+L + A+G+ +L +HRDL A NVL+ KI DFGL R
Sbjct: 157 DLNVLTFEDLLCFAYQVAKGMEFLEF---KSCVHRDLAARNVLVTHGKVVKICDFGLARD 213
Query: 592 FGGDETEGNTNRVVGTY---------DGQFSIKSDVFSFGILLLEIVSGKKNRGFYRSDT 642
D +G ++IKSDV+S+GILL EI S N Y
Sbjct: 214 IMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVN--PYPGIP 271
Query: 643 KVNLIGHLWDEGIPLRLIDACIQDSCNLADVIRCIHIGLLCVQQHPEDRPCMPSVILMLG 702
L G + ++ I C RP P++ LG
Sbjct: 272 VDANFYKLIQNGFKMDQPFYATEE---------IYIIMQSCWAFDSRKRPSFPNLTSFLG 322
Query: 703 SEI 705
++
Sbjct: 323 CQL 325
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 187 bits (476), Expect = 1e-54
Identities = 68/279 (24%), Positives = 120/279 (43%), Gaps = 33/279 (11%)
Query: 438 ATDNFSI-NNKLGEGGFGPVYKGTLV---DGQEIAVKRLSKISEQG-LKELKNEVILFSK 492
DN I + +LG G FG V +G ++A+K L + +E+ +E+ E + +
Sbjct: 6 KRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQ 65
Query: 493 LQHRNLVKLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGL 552
L + +V+L+G C Q E +L+ E L F+ + + S ++ + G+
Sbjct: 66 LDNPYIVRLIGVC-QAEALMLVMEMAGGGPLHKFLVGKREE--IPVSNVAELLHQVSMGM 122
Query: 553 LYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGN-TNRVVGTY--- 608
YL + +HRDL A NVLL KISDFGL + G D++ +
Sbjct: 123 KYLEE---KNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWY 179
Query: 609 ------DGQFSIKSDVFSFGILLLEIVSGKKNRGFYRSDTKVNLIGHLWDEGIPLRLIDA 662
+FS +SDV+S+G+ + E +S + Y+ ++ + ++G +
Sbjct: 180 APECINFRKFSSRSDVWSYGVTMWEALSYGQK--PYKKMKGPEVMAFI-EQGKRMECPPE 236
Query: 663 CIQDSCNLADVIRCIHIGLLCVQQHPEDRPCMPSVILML 701
C + L ++ C EDRP +V +
Sbjct: 237 CPPE---LYALMS------DCWIYKWEDRPDFLTVEQRM 266
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 186 bits (473), Expect = 1e-54
Identities = 64/271 (23%), Positives = 105/271 (38%), Gaps = 28/271 (10%)
Query: 440 DNFSINNKLGEGGFGPVYKGTLVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLV 499
+ + +LG G FG V G ++A+K + + E E + L H LV
Sbjct: 4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKE-GSMSEDEFIEEAKVMMNLSHEKLV 62
Query: 500 KLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDS 559
+L G C + +I E+M N L +++ + R Q + + YL
Sbjct: 63 QLYGVCTKQRPIFIITEYMANGCLLNYLREMRHR--FQTQQLLEMCKDVCEAMEYLESK- 119
Query: 560 RLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNTNRVVGTY---------DG 610
+ +HRDL A N L++ K+SDFGL R DE +
Sbjct: 120 --QFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVG-SKFPVRWSPPEVLMYS 176
Query: 611 QFSIKSDVFSFGILLLEIVSGKKNRGFYRSDTKVNLIGHLWDEGIPLRLIDACIQDSCNL 670
+FS KSD+++FG+L+ EI S K Y T H+ +G+ L +
Sbjct: 177 KFSSKSDIWAFGVLMWEIYSLGKM--PYERFTNSETAEHI-AQGLRLYRPHLASEK---- 229
Query: 671 ADVIRCIHIGLLCVQQHPEDRPCMPSVILML 701
I C + ++RP ++ +
Sbjct: 230 -----VYTIMYSCWHEKADERPTFKILLSNI 255
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 187 bits (475), Expect = 3e-54
Identities = 69/298 (23%), Positives = 107/298 (35%), Gaps = 46/298 (15%)
Query: 440 DNFSINNKLGEGGFGPVYKGTLV------DGQEIAVKRLSKISEQG-LKELKNEVILFSK 492
+ S LG G FG V + T +AVK L + + L +E+ + S
Sbjct: 23 NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSY 82
Query: 493 L-QHRNLVKLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQTRRTL---------------L 536
L H N+V LLG C G L+I E+ L +F+ + + L
Sbjct: 83 LGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELAL 142
Query: 537 DWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDE 596
D A+G+ +L IHRDL A N+LL KI DFGL R D
Sbjct: 143 DLEDLLSFSYQVAKGMAFLAS---KNCIHRDLAARNILLTHGRITKICDFGLARDIKNDS 199
Query: 597 TEGNTNRVVGT---------YDGQFSIKSDVFSFGILLLEIVSGKKNRGFYRSDTKVNLI 647
++ ++ +SDV+S+GI L E+ S + Y +
Sbjct: 200 NYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSS--PYPGMPVDSKF 257
Query: 648 GHLWDEGIPLRLIDACIQDSCNLADVIRCIHIGLLCVQQHPEDRPCMPSVILMLGSEI 705
+ EG + + + I C P RP ++ ++ +I
Sbjct: 258 YKMIKEGFRMLSPEHAPAE---------MYDIMKTCWDADPLKRPTFKQIVQLIEKQI 306
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 186 bits (473), Expect = 6e-54
Identities = 77/322 (23%), Positives = 128/322 (39%), Gaps = 50/322 (15%)
Query: 440 DNFSINNKLGEGGFGPVYKGTLVDG---QEIAVKRLSKI-SEQGLKELKNEVILFSKL-Q 494
++ + +GEG FG V K + + A+KR+ + S+ ++ E+ + KL
Sbjct: 10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGH 69
Query: 495 HRNLVKLLGCCIQGEEKLLIYEFMPNKSLDSFI-------------FDQTRRTLLDWSQR 541
H N++ LLG C L E+ P+ +L F+ + + L Q
Sbjct: 70 HPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQL 129
Query: 542 FHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNT 601
H ARG+ YL Q + IHRDL A N+L+ ++ KI+DFGL R G E
Sbjct: 130 LHFAADVARGMDYLSQ---KQFIHRDLAARNILVGENYVAKIADFGLSR---GQEVYVKK 183
Query: 602 NRVVGTY---------DGQFSIKSDVFSFGILLLEIVSGKKNRGFYRSDTKVNLIGHLWD 652
++ SDV+S+G+LL EIVS Y T L
Sbjct: 184 TMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGT--PYCGMTCAELY-EKLP 240
Query: 653 EGIPLRLIDACIQDSCNLADVIRCIHIGLLCVQQHPEDRPCMPSVILMLGSEILLPQPKQ 712
+G L C + + C ++ P +RP +++ L +L + K
Sbjct: 241 QGYRLEKPLNCDDE---------VYDLMRQCWREKPYERPSFAQILVSL--NRMLEERKT 289
Query: 713 PGYLADRKSTEPYSSSSMPESS 734
+ E ++ + + S+
Sbjct: 290 Y---VNTTLYEKFTYAGIDCSA 308
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 184 bits (468), Expect = 9e-54
Identities = 66/274 (24%), Positives = 111/274 (40%), Gaps = 28/274 (10%)
Query: 440 DNFSINNKLGEGGFGPVYKGT-LVDGQEIAVKRLSK--ISEQGLKELKNEVILFSKLQHR 496
+++ + +G G +G K DG+ + K L ++E + L +EV L +L+H
Sbjct: 4 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHP 63
Query: 497 NLVKLLGCCIQGEEKLL--IYEFMPNKSLDSFIFDQTR-RTLLDWSQRFHIICGTARGLL 553
N+V+ I L + E+ L S I T+ R LD ++ L
Sbjct: 64 NIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALK 123
Query: 554 YLHQ--DSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNTNRVVGTY--- 608
H+ D ++HRDLK +NV LD N K+ DFGL R D + Y
Sbjct: 124 ECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKAFVGTPYYMSP 183
Query: 609 ----DGQFSIKSDVFSFGILLLEIVSGKKNRGFYRSDTKVNLIGHLWDEGIPLRLIDACI 664
++ KSD++S G LL E+ + + + ++ L G + EG R+
Sbjct: 184 EQMNRMSYNEKSDIWSLGCLLYELCALMP---PFTAFSQKELAGKI-REGKFRRIPYRY- 238
Query: 665 QDSCNLADVIRCIHIGLLCVQQHPEDRPCMPSVI 698
S L ++I + RP + ++
Sbjct: 239 --SDELNEIITR------MLNLKDYHRPSVEEIL 264
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 186 bits (472), Expect = 1e-53
Identities = 63/292 (21%), Positives = 105/292 (35%), Gaps = 34/292 (11%)
Query: 438 ATDNFSINNKLGEGGFGPVYKGT-LVDGQEIAVKRLSK-ISEQGLKELKNEVILFSKLQH 495
D+F ++LG G G V+K + G +A K + I ++ E+ + +
Sbjct: 4 KDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNS 63
Query: 496 RNLVKLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYL 555
+V G E + E M SLD + R + + +GL YL
Sbjct: 64 PYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGR---IPEQILGKVSIAVIKGLTYL 120
Query: 556 HQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNTNRVVGTY------- 608
+ +I+HRD+K SN+L++ K+ DFG+ + N VGT
Sbjct: 121 R--EKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQL----IDSMANSFVGTRSYMSPER 174
Query: 609 --DGQFSIKSDVFSFGILLLEIVSGKKNRGFYRSDTKVNLIGHLWDEGIPLRLIDACIQD 666
+S++SD++S G+ L+E+ G+ D K L L+ C +
Sbjct: 175 LQGTHYSVQSDIWSMGLSLVEMAVGR--YPIPPPDAKE------------LELMFGCQVE 220
Query: 667 SCNLADVIRCIHIGLLCVQQHPEDRPCMPSVILMLGSEILLPQPKQPGYLAD 718
R G + RP M L+ P G +
Sbjct: 221 GDAAETPPRPRTPGRPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSL 272
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 185 bits (470), Expect = 1e-53
Identities = 70/274 (25%), Positives = 118/274 (43%), Gaps = 34/274 (12%)
Query: 445 NNKLGEGGFGPVYKGTLVD----GQEIAVKRLSKISEQG-LKELKNEVILFSKLQHRNLV 499
N +G G FG VY GTL+D AVK L++I++ G + + E I+ H N++
Sbjct: 32 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVL 91
Query: 500 KLLGCCIQGEEK-LLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQD 558
LLG C++ E L++ +M + L +FI ++T + F + +
Sbjct: 92 SLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKG-----MKFL 146
Query: 559 SRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNTNR--VVGTY-------- 608
+ + +HRDL A N +LD+ K++DFGL R E + N+
Sbjct: 147 ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESL 206
Query: 609 -DGQFSIKSDVFSFGILLLEIVSGKKNRGFYRSDTKVNLIGHLWDEGIPLRLIDACIQDS 667
+F+ KSDV+SFG+LL E+++ Y ++ +L +G L + C
Sbjct: 207 QTQKFTTKSDVWSFGVLLWELMTRGAP--PYPDVNTFDITVYLL-QGRRLLQPEYCPDP- 262
Query: 668 CNLADVIRCIHIGLLCVQQHPEDRPCMPSVILML 701
+ L C E RP ++ +
Sbjct: 263 --------LYEVMLKCWHPKAEMRPSFSELVSRI 288
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 184 bits (469), Expect = 2e-53
Identities = 67/280 (23%), Positives = 114/280 (40%), Gaps = 40/280 (14%)
Query: 431 ELATIANATDNFSINNKLGEGGFGPVYKGT-LVDGQEIAVKRLSK---ISEQGLKELKNE 486
EL + FS ++G G FG VY + + + +A+K++S S + +++ E
Sbjct: 6 ELFFKDDPEKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKE 65
Query: 487 VILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIIC 546
V KL+H N ++ GC ++ L+ E+ + D + L + +
Sbjct: 66 VRFLQKLRHPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEV---HKKPLQEVEIAAVTH 122
Query: 547 GTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNTNRVVG 606
G +GL YLH +IHRD+KA N+LL + K+ DFG N VG
Sbjct: 123 GALQGLAYLHS---HNMIHRDVKAGNILLSEPGLVKLGDFGSASIM------APANSFVG 173
Query: 607 TY------------DGQFSIKSDVFSFGILLLEIVSGKKNRGFYRSDTKVNLIGHLWDEG 654
T +GQ+ K DV+S GI +E+ + + ++ + H+
Sbjct: 174 TPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAER---KPPLFNMNAMSALYHIAQNE 230
Query: 655 IPLRLIDACIQDSCNLADVIRCIHIGLLCVQQHPEDRPCM 694
P S + + C+Q+ P+DRP
Sbjct: 231 SPALQSGHW---SEYFRNFVDS------CLQKIPQDRPTS 261
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 180 bits (459), Expect = 2e-52
Identities = 60/270 (22%), Positives = 105/270 (38%), Gaps = 29/270 (10%)
Query: 440 DNFSINNKLGEGGFGPVYKGT-LVDGQEIAVKRLSK-ISEQGLKELKNEVILFSKLQHRN 497
+++ + LGEG +G V V + +AVK + + + +K E+ + L H N
Sbjct: 5 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHEN 64
Query: 498 LVKLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQ 557
+VK G +G + L E+ L I + G++YLH
Sbjct: 65 VVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIG---MPEPDAQRFFHQLMAGVVYLHG 121
Query: 558 DSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNTNRVVGTYD-------- 609
+ I HRD+K N+LLD+ N KISDFGL F + E N++ GT
Sbjct: 122 ---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLK 178
Query: 610 --GQFSIKSDVFSFGILLLEIVSGKKNRGFYRSDTKVNLIGHLWDEGIPLRLIDACIQDS 667
+ DV+S GI+L +++G+ + + ++ L
Sbjct: 179 RREFHAEPVDVWSCGIVLTAMLAGELP--WDQPSDSCQEYSDWKEKKTYLNPWKKI---D 233
Query: 668 CNLADVIRCIHIGLLCVQQHPEDRPCMPSV 697
++ + ++P R +P +
Sbjct: 234 SAPLALLHK------ILVENPSARITIPDI 257
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 179 bits (455), Expect = 7e-52
Identities = 55/273 (20%), Positives = 109/273 (39%), Gaps = 35/273 (12%)
Query: 442 FSINNKLGEGGFGPVYKGTLVD-GQEIAVKRLSK--ISEQGLKELKNEVILFSKLQHRNL 498
+ ++G G F VYKG + E+A L +++ + K E + LQH N+
Sbjct: 11 LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNI 70
Query: 499 VKLLGCCIQGEEK----LLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLY 554
V+ + +L+ E M + +L +++ R ++ +GL +
Sbjct: 71 VRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLK---RFKVMKIKVLRSWCRQILKGLQF 127
Query: 555 LHQDSRLRIIHRDLKASNVLL-DQDMNPKISDFGLVRTFGGDETEGNTNRVVGT------ 607
LH + IIHRDLK N+ + + KI D GL V+GT
Sbjct: 128 LHTRTP-PIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRAS----FAKAVIGTPEFMAP 182
Query: 608 --YDGQFSIKSDVFSFGILLLEIVSGKKNRGFYRSDTKVNLIGHLWDEGIPLRLIDACIQ 665
Y+ ++ DV++FG+ +LE+ + + + + + P I
Sbjct: 183 EMYEEKYDESVDVYAFGMCMLEMATSE--YPYSECQNAAQIYRRVTSGVKPASFDKVAIP 240
Query: 666 DSCNLADVIRCIHIGLLCVQQHPEDRPCMPSVI 698
+ + ++I C++Q+ ++R + ++
Sbjct: 241 E---VKEIIEG------CIRQNKDERYSIKDLL 264
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 179 bits (455), Expect = 7e-52
Identities = 68/279 (24%), Positives = 103/279 (36%), Gaps = 34/279 (12%)
Query: 440 DNFSINNKLGEGGFGPVYKGTLV----DGQEIAVKRLSK---ISEQGLKELKNEVILFSK 492
+ + KLG+G FG V +G +AVK L + + + EV
Sbjct: 8 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHS 67
Query: 493 LQHRNLVKLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGL 552
L HRNL++L G + K+ + E P SL + A G+
Sbjct: 68 LDHRNLIRLYGVVLTPPMKM-VTELAPLGSLLDRLRKHQGH--FLLGTLSRYAVQVAEGM 124
Query: 553 LYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEG-NTNRVVGTY--- 608
YL R IHRDL A N+LL KI DFGL+R ++ +
Sbjct: 125 GYLES---KRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWC 181
Query: 609 ------DGQFSIKSDVFSFGILLLEIVSGKKNRGFYRSDTKVNLIGHLWDEGIPLRLIDA 662
FS SD + FG+ L E+ + + + ++ + EG L +
Sbjct: 182 APESLKTRTFSHASDTWMFGVTLWEMFTYGQE--PWIGLNGSQILHKIDKEGERLPRPED 239
Query: 663 CIQDSCNLADVIRCIHIGLLCVQQHPEDRPCMPSVILML 701
C QD ++ + C PEDRP ++ L
Sbjct: 240 CPQD---------IYNVMVQCWAHKPEDRPTFVALRDFL 269
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 180 bits (456), Expect = 1e-51
Identities = 70/299 (23%), Positives = 127/299 (42%), Gaps = 39/299 (13%)
Query: 440 DNFSINNKLGEGGFGPVYKGTL------VDGQEIAVKRLSKI-SEQGLKELKNEVILFSK 492
+ +++ +LG+G FG VY+G +A+K +++ S + E NE + +
Sbjct: 20 EKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKE 79
Query: 493 LQHRNLVKLLGCCIQGEEKLLIYEFMPNKSLDSFIF-------DQTRRTLLDWSQRFHII 545
++V+LLG QG+ L+I E M L S++ + S+ +
Sbjct: 80 FNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMA 139
Query: 546 CGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNTNRVV 605
A G+ YL+ + + +HRDL A N ++ +D KI DFG+ R + + +
Sbjct: 140 GEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGL 196
Query: 606 GTY---------DGQFSIKSDVFSFGILLLEIVSGKKNRGFYRSDTKVNLIGHLWDEGIP 656
DG F+ SDV+SFG++L EI + + Y+ + ++ EG
Sbjct: 197 LPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQ--PYQGLSNEQVL-RFVMEGGL 253
Query: 657 LRLIDACIQDSCNLADVIRCIHIGLLCVQQHPEDRPCMPSVILMLGSEILLPQPKQPGY 715
L D C + +C Q +P+ RP +I + E + P ++ +
Sbjct: 254 LDKPDNCPDM---------LFELMRMCWQYNPKMRPSFLEIISSI-KEEMEPGFREVSF 302
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 177 bits (451), Expect = 3e-51
Identities = 68/272 (25%), Positives = 108/272 (39%), Gaps = 34/272 (12%)
Query: 445 NNKLGEGGFGPVYKGTLVD---GQEIAVKRLSK--ISEQGLKELKNEVILFSKLQHRNLV 499
+ +LG G FG V KG + +AVK L EL E + +L + +V
Sbjct: 12 DKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIV 71
Query: 500 KLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDS 559
+++G C + E +L+ E L+ ++ + ++ + G+ YL +
Sbjct: 72 RMIGIC-EAESWMLVMEMAELGPLNKYLQQNRH---VKDKNIIELVHQVSMGMKYLEES- 126
Query: 560 RLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNTN-RVVGT---------YD 609
+HRDL A NVLL KISDFGL + DE
Sbjct: 127 --NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINY 184
Query: 610 GQFSIKSDVFSFGILLLEIVSGKKNRGFYRSDTKVNLIGHLWDEGIPLRLIDACIQDSCN 669
+FS KSDV+SFG+L+ E S + YR + + ++G + C ++
Sbjct: 185 YKFSSKSDVWSFGVLMWEAFSYGQK--PYRGMKGSEVT-AMLEKGERMGCPAGCPRE--- 238
Query: 670 LADVIRCIHIGLLCVQQHPEDRPCMPSVILML 701
+ LC E+RP +V L L
Sbjct: 239 ------MYDLMNLCWTYDVENRPGFAAVELRL 264
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 179 bits (454), Expect = 3e-51
Identities = 73/326 (22%), Positives = 128/326 (39%), Gaps = 38/326 (11%)
Query: 435 IANATDNFSINNKLGEGGFGPVYKGTLVDGQE-----IAVKRLSKI-SEQGLKELKNEVI 488
I T+ F LG G FG VYKG + E +A+K L + S + KE+ +E
Sbjct: 5 ILKETE-FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAY 63
Query: 489 LFSKLQHRNLVKLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGT 548
+ + + + ++ +LLG C+ LI + MP L ++ + +
Sbjct: 64 VMASVDNPHVCRLLGICLTSTV-QLITQLMPFGCLLDYVREHKDNI--GSQYLLNWCVQI 120
Query: 549 ARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNTNRVVGTY 608
A+G+ YL R++HRDL A NVL+ + KI+DFGL + G +E E +
Sbjct: 121 AKGMNYLED---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPI 177
Query: 609 ---------DGQFSIKSDVFSFGILLLEIVSGKKNRGFYRSDTKVNLIGHLWDEGIPLRL 659
++ +SDV+S+G+ + E+++ Y + L ++G L
Sbjct: 178 KWMALESILHRIYTHQSDVWSYGVTVWELMTFGSK--PYDGIPASEISSIL-EKGERLPQ 234
Query: 660 IDACIQDSCNLADVIRCIHIGLLCVQQHPEDRPCMPSVILMLGSEILLPQPKQPGYLADR 719
C D I + C + RP +I+ PQ YL +
Sbjct: 235 PPICTID---------VYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQR----YLVIQ 281
Query: 720 KSTEPYSSSSMPESSSTNTLTISELE 745
+ S + + +++
Sbjct: 282 GDERMHLPSPTDSNFYRALMDEEDMD 307
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 176 bits (447), Expect = 2e-50
Identities = 56/274 (20%), Positives = 121/274 (44%), Gaps = 30/274 (10%)
Query: 431 ELATIANATDNFSINNKLGEGGFGPVYKGT-LVDGQEIAVKRLSKISEQGLKELKNEVIL 489
+ ++ + ++ K+G+G G VY + GQE+A+++++ + + + NE+++
Sbjct: 11 SIVSVGDPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILV 70
Query: 490 FSKLQHRNLVKLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTA 549
+ ++ N+V L + G+E ++ E++ SL + + D Q +
Sbjct: 71 MRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCM----DEGQIAAVCRECL 126
Query: 550 RGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNTNRVVGT-- 607
+ L +LH ++IHRD+K+ N+LL D + K++DFG +++ + +VGT
Sbjct: 127 QALEFLHS---NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS--KRSTMVGTPY 181
Query: 608 -------YDGQFSIKSDVFSFGILLLEIVSGKKNRGFYRSDTKVNLIGHLWDEGIPLRLI 660
+ K D++S GI+ +E++ G+ Y ++ + + + G P
Sbjct: 182 WMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEP---PYLNENPLRALYLIATNGTPELQN 238
Query: 661 DACIQDSCNLADVIRCIHIGLLCVQQHPEDRPCM 694
+ S D + C+ E R
Sbjct: 239 PEKL--SAIFRDFLNR------CLDMDVEKRGSA 264
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 176 bits (447), Expect = 2e-50
Identities = 70/295 (23%), Positives = 104/295 (35%), Gaps = 45/295 (15%)
Query: 440 DNFSINNKLGEGGFGPVYKGT------LVDGQEIAVKRLSKISEQGLKE--LKNEVILFS 491
D + LG G FG V + + +AVK L + + + IL
Sbjct: 13 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIH 72
Query: 492 KLQHRNLVKLLGCCIQGEEKLLI-YEFMPNKSLDSFIFDQ-------------TRRTLLD 537
H N+V LLG C + L++ EF +L +++ + + L
Sbjct: 73 IGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLT 132
Query: 538 WSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDET 597
A+G+ +L + IHRDL A N+LL + KI DFGL R D
Sbjct: 133 LEHLICYSFQVAKGMEFLAS---RKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPD 189
Query: 598 EGNTNRVVGTY---------DGQFSIKSDVFSFGILLLEIVSGKKNRGFYRSDTKVNLIG 648
D ++I+SDV+SFG+LL EI S + Y
Sbjct: 190 YVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGAS--PYPGVKIDEEFC 247
Query: 649 HLWDEGIPLRLIDACIQDSCNLADVIRCIHIGLLCVQQHPEDRPCMPSVILMLGS 703
EG +R D + L C P RP ++ LG+
Sbjct: 248 RRLKEGTRMRAPDYTTPE---------MYQTMLDCWHGEPSQRPTFSELVEHLGN 293
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 174 bits (441), Expect = 7e-50
Identities = 67/285 (23%), Positives = 122/285 (42%), Gaps = 33/285 (11%)
Query: 440 DNFSINNKLGEGGFGPVYKGTLVDGQE-----IAVKRLSK-ISEQGLKELKNEVILFSKL 493
+ +G G FG VYKG L +A+K L +E+ + E + +
Sbjct: 7 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQF 66
Query: 494 QHRNLVKLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLL 553
H N+++L G + + ++I E+M N +LD F+ ++ Q ++ G A G+
Sbjct: 67 SHHNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDGE--FSVLQLVGMLRGIAAGMK 124
Query: 554 YLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNT-NRVVGT----- 607
YL + +HRDL A N+L++ ++ K+SDFGL R D T +
Sbjct: 125 YLA---NMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTA 181
Query: 608 ----YDGQFSIKSDVFSFGILLLEIVSGKKNRGFYRSDTKVNLIGHLWDEGIPLRLIDAC 663
+F+ SDV+SFGI++ E+++ + + S+ +V ++ I+
Sbjct: 182 PEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEV------------MKAINDG 229
Query: 664 IQDSCNLADVIRCIHIGLLCVQQHPEDRPCMPSVILMLGSEILLP 708
+ + + + C QQ RP ++ +L I P
Sbjct: 230 FRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRAP 274
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 168 bits (426), Expect = 6e-48
Identities = 65/272 (23%), Positives = 105/272 (38%), Gaps = 37/272 (13%)
Query: 440 DNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSK---ISEQGLKELKNEVILFSKLQH 495
++F I LG+G FG VY +A+K L K +L+ EV + S L+H
Sbjct: 6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRH 65
Query: 496 RNLVKLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYL 555
N+++L G LI E+ P ++ + ++ D + I A L Y
Sbjct: 66 PNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK---FDEQRTATYITELANALSYC 122
Query: 556 HQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNTNRVVGTYD------ 609
H R+IHRD+K N+LL KI+DFG + GT D
Sbjct: 123 HS---KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR----RTTLCGTLDYLPPEM 175
Query: 610 ---GQFSIKSDVFSFGILLLEIVSGKKNRGFYRSDTKVNLIGHLWDEGIPLRLIDACIQD 666
K D++S G+L E + GK + ++T + + D
Sbjct: 176 IEGRMHDEKVDLWSLGVLCYEFLVGKP---PFEANTYQETYKRISR--VEFTFPDFV--- 227
Query: 667 SCNLADVIRCIHIGLLCVQQHPEDRPCMPSVI 698
+ D+I ++ +P RP + V+
Sbjct: 228 TEGARDLISR------LLKHNPSQRPMLREVL 253
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 167 bits (424), Expect = 2e-47
Identities = 62/281 (22%), Positives = 105/281 (37%), Gaps = 34/281 (12%)
Query: 440 DNFSINNKLGEGGFGPVYKGTLVD----GQEIAVKRLSKISEQGLKE-LKNEVILFSKLQ 494
+ + +GEG FG V++G + +A+K + ++E E + +
Sbjct: 7 ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFD 66
Query: 495 HRNLVKLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLY 554
H ++VKL+G + +I E L SF+ + LD + + L Y
Sbjct: 67 HPHIVKLIGVITENP-VWIIMELCTLGELRSFLQVRKYS--LDLASLILYAYQLSTALAY 123
Query: 555 LHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNTNRVVGTY------ 608
L R +HRD+ A NVL+ + K+ DFGL R + D T ++
Sbjct: 124 LE---SKRFVHRDIAARNVLVSSNDCVKLGDFGLSR-YMEDSTYYKASKGKLPIKWMAPE 179
Query: 609 ---DGQFSIKSDVFSFGILLLEIVSGKKNRGFYRSDTKVNLIGHLWDEGIPLRLIDACIQ 665
+F+ SDV+ FG+ + EI+ + + + G L + C
Sbjct: 180 SINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNND---VIGRIENGERLPMPPNC-- 234
Query: 666 DSCNLADVIRCIHIGLLCVQQHPEDRPCMPSVILMLGSEIL 706
L ++ C P RP + L S IL
Sbjct: 235 -PPTLYSLMTK------CWAYDPSRRPRFTELKAQL-STIL 267
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 166 bits (422), Expect = 5e-47
Identities = 73/294 (24%), Positives = 113/294 (38%), Gaps = 47/294 (15%)
Query: 440 DNFSINNKLGEGGFGPVYKGTLV--------DGQEIAVKRLSK-ISEQGLKELKNEVILF 490
D + LGEG FG V + ++AVK L +E+ L +L +E+ +
Sbjct: 13 DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMM 72
Query: 491 SKL-QHRNLVKLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQTRRTL-------------L 536
+ +H+N++ LLG C Q +I E+ +L ++ + L L
Sbjct: 73 KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQL 132
Query: 537 DWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDE 596
ARG+ YL + IHRDL A NVL+ +D KI+DFGL R +
Sbjct: 133 SSKDLVSCAYQVARGMEYLAS---KKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHID 189
Query: 597 TEGNTNRVVGT---------YDGQFSIKSDVFSFGILLLEIVSGKKNRGFYRSDTKVNLI 647
T +D ++ +SDV+SFG+LL EI + + Y L
Sbjct: 190 YYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGS--PYPGVPVEELF 247
Query: 648 GHLWDEGIPLRLIDACIQDSCNLADVIRCIHIGLLCVQQHPEDRPCMPSVILML 701
L EG + C + + C P RP ++ L
Sbjct: 248 -KLLKEGHRMDKPSNCTNE---------LYMMMRDCWHAVPSQRPTFKQLVEDL 291
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 165 bits (418), Expect = 8e-46
Identities = 62/316 (19%), Positives = 111/316 (35%), Gaps = 33/316 (10%)
Query: 440 DNFSINNKLGEGGFGPVYKGT-LVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNL 498
D++ I+ +LG G FG V++ T G A K + E + ++ E+ S L+H L
Sbjct: 26 DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTL 85
Query: 499 VKLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQD 558
V L E ++IYEFM L + D+ + + + + +GL ++H
Sbjct: 86 VNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNK--MSEDEAVEYMRQVCKGLCHMH-- 141
Query: 559 SRLRIIHRDLKASNVLLDQDMNP--KISDFGLVRTFGGDETEGNTNRVVG------TYDG 610
+H DLK N++ + K+ DFGL ++ T
Sbjct: 142 -ENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTTGTAEFAAPEVAEGK 200
Query: 611 QFSIKSDVFSFGILLLEIVSGKKNRGFYRSDTKVNLIGHLWDEGIPLRLIDACIQDSCNL 670
+D++S G+L ++SG F + L + + I S +
Sbjct: 201 PVGYYTDMWSVGVLSYILLSGL--SPFGGENDDETLRNVKSCDWNMDDSAFSGI--SEDG 256
Query: 671 ADVIRCIHIGLLCVQQHPEDRPCMPSV--------ILMLGSEILLPQPKQPGYLADRKST 722
D IR + P R + G + +P + K+
Sbjct: 257 KDFIRK------LLLADPNTRMTIHQALEHPWLTPGNAPGRDSQIPSSRYTKIRDSIKTK 310
Query: 723 -EPYSSSSMPESSSTN 737
+ + P +N
Sbjct: 311 YDAWPEPLPPLGRISN 326
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 158 bits (401), Expect = 2e-43
Identities = 63/322 (19%), Positives = 113/322 (35%), Gaps = 35/322 (10%)
Query: 440 DNFSINNKLGEGGFGPVYKGT-LVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNL 498
D + I +LG G FG V++ G+ K ++ +KNE+ + ++L H L
Sbjct: 29 DYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKL 88
Query: 499 VKLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQD 558
+ L E +LI EF+ L I + + + ++ + + GL ++H
Sbjct: 89 INLHDAFEDKYEMVLILEFLSGGELFDRIAAEDYK--MSEAEVINYMRQACEGLKHMH-- 144
Query: 559 SRLRIIHRDLKASNVLLDQDMNP--KISDFGLVRTFGGDETEGNTNRVVGTYD------- 609
I+H D+K N++ + KI DFGL DE T +
Sbjct: 145 -EHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEI---VKVTTATAEFAAPEIV 200
Query: 610 --GQFSIKSDVFSFGILLLEIVSGKKNRGFYRSDTKVNLIGHLWDEGIPLRLIDACIQDS 667
+D+++ G+L ++SG F D L + + + S
Sbjct: 201 DREPVGFYTDMWAIGVLGYVLLSGL--SPFAGEDDLETLQNVKRCDWEFDEDAFSSV--S 256
Query: 668 CNLADVIRCIHIGLLCVQQHPEDRPCMPSV-----ILMLGSEILLPQPKQPGYLADRKST 722
D I+ +Q+ P R + + S + P +K
Sbjct: 257 PEAKDFIKN------LLQKEPRKRLTVHDALEHPWLKGDHSNLTSRIPSSRYNKIRQKIK 310
Query: 723 EPYSSSSMPESSSTNTLTISEL 744
E Y+ P+ + S L
Sbjct: 311 EKYADWPAPQPAIGRIANFSSL 332
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 155 bits (394), Expect = 3e-43
Identities = 56/206 (27%), Positives = 86/206 (41%), Gaps = 19/206 (9%)
Query: 440 DNFSINNKLGEGGFGPVYKGT-LVDGQEIAVKRLSK---ISEQGLKELKNEVILFSKLQH 495
++F LGEG F V L +E A+K L K I E + + E + S+L H
Sbjct: 8 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 67
Query: 496 RNLVKLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYL 555
VKL E+ + N L +I D + L YL
Sbjct: 68 PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGS---FDETCTRFYTAEIVSALEYL 124
Query: 556 HQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNTNRVVGTY------- 608
H IIHRDLK N+LL++DM+ +I+DFG + + + N VGT
Sbjct: 125 H---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPEL 181
Query: 609 --DGQFSIKSDVFSFGILLLEIVSGK 632
+ SD+++ G ++ ++V+G
Sbjct: 182 LTEKSACKSSDLWALGCIIYQLVAGL 207
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 155 bits (393), Expect = 2e-42
Identities = 58/266 (21%), Positives = 101/266 (37%), Gaps = 30/266 (11%)
Query: 440 DNFSINNKLGEGGFGPVYKGTLVD-GQEIAVKRLSK---ISEQGLKELKNEVI---LFSK 492
++FS++ +G GGFG VY D G+ A+K L K +QG NE I L S
Sbjct: 4 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVST 63
Query: 493 LQHRNLVKLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGL 552
+V + ++ I + M L + + + + GL
Sbjct: 64 GDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLS---QHGVFSEADMRFYAAEIILGL 120
Query: 553 LYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNTNRVVGTYDGQ- 611
++H +++RDLK +N+LLD+ + +ISD GL F + +
Sbjct: 121 EHMHN---RFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASVGTHGYMAPEVL 177
Query: 612 -----FSIKSDVFSFGILLLEIVSGKKNRGFYRSDTKVNLIGHLWDEGIPLRLIDACIQD 666
+ +D FS G +L +++ G F + TK + + L D+
Sbjct: 178 QKGVAYDSSADWFSLGCMLFKLLRGHSP--FRQHKTKDKHEIDRMTLTMAVELPDSF--- 232
Query: 667 SCNLADVIRCIHIGLLCVQQHPEDRP 692
S L ++ +Q+ R
Sbjct: 233 SPELRSLLEG------LLQRDVNRRL 252
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 152 bits (386), Expect = 8e-42
Identities = 49/262 (18%), Positives = 92/262 (35%), Gaps = 25/262 (9%)
Query: 440 DNFSINNKLGEGGFGPVYKGT-LVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNL 498
+ + I LG G FG V++ + K + K+ +K E+ + + +HRN+
Sbjct: 5 EKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFV-KVKGTDQVLVKKEISILNIARHRNI 63
Query: 499 VKLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQD 558
+ L EE ++I+EF+ + I T L+ + + L +LH
Sbjct: 64 LHLHESFESMEELVMIFEFISGLDIFERI--NTSAFELNEREIVSYVHQVCEALQFLHS- 120
Query: 559 SRLRIIHRDLKASNVLLDQDMNP--KISDFGLVRTFGGDETEGNTNRVVGTY------DG 610
I H D++ N++ + KI +FG R + Y
Sbjct: 121 --HNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLLFTAPEYYAPEVHQHD 178
Query: 611 QFSIKSDVFSFGILLLEIVSGKKNRGFYRSDTKVNLIGHLWDEGIPLRLIDACIQDSCNL 670
S +D++S G L+ ++SG F + + + E I S
Sbjct: 179 VVSTATDMWSLGTLVYVLLSGI--NPFLAETNQQIIENIMNAEYTFDEEAFKEI--SIEA 234
Query: 671 ADVIRCIHIGLLCVQQHPEDRP 692
D + + + + R
Sbjct: 235 MDFVDR------LLVKERKSRM 250
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 149 bits (376), Expect = 6e-41
Identities = 55/272 (20%), Positives = 104/272 (38%), Gaps = 34/272 (12%)
Query: 439 TDNFSINNKLGEGGFGPVYKGT-LVDGQEIAVKRLSK---ISEQGLKELKNEVILFSKLQ 494
+D + + LG GG V+ L +++AVK L + E + L
Sbjct: 6 SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALN 65
Query: 495 HRNLVKLLGCCI----QGEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTAR 550
H +V + G ++ E++ +L + + + + +I +
Sbjct: 66 HPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGP---MTPKRAIEVIADACQ 122
Query: 551 GLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEG-NTNRVVGTY- 608
L + H + IIHRD+K +N+++ K+ DFG+ R T V+GT
Sbjct: 123 ALNFSH---QNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQ 179
Query: 609 --------DGQFSIKSDVFSFGILLLEIVSGKKNRGFYRSDTKVNLIGHLWDEGIPLRLI 660
+SDV+S G +L E+++G+ F H+ ++ IP
Sbjct: 180 YLSPEQARGDSVDARSDVYSLGCVLYEVLTGE--PPFTGDSPVSVAYQHVREDPIPPSAR 237
Query: 661 DACIQDSCNLADVIRCIHIGLLCVQQHPEDRP 692
+ S +L V+ + ++PE+R
Sbjct: 238 HEGL--SADLDAVVLK------ALAKNPENRY 261
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 145 bits (368), Expect = 7e-40
Identities = 53/279 (18%), Positives = 101/279 (36%), Gaps = 45/279 (16%)
Query: 440 DNFSINNKLGEGGFGPVYKGT-LVDGQEIAVKRLSK---------ISEQGLKELKNEVIL 489
+N+ LG G V + +E AVK + ++ + EV +
Sbjct: 3 ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDI 62
Query: 490 FSKLQ-HRNLVKLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGT 548
K+ H N+++L L+++ M L ++ T + L + I+
Sbjct: 63 LRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYL---TEKVTLSEKETRKIMRAL 119
Query: 549 ARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNTNRVVGTY 608
+ LH +L I+HRDLK N+LLD DMN K++DFG E V GT
Sbjct: 120 LEVICALH---KLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEK---LREVCGTP 173
Query: 609 ---------------DGQFSIKSDVFSFGILLLEIVSGKKNRGFYRSDTKVNLIGHLWDE 653
+ + D++S G+++ +++G + ++ ++ +
Sbjct: 174 SYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSP---PFWHRKQMLMLRMIMSG 230
Query: 654 GIPLRLIDACIQDSCNLADVIRCIHIGLLCVQQHPEDRP 692
S + D++ + P+ R
Sbjct: 231 NYQFG-SPEWDDYSDTVKDLVSR------FLVVQPQKRY 262
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 146 bits (368), Expect = 3e-39
Identities = 56/292 (19%), Positives = 110/292 (37%), Gaps = 21/292 (7%)
Query: 434 TIANATDNFSINNKLGEGGFGPVYKGT-LVDGQEIAVKRLSKISEQG-LKELKNEVILFS 491
+ + ++ + +GEG +G V V+ +A+K++S Q + E+ +
Sbjct: 2 QVFDVGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILL 61
Query: 492 KLQHRNLVKLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARG 551
+ +H N++ + + + ++ + + ++ + L + + RG
Sbjct: 62 RFRHENIIGINDIIRAPTIEQMKDVYLVTHLMGADLYKLLKTQHLSNDHICYFLYQILRG 121
Query: 552 LLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNTNRVVGTY--- 608
L Y+H ++HRDLK SN+LL+ + KI DFGL R D
Sbjct: 122 LKYIHS---ANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWY 178
Query: 609 --------DGQFSIKSDVFSFGILLLEIVSGKKNRGFYRSDTKVNLIGHLWDEGIPLRLI 660
++ D++S G +L E++S + F L L G P +
Sbjct: 179 RAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR--PIFPGKHYLDQLNHILGILGSPSQED 236
Query: 661 DACIQDSCNLADVIRCIHIGLLCVQQHPEDRPCMPSVILMLGSEILLPQPKQ 712
CI + ++ H + + P S L L ++L P +
Sbjct: 237 LNCIINLKARNYLLSLPHKNKVPWNRLF---PNADSKALDLLDKMLTFNPHK 285
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 144 bits (363), Expect = 7e-39
Identities = 54/267 (20%), Positives = 92/267 (34%), Gaps = 27/267 (10%)
Query: 437 NATDNFSINNKLGEGGFGPVYKGT-LVDGQEIAVKRLSKISEQG-LKELKNEVILFSKLQ 494
+ D + + LG G F V + +A+K ++K + +G ++NE+ + K++
Sbjct: 6 DIRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIK 65
Query: 495 HRNLVKLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLY 554
H N+V L G LI + + L I + +I + Y
Sbjct: 66 HPNIVALDDIYESGGHLYLIMQLVSGGELFDRI---VEKGFYTERDASRLIFQVLDAVKY 122
Query: 555 LHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNTNRVVGTY------ 608
LH + + LD+D ISDFGL + + GT
Sbjct: 123 LHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSV---LSTACGTPGYVAPE 179
Query: 609 ---DGQFSIKSDVFSFGILLLEIVSGKKNRGFYRSDTKVNLIGHLWDEGIPLRLIDACIQ 665
+S D +S G++ ++ G FY + L E I
Sbjct: 180 VLAQKPYSKAVDCWSIGVIAYILLCGY--PPFYDENDAKLFEQILKAEYEFDSPYWDDI- 236
Query: 666 DSCNLADVIRCIHIGLLCVQQHPEDRP 692
S + D IR +++ PE R
Sbjct: 237 -SDSAKDFIRH------LMEKDPEKRF 256
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 144 bits (363), Expect = 1e-38
Identities = 63/274 (22%), Positives = 108/274 (39%), Gaps = 36/274 (13%)
Query: 440 DNFSINNKLGEGGFGPVYKGT-LVDGQEIAVKRLSK---ISEQGLKELKNEV-ILFSKLQ 494
++F ++ LG+G FG V+ Q A+K L K + + ++ E +L +
Sbjct: 2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWE 61
Query: 495 HRNLVKLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLY 554
H L + E + E++ L I + D S+ GL +
Sbjct: 62 HPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHK---FDLSRATFYAAEIILGLQF 118
Query: 555 LHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNTNRVVGTYD----- 609
LH I++RDLK N+LLD+D + KI+DFG+ + + + NT GT D
Sbjct: 119 LH---SKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNT--FCGTPDYIAPE 173
Query: 610 ----GQFSIKSDVFSFGILLLEIVSGKKNRGFYRSDTKVNLIGHLWDEGIPLRLIDACIQ 665
+++ D +SFG+LL E++ G+ F+ D + D R +
Sbjct: 174 ILLGQKYNHSVDWWSFGVLLYEMLIGQ--SPFHGQDEEELFHSIRMDNPFYPRWL----- 226
Query: 666 DSCNLADVIRCIHIGLLCVQQHPEDRPCMPSVIL 699
D++ + PE R + I
Sbjct: 227 -EKEAKDLLVK------LFVREPEKRLGVRGDIR 253
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 142 bits (359), Expect = 3e-38
Identities = 55/261 (21%), Positives = 102/261 (39%), Gaps = 28/261 (10%)
Query: 440 DNFSINNKLGEGGFGPVYKGT-LVDGQEIAVKRLSK---ISEQGLKELKNEVILFSKLQH 495
+F I LG G FG V+ +G+ A+K L K + + ++ +E ++ S + H
Sbjct: 4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTH 63
Query: 496 RNLVKLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYL 555
++++ G ++ +I +++ L S + R +C L L
Sbjct: 64 PFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVC------LAL 117
Query: 556 HQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNTNR----VVGTYDGQ 611
II+RDLK N+LLD++ + KI+DFG +
Sbjct: 118 EYLHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDVTYTLCGTPDYIAPEVVSTKP 177
Query: 612 FSIKSDVFSFGILLLEIVSGKKNRGFYRSDTKVNLIGHLWDEGIPLRLIDACIQDSCNLA 671
++ D +SFGIL+ E+++G FY S+T L E + ++
Sbjct: 178 YNKSIDWWSFGILIYEMLAGYTP--FYDSNTMKTYEKILNAELRFPPFFNE------DVK 229
Query: 672 DVIRCIHIGLLCVQQHPEDRP 692
D++ + + R
Sbjct: 230 DLLSR------LITRDLSQRL 244
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 141 bits (356), Expect = 5e-38
Identities = 55/204 (26%), Positives = 92/204 (45%), Gaps = 16/204 (7%)
Query: 440 DNFSINNKLGEGGFGPVYKGT-LVDGQEIAVKRLSK--ISEQGLKELKNEVILFSKLQHR 496
+NF K+GEG +G VYK + G+ +A+K++ +E E+ L +L H
Sbjct: 2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 61
Query: 497 NLVKLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLH 556
N+VKLL + L++EF+ D + T + + +GL + H
Sbjct: 62 NIVKLLDVIHTENKLYLVFEFLHQDLKK--FMDASALTGIPLPLIKSYLFQLLQGLAFCH 119
Query: 557 QDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNTNRVVGTY-------- 608
R++HRDLK N+L++ + K++DFGL R FG V Y
Sbjct: 120 SH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLG 176
Query: 609 DGQFSIKSDVFSFGILLLEIVSGK 632
+S D++S G + E+V+ +
Sbjct: 177 CKYYSTAVDIWSLGCIFAEMVTRR 200
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 139 bits (352), Expect = 2e-37
Identities = 49/280 (17%), Positives = 99/280 (35%), Gaps = 31/280 (11%)
Query: 440 DNFSINNKLGEGGFGPVYKGT-LVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNL 498
+ + + K+G G FG +Y GT + G+E+A+K ++ +L E ++ +Q
Sbjct: 7 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH--PQLHIESKIYKMMQGGVG 64
Query: 499 VKLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQD 558
+ + C + ++ + SL+ +R+ + + Y+H
Sbjct: 65 IPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCSRK--FSLKTVLLLADQMISRIEYIH-- 120
Query: 559 SRLRIIHRDLKASNVL---LDQDMNPKISDFGLVRTFGGDETEGN-----TNRVVGTY-- 608
IHRD+K N L + I DFGL + + T + + GT
Sbjct: 121 -SKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARY 179
Query: 609 -------DGQFSIKSDVFSFGILLLEIVSGKKNRGFYRSDTKVNLIGHLWDEGIPLRLID 661
+ S + D+ S G +L+ G ++ TK + ++ + +
Sbjct: 180 ASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEV 239
Query: 662 ACIQDSCNLADVIRCIHIGLLCVQQHPEDRPCMPSVILML 701
C A + C +D+P + +
Sbjct: 240 LCKGYPSEFATYLNF------CRSLRFDDKPDYSYLRQLF 273
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 139 bits (351), Expect = 2e-37
Identities = 54/203 (26%), Positives = 90/203 (44%), Gaps = 16/203 (7%)
Query: 440 DNFSINNKLGEGGFGPVYKGTLVDGQEIAVK--RLSKISEQGLKELKNEVILFSKLQHRN 497
+ + K+GEG +G VYK G+ A+K RL K E E+ + +L+H N
Sbjct: 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSN 61
Query: 498 LVKLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQ 557
+VKL + +L++E + + L+ + G+ Y H
Sbjct: 62 IVKLYDVIHTKKRLVLVFEHLDQDLKKLLDVCEGG---LESVTAKSFLLQLLNGIAYCHD 118
Query: 558 DSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNTNRVVGTY--------D 609
R++HRDLK N+L++++ KI+DFGL R FG + V Y
Sbjct: 119 ---RRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIVTLWYRAPDVLMGS 175
Query: 610 GQFSIKSDVFSFGILLLEIVSGK 632
++S D++S G + E+V+G
Sbjct: 176 KKYSTTIDIWSVGCIFAEMVNGT 198
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 137 bits (346), Expect = 1e-36
Identities = 40/282 (14%), Positives = 101/282 (35%), Gaps = 33/282 (11%)
Query: 440 DNFSINNKLGEGGFGPVYKGT-LVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNL 498
++ + ++GEG FG +++GT L++ Q++A+K + S+ +L++E + L
Sbjct: 5 VHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDA--PQLRDEYRTYKLLAGCTG 62
Query: 499 VKLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQD 558
+ + Q ++ + SL+ + R+ + +H+
Sbjct: 63 IPNVYYFGQEGLHNVLVIDLLGPSLEDLLDLCGRK--FSVKTVAMAAKQMLARVQSIHE- 119
Query: 559 SRLRIIHRDLKASNVLLDQDMNP-----KISDFGLVRTFGGDETEGN-----TNRVVGT- 607
+++RD+K N L+ + + + DFG+V+ + T+ + + GT
Sbjct: 120 --KSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTA 177
Query: 608 --------YDGQFSIKSDVFSFGILLLEIVSGKKNRGFYRSDTKVNLIGHLWDEGIPLRL 659
+ S + D+ + G + + + G ++ T + ++ L
Sbjct: 178 RYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTPL 237
Query: 660 IDACIQDSCNLADVIRCIHIGLLCVQQHPEDRPCMPSVILML 701
+ C + + P + +
Sbjct: 238 RELCAGFPEEFYKYMHY------ARNLAFDATPDYDYLQGLF 273
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 138 bits (349), Expect = 1e-36
Identities = 54/234 (23%), Positives = 90/234 (38%), Gaps = 24/234 (10%)
Query: 440 DNFSINNKLGEGGFGPVYKGTLVD-GQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNL 498
+++ +G G FG VY+ L D G+ +A+K++ + E+ + KL H N+
Sbjct: 20 VSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRF----KNRELQIMRKLDHCNI 75
Query: 499 VKLLGCCIQGEEK------LLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGL 552
V+L EK L+ +++P + L + R L
Sbjct: 76 VRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSL 135
Query: 553 LYLHQDSRLRIIHRDLKASNVLLDQD-MNPKISDFGLVRTFGGDETEGNTNRVVGTY--- 608
Y+H I HRD+K N+LLD D K+ DFG + E +
Sbjct: 136 AYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRAPE 192
Query: 609 ----DGQFSIKSDVFSFGILLLEIVSGKKNRGFYRSDTKVNLIGHLWDEGIPLR 658
++ DV+S G +L E++ G+ F L+ + G P R
Sbjct: 193 LIFGATDYTSSIDVWSAGCVLAELLLGQ--PIFPGDSGVDQLVEIIKVLGTPTR 244
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 135 bits (339), Expect = 1e-35
Identities = 58/290 (20%), Positives = 106/290 (36%), Gaps = 44/290 (15%)
Query: 438 ATDNFSINNKLGEGGFGPVYKGTLV--DGQEIAVKRLSK--ISEQGLKELKNEVILFSKL 493
A + ++GEG +G V+K + G+ +A+KR+ E EV + L
Sbjct: 5 ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHL 64
Query: 494 ---QHRNLVKLLGCCIQGEEKLLIYEFMPNKSLDS---FIFDQTRRTLLDWSQRFHIICG 547
+H N+V+L C + + +D D+ + ++
Sbjct: 65 ETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQ 124
Query: 548 TARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNTNRVVGT 607
RGL +LH R++HRDLK N+L+ K++DFGL R + + VV T
Sbjct: 125 LLRGLDFLHS---HRVVHRDLKPQNILVTSSGQIKLADFGLARIY---SFQMALTSVVVT 178
Query: 608 ---------YDGQFSIKSDVFSFGILLLEIVSGKKNRGFYRSDTKVNLIGHL-------- 650
++ D++S G + E+ K +R + V+ +G +
Sbjct: 179 LWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKP---LFRGSSDVDQLGKILDVIGLPG 235
Query: 651 ---WDEGIPLRLIDACIQDSCNLADVIRCIHIGLL-----CVQQHPEDRP 692
W + L + + + + I C+ +P R
Sbjct: 236 EEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRI 285
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 129 bits (325), Expect = 7e-34
Identities = 54/203 (26%), Positives = 88/203 (43%), Gaps = 24/203 (11%)
Query: 446 NKLGEGGFGPVYKGT-LVDGQEIAVKRLSKISEQGLKE-----LKNEVILFSKLQHRNLV 499
+ LGEG F VYK Q +A+K++ K+ E+ L +L H N++
Sbjct: 4 DFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNII 63
Query: 500 KLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDS 559
LL L+++FM + +L S + T +GL YLHQ
Sbjct: 64 GLLDAFGHKSNISLVFDFMETDLEV---IIKDNSLVLTPSHIKAYMLMTLQGLEYLHQH- 119
Query: 560 RLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNTNRVVGTY----------D 609
I+HRDLK +N+LLD++ K++DFGL ++FG V T
Sbjct: 120 --WILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNR--AYTHQVVTRWYRAPELLFGA 175
Query: 610 GQFSIKSDVFSFGILLLEIVSGK 632
+ + D+++ G +L E++
Sbjct: 176 RMYGVGVDMWAVGCILAELLLRV 198
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 130 bits (326), Expect = 9e-34
Identities = 48/216 (22%), Positives = 89/216 (41%), Gaps = 29/216 (13%)
Query: 440 DNFSINNKLGEGGFGPVYKGT-LVDGQEIAVKRLSK--ISEQGLKELKNEVILFSKLQHR 496
+ K+G+G FG V+K GQ++A+K++ E E+ + L+H
Sbjct: 10 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHE 69
Query: 497 NLVKLLGCCIQGEEK--------LLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGT 548
N+V L+ C L+++F + + TL + + ++
Sbjct: 70 NVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQML--- 126
Query: 549 ARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNTNR--VVG 606
L L+ R +I+HRD+KA+NVL+ +D K++DFGL R F + V
Sbjct: 127 ---LNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVV 183
Query: 607 T----------YDGQFSIKSDVFSFGILLLEIVSGK 632
T + + D++ G ++ E+ +
Sbjct: 184 TLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRS 219
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 130 bits (327), Expect = 1e-33
Identities = 49/266 (18%), Positives = 95/266 (35%), Gaps = 35/266 (13%)
Query: 440 DNFSINNKLGEGGFGPVYKGT-LVDGQEIAVKRLSK---ISEQGLKELKNEVILFSKLQH 495
++F LG+G FG V G+ A+K L K I++ + E + +H
Sbjct: 5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRH 64
Query: 496 RNLVKLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYL 555
L L + + E+ L + +R + + A + L
Sbjct: 65 PFLTALKYAFQTHDRLCFVMEYANGGELFFHL---SRERVFTEERARFYG---AEIVSAL 118
Query: 556 HQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNTNRVVGTY------- 608
+++RD+K N++LD+D + KI+DFGL + D GT
Sbjct: 119 EYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGA--TMKTFCGTPEYLAPEV 176
Query: 609 --DGQFSIKSDVFSFGILLLEIVSGKKNRGFYRSDTKVNLIGHLWDEGIPLRLIDACIQD 666
D + D + G+++ E++ G+ + + L + E +R
Sbjct: 177 LEDNDYGRAVDWWGLGVVMYEMMCGRL---PFYNQDHERLFELILME--EIRFPRTL--- 228
Query: 667 SCNLADVIRCIHIGLLCVQQHPEDRP 692
S ++ +++ P+ R
Sbjct: 229 SPEAKSLLAG------LLKKDPKQRL 248
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 127 bits (320), Expect = 3e-33
Identities = 63/315 (20%), Positives = 115/315 (36%), Gaps = 52/315 (16%)
Query: 437 NATDNFSINNKLGEGGFGPVYKGT-LVDGQEIAVKRLSKIS------EQGLKELKNEVIL 489
N D + +LG G F V K G + A K + K ++++ EV +
Sbjct: 7 NVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSI 66
Query: 490 FSKLQHRNLVKLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTA 549
++QH N++ L + +LI E + L F+ ++ L + +
Sbjct: 67 LKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKES---LTEEEATEFLKQIL 123
Query: 550 RGLLYLHQDSRLRIIHRDLKASNVLLDQDMNP----KISDFGLVRTFGGDETEGNTNRVV 605
G+ YLH L+I H DLK N++L P KI DFGL +
Sbjct: 124 NGVYYLH---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNE---FKNIF 177
Query: 606 GTY---------DGQFSIKSDVFSFGILLLEIVSGKKNRGFYRSDTKVNLIGHLWDEGIP 656
GT +++D++S G++ ++SG + DTK + ++
Sbjct: 178 GTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGAS---PFLGDTKQETLANVSAVNYE 234
Query: 657 LRLIDACIQDSCNLADVIRCIHIGLLCVQQHPEDRPCMPSVILMLGSEILLPQPKQPGYL 716
+ S D IR + + P+ R + + L + P ++
Sbjct: 235 FE-DEYFSNTSALAKDFIRR------LLVKDPKKRMTI--------QDSL----QHP-WI 274
Query: 717 ADRKSTEPYSSSSMP 731
+ + + SS+
Sbjct: 275 KPKDTQQALSSAWSH 289
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 125 bits (316), Expect = 8e-33
Identities = 60/279 (21%), Positives = 97/279 (34%), Gaps = 49/279 (17%)
Query: 440 DNFSINNKLGEGGFGPVYKGT-LVDGQEIAVKRLSKISEQGLKELKN------EVILFSK 492
+ + LG GGFG VY G + D +A+K + K EL N EV+L K
Sbjct: 4 SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKK 63
Query: 493 LQ--HRNLVKLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTAR 550
+ +++LL + + +LI E T R L
Sbjct: 64 VSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFI--TERGALQEELARSFFWQVLE 121
Query: 551 GLLYLHQDSRLRIIHRDLKASNVLLDQD-MNPKISDFGLVRTFGGDETEGNTNRVVGT-- 607
+ + H ++HRD+K N+L+D + K+ DFG + GT
Sbjct: 122 AVRHCHN---CGVLHRDIKDENILIDLNRGELKLIDFGSGALL----KDTVYTDFDGTRV 174
Query: 608 --------YDGQFSIKSDVFSFGILLLEIVSGKKNRGFYRSDTKVNLIGHLWDEGIPLRL 659
Y + V+S GILL ++V G + D ++ + + +
Sbjct: 175 YSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDI---PFEHDEEIIRGQVFFRQRV---- 227
Query: 660 IDACIQDSCNLADVIRCIHIGLLCVQQHPEDRPCMPSVI 698
S +IR C+ P DRP +
Sbjct: 228 -------SSECQHLIRW------CLALRPSDRPTFEEIQ 253
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 126 bits (318), Expect = 2e-32
Identities = 57/304 (18%), Positives = 105/304 (34%), Gaps = 32/304 (10%)
Query: 402 RNIAEKTENSRETDQENEDQNIDLELPLFELATIANATDNFSINNKLGEGGFGPVYKGT- 460
+ +E+ + ED E P A + D F LG G FG V
Sbjct: 7 KKGSEQESVKEFLAKAKEDFLKKWETPSQNTAQL----DQFDRIKTLGTGSFGRVMLVKH 62
Query: 461 LVDGQEIAVKRLSK---ISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEF 517
G A+K L K + + ++ NE + + LVKL ++ E+
Sbjct: 63 KESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEY 122
Query: 518 MPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQ 577
+ + S + R YLH L +I+RDLK N+L+DQ
Sbjct: 123 VAGGEMFSHLRRIGR---FSEPHARFYAAQIVLTFEYLHS---LDLIYRDLKPENLLIDQ 176
Query: 578 DMNPKISDFGLVRTFGGDET--EGNTNRVVGTY--DGQFSIKSDVFSFGILLLEIVSGKK 633
+++DFG + G G + ++ D ++ G+L+ E+ +G
Sbjct: 177 QGYIQVTDFGFAKRVKGRTWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYP 236
Query: 634 NRGFYRSDTKVNLIGHLWDEGIPL---------RLIDACIQDSCNLADVIRCIHIGLLCV 684
+ +D + + + + L+ +Q +L + G+ +
Sbjct: 237 ---PFFADQPIQIYEKIVSGKVRFPSHFSSDLKDLLRNLLQ--VDLTKRFGNLKNGVNDI 291
Query: 685 QQHP 688
+ H
Sbjct: 292 KNHK 295
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 124 bits (311), Expect = 4e-32
Identities = 45/205 (21%), Positives = 83/205 (40%), Gaps = 17/205 (8%)
Query: 440 DNFSINNKLGEGGFGPVYKGT-LVDGQEIAVKRLSK--ISEQGLKELKNEVILFSKLQHR 496
+ K+GEG +G V+K + +A+KR+ E E+ L +L+H+
Sbjct: 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHK 61
Query: 497 NLVKLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLH 556
N+V+L ++ L++EF F + + L L
Sbjct: 62 NIVRLHDVLHSDKKLTLVFEFCDQDLKKYFDSCN------GDLDPEIVKSFLFQLLKGLG 115
Query: 557 QDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNTNRVVGTY-------- 608
++HRDLK N+L++++ K+++FGL R FG + V Y
Sbjct: 116 FCHSRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEVVTLWYRPPDVLFG 175
Query: 609 DGQFSIKSDVFSFGILLLEIVSGKK 633
+S D++S G + E+ + +
Sbjct: 176 AKLYSTSIDMWSAGCIFAELANAGR 200
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 125 bits (315), Expect = 4e-32
Identities = 44/269 (16%), Positives = 92/269 (34%), Gaps = 31/269 (11%)
Query: 440 DNFSINNK-LGEGGFGPVYKGT-LVDGQEIAVKRLSKISEQGLKELKNEV-ILFSKLQHR 496
D++ + ++ LG G G V + ++ A+K L + + EV + + Q
Sbjct: 11 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCP 65
Query: 497 NLVKLLGCCIQGEEK----LLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGL 552
++V+++ L++ E + L S I D+ + + I+ +
Sbjct: 66 HIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAF-TEREASEIMKSIGEAI 124
Query: 553 LYLHQDSRLRIIHRDLKASNVLLDQDMNP---KISDFGLVRTFGGDETEGNTNRVVGTY- 608
YLH + I HRD+K N+L K++DFG + +
Sbjct: 125 QYLHS---INIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVA 181
Query: 609 -----DGQFSIKSDVFSFGILLLEIVSGKKNRGFYRSDTKVNLIGHLWDEGIPLRLIDAC 663
++ D++S G+++ ++ G + G
Sbjct: 182 PEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEW 241
Query: 664 IQDSCNLADVIRCIHIGLLCVQQHPEDRP 692
+ S + +IR ++ P R
Sbjct: 242 SEVSEEVKMLIRN------LLKTEPTQRM 264
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 122 bits (307), Expect = 4e-31
Identities = 49/202 (24%), Positives = 88/202 (43%), Gaps = 12/202 (5%)
Query: 440 DNFSINNKLGEGGFGPVYKGT-LVDGQEIAVKRLSK--ISEQGLKELKNEVILFSKLQHR 496
+ +G G +G V G ++A+K+L + SE K E+ L ++H
Sbjct: 18 AVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHE 77
Query: 497 NLVKLLGCCIQGEEKLLIYEF-MPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYL 555
N++ LL E +F + + + + + L + ++ +GL Y+
Sbjct: 78 NVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMKHEKLGEDRIQFLVYQMLKGLRYI 137
Query: 556 HQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNTNRV-----VGTYDG 610
H IIHRDLK N+ +++D KI DFGL R + T R V
Sbjct: 138 H---AAGIIHRDLKPGNLAVNEDCELKILDFGLARQADSEMTGYVVTRWYRAPEVILNWM 194
Query: 611 QFSIKSDVFSFGILLLEIVSGK 632
+++ D++S G ++ E+++GK
Sbjct: 195 RYTQTVDIWSVGCIMAEMITGK 216
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 121 bits (304), Expect = 8e-31
Identities = 58/272 (21%), Positives = 106/272 (38%), Gaps = 35/272 (12%)
Query: 440 DNFSINNKLGEGGFGPVYKGTLV----DGQEIAVKRLSKIS----EQGLKELKNEVILFS 491
+NF + LG G +G V+ + G+ A+K L K + + + + E +
Sbjct: 24 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLE 83
Query: 492 KLQHR-NLVKLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTAR 550
++ LV L + LI +++ L + + + R T + I
Sbjct: 84 HIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEI----- 138
Query: 551 GLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNTNRVVGTY-- 608
+L L +L II+RD+K N+LLD + + ++DFGL + F DETE +
Sbjct: 139 -VLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFCGTIEYM 197
Query: 609 --------DGQFSIKSDVFSFGILLLEIVSGKKNRGFYRSDTKVNLIGHLWDEGIPLRLI 660
D D +S G+L+ E+++G + D + N + I
Sbjct: 198 APDIVRGGDSGHDKAVDWWSLGVLMYELLTGAS---PFTVDGEKNSQAEIS-RRILKSEP 253
Query: 661 DACIQDSCNLADVIRCIHIGLLCVQQHPEDRP 692
+ S D+I+ + + P+ R
Sbjct: 254 PYPQEMSALAKDLIQR------LLMKDPKKRL 279
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 111 bits (277), Expect = 4e-27
Identities = 51/208 (24%), Positives = 90/208 (43%), Gaps = 12/208 (5%)
Query: 434 TIANATDNFSINNKLGEGGFGPVYKGT-LVDGQEIAVKRLSK--ISEQGLKELKNEVILF 490
TI + + + +G G +G V G +AVK+LS+ S K E+ L
Sbjct: 12 TIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLL 71
Query: 491 SKLQHRNLVKLLGCCIQGEE-KLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTA 549
++H N++ LL + ++ + + + + + L +I
Sbjct: 72 KHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQIL 131
Query: 550 RGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNTNRV----- 604
RGL Y+H IIHRDLK SN+ +++D KI DFGL R + T R
Sbjct: 132 RGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATRWYRAPE 188
Query: 605 VGTYDGQFSIKSDVFSFGILLLEIVSGK 632
+ ++ D++S G ++ E+++G+
Sbjct: 189 IMLNWMHYNQTVDIWSVGCIMAELLTGR 216
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 110 bits (275), Expect = 6e-27
Identities = 40/208 (19%), Positives = 84/208 (40%), Gaps = 30/208 (14%)
Query: 440 DNFSINNKLGEGGFGPVYKGT-LVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQ-HRN 497
D++ + KLG G + V++ + + +++ VK L + + K++K E+ + L+ N
Sbjct: 35 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKK---KKIKREIKILENLRGGPN 91
Query: 498 LVKLLGCCIQGEEKL--LIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYL 555
++ L + L++E + N L + + L Y
Sbjct: 92 IITLADIVKDPVSRTPALVFEHVNNTDFKQLY------QTLTDYDIRFYMYEILKALDYC 145
Query: 556 HQDSRLRIIHRDLKASNVLLD-QDMNPKISDFGLVRTFGGDETEGNTNRVVGTY------ 608
H + I+HRD+K NV++D + ++ D+GL + + N V +
Sbjct: 146 HS---MGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQE---YNVRVASRYFKGPE 199
Query: 609 ----DGQFSIKSDVFSFGILLLEIVSGK 632
+ D++S G +L ++ K
Sbjct: 200 LLVDYQMYDYSLDMWSLGCMLASMIFRK 227
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 103 bits (258), Expect = 5e-26
Identities = 36/199 (18%), Positives = 65/199 (32%), Gaps = 24/199 (12%)
Query: 443 SINNKLGEGGFGPVYKGTLVDGQEIAVK--RLSKIS--------EQGLKELKNEVILFSK 492
+I +GEG V+ E VK ++ S + G I ++
Sbjct: 3 AIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSAR 62
Query: 493 LQHRNLVKLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGL 552
+ R L KL G + +Y + N L I + + + ++ +
Sbjct: 63 NEFRALQKLQGLAVPK-----VYAWEGNAVLMELIDAKELYRVRVENPD-EVLDMILEEV 116
Query: 553 LYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNTNRVVGT----Y 608
+ I+H DL NVL+ + I DF G + R V +
Sbjct: 117 AKFYHR---GIVHGDLSQYNVLVS-EEGIWIIDFPQSVEVGEEGWREILERDVRNIITYF 172
Query: 609 DGQFSIKSDVFSFGILLLE 627
+ + D+ S +L+
Sbjct: 173 SRTYRTEKDINSAIDRILQ 191
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 107 bits (268), Expect = 6e-26
Identities = 50/211 (23%), Positives = 85/211 (40%), Gaps = 30/211 (14%)
Query: 440 DNFSINNKLGEGGFGPVYKGT-LVDGQEIAVKRLSK--ISEQGLKELKNEVILFSKLQHR 496
+ +G G G V V + +A+K+LS+ ++ K E++L + H+
Sbjct: 17 KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHK 76
Query: 497 NLVKLLGCCI------QGEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTAR 550
N++ LL + ++ L+ E M + D + +++
Sbjct: 77 NIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMEL------DHERMSYLLYQMLC 130
Query: 551 GLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNTNRVVGT--- 607
G+ +LH IIHRDLK SN+++ D KI DFGL RT G V T
Sbjct: 131 GIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFM---MTPYVVTRYY 184
Query: 608 ------YDGQFSIKSDVFSFGILLLEIVSGK 632
+ D++S G ++ E+V K
Sbjct: 185 RAPEVILGMGYKENVDIWSVGCIMGEMVRHK 215
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 97.0 bits (240), Expect = 3e-22
Identities = 37/215 (17%), Positives = 76/215 (35%), Gaps = 27/215 (12%)
Query: 442 FSINNKLGEGGFGPVYKGT-LVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVK 500
+ + KLG G F V+ +V+ +A+K + + + ++E+ L ++ + K
Sbjct: 15 YILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRG-DKVYTEAAEDEIKLLQRVNDADNTK 73
Query: 501 LLGCCIQGEEKLLIY-------------EFMPNKSLDSFIFDQTRRTLLDWSQRFHIICG 547
KLL + F + + + I
Sbjct: 74 EDSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQ 133
Query: 548 TARGLLYLHQDSRLRIIHRDLKASNVLLDQ-DMNPKISDFGLVRTFGGDETEGNTNRVVG 606
GL Y+H+ R IIH D+K NVL++ D + + + + +
Sbjct: 134 LLLGLDYMHR--RCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNSIQ 191
Query: 607 TYD---------GQFSIKSDVFSFGILLLEIVSGK 632
T + + +D++S L+ E+++G
Sbjct: 192 TREYRSPEVLLGAPWGCGADIWSTACLIFELITGD 226
|
| >d1kj1a_ b.78.1.1 (A:) Lectin (agglutinin) {Garlic (Allium sativum) [TaxId: 4682]} Length = 109 | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Lectin (agglutinin) species: Garlic (Allium sativum) [TaxId: 4682]
Score = 66.5 bits (162), Expect = 5e-14
Identities = 16/84 (19%), Positives = 30/84 (35%), Gaps = 9/84 (10%)
Query: 12 YPPHEVVWVANRLNPINDSFGFLMINKTGNLVLTSQSNIVVWSAYLSKEVQTPVVLQLLD 71
Y VW +N ++ GN V+ +W+++ + VL L +
Sbjct: 34 YDHSTSVWASNTGILGKK-GCKAVLQSDGNFVVYDAEGRSLWASHSVRG-NGNYVLVLQE 91
Query: 72 SGNLVLRDEHDGDSETYFWQSFDY 95
GN+V+ + W + Y
Sbjct: 92 DGNVVIYG-------SDIWSTGTY 108
|
| >d1dlpa2 b.78.1.1 (A:116-235) Fetuin-binding protein Scafet precursor {Bluebell (Scilla campanulata) [TaxId: 81759]} Length = 120 | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Fetuin-binding protein Scafet precursor species: Bluebell (Scilla campanulata) [TaxId: 81759]
Score = 55.7 bits (134), Expect = 4e-10
Identities = 16/102 (15%), Positives = 32/102 (31%), Gaps = 13/102 (12%)
Query: 2 MLADKEPNKSYPPHEVVWVANRLNPINDSFGFLMINKTGNLVLTSQSNIVVWSAYLSKEV 61
+L + N ++P + + S L + NLVL + + V + K
Sbjct: 12 ILYSTQGNDNHP-----QTLHATQSLQLSPYRLSMETDCNLVLFDRDDRVWSTNTAGK-- 64
Query: 62 QTPVVLQLLDSGNLVLRDEHDGDSETYFWQSFD--YPSDTLL 101
T L +G + + + W S + +
Sbjct: 65 GTGCRAVLQPNGRMDVLT----NQNIAVWTSGNSRSAGRYVF 102
|
| >d1dlpa2 b.78.1.1 (A:116-235) Fetuin-binding protein Scafet precursor {Bluebell (Scilla campanulata) [TaxId: 81759]} Length = 120 | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Fetuin-binding protein Scafet precursor species: Bluebell (Scilla campanulata) [TaxId: 81759]
Score = 40.7 bits (95), Expect = 7e-05
Identities = 13/68 (19%), Positives = 24/68 (35%), Gaps = 3/68 (4%)
Query: 12 YPPHEVVWVANRLNPINDSFGFLMINKTGNLVLTSQSNIVVWSAYLSKEVQTPVVLQLLD 71
+ + VW N ++ G + + + NI VW++ S+ V L
Sbjct: 50 FDRDDRVWSTNTAGKGTGCR--AVLQPNGRMDVLTNQNIAVWTSGNSRS-AGRYVFVLQP 106
Query: 72 SGNLVLRD 79
NL +
Sbjct: 107 DRNLAIYG 114
|
| >d1xd5a_ b.78.1.1 (A:) Gastrodianin (antifungal protein) {Gastrodia elata [TaxId: 91201]} Length = 112 | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Gastrodianin (antifungal protein) species: Gastrodia elata [TaxId: 91201]
Score = 53.3 bits (127), Expect = 3e-09
Identities = 18/87 (20%), Positives = 30/87 (34%), Gaps = 8/87 (9%)
Query: 12 YPPHEVVWVANRLNPINDSFGFLMINKTGNLVLTSQSNIVVWSAYLSKEVQTPVVLQLLD 71
Y + VW + + L + GNLV+ S S + S + L L
Sbjct: 34 YDNNRAVWASGTNGKASGCV--LKMQNDGNLVIYSGSRAIWASNTNRQ--NGNYYLILQR 89
Query: 72 SGNLVLRDEHDGDSETYFWQSFDYPSD 98
N+V+ D +S W + +
Sbjct: 90 DRNVVIYD----NSNNAIWATHTNVGN 112
|
| >d1jpca_ b.78.1.1 (A:) Lectin (agglutinin) {Snowdrop (Galanthus nivalis) [TaxId: 4670]} Length = 108 | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Lectin (agglutinin) species: Snowdrop (Galanthus nivalis) [TaxId: 4670]
Score = 52.3 bits (125), Expect = 5e-09
Identities = 17/84 (20%), Positives = 30/84 (35%), Gaps = 10/84 (11%)
Query: 12 YPPHEVVWVANRLNPINDSFGFLMINKTGNLVLTSQSNIVVWSAYLSKEVQTPVVLQLLD 71
Y + +W N F L + GNLV+ + SN +W++ + V L
Sbjct: 34 YDVDKPIWATNTGGLSRSCF--LSMQTDGNLVVYNPSNKPIWASNTGGQNGNYV-CILQK 90
Query: 72 SGNLVLRDEHDGDSETYFWQSFDY 95
N+V+ W + +
Sbjct: 91 DRNVVIYGTD-------RWATGTH 107
|
| >d1b2pa_ b.78.1.1 (A:) Lectin (agglutinin) {Bluebell (Scilla campanulata) [TaxId: 81759]} Length = 119 | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Lectin (agglutinin) species: Bluebell (Scilla campanulata) [TaxId: 81759]
Score = 50.0 bits (119), Expect = 4e-08
Identities = 16/84 (19%), Positives = 30/84 (35%), Gaps = 10/84 (11%)
Query: 12 YPPHEVVWVANRLNPINDSFGFLMINKTGNLVLTSQSNIVVWSAYLSKEVQTPVVLQLLD 71
Y + +W N N ++ G LV+ + N+ VW + ++ + V L L
Sbjct: 45 YDNNNPIWATNTGGLGNGCR--AVLQPDGVLVVITNENVTVWQSPVAGKAGHYV-LVLQP 101
Query: 72 SGNLVLRDEHDGDSETYFWQSFDY 95
N+V+ W +
Sbjct: 102 DRNVVIYG-------DALWATQTV 118
|
| >d1dlpa1 b.78.1.1 (A:1-115) Fetuin-binding protein Scafet precursor {Bluebell (Scilla campanulata) [TaxId: 81759]} Length = 115 | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Fetuin-binding protein Scafet precursor species: Bluebell (Scilla campanulata) [TaxId: 81759]
Score = 43.8 bits (103), Expect = 6e-06
Identities = 16/75 (21%), Positives = 25/75 (33%), Gaps = 7/75 (9%)
Query: 19 WVANRLNPINDSFGFLMINKTGNLVLTSQSNIVVWSAYLSKEVQTPVVLQLLDSGNLVLR 78
+ + S + NLVL S++ VW++ + T L G LV+
Sbjct: 15 QTLHAAQSLELSSFRFTMQSDCNLVLFD-SDVRVWASNTAG--ATGCRAVLQSDGLLVIL 71
Query: 79 DEHDGDSETYFWQSF 93
T W S
Sbjct: 72 T----AQNTIRWSSG 82
|
Homologous Domains Detected by HHsearch
Original result of HHsearch against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 747 | |||
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 100.0 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 100.0 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 100.0 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 100.0 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 100.0 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 100.0 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 100.0 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 100.0 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 100.0 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 100.0 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 100.0 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 100.0 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 100.0 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 100.0 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 100.0 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 100.0 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 100.0 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 100.0 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 100.0 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 100.0 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 100.0 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 100.0 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 100.0 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 100.0 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 100.0 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 100.0 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 100.0 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 100.0 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 100.0 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 100.0 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 100.0 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 100.0 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 100.0 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 100.0 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 100.0 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 100.0 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 100.0 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 100.0 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 100.0 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 100.0 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.88 | |
| d1dlpa2 | 120 | Fetuin-binding protein Scafet precursor {Bluebell | 99.6 | |
| d1kj1a_ | 109 | Lectin (agglutinin) {Garlic (Allium sativum) [TaxI | 99.51 | |
| d1dlpa1 | 115 | Fetuin-binding protein Scafet precursor {Bluebell | 99.48 | |
| d1xd5a_ | 112 | Gastrodianin (antifungal protein) {Gastrodia elata | 99.47 | |
| d1jpca_ | 108 | Lectin (agglutinin) {Snowdrop (Galanthus nivalis) | 99.44 | |
| d1b2pa_ | 119 | Lectin (agglutinin) {Bluebell (Scilla campanulata) | 99.15 | |
| d1b2pa_ | 119 | Lectin (agglutinin) {Bluebell (Scilla campanulata) | 98.9 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 98.9 | |
| d1kj1a_ | 109 | Lectin (agglutinin) {Garlic (Allium sativum) [TaxI | 98.88 | |
| d1jpca_ | 108 | Lectin (agglutinin) {Snowdrop (Galanthus nivalis) | 98.81 | |
| d1dlpa2 | 120 | Fetuin-binding protein Scafet precursor {Bluebell | 98.62 | |
| d1xd5a_ | 112 | Gastrodianin (antifungal protein) {Gastrodia elata | 98.61 | |
| d1dlpa1 | 115 | Fetuin-binding protein Scafet precursor {Bluebell | 98.6 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 98.37 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 98.08 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 97.57 | |
| d1nw1a_ | 395 | Choline kinase {Caenorhabditis elegans [TaxId: 623 | 97.27 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 96.15 |
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=0 Score=344.50 Aligned_cols=254 Identities=26% Similarity=0.431 Sum_probs=200.7
Q ss_pred HHHHHHCCCCCCCEECCCCCEEEEEEEECC-CCEEEEEEECCCCCCCHHHHHHHHHHHHCCCCCCEEEEEEEEEECCEEE
Q ss_conf 899972397855421424980099999669-8499999913433106899999999983059973233774899498227
Q 004521 434 TIANATDNFSINNKLGEGGFGPVYKGTLVD-GQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKL 512 (747)
Q Consensus 434 ~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~-g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~ 512 (747)
+++...++|++.+.||+|+||+||+|.+.. ++.||||+++. .....++|.+|+.++++++||||++++|++.+.+..+
T Consensus 11 ~wei~~~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~-~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ 89 (287)
T d1opja_ 11 KWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKE-DTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFY 89 (287)
T ss_dssp TTBCCGGGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCT-TCSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCE
T ss_pred CCEECHHHEEEEEEEEECCCEEEEEEEECCCCEEEEEEEECC-CCCHHHHHHHHHHHHHHCCCCCEECCCCCEEECCEEE
T ss_conf 517457993986598208880899999999996999999777-6103999999999998679998826775274578547
Q ss_pred EEEECCCCCCHHHHHHHCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCCEEECCCCCCCC
Q ss_conf 99950799994467631289876785678999999999999834159994673266768379858999447125675003
Q 004521 513 LIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTF 592 (747)
Q Consensus 513 lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dikp~NIll~~~~~~ki~DfGla~~~ 592 (747)
+||||+++|+|.+++... ....+++..+..++.|++.||+|||+.+ |+||||||+|||+++++.+||+|||+|+..
T Consensus 90 iv~E~~~~g~l~~~l~~~-~~~~~~~~~~~~i~~qi~~gL~yLH~~~---iiHrDlKp~NILl~~~~~~Kl~DFG~a~~~ 165 (287)
T d1opja_ 90 IITEFMTYGNLLDYLREC-NRQEVSAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLM 165 (287)
T ss_dssp EEEECCTTCBHHHHHHHS-CTTTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCCCTTTC
T ss_pred EEEECCCCCCHHHHHHHC-CCCCHHHHHHHHHHHHHHHHHHHHHHCC---CCCCCCCCCEEEECCCCCEEECCCCCEEEC
T ss_conf 876314676067775303-5541579999999999999788898789---305760457689989992898324454653
Q ss_pred CCCCCCCCCCEEEEC---------CCCCCCCCCCCHHHHHHHHHHHHCCCCCCCCCCCCHHHHHHHHHHCCCCCCCCCHH
Q ss_conf 899875444402102---------37888844640237899999881998999988764022448677219865224301
Q 004521 593 GGDETEGNTNRVVGT---------YDGQFSIKSDVFSFGILLLEIVSGKKNRGFYRSDTKVNLIGHLWDEGIPLRLIDAC 663 (747)
Q Consensus 593 ~~~~~~~~~~~~~~~---------~~~~~s~~sDVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 663 (747)
.......... ..++ .+..++.++|||||||++|||+++..|+. .......... ....+......+.
T Consensus 166 ~~~~~~~~~~-~~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~~~~p~~--~~~~~~~~~~-~i~~~~~~~~~~~- 240 (287)
T d1opja_ 166 TGDTYTAHAG-AKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPY--PGIDLSQVYE-LLEKDYRMERPEG- 240 (287)
T ss_dssp CSSSSEEETT-EEECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCSS--TTCCHHHHHH-HHHTTCCCCCCTT-
T ss_pred CCCCCEEECC-CCCCCCCCCHHHHCCCCCCCHHHHHHHHHHHHHHHHCCCCCC--CCCHHHHHHH-HHHCCCCCCCCCC-
T ss_conf 7887221035-566546669278727999810430217899999986799887--7425999999-9855888888743-
Q ss_pred HHCCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHCCCC
Q ss_conf 106699999999999997616899999999889999854898
Q 004521 664 IQDSCNLADVIRCIHIGLLCVQQHPEDRPCMPSVILMLGSEI 705 (747)
Q Consensus 664 l~~~~~~~~~~~~~~l~~~Cl~~dP~~RPt~~~v~~~L~~~~ 705 (747)
. ...+.+++.+||+.||.+||||.+|++.|+...
T Consensus 241 ----~----~~~l~~li~~cl~~dP~~Rps~~ei~~~L~~~~ 274 (287)
T d1opja_ 241 ----C----PEKVYELMRACWQWNPSDRPSFAEIHQAFETMF 274 (287)
T ss_dssp ----C----CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTT
T ss_pred ----C----HHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHH
T ss_conf ----3----099999999975779768939999999999998
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=335.70 Aligned_cols=247 Identities=27% Similarity=0.455 Sum_probs=195.9
Q ss_pred HCCCCCCCEECCCCCEEEEEEEECCCCEEEEEEECCCCCCCHHHHHHHHHHHHCCCCCCEEEEEEEEEECCEEEEEEECC
Q ss_conf 23978554214249800999996698499999913433106899999999983059973233774899498227999507
Q 004521 439 TDNFSINNKLGEGGFGPVYKGTLVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFM 518 (747)
Q Consensus 439 ~~~~~~~~~lg~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~e~~ 518 (747)
.++|++.+.||+|+||+||+|++.+++.||||+++. .....++|.+|++++++++||||++++|++...+..++||||+
T Consensus 4 p~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~-~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~lv~E~~ 82 (263)
T d1sm2a_ 4 PSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIRE-GAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFM 82 (263)
T ss_dssp CSCEEEEEEEECCSSCCEEEEEETTTEEEEEEECCS-SSSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECC
T ss_pred HHHCEEEEEEEECCCEEEEEEEECCCCEEEEEEECC-CCCCHHHHHHHHHHHHHCCCCCCCCCCCEECCCCCEEEEEEEC
T ss_conf 699588889820888299999988999999999878-8676899999999999668997565352431599337999836
Q ss_pred CCCCHHHHHHHCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCCEEECCCCCCCCCCCCCC
Q ss_conf 99994467631289876785678999999999999834159994673266768379858999447125675003899875
Q 004521 519 PNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETE 598 (747)
Q Consensus 519 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dikp~NIll~~~~~~ki~DfGla~~~~~~~~~ 598 (747)
++|+|.+++... ...+++..++.++.|+|.||.|||+.+ |+||||||+|||+++++.+||+|||+++........
T Consensus 83 ~~g~L~~~l~~~--~~~~~~~~~~~i~~qia~gl~~lH~~~---iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~ 157 (263)
T d1sm2a_ 83 EHGCLSDYLRTQ--RGLFAAETLLGMCLDVCEGMAYLEEAC---VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYT 157 (263)
T ss_dssp TTCBHHHHHHTT--TTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCTTCSGGGEEECGGGCEEECSCC-----------
T ss_pred CCCCHHHHHHCC--CCCCCHHHHHHHHHHHHHHHHHHHCCC---EEECCCCHHHEEECCCCCEEECCCCHHEECCCCCCE
T ss_conf 999189975201--347889999999999999877653164---310443153266668877686553210023688733
Q ss_pred CCCCEEEEC---------CCCCCCCCCCCHHHHHHHHHHHHCCCCCCCCCCCCHHHHHHHHHHCCCCCCCCCHHHHCCCC
Q ss_conf 444402102---------37888844640237899999881998999988764022448677219865224301106699
Q 004521 599 GNTNRVVGT---------YDGQFSIKSDVFSFGILLLEIVSGKKNRGFYRSDTKVNLIGHLWDEGIPLRLIDACIQDSCN 669 (747)
Q Consensus 599 ~~~~~~~~~---------~~~~~s~~sDVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~ 669 (747)
.... ..++ .+..++.++|||||||++|||+|+..|+. ...........+ ..+....... ..
T Consensus 158 ~~~~-~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t~~~~~~--~~~~~~~~~~~i-~~~~~~~~p~-----~~- 227 (263)
T d1sm2a_ 158 SSTG-TKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPY--ENRSNSEVVEDI-STGFRLYKPR-----LA- 227 (263)
T ss_dssp --------CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTT--CSCCHHHHHHHH-HHTCCCCCCT-----TS-
T ss_pred EECC-EECCCCCCCHHHHCCCCCCCHHHHCCHHHHHHHHHHCCCCCC--CCCCHHHHHHHH-HHCCCCCCCC-----CC-
T ss_conf 5043-001766678578607999840332105999999987898887--789999999999-8068889954-----36-
Q ss_pred HHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHCCC
Q ss_conf 99999999999761689999999988999985489
Q 004521 670 LADVIRCIHIGLLCVQQHPEDRPCMPSVILMLGSE 704 (747)
Q Consensus 670 ~~~~~~~~~l~~~Cl~~dP~~RPt~~~v~~~L~~~ 704 (747)
..++.+++.+||+.||.+||+|++|++.|+..
T Consensus 228 ---~~~l~~li~~cl~~~p~~Rps~~~il~~L~~i 259 (263)
T d1sm2a_ 228 ---STHVYQIMNHCWKERPEDRPAFSRLLRQLAEI 259 (263)
T ss_dssp ---CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred ---CHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHH
T ss_conf ---79999999997657976891999999999999
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=336.44 Aligned_cols=251 Identities=27% Similarity=0.466 Sum_probs=192.4
Q ss_pred HCCCCCCCEECCCCCEEEEEEEECCCCEEEEEEECC--CCCCCHHHHHHHHHHHHCCCCCCEEEEEEEEEECCEEEEEEE
Q ss_conf 239785542142498009999966984999999134--331068999999999830599732337748994982279995
Q 004521 439 TDNFSINNKLGEGGFGPVYKGTLVDGQEIAVKRLSK--ISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYE 516 (747)
Q Consensus 439 ~~~~~~~~~lg~G~~g~Vy~~~~~~g~~vavK~l~~--~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~e 516 (747)
.++|++.+.||+|+||+||+|+.. ..||||+++. ......+.|.+|+.++++++||||++++|++.+ +..++|||
T Consensus 7 ~~~~~~~~~lG~G~fg~Vy~~~~~--~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~-~~~~lv~E 83 (276)
T d1uwha_ 7 DGQITVGQRIGSGSFGTVYKGKWH--GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTA-PQLAIVTQ 83 (276)
T ss_dssp TTCCCCCSEEEECSSCEEEEEESS--SEEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEEEE
T ss_pred CCCEEEEEEEEECCCCEEEEEEEC--CEEEEEEEECCCCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEEC-CEEEEEEE
T ss_conf 451899889830788589999999--989999997346998999999999999984799878645679715-58999996
Q ss_pred CCCCCCHHHHHHHCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCCEEECCCCCCCCCCCC
Q ss_conf 07999944676312898767856789999999999998341599946732667683798589994471256750038998
Q 004521 517 FMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDE 596 (747)
Q Consensus 517 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dikp~NIll~~~~~~ki~DfGla~~~~~~~ 596 (747)
|+++|+|.+++... ...+++..+..++.|+|.||+|||+.+ |+||||||+|||++.++.+||+|||+|+......
T Consensus 84 y~~~g~L~~~l~~~--~~~~~~~~~~~i~~qi~~gl~yLH~~~---ivHrDlKp~NiLl~~~~~~Kl~DFGla~~~~~~~ 158 (276)
T d1uwha_ 84 WCEGSSLYHHLHII--ETKFEMIKLIDIARQTAQGMDYLHAKS---IIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWS 158 (276)
T ss_dssp CCCEEEHHHHHHTS--CCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEETTSSEEECCCCCSCC-----
T ss_pred CCCCCCHHHHHHHC--CCCCCHHHHHHHHHHHHHHHHHHHCCC---EECCCCCHHHEEECCCCCEEECCCCCEEECCCCC
T ss_conf 58998889998523--578999999999999999988875099---9516147899798189978875002213335567
Q ss_pred CCCCCCEEEECC------------CCCCCCCCCCHHHHHHHHHHHHCCCCCCCCCCCCHHHHHHHHHHCCCCCCCCCHHH
Q ss_conf 754444021023------------78888446402378999998819989999887640224486772198652243011
Q 004521 597 TEGNTNRVVGTY------------DGQFSIKSDVFSFGILLLEIVSGKKNRGFYRSDTKVNLIGHLWDEGIPLRLIDACI 664 (747)
Q Consensus 597 ~~~~~~~~~~~~------------~~~~s~~sDVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 664 (747)
.........++. ...|+.++|||||||++|||+||+.||...... ..+......+........ .
T Consensus 159 ~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~---~~~~~~~~~~~~~p~~~~-~ 234 (276)
T d1uwha_ 159 GSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNR---DQIIFMVGRGYLSPDLSK-V 234 (276)
T ss_dssp -------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCH---HHHHHHHHHTSCCCCGGG-S
T ss_pred CCCCCCCCCCCCCCCCHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCHH---HHHHHHHHCCCCCCCCHH-C
T ss_conf 763125665574317999995056899995315163599999999788998998969---999999965888986000-3
Q ss_pred HCCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHCCCC
Q ss_conf 06699999999999997616899999999889999854898
Q 004521 665 QDSCNLADVIRCIHIGLLCVQQHPEDRPCMPSVILMLGSEI 705 (747)
Q Consensus 665 ~~~~~~~~~~~~~~l~~~Cl~~dP~~RPt~~~v~~~L~~~~ 705 (747)
.... ...+.+++.+||+.||.+||||.+|++.|+.+.
T Consensus 235 ~~~~----~~~l~~li~~cl~~dp~~RPt~~~il~~Le~l~ 271 (276)
T d1uwha_ 235 RSNC----PKAMKRLMAECLKKKRDERPLFPQILASIELLA 271 (276)
T ss_dssp CTTC----CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred CCCC----HHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHH
T ss_conf 6555----499999999975889768929999999999999
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=0 Score=337.29 Aligned_cols=249 Identities=27% Similarity=0.413 Sum_probs=194.3
Q ss_pred CCCCCCCEECCCCCEEEEEEEECC-C---CEEEEEEECC-CCCCCHHHHHHHHHHHHCCCCCCEEEEEEEEEECCEEEEE
Q ss_conf 397855421424980099999669-8---4999999134-3310689999999998305997323377489949822799
Q 004521 440 DNFSINNKLGEGGFGPVYKGTLVD-G---QEIAVKRLSK-ISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLI 514 (747)
Q Consensus 440 ~~~~~~~~lg~G~~g~Vy~~~~~~-g---~~vavK~l~~-~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV 514 (747)
++|++.+.||+|+||+||+|.+.. + ..||||.+.. ......+.|.+|+.++++++|||||+++|++...+..++|
T Consensus 26 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~iv 105 (299)
T d1jpaa_ 26 SCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMII 105 (299)
T ss_dssp GGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEEE
T ss_pred HHCEEEEEEEECCCEEEEEEEEECCCCEEEEEEEEEECCCCCHHHHHHHHHHHHHHHHCCCCCCCCEEEEEEECCEEEEE
T ss_conf 04278569802788299999995799788999999978445989999999999999857998886189999628877999
Q ss_pred EECCCCCCHHHHHHHCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCCEEECCCCCCCCCC
Q ss_conf 95079999446763128987678567899999999999983415999467326676837985899944712567500389
Q 004521 515 YEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGG 594 (747)
Q Consensus 515 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dikp~NIll~~~~~~ki~DfGla~~~~~ 594 (747)
|||+++|+|.+++... ...+++..++.++.|+|.||.|||+.+ ++||||||+||||+.++.+||+|||+|+.+..
T Consensus 106 ~Ey~~~g~L~~~~~~~--~~~l~~~~~~~i~~qia~gl~yLH~~~---iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~~ 180 (299)
T d1jpaa_ 106 TEFMENGSLDSFLRQN--DGQFTVIQLVGMLRGIAAGMKYLADMN---YVHRDLAARNILVNSNLVCKVSDFGLSRFLED 180 (299)
T ss_dssp EECCTTEEHHHHHHTT--TTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCC--------
T ss_pred EEECCCCCCEEEECCC--CCCCCHHHHHHHHHHHHHHHHHHHHCC---CCCCCCCCCEEEECCCCCEEECCCCCCEECCC
T ss_conf 9722798530021045--679999999999999999889885279---83576150448988999199888443157567
Q ss_pred CCCCCCCCE---EEEC---------CCCCCCCCCCCHHHHHHHHHHHH-CCCCCCCCCCCCHHHHHHHHHHCCCCCCCCC
Q ss_conf 987544440---2102---------37888844640237899999881-9989999887640224486772198652243
Q 004521 595 DETEGNTNR---VVGT---------YDGQFSIKSDVFSFGILLLEIVS-GKKNRGFYRSDTKVNLIGHLWDEGIPLRLID 661 (747)
Q Consensus 595 ~~~~~~~~~---~~~~---------~~~~~s~~sDVwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~d 661 (747)
......... ..++ ....++.++|||||||++|||+| |+.||.... .......+ ..+.......
T Consensus 181 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~---~~~~~~~i-~~~~~~~~~~ 256 (299)
T d1jpaa_ 181 DTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMT---NQDVINAI-EQDYRLPPPM 256 (299)
T ss_dssp ---------------CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCC---HHHHHHHH-HTTCCCCCCT
T ss_pred CCCCCEEEECCCCCCCCCCCCHHHHHCCCCCCCCCCCCCHHHHHHHHHCCCCCCCCCC---HHHHHHHH-HCCCCCCCCC
T ss_conf 7776536502566688300387888369978612144535789999867999999999---99999999-7378899974
Q ss_pred HHHHCCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHCCCCC
Q ss_conf 011066999999999999976168999999998899998548989
Q 004521 662 ACIQDSCNLADVIRCIHIGLLCVQQHPEDRPCMPSVILMLGSEIL 706 (747)
Q Consensus 662 ~~l~~~~~~~~~~~~~~l~~~Cl~~dP~~RPt~~~v~~~L~~~~~ 706 (747)
.....+.+++.+||+.||.+||+|.+|++.|+..+.
T Consensus 257 ---------~~~~~l~~li~~cl~~~P~~RPs~~ei~~~L~~~l~ 292 (299)
T d1jpaa_ 257 ---------DCPSALHQLMLDCWQKDRNHRPKFGQIVNTLDKMIR 292 (299)
T ss_dssp ---------TCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHH
T ss_pred ---------CCHHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHHC
T ss_conf ---------226999999999758797689299999999999841
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=334.57 Aligned_cols=251 Identities=29% Similarity=0.422 Sum_probs=196.2
Q ss_pred HHHCCCCCCCEECCCCCEEEEEEEECC-C-----CEEEEEEECC-CCCCCHHHHHHHHHHHHCC-CCCCEEEEEEEEEEC
Q ss_conf 972397855421424980099999669-8-----4999999134-3310689999999998305-997323377489949
Q 004521 437 NATDNFSINNKLGEGGFGPVYKGTLVD-G-----QEIAVKRLSK-ISEQGLKELKNEVILFSKL-QHRNLVKLLGCCIQG 508 (747)
Q Consensus 437 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~-g-----~~vavK~l~~-~~~~~~~~~~~E~~~l~~l-~H~nIv~l~g~~~~~ 508 (747)
...++|++.+.||+|+||+||+|+... + ..||+|.+.. ........+.+|+.++.++ +|||||++++++.+.
T Consensus 34 i~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~ 113 (325)
T d1rjba_ 34 FPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLS 113 (325)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred CCHHHEEEEEEEEECCCEEEEEEEECCCCCCCCEEEEEEEEECCCCCHHHHHHHHHHHHHHHHHCCCCCEEEEEEEEEEC
T ss_conf 77899397019830788199999985788554204999999663358789999999999999715899686877888629
Q ss_pred CEEEEEEECCCCCCHHHHHHHCCC--------------------CCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCC
Q ss_conf 822799950799994467631289--------------------876785678999999999999834159994673266
Q 004521 509 EEKLLIYEFMPNKSLDSFIFDQTR--------------------RTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDL 568 (747)
Q Consensus 509 ~~~~lV~e~~~~gsL~~~l~~~~~--------------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Di 568 (747)
+..++||||+++|+|.+++..... ...+++..++.++.|++.||+|||+.+ |+||||
T Consensus 114 ~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~~---IiHRDl 190 (325)
T d1rjba_ 114 GPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKS---CVHRDL 190 (325)
T ss_dssp SSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTT---EEETTC
T ss_pred CEEEEEEECCCCCCHHHHHHHCCCCCCCHHHHHCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCC---EEECCC
T ss_conf 95899997279995999998625777510221000012220012577899999999999999999997399---050527
Q ss_pred CCCCEEECCCCCCEEECCCCCCCCCCCCCCCCCCEEEECC---------CCCCCCCCCCHHHHHHHHHHHH-CCCCCCCC
Q ss_conf 7683798589994471256750038998754444021023---------7888844640237899999881-99899998
Q 004521 569 KASNVLLDQDMNPKISDFGLVRTFGGDETEGNTNRVVGTY---------DGQFSIKSDVFSFGILLLEIVS-GKKNRGFY 638 (747)
Q Consensus 569 kp~NIll~~~~~~ki~DfGla~~~~~~~~~~~~~~~~~~~---------~~~~s~~sDVwSlGvil~ellt-g~~p~~~~ 638 (747)
||+|||++.++.+||+|||+|+...............++. +..++.++|||||||++|||+| |+.||...
T Consensus 191 Kp~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwS~Gvil~emlt~g~~Pf~~~ 270 (325)
T d1rjba_ 191 AARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGI 270 (325)
T ss_dssp SGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTC
T ss_pred CHHCCCCCCCCEEEEEECCCCCCCCCCCCEEEECCCCCCCCCCCHHHHCCCCCCCCEECCCHHHHHHHHHHCCCCCCCCC
T ss_conf 03214434598289851422220457786156234357876578388727999963303000399999983899999998
Q ss_pred CCCCHHHHHHHHHHCCCCCCCCCHHHHCCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHC
Q ss_conf 8764022448677219865224301106699999999999997616899999999889999854
Q 004521 639 RSDTKVNLIGHLWDEGIPLRLIDACIQDSCNLADVIRCIHIGLLCVQQHPEDRPCMPSVILMLG 702 (747)
Q Consensus 639 ~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dP~~RPt~~~v~~~L~ 702 (747)
... ..+......+........ . ...+.+++.+||+.||++||||.+|+++|.
T Consensus 271 ~~~---~~~~~~~~~~~~~~~p~~-----~----~~~l~~li~~cl~~dP~~RPt~~ei~~~L~ 322 (325)
T d1rjba_ 271 PVD---ANFYKLIQNGFKMDQPFY-----A----TEEIYIIMQSCWAFDSRKRPSFPNLTSFLG 322 (325)
T ss_dssp CCS---HHHHHHHHTTCCCCCCTT-----C----CHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred CHH---HHHHHHHHCCCCCCCCCC-----C----CHHHHHHHHHHCCCCHHHCCCHHHHHHHHH
T ss_conf 989---999999856998998876-----7----899999999975889668939999999974
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=334.89 Aligned_cols=247 Identities=31% Similarity=0.488 Sum_probs=192.5
Q ss_pred HHCCCCCCCEECCCCCEEEEEEEECCCCEEEEEEECCCCCCCHHHHHHHHHHHHCCCCCCEEEEEEEEEECCEEEEEEEC
Q ss_conf 72397855421424980099999669849999991343310689999999998305997323377489949822799950
Q 004521 438 ATDNFSINNKLGEGGFGPVYKGTLVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEF 517 (747)
Q Consensus 438 ~~~~~~~~~~lg~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~e~ 517 (747)
..++|++.+.||+|+||.||+|.+.+++.||||+++. .....+.|.+|+.++++++|||||+++|++. .+..++||||
T Consensus 11 ~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~~~~-~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~-~~~~~iv~Ey 88 (272)
T d1qpca_ 11 PRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQ-GSMSPDAFLAEANLMKQLQHQRLVRLYAVVT-QEPIYIITEY 88 (272)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECT-TSSCHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSCEEEEEC
T ss_pred CHHHEEEEEEEECCCCCEEEEEEECCCCEEEEEEECC-CCCCHHHHHHHHHHHHHCCCCCEEEEEEEEC-CCCEEEEEEE
T ss_conf 8899388679810798289999999999999999864-7688899999999998679998857873104-5976999995
Q ss_pred CCCCCHHHHHHHCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCCEEECCCCCCCCCCCCC
Q ss_conf 79999446763128987678567899999999999983415999467326676837985899944712567500389987
Q 004521 518 MPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDET 597 (747)
Q Consensus 518 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dikp~NIll~~~~~~ki~DfGla~~~~~~~~ 597 (747)
+++|+|.+++.... ...+++..++.|+.|+++||.|||+.+ |+||||||+||||++++.+||+|||+|+.+.....
T Consensus 89 ~~~g~L~~~~~~~~-~~~l~~~~~~~i~~qi~~gl~~lH~~~---ivHrDiKp~NIll~~~~~~Kl~DFGla~~~~~~~~ 164 (272)
T d1qpca_ 89 MENGSLVDFLKTPS-GIKLTINKLLDMAAQIAEGMAFIEERN---YIHRDLRAANILVSDTLSCKIADFGLARLIEDNEY 164 (272)
T ss_dssp CTTCBHHHHTTSHH-HHTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCEECSSSCE
T ss_pred CCCCCHHHHHHHCC-CCCCCHHHHHHHHHHHHHHHHHHHHCC---CCCCCCCHHHEEEECCCCEEECCCCCEEECCCCCC
T ss_conf 78982888875147-898878899999999999999997489---54675642251562024404234101477358864
Q ss_pred CCCCCEEEEC---------CCCCCCCCCCCHHHHHHHHHHHHCCCCCCCCCCCCHHHHHHHHHHCCCCCCCCCHHHHCCC
Q ss_conf 5444402102---------3788884464023789999988199899998876402244867721986522430110669
Q 004521 598 EGNTNRVVGT---------YDGQFSIKSDVFSFGILLLEIVSGKKNRGFYRSDTKVNLIGHLWDEGIPLRLIDACIQDSC 668 (747)
Q Consensus 598 ~~~~~~~~~~---------~~~~~s~~sDVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~ 668 (747)
..... ..++ ....++.++|||||||++|||+||..|+. ...........+ ..+......+. .
T Consensus 165 ~~~~~-~~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt~~~~~~--~~~~~~~~~~~i-~~~~~~~~p~~-----~ 235 (272)
T d1qpca_ 165 TAREG-AKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPY--PGMTNPEVIQNL-ERGYRMVRPDN-----C 235 (272)
T ss_dssp ECCTT-CCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSS--TTCCHHHHHHHH-HTTCCCCCCTT-----C
T ss_pred CCCCC-CCCCCCCCCHHHHHCCCCCCHHHHHHHHHHHHHHHHCCCCCC--CCCCHHHHHHHH-HHCCCCCCCCC-----C
T ss_conf 42035-677444458289837999824564525799999996898888--888999999999-70688889655-----7
Q ss_pred CHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHCC
Q ss_conf 99999999999976168999999998899998548
Q 004521 669 NLADVIRCIHIGLLCVQQHPEDRPCMPSVILMLGS 703 (747)
Q Consensus 669 ~~~~~~~~~~l~~~Cl~~dP~~RPt~~~v~~~L~~ 703 (747)
...+.+++.+||+.||++||||.+|+++|+.
T Consensus 236 ----~~~l~~li~~cl~~~P~~Rpt~~ei~~~L~~ 266 (272)
T d1qpca_ 236 ----PEELYQLMRLCWKERPEDRPTFDYLRSVLED 266 (272)
T ss_dssp ----CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred ----HHHHHHHHHHHCCCCHHHCCCHHHHHHHHHH
T ss_conf ----1999999999758897689399999998611
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=327.36 Aligned_cols=240 Identities=23% Similarity=0.395 Sum_probs=191.8
Q ss_pred CCCCCCCEECCCCCEEEEEEEECC-CCEEEEEEECCCCCCCHHHHHHHHHHHHCCCCCCEEEEEEEEEECCEEEEEEECC
Q ss_conf 397855421424980099999669-8499999913433106899999999983059973233774899498227999507
Q 004521 440 DNFSINNKLGEGGFGPVYKGTLVD-GQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFM 518 (747)
Q Consensus 440 ~~~~~~~~lg~G~~g~Vy~~~~~~-g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~e~~ 518 (747)
++|++.++||+|+||+||+|.... ++.||||++........+.+.+|+.++++++||||+++++++...+..++||||+
T Consensus 20 ~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmEy~ 99 (293)
T d1yhwa1 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYL 99 (293)
T ss_dssp TTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred CCCEEEEEEECCCCCEEEEEEECCCCCEEEEEEEECCCCHHHHHHHHHHHHHHHCCCCCEEEEEEEEEECCEEEEEEEEC
T ss_conf 05388789812858299999998999899999984301727999999999998679998805857798899989999703
Q ss_pred CCCCHHHHHHHCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCCEEECCCCCCCCCCCCCC
Q ss_conf 99994467631289876785678999999999999834159994673266768379858999447125675003899875
Q 004521 519 PNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETE 598 (747)
Q Consensus 519 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dikp~NIll~~~~~~ki~DfGla~~~~~~~~~ 598 (747)
++|+|.+++.. ..+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+|+.+......
T Consensus 100 ~gg~L~~~~~~----~~l~~~~~~~i~~qi~~aL~yLH~~~---iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~~~~~ 172 (293)
T d1yhwa1 100 AGGSLTDVVTE----TCMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK 172 (293)
T ss_dssp TTCBHHHHHHH----SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECCSTTCC
T ss_pred CCCCHHHHHHC----CCCCHHHHHHHHHHHHHHHHHHHHCC---CCCCCCCHHHEEECCCCCEEECCCHHHEEECCCCCC
T ss_conf 79808988641----59999999999999999999999879---722677688868878996864251564132136664
Q ss_pred CCCCEEEEC---------CCCCCCCCCCCHHHHHHHHHHHHCCCCCCCCCCCCHHHHHHHHHHCCCCCCCCCHHHHCCCC
Q ss_conf 444402102---------37888844640237899999881998999988764022448677219865224301106699
Q 004521 599 GNTNRVVGT---------YDGQFSIKSDVFSFGILLLEIVSGKKNRGFYRSDTKVNLIGHLWDEGIPLRLIDACIQDSCN 669 (747)
Q Consensus 599 ~~~~~~~~~---------~~~~~s~~sDVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~ 669 (747)
.. ...|+ .+..++.++||||+||++|||++|+.||.... ....+......+.........+
T Consensus 173 ~~--~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~---~~~~~~~~~~~~~~~~~~~~~~----- 242 (293)
T d1yhwa1 173 RS--TMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNEN---PLRALYLIATNGTPELQNPEKL----- 242 (293)
T ss_dssp BC--CCCSCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHSSCTTTTSC---HHHHHHHHHHHCSCCCSSGGGS-----
T ss_pred CC--CCCCCCCCCCHHHHCCCCCCCHHCEEHHHHHHHHHHHCCCCCCCCC---HHHHHHHHHHCCCCCCCCCCCC-----
T ss_conf 44--4444777368266447998801203137299999804889989979---9999999985799988885537-----
Q ss_pred HHHHHHHHHHHHHCCCCCCCCCCCHHHHHH
Q ss_conf 999999999997616899999999889999
Q 004521 670 LADVIRCIHIGLLCVQQHPEDRPCMPSVIL 699 (747)
Q Consensus 670 ~~~~~~~~~l~~~Cl~~dP~~RPt~~~v~~ 699 (747)
...+.+++.+||+.||.+|||+.|+++
T Consensus 243 ---s~~~~~li~~~L~~dP~~R~s~~eil~ 269 (293)
T d1yhwa1 243 ---SAIFRDFLNRCLDMDVEKRGSAKELLQ 269 (293)
T ss_dssp ---CHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred ---CHHHHHHHHHHCCCCHHHCCCHHHHHC
T ss_conf ---999999999986699668909999964
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=329.97 Aligned_cols=244 Identities=25% Similarity=0.327 Sum_probs=188.8
Q ss_pred HCCCCCCCEECCCCCEEEEEEEECC-CCEEEEEEECCC-CCCCHHHHHHHHHHHHCCCCCCEEEEEEEEEECCEEEEEEE
Q ss_conf 2397855421424980099999669-849999991343-31068999999999830599732337748994982279995
Q 004521 439 TDNFSINNKLGEGGFGPVYKGTLVD-GQEIAVKRLSKI-SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYE 516 (747)
Q Consensus 439 ~~~~~~~~~lg~G~~g~Vy~~~~~~-g~~vavK~l~~~-~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~e 516 (747)
.++|++.+.||+|+||+||+|+... ++.||||++... ..+..+.+.+|+.++++++||||+++++++.+.+..++|||
T Consensus 4 ~~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~~~ivmE 83 (271)
T d1nvra_ 4 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLE 83 (271)
T ss_dssp TTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred CCCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEEEHHHCCHHHHHHHHHHHHHHHCCCCCEEEEEEEECCCCEEEEEEE
T ss_conf 74608998972174809999999999979999998456641279999999999985799888469654046743679886
Q ss_pred CCCCCCHHHHHHHCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCCEEECCCCCCCCCCCC
Q ss_conf 07999944676312898767856789999999999998341599946732667683798589994471256750038998
Q 004521 517 FMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDE 596 (747)
Q Consensus 517 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dikp~NIll~~~~~~ki~DfGla~~~~~~~ 596 (747)
|+++|+|.+++.. ...+++..+..++.|++.||+|||+.+ |+||||||+|||+++++.+||+|||+|+......
T Consensus 84 y~~gg~L~~~l~~---~~~l~e~~~~~i~~qi~~al~ylH~~~---IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~~~~ 157 (271)
T d1nvra_ 84 YCSGGELFDRIEP---DIGMPEPDAQRFFHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNN 157 (271)
T ss_dssp CCTTEEGGGGSBT---TTBCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTCCEEECCCTTCEECEETT
T ss_pred CCCCCCHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHCC---CCCCCCCHHHEEECCCCCEEECCCHHHEEECCCC
T ss_conf 4589808999753---799999999999999999999999759---8357546899788789987983231422404688
Q ss_pred CCCCCCEEEECC---------CCCC-CCCCCCHHHHHHHHHHHHCCCCCCCCCCCCHHHHHHHHHHCCCCCCCCCHHHHC
Q ss_conf 754444021023---------7888-844640237899999881998999988764022448677219865224301106
Q 004521 597 TEGNTNRVVGTY---------DGQF-SIKSDVFSFGILLLEIVSGKKNRGFYRSDTKVNLIGHLWDEGIPLRLIDACIQD 666 (747)
Q Consensus 597 ~~~~~~~~~~~~---------~~~~-s~~sDVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 666 (747)
.........||. +..+ +.++||||+||++|||++|+.||....... .............. ....
T Consensus 158 ~~~~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~--~~~~~~~~~~~~~~-~~~~--- 231 (271)
T d1nvra_ 158 RERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSC--QEYSDWKEKKTYLN-PWKK--- 231 (271)
T ss_dssp EECCBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTS--HHHHHHHTTCTTST-TGGG---
T ss_pred CCCCCCCEEECCCCCCHHHHCCCCCCCCCEEEEHHHHHHHHHHHCCCCCCCCCHHH--HHHHHHHCCCCCCC-CCCC---
T ss_conf 65311132557474287286189999971016173799999982997888898599--99999863888788-6446---
Q ss_pred CCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHH
Q ss_conf 699999999999997616899999999889999
Q 004521 667 SCNLADVIRCIHIGLLCVQQHPEDRPCMPSVIL 699 (747)
Q Consensus 667 ~~~~~~~~~~~~l~~~Cl~~dP~~RPt~~~v~~ 699 (747)
.+ ..+.+++.+||+.||.+|||+.++++
T Consensus 232 -~s----~~~~~li~~~L~~dP~~R~t~~eil~ 259 (271)
T d1nvra_ 232 -ID----SAPLALLHKILVENPSARITIPDIKK 259 (271)
T ss_dssp -SC----HHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred -CC----HHHHHHHHHHCCCCHHHCCCHHHHHC
T ss_conf -99----99999999976799668909999961
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=325.97 Aligned_cols=245 Identities=26% Similarity=0.420 Sum_probs=196.5
Q ss_pred HCCCCCCCEECCCCCEEEEEEEECCCCEEEEEEECCCCCCCHHHHHHHHHHHHCCCCCCEEEEEEEEEECCEEEEEEECC
Q ss_conf 23978554214249800999996698499999913433106899999999983059973233774899498227999507
Q 004521 439 TDNFSINNKLGEGGFGPVYKGTLVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFM 518 (747)
Q Consensus 439 ~~~~~~~~~lg~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~e~~ 518 (747)
.++|++.++||+|+||+||+|++++++.||||.++. .....++|++|+.++++++||||++++|++.+++..++||||+
T Consensus 3 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~l~~-~~~~~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~~~iv~Ey~ 81 (258)
T d1k2pa_ 3 PKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKE-GSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYM 81 (258)
T ss_dssp CCCCCCCCCCCEETTEEEEEEEETTTEEEEEEEEES-SSSCHHHHHHHHHHHHTCCCTTBCCEEEEECCSSSEEEEEECC
T ss_pred HHHCEEEEEEECCCCEEEEEEEECCCCEEEEEEECC-CCCCHHHHHHHHHHHHHCCCCCEEEEEEEEEECCCEEEEEECC
T ss_conf 699799689820788399999988998999999874-7577899999999999668986015889985078169999704
Q ss_pred CCCCHHHHHHHCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCCEEECCCCCCCCCCCCCC
Q ss_conf 99994467631289876785678999999999999834159994673266768379858999447125675003899875
Q 004521 519 PNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETE 598 (747)
Q Consensus 519 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dikp~NIll~~~~~~ki~DfGla~~~~~~~~~ 598 (747)
++|+|..++... ...+++..+++++.|+++||.|||+.+ |+||||||+||++++++.+||+|||+++.+......
T Consensus 82 ~~g~l~~~~~~~--~~~~~~~~~~~i~~qi~~gl~~LH~~~---iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~~ 156 (258)
T d1k2pa_ 82 ANGCLLNYLREM--RHRFQTQQLLEMCKDVCEAMEYLESKQ---FLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYT 156 (258)
T ss_dssp TTEEHHHHHHSG--GGCCCHHHHHHHHHHHHHHHHHHHHTT---BCCSCCSGGGEEECTTCCEEECCCSSCCBCSSSSCC
T ss_pred CCCCHHHHHHCC--CCCCCHHHHHHHHHHHHHHHHHHHHCC---CCCCCCCCEEEEECCCCCEEECCCHHHEECCCCCCE
T ss_conf 899388864102--467768999999999999999875468---434665413588769984798861442023578722
Q ss_pred CCCCEEEEC---------CCCCCCCCCCCHHHHHHHHHHHH-CCCCCCCCCCCCHHHHHHHHHHCCCCCCCCCHHHHCCC
Q ss_conf 444402102---------37888844640237899999881-99899998876402244867721986522430110669
Q 004521 599 GNTNRVVGT---------YDGQFSIKSDVFSFGILLLEIVS-GKKNRGFYRSDTKVNLIGHLWDEGIPLRLIDACIQDSC 668 (747)
Q Consensus 599 ~~~~~~~~~---------~~~~~s~~sDVwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~ 668 (747)
.... ..++ .+..++.++||||||+++|||+| |+.||.... ..+....+ ..+....... ..
T Consensus 157 ~~~~-~~~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~---~~~~~~~i-~~~~~~~~p~-----~~ 226 (258)
T d1k2pa_ 157 SSVG-SKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFT---NSETAEHI-AQGLRLYRPH-----LA 226 (258)
T ss_dssp CCCC-SCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSC---HHHHHHHH-HTTCCCCCCT-----TC
T ss_pred EECC-CCCCCCCCCCHHHCCCCCCCCEEECCCCHHHHHHHHCCCCCCCCCC---HHHHHHHH-HHCCCCCCCC-----CC
T ss_conf 5246-5788775780786379988521033643246739755999988999---99999999-8079789965-----46
Q ss_pred CHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHCC
Q ss_conf 99999999999976168999999998899998548
Q 004521 669 NLADVIRCIHIGLLCVQQHPEDRPCMPSVILMLGS 703 (747)
Q Consensus 669 ~~~~~~~~~~l~~~Cl~~dP~~RPt~~~v~~~L~~ 703 (747)
+ ..+.+++.+||+.||++|||+.+|++.|..
T Consensus 227 ~----~~l~~li~~cl~~dP~~RPt~~eil~~L~d 257 (258)
T d1k2pa_ 227 S----EKVYTIMYSCWHEKADERPTFKILLSNILD 257 (258)
T ss_dssp C----HHHHHHHHHTTCSSGGGSCCHHHHHHHHHC
T ss_pred C----HHHHHHHHHHCCCCHHHCCCHHHHHHHHHC
T ss_conf 5----999999999766897689399999987418
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=0 Score=331.64 Aligned_cols=258 Identities=26% Similarity=0.434 Sum_probs=200.0
Q ss_pred HHHHHHHHCCCCCCCEECCCCCEEEEEEEEC------CCCEEEEEEECCC-CCCCHHHHHHHHHHHHCCCCCCEEEEEEE
Q ss_conf 8889997239785542142498009999966------9849999991343-31068999999999830599732337748
Q 004521 432 LATIANATDNFSINNKLGEGGFGPVYKGTLV------DGQEIAVKRLSKI-SEQGLKELKNEVILFSKLQHRNLVKLLGC 504 (747)
Q Consensus 432 ~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~------~g~~vavK~l~~~-~~~~~~~~~~E~~~l~~l~H~nIv~l~g~ 504 (747)
+.+++...++|++.+.||+|+||+||+|+.. +++.||||++... ..+..++|.+|+.++++++||||++++++
T Consensus 5 ~~~~e~p~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~ 84 (301)
T d1lufa_ 5 LLSLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGV 84 (301)
T ss_dssp HHHTBCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEE
T ss_pred HHHCCCCHHHCEEEEEEEECCCEEEEEEEECCCCCCCCCEEEEEEEECHHCCHHHHHHHHHHHHHHHHCCCCCCCCCEEE
T ss_conf 33113898893886798207883999999888765778829999998821085799999999999996689976552466
Q ss_pred EEECCEEEEEEECCCCCCHHHHHHHCCC---------------------CCCCCHHHHHHHHHHHHHHHHHHHHCCCCCE
Q ss_conf 9949822799950799994467631289---------------------8767856789999999999998341599946
Q 004521 505 CIQGEEKLLIYEFMPNKSLDSFIFDQTR---------------------RTLLDWSQRFHIICGTARGLLYLHQDSRLRI 563 (747)
Q Consensus 505 ~~~~~~~~lV~e~~~~gsL~~~l~~~~~---------------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~i 563 (747)
+......++|+||+++|+|.+++..... ...+++..++.++.|++.||+|||+.+ +
T Consensus 85 ~~~~~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~~---i 161 (301)
T d1lufa_ 85 CAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERK---F 161 (301)
T ss_dssp ECSSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTT---C
T ss_pred ECCCCCEEEEEEECCCCCHHHHHHHCCCCCCCCCCCCCCCHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHCCCCC---E
T ss_conf 6059803899981589929999985275542100001110012103467889899999999999999855413578---6
Q ss_pred EECCCCCCCEEECCCCCCEEECCCCCCCCCCCCCCCCCCEEEEC---------CCCCCCCCCCCHHHHHHHHHHHHCCC-
Q ss_conf 73266768379858999447125675003899875444402102---------37888844640237899999881998-
Q 004521 564 IHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNTNRVVGT---------YDGQFSIKSDVFSFGILLLEIVSGKK- 633 (747)
Q Consensus 564 iH~Dikp~NIll~~~~~~ki~DfGla~~~~~~~~~~~~~~~~~~---------~~~~~s~~sDVwSlGvil~elltg~~- 633 (747)
+||||||+|||++.++.+||+|||+|+.+.............++ .+..++.++|||||||++|||+++..
T Consensus 162 vHrDlKp~NILld~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~t~ksDVwS~Gvvl~ell~~~~~ 241 (301)
T d1lufa_ 162 VHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQ 241 (301)
T ss_dssp CCSCCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCC
T ss_pred EEEEECCCCEEECCCCCEEECCCHHHEECCCCCCCCCCCCCCCCCCCCCHHHHCCCCCCHHHHHCCCHHHHHHHHCCCCC
T ss_conf 85488401168989992898331442113677641115777767676798997268898056302523629999806899
Q ss_pred CCCCCCCCCHHHHHHHHHHCCCCCCCCCHHHHCCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHCCCC
Q ss_conf 999988764022448677219865224301106699999999999997616899999999889999854898
Q 004521 634 NRGFYRSDTKVNLIGHLWDEGIPLRLIDACIQDSCNLADVIRCIHIGLLCVQQHPEDRPCMPSVILMLGSEI 705 (747)
Q Consensus 634 p~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dP~~RPt~~~v~~~L~~~~ 705 (747)
|+. .....+....+ ..+......+. .+ .++.+++.+||+.||.+||||.+|+++|+...
T Consensus 242 p~~---~~~~~e~~~~v-~~~~~~~~p~~-----~~----~~~~~li~~cl~~~P~~RPt~~ev~~~L~~i~ 300 (301)
T d1lufa_ 242 PYY---GMAHEEVIYYV-RDGNILACPEN-----CP----LELYNLMRLCWSKLPADRPSFCSIHRILQRMC 300 (301)
T ss_dssp TTT---TSCHHHHHHHH-HTTCCCCCCTT-----CC----HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTT
T ss_pred CCC---CCCHHHHHHHH-HCCCCCCCCCC-----CH----HHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHC
T ss_conf 999---98999999999-73997888732-----52----99999999974889657939999999999842
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=327.67 Aligned_cols=246 Identities=27% Similarity=0.425 Sum_probs=191.1
Q ss_pred CCCCCCC-EECCCCCEEEEEEEECC---CCEEEEEEECCC-CCCCHHHHHHHHHHHHCCCCCCEEEEEEEEEECCEEEEE
Q ss_conf 3978554-21424980099999669---849999991343-310689999999998305997323377489949822799
Q 004521 440 DNFSINN-KLGEGGFGPVYKGTLVD---GQEIAVKRLSKI-SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLI 514 (747)
Q Consensus 440 ~~~~~~~-~lg~G~~g~Vy~~~~~~---g~~vavK~l~~~-~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV 514 (747)
++|.+.+ +||+|+||.||+|.+.. +..||||.++.. .....++|.+|++++++++|||||+++|++.. +..++|
T Consensus 8 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~-~~~~lv 86 (285)
T d1u59a_ 8 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLV 86 (285)
T ss_dssp GGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEE
T ss_pred CCEEECCCEEECCCCEEEEEEEEECCCCCEEEEEEEECHHCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEECC-CEEEEE
T ss_conf 4718878487306080999999960897689999998820397899999999999986799888068656036-807999
Q ss_pred EECCCCCCHHHHHHHCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCCEEECCCCCCCCCC
Q ss_conf 95079999446763128987678567899999999999983415999467326676837985899944712567500389
Q 004521 515 YEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGG 594 (747)
Q Consensus 515 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dikp~NIll~~~~~~ki~DfGla~~~~~ 594 (747)
|||+++|+|.+++.. .+..+++..+..++.|++.||+|||+.+ ++||||||+|||++.++.+||+|||+|+.+..
T Consensus 87 mE~~~~g~L~~~l~~--~~~~l~~~~~~~i~~qi~~gL~ylH~~~---iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~ 161 (285)
T d1u59a_ 87 MEMAGGGPLHKFLVG--KREEIPVSNVAELLHQVSMGMKYLEEKN---FVHRDLAARNVLLVNRHYAKISDFGLSKALGA 161 (285)
T ss_dssp EECCTTEEHHHHHTT--CTTTSCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEEETTEEEECCCTTCEECTT
T ss_pred EEECCCCCHHHHHHC--CCCCCCHHHHHHHHHHHHHHHHHHHHCC---EECCCCCHHHEEECCCCCEEECCCHHHHCCCC
T ss_conf 980789968997521--2569999999999999999878998688---10576764660454688542033134211554
Q ss_pred CCCCCCC-CEEEEC---------CCCCCCCCCCCHHHHHHHHHHHH-CCCCCCCCCCCCHHHHHHHHHHCCCCCCCCCHH
Q ss_conf 9875444-402102---------37888844640237899999881-998999988764022448677219865224301
Q 004521 595 DETEGNT-NRVVGT---------YDGQFSIKSDVFSFGILLLEIVS-GKKNRGFYRSDTKVNLIGHLWDEGIPLRLIDAC 663 (747)
Q Consensus 595 ~~~~~~~-~~~~~~---------~~~~~s~~sDVwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 663 (747)
....... ....++ ....++.++|||||||++|||+| |+.||..... .+.... ...+........
T Consensus 162 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~---~~~~~~-i~~~~~~~~p~~- 236 (285)
T d1u59a_ 162 DDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKG---PEVMAF-IEQGKRMECPPE- 236 (285)
T ss_dssp CSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCT---HHHHHH-HHTTCCCCCCTT-
T ss_pred CCCCCCCCCCCCCCCCCCCHHHHHCCCCCCCCHHHCCHHHHHHHHHCCCCCCCCCCH---HHHHHH-HHCCCCCCCCCC-
T ss_conf 343211356211374335868872799995412322017899999389999999799---999999-981899999976-
Q ss_pred HHCCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHCCC
Q ss_conf 10669999999999999761689999999988999985489
Q 004521 664 IQDSCNLADVIRCIHIGLLCVQQHPEDRPCMPSVILMLGSE 704 (747)
Q Consensus 664 l~~~~~~~~~~~~~~l~~~Cl~~dP~~RPt~~~v~~~L~~~ 704 (747)
.+ ..+.+++.+||+.||++||+|.+|++.|+..
T Consensus 237 ----~~----~~l~~li~~cl~~~p~~RPs~~~i~~~L~~~ 269 (285)
T d1u59a_ 237 ----CP----PELYALMSDCWIYKWEDRPDFLTVEQRMRAC 269 (285)
T ss_dssp ----CC----HHHHHHHHHTTCSSGGGSCCHHHHHHHHHHH
T ss_pred ----CC----HHHHHHHHHHCCCCHHHCCCHHHHHHHHHHH
T ss_conf ----78----9999999997577976890999999999999
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=328.46 Aligned_cols=244 Identities=25% Similarity=0.340 Sum_probs=190.8
Q ss_pred CCCCCCCEECCCCCEEEEEEEECC-CCEEEEEEECCCCCCCHHHHHHHHHHHHCCCCCCEEEEEEEEEECCEEEEEEECC
Q ss_conf 397855421424980099999669-8499999913433106899999999983059973233774899498227999507
Q 004521 440 DNFSINNKLGEGGFGPVYKGTLVD-GQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFM 518 (747)
Q Consensus 440 ~~~~~~~~lg~G~~g~Vy~~~~~~-g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~e~~ 518 (747)
+.|++.+.||+|+||.||+|+... ++.||||++........+.+.+|++++++++||||+++++++.+.+..++||||+
T Consensus 12 d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lvmEy~ 91 (288)
T d2jfla1 12 DFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFC 91 (288)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSSSGGGGGTHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred CCEEEEEEEEECCCCEEEEEEECCCCEEEEEEEECCCCHHHHHHHHHHHHHHHHCCCCCCCEEEEEEEECCEEEEEEECC
T ss_conf 37598479930778199999999999399999987289999999999999998679999884988980099589999627
Q ss_pred CCCCHHHHHHHCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCCEEECCCCCCCCCCCCC-
Q ss_conf 9999446763128987678567899999999999983415999467326676837985899944712567500389987-
Q 004521 519 PNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDET- 597 (747)
Q Consensus 519 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dikp~NIll~~~~~~ki~DfGla~~~~~~~~- 597 (747)
++|+|.+++.+.. ..+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+|+.......
T Consensus 92 ~~g~L~~~~~~~~--~~l~e~~~~~i~~qi~~gL~ylH~~~---ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~~~~~ 166 (288)
T d2jfla1 92 AGGAVDAVMLELE--RPLTESQIQVVCKQTLDALNYLHDNK---IIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQR 166 (288)
T ss_dssp TTEEHHHHHHHHT--SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECHHHHHH
T ss_pred CCCCHHHHHHHCC--CCCCHHHHHHHHHHHHHHHHHHHHCC---EEEEECCHHHEEECCCCCEEEEECHHHHCCCCCCCC
T ss_conf 9981889998628--99999999999999999999999889---887140700314878999899716123035778641
Q ss_pred ---------CCCCCEEEE--CCCCCCCCCCCCHHHHHHHHHHHHCCCCCCCCCCCCHHHHHHHHHHCCCCCCCCCHHHHC
Q ss_conf ---------544440210--237888844640237899999881998999988764022448677219865224301106
Q 004521 598 ---------EGNTNRVVG--TYDGQFSIKSDVFSFGILLLEIVSGKKNRGFYRSDTKVNLIGHLWDEGIPLRLIDACIQD 666 (747)
Q Consensus 598 ---------~~~~~~~~~--~~~~~~s~~sDVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 666 (747)
...++...+ .....|+.++|||||||++|||++|+.||..... ...+........ ..+..+.
T Consensus 167 ~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~---~~~~~~i~~~~~-~~~~~~~--- 239 (288)
T d2jfla1 167 RDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNP---MRVLLKIAKSEP-PTLAQPS--- 239 (288)
T ss_dssp HTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCG---GGHHHHHHHSCC-CCCSSGG---
T ss_pred CCCCCCCCCCCCHHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHHCCCCCCCCCH---HHHHHHHHCCCC-CCCCCCC---
T ss_conf 001025626479999832025788888066578789999998208899999899---999999970799-8777656---
Q ss_pred CCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHH
Q ss_conf 699999999999997616899999999889999
Q 004521 667 SCNLADVIRCIHIGLLCVQQHPEDRPCMPSVIL 699 (747)
Q Consensus 667 ~~~~~~~~~~~~l~~~Cl~~dP~~RPt~~~v~~ 699 (747)
.. ...+.+++.+||+.||.+|||+.|+++
T Consensus 240 ~~----s~~~~~li~~~L~~dp~~R~t~~ell~ 268 (288)
T d2jfla1 240 RW----SSNFKDFLKKCLEKNVDARWTTSQLLQ 268 (288)
T ss_dssp GS----CHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred CC----CHHHHHHHHHHCCCCHHHCCCHHHHHC
T ss_conf 69----999999999976699668919999962
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=328.17 Aligned_cols=249 Identities=27% Similarity=0.447 Sum_probs=195.9
Q ss_pred HCCCCCCCEECCCCCEEEEEEEECCCCEEEEEEECCCCCCCHHHHHHHHHHHHCCCCCCEEEEEEEEEECCEEEEEEECC
Q ss_conf 23978554214249800999996698499999913433106899999999983059973233774899498227999507
Q 004521 439 TDNFSINNKLGEGGFGPVYKGTLVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFM 518 (747)
Q Consensus 439 ~~~~~~~~~lg~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~e~~ 518 (747)
.++|++.+.||+|+||+||+|++.+++.||||+++. .....+.|.+|+.++++++|+|||+++|++. .+..++||||+
T Consensus 16 ~~~~~i~~~iG~G~fg~Vy~~~~~~~~~vAiK~l~~-~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~-~~~~~lv~Ey~ 93 (285)
T d1fmka3 16 RESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKP-GTMSPEAFLQEAQVMKKLRHEKLVQLYAVVS-EEPIYIVTEYM 93 (285)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCT-TSSCHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSCEEEECCC
T ss_pred HHHEEEEEEEEECCCEEEEEEEECCCCEEEEEEECC-CCCCHHHHHHHHHHHHHCCCCCEEEEEEEEE-CCCEEEEEEEC
T ss_conf 799798469930798099999999999999999880-4488899999999998666678868999982-39759999944
Q ss_pred CCCCHHHHHHHCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCCEEECCCCCCCCCCCCCC
Q ss_conf 99994467631289876785678999999999999834159994673266768379858999447125675003899875
Q 004521 519 PNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETE 598 (747)
Q Consensus 519 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dikp~NIll~~~~~~ki~DfGla~~~~~~~~~ 598 (747)
++|+|..++.... ...+++..++.++.|++.||.|||+.+ ++||||||+||||+.++.+||+|||+|+........
T Consensus 94 ~~g~l~~~~~~~~-~~~l~~~~~~~i~~~i~~gl~~LH~~~---ivH~DlKp~NIll~~~~~~kl~DfGla~~~~~~~~~ 169 (285)
T d1fmka3 94 SKGSLLDFLKGET-GKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYT 169 (285)
T ss_dssp TTCBHHHHHSHHH-HTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCCTTC--------
T ss_pred CCCCHHHHHHHCC-CCCCHHHHHHHHHHHHHHHHHHHHHHH---EECCCCCCEEEEECCCCCEEECCCCHHHHCCCCCCE
T ss_conf 7994354200003-553059999999999999999875411---433531230799989992998442555425688733
Q ss_pred CCCCEEEEC---------CCCCCCCCCCCHHHHHHHHHHHHCCCCCCCCCCCCHHHHHHHHHHCCCCCCCCCHHHHCCCC
Q ss_conf 444402102---------37888844640237899999881998999988764022448677219865224301106699
Q 004521 599 GNTNRVVGT---------YDGQFSIKSDVFSFGILLLEIVSGKKNRGFYRSDTKVNLIGHLWDEGIPLRLIDACIQDSCN 669 (747)
Q Consensus 599 ~~~~~~~~~---------~~~~~s~~sDVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~ 669 (747)
... ...++ ..+.++.++||||||+++|||++|..|+.. .......+..+ ..+....... ..
T Consensus 170 ~~~-~~~gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t~~~p~~~--~~~~~~~~~~i-~~~~~~~~~~-----~~- 239 (285)
T d1fmka3 170 ARQ-GAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYP--GMVNREVLDQV-ERGYRMPCPP-----EC- 239 (285)
T ss_dssp -------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSST--TCCHHHHHHHH-HTTCCCCCCT-----TS-
T ss_pred EEC-CCCCCCCCCCHHHHHCCCCCCHHHHHCCHHHHHHHHHCCCCCCC--CCCHHHHHHHH-HHCCCCCCCC-----CC-
T ss_conf 524-54556654580898379989177413235899999868999998--88899999999-8268999983-----23-
Q ss_pred HHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHCCCCC
Q ss_conf 9999999999976168999999998899998548989
Q 004521 670 LADVIRCIHIGLLCVQQHPEDRPCMPSVILMLGSEIL 706 (747)
Q Consensus 670 ~~~~~~~~~l~~~Cl~~dP~~RPt~~~v~~~L~~~~~ 706 (747)
...+.+++.+||+.||++||+|.+|+++|+....
T Consensus 240 ---~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~~~~ 273 (285)
T d1fmka3 240 ---PESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFT 273 (285)
T ss_dssp ---CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTS
T ss_pred ---CHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHHC
T ss_conf ---7999999999756697589199999998766623
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=328.19 Aligned_cols=252 Identities=26% Similarity=0.395 Sum_probs=195.3
Q ss_pred HCCCCCCCEECCCCCEEEEEEEECCC-----CEEEEEEECCC-CCCCHHHHHHHHHHHHCCCCCCEEEEEEEEEECCEEE
Q ss_conf 23978554214249800999996698-----49999991343-3106899999999983059973233774899498227
Q 004521 439 TDNFSINNKLGEGGFGPVYKGTLVDG-----QEIAVKRLSKI-SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKL 512 (747)
Q Consensus 439 ~~~~~~~~~lg~G~~g~Vy~~~~~~g-----~~vavK~l~~~-~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~ 512 (747)
.+.|++.+.||+|+||.||+|.+... ..||||++... ......+|.+|+.++++++|||||+++|++.+....+
T Consensus 6 ~~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~~~~~ 85 (283)
T d1mqba_ 6 PSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMM 85 (283)
T ss_dssp TTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEE
T ss_pred HHHEEEEEEEEECCCEEEEEEEEECCCCEEEEEEEEEEECCCCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEECCCCEE
T ss_conf 89968615981177909999999689987879999999884459689999999999998568987832367783388038
Q ss_pred EEEECCCCCCHHHHHHHCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCCEEECCCCCCCC
Q ss_conf 99950799994467631289876785678999999999999834159994673266768379858999447125675003
Q 004521 513 LIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTF 592 (747)
Q Consensus 513 lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dikp~NIll~~~~~~ki~DfGla~~~ 592 (747)
+|+||+.+++|.+++... ...+++..+..++.|++.||+|||+.+ |+||||||+||||+.++.+||+|||+++.+
T Consensus 86 ~v~e~~~~~~l~~~~~~~--~~~~~~~~~~~i~~~i~~gl~~lH~~~---iiHrDlKp~NILl~~~~~~Kl~DFGla~~~ 160 (283)
T d1mqba_ 86 IITEYMENGALDKFLREK--DGEFSVLQLVGMLRGIAAGMKYLANMN---YVHRDLAARNILVNSNLVCKVSDFGLSRVL 160 (283)
T ss_dssp EEEECCTTEEHHHHHHHT--TTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCCCC----
T ss_pred EEEEECCCCCCHHHHHCC--CCCCCHHHHHHHHHHHHHHHHHCCCCC---CCCCCCCCCEEEECCCCEEEECCCCHHHCC
T ss_conf 999721357402221023--454208999999999998541212123---425765644278889984998455103003
Q ss_pred CCCCCCCCC-CEEEEC---------CCCCCCCCCCCHHHHHHHHHHHHCCCCCCCCCCCCHHHHHHHHHHCCCCCCCCCH
Q ss_conf 899875444-402102---------3788884464023789999988199899998876402244867721986522430
Q 004521 593 GGDETEGNT-NRVVGT---------YDGQFSIKSDVFSFGILLLEIVSGKKNRGFYRSDTKVNLIGHLWDEGIPLRLIDA 662 (747)
Q Consensus 593 ~~~~~~~~~-~~~~~~---------~~~~~s~~sDVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 662 (747)
......... ....++ .+..++.++|||||||++|||+++..|+... ......... ...+........
T Consensus 161 ~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~t~~~~~~~~--~~~~~~~~~-i~~~~~~~~~~~ 237 (283)
T d1mqba_ 161 EDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWE--LSNHEVMKA-INDGFRLPTPMD 237 (283)
T ss_dssp -------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTT--CCHHHHHHH-HHTTCCCCCCTT
T ss_pred CCCCCCCEEECCCCCCCCCCCHHHHCCCCCCCCCCCCCCHHHHHHHHHCCCCCCCC--CCHHHHHHH-HHCCCCCCCCHH
T ss_conf 57876526742677773434888870499997355634489899999679886556--899999999-863578998504
Q ss_pred HHHCCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHCCCCCC
Q ss_conf 110669999999999999761689999999988999985489899
Q 004521 663 CIQDSCNLADVIRCIHIGLLCVQQHPEDRPCMPSVILMLGSEILL 707 (747)
Q Consensus 663 ~l~~~~~~~~~~~~~~l~~~Cl~~dP~~RPt~~~v~~~L~~~~~~ 707 (747)
....+.+++.+||+.||++||+|.+|+++|+.....
T Consensus 238 ---------~~~~l~~li~~cl~~~p~~RPt~~eil~~L~~l~~~ 273 (283)
T d1mqba_ 238 ---------CPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRA 273 (283)
T ss_dssp ---------CBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHS
T ss_pred ---------HHHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHHHC
T ss_conf ---------579999999997767976893999999999998669
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=100.00 E-value=0 Score=323.37 Aligned_cols=247 Identities=21% Similarity=0.261 Sum_probs=193.7
Q ss_pred HCCCCCCCEECCCCCEEEEEEEEC-CCCEEEEEEECCCCCCCHHHHHHHHHHHHCCCCCCEEEEEEEEEECCEEEEEEEC
Q ss_conf 239785542142498009999966-9849999991343310689999999998305997323377489949822799950
Q 004521 439 TDNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEF 517 (747)
Q Consensus 439 ~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~e~ 517 (747)
.++|++.+.||+|+||.||+|+.. +++.||||++..........+.+|+.++++++||||+++++++.+.+..++||||
T Consensus 28 ~d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivmE~ 107 (352)
T d1koba_ 28 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEF 107 (352)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEEC
T ss_pred CCCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEECCCCHHHHHHHHHHHHHHHHCCCCCCCCEEEEEEECCEEEEEEEC
T ss_conf 40359989993177829999999899979999998872646799999999999867997989199999989999999982
Q ss_pred CCCCCHHHHHHHCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEEC--CCCCCEEECCCCCCCCCCC
Q ss_conf 79999446763128987678567899999999999983415999467326676837985--8999447125675003899
Q 004521 518 MPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLD--QDMNPKISDFGLVRTFGGD 595 (747)
Q Consensus 518 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dikp~NIll~--~~~~~ki~DfGla~~~~~~ 595 (747)
+++|+|.+++.. ....+++..+..++.||+.||.|||+.+ |+||||||+|||++ .++.+||+|||+|+.+...
T Consensus 108 ~~gg~L~~~~~~--~~~~l~e~~~~~i~~qi~~aL~ylH~~~---iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~~~~ 182 (352)
T d1koba_ 108 LSGGELFDRIAA--EDYKMSEAEVINYMRQACEGLKHMHEHS---IVHLDIKPENIMCETKKASSVKIIDFGLATKLNPD 182 (352)
T ss_dssp CCCCBHHHHTTC--TTCCBCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSTTCCCEEECCCTTCEECCTT
T ss_pred CCCCHHHHHHHH--CCCCCCHHHHHHHHHHHHHHHHHHHHCC---EEECCCCCCCCCCCCCCCCEEEEEECCCCEECCCC
T ss_conf 899808888986--3899899999999999999999999779---26513144553113467884899525630343788
Q ss_pred CCCCCCCEEEEC---------CCCCCCCCCCCHHHHHHHHHHHHCCCCCCCCCCCCHHHHHHHHHHCCCC-CCCCCHHHH
Q ss_conf 875444402102---------3788884464023789999988199899998876402244867721986-522430110
Q 004521 596 ETEGNTNRVVGT---------YDGQFSIKSDVFSFGILLLEIVSGKKNRGFYRSDTKVNLIGHLWDEGIP-LRLIDACIQ 665 (747)
Q Consensus 596 ~~~~~~~~~~~~---------~~~~~s~~sDVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~-~~~~d~~l~ 665 (747)
..... ..++ .+..++.++||||+||++|||++|+.||... .....+..+...... .....
T Consensus 183 ~~~~~---~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~---~~~~~~~~i~~~~~~~~~~~~---- 252 (352)
T d1koba_ 183 EIVKV---TTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGE---DDLETLQNVKRCDWEFDEDAF---- 252 (352)
T ss_dssp SCEEE---ECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCS---SHHHHHHHHHHCCCCCCSSTT----
T ss_pred CCEEE---CCCCCCCCCHHHHCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCC---CHHHHHHHHHHCCCCCCCCCC----
T ss_conf 72010---04764534899974799897633389899999999688998997---999999999847889893002----
Q ss_pred CCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHH--HCCC
Q ss_conf 66999999999999976168999999998899998--5489
Q 004521 666 DSCNLADVIRCIHIGLLCVQQHPEDRPCMPSVILM--LGSE 704 (747)
Q Consensus 666 ~~~~~~~~~~~~~l~~~Cl~~dP~~RPt~~~v~~~--L~~~ 704 (747)
... ...+.+++.+||+.||.+|||+.++++. +++.
T Consensus 253 ~~~----s~~~~~li~~~L~~dp~~R~s~~eil~Hp~~~~~ 289 (352)
T d1koba_ 253 SSV----SPEAKDFIKNLLQKEPRKRLTVHDALEHPWLKGD 289 (352)
T ss_dssp TTS----CHHHHHHHHTTSCSSGGGSCCHHHHHTSTTTSSC
T ss_pred CCC----CHHHHHHHHHHCCCCHHHCCCHHHHHCCHHHCCC
T ss_conf 479----9999999999756996689189999609734888
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=100.00 E-value=0 Score=319.87 Aligned_cols=244 Identities=22% Similarity=0.316 Sum_probs=192.4
Q ss_pred HCCCCCCCEECCCCCEEEEEEEEC-CCCEEEEEEECCCCCCCHHHHHHHHHHHHCCCCCCEEEEEEEEEECCEEEEEEEC
Q ss_conf 239785542142498009999966-9849999991343310689999999998305997323377489949822799950
Q 004521 439 TDNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEF 517 (747)
Q Consensus 439 ~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~e~ 517 (747)
.++|++.+.||+|+||.||+|+.. +|+.||||++........+.+.+|+.++++++||||+++++++.+.+..++||||
T Consensus 25 l~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE~ 104 (350)
T d1koaa2 25 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEF 104 (350)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEEETTEEEEEECC
T ss_pred CCCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEECCCCHHHHHHHHHHHHHHHHCCCCCCCCEEEEEEECCEEEEEEEC
T ss_conf 65758988984076819999998899989999998452431699999999999867997999299999989999999985
Q ss_pred CCCCCHHHHHHHCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECC--CCCCEEECCCCCCCCCCC
Q ss_conf 799994467631289876785678999999999999834159994673266768379858--999447125675003899
Q 004521 518 MPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQ--DMNPKISDFGLVRTFGGD 595 (747)
Q Consensus 518 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dikp~NIll~~--~~~~ki~DfGla~~~~~~ 595 (747)
+++|+|.+++.. ....+++..+..++.||+.||.|||+.+ |+||||||+|||++. ++.+||+|||+|+.+...
T Consensus 105 ~~gg~L~~~l~~--~~~~l~e~~~~~i~~qi~~aL~ylH~~~---iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~~~~ 179 (350)
T d1koaa2 105 MSGGELFEKVAD--EHNKMSEDEAVEYMRQVCKGLCHMHENN---YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPK 179 (350)
T ss_dssp CCSCBHHHHHTC--TTSCBCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSTTSCCEEECCCTTCEECCTT
T ss_pred CCCCCHHHHHHH--HCCCCCHHHHHHHHHHHHHHHHHHHHCC---CEEEEECHHHEEECCCCCCEEEEEECCHHEECCCC
T ss_conf 799889999976--2378999999999999999999997569---76000154673641688986999545210442565
Q ss_pred CCCCCCCEEEEC---------CCCCCCCCCCCHHHHHHHHHHHHCCCCCCCCCCCCHHHHHHHHHHCCCCCCCCCHHHHC
Q ss_conf 875444402102---------37888844640237899999881998999988764022448677219865224301106
Q 004521 596 ETEGNTNRVVGT---------YDGQFSIKSDVFSFGILLLEIVSGKKNRGFYRSDTKVNLIGHLWDEGIPLRLIDACIQD 666 (747)
Q Consensus 596 ~~~~~~~~~~~~---------~~~~~s~~sDVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 666 (747)
.... ...++ .+..++.++||||+||++|||++|+.||... .....+..+........ .... .
T Consensus 180 ~~~~---~~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~---~~~~~~~~i~~~~~~~~--~~~~-~ 250 (350)
T d1koaa2 180 QSVK---VTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGE---NDDETLRNVKSCDWNMD--DSAF-S 250 (350)
T ss_dssp SCEE---EECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHHHSSCSSCCS---SHHHHHHHHHHTCCCSC--CGGG-G
T ss_pred CCCC---EECCCCCCCCHHHHCCCCCCHHHHHHHHHHHHHHHHHCCCCCCCC---CHHHHHHHHHHCCCCCC--CCCC-C
T ss_conf 4320---006862421889975899872676554659999998598998997---99999999984788989--4223-5
Q ss_pred CCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHH
Q ss_conf 6999999999999976168999999998899998
Q 004521 667 SCNLADVIRCIHIGLLCVQQHPEDRPCMPSVILM 700 (747)
Q Consensus 667 ~~~~~~~~~~~~l~~~Cl~~dP~~RPt~~~v~~~ 700 (747)
..+ ..+.+++.+||+.||.+|||+.++++.
T Consensus 251 ~~s----~~~~~li~~~L~~dP~~R~t~~eil~h 280 (350)
T d1koaa2 251 GIS----EDGKDFIRKLLLADPNTRMTIHQALEH 280 (350)
T ss_dssp GCC----HHHHHHHHHHCCSSGGGSCCHHHHHHS
T ss_pred CCC----HHHHHHHHHHCCCCHHHCCCHHHHHCC
T ss_conf 899----999999999756896679089998629
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=326.03 Aligned_cols=252 Identities=22% Similarity=0.309 Sum_probs=189.5
Q ss_pred HHCCCCCCCEECCCCCEEEEEEEECC-CCEEEEEEECCC-CCCCHHHHHHHHHHHHCCCCCCEEEEEEEEEECCEEEEEE
Q ss_conf 72397855421424980099999669-849999991343-3106899999999983059973233774899498227999
Q 004521 438 ATDNFSINNKLGEGGFGPVYKGTLVD-GQEIAVKRLSKI-SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIY 515 (747)
Q Consensus 438 ~~~~~~~~~~lg~G~~g~Vy~~~~~~-g~~vavK~l~~~-~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~ 515 (747)
..++|++.++||+|+||+||+|+... ++.||+|+++.. .......+.+|+.++++++||||+++++++.+....++||
T Consensus 4 ~~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~iVm 83 (322)
T d1s9ja_ 4 KDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICM 83 (322)
T ss_dssp CGGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCCCTTHHHHHHHHGGGGGGCCCTTBCCEEEEEECSSEEEEEE
T ss_pred CCCCCEEEEEEECCCCEEEEEEEECCCCCEEEEEEECHHHCHHHHHHHHHHHHHHHHCCCCCCCCEEEEEEECCEEEEEE
T ss_conf 75688897897127780999999989996999999875409789999999999998679999994999999899999999
Q ss_pred ECCCCCCHHHHHHHCCCCCCCCHHHHHHHHHHHHHHHHHHHHC-CCCCEEECCCCCCCEEECCCCCCEEECCCCCCCCCC
Q ss_conf 5079999446763128987678567899999999999983415-999467326676837985899944712567500389
Q 004521 516 EFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQD-SRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGG 594 (747)
Q Consensus 516 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~-~~~~iiH~Dikp~NIll~~~~~~ki~DfGla~~~~~ 594 (747)
||+++|+|.+++.+. ..+++..+..++.|++.||.|||+. + |+||||||+|||++.++.+||+|||+|+.+..
T Consensus 84 Ey~~gg~L~~~l~~~---~~l~~~~~~~~~~qil~aL~yLH~~~~---IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~ 157 (322)
T d1s9ja_ 84 EHMDGGSLDQVLKKA---GRIPEQILGKVSIAVIKGLTYLREKHK---IMHRDVKPSNILVNSRGEIKLCDFGVSGQLID 157 (322)
T ss_dssp ECCTTEEHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHHHC---CCCSCCSGGGEEECTTCCEEECCCCCCHHHHH
T ss_pred ECCCCCCHHHHHHHC---CCCCHHHHHHHHHHHHHHHHHHHHHCC---EECCCCCHHHEEECCCCCEEEEECCCCCCCCC
T ss_conf 767998689987424---999999999999999999999998599---97144577994687899899954877625678
Q ss_pred CCCCCCCCEEEEC---------CCCCCCCCCCCHHHHHHHHHHHHCCCCCCCCCCCCHHHHHHHHHHCCCCC--------
Q ss_conf 9875444402102---------37888844640237899999881998999988764022448677219865--------
Q 004521 595 DETEGNTNRVVGT---------YDGQFSIKSDVFSFGILLLEIVSGKKNRGFYRSDTKVNLIGHLWDEGIPL-------- 657 (747)
Q Consensus 595 ~~~~~~~~~~~~~---------~~~~~s~~sDVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~-------- 657 (747)
.... ...|+ .+..|+.++||||+||++|||++|+.||............... ..+...
T Consensus 158 ~~~~----~~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~ 232 (322)
T d1s9ja_ 158 SMAN----SFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQ-VEGDAAETPPRPRT 232 (322)
T ss_dssp HTC-------CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHHHSSCCSSCCCTTHHHHHC------------------
T ss_pred CCCC----CCCCCCCCCCCHHHCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHH-HCCCCCCCCCCCCC
T ss_conf 8621----113771411946875899894888998999999999888998998878999999887-51775457742123
Q ss_pred -------------------CCCCHHHHCC----CCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHH
Q ss_conf -------------------2243011066----999999999999976168999999998899998
Q 004521 658 -------------------RLIDACIQDS----CNLADVIRCIHIGLLCVQQHPEDRPCMPSVILM 700 (747)
Q Consensus 658 -------------------~~~d~~l~~~----~~~~~~~~~~~l~~~Cl~~dP~~RPt~~~v~~~ 700 (747)
...+...... ........+.+++.+||+.||.+|||+.|+++.
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~L~H 298 (322)
T d1s9ja_ 233 PGRPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVH 298 (322)
T ss_dssp -------------CCCCHHHHHHHHHTSCCCCCCBTTBCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred CCCCCCCCCCCCCCCHHHHHHHHHHHCCCCCCCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHHC
T ss_conf 332211112223541347788766502687667644489999999999868994679089999609
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=322.90 Aligned_cols=238 Identities=29% Similarity=0.416 Sum_probs=185.4
Q ss_pred CEECCCCCEEEEEEEECC---CCEEEEEEECCC--CCCCHHHHHHHHHHHHCCCCCCEEEEEEEEEECCEEEEEEECCCC
Q ss_conf 421424980099999669---849999991343--310689999999998305997323377489949822799950799
Q 004521 446 NKLGEGGFGPVYKGTLVD---GQEIAVKRLSKI--SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMPN 520 (747)
Q Consensus 446 ~~lg~G~~g~Vy~~~~~~---g~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~e~~~~ 520 (747)
++||+|+||+||+|.+.. ++.||||+++.. .....++|.+|+.++++++||||++++|+|.. +..++||||+++
T Consensus 13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~-~~~~lvmE~~~~ 91 (277)
T d1xbba_ 13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAEL 91 (277)
T ss_dssp EEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEES-SSEEEEEECCTT
T ss_pred CCCCCCCCEEEEEEEECCCCCCEEEEEEEECHHHCCHHHHHHHHHHHHHHHHCCCCCCCEEEEEECC-CCEEEEEECCCC
T ss_conf 7834587829999998169738599999988010898999999999999986799898527777505-977999974788
Q ss_pred CCHHHHHHHCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCCEEECCCCCCCCCCCCCCCC
Q ss_conf 99446763128987678567899999999999983415999467326676837985899944712567500389987544
Q 004521 521 KSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGN 600 (747)
Q Consensus 521 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dikp~NIll~~~~~~ki~DfGla~~~~~~~~~~~ 600 (747)
|+|.+++... ..+++..++.++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++.+........
T Consensus 92 g~L~~~l~~~---~~l~~~~~~~i~~qi~~gl~ylH~~~---iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~~~~~ 165 (277)
T d1xbba_ 92 GPLNKYLQQN---RHVKDKNIIELVHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYK 165 (277)
T ss_dssp EEHHHHHHHC---TTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSEEE
T ss_pred CCHHHHHHHC---CCCCHHHHHHHHHHHHHHHHHHHHCC---CCCCCCCCHHHCCCCCCCCCCCCHHHHHHCCCCCCCCC
T ss_conf 9689997522---57899999999999999976687479---55677761131023567512341345331343234432
Q ss_pred C-CEEEEC---------CCCCCCCCCCCHHHHHHHHHHHH-CCCCCCCCCCCCHHHHHHHHHHCCCCCCCCCHHHHCCCC
Q ss_conf 4-402102---------37888844640237899999881-998999988764022448677219865224301106699
Q 004521 601 T-NRVVGT---------YDGQFSIKSDVFSFGILLLEIVS-GKKNRGFYRSDTKVNLIGHLWDEGIPLRLIDACIQDSCN 669 (747)
Q Consensus 601 ~-~~~~~~---------~~~~~s~~sDVwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~ 669 (747)
. ....++ .+..++.++|||||||++|||+| |+.||.... ..+....+ ..+........ .
T Consensus 166 ~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~---~~~~~~~i-~~~~~~~~p~~-----~- 235 (277)
T d1xbba_ 166 AQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMK---GSEVTAML-EKGERMGCPAG-----C- 235 (277)
T ss_dssp C----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCC---HHHHHHHH-HTTCCCCCCTT-----C-
T ss_pred CCCCCCCCCEECCCHHHCCCCCCCHHHHCCCHHHHHHHHHCCCCCCCCCC---HHHHHHHH-HCCCCCCCCCC-----C-
T ss_conf 24456778420391665379998434430340313289658999999989---99999999-82899999865-----6-
Q ss_pred HHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHCC
Q ss_conf 9999999999976168999999998899998548
Q 004521 670 LADVIRCIHIGLLCVQQHPEDRPCMPSVILMLGS 703 (747)
Q Consensus 670 ~~~~~~~~~l~~~Cl~~dP~~RPt~~~v~~~L~~ 703 (747)
...+.+++.+||+.||.+||+|.+|+++|+.
T Consensus 236 ---~~~~~~li~~cl~~dp~~RPs~~~i~~~L~~ 266 (277)
T d1xbba_ 236 ---PREMYDLMNLCWTYDVENRPGFAAVELRLRN 266 (277)
T ss_dssp ---CHHHHHHHHHHTCSSTTTSCCHHHHHHHHHH
T ss_pred ---CHHHHHHHHHHCCCCHHHCCCHHHHHHHHHC
T ss_conf ---7999999999758897689098999998528
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=0 Score=324.55 Aligned_cols=242 Identities=26% Similarity=0.386 Sum_probs=188.7
Q ss_pred CCCCCCCEECCCCCEEEEEEEECC-CCEEEEEEECCC---CCCCHHHHHHHHHHHHCCCCCCEEEEEEEEEECCEEEEEE
Q ss_conf 397855421424980099999669-849999991343---3106899999999983059973233774899498227999
Q 004521 440 DNFSINNKLGEGGFGPVYKGTLVD-GQEIAVKRLSKI---SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIY 515 (747)
Q Consensus 440 ~~~~~~~~lg~G~~g~Vy~~~~~~-g~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~ 515 (747)
+.|+..+.||+|+||+||+|+... ++.||||++... .....+.+.+|+.++++++||||+++++++.+.+..++||
T Consensus 15 ~~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv~ 94 (309)
T d1u5ra_ 15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM 94 (309)
T ss_dssp HHEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred HHCEEEEEEECCCCEEEEEEEECCCCCEEEEEEECHHHCCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEEECCEEEEEE
T ss_conf 85676279701888099999998999399999984444358899999999999999778999823899999899889999
Q ss_pred ECCCCCCHHHHHHHCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCCEEECCCCCCCCCCC
Q ss_conf 50799994467631289876785678999999999999834159994673266768379858999447125675003899
Q 004521 516 EFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGD 595 (747)
Q Consensus 516 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dikp~NIll~~~~~~ki~DfGla~~~~~~ 595 (747)
||+++|+|..++.. +..+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+|+.....
T Consensus 95 E~~~~g~l~~~~~~---~~~l~e~~~~~i~~qi~~aL~yLH~~~---iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~~~ 168 (309)
T d1u5ra_ 95 EYCLGSASDLLEVH---KKPLQEVEIAAVTHGALQGLAYLHSHN---MIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA 168 (309)
T ss_dssp ECCSEEHHHHHHHH---TSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEEETTTEEEECCCTTCBSSSSB
T ss_pred EECCCCCHHHHHHH---CCCCCHHHHHHHHHHHHHHHHHHHHCC---EECCCCCCCEEEECCCCCEEEEECCCCCCCCCC
T ss_conf 80699945789973---799999999999999999999998689---766678842179879997898443653346778
Q ss_pred CCCCCCCEEEEC------CCCCCCCCCCCHHHHHHHHHHHHCCCCCCCCCCCCHHHHHHHHHHCCCCCCCCCHHHHCCCC
Q ss_conf 875444402102------37888844640237899999881998999988764022448677219865224301106699
Q 004521 596 ETEGNTNRVVGT------YDGQFSIKSDVFSFGILLLEIVSGKKNRGFYRSDTKVNLIGHLWDEGIPLRLIDACIQDSCN 669 (747)
Q Consensus 596 ~~~~~~~~~~~~------~~~~~s~~sDVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~ 669 (747)
.....+.....+ ....|+.++|||||||++|||++|+.||... .....+........ ..+.... .+
T Consensus 169 ~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~---~~~~~~~~i~~~~~-~~~~~~~----~s 240 (309)
T d1u5ra_ 169 NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNM---NAMSALYHIAQNES-PALQSGH----WS 240 (309)
T ss_dssp CCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTS---CHHHHHHHHHHSCC-CCCSCTT----SC
T ss_pred CCCCCCCCCCCHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCC---CHHHHHHHHHHCCC-CCCCCCC----CC
T ss_conf 7313476636889983467888672145455899999998788999997---99999999982899-9888788----89
Q ss_pred HHHHHHHHHHHHHCCCCCCCCCCCHHHHHH
Q ss_conf 999999999997616899999999889999
Q 004521 670 LADVIRCIHIGLLCVQQHPEDRPCMPSVIL 699 (747)
Q Consensus 670 ~~~~~~~~~l~~~Cl~~dP~~RPt~~~v~~ 699 (747)
..+.+++.+||+.||.+|||+.++++
T Consensus 241 ----~~~~~li~~~L~~dP~~Rpt~~ell~ 266 (309)
T d1u5ra_ 241 ----EYFRNFVDSCLQKIPQDRPTSEVLLK 266 (309)
T ss_dssp ----HHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred ----HHHHHHHHHHCCCCHHHCCCHHHHHH
T ss_conf ----99999999977379657918999971
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=322.62 Aligned_cols=240 Identities=23% Similarity=0.302 Sum_probs=191.6
Q ss_pred CCCCCCCEECCCCCEEEEEEEEC-CCCEEEEEEECC---CCCCCHHHHHHHHHHHHCCCCCCEEEEEEEEEECCEEEEEE
Q ss_conf 39785542142498009999966-984999999134---33106899999999983059973233774899498227999
Q 004521 440 DNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSK---ISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIY 515 (747)
Q Consensus 440 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~---~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~ 515 (747)
++|++.+.||+|+||+||+|+.. +++.||||.+.+ ......+.+.+|+.++++++||||+++++++.+.+..++||
T Consensus 8 ~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ivm 87 (288)
T d1uu3a_ 8 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL 87 (288)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSSEEEEEE
T ss_pred CCCEEEEEEEECCCEEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEEECCEEEEEE
T ss_conf 87789889850879099999998999799999986577557778999999999998768888617999999899889999
Q ss_pred ECCCCCCHHHHHHHCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCCEEECCCCCCCCCCC
Q ss_conf 50799994467631289876785678999999999999834159994673266768379858999447125675003899
Q 004521 516 EFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGD 595 (747)
Q Consensus 516 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dikp~NIll~~~~~~ki~DfGla~~~~~~ 595 (747)
||+++|+|.+++... ..+++..+..++.|++.||+|||+.+ |+||||||+|||+++++.+||+|||+|+.+...
T Consensus 88 Ey~~gg~L~~~~~~~---~~l~e~~~~~~~~qi~~al~ylH~~~---iiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~~ 161 (288)
T d1uu3a_ 88 SYAKNGELLKYIRKI---GSFDETCTRFYTAEIVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPE 161 (288)
T ss_dssp CCCTTEEHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCEECC--
T ss_pred ECCCCCCHHHHHHCC---CCCCHHHHHHHHHHHHHHHHHHCCCC---EECCCCCCCCCCCCCCCEEEECCCCCCEECCCC
T ss_conf 704898777765315---99999999999999999997621650---884767741236688853886032102422567
Q ss_pred CCCCCCCEEEECC---------CCCCCCCCCCHHHHHHHHHHHHCCCCCCCCCCCCHHHHHHHHHHCCCCCCCCCHHHHC
Q ss_conf 8754444021023---------7888844640237899999881998999988764022448677219865224301106
Q 004521 596 ETEGNTNRVVGTY---------DGQFSIKSDVFSFGILLLEIVSGKKNRGFYRSDTKVNLIGHLWDEGIPLRLIDACIQD 666 (747)
Q Consensus 596 ~~~~~~~~~~~~~---------~~~~s~~sDVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 666 (747)
..........|+. +..++.++||||+||++|||++|+.||... ........+... .. .+..
T Consensus 162 ~~~~~~~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~---~~~~~~~~i~~~-~~-~~p~----- 231 (288)
T d1uu3a_ 162 SKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAG---NEYLIFQKIIKL-EY-DFPE----- 231 (288)
T ss_dssp --------CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSSCCS---SHHHHHHHHHTT-CC-CCCT-----
T ss_pred CCCCCCCCCCCCCCCCCCEEECCCCCCCCCCEEHHHHHHHHHHHCCCCCCCC---CHHHHHHHHHCC-CC-CCCC-----
T ss_conf 7643335556775525844002689896662304569999980388998995---999999999718-99-9985-----
Q ss_pred CCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHH
Q ss_conf 699999999999997616899999999889999
Q 004521 667 SCNLADVIRCIHIGLLCVQQHPEDRPCMPSVIL 699 (747)
Q Consensus 667 ~~~~~~~~~~~~l~~~Cl~~dP~~RPt~~~v~~ 699 (747)
..+ ..+.+++.+||+.||.+|||++|+++
T Consensus 232 ~~s----~~~~~li~~~L~~dP~~R~t~~e~~~ 260 (288)
T d1uu3a_ 232 KFF----PKARDLVEKLLVLDATKRLGCEEMEG 260 (288)
T ss_dssp TCC----HHHHHHHHTTSCSSGGGSTTSGGGTC
T ss_pred CCC----HHHHHHHHHHCCCCHHHCCCHHHHCC
T ss_conf 479----99999999985579768919789737
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=318.00 Aligned_cols=237 Identities=26% Similarity=0.328 Sum_probs=190.4
Q ss_pred HCCCCCCCEECCCCCEEEEEEEECC-CCEEEEEEECC---CCCCCHHHHHHHHHHHHCCCCCCEEEEEEEEEECCEEEEE
Q ss_conf 2397855421424980099999669-84999999134---3310689999999998305997323377489949822799
Q 004521 439 TDNFSINNKLGEGGFGPVYKGTLVD-GQEIAVKRLSK---ISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLI 514 (747)
Q Consensus 439 ~~~~~~~~~lg~G~~g~Vy~~~~~~-g~~vavK~l~~---~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV 514 (747)
.++|++.+.||+|+||.||+|+... ++.||+|.+.+ ........+.+|+.++++++||||+++++++.+.+..++|
T Consensus 5 l~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~iv 84 (263)
T d2j4za1 5 LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLI 84 (263)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred HHHEEEEEEEECCCCCEEEEEEECCCCCEEEEEEECHHHCCCHHHHHHHHHHHHHHHHCCCCCCCEEEEEEEECCEEEEE
T ss_conf 53769988985177858999999899949999998168856768999999999999856888888599999989998999
Q ss_pred EECCCCCCHHHHHHHCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCCEEECCCCCCCCCC
Q ss_conf 95079999446763128987678567899999999999983415999467326676837985899944712567500389
Q 004521 515 YEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGG 594 (747)
Q Consensus 515 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dikp~NIll~~~~~~ki~DfGla~~~~~ 594 (747)
|||+++|+|.+++... ..+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+|+....
T Consensus 85 mEy~~~g~L~~~l~~~---~~l~e~~~~~i~~qi~~al~~lH~~~---ivHrDiKp~Nill~~~~~~kl~DFG~a~~~~~ 158 (263)
T d2j4za1 85 LEYAPLGTVYRELQKL---SKFDEQRTATYITELANALSYCHSKR---VIHRDIKPENLLLGSAGELKIADFGWSVHAPS 158 (263)
T ss_dssp EECCTTCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCCSCSCCCC
T ss_pred EEECCCCCHHHHHHHC---CCCCHHHHHHHHHHHHHHHHHHHHCC---EEEEEECCCCCEECCCCCEEECCCCEEEECCC
T ss_conf 8504798589887504---89999999999999999999999889---46522023441466899871155563354488
Q ss_pred CCCCCCCCEEEECC---------CCCCCCCCCCHHHHHHHHHHHHCCCCCCCCCCCCHHHHHHHHHHCCCCCCCCCHHHH
Q ss_conf 98754444021023---------788884464023789999988199899998876402244867721986522430110
Q 004521 595 DETEGNTNRVVGTY---------DGQFSIKSDVFSFGILLLEIVSGKKNRGFYRSDTKVNLIGHLWDEGIPLRLIDACIQ 665 (747)
Q Consensus 595 ~~~~~~~~~~~~~~---------~~~~s~~sDVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 665 (747)
..... ..|+. +..++.++|||||||++|||++|+.||... ............ .. .+.+
T Consensus 159 ~~~~~----~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~---~~~~~~~~i~~~-~~-~~p~---- 225 (263)
T d2j4za1 159 SRRTT----LCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEAN---TYQETYKRISRV-EF-TFPD---- 225 (263)
T ss_dssp CCCEE----TTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCS---SHHHHHHHHHTT-CC-CCCT----
T ss_pred CCCCC----CCCCCCCCCHHHHCCCCCCCHHHHHHHHHHHHHHHCCCCCCCCC---CHHHHHHHHHCC-CC-CCCC----
T ss_conf 85235----57887634999975899893144046759999983299998889---999999999718-99-9986----
Q ss_pred CCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHH
Q ss_conf 6699999999999997616899999999889999
Q 004521 666 DSCNLADVIRCIHIGLLCVQQHPEDRPCMPSVIL 699 (747)
Q Consensus 666 ~~~~~~~~~~~~~l~~~Cl~~dP~~RPt~~~v~~ 699 (747)
.. ...+.+++.+||+.||.+|||+.|+++
T Consensus 226 -~~----s~~~~~li~~~L~~dp~~R~t~~eil~ 254 (263)
T d2j4za1 226 -FV----TEGARDLISRLLKHNPSQRPMLREVLE 254 (263)
T ss_dssp -TS----CHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred -CC----CHHHHHHHHHHCCCCHHHCCCHHHHHC
T ss_conf -68----999999999976479768909999971
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=320.57 Aligned_cols=246 Identities=26% Similarity=0.450 Sum_probs=192.0
Q ss_pred CCCCCCCEECCCCCEEEEEEEECC-CC----EEEEEEECC-CCCCCHHHHHHHHHHHHCCCCCCEEEEEEEEEECCEEEE
Q ss_conf 397855421424980099999669-84----999999134-331068999999999830599732337748994982279
Q 004521 440 DNFSINNKLGEGGFGPVYKGTLVD-GQ----EIAVKRLSK-ISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLL 513 (747)
Q Consensus 440 ~~~~~~~~lg~G~~g~Vy~~~~~~-g~----~vavK~l~~-~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~l 513 (747)
++|++.++||+|+||+||+|.+.. ++ .||+|+++. ......++|.+|+.++++++|||||+++|+|.+. ..++
T Consensus 9 ~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~-~~~~ 87 (317)
T d1xkka_ 9 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQL 87 (317)
T ss_dssp TTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC----CTHHHHHHHHHHHHHCCCTTBCCEEEEEESS-SEEE
T ss_pred HHCEEEEEEECCCCEEEEEEEECCCCCEEEEEEEEEEECCCCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEECC-CEEE
T ss_conf 999783198208992999999958998898999999965134979999999999999867998881589999619-8369
Q ss_pred EEECCCCCCHHHHHHHCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCCEEECCCCCCCCC
Q ss_conf 99507999944676312898767856789999999999998341599946732667683798589994471256750038
Q 004521 514 IYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFG 593 (747)
Q Consensus 514 V~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dikp~NIll~~~~~~ki~DfGla~~~~ 593 (747)
++|++.+++|.+++... ...+++..++.++.|+|.||.|||+.+ |+||||||+|||++.++.+||+|||+|+...
T Consensus 88 v~e~~~~~~l~~~~~~~--~~~~~~~~~~~i~~qi~~gl~yLH~~~---iiHrDlKp~NIll~~~~~~kl~DFGla~~~~ 162 (317)
T d1xkka_ 88 ITQLMPFGCLLDYVREH--KDNIGSQYLLNWCVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLG 162 (317)
T ss_dssp EEECCTTCBHHHHHHHT--SSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEETTEEEECCCSHHHHTT
T ss_pred EEEECCCCCCCCCCCCC--CCCCCHHHHHHHHHHHHHHHHHHHHCC---CCCCCCHHHCCEECCCCCEEEECCCCCEECC
T ss_conf 99842687401011133--457999999999999999999998769---5047621203116799875860255222335
Q ss_pred CCCCCCCCCEEEEC---------CCCCCCCCCCCHHHHHHHHHHHH-CCCCCCCCCCCCHHHHHHHHHHCCCCCCCCCHH
Q ss_conf 99875444402102---------37888844640237899999881-998999988764022448677219865224301
Q 004521 594 GDETEGNTNRVVGT---------YDGQFSIKSDVFSFGILLLEIVS-GKKNRGFYRSDTKVNLIGHLWDEGIPLRLIDAC 663 (747)
Q Consensus 594 ~~~~~~~~~~~~~~---------~~~~~s~~sDVwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 663 (747)
............++ .++.++.++|||||||++|||+| |..|+...... ..... ...+......+.
T Consensus 163 ~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~~~---~~~~~-i~~~~~~~~p~~- 237 (317)
T d1xkka_ 163 AEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPAS---EISSI-LEKGERLPQPPI- 237 (317)
T ss_dssp TTCC--------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCGG---GHHHH-HHHTCCCCCCTT-
T ss_pred CCCCCCCCCCCCCCCCCCCHHHHHCCCCCHHHHHHHHHHHHHHHHHCCCCCCCCCCHH---HHHHH-HHCCCCCCCCCC-
T ss_conf 4445322365105864467088746999835654407999999997799999999989---99999-975998999855-
Q ss_pred HHCCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHCCC
Q ss_conf 10669999999999999761689999999988999985489
Q 004521 664 IQDSCNLADVIRCIHIGLLCVQQHPEDRPCMPSVILMLGSE 704 (747)
Q Consensus 664 l~~~~~~~~~~~~~~l~~~Cl~~dP~~RPt~~~v~~~L~~~ 704 (747)
....+.+++.+||+.||.+|||+.+|++.|+..
T Consensus 238 --------~~~~~~~li~~cl~~dP~~RPs~~eil~~l~~~ 270 (317)
T d1xkka_ 238 --------CTIDVYMIMVKCWMIDADSRPKFRELIIEFSKM 270 (317)
T ss_dssp --------BCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred --------CCHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHH
T ss_conf --------689999999984789934691999999999998
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=321.65 Aligned_cols=260 Identities=27% Similarity=0.399 Sum_probs=197.4
Q ss_pred CHHHHHHHHCCCCCCCEECCCCCEEEEEEEECC------CCEEEEEEECC-CCCCCHHHHHHHHHHHHCC-CCCCEEEEE
Q ss_conf 488899972397855421424980099999669------84999999134-3310689999999998305-997323377
Q 004521 431 ELATIANATDNFSINNKLGEGGFGPVYKGTLVD------GQEIAVKRLSK-ISEQGLKELKNEVILFSKL-QHRNLVKLL 502 (747)
Q Consensus 431 ~~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~------g~~vavK~l~~-~~~~~~~~~~~E~~~l~~l-~H~nIv~l~ 502 (747)
+..+++...++|++.+.||+|+||.||+|.... ++.||||+++. ......+.+..|...+.++ +|+||+.++
T Consensus 4 ~~~~wei~~~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~ 83 (299)
T d1ywna1 4 DASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLL 83 (299)
T ss_dssp CHHHHBCCGGGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----CHHHHHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred CCCCCCCCHHHEEEEEEEEECCCEEEEEEEECCCCCCCCCEEEEEEEECCCCCCHHHHHHHHHHHHHHHHCCCCEEEEEE
T ss_conf 98252616799798449841678399999986777555783999999860017178999999999988614998499741
Q ss_pred EEEEECC-EEEEEEECCCCCCHHHHHHHCCC-------------CCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCC
Q ss_conf 4899498-22799950799994467631289-------------876785678999999999999834159994673266
Q 004521 503 GCCIQGE-EKLLIYEFMPNKSLDSFIFDQTR-------------RTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDL 568 (747)
Q Consensus 503 g~~~~~~-~~~lV~e~~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Di 568 (747)
+++...+ ..++||||+++|+|.+++..... ...+++..+..++.|++.||.|||+.+ |+||||
T Consensus 84 ~~~~~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~---ivHrDl 160 (299)
T d1ywna1 84 GACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRDL 160 (299)
T ss_dssp EEECSTTSCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHTT---CCCSCC
T ss_pred EEECCCCCEEEEEEEECCCCCHHHHHHHCCCCCCCCCCCHHHHHCCCCCHHHHHHHHHHHHHHHHHHHHCC---CCCCCC
T ss_conf 15404797579999845899299999853666665322202332146899999999999999999887379---717867
Q ss_pred CCCCEEECCCCCCEEECCCCCCCCCCCCCCCCCCEEEECC---------CCCCCCCCCCHHHHHHHHHHHHCCC-CCCCC
Q ss_conf 7683798589994471256750038998754444021023---------7888844640237899999881998-99998
Q 004521 569 KASNVLLDQDMNPKISDFGLVRTFGGDETEGNTNRVVGTY---------DGQFSIKSDVFSFGILLLEIVSGKK-NRGFY 638 (747)
Q Consensus 569 kp~NIll~~~~~~ki~DfGla~~~~~~~~~~~~~~~~~~~---------~~~~s~~sDVwSlGvil~elltg~~-p~~~~ 638 (747)
||+|||+++++.+||+|||+|+...............++. +..++.++|||||||++|||+|+.. |+...
T Consensus 161 Kp~NILl~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gvil~ellt~~~~p~~~~ 240 (299)
T d1ywna1 161 AARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGV 240 (299)
T ss_dssp CGGGEEECGGGCEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTC
T ss_pred CCCCEEECCCCCEEECCCCCHHHCCCCCCCCCCCCEEECCCCCCHHHHHCCCCCCCCCEEEHHHHHHHHHHCCCCCCCCC
T ss_conf 73106577998289845752001135665222475166721020368646889966322136789999986889999899
Q ss_pred CCCCHHHHHHHHHHCCCCCCCCCHHHHCCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHCCCC
Q ss_conf 8764022448677219865224301106699999999999997616899999999889999854898
Q 004521 639 RSDTKVNLIGHLWDEGIPLRLIDACIQDSCNLADVIRCIHIGLLCVQQHPEDRPCMPSVILMLGSEI 705 (747)
Q Consensus 639 ~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dP~~RPt~~~v~~~L~~~~ 705 (747)
.. ...+......+......+.. ...+.+++.+||+.||.+||||.+|+++|+.++
T Consensus 241 ~~---~~~~~~~~~~~~~~~~~~~~---------~~~l~~li~~cl~~dP~~Rpt~~eil~~L~~il 295 (299)
T d1ywna1 241 KI---DEEFCRRLKEGTRMRAPDYT---------TPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLL 295 (299)
T ss_dssp CC---SHHHHHHHHHTCCCCCCTTC---------CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred CH---HHHHHHHHHCCCCCCCCCCC---------CHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHH
T ss_conf 98---99999999638988888657---------899999999976779667919999999997998
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=323.67 Aligned_cols=246 Identities=26% Similarity=0.357 Sum_probs=190.9
Q ss_pred HCCCCCCCEECCCCCEEEEEEEECC-CCEEEEEEECCC--CCCCHHHHHHHHHHHHCCCCCCEEEEEEEEEE--CCEEEE
Q ss_conf 2397855421424980099999669-849999991343--31068999999999830599732337748994--982279
Q 004521 439 TDNFSINNKLGEGGFGPVYKGTLVD-GQEIAVKRLSKI--SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQ--GEEKLL 513 (747)
Q Consensus 439 ~~~~~~~~~lg~G~~g~Vy~~~~~~-g~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~--~~~~~l 513 (747)
.++|++.+.||+|+||+||+|+... ++.||+|.+... .+...+.+.+|++++++++||||+++++++.+ .+..++
T Consensus 3 ~edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~i 82 (269)
T d2java1 3 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYI 82 (269)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEEE
T ss_pred CHHCEEEEEEECCCCEEEEEEEECCCCCEEEEEEECHHHCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEEECCCCEEEE
T ss_conf 33379967983088919999999999979999998746579799999999999999778999824899999178998999
Q ss_pred EEECCCCCCHHHHHHHCC-CCCCCCHHHHHHHHHHHHHHHHHHHHCC--CCCEEECCCCCCCEEECCCCCCEEECCCCCC
Q ss_conf 995079999446763128-9876785678999999999999834159--9946732667683798589994471256750
Q 004521 514 IYEFMPNKSLDSFIFDQT-RRTLLDWSQRFHIICGTARGLLYLHQDS--RLRIIHRDLKASNVLLDQDMNPKISDFGLVR 590 (747)
Q Consensus 514 V~e~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~gL~yLH~~~--~~~iiH~Dikp~NIll~~~~~~ki~DfGla~ 590 (747)
||||+++|+|.+++.... ....+++..++.++.|++.||.|||+.+ ..+|+||||||+|||++.++.+||+|||+|+
T Consensus 83 vmEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG~a~ 162 (269)
T d2java1 83 VMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLAR 162 (269)
T ss_dssp EEECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCHHHHH
T ss_pred EEECCCCCCHHHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHHHHHHCCCCCCEEECCCCHHHCCCCCCCCEEEEECCCEE
T ss_conf 99568999389999851545789999999999999999999999716778878858676542574788857980010003
Q ss_pred CCCCCCCCCCCCEEEEC---------CCCCCCCCCCCHHHHHHHHHHHHCCCCCCCCCCCCHHHHHHHHHHCCCCCCCCC
Q ss_conf 03899875444402102---------378888446402378999998819989999887640224486772198652243
Q 004521 591 TFGGDETEGNTNRVVGT---------YDGQFSIKSDVFSFGILLLEIVSGKKNRGFYRSDTKVNLIGHLWDEGIPLRLID 661 (747)
Q Consensus 591 ~~~~~~~~~~~~~~~~~---------~~~~~s~~sDVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~d 661 (747)
.+........ ...++ .+..++.++|||||||++|||++|+.||.... .......+ ..+....+..
T Consensus 163 ~~~~~~~~~~--~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel~tg~~Pf~~~~---~~~~~~~i-~~~~~~~~~~ 236 (269)
T d2java1 163 ILNHDTSFAK--AFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFS---QKELAGKI-REGKFRRIPY 236 (269)
T ss_dssp HC-------------CCCSCCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSS---HHHHHHHH-HHTCCCCCCT
T ss_pred ECCCCCCCCC--CCCCCCCCCCHHHHCCCCCCHHHHHHHHCHHHHHHHHCCCCCCCCC---HHHHHHHH-HCCCCCCCCC
T ss_conf 2245777556--6778823279999839999938988752789999801889989989---99999999-7189988974
Q ss_pred HHHHCCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHH
Q ss_conf 01106699999999999997616899999999889999
Q 004521 662 ACIQDSCNLADVIRCIHIGLLCVQQHPEDRPCMPSVIL 699 (747)
Q Consensus 662 ~~l~~~~~~~~~~~~~~l~~~Cl~~dP~~RPt~~~v~~ 699 (747)
..+ ..+.+++.+||+.||.+|||+.|+++
T Consensus 237 -----~~s----~~l~~li~~~L~~dp~~Rps~~ell~ 265 (269)
T d2java1 237 -----RYS----DELNEIITRMLNLKDYHRPSVEEILE 265 (269)
T ss_dssp -----TSC----HHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred -----CCC----HHHHHHHHHHCCCCHHHCCCHHHHHH
T ss_conf -----359----99999999976799557918999972
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=318.73 Aligned_cols=256 Identities=27% Similarity=0.449 Sum_probs=198.6
Q ss_pred HHHHCCCCCCCEECCCCCEEEEEEEEC------CCCEEEEEEECCC-CCCCHHHHHHHHHHHHCCCCCCEEEEEEEEEEC
Q ss_conf 997239785542142498009999966------9849999991343-310689999999998305997323377489949
Q 004521 436 ANATDNFSINNKLGEGGFGPVYKGTLV------DGQEIAVKRLSKI-SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQG 508 (747)
Q Consensus 436 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~------~g~~vavK~l~~~-~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~ 508 (747)
+...++|++.+.||+|+||+||+|.+. .+..||||+++.. .......|.+|+.++++++||||++++|++...
T Consensus 16 ei~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~ 95 (308)
T d1p4oa_ 16 EVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQG 95 (308)
T ss_dssp BCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSS
T ss_pred EECHHHEEEEEEEEECCCEEEEEEEECCCCCCCCCCEEEEEEECCCCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEECC
T ss_conf 42689918835982078818999998786447789689999987012868999999999999976999884125478428
Q ss_pred CEEEEEEECCCCCCHHHHHHHC-------CCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCC
Q ss_conf 8227999507999944676312-------898767856789999999999998341599946732667683798589994
Q 004521 509 EEKLLIYEFMPNKSLDSFIFDQ-------TRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNP 581 (747)
Q Consensus 509 ~~~~lV~e~~~~gsL~~~l~~~-------~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dikp~NIll~~~~~~ 581 (747)
...++||||+++|+|.+++... .....+++..+..++.++|.||.|||+.+ |+||||||+|||+++++++
T Consensus 96 ~~~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~~---ivHrDlk~~NiLld~~~~~ 172 (308)
T d1p4oa_ 96 QPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANK---FVHRDLAARNCMVAEDFTV 172 (308)
T ss_dssp SSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCSGGGEEECTTCCE
T ss_pred CCEEEEEEECCCCCHHHHHHHCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCC---EEECEECCCCEEECCCCEE
T ss_conf 8106777604899889998750332113444688799999999999999999876479---6543286775403599649
Q ss_pred EEECCCCCCCCCCCCCCCCCCEEEECC---------CCCCCCCCCCHHHHHHHHHHHHCCCCCCCCCCCCHHHHHHHHHH
Q ss_conf 471256750038998754444021023---------78888446402378999998819989999887640224486772
Q 004521 582 KISDFGLVRTFGGDETEGNTNRVVGTY---------DGQFSIKSDVFSFGILLLEIVSGKKNRGFYRSDTKVNLIGHLWD 652 (747)
Q Consensus 582 ki~DfGla~~~~~~~~~~~~~~~~~~~---------~~~~s~~sDVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~ 652 (747)
||+|||+|+.+.............++. +..++.++||||||+++|||+||..++ +........+..+ .
T Consensus 173 Kl~DFGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~il~El~t~~~~p--~~~~~~~~~~~~i-~ 249 (308)
T d1p4oa_ 173 KIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQP--YQGLSNEQVLRFV-M 249 (308)
T ss_dssp EECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCT--TTTSCHHHHHHHH-H
T ss_pred EEEECCCCEECCCCCCEEECCCEECCCCCCCHHHHCCCCCCCCCCCCCHHHHHHHHHHCCCCC--CCCCCHHHHHHHH-H
T ss_conf 994245420235776303134023163237888873699883334443789999999689999--9998999999999-8
Q ss_pred CCCCCCCCCHHHHCCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHCCCCC
Q ss_conf 198652243011066999999999999976168999999998899998548989
Q 004521 653 EGIPLRLIDACIQDSCNLADVIRCIHIGLLCVQQHPEDRPCMPSVILMLGSEIL 706 (747)
Q Consensus 653 ~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dP~~RPt~~~v~~~L~~~~~ 706 (747)
.+......+. . ...+.+++.+||+.||.+||||.+|+++|+...+
T Consensus 250 ~~~~~~~p~~-----~----~~~l~~li~~cl~~~P~~RPs~~~il~~L~~~~~ 294 (308)
T d1p4oa_ 250 EGGLLDKPDN-----C----PDMLFELMRMCWQYNPKMRPSFLEIISSIKEEME 294 (308)
T ss_dssp TTCCCCCCTT-----C----CHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSC
T ss_pred HCCCCCCCCC-----C----HHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHCC
T ss_conf 0888888633-----5----3999999999757796589399999999787617
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=319.11 Aligned_cols=254 Identities=26% Similarity=0.374 Sum_probs=197.1
Q ss_pred HHHCCCCCCCEECCCCCEEEEEEEEC------CCCEEEEEEECCC-CCCCHHHHHHHHHHHHCC-CCCCEEEEEEEEEEC
Q ss_conf 97239785542142498009999966------9849999991343-310689999999998305-997323377489949
Q 004521 437 NATDNFSINNKLGEGGFGPVYKGTLV------DGQEIAVKRLSKI-SEQGLKELKNEVILFSKL-QHRNLVKLLGCCIQG 508 (747)
Q Consensus 437 ~~~~~~~~~~~lg~G~~g~Vy~~~~~------~g~~vavK~l~~~-~~~~~~~~~~E~~~l~~l-~H~nIv~l~g~~~~~ 508 (747)
...++|++.++||+|+||.||+|++. .++.||||+++.. ......+|.+|+.++.++ +||||++++|++...
T Consensus 20 ~~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~~~ 99 (311)
T d1t46a_ 20 FPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIG 99 (311)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred CCHHHEEEEEEEEECCCEEEEEEEEECCCCCCCCEEEEEEEECCCCCHHHHHHHHHHHHHHHHCCCCCCEEEEEEEEEEC
T ss_conf 77899698549820688299999980664477886999999874248779999999999987626999887899898319
Q ss_pred CEEEEEEECCCCCCHHHHHHHCC---------------CCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCE
Q ss_conf 82279995079999446763128---------------987678567899999999999983415999467326676837
Q 004521 509 EEKLLIYEFMPNKSLDSFIFDQT---------------RRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNV 573 (747)
Q Consensus 509 ~~~~lV~e~~~~gsL~~~l~~~~---------------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dikp~NI 573 (747)
...++||||+++|+|.+++.... ....+++..+..++.||+.||+|||.++ ++||||||+||
T Consensus 100 ~~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~~---ivHrDLKp~NI 176 (311)
T d1t46a_ 100 GPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKN---CIHRDLAARNI 176 (311)
T ss_dssp SSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGE
T ss_pred CEEEEEEECCCCCCHHHHHHHCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCC---EEECCCCCCCC
T ss_conf 978999973799879999985356654444453322233458899999999999999999887579---26662410210
Q ss_pred EECCCCCCEEECCCCCCCCCCCCCCCCCCEEEECC---------CCCCCCCCCCHHHHHHHHHHHHCCCCCCCCCCCCHH
Q ss_conf 98589994471256750038998754444021023---------788884464023789999988199899998876402
Q 004521 574 LLDQDMNPKISDFGLVRTFGGDETEGNTNRVVGTY---------DGQFSIKSDVFSFGILLLEIVSGKKNRGFYRSDTKV 644 (747)
Q Consensus 574 ll~~~~~~ki~DfGla~~~~~~~~~~~~~~~~~~~---------~~~~s~~sDVwSlGvil~elltg~~p~~~~~~~~~~ 644 (747)
+++..+.+||+|||+++...............++. +..++.++||||||+++|||+|+..|+..... ..
T Consensus 177 l~~~~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwS~G~~l~ellt~g~p~~~~~~--~~ 254 (311)
T d1t46a_ 177 LLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMP--VD 254 (311)
T ss_dssp EEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCC--SS
T ss_pred CCCCCCCCCCCCCCHHEECCCCCCCEEEEECCCCHHHCCHHHHCCCCCCCCCCCCCHHHHHHHHHHCCCCCCCCCC--HH
T ss_conf 0002575210234010233678861586201359687677886179999740010258999999858998877899--89
Q ss_pred HHHHHHHHCCCCCCCCCHHHHCCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHCCC
Q ss_conf 244867721986522430110669999999999999761689999999988999985489
Q 004521 645 NLIGHLWDEGIPLRLIDACIQDSCNLADVIRCIHIGLLCVQQHPEDRPCMPSVILMLGSE 704 (747)
Q Consensus 645 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dP~~RPt~~~v~~~L~~~ 704 (747)
..+......+........ ....+.+++.+||+.||.+||+|.+|+++|+..
T Consensus 255 ~~~~~~i~~~~~~~~~~~---------~~~~l~~Li~~cl~~dP~~RPs~~~il~~L~~~ 305 (311)
T d1t46a_ 255 SKFYKMIKEGFRMLSPEH---------APAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQ 305 (311)
T ss_dssp HHHHHHHHHTCCCCCCTT---------SCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred HHHHHHHHCCCCCCCCCC---------CCHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHH
T ss_conf 999999866898898543---------659999999997577965792999999999876
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=318.28 Aligned_cols=252 Identities=29% Similarity=0.459 Sum_probs=193.9
Q ss_pred CCCCCCCEECCCCCEEEEEEEECC-CC--EEEEEEECC-CCCCCHHHHHHHHHHHHCC-CCCCEEEEEEEEEECCEEEEE
Q ss_conf 397855421424980099999669-84--999999134-3310689999999998305-997323377489949822799
Q 004521 440 DNFSINNKLGEGGFGPVYKGTLVD-GQ--EIAVKRLSK-ISEQGLKELKNEVILFSKL-QHRNLVKLLGCCIQGEEKLLI 514 (747)
Q Consensus 440 ~~~~~~~~lg~G~~g~Vy~~~~~~-g~--~vavK~l~~-~~~~~~~~~~~E~~~l~~l-~H~nIv~l~g~~~~~~~~~lV 514 (747)
++|++.++||+|+||.||+|++.. +. .||||++.. ...+..+.|.+|+.+++++ +||||++++|++.+.+..++|
T Consensus 10 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~iV 89 (309)
T d1fvra_ 10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA 89 (309)
T ss_dssp GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEE
T ss_pred HHCEEEEEEEECCCCEEEEEEECCCCEEEEEEEEEECCCCCHHHHHHHHHHHHHHHHCCCCCCEEEEEEEEECCCEEEEE
T ss_conf 99688779820788289999998999699999999782338579999999999998622899883678888418736999
Q ss_pred EECCCCCCHHHHHHHC-------------CCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCC
Q ss_conf 9507999944676312-------------898767856789999999999998341599946732667683798589994
Q 004521 515 YEFMPNKSLDSFIFDQ-------------TRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNP 581 (747)
Q Consensus 515 ~e~~~~gsL~~~l~~~-------------~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dikp~NIll~~~~~~ 581 (747)
|||+++|+|.+++... .....+++..++.++.|+|.||.|||+.+ ++||||||+|||++.++.+
T Consensus 90 ~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~~---iiHrDlkp~NIL~~~~~~~ 166 (309)
T d1fvra_ 90 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYVA 166 (309)
T ss_dssp ECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECGGGCE
T ss_pred EEECCCCCHHHHHHHCCCCCCCHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHHHCCC---CCCCCCCCCEEEECCCCCE
T ss_conf 9802898699998640355555123101234578999999999999999987663089---5455505204898688763
Q ss_pred EEECCCCCCCCCCCCCCCC---CCEEE---ECCCCCCCCCCCCHHHHHHHHHHHHCCCCCCCCCCCCHHHHHHHHHHCCC
Q ss_conf 4712567500389987544---44021---02378888446402378999998819989999887640224486772198
Q 004521 582 KISDFGLVRTFGGDETEGN---TNRVV---GTYDGQFSIKSDVFSFGILLLEIVSGKKNRGFYRSDTKVNLIGHLWDEGI 655 (747)
Q Consensus 582 ki~DfGla~~~~~~~~~~~---~~~~~---~~~~~~~s~~sDVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~ 655 (747)
||+|||+++.......... +.... ...+..++.++||||||+++|||++|..|+ +...........+ ..+.
T Consensus 167 kl~DfG~a~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSfGvil~ell~~~~~p--~~~~~~~~~~~~i-~~~~ 243 (309)
T d1fvra_ 167 KIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTP--YCGMTCAELYEKL-PQGY 243 (309)
T ss_dssp EECCTTCEESSCEECCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCT--TTTCCHHHHHHHG-GGTC
T ss_pred EECCCCCCCCCCCCCCCCCEECCCCCCCHHHHCCCCCCCCCEEEHHHHHHHHHHHCCCCC--CCCCCHHHHHHHH-HHCC
T ss_conf 874344322444223455301377555538752699996221531388999998368999--9999999999999-8268
Q ss_pred CCCCCCHHHHCCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHCCCCC
Q ss_conf 652243011066999999999999976168999999998899998548989
Q 004521 656 PLRLIDACIQDSCNLADVIRCIHIGLLCVQQHPEDRPCMPSVILMLGSEIL 706 (747)
Q Consensus 656 ~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dP~~RPt~~~v~~~L~~~~~ 706 (747)
....... ....+.+++.+||+.||++||+|.+|++.|+....
T Consensus 244 ~~~~~~~---------~~~~~~~li~~cl~~dP~~RPs~~eil~~L~~i~~ 285 (309)
T d1fvra_ 244 RLEKPLN---------CDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLE 285 (309)
T ss_dssp CCCCCTT---------BCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CCCCCCC---------CCHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHHH
T ss_conf 8888766---------78999999999767896689499999999999986
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=313.34 Aligned_cols=242 Identities=21% Similarity=0.349 Sum_probs=183.0
Q ss_pred CCCCEECCCCCEEEEEEEECC-CCEEEEEEECCC--CCCCHHHHHHHHHHHHCCCCCCEEEEEEEEEE----CCEEEEEE
Q ss_conf 855421424980099999669-849999991343--31068999999999830599732337748994----98227999
Q 004521 443 SINNKLGEGGFGPVYKGTLVD-GQEIAVKRLSKI--SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQ----GEEKLLIY 515 (747)
Q Consensus 443 ~~~~~lg~G~~g~Vy~~~~~~-g~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~----~~~~~lV~ 515 (747)
++.++||+|+||+||+|.+.. ++.||+|++... .....+.+.+|++++++++||||+++++++.. ....++||
T Consensus 12 ~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~~~ivm 91 (270)
T d1t4ha_ 12 KFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVT 91 (270)
T ss_dssp EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEEEE
T ss_pred EEEEEEECCCCCEEEEEEECCCCEEEEEEEECHHHCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEEECCCCCCEEEEEE
T ss_conf 85169700828499999999999599999985122798999999999999985799985069999840334588899999
Q ss_pred ECCCCCCHHHHHHHCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEEC-CCCCCEEECCCCCCCCCC
Q ss_conf 5079999446763128987678567899999999999983415999467326676837985-899944712567500389
Q 004521 516 EFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLD-QDMNPKISDFGLVRTFGG 594 (747)
Q Consensus 516 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dikp~NIll~-~~~~~ki~DfGla~~~~~ 594 (747)
||+++|+|.+++... ..+++..+..++.|++.||+|||+++ .+|+||||||+|||++ +++.+||+|||+|+....
T Consensus 92 E~~~~g~L~~~l~~~---~~~~~~~~~~~~~qi~~gl~yLH~~~-~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~~~~~ 167 (270)
T d1t4ha_ 92 ELMTSGTLKTYLKRF---KVMKIKVLRSWCRQILKGLQFLHTRT-PPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRA 167 (270)
T ss_dssp ECCCSCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHTSS-SCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCCT
T ss_pred ECCCCCCHHHHHHCC---CCCCHHHHHHHHHHHHHHHHHHHHCC-CCEEECCCCHHHCEEECCCCCEEEEECCCCEECCC
T ss_conf 578989489997513---55469999999999999999999789-97996876743511667999889800576542368
Q ss_pred CCCCCC--CCEE--EECCCCCCCCCCCCHHHHHHHHHHHHCCCCCCCCCCCCHHHHHHHHHHCCCCCCCCCHHHHCCCCH
Q ss_conf 987544--4402--102378888446402378999998819989999887640224486772198652243011066999
Q 004521 595 DETEGN--TNRV--VGTYDGQFSIKSDVFSFGILLLEIVSGKKNRGFYRSDTKVNLIGHLWDEGIPLRLIDACIQDSCNL 670 (747)
Q Consensus 595 ~~~~~~--~~~~--~~~~~~~~s~~sDVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~ 670 (747)
...... +... +....+.++.++|||||||++|||++|+.||.... ........+ ..+......+ ....
T Consensus 168 ~~~~~~~GT~~Y~aPE~~~~~~~~~~DIwSlGvilyel~~g~~Pf~~~~--~~~~~~~~i-~~~~~~~~~~----~~~~- 239 (270)
T d1t4ha_ 168 SFAKAVIGTPEFMAPEMYEEKYDESVDVYAFGMCMLEMATSEYPYSECQ--NAAQIYRRV-TSGVKPASFD----KVAI- 239 (270)
T ss_dssp TSBEESCSSCCCCCGGGGGTCCCTHHHHHHHHHHHHHHHHSSCTTTTCS--SHHHHHHHH-TTTCCCGGGG----GCCC-
T ss_pred CCCCCCCCCCCCCCHHHHCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCC--CHHHHHHHH-HCCCCCCCCC----CCCC-
T ss_conf 7667755381300898847899986711007999999987889998765--599999999-7389986567----5578-
Q ss_pred HHHHHHHHHHHHCCCCCCCCCCCHHHHHH
Q ss_conf 99999999997616899999999889999
Q 004521 671 ADVIRCIHIGLLCVQQHPEDRPCMPSVIL 699 (747)
Q Consensus 671 ~~~~~~~~l~~~Cl~~dP~~RPt~~~v~~ 699 (747)
..+.+++.+||+.||++|||+.|+++
T Consensus 240 ---~~~~~li~~~l~~dp~~R~s~~ell~ 265 (270)
T d1t4ha_ 240 ---PEVKEIIEGCIRQNKDERYSIKDLLN 265 (270)
T ss_dssp ---HHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred ---HHHHHHHHHHCCCCHHHCCCHHHHHC
T ss_conf ---99999999976379758929999967
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=313.65 Aligned_cols=244 Identities=27% Similarity=0.434 Sum_probs=188.6
Q ss_pred CCEECCCCCEEEEEEEECCC----CEEEEEEECC-CCCCCHHHHHHHHHHHHCCCCCCEEEEEEEEEEC-CEEEEEEECC
Q ss_conf 54214249800999996698----4999999134-3310689999999998305997323377489949-8227999507
Q 004521 445 NNKLGEGGFGPVYKGTLVDG----QEIAVKRLSK-ISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQG-EEKLLIYEFM 518 (747)
Q Consensus 445 ~~~lg~G~~g~Vy~~~~~~g----~~vavK~l~~-~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~-~~~~lV~e~~ 518 (747)
.++||+|+||+||+|.+... ..||||+++. ......++|.+|++++++++||||++++|++... ...++||||+
T Consensus 32 ~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~E~~ 111 (311)
T d1r0pa_ 32 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYM 111 (311)
T ss_dssp EEEEEEETTEEEEEEEECC----CEEEEEEEECCCCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEEEEECC
T ss_pred CEEEEECCCEEEEEEEEECCCCEEEEEEEEEECCCCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEEECCCCEEEEEEEE
T ss_conf 66981368809999999779987999999998843697899999999999986789998678678980699438999874
Q ss_pred CCCCHHHHHHHCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCCEEECCCCCCCCCCCCCC
Q ss_conf 99994467631289876785678999999999999834159994673266768379858999447125675003899875
Q 004521 519 PNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETE 598 (747)
Q Consensus 519 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dikp~NIll~~~~~~ki~DfGla~~~~~~~~~ 598 (747)
++|+|.+++... ...+++..++.++.|++.||.|||+.+ |+||||||+|||+++++.+||+|||+++........
T Consensus 112 ~~g~l~~~~~~~--~~~~~~~~~~~i~~qia~gL~~lH~~~---iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~~~~~ 186 (311)
T d1r0pa_ 112 KHGDLRNFIRNE--THNPTVKDLIGFGLQVAKGMKFLASKK---FVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFD 186 (311)
T ss_dssp TTCBHHHHHHCT--TCCCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTCCEEECSSGGGCCTTTTTCC
T ss_pred ECCCHHHHHCCC--CCCCHHHHHHHHHHHHHHHHHHHCCCC---CCCCCCCHHHEEECCCCCEEEECCCCHHHCCCCCCC
T ss_conf 067414421013--454048999999999887652003367---625776687576779998899106523225566555
Q ss_pred CCC--CEEEEC---------CCCCCCCCCCCHHHHHHHHHHHHCCCCCCCCCCCCHHHHHHHHHHCCCCCCCCCHHHHCC
Q ss_conf 444--402102---------378888446402378999998819989999887640224486772198652243011066
Q 004521 599 GNT--NRVVGT---------YDGQFSIKSDVFSFGILLLEIVSGKKNRGFYRSDTKVNLIGHLWDEGIPLRLIDACIQDS 667 (747)
Q Consensus 599 ~~~--~~~~~~---------~~~~~s~~sDVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~ 667 (747)
... ....++ ....++.++||||||+++|||+||+.|+.... ........+ ..+......+.
T Consensus 187 ~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl~El~t~~~p~~~~~--~~~~~~~~i-~~g~~~~~p~~----- 258 (311)
T d1r0pa_ 187 SVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDV--NTFDITVYL-LQGRRLLQPEY----- 258 (311)
T ss_dssp CTTCTTCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCC--------CHHHH-HTTCCCCCCTT-----
T ss_pred CCEECCCCCCCCCCCCHHHHHCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCC--CHHHHHHHH-HCCCCCCCCCC-----
T ss_conf 3100256555645567688743799974574661999999997899998889--999999999-80898899644-----
Q ss_pred CCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHCCCC
Q ss_conf 99999999999997616899999999889999854898
Q 004521 668 CNLADVIRCIHIGLLCVQQHPEDRPCMPSVILMLGSEI 705 (747)
Q Consensus 668 ~~~~~~~~~~~l~~~Cl~~dP~~RPt~~~v~~~L~~~~ 705 (747)
. ...+.+++.+||+.||++||+|.||++.|+...
T Consensus 259 ~----~~~l~~li~~cl~~dP~~RPs~~ei~~~L~~i~ 292 (311)
T d1r0pa_ 259 C----PDPLYEVMLKCWHPKAEMRPSFSELVSRISAIF 292 (311)
T ss_dssp C----CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred C----CHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHH
T ss_conf 7----599999999976889768939999999999999
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=8.4e-45 Score=304.82 Aligned_cols=235 Identities=20% Similarity=0.246 Sum_probs=189.9
Q ss_pred CCCCCCCEECCCCCEEEEEEEEC-CCCEEEEEEECC---CCCCCHHHHHHHHHHHHCCCCCCEEEEEEEEEECCEEEEEE
Q ss_conf 39785542142498009999966-984999999134---33106899999999983059973233774899498227999
Q 004521 440 DNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSK---ISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIY 515 (747)
Q Consensus 440 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~---~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~ 515 (747)
++|++.+.||+|+||.||+|++. +|+.||||++.+ ......+.+.+|+.+++.++||||+++++++......++|+
T Consensus 41 d~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~v~ 120 (350)
T d1rdqe_ 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVM 120 (350)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred CCEEEEEEEECCCCCEEEEEEECCCCCEEEEEEECHHHCCCHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCCCCCCCCC
T ss_conf 37089889611768089999998999899999982677458899999999999999748772740344443222223222
Q ss_pred ECCCCCCHHHHHHHCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCCEEECCCCCCCCCCC
Q ss_conf 50799994467631289876785678999999999999834159994673266768379858999447125675003899
Q 004521 516 EFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGD 595 (747)
Q Consensus 516 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dikp~NIll~~~~~~ki~DfGla~~~~~~ 595 (747)
||+.+|+|..++.... .+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+|+.+...
T Consensus 121 e~~~~g~l~~~l~~~~---~l~e~~~~~i~~qi~~aL~yLH~~~---iiHRDIKP~NILl~~~g~ikL~DFG~a~~~~~~ 194 (350)
T d1rdqe_ 121 EYVAGGEMFSHLRRIG---RFSEPHARFYAAQIVLTFEYLHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR 194 (350)
T ss_dssp ECCTTCBHHHHHHHHC---CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECSSC
T ss_pred CCCCCCCHHHHHHHCC---CCCHHHHHHHHHHHHHHHHHHHHCC---EECCCCCHHHCCCCCCCCEEEEECEEEEECCCC
T ss_conf 2334662266675158---9899999999999999899998599---861767999936077897886101033322566
Q ss_pred CCCCCCCEEEEC---------CCCCCCCCCCCHHHHHHHHHHHHCCCCCCCCCCCCHHHHHHHHHHCCCCCCCCCHHHHC
Q ss_conf 875444402102---------37888844640237899999881998999988764022448677219865224301106
Q 004521 596 ETEGNTNRVVGT---------YDGQFSIKSDVFSFGILLLEIVSGKKNRGFYRSDTKVNLIGHLWDEGIPLRLIDACIQD 666 (747)
Q Consensus 596 ~~~~~~~~~~~~---------~~~~~s~~sDVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 666 (747)
... ..|+ .+..++.++|||||||++|||++|+.||.. .........+.... .. .. .
T Consensus 195 ~~~-----~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~---~~~~~~~~~i~~~~-~~-~p-----~ 259 (350)
T d1rdqe_ 195 TWT-----LCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFA---DQPIQIYEKIVSGK-VR-FP-----S 259 (350)
T ss_dssp BCC-----CEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCC---SSHHHHHHHHHHCC-CC-CC-----T
T ss_pred CCC-----CCCCCCCCCHHHHCCCCCCCCCCCCCHHHHHHHHHHCCCCCCC---CCHHHHHHHHHCCC-CC-CC-----C
T ss_conf 643-----3676356788997179988533114500789999758899899---59999999986179-88-97-----6
Q ss_pred CCCHHHHHHHHHHHHHCCCCCCCCCC-----CHHHHHH
Q ss_conf 69999999999999761689999999-----9889999
Q 004521 667 SCNLADVIRCIHIGLLCVQQHPEDRP-----CMPSVIL 699 (747)
Q Consensus 667 ~~~~~~~~~~~~l~~~Cl~~dP~~RP-----t~~~v~~ 699 (747)
..+ ..+.+++.+||+.||.+|+ ++.++++
T Consensus 260 ~~s----~~~~~li~~~L~~dP~kR~~~~r~t~~ell~ 293 (350)
T d1rdqe_ 260 HFS----SDLKDLLRNLLQVDLTKRFGNLKNGVNDIKN 293 (350)
T ss_dssp TCC----HHHHHHHHHHSCSCTTTCTTSSTTTTHHHHT
T ss_pred CCC----HHHHHHHHHHHHHCHHHCCCCCCCCHHHHHC
T ss_conf 689----9999999998340998606553454999971
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7e-45 Score=305.57 Aligned_cols=239 Identities=21% Similarity=0.251 Sum_probs=190.4
Q ss_pred HCCCCCCCEECCCCCEEEEEEEEC-CCCEEEEEEECCC---CCCCHHHHHHHHHHHHCCCCCCEEEEEEEEEECCEEEEE
Q ss_conf 239785542142498009999966-9849999991343---310689999999998305997323377489949822799
Q 004521 439 TDNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKI---SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLI 514 (747)
Q Consensus 439 ~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV 514 (747)
.++|++.+.||+|+||.||+++.. +++.||+|++++. .....+.+.+|+.++++++||||+++++++.+....++|
T Consensus 4 l~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~iv 83 (337)
T d1o6la_ 4 MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFV 83 (337)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEE
T ss_pred HHHCEEEEEEECCCCEEEEEEEECCCCCEEEEEEECHHHCCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEECCCCCCCCC
T ss_conf 47428988983176849999999899989999998156544979999999999999867999887787640356421110
Q ss_pred EECCCCCCHHHHHHHCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCCEEECCCCCCCCCC
Q ss_conf 95079999446763128987678567899999999999983415999467326676837985899944712567500389
Q 004521 515 YEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGG 594 (747)
Q Consensus 515 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dikp~NIll~~~~~~ki~DfGla~~~~~ 594 (747)
|||+++|+|.+++... ..+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+|+....
T Consensus 84 ~ey~~gg~L~~~~~~~---~~~~e~~~~~~~~qil~al~ylH~~~---iiHRDlKP~NILl~~~g~vkl~DFG~a~~~~~ 157 (337)
T d1o6la_ 84 MEYANGGELFFHLSRE---RVFTEERARFYGAEIVSALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCKEGIS 157 (337)
T ss_dssp EECCTTCBHHHHHHHH---SCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCSCC
T ss_pred EECCCCCCHHHHHHCC---CCCCHHHHHHHHHHHHHHHHHHHHCC---CCCCCCCHHHEEECCCCCEEEEECCCCCCCCC
T ss_conf 0035798605555325---67759999999999965211343159---62246477784765899888820565200356
Q ss_pred CCCCCCCCEEEEC---------CCCCCCCCCCCHHHHHHHHHHHHCCCCCCCCCCCCHHHHHHHHHHCCCCCCCCCHHHH
Q ss_conf 9875444402102---------3788884464023789999988199899998876402244867721986522430110
Q 004521 595 DETEGNTNRVVGT---------YDGQFSIKSDVFSFGILLLEIVSGKKNRGFYRSDTKVNLIGHLWDEGIPLRLIDACIQ 665 (747)
Q Consensus 595 ~~~~~~~~~~~~~---------~~~~~s~~sDVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 665 (747)
...... ...|+ .+..|+.++||||+||++|||++|+.||.... ...+....... .. .+..
T Consensus 158 ~~~~~~--~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~G~~pf~~~~---~~~~~~~i~~~-~~-~~p~---- 226 (337)
T d1o6la_ 158 DGATMK--TFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQD---HERLFELILME-EI-RFPR---- 226 (337)
T ss_dssp TTCCBC--CCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSS---HHHHHHHHHHC-CC-CCCT----
T ss_pred CCCCCC--CCEECHHHHHHHHCCCCCCCHHHCCCCHHHHHHHHHHCCCCCCCCC---HHHHHHHHHCC-CC-CCCC----
T ss_conf 786205--5100889966665048988833310223067889987899999969---99999998528-99-8986----
Q ss_pred CCCCHHHHHHHHHHHHHCCCCCCCCCCC-----HHHHHH
Q ss_conf 6699999999999997616899999999-----889999
Q 004521 666 DSCNLADVIRCIHIGLLCVQQHPEDRPC-----MPSVIL 699 (747)
Q Consensus 666 ~~~~~~~~~~~~~l~~~Cl~~dP~~RPt-----~~~v~~ 699 (747)
..+ ..+.+++.+||+.||.+||+ +.++++
T Consensus 227 -~~s----~~~~dli~~~L~~dP~~R~~~~~~~~~eil~ 260 (337)
T d1o6la_ 227 -TLS----PEAKSLLAGLLKKDPKQRLGGGPSDAKEVME 260 (337)
T ss_dssp -TSC----HHHHHHHHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred -CCC----HHHHHHHHHHCCCCCHHHCCCCCCCHHHHHC
T ss_conf -689----9999999866638934422565234999972
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=1.4e-45 Score=310.23 Aligned_cols=244 Identities=22% Similarity=0.276 Sum_probs=184.1
Q ss_pred HCCCCCCCEECCCCCEEEEEEEECC-CCEEEEEEECCC---CCCCHHHHHH---HHHHHHCCCCCCEEEEEEEEEECCEE
Q ss_conf 2397855421424980099999669-849999991343---3106899999---99998305997323377489949822
Q 004521 439 TDNFSINNKLGEGGFGPVYKGTLVD-GQEIAVKRLSKI---SEQGLKELKN---EVILFSKLQHRNLVKLLGCCIQGEEK 511 (747)
Q Consensus 439 ~~~~~~~~~lg~G~~g~Vy~~~~~~-g~~vavK~l~~~---~~~~~~~~~~---E~~~l~~l~H~nIv~l~g~~~~~~~~ 511 (747)
.++|++.+.||+|+||.||+|+... ++.||||++.+. .......+.+ ++.+++.++||||+++++++...+..
T Consensus 3 lddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~~~ 82 (364)
T d1omwa3 3 MNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKL 82 (364)
T ss_dssp STTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEE
T ss_pred HHHCEEEEEEECCCCEEEEEEEECCCCCEEEEEEECHHHCCHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEEEEEECCEE
T ss_conf 77685101884288909999999999979999998458754266799999999999998508998588999999989988
Q ss_pred EEEEECCCCCCHHHHHHHCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCCEEECCCCCCC
Q ss_conf 79995079999446763128987678567899999999999983415999467326676837985899944712567500
Q 004521 512 LLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRT 591 (747)
Q Consensus 512 ~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dikp~NIll~~~~~~ki~DfGla~~ 591 (747)
++||||+++|+|.+++... ..+++..+..++.||+.||.|||+.+ ++||||||+|||++.++.+||+|||+|+.
T Consensus 83 ~ivmE~~~gg~L~~~l~~~---~~~~e~~~~~~~~qi~~aL~ylH~~~---iiHrDlKP~NILl~~~g~iKl~DFGla~~ 156 (364)
T d1omwa3 83 SFILDLMNGGDLHYHLSQH---GVFSEADMRFYAAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACD 156 (364)
T ss_dssp EEEECCCCSCBHHHHHHHH---CSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECSSSCEEECCCTTCEE
T ss_pred EEEEEECCCCCHHHHHHHC---CCCCHHHHHHHHHHHHHHHHHHHHCC---CCCEEECCCEEEECCCCCEEEEEECEEEE
T ss_conf 9999914898389998732---55327899999999999999999779---62204442216785889679822010233
Q ss_pred CCCCCCCCCC--CEEEEC----CCCCCCCCCCCHHHHHHHHHHHHCCCCCCCCCCCCHHHHHHHHHHCCCCCCCCCHHHH
Q ss_conf 3899875444--402102----3788884464023789999988199899998876402244867721986522430110
Q 004521 592 FGGDETEGNT--NRVVGT----YDGQFSIKSDVFSFGILLLEIVSGKKNRGFYRSDTKVNLIGHLWDEGIPLRLIDACIQ 665 (747)
Q Consensus 592 ~~~~~~~~~~--~~~~~~----~~~~~s~~sDVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 665 (747)
+......... .....+ .+..++.++|||||||++|||+||+.||................ . ......+
T Consensus 157 ~~~~~~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~~~~-~-~~~~~~~---- 230 (364)
T d1omwa3 157 FSKKKPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTL-T-MAVELPD---- 230 (364)
T ss_dssp CSSSCCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSCHHHHHHHSS-S-CCCCCCS----
T ss_pred CCCCCCCCCCCCCCCCHHHHHHCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHCC-C-CCCCCCC----
T ss_conf 378864331134554216876038999844104677899999985999888899899999998604-6-8887887----
Q ss_pred CCCCHHHHHHHHHHHHHCCCCCCCCCCC-----HHHHHH
Q ss_conf 6699999999999997616899999999-----889999
Q 004521 666 DSCNLADVIRCIHIGLLCVQQHPEDRPC-----MPSVIL 699 (747)
Q Consensus 666 ~~~~~~~~~~~~~l~~~Cl~~dP~~RPt-----~~~v~~ 699 (747)
..+ ..+.+++.+||+.||.+||+ +.++++
T Consensus 231 -~~s----~~~~~li~~~L~~dP~~R~t~~~~~a~eil~ 264 (364)
T d1omwa3 231 -SFS----PELRSLLEGLLQRDVNRRLGCLGRGAQEVKE 264 (364)
T ss_dssp -SSC----HHHHHHHHHHTCSSTTTSTTTSSSTHHHHHT
T ss_pred -CCC----HHHHHHHHHHCCCCHHHHCCCCCCCHHHHHC
T ss_conf -789----9999999998566988808874357999974
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=0 Score=313.36 Aligned_cols=248 Identities=21% Similarity=0.288 Sum_probs=191.7
Q ss_pred HCCCCCCCEECCCCCEEEEEEEECC-CCEEEEEEECCC-CCCCHHHHHHHHHHHHCCCCCCEEEEEEEEEECCEEEEEEE
Q ss_conf 2397855421424980099999669-849999991343-31068999999999830599732337748994982279995
Q 004521 439 TDNFSINNKLGEGGFGPVYKGTLVD-GQEIAVKRLSKI-SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYE 516 (747)
Q Consensus 439 ~~~~~~~~~lg~G~~g~Vy~~~~~~-g~~vavK~l~~~-~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~e 516 (747)
.+.|++.+.||+|+||+||+|+... ++.||||.+... .......+.+|+.++++++||||+++++++.+.+..++|||
T Consensus 8 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lvmE 87 (307)
T d1a06a_ 8 RDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIMQ 87 (307)
T ss_dssp GGTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC----------CHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred CCCEEEEEEEEECCCEEEEEEEECCCCCEEEEEEECHHHHHHHHHHHHHHHHHHHHCCCCCCCCEEEEEEECCEEEEEEE
T ss_conf 66669988994065839999999999989999998157731289999999999986799899919899998998889885
Q ss_pred CCCCCCHHHHHHHCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEEC---CCCCCEEECCCCCCCCC
Q ss_conf 079999446763128987678567899999999999983415999467326676837985---89994471256750038
Q 004521 517 FMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLD---QDMNPKISDFGLVRTFG 593 (747)
Q Consensus 517 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dikp~NIll~---~~~~~ki~DfGla~~~~ 593 (747)
|+++|+|.+++.. ...+++..+..++.|++.||+|||+.+ |+||||||+|||+. +++.+||+|||+|+...
T Consensus 88 ~~~gg~L~~~l~~---~~~l~e~~~~~~~~qi~~al~ylH~~~---iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~~~ 161 (307)
T d1a06a_ 88 LVSGGELFDRIVE---KGFYTERDASRLIFQVLDAVKYLHDLG---IVHRDLKPENLLYYSLDEDSKIMISDFGLSKMED 161 (307)
T ss_dssp CCCSCBHHHHHHT---CSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESSSSTTCCEEECCC-------
T ss_pred CCCCCCHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHCE---EEEEEECCCCEEECCCCCCCEEEEECCCEEEECC
T ss_conf 2689848886530---367887899999999999987524130---5568704630011046888249983154358725
Q ss_pred CCCCCCCCCEEEEC---------CCCCCCCCCCCHHHHHHHHHHHHCCCCCCCCCCCCHHHHHHHHHHCCCCCCCCCHHH
Q ss_conf 99875444402102---------378888446402378999998819989999887640224486772198652243011
Q 004521 594 GDETEGNTNRVVGT---------YDGQFSIKSDVFSFGILLLEIVSGKKNRGFYRSDTKVNLIGHLWDEGIPLRLIDACI 664 (747)
Q Consensus 594 ~~~~~~~~~~~~~~---------~~~~~s~~sDVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 664 (747)
...... ...|+ .+..++.++||||+||++|||++|+.||... ................. .+ .
T Consensus 162 ~~~~~~---~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~---~~~~~~~~i~~~~~~~~--~~-~ 232 (307)
T d1a06a_ 162 PGSVLS---TACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDE---NDAKLFEQILKAEYEFD--SP-Y 232 (307)
T ss_dssp --------------CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCS---SHHHHHHHHHTTCCCCC--TT-T
T ss_pred CCCEEE---EEEECCCCCCCHHHCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCC---CHHHHHHHHHCCCCCCC--CC-C
T ss_conf 897044---003284225918873799980787345159999998597999998---99999999861687778--76-6
Q ss_pred HCCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHH--HCCCC
Q ss_conf 066999999999999976168999999998899998--54898
Q 004521 665 QDSCNLADVIRCIHIGLLCVQQHPEDRPCMPSVILM--LGSEI 705 (747)
Q Consensus 665 ~~~~~~~~~~~~~~l~~~Cl~~dP~~RPt~~~v~~~--L~~~~ 705 (747)
....+ ..+.+++.+||+.||.+|||+.|+++. +.+..
T Consensus 233 ~~~~s----~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~~~ 271 (307)
T d1a06a_ 233 WDDIS----DSAKDFIRHLMEKDPEKRFTCEQALQHPWIAGDT 271 (307)
T ss_dssp TTTSC----HHHHHHHHHHSCSSGGGSCCHHHHHHSTTTTSSC
T ss_pred CCCCC----HHHHHHHHHHCCCCHHHCCCHHHHHCCHHHCCCC
T ss_conf 66789----9999999997608975791899986298447997
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=317.92 Aligned_cols=246 Identities=27% Similarity=0.390 Sum_probs=191.9
Q ss_pred CCCCCCCEECCCCCEEEEEEEECC--C--CEEEEEEECCC---CCCCHHHHHHHHHHHHCCCCCCEEEEEEEEEECCEEE
Q ss_conf 397855421424980099999669--8--49999991343---3106899999999983059973233774899498227
Q 004521 440 DNFSINNKLGEGGFGPVYKGTLVD--G--QEIAVKRLSKI---SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKL 512 (747)
Q Consensus 440 ~~~~~~~~lg~G~~g~Vy~~~~~~--g--~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~ 512 (747)
++|++.+.||+|+||.||+|+... + ..||||++++. ..+..++|.+|+.++++++||||++++|++.+ ...+
T Consensus 8 ~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~-~~~~ 86 (273)
T d1u46a_ 8 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLT-PPMK 86 (273)
T ss_dssp GGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCE
T ss_pred HHEEEEEEEECCCCEEEEEEEEECCCCCEEEEEEEEECHHHCCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEEE-CCHH
T ss_conf 891997898038883999999988999079999999983555798999999999999986899998789877740-1001
Q ss_pred EEEECCCCCCHHHHHHHCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCCEEECCCCCCCC
Q ss_conf 99950799994467631289876785678999999999999834159994673266768379858999447125675003
Q 004521 513 LIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTF 592 (747)
Q Consensus 513 lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dikp~NIll~~~~~~ki~DfGla~~~ 592 (747)
+||||+++|+|.+++... ...+++..+..++.|+|.||.|||+.+ |+||||||+||+++.++.+||+|||+++..
T Consensus 87 lv~e~~~~~~l~~~~~~~--~~~l~~~~~~~~~~qi~~gl~ylH~~~---iiHrDikp~NIll~~~~~vkl~DfGl~~~~ 161 (273)
T d1u46a_ 87 MVTELAPLGSLLDRLRKH--QGHFLLGTLSRYAVQVAEGMGYLESKR---FIHRDLAARNLLLATRDLVKIGDFGLMRAL 161 (273)
T ss_dssp EEEECCTTCBHHHHHHHH--GGGSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEEEETTEEEECCCTTCEEC
T ss_pred EEEEEECCCCHHHHHHCC--CCCCCHHHHHHHHHHHHHHHHHHHHCC---EEEEEECHHHHCCCCCCCEEECCCHHHHHC
T ss_conf 146542386125444212--689999999999999999998752178---752056688815655654332561155530
Q ss_pred CCCCCCCCCCE-EEEC---------CCCCCCCCCCCHHHHHHHHHHHH-CCCCCCCCCCCCHHHHHHHHHHCCCCCCCCC
Q ss_conf 89987544440-2102---------37888844640237899999881-9989999887640224486772198652243
Q 004521 593 GGDETEGNTNR-VVGT---------YDGQFSIKSDVFSFGILLLEIVS-GKKNRGFYRSDTKVNLIGHLWDEGIPLRLID 661 (747)
Q Consensus 593 ~~~~~~~~~~~-~~~~---------~~~~~s~~sDVwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~d 661 (747)
........... ..++ .+..++.++||||||+++|||+| |+.||. ..............+.......
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~emlt~G~~Pf~---~~~~~~~~~~i~~~~~~~~~~~ 238 (273)
T d1u46a_ 162 PQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWI---GLNGSQILHKIDKEGERLPRPE 238 (273)
T ss_dssp CC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTT---TCCHHHHHHHHHTSCCCCCCCT
T ss_pred CCCCCCCEECCCCCCCCCCCCHHHHHCCCCCCCHHHHHHHHHHHHHHHCCCCCCC---CCCHHHHHHHHHHCCCCCCCCC
T ss_conf 3588752654763257310799998379999421566148999999968999999---9699999999984799999854
Q ss_pred HHHHCCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHCC
Q ss_conf 011066999999999999976168999999998899998548
Q 004521 662 ACIQDSCNLADVIRCIHIGLLCVQQHPEDRPCMPSVILMLGS 703 (747)
Q Consensus 662 ~~l~~~~~~~~~~~~~~l~~~Cl~~dP~~RPt~~~v~~~L~~ 703 (747)
. .+ ..+.+++.+||+.||++||||.+|+.+|..
T Consensus 239 ~-----~~----~~l~~li~~cl~~dp~~RPt~~ei~~~L~~ 271 (273)
T d1u46a_ 239 D-----CP----QDIYNVMVQCWAHKPEDRPTFVALRDFLLE 271 (273)
T ss_dssp T-----CC----HHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred C-----CC----HHHHHHHHHHCCCCHHHCCCHHHHHHHHHH
T ss_conf 4-----53----999999999768896679299999999996
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-45 Score=309.28 Aligned_cols=245 Identities=21% Similarity=0.265 Sum_probs=188.8
Q ss_pred HCCCCCCCEECCCCCEEEEEEEEC-CCCEEEEEEECCC------CCCCHHHHHHHHHHHHCCCCCCEEEEEEEEEECCEE
Q ss_conf 239785542142498009999966-9849999991343------310689999999998305997323377489949822
Q 004521 439 TDNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKI------SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEK 511 (747)
Q Consensus 439 ~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~------~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~ 511 (747)
.+.|++.+.||+|+||+||+|+.. +|+.||||++++. .....+.+.+|+.++++++||||+++++++.+.+..
T Consensus 9 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~ 88 (293)
T d1jksa_ 9 DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDV 88 (293)
T ss_dssp GGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred CCCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEEEHHHCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCEEEEEEECCEE
T ss_conf 56779827981178959999999999989999998756632134068999999999999867998999388999979989
Q ss_pred EEEEECCCCCCHHHHHHHCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCC----CCEEECCC
Q ss_conf 79995079999446763128987678567899999999999983415999467326676837985899----94471256
Q 004521 512 LLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDM----NPKISDFG 587 (747)
Q Consensus 512 ~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dikp~NIll~~~~----~~ki~DfG 587 (747)
++||||+++|+|.+++... ..+++..+..++.|++.||+|||+.+ |+||||||+|||++.++ .+||+|||
T Consensus 89 ~iv~E~~~gg~L~~~i~~~---~~l~~~~~~~~~~qi~~al~yLH~~~---ivHrDiKp~Nill~~~~~~~~~vkl~DfG 162 (293)
T d1jksa_ 89 ILILELVAGGELFDFLAEK---ESLTEEEATEFLKQILNGVYYLHSLQ---IAHFDLKPENIMLLDRNVPKPRIKIIDFG 162 (293)
T ss_dssp EEEEECCCSCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCSSSSSCCEEECCCT
T ss_pred EEEEECCCCCCCCCHHCCC---CCCCHHHHHHHHHHHHHHHHHHHHCC---EEECCCCCCEEEEECCCCCCCCEEECCHH
T ss_conf 9999867786431001035---64215578999999999987666254---22113330127982589866646964334
Q ss_pred CCCCCCCCCCCCCC---CEEEEC---CCCCCCCCCCCHHHHHHHHHHHHCCCCCCCCCCCCHHHHHHHHHHCCCCCCCCC
Q ss_conf 75003899875444---402102---378888446402378999998819989999887640224486772198652243
Q 004521 588 LVRTFGGDETEGNT---NRVVGT---YDGQFSIKSDVFSFGILLLEIVSGKKNRGFYRSDTKVNLIGHLWDEGIPLRLID 661 (747)
Q Consensus 588 la~~~~~~~~~~~~---~~~~~~---~~~~~s~~sDVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~d 661 (747)
+|+........... .....+ .+..++.++||||+||++|||++|+.||... .....+..+.. +... ...
T Consensus 163 ~a~~~~~~~~~~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~---~~~~~~~~i~~-~~~~-~~~ 237 (293)
T d1jksa_ 163 LAHKIDFGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGD---TKQETLANVSA-VNYE-FED 237 (293)
T ss_dssp TCEECTTSCBCSCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCS---SHHHHHHHHHT-TCCC-CCH
T ss_pred HHHHCCCCCCCCCCCCCCCCCCHHHHCCCCCCCCCCCHHHHHHHHHHHCCCCCCCCC---CHHHHHHHHHH-CCCC-CCC
T ss_conf 421057776312247777430999981899997665221409999997088998899---99999999981-6888-870
Q ss_pred HHHHCCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHH
Q ss_conf 01106699999999999997616899999999889999
Q 004521 662 ACIQDSCNLADVIRCIHIGLLCVQQHPEDRPCMPSVIL 699 (747)
Q Consensus 662 ~~l~~~~~~~~~~~~~~l~~~Cl~~dP~~RPt~~~v~~ 699 (747)
. ..... ...+.+++.+||+.||.+|||+.++++
T Consensus 238 ~-~~~~~----s~~~~~li~~~L~~dP~~R~s~~eil~ 270 (293)
T d1jksa_ 238 E-YFSNT----SALAKDFIRRLLVKDPKKRMTIQDSLQ 270 (293)
T ss_dssp H-HHTTS----CHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred H-HCCCC----CHHHHHHHHHHCCCCHHHCCCHHHHHC
T ss_conf 1-04788----999999999986389668919999961
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-45 Score=310.49 Aligned_cols=242 Identities=18% Similarity=0.243 Sum_probs=188.8
Q ss_pred HCCCCCCCEECCCCCEEEEEEEECC-CCEEEEEEECCCCCCCHHHHHHHHHHHHCCCCCCEEEEEEEEEECCEEEEEEEC
Q ss_conf 2397855421424980099999669-849999991343310689999999998305997323377489949822799950
Q 004521 439 TDNFSINNKLGEGGFGPVYKGTLVD-GQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEF 517 (747)
Q Consensus 439 ~~~~~~~~~lg~G~~g~Vy~~~~~~-g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~e~ 517 (747)
.++|++.+.||+|+||+||+|.... ++.||+|.++.. ......+.+|+.+++.++||||+++++++.+.+..++||||
T Consensus 4 ~~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~-~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~lvmE~ 82 (321)
T d1tkia_ 4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVK-GTDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEF 82 (321)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCC-THHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECC
T ss_pred CCCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEECCC-CCCHHHHHHHHHHHHHCCCCCCCEEEEEEEECCEEEEEEEC
T ss_conf 01058878983177839999999899969999997578-66599999999999857997989098999889988999953
Q ss_pred CCCCCHHHHHHHCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCC--CCCEEECCCCCCCCCCC
Q ss_conf 7999944676312898767856789999999999998341599946732667683798589--99447125675003899
Q 004521 518 MPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQD--MNPKISDFGLVRTFGGD 595 (747)
Q Consensus 518 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dikp~NIll~~~--~~~ki~DfGla~~~~~~ 595 (747)
+++|+|.+++... ...+++..+..++.|++.||+|||+.+ |+||||||+|||++.+ ..+||+|||+++.....
T Consensus 83 ~~gg~L~~~i~~~--~~~l~e~~~~~i~~qi~~al~yLH~~~---iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~~~~ 157 (321)
T d1tkia_ 83 ISGLDIFERINTS--AFELNEREIVSYVHQVCEALQFLHSHN---IGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPG 157 (321)
T ss_dssp CCCCBHHHHHTSS--SCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSCCCEEECCCTTCEECCTT
T ss_pred CCCCCHHHHHHHC--CCCCCHHHHHHHHHHHHHHHHHHHHCC---CCCCCCCCCCEEECCCCCEEEEECCCCHHHCCCCC
T ss_conf 8998088998753--899999999999999999999998769---97513554443443788518997644111003467
Q ss_pred CCCCCCCEEEEC---------CCCCCCCCCCCHHHHHHHHHHHHCCCCCCCCCCCCHHHHHHHHHHCCCCCCCCCHHHHC
Q ss_conf 875444402102---------37888844640237899999881998999988764022448677219865224301106
Q 004521 596 ETEGNTNRVVGT---------YDGQFSIKSDVFSFGILLLEIVSGKKNRGFYRSDTKVNLIGHLWDEGIPLRLIDACIQD 666 (747)
Q Consensus 596 ~~~~~~~~~~~~---------~~~~~s~~sDVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 666 (747)
..... ..++ .+..++.++||||+||++|||++|+.||.... .......+...... +... ...
T Consensus 158 ~~~~~---~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~G~~Pf~~~~---~~~~~~~i~~~~~~--~~~~-~~~ 228 (321)
T d1tkia_ 158 DNFRL---LFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAET---NQQIIENIMNAEYT--FDEE-AFK 228 (321)
T ss_dssp CEEEE---EESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSS---HHHHHHHHHHTCCC--CCHH-HHT
T ss_pred CCCCC---CCCCCCCCCCHHCCCCCCCCHHHCCCHHHHHHHHHHCCCCCCCCC---HHHHHHHHHHCCCC--CCHH-HCC
T ss_conf 75321---223322234021048777840113027999999982899999989---99999999838999--8802-236
Q ss_pred CCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHH
Q ss_conf 699999999999997616899999999889999
Q 004521 667 SCNLADVIRCIHIGLLCVQQHPEDRPCMPSVIL 699 (747)
Q Consensus 667 ~~~~~~~~~~~~l~~~Cl~~dP~~RPt~~~v~~ 699 (747)
..+ ..+.+++.+||+.||.+|||+.|+++
T Consensus 229 ~~s----~~~~~li~~~L~~dp~~R~s~~eil~ 257 (321)
T d1tkia_ 229 EIS----IEAMDFVDRLLVKERKSRMTASEALQ 257 (321)
T ss_dssp TSC----HHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred CCC----HHHHHHHHHHCCCCHHHCCCHHHHHC
T ss_conf 789----99999999986699668909999963
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=312.30 Aligned_cols=252 Identities=29% Similarity=0.433 Sum_probs=196.6
Q ss_pred HHCCCCCCCEECCCCCEEEEEEEECC--------CCEEEEEEECCC-CCCCHHHHHHHHHHHHCC-CCCCEEEEEEEEEE
Q ss_conf 72397855421424980099999669--------849999991343-310689999999998305-99732337748994
Q 004521 438 ATDNFSINNKLGEGGFGPVYKGTLVD--------GQEIAVKRLSKI-SEQGLKELKNEVILFSKL-QHRNLVKLLGCCIQ 507 (747)
Q Consensus 438 ~~~~~~~~~~lg~G~~g~Vy~~~~~~--------g~~vavK~l~~~-~~~~~~~~~~E~~~l~~l-~H~nIv~l~g~~~~ 507 (747)
..++|++.+.||+|+||.||+|+... +..||||+++.. ......++.+|...+.++ +||||+++++++.+
T Consensus 11 ~~~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~~~ 90 (299)
T d1fgka_ 11 PRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQ 90 (299)
T ss_dssp CGGGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred CHHHEEEEEEEEECCCCEEEEEEECCCCCCCCCCCEEEEEEEECCCCCHHHHHHHHHHHHHHHHHCCCCEEEECCCCCCC
T ss_conf 58996970098516782899999857875556675499999988112868899999999999981399969734652201
Q ss_pred CCEEEEEEECCCCCCHHHHHHHCCC-------------CCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEE
Q ss_conf 9822799950799994467631289-------------876785678999999999999834159994673266768379
Q 004521 508 GEEKLLIYEFMPNKSLDSFIFDQTR-------------RTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVL 574 (747)
Q Consensus 508 ~~~~~lV~e~~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dikp~NIl 574 (747)
+...++||||+++|+|.+++..... ...+++..++.++.|++.||+|||+.+ ++||||||+|||
T Consensus 91 ~~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~~---ivHrDiKp~NiL 167 (299)
T d1fgka_ 91 DGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKK---CIHRDLAARNVL 167 (299)
T ss_dssp SSSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEE
T ss_pred CCEEEEEEECCCCCCHHHHHHHHCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCC---EEEEEECCCCEE
T ss_conf 88689999736999099999860677643222334574346799999999999999998766379---786302210224
Q ss_pred ECCCCCCEEECCCCCCCCCCCCCCCCCCEEEEC---------CCCCCCCCCCCHHHHHHHHHHHH-CCCCCCCCCCCCHH
Q ss_conf 858999447125675003899875444402102---------37888844640237899999881-99899998876402
Q 004521 575 LDQDMNPKISDFGLVRTFGGDETEGNTNRVVGT---------YDGQFSIKSDVFSFGILLLEIVS-GKKNRGFYRSDTKV 644 (747)
Q Consensus 575 l~~~~~~ki~DfGla~~~~~~~~~~~~~~~~~~---------~~~~~s~~sDVwSlGvil~ellt-g~~p~~~~~~~~~~ 644 (747)
++.++.+||+|||+++...............++ .++.|+.++||||||+++|||++ |..|+... ...
T Consensus 168 l~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~y~~k~DiwS~Gvvl~ell~~g~~p~~~~---~~~ 244 (299)
T d1fgka_ 168 VTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGV---PVE 244 (299)
T ss_dssp ECTTCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTC---CHH
T ss_pred ECCCCCEEECCCHHHCCCCCCCCCCCCCCCCCCHHHHHHHHHCCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCC---CHH
T ss_conf 54789767622111011355555431466788846632667517988825554775888887401798989999---999
Q ss_pred HHHHHHHHCCCCCCCCCHHHHCCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHCCCC
Q ss_conf 2448677219865224301106699999999999997616899999999889999854898
Q 004521 645 NLIGHLWDEGIPLRLIDACIQDSCNLADVIRCIHIGLLCVQQHPEDRPCMPSVILMLGSEI 705 (747)
Q Consensus 645 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dP~~RPt~~~v~~~L~~~~ 705 (747)
.... ....+........ . ...+.+++.+||+.||.+|||+.+|+++|+.++
T Consensus 245 ~~~~-~i~~~~~~~~p~~-----~----~~~l~~li~~cl~~dP~~Rps~~eil~~L~~i~ 295 (299)
T d1fgka_ 245 ELFK-LLKEGHRMDKPSN-----C----TNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIV 295 (299)
T ss_dssp HHHH-HHHTTCCCCCCSS-----C----CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred HHHH-HHHCCCCCCCCCC-----C----HHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHH
T ss_conf 9999-9972888898743-----5----299999999976679767939999999998886
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=313.11 Aligned_cols=246 Identities=24% Similarity=0.378 Sum_probs=191.3
Q ss_pred HCCCCCCCEECCCCCEEEEEEEECC----CCEEEEEEECCC-CCCCHHHHHHHHHHHHCCCCCCEEEEEEEEEECCEEEE
Q ss_conf 2397855421424980099999669----849999991343-31068999999999830599732337748994982279
Q 004521 439 TDNFSINNKLGEGGFGPVYKGTLVD----GQEIAVKRLSKI-SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLL 513 (747)
Q Consensus 439 ~~~~~~~~~lg~G~~g~Vy~~~~~~----g~~vavK~l~~~-~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~l 513 (747)
.++|++.+.||+|+||.||+|++.. +..||||.++.. .....+.|.+|+.++++++||||++++|++. .+..++
T Consensus 6 ~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~~~i 84 (273)
T d1mp8a_ 6 RERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVWI 84 (273)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSCEE
T ss_pred HHHEEEEEEEEECCCCEEEEEEEECCCCEEEEEEEEEECCCCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEE-CCEEEE
T ss_conf 8996987799307882999999936996449999999365668799999999999998689999856988995-374799
Q ss_pred EEECCCCCCHHHHHHHCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCCEEECCCCCCCCC
Q ss_conf 99507999944676312898767856789999999999998341599946732667683798589994471256750038
Q 004521 514 IYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFG 593 (747)
Q Consensus 514 V~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dikp~NIll~~~~~~ki~DfGla~~~~ 593 (747)
||||+++|+|.+++... ...+++..++.++.|++.||.|||+.+ ++||||||+||+++.++.+||+|||+|+.+.
T Consensus 85 v~E~~~~g~l~~~~~~~--~~~l~~~~~~~~~~qi~~gl~ylH~~~---iiHrDlKp~NIll~~~~~~Kl~DfG~a~~~~ 159 (273)
T d1mp8a_ 85 IMELCTLGELRSFLQVR--KYSLDLASLILYAYQLSTALAYLESKR---FVHRDIAARNVLVSSNDCVKLGDFGLSRYME 159 (273)
T ss_dssp EEECCTTEEHHHHHHHT--TTTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECC--------
T ss_pred EEEECCCCCHHHHHHCC--CCCCCHHHHHHHHHHHHHHHHHHCCCC---EECCCCCHHHEEECCCCCEEECCCHHHEECC
T ss_conf 99840698077654224--789999999999999987752302267---4414102655320678967876503421336
Q ss_pred CCCCCCCCCEEEEC---------CCCCCCCCCCCHHHHHHHHHHHH-CCCCCCCCCCCCHHHHHHHHHHCCCCCCCCCHH
Q ss_conf 99875444402102---------37888844640237899999881-998999988764022448677219865224301
Q 004521 594 GDETEGNTNRVVGT---------YDGQFSIKSDVFSFGILLLEIVS-GKKNRGFYRSDTKVNLIGHLWDEGIPLRLIDAC 663 (747)
Q Consensus 594 ~~~~~~~~~~~~~~---------~~~~~s~~sDVwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 663 (747)
........ ...++ .+..++.++|||||||++|||++ |..|+..... ......+ ..+....+..
T Consensus 160 ~~~~~~~~-~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~---~~~~~~i-~~~~~~~~~~-- 232 (273)
T d1mp8a_ 160 DSTYYKAS-KGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKN---NDVIGRI-ENGERLPMPP-- 232 (273)
T ss_dssp ------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCG---GGHHHHH-HTTCCCCCCT--
T ss_pred CCCCEECC-CEECCCCCCHHHHHCCCCCCCCCCCCCCHHHHHHHHHCCCCCCCCCCH---HHHHHHH-HCCCCCCCCC--
T ss_conf 77623305-400583103266751699887452444247899998269999888999---9999999-8189998987--
Q ss_pred HHCCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHCCC
Q ss_conf 10669999999999999761689999999988999985489
Q 004521 664 IQDSCNLADVIRCIHIGLLCVQQHPEDRPCMPSVILMLGSE 704 (747)
Q Consensus 664 l~~~~~~~~~~~~~~l~~~Cl~~dP~~RPt~~~v~~~L~~~ 704 (747)
.. ...+.+++.+||+.||.+|||+.+|++.|+..
T Consensus 233 ---~~----~~~~~~li~~cl~~dp~~Rps~~ei~~~L~~i 266 (273)
T d1mp8a_ 233 ---NC----PPTLYSLMTKCWAYDPSRRPRFTELKAQLSTI 266 (273)
T ss_dssp ---TC----CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred ---CC----CHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHH
T ss_conf ---77----99999999997687976892999999999999
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=316.05 Aligned_cols=246 Identities=27% Similarity=0.441 Sum_probs=191.7
Q ss_pred HCCCCCCCEECCCCCEEEEEEEECCCCEEEEEEECCCCCCCHHHHHHHHHHHHCCCCCCEEEEEEEEEEC-CEEEEEEEC
Q ss_conf 2397855421424980099999669849999991343310689999999998305997323377489949-822799950
Q 004521 439 TDNFSINNKLGEGGFGPVYKGTLVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQG-EEKLLIYEF 517 (747)
Q Consensus 439 ~~~~~~~~~lg~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~-~~~~lV~e~ 517 (747)
.++|++.+.||+|+||.||+|.+ .+..||||+++. ....+.|.+|++++++++||||++++|++.+. +..++||||
T Consensus 6 ~~~~~~~~~lG~G~fg~Vy~~~~-~~~~vAvK~i~~--~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~ey 82 (262)
T d1byga_ 6 MKELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKN--DATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEY 82 (262)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEE-TTEEEEEEECCC--CC--HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECC
T ss_pred HHHEEEEEEEECCCCEEEEEEEE-CCEEEEEEEECC--HHHHHHHHHHHHHHHHCCCCCEEEEEEEEEECCCCEEEEEEC
T ss_conf 89948857982079808999999-990999999885--777999999999998678989854987887238928999963
Q ss_pred CCCCCHHHHHHHCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCCEEECCCCCCCCCCCCC
Q ss_conf 79999446763128987678567899999999999983415999467326676837985899944712567500389987
Q 004521 518 MPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDET 597 (747)
Q Consensus 518 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dikp~NIll~~~~~~ki~DfGla~~~~~~~~ 597 (747)
+++|+|.+++.... ...+++..++.++.|++.||.|||+.+ ++||||||+|||++.++.+||+|||+++.......
T Consensus 83 ~~~g~L~~~l~~~~-~~~l~~~~~~~i~~~i~~al~ylH~~~---ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~~~~~~ 158 (262)
T d1byga_ 83 MAKGSLVDYLRSRG-RSVLGGDCLLKFSLDVCEAMEYLEGNN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQD 158 (262)
T ss_dssp CTTEEHHHHHHHHH-HHHCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTSCEEECCCCC---------
T ss_pred CCCCCHHHHHHHCC-CCCCCHHHHHHHHHHHHHHCCCCCCCC---EECCCCCHHHHEECCCCCEEECCCCCCEECCCCCC
T ss_conf 69998999987457-888899999999999985232113376---55366656760146899776324560034478776
Q ss_pred CCCCCE-EEE---CCCCCCCCCCCCHHHHHHHHHHHH-CCCCCCCCCCCCHHHHHHHHHHCCCCCCCCCHHHHCCCCHHH
Q ss_conf 544440-210---237888844640237899999881-998999988764022448677219865224301106699999
Q 004521 598 EGNTNR-VVG---TYDGQFSIKSDVFSFGILLLEIVS-GKKNRGFYRSDTKVNLIGHLWDEGIPLRLIDACIQDSCNLAD 672 (747)
Q Consensus 598 ~~~~~~-~~~---~~~~~~s~~sDVwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~ 672 (747)
...... ... ..+..++.++||||||+++|||+| |+.|+.... ..+....+ ..+....+.+. .+
T Consensus 159 ~~~~~~~y~aPE~l~~~~~t~~sDIwSfG~il~el~t~~~~p~~~~~---~~~~~~~i-~~~~~~~~~~~-----~~--- 226 (262)
T d1byga_ 159 TGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIP---LKDVVPRV-EKGYKMDAPDG-----CP--- 226 (262)
T ss_dssp ---CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSC---GGGHHHHH-TTTCCCCCCTT-----CC---
T ss_pred CCCCCCCCCCHHHHHCCCCCHHHHHHHHHHHHHHHHHCCCCCCCCCC---HHHHHHHH-HCCCCCCCCCC-----CC---
T ss_conf 55666467781787279888588777579999999978999999999---99999999-80899999765-----79---
Q ss_pred HHHHHHHHHHCCCCCCCCCCCHHHHHHHHCCC
Q ss_conf 99999999761689999999988999985489
Q 004521 673 VIRCIHIGLLCVQQHPEDRPCMPSVILMLGSE 704 (747)
Q Consensus 673 ~~~~~~l~~~Cl~~dP~~RPt~~~v~~~L~~~ 704 (747)
..+.+++.+||+.||.+||||.+|+++|+..
T Consensus 227 -~~~~~li~~cl~~dP~~Rps~~~l~~~L~~i 257 (262)
T d1byga_ 227 -PAVYEVMKNCWHLDAAMRPSFLQLREQLEHI 257 (262)
T ss_dssp -HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred -HHHHHHHHHHCCCCHHHCCCHHHHHHHHHHH
T ss_conf -9999999997566976893999999999999
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.2e-45 Score=307.08 Aligned_cols=254 Identities=23% Similarity=0.329 Sum_probs=186.8
Q ss_pred CCCCCCCEECCCCCEEEEEEEEC-CCCEEEEEEECCC--CCCCHHHHHHHHHHHHCCCCCCEEEEEEEEEECCEEEEEEE
Q ss_conf 39785542142498009999966-9849999991343--31068999999999830599732337748994982279995
Q 004521 440 DNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKI--SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYE 516 (747)
Q Consensus 440 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~e 516 (747)
++|++.++||+|+||+||+|+.. +++.||||+++.. .......+.+|++++++++||||+++++++.+....++|||
T Consensus 2 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~~~iv~e 81 (298)
T d1gz8a_ 2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFE 81 (298)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred CCCEECCEEECCCCEEEEEEEECCCCCEEEEEEEEHHHCCHHHHHHHHHHHHHHHHCCCCCEEEECCCCCCCCCEEEEEE
T ss_conf 99776517723768099999999999799999980222575899999999999986799838874453322432037886
Q ss_pred CCCCCCHHHHHHHCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCCEEECCCCCCCCCCCC
Q ss_conf 07999944676312898767856789999999999998341599946732667683798589994471256750038998
Q 004521 517 FMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDE 596 (747)
Q Consensus 517 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dikp~NIll~~~~~~ki~DfGla~~~~~~~ 596 (747)
|+.+ ++..++... ....+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+|+......
T Consensus 82 ~~~~-~~~~~~~~~-~~~~l~e~~~~~~~~qil~~L~yLH~~~---IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~~~~ 156 (298)
T d1gz8a_ 82 FLHQ-DLKKFMDAS-ALTGIPLPLIKSYLFQLLQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV 156 (298)
T ss_dssp CCSE-EHHHHHHHT-TTTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECSTTHHHHHCCCS
T ss_pred ECCC-CHHHHHHHH-CCCCCCHHHHHHHHHHHHHHHHHHHCCC---EECCCCCCHHEEECCCCCCEECCCCCCEECCCCC
T ss_conf 2377-445554420-2568888999999999999999865288---9921357114011346762103578613436886
Q ss_pred CCCCCCEEEEC----------CCCCCCCCCCCHHHHHHHHHHHHCCCCCCCCCCCCHHHHHHHHH-HCCCCCCCCCHHH-
Q ss_conf 75444402102----------37888844640237899999881998999988764022448677-2198652243011-
Q 004521 597 TEGNTNRVVGT----------YDGQFSIKSDVFSFGILLLEIVSGKKNRGFYRSDTKVNLIGHLW-DEGIPLRLIDACI- 664 (747)
Q Consensus 597 ~~~~~~~~~~~----------~~~~~s~~sDVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~-~~~~~~~~~d~~l- 664 (747)
..... ..++ ....++.++||||+||++|||++|+.||...... ..+.... ..+.......+..
T Consensus 157 ~~~~~--~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~---~~~~~i~~~~~~~~~~~~~~~~ 231 (298)
T d1gz8a_ 157 RTYTH--EVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEI---DQLFRIFRTLGTPDEVVWPGVT 231 (298)
T ss_dssp BCTTC--CBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH---HHHHHHHHHHCCCCTTTSTTGG
T ss_pred CCCEE--ECCCCEEEEHHHHCCCCCCCCCCCCCCCCHHHHHHHHCCCCCCCCCHH---HHHHHHHHHCCCCCHHHCCCCC
T ss_conf 41001--036521541122136657774221033331342796687998988999---9999999832898333144422
Q ss_pred -----------HCCCCHHH-----HHHHHHHHHHCCCCCCCCCCCHHHHHHH--HCC
Q ss_conf -----------06699999-----9999999976168999999998899998--548
Q 004521 665 -----------QDSCNLAD-----VIRCIHIGLLCVQQHPEDRPCMPSVILM--LGS 703 (747)
Q Consensus 665 -----------~~~~~~~~-----~~~~~~l~~~Cl~~dP~~RPt~~~v~~~--L~~ 703 (747)
........ ...+.+++.+||+.||.+|||+.|+++. +++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~H~ff~~ 288 (298)
T d1gz8a_ 232 SMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQD 288 (298)
T ss_dssp GSTTCCTTSCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGTT
T ss_pred CCCCCCCCCCCCCCCCHHHHCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCCHHHCC
T ss_conf 242124345432222044416678999999999976399557918999967870146
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=100.00 E-value=7e-45 Score=305.58 Aligned_cols=246 Identities=20% Similarity=0.270 Sum_probs=189.1
Q ss_pred HCCCCCCCEECCCCCEEEEEEEEC-CCCEEEEEEECCCC---------CCCHHHHHHHHHHHHCCC-CCCEEEEEEEEEE
Q ss_conf 239785542142498009999966-98499999913433---------106899999999983059-9732337748994
Q 004521 439 TDNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKIS---------EQGLKELKNEVILFSKLQ-HRNLVKLLGCCIQ 507 (747)
Q Consensus 439 ~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~---------~~~~~~~~~E~~~l~~l~-H~nIv~l~g~~~~ 507 (747)
.++|++.+.||+|+||+||+++.. +++.+|||++.+.. ....+.+.+|+.++++++ ||||+++++++.+
T Consensus 2 ~~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~ 81 (277)
T d1phka_ 2 YENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYET 81 (277)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEC
T ss_pred CCCCEECEEEECCCCEEEEEEEECCCCCEEEEEEEECCCCCCHHHHHHHHHHHHHHHHHHHHHHHCCCCCEEEEEEECCC
T ss_conf 66388852884176849999999999989999999624464114788899999999999999985079974799762146
Q ss_pred CCEEEEEEECCCCCCHHHHHHHCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCCEEECCC
Q ss_conf 98227999507999944676312898767856789999999999998341599946732667683798589994471256
Q 004521 508 GEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFG 587 (747)
Q Consensus 508 ~~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dikp~NIll~~~~~~ki~DfG 587 (747)
.+..++||||+++|+|.+++... ..+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||
T Consensus 82 ~~~~~ivmE~~~~g~L~~~l~~~---~~l~e~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~Nill~~~~~~kl~DFG 155 (277)
T d1phka_ 82 NTFFFLVFDLMKKGELFDYLTEK---VTLSEKETRKIMRALLEVICALHKLN---IVHRDLKPENILLDDDMNIKLTDFG 155 (277)
T ss_dssp SSEEEEEEECCTTCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCT
T ss_pred CCCEEEEEECCCCCHHHHHHHHC---CCCCHHHHHHHHHHHHHHHHHHHHCC---CCCCCCCCCEEEECCCCCEEECCCH
T ss_conf 76059999768986689999865---99999999999999999999998759---9432346254898689983871240
Q ss_pred CCCCCCCCCCCCCC---CEEEEC---------CCCCCCCCCCCHHHHHHHHHHHHCCCCCCCCCCCCHHHHHHHHHHCCC
Q ss_conf 75003899875444---402102---------378888446402378999998819989999887640224486772198
Q 004521 588 LVRTFGGDETEGNT---NRVVGT---------YDGQFSIKSDVFSFGILLLEIVSGKKNRGFYRSDTKVNLIGHLWDEGI 655 (747)
Q Consensus 588 la~~~~~~~~~~~~---~~~~~~---------~~~~~s~~sDVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~ 655 (747)
+++.+......... .....+ ....++.++||||+||++|||++|+.||.... .......+.. +.
T Consensus 156 ~a~~~~~~~~~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~---~~~~~~~i~~-~~ 231 (277)
T d1phka_ 156 FSCQLDPGEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRK---QMLMLRMIMS-GN 231 (277)
T ss_dssp TCEECCTTCCBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSS---HHHHHHHHHH-TC
T ss_pred HEEECCCCCCEEEEECCCCCCCHHHHHCCCCCCCCCCCCHHEECCCCHHHHHHCCCCCCCCCCC---HHHHHHHHHH-CC
T ss_conf 3167268872134524678889888605344567889923318565602310322888988999---9999999981-89
Q ss_pred CCCCCCHHHHCCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHH
Q ss_conf 652243011066999999999999976168999999998899998
Q 004521 656 PLRLIDACIQDSCNLADVIRCIHIGLLCVQQHPEDRPCMPSVILM 700 (747)
Q Consensus 656 ~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dP~~RPt~~~v~~~ 700 (747)
.. ...+.. ...+ ..+.+++.+||+.||.+||++.+|++.
T Consensus 232 ~~-~~~~~~-~~~s----~~~~~li~~~L~~~p~~R~s~~eil~h 270 (277)
T d1phka_ 232 YQ-FGSPEW-DDYS----DTVKDLVSRFLVVQPQKRYTAEEALAH 270 (277)
T ss_dssp CC-CCTTTG-GGSC----HHHHHHHHHHCCSSGGGSCCHHHHTTS
T ss_pred CC-CCCCCC-CCCC----HHHHHHHHHHCCCCHHHCCCHHHHHCC
T ss_conf 88-898543-4689----999999999765896689199999739
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=8.4e-45 Score=305.11 Aligned_cols=242 Identities=21% Similarity=0.270 Sum_probs=189.0
Q ss_pred HCCCCCCCEECCCCCEEEEEEEECC-CCEEEEEEECC---CCCCCHHHHHHHHHHHHCCCCCCEEEEEEEEEECCEEEEE
Q ss_conf 2397855421424980099999669-84999999134---3310689999999998305997323377489949822799
Q 004521 439 TDNFSINNKLGEGGFGPVYKGTLVD-GQEIAVKRLSK---ISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLI 514 (747)
Q Consensus 439 ~~~~~~~~~lg~G~~g~Vy~~~~~~-g~~vavK~l~~---~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV 514 (747)
.++|++.+.||+|+||+||+|+... |+.||||++++ ......+.+.+|+.++++++||||+++++++.+.+..++|
T Consensus 3 l~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~iv 82 (316)
T d1fota_ 3 LQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMI 82 (316)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEE
T ss_pred HHHEEEEEEEECCCCCEEEEEEECCCCCEEEEEEECHHHCCCHHHHHHHHHHHHHHHHCCCCCHHHEEEEEEECCEEEEE
T ss_conf 54708888972076808999999899979999998457754889999999999999863696753303568528800567
Q ss_pred EECCCCCCHHHHHHHCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCCEEECCCCCCCCCC
Q ss_conf 95079999446763128987678567899999999999983415999467326676837985899944712567500389
Q 004521 515 YEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGG 594 (747)
Q Consensus 515 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dikp~NIll~~~~~~ki~DfGla~~~~~ 594 (747)
|||+++|+|..++... ..+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+|+....
T Consensus 83 mE~~~gg~l~~~~~~~---~~~~~~~~~~~~~qi~~al~~lH~~~---iiHrDiKp~NILl~~~g~vkL~DFG~a~~~~~ 156 (316)
T d1fota_ 83 MDYIEGGELFSLLRKS---QRFPNPVAKFYAAEVCLALEYLHSKD---IIYRDLKPENILLDKNGHIKITDFGFAKYVPD 156 (316)
T ss_dssp ECCCCSCBHHHHHHHT---SSCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECTTSCEEECCCSSCEECSS
T ss_pred EEECCCCCCCCCCCCC---CCCCCCHHHHHHHHHHHHHHHHCCCC---EECCCCCCHHEEECCCCCEEEECCCCCEEECC
T ss_conf 6503786322343222---21110079999999987655412476---77055681050386899889831752167124
Q ss_pred CCCCCC-CCEEEEC---CCCCCCCCCCCHHHHHHHHHHHHCCCCCCCCCCCCHHHHHHHHHHCCCCCCCCCHHHHCCCCH
Q ss_conf 987544-4402102---378888446402378999998819989999887640224486772198652243011066999
Q 004521 595 DETEGN-TNRVVGT---YDGQFSIKSDVFSFGILLLEIVSGKKNRGFYRSDTKVNLIGHLWDEGIPLRLIDACIQDSCNL 670 (747)
Q Consensus 595 ~~~~~~-~~~~~~~---~~~~~s~~sDVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~ 670 (747)
...... +.....+ .+..++.++||||+||++|||++|+.||... ........+.... .. +. + ..+
T Consensus 157 ~~~~~~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyemltG~~Pf~~~---~~~~~~~~i~~~~-~~-~p-~----~~s- 225 (316)
T d1fota_ 157 VTYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDS---NTMKTYEKILNAE-LR-FP-P----FFN- 225 (316)
T ss_dssp CBCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCS---SHHHHHHHHHHCC-CC-CC-T----TSC-
T ss_pred CCCCCCCCCCCCCHHHHCCCCCCCHHHCCCCCHHHHHHHHCCCCCCCC---CHHHHHHHHHCCC-CC-CC-C----CCC-
T ss_conf 564345763435999983899980430465333689997598999996---9999999997089-88-99-7----789-
Q ss_pred HHHHHHHHHHHHCCCCCCCCCC-----CHHHHHHH
Q ss_conf 9999999999761689999999-----98899998
Q 004521 671 ADVIRCIHIGLLCVQQHPEDRP-----CMPSVILM 700 (747)
Q Consensus 671 ~~~~~~~~l~~~Cl~~dP~~RP-----t~~~v~~~ 700 (747)
..+.+++.+||+.||.+|| +++++++.
T Consensus 226 ---~~~~~li~~~L~~dp~~R~~~~r~t~~~il~H 257 (316)
T d1fota_ 226 ---EDVKDLLSRLITRDLSQRLGNLQNGTEDVKNH 257 (316)
T ss_dssp ---HHHHHHHHHHTCSCTTTCTTSSTTTTHHHHTS
T ss_pred ---HHHHHHHHHHHHHCHHHCCCCCHHHHHHHHCC
T ss_conf ---99999999995449976664310219999819
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.8e-45 Score=307.52 Aligned_cols=249 Identities=24% Similarity=0.245 Sum_probs=181.7
Q ss_pred CCCEECCCCCEEEEEEEECC-CCEEEEEEECCCCC-----CCHHHHHHHHHHHHCCCCCCEEEEEEEEEECCEEEEEEEC
Q ss_conf 55421424980099999669-84999999134331-----0689999999998305997323377489949822799950
Q 004521 444 INNKLGEGGFGPVYKGTLVD-GQEIAVKRLSKISE-----QGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEF 517 (747)
Q Consensus 444 ~~~~lg~G~~g~Vy~~~~~~-g~~vavK~l~~~~~-----~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~e~ 517 (747)
..++||+|+||+||+|+... ++.||||+++.... ...+.+.+|+.++++++||||+++++++...+..++||||
T Consensus 2 ~l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~ivmE~ 81 (299)
T d1ua2a_ 2 KLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDF 81 (299)
T ss_dssp EEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEEC
T ss_pred CCEEECCCCCEEEEEEEECCCCCEEEEEEEEHHHHHHHHHHHHHHHHHHHHHHHHCCCCCEEEEEEEECCCCCEEEHHHH
T ss_conf 56385127282999999999996999999842021245679999999999999867999986898542258740220455
Q ss_pred CCCCCHHHHHHHCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCCEEECCCCCCCCCCCCC
Q ss_conf 79999446763128987678567899999999999983415999467326676837985899944712567500389987
Q 004521 518 MPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDET 597 (747)
Q Consensus 518 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dikp~NIll~~~~~~ki~DfGla~~~~~~~~ 597 (747)
+.++++..+. .....+++..+..++.|++.||+|||+.+ ++||||||+|||++.++.+||+|||+|+.......
T Consensus 82 ~~~~~~~~~~---~~~~~l~~~~~~~~~~qil~aL~~lH~~~---iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~~~~ 155 (299)
T d1ua2a_ 82 METDLEVIIK---DNSLVLTPSHIKAYMLMTLQGLEYLHQHW---ILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNR 155 (299)
T ss_dssp CSEEHHHHHT---TCCSSCCSSHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCCC
T ss_pred HCCHHHHHHH---HCCCCCCHHHHHHHHHHHHHHHHHHHCCC---EECCCCCCCEEEECCCCCCCCCCCCCCCCCCCCCC
T ss_conf 3450776554---12667789999999999999998863163---55035776258853778411465761000578755
Q ss_pred CCCCCEEEEC----------CCCCCCCCCCCHHHHHHHHHHHHCCCCCCCCCCCCHHHHHHHHHHCCCCCCCCCH-----
Q ss_conf 5444402102----------3788884464023789999988199899998876402244867721986522430-----
Q 004521 598 EGNTNRVVGT----------YDGQFSIKSDVFSFGILLLEIVSGKKNRGFYRSDTKVNLIGHLWDEGIPLRLIDA----- 662 (747)
Q Consensus 598 ~~~~~~~~~~----------~~~~~s~~sDVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~d~----- 662 (747)
.... ..++ ....++.++|||||||++|||++|..||......+....+.............+.
T Consensus 156 ~~~~--~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~l~~i~~~~~~~~~~~~~~~~~~~~ 233 (299)
T d1ua2a_ 156 AYTH--QVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPD 233 (299)
T ss_dssp CCCC--SCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSSSTTSSTT
T ss_pred CCCC--EECCHHHCCHHHHCCCCCCCHHHHHHHCCHHHHHHHHCCCCCCCCCHHHHHHHHHHHCCCCCHHHCCCHHCCCH
T ss_conf 4330--20473336399972677888056436304289999859699999999999999998518997254521000213
Q ss_pred ----HHHCCCCHHH-----HHHHHHHHHHCCCCCCCCCCCHHHHHHH
Q ss_conf ----1106699999-----9999999976168999999998899998
Q 004521 663 ----CIQDSCNLAD-----VIRCIHIGLLCVQQHPEDRPCMPSVILM 700 (747)
Q Consensus 663 ----~l~~~~~~~~-----~~~~~~l~~~Cl~~dP~~RPt~~~v~~~ 700 (747)
.......... ...+.+++.+||+.||++|||+.|+++.
T Consensus 234 ~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~H 280 (299)
T d1ua2a_ 234 YVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKM 280 (299)
T ss_dssp CCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTS
T ss_pred HHHHCCCCCCCHHHHCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCC
T ss_conf 44303478988678565689999999999763894569089999679
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-45 Score=309.55 Aligned_cols=253 Identities=21% Similarity=0.285 Sum_probs=183.0
Q ss_pred CCCCCCCEECCCCCEEEEEEEECCCCEEEEEEECCCCCCCHHHHH--HHHHHHHCCCCCCEEEEEEEEEECC----EEEE
Q ss_conf 397855421424980099999669849999991343310689999--9999983059973233774899498----2279
Q 004521 440 DNFSINNKLGEGGFGPVYKGTLVDGQEIAVKRLSKISEQGLKELK--NEVILFSKLQHRNLVKLLGCCIQGE----EKLL 513 (747)
Q Consensus 440 ~~~~~~~~lg~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~--~E~~~l~~l~H~nIv~l~g~~~~~~----~~~l 513 (747)
.+|.+.+.||+|+||.||+|++ +|+.||||+++.. ..+.+. .|+..+..++||||++++|++.+.+ ..++
T Consensus 3 ~~~~l~~~iG~G~fg~Vy~~~~-~g~~vAvK~~~~~---~~~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~~~l 78 (303)
T d1vjya_ 3 RTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSR---EERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWL 78 (303)
T ss_dssp GGEEEEEEEECCSSSEEEEEEE-TTEEEEEEEECGG---GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEE
T ss_pred CEEEEEEEEEECCCEEEEEEEE-CCEEEEEEEECCC---CHHHHHHHHHHHHHHHCCCCCCCCEEEEEEECCCCCEEEEE
T ss_conf 6899988982078819999999-9989999998720---04679999999999627998683268899837986048999
Q ss_pred EEECCCCCCHHHHHHHCCCCCCCCHHHHHHHHHHHHHHHHHHHHC-----CCCCEEECCCCCCCEEECCCCCCEEECCCC
Q ss_conf 995079999446763128987678567899999999999983415-----999467326676837985899944712567
Q 004521 514 IYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQD-----SRLRIIHRDLKASNVLLDQDMNPKISDFGL 588 (747)
Q Consensus 514 V~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~-----~~~~iiH~Dikp~NIll~~~~~~ki~DfGl 588 (747)
||||+++|+|.+++... .++|..++.++.++|.||.|||+. ...+|+||||||+||||+.++.+||+|||+
T Consensus 79 v~Ey~~~g~L~~~l~~~----~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~DFGl 154 (303)
T d1vjya_ 79 VSDYHEHGSLFDYLNRY----TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGL 154 (303)
T ss_dssp EEECCTTCBHHHHHHHC----CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCTT
T ss_pred EEECCCCCCHHHHHHCC----CCCHHHHHHHHHHHHHHHHHHHHHHHHHCCCCCEECCCCCCCCEEECCCCCEEEEECCC
T ss_conf 99646698989998658----99989999999999999999887665204689866153173135786887768876386
Q ss_pred CCCCCCCCCCC--CCCEEEECC--------C-------CCCCCCCCCHHHHHHHHHHHHCCCCCCCCCCCCH--------
Q ss_conf 50038998754--444021023--------7-------8888446402378999998819989999887640--------
Q 004521 589 VRTFGGDETEG--NTNRVVGTY--------D-------GQFSIKSDVFSFGILLLEIVSGKKNRGFYRSDTK-------- 643 (747)
Q Consensus 589 a~~~~~~~~~~--~~~~~~~~~--------~-------~~~s~~sDVwSlGvil~elltg~~p~~~~~~~~~-------- 643 (747)
++......... ......++. . ..++.++|||||||+||||+||..|+........
T Consensus 155 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~~~~~~~~ 234 (303)
T d1vjya_ 155 AVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPS 234 (303)
T ss_dssp CEEEETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCS
T ss_pred CCCCCCCCCCEECCCCCEECCCCCCCHHHCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHCCCCCCCCCCCCCCHHHCCCC
T ss_conf 62346777620013552503547678221056545467776750122015999999962899887663112410122556
Q ss_pred ---HHHHHHHH-HCCCCCCCCCHHHHCCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHCCC
Q ss_conf ---22448677-21986522430110669999999999999761689999999988999985489
Q 004521 644 ---VNLIGHLW-DEGIPLRLIDACIQDSCNLADVIRCIHIGLLCVQQHPEDRPCMPSVILMLGSE 704 (747)
Q Consensus 644 ---~~~~~~~~-~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dP~~RPt~~~v~~~L~~~ 704 (747)
........ ..+....+.+ ..........+.+++.+||+.||.+||||.+|++.|+.+
T Consensus 235 ~~~~~~~~~~~~~~~~~p~~~~----~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~~L~~i 295 (303)
T d1vjya_ 235 DPSVEEMRKVVCEQKLRPNIPN----RWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQL 295 (303)
T ss_dssp SCCHHHHHHHHTTSCCCCCCCG----GGGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHH
T ss_pred CCHHHHHHHHHHCCCCCCCCCC----CCCCHHHHHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHH
T ss_conf 4309999998750246888776----557768999999999997606985895999999999988
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-44 Score=303.83 Aligned_cols=238 Identities=24% Similarity=0.333 Sum_probs=187.1
Q ss_pred CCCCCCCEECCCCCEEEEEEEECC-CCEEEEEEECCC---CCCCHHHHHHHHHHHH-CCCCCCEEEEEEEEEECCEEEEE
Q ss_conf 397855421424980099999669-849999991343---3106899999999983-05997323377489949822799
Q 004521 440 DNFSINNKLGEGGFGPVYKGTLVD-GQEIAVKRLSKI---SEQGLKELKNEVILFS-KLQHRNLVKLLGCCIQGEEKLLI 514 (747)
Q Consensus 440 ~~~~~~~~lg~G~~g~Vy~~~~~~-g~~vavK~l~~~---~~~~~~~~~~E~~~l~-~l~H~nIv~l~g~~~~~~~~~lV 514 (747)
++|++.+.||+|+||+||+|+... ++.||||++++. .....+.+..|..++. .++||||+++++++.+++..++|
T Consensus 2 ddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~yiv 81 (320)
T d1xjda_ 2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFV 81 (320)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEE
T ss_pred CCEEEEEEEECCCCCEEEEEEECCCCCEEEEEEECHHHCCCHHHHHHHHHHHHHHHHHCCCCCEEEEEEEECCCCCEEEE
T ss_conf 97188658940878289999999999899999980555338489999999999999847999687898897049831677
Q ss_pred EECCCCCCHHHHHHHCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCCEEECCCCCCCCCC
Q ss_conf 95079999446763128987678567899999999999983415999467326676837985899944712567500389
Q 004521 515 YEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGG 594 (747)
Q Consensus 515 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dikp~NIll~~~~~~ki~DfGla~~~~~ 594 (747)
|||+++|+|.+++.... .+++..+..++.|++.||+|||+.+ ++||||||+|||+++++.+||+|||+++....
T Consensus 82 mEy~~~g~L~~~i~~~~---~~~e~~~~~~~~qi~~al~ylH~~~---iiHrDikp~NiL~~~~~~~kl~DFG~a~~~~~ 155 (320)
T d1xjda_ 82 MEYLNGGDLMYHIQSCH---KFDLSRATFYAAEIILGLQFLHSKG---IVYRDLKLDNILLDKDGHIKIADFGMCKENML 155 (320)
T ss_dssp EECCTTCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCCCC
T ss_pred EEECCCCCHHHHHHCCC---CCCHHHHHHHHHHHHHHHHHHHHCC---EEECCCCCCCEEECCCCCEECCCCCHHHHCCC
T ss_conf 75037980899864047---8999999999999999999998689---34034765404444899630155530232356
Q ss_pred CCCCCCCCEEEEC---------CCCCCCCCCCCHHHHHHHHHHHHCCCCCCCCCCCCHHHHHHHHHHCCCCCCCCCHHHH
Q ss_conf 9875444402102---------3788884464023789999988199899998876402244867721986522430110
Q 004521 595 DETEGNTNRVVGT---------YDGQFSIKSDVFSFGILLLEIVSGKKNRGFYRSDTKVNLIGHLWDEGIPLRLIDACIQ 665 (747)
Q Consensus 595 ~~~~~~~~~~~~~---------~~~~~s~~sDVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 665 (747)
...... ...|+ .+..++.++||||+||++|||++|+.||... ........+. .+.+ .+.
T Consensus 156 ~~~~~~--~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~PF~~~---~~~~~~~~i~-~~~~-~~p----- 223 (320)
T d1xjda_ 156 GDAKTN--TFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQ---DEEELFHSIR-MDNP-FYP----- 223 (320)
T ss_dssp TTCCBC--CCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCS---SHHHHHHHHH-HCCC-CCC-----
T ss_pred CCCCCC--CCCCCCCCCCHHHHCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCC---CHHHHHHHHH-CCCC-CCC-----
T ss_conf 653345--457877768999982799883232011227898987388999998---9999999997-1899-897-----
Q ss_pred CCCCHHHHHHHHHHHHHCCCCCCCCCCCHH-HHHH
Q ss_conf 669999999999999761689999999988-9999
Q 004521 666 DSCNLADVIRCIHIGLLCVQQHPEDRPCMP-SVIL 699 (747)
Q Consensus 666 ~~~~~~~~~~~~~l~~~Cl~~dP~~RPt~~-~v~~ 699 (747)
...+ ..+.+++.+||+.||.+||++. ++++
T Consensus 224 ~~~s----~~~~dli~~~L~~dP~~R~s~~~~l~~ 254 (320)
T d1xjda_ 224 RWLE----KEAKDLLVKLFVREPEKRLGVRGDIRQ 254 (320)
T ss_dssp TTSC----HHHHHHHHHHSCSSGGGSBTTBSCGGG
T ss_pred CCCC----HHHHHHHHHHCCCCCCCCCCHHHHHHH
T ss_conf 5679----999999999654489878388999980
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-44 Score=303.87 Aligned_cols=255 Identities=17% Similarity=0.196 Sum_probs=183.8
Q ss_pred HCCCCCCC-EECCCCCEEEEEEEEC-CCCEEEEEEECCCCCCCHHHHHHHHHHHHCC-CCCCEEEEEEEEEE----CCEE
Q ss_conf 23978554-2142498009999966-9849999991343310689999999998305-99732337748994----9822
Q 004521 439 TDNFSINN-KLGEGGFGPVYKGTLV-DGQEIAVKRLSKISEQGLKELKNEVILFSKL-QHRNLVKLLGCCIQ----GEEK 511 (747)
Q Consensus 439 ~~~~~~~~-~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l-~H~nIv~l~g~~~~----~~~~ 511 (747)
.++|++.. .||+|+||.||+|+.. +++.||||+++. ...+.+|+.++.++ +||||+++++++.+ ....
T Consensus 10 ~~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~-----~~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~~~~ 84 (335)
T d2ozaa1 10 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD-----CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCL 84 (335)
T ss_dssp GGTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEC-----SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEE
T ss_pred CCCEEEEEEEEEECCCEEEEEEEECCCCCEEEEEEECC-----CHHHHHHHHHHHHHCCCCCCCEEEEEEEECCCCCCEE
T ss_conf 14879810796545486999999889998999999897-----4779999999998669999782989995034689789
Q ss_pred EEEEECCCCCCHHHHHHHCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECC---CCCCEEECCCC
Q ss_conf 799950799994467631289876785678999999999999834159994673266768379858---99944712567
Q 004521 512 LLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQ---DMNPKISDFGL 588 (747)
Q Consensus 512 ~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dikp~NIll~~---~~~~ki~DfGl 588 (747)
++||||+++|+|.+++.... ...+++..+..++.|++.||+|||+.+ |+||||||+|||++. .+.+||+|||+
T Consensus 85 ~ivmEy~~gg~L~~~i~~~~-~~~l~e~~~~~i~~qi~~al~ylH~~~---iiHRDiKp~NIll~~~~~~~~~Kl~DFG~ 160 (335)
T d2ozaa1 85 LIVMECLDGGELFSRIQDRG-DQAFTEREASEIMKSIGEAIQYLHSIN---IAHRDVKPENLLYTSKRPNAILKLTDFGF 160 (335)
T ss_dssp EEEEECCCSEEHHHHHHSCS-CCCEEHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCSSTTCCEEECCCTT
T ss_pred EEEEECCCCCCHHHHHHHCC-CCCCCHHHHHHHHHHHHHHHHHHHHCC---CCCCCCCCCCCCCCCCCCCCCCCCCCCCE
T ss_conf 99997789984999998627-877579999999999999999999769---86444100220113555566311354551
Q ss_pred CCCCCCCCCCCCC---CEEEEC---CCCCCCCCCCCHHHHHHHHHHHHCCCCCCCCCCCCHHHHHHHHHHCCCCCCCCCH
Q ss_conf 5003899875444---402102---3788884464023789999988199899998876402244867721986522430
Q 004521 589 VRTFGGDETEGNT---NRVVGT---YDGQFSIKSDVFSFGILLLEIVSGKKNRGFYRSDTKVNLIGHLWDEGIPLRLIDA 662 (747)
Q Consensus 589 a~~~~~~~~~~~~---~~~~~~---~~~~~s~~sDVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 662 (747)
|+........... .....+ .+..|+.++|||||||++|||+||+.||...........+......+.. .+..+
T Consensus 161 a~~~~~~~~~~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~lltg~~Pf~~~~~~~~~~~~~~~i~~~~~-~~~~~ 239 (335)
T d2ozaa1 161 AKETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQY-EFPNP 239 (335)
T ss_dssp CEECCCCCCCCCCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHTTSSCSCEETTCC--------CCCSCSS-SCCTT
T ss_pred EEECCCCCCCCCCCCCCCCCCCHHHCCCCCCHHHHHHHHCHHHHHHHHCCCCCCCCCHHHHHHHHHHHHHCCCC-CCCCC
T ss_conf 23336888643226775637927774898888888876451677886588998898877889999999853888-88985
Q ss_pred HHHCCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHH--HCCCCCCC
Q ss_conf 11066999999999999976168999999998899998--54898999
Q 004521 663 CIQDSCNLADVIRCIHIGLLCVQQHPEDRPCMPSVILM--LGSEILLP 708 (747)
Q Consensus 663 ~l~~~~~~~~~~~~~~l~~~Cl~~dP~~RPt~~~v~~~--L~~~~~~~ 708 (747)
.. ..-...+.+++.+||+.||.+||++.++++. +......+
T Consensus 240 ~~-----~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~~~~~~ 282 (335)
T d2ozaa1 240 EW-----SEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVP 282 (335)
T ss_dssp HH-----HHSCHHHHHHHHHHSCSSTTTSCCHHHHHHSHHHHTTTSSC
T ss_pred CC-----CCCCHHHHHHHHHHCCCCHHHCCCHHHHHCCHHHHCCCCCC
T ss_conf 43-----46999999999997569965790999997098761788788
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=100.00 E-value=8.4e-45 Score=304.94 Aligned_cols=251 Identities=22% Similarity=0.300 Sum_probs=187.0
Q ss_pred CCCCCCCEECCCCCEEEEEEEECCCCEEEEEEECCC--CCCCHHHHHHHHHHHHCCCCCCEEEEEEEEEECCEEEEEEEC
Q ss_conf 397855421424980099999669849999991343--310689999999998305997323377489949822799950
Q 004521 440 DNFSINNKLGEGGFGPVYKGTLVDGQEIAVKRLSKI--SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEF 517 (747)
Q Consensus 440 ~~~~~~~~lg~G~~g~Vy~~~~~~g~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~e~ 517 (747)
++|++.++||+|+||+||+|++.+++.||||++... .....+.+.+|+.++++++||||+++++++...+..++++|+
T Consensus 2 ~~Y~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i~~e~ 81 (286)
T d1ob3a_ 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEH 81 (286)
T ss_dssp CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred CCCEECCEEECCCCCEEEEEEECCCCEEEEEEEEHHHCCHHHHHHHHHHHHHHHHCCCCCEEEEEEECCCCCCEEEEEEE
T ss_conf 99634318722778189999968999999999812326858999999999999867998687660120467731589974
Q ss_pred CCCCCHHHHHHHCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCCEEECCCCCCCCCCCCC
Q ss_conf 79999446763128987678567899999999999983415999467326676837985899944712567500389987
Q 004521 518 MPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDET 597 (747)
Q Consensus 518 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dikp~NIll~~~~~~ki~DfGla~~~~~~~~ 597 (747)
+.++.+..+.. ....+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||.+........
T Consensus 82 ~~~~~~~~~~~---~~~~l~~~~~~~i~~qi~~~L~~LH~~~---IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~~~~ 155 (286)
T d1ob3a_ 82 LDQDLKKLLDV---CEGGLESVTAKSFLLQLLNGIAYCHDRR---VLHRDLKPQNLLINREGELKIADFGLARAFGIPVR 155 (286)
T ss_dssp CSEEHHHHHHT---STTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECCTTHHHHHCC---
T ss_pred EHHHHHHHHHH---HCCCCCHHHHHHHHHHHHHHHHHHCCCC---EEECCCCCCEEEECCCCCEEECCCCCCEECCCCCC
T ss_conf 00456789986---0477514456899999999999860574---88267877505686899787323664301146765
Q ss_pred CCCCC-----EEEEC---CCCCCCCCCCCHHHHHHHHHHHHCCCCCCCCCCCCHHHHHHHHHH-CCCC--C---------
Q ss_conf 54444-----02102---378888446402378999998819989999887640224486772-1986--5---------
Q 004521 598 EGNTN-----RVVGT---YDGQFSIKSDVFSFGILLLEIVSGKKNRGFYRSDTKVNLIGHLWD-EGIP--L--------- 657 (747)
Q Consensus 598 ~~~~~-----~~~~~---~~~~~s~~sDVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~-~~~~--~--------- 657 (747)
..... +.... ....++.++||||+||++|||++|+.||..... ...+..... .+.. .
T Consensus 156 ~~~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~---~~~~~~i~~~~~~~~~~~~~~~~~~~ 232 (286)
T d1ob3a_ 156 KYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSE---ADQLMRIFRILGTPNSKNWPNVTELP 232 (286)
T ss_dssp ------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSH---HHHHHHHHHHHCCCCTTTSTTGGGST
T ss_pred CCCEECCCCHHHHHHHHHCCCCCCCCEEEHHCCCHHHHHHHCCCCCCCCCH---HHHHHHHHHHHCCCCHHHCCCHHHHH
T ss_conf 410102431101378871788888410021117589999779799898898---99999999863899711042123332
Q ss_pred ------CCCCHHHHCCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHH
Q ss_conf ------224301106699999999999997616899999999889999
Q 004521 658 ------RLIDACIQDSCNLADVIRCIHIGLLCVQQHPEDRPCMPSVIL 699 (747)
Q Consensus 658 ------~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dP~~RPt~~~v~~ 699 (747)
....+.........-...+.+++.+||+.||++|||++|+++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~ 280 (286)
T d1ob3a_ 233 KYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE 280 (286)
T ss_dssp TCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred HCCCCCCCCCCCCHHHHCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHC
T ss_conf 214333335676466651258999999999986689668909999856
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=100.00 E-value=5.5e-44 Score=299.61 Aligned_cols=248 Identities=21% Similarity=0.300 Sum_probs=190.2
Q ss_pred HCCCCCCCEECCCCCEEEEEEEEC-CCCEEEEEEECCC---CCCCHHHHHHHHHHHHCCCCCCEEEEEEEEEECCE----
Q ss_conf 239785542142498009999966-9849999991343---31068999999999830599732337748994982----
Q 004521 439 TDNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKI---SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEE---- 510 (747)
Q Consensus 439 ~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~---- 510 (747)
.++|++.+.||+|+||.||+|+.. +++.||||.++.. .......+.+|+.+++.++||||+++++++.....
T Consensus 6 ~drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~~~ 85 (277)
T d1o6ya_ 6 SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPL 85 (277)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSSEE
T ss_pred CCEEEEEEEEEECCCEEEEEEEECCCCCEEEEEEECHHHCCCHHHHHHHHHHHHHHHHCCCCCCCCCCCEEEECCCCCCE
T ss_conf 62069868996089929999999999989999998556646989999999999999856999887311435432688766
Q ss_pred EEEEEECCCCCCHHHHHHHCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCCEEECCCCCC
Q ss_conf 27999507999944676312898767856789999999999998341599946732667683798589994471256750
Q 004521 511 KLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVR 590 (747)
Q Consensus 511 ~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dikp~NIll~~~~~~ki~DfGla~ 590 (747)
.++||||+++++|.+++... ..+++..+..++.|++.||+|||+.+ |+||||||+|||++.++..+|+|||.++
T Consensus 86 ~~lvmE~~~g~~L~~~~~~~---~~l~~~~~~~i~~qi~~al~~lH~~~---iiHrDiKP~NIll~~~~~~~l~d~~~~~ 159 (277)
T d1o6ya_ 86 PYIVMEYVDGVTLRDIVHTE---GPMTPKRAIEVIADACQALNFSHQNG---IIHRDVKPANIMISATNAVKVMDFGIAR 159 (277)
T ss_dssp EEEEEECCCEEEHHHHHHHH---CSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTSCEEECCCTTCE
T ss_pred EEEEEECCCCCEEHHHHCCC---CCCCHHHHHHHHHHHHHHHHHHHHCC---CCCCCCCCCCCCCCCCCCCEEEHHHHHH
T ss_conf 99999778898710112035---89999999999999999999998579---5276346755665754320100344432
Q ss_pred CCCCCCCC-CCCCEEEEC---------CCCCCCCCCCCHHHHHHHHHHHHCCCCCCCCCCCCHHHHHHHHHHCCCC-CCC
Q ss_conf 03899875-444402102---------3788884464023789999988199899998876402244867721986-522
Q 004521 591 TFGGDETE-GNTNRVVGT---------YDGQFSIKSDVFSFGILLLEIVSGKKNRGFYRSDTKVNLIGHLWDEGIP-LRL 659 (747)
Q Consensus 591 ~~~~~~~~-~~~~~~~~~---------~~~~~s~~sDVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~-~~~ 659 (747)
........ .......|+ .+..++.++|||||||++|||+||+.||... ............... ...
T Consensus 160 ~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~---~~~~~~~~~~~~~~~~~~~ 236 (277)
T d1o6ya_ 160 AIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGD---SPVSVAYQHVREDPIPPSA 236 (277)
T ss_dssp ECC----------------TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCS---SHHHHHHHHHHCCCCCGGG
T ss_pred HHCCCCCCCCCCCCCCCCCCCCCHHHHCCCCCCCCEECCCCHHHHHHHHHCCCCCCCC---CHHHHHHHHHHCCCCCCCH
T ss_conf 2123544333346425762436999983999996632026528999997697998996---9999999998469999710
Q ss_pred CCHHHHCCCCHHHHHHHHHHHHHCCCCCCCCCC-CHHHHHHHHCC
Q ss_conf 430110669999999999999761689999999-98899998548
Q 004521 660 IDACIQDSCNLADVIRCIHIGLLCVQQHPEDRP-CMPSVILMLGS 703 (747)
Q Consensus 660 ~d~~l~~~~~~~~~~~~~~l~~~Cl~~dP~~RP-t~~~v~~~L~~ 703 (747)
.. ...+ ..+.+++.+||+.||.+|| ++++++..|..
T Consensus 237 ~~----~~~s----~~l~~li~~~L~~dp~~R~~sa~~l~~~l~r 273 (277)
T d1o6ya_ 237 RH----EGLS----ADLDAVVLKALAKNPENRYQTAAEMRADLVR 273 (277)
T ss_dssp TS----SSCC----HHHHHHHHHHTCSSGGGSCSSHHHHHHHHHH
T ss_pred HC----CCCC----HHHHHHHHHHCCCCHHHCHHHHHHHHHHHHH
T ss_conf 03----4789----9999999998667976777399999999999
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.8e-44 Score=297.95 Aligned_cols=253 Identities=21% Similarity=0.232 Sum_probs=177.7
Q ss_pred CCCCCCEECCCCCEEEEEEEECC-CCEEEEEEECCCCCCCHHHHHHHHHHHHCCCCCCEEEEEEEEEECC------EEEE
Q ss_conf 97855421424980099999669-8499999913433106899999999983059973233774899498------2279
Q 004521 441 NFSINNKLGEGGFGPVYKGTLVD-GQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGE------EKLL 513 (747)
Q Consensus 441 ~~~~~~~lg~G~~g~Vy~~~~~~-g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~------~~~l 513 (747)
+|+..++||+|+||+||+|++.. ++.||||++..... .+.+|+.++++++|+||+++++++.... +.++
T Consensus 21 ~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~----~~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~~~l 96 (350)
T d1q5ka_ 21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR----FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNL 96 (350)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSS----SCCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCEEEE
T ss_pred CCEEEEEEEECCCEEEEEEEECCCCCEEEEEEECCCCH----HHHHHHHHHHHCCCCCCCCEEEEEEECCCCCCCEEEEE
T ss_conf 76751698217683999999999997999999881606----89999999986689898738789974476577318999
Q ss_pred EEECCCCCCHHHHHHHCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCC-CCEEECCCCCCCC
Q ss_conf 995079999446763128987678567899999999999983415999467326676837985899-9447125675003
Q 004521 514 IYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDM-NPKISDFGLVRTF 592 (747)
Q Consensus 514 V~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dikp~NIll~~~~-~~ki~DfGla~~~ 592 (747)
||||++++.+..+.........+++..+..++.|++.||+|||+.+ |+||||||+|||++.++ .+||+|||+++..
T Consensus 97 v~Ey~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~~~---IiHrDiKp~NILl~~~~~~~kl~DFG~a~~~ 173 (350)
T d1q5ka_ 97 VLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL 173 (350)
T ss_dssp EEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECTTTCCEEECCCTTCEEC
T ss_pred EEECCCCCCHHHHHHHHHCCCCCCHHHHHHHHHHHHHHHHHHHHCC---CCCCCCCCCEEEEECCCCCEEEECCCCHHHC
T ss_conf 9841688607888863103689999999999999999999998668---7645788603787358971167336605440
Q ss_pred CCCCCCCCC---CEEEEC---C-CCCCCCCCCCHHHHHHHHHHHHCCCCCCCCCCCCHHHHHHHH--------H------
Q ss_conf 899875444---402102---3-788884464023789999988199899998876402244867--------7------
Q 004521 593 GGDETEGNT---NRVVGT---Y-DGQFSIKSDVFSFGILLLEIVSGKKNRGFYRSDTKVNLIGHL--------W------ 651 (747)
Q Consensus 593 ~~~~~~~~~---~~~~~~---~-~~~~s~~sDVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~--------~------ 651 (747)
......... .....+ . ...++.++||||+||++|||++|+.||...........+... +
T Consensus 174 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~~~~~~ 253 (350)
T d1q5ka_ 174 VRGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPN 253 (350)
T ss_dssp CTTSCCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCC-
T ss_pred CCCCCCCCCCCCCCCCCHHHHHCCCCCCCCEEECCCCEEEEEHHHCCCCCCCCCHHHHHHHHHHHHCCCHHHHHHHHCCC
T ss_conf 47765320025555568277640468882100024652778550287998987999999999997489817765430621
Q ss_pred -HCCCCCCCCCHHHHCCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHH
Q ss_conf -2198652243011066999999999999976168999999998899998
Q 004521 652 -DEGIPLRLIDACIQDSCNLADVIRCIHIGLLCVQQHPEDRPCMPSVILM 700 (747)
Q Consensus 652 -~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dP~~RPt~~~v~~~ 700 (747)
........................+.+++.+||+.||.+|||+.|+++.
T Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~H 303 (350)
T d1q5ka_ 254 YTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAH 303 (350)
T ss_dssp --CCCCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred HHHCCCCCCCCCCHHHHCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCC
T ss_conf 01103554456744443156899999999999765895579299999669
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.2e-43 Score=291.98 Aligned_cols=253 Identities=20% Similarity=0.241 Sum_probs=187.1
Q ss_pred CCCCCCCEECCCCCEEEEEEEEC-CCCEEEEEEECCC--CCCCHHHHHHHHHHHHCCCCCCEEEEEEEEEECCEEEEEEE
Q ss_conf 39785542142498009999966-9849999991343--31068999999999830599732337748994982279995
Q 004521 440 DNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKI--SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYE 516 (747)
Q Consensus 440 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~e 516 (747)
++|++.++||+|+||+||+|++. +++.||||+++.. .......+++|+.+++.++|+||+++++++......++|+|
T Consensus 2 ~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~iv~~ 81 (292)
T d1unla_ 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE 81 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred CCCEEEEEEECCCCEEEEEEEECCCCCEEEEEEEEHHHCCHHHHHHHHHHHHHHHHCCCCCEEEECCCCCCCCCEEEEEE
T ss_conf 99786269712868199999999999699999980321786899999999999985675788821354444431158863
Q ss_pred CCCCCCHHHHHHHCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCCEEECCCCCCCCCCCC
Q ss_conf 07999944676312898767856789999999999998341599946732667683798589994471256750038998
Q 004521 517 FMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDE 596 (747)
Q Consensus 517 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dikp~NIll~~~~~~ki~DfGla~~~~~~~ 596 (747)
++.+++|..++.. ...+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||.++......
T Consensus 82 ~~~~~~l~~~~~~---~~~~~~~~~~~~~~q~~~aL~~lH~~~---IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~~~~ 155 (292)
T d1unla_ 82 FCDQDLKKYFDSC---NGDLDPEIVKSFLFQLLKGLGFCHSRN---VLHRDLKPQNLLINRNGELKLANFGLARAFGIPV 155 (292)
T ss_dssp CCSEEHHHHHHHT---TTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECCSCC
T ss_pred ECCCCCCCCCCCC---CCCCCHHHHHHHHHHHHHHHHHHHCCC---EEEECCCCCCCCCCCCCCEEEEECCHHHCCCCCC
T ss_conf 0233222112123---565403678999999999987743399---8600146761211337826652046011046887
Q ss_pred CCCCCCE----EEEC----CCCCCCCCCCCHHHHHHHHHHHHCCCCCCCCCCCCHHHHHHHH---HHCCCCC------CC
Q ss_conf 7544440----2102----3788884464023789999988199899998876402244867---7219865------22
Q 004521 597 TEGNTNR----VVGT----YDGQFSIKSDVFSFGILLLEIVSGKKNRGFYRSDTKVNLIGHL---WDEGIPL------RL 659 (747)
Q Consensus 597 ~~~~~~~----~~~~----~~~~~s~~sDVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~---~~~~~~~------~~ 659 (747)
....... .... ....++.++||||+||++|||++|+.|+.. ........... ....... ..
T Consensus 156 ~~~~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (292)
T d1unla_ 156 RCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFP--GNDVDDQLKRIFRLLGTPTEEQWPSMTKL 233 (292)
T ss_dssp SCCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCC--CSSHHHHHHHHHHHHCCCCTTTCTTGGGS
T ss_pred CCCEEECCCCCHHHHHHHCCCCCCCCHHHCCCCCHHHHHHHHCCCCCCC--CCCHHHHHHHHHHHCCCCCHHHHHHHHHC
T ss_conf 5100103443101466750698888044402654188998518999988--99999999999861189973551344322
Q ss_pred --------CCHHHH-CCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHH
Q ss_conf --------430110-66999999999999976168999999998899998
Q 004521 660 --------IDACIQ-DSCNLADVIRCIHIGLLCVQQHPEDRPCMPSVILM 700 (747)
Q Consensus 660 --------~d~~l~-~~~~~~~~~~~~~l~~~Cl~~dP~~RPt~~~v~~~ 700 (747)
...... .......-..+.+++.+||+.||.+|||++|+++.
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~H 283 (292)
T d1unla_ 234 PDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQH 283 (292)
T ss_dssp TTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred CCCCCCCCCCCCCHHHHCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCC
T ss_conf 21133444544310433065689999999999864996689099999649
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-42 Score=290.73 Aligned_cols=254 Identities=19% Similarity=0.266 Sum_probs=182.0
Q ss_pred CCCCCCCEECCCCCEEEEEEEEC-CCCEEEEEEECCCC-CCCHHHHHHHHHHHHCCCCCCEEEEEEEEEECC----EEEE
Q ss_conf 39785542142498009999966-98499999913433-106899999999983059973233774899498----2279
Q 004521 440 DNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKIS-EQGLKELKNEVILFSKLQHRNLVKLLGCCIQGE----EKLL 513 (747)
Q Consensus 440 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~----~~~l 513 (747)
++|++.++||+|+||+||+|+.. +++.||||++.+.. ....+.+++|+.++++++||||+++++++.... ..++
T Consensus 8 ~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~~~~ 87 (345)
T d1pmea_ 8 PRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVY 87 (345)
T ss_dssp TTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCEE
T ss_pred CCEEEEEEEEECCCEEEEEEEECCCCCEEEEEEEEHHCCHHHHHHHHHHHHHHHHCCCCCCCCEEEEEEECCCCCCCEEE
T ss_conf 98599789940648099999999999499999980310958999999999999976898988588899505645541499
Q ss_pred EEECCCCCCHHHHHHHCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCCEEECCCCCCCCC
Q ss_conf 99507999944676312898767856789999999999998341599946732667683798589994471256750038
Q 004521 514 IYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFG 593 (747)
Q Consensus 514 V~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dikp~NIll~~~~~~ki~DfGla~~~~ 593 (747)
+++++.+|+|.+++... .+++..+..++.|++.||+|||+++ |+||||||+|||++.++.+||+|||+|+...
T Consensus 88 l~~~~~~g~L~~~l~~~----~l~~~~i~~i~~qil~al~yLH~~~---iiHRDIKp~NILl~~~~~~kl~DfG~a~~~~ 160 (345)
T d1pmea_ 88 LVTHLMGADLYKLLKTQ----HLSNDHICYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARVAD 160 (345)
T ss_dssp EEEECCCEEHHHHHHHC----CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEECC
T ss_pred EEEEECCCCHHHHHHCC----CCCHHHHHHHHHHHHHHHHHHHHCC---CCCCCCCCCEEEECCCCCEEECCCCCEEECC
T ss_conf 99962598656644058----9999999999999999999999789---8677787643788799977875457056504
Q ss_pred CCCCCCC-CCEEEEC----------CCCCCCCCCCCHHHHHHHHHHHHCCCCCCCCCCCCHHHHHHHHHHCCCCC-----
Q ss_conf 9987544-4402102----------37888844640237899999881998999988764022448677219865-----
Q 004521 594 GDETEGN-TNRVVGT----------YDGQFSIKSDVFSFGILLLEIVSGKKNRGFYRSDTKVNLIGHLWDEGIPL----- 657 (747)
Q Consensus 594 ~~~~~~~-~~~~~~~----------~~~~~s~~sDVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~----- 657 (747)
....... .....++ ....++.++||||+|+++|||++|+.||......................
T Consensus 161 ~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (345)
T d1pmea_ 161 PDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCI 240 (345)
T ss_dssp GGGCBCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHTC
T ss_pred CCCCCCEEECCCCCCCEECHHHHHHCCCCCCCHHHHHCCCCEEHHHHHCCCCCCCCCHHHHHHHHHHHCCCCCHHHHHHH
T ss_conf 77764101011026520003878604788874101004670133776697997888889999987652069975664234
Q ss_pred ---CCCCHH----HHCCCCHHH-----HHHHHHHHHHCCCCCCCCCCCHHHHHHH
Q ss_conf ---224301----106699999-----9999999976168999999998899998
Q 004521 658 ---RLIDAC----IQDSCNLAD-----VIRCIHIGLLCVQQHPEDRPCMPSVILM 700 (747)
Q Consensus 658 ---~~~d~~----l~~~~~~~~-----~~~~~~l~~~Cl~~dP~~RPt~~~v~~~ 700 (747)
...... ......... -.++.+++.+||+.||.+|||+.++++.
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ta~e~L~h 295 (345)
T d1pmea_ 241 INLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAH 295 (345)
T ss_dssp CCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred HHHHHHCCCCCCCCCCCCCHHHHCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCC
T ss_conf 3322220244677557787778378999999999999764895679089998619
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-42 Score=291.21 Aligned_cols=255 Identities=22% Similarity=0.276 Sum_probs=186.3
Q ss_pred HCCCCCCCEECCCCCEEEEEEEECC-CCEEEEEEECCC--CCCCHHHHHHHHHHHHCCCCCCEEEEEEEEEECC------
Q ss_conf 2397855421424980099999669-849999991343--3106899999999983059973233774899498------
Q 004521 439 TDNFSINNKLGEGGFGPVYKGTLVD-GQEIAVKRLSKI--SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGE------ 509 (747)
Q Consensus 439 ~~~~~~~~~lg~G~~g~Vy~~~~~~-g~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~------ 509 (747)
.++|++.++||+|+||+||+|.... ++.||||+++.. .....+.+.+|+.++++++||||+++++++...+
T Consensus 17 ~~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~~ 96 (346)
T d1cm8a_ 17 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT 96 (346)
T ss_dssp BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCC
T ss_pred CCCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEECHHHCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEECCCCCCCCCC
T ss_conf 77189988980177819999999999989999998522259699999999999998668987547999863576555541
Q ss_pred EEEEEEECCCCCCHHHHHHHCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCCEEECCCCC
Q ss_conf 22799950799994467631289876785678999999999999834159994673266768379858999447125675
Q 004521 510 EKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLV 589 (747)
Q Consensus 510 ~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dikp~NIll~~~~~~ki~DfGla 589 (747)
+.++||||+ +.+|..+... ..+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+|
T Consensus 97 ~~~lv~e~~-~~~l~~~~~~----~~l~~~~~~~~~~qi~~aL~~LH~~~---IiHrDiKp~NIL~~~~~~~kl~Dfg~a 168 (346)
T d1cm8a_ 97 DFYLVMPFM-GTDLGKLMKH----EKLGEDRIQFLVYQMLKGLRYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGLA 168 (346)
T ss_dssp CCEEEEECC-SEEHHHHHHH----CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTC
T ss_pred EEEEEEECC-CCCHHHHHHH----CCCCHHHHHHHHHHHHHHHHHHHHCC---CCCCCCCCCHHHCCCCCCCCCCCCCCE
T ss_conf 599998405-5218999874----02269999999999999999987378---764566851111210012211343102
Q ss_pred CCCCCCCCCCCCCEE-EEC---C-CCCCCCCCCCHHHHHHHHHHHHCCCCCCCCCCCCHHHHHHHHH--------HC---
Q ss_conf 003899875444402-102---3-7888844640237899999881998999988764022448677--------21---
Q 004521 590 RTFGGDETEGNTNRV-VGT---Y-DGQFSIKSDVFSFGILLLEIVSGKKNRGFYRSDTKVNLIGHLW--------DE--- 653 (747)
Q Consensus 590 ~~~~~~~~~~~~~~~-~~~---~-~~~~s~~sDVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~--------~~--- 653 (747)
+.............. ..+ . ...++.++||||+||++|||++|+.|+................ ..
T Consensus 169 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 248 (346)
T d1cm8a_ 169 RQADSEMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQS 248 (346)
T ss_dssp EECCSSCCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHTCSC
T ss_pred ECCCCCCCCCCCCCCCCCHHHHCCCCCCCCCCHHHCCHHHHHHHHHCCCCCCCCCHHHHHHHHHHCCCCCCHHHHHHHCC
T ss_conf 20687631024553335889981787899650103003899999978699888976899999985037884888865300
Q ss_pred ----------CCCCCCCCHHHHCCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHH--HCCCC
Q ss_conf ----------98652243011066999999999999976168999999998899998--54898
Q 004521 654 ----------GIPLRLIDACIQDSCNLADVIRCIHIGLLCVQQHPEDRPCMPSVILM--LGSEI 705 (747)
Q Consensus 654 ----------~~~~~~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dP~~RPt~~~v~~~--L~~~~ 705 (747)
...............+ ..+.+++.+||+.||.+|||+.++++. ++...
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~s----~~~~dli~~mL~~dP~~R~ta~eiL~Hp~f~~~~ 308 (346)
T d1cm8a_ 249 DEAKNYMKGLPELEKKDFASILTNAS----PLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLH 308 (346)
T ss_dssp HHHHHHHHHSCCCCCCCGGGTCTTCC----HHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTC
T ss_pred HHHHHHHCCCCCCCCCCHHHHCCCCC----HHHHHHHHHHCCCCHHHCCCHHHHHCCHHHCCCC
T ss_conf 03443311578666556677556899----9999999997729955792999996396237587
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.1e-42 Score=287.46 Aligned_cols=256 Identities=21% Similarity=0.298 Sum_probs=184.1
Q ss_pred HCCCCCCCEECCCCCEEEEEEEEC-CCCEEEEEEECC--CCCCCHHHHHHHHHHHHCCCCCCEEEEEEEEEE--------
Q ss_conf 239785542142498009999966-984999999134--331068999999999830599732337748994--------
Q 004521 439 TDNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSK--ISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQ-------- 507 (747)
Q Consensus 439 ~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~--~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~-------- 507 (747)
.++|++.++||+|+||+||+|+.. +++.||||++.. ........+.+|+.++++++|+||+++++++..
T Consensus 9 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~~ 88 (318)
T d3blha1 9 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRC 88 (318)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC--------
T ss_pred CCCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEEEHHHCCHHHHHHHHHHHHHHHHHCCCCCCCEEEEEECCCCCCCCC
T ss_conf 27988999972274829999999899979999998422246378999999999999835999660676540246544445
Q ss_pred CCEEEEEEECCCCCCHHHHHHHCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCCEEECCC
Q ss_conf 98227999507999944676312898767856789999999999998341599946732667683798589994471256
Q 004521 508 GEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFG 587 (747)
Q Consensus 508 ~~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dikp~NIll~~~~~~ki~DfG 587 (747)
....++||||+.++.+..+. .....++...+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||
T Consensus 89 ~~~~~iv~e~~~~~~~~~~~---~~~~~~~~~~~~~i~~qil~~l~~lH~~~---ivHrDlKp~NILl~~~~~~kl~dfg 162 (318)
T d3blha1 89 KGSIYLVFDFCEHDLAGLLS---NVLVKFTLSEIKRVMQMLLNGLYYIHRNK---ILHRDMKAANVLITRDGVLKLADFG 162 (318)
T ss_dssp --CEEEEEECCCEEHHHHHT---CTTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEECCCT
T ss_pred CCEEEEEEECCCCCCCCHHH---HCCCCCCCHHHHHHHHHHHHHHHHHCCCC---EEECCCCCHHEEECCCCCEEEEECC
T ss_conf 76389998535787410122---20344330899999999999998852299---8856767222036689968763135
Q ss_pred CCCCCCCCCCCCC--CCEEEECC----------CCCCCCCCCCHHHHHHHHHHHHCCCCCCCCCCCCHHHHHHHHHHCCC
Q ss_conf 7500389987544--44021023----------78888446402378999998819989999887640224486772198
Q 004521 588 LVRTFGGDETEGN--TNRVVGTY----------DGQFSIKSDVFSFGILLLEIVSGKKNRGFYRSDTKVNLIGHLWDEGI 655 (747)
Q Consensus 588 la~~~~~~~~~~~--~~~~~~~~----------~~~~s~~sDVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~ 655 (747)
+++.+........ .....++. ...++.++||||+||++|||++|+.||...........+........
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~~~~~~~~i~~~~~~~~ 242 (318)
T d3blha1 163 LARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSIT 242 (318)
T ss_dssp TCEECCC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCC
T ss_pred EEEECCCCCCCCCCCCCCEECCHHHHHHHHHCCCCCCCCHHHCCCCCCEEEEHHHCCCCCCCCCHHHHHHHHHHHCCCCC
T ss_conf 00223554443211356602497874289970799989178700678646617448799899899999999998418998
Q ss_pred ---CCCC--------CCHHHHCCCCHHH-------HHHHHHHHHHCCCCCCCCCCCHHHHHHH
Q ss_conf ---6522--------4301106699999-------9999999976168999999998899998
Q 004521 656 ---PLRL--------IDACIQDSCNLAD-------VIRCIHIGLLCVQQHPEDRPCMPSVILM 700 (747)
Q Consensus 656 ---~~~~--------~d~~l~~~~~~~~-------~~~~~~l~~~Cl~~dP~~RPt~~~v~~~ 700 (747)
.... ............+ ...+.+++.+||+.||++|||+.|+++.
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~H 305 (318)
T d3blha1 243 PEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNH 305 (318)
T ss_dssp TTTSTTCCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred HHHCCCCCHHHHHHHHCCCCCCCCCCHHHHCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCC
T ss_conf 255344320344433201334455503340444599899999999873896589099999749
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.7e-42 Score=288.62 Aligned_cols=254 Identities=22% Similarity=0.293 Sum_probs=177.5
Q ss_pred HCCCCCCCEECCCCCEEEEEEEEC-C-CCEEEEEEECCC--CCCCHHHHHHHHHHHHCC---CCCCEEEEEEEEEE----
Q ss_conf 239785542142498009999966-9-849999991343--310689999999998305---99732337748994----
Q 004521 439 TDNFSINNKLGEGGFGPVYKGTLV-D-GQEIAVKRLSKI--SEQGLKELKNEVILFSKL---QHRNLVKLLGCCIQ---- 507 (747)
Q Consensus 439 ~~~~~~~~~lg~G~~g~Vy~~~~~-~-g~~vavK~l~~~--~~~~~~~~~~E~~~l~~l---~H~nIv~l~g~~~~---- 507 (747)
.++|++.++||+|+||+||+|++. . ++.||||+++.. .......+.+|+.+++.+ +||||+++++++..
T Consensus 6 ~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~~ 85 (305)
T d1blxa_ 6 DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTD 85 (305)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECS
T ss_pred CCCEEEEEEEECCCCEEEEEEEEECCCCEEEEEEEEEHHHCCCHHHHHHHHHHHHHHHHHHCCCCCCCEEEEEECCCCCC
T ss_conf 58979888992155869999999888998999999802324516799999999999987425898802366322146666
Q ss_pred -CCEEEEEEECCCCCCHHHHHHHCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCCEEECC
Q ss_conf -9822799950799994467631289876785678999999999999834159994673266768379858999447125
Q 004521 508 -GEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDF 586 (747)
Q Consensus 508 -~~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dikp~NIll~~~~~~ki~Df 586 (747)
....++++||+.++.+...... ....+++..+..++.|++.||+|||+.+ |+||||||+|||++..+.+||+||
T Consensus 86 ~~~~~~~~~e~~~~~~~~~~~~~--~~~~~~~~~~~~~~~qi~~aL~yLH~~~---ivHrDiKp~NILi~~~~~~kl~df 160 (305)
T d1blxa_ 86 RETKLTLVFEHVDQDLTTYLDKV--PEPGVPTETIKDMMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLADF 160 (305)
T ss_dssp SEEEEEEEEECCSCBHHHHHHHS--CTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECSC
T ss_pred CCCEEEEEEEECCCCCHHHHHHC--CCCCCCHHHHHHHHHHHHHHHHHHHHCC---EEECCCCCCEEEECCCCCEEECCH
T ss_conf 67469999974058714444430--3789998999999999999999997588---983579862789858997542100
Q ss_pred CCCCCCCCCCCCCCCCEEEEC---------CCCCCCCCCCCHHHHHHHHHHHHCCCCCCCCCCCCHHHHHHHHHHCC---
Q ss_conf 675003899875444402102---------37888844640237899999881998999988764022448677219---
Q 004521 587 GLVRTFGGDETEGNTNRVVGT---------YDGQFSIKSDVFSFGILLLEIVSGKKNRGFYRSDTKVNLIGHLWDEG--- 654 (747)
Q Consensus 587 Gla~~~~~~~~~~~~~~~~~~---------~~~~~s~~sDVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~--- 654 (747)
|+++........ ....|| .+..|+.++||||+||++|||++|+.||...........+.......
T Consensus 161 g~~~~~~~~~~~---~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~ 237 (305)
T d1blxa_ 161 GLARIYSFQMAL---TSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEE 237 (305)
T ss_dssp CSCCCCCGGGGG---CCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCGG
T ss_pred HHHHHHCCCCCC---CCCCCCHHHCCCCHHCCCCCCHHEHHHCHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHHCCCCHH
T ss_conf 010110023457---77654851148310017988811100032899999987879989989899999999840799611
Q ss_pred -CC--CCCCCHHH-------HCCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHH
Q ss_conf -86--52243011-------066999999999999976168999999998899998
Q 004521 655 -IP--LRLIDACI-------QDSCNLADVIRCIHIGLLCVQQHPEDRPCMPSVILM 700 (747)
Q Consensus 655 -~~--~~~~d~~l-------~~~~~~~~~~~~~~l~~~Cl~~dP~~RPt~~~v~~~ 700 (747)
.. ........ ...........+.+++.+||+.||.+|||+.|+++.
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~H 293 (305)
T d1blxa_ 238 DWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSH 293 (305)
T ss_dssp GSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred CCCCCCCCHHHHHCCCCCCCHHHCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCC
T ss_conf 05321111033302234564544044589999999999874896679189999669
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.9e-42 Score=288.43 Aligned_cols=243 Identities=22% Similarity=0.276 Sum_probs=185.2
Q ss_pred CCCCCCCEECCCCCEEEEEEEEC----CCCEEEEEEECCC----CCCCHHHHHHHHHHHHCCCC-CCEEEEEEEEEECCE
Q ss_conf 39785542142498009999966----9849999991343----31068999999999830599-732337748994982
Q 004521 440 DNFSINNKLGEGGFGPVYKGTLV----DGQEIAVKRLSKI----SEQGLKELKNEVILFSKLQH-RNLVKLLGCCIQGEE 510 (747)
Q Consensus 440 ~~~~~~~~lg~G~~g~Vy~~~~~----~g~~vavK~l~~~----~~~~~~~~~~E~~~l~~l~H-~nIv~l~g~~~~~~~ 510 (747)
++|++.+.||+|+||+||+|+.. +|+.||||.+++. .....+.+.+|+.++++++| |||+++++++.+...
T Consensus 24 ~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~~~ 103 (322)
T d1vzoa_ 24 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETK 103 (322)
T ss_dssp GGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTE
T ss_pred HCEEEEEEEECCCCEEEEEEEECCCCCCCCEEEEEEEEHHHHCCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEECCCCC
T ss_conf 02599989832878399999987658879489999983677210168999999999999864679839996200024873
Q ss_pred EEEEEECCCCCCHHHHHHHCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCCEEECCCCCC
Q ss_conf 27999507999944676312898767856789999999999998341599946732667683798589994471256750
Q 004521 511 KLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVR 590 (747)
Q Consensus 511 ~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dikp~NIll~~~~~~ki~DfGla~ 590 (747)
.++|+||+.+|+|.+++.... .+.+.....++.|++.||+|||+.+ ++||||||+|||++.++.+||+|||+++
T Consensus 104 ~~~v~e~~~~~~L~~~i~~~~---~~~e~~~~~~~~Qi~~al~~lH~~~---ivHrDiKp~Nill~~~~~vkL~DFG~a~ 177 (322)
T d1vzoa_ 104 LHLILDYINGGELFTHLSQRE---RFTEHEVQIYVGEIVLALEHLHKLG---IIYRDIKLENILLDSNGHVVLTDFGLSK 177 (322)
T ss_dssp EEEEECCCCSCBHHHHHHHHS---CCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEESCSSEEE
T ss_pred EEEEEECCCCCHHHHHHHHCC---CCCHHHHHHHHHHHHHHHHHHHCCC---EEECCCCCCCEEECCCCCEEEEECCCHH
T ss_conf 001231234117999987304---5437888888999999998851499---8965477320124699988874132022
Q ss_pred CCCCCCCCCCCCEEEECC-----------CCCCCCCCCCHHHHHHHHHHHHCCCCCCCCCCCCHHHHHHHHHHCCCCCCC
Q ss_conf 038998754444021023-----------788884464023789999988199899998876402244867721986522
Q 004521 591 TFGGDETEGNTNRVVGTY-----------DGQFSIKSDVFSFGILLLEIVSGKKNRGFYRSDTKVNLIGHLWDEGIPLRL 659 (747)
Q Consensus 591 ~~~~~~~~~~~~~~~~~~-----------~~~~s~~sDVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 659 (747)
.+.......... ..++. ...++.++||||+||+||||++|+.||...........+.......... +
T Consensus 178 ~~~~~~~~~~~~-~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~~~~i~~~~~~~~~~-~ 255 (322)
T d1vzoa_ 178 EFVADETERAYD-FCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPP-Y 255 (322)
T ss_dssp ECCGGGGGGGCG-GGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHHHHCCCC-C
T ss_pred HHCCCCCCCCCC-CCCCCCCCHHHHHHCCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHCCCCCCC-C
T ss_conf 203444432212-22333331068760577688713251777799999976899988887777999999833568998-8
Q ss_pred CCHHHHCCCCHHHHHHHHHHHHHCCCCCCCCCCC-----HHHHHH
Q ss_conf 4301106699999999999997616899999999-----889999
Q 004521 660 IDACIQDSCNLADVIRCIHIGLLCVQQHPEDRPC-----MPSVIL 699 (747)
Q Consensus 660 ~d~~l~~~~~~~~~~~~~~l~~~Cl~~dP~~RPt-----~~~v~~ 699 (747)
. . .....+.+++.+||+.||.+||+ ++|+++
T Consensus 256 ~-----~----~~s~~~~~li~~~l~~dP~~R~s~~~~t~~eil~ 291 (322)
T d1vzoa_ 256 P-----Q----EMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKE 291 (322)
T ss_dssp C-----T----TSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHT
T ss_pred C-----C----CCCHHHHHHHHHHCCCCHHHCCCCCCCCHHHHHC
T ss_conf 6-----5----4799999999997445898819997450999974
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=100.00 E-value=2.3e-41 Score=282.63 Aligned_cols=248 Identities=17% Similarity=0.267 Sum_probs=179.5
Q ss_pred CCCCCCCEECCCCCEEEEEEEEC-CCCEEEEEEECCCCCCCHHHHHHHHHHHHCCC-CCCEEEEEEEEEEC--CEEEEEE
Q ss_conf 39785542142498009999966-98499999913433106899999999983059-97323377489949--8227999
Q 004521 440 DNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKISEQGLKELKNEVILFSKLQ-HRNLVKLLGCCIQG--EEKLLIY 515 (747)
Q Consensus 440 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~-H~nIv~l~g~~~~~--~~~~lV~ 515 (747)
++|++.++||+|+||+||+|+.. +++.||||+++. ...+.+.+|+.++..++ ||||+++++++... ...++||
T Consensus 35 d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~---~~~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~~~v~ 111 (328)
T d3bqca1 35 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKP---VKKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVF 111 (328)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECS---SCHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSEEEEE
T ss_pred CCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEECH---HHHHHHHHHHHHHHHCCCCCCCCEEEEEEEECCCCCEEEEE
T ss_conf 671897898317481999999889997999999888---99999999999998515799876799999816877126888
Q ss_pred ECCCCCCHHHHHHHCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCC-CCEEECCCCCCCCCC
Q ss_conf 5079999446763128987678567899999999999983415999467326676837985899-944712567500389
Q 004521 516 EFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDM-NPKISDFGLVRTFGG 594 (747)
Q Consensus 516 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dikp~NIll~~~~-~~ki~DfGla~~~~~ 594 (747)
||+.+++|..+. ..+++..+..++.|++.||.|||+.+ |+||||||+|||++.++ .+||+|||+|+....
T Consensus 112 e~~~~~~L~~~~------~~l~e~~i~~i~~qil~aL~~LH~~g---IvHrDiKp~NILi~~~~~~vkl~DFG~a~~~~~ 182 (328)
T d3bqca1 112 EHVNNTDFKQLY------QTLTDYDIRFYMYEILKALDYCHSMG---IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHP 182 (328)
T ss_dssp ECCCSCBGGGTT------TSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTTEEEECCGGGCEECCT
T ss_pred EECCCCCHHHHH------CCCCHHHHHHHHHHHHHHHHHHHHCC---CCCCCCCCCCEEECCCCCEEEECCCCCCEECCC
T ss_conf 631798589974------68999999999999999998876433---443456441237748998366415654266468
Q ss_pred CCCCCC---CCEEEEC---C-CCCCCCCCCCHHHHHHHHHHHHCCCCCCCCCCCCHHHH-HHHH----------HHCCCC
Q ss_conf 987544---4402102---3-78888446402378999998819989999887640224-4867----------721986
Q 004521 595 DETEGN---TNRVVGT---Y-DGQFSIKSDVFSFGILLLEIVSGKKNRGFYRSDTKVNL-IGHL----------WDEGIP 656 (747)
Q Consensus 595 ~~~~~~---~~~~~~~---~-~~~~s~~sDVwSlGvil~elltg~~p~~~~~~~~~~~~-~~~~----------~~~~~~ 656 (747)
...... +.....+ . ...++.++||||+|+++|||++|+.|+........... +... ......
T Consensus 183 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~ 262 (328)
T d3bqca1 183 GQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIE 262 (328)
T ss_dssp TCCCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTCC
T ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHHHHHCCCHHHHHHHHCCCC
T ss_conf 87444322486424761026888888452323354555876048899988760189999999987884155555422544
Q ss_pred --CC-----------CCCHHHHCCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHH
Q ss_conf --52-----------24301106699999999999997616899999999889999
Q 004521 657 --LR-----------LIDACIQDSCNLADVIRCIHIGLLCVQQHPEDRPCMPSVIL 699 (747)
Q Consensus 657 --~~-----------~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dP~~RPt~~~v~~ 699 (747)
.. .................+.+++.+||+.||.+|||++|+++
T Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~ 318 (328)
T d3bqca1 263 LDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAME 318 (328)
T ss_dssp CCGGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred CCCCCCHHCCCCCCCCHHHCCCCCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHC
T ss_conf 47430000033343311211552112448999999999986699568908999964
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=4.7e-41 Score=280.56 Aligned_cols=251 Identities=19% Similarity=0.294 Sum_probs=182.4
Q ss_pred CCCCCCCEECCCCCEEEEEEEECC-CCEEEEEEECCCCCCCHHHHHHHHHHHHCCCCCC-EEEEEEEEEECCEEEEEEEC
Q ss_conf 397855421424980099999669-8499999913433106899999999983059973-23377489949822799950
Q 004521 440 DNFSINNKLGEGGFGPVYKGTLVD-GQEIAVKRLSKISEQGLKELKNEVILFSKLQHRN-LVKLLGCCIQGEEKLLIYEF 517 (747)
Q Consensus 440 ~~~~~~~~lg~G~~g~Vy~~~~~~-g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~n-Iv~l~g~~~~~~~~~lV~e~ 517 (747)
++|++.+.||+|+||.||+|++.. ++.||||.+.... ...++..|+++++.++|++ |+.+.++..+....++||||
T Consensus 7 ~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~--~~~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~ivme~ 84 (299)
T d1ckia_ 7 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKT--KHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMEL 84 (299)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCT--TSCCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEEEEEEC
T ss_pred CEEEEEEEEEECCCCEEEEEEECCCCCEEEEEEECHHC--CCHHHHHHHHHHHHCCCCCCCCEEEEEEECCCEEEEEEEE
T ss_conf 88999689850788099999998899899999972100--5888999999999703899601799999519877899987
Q ss_pred CCCCCHHHHHHHCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEEC---CCCCCEEECCCCCCCCCC
Q ss_conf 79999446763128987678567899999999999983415999467326676837985---899944712567500389
Q 004521 518 MPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLD---QDMNPKISDFGLVRTFGG 594 (747)
Q Consensus 518 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dikp~NIll~---~~~~~ki~DfGla~~~~~ 594 (747)
+. ++|...+... ...+++..+..++.|++.||+|||+.+ |+||||||+|||++ .+..+||+|||+|+.+..
T Consensus 85 ~~-~~l~~~~~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~---iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~~~ 158 (299)
T d1ckia_ 85 LG-PSLEDLFNFC--SRKFSLKTVLLLADQMISRIEYIHSKN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRD 158 (299)
T ss_dssp CC-CBHHHHHHHT--TTCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECCGGGTTCEEECCCSSCEECBC
T ss_pred CC-CCHHHHHHHC--CCCCCHHHHHHHHHHHHHHHHHHHHCC---EEECCCCHHHCCCCCCCCCCEEEEECCCCCEECCC
T ss_conf 38-7133324430--688768999999999999999999799---44266787660643357776156504675134255
Q ss_pred CCCCC-----CCCEEEECC---------CCCCCCCCCCHHHHHHHHHHHHCCCCCCCCCCCCHHHHHHHHHHCCCCCCCC
Q ss_conf 98754-----444021023---------7888844640237899999881998999988764022448677219865224
Q 004521 595 DETEG-----NTNRVVGTY---------DGQFSIKSDVFSFGILLLEIVSGKKNRGFYRSDTKVNLIGHLWDEGIPLRLI 660 (747)
Q Consensus 595 ~~~~~-----~~~~~~~~~---------~~~~s~~sDVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 660 (747)
..... ......|+. +..++.++||||||+++|||++|+.||................... ....
T Consensus 159 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~--~~~~ 236 (299)
T d1ckia_ 159 ARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKK--MSTP 236 (299)
T ss_dssp TTTCCBCCCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHHHHSSCTTCCCC-------HHHHHHHH--HHSC
T ss_pred CCCCCCEECCCCCCCCCCCCCCCHHHHHCCCCCCHHHEEECCHHHHHHHHCCCCCCCCCHHHHHHHHHHHHCCC--CCCC
T ss_conf 44554100013577678735329999918998983218861778999984987665530577999999852356--7898
Q ss_pred CHHHHCCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHCCC
Q ss_conf 30110669999999999999761689999999988999985489
Q 004521 661 DACIQDSCNLADVIRCIHIGLLCVQQHPEDRPCMPSVILMLGSE 704 (747)
Q Consensus 661 d~~l~~~~~~~~~~~~~~l~~~Cl~~dP~~RPt~~~v~~~L~~~ 704 (747)
.+.+....+ ..+.+++..||+.+|++||++.++.+.|+..
T Consensus 237 ~~~~~~~~p----~~~~~li~~cl~~~p~~RP~~~~i~~~l~~~ 276 (299)
T d1ckia_ 237 IEVLCKGYP----SEFATYLNFCRSLRFDDKPDYSYLRQLFRNL 276 (299)
T ss_dssp HHHHTTTSC----HHHHHHHHHHHHSCTTCCCCHHHHHHHHHHH
T ss_pred HHHHCCCCC----HHHHHHHHHHCCCCHHHCCCHHHHHHHHHHH
T ss_conf 357534788----9999999998439955791999999999999
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.3e-42 Score=289.03 Aligned_cols=231 Identities=24% Similarity=0.369 Sum_probs=178.2
Q ss_pred CCCCCCCEECCCCCEEEEEEEEC-CCCEEEEEEECCCCC------CCHHHHHHHHHHHHCCC--CCCEEEEEEEEEECCE
Q ss_conf 39785542142498009999966-984999999134331------06899999999983059--9732337748994982
Q 004521 440 DNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKISE------QGLKELKNEVILFSKLQ--HRNLVKLLGCCIQGEE 510 (747)
Q Consensus 440 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~~------~~~~~~~~E~~~l~~l~--H~nIv~l~g~~~~~~~ 510 (747)
++|++.+.||+|+||.||+|+.. +++.||||++.+... .....+.+|+.++++++ ||||+++++++...+.
T Consensus 4 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~~~ 83 (273)
T d1xwsa_ 4 SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDS 83 (273)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSSE
T ss_pred CEEEEEEEEEECCCEEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCEEEEEEEECCE
T ss_conf 83799679840878399999999999799999985688443345567999999999999743589881279999830996
Q ss_pred EEEEEECCCC-CCHHHHHHHCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCC-CCCEEECCCC
Q ss_conf 2799950799-9944676312898767856789999999999998341599946732667683798589-9944712567
Q 004521 511 KLLIYEFMPN-KSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQD-MNPKISDFGL 588 (747)
Q Consensus 511 ~~lV~e~~~~-gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dikp~NIll~~~-~~~ki~DfGl 588 (747)
.++||||+.+ +++.+++... ..+++..+..++.|++.||+|||+.+ |+||||||+|||++.+ +.+||+|||+
T Consensus 84 ~~lv~e~~~~~~~l~~~~~~~---~~l~e~~~~~~~~qi~~al~~lH~~~---iiHrDiKp~NIll~~~~~~vkl~DFG~ 157 (273)
T d1xwsa_ 84 FVLILERPEPVQDLFDFITER---GALQEELARSFFWQVLEAVRHCHNCG---VLHRDIKDENILIDLNRGELKLIDFGS 157 (273)
T ss_dssp EEEEEECCSSEEEHHHHHHHH---CSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEETTTTEEEECCCTT
T ss_pred EEEEEEECCCCCHHHHHHHCC---CCCCHHHHHHHHHHHHHHHHHHHHCC---CCCCCCCCCCEEEECCCCEEEECCCCC
T ss_conf 899998336862289998615---89999999999999999999998779---755667611147744788489775465
Q ss_pred CCCCCCCCCCCCCCEEEECC----------CCCCCCCCCCHHHHHHHHHHHHCCCCCCCCCCCCHHHHHHHHHHCCCCCC
Q ss_conf 50038998754444021023----------78888446402378999998819989999887640224486772198652
Q 004521 589 VRTFGGDETEGNTNRVVGTY----------DGQFSIKSDVFSFGILLLEIVSGKKNRGFYRSDTKVNLIGHLWDEGIPLR 658 (747)
Q Consensus 589 a~~~~~~~~~~~~~~~~~~~----------~~~~s~~sDVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 658 (747)
|+......... ..|+. ...++.++||||+||++|||++|+.||... . . .......
T Consensus 158 a~~~~~~~~~~----~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~---~--~----i~~~~~~-- 222 (273)
T d1xwsa_ 158 GALLKDTVYTD----FDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHD---E--E----IIRGQVF-- 222 (273)
T ss_dssp CEECCSSCBCC----CCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSH---H--H----HHHCCCC--
T ss_pred CEECCCCCCCC----CCCCCCCCCHHHHCCCCCCCCCCCCCCCEEEEHHHHHCCCCCCCC---H--H----HHHCCCC--
T ss_conf 35324445566----565877479999848997886533255403453675688998873---6--7----7615447--
Q ss_pred CCCHHHHCCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHH
Q ss_conf 243011066999999999999976168999999998899998
Q 004521 659 LIDACIQDSCNLADVIRCIHIGLLCVQQHPEDRPCMPSVILM 700 (747)
Q Consensus 659 ~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dP~~RPt~~~v~~~ 700 (747)
.. ...+ ..+.+++.+||+.||.+|||+.|+++.
T Consensus 223 -~~----~~~s----~~~~~li~~~L~~dp~~R~s~~eil~h 255 (273)
T d1xwsa_ 223 -FR----QRVS----SECQHLIRWCLALRPSDRPTFEEIQNH 255 (273)
T ss_dssp -CS----SCCC----HHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred -CC----CCCC----HHHHHHHHHHCCCCHHHCCCHHHHHCC
T ss_conf -78----7799----999999999760897589399998539
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6e-42 Score=286.37 Aligned_cols=256 Identities=23% Similarity=0.312 Sum_probs=183.5
Q ss_pred HCCCCCCCEECCCCCEEEEEEEEC-CCCEEEEEEECCC--CCCCHHHHHHHHHHHHCCCCCCEEEEEEEEEEC-----CE
Q ss_conf 239785542142498009999966-9849999991343--310689999999998305997323377489949-----82
Q 004521 439 TDNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKI--SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQG-----EE 510 (747)
Q Consensus 439 ~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~-----~~ 510 (747)
.++|++.++||+|+||+||+|+.. +++.||||++++. .....+.+.+|+.++++++|+||+++++++... ..
T Consensus 17 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~~ 96 (348)
T d2gfsa1 17 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN 96 (348)
T ss_dssp ETTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTCC
T ss_pred CCCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEECCHHCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEEECCCCCCCC
T ss_conf 98718888983178839999999999979999998820028689999999999998668987425999996346456686
Q ss_pred EEEEEECCCCCCHHHHHHHCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCCEEECCCCCC
Q ss_conf 27999507999944676312898767856789999999999998341599946732667683798589994471256750
Q 004521 511 KLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVR 590 (747)
Q Consensus 511 ~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dikp~NIll~~~~~~ki~DfGla~ 590 (747)
.+++++++.+|+|.+++.. ..+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+|++|||++.
T Consensus 97 ~~~i~~~~~gg~L~~~~~~----~~l~e~~~~~i~~qil~aL~~LH~~g---iiHrDiKp~NILi~~~~~~kl~dfg~a~ 169 (348)
T d2gfsa1 97 DVYLVTHLMGADLNNIVKC----QKLTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR 169 (348)
T ss_dssp CCEEEEECCSEEHHHHHTT----CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECCC----
T ss_pred EEEEEEEECCCCHHHHCCC----CCCCHHHHHHHHHHHHHHHHHHHHCC---CCCCCCCCCCCCCCCCCCCCCCCCCHHC
T ss_conf 4999996258862320022----45309999999999999999997388---7651667763345543220013210001
Q ss_pred CCCCCCCCCCCCEE-EEC---C-CCCCCCCCCCHHHHHHHHHHHHCCCCCCCCCCCCHHHHHHHHHHCCCCC-CCC----
Q ss_conf 03899875444402-102---3-7888844640237899999881998999988764022448677219865-224----
Q 004521 591 TFGGDETEGNTNRV-VGT---Y-DGQFSIKSDVFSFGILLLEIVSGKKNRGFYRSDTKVNLIGHLWDEGIPL-RLI---- 660 (747)
Q Consensus 591 ~~~~~~~~~~~~~~-~~~---~-~~~~s~~sDVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~-~~~---- 660 (747)
.............. ... . ...++.++||||+||++|||++|+.||...........+... .+... ...
T Consensus 170 ~~~~~~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~~~~~~i~~~--~~~~~~~~~~~~~ 247 (348)
T d2gfsa1 170 HTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRL--VGTPGAELLKKIS 247 (348)
T ss_dssp CCTGGGSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHH--HCCCCHHHHTTCC
T ss_pred CCCCCCCCCCCCCCCCCCHHHCCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHH--CCCCCHHHHHHCC
T ss_conf 25754444345435558355337756785512432058999997688997889889999999973--0799757732001
Q ss_pred ----CH----HH-HCCCCHH-----HHHHHHHHHHHCCCCCCCCCCCHHHHHH--HHCC
Q ss_conf ----30----11-0669999-----9999999997616899999999889999--8548
Q 004521 661 ----DA----CI-QDSCNLA-----DVIRCIHIGLLCVQQHPEDRPCMPSVIL--MLGS 703 (747)
Q Consensus 661 ----d~----~l-~~~~~~~-----~~~~~~~l~~~Cl~~dP~~RPt~~~v~~--~L~~ 703 (747)
.. .. ....... ....+.+++.+||+.||.+|||+.|+++ .+..
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~elL~Hp~f~~ 306 (348)
T d2gfsa1 248 SESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQ 306 (348)
T ss_dssp CHHHHHHHTTSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTT
T ss_pred CHHHHHHHHHCCCCCCCCHHHHCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCCHHHCC
T ss_conf 02445444303557875556626789999999999977588345938999855995487
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=100.00 E-value=5.5e-40 Score=273.63 Aligned_cols=251 Identities=15% Similarity=0.202 Sum_probs=188.1
Q ss_pred CCCCCCCEECCCCCEEEEEEEECC-CCEEEEEEECCCCCCCHHHHHHHHHHHHCCCC-CCEEEEEEEEEECCEEEEEEEC
Q ss_conf 397855421424980099999669-84999999134331068999999999830599-7323377489949822799950
Q 004521 440 DNFSINNKLGEGGFGPVYKGTLVD-GQEIAVKRLSKISEQGLKELKNEVILFSKLQH-RNLVKLLGCCIQGEEKLLIYEF 517 (747)
Q Consensus 440 ~~~~~~~~lg~G~~g~Vy~~~~~~-g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H-~nIv~l~g~~~~~~~~~lV~e~ 517 (747)
++|++.+.||+|+||+||+|++.. ++.||||.+.... ....+.+|++.+..+.| +|++.++++.......++||||
T Consensus 5 ~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~--~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~~vme~ 82 (293)
T d1csna_ 5 VHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS--DAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVIDL 82 (293)
T ss_dssp TTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCT--TSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEEC
T ss_pred CCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEECCCC--CCHHHHHHHHHHHHHCCCCCCCEEEEEEECCCCCEEEEEE
T ss_conf 80699799841788299999998899799999975025--8299999999999964899987799996018811799996
Q ss_pred CCCCCHHHHHHHCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECC-----CCCCEEECCCCCCCC
Q ss_conf 799994467631289876785678999999999999834159994673266768379858-----999447125675003
Q 004521 518 MPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQ-----DMNPKISDFGLVRTF 592 (747)
Q Consensus 518 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dikp~NIll~~-----~~~~ki~DfGla~~~ 592 (747)
+ +++|.+++... ...++...+..++.|++.||+|||+.+ |+||||||+|||++. .+.+||+|||+|+.+
T Consensus 83 ~-~~~l~~~~~~~--~~~~~~~~~~~i~~q~~~~l~~lH~~g---iiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~~~ 156 (293)
T d1csna_ 83 L-GPSLEDLLDLC--GRKFSVKTVAMAAKQMLARVQSIHEKS---LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFY 156 (293)
T ss_dssp C-CCBHHHHHHHT--TTCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECCSSSTTTTCEEECCCTTCEES
T ss_pred C-CCCHHHHHHHH--CCCHHHHHHHHHHHHHHHHHHHHHHCC---CEECCCCCCCEEECCCCCCCCCCEEECCCCEEEEC
T ss_conf 4-88879999752--031106899999999999999999779---66266771315234754344795687236605771
Q ss_pred CCCCCCC-----CCCEEEECC---------CCCCCCCCCCHHHHHHHHHHHHCCCCCCCCCCCCHHHHHHHHHHCCCCCC
Q ss_conf 8998754-----444021023---------78888446402378999998819989999887640224486772198652
Q 004521 593 GGDETEG-----NTNRVVGTY---------DGQFSIKSDVFSFGILLLEIVSGKKNRGFYRSDTKVNLIGHLWDEGIPLR 658 (747)
Q Consensus 593 ~~~~~~~-----~~~~~~~~~---------~~~~s~~sDVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 658 (747)
....... ......||. +..++.++||||||+++|||++|+.||......................
T Consensus 157 ~~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~i~~~~~~~- 235 (293)
T d1csna_ 157 RDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQST- 235 (293)
T ss_dssp BCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHHS-
T ss_pred CCCCCCCCEEECCCCCEEECHHHCCHHHHCCCCCCHHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHHHHCCCCC-
T ss_conf 4676654111024676277510267989648888869998983199999986987678853021999999997056799-
Q ss_pred CCCHHHHCCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHCCC
Q ss_conf 2430110669999999999999761689999999988999985489
Q 004521 659 LIDACIQDSCNLADVIRCIHIGLLCVQQHPEDRPCMPSVILMLGSE 704 (747)
Q Consensus 659 ~~d~~l~~~~~~~~~~~~~~l~~~Cl~~dP~~RPt~~~v~~~L~~~ 704 (747)
....+....+ ..+.+++..|+..+|++||++..+.+.|+..
T Consensus 236 -~~~~l~~~~p----~~l~~ii~~~~~~~~~~rP~y~~l~~~l~~~ 276 (293)
T d1csna_ 236 -PLRELCAGFP----EEFYKYMHYARNLAFDATPDYDYLQGLFSKV 276 (293)
T ss_dssp -CHHHHTTTSC----HHHHHHHHHHHHCCTTCCCCHHHHHHHHHHH
T ss_pred -CHHHHCCCCC----HHHHHHHHHHHCCCCCCCCCHHHHHHHHHHH
T ss_conf -9589657998----9999999998439930085999999999999
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.4e-41 Score=279.28 Aligned_cols=252 Identities=21% Similarity=0.233 Sum_probs=181.7
Q ss_pred CCCCCCCEECCCCCEEEEEEEECC-CCEEEEEEECCC--CCCCHHHHHHHHHHHHCCCCCCEEEEEEEEEEC------CE
Q ss_conf 397855421424980099999669-849999991343--310689999999998305997323377489949------82
Q 004521 440 DNFSINNKLGEGGFGPVYKGTLVD-GQEIAVKRLSKI--SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQG------EE 510 (747)
Q Consensus 440 ~~~~~~~~lg~G~~g~Vy~~~~~~-g~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~------~~ 510 (747)
++|++.++||+|+||+||+|++.. ++.||||++... .......+.+|+.++++++||||+++++++... .+
T Consensus 17 ~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~~~ 96 (355)
T d2b1pa1 17 KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQD 96 (355)
T ss_dssp TTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCCE
T ss_pred CCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEECHHHCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEECCCCCCCCCE
T ss_conf 77599889621758599999999999899999988233697999999999999986489876489989702564345762
Q ss_pred EEEEEECCCCCCHHHHHHHCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCCEEECCCCCC
Q ss_conf 27999507999944676312898767856789999999999998341599946732667683798589994471256750
Q 004521 511 KLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVR 590 (747)
Q Consensus 511 ~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dikp~NIll~~~~~~ki~DfGla~ 590 (747)
.++||||+.++.+ +.+. ..+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+|++|||+++
T Consensus 97 ~~iv~Ey~~~~l~-~~~~-----~~~~~~~i~~~~~qil~gl~~LH~~g---iiHrDlKP~Nil~~~~~~~kl~df~~~~ 167 (355)
T d2b1pa1 97 VYLVMELMDANLC-QVIQ-----MELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLAR 167 (355)
T ss_dssp EEEEEECCSEEHH-HHHT-----SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCCCC--
T ss_pred EEEEEECCCHHHH-HHHH-----CCCCHHHHHHHHHHHHHHHHHHHHCC---CCCCCCCCCCCCCCCCCCEEEECHHHHH
T ss_conf 6999841446778-7650-----38999999999999999998865221---1245677632113654431320102321
Q ss_pred CCCCCCCCCCC---CEEE---ECCCCCCCCCCCCHHHHHHHHHHHHCCCCCCCCCCCCHHHHHHHH--------HH----
Q ss_conf 03899875444---4021---023788884464023789999988199899998876402244867--------72----
Q 004521 591 TFGGDETEGNT---NRVV---GTYDGQFSIKSDVFSFGILLLEIVSGKKNRGFYRSDTKVNLIGHL--------WD---- 652 (747)
Q Consensus 591 ~~~~~~~~~~~---~~~~---~~~~~~~s~~sDVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~--------~~---- 652 (747)
........... .... -..+..++.++||||+||++|||++|+.||...........+... +.
T Consensus 168 ~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~ell~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 247 (355)
T d2b1pa1 168 TAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQP 247 (355)
T ss_dssp -------------CCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHTTSCH
T ss_pred CCCCCCCCCCCCCCCCCCCHHHHCCCCCCCCCCCCCCCCHHHHHHHCCCCCCCCCHHHHHHHHHHHCCCCCHHHHHHHHH
T ss_conf 14666553322146555581331477778774333566257898659899888977889999997205898799987656
Q ss_pred ------CCC--CCC-----CCCHHHHCCCC---HHHHHHHHHHHHHCCCCCCCCCCCHHHHHHH
Q ss_conf ------198--652-----24301106699---9999999999976168999999998899998
Q 004521 653 ------EGI--PLR-----LIDACIQDSCN---LADVIRCIHIGLLCVQQHPEDRPCMPSVILM 700 (747)
Q Consensus 653 ------~~~--~~~-----~~d~~l~~~~~---~~~~~~~~~l~~~Cl~~dP~~RPt~~~v~~~ 700 (747)
... ... ........... ......+.+++.+||+.||++|||++|+++.
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL~H 311 (355)
T d2b1pa1 248 TVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQH 311 (355)
T ss_dssp HHHHHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred HHHHHHHCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCC
T ss_conf 6777764175435666421264333543210133379999999999876994579089999669
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=4.3e-37 Score=254.90 Aligned_cols=271 Identities=17% Similarity=0.172 Sum_probs=183.9
Q ss_pred CCCCCCCEECCCCCEEEEEEEEC-CCCEEEEEEECCCCCCCHHHHHHHHHHHHCCC-----------CCCEEEEEEEEEE
Q ss_conf 39785542142498009999966-98499999913433106899999999983059-----------9732337748994
Q 004521 440 DNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKISEQGLKELKNEVILFSKLQ-----------HRNLVKLLGCCIQ 507 (747)
Q Consensus 440 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~-----------H~nIv~l~g~~~~ 507 (747)
++|++.++||+|+||+||+|+.. +++.||||++++. ....+.+.+|+.+++.++ |+||+++++++..
T Consensus 13 ~rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~-~~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~~~ 91 (362)
T d1q8ya_ 13 ARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGD-KVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNH 91 (362)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEE
T ss_pred CCEEEEEEEEECCCEEEEEEEECCCCCEEEEEEEECC-CCCHHHHHHHHHHHHHHCCHHHHHHHHCCCCCEEEEEEEEEE
T ss_conf 8579989975077818999999999979999998343-133689999999999840145555542276764789987631
Q ss_pred C--CEEEEEEECCCCCCHHHHHHHCCCCCCCCHHHHHHHHHHHHHHHHHHHH-CCCCCEEECCCCCCCEEECCCCC----
Q ss_conf 9--8227999507999944676312898767856789999999999998341-59994673266768379858999----
Q 004521 508 G--EEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQ-DSRLRIIHRDLKASNVLLDQDMN---- 580 (747)
Q Consensus 508 ~--~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~-~~~~~iiH~Dikp~NIll~~~~~---- 580 (747)
. ...++++++...+..............+++..+..++.|++.||+|||+ .+ |+||||||+|||++.++.
T Consensus 92 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh~~~~---IvHrDlKp~NIll~~~~~~~~~ 168 (362)
T d1q8ya_ 92 KGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCG---IIHTDIKPENVLMEIVDSPENL 168 (362)
T ss_dssp EETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTC---EECSCCSGGGEEEEEEETTTTE
T ss_pred CCCCCEEEEEEECCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHHCC---CCCCCCCHHHEEEECCCCCCCC
T ss_conf 2565202343200035420000012234678689999999999999888764058---6465677057056305765644
Q ss_pred --CEEECCCCCCCCCCCCCCCCCCE-EEE---CCCCCCCCCCCCHHHHHHHHHHHHCCCCCCCCCCCCHH---HHHHH-H
Q ss_conf --44712567500389987544440-210---23788884464023789999988199899998876402---24486-7
Q 004521 581 --PKISDFGLVRTFGGDETEGNTNR-VVG---TYDGQFSIKSDVFSFGILLLEIVSGKKNRGFYRSDTKV---NLIGH-L 650 (747)
Q Consensus 581 --~ki~DfGla~~~~~~~~~~~~~~-~~~---~~~~~~s~~sDVwSlGvil~elltg~~p~~~~~~~~~~---~~~~~-~ 650 (747)
++|+|||.+.............. ... .....++.++||||+|++++||++|+.||......... ..+.. .
T Consensus 169 ~~~kl~dfg~s~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pF~~~~~~~~~~~~~~~~~~~ 248 (362)
T d1q8ya_ 169 IQIKIADLGNACWYDEHYTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQII 248 (362)
T ss_dssp EEEEECCCTTCEETTBCCCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHHHHHHHHH
T ss_pred CEEEEEECCCCCCCCCCCCCCCCCCCCCCHHHCCCCCCCCCCCCCCHHHHHHHHHHCCCCCCCCCCCCCCCHHHHHHHHH
T ss_conf 30567531442123445422366521057132146677764320123789999987889989875543210268999999
Q ss_pred HHCCC---------------------CCCC-------CCHH--HHCCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHH
Q ss_conf 72198---------------------6522-------4301--1066999999999999976168999999998899998
Q 004521 651 WDEGI---------------------PLRL-------IDAC--IQDSCNLADVIRCIHIGLLCVQQHPEDRPCMPSVILM 700 (747)
Q Consensus 651 ~~~~~---------------------~~~~-------~d~~--l~~~~~~~~~~~~~~l~~~Cl~~dP~~RPt~~~v~~~ 700 (747)
..-+. ...+ .... ............+.+++.+||+.||.+|||+.|+++.
T Consensus 249 ~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~Rpta~e~L~H 328 (362)
T d1q8ya_ 249 ELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAGGLVNH 328 (362)
T ss_dssp HHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCHHHHHTC
T ss_pred HHHCCCCHHHHHCCCCCCCCCCCCHHHHCCCCCCCCCHHHHCCCCCCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCC
T ss_conf 98379987886245322000132012202432357764442100015674358999999999877994579089999669
Q ss_pred --HCCC---CCCCCCCCCC
Q ss_conf --5489---8999999996
Q 004521 701 --LGSE---ILLPQPKQPG 714 (747)
Q Consensus 701 --L~~~---~~~~~p~~p~ 714 (747)
++.. ..+..|+.+.
T Consensus 329 p~f~~~~~~~~~~~p~~~~ 347 (362)
T d1q8ya_ 329 PWLKDTLGMEEIRVPDREL 347 (362)
T ss_dssp GGGTTCTTCTTCCCTTSCT
T ss_pred CCCCCCCCCCCCCCCCCCC
T ss_conf 3407898744477998666
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.88 E-value=3e-23 Score=165.08 Aligned_cols=166 Identities=19% Similarity=0.189 Sum_probs=122.7
Q ss_pred CCCCEECCCCCEEEEEEEECCCCEEEEEEECCCCC------------------CCHHHHHHHHHHHHCCCCCCEEEEEEE
Q ss_conf 85542142498009999966984999999134331------------------068999999999830599732337748
Q 004521 443 SINNKLGEGGFGPVYKGTLVDGQEIAVKRLSKISE------------------QGLKELKNEVILFSKLQHRNLVKLLGC 504 (747)
Q Consensus 443 ~~~~~lg~G~~g~Vy~~~~~~g~~vavK~l~~~~~------------------~~~~~~~~E~~~l~~l~H~nIv~l~g~ 504 (747)
.+.++||+|+||.||+|...+|+.||||.++.... .......+|...+.++.|.+++..+++
T Consensus 3 ~vg~~IG~G~~g~Vy~a~~~~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~~~ 82 (191)
T d1zara2 3 AIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVYAW 82 (191)
T ss_dssp EEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEEEE
T ss_pred HHCCEEEECCCEEEEEEECCCCCEEEEEEEECCCCHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHCCCCCCCEEEEE
T ss_conf 22778024856599999979999999999860443466655656300088899999977899999998169991449986
Q ss_pred EEECCEEEEEEECCCCCCHHHHHHHCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCCEEE
Q ss_conf 99498227999507999944676312898767856789999999999998341599946732667683798589994471
Q 004521 505 CIQGEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKIS 584 (747)
Q Consensus 505 ~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dikp~NIll~~~~~~ki~ 584 (747)
. ..+++|||+++..+.. ++......++.|++.++.|||..+ ++||||||+|||+++++ ++|+
T Consensus 83 ~----~~~lvme~~~~~~~~~----------l~~~~~~~i~~ql~~~l~~lH~~g---iiHrDiKP~NILv~~~~-~~li 144 (191)
T d1zara2 83 E----GNAVLMELIDAKELYR----------VRVENPDEVLDMILEEVAKFYHRG---IVHGDLSQYNVLVSEEG-IWII 144 (191)
T ss_dssp E----TTEEEEECCCCEEGGG----------CCCSCHHHHHHHHHHHHHHHHHTT---EECSCCSTTSEEEETTE-EEEC
T ss_pred C----CCEEEEEEECCCCCCC----------HHHHHHHHHHHHHHHHHHHHHHCC---EEECCCCHHHEEEECCC-EEEE
T ss_conf 2----8889999504565420----------015789999999999999982688---89836890361142898-9998
Q ss_pred CCCCCCCCCCCCCCCCCCE----EEECCCCCCCCCCCCHHHHHHHH
Q ss_conf 2567500389987544440----21023788884464023789999
Q 004521 585 DFGLVRTFGGDETEGNTNR----VVGTYDGQFSIKSDVFSFGILLL 626 (747)
Q Consensus 585 DfGla~~~~~~~~~~~~~~----~~~~~~~~~s~~sDVwSlGvil~ 626 (747)
|||+|+............. ....+...|+.++|+||..--++
T Consensus 145 DFG~a~~~~~~~~~~~l~rd~~~~~~~f~r~y~~~~d~~s~~~~~~ 190 (191)
T d1zara2 145 DFPQSVEVGEEGWREILERDVRNIITYFSRTYRTEKDINSAIDRIL 190 (191)
T ss_dssp CCTTCEETTSTTHHHHHHHHHHHHHHHHHHHHCCCCCHHHHHHHHH
T ss_pred ECCCCCCCCCCCCHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHH
T ss_conf 7788430899870999987799999997578998446899999874
|
| >d1dlpa2 b.78.1.1 (A:116-235) Fetuin-binding protein Scafet precursor {Bluebell (Scilla campanulata) [TaxId: 81759]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Fetuin-binding protein Scafet precursor species: Bluebell (Scilla campanulata) [TaxId: 81759]
Probab=99.60 E-value=1.8e-15 Score=114.68 Aligned_cols=99 Identities=17% Similarity=0.212 Sum_probs=82.1
Q ss_pred CCCCCCCEEEECCCCCCCCCCCCEEEEECCCCEEEECCCCCEEEEECCCCCCCCCEEEEEECCCCEEEEECCCCCCCCEE
Q ss_conf 99999946997579999889951399930872999928992899834656767751899903658799708899987305
Q 004521 10 KSYPPHEVVWVANRLNPINDSFGFLMINKTGNLVLTSQSNIVVWSAYLSKEVQTPVVLQLLDSGNLVLRDEHDGDSETYF 89 (747)
Q Consensus 10 ~~~~~~t~VW~Anr~~p~~~~~~~l~~~~~G~Lvl~~~~~~~vWs~~~~~~~~~~~~~~l~d~GNlVl~~~~~~~~~~~~ 89 (747)
.+++.++.+|++|+++|+....-+|.+..||||||.+. +.++|++++.+. .....+.|+++|||||++.+ +.++
T Consensus 15 ~~~~~~~~~~~l~~~q~l~~g~y~L~~q~DGNLvL~~~-~~~vW~s~t~~~-~~~~~~~l~~~GnLvl~d~~----~~~l 88 (120)
T d1dlpa2 15 STQGNDNHPQTLHATQSLQLSPYRLSMETDCNLVLFDR-DDRVWSTNTAGK-GTGCRAVLQPNGRMDVLTNQ----NIAV 88 (120)
T ss_dssp CC--CCCCCCEECSSCCCBCSSCEEEEETTTEEEEEBT-TBCCSCCCCCSS-CSSCEEEEETTTEEEEEETT----TEEE
T ss_pred CCCCCCCCCCEECCCCEEECCCEEEEECCCCCEEEECC-CCEEEEECCCCC-CCCEEEEEECCEEEEEECCC----CCEE
T ss_conf 28988885628839972174887999968983899649-968999752247-77479999077649999299----9889
Q ss_pred EEECCCCCCCCCCCCCCCCCCCCCCCCEEEECCCCCCCCCCCEEEEEECCCCCEEE
Q ss_conf 54337888743467842332234654227752679999996219987218996299
Q 004521 90 WQSFDYPSDTLLPGMKLGWDLKTGLERRVTSWKSFDDPSPGDFIWAIERQDNPEVV 145 (747)
Q Consensus 90 WqSFd~PtDtlLpgq~l~~~~~~~~~~~l~s~~s~~dps~g~~~~~~~~~~~~~~~ 145 (747)
||||. +.+.|.|.+.|+++|++.++
T Consensus 89 W~S~t-------------------------------~~~~~~~~l~Lq~DGnlvlY 113 (120)
T d1dlpa2 89 WTSGN-------------------------------SRSAGRYVFVLQPDRNLAIY 113 (120)
T ss_dssp EECCC-------------------------------CCSSSCCEEEECSSSCEEEE
T ss_pred EEECC-------------------------------CCCCCCEEEEECCCCCEEEE
T ss_conf 98199-------------------------------99998489998889869996
|
| >d1kj1a_ b.78.1.1 (A:) Lectin (agglutinin) {Garlic (Allium sativum) [TaxId: 4682]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Lectin (agglutinin) species: Garlic (Allium sativum) [TaxId: 4682]
Probab=99.51 E-value=6e-14 Score=104.78 Aligned_cols=73 Identities=21% Similarity=0.353 Sum_probs=62.4
Q ss_pred CCCEEEECCCCCCCCCCCCEEEEECCCCEEEECCCCCEEEEECCCCCCCCCEEEEEECCCCEEEEECCCCCCCCEEEEEC
Q ss_conf 99469975799998899513999308729999289928998346567677518999036587997088999873055433
Q 004521 14 PHEVVWVANRLNPINDSFGFLMINKTGNLVLTSQSNIVVWSAYLSKEVQTPVVLQLLDSGNLVLRDEHDGDSETYFWQSF 93 (747)
Q Consensus 14 ~~t~VW~Anr~~p~~~~~~~l~~~~~G~Lvl~~~~~~~vWs~~~~~~~~~~~~~~l~d~GNlVl~~~~~~~~~~~~WqSF 93 (747)
..++||+||++.|+... +.|.|+.+|+|||.++++.++|++++... ....+|.|+|+|||||++. .+|||+
T Consensus 36 ~~~~vW~ant~~~~~~~-~~l~l~~dGnLvl~~~~g~~vW~s~t~~~-~~~~~l~L~ddGNlvly~~-------~~W~S~ 106 (109)
T d1kj1a_ 36 HSTSVWASNTGILGKKG-CKAVLQSDGNFVVYDAEGRSLWASHSVRG-NGNYVLVLQEDGNVVIYGS-------DIWSTG 106 (109)
T ss_dssp TTEEEEECCCCCTTCCC-CEEEECTTSCEEEECSSSCEEEECCCCCC-SSCCEEEECTTSCEEEECC-------EEEECC
T ss_pred CCEEEEEECCCCCCCEE-EEEEECCCCEEEEEECCCCEEEEEEEECC-CCCEEEEEECCCCEEEECC-------CEECCC
T ss_conf 99899983789987510-79999379609999089867999730889-9977999947975999799-------872179
Q ss_pred CC
Q ss_conf 78
Q 004521 94 DY 95 (747)
Q Consensus 94 d~ 95 (747)
-|
T Consensus 107 t~ 108 (109)
T d1kj1a_ 107 TY 108 (109)
T ss_dssp CC
T ss_pred CC
T ss_conf 85
|
| >d1dlpa1 b.78.1.1 (A:1-115) Fetuin-binding protein Scafet precursor {Bluebell (Scilla campanulata) [TaxId: 81759]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Fetuin-binding protein Scafet precursor species: Bluebell (Scilla campanulata) [TaxId: 81759]
Probab=99.48 E-value=2.7e-14 Score=107.05 Aligned_cols=105 Identities=17% Similarity=0.239 Sum_probs=84.9
Q ss_pred CCCCEEEECCCCCCCCCCCCEEEEECCCCEEEECCCCCEEEEECCCCCCCCCEEEEEECCCCEEEEECCCCCCCCEEEEE
Q ss_conf 99946997579999889951399930872999928992899834656767751899903658799708899987305543
Q 004521 13 PPHEVVWVANRLNPINDSFGFLMINKTGNLVLTSQSNIVVWSAYLSKEVQTPVVLQLLDSGNLVLRDEHDGDSETYFWQS 92 (747)
Q Consensus 13 ~~~t~VW~Anr~~p~~~~~~~l~~~~~G~Lvl~~~~~~~vWs~~~~~~~~~~~~~~l~d~GNlVl~~~~~~~~~~~~WqS 92 (747)
++.+..|+.+.++++.....+|.+..||||||.++ +.++|++++.+ ..+..+.|+++|||||++.. +.++|||
T Consensus 9 ~~~~~~~tl~~~~~l~~g~~~l~~q~DGNLvL~~~-~~~vW~s~t~~--~~~~~l~l~~dGNLvl~d~~----~~~vWsS 81 (115)
T d1dlpa1 9 HEGSHPQTLHAAQSLELSSFRFTMQSDCNLVLFDS-DVRVWASNTAG--ATGCRAVLQSDGLLVILTAQ----NTIRWSS 81 (115)
T ss_dssp SSSCSCSCCCTTCEECSTTEEEEECTTSCEEEEES-SSEEECCCCCS--CSCCBCCBCSSSCBCCBCTT----TCCSCCC
T ss_pred CCCCCCCEECCCCCEECCCEEEEECCCCEEEEECC-CEEEEECCCCC--CCCEEEEEECCCCEEEECCC----CCEEEEC
T ss_conf 89988212469981775988999979983999819-90689711689--97568999446789999058----9789981
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCEEEECCCCCCCCCCCEEEEEECCCCCEEEEEECCEEEEECCCC
Q ss_conf 3788874346784233223465422775267999999621998721899629998188438962899
Q 004521 93 FDYPSDTLLPGMKLGWDLKTGLERRVTSWKSFDDPSPGDFIWAIERQDNPEVVMWKGSRKFYRTGPW 159 (747)
Q Consensus 93 Fd~PtDtlLpgq~l~~~~~~~~~~~l~s~~s~~dps~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (747)
|. +.+.|.|.+.|+++|++.+ + +.++|.+|.-
T Consensus 82 ~t-------------------------------~~~~g~y~l~Lq~DGNlvl--Y--~~~~Wssgt~ 113 (115)
T d1dlpa1 82 GT-------------------------------KGSIGNYVLVLQPDRTVTI--Y--GPGLWDSGTS 113 (115)
T ss_dssp CC-------------------------------CCCSSCCEEEECSSSCEEE--E--CSEEEECSCC
T ss_pred CC-------------------------------CCCCCCEEEEECCCCCEEE--E--CCCEECCCCC
T ss_conf 88-------------------------------8999978999989986999--6--8976438898
|
| >d1xd5a_ b.78.1.1 (A:) Gastrodianin (antifungal protein) {Gastrodia elata [TaxId: 91201]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Gastrodianin (antifungal protein) species: Gastrodia elata [TaxId: 91201]
Probab=99.47 E-value=2.2e-13 Score=101.14 Aligned_cols=77 Identities=21% Similarity=0.385 Sum_probs=62.9
Q ss_pred CCCEEEECCCCCCCCCCCCEEEEECCCCEEEECCCCCEEEEECCCCCCCCCEEEEEECCCCEEEEECCCCCCCCEEEEEC
Q ss_conf 99469975799998899513999308729999289928998346567677518999036587997088999873055433
Q 004521 14 PHEVVWVANRLNPINDSFGFLMINKTGNLVLTSQSNIVVWSAYLSKEVQTPVVLQLLDSGNLVLRDEHDGDSETYFWQSF 93 (747)
Q Consensus 14 ~~t~VW~Anr~~p~~~~~~~l~~~~~G~Lvl~~~~~~~vWs~~~~~~~~~~~~~~l~d~GNlVl~~~~~~~~~~~~WqSF 93 (747)
..++||.||++.|.. .+.|.|+.+|+|||.+++ ..+|++++.+. ....+|.|+|+|||||++.+ +.++|||+
T Consensus 36 ~~~~vW~s~~~~~~~--~~~l~l~~dGnLvl~~~~-~~~w~s~t~~~-~~~~~l~L~ddGNlvly~~~----~~~~W~S~ 107 (112)
T d1xd5a_ 36 NNRAVWASGTNGKAS--GCVLKMQNDGNLVIYSGS-RAIWASNTNRQ-NGNYYLILQRDRNVVIYDNS----NNAIWATH 107 (112)
T ss_dssp TTEEEEECCCTTSCS--SEEEEECTTSCEEEEETT-EEEEECCCCCS-CCCCEEEECTTSCEEEECTT----SCEEEECC
T ss_pred CCCEEEECCCCCCCC--CCEEEEECCCCEEEEECC-CEEEEEEECCC-CCCEEEEECCCCCEEEECCC----CCEEECCC
T ss_conf 983899846734788--857999615349999348-74999830368-87259999678999999899----96796188
Q ss_pred CCCCC
Q ss_conf 78887
Q 004521 94 DYPSD 98 (747)
Q Consensus 94 d~PtD 98 (747)
.+|++
T Consensus 108 t~~~n 112 (112)
T d1xd5a_ 108 TNVGN 112 (112)
T ss_dssp CCCCC
T ss_pred CCCCC
T ss_conf 85698
|
| >d1jpca_ b.78.1.1 (A:) Lectin (agglutinin) {Snowdrop (Galanthus nivalis) [TaxId: 4670]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Lectin (agglutinin) species: Snowdrop (Galanthus nivalis) [TaxId: 4670]
Probab=99.44 E-value=2.8e-13 Score=100.45 Aligned_cols=72 Identities=22% Similarity=0.327 Sum_probs=60.2
Q ss_pred CCCEEEECCCCCCCCCCCCEEEEECCCCEEEECCCCCEEEEECCCCCCCCCEEEEEECCCCEEEEECCCCCCCCEEEEEC
Q ss_conf 99469975799998899513999308729999289928998346567677518999036587997088999873055433
Q 004521 14 PHEVVWVANRLNPINDSFGFLMINKTGNLVLTSQSNIVVWSAYLSKEVQTPVVLQLLDSGNLVLRDEHDGDSETYFWQSF 93 (747)
Q Consensus 14 ~~t~VW~Anr~~p~~~~~~~l~~~~~G~Lvl~~~~~~~vWs~~~~~~~~~~~~~~l~d~GNlVl~~~~~~~~~~~~WqSF 93 (747)
..++||.||++.|.. .+.+.++.+|+|+|.++++.++|++++... ....+|.|+|+|||||++. .+||||
T Consensus 36 ~~~~vW~s~~~~~~~--~~~l~l~~~Gnlvl~~~~g~~vWsS~t~~~-~~~~~l~L~ddGNlVly~~-------~~W~S~ 105 (108)
T d1jpca_ 36 VDKPIWATNTGGLSR--SCFLSMQTDGNLVVYNPSNKPIWASNTGGQ-NGNYVCILQKDRNVVIYGT-------DRWATG 105 (108)
T ss_dssp TTEEEEECCCTTSCS--SCEEEECTTSCEEEECTTCCEEEECCCCCS-CSCEEEEECTTSCEEEEEC-------CCCCCC
T ss_pred CCCEEEEECCCCCCC--CCEEEEECCCEEEEECCCCCCEEECCCCCC-CCCEEEEECCCCCEEEECC-------CCCCCC
T ss_conf 990215707889987--547998126039997798551277045588-8767999968889999699-------845688
Q ss_pred CC
Q ss_conf 78
Q 004521 94 DY 95 (747)
Q Consensus 94 d~ 95 (747)
+|
T Consensus 106 t~ 107 (108)
T d1jpca_ 106 TH 107 (108)
T ss_dssp CC
T ss_pred CC
T ss_conf 88
|
| >d1b2pa_ b.78.1.1 (A:) Lectin (agglutinin) {Bluebell (Scilla campanulata) [TaxId: 81759]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Lectin (agglutinin) species: Bluebell (Scilla campanulata) [TaxId: 81759]
Probab=99.15 E-value=1.9e-10 Score=82.12 Aligned_cols=85 Identities=19% Similarity=0.289 Sum_probs=62.2
Q ss_pred EEEEECCCCEEEECCCCCEEEEECCCCCCCCCEEEEEECCCCEEEEECCCCCCCCEEEEECCCCCCCCCCCCCCCCCCCC
Q ss_conf 39993087299992899289983465676775189990365879970889998730554337888743467842332234
Q 004521 33 FLMINKTGNLVLTSQSNIVVWSAYLSKEVQTPVVLQLLDSGNLVLRDEHDGDSETYFWQSFDYPSDTLLPGMKLGWDLKT 112 (747)
Q Consensus 33 ~l~~~~~G~Lvl~~~~~~~vWs~~~~~~~~~~~~~~l~d~GNlVl~~~~~~~~~~~~WqSFd~PtDtlLpgq~l~~~~~~ 112 (747)
.|.+..||||||.++ +.++|++++.+. .....+.|.++|||||++.+ +.++|+|.-
T Consensus 33 ~l~mQ~DGNLVLy~~-~~~vWssnt~~~-~~~~~l~l~~dGnLvL~d~~----g~~vWsS~t------------------ 88 (119)
T d1b2pa_ 33 RFIMQTDCNLVLYDN-NNPIWATNTGGL-GNGCRAVLQPDGVLVVITNE----NVTVWQSPV------------------ 88 (119)
T ss_dssp EEEECTTSCEEEEET-TEEEEECCCTTS-CSSCEEEECTTSCEEEECTT----CCEEEECSC------------------
T ss_pred EEEECCCCCEEEEEC-CEEEEEECCCCC-CCCEEEEEEECCCEEEECCC----CCEEEECCC------------------
T ss_conf 999889982999979-967999467887-74169999837779998999----857997887------------------
Q ss_pred CCCCEEEECCCCCCCCCCCEEEEEECCCCCEEEEEECCEEEEECCC
Q ss_conf 6542277526799999962199872189962999818843896289
Q 004521 113 GLERRVTSWKSFDDPSPGDFIWAIERQDNPEVVMWKGSRKFYRTGP 158 (747)
Q Consensus 113 ~~~~~l~s~~s~~dps~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 158 (747)
.-+.|.|.+.|+++|++.++ . .+.|.++.
T Consensus 89 -------------~~~~~~~~l~Lq~DGNlvlY--g--~~~W~S~T 117 (119)
T d1b2pa_ 89 -------------AGKAGHYVLVLQPDRNVVIY--G--DALWATQT 117 (119)
T ss_dssp -------------CCCSSCEEEEECTTSCEEEE--E--SEEEECCC
T ss_pred -------------CCCCCCEEEEECCCCCEEEE--C--CCEECCCC
T ss_conf -------------69988659999699889997--9--98841697
|
| >d1b2pa_ b.78.1.1 (A:) Lectin (agglutinin) {Bluebell (Scilla campanulata) [TaxId: 81759]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Lectin (agglutinin) species: Bluebell (Scilla campanulata) [TaxId: 81759]
Probab=98.90 E-value=1.2e-08 Score=70.43 Aligned_cols=72 Identities=21% Similarity=0.353 Sum_probs=55.2
Q ss_pred CCCEEEECCCCCCCCCCCCEEEEECCCCEEEECCCCCEEEEECCCCCCCCCEEEEEECCCCEEEEECCCCCCCCEEEEEC
Q ss_conf 99469975799998899513999308729999289928998346567677518999036587997088999873055433
Q 004521 14 PHEVVWVANRLNPINDSFGFLMINKTGNLVLTSQSNIVVWSAYLSKEVQTPVVLQLLDSGNLVLRDEHDGDSETYFWQSF 93 (747)
Q Consensus 14 ~~t~VW~Anr~~p~~~~~~~l~~~~~G~Lvl~~~~~~~vWs~~~~~~~~~~~~~~l~d~GNlVl~~~~~~~~~~~~WqSF 93 (747)
..++||.||+..+.. ...|.|..+|+|+|.|+++.++|++++.+. ....++.|+|+|||||++. .+|||.
T Consensus 47 ~~~~vWssnt~~~~~--~~~l~l~~dGnLvL~d~~g~~vWsS~t~~~-~~~~~l~Lq~DGNlvlYg~-------~~W~S~ 116 (119)
T d1b2pa_ 47 NNNPIWATNTGGLGN--GCRAVLQPDGVLVVITNENVTVWQSPVAGK-AGHYVLVLQPDRNVVIYGD-------ALWATQ 116 (119)
T ss_dssp TTEEEEECCCTTSCS--SCEEEECTTSCEEEECTTCCEEEECSCCCC-SSCEEEEECTTSCEEEEES-------EEEECC
T ss_pred CCEEEEEECCCCCCC--CEEEEEEECCCEEEECCCCCEEEECCCCCC-CCCEEEEECCCCCEEEECC-------CEECCC
T ss_conf 996799946788774--169999837779998999857997887699-8865999969988999799-------884169
Q ss_pred CC
Q ss_conf 78
Q 004521 94 DY 95 (747)
Q Consensus 94 d~ 95 (747)
..
T Consensus 117 T~ 118 (119)
T d1b2pa_ 117 TV 118 (119)
T ss_dssp CC
T ss_pred CC
T ss_conf 74
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=98.90 E-value=2.3e-08 Score=68.60 Aligned_cols=150 Identities=15% Similarity=0.062 Sum_probs=102.1
Q ss_pred HHHHHHHCCCCCCCEECCCCCEEEEEEEECCCCEEEEEEECCCCCCCHHHHHHHHHHHHCCC-CCCEEEEEEEEEECCEE
Q ss_conf 88999723978554214249800999996698499999913433106899999999983059-97323377489949822
Q 004521 433 ATIANATDNFSINNKLGEGGFGPVYKGTLVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQ-HRNLVKLLGCCIQGEEK 511 (747)
Q Consensus 433 ~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~-H~nIv~l~g~~~~~~~~ 511 (747)
.++......|+..+..+-++...||+... ++..+++|+...........+.+|...+..+. +-.+.+++.+....+..
T Consensus 7 ~~l~~~~~~~~~~~~~~G~s~~~v~rv~~-~~~~~vlk~~~~~~~~~~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~~~ 85 (263)
T d1j7la_ 7 PELKKLIEKYRCVKDTEGMSPAKVYKLVG-ENENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWS 85 (263)
T ss_dssp HHHHHHHTTSEEEECSCCCSSSEEEEEEC-SSCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEE
T ss_pred HHHHHHHHCEEEEECCCCCCCCCEEEEEE-CCCEEEEEECCCCCCCCHHHHHHHHHHHHHHHCCCCCCCEEEEEECCCCE
T ss_conf 99997513527997678998771899990-89869999848876532556999999999876069987289997508964
Q ss_pred EEEEECCCCCCHHHHHHHCCCCCCCCHHHHHHHHHHHHHHHHHHHHC---------------------------------
Q ss_conf 79995079999446763128987678567899999999999983415---------------------------------
Q 004521 512 LLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQD--------------------------------- 558 (747)
Q Consensus 512 ~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~--------------------------------- 558 (747)
++||+++++.++.+.... ......++.++++.+..||+.
T Consensus 86 ~lv~~~l~G~~~~~~~~~--------~~~~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 157 (263)
T d1j7la_ 86 NLLMSEADGVLCSEEYED--------EQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCEN 157 (263)
T ss_dssp EEEEECCSSEEHHHHTTT--------CSCHHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCCGGG
T ss_pred EEEEEECCCCCCCCCCCC--------CCCHHHHHHHHHHHHHHHHCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHHHC
T ss_conf 999986043343543344--------026999999899999998556842143576446565557789987765555430
Q ss_pred -----------------------CCCCEEECCCCCCCEEECCCCCCEEECCCCCCC
Q ss_conf -----------------------999467326676837985899944712567500
Q 004521 559 -----------------------SRLRIIHRDLKASNVLLDQDMNPKISDFGLVRT 591 (747)
Q Consensus 559 -----------------------~~~~iiH~Dikp~NIll~~~~~~ki~DfGla~~ 591 (747)
....++|+|+.|.|||++++..+-|+||+.+..
T Consensus 158 ~~~~~~~~~~~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~~ 213 (263)
T d1j7la_ 158 WEEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSGR 213 (263)
T ss_dssp GSTTCSCSSHHHHHHHHHHSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred CCCCCCCHHHHHHHHHHHHCCCCCCCEEEEEECCCCCEEECCCCEEEEEECHHCCC
T ss_conf 33232005799999999844986781789860047642364996599960231441
|
| >d1kj1a_ b.78.1.1 (A:) Lectin (agglutinin) {Garlic (Allium sativum) [TaxId: 4682]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Lectin (agglutinin) species: Garlic (Allium sativum) [TaxId: 4682]
Probab=98.88 E-value=2e-08 Score=69.00 Aligned_cols=88 Identities=19% Similarity=0.373 Sum_probs=66.6
Q ss_pred CEEEEECCCCEEEECCCCCEEEEECCCCCCCCCEEEEEECCCCEEEEECCCCCCCCEEEEECCCCCCCCCCCCCCCCCCC
Q ss_conf 13999308729999289928998346567677518999036587997088999873055433788874346784233223
Q 004521 32 GFLMINKTGNLVLTSQSNIVVWSAYLSKEVQTPVVLQLLDSGNLVLRDEHDGDSETYFWQSFDYPSDTLLPGMKLGWDLK 111 (747)
Q Consensus 32 ~~l~~~~~G~Lvl~~~~~~~vWs~~~~~~~~~~~~~~l~d~GNlVl~~~~~~~~~~~~WqSFd~PtDtlLpgq~l~~~~~ 111 (747)
-.|.+..||||||.. .+.+||++++.........+.|.++|||||++.+ +.++|+|-
T Consensus 21 ~~l~~q~dgnLvl~~-~~~~vW~ant~~~~~~~~~l~l~~dGnLvl~~~~----g~~vW~s~------------------ 77 (109)
T d1kj1a_ 21 YHFIMQEDCNLVLYD-HSTSVWASNTGILGKKGCKAVLQSDGNFVVYDAE----GRSLWASH------------------ 77 (109)
T ss_dssp EEEEECTTSCEEEEE-TTEEEEECCCCCTTCCCCEEEECTTSCEEEECSS----SCEEEECC------------------
T ss_pred EEEEECCCCEEEEEE-CCEEEEEECCCCCCCEEEEEEECCCCEEEEEECC----CCEEEEEE------------------
T ss_conf 899944898699986-9989998378998751079999379609999089----86799973------------------
Q ss_pred CCCCCEEEECCCCCCCCCCCEEEEEECCCCCEEEEEECCEEEEECCCC
Q ss_conf 465422775267999999621998721899629998188438962899
Q 004521 112 TGLERRVTSWKSFDDPSPGDFIWAIERQDNPEVVMWKGSRKFYRTGPW 159 (747)
Q Consensus 112 ~~~~~~l~s~~s~~dps~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (747)
...+.|.|.+.|+++|++.++ + .+.|.++.+
T Consensus 78 -------------t~~~~~~~~l~L~ddGNlvly--~--~~~W~S~t~ 108 (109)
T d1kj1a_ 78 -------------SVRGNGNYVLVLQEDGNVVIY--G--SDIWSTGTY 108 (109)
T ss_dssp -------------CCCCSSCCEEEECTTSCEEEE--C--CEEEECCCC
T ss_pred -------------EECCCCCEEEEEECCCCEEEE--C--CCEECCCCC
T ss_conf -------------088999779999479759997--9--987217985
|
| >d1jpca_ b.78.1.1 (A:) Lectin (agglutinin) {Snowdrop (Galanthus nivalis) [TaxId: 4670]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Lectin (agglutinin) species: Snowdrop (Galanthus nivalis) [TaxId: 4670]
Probab=98.81 E-value=2.3e-08 Score=68.61 Aligned_cols=86 Identities=19% Similarity=0.369 Sum_probs=63.8
Q ss_pred CEEEEECCCCEEEECCCCCEEEEECCCCCCCCCEEEEEECCCCEEEEECCCCCCCCEEEEECCCCCCCCCCCCCCCCCCC
Q ss_conf 13999308729999289928998346567677518999036587997088999873055433788874346784233223
Q 004521 32 GFLMINKTGNLVLTSQSNIVVWSAYLSKEVQTPVVLQLLDSGNLVLRDEHDGDSETYFWQSFDYPSDTLLPGMKLGWDLK 111 (747)
Q Consensus 32 ~~l~~~~~G~Lvl~~~~~~~vWs~~~~~~~~~~~~~~l~d~GNlVl~~~~~~~~~~~~WqSFd~PtDtlLpgq~l~~~~~ 111 (747)
-+|.+..||||||.+ .+.+||++++.+. .....+.|.++|||||++.+ +.++|+|=
T Consensus 21 ~~l~~q~DGNLvly~-~~~~vW~s~~~~~-~~~~~l~l~~~Gnlvl~~~~----g~~vWsS~------------------ 76 (108)
T d1jpca_ 21 FVFIMQEDCNLVLYD-VDKPIWATNTGGL-SRSCFLSMQTDGNLVVYNPS----NKPIWASN------------------ 76 (108)
T ss_dssp EEEEECTTSCEEEEE-TTEEEEECCCTTS-CSSCEEEECTTSCEEEECTT----CCEEEECC------------------
T ss_pred EEEEECCCCEEEEEE-CCCEEEEECCCCC-CCCCEEEEECCCEEEEECCC----CCCEEECC------------------
T ss_conf 899987898099970-9902157078899-87547998126039997798----55127704------------------
Q ss_pred CCCCCEEEECCCCCCCCCCCEEEEEECCCCCEEEEEECCEEEEECCC
Q ss_conf 46542277526799999962199872189962999818843896289
Q 004521 112 TGLERRVTSWKSFDDPSPGDFIWAIERQDNPEVVMWKGSRKFYRTGP 158 (747)
Q Consensus 112 ~~~~~~l~s~~s~~dps~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 158 (747)
.....+.|.+.|+.+|++.++ . .+.|.++.
T Consensus 77 -------------t~~~~~~~~l~L~ddGNlVly--~--~~~W~S~t 106 (108)
T d1jpca_ 77 -------------TGGQNGNYVCILQKDRNVVIY--G--TDRWATGT 106 (108)
T ss_dssp -------------CCCSCSCEEEEECTTSCEEEE--E--CCCCCCCC
T ss_pred -------------CCCCCCCEEEEECCCCCEEEE--C--CCCCCCCC
T ss_conf -------------558887679999688899996--9--98456888
|
| >d1dlpa2 b.78.1.1 (A:116-235) Fetuin-binding protein Scafet precursor {Bluebell (Scilla campanulata) [TaxId: 81759]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Fetuin-binding protein Scafet precursor species: Bluebell (Scilla campanulata) [TaxId: 81759]
Probab=98.62 E-value=4.9e-08 Score=66.43 Aligned_cols=110 Identities=16% Similarity=0.153 Sum_probs=67.3
Q ss_pred EEECCCCEEEEECCCCCCCCEEEEECCCCCCCCCCCCCCCCCCCCCCCCEEEECCCCCCCCCCCEEEEEECCCCCEEEEE
Q ss_conf 99036587997088999873055433788874346784233223465422775267999999621998721899629998
Q 004521 68 QLLDSGNLVLRDEHDGDSETYFWQSFDYPSDTLLPGMKLGWDLKTGLERRVTSWKSFDDPSPGDFIWAIERQDNPEVVMW 147 (747)
Q Consensus 68 ~l~d~GNlVl~~~~~~~~~~~~WqSFd~PtDtlLpgq~l~~~~~~~~~~~l~s~~s~~dps~g~~~~~~~~~~~~~~~~~ 147 (747)
.++++||+|+++. +|++.|+++|.++|.|. .|.|.+.|+.+|++. ++
T Consensus 4 v~~~~~n~il~~~----------~~~~~~~~~l~~~q~l~---------------------~g~y~L~~q~DGNLv--L~ 50 (120)
T d1dlpa2 4 VVANNGNSILYST----------QGNDNHPQTLHATQSLQ---------------------LSPYRLSMETDCNLV--LF 50 (120)
T ss_dssp CCSSCCCEECCCC------------CCCCCCEECSSCCCB---------------------CSSCEEEEETTTEEE--EE
T ss_pred EEEECCCEEEECC----------CCCCCCCCEECCCCEEE---------------------CCCEEEEECCCCCEE--EE
T ss_conf 7872898699828----------98888562883997217---------------------488799996898389--96
Q ss_pred ECCEEEEECCCCCCCCEECCCCCCCCCEEEEEEECCCEEEEEEEECCCCCEEEEEEEEEEEEEEEE
Q ss_conf 188438962899996110489998981288996528358999972499617899995320578899
Q 004521 148 KGSRKFYRTGPWNGLRFSAPSLRPNPIFSFSFVSNDVELYYTFNITNKAVISRIVMNQTLYVRRRF 213 (747)
Q Consensus 148 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~rl~l~~~G~l~~~~ 213 (747)
+...++|.+.......-....++.++.+ .+.+..++..............+++|++||+|+ +|
T Consensus 51 ~~~~~vW~s~t~~~~~~~~~~l~~~GnL--vl~d~~~~~lW~S~t~~~~~~~~l~Lq~DGnlv-lY 113 (120)
T d1dlpa2 51 DRDDRVWSTNTAGKGTGCRAVLQPNGRM--DVLTNQNIAVWTSGNSRSAGRYVFVLQPDRNLA-IY 113 (120)
T ss_dssp BTTBCCSCCCCCSSCSSCEEEEETTTEE--EEEETTTEEEEECCCCCSSSCCEEEECSSSCEE-EE
T ss_pred CCCCEEEEECCCCCCCCEEEEEECCEEE--EEECCCCCEEEEECCCCCCCCEEEEECCCCCEE-EE
T ss_conf 4996899975224777479999077649--999299988998199999984899988898699-96
|
| >d1xd5a_ b.78.1.1 (A:) Gastrodianin (antifungal protein) {Gastrodia elata [TaxId: 91201]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Gastrodianin (antifungal protein) species: Gastrodia elata [TaxId: 91201]
Probab=98.61 E-value=2e-07 Score=62.52 Aligned_cols=88 Identities=23% Similarity=0.408 Sum_probs=47.2
Q ss_pred CEEEEECCCCEEEECCCCCEEEEECCCCCCCCCEEEEEECCCCEEEEECCCCCCCCEEEEECCCCCCCCCCCCCCCCCCC
Q ss_conf 13999308729999289928998346567677518999036587997088999873055433788874346784233223
Q 004521 32 GFLMINKTGNLVLTSQSNIVVWSAYLSKEVQTPVVLQLLDSGNLVLRDEHDGDSETYFWQSFDYPSDTLLPGMKLGWDLK 111 (747)
Q Consensus 32 ~~l~~~~~G~Lvl~~~~~~~vWs~~~~~~~~~~~~~~l~d~GNlVl~~~~~~~~~~~~WqSFd~PtDtlLpgq~l~~~~~ 111 (747)
-.|.+..||||||.+ .+.+||++++... ...+.+.|..+|||||++. +..+|.|
T Consensus 21 ~~l~~q~DGNLvly~-~~~~vW~s~~~~~-~~~~~l~l~~dGnLvl~~~-----~~~~w~s------------------- 74 (112)
T d1xd5a_ 21 YLFIIQNDCNLVLYD-NNRAVWASGTNGK-ASGCVLKMQNDGNLVIYSG-----SRAIWAS------------------- 74 (112)
T ss_dssp EEEEECTTSCEEEEE-TTEEEEECCCTTS-CSSEEEEECTTSCEEEEET-----TEEEEEC-------------------
T ss_pred EEEEECCCCCEEEEC-CCCEEEECCCCCC-CCCCEEEEECCCCEEEEEC-----CCEEEEE-------------------
T ss_conf 999981799889873-9838998467347-8885799961534999934-----8749998-------------------
Q ss_pred CCCCCEEEECCCCCCCCCCCEEEEEECCCCCEEEEEECCEEEEECCC
Q ss_conf 46542277526799999962199872189962999818843896289
Q 004521 112 TGLERRVTSWKSFDDPSPGDFIWAIERQDNPEVVMWKGSRKFYRTGP 158 (747)
Q Consensus 112 ~~~~~~l~s~~s~~dps~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 158 (747)
...-..+.+++.|+.+|++.++ -....+.|.++.
T Consensus 75 ------------~t~~~~~~~~l~L~ddGNlvly-~~~~~~~W~S~t 108 (112)
T d1xd5a_ 75 ------------NTNRQNGNYYLILQRDRNVVIY-DNSNNAIWATHT 108 (112)
T ss_dssp ------------CCCCSCCCCEEEECTTSCEEEE-CTTSCEEEECCC
T ss_pred ------------EECCCCCCEEEEECCCCCEEEE-CCCCCEEECCCC
T ss_conf ------------3036887259999678999999-899967961888
|
| >d1dlpa1 b.78.1.1 (A:1-115) Fetuin-binding protein Scafet precursor {Bluebell (Scilla campanulata) [TaxId: 81759]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Fetuin-binding protein Scafet precursor species: Bluebell (Scilla campanulata) [TaxId: 81759]
Probab=98.60 E-value=1.1e-08 Score=70.77 Aligned_cols=69 Identities=20% Similarity=0.283 Sum_probs=45.0
Q ss_pred CCEEEECCCCCCCCCCCCEEEEECCCCEEEECCCCCEEEEECCCCCCCCCEEEEEECCCCEEEEECCCCCCCCEEEEECC
Q ss_conf 94699757999988995139993087299992899289983465676775189990365879970889998730554337
Q 004521 15 HEVVWVANRLNPINDSFGFLMINKTGNLVLTSQSNIVVWSAYLSKEVQTPVVLQLLDSGNLVLRDEHDGDSETYFWQSFD 94 (747)
Q Consensus 15 ~t~VW~Anr~~p~~~~~~~l~~~~~G~Lvl~~~~~~~vWs~~~~~~~~~~~~~~l~d~GNlVl~~~~~~~~~~~~WqSFd 94 (747)
..+||.+|...+ ..+++.|..+|+|||.|..+.+||++.+... ....+++|+++|||||++. .+|+|-.
T Consensus 44 ~~~vW~s~t~~~---~~~~l~l~~dGNLvl~d~~~~~vWsS~t~~~-~g~y~l~Lq~DGNlvlY~~-------~~Wssgt 112 (115)
T d1dlpa1 44 DVRVWASNTAGA---TGCRAVLQSDGLLVILTAQNTIRWSSGTKGS-IGNYVLVLQPDRTVTIYGP-------GLWDSGT 112 (115)
T ss_dssp SSEEECCCCCSC---SCCBCCBCSSSCBCCBCTTTCCSCCCCCCCC-SSCCEEEECSSSCEEEECS-------EEEECSC
T ss_pred CEEEEECCCCCC---CCEEEEEECCCCEEEECCCCCEEEECCCCCC-CCCEEEEECCCCCEEEECC-------CEECCCC
T ss_conf 906897116899---7568999446789999058978998188899-9978999989986999689-------7643889
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=98.37 E-value=2.9e-06 Score=54.91 Aligned_cols=132 Identities=18% Similarity=0.154 Sum_probs=84.7
Q ss_pred CEECCCCC-EEEEEEEECCCCEEEEEEECCCCCCCHHHHHHHHHHHHCCC--CCCEEEEEEEEEECCEEEEEEECCCCCC
Q ss_conf 42142498-00999996698499999913433106899999999983059--9732337748994982279995079999
Q 004521 446 NKLGEGGF-GPVYKGTLVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQ--HRNLVKLLGCCIQGEEKLLIYEFMPNKS 522 (747)
Q Consensus 446 ~~lg~G~~-g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~--H~nIv~l~g~~~~~~~~~lV~e~~~~gs 522 (747)
+.+..|.. ..||+....++..+++|....... ..+..|...+..+. ...+.+++++..+.+..++||+++++.+
T Consensus 16 ~~~~~G~s~~~v~r~~~~~~~~~vlK~~~~~~~---~~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v~~~i~G~~ 92 (255)
T d1nd4a_ 16 AQQTIGCSDAAVFRLSAQGRPVLFVKTDLSGAL---NELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQD 92 (255)
T ss_dssp EECSCTTSSCEEEEEECTTSCCEEEEEECSCTT---SCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEE
T ss_pred EECCCCCCCCEEEEEEECCCCEEEEEECCCCCH---HHHHHHHHHHHHHHHCCCCCCCEEEECCCCCCEEEEEEEEECCC
T ss_conf 876786547758999938987899995896677---68999999999998659998861322245661599987441355
Q ss_pred HHHHHHHCCCCCCCCHHHHHHHHHHHHHHHHHHHH---------------------------------------------
Q ss_conf 44676312898767856789999999999998341---------------------------------------------
Q 004521 523 LDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQ--------------------------------------------- 557 (747)
Q Consensus 523 L~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~--------------------------------------------- 557 (747)
+.+.. .. ...++.+++..|.-||.
T Consensus 93 ~~~~~--------~~---~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 161 (255)
T d1nd4a_ 93 LLSSH--------LA---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAEL 161 (255)
T ss_dssp TTTSC--------CC---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHHH
T ss_pred CCCCC--------CC---HHHHHHHHHHHHHHHCCCCHHHCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCHHHHHHHHHH
T ss_conf 43221--------26---89999999999998736885448875541246889999998754110113401121379999
Q ss_pred ----------CCCCCEEECCCCCCCEEECCCCCCEEECCCCCCC
Q ss_conf ----------5999467326676837985899944712567500
Q 004521 558 ----------DSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRT 591 (747)
Q Consensus 558 ----------~~~~~iiH~Dikp~NIll~~~~~~ki~DfGla~~ 591 (747)
.....++|+|+.|.|||++.+..+-|+||+.+..
T Consensus 162 ~~~l~~~~~~~~~~~liHgD~~~~Nvl~~~~~~~~iID~~~~~~ 205 (255)
T d1nd4a_ 162 FARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLGV 205 (255)
T ss_dssp HHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCEE
T ss_pred HHHHHHHCCCCCCCEEEECCCCCCCEEEECCCEEEEEECHHCCC
T ss_conf 99998718765795678678887635773796589998533265
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=98.08 E-value=8e-05 Score=45.59 Aligned_cols=77 Identities=10% Similarity=0.172 Sum_probs=50.6
Q ss_pred CCEECCCCCEEEEEEEECC-CCEEEEEEECCC---C----CCCHHHHHHHHHHHHCCC-C--CCEEEEEEEEEECCEEEE
Q ss_conf 5421424980099999669-849999991343---3----106899999999983059-9--732337748994982279
Q 004521 445 NNKLGEGGFGPVYKGTLVD-GQEIAVKRLSKI---S----EQGLKELKNEVILFSKLQ-H--RNLVKLLGCCIQGEEKLL 513 (747)
Q Consensus 445 ~~~lg~G~~g~Vy~~~~~~-g~~vavK~l~~~---~----~~~~~~~~~E~~~l~~l~-H--~nIv~l~g~~~~~~~~~l 513 (747)
.+.||.|....||+....+ ++.++||.-... . .........|...+..+. + ..+.+++.+ +....++
T Consensus 31 ~~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~--d~~~~~l 108 (392)
T d2pula1 31 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVT 108 (392)
T ss_dssp EEECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEE
T ss_pred EEEECCCCEEEEEEEEECCCCEEEEEECCCCHHCCCCCCCCCCHHHHHHHHHHHHHHHHHCCCCCCEEEEE--CCCCCEE
T ss_conf 99807985276899995799848999617713034677788877899999999998650579885528998--5988779
Q ss_pred EEECCCCCCH
Q ss_conf 9950799994
Q 004521 514 IYEFMPNKSL 523 (747)
Q Consensus 514 V~e~~~~gsL 523 (747)
|||++++..+
T Consensus 109 vmE~L~~~~~ 118 (392)
T d2pula1 109 VMEDLSHLKI 118 (392)
T ss_dssp EECCCTTSEE
T ss_pred EEECCCCCCC
T ss_conf 8713577653
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=97.57 E-value=0.00037 Score=41.27 Aligned_cols=135 Identities=13% Similarity=0.106 Sum_probs=68.1
Q ss_pred EEEEEEEECCCCEEEEEEECCCCCCCHHHHHHHHHHHHCCCCCCE--EEEE-----EEEEECCEEEEEEECCCCCCHHH-
Q ss_conf 009999966984999999134331068999999999830599732--3377-----48994982279995079999446-
Q 004521 454 GPVYKGTLVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNL--VKLL-----GCCIQGEEKLLIYEFMPNKSLDS- 525 (747)
Q Consensus 454 g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~nI--v~l~-----g~~~~~~~~~lV~e~~~~gsL~~- 525 (747)
-.||++...+|..+++|.-+.. .....++..|...+..|....+ +..+ ......+..+.++++++|..+..
T Consensus 36 N~vy~v~~~dg~~~VlK~~rp~-~~s~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G~~~~~~ 114 (325)
T d1zyla1 36 NRVYQFQDEDRRRFVVKFYRPE-RWTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGGRQFEAD 114 (325)
T ss_dssp SEEEEECCTTCCCEEEEEECTT-TSCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCCEECCSS
T ss_pred CEEEEEECCCCCEEEEEEECCC-CCCHHHHHHHHHHHHHHHHCCCCCCCCEECCCCEEEEEEEEEEEEEEECCCCCCCCC
T ss_conf 0269998389997999984787-788999999999999998559987875206898056653479999865277688999
Q ss_pred ---HH----------HH------CCCCCC-------------------CCHH---HHHHHHHHHHHHHHHH-HHCCCCCE
Q ss_conf ---76----------31------289876-------------------7856---7899999999999983-41599946
Q 004521 526 ---FI----------FD------QTRRTL-------------------LDWS---QRFHIICGTARGLLYL-HQDSRLRI 563 (747)
Q Consensus 526 ---~l----------~~------~~~~~~-------------------l~~~---~~~~i~~~ia~gL~yL-H~~~~~~i 563 (747)
.+ +. ...+.. ++.. .....+..+...+.-+ ....+..+
T Consensus 115 ~~~~~~~lG~~LA~lH~~~~~~~~~~r~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~~~~~~~p~~l 194 (325)
T d1zyla1 115 NIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAHWREDFTVLR 194 (325)
T ss_dssp CHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHHCCSCSCCEE
T ss_pred CHHHHHHHHHHHHHHHHHCCCCCCCCCCCCCHHHHHHHHHHHHHHCCCCCHHHHHHHHHHHHHHHHHHHHHCCCCCCCEE
T ss_conf 99999998999999886303578655677897887665689998747699889899999999999999984545687120
Q ss_pred EECCCCCCCEEECCCCCCEEECCCCCCC
Q ss_conf 7326676837985899944712567500
Q 004521 564 IHRDLKASNVLLDQDMNPKISDFGLVRT 591 (747)
Q Consensus 564 iH~Dikp~NIll~~~~~~ki~DfGla~~ 591 (747)
||+|+.+.|||++.+ ..++||+.+..
T Consensus 195 iHgDlh~~NvL~~~~--~~~IDFdd~~~ 220 (325)
T d1zyla1 195 LHGDCHAGNILWRDG--PMFVDLDDARN 220 (325)
T ss_dssp CCSSCSGGGEEESSS--EEECCCTTCCE
T ss_pred ECCCCCCCCEEEECC--CEEEECHHCCC
T ss_conf 247888042878389--35886520146
|
| >d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Choline kinase domain: Choline kinase species: Caenorhabditis elegans [TaxId: 6239]
Probab=97.27 E-value=0.0025 Score=35.85 Aligned_cols=73 Identities=16% Similarity=0.228 Sum_probs=43.8
Q ss_pred CCEECCCCCEEEEEEEECCC--------CEEEEEEECCCCCCCHHHHHHHHHHHHCCC-CCCEEEEEEEEEECCEEEEEE
Q ss_conf 54214249800999996698--------499999913433106899999999983059-973233774899498227999
Q 004521 445 NNKLGEGGFGPVYKGTLVDG--------QEIAVKRLSKISEQGLKELKNEVILFSKLQ-HRNLVKLLGCCIQGEEKLLIY 515 (747)
Q Consensus 445 ~~~lg~G~~g~Vy~~~~~~g--------~~vavK~l~~~~~~~~~~~~~E~~~l~~l~-H~nIv~l~g~~~~~~~~~lV~ 515 (747)
.+.|..|-.-.+|+....++ +.|.++..-. ........+|..+++.+. +.-..++++++. -.+|+
T Consensus 47 v~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g~--~~~~idr~~E~~i~~~ls~~gl~Pkll~~~~----~g~I~ 120 (395)
T d1nw1a_ 47 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFN--PETESHLVAESVIFTLLSERHLGPKLYGIFS----GGRLE 120 (395)
T ss_dssp EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECS--CCCHHHHHHHHHHHHHHHHTTSSSCEEEEET----TEEEE
T ss_pred EEECCCCCCCCEEEEEECCCCCCCCCCCCCEEEEECCC--CCHHHHHHHHHHHHHHHHHCCCCCEEEEECC----CCEEE
T ss_conf 99917853343489996887754457898179996599--6116589999999999975799980899818----95699
Q ss_pred ECCCCCCH
Q ss_conf 50799994
Q 004521 516 EFMPNKSL 523 (747)
Q Consensus 516 e~~~~gsL 523 (747)
||+++..|
T Consensus 121 efi~g~~l 128 (395)
T d1nw1a_ 121 EYIPSRPL 128 (395)
T ss_dssp CCCCEEEC
T ss_pred EEECCCCC
T ss_conf 97345548
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=96.15 E-value=0.029 Score=29.00 Aligned_cols=49 Identities=22% Similarity=0.159 Sum_probs=36.6
Q ss_pred CCCEEECCCCCCCEEECCCCCCEEECCCCCCCCCCCCCCCCCCEEEECCCCCCCCCCCCHHHHHHHHHHHHC
Q ss_conf 994673266768379858999447125675003899875444402102378888446402378999998819
Q 004521 560 RLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNTNRVVGTYDGQFSIKSDVFSFGILLLEIVSG 631 (747)
Q Consensus 560 ~~~iiH~Dikp~NIll~~~~~~ki~DfGla~~~~~~~~~~~~~~~~~~~~~~~s~~sDVwSlGvil~elltg 631 (747)
+.++||+|+.+.||+++.+...-|.||+.+..- -=+|-+++++..++..
T Consensus 182 ~~giIHgDl~~dNvl~~~~~v~gvIDF~~~~~~-----------------------~~~~DLAi~~~~~~~~ 230 (316)
T d2ppqa1 182 PAGVIHADLFQDNVFFLGDELSGLIDFYFACND-----------------------LLAYDVSICLNAWCFE 230 (316)
T ss_dssp CEEEECSCCCGGGEEEETTEEEEECCCTTCEEE-----------------------EHHHHHHHHHHHHSBC
T ss_pred CCCCCCCCCCHHHHHCCCCCCEEEECCCCCCCC-----------------------HHHHHHHHHHHHHHHC
T ss_conf 450333786365640204541267422212364-----------------------0251189988877603
|